Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AADAT "KAT2, KATII, KYAT2" ENSG00000109576 "Aminoadipate aminotransferase" Q8N5Z0 4 170060222-170091699 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 67.1" "Cell type enhanced" "Detected in many" "Astrocytes: 22.2;Extravillous trophoblasts: 71.3;Hepatocytes: 29.3;Spermatogonia: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA037502 Enhanced Approved "Vesicles,Plasma membrane" NA NA "Cluster 85: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Plasma membrane" Vesicles "HPA037502: AB_10671759" "unprognostic (1.90e-1)" "unprognostic (1.82e-2)" "prognostic favorable (5.59e-4)" "unprognostic (4.21e-2)" "unprognostic (1.30e-1)" "unprognostic (1.06e-1)" "unprognostic (7.41e-2)" "unprognostic (1.03e-2)" "unprognostic (2.97e-2)" "unprognostic (3.38e-2)" "unprognostic (1.23e-2)" "unprognostic (3.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-3)" "unprognostic (1.17e-2)" 3.3 2.8 6.2 1.9 6.8 0.3 4.7 3.8 9.8 9.8 11.3 6.2 1.6 10.5 5.9 2.6 6.3 3.9 2.7 6.5 6.7 6.8 67.1 4.9 0.7 5.8 5.6 4.7 5.6 6.0 6.1 1.9 6.5 14.4 5.0 11.8 1.7 5.3 4.0 1.4 2.3 7.3 4.8 1.7 3.6 8.2 6.1 1.5 7.5 2.4 0.8 6.4 5.7 8.7 3.5 8.5 25.0 0.0 4.9 18.9 9.0 8.7 4.2 4.9 5.0 8.4 1.0 0.1 1.4 9.8 6.5 2.9 11.3 4.1 3.4 0.0 9.7 0.0 10.0 14.0 3.9 0.1 3.8 7.7 2.5 4.0 5.1 13.5 4.7 11.4 1.5 0.1 19.0 8.9 4.3 0.1 19.0 9.6 7.6 0.0 7.8 0.0 4.4 15.3 20.1 23.5 7.0 1.7 8.5 8.0 0.1 1.7 3.2 12.5 13.4 14.3 13.9 0.1 0.0 0.1 12.5 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 6.8 3.8 9.8 6.5 6.7 5.8 5.6 6.5 4.8 6.1 8.7 0.9 0.0 5.9 22.2 0.3 0.9 2.8 0.9 6.2 6.0 3.9 1.0 1.2 1.5 2.1 0.0 2.1 2.8 0.0 0.7 0.0 1.6 0.5 3.7 7.4 0.7 6.7 0.0 15.4 2.2 71.3 3.2 3.1 6.0 0.0 6.2 0.7 29.3 1.6 0.0 13.6 2.8 0.0 0.3 0.9 1.4 1.2 0.4 1.8 5.6 0.0 2.7 0.0 17.6 14.0 1.1 1.6 2.2 0.0 4.0 0.2 8.4 8.5 9.1 6.6 3.9 4.2 14.5 27.1 3.0 0.4 5.6 0.3 3.3 3.1 1.8 ABCA1 "ABC1, HDLDT1, TGD" ENSG00000165029 "ATP binding cassette subfamily A member 1" O95477 9 104781006-104928155 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Translocase "Atherosclerosis, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 105.8;Hepatocytes: 175.5;Kupffer cells: 169.1;Langerhans cells: 109.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 13.1;neutrophil: 10.6" "Lineage enriched" "Detected in many" 8 "granulocytes: 13.1" "Cell line enhanced" "Detected in many" "HSkMC: 34.1;U-87 MG: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057283, CAB069889" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 15: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Vesicles" "CAB069889: AB_10002789, HPA057283: AB_2683396" "unprognostic (1.58e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (2.80e-1)" "unprognostic (7.47e-3)" "unprognostic (1.85e-1)" "unprognostic (9.22e-2)" "unprognostic (9.80e-2)" "unprognostic (2.04e-1)" "unprognostic (7.28e-3)" "unprognostic (2.14e-1)" "unprognostic (4.78e-2)" "unprognostic (1.04e-2)" "unprognostic (2.00e-3)" "unprognostic (2.51e-2)" "unprognostic (6.71e-2)" "unprognostic (2.57e-1)" 24.7 36.5 12.0 11.0 29.1 20.7 13.3 14.4 12.5 7.4 4.1 16.3 4.5 5.6 8.2 4.9 8.0 15.0 4.6 10.4 13.7 7.2 38.7 12.3 8.9 19.5 26.2 8.9 4.0 1.8 2.5 22.7 19.0 4.1 9.9 3.7 5.7 5.0 10.9 13.4 8.1 7.6 16.4 7.1 6.7 3.6 27.3 11.0 5.1 3.4 5.4 19.7 7.6 20.7 0.0 5.6 4.6 0.0 13.1 4.9 4.1 5.9 22.6 1.9 2.1 0.8 0.8 8.2 6.4 5.9 21.7 0.0 2.5 0.3 1.7 0.0 0.0 0.9 1.9 20.3 23.5 0.0 13.8 34.1 1.5 22.7 0.4 21.6 2.2 0.7 0.0 20.2 0.5 0.8 5.2 11.1 6.5 1.2 1.7 0.1 0.0 0.4 3.7 3.9 0.7 0.2 6.2 1.0 1.2 8.7 0.1 4.1 2.1 6.0 0.4 8.0 6.5 7.9 4.0 4.8 79.0 0.0 0.1 2.4 0.8 13.1 0.1 1.0 0.2 1.2 0.3 0.0 0.2 1.5 0.6 0.0 10.6 0.1 1.7 0.1 0.1 0.2 12.0 29.1 14.4 12.5 10.4 13.7 19.5 26.2 19.0 16.4 27.3 20.7 35.8 105.8 9.3 71.5 21.1 29.7 5.9 6.3 61.5 18.4 4.6 7.0 8.9 22.8 11.7 11.0 47.9 31.1 2.4 8.4 0.0 4.5 1.9 17.1 76.0 18.7 9.1 1.3 8.1 1.5 6.9 44.0 14.3 29.4 46.9 3.6 31.4 175.5 75.0 0.0 22.5 2.2 8.2 169.1 109.5 2.5 31.1 74.8 26.6 38.4 6.4 0.5 0.0 57.8 7.7 4.9 5.0 28.2 2.2 2.6 0.1 18.0 8.4 6.7 46.0 24.3 23.4 1.0 1.8 17.1 19.5 8.9 6.5 39.5 3.2 13.3 ABCG1 ABC8 ENSG00000160179 "ATP binding cassette subfamily G member 1" P45844 21 42199689-42297244 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 35.5;neutrophil: 36.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 36.6" "Cell line enhanced" "Detected in many" "hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031470, HPA031471" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "HPA031470: AB_10599188, HPA031471: AB_10600201" "unprognostic (2.89e-2)" "unprognostic (2.53e-2)" "unprognostic (9.96e-2)" "unprognostic (4.20e-3)" "unprognostic (2.87e-1)" "unprognostic (3.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (3.66e-3)" "unprognostic (6.37e-2)" "prognostic favorable (7.16e-6)" "unprognostic (1.40e-2)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.42e-2)" 17.2 37.7 18.3 12.1 25.5 8.1 15.2 14.4 20.2 8.1 20.0 14.1 17.5 4.9 3.9 4.1 6.3 13.8 10.5 15.5 17.0 10.2 6.3 29.4 18.1 12.0 19.9 6.3 5.3 24.4 10.7 13.7 13.3 6.2 15.0 29.1 16.1 7.0 19.6 16.8 22.0 4.0 12.2 31.2 15.9 1.1 20.3 18.9 8.5 6.2 12.1 12.9 5.0 24.7 0.0 6.0 4.6 2.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 3.1 1.9 0.8 0.0 0.7 0.9 0.0 8.8 0.0 8.5 0.5 10.2 19.2 0.0 17.4 0.0 0.4 2.0 25.5 0.1 3.9 0.0 18.2 38.4 0.0 0.1 0.0 33.2 31.5 0.2 1.4 54.9 10.3 0.4 0.0 25.8 0.0 2.8 22.3 5.8 3.7 13.5 0.0 0.4 5.7 0.9 11.8 0.0 4.7 0.1 0.0 13.1 4.2 0.0 0.1 3.3 0.5 1.7 1.7 35.5 3.0 0.5 5.6 5.5 6.1 6.0 1.1 7.0 5.8 5.0 36.6 7.4 0.3 2.5 7.4 2.1 18.3 25.5 14.4 20.2 15.5 17.0 12.0 19.9 13.3 12.2 20.3 24.7 38.2 6.4 8.2 0.3 21.3 8.9 6.9 3.2 5.7 48.4 4.1 6.9 9.5 4.3 5.9 25.8 50.1 7.0 7.0 33.4 3.9 2.6 4.5 21.6 6.3 33.8 3.5 5.7 13.2 1.2 1.8 7.5 11.2 45.3 0.0 1.2 42.8 0.6 16.0 11.8 17.8 12.1 8.2 44.5 23.4 7.6 0.3 20.9 3.6 7.5 4.3 16.1 3.1 43.2 40.6 2.3 8.3 1.9 4.0 3.0 36.6 1.1 4.5 122.6 6.6 1.6 3.5 0.6 0.5 1.0 6.7 63.1 21.4 10.4 1.1 9.1 ABHD17A "C19orf27, FAM108A1, MGC5244" ENSG00000129968 "Abhydrolase domain containing 17A, depalmitoylase" Q96GS6 19 1876810-1885496 "Enzymes, Predicted intracellular proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 338.2;NK-cells: 383.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 90.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043270, HPA047226, HPA069225" Uncertain Approved "Nuclear speckles,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Nuclear speckles" "HPA043270: AB_2678401, HPA047226: AB_2679991, HPA069225: " "unprognostic (3.77e-2)" "unprognostic (1.85e-1)" "unprognostic (3.57e-2)" "prognostic favorable (1.73e-4)" "unprognostic (3.70e-2)" "prognostic favorable (6.46e-4)" "unprognostic (1.69e-2)" "unprognostic (1.92e-2)" "unprognostic (5.09e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.76e-5)" "unprognostic (1.29e-2)" "unprognostic (1.85e-3)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (3.17e-1)" "unprognostic (1.60e-2)" 49.8 51.5 61.3 8.8 50.0 13.4 44.1 53.0 104.9 43.9 16.0 50.3 13.6 46.5 2.1 63.6 42.3 4.1 79.9 70.8 36.6 47.3 42.9 52.7 10.7 66.9 54.2 41.7 42.9 7.5 45.1 11.6 60.6 52.5 2.0 1.9 40.4 8.2 56.9 73.3 41.8 3.2 56.3 69.3 45.4 33.4 61.4 8.6 43.0 10.7 3.9 45.3 45.9 56.9 43.0 14.7 6.0 16.7 7.8 9.6 32.5 28.6 8.8 8.4 7.7 7.4 7.5 21.1 11.3 8.3 1.9 26.9 3.0 11.8 1.2 48.9 61.8 15.9 6.7 19.2 10.7 16.4 50.9 10.5 8.8 4.9 3.4 5.5 16.2 20.6 27.6 23.9 6.1 24.1 28.3 31.0 31.2 8.3 32.3 32.8 14.3 32.0 5.9 9.4 19.4 43.9 14.8 16.0 29.8 2.4 16.6 28.3 31.3 9.4 21.4 38.1 28.3 90.8 58.8 18.2 20.6 21.0 15.5 1.6 1.0 4.2 5.2 0.6 3.8 3.7 2.3 3.5 1.0 1.4 2.5 2.7 1.1 3.1 0.6 1.0 2.4 0.9 61.3 50.0 53.0 104.9 70.8 36.6 66.9 54.2 60.6 56.3 61.4 56.9 125.3 3.2 5.8 13.4 35.6 32.2 21.5 10.4 12.5 41.2 43.9 35.6 4.0 24.3 12.1 14.7 39.6 77.8 338.2 61.8 9.8 31.0 6.4 28.4 43.7 67.6 30.5 22.3 12.8 37.8 43.2 29.8 29.6 37.8 10.2 31.6 65.0 21.5 66.3 55.5 12.5 34.9 12.2 36.1 28.7 6.4 30.1 42.8 26.6 19.7 35.0 66.0 383.1 5.0 63.1 42.7 31.9 36.5 58.7 25.9 38.6 19.5 7.5 35.5 13.1 31.0 44.1 16.3 20.7 21.2 45.9 65.7 117.1 66.1 34.0 32.3 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6, acylglycerol lipase" Q9BV23 3 58237532-58295693 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 60.6;Oligodendrocytes: 88.6;Proximal enterocytes: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 45: Intestine - Brush border" "Cluster 3: HMC-1 - Innate immune response" "Cluster 2: Hepatocytes - Metabolism" Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: AB_2686583" "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favorable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 12.2 12.9 24.0 6.4 33.9 0.9 8.9 34.1 32.4 4.4 19.4 12.7 39.5 6.1 14.7 6.4 9.1 5.8 5.7 31.6 26.9 35.6 64.9 8.5 8.0 31.7 32.3 5.0 2.7 8.9 16.6 6.4 31.7 5.5 11.1 9.2 4.0 14.3 4.6 25.5 52.3 9.2 28.8 35.0 12.9 3.9 35.5 5.5 9.1 5.4 7.6 5.8 5.9 49.8 3.5 12.0 1.8 8.5 23.2 4.2 21.2 8.9 8.1 9.2 12.5 6.9 4.8 6.6 0.8 4.7 28.5 9.9 8.3 3.9 8.4 11.3 4.2 5.7 8.1 9.7 7.8 1.7 28.1 3.9 18.4 8.8 3.8 10.6 5.0 10.6 6.8 15.0 7.2 2.6 11.7 0.7 6.1 28.5 27.3 4.2 3.8 14.8 14.5 4.8 10.8 4.4 9.9 5.1 19.0 3.7 3.6 4.5 5.8 6.6 7.0 16.6 10.8 4.2 13.5 0.3 17.1 16.9 9.3 0.0 2.2 1.7 1.6 7.4 1.5 3.6 0.9 1.9 3.7 2.5 0.9 1.1 0.0 0.7 5.2 5.4 1.2 1.0 24.0 33.9 34.1 32.4 31.6 26.9 31.7 32.3 31.7 28.8 35.5 49.8 27.1 0.0 1.8 11.4 13.6 8.7 3.0 2.7 6.2 13.3 2.1 1.5 5.6 5.7 4.9 3.7 4.2 2.0 7.7 11.2 1.9 3.0 1.0 9.8 7.9 14.1 0.0 5.7 33.6 1.9 0.9 2.9 7.7 1.5 11.4 10.1 21.4 60.6 8.9 15.2 34.3 4.0 0.0 16.7 20.0 0.7 6.8 12.1 3.6 11.2 11.5 11.2 6.2 37.7 88.6 1.9 1.4 8.2 2.0 1.8 55.1 17.4 13.8 3.3 0.0 2.9 3.9 0.5 2.2 6.9 24.6 0.5 5.1 16.0 5.8 2.0 ABL2 "ABLL, ARG" ENSG00000143322 "ABL proto-oncogene 2, non-receptor tyrosine kinase" P42684 1 179099330-179229684 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 166.8;Langerhans cells: 188.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "hTERT-HME1: 73.5;TIME: 70.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001866, CAB017106, HPA072754" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 41: Macrophages - Immune response" Nucleoplasm Vesicles "CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212" "unprognostic (3.05e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.07e-1)" "unprognostic (4.71e-2)" "unprognostic (9.45e-2)" "unprognostic (8.23e-3)" "unprognostic (1.91e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-1)" "unprognostic (6.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.73e-1)" "prognostic unfavorable (1.78e-7)" "unprognostic (4.76e-2)" "unprognostic (4.14e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (8.40e-4)" 9.3 3.2 5.9 4.9 6.7 2.7 5.7 6.1 6.1 5.4 2.0 4.6 2.8 3.7 2.7 2.5 3.2 11.8 3.9 7.4 5.0 3.6 2.7 6.5 2.7 3.8 4.4 3.5 5.7 4.2 3.8 4.1 3.9 3.5 3.3 9.2 3.5 2.6 3.1 4.2 3.2 4.5 3.0 2.7 3.7 4.4 5.6 4.1 3.8 4.2 2.5 6.4 4.0 4.8 24.2 13.1 8.7 5.8 7.3 16.8 5.3 26.3 21.6 31.9 23.1 9.9 7.2 13.7 18.9 19.2 21.7 11.0 12.6 9.1 44.6 8.5 11.4 6.7 12.4 4.9 13.3 7.5 2.1 15.6 11.6 45.3 73.5 13.9 36.2 7.0 16.1 3.8 42.6 6.5 5.9 4.0 8.3 5.0 4.3 8.6 14.4 6.5 10.8 4.0 5.2 11.9 22.0 7.0 53.8 13.2 6.2 6.4 70.7 33.3 24.5 15.7 42.8 7.0 9.3 14.1 15.6 4.0 32.4 1.4 0.3 0.0 0.5 0.1 0.2 0.5 0.3 0.3 0.2 0.7 0.4 0.5 0.6 0.5 0.1 0.5 0.2 0.1 5.9 6.7 6.1 6.1 7.4 5.0 3.8 4.4 3.9 3.0 5.6 4.8 33.5 22.4 24.0 44.1 14.4 46.9 43.6 16.3 12.5 40.0 18.7 9.5 8.9 22.8 10.8 11.0 166.8 9.3 7.7 15.5 11.7 14.3 15.6 12.3 23.4 67.2 27.0 9.9 81.6 13.9 8.2 67.6 10.2 21.5 17.1 19.5 31.1 15.3 22.9 25.2 62.0 11.0 10.2 34.9 188.1 32.2 15.2 67.7 69.4 45.0 13.9 11.3 8.2 72.4 57.1 45.5 16.0 13.5 10.3 42.6 9.9 9.4 11.0 35.7 6.6 32.3 30.5 17.8 30.5 11.5 38.4 10.4 12.4 11.6 14.9 25.3 ABTB2 "ABTB2A, BTBD22, DKFZP586C1619" ENSG00000166016 "Ankyrin repeat and BTB domain containing 2" Q8N961 11 34150987-34358010 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 126.2;Syncytiotrophoblasts: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "eosinophil: 5.0;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 14 "dendritic cells: 1.6;granulocytes: 5.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020065, HPA030699" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Vesicles "HPA020065: AB_1844459, HPA030699: AB_2673576" "unprognostic (3.00e-1)" "prognostic unfavorable (5.70e-5)" "unprognostic (2.61e-1)" "unprognostic (9.09e-2)" "unprognostic (3.17e-2)" "unprognostic (2.40e-2)" "unprognostic (1.34e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-3)" "unprognostic (2.86e-1)" "prognostic favorable (3.51e-5)" "unprognostic (1.50e-1)" "unprognostic (1.42e-1)" "unprognostic (3.81e-2)" "unprognostic (6.58e-2)" 2.3 13.0 7.9 2.0 12.6 2.5 2.0 18.1 6.7 8.1 1.2 3.4 8.8 6.1 4.4 4.1 4.6 2.1 12.8 5.3 8.5 9.4 11.6 2.9 2.1 24.1 16.3 2.5 2.3 0.5 3.5 3.2 16.7 4.9 2.5 2.6 6.7 4.3 16.9 6.8 7.0 2.5 12.7 0.9 2.5 2.7 15.9 2.4 2.0 7.2 2.0 3.6 5.6 20.3 5.6 16.2 6.4 1.8 1.7 0.1 6.4 3.2 2.5 2.8 5.3 4.0 4.0 0.2 5.3 4.1 16.5 10.5 3.6 3.7 2.3 0.2 8.8 0.1 9.8 17.4 1.0 8.9 1.2 0.9 2.0 5.6 2.4 10.1 0.0 0.7 1.9 0.5 1.8 13.8 0.3 10.7 8.0 8.1 8.8 1.7 3.8 6.3 10.0 13.0 8.1 6.6 8.1 24.6 6.5 4.2 5.3 3.8 0.9 3.1 0.5 9.8 5.8 0.9 0.4 0.1 7.1 2.5 9.7 0.0 0.1 5.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 7.9 12.6 18.1 6.7 5.3 8.5 24.1 16.3 16.7 12.7 15.9 20.3 0.7 0.0 2.3 18.9 1.1 4.7 3.2 1.3 1.2 2.1 3.0 3.3 10.0 2.8 1.1 12.9 0.0 2.7 2.5 12.2 5.9 4.6 1.2 3.4 4.5 0.9 7.2 0.0 4.0 4.5 1.1 5.8 4.6 10.7 1.3 0.3 0.0 6.8 0.8 0.0 8.9 2.3 4.1 0.8 6.1 0.3 1.2 1.2 1.8 6.5 9.3 7.5 0.0 50.3 126.2 10.5 9.1 6.0 2.1 9.3 15.5 2.0 0.3 0.6 0.0 4.3 2.4 0.5 1.1 1.0 4.8 28.3 2.9 0.4 2.9 7.5 AC024598.1 ENSG00000285837 "Novel protein" 10 62374192-62672011 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "gallbladder: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.1;TIME: 2.5" HPA052446 Uncertain Approved Vesicles,Centrosome NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Vesicles, Centrosome" "HPA052446: AB_2681836" 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.7 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.3 0.7 0.1 0.4 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.0" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles Yes No "Cluster 33: Neutrophils - Chromatin organization" "Cluster 85: Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Vesicles" "HPA051772: AB_2681603" "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favorable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favorable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favorable (6.53e-4)" 11.1 17.2 14.4 6.3 14.1 4.1 12.9 13.9 16.6 19.1 13.1 21.2 29.9 14.4 4.0 7.1 22.3 6.6 11.8 13.4 13.9 24.6 93.0 9.6 9.9 14.2 14.0 19.3 20.0 14.5 15.8 4.3 13.4 21.6 5.7 10.3 14.1 12.2 6.8 9.0 25.9 5.7 14.5 16.2 14.7 4.2 14.2 5.4 21.1 5.1 6.4 15.7 13.6 13.2 7.9 15.4 1.9 4.2 3.5 6.4 5.1 2.9 6.1 4.7 9.2 6.0 10.8 8.4 7.4 4.3 2.8 7.3 2.6 4.8 1.9 12.2 5.9 4.2 11.3 12.0 7.5 1.6 11.1 6.4 4.6 1.7 2.4 16.1 4.6 7.7 2.7 13.1 2.3 5.3 6.0 2.1 0.3 8.3 4.2 4.8 0.5 18.8 11.8 5.1 3.1 1.4 2.1 3.1 8.9 1.0 20.1 3.0 1.7 1.2 3.6 1.8 1.8 20.4 5.9 2.6 6.8 2.1 2.0 4.4 2.3 3.5 2.9 2.6 3.2 3.7 3.4 3.2 2.0 5.0 3.7 4.3 0.5 4.0 1.7 1.3 4.3 3.2 14.4 14.1 13.9 16.6 13.4 13.9 14.2 14.0 13.4 14.5 14.2 13.2 5.7 3.2 3.0 12.4 7.8 1.9 5.9 3.9 2.8 16.6 7.4 6.9 9.7 14.3 2.6 3.7 22.9 6.3 5.9 9.6 7.9 7.3 1.4 2.0 2.7 5.3 6.0 2.1 7.2 7.1 1.3 7.3 4.6 3.6 8.2 7.4 5.0 21.8 5.3 11.8 8.5 7.8 6.1 1.9 2.6 5.0 6.8 3.1 3.6 2.8 4.5 14.7 5.2 4.5 1.9 5.6 12.5 7.5 5.2 3.1 56.8 25.6 2.6 16.8 6.6 8.7 7.7 2.5 5.2 3.1 1.8 6.3 6.4 4.4 9.1 2.8 ACBD7 "bA455B2.2, FLJ38219" ENSG00000176244 "Acyl-CoA binding domain containing 7" Q8N6N7 10 15075475-15088776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 37.8;choroid plexus: 17.1" "Cell type enriched" "Detected in some" 5 "Astrocytes: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 28.7;MOLT-4: 29.2;U-698: 21.8" "Region enriched" "Detected in all" 5 "olfactory bulb: 17.6" "Low region specificity" "Detected in all" "HPA043326, HPA062478" Approved Vesicles,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Vesicles, Cytosol" "HPA043326: AB_2678429, HPA062478: AB_2684777" "unprognostic (2.15e-1)" "unprognostic (8.94e-2)" "unprognostic (7.79e-3)" "unprognostic (6.53e-3)" "unprognostic (7.30e-2)" "unprognostic (6.89e-3)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.32e-1)" "unprognostic (6.34e-2)" "unprognostic (3.59e-3)" "unprognostic (3.06e-1)" "unprognostic (2.18e-4)" "unprognostic (9.72e-2)" "unprognostic (2.95e-1)" "unprognostic (2.14e-1)" "unprognostic (6.90e-2)" 0.3 0.3 34.9 0.4 36.0 1.4 4.2 28.8 37.8 0.2 17.1 0.4 0.9 0.3 0.8 0.4 1.9 0.4 0.2 31.6 29.7 0.4 0.4 0.4 0.7 33.7 37.1 0.4 0.4 0.3 0.6 0.3 26.3 0.4 0.4 7.7 2.3 0.5 0.9 1.3 0.5 0.2 27.2 0.4 0.5 3.0 35.1 6.7 1.7 0.0 0.5 0.3 0.1 23.2 3.4 0.8 12.7 7.0 1.0 0.6 1.8 0.8 0.7 1.9 3.0 3.8 4.2 2.9 4.3 2.5 2.6 0.6 6.9 1.8 2.9 6.0 10.2 3.4 1.1 2.3 0.1 0.4 1.3 0.3 0.1 1.0 0.1 3.2 2.9 28.7 2.4 3.6 2.5 10.5 29.2 4.5 6.3 1.0 2.0 16.4 4.3 6.9 1.6 1.0 9.7 6.6 2.7 8.6 1.1 4.7 10.9 0.6 1.6 0.7 6.6 1.3 2.8 10.4 19.1 21.8 2.1 0.5 0.7 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.8 0.3 0.1 0.3 0.1 0.0 34.9 36.0 28.8 37.8 31.6 29.7 33.7 37.1 26.3 27.2 35.1 23.2 0.1 0.0 0.6 28.1 0.1 0.1 0.1 0.0 0.6 0.2 0.5 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.2 0.0 0.0 5.3 2.6 0.1 0.4 1.8 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.1 0.0 1.0 0.0 0.6 0.0 1.5 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.1 1.6 0.8 0.0 0.3 0.3 2.9 0.4 0.5 0.0 0.1 0.2 0.1 0.1 0.1 ACHE YT ENSG00000087085 "Acetylcholinesterase (Cartwright blood group)" P22303 7 100889994-100896974 "Blood group antigen proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter degradation" "Blood group antigen, Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 98.2;skeletal muscle: 163.2;tongue: 48.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 86.2;Erythroid cells: 37.7;Exocrine glandular cells: 39.7;Horizontal cells: 55.5;Paneth cells: 118.3;Proximal enterocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.9;CACO-2: 13.0;K-562: 13.9;Karpas-707: 19.7;U-2 OS: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027098 Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 990000 "Cluster 80: Striated muscle - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA027098: AB_2672111" "unprognostic (2.23e-1)" "unprognostic (9.44e-2)" "unprognostic (2.71e-2)" "unprognostic (5.80e-3)" "prognostic unfavorable (5.27e-4)" "unprognostic (2.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.36e-2)" "unprognostic (2.48e-2)" "unprognostic (8.92e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.88e-5)" "unprognostic (2.95e-1)" "unprognostic (2.59e-2)" "unprognostic (9.28e-2)" "unprognostic (8.38e-2)" 1.4 4.7 20.9 2.2 16.8 7.9 2.0 37.1 32.5 5.0 0.0 7.6 4.9 2.6 0.2 2.3 3.2 1.3 12.5 8.0 98.2 8.8 4.1 4.4 3.5 66.1 54.2 4.6 4.3 4.7 8.3 0.7 72.7 8.1 1.8 5.7 7.1 1.6 163.2 1.3 9.1 0.5 26.2 3.5 2.4 3.9 58.1 3.6 2.3 48.0 1.5 1.4 3.7 10.5 0.0 0.2 0.2 0.2 0.3 0.0 7.9 0.3 0.0 0.1 0.2 13.0 0.1 0.0 0.6 0.0 1.2 0.6 2.0 0.1 0.0 4.6 0.5 0.2 0.1 0.2 0.1 0.0 0.4 0.5 0.1 0.1 0.0 0.0 0.0 0.1 13.9 19.7 0.1 4.3 0.0 0.2 1.1 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.8 1.5 0.1 0.8 0.0 2.9 0.0 0.0 0.2 0.5 6.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 16.8 37.1 32.5 8.0 98.2 66.1 54.2 72.7 26.2 58.1 10.5 0.5 0.0 0.0 3.3 0.5 0.8 20.9 0.9 6.2 13.5 2.9 1.1 6.4 5.7 0.4 0.0 0.0 8.2 0.9 86.2 0.0 10.5 0.0 0.5 1.5 2.1 3.5 37.7 4.7 39.7 2.6 3.0 1.5 2.4 0.0 7.4 2.2 0.4 0.8 55.5 9.7 12.0 0.0 0.3 6.6 0.4 0.6 1.7 1.8 1.0 4.6 11.4 0.0 8.5 0.8 20.1 118.3 0.7 1.8 20.4 45.6 1.1 0.1 6.8 0.0 13.5 4.9 4.1 8.0 1.7 1.0 7.1 0.6 1.4 4.6 15.2 ACKR3 "CMKOR1, CXCR7, GPR159, RDC1" ENSG00000144476 "Atypical chemokine receptor 3" P25106 2 236567787-236582354 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 39.6;Endothelial cells: 59.8;Fibroblasts: 171.2;Smooth muscle cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "NK-cells: 4.7;T-cells: 3.8" "Cell line enhanced" "Detected in many" "HeLa: 103.7;MCF7: 80.0;RT4: 312.3;SiHa: 97.0;U-2197: 328.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032003, HPA049718" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "HPA032003: AB_2674107, HPA049718: AB_2680859" "unprognostic (1.65e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.50e-1)" "unprognostic (1.92e-3)" "unprognostic (2.10e-1)" "unprognostic (1.23e-1)" "unprognostic (7.34e-3)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (9.70e-3)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.76e-6)" "prognostic unfavorable (2.01e-4)" "unprognostic (9.71e-2)" "unprognostic (8.57e-3)" "prognostic unfavorable (2.93e-4)" 116.2 5.2 13.0 14.3 13.5 3.5 70.4 13.1 15.6 29.2 18.3 38.7 11.8 17.3 10.5 25.0 33.7 30.8 68.5 13.7 18.9 11.3 28.3 26.3 10.5 22.3 16.0 15.9 37.9 5.0 24.4 123.3 14.4 20.1 24.7 1.7 21.4 16.8 35.4 38.1 34.1 24.2 14.3 56.0 27.9 14.6 14.5 6.4 58.1 37.9 5.6 107.0 38.2 13.6 0.0 0.1 6.3 0.0 10.5 0.2 44.9 2.6 1.4 2.3 4.6 0.5 0.1 0.0 5.1 0.2 16.9 68.0 0.2 24.0 0.4 0.1 0.0 0.1 103.7 0.2 0.1 0.2 0.1 3.2 61.0 0.3 0.0 15.4 11.2 0.3 1.2 0.1 0.0 80.0 0.2 0.2 11.0 0.0 0.7 0.1 7.6 0.8 0.0 312.3 0.4 0.1 97.0 0.5 0.0 23.9 0.0 0.3 0.0 0.8 23.3 328.5 0.1 1.4 0.0 0.1 1.2 6.6 0.5 0.0 0.1 0.0 2.5 0.2 3.8 0.3 1.3 3.2 0.1 0.6 1.1 1.5 0.0 4.7 0.4 0.0 2.0 0.5 13.0 13.5 13.1 15.6 13.7 18.9 22.3 16.0 14.4 14.3 14.5 13.6 33.2 9.6 4.8 20.5 1.1 22.0 0.2 39.6 1.2 1.7 0.2 1.0 9.1 0.0 24.8 0.0 0.0 0.1 0.7 1.0 0.0 0.2 0.9 13.5 24.2 59.8 0.0 0.0 0.7 10.4 0.8 171.2 1.1 24.8 6.3 6.3 33.5 2.5 0.8 0.0 2.3 0.1 6.1 4.1 10.1 0.4 1.5 6.9 1.8 12.2 0.8 0.1 1.0 1.0 0.1 1.3 5.3 1.2 0.5 0.5 3.3 0.9 5.8 0.1 0.0 35.7 37.1 0.2 0.3 1.1 15.9 0.3 1.5 1.1 0.2 2.6 ACKR4 "CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1" ENSG00000129048 "Atypical chemokine receptor 4" Q9NPB9 3 132597270-132618967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Fibroblasts: 21.4;Proximal enterocytes: 19.1;Respiratory ciliated cells: 15.7" "Cancer enhanced" "Detected in many" "stomach cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "BJ hTERT+: 285.1" "Group enriched" "Detected in some" 7 "cerebellum: 4.7;pons and medulla: 1.5" "Low region specificity" "Detected in all" HPA054926 Approved Vesicles,Mitochondria NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 31: Skin - Epidermis development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Mitochondria" "HPA054926: " "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-2)" "unprognostic (8.27e-2)" "unprognostic (5.17e-2)" "unprognostic (4.55e-3)" "unprognostic (8.93e-2)" "unprognostic (2.26e-1)" "unprognostic (4.85e-2)" "unprognostic (4.20e-3)" "unprognostic (1.03e-3)" "unprognostic (2.69e-3)" "unprognostic (1.95e-1)" "unprognostic (2.01e-1)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" 11.1 1.4 0.6 1.0 0.2 0.8 5.5 0.3 0.3 0.7 0.9 1.9 15.8 3.7 1.7 1.4 2.0 6.5 5.7 0.4 0.0 1.1 1.0 8.0 2.1 0.3 0.5 1.0 2.6 0.0 6.7 0.2 0.3 0.5 1.3 0.6 7.1 1.9 0.5 8.9 13.0 2.2 0.3 1.6 10.2 0.4 0.1 0.5 1.4 1.0 1.6 4.6 1.1 0.2 0.2 0.0 0.2 0.2 19.9 10.7 0.1 47.7 285.1 2.8 7.9 0.2 0.4 3.3 0.0 29.9 0.2 0.1 0.0 0.0 1.8 1.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 1.3 0.0 0.0 4.9 0.1 0.2 0.6 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.0 0.5 0.1 0.7 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.3 0.4 0.0 0.3 0.5 0.3 0.3 0.1 0.2 1.6 38.5 1.1 0.7 0.1 6.5 0.6 1.3 0.0 1.6 0.3 0.3 0.7 1.5 2.3 5.5 6.2 0.2 0.1 1.1 0.0 0.2 2.9 2.9 0.6 3.9 0.0 0.0 0.6 12.1 0.1 21.4 10.7 0.6 0.0 0.7 9.7 0.2 0.4 1.7 0.5 0.8 0.0 0.3 5.1 0.4 2.1 0.3 1.8 1.9 6.8 0.9 0.0 0.0 0.3 5.1 0.1 2.6 0.5 0.4 19.1 3.0 15.7 3.4 0.0 1.3 2.6 0.1 0.1 0.6 6.5 0.3 0.5 12.5 3.7 1.2 ACOT8 "hACTE-III, hTE, NAP1, PTE-2, PTE1" ENSG00000101473 "Acyl-CoA thioesterase 8" O14734 20 45841721-45857405 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 104.2;Late spermatids: 90.3;Proximal enterocytes: 105.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010261 Approved Supported Vesicles,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles Mitochondria "CAB010261: AB_2221664" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (4.27e-1)" "unprognostic (1.03e-3)" "unprognostic (2.92e-2)" "unprognostic (4.70e-1)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" "unprognostic (2.03e-2)" "prognostic favorable (3.18e-4)" "unprognostic (2.79e-1)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (2.98e-1)" 8.3 31.7 27.8 8.6 29.8 18.1 7.6 28.2 35.2 9.3 24.3 18.5 21.1 8.5 11.0 17.5 10.7 9.2 28.1 29.8 28.6 21.3 26.0 11.0 12.6 27.0 28.5 8.0 15.6 15.1 15.4 7.1 28.7 12.7 12.8 9.2 12.8 5.9 28.7 17.0 20.5 6.4 26.0 12.3 21.3 20.2 28.7 13.1 11.4 17.8 9.7 11.0 10.4 28.1 16.8 20.2 6.8 13.4 18.3 11.0 11.7 11.1 9.5 15.1 13.7 29.2 22.7 20.8 48.2 16.3 35.4 32.3 13.0 27.8 6.6 15.5 22.3 21.2 25.1 28.5 16.9 19.9 19.3 12.9 21.3 15.1 10.9 22.6 9.4 23.6 18.8 24.2 11.0 47.4 28.7 27.0 11.8 32.4 52.2 14.0 12.2 37.6 16.5 19.1 23.1 10.8 24.9 61.7 39.5 10.6 34.4 48.8 11.6 37.9 8.5 19.5 18.9 20.7 33.8 14.0 46.3 21.2 20.8 34.3 34.3 43.6 24.8 34.6 21.8 27.5 23.2 21.9 36.7 27.9 20.0 21.6 25.0 16.3 34.2 23.3 31.9 26.7 27.8 29.8 28.2 35.2 29.8 28.6 27.0 28.5 28.7 26.0 28.7 28.1 8.2 35.3 14.1 5.9 17.9 6.1 12.3 21.9 8.6 19.2 9.8 10.9 9.3 11.5 17.7 12.9 16.7 34.2 11.8 104.2 64.6 21.6 38.5 14.2 10.4 10.9 19.2 17.0 12.3 21.0 20.9 11.4 19.9 14.0 14.0 27.6 11.4 25.5 27.8 8.4 12.0 37.3 10.2 18.6 7.1 90.3 9.9 17.5 10.6 3.7 27.5 17.8 34.0 5.0 9.6 21.6 68.4 8.6 21.3 11.3 105.4 81.5 27.1 22.8 13.1 5.8 12.8 27.0 10.2 16.1 8.0 19.4 13.9 37.6 30.3 16.0 ACOX2 "BRCACOX, BRCOX, THCCox" ENSG00000168306 "Acyl-CoA oxidase 2" Q99424 3 58505136-58537283 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 177.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA038280, HPA064845" Enhanced Approved Vesicles,Cytosol No No 29000 "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" Vesicles Cytosol "HPA038280: AB_10672623, HPA064845: AB_2685368" "unprognostic (6.62e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (2.51e-2)" "unprognostic (8.34e-2)" "unprognostic (1.48e-2)" "unprognostic (8.67e-3)" "unprognostic (6.45e-2)" "unprognostic (1.00e-1)" "unprognostic (1.85e-1)" "unprognostic (1.70e-3)" "unprognostic (1.26e-2)" "unprognostic (1.68e-3)" "unprognostic (4.00e-3)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (5.63e-3)" 8.8 8.3 4.1 2.1 4.6 0.1 5.8 4.4 4.5 9.3 16.8 12.9 25.4 9.4 5.8 6.3 10.8 8.2 16.7 4.3 4.5 42.1 177.3 6.2 1.7 5.3 4.8 11.2 4.6 9.6 4.6 3.4 4.4 10.8 8.3 1.8 7.2 9.8 8.2 2.9 21.6 11.2 4.5 1.4 4.0 4.9 4.9 4.0 16.1 17.0 1.2 8.7 6.0 4.1 0.0 0.0 0.2 0.0 16.4 25.9 4.7 3.1 0.2 0.0 0.4 0.8 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 2.3 0.0 0.0 17.4 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 4.6 4.4 4.5 4.3 4.5 5.3 4.8 4.4 4.5 4.9 4.1 1.9 3.2 5.8 11.1 0.6 0.6 7.6 0.5 5.7 0.3 1.3 3.8 14.3 4.3 0.9 3.7 0.0 0.7 0.0 4.2 15.6 0.3 0.1 0.4 1.3 1.6 3.0 2.7 0.6 1.9 0.4 8.6 2.0 0.2 1.3 8.6 6.1 89.0 5.2 1.7 0.6 5.1 0.0 1.9 0.4 1.8 10.8 1.7 0.0 1.0 0.5 10.8 0.0 0.5 0.0 0.4 0.8 8.6 0.1 0.6 27.9 51.0 0.0 0.8 6.6 7.0 5.2 0.4 0.4 3.0 0.3 0.8 0.3 9.6 4.6 3.8 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647433 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "testis: 283.5" "Cell type enhanced" "Detected in many" "Early spermatids: 1097.8;Late spermatids: 723.5;Macrophages: 220.0;Spermatocytes: 387.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 12.5;intermediate monocyte: 15.8;myeloid DC: 17.7;non-classical monocyte: 31.0" "Group enriched" "Detected in many" 9 "dendritic cells: 17.7;monocytes: 31.0" "Cell line enhanced" "Detected in some" "HEL: 5.3;HMC-1: 6.7;U-266/70: 15.0;U-266/84: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Secreted in male reproductive system" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 2.2 0.9 0.9 3.8 1.3 10.7 1.1 1.9 1.4 1.9 1.1 2.9 8.4 1.4 14.2 0.9 2.1 4.1 0.6 0.9 1.0 1.8 2.2 2.8 5.5 1.3 1.2 0.7 2.9 0.3 0.9 2.3 1.3 2.0 2.1 1.8 1.3 1.1 0.4 1.7 8.1 2.1 1.1 9.2 1.9 283.5 1.2 3.0 13.8 0.4 3.6 2.4 0.9 1.5 0.2 0.1 0.8 2.5 0.8 1.2 1.3 0.0 0.0 0.1 0.1 0.0 1.8 0.3 0.8 0.2 0.1 0.0 0.4 0.0 0.2 0.8 0.0 5.3 0.6 0.0 1.8 0.1 6.7 0.1 3.3 0.9 0.1 0.6 0.6 1.7 3.5 0.0 0.1 0.3 0.2 1.9 1.5 4.3 0.0 0.3 0.1 0.3 0.5 0.1 1.0 0.3 0.0 0.7 1.1 1.2 0.0 1.9 0.7 0.1 0.8 0.5 0.0 15.0 10.5 0.5 0.5 2.0 0.0 1.5 12.5 1.2 0.2 15.8 0.0 1.3 0.0 0.0 17.7 1.9 0.2 0.1 2.6 0.7 31.0 4.5 0.0 10.6 0.9 1.3 1.9 1.4 0.9 1.0 1.3 1.2 1.3 1.1 1.2 1.5 0.3 0.0 1.3 0.7 1.5 0.1 0.1 0.0 1.2 1.7 0.5 0.5 1.0 0.0 0.1 0.0 0.0 0.1 1.9 0.9 0.0 0.2 1097.8 0.7 0.5 1.5 0.0 5.7 0.2 0.5 0.3 0.5 0.0 0.8 6.3 0.4 1.8 0.3 9.8 0.0 0.3 0.8 0.0 20.5 3.4 723.5 8.1 220.0 0.0 1.0 7.6 1.1 10.3 0.0 0.4 0.1 1.6 4.5 0.5 0.0 7.6 1.1 0.2 1.3 6.6 0.3 0.2 387.5 7.5 0.3 0.0 0.1 1.0 0.4 1.1 0.1 ADAM10 "CD156C, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588809-58749791 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 377.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 296.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 690000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 18: U-2197 - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Plasma membrane" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavorable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 14.9 8.7 11.4 19.0 18.6 18.7 15.2 20.2 15.0 16.0 9.7 22.2 15.9 16.3 7.7 15.4 13.9 18.9 12.1 12.2 12.7 18.0 16.1 21.0 22.2 18.2 17.6 14.1 8.8 7.9 8.2 29.0 17.5 25.2 17.2 10.8 9.3 12.2 6.1 16.9 17.5 13.3 13.7 29.0 20.3 8.5 15.5 42.7 28.6 7.1 16.4 28.0 10.4 25.2 48.4 88.5 27.6 31.2 34.8 49.8 70.0 39.0 116.0 28.6 39.1 39.9 62.6 22.7 118.0 35.2 49.2 95.9 16.8 43.5 37.0 30.1 19.3 38.7 35.1 42.1 40.8 25.0 103.8 44.4 30.0 19.9 29.2 41.1 55.6 45.0 24.5 57.9 50.4 15.4 89.5 32.0 40.2 15.4 14.6 36.4 91.6 57.1 66.6 121.4 29.9 20.3 44.0 52.8 73.1 60.0 30.4 55.0 41.4 37.1 41.2 296.6 39.6 30.7 70.7 23.5 54.1 50.8 67.3 30.9 36.2 19.2 12.8 41.1 19.2 8.3 12.7 11.6 23.6 9.6 12.7 10.8 51.5 17.7 48.6 10.2 18.2 25.8 11.4 18.6 20.2 15.0 12.2 12.7 18.2 17.6 17.5 13.7 15.5 25.2 60.1 83.3 50.8 83.2 37.9 26.6 30.7 33.3 33.0 22.7 61.6 30.9 40.0 30.0 46.7 80.9 27.1 35.6 69.4 79.0 1.9 56.0 21.2 39.5 56.4 72.5 36.1 20.8 106.1 31.8 57.8 36.1 53.0 74.0 30.3 31.5 71.4 36.2 63.8 45.4 96.2 43.6 36.7 90.1 28.9 19.4 18.0 77.9 46.2 147.1 69.0 30.6 44.3 75.9 377.6 48.9 48.1 17.0 51.0 89.1 45.1 23.7 41.2 33.4 13.1 34.4 42.8 20.3 17.8 39.5 22.3 26.5 51.3 34.1 39.5 83.9 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284917 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 27.4" "Cell type enhanced" "Detected in many" "Early spermatids: 189.0;Excitatory neurons: 37.3;Late spermatids: 50.5;Spermatocytes: 99.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.0;MCF7: 1.1;U-2 OS: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: AB_2684699" "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 1.0 1.0 1.0 0.2 0.9 0.4 1.0 3.2 1.5 0.6 0.0 0.5 0.0 0.4 0.6 0.2 0.5 0.4 0.7 0.9 1.3 0.2 0.0 0.3 0.1 0.1 0.5 0.6 1.8 0.0 0.4 0.1 0.4 0.6 0.4 0.9 0.5 0.3 0.2 0.7 0.2 0.1 0.1 0.7 0.3 27.4 1.0 0.0 0.3 0.1 0.1 0.5 0.4 1.3 0.2 0.4 0.0 0.2 0.6 0.0 0.0 0.4 0.1 0.4 0.2 0.1 0.9 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.2 0.5 1.1 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 1.0 0.9 3.2 1.5 0.9 1.3 0.1 0.5 0.4 0.1 1.0 1.3 1.0 0.0 0.0 11.8 0.0 0.9 1.1 0.7 0.6 8.2 2.5 2.3 1.7 1.5 0.4 1.8 18.8 0.3 0.1 0.4 0.0 0.4 189.0 5.7 3.6 1.0 4.2 0.0 37.3 1.3 0.2 2.4 0.0 9.8 0.0 3.3 0.7 0.4 0.5 0.0 29.8 1.1 0.0 0.0 1.0 50.5 2.8 0.6 0.0 9.4 0.1 1.0 0.0 18.6 17.6 2.8 0.1 3.0 0.1 1.7 0.0 0.2 1.4 3.8 0.0 3.4 0.9 99.9 2.9 0.5 0.0 0.1 0.2 3.7 1.4 1.5 ADAM9 "CORD9, KIAA0021, MCMP, MDC9, Mltng" ENSG00000168615 "ADAM metallopeptidase domain 9" Q13443 8 38996754-39105445 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 179.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004000 Approved "Endoplasmic reticulum,Vesicles" "Secreted - unknown location" NA NA 740000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles "Endoplasmic reticulum" "HPA004000: AB_1844584" "prognostic unfavorable (1.14e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.32e-3)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (7.21e-6)" "unprognostic (5.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.52e-5)" "unprognostic (5.83e-2)" "prognostic unfavorable (3.99e-4)" "unprognostic (2.80e-1)" "unprognostic (5.76e-2)" "unprognostic (2.27e-1)" "unprognostic (1.23e-2)" 34.2 28.0 7.1 28.8 8.2 2.1 21.5 8.5 8.3 34.8 11.4 32.9 24.5 29.7 15.2 29.7 19.3 47.1 32.1 6.0 8.4 34.9 13.5 51.4 9.7 10.2 7.5 16.8 12.7 52.5 7.8 47.4 9.0 34.9 41.7 18.5 54.9 34.8 24.1 16.1 23.0 51.6 9.4 24.0 44.2 11.1 10.6 5.9 39.9 25.0 13.2 56.1 24.3 11.5 188.3 163.6 63.5 32.6 117.2 374.0 67.0 259.6 382.4 191.7 177.9 82.7 147.1 10.1 86.1 247.2 156.7 79.5 30.8 249.7 373.2 6.9 21.5 12.1 102.8 73.0 226.4 8.9 19.1 287.5 139.2 193.3 212.7 341.0 268.9 15.2 21.5 53.2 406.2 25.0 7.2 4.4 8.3 175.2 46.7 3.8 106.3 27.6 299.3 62.4 6.4 11.5 78.4 90.9 57.8 72.9 67.3 12.0 374.2 109.9 97.9 213.9 124.1 12.9 29.5 7.7 175.8 12.0 72.1 0.3 4.0 0.5 0.1 1.3 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.1 0.5 0.8 0.6 0.3 0.1 0.9 7.1 8.2 8.5 8.3 6.0 8.4 10.2 7.5 9.0 9.4 10.6 11.5 14.4 48.1 37.0 16.0 3.8 35.9 66.6 78.3 26.7 19.3 23.4 9.8 49.7 24.3 82.1 35.0 20.9 24.1 8.9 44.4 3.9 90.2 14.4 42.1 35.3 20.5 10.7 2.5 47.5 115.4 85.1 42.0 80.5 82.1 5.1 26.4 25.0 7.5 125.9 5.0 38.0 32.2 44.7 60.2 44.8 7.8 28.6 54.7 21.4 33.7 21.8 17.5 1.0 30.7 26.7 179.4 30.6 24.8 5.2 108.7 24.9 41.1 51.9 25.1 13.1 31.3 31.9 4.3 2.5 20.2 21.5 34.3 5.6 11.2 32.7 103.8 ADAMTS19 ENSG00000145808 "ADAM metallopeptidase with thrombospondin type 1 motif 19" 5 129460281-129738683 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 3.3;cervix: 10.2;endometrium 1: 9.8;placenta: 3.7;smooth muscle: 5.9" "Group enriched" "Detected in some" 4 "Excitatory neurons: 82.6;Inhibitory neurons: 79.7;Oligodendrocytes: 31.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7;testis cancer: 1.2" "Region enhanced" "Detected in some" "basal ganglia: 3.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MCF7: 15.9;SH-SY5Y: 34.8" "Region enriched" "Detected in single" 5 "olfactory bulb: 2.6" "Low region specificity" "Detected in many" "HPA056171, HPA058438" Uncertain Approved Vesicles,Midbody "Secreted to extracellular matrix" Yes NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Midbody" "HPA056171: AB_2683054, HPA058438: AB_2683718" "unprognostic (1.14e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.10e-3)" "unprognostic (1.09e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-2)" "unprognostic (4.17e-2)" "unprognostic (5.99e-3)" "unprognostic (5.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.88e-2)" "unprognostic (3.06e-2)" 0.0 0.6 1.0 0.0 3.3 0.0 0.0 0.0 1.5 10.2 0.1 0.2 0.1 9.8 0.0 0.2 0.2 0.0 0.2 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 0.0 3.7 0.0 0.1 0.3 0.5 0.3 0.0 0.5 0.0 0.1 5.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 15.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 34.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.3 0.0 1.5 0.8 0.2 0.0 0.5 0.0 0.0 0.3 0.6 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 1.4 0.0 0.0 1.8 0.0 15.6 0.0 0.3 0.0 0.0 1.5 0.5 8.9 0.2 0.0 0.0 82.6 0.2 0.7 1.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 79.7 0.1 0.0 0.0 0.3 0.7 0.0 0.1 0.0 1.0 0.0 1.1 0.0 12.5 31.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.4 0.1 0.1 0.0 5.2 0.1 0.1 0.3 0.0 ADAMTS2 "ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP" ENSG00000087116 "ADAM metallopeptidase with thrombospondin type 1 motif 2" O95450 5 179110853-179345461 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 32.2;Excitatory neurons: 17.9;Fibroblasts: 30.7;Hepatic stellate cells: 17.2;Kupffer cells: 71.4;Sertoli cells: 26.3;Smooth muscle cells: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 36.0;ASC TERT1: 35.8;BJ: 31.4;fHDF/TERT166: 39.3;HHSteC: 115.5;HSkMC: 94.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028363, HPA028444" Uncertain Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA 2000000 "Cluster 64: Macrophages - Immune response" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" Vesicles "HPA028363: , HPA028444: AB_10601964" "unprognostic (6.78e-2)" "unprognostic (7.83e-2)" "unprognostic (1.13e-1)" "unprognostic (5.50e-2)" "unprognostic (8.85e-3)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.22e-2)" "unprognostic (1.58e-1)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.71e-8)" "unprognostic (1.32e-3)" "unprognostic (1.03e-2)" "unprognostic (7.16e-3)" "unprognostic (1.48e-2)" 36.9 10.9 0.8 2.4 4.2 0.3 22.7 0.9 3.5 20.6 0.9 10.5 1.4 21.7 0.5 5.5 15.5 6.1 22.3 0.5 0.9 7.5 15.8 29.6 1.8 4.5 3.3 12.1 5.8 0.4 15.1 9.7 4.2 9.0 1.4 0.2 5.3 1.8 2.9 9.4 11.6 9.1 0.2 38.4 9.3 3.9 2.5 0.4 6.8 0.8 0.6 15.0 16.7 2.2 0.0 0.0 0.1 0.7 36.0 35.8 0.0 31.4 5.4 11.5 12.4 0.1 0.0 0.0 0.2 39.3 0.7 0.1 1.8 0.0 5.1 0.0 1.5 0.0 0.1 2.3 115.5 0.0 0.0 94.4 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.1 0.8 0.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 5.9 1.2 0.1 0.0 0.4 1.9 0.0 10.7 0.0 19.1 3.0 24.5 0.0 0.3 0.0 0.0 0.9 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.8 4.2 0.9 3.5 0.5 0.9 4.5 3.3 4.2 0.2 2.5 2.2 3.3 0.0 1.1 1.6 0.1 2.2 0.4 0.0 2.2 0.3 0.2 5.2 1.5 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.3 0.9 32.2 1.4 0.0 0.0 17.9 0.0 0.3 30.7 0.0 0.8 1.3 6.5 17.2 0.5 5.1 0.0 8.5 0.0 0.0 71.4 4.4 3.4 5.0 10.4 0.0 4.7 0.3 0.1 0.0 3.0 2.4 0.5 0.0 12.8 0.1 0.4 0.0 0.2 0.0 0.0 26.3 4.7 20.4 2.1 4.8 0.2 2.7 0.0 0.4 0.6 0.0 0.1 ADAMTS9 KIAA1312 ENSG00000163638 "ADAM metallopeptidase with thrombospondin type 1 motif 9" Q9P2N4 3 64515654-64688000 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.2" "Cell type enhanced" "Detected in many" "Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028567, HPA028577, HPA028601" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" No NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "Endoplasmic reticulum" "HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (4.83e-2)" "unprognostic (3.08e-1)" "unprognostic (1.37e-2)" "unprognostic (7.80e-3)" "unprognostic (5.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (7.67e-2)" "unprognostic (3.16e-3)" "unprognostic (1.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-3)" "unprognostic (5.00e-3)" 41.2 4.8 4.0 12.2 5.0 0.1 19.0 5.5 5.3 16.2 7.9 8.1 1.2 13.2 1.1 5.3 10.2 7.8 15.6 4.4 5.6 9.5 2.7 13.6 1.9 10.8 8.1 7.3 9.8 6.3 2.2 31.7 8.5 7.9 2.7 1.4 3.2 3.7 7.4 2.6 3.7 12.1 8.0 4.1 4.7 0.8 8.1 1.0 7.3 7.3 1.1 22.5 9.0 6.4 0.0 1.2 13.9 0.0 0.6 0.1 1.3 0.2 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.3 0.4 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 0.0 8.8 2.6 0.0 0.0 0.5 0.0 23.6 0.0 0.5 0.0 0.3 0.1 0.0 0.0 7.5 1.1 0.0 0.0 2.4 0.1 27.1 0.3 0.1 128.3 0.0 0.0 0.0 40.5 0.0 0.7 5.4 0.8 0.4 0.0 0.8 0.0 0.0 0.0 0.5 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 5.0 5.5 5.3 4.4 5.6 10.8 8.1 8.5 8.0 8.1 6.4 166.3 3.2 4.8 84.2 0.0 17.5 87.2 0.0 4.6 0.0 6.9 15.9 6.6 2.8 2.6 38.6 2.1 1.0 0.2 1.1 0.0 69.7 0.9 13.2 179.1 221.0 1.2 0.0 4.2 3.3 0.6 31.4 1.5 33.8 0.0 8.4 27.1 0.3 7.5 0.0 14.3 1.1 0.0 0.3 20.1 0.4 2.5 2.7 26.6 21.5 0.0 0.2 0.0 26.7 0.6 45.5 1.0 2.2 0.0 115.7 0.0 10.8 0.1 0.1 0.0 20.7 94.8 0.3 0.7 1.3 13.5 1.6 3.2 12.1 0.9 36.7 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732392-14778560 "CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 19.4" "Group enriched" "Detected in many" 4 "granulocytes: 47.9;Kupffer cells: 69.4;Macrophages: 73.2;monocytes: 49.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 70.0;eosinophil: 74.7;intermediate monocyte: 46.9;neutrophil: 55.7;non-classical monocyte: 89.9" "Group enriched" "Detected in many" 9 "granulocytes: 74.7;monocytes: 89.9" "Cell line enhanced" "Detected in many" "HEL: 11.8;HMC-1: 18.3;NB-4: 11.5;RPMI-8226: 8.4;U-937: 14.9" "Low region specificity" "Detected in many" HPA055200 Uncertain Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 4.9 1.5 1.0 19.4 1.3 6.9 1.8 1.2 2.1 0.9 1.3 1.4 1.9 0.7 0.7 0.9 0.9 2.5 0.5 1.0 1.5 2.1 2.0 4.2 3.0 2.5 1.6 0.1 0.8 1.1 0.5 1.6 2.2 1.1 1.9 0.6 1.0 2.8 0.6 2.0 2.3 1.6 1.1 15.6 1.5 0.4 1.8 2.4 0.6 0.9 2.2 5.4 0.9 2.4 0.3 1.2 0.1 0.2 0.0 0.3 1.2 0.9 1.3 0.0 0.0 0.2 0.2 0.1 0.1 0.7 2.3 1.9 0.3 0.1 0.0 0.2 0.2 11.8 3.8 0.2 0.5 4.3 18.3 0.9 1.6 4.1 0.6 0.1 0.1 1.0 2.7 0.4 1.3 0.5 1.5 11.5 0.4 0.8 0.2 0.1 1.5 8.4 0.0 0.3 0.0 0.2 2.4 2.0 0.4 0.2 0.3 5.4 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.2 1.1 14.9 0.6 70.0 13.9 74.7 0.2 46.9 0.2 0.2 0.2 0.1 9.3 0.3 0.1 0.2 55.7 3.3 89.9 1.9 0.1 7.3 1.0 1.3 1.2 2.1 1.0 1.5 2.5 1.6 2.2 1.1 1.8 2.4 0.6 3.2 7.7 0.7 1.9 0.0 4.8 0.0 0.6 0.8 1.6 1.5 0.8 0.0 2.5 0.0 0.0 0.2 12.8 0.0 0.0 0.0 2.0 0.7 3.5 1.8 1.2 3.8 0.9 0.0 0.5 1.9 1.1 0.9 47.9 0.1 0.7 0.5 12.8 0.0 1.2 0.1 0.0 69.4 0.0 2.5 0.0 73.2 0.0 0.0 49.2 0.0 2.1 0.5 12.0 0.0 0.2 0.4 2.1 2.4 0.1 0.1 2.2 0.9 0.0 2.0 1.5 0.3 0.5 0.6 0.0 0.4 3.0 0.1 0.1 3.0 ADRA2B "ADRA2L1, ADRA2RL1, ADRARL1" ENSG00000274286 "Adrenoceptor alpha 2B" P18089 2 96112876-96116571 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 9.0;Langerhans cells: 8.0;Sertoli cells: 32.9;Smooth muscle cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;EFO-21: 1.0" "Group enriched" "Detected in some" 6 "basal ganglia: 2.5;cerebellum: 1.0;thalamus: 3.2" "Low region specificity" "Detected in some" "HPA066029, HPA074948" Approved Supported Vesicles,Cytosol NA NA "Cluster 18: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles Cytosol "HPA066029: AB_2685599, HPA074948: " "unprognostic (6.16e-2)" "unprognostic (1.31e-2)" "unprognostic (1.76e-2)" "unprognostic (4.93e-4)" "unprognostic (1.84e-2)" "unprognostic (5.24e-2)" "unprognostic (6.80e-5)" "unprognostic (4.85e-2)" "unprognostic (1.69e-1)" "unprognostic (3.16e-2)" "unprognostic (8.34e-2)" "unprognostic (2.54e-1)" "unprognostic (2.21e-1)" "unprognostic (4.43e-2)" "unprognostic (3.39e-1)" "unprognostic (1.36e-1)" "unprognostic (6.55e-2)" 6.4 2.1 1.5 0.3 1.7 0.8 3.0 1.4 2.7 1.5 4.9 2.3 0.3 1.9 3.8 0.7 3.0 0.6 10.1 1.2 1.4 5.1 7.0 0.5 0.2 1.8 1.6 1.7 0.8 0.5 0.5 0.8 1.7 1.4 0.3 0.0 2.2 1.5 6.4 1.9 2.6 0.7 1.3 8.6 2.2 1.6 2.6 0.2 1.3 5.0 0.1 2.5 1.8 2.4 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.7 1.4 2.7 1.2 1.4 1.8 1.6 1.7 1.3 2.6 2.4 2.9 0.0 0.0 0.0 0.9 1.1 0.7 0.7 0.6 0.0 0.9 0.9 2.5 0.0 1.5 1.8 0.0 0.8 2.9 0.1 0.0 0.2 0.0 2.2 1.0 2.4 2.4 0.0 0.0 0.6 0.2 1.0 1.1 9.0 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.2 0.0 0.3 8.0 0.0 1.8 5.1 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.4 0.7 0.0 0.1 1.4 0.0 32.9 0.7 13.3 0.0 0.3 0.6 1.4 0.4 2.8 0.1 0.1 0.3 AGK "FLJ10842, MULK" ENSG00000006530 "Acylglycerol kinase" Q53H12 7 141551278-141655244 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Cardiomyopathy, Cataract, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.4;Inhibitory neurons: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 97.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020959, HPA053471" Supported Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Mitochondria Vesicles "HPA020959: AB_1854206, HPA053471: AB_2682164" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (9.47e-3)" "unprognostic (5.43e-2)" "unprognostic (2.15e-2)" "unprognostic (3.68e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (1.14e-1)" "unprognostic (6.24e-3)" "unprognostic (7.90e-2)" "unprognostic (9.29e-2)" "unprognostic (9.65e-2)" "unprognostic (3.30e-1)" "unprognostic (1.18e-1)" 10.1 14.7 9.4 8.5 10.9 5.6 11.9 8.3 12.8 11.5 10.2 11.8 5.9 11.7 14.5 12.2 12.2 7.8 30.4 11.1 10.8 15.7 14.1 11.6 12.1 8.0 8.8 11.3 10.1 21.5 13.7 10.0 9.0 12.8 13.1 12.7 13.7 11.4 8.6 9.6 12.0 15.4 8.2 16.6 12.2 6.6 10.0 14.0 12.7 10.0 14.7 10.8 11.5 9.0 23.7 25.6 26.7 21.8 21.2 29.4 16.2 23.5 29.3 44.5 50.9 24.7 18.3 26.3 24.0 26.8 40.5 18.7 41.6 32.8 51.0 33.8 32.7 26.1 10.7 18.7 34.1 15.6 12.5 29.9 26.9 36.3 33.1 19.8 34.1 32.3 36.3 36.9 25.3 24.6 47.3 9.1 25.6 19.9 32.4 29.2 4.2 80.1 33.1 20.8 23.3 29.6 24.6 29.7 27.1 26.1 16.3 20.2 19.5 18.9 14.1 23.8 38.1 29.5 31.9 14.4 30.7 9.1 50.4 0.4 7.1 1.2 22.1 13.9 15.3 10.8 17.3 26.0 16.2 6.5 12.8 23.5 1.2 97.3 8.2 6.3 18.9 15.7 9.4 10.9 8.3 12.8 11.1 10.8 8.0 8.8 9.0 8.2 10.0 9.0 8.4 0.0 6.0 22.5 11.4 3.1 5.6 7.9 5.2 11.8 5.5 5.1 18.1 2.8 6.6 12.9 8.4 15.7 15.8 3.0 9.8 6.6 9.9 7.4 9.0 7.5 0.0 11.8 43.4 6.9 8.2 7.7 10.7 6.6 8.2 9.9 4.2 4.1 7.0 15.2 43.0 3.9 12.2 5.1 4.9 12.0 6.8 5.6 7.2 26.2 12.4 11.2 27.8 38.7 37.9 6.1 2.1 10.5 22.1 2.9 2.4 8.2 7.6 17.4 0.0 6.2 8.0 6.2 4.9 11.3 2.7 9.2 15.0 14.2 5.6 3.8 AGR3 "BCMP11, hAG-3, HAG3, PDIA18" ENSG00000173467 "Anterior gradient 3, protein disulphide isomerase family member" Q8TD06 7 16859412-16881987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 225.2;intestine: 237.6;lung: 152.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 861.1;Intestinal goblet cells: 701.9;Paneth cells: 744.5;Proximal enterocytes: 1051.2;Respiratory ciliated cells: 1771.2;Undifferentiated cells: 495.4" "Cancer enhanced" "Detected in many" "breast cancer: 104.5" "Region enhanced" "Detected in some" "midbrain: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "OE19: 109.8;T-47d: 339.3" "Region enriched" "Detected in some" 5 "olfactory bulb: 4.6" HPA053942 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA 67000 "Cluster 9: Intestine - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Endoplasmic reticulum" Vesicles "HPA053942: AB_2682317" "unprognostic (2.18e-2)" "unprognostic (2.02e-1)" "unprognostic (2.13e-1)" "unprognostic (9.59e-2)" "unprognostic (3.32e-3)" "unprognostic (3.08e-2)" "unprognostic (1.49e-1)" "unprognostic (1.46e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.96e-1)" "unprognostic (6.66e-2)" "unprognostic (1.57e-1)" 0.6 0.1 0.0 11.0 0.0 0.0 69.6 0.0 0.2 25.0 0.1 219.9 167.2 8.7 0.0 1.5 225.2 48.3 0.1 0.1 0.4 2.5 0.3 152.7 0.2 2.0 3.4 0.3 10.7 0.0 21.2 0.8 1.0 4.8 214.9 0.0 30.9 0.8 0.0 1.5 237.6 8.7 0.7 0.3 99.9 0.2 0.2 0.0 7.3 0.0 0.8 27.6 0.2 0.5 0.0 0.6 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 109.8 0.0 0.0 0.0 2.3 8.1 0.0 1.3 0.4 0.0 0.6 0.0 0.0 339.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 2.0 3.4 1.0 0.7 0.2 0.5 0.7 333.3 408.1 0.3 1.4 2.7 12.5 108.5 0.0 0.0 105.1 51.9 0.1 31.5 319.9 29.5 0.0 3.4 0.7 380.0 1.9 30.4 0.0 861.1 7.4 1.9 112.7 0.0 0.2 71.4 3.3 5.3 71.4 39.2 20.8 0.0 0.0 0.0 0.5 0.0 0.2 701.9 134.3 0.0 0.3 0.0 0.3 2.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 16.6 744.5 0.0 0.4 7.1 1051.2 0.0 1771.2 0.0 0.0 0.0 27.9 0.0 0.1 0.0 9.8 2.2 4.1 0.0 495.4 117.9 AGTPBP1 "CCP1, KIAA1035, Nna1" ENSG00000135049 "ATP/GTP binding protein 1" Q9UPW5 9 85546539-85742029 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 60.1;brain: 73.4;retina: 46.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 176.7;Inhibitory neurons: 163.0;Oligodendrocytes: 463.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057208, HPA071094" Approved Approved Nucleoli,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoli, Vesicles" "HPA057208: AB_2683370, HPA071094: " "unprognostic (2.15e-1)" "unprognostic (3.78e-2)" "unprognostic (4.93e-3)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (8.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-1)" "unprognostic (8.26e-3)" "unprognostic (5.69e-3)" "unprognostic (6.31e-2)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (9.60e-3)" "unprognostic (1.25e-1)" 8.4 5.5 31.1 9.5 44.3 60.1 6.2 23.2 36.3 4.7 0.0 5.1 3.7 4.9 3.9 5.3 4.6 5.3 12.2 20.1 30.3 6.9 4.6 14.4 9.4 30.5 28.6 3.6 6.7 7.5 5.3 6.1 31.5 4.7 5.8 46.5 4.1 3.0 16.5 6.2 5.1 6.5 32.0 14.8 5.5 14.1 34.3 12.4 5.8 20.5 8.4 5.7 4.3 73.4 5.1 9.6 27.9 11.1 5.6 6.0 10.6 7.4 6.4 7.4 8.4 5.2 8.6 31.3 6.2 7.7 13.2 2.9 13.0 9.4 6.9 33.6 11.8 5.3 11.5 9.3 11.8 24.5 6.2 5.8 10.8 7.0 23.5 4.8 11.9 15.9 6.7 24.5 3.3 8.0 19.3 14.5 19.3 18.1 6.8 17.3 10.2 9.8 12.8 5.4 33.5 23.7 8.4 9.1 15.4 26.1 3.5 7.8 12.0 4.8 8.5 30.4 8.9 16.7 14.8 14.3 10.1 23.5 9.8 37.4 14.4 12.7 9.0 8.4 8.8 2.3 4.4 7.0 15.6 1.7 3.7 7.0 21.2 6.8 6.7 2.5 5.1 9.6 31.1 44.3 23.2 36.3 20.1 30.3 30.5 28.6 31.5 32.0 34.3 73.4 22.3 64.1 12.8 46.0 14.3 7.9 2.6 2.9 8.0 38.0 4.7 4.8 48.3 0.0 13.8 3.7 102.2 4.1 41.8 4.3 7.9 5.7 52.5 29.3 8.6 12.0 7.7 16.8 176.7 4.0 4.3 6.9 9.2 22.0 27.1 9.2 8.2 3.7 8.1 35.3 163.0 5.6 6.1 35.4 24.1 53.9 1.8 42.8 3.6 61.8 46.6 16.7 47.4 82.9 463.5 5.1 1.2 2.6 26.2 3.8 3.2 9.8 14.7 59.1 13.1 9.3 10.4 46.6 29.2 9.2 10.7 2.9 26.3 6.4 4.7 2.3 AGTRAP ATRAP ENSG00000177674 "Angiotensin II receptor associated protein" Q6RW13 1 11736084-11754802 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 446.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 196.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044120 Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" Vesicles "Golgi apparatus" "HPA044120: AB_10960748" "unprognostic (1.08e-3)" "unprognostic (2.98e-3)" "unprognostic (6.10e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (6.57e-7)" "unprognostic (4.44e-2)" "unprognostic (7.96e-2)" "unprognostic (4.31e-2)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (1.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (2.33e-3)" "unprognostic (5.89e-2)" 44.1 50.3 26.6 30.2 28.5 132.3 44.3 27.1 32.4 34.6 44.0 29.3 11.2 24.7 47.7 53.6 48.3 25.2 37.0 24.5 30.5 65.8 29.5 62.3 23.4 37.3 28.8 26.9 67.3 25.7 31.2 22.0 31.3 79.1 9.3 3.4 39.0 21.0 54.3 38.8 25.7 20.3 28.4 83.4 33.7 24.7 31.8 11.3 40.8 12.4 13.3 43.9 43.3 31.1 55.9 66.7 16.7 36.9 27.5 34.9 30.5 28.6 49.0 34.8 30.2 42.0 129.7 5.4 126.7 35.4 87.3 45.8 27.9 135.3 10.7 3.1 61.5 1.6 38.4 51.8 84.9 27.6 64.3 34.6 105.4 112.9 59.2 42.4 46.9 17.3 73.8 52.8 19.8 44.6 13.7 80.9 29.7 24.0 67.3 4.6 15.0 27.5 56.7 5.2 14.6 22.0 52.5 26.4 48.4 22.3 59.8 57.4 26.0 44.1 30.8 70.3 30.9 19.6 24.2 33.3 111.7 196.1 20.7 483.4 844.2 694.6 185.7 442.7 90.4 47.0 66.9 109.8 312.2 38.2 72.0 93.5 756.8 73.0 385.2 25.5 90.8 577.4 26.6 28.5 27.1 32.4 24.5 30.5 37.3 28.8 31.3 28.4 31.8 31.1 46.2 22.4 27.4 3.9 12.1 11.6 30.7 112.4 16.5 1.0 54.8 56.0 12.0 32.9 41.6 36.8 6.2 15.7 60.1 6.9 9.8 95.5 20.6 75.3 30.8 36.1 7.2 21.0 0.2 446.7 92.4 45.3 11.2 41.1 88.0 19.1 42.1 7.7 118.3 3.3 0.2 12.3 20.3 143.5 18.9 23.4 37.9 97.8 28.4 1.9 107.4 19.4 122.6 0.5 7.0 96.9 22.5 27.1 8.6 66.5 8.6 55.3 78.5 5.6 13.1 13.0 23.8 3.5 36.1 34.4 13.5 13.1 45.0 50.4 18.2 25.2 AL049629.2 ENSG00000284969 "Novel protein" 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Ductal cells: 9.1;Exocrine glandular cells: 14.4;Pancreatic endocrine cells: 44.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.8;HUVEC TERT2: 55.1;TIME: 66.2;U-2197: 57.6" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 2.5 0.7 1.5 2.3 1.4 1.5 1.1 1.5 1.6 0.5 2.5 0.7 1.4 1.3 1.8 1.2 0.6 2.1 1.1 1.4 1.7 1.6 0.8 1.7 0.3 1.8 2.0 0.6 0.7 1.0 1.5 1.8 0.5 0.7 0.6 2.4 0.7 3.5 0.3 0.3 0.6 1.8 0.5 2.9 1.1 1.8 0.2 0.8 1.1 1.4 2.3 2.1 1.3 3.3 0.2 2.4 3.4 7.9 0.1 18.5 8.4 2.3 2.2 0.1 9.6 0.0 2.3 12.5 1.1 2.2 0.3 42.8 4.0 2.0 0.4 0.3 7.1 0.8 0.8 0.4 1.2 3.0 2.7 1.0 14.7 1.9 55.1 0.3 0.5 7.4 15.4 1.0 1.8 0.8 0.5 1.3 24.8 0.4 1.5 1.3 4.9 2.2 0.0 0.3 2.0 3.4 7.3 0.2 1.0 0.0 66.2 7.0 2.7 57.6 7.4 3.8 3.7 0.3 16.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 1.4 1.5 1.6 1.4 1.7 1.8 2.0 1.8 1.8 1.8 2.1 0.5 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.7 0.2 2.1 0.0 0.0 0.0 14.4 0.0 0.2 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 AL592490.1 ENSG00000197991 "Novel protein" 13 61409858-61427849 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" Yes NA "Cluster 11: Alveolar cells - Smell perception" Vesicles "Cytokinetic bridge" "HPA062669: AB_2732687" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALG13 "CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W" ENSG00000101901 "ALG13 UDP-N-acetylglucosaminyltransferase subunit" Q9NP73 X 111665811-111760649 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Congenital disorder of glycosylation, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002853, HPA005498" Approved Approved Vesicles,Cytosol NA NA 11000000 "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Vesicles Cytosol "HPA002853: AB_1078131, HPA005498: " "unprognostic (4.13e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-2)" "unprognostic (1.51e-1)" "unprognostic (6.97e-2)" "unprognostic (6.14e-2)" "unprognostic (2.74e-1)" "unprognostic (6.55e-3)" "unprognostic (2.26e-2)" "unprognostic (3.39e-3)" "unprognostic (1.73e-2)" "unprognostic (4.62e-3)" "prognostic unfavorable (1.10e-6)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.45e-2)" 15.1 17.9 10.5 18.8 11.7 16.6 18.3 11.5 19.0 17.2 12.3 18.2 13.7 16.1 20.5 14.7 15.4 16.4 13.2 10.2 13.8 21.0 23.8 13.8 23.4 12.6 12.1 15.8 14.7 23.4 17.9 14.1 13.3 17.7 19.4 11.8 15.6 13.4 9.2 19.4 17.3 17.5 11.4 18.5 15.5 17.4 11.8 17.3 18.2 9.9 20.1 21.3 14.7 16.6 22.3 24.4 21.8 13.8 13.8 19.6 12.3 17.7 18.3 22.4 27.5 24.9 23.1 19.5 33.0 24.7 46.5 12.6 26.1 12.5 23.5 14.4 17.6 10.7 26.1 28.4 20.3 19.5 40.5 23.6 22.8 18.0 38.6 23.3 24.8 21.8 23.9 53.5 22.5 55.8 16.4 17.6 19.9 66.3 33.6 12.8 13.9 26.7 36.6 34.0 13.1 19.1 25.2 15.2 16.3 21.7 13.6 18.5 16.7 19.2 9.7 24.9 34.4 25.8 47.1 31.5 20.5 25.5 15.2 39.5 15.8 16.6 9.5 16.3 9.3 10.6 10.6 9.2 18.5 12.1 13.0 10.8 3.0 4.6 12.9 9.5 14.6 9.6 10.5 11.7 11.5 19.0 10.2 13.8 12.6 12.1 13.3 11.4 11.8 16.6 50.9 16.0 30.8 33.6 127.9 35.2 65.8 53.5 33.6 15.1 33.9 31.6 18.7 22.8 36.0 18.4 10.4 27.3 73.9 39.2 45.0 37.4 21.1 48.2 31.1 37.4 26.5 27.1 64.7 52.1 39.1 34.6 37.2 47.9 109.8 15.7 28.2 28.4 42.5 11.8 57.4 49.0 46.8 39.2 52.3 9.4 21.5 56.1 28.4 83.4 41.8 16.0 29.9 41.7 77.5 58.0 55.6 16.1 60.4 46.9 38.5 55.5 35.3 16.5 26.3 38.7 46.2 32.6 22.4 26.5 35.4 48.7 71.1 28.8 32.8 64.6 ALOX12B 12R-LOX ENSG00000179477 "Arachidonate 12-lipoxygenase, 12R type" O75342 17 8072636-8087716 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 90.2" "Cell type enhanced" "Detected in some" "Horizontal cells: 1.7;Rod photoreceptor cells: 1.2;Spermatogonia: 1.2;Suprabasal keratinocytes: 1.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 11.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "basophil: 4.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "A549: 1.1;HEK 293: 1.3;hTCEpi: 1.6;JURKAT: 2.7;OE19: 1.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA024002 Supported Supported Vesicles,Cytosol NA NA 7000 "Cluster 46: Basophils - DNA binding" "Cluster 31: Skin - Epidermis development" "Cluster 21: OE19 - Mitochondria" "Cluster 62: Horizontal cells - Visual perception" Cytosol Vesicles "HPA024002: AB_1844757" "unprognostic (1.27e-2)" "unprognostic (1.59e-2)" "unprognostic (4.28e-3)" "unprognostic (1.38e-2)" "unprognostic (3.94e-3)" "unprognostic (1.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-1)" "unprognostic (4.40e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.02e-1)" "unprognostic (8.01e-2)" "unprognostic (3.46e-2)" 0.0 0.0 0.4 0.1 0.5 0.1 2.1 0.4 0.6 5.7 0.0 0.1 0.3 0.0 0.0 5.6 0.2 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.5 0.4 0.2 0.0 0.2 1.2 0.1 0.0 0.5 0.4 0.1 0.6 0.8 0.0 0.4 90.2 0.2 0.0 0.1 0.2 0.2 0.2 0.4 0.6 0.0 0.0 19.1 0.0 15.0 0.1 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.2 0.3 0.0 0.0 0.0 1.3 0.0 0.4 0.1 0.0 0.2 0.0 0.0 1.6 0.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.8 0.0 0.9 0.0 0.4 0.4 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.0 0.4 0.6 0.1 0.2 0.0 0.1 0.5 0.7 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.5 0.4 0.6 0.4 0.2 0.4 0.2 0.5 0.1 0.4 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.5 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.8 1.2 0.0 1.8 0.0 0.0 0.0 0.1 0.1 AMACR "P504S, RACE" ENSG00000242110 "Alpha-methylacyl-CoA racemase" Q9UHK6 5 33986165-34008104 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 134.3;liver: 180.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5" "Group enriched" "Detected in all" 4 "liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 175.4;U-266/84: 98.0" "Low region specificity" "Detected in all" "CAB001809, HPA019527, HPA020912" Enhanced Supported "Vesicles,Plasma membrane" NA NA 70000 "Cluster 14: Monocytes - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Plasma membrane" "CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034" "unprognostic (8.96e-2)" "unprognostic (5.20e-3)" "prognostic favorable (7.11e-4)" "unprognostic (9.55e-2)" "unprognostic (1.39e-1)" "unprognostic (9.12e-3)" "unprognostic (1.68e-1)" "unprognostic (5.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-1)" "unprognostic (5.59e-5)" "unprognostic (1.95e-2)" "unprognostic (5.52e-3)" "unprognostic (6.32e-2)" "unprognostic (3.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" 8.6 15.0 5.9 5.0 5.5 3.0 6.4 4.6 6.0 6.5 4.6 40.0 18.0 4.7 9.6 15.6 6.2 20.5 10.1 5.4 7.8 134.3 180.6 9.2 3.6 5.9 6.4 7.8 13.8 13.0 5.7 7.7 6.6 39.3 42.9 12.0 60.7 12.5 19.2 4.9 15.9 7.0 5.8 5.4 34.8 4.3 8.4 4.8 8.3 14.9 5.6 8.8 8.5 5.8 12.7 20.2 11.1 14.3 7.7 11.9 19.1 16.6 12.2 7.6 5.7 66.1 15.1 4.1 8.7 23.6 28.6 5.8 2.8 12.0 7.7 12.7 10.9 9.8 13.7 19.0 5.4 6.0 3.0 18.1 6.0 9.7 3.6 10.7 8.5 8.3 3.8 14.7 22.4 9.6 5.0 7.6 10.0 9.4 32.9 6.0 18.6 6.5 33.2 62.4 6.1 8.7 27.6 19.3 16.9 9.1 14.9 5.9 15.6 24.6 5.4 6.2 13.6 175.4 98.0 7.4 7.0 12.1 18.8 0.3 6.0 9.3 8.3 8.0 7.0 7.1 7.2 6.4 8.9 5.2 6.6 4.8 10.0 8.7 14.2 4.6 7.9 6.0 5.9 5.5 4.6 6.0 5.4 7.8 5.9 6.4 6.6 5.8 8.4 5.8 0.8 3.2 4.1 0.0 2.2 0.4 0.4 0.9 1.8 4.3 1.4 0.9 1.1 8.6 3.7 1.8 0.0 1.0 2.2 19.7 5.9 0.8 8.9 2.3 1.2 3.0 4.2 2.1 0.0 3.8 1.0 2.9 4.1 1.5 0.0 1.2 1.1 21.6 1.1 5.0 0.0 5.1 4.1 0.9 0.2 21.6 0.6 1.2 0.0 0.0 1.5 9.3 3.1 0.0 0.0 2.6 4.5 2.2 1.6 0.6 4.7 38.5 3.1 0.9 0.0 1.7 3.7 0.7 0.7 3.4 0.6 0.3 1.5 1.2 4.4 0.4 AMBN ENSG00000178522 Ameloblastin Q9NP70 4 70592256-70607288 "Disease related genes, Human disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Microglial cells: 1.9" "Group enriched" "Detected in some" 7 "cervical cancer: 2.6;endometrial cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HEK 293: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036099 Uncertain Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Nucleoplasm "HPA036099: " "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMBRA1 "DCAF3, FLJ20294, KIAA1736, WDR94" ENSG00000110497 "Autophagy and beclin 1 regulator 1" Q9C0C7 11 46396414-46594125 "Predicted intracellular proteins" "Autophagy, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 65.6;Excitatory neurons: 101.4;Inhibitory neurons: 101.9;Microglial cells: 84.3;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 136.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 11.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017825, HPA038535" Approved Approved Vesicles,Mitochondria NA NA "Cluster 38: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Mitochondria "CAB017825: , HPA038535: AB_2676068" "unprognostic (1.76e-3)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.56e-1)" "unprognostic (6.00e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-3)" "unprognostic (7.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.98e-2)" "unprognostic (5.53e-3)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (2.90e-1)" "unprognostic (8.17e-2)" "unprognostic (1.61e-2)" "unprognostic (7.98e-2)" 10.2 16.4 7.5 6.7 9.1 11.6 10.5 7.8 9.1 10.4 7.4 10.1 10.0 11.7 5.8 10.6 10.1 6.4 8.4 7.9 6.4 8.2 9.1 8.6 8.2 6.6 6.1 11.6 8.3 12.3 9.2 7.6 7.3 9.8 7.0 7.8 10.6 7.6 13.0 17.4 9.8 8.8 5.4 10.3 9.7 12.6 8.4 13.5 9.4 8.3 8.1 9.4 10.0 10.8 8.7 23.0 15.5 16.8 16.1 12.0 9.6 8.5 16.1 13.6 14.1 17.4 14.8 17.5 8.5 15.1 16.1 15.4 7.9 15.0 10.0 15.3 25.5 11.9 14.6 22.5 10.5 17.3 14.6 16.7 11.6 8.6 16.3 14.8 14.3 14.9 20.8 11.7 10.2 21.4 22.2 12.2 26.1 19.6 12.4 21.5 21.3 9.7 13.1 15.4 12.5 13.9 14.7 16.6 15.6 10.1 17.2 11.6 15.2 12.5 11.1 14.6 12.8 13.2 11.3 18.1 11.1 9.6 11.3 11.8 2.2 1.7 2.6 1.1 2.2 2.4 1.9 2.0 2.0 2.1 1.9 1.7 2.5 1.4 1.9 2.1 3.2 1.9 7.5 9.1 7.8 9.1 7.9 6.4 6.6 6.1 7.3 5.4 8.4 10.8 5.1 3.2 5.6 65.6 7.2 4.1 2.5 3.4 4.0 6.6 5.1 5.2 8.2 4.3 4.3 0.0 2.1 4.0 5.9 16.0 0.0 6.9 13.8 5.2 5.3 4.7 9.6 10.3 101.4 9.3 2.1 6.7 13.7 8.3 4.5 8.8 3.6 4.1 5.2 5.0 101.9 9.7 2.0 3.5 2.3 6.7 5.3 4.8 5.4 84.3 3.1 3.2 6.2 84.9 136.4 8.4 7.5 7.9 6.6 3.5 8.2 3.2 4.4 5.7 13.1 4.2 5.8 2.1 2.1 7.4 4.5 6.8 6.4 7.9 6.4 4.2 AMH MIS ENSG00000104899 "Anti-Mullerian hormone" P03971 19 2249309-2252073 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Differentiation, Gonadal differentiation" "Growth factor" "Disease variant, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "pituitary gland: 3.9;testis: 10.5" "Cell type enriched" "Detected in many" 61 "Granulosa cells: 1567.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 16.9;NTERA-2: 6.4;REH: 7.0;SH-SY5Y: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066973 Approved Vesicles,Aggresome "Secreted to blood" NA NA 1580000 280000 "Cluster 78: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Aggresome" "HPA066973: AB_2732754" "unprognostic (8.10e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.21e-5)" "unprognostic (8.73e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (8.03e-2)" "unprognostic (8.99e-2)" "unprognostic (2.55e-1)" "unprognostic (3.53e-1)" "unprognostic (5.95e-3)" "unprognostic (1.34e-2)" "unprognostic (8.73e-8)" "unprognostic (4.64e-2)" "unprognostic (4.14e-2)" "unprognostic (2.15e-1)" "unprognostic (2.76e-1)" 0.2 0.2 0.7 0.0 1.2 0.0 0.2 1.2 1.3 0.4 0.0 0.8 0.0 0.3 0.0 0.3 0.4 0.0 0.2 0.2 0.4 0.5 0.3 0.3 0.0 0.4 0.5 1.1 1.2 0.0 3.9 0.0 0.4 0.5 0.0 0.0 0.2 0.0 1.5 0.2 0.4 0.0 0.6 0.2 0.2 10.5 0.6 0.0 0.3 0.0 0.0 0.2 0.3 0.4 2.8 0.2 0.1 0.4 0.0 0.0 4.3 0.6 0.0 0.0 0.0 0.1 0.2 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 16.9 0.1 0.8 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.6 0.4 0.0 0.5 0.1 1.3 6.4 0.0 1.5 7.0 1.4 0.9 0.0 0.2 0.4 7.7 0.1 0.0 1.7 0.0 0.8 0.0 0.7 0.6 1.3 0.9 2.5 4.7 3.7 0.8 0.3 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 1.2 1.3 0.2 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.3 0.0 0.0 2.0 0.0 0.1 0.2 0.1 0.6 12.1 1.6 2.2 1.1 1.5 0.0 0.0 2.1 0.3 0.4 1.1 0.0 0.3 2.0 0.7 0.8 0.5 1.2 0.4 1.6 0.2 0.3 0.4 0.0 1.5 0.0 1567.5 0.7 0.3 0.1 8.4 11.5 1.0 0.0 0.0 0.0 9.2 1.5 2.3 0.0 1.9 0.1 6.3 0.0 1.0 2.2 0.0 0.0 0.4 0.1 0.1 0.9 0.2 0.1 2.3 0.0 9.2 25.6 8.1 0.6 0.7 0.1 0.0 0.4 0.0 0.8 0.2 ANAPC15 "APC15, C11orf51, DKFZP564M082, HSPC020" ENSG00000110200 "Anaphase promoting complex subunit 15" P60006 11 72106378-72112780 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036596 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm Vesicles "HPA036596: AB_10671961" "unprognostic (1.17e-1)" "unprognostic (5.83e-2)" "unprognostic (4.23e-2)" "unprognostic (3.05e-2)" "unprognostic (1.86e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (9.18e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.55e-4)" "unprognostic (9.34e-3)" "unprognostic (1.76e-1)" "unprognostic (1.26e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.77e-1)" "unprognostic (9.08e-2)" 28.9 44.2 47.0 30.0 47.5 95.9 30.0 47.8 61.1 24.3 45.8 67.1 30.7 43.4 38.3 53.2 30.4 18.3 62.2 47.2 47.7 48.8 44.0 30.0 43.5 46.4 46.8 22.4 39.2 25.4 32.8 19.2 47.2 52.0 40.6 42.8 39.9 38.8 95.2 39.6 40.1 31.9 46.4 41.2 46.5 72.0 46.3 72.6 44.7 64.3 44.3 41.6 29.5 49.0 74.0 109.4 87.5 55.8 25.5 41.2 41.4 77.1 70.1 121.3 80.2 128.8 78.4 98.8 72.9 110.3 59.0 122.6 133.4 144.0 113.9 64.0 63.3 113.1 124.9 84.5 30.2 110.8 101.3 43.2 56.2 68.9 91.6 45.4 80.7 136.7 83.3 66.6 80.0 127.2 214.5 102.9 70.9 155.3 62.3 89.6 217.4 67.2 106.1 50.5 61.9 53.8 79.0 76.5 127.0 46.8 89.6 58.6 73.4 55.5 72.9 110.5 82.8 68.0 71.5 125.3 34.0 87.8 31.7 29.7 168.5 136.3 73.3 114.2 78.0 94.5 93.4 86.3 148.8 71.4 110.9 101.5 68.4 72.4 107.4 119.1 153.0 124.1 47.0 47.5 47.8 61.1 47.2 47.7 46.4 46.8 47.2 46.4 46.3 49.0 20.1 16.0 16.5 2.9 36.1 41.8 71.2 83.5 44.3 32.9 43.2 55.6 3.9 12.8 50.6 23.9 27.1 84.7 40.5 82.9 123.3 49.4 15.4 38.8 21.3 22.8 49.6 34.1 7.1 102.7 78.8 18.3 36.7 27.8 30.4 27.2 15.0 44.1 82.8 13.5 7.3 66.2 61.1 48.5 47.5 13.4 6.8 48.0 26.6 1.0 58.8 44.1 36.0 5.5 5.2 53.1 61.4 23.0 47.1 43.8 56.2 123.6 45.6 43.3 19.7 16.0 35.3 115.9 139.9 53.8 41.1 46.7 41.1 32.3 71.5 61.7 ANGPTL4 "ARP4, FIAF, HFARP, NL2, PGAR, pp1158" ENSG00000167772 "Angiopoietin like 4" Q9BY76 19 8363289-8374370 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 195.8;breast: 165.0;liver: 183.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 318.9;Hepatocytes: 148.4;Pancreatic endocrine cells: 230.4;Proximal enterocytes: 146.3;Skeletal myocytes: 198.3" "Cancer enriched" "Detected in all" 4 "renal cancer: 212.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 3.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "ASC diff: 54.6;HBEC3-KT: 226.5;LHCN-M2: 60.9;TIME: 114.6;U-138 MG: 65.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA007879, CAB033770" Approved Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 7750000 3100000 "Cluster 41: Basophils - Cellular respiration" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Vesicles" "CAB033770: AB_2057427, HPA007879: AB_1078158" "unprognostic (1.26e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (7.53e-4)" "unprognostic (1.88e-2)" "unprognostic (7.68e-3)" "unprognostic (3.58e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.50e-4)" "unprognostic (3.18e-1)" "unprognostic (3.90e-3)" "unprognostic (9.69e-3)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.00e-2)" 195.8 23.0 25.2 15.4 31.8 1.4 165.0 26.2 32.6 18.8 14.0 25.6 11.5 6.8 0.1 41.2 7.9 9.4 45.4 27.7 27.0 51.9 183.7 46.6 2.0 30.1 37.6 9.1 70.8 1.0 16.1 18.3 27.2 30.4 0.9 3.2 19.1 2.6 24.8 30.2 28.0 6.0 27.3 13.1 21.7 6.7 33.8 0.7 34.1 6.2 2.8 26.6 32.1 33.7 0.1 2.2 1.2 3.3 54.6 12.0 0.7 4.4 0.5 0.7 0.2 0.0 20.9 0.2 30.6 8.8 4.5 3.0 0.0 226.5 0.4 1.9 0.4 0.3 0.9 0.9 1.2 0.1 0.2 5.6 1.0 34.0 0.7 6.2 17.4 0.6 1.1 0.5 60.9 1.8 0.2 2.1 0.3 0.0 1.8 1.3 0.1 1.0 11.1 4.0 0.2 0.5 26.2 2.7 4.3 1.5 6.8 0.4 114.6 65.1 0.3 33.3 0.0 0.3 0.1 0.2 44.9 0.0 12.4 3.3 0.1 0.4 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.3 0.0 0.1 0.2 0.1 25.2 31.8 26.2 32.6 27.7 27.0 30.1 37.6 27.2 27.3 33.8 33.7 53.5 38.5 5.8 128.0 1.2 14.0 39.8 318.9 17.1 0.2 71.8 49.0 5.3 1.5 85.7 14.7 0.0 7.4 2.5 17.1 0.0 107.1 0.7 4.2 6.9 28.9 0.0 0.0 0.4 18.0 111.2 89.1 46.9 13.8 2.5 1.5 17.9 148.4 8.3 0.0 0.6 14.2 16.2 1.6 10.3 2.2 88.0 5.0 8.8 2.8 2.0 2.7 0.0 1.0 4.5 230.4 8.4 131.7 1.0 38.3 146.3 4.5 19.0 0.1 32.9 198.3 121.5 0.0 3.1 21.8 11.5 40.1 2.3 20.7 6.7 77.7 ANKRD26 "KIAA1074, THC2" ENSG00000107890 "Ankyrin repeat domain 26" Q9UPS8 10 26973793-27100494 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 130.6;Cone photoreceptor cells: 200.1;Excitatory neurons: 136.8;Inhibitory neurons: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA040654, HPA041460" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "HPA040654: AB_10795370, HPA041460: AB_10795120" "unprognostic (1.92e-1)" "unprognostic (3.41e-1)" "unprognostic (2.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.02e-1)" "unprognostic (2.09e-2)" "unprognostic (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (4.08e-2)" "unprognostic (1.53e-2)" "unprognostic (1.03e-2)" "unprognostic (2.53e-3)" "unprognostic (5.35e-2)" "unprognostic (1.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.99e-1)" 2.3 2.6 4.7 1.6 5.4 1.5 3.8 5.9 8.6 3.9 5.0 2.5 1.7 3.3 3.0 2.0 3.0 2.0 4.1 4.4 4.0 2.7 2.8 1.9 3.5 4.7 3.8 4.0 2.6 4.0 4.6 3.2 2.7 2.6 2.8 10.0 2.3 2.5 6.7 2.5 2.0 2.5 2.8 2.5 2.2 4.0 4.9 3.1 2.7 7.5 2.2 2.2 2.7 5.8 7.7 5.4 9.8 3.7 6.1 6.7 3.4 10.1 3.7 9.2 8.5 5.2 5.1 17.9 3.1 4.7 6.5 8.1 9.6 4.7 11.0 7.4 7.2 1.1 7.9 7.9 4.5 4.5 1.2 4.7 2.9 9.5 3.2 7.5 8.4 5.5 14.8 4.8 9.3 4.3 5.5 2.8 3.9 2.8 3.5 6.6 13.8 4.3 5.7 3.1 8.5 4.7 9.6 2.0 8.1 7.1 8.5 3.1 7.6 7.7 5.2 9.9 5.7 1.9 2.6 11.7 7.3 9.9 3.5 1.0 0.2 0.2 0.2 0.1 0.7 1.2 0.4 0.4 0.3 0.6 1.6 0.5 0.1 1.6 0.1 2.1 0.4 0.2 4.7 5.4 5.9 8.6 4.4 4.0 4.7 3.8 2.7 2.8 4.9 5.8 19.5 22.4 28.8 130.6 14.3 4.2 7.6 9.0 8.6 77.8 13.5 17.7 70.9 7.2 19.4 3.7 200.1 24.8 8.6 8.3 5.9 14.5 19.0 47.7 38.6 20.4 20.9 6.3 136.8 13.1 13.1 21.3 8.2 16.5 5.1 43.5 13.6 8.3 11.9 79.1 185.9 9.3 10.2 5.7 5.4 6.4 30.4 11.8 3.6 45.0 12.4 45.0 18.6 87.0 67.2 11.3 4.2 27.1 7.8 5.3 12.1 5.6 49.5 117.9 32.9 30.1 15.6 60.7 57.2 8.9 8.0 13.7 12.9 46.1 14.6 5.0 ANKRD27 "DKFZp434L0718, FLJ00040, VARP" ENSG00000105186 "Ankyrin repeat domain 27" Q96NW4 19 32597006-32676597 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 137.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042769 Approved Supported Vesicles,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 36: HEL - Hemostasis" "Cluster 59: Non-specific - Transcription" Vesicles Cytosol "HPA042769: AB_10796584" "unprognostic (2.16e-3)" "unprognostic (6.04e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (1.63e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.21e-5)" "unprognostic (9.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.90e-2)" "unprognostic (6.22e-3)" "unprognostic (3.74e-2)" "unprognostic (2.14e-1)" "unprognostic (4.94e-2)" "unprognostic (4.07e-1)" "unprognostic (2.26e-2)" 8.9 7.4 10.8 8.9 12.9 10.4 8.7 12.1 12.6 10.3 21.5 17.2 7.6 10.0 8.8 14.3 8.0 7.7 9.6 11.8 9.8 9.7 4.4 10.3 11.1 12.0 12.9 8.3 7.2 9.3 6.8 13.6 12.4 12.3 11.9 11.7 9.7 13.5 20.7 12.4 10.7 11.6 8.9 9.0 11.0 17.3 12.1 16.7 13.3 10.8 11.5 16.9 11.1 11.8 32.0 36.0 11.5 20.8 23.5 18.0 28.1 18.0 18.0 19.4 25.4 28.8 19.0 34.7 16.5 23.0 20.4 19.4 29.6 22.3 32.0 47.3 15.1 137.9 13.7 23.9 29.4 53.5 47.6 13.1 28.8 20.9 33.8 13.5 19.7 25.3 37.5 76.3 15.1 31.5 20.8 46.2 6.0 40.2 13.8 30.6 15.6 12.7 15.6 30.5 21.3 8.6 17.6 29.6 21.0 15.2 12.4 25.7 18.5 21.1 22.4 19.6 28.0 19.7 12.7 23.8 21.0 51.8 13.8 36.5 11.1 28.5 13.9 15.7 17.5 7.5 14.3 15.6 12.6 6.9 10.9 11.7 9.0 30.6 13.3 6.2 13.2 13.3 10.8 12.9 12.1 12.6 11.8 9.8 12.0 12.9 12.4 8.9 12.1 11.8 6.8 16.0 9.4 18.3 10.0 15.6 5.5 5.6 14.2 9.4 9.0 5.1 9.2 7.2 5.7 9.2 20.9 14.9 9.7 9.3 0.0 3.3 5.1 7.5 9.4 7.1 9.1 26.5 35.5 5.9 10.6 7.6 5.6 11.6 12.0 10.1 4.6 4.8 8.4 11.8 16.3 9.6 8.2 12.0 12.1 16.2 10.8 8.7 16.0 12.2 6.0 5.8 9.2 11.1 18.7 7.1 10.3 9.4 8.0 10.0 10.8 7.7 7.1 14.7 0.0 6.8 9.3 4.1 17.1 14.7 15.5 15.2 14.0 7.2 8.9 8.4 ANKRD39 MGC41816 ENSG00000213337 "Ankyrin repeat domain 39" Q53RE8 2 96836611-96858016 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 263.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042678 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm Vesicles "HPA042678: AB_10794532" "unprognostic (6.26e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (9.53e-2)" "unprognostic (2.28e-2)" "unprognostic (2.09e-1)" "unprognostic (4.03e-2)" "unprognostic (1.68e-1)" "unprognostic (9.25e-2)" "unprognostic (3.12e-3)" "prognostic favorable (6.12e-5)" "unprognostic (6.15e-2)" "prognostic unfavorable (6.78e-9)" "unprognostic (3.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.03e-2)" "prognostic favorable (5.21e-4)" 6.8 14.1 13.1 7.2 13.4 10.5 7.3 15.9 18.7 6.9 8.9 11.0 8.3 10.2 2.9 7.5 10.2 5.9 14.9 13.2 13.2 7.9 14.8 6.2 11.0 13.0 12.5 6.6 8.3 12.3 16.0 5.5 13.4 8.2 4.0 5.3 7.4 6.8 7.9 8.7 7.4 6.2 12.3 9.7 8.3 4.1 12.5 7.4 5.8 4.5 6.5 8.5 6.8 14.5 24.0 15.7 8.8 19.2 2.9 5.7 21.1 18.1 8.4 22.5 17.3 38.8 9.9 15.2 26.4 13.2 17.7 10.3 11.2 17.3 5.0 17.6 34.1 11.0 14.4 53.5 14.8 24.9 25.6 11.0 10.2 20.5 7.9 8.4 16.3 31.1 23.5 263.1 8.4 37.9 23.3 19.5 11.1 8.1 35.8 17.8 6.2 85.3 11.8 12.3 20.3 13.3 13.1 30.6 23.7 8.0 9.3 13.5 8.2 14.0 13.8 16.0 32.5 13.4 16.2 25.3 14.0 28.5 14.9 20.1 16.0 13.4 44.4 20.8 37.7 41.6 43.6 39.3 16.6 33.2 24.0 29.2 8.3 37.6 23.5 70.4 71.0 21.1 13.1 13.4 15.9 18.7 13.2 13.2 13.0 12.5 13.4 12.3 12.5 14.5 14.0 6.4 8.9 2.6 16.9 9.4 17.2 25.7 9.1 25.2 14.9 23.2 19.5 18.6 17.6 9.2 4.2 44.9 28.1 15.1 25.4 28.8 6.1 18.1 18.7 12.9 18.6 13.5 4.6 32.0 38.6 14.9 11.7 11.8 12.7 12.7 10.8 32.0 31.6 33.7 5.3 19.9 18.3 11.1 10.4 2.9 12.5 13.8 28.4 1.0 9.3 15.9 37.0 4.5 5.9 41.3 11.3 14.7 26.2 12.5 23.4 29.4 35.0 29.8 26.3 24.9 18.8 13.6 14.3 18.9 17.8 21.6 24.4 33.5 16.9 15.7 ANO10 "FLJ10375, MGC47890, SCAR10, TMEM16K" ENSG00000160746 "Anoctamin 10" Q9NW15 3 43354859-43691594 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 123.3;Excitatory neurons: 77.4;Inhibitory neurons: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016624, HPA051569" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" Vesicles "HPA016624: , HPA051569: AB_2681537" "unprognostic (1.51e-3)" "unprognostic (1.38e-2)" "prognostic favorable (6.70e-4)" "prognostic favorable (1.11e-4)" "unprognostic (4.23e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (7.99e-3)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.41e-6)" "unprognostic (9.83e-3)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (5.71e-2)" 26.6 14.1 17.6 15.1 18.6 33.0 21.8 23.9 20.9 22.3 18.4 39.4 61.1 21.6 13.6 25.3 13.9 19.4 12.7 18.1 21.1 29.9 14.1 16.9 7.6 22.7 22.9 13.9 15.2 23.7 13.9 18.1 23.2 14.2 33.7 10.1 28.6 20.2 15.5 32.0 54.7 28.0 19.6 9.1 13.5 13.0 19.8 7.1 24.5 11.6 9.7 18.1 21.5 24.1 30.6 23.6 26.1 27.4 101.1 53.5 31.2 87.7 141.1 42.0 54.4 16.2 27.5 3.1 27.4 114.8 43.1 16.3 20.6 47.0 52.6 33.6 14.2 39.4 28.7 17.7 43.9 7.2 31.1 50.5 36.3 53.6 71.8 79.4 100.3 18.7 30.8 24.9 95.2 20.8 7.8 5.2 31.3 23.7 28.6 6.3 18.7 10.2 85.5 31.4 6.4 19.4 34.4 27.0 19.8 45.3 59.5 14.5 84.7 66.2 24.4 70.2 40.7 15.7 22.9 1.1 60.2 14.6 44.2 7.4 19.0 1.4 6.7 11.1 3.8 2.7 4.6 4.5 13.1 2.5 3.9 6.0 32.8 9.7 12.7 2.3 5.4 7.0 17.6 18.6 23.9 20.9 18.1 21.1 22.7 22.9 23.2 19.6 19.8 24.1 24.3 6.4 3.2 70.2 4.1 5.6 5.8 6.9 8.0 8.0 18.2 8.4 5.2 8.6 13.2 14.7 0.0 14.4 3.7 38.5 123.3 21.6 2.9 11.8 23.6 17.8 9.6 11.8 77.4 17.8 19.5 10.6 10.2 31.2 2.5 6.8 23.6 10.7 11.6 10.1 97.9 23.8 10.2 9.6 5.3 5.2 5.6 9.1 14.2 69.3 9.2 17.1 5.2 71.4 46.4 11.7 22.1 10.1 2.6 4.4 58.4 19.0 4.0 3.6 6.6 19.1 15.7 17.1 23.6 8.7 6.1 17.1 5.8 6.2 26.9 4.8 AP1G1 "ADTG, CLAPG1" ENSG00000166747 "Adaptor related protein complex 1 subunit gamma 1" O43747 16 71729000-71809201 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 268.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009049, HPA041224" Approved Enhanced Vesicles,Cytosol NA NA 62000 "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles Cytosol "CAB009049: AB_2058329, HPA041224: AB_2677370" "unprognostic (4.84e-2)" "unprognostic (5.07e-2)" "unprognostic (2.65e-2)" "unprognostic (2.91e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (8.90e-2)" "unprognostic (9.16e-2)" "unprognostic (2.72e-1)" "unprognostic (2.22e-2)" "unprognostic (4.30e-2)" "prognostic favorable (2.96e-8)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.75e-1)" 19.0 25.7 15.4 23.4 16.4 76.7 24.8 19.6 20.8 20.3 26.9 23.6 22.6 17.8 25.5 26.7 18.0 18.9 13.6 16.8 14.9 36.4 33.2 21.4 24.6 14.4 14.5 15.3 24.2 40.4 16.8 17.5 15.8 22.5 25.7 52.8 22.6 16.3 28.2 26.6 23.6 16.1 13.5 22.4 29.3 30.7 15.6 24.9 24.0 36.5 30.4 20.6 18.4 24.3 43.9 62.4 46.3 48.1 48.2 45.4 41.0 44.6 42.1 56.8 54.5 64.3 47.1 55.0 41.9 60.4 41.5 55.4 62.7 49.3 74.4 21.6 33.8 36.2 31.7 46.5 28.9 44.7 114.1 39.1 33.4 76.0 46.9 36.1 50.2 35.8 47.8 23.0 56.1 80.0 39.2 35.3 43.7 34.6 26.8 62.9 37.3 59.3 53.7 49.3 42.5 25.5 55.7 34.8 24.5 46.6 61.0 33.7 60.2 49.4 37.9 27.3 32.9 35.1 50.2 109.2 40.3 34.4 43.3 5.7 6.9 10.0 6.7 7.6 6.8 5.4 5.9 7.5 7.5 5.7 4.6 5.8 14.9 6.7 6.4 5.2 6.6 4.2 15.4 16.4 19.6 20.8 16.8 14.9 14.4 14.5 15.8 13.5 15.6 24.3 32.6 32.1 31.1 42.4 34.2 28.8 27.4 17.3 22.8 26.8 47.6 25.4 13.4 35.8 25.2 36.8 73.0 14.4 40.6 39.3 19.6 21.1 268.8 55.8 37.9 26.0 23.4 9.9 54.2 21.8 13.3 24.0 46.4 84.8 21.0 26.2 21.4 58.5 16.7 30.3 59.0 25.7 12.2 30.4 27.2 130.7 17.7 32.4 23.2 36.5 25.1 16.4 24.7 53.8 79.2 30.5 24.2 19.9 30.6 36.9 30.5 46.4 31.7 66.6 19.7 33.0 26.4 35.8 37.1 32.4 38.6 24.5 33.4 23.0 26.4 47.8 AP1S1 "AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2" ENSG00000106367 "Adaptor related protein complex 1 subunit sigma 1" P61966 7 101154456-101161596 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Ichthyosis, Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060945 Supported Supported "Golgi apparatus,Vesicles" NA Yes "Cluster 28: Myeloid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus, Vesicles" "HPA060945: AB_2684393" "unprognostic (1.98e-2)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.98e-3)" "unprognostic (8.70e-3)" "unprognostic (7.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.76e-1)" "unprognostic (7.79e-2)" "unprognostic (1.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.81e-2)" "unprognostic (2.14e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" 14.4 24.6 72.2 13.9 75.7 5.8 17.2 43.7 82.6 18.3 34.6 28.6 39.0 16.9 17.0 34.2 13.8 12.8 11.8 85.2 59.6 41.2 36.2 14.7 11.9 53.6 51.9 13.5 21.9 22.8 31.0 15.9 53.4 22.2 22.4 14.6 20.3 9.3 6.4 39.2 30.3 12.7 46.1 20.2 22.0 16.4 62.5 19.1 15.2 8.5 13.6 20.1 19.5 62.7 121.0 87.3 63.3 118.4 42.8 70.4 138.2 76.8 51.1 50.8 52.8 47.3 147.5 24.9 127.5 84.6 97.1 59.0 35.3 116.0 45.6 57.0 56.6 16.8 52.0 61.4 54.2 46.8 87.7 79.1 91.0 49.4 20.6 76.7 76.8 54.1 56.7 103.2 129.9 292.1 40.4 107.8 97.8 177.0 188.2 24.9 27.2 54.6 127.8 88.8 47.5 157.7 40.4 121.1 151.4 101.6 50.7 46.8 79.0 74.1 132.3 27.6 55.2 21.4 51.4 48.4 195.2 50.1 152.9 0.5 3.3 0.3 2.3 3.1 2.2 2.6 3.2 2.5 4.6 2.0 1.9 1.8 1.2 1.3 1.8 5.0 3.3 2.4 72.2 75.7 43.7 82.6 85.2 59.6 53.6 51.9 53.4 46.1 62.5 62.7 34.4 6.4 0.0 2.3 17.9 38.7 29.7 173.0 46.7 30.7 54.8 49.0 1.1 45.8 72.9 55.2 8.4 170.7 19.8 88.4 344.4 128.2 2.5 28.8 34.2 36.7 90.3 16.2 21.2 111.7 101.3 27.7 42.8 31.9 5.7 85.3 28.9 43.0 95.2 30.3 10.3 96.5 116.0 24.8 21.6 3.4 35.1 27.3 53.4 7.5 58.0 34.1 17.5 2.5 9.8 183.3 86.1 21.8 17.4 34.9 241.3 304.8 34.9 22.3 19.7 11.4 38.4 13.1 70.9 51.4 45.5 60.5 19.5 157.4 119.9 38.2 AP1S2 "MRX59, MRXS5, PGS, SIGMA1B" ENSG00000182287 "Adaptor related protein complex 1 subunit sigma 2" P56377 X 15825806-15854931 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "epididymis: 663.3" "Cell type enhanced" "Detected in all" "Hofbauer cells: 259.8;Kupffer cells: 392.6;Langerhans cells: 609.2;Macrophages: 362.7;monocytes: 630.0" "Group enriched" "Detected in all" 4 "endometrial cancer: 13.1;glioma: 22.0;melanoma: 49.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 326.8;intermediate monocyte: 325.0;myeloid DC: 221.1;non-classical monocyte: 175.4;plasmacytoid DC: 82.2" "Group enriched" "Detected in all" 5 "dendritic cells: 221.1;monocytes: 326.8" "Cell line enhanced" "Detected in all" "Karpas-707: 298.0;SK-MEL-30: 442.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049894, HPA060945" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Vesicles" "HPA049894: AB_2680939, HPA060945: AB_2684393" "prognostic favorable (9.86e-4)" "unprognostic (4.62e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" "unprognostic (2.47e-3)" "unprognostic (3.85e-1)" "unprognostic (2.03e-3)" "unprognostic (5.76e-2)" "unprognostic (1.43e-2)" "prognostic favorable (5.53e-6)" "unprognostic (1.85e-2)" "unprognostic (5.61e-2)" "unprognostic (5.08e-2)" "unprognostic (6.35e-2)" "unprognostic (3.13e-1)" "unprognostic (9.34e-2)" "unprognostic (6.47e-2)" 28.3 21.4 24.6 36.7 28.4 38.3 15.0 32.0 36.9 31.6 27.3 42.1 11.9 52.2 663.3 21.4 13.5 20.1 74.8 25.1 48.0 13.1 15.9 25.8 33.2 42.7 35.8 8.8 7.8 16.7 19.4 42.0 47.0 11.6 22.0 43.7 9.5 30.5 70.1 14.0 20.1 76.3 34.4 43.0 19.5 23.4 29.6 28.7 12.5 93.7 28.8 26.1 12.7 33.8 12.0 14.2 130.1 78.4 29.5 19.1 5.0 47.1 22.7 31.1 41.1 9.6 11.1 22.6 183.0 72.6 50.4 16.1 31.7 10.8 57.0 30.1 64.9 15.3 16.7 14.7 24.2 63.1 16.9 12.2 11.2 36.0 33.1 50.4 78.1 19.1 14.3 298.0 72.4 8.7 12.9 39.5 171.0 6.4 42.5 29.5 116.7 50.6 37.4 2.5 14.8 69.2 18.4 4.8 442.2 84.1 52.7 69.2 43.9 67.8 21.2 92.5 41.9 25.5 58.7 37.3 33.6 28.0 159.7 50.9 326.8 34.6 21.1 325.0 24.8 30.8 25.5 20.6 221.1 28.0 18.5 18.1 52.8 27.9 175.4 82.2 38.1 228.0 24.6 28.4 32.0 36.9 25.1 48.0 42.7 35.8 47.0 34.4 29.6 33.8 130.8 3.2 13.1 37.2 77.0 55.2 12.7 9.1 8.6 34.7 12.0 11.4 195.6 12.8 3.2 9.2 12.5 5.3 114.2 9.2 33.2 13.7 5.1 50.4 32.6 166.3 26.9 32.6 15.1 6.4 18.9 38.0 7.7 78.0 78.6 15.6 147.4 8.6 259.8 11.8 73.2 8.4 12.2 392.6 609.2 17.5 17.4 362.7 149.4 31.9 630.0 21.1 62.8 19.1 85.0 10.3 14.0 7.2 26.0 19.0 6.5 9.0 1.6 39.3 39.5 26.7 39.1 55.7 28.8 10.6 51.6 5.6 58.3 4.0 8.5 6.7 AP2A2 "ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899" ENSG00000183020 "Adaptor related protein complex 2 subunit alpha 2" O94973 11 924894-1012245 "Plasma proteins, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017514, HPA043040" Supported Supported Nucleoplasm,Vesicles NA NA 10000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" Vesicles Nucleoplasm "CAB017514: AB_2056344, HPA043040: AB_2678283" "unprognostic (1.90e-1)" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (1.28e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (9.27e-5)" "unprognostic (1.34e-2)" "unprognostic (4.09e-1)" "unprognostic (1.70e-1)" "prognostic favorable (4.57e-4)" "unprognostic (2.41e-1)" "unprognostic (2.86e-3)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (1.40e-1)" "unprognostic (2.08e-2)" 20.1 18.0 3.5 1.3 5.1 4.5 16.6 10.8 9.9 20.3 1.4 23.0 5.4 17.9 1.5 12.7 18.1 2.0 19.1 5.5 3.5 34.4 29.9 18.9 3.2 0.9 2.1 17.5 25.3 3.7 25.6 5.2 3.0 20.3 4.9 5.8 14.6 4.0 14.1 14.5 19.6 5.6 0.0 57.6 20.6 15.5 3.3 3.8 13.9 1.6 2.5 19.0 15.7 1.4 7.5 2.9 3.7 10.7 13.8 14.2 9.1 10.2 3.3 6.0 4.9 1.3 7.3 7.4 8.7 12.3 5.7 8.9 8.9 5.6 3.9 5.5 23.2 2.1 10.4 3.9 5.3 2.8 4.9 16.8 6.1 3.1 6.1 14.8 8.5 5.0 5.9 4.7 6.3 0.4 2.6 3.2 2.0 9.1 17.9 4.2 2.6 8.1 9.2 6.2 12.3 10.0 11.4 9.2 1.7 6.3 5.4 0.8 13.3 1.9 2.3 2.8 5.2 4.3 3.9 5.3 4.0 3.7 3.1 1.5 1.7 1.5 1.1 1.7 0.5 0.5 1.1 0.6 1.4 1.0 1.1 1.2 2.1 1.1 1.4 1.3 2.1 0.6 3.5 5.1 10.8 9.9 5.5 3.5 0.9 2.1 3.0 0.0 3.3 1.4 38.1 38.5 21.8 29.4 14.3 14.3 12.4 13.3 7.4 50.9 27.2 23.0 12.9 21.5 15.9 62.5 60.5 42.1 17.3 45.3 39.2 37.5 46.7 64.0 44.6 36.6 35.2 27.1 37.2 18.0 45.2 28.7 16.3 86.7 27.3 31.0 80.3 59.8 82.8 101.0 36.4 32.3 18.3 104.7 26.9 28.3 34.5 51.8 8.8 41.2 31.2 30.4 39.1 23.1 21.9 25.8 24.2 27.8 13.6 16.9 43.5 70.4 23.5 69.2 26.3 20.7 22.6 72.7 28.0 11.2 11.4 28.5 19.7 30.5 37.0 11.5 APOA1 ENSG00000118137 "Apolipoprotein A1" P02647 11 116835751-116837622 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 19248.5" "Group enriched" "Detected in many" 21 "Hepatocytes: 27332.1;Proximal enterocytes: 18348.1" "Cancer enriched" "Detected in many" 48 "liver cancer: 4515.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 17 "Hep G2: 3460.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016778, HPA046715" Supported Approved Vesicles,Cytosol "Secreted to blood" NA NA 1450000000000 110000000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles Cytosol "CAB016778: , HPA046715: AB_2679768" "unprognostic (1.88e-3)" "unprognostic (4.53e-2)" "unprognostic (7.46e-2)" "unprognostic (4.00e-3)" "unprognostic (3.70e-2)" "unprognostic (1.41e-1)" "prognostic favorable (5.05e-4)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (9.60e-3)" "unprognostic (1.59e-3)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.67e-8)" "unprognostic (3.46e-3)" "unprognostic (1.15e-1)" "unprognostic (6.24e-2)" "unprognostic (9.54e-2)" 3.2 1.4 1.2 3.6 1.2 0.0 2.1 1.1 1.4 0.8 0.8 7.4 1709.3 3.5 0.4 1.1 6.1 1.7 67.2 1.0 1.1 3.7 19248.5 2.7 3.2 1.1 1.1 23.1 2.5 0.0 4.2 1.6 1.1 1.1 0.2 0.1 0.7 1.0 0.8 1.0 4053.7 2.1 1.1 9.0 14.6 384.5 1.2 0.9 3.7 0.2 0.1 0.5 1.5 1.2 0.0 0.0 0.6 0.1 0.0 0.0 15.0 0.0 0.0 0.0 0.0 203.4 0.3 3.1 6.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 7.3 1.9 3460.4 0.0 16.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.2 0.3 15.0 1.2 1.2 0.1 0.5 15.0 20.3 0.0 2.6 5.7 20.7 8.9 0.0 0.0 3.9 0.0 0.1 2.6 0.0 0.4 2.1 0.1 1.2 0.2 4.9 0.0 5.5 0.2 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.5 0.2 0.1 0.2 0.5 0.0 0.2 0.0 1.2 0.6 0.1 1.2 1.2 1.1 1.4 1.0 1.1 1.1 1.1 1.1 1.1 1.2 1.2 2.0 3.2 3.3 0.3 49.7 0.1 0.5 0.2 0.6 0.5 0.9 0.9 37.0 479.0 1.3 0.0 0.0 0.6 5.1 0.4 0.0 0.1 36.9 15.2 4.3 50.3 1.8 541.9 0.5 1.1 4.2 5.8 17.9 1.7 2.5 419.2 458.7 27332.1 3.3 0.0 0.8 458.8 0.0 681.2 2.0 149.7 22.4 2.1 0.0 0.0 0.0 0.3 3.1 0.0 0.3 0.3 458.2 4.9 1.0 0.1 18348.1 9.0 0.4 0.6 6.6 1.6 13.0 39.8 11.2 0.0 0.6 4.2 35.7 1051.7 175.7 0.3 APOB ENSG00000084674 "Apolipoprotein B" P04114 2 21001429-21044073 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Atherosclerosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 143 "intestine: 304.3;liver: 1191.0" "Group enriched" "Detected in some" 8 "Hepatocytes: 2967.4;Proximal enterocytes: 1585.9" "Cancer enriched" "Detected in some" 99 "liver cancer: 295.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "Hep G2: 1079.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016070, HPA049793" Supported Supported Vesicles,Cytosol "Secreted to blood" NA NA 1490000000000 100000000000 "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Vesicles, Cytosol" "CAB016070: AB_626690, HPA049793: AB_2680885" "unprognostic (1.63e-2)" "unprognostic (2.71e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (1.04e-2)" "unprognostic (7.31e-2)" "unprognostic (1.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.43e-2)" "unprognostic (8.89e-3)" "unprognostic (3.01e-1)" "unprognostic (4.59e-3)" "unprognostic (3.60e-3)" "unprognostic (2.89e-2)" "unprognostic (2.38e-1)" "unprognostic (2.99e-1)" "unprognostic (6.23e-2)" 2.7 0.0 0.1 0.2 0.2 0.1 0.9 0.1 0.1 0.7 0.2 0.4 181.4 0.2 0.0 0.1 0.1 0.5 5.2 0.1 0.3 0.3 1191.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.1 0.5 304.3 0.2 0.2 0.5 0.3 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 35.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1079.8 0.0 0.6 0.1 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.5 0.6 0.0 0.6 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.3 0.2 0.2 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 277.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 1.6 3.5 0.0 104.2 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.1 52.8 2967.4 0.1 0.0 0.2 30.8 0.0 69.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.5 1.5 0.0 0.0 1585.9 0.6 0.0 0.0 0.0 1.1 0.2 0.5 0.3 0.0 0.0 0.0 3.9 0.9 14.5 0.0 APP AD1 ENSG00000142192 "Amyloid beta precursor protein" P05067 21 25880550-26171128 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 870.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 38.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000157, HPA001462" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 26000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" Vesicles "CAB000157: AB_323833, HPA001462: AB_1078185" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (3.69e-3)" "unprognostic (2.54e-1)" "unprognostic (8.22e-2)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "unprognostic (4.28e-2)" "unprognostic (5.35e-2)" "prognostic favorable (2.79e-6)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" "unprognostic (5.23e-2)" "unprognostic (2.08e-3)" 249.9 498.0 413.0 157.4 457.6 134.4 447.5 413.1 572.4 264.2 396.8 357.2 226.4 281.1 293.3 178.6 308.1 350.8 389.0 456.2 405.3 532.5 298.2 279.4 78.9 425.0 481.9 306.2 323.5 278.6 155.4 451.9 448.7 260.6 328.5 209.3 270.7 343.6 107.5 218.6 200.3 379.9 419.7 154.4 213.5 165.6 426.4 159.2 469.9 176.0 78.2 304.9 151.7 523.5 388.7 489.9 538.4 448.5 707.7 869.8 559.8 757.1 1029.2 386.6 449.3 286.4 941.0 0.9 848.3 614.8 505.1 255.6 326.4 921.6 324.4 14.7 253.1 0.8 275.6 204.1 688.0 372.0 19.6 790.4 990.7 456.8 823.0 1584.3 1750.7 158.6 0.8 39.0 614.5 433.1 6.5 4.0 416.2 644.9 418.6 241.2 505.2 325.3 1283.3 270.1 267.3 385.6 824.0 549.0 393.4 720.0 482.4 400.1 1837.1 850.8 350.2 310.4 371.6 232.3 3.1 4.8 690.4 1.6 836.3 1.1 7.5 0.0 0.2 2.2 0.3 0.8 2.2 0.7 5.6 2.2 2.3 0.6 1.5 0.5 1.6 38.1 0.6 3.3 413.0 457.6 413.1 572.4 456.2 405.3 425.0 481.9 448.7 419.7 426.4 523.5 330.2 109.0 39.6 70.5 47.6 181.6 215.6 449.0 306.7 45.2 280.3 199.6 143.2 296.0 214.0 502.1 29.2 472.6 180.7 395.2 56.7 398.7 46.1 78.8 162.2 416.0 162.6 29.2 481.6 180.4 141.2 309.5 164.7 110.7 8.2 100.3 539.7 125.7 76.3 84.1 525.5 303.1 256.3 61.6 79.9 61.8 242.6 69.9 161.9 189.3 89.9 329.9 4.1 423.2 870.8 205.4 223.1 296.8 24.0 187.5 95.2 165.8 164.7 24.5 118.3 336.5 198.5 38.3 86.9 85.9 106.1 552.1 27.0 111.4 283.5 133.6 AQP10 ENSG00000143595 "Aquaporin 10" Q96PS8 1 154321090-154325325 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 68.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 1.5;Erythroid cells: 1.3;granulocytes: 5.7;Hepatic stellate cells: 1.4;Macrophages: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 18.0;HMC-1: 7.1;K-562: 21.0;SH-SY5Y: 4.8" "Not detected" "Not detected" "HPA062621, HPA065947" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 51: Myeloid cells - Hemostasis" "Plasma membrane" Vesicles "HPA062621: , HPA065947: AB_2685584" "unprognostic (6.84e-2)" "unprognostic (4.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (8.45e-4)" "unprognostic (1.63e-1)" "unprognostic (3.07e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 68.5 0.0 0.1 0.1 4.6 0.1 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 49.7 0.0 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.4 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.1 5.7 0.2 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.1 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610356 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.6;liver: 16.1" "Cell type enhanced" "Detected in many" "Early spermatids: 42.0;Hepatocytes: 35.9;Late spermatids: 65.0;Muller glia cells: 30.7;Proximal enterocytes: 33.2;Spermatocytes: 56.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 8.2;GAMG: 12.3;Hep G2: 13.6;OE19: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favorable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 13.2 3.4 0.7 3.0 0.6 1.2 4.6 3.3 0.8 1.0 2.3 28.6 0.8 1.0 0.4 0.8 1.2 0.8 2.6 3.4 6.0 16.1 0.5 0.8 3.3 3.1 6.0 4.0 0.5 1.5 0.8 3.5 4.0 2.1 5.6 0.7 0.4 0.9 0.9 25.3 0.4 2.7 0.9 2.4 8.1 3.0 0.1 1.5 0.2 0.1 0.8 0.6 3.0 1.0 3.4 1.4 2.2 3.1 0.8 1.3 1.6 0.8 1.6 0.7 8.2 1.6 1.6 0.7 0.8 12.3 0.9 0.6 0.1 0.8 4.7 1.2 1.3 1.3 13.6 1.0 2.8 1.4 0.8 0.3 0.9 0.2 1.9 0.3 0.4 0.9 1.0 1.9 1.7 0.9 2.0 1.4 7.8 3.1 1.3 3.3 0.6 0.9 1.2 1.3 0.9 2.1 0.5 0.8 1.1 1.5 0.3 0.9 1.2 3.7 2.4 1.0 1.0 0.8 1.3 0.4 0.2 1.8 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.2 0.4 0.0 0.5 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.2 3.4 3.0 4.6 3.3 2.6 3.4 3.3 3.1 3.5 2.7 3.0 3.0 0.6 0.0 0.0 3.9 0.8 0.1 0.9 0.4 1.8 7.5 2.1 1.3 0.7 7.2 0.2 1.8 0.0 7.5 0.6 10.8 0.0 1.1 42.0 1.2 0.8 0.5 4.2 0.0 13.5 4.0 11.4 1.5 3.6 0.8 4.5 17.1 0.4 35.9 1.2 0.0 14.6 2.9 0.0 0.6 0.4 65.0 15.5 0.5 1.8 1.0 0.0 30.7 0.0 9.0 9.9 2.5 5.5 11.3 0.3 1.4 33.2 19.9 0.2 5.0 0.0 0.5 1.2 56.0 6.4 0.4 0.1 15.9 0.7 21.4 6.4 0.4 ARC "Arg3.1, KIAA0278" ENSG00000198576 "Activity regulated cytoskeleton associated protein" Q7LC44 8 142611049-142614479 "Predicted intracellular proteins" "Endocytosis, Transport" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 122.9;pituitary gland: 67.6" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 57.0;Endometrial stromal cells: 47.8;Enteroendocrine cells: 164.2;Skeletal myocytes: 57.7" "Cancer enriched" "Detected in many" 12 "glioma: 36.1" "Group enriched" "Detected in all" 6 "cerebral cortex: 122.9;hippocampal formation: 34.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 8.1;HEK 293: 10.0;SCLC-21H: 23.6;U-2 OS: 11.5;U-87 MG: 12.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basal ganglia: 20.7;cerebral cortex: 75.1;hippocampal formation: 42.4;olfactory bulb: 22.9" "HPA056430, CAB079013" Supported Approved Vesicles,Microtubules NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 36: Stromal cells - Cell proliferation" "Vesicles, Microtubules" "CAB079013: , HPA056430: AB_2683130" "unprognostic (1.40e-3)" "unprognostic (2.95e-2)" "unprognostic (4.35e-3)" "unprognostic (4.87e-4)" "unprognostic (6.83e-2)" "unprognostic (8.12e-2)" "unprognostic (5.13e-2)" "unprognostic (1.77e-1)" "unprognostic (5.07e-2)" "unprognostic (9.43e-2)" "unprognostic (4.15e-3)" "unprognostic (1.40e-1)" "unprognostic (2.14e-2)" "unprognostic (1.01e-2)" "unprognostic (7.42e-2)" "unprognostic (1.54e-1)" "unprognostic (3.35e-2)" 14.2 10.2 6.6 0.4 8.2 0.2 1.2 4.5 122.9 3.3 2.7 1.6 0.2 0.9 0.9 1.6 1.9 2.0 2.1 34.2 14.1 4.0 0.3 8.1 0.0 6.4 4.0 0.6 4.0 0.0 67.6 0.9 4.8 0.8 0.1 0.8 0.8 3.8 0.4 10.9 1.1 0.3 3.6 0.7 8.7 0.6 8.9 0.1 1.0 0.4 0.1 0.7 4.5 13.4 0.0 0.1 0.4 8.1 0.1 0.8 0.0 1.7 0.0 0.4 0.2 0.2 0.0 0.0 1.1 0.3 0.3 0.1 0.5 0.0 0.0 0.0 10.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.1 0.0 0.0 0.1 3.5 0.0 0.0 3.7 1.4 1.8 0.0 0.8 0.0 0.0 0.0 23.6 5.5 0.6 0.0 0.3 0.0 0.1 0.1 0.0 1.3 11.5 0.9 0.2 2.2 0.1 0.0 12.8 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 8.2 4.5 122.9 34.2 14.1 6.4 4.0 4.8 3.6 8.9 13.4 19.7 0.0 3.0 1.6 1.9 5.1 16.6 2.6 1.2 8.4 33.2 57.0 4.5 4.3 0.8 0.0 0.0 0.1 5.8 6.0 0.0 1.6 0.1 9.2 47.8 9.8 164.2 0.0 17.0 0.0 0.4 24.1 21.9 10.3 0.0 0.5 7.5 0.0 1.6 3.3 0.8 6.2 4.1 0.8 7.0 0.0 0.3 8.2 7.2 1.0 0.1 15.2 0.0 3.5 0.8 0.1 0.0 1.9 1.1 10.3 0.3 0.0 0.3 2.8 0.0 57.7 27.0 0.2 0.6 4.7 6.5 0.1 4.2 0.5 4.1 2.7 ARHGAP25 KIAA0053 ENSG00000163219 "Rho GTPase activating protein 25" P42331 2 68679601-68826833 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 72.8" "Cell type enhanced" "Detected in many" "B-cells: 88.7;granulocytes: 210.8;Microglial cells: 88.1;NK-cells: 103.0;T-cells: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 657.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 66.7;HMC-1: 256.1;NB-4: 47.3;U-266/70: 50.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035346, HPA061395" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Vesicles" "HPA035346: AB_10601116, HPA061395: AB_2684501" "unprognostic (1.13e-3)" "prognostic favorable (7.72e-4)" "unprognostic (2.45e-2)" "unprognostic (4.44e-3)" "unprognostic (8.07e-2)" "unprognostic (1.36e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.00e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (3.10e-1)" "unprognostic (4.26e-2)" "unprognostic (3.61e-1)" "unprognostic (4.49e-2)" 11.1 5.2 5.2 38.8 5.4 37.4 8.0 5.6 7.9 6.0 5.1 7.2 6.2 6.7 22.7 4.3 4.7 11.7 6.7 5.2 5.6 7.1 10.1 21.3 71.4 7.6 6.0 16.7 2.1 2.3 3.5 10.7 6.7 5.0 9.6 0.6 5.1 3.8 3.2 6.2 23.3 8.3 7.1 72.8 8.8 2.5 7.0 27.3 5.1 8.4 67.3 11.9 4.7 8.4 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 20.8 0.5 0.0 0.1 2.5 0.0 20.5 0.0 2.3 0.0 66.7 0.0 0.0 1.0 14.8 256.1 0.2 2.4 0.4 8.1 0.0 0.0 22.2 0.4 23.6 0.0 0.0 17.2 47.3 1.2 0.2 0.0 18.7 4.3 0.8 0.0 5.4 4.1 0.6 0.2 0.0 1.4 1.4 0.0 12.3 3.5 0.1 0.9 0.1 0.5 50.8 29.0 16.8 0.2 33.3 0.3 234.8 60.8 528.7 171.3 75.9 107.0 156.4 76.2 150.0 37.4 100.8 54.2 95.2 657.3 170.6 94.8 52.3 102.0 132.0 5.2 5.4 5.6 7.9 5.2 5.6 7.6 6.0 6.7 7.1 7.0 8.4 14.1 3.2 15.0 0.3 88.7 5.6 12.4 2.9 5.7 0.8 0.7 6.1 1.4 1.5 2.0 0.0 0.0 0.5 35.1 0.1 1.9 0.1 1.8 0.7 0.6 16.6 3.0 11.6 15.5 0.2 0.4 3.5 2.0 0.4 210.8 0.1 15.4 1.0 48.6 0.0 0.9 0.5 2.0 27.3 12.8 3.6 1.5 22.6 1.8 88.1 40.9 0.5 103.0 0.5 0.9 0.0 0.1 2.6 34.7 1.2 0.0 0.2 5.2 0.2 6.6 0.8 2.1 0.6 1.3 2.5 1.4 0.3 53.7 1.8 0.2 2.5 ARL4D ARF4L ENSG00000175906 "ADP ribosylation factor like GTPase 4D" P49703 17 43398993-43401137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 224.3;Early spermatids: 220.8;Rod photoreceptor cells: 259.6;Squamous epithelial cells: 223.4;Suprabasal keratinocytes: 254.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 32.3;naive B-cell: 36.1" "Lineage enriched" "Detected in all" 4 "B-cells: 36.1" "Cell line enhanced" "Detected in many" "HHSteC: 57.1;hTCEpi: 76.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 8.7;cerebral cortex: 8.8;hippocampal formation: 5.7;olfactory bulb: 4.2;spinal cord: 5.4" HPA060379 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 77: Retina - Visual perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" Vesicles "Golgi apparatus" "HPA060379: AB_2684269" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (2.34e-2)" "prognostic favorable (1.16e-5)" "unprognostic (7.71e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.47e-1)" "unprognostic (4.59e-2)" "unprognostic (4.45e-1)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (7.87e-2)" "unprognostic (2.00e-3)" "unprognostic (3.49e-2)" "unprognostic (6.48e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (9.25e-4)" 21.0 4.3 7.9 2.2 8.7 0.9 7.2 9.1 11.6 29.3 12.6 27.9 2.0 20.2 4.7 82.2 22.1 7.3 12.7 8.1 7.1 30.5 56.4 16.2 1.6 5.6 5.7 9.7 2.2 8.1 21.6 7.7 5.7 11.0 3.5 85.1 16.9 15.2 1.9 44.9 6.0 14.8 5.4 16.7 7.6 32.1 5.7 1.6 38.3 3.4 3.0 28.5 39.5 9.3 8.7 10.9 6.7 5.2 12.5 17.2 3.1 21.0 21.5 14.6 18.8 9.7 37.7 0.1 10.3 22.6 10.0 23.4 4.5 32.0 10.0 1.9 7.5 0.7 8.7 22.5 57.1 2.4 2.1 19.2 76.1 21.3 45.8 13.2 6.3 2.3 1.4 0.4 14.3 0.5 5.4 5.0 7.1 0.8 10.1 9.1 1.5 1.0 24.9 18.8 7.9 5.6 16.5 0.4 15.8 14.4 30.6 8.5 1.3 21.0 6.7 27.2 6.4 2.1 1.1 0.0 25.8 1.9 7.1 0.1 2.8 2.1 5.1 4.3 3.2 32.3 4.2 4.7 8.4 36.1 4.6 5.2 0.0 2.1 1.4 2.5 1.0 4.6 7.9 8.7 9.1 11.6 8.1 7.1 5.6 5.7 5.7 5.4 5.7 9.3 28.8 0.0 1.7 0.7 37.9 224.3 41.4 142.2 132.1 155.5 35.3 60.6 12.7 5.7 49.5 132.4 116.7 39.9 37.4 1.5 76.3 2.3 220.8 55.5 33.3 32.2 11.9 4.0 9.1 1.8 24.1 52.3 5.6 69.6 0.0 20.7 22.9 29.7 8.1 16.8 9.3 5.4 26.4 4.1 77.9 55.3 15.8 16.6 26.6 1.0 1.4 70.1 2.1 2.5 1.3 3.7 0.9 22.6 1.4 9.5 0.3 17.6 7.6 259.6 13.1 11.1 45.1 25.0 9.2 223.4 254.6 105.5 31.7 19.3 4.6 78.1 ARMCX4 "CXorf35, GASP4, MGC40053" ENSG00000196440 "Armadillo repeat containing X-linked 4" Q5H9R4 X 101418287-101533459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 66.6;Excitatory neurons: 59.1;Inhibitory neurons: 87.5;Microglial cells: 63.7;Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 75.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000429, HPA051930" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Vesicles "HPA000429: AB_1078210, HPA051930: AB_2681665" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.10e-2)" "unprognostic (6.91e-3)" "unprognostic (2.81e-3)" "unprognostic (7.28e-2)" "unprognostic (3.67e-4)" "unprognostic (2.33e-2)" "unprognostic (4.29e-1)" "prognostic favorable (8.20e-5)" "unprognostic (1.94e-2)" "unprognostic (1.40e-2)" "unprognostic (6.94e-3)" "unprognostic (1.69e-1)" "unprognostic (1.88e-1)" "unprognostic (4.92e-2)" 2.1 4.0 1.8 1.1 2.1 0.7 2.7 1.4 2.0 2.8 0.0 2.5 0.9 3.6 2.5 1.0 3.0 1.3 1.8 2.0 3.0 2.4 1.0 1.8 0.9 1.8 2.1 7.1 2.0 4.5 4.5 1.7 2.1 3.6 1.6 1.6 1.9 4.7 1.9 2.1 2.1 2.6 1.1 1.7 1.8 0.9 2.2 0.9 2.7 1.0 0.8 2.3 1.8 2.3 2.4 0.6 7.9 0.0 3.7 3.9 0.8 5.5 4.3 4.4 8.5 1.9 0.7 0.0 2.1 8.2 0.1 0.9 0.0 0.1 7.2 0.0 0.9 0.6 2.5 0.0 2.2 0.0 3.0 2.4 0.4 9.6 0.0 0.0 7.8 0.0 0.0 0.7 2.0 0.0 0.3 0.3 5.8 0.8 0.0 0.4 6.5 0.0 1.1 1.4 5.3 4.9 0.8 0.0 3.0 1.3 0.6 1.2 2.9 2.0 1.2 6.1 0.0 0.0 0.0 0.0 3.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 1.4 2.0 2.0 3.0 1.8 2.1 2.1 1.1 2.2 2.3 8.7 3.2 6.8 66.6 2.2 2.4 7.7 1.7 5.7 24.5 9.1 7.1 10.5 2.8 7.9 27.6 8.4 1.7 2.6 2.3 17.6 2.7 0.2 5.6 8.9 8.0 3.0 1.3 59.1 2.3 0.7 11.0 2.0 8.3 3.8 13.3 5.3 2.5 2.3 23.5 87.5 2.3 6.1 3.8 5.1 0.7 10.5 2.4 17.8 63.7 2.8 11.6 4.1 78.4 75.6 2.0 3.9 12.4 2.2 5.3 4.7 4.8 9.8 7.8 0.0 8.1 10.9 1.3 1.3 1.8 3.4 1.5 2.2 8.4 4.0 4.5 ARNTL "bHLHe5, BMAL1, JAP3, MOP3, PASD3" ENSG00000133794 "Aryl hydrocarbon receptor nuclear translocator like" O00327 11 13276652-13387266 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 63.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 11.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045962, HPA050938" Supported Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "CAB045962: AB_11124144, HPA050938: AB_2681282" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (9.00e-2)" "unprognostic (1.77e-1)" "unprognostic (3.72e-1)" "unprognostic (3.76e-2)" "unprognostic (8.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (2.10e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (7.08e-2)" 15.0 13.3 3.2 5.1 4.8 7.4 14.1 4.8 8.3 10.5 3.2 12.4 5.2 11.6 1.6 10.5 11.5 4.0 9.5 5.5 1.9 7.2 19.4 15.0 5.8 1.6 2.6 19.7 10.3 1.5 12.3 4.4 2.2 8.5 4.1 23.4 12.7 3.4 27.0 17.6 12.4 5.6 1.9 11.6 10.9 10.9 4.4 14.1 18.9 8.2 6.4 9.3 11.5 7.4 8.2 9.0 7.5 4.0 15.0 9.0 5.7 9.5 8.1 8.6 9.7 3.7 10.9 0.1 2.6 5.2 10.4 3.4 5.3 10.3 7.7 13.6 6.3 3.9 6.6 1.8 23.7 1.8 16.2 10.1 21.3 3.7 14.1 5.9 6.2 12.6 2.5 14.9 6.9 4.7 4.7 0.9 1.6 5.4 4.3 5.1 11.4 3.4 5.7 1.8 1.2 12.2 6.1 0.7 7.6 7.1 5.7 7.0 11.5 6.2 6.8 20.3 5.5 4.1 12.0 0.0 6.4 4.1 8.3 4.3 8.3 17.9 18.1 9.0 25.2 2.6 16.8 15.6 8.4 3.1 9.4 11.1 24.5 14.1 8.9 1.1 11.1 10.7 3.2 4.8 4.8 8.3 5.5 1.9 1.6 2.6 2.2 1.9 4.4 7.4 4.9 25.6 21.0 49.9 9.0 30.8 13.4 7.3 10.2 28.3 6.1 5.0 8.8 10.0 11.1 1.8 16.7 17.6 34.8 8.6 17.6 6.8 1.5 6.1 14.2 6.6 1.2 3.0 63.6 6.4 2.2 10.3 11.7 12.9 2.5 6.9 10.8 22.9 8.2 30.3 30.5 4.6 4.1 14.0 12.3 4.2 12.8 11.9 3.6 18.7 13.1 18.8 32.0 34.2 11.9 8.3 9.3 19.9 11.5 8.0 13.5 11.3 5.3 30.9 13.1 6.6 10.7 4.7 5.4 9.4 32.4 6.3 33.0 4.7 4.5 12.0 ARPC1B "ARC41, p40-ARC, p41-ARC" ENSG00000130429 "Actin related protein 2/3 complex subunit 1B" O15143 7 99374249-99394816 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 317.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 948.7;Hofbauer cells: 1088.1;Kupffer cells: 1035.5;monocytes: 1029.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 899.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004832 Enhanced Supported Vesicles,Cytosol NA NA 13000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 51: Myeloid cells - Hemostasis" "Vesicles, Cytosol" "HPA004832: AB_1845044" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (2.84e-3)" "unprognostic (2.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (2.57e-4)" "unprognostic (4.37e-2)" "unprognostic (7.76e-2)" "unprognostic (1.02e-2)" "unprognostic (1.56e-1)" "unprognostic (4.86e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (1.18e-1)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (7.27e-2)" 132.2 71.6 19.6 173.3 20.4 209.8 99.1 20.5 25.9 71.7 23.9 104.4 106.6 71.0 14.2 51.6 73.9 48.9 70.1 18.2 21.7 84.4 81.7 169.5 202.1 28.9 23.5 30.1 51.4 14.3 52.4 66.4 26.8 67.4 32.5 1.1 72.4 30.1 18.6 43.2 160.2 39.4 27.3 317.3 66.2 20.4 33.3 62.2 90.1 19.5 95.5 85.1 57.5 28.4 124.3 219.3 16.1 47.5 62.9 225.0 167.9 165.8 170.5 68.7 60.5 146.3 477.8 215.4 308.2 188.5 146.9 93.1 22.4 152.5 27.5 175.5 59.9 157.0 61.6 98.4 179.7 159.5 515.8 125.7 77.3 96.2 94.3 134.6 181.5 113.3 177.9 508.0 100.2 574.5 158.8 332.5 59.6 148.9 435.5 139.5 14.6 536.2 141.2 59.7 13.2 42.1 116.4 506.3 899.5 54.4 119.7 322.4 262.0 190.1 155.8 339.0 216.6 91.4 190.1 263.5 189.9 411.0 350.4 1026.1 2400.1 1973.2 770.3 2458.8 723.9 786.7 883.0 857.2 2054.4 699.1 510.2 680.0 1963.4 633.5 2382.6 1172.9 1315.9 4198.2 19.6 20.4 20.5 25.9 18.2 21.7 28.9 23.5 26.8 27.3 33.3 28.4 182.2 41.7 86.6 1.0 279.2 60.5 141.3 587.9 58.1 9.6 50.8 34.3 9.1 107.2 260.2 130.6 8.4 588.4 416.3 264.9 25.4 407.1 3.2 37.7 37.2 265.5 112.7 84.9 3.2 414.5 948.7 99.7 62.7 41.3 192.2 31.0 226.3 54.5 1088.1 1.7 2.3 97.6 203.4 1035.5 422.8 8.4 37.3 789.1 179.7 28.1 1029.7 21.4 498.5 0.5 1.6 405.1 268.7 18.0 154.0 132.4 516.0 110.9 214.0 14.7 92.1 29.5 238.5 2.7 15.5 26.3 37.1 303.2 324.4 20.4 161.1 187.6 ARRDC4 FLJ36045 ENSG00000140450 "Arrestin domain containing 4" Q8NCT1 15 97960703-97973833 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 82.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 105.7;Paneth cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.1;classical monocyte: 2.5;eosinophil: 1.5;intermediate monocyte: 1.7;myeloid DC: 1.1;neutrophil: 1.4" "Group enriched" "Detected in many" 8 "dendritic cells: 1.1;granulocytes: 1.5;monocytes: 2.5" "Cell line enhanced" "Detected in many" "BJ: 103.2;HSkMC: 55.8;hTCEpi: 86.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039934, HPA042109" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" Vesicles "HPA039934: , HPA042109: AB_10795606" "unprognostic (2.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-3)" "unprognostic (4.49e-3)" "unprognostic (8.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.78e-1)" "unprognostic (7.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (2.02e-3)" "unprognostic (2.90e-2)" "unprognostic (1.65e-1)" "unprognostic (3.04e-2)" "unprognostic (6.77e-2)" 12.5 12.2 21.6 16.5 24.6 11.5 19.8 24.1 22.4 16.2 16.9 43.9 15.8 14.6 15.6 10.0 14.5 17.2 12.1 30.5 39.1 25.1 30.2 19.8 7.5 76.6 24.1 7.3 34.7 6.3 8.9 18.3 73.9 10.9 23.0 4.5 8.1 16.4 14.8 35.5 22.6 18.1 45.9 8.0 26.9 14.7 20.5 5.7 17.3 9.6 5.1 14.9 10.8 82.8 5.8 0.2 0.8 15.0 6.6 47.7 0.0 103.2 45.8 13.5 6.0 6.2 3.6 0.0 14.2 4.8 1.2 6.0 3.7 36.0 21.6 0.0 9.6 10.1 1.9 4.1 2.6 7.0 15.2 55.8 86.9 15.4 17.9 18.8 0.7 2.9 14.4 0.0 4.9 19.2 1.2 5.8 3.0 17.4 2.1 0.1 0.9 0.2 26.3 12.7 5.0 8.8 15.7 5.7 29.5 3.1 2.1 10.6 0.1 4.0 2.9 21.2 5.0 0.0 0.0 0.2 8.7 1.2 10.6 1.1 2.5 1.5 0.0 1.7 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.0 1.4 0.0 0.2 0.2 0.0 0.4 21.6 24.6 24.1 22.4 30.5 39.1 76.6 24.1 73.9 45.9 20.5 82.8 5.7 3.2 10.4 19.9 4.0 25.4 3.1 11.0 23.9 1.6 14.4 8.3 12.9 8.6 9.4 22.0 6.2 0.3 1.4 105.7 7.9 2.7 4.5 21.5 17.6 5.9 38.3 4.4 8.1 8.2 0.2 12.3 15.8 18.0 23.5 1.4 6.4 17.1 21.5 0.0 6.0 29.5 10.2 23.9 10.5 10.9 5.0 19.7 24.9 3.7 13.4 0.7 3.1 38.7 3.4 12.0 82.4 8.2 0.2 12.2 30.2 3.1 15.6 3.5 0.0 7.8 12.5 2.0 12.6 11.8 31.1 0.7 1.3 17.5 31.3 12.2 ARSD ENSG00000006756 "Arylsulfatase D" P51689 X 2903972-2929349 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 109.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.2;EFO-21: 24.5" "HPA004694, HPA063835" Approved Approved "Vesicles,Lipid droplets" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Vesicles, Lipid droplets" "HPA004694: AB_1078221, HPA063835: AB_2685132" "unprognostic (3.92e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.21e-4)" "unprognostic (5.90e-3)" "unprognostic (6.32e-3)" "unprognostic (1.73e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (4.09e-3)" "unprognostic (7.18e-2)" "unprognostic (3.93e-1)" "prognostic favorable (1.97e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (4.99e-2)" "unprognostic (2.11e-3)" 8.4 7.8 4.3 6.1 4.1 4.9 23.6 4.2 4.5 23.9 10.7 20.5 21.0 11.2 15.9 10.0 28.0 11.4 4.8 4.1 5.1 38.9 40.0 16.8 3.6 6.3 5.7 18.7 32.4 12.7 4.2 8.6 5.4 19.3 14.8 1.7 17.5 13.3 1.7 7.3 15.4 7.6 5.6 7.2 30.4 3.8 4.6 2.8 21.1 3.2 4.2 11.7 8.4 5.0 6.9 12.0 3.2 15.4 13.6 7.7 0.1 3.9 7.1 1.7 1.1 0.7 23.2 0.0 24.5 7.9 18.1 0.0 0.6 2.0 1.6 0.2 0.0 0.0 0.0 4.0 7.5 0.0 9.1 12.3 6.3 3.4 3.6 11.1 11.5 0.0 0.0 0.1 7.6 16.9 0.1 1.7 2.7 21.3 5.0 2.9 0.0 0.2 12.3 0.1 0.0 8.5 5.4 6.3 4.1 8.5 17.1 13.1 10.6 0.0 0.5 1.2 1.8 0.1 0.0 0.0 11.1 8.2 8.8 1.5 5.8 4.1 1.7 5.0 0.6 1.3 0.8 1.4 4.4 0.8 0.2 0.9 1.0 2.0 2.0 3.0 0.3 2.5 4.3 4.1 4.2 4.5 4.1 5.1 6.3 5.7 5.4 5.6 4.6 5.0 13.4 19.2 36.4 9.8 4.5 5.0 13.9 11.3 10.8 4.9 45.0 30.9 5.6 74.4 23.1 44.1 0.0 19.1 8.6 44.3 19.6 35.1 0.7 68.6 19.6 13.8 67.9 3.4 0.9 53.9 25.0 7.9 31.6 67.8 16.5 66.8 11.7 109.9 18.5 0.0 1.7 56.2 10.2 17.8 6.4 1.4 6.2 16.1 14.2 6.5 23.1 5.8 11.3 3.5 1.5 47.4 47.9 6.8 1.6 18.1 53.1 23.4 25.8 0.9 6.6 15.1 10.7 1.3 3.9 16.2 7.2 26.0 4.3 38.3 60.9 16.4 ARSK "DKFZp313G1735, TSULF" ENSG00000164291 "Arylsulfatase family member K" Q6UWY0 5 95555101-95605102 "Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 19.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042384 Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" Vesicles Nucleoplasm "HPA042384: AB_10795703" "unprognostic (9.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.03e-3)" "unprognostic (2.39e-1)" "unprognostic (3.33e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (3.39e-1)" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (7.61e-2)" "unprognostic (2.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.91e-2)" "unprognostic (2.32e-1)" "unprognostic (8.20e-2)" "unprognostic (1.06e-2)" 3.0 3.7 2.1 2.2 2.3 2.3 3.3 2.8 3.0 3.8 2.1 2.7 2.2 3.6 4.2 2.9 3.2 3.1 2.6 2.4 2.1 5.4 3.7 2.9 2.7 1.9 1.9 5.8 4.9 19.1 2.6 5.5 2.3 4.9 2.5 3.6 2.8 4.9 2.3 3.3 2.2 3.0 1.7 2.4 4.2 1.6 2.6 3.7 5.0 2.7 2.0 3.2 3.3 2.2 5.1 3.2 6.6 6.6 32.4 16.8 9.5 15.9 9.2 6.1 12.4 3.9 7.8 6.9 8.1 5.5 10.9 4.6 5.8 10.1 13.3 7.4 8.5 5.5 7.7 6.7 9.4 3.1 4.4 12.4 8.9 9.2 5.9 12.8 10.0 9.3 5.6 7.4 13.7 2.5 8.5 5.9 8.6 1.6 15.3 5.2 10.6 11.0 14.1 1.2 4.7 4.8 9.7 3.1 10.0 9.1 8.9 3.2 18.1 9.6 7.8 15.0 9.9 6.2 11.2 8.4 9.6 8.0 36.5 12.9 1.1 2.1 4.0 1.2 4.7 4.9 4.7 5.4 0.6 5.0 7.0 5.2 0.9 3.3 0.7 2.2 3.9 1.8 2.1 2.3 2.8 3.0 2.4 2.1 1.9 1.9 2.3 1.7 2.6 2.2 6.8 3.2 2.2 9.1 6.6 4.5 6.8 7.4 5.7 7.3 4.4 7.2 4.6 1.5 3.7 7.3 12.5 11.8 6.6 1.9 3.9 4.1 9.2 7.1 10.3 6.2 3.0 10.1 11.0 2.5 47.4 13.6 2.0 5.7 22.9 8.1 6.8 16.5 4.6 10.1 9.7 2.0 10.2 3.2 5.4 2.9 10.8 4.9 5.4 7.5 5.1 12.7 14.4 7.1 10.0 2.6 3.2 11.7 7.1 3.9 3.2 4.8 6.8 10.4 0.0 10.2 10.9 7.4 8.6 5.1 7.0 5.1 9.8 11.8 3.4 2.1 ASAP3 "CENTB6, DDEFL1, FLJ20199, UPLC1" ENSG00000088280 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 3" Q8TDY4 1 23428563-23484568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 35.9;Extravillous trophoblasts: 43.3;Granulosa cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 31.8;ASC TERT1: 29.9;HSkMC: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020537, HPA020546" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 50: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Vesicles Nucleoplasm "HPA020537: AB_2670467, HPA020546: AB_2670470" "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.56e-4)" "unprognostic (3.87e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "prognostic favorable (2.80e-4)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.24e-1)" "unprognostic (1.18e-1)" "prognostic favorable (5.12e-5)" "unprognostic (3.39e-3)" "unprognostic (3.92e-2)" "unprognostic (2.02e-2)" "unprognostic (7.27e-2)" 24.1 39.1 11.5 3.2 11.6 0.1 21.9 12.5 12.4 32.6 10.0 18.4 1.6 18.6 4.2 32.3 24.3 5.1 30.1 10.5 11.2 21.4 19.8 15.9 1.6 14.5 12.7 58.3 22.2 11.7 18.6 8.0 13.2 31.0 5.2 3.0 38.0 8.0 42.9 52.9 11.0 5.9 12.7 5.0 25.4 18.2 13.4 1.0 29.0 11.7 4.2 21.3 33.4 12.1 1.8 1.8 17.6 11.6 31.8 29.9 21.6 3.2 3.8 4.9 6.3 1.3 0.1 9.2 3.7 6.3 2.9 8.4 12.2 2.9 2.8 0.4 1.6 0.5 4.8 11.8 17.1 0.0 0.9 38.4 4.4 7.9 7.1 14.6 3.9 1.3 6.4 0.0 3.1 3.9 1.3 0.1 3.0 5.0 4.2 4.9 1.9 0.0 3.4 3.7 0.6 6.0 14.1 3.5 3.5 8.7 13.2 0.1 1.4 2.1 5.2 5.9 0.2 3.9 4.2 1.1 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 11.5 11.6 12.5 12.4 10.5 11.2 14.5 12.7 13.2 12.7 13.4 12.1 4.5 9.6 6.7 35.9 0.3 2.0 1.5 2.0 2.8 1.1 6.3 3.7 15.5 0.0 4.1 3.7 0.0 2.1 0.0 6.7 3.9 5.8 5.1 2.4 7.3 6.6 1.2 0.0 7.6 6.1 43.3 12.2 10.2 4.4 1.3 28.3 3.9 4.0 1.8 0.0 4.9 8.5 2.0 0.0 1.3 8.1 12.5 0.4 0.0 7.5 0.1 8.3 0.0 18.1 4.2 2.5 2.1 13.5 0.2 2.4 0.8 5.4 4.3 0.6 0.0 2.0 3.4 8.2 11.8 3.7 4.3 1.4 0.2 15.9 5.2 2.1 ASGR1 CLEC4H1 ENSG00000141505 "Asialoglycoprotein receptor 1" P07306 17 7173431-7179564 "Predicted intracellular proteins, Predicted secreted proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 41 "liver: 1092.3" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 1107.9" "Cancer enriched" "Detected in many" 90 "liver cancer: 131.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 115.2;intermediate monocyte: 55.5;myeloid DC: 41.2" "Group enriched" "Detected in many" 8 "dendritic cells: 41.2;monocytes: 115.2" "Cell line enriched" "Detected in some" 29 "Hep G2: 493.2" "Region enriched" "Detected in all" 9 "cerebellum: 44.1" "Not detected" "Not detected" "HPA011954, HPA012852" Enhanced Supported "Vesicles,Cell Junctions" "Secreted to blood" NA NA 10000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Cell Junctions" "HPA011954: AB_1845079, HPA012852: AB_1845080" "unprognostic (3.56e-3)" "unprognostic (3.57e-1)" "unprognostic (8.76e-2)" "unprognostic (4.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-2)" "unprognostic (5.37e-2)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (8.55e-5)" "unprognostic (1.55e-1)" "unprognostic (8.33e-11)" "unprognostic (1.45e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-3)" "unprognostic (4.46e-3)" 2.6 1.5 7.7 3.7 7.8 2.5 1.8 17.0 10.9 1.6 7.0 1.2 2.2 1.3 0.6 1.7 1.8 2.9 1.1 7.9 7.6 1.4 1092.3 3.9 1.3 8.0 8.2 1.1 0.9 7.0 2.9 0.5 8.3 1.7 0.5 4.8 0.9 0.3 1.5 4.4 1.4 1.3 6.0 4.8 1.4 26.5 7.8 0.4 5.8 0.4 0.3 1.7 1.5 8.7 0.3 0.7 9.2 4.2 0.0 0.2 0.8 0.8 0.9 0.9 1.6 16.8 0.5 0.3 1.1 0.2 0.4 0.2 0.3 0.2 0.4 0.3 0.8 1.2 1.4 493.2 0.1 0.8 1.7 1.2 0.2 0.5 0.1 0.6 8.4 7.4 1.1 0.6 0.5 0.4 0.7 1.2 1.7 0.2 0.4 0.9 3.5 0.2 0.1 0.7 0.6 3.5 0.7 0.3 0.6 1.5 0.5 0.2 1.2 0.9 3.4 0.7 0.4 0.2 0.3 0.5 0.6 0.4 0.3 10.0 115.2 0.4 0.2 55.5 1.1 0.5 0.2 0.2 41.2 0.5 0.3 0.4 3.3 0.5 14.9 1.8 0.3 36.7 7.7 7.8 17.0 10.9 7.9 7.6 8.0 8.2 8.3 6.0 7.8 8.7 6.0 0.0 4.7 2.9 2.6 3.2 1.7 2.0 3.4 37.8 5.6 6.0 1.5 55.8 2.0 3.7 160.6 3.6 2.9 1.4 3.9 0.9 235.4 4.2 3.6 13.2 15.6 16.8 4.6 0.2 3.7 1.9 3.6 16.5 0.0 5.1 27.5 1107.9 39.9 15.2 4.8 2.3 2.0 97.4 11.9 115.8 2.5 52.6 0.0 1.9 77.2 3.6 0.0 2.0 0.6 0.3 1.3 1.2 0.0 0.9 0.2 6.8 1.6 42.3 0.0 0.8 1.9 6.5 9.7 9.9 4.8 12.4 1.4 1.6 1.3 2.4 ASTN1 ASTN ENSG00000152092 "Astrotactin 1" O14525 1 176857302-177164973 "Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 14.9;brain: 29.8;retina: 14.0" "Group enriched" "Detected in some" 6 "Astrocytes: 191.3;Excitatory neurons: 218.7;Inhibitory neurons: 275.6;Oligodendrocyte precursor cells: 280.0" "Cancer enriched" "Detected in some" 14 "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.8;NTERA-2: 4.4;SCLC-21H: 2.7;U-2 OS: 3.4;U-266/84: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074112 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 65: Brain - Ion transport" "Cluster 16: U-266 - Nucleosome" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA074112: AB_2686662" "unprognostic (4.41e-3)" "unprognostic (1.48e-2)" "unprognostic (4.03e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (2.03e-4)" "unprognostic (3.86e-3)" "unprognostic (1.08e-1)" "unprognostic (4.36e-1)" "unprognostic (1.67e-3)" "unprognostic (1.98e-1)" "unprognostic (6.77e-2)" "unprognostic (4.74e-3)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (1.16e-1)" 0.8 14.9 22.9 0.4 27.1 0.0 0.7 3.0 29.8 0.4 0.0 0.5 0.3 0.9 3.3 0.0 1.6 0.6 0.5 28.5 23.3 0.1 0.2 0.2 0.1 6.1 10.7 5.7 0.5 0.1 9.0 0.3 7.5 1.0 0.3 14.0 0.9 1.6 0.1 0.1 0.3 0.9 11.5 2.2 0.3 0.7 22.7 0.0 0.0 0.3 0.3 0.0 0.4 11.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 27.1 3.0 29.8 28.5 23.3 6.1 10.7 7.5 11.5 22.7 11.5 0.0 0.0 0.0 191.3 0.0 0.1 0.0 0.0 0.0 7.9 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.8 0.3 0.2 0.0 0.0 218.7 0.0 0.1 0.7 0.0 0.2 0.0 4.0 5.0 0.0 0.5 23.5 275.6 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 25.3 0.0 0.8 0.0 280.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.7 4.4 1.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 ATG12 "APG12, APG12L" ENSG00000145782 "Autophagy related 12" O94817 5 115828200-115841837 "Predicted intracellular proteins, Transporters" "Autophagy, Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013272, HPA068989" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Vesicles" "CAB013272: AB_2533272, HPA068989: " "unprognostic (2.48e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-1)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.72e-2)" "unprognostic (2.87e-2)" "unprognostic (5.51e-2)" "unprognostic (9.36e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.54e-7)" "unprognostic (1.27e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (5.11e-2)" 15.5 10.5 12.3 10.7 12.7 11.3 10.2 12.9 16.9 12.0 10.5 10.4 11.6 10.8 11.9 11.3 9.8 11.6 9.7 12.6 13.3 7.1 18.4 10.4 13.6 13.2 13.2 12.0 9.5 7.4 8.7 13.6 13.7 10.8 11.1 9.6 7.9 10.9 11.1 9.0 11.9 12.7 12.7 11.2 8.8 9.4 12.8 14.0 8.6 12.6 11.6 11.8 8.8 15.0 20.7 10.9 26.3 24.1 42.9 57.4 20.0 34.9 38.3 22.6 36.5 15.8 16.5 17.8 14.5 32.1 35.3 11.3 20.5 29.4 36.4 93.2 20.2 11.5 13.0 14.8 33.7 12.8 22.0 43.0 31.5 25.1 29.6 26.3 27.6 19.0 16.8 24.4 43.5 13.5 27.2 20.2 17.9 15.7 23.6 19.8 25.4 25.7 15.7 13.7 25.8 27.6 37.3 14.7 36.6 20.0 20.3 19.2 28.3 41.3 18.9 38.2 36.0 18.7 31.5 28.9 37.7 27.2 39.6 15.4 11.5 19.3 11.8 13.6 16.5 12.3 14.3 11.7 10.3 12.2 14.6 14.1 20.9 14.4 17.4 13.8 12.3 11.0 12.3 12.7 12.9 16.9 12.6 13.3 13.2 13.2 13.7 12.7 12.8 15.0 52.5 44.8 41.0 17.0 82.8 85.8 65.4 81.6 44.3 42.3 46.8 36.1 45.2 38.6 56.9 25.8 77.2 61.8 92.3 50.3 37.2 60.6 28.7 49.0 60.7 55.1 41.8 23.8 28.5 81.6 134.1 75.2 36.2 55.8 96.9 48.8 47.5 57.9 68.2 30.3 26.5 54.5 59.0 72.1 69.8 14.9 64.0 53.7 53.4 19.7 76.8 34.1 99.9 26.7 35.5 105.5 45.8 53.8 50.1 68.4 56.3 44.3 49.7 59.2 26.3 39.5 50.5 50.0 45.1 40.0 84.7 88.7 78.8 45.1 46.0 78.1 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917211 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 16.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 16.4 20.1 11.4 6.5 10.9 60.2 16.9 8.6 40.1 19.9 11.4 18.9 7.5 18.2 1.8 15.7 19.2 4.2 18.4 11.5 9.8 22.0 59.2 24.2 6.1 13.9 12.3 24.9 22.7 4.9 21.6 4.9 12.7 21.6 2.6 1.9 15.2 5.7 26.7 34.9 21.4 3.3 9.0 25.7 23.2 15.3 11.4 5.4 19.3 4.4 3.3 17.7 15.6 10.4 13.2 12.6 4.4 12.0 5.7 4.0 12.3 7.1 10.3 9.4 6.8 11.0 9.9 9.3 14.7 6.0 12.0 10.8 4.5 8.3 2.5 9.1 15.7 8.7 19.1 10.0 8.4 6.5 18.2 10.9 7.1 11.8 6.3 5.4 7.9 9.5 16.1 7.3 4.1 21.3 7.8 21.9 5.1 3.5 14.3 8.6 7.1 13.5 5.0 10.9 16.5 6.7 10.6 14.6 13.3 3.3 14.3 8.1 10.1 9.0 8.6 18.3 5.3 14.7 5.5 6.5 13.0 5.2 5.6 3.0 2.0 2.2 2.5 2.1 2.1 0.8 1.7 2.2 1.4 0.9 1.3 2.4 16.9 1.8 1.7 2.4 0.9 1.2 11.4 10.9 8.6 40.1 11.5 9.8 13.9 12.3 12.7 9.0 11.4 10.4 9.8 9.6 16.2 20.2 17.0 28.9 8.7 35.7 16.5 16.6 15.8 10.3 8.1 7.2 17.6 9.2 33.3 12.7 40.1 38.8 1.9 10.2 2.5 12.4 9.2 10.2 35.9 16.2 7.6 10.3 5.3 12.6 16.8 24.4 9.5 15.4 7.9 23.2 10.9 13.5 8.4 17.6 24.4 20.1 19.9 3.6 12.8 24.2 30.2 5.6 11.9 12.3 19.6 6.6 7.1 14.9 21.7 10.1 27.3 12.2 26.8 6.6 13.3 26.0 13.1 11.6 10.6 9.0 6.2 16.3 38.4 66.9 40.2 27.2 19.0 15.9 ATM "ATA, ATC, ATD, ATDC, TEL1, TELO1" ENSG00000149311 "ATM serine/threonine kinase" Q13315 11 108222832-108369102 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 210.6;NK-cells: 339.8;Oligodendrocytes: 217.6;Rod photoreceptor cells: 200.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 78.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000102, HPA067142" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Vesicles "CAB000102: , HPA067142: AB_2685789" "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.04e-1)" "unprognostic (2.36e-1)" "unprognostic (5.70e-2)" "unprognostic (2.86e-2)" "unprognostic (6.32e-3)" "unprognostic (1.05e-1)" "unprognostic (8.19e-2)" "unprognostic (1.63e-1)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (2.17e-3)" "unprognostic (3.10e-1)" "unprognostic (7.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-1)" 6.2 7.4 8.2 17.5 15.0 16.2 8.5 17.0 12.3 8.7 16.1 6.7 5.2 10.0 9.9 4.0 7.5 8.2 7.0 7.3 11.3 5.8 7.8 7.6 33.7 15.8 13.1 15.8 14.8 9.3 12.1 8.0 17.0 6.3 7.0 20.6 11.4 6.1 4.4 7.5 12.6 6.9 10.3 22.2 8.6 5.2 12.7 18.2 8.8 6.0 25.9 7.1 6.9 28.8 4.3 6.8 14.8 7.6 20.2 29.1 3.1 10.9 13.5 6.4 11.3 7.1 10.3 18.3 14.0 10.2 9.6 7.7 11.6 10.8 9.0 12.3 5.7 15.2 8.7 10.2 10.5 16.4 17.0 18.3 6.3 10.0 21.2 15.2 14.1 16.5 12.4 9.9 14.3 3.4 10.6 18.5 9.8 8.6 7.4 9.7 9.7 24.9 8.1 7.5 9.0 10.5 11.1 4.7 20.6 13.2 9.3 10.1 23.7 15.8 8.4 7.3 9.0 6.2 7.0 78.3 7.0 19.0 18.8 21.3 5.5 4.0 16.5 5.7 11.1 11.6 11.7 12.5 2.6 13.0 21.1 20.4 9.9 9.7 13.3 6.2 6.1 5.3 8.2 15.0 17.0 12.3 7.3 11.3 15.8 13.1 17.0 10.3 12.7 28.8 23.7 38.5 20.8 62.7 146.4 12.6 17.5 21.1 28.5 111.0 19.6 14.2 39.9 12.8 19.5 22.0 210.6 16.9 140.2 4.2 5.9 9.9 19.2 14.4 52.1 25.9 20.4 39.1 70.2 12.3 13.2 39.0 12.8 20.9 13.3 45.9 32.9 23.3 29.1 60.6 82.8 14.9 26.4 96.4 34.0 5.1 39.4 69.2 26.6 178.9 63.2 27.3 339.8 85.5 217.6 7.6 7.6 27.8 96.5 9.1 8.9 11.1 16.0 200.1 26.3 41.4 29.2 31.5 37.4 15.8 12.4 4.2 147.7 52.3 11.5 10.2 ATP11A "ATPIH, ATPIS, KIAA1021" ENSG00000068650 "ATPase phospholipid transporting 11A" P98196 13 112690329-112887168 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035583, HPA035584" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Vesicles "Golgi apparatus" "HPA035583: AB_10671106, HPA035584: AB_10672096" "unprognostic (1.67e-1)" "unprognostic (5.06e-3)" "unprognostic (1.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.58e-2)" "unprognostic (8.84e-2)" "unprognostic (5.87e-3)" "unprognostic (1.80e-2)" "unprognostic (6.97e-2)" "unprognostic (1.54e-3)" "unprognostic (3.93e-2)" "unprognostic (4.23e-1)" "prognostic favorable (7.44e-4)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.26e-2)" "unprognostic (7.40e-3)" 10.2 10.4 12.3 8.9 22.0 18.2 6.1 18.3 16.8 13.0 5.7 4.4 9.9 10.1 5.8 7.0 8.7 15.0 21.4 9.7 12.5 12.7 10.1 39.5 5.8 25.3 22.2 6.5 12.4 23.1 16.2 10.1 22.9 4.3 3.2 14.9 9.0 3.9 13.1 8.9 8.3 9.1 15.7 8.9 5.3 8.9 21.9 8.2 13.9 17.3 6.1 6.5 5.9 40.2 28.0 14.0 17.5 20.5 8.7 11.7 30.9 13.0 7.6 10.9 8.8 44.5 31.5 14.1 15.5 11.0 14.0 23.2 15.8 10.8 10.5 14.2 14.9 16.3 11.9 23.3 13.6 30.8 25.5 7.9 8.2 13.2 8.0 8.8 29.0 12.6 11.4 2.3 7.7 10.5 14.1 19.4 7.5 31.8 9.9 12.2 7.1 8.1 59.3 6.4 27.8 7.7 12.7 16.3 10.7 22.4 6.2 40.4 19.2 0.0 23.3 14.1 9.9 7.4 15.5 5.9 4.8 28.3 12.2 0.0 1.1 1.7 0.4 1.6 0.3 0.6 0.2 0.2 0.6 1.8 0.3 0.2 3.1 0.0 1.5 0.5 0.0 0.3 12.3 22.0 18.3 16.8 9.7 12.5 25.3 22.2 22.9 15.7 21.9 40.2 25.6 218.0 215.0 22.2 11.3 10.8 3.4 4.9 1.2 42.0 5.2 3.7 42.3 31.5 29.4 16.5 235.6 1.7 7.0 2.4 5.9 32.7 0.9 51.2 24.2 34.2 12.0 3.8 35.0 11.4 32.2 16.5 8.6 176.3 12.0 62.2 27.1 16.5 20.7 13.5 32.5 3.5 14.2 33.6 16.9 1.9 11.1 29.3 10.6 48.7 36.9 11.0 6.2 33.7 138.3 24.3 6.1 4.9 7.7 7.7 10.5 15.7 13.3 44.8 0.0 9.5 12.8 4.0 10.1 6.3 9.7 8.6 8.4 8.7 5.9 3.9 ATPSCKMT "FAM173B, JS-2" ENSG00000150756 "ATP synthase c subunit lysine N-methyltransferase" Q6P4H8 5 10225507-10249897 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 7.1;Cytotrophoblasts: 5.9;Extravillous trophoblasts: 4.1;Fibroblasts: 2.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 2.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 69.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074513 Approved Nucleoplasm,Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 20: HeLa - Mitochondria" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Vesicles" "HPA074513: AB_2686698" "prognostic unfavorable (1.32e-6)" "unprognostic (8.87e-3)" "unprognostic (1.23e-3)" "unprognostic (1.20e-1)" "unprognostic (9.24e-2)" "unprognostic (1.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-2)" "unprognostic (6.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-1)" "unprognostic (9.06e-2)" "unprognostic (5.61e-2)" "unprognostic (1.03e-1)" 8.5 10.3 12.4 5.4 13.0 3.9 6.6 13.5 15.5 5.7 13.8 7.4 6.1 6.9 9.1 5.8 6.5 7.2 6.9 11.7 14.3 9.0 9.9 5.1 7.8 13.2 13.6 6.3 5.1 17.1 9.9 4.1 13.2 8.8 8.7 5.0 7.4 8.3 6.7 5.8 5.6 7.5 12.0 4.5 6.2 5.7 13.4 6.9 8.8 7.4 6.8 7.1 5.3 14.8 14.1 13.3 13.9 13.8 12.7 9.8 4.8 20.4 9.2 9.2 8.0 14.1 21.0 16.8 35.2 13.0 27.7 9.6 19.6 17.0 15.8 30.9 13.2 14.5 47.6 11.4 9.7 22.8 16.5 9.1 18.3 17.4 5.5 11.8 19.7 17.8 19.9 18.0 26.6 11.9 11.6 20.2 9.1 29.9 17.4 15.8 9.7 15.9 24.6 16.5 11.1 10.9 69.3 24.5 12.2 10.5 25.7 23.2 11.2 22.4 13.9 14.2 14.9 11.9 14.5 19.7 14.1 25.3 9.0 3.2 5.8 8.1 4.3 6.7 5.3 3.8 4.2 5.5 5.8 2.6 4.1 5.4 2.2 3.8 5.5 2.1 5.4 2.6 12.4 13.0 13.5 15.5 11.7 14.3 13.2 13.6 13.2 12.0 13.4 14.8 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 5.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 4.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 AUP1 ENSG00000115307 "AUP1 lipid droplet regulating VLDL assembly factor" Q9Y679 2 74526645-74529760 "Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007674 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 22: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Vesicles" "HPA007674: AB_1078251" "unprognostic (1.09e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-2)" "unprognostic (2.11e-2)" "unprognostic (5.97e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (2.29e-4)" "unprognostic (2.00e-1)" "unprognostic (2.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-1)" "prognostic unfavorable (2.97e-9)" "unprognostic (9.68e-2)" "unprognostic (1.59e-1)" "unprognostic (3.35e-1)" "unprognostic (3.96e-2)" 48.0 42.2 68.0 44.4 69.0 78.8 52.6 71.0 85.8 56.0 72.1 76.9 70.6 38.7 78.6 49.9 45.3 46.0 38.4 67.6 71.0 48.8 106.9 48.7 41.3 73.0 69.6 38.1 127.3 77.6 2.1 60.6 69.7 38.9 81.0 32.4 89.1 46.3 57.7 42.3 68.5 55.8 70.5 39.5 56.7 24.5 70.1 42.5 50.9 66.6 51.5 69.6 20.7 72.1 114.2 133.4 55.3 87.5 183.1 107.7 124.9 89.1 152.6 122.3 77.3 196.9 130.6 126.4 61.9 126.5 210.3 143.4 140.4 115.1 98.5 100.1 128.7 153.6 71.2 180.7 181.5 97.8 127.9 128.5 256.7 174.4 198.6 101.1 117.3 105.1 202.2 164.5 134.0 124.6 79.0 200.6 111.4 298.3 111.9 95.3 150.0 270.3 139.3 90.9 80.7 79.6 65.2 200.4 162.2 70.8 90.2 156.7 59.3 162.9 97.2 50.6 146.8 87.9 88.1 120.4 129.6 155.9 184.9 113.8 132.9 108.9 81.9 169.3 89.6 90.6 81.0 82.0 124.6 113.9 72.9 75.8 68.8 85.3 144.7 118.3 107.9 132.2 68.0 69.0 71.0 85.8 67.6 71.0 73.0 69.6 69.7 70.5 70.1 72.1 64.8 67.3 44.6 22.5 97.3 73.2 120.7 161.1 80.8 31.7 71.4 59.6 34.9 74.4 108.1 68.0 14.6 140.0 86.6 150.4 23.5 125.2 24.3 36.2 50.1 74.9 73.8 72.4 17.7 208.7 217.3 73.0 121.8 58.7 89.9 57.3 50.0 114.3 161.8 37.0 16.1 127.7 136.3 83.5 95.5 29.7 44.4 95.2 97.8 17.8 67.2 74.5 72.1 14.6 23.4 153.1 141.3 38.0 229.9 141.1 196.0 59.6 46.6 43.2 59.2 60.0 104.2 85.9 64.6 95.7 78.7 223.8 77.6 68.4 134.2 143.9 AXIN1 PPP1R49 ENSG00000103126 "Axin 1" O15169 16 287440-352723 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012987 Approved Supported Nucleoli,Vesicles NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoli, Vesicles" "CAB012987: AB_2533178" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (7.64e-2)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.38e-5)" "unprognostic (1.23e-1)" "unprognostic (3.58e-1)" "unprognostic (1.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (4.41e-2)" "unprognostic (1.94e-1)" "unprognostic (1.23e-2)" "unprognostic (1.03e-1)" 11.9 9.3 10.5 9.2 10.8 23.0 11.5 14.8 12.5 12.9 9.1 17.1 12.3 13.2 3.1 16.3 11.8 6.2 11.6 10.0 9.2 11.6 11.2 13.7 10.5 10.2 10.2 13.8 13.0 7.2 12.6 5.8 9.8 12.9 6.9 2.6 11.5 6.0 21.1 20.1 15.0 5.4 9.2 15.0 12.9 11.8 10.1 12.5 11.9 7.0 6.6 14.5 13.1 11.9 18.1 25.6 13.4 23.7 9.8 9.0 28.0 11.9 10.8 16.1 13.8 37.9 20.4 27.7 18.0 12.3 19.4 25.4 21.1 18.5 7.2 27.5 34.6 18.0 21.9 27.6 16.6 20.9 19.3 9.0 31.7 16.6 20.3 14.1 10.7 19.8 45.6 14.8 7.4 48.1 22.7 14.5 30.6 21.6 15.4 42.4 12.2 38.8 12.2 10.5 30.4 18.6 22.6 24.9 38.3 10.0 16.5 26.1 12.4 15.9 17.0 18.5 17.5 17.3 18.1 34.2 7.5 13.7 15.9 1.2 0.9 5.0 8.3 0.8 7.6 1.5 2.4 5.8 0.7 1.2 2.4 3.4 2.7 3.5 0.6 1.2 2.6 2.3 10.5 10.8 14.8 12.5 10.0 9.2 10.2 10.2 9.8 9.2 10.1 11.9 7.9 3.2 8.6 4.9 5.7 18.4 7.6 8.5 5.7 4.3 11.2 9.5 4.9 5.7 7.2 3.7 0.0 3.5 30.1 27.4 0.0 7.2 1.4 10.2 7.0 6.3 10.8 8.6 18.5 6.9 27.5 6.7 15.3 14.4 10.8 10.5 5.7 5.1 7.5 5.0 12.7 15.1 6.1 6.2 9.0 2.1 5.3 6.7 10.6 1.0 5.7 4.5 28.8 8.5 8.9 11.0 12.2 4.9 7.0 13.4 11.1 2.4 7.7 5.7 13.1 8.7 7.6 5.5 8.8 7.2 15.2 3.7 12.4 5.0 15.7 10.5 AZGP1 "ZA2G, ZAG" ENSG00000160862 "Alpha-2-glycoprotein 1, zinc-binding" P25311 7 99966720-99976042 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 2809.6;salivary gland: 3847.3" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2" "Group enriched" "Detected in many" 12 "breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012582, HPA012876, CAB016087, CAB032276" Enhanced Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 55200000000 74000000000 "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 35: Glandular cells - Unknown function" Vesicles Nucleoplasm "CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: " "unprognostic (8.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.41e-1)" "unprognostic (5.42e-3)" "unprognostic (4.98e-2)" "unprognostic (5.74e-3)" "prognostic favorable (2.90e-4)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (1.79e-1)" "prognostic favorable (1.53e-4)" "unprognostic (2.18e-1)" "unprognostic (2.08e-2)" "unprognostic (9.80e-2)" "unprognostic (3.51e-3)" 128.6 3.9 17.1 2.7 28.8 0.4 1061.4 23.1 18.8 3.4 16.0 6.7 30.9 1.5 2.5 22.0 3.0 38.7 114.7 14.9 22.2 326.8 2809.6 14.8 0.4 20.2 23.3 6.0 752.1 0.1 1.3 0.5 27.1 1051.4 4.2 3.6 3847.3 40.2 1.7 206.8 28.6 0.3 14.0 1.4 315.2 25.9 21.4 0.8 1.9 2.3 1.5 5.8 7.5 24.5 0.2 0.0 0.0 0.0 11.3 0.0 5.5 0.0 0.0 0.0 0.0 0.1 4.0 14.2 0.7 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.3 0.1 56.6 4.9 1.5 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.3 29.9 0.0 0.0 0.0 5.1 0.2 158.9 0.0 0.0 1.7 130.4 0.0 0.0 0.0 2.0 1.0 25.4 13.0 0.0 41.8 0.0 0.0 0.5 0.1 1.8 0.9 1.9 0.8 0.4 0.0 0.5 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 28.8 23.1 18.8 14.9 22.2 20.2 23.3 27.1 14.0 21.4 24.5 9.9 22.4 276.8 0.0 14.7 4.2 422.1 25.3 0.0 0.0 1315.5 704.8 115.9 451.8 63.0 5.5 2.1 0.0 10.4 5.5 46.9 11.7 1.9 1.4 1.2 14.2 12.4 85.5 0.1 254.2 0.0 7.7 94.8 5.5 3.8 1.2 65.3 4270.8 0.0 0.0 0.1 13.1 901.3 93.1 0.7 4.2 0.9 14.8 62.2 1.0 2.0 23.7 0.0 7.5 7.3 221.5 6.4 0.0 0.3 1691.9 15.3 596.1 6.3 0.3 0.0 0.0 11.9 7.4 0.4 9.9 9.7 0.0 12.3 0.1 12.6 674.2 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 459939-563509 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 61.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.2 7.0 0.5 3.2 0.7 2.1 1.3 0.0 1.0 7.4 1.0 18.4 1.0 6.2 2.7 7.5 3.7 2.2 23.9 0.5 0.0 4.6 0.1 5.2 0.1 0.0 0.0 0.4 2.6 16.9 9.3 0.1 0.0 2.0 12.5 0.1 4.8 0.7 1.5 14.8 2.0 2.2 0.0 0.3 61.0 8.0 0.0 2.3 2.3 0.1 0.7 1.4 5.6 0.7 0.0 0.0 0.3 1.2 0.0 0.0 33.5 0.0 0.0 0.0 0.0 8.0 6.6 0.0 0.9 0.0 0.7 3.6 8.0 1.1 0.1 13.2 12.5 0.0 0.0 1.8 0.0 0.1 5.3 0.0 5.3 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.4 0.0 0.1 14.8 10.5 0.6 0.5 5.0 0.0 7.1 6.8 3.8 2.7 0.8 0.3 1.0 4.9 0.8 2.9 0.0 0.0 2.7 0.2 0.9 0.0 0.0 0.0 0.0 9.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 7.0 1.3 0.3 7.5 6.0 3.4 0.0 0.6 2.9 0.6 15.1 1.5 6.2 9.2 0.0 0.0 0.6 81.1 0.0 12.0 26.3 20.4 4.8 0.6 10.3 0.0 32.6 4.8 0.1 1.6 128.0 47.4 0.0 0.1 0.0 0.1 0.7 0.0 5.2 18.6 2.0 0.0 1.1 89.2 0.0 0.5 0.0 2.8 0.6 0.0 0.0 1.0 3.6 16.6 33.4 0.0 0.2 12.7 1.9 0.2 9.1 0.2 0.0 0.2 0.8 2.8 1.3 0.9 17.3 0.0 1.5 1.9 26.1 14.4 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" NA NA 3100000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Vesicles" "HPA007620: AB_2667879, HPA047739: AB_2680141" "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavorable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 29.0 19.0 61.4 13.0 55.0 6.6 24.6 48.0 70.1 28.4 44.0 43.7 12.5 31.0 9.6 32.4 20.0 14.9 40.8 58.4 51.6 24.6 38.8 19.6 5.9 53.6 53.6 19.6 51.5 14.2 24.7 10.1 53.0 31.2 10.2 8.9 27.3 23.8 61.0 32.8 15.2 26.3 52.6 12.0 22.4 22.6 55.2 3.1 14.3 33.2 6.8 37.0 26.8 52.6 61.6 38.4 45.3 76.0 51.3 54.5 37.8 54.2 55.9 54.8 50.9 30.4 51.4 38.4 31.6 112.3 52.5 39.9 36.8 72.8 14.0 39.6 80.2 23.2 37.8 66.9 43.2 20.6 0.8 47.0 79.1 39.3 71.4 55.3 65.5 15.9 51.7 25.3 46.7 45.3 15.3 18.6 65.6 35.7 56.7 44.3 48.2 62.7 33.9 29.3 72.7 58.5 31.1 89.4 38.5 16.9 38.6 17.5 39.3 90.8 102.4 63.8 78.5 7.6 17.8 15.9 40.4 16.9 64.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 61.4 55.0 48.0 70.1 58.4 51.6 53.6 53.6 53.0 52.6 55.2 52.6 9.7 0.0 8.8 7.5 2.2 7.8 10.3 10.8 1.8 13.3 15.0 18.9 14.0 7.2 7.4 14.7 4.2 2.0 1.2 10.2 1.9 13.3 16.4 6.2 16.2 10.4 16.3 1.3 8.0 20.6 8.0 15.2 13.7 8.7 0.0 23.8 6.1 18.7 2.3 18.5 5.6 22.6 2.0 1.0 3.3 6.7 16.4 1.5 3.6 1.0 1.6 15.0 0.0 5.0 9.8 27.3 6.1 12.4 5.0 25.9 6.4 8.8 4.4 12.2 6.6 9.8 14.3 6.2 15.6 7.6 12.6 0.5 1.7 21.1 15.3 16.1 BARX1 ENSG00000131668 "BARX homeobox 1" Q9HBU1 9 93951627-93955355 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "stomach 1: 166.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.0;Early spermatids: 2.6;Fibroblasts: 2.9;Smooth muscle cells: 1.2" "Cancer enhanced" "Detected in many" "stomach cancer: 19.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 29.5;HMC-1: 69.8;NTERA-2: 20.7;THP-1: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA055858 Approved Nucleoplasm,Vesicles NA NA "Cluster 4: Stomach - Digestion" "Cluster 3: HMC-1 - Innate immune response" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm Vesicles "HPA055858: AB_2682947" "unprognostic (6.19e-4)" "unprognostic (4.81e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.16e-6)" "unprognostic (4.96e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.46e-2)" "unprognostic (5.20e-3)" "unprognostic (1.23e-2)" "unprognostic (8.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (9.68e-13)" "unprognostic (7.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.60e-1)" "unprognostic (2.16e-2)" 17.1 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 2.9 0.0 0.3 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.6 15.1 1.5 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 166.5 3.9 0.0 0.0 1.0 0.5 0.4 0.0 0.0 0.0 0.0 2.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.0 4.3 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 69.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.4 20.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.3 5.8 0.0 28.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.9 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BBOX1 "BBH, BBOX, G-BBH, gamma-BBH" ENSG00000129151 "Gamma-butyrobetaine hydroxylase 1" O75936 11 27040725-27127809 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 467.9;liver: 131.9" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 1623.0" "Group enriched" "Detected in many" 6 "glioma: 23.7;renal cancer: 59.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTCEpi: 13.7;RPTEC TERT1: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007600, HPA027823" Enhanced Approved Uncertain "Vesicles,Actin filaments" NA NA 35000 "Cluster 7: Kidney - Transmembrane transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Actin filaments" "HPA007600: AB_1845284, HPA027823: AB_10602394" "unprognostic (9.96e-3)" "unprognostic (1.80e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (7.03e-2)" "unprognostic (6.66e-2)" "unprognostic (7.05e-3)" "unprognostic (1.13e-2)" "unprognostic (3.03e-1)" "unprognostic (6.89e-2)" "unprognostic (2.03e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.45e-5)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (3.22e-1)" "unprognostic (1.73e-3)" 1.4 0.0 24.3 0.0 23.4 0.0 25.1 28.8 34.0 5.1 17.3 0.2 0.0 0.1 8.1 17.5 9.0 9.6 0.0 22.8 25.6 467.9 131.9 0.3 0.1 27.2 33.1 0.0 0.8 0.0 6.9 0.3 35.0 0.5 0.0 0.4 6.1 4.1 0.9 51.8 0.0 0.0 28.8 0.0 0.2 0.1 25.2 1.1 9.6 0.0 0.6 0.1 11.3 27.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 13.7 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.2 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 23.4 28.8 34.0 22.8 25.6 27.2 33.1 35.0 28.8 25.2 27.0 0.1 0.0 0.6 66.3 5.3 8.2 9.0 80.9 0.6 0.0 16.3 11.0 0.0 15.7 18.1 46.0 0.0 0.3 0.2 0.0 223.0 0.7 1.1 10.3 0.1 0.3 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.4 27.9 0.0 0.0 0.8 0.0 12.2 0.6 1.1 1.1 0.0 7.1 1.8 4.7 0.0 13.8 0.0 2.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 1623.0 9.4 0.4 0.0 0.0 1.4 0.0 0.6 16.9 35.8 0.3 5.0 0.0 0.0 2.6 BCL2L12 ENSG00000126453 "BCL2 like 12" Q9HB09 19 49665142-49673916 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020856 Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Vesicles "Plasma membrane" "HPA020856: AB_1845320" "unprognostic (2.59e-1)" "unprognostic (3.96e-2)" "unprognostic (2.24e-1)" "unprognostic (5.72e-2)" "unprognostic (3.64e-1)" "unprognostic (3.68e-2)" "unprognostic (6.80e-3)" "unprognostic (3.87e-3)" "unprognostic (6.12e-2)" "unprognostic (8.90e-2)" "unprognostic (1.60e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (8.75e-5)" "unprognostic (8.67e-2)" "unprognostic (3.62e-2)" "unprognostic (2.37e-1)" "unprognostic (2.56e-1)" 8.5 8.5 3.8 14.7 3.9 18.2 9.5 3.9 5.1 8.3 5.0 11.9 10.5 9.9 3.2 13.4 9.5 6.5 9.4 3.6 3.8 7.8 16.6 9.6 20.6 4.4 4.2 9.7 15.5 4.5 2.7 10.3 4.1 11.3 7.3 1.7 11.7 5.0 14.0 8.5 11.9 6.8 4.1 16.7 11.7 10.1 4.1 17.3 7.6 13.5 15.8 9.6 8.7 4.3 105.2 63.7 49.8 94.8 12.6 12.6 56.9 58.2 23.3 57.2 60.6 89.2 55.4 58.4 26.7 20.2 32.4 49.7 46.3 39.4 30.7 74.1 97.4 53.1 43.5 62.0 11.4 56.6 62.2 15.5 19.0 64.3 18.2 11.5 38.7 79.2 138.8 73.3 30.8 59.1 67.6 91.8 62.4 61.8 77.4 86.6 54.3 62.7 24.8 52.0 0.9 29.4 59.5 79.0 41.8 35.6 33.0 70.3 22.8 64.1 75.2 45.5 96.4 61.2 102.4 114.3 27.2 78.0 64.3 11.0 7.4 17.0 12.5 12.2 14.6 14.8 13.2 12.3 6.5 14.6 12.8 13.1 10.9 15.8 8.6 25.9 14.4 6.3 3.8 3.9 3.9 5.1 3.6 3.8 4.4 4.2 4.1 4.1 4.1 4.3 10.2 9.6 13.1 3.3 22.1 32.2 37.4 23.3 14.2 1.0 35.2 34.2 5.0 10.0 16.5 5.5 0.0 70.3 18.2 14.6 7.9 25.7 8.3 17.0 11.5 13.2 6.7 18.5 0.2 25.8 126.3 16.2 9.2 20.1 9.5 18.9 11.0 13.1 37.6 0.0 0.2 15.7 18.3 12.6 16.1 6.4 6.5 15.5 26.6 1.0 22.1 3.5 24.7 0.0 1.6 34.5 16.6 6.0 44.3 20.5 6.5 10.4 12.6 1.2 13.1 14.0 15.1 11.6 22.3 19.7 19.5 55.7 15.7 11.7 23.3 27.7 BCL7A BCL7 ENSG00000110987 "BAF chromatin remodeling complex subunit BCL7A" Q4VC05 12 122019422-122062044 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 77.9;Horizontal cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 1.0;naive B-cell: 2.1;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 14 "B-cells: 2.1;dendritic cells: 2.8" "Cell line enhanced" "Detected in many" "Daudi: 71.9;MOLT-4: 71.4;U-698: 95.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019762 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Vesicles" "HPA019762: AB_10962489" "unprognostic (3.27e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (5.18e-1)" "unprognostic (5.13e-2)" "unprognostic (1.06e-2)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.86e-2)" "unprognostic (8.56e-2)" "unprognostic (6.16e-3)" "unprognostic (1.51e-2)" 3.1 2.8 9.2 5.2 10.8 9.8 5.7 8.9 11.2 5.1 0.0 4.0 2.5 4.5 6.7 2.8 8.4 2.4 7.6 9.6 3.2 9.1 4.9 3.9 16.2 3.5 4.7 3.7 9.1 9.1 5.2 1.9 3.3 5.1 2.9 4.1 7.0 5.9 11.5 8.2 3.0 3.3 2.9 5.8 3.8 2.2 4.5 24.7 9.0 8.9 15.4 4.8 4.8 9.1 6.0 6.2 29.9 17.9 2.2 1.1 6.0 3.2 3.1 5.3 4.9 3.2 2.4 71.9 9.2 2.7 2.7 8.8 22.7 16.4 5.3 0.0 25.0 3.5 0.4 5.5 6.5 13.8 8.1 4.7 21.3 3.9 26.7 8.1 7.7 42.3 18.3 0.0 4.3 10.7 71.4 1.3 10.7 9.7 11.0 33.2 8.5 1.2 13.4 14.3 26.5 28.9 3.4 0.8 13.1 7.7 17.4 13.6 6.9 0.7 5.1 10.0 6.1 9.4 5.4 95.8 2.1 9.3 6.7 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.3 2.1 0.1 0.1 0.1 0.0 0.0 2.8 0.0 0.1 9.2 10.8 8.9 11.2 9.6 3.2 3.5 4.7 3.3 2.9 4.5 9.1 4.6 22.4 9.2 8.5 51.6 35.9 77.9 26.5 22.8 41.8 32.7 33.5 28.6 42.9 19.0 38.6 18.8 1.5 38.1 5.9 58.7 33.5 6.9 39.3 10.9 5.6 21.5 18.7 15.9 10.9 0.9 11.9 7.1 26.8 10.8 16.6 5.3 18.6 4.2 107.7 19.9 8.6 16.2 2.2 14.3 18.7 14.0 9.8 12.4 1.9 6.2 5.5 1.0 13.6 16.2 10.0 6.9 7.9 6.8 29.9 1.6 31.3 20.7 14.0 6.6 34.7 16.6 0.7 7.7 5.3 30.1 0.5 3.2 42.9 11.7 32.3 BHLHE41 "BHLHB3, DEC2, SHARP-1, SHARP1" ENSG00000123095 "Basic helix-loop-helix family member e41" Q9C0J9 12 26120030-26125037 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 122.4;skeletal muscle: 92.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 347.5;Cone photoreceptor cells: 183.5;Horizontal cells: 250.7;Muller glia cells: 239.8;Rod photoreceptor cells: 309.5" "Cancer enhanced" "Detected in all" "thyroid cancer: 78.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.9" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 92.4;RT4: 126.6;U-266/70: 52.6;U-87 MG: 44.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056035, HPA077617" Supported Nucleoplasm,Vesicles NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 15: RT4 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm Vesicles "HPA056035: AB_2683017, HPA077617: " "unprognostic (1.57e-3)" "unprognostic (1.57e-2)" "unprognostic (2.32e-2)" "unprognostic (6.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.96e-2)" "prognostic unfavorable (8.73e-5)" "unprognostic (5.23e-2)" "unprognostic (1.65e-1)" "unprognostic (5.61e-3)" "prognostic favorable (1.09e-4)" 10.6 14.6 35.4 7.4 46.7 0.5 13.6 52.5 35.2 38.8 11.8 9.5 2.7 8.1 19.3 3.2 45.5 18.3 20.0 30.5 39.5 3.8 0.7 11.6 7.9 58.1 48.7 12.9 7.7 6.5 16.7 10.5 62.3 9.7 11.1 122.4 18.4 14.0 92.5 5.6 6.3 4.1 60.2 9.1 4.9 4.3 49.8 6.3 57.8 12.9 17.9 21.3 9.9 67.1 11.4 0.1 0.3 0.0 20.4 9.4 4.7 2.2 3.8 0.4 1.4 0.0 13.4 0.0 1.9 4.4 31.4 11.3 0.4 1.9 1.1 0.1 1.7 1.0 0.2 0.0 0.9 5.7 0.3 1.5 1.1 7.8 15.0 92.4 0.0 0.1 0.0 39.6 2.4 1.3 0.0 3.9 10.4 3.7 7.8 0.0 1.9 31.6 4.9 126.6 0.2 0.2 1.4 0.6 29.7 0.6 0.0 0.2 6.7 7.1 8.2 0.8 5.9 52.6 32.3 0.1 44.9 4.4 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.4 46.7 52.5 35.2 30.5 39.5 58.1 48.7 62.3 60.2 49.8 67.1 1.6 0.0 1.1 46.0 25.0 6.0 59.8 34.1 10.8 347.5 9.2 56.0 46.7 37.1 11.2 29.5 183.5 26.6 0.2 55.0 0.0 40.6 0.6 78.5 27.1 12.0 13.1 0.0 10.1 21.9 3.6 22.7 3.1 60.8 5.7 0.2 2.5 0.1 91.1 250.7 12.4 4.4 0.0 4.0 4.4 1.3 30.1 39.8 14.2 120.9 27.4 239.8 0.0 22.1 56.2 21.9 12.0 26.7 61.8 49.0 0.4 2.3 34.8 309.5 6.6 13.0 7.5 0.5 3.7 3.5 3.3 7.1 2.4 2.3 5.0 83.8 BLNK "BASH, bca, BLNK-s, Ly57, SLP-65, SLP65" ENSG00000095585 "B cell linker" Q8WV28 10 96189171-96271587 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.5" "Cell type enhanced" "Detected in many" "B-cells: 94.2;dendritic cells: 64.0;Microglial cells: 157.4;Plasma cells: 80.4;Proximal enterocytes: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "memory B-cell: 161.2;naive B-cell: 140.5;plasmacytoid DC: 231.5" "Group enriched" "Detected in many" 101 "B-cells: 161.2;dendritic cells: 231.5" "Group enriched" "Detected in some" 6 "Daudi: 68.7;REH: 168.4;RPMI-8226: 94.4;U-698: 251.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009333, CAB016291, HPA038309, HPA038310" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" Vesicles "CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946" "unprognostic (4.86e-2)" "unprognostic (6.05e-3)" "unprognostic (1.00e-2)" "unprognostic (2.73e-2)" "unprognostic (2.29e-1)" "unprognostic (1.63e-3)" "unprognostic (1.08e-2)" "unprognostic (5.19e-2)" "unprognostic (2.97e-1)" "unprognostic (1.02e-1)" "unprognostic (8.94e-2)" "unprognostic (3.73e-1)" "unprognostic (1.84e-2)" "unprognostic (5.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.46e-3)" "prognostic favorable (2.67e-6)" 2.2 3.2 3.8 27.5 3.4 10.1 6.3 2.4 4.1 7.1 13.9 16.9 38.9 2.4 30.1 39.9 6.1 10.8 1.0 3.5 5.1 28.5 39.2 6.6 57.6 4.7 4.0 1.5 12.1 17.4 1.8 6.4 5.0 7.3 18.2 1.4 10.9 13.2 0.5 8.0 34.0 3.0 3.8 54.0 29.2 1.3 4.9 10.6 11.6 1.1 70.5 9.9 15.8 5.2 0.3 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.2 0.2 68.7 0.4 0.0 0.3 0.6 0.1 0.8 0.1 5.5 0.2 0.3 0.3 0.1 0.0 0.1 1.4 0.1 8.7 0.0 0.0 0.1 0.0 0.8 0.3 6.4 0.0 0.7 0.4 0.2 0.2 0.2 0.0 168.4 0.3 94.4 0.9 13.0 0.3 0.3 0.2 15.1 0.1 0.2 23.7 1.1 0.2 0.2 0.8 0.1 0.2 5.4 0.4 251.4 0.1 0.5 0.1 0.3 1.6 0.2 0.3 1.3 0.1 161.2 0.3 0.2 20.6 140.5 0.1 0.1 1.1 1.9 0.1 231.5 0.6 8.1 3.8 3.4 2.4 4.1 3.5 5.1 4.7 4.0 5.0 3.8 4.9 5.2 0.4 6.4 7.7 0.7 94.2 1.1 21.0 13.1 21.1 0.0 4.1 3.4 1.2 30.0 7.3 40.5 0.0 23.0 64.0 9.2 27.4 14.6 3.1 14.4 1.9 0.3 4.9 5.3 1.0 13.8 17.5 0.7 35.7 22.9 1.3 0.0 2.9 27.8 22.8 0.0 1.3 19.4 30.5 9.0 13.8 1.1 0.3 18.2 1.8 157.4 4.8 0.0 0.0 2.5 0.9 4.4 22.4 0.0 80.4 5.1 64.6 2.3 3.4 0.0 6.6 0.3 0.7 1.6 0.1 34.7 1.4 41.5 3.6 0.5 22.5 23.8 BLOC1S4 "BCAS4L, CNO, FLJ11230" ENSG00000186222 "Biogenesis of lysosomal organelles complex 1 subunit 4" Q9NUP1 4 6716174-6717664 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043840 Approved Approved Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles Cytosol "HPA043840: AB_10965701" "unprognostic (3.09e-1)" "unprognostic (8.40e-2)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (1.80e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-1)" "unprognostic (9.24e-3)" "unprognostic (5.62e-3)" 8.6 11.7 8.0 7.9 8.2 9.8 8.9 8.3 8.7 9.4 9.1 8.9 9.2 9.9 7.1 11.1 9.3 6.5 8.0 8.3 7.7 10.0 11.3 6.3 12.1 8.1 8.2 12.0 7.9 5.6 7.2 7.7 8.3 9.4 5.7 4.3 8.2 6.4 10.8 8.6 11.4 5.1 8.4 13.1 8.8 6.3 8.3 8.9 7.6 5.7 8.6 9.6 8.6 8.6 15.3 10.3 15.2 15.6 11.7 15.0 30.5 12.0 13.2 11.0 9.7 9.2 16.0 14.4 12.6 10.9 15.5 10.1 8.6 14.0 8.4 11.7 14.1 22.0 10.3 23.2 14.3 10.8 19.7 14.2 13.6 8.7 7.5 10.8 10.3 12.3 29.3 12.6 11.6 15.1 17.6 37.5 19.7 11.2 20.0 17.9 16.8 13.0 15.3 13.3 13.1 17.5 9.9 7.1 22.7 11.6 22.4 20.8 11.6 10.0 8.9 11.8 15.4 18.8 19.8 19.4 11.2 19.6 16.3 2.5 2.7 14.0 4.4 4.6 4.5 6.3 5.4 4.8 3.6 5.2 8.4 4.5 1.4 2.5 3.1 3.4 5.1 1.7 8.0 8.2 8.3 8.7 8.3 7.7 8.1 8.2 8.3 8.4 8.3 8.6 18.7 6.4 5.9 3.9 40.8 23.6 35.2 4.9 26.7 29.1 25.2 27.8 5.3 21.5 5.7 23.9 6.2 65.1 49.5 21.7 25.4 9.7 2.5 28.6 28.0 20.2 11.4 26.5 6.8 7.0 93.1 27.8 21.9 25.3 3.8 18.7 32.5 23.6 35.8 30.3 6.6 22.8 4.1 24.0 22.2 1.6 32.3 16.6 30.2 5.6 18.1 38.4 60.8 4.5 8.3 9.9 33.9 22.6 19.7 40.3 33.9 51.3 4.6 24.7 6.6 26.6 20.0 16.0 14.3 23.1 24.9 63.3 47.7 39.1 24.2 34.8 BORCS5 "LOH12CR1, LOH1CR12" ENSG00000165714 "BLOC-1 related complex subunit 5" Q969J3 12 12357078-12471233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 42.6;T-cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039509, HPA043627" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Plasma membrane" "HPA039509: AB_2676550, HPA043627: AB_2678588" "unprognostic (1.82e-1)" "unprognostic (2.87e-1)" "unprognostic (2.81e-1)" "unprognostic (2.41e-1)" "unprognostic (8.00e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (6.78e-2)" "unprognostic (6.16e-2)" "unprognostic (2.79e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-1)" "unprognostic (9.51e-2)" 6.3 8.1 5.1 2.5 7.1 6.2 6.1 5.2 6.4 6.6 2.3 5.8 1.7 5.8 5.8 8.0 5.7 2.4 7.1 4.1 5.8 5.9 8.5 6.5 2.9 5.6 5.4 4.9 7.2 3.8 7.1 2.7 6.2 5.9 2.2 2.8 5.4 1.9 8.4 8.7 4.7 3.0 4.7 6.2 5.9 9.1 5.4 3.1 4.6 3.3 3.9 5.6 6.8 8.2 3.9 4.1 2.9 3.0 6.4 8.7 3.3 3.4 3.9 4.1 5.1 10.0 3.9 4.9 2.0 5.5 2.9 2.7 5.0 4.9 4.4 14.0 4.5 2.7 3.9 5.7 6.1 2.9 3.8 4.9 3.5 5.6 6.5 6.5 4.9 6.1 3.8 6.6 5.4 8.4 4.2 3.0 9.0 4.1 2.6 3.4 4.1 5.3 5.1 2.6 3.6 4.1 3.3 3.0 7.5 9.6 2.3 3.1 4.1 2.7 6.1 3.5 3.1 3.4 3.2 11.1 5.8 4.4 4.6 2.8 6.1 9.5 10.1 10.3 11.9 7.7 11.5 11.2 7.3 5.9 7.6 7.7 6.7 12.4 6.7 5.1 14.2 7.0 5.1 7.1 5.2 6.4 4.1 5.8 5.6 5.4 6.2 4.7 5.4 8.2 11.1 9.6 2.3 0.0 37.9 0.0 11.9 0.0 10.8 16.9 10.5 8.4 0.0 10.0 2.5 7.3 12.5 9.2 42.6 2.2 9.8 9.5 5.6 8.8 9.0 6.7 4.9 5.9 0.0 12.4 11.7 8.3 19.9 8.9 2.5 7.4 6.1 5.1 14.5 13.5 0.0 3.8 0.0 11.0 0.0 3.9 5.3 26.3 0.0 0.0 19.0 12.5 14.4 0.0 0.0 9.5 3.5 7.2 33.0 9.1 10.3 14.1 2.9 16.6 26.3 8.3 8.1 23.4 8.6 14.6 0.0 14.5 39.5 7.5 4.6 8.3 BORCS6 "C17orf59, FLJ20014" ENSG00000196544 "BLOC-1 related complex subunit 6" Q96GS4 17 8188345-8190180 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045415, HPA060791" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 11000 "Cluster 2: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Vesicles" "HPA045415: AB_10964575, HPA060791: AB_2684367" "unprognostic (2.11e-1)" "unprognostic (7.22e-3)" "unprognostic (3.25e-2)" "prognostic favorable (2.78e-4)" "unprognostic (3.84e-2)" "unprognostic (9.91e-3)" "unprognostic (7.51e-2)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" "unprognostic (6.93e-2)" "prognostic favorable (2.60e-4)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (2.18e-2)" "unprognostic (4.38e-2)" "unprognostic (3.28e-1)" "unprognostic (3.10e-2)" 6.4 8.4 9.8 5.0 9.9 4.2 5.7 10.1 10.4 5.7 7.9 8.3 7.2 6.6 3.7 10.9 5.2 2.3 10.1 9.1 8.9 7.7 8.0 5.4 6.7 11.8 10.0 4.1 14.4 6.1 4.7 4.0 10.7 6.2 2.7 3.1 6.2 4.9 15.0 12.5 8.6 2.8 9.8 11.6 8.2 5.5 9.9 5.3 5.7 6.0 4.9 7.1 6.5 10.8 6.3 7.5 2.5 5.1 5.3 3.9 10.0 4.6 5.1 4.4 4.7 4.2 4.2 5.9 9.9 3.7 4.2 9.2 3.9 5.4 1.5 17.8 16.3 4.5 7.0 6.5 6.0 2.7 9.5 4.0 5.7 4.0 4.6 3.9 7.2 8.6 5.1 12.0 2.7 6.7 9.0 7.7 1.8 4.0 8.3 10.6 3.2 8.9 6.1 3.5 3.0 6.9 4.7 3.5 4.2 2.5 5.1 4.2 5.8 2.7 2.4 4.2 5.0 18.0 8.8 2.7 3.9 9.5 3.3 46.4 18.6 50.7 27.8 18.7 22.7 23.5 23.4 29.6 20.9 23.3 22.0 24.9 17.0 28.5 23.1 18.3 23.5 21.4 9.8 9.9 10.1 10.4 9.1 8.9 11.8 10.0 10.7 9.8 9.9 10.8 13.5 9.6 6.4 0.0 21.6 0.0 2.6 0.0 14.2 23.1 9.0 9.5 0.0 11.5 0.6 5.5 6.2 20.4 22.3 12.2 7.9 9.7 2.4 5.6 3.8 10.9 1.2 11.4 0.0 17.7 12.0 4.4 4.1 5.7 3.8 5.2 12.5 9.4 20.9 18.5 0.0 8.6 0.0 21.1 0.0 3.2 5.9 21.5 0.0 0.0 25.6 23.8 45.3 0.0 0.0 11.3 18.3 6.8 18.5 3.5 29.8 10.3 0.0 19.7 32.9 4.3 6.7 9.0 1.3 17.3 0.0 6.2 18.7 9.4 7.5 1.5 BORCS8 MEF2BNB ENSG00000254901 "BLOC-1 related complex subunit 8" Q96FH0 19 19176903-19192591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045700 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "HPA045700: AB_10968570" "unprognostic (4.23e-3)" "unprognostic (1.61e-2)" "unprognostic (2.75e-1)" "unprognostic (3.58e-2)" "unprognostic (2.28e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (6.82e-2)" "prognostic favorable (4.05e-5)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (3.16e-1)" "unprognostic (1.38e-2)" "unprognostic (3.00e-2)" 12.7 12.4 27.2 11.9 27.1 15.9 8.4 27.1 34.7 6.1 25.3 9.7 11.0 6.5 6.4 11.7 10.8 7.6 17.4 27.2 29.7 13.4 10.7 10.5 12.5 28.0 27.7 5.3 11.0 15.9 20.3 7.6 28.8 10.0 8.7 5.5 9.9 7.9 14.3 8.7 8.1 8.8 25.4 10.1 9.8 8.6 27.2 12.2 12.5 18.0 8.7 10.8 6.3 28.4 21.9 15.4 13.5 14.4 17.8 8.7 22.5 22.4 16.3 25.9 25.7 17.9 26.1 12.9 36.6 22.1 19.1 12.9 12.9 28.5 9.9 12.6 18.9 11.1 23.0 18.0 14.8 17.4 17.8 13.6 15.0 23.2 9.2 11.0 29.7 19.0 26.1 21.1 28.5 38.6 25.7 14.5 9.8 23.3 18.7 10.3 9.9 18.7 27.3 17.1 26.2 14.5 22.4 17.0 15.9 10.0 20.8 17.3 17.0 14.1 14.9 32.5 34.3 15.7 15.3 15.3 16.8 14.0 27.8 45.3 32.4 57.2 14.5 44.9 12.5 27.0 15.4 14.6 22.2 19.6 12.9 13.2 79.9 14.9 45.9 30.1 19.7 20.0 27.2 27.1 27.1 34.7 27.2 29.7 28.0 27.7 28.8 25.4 27.2 28.4 16.6 12.8 21.6 0.0 13.6 0.0 15.4 0.0 5.2 17.0 19.6 18.5 0.0 25.8 7.4 14.7 10.4 31.8 22.5 11.6 43.0 38.0 5.0 25.4 12.1 12.3 10.9 10.8 0.0 32.7 34.9 11.1 13.3 15.7 10.1 11.6 12.1 16.6 41.0 18.5 0.0 9.3 0.0 23.4 0.0 5.2 7.8 24.0 0.0 0.0 37.1 13.2 15.5 0.0 0.0 42.4 9.5 6.8 15.3 14.7 25.6 40.8 13.1 18.3 0.0 11.6 15.0 33.8 23.9 7.4 0.0 39.5 14.0 18.6 9.5 17.2 BRAF BRAF1 ENSG00000157764 "B-Raf proto-oncogene, serine/threonine kinase" P15056 7 140719327-140924929 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 252.3;Inhibitory neurons: 242.4;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 202.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001328, CAB004552, HPA071048" Approved Approved Vesicles,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles Cytosol "CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336" "unprognostic (2.98e-3)" "unprognostic (5.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.66e-3)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.07e-2)" "unprognostic (4.23e-2)" "unprognostic (4.07e-2)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (1.91e-2)" "unprognostic (3.79e-3)" "unprognostic (2.08e-1)" "unprognostic (1.76e-1)" "unprognostic (8.01e-2)" "unprognostic (5.46e-2)" 8.8 5.8 6.3 5.6 7.7 15.9 8.8 12.5 8.7 8.2 5.4 8.6 4.7 8.3 8.3 7.5 8.0 5.8 7.6 8.3 6.7 7.6 6.6 9.9 6.9 4.0 3.6 9.8 8.3 11.5 9.0 7.2 4.6 8.2 5.4 17.0 7.2 5.9 8.6 10.4 6.9 6.0 3.1 6.7 7.8 13.7 5.2 8.7 10.2 8.4 6.4 9.9 8.5 6.7 6.3 5.2 7.7 9.4 9.1 11.8 12.3 6.8 7.5 5.4 7.6 5.7 6.7 10.8 5.0 7.3 8.4 3.4 6.8 5.5 10.0 9.8 5.4 7.1 5.1 5.2 7.6 11.7 6.8 7.9 6.1 6.0 12.0 8.2 6.6 7.7 11.3 19.1 9.8 3.3 15.6 12.0 6.9 6.2 3.1 10.1 6.5 8.9 5.3 11.9 8.9 7.3 7.9 4.9 7.3 7.5 4.5 7.8 9.7 5.9 4.3 12.9 5.5 21.6 12.9 16.7 9.7 11.3 6.6 1.9 1.0 4.1 1.5 0.9 1.0 1.3 1.5 1.2 0.8 1.1 2.6 1.3 2.0 3.5 1.3 1.0 1.5 0.6 6.3 7.7 12.5 8.7 8.3 6.7 4.0 3.6 4.6 3.1 5.2 6.7 43.4 22.4 45.7 151.1 58.4 21.5 24.6 6.0 23.3 29.7 31.2 21.2 19.8 10.0 18.7 25.8 35.5 15.7 73.5 8.8 7.9 14.3 68.6 50.6 37.4 23.4 19.2 14.9 252.3 9.8 12.9 22.0 21.9 69.2 24.7 45.5 9.3 9.6 9.4 25.2 242.4 9.8 8.2 13.6 37.1 36.5 16.4 30.1 16.0 126.5 14.6 11.3 15.5 206.1 202.6 15.4 8.1 10.1 48.7 23.8 8.0 13.4 20.0 33.0 6.6 24.1 24.7 43.8 26.0 14.5 24.0 75.5 41.4 30.9 8.7 33.4 BST2 "CD317, tetherin" ENSG00000130303 "Bone marrow stromal cell antigen 2" Q10589 19 17402939-17405630 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 694.2" "Cell type enhanced" "Detected in many" "Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA017060, HPA073472" Enhanced Supported "Golgi apparatus,Vesicles" NA NA 260000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Vesicles" "HPA017060: AB_1845467, HPA073472: " "prognostic favorable (6.69e-4)" "unprognostic (1.75e-1)" "unprognostic (8.42e-3)" "unprognostic (8.93e-3)" "unprognostic (4.87e-2)" "unprognostic (2.25e-1)" "unprognostic (2.26e-1)" "unprognostic (1.07e-1)" "unprognostic (3.25e-1)" "unprognostic (6.46e-2)" "unprognostic (6.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.56e-9)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" 226.0 509.8 86.7 95.6 87.6 103.7 152.9 84.0 125.7 93.4 81.7 94.1 47.4 58.7 59.5 40.3 248.0 109.4 111.2 85.1 84.5 160.1 227.8 141.4 128.0 101.5 85.9 694.2 26.3 13.8 56.8 203.0 88.4 88.6 33.3 2.0 77.7 105.2 46.1 24.8 109.1 76.0 97.0 238.5 84.1 35.4 91.1 123.5 54.0 50.8 65.8 82.9 88.6 90.8 327.0 0.5 0.9 145.6 0.0 1.0 49.6 1.3 24.9 459.5 615.0 150.5 286.1 252.2 338.2 197.6 14.6 1.3 212.9 23.9 14.3 279.1 1.8 3.6 525.7 149.8 256.7 120.1 304.7 1.3 0.0 153.0 0.1 4.4 119.0 6.0 146.3 603.4 0.0 89.5 57.7 208.6 158.0 0.1 407.9 105.5 0.8 530.7 110.1 1.5 0.6 1.4 325.5 12.3 410.5 12.3 243.1 166.3 1.5 1.9 11.4 0.5 3.3 308.3 439.3 168.0 1.3 470.8 2.2 229.7 345.3 125.3 171.4 385.5 163.0 115.2 143.2 160.0 283.8 146.5 114.8 132.6 113.3 353.2 359.3 421.7 143.3 367.9 86.7 87.6 84.0 125.7 85.1 84.5 101.5 85.9 88.4 97.0 91.1 90.8 1193.2 57.7 13.6 4.9 90.7 33.1 19.6 255.7 48.9 0.2 86.2 168.5 7.0 50.1 68.5 49.7 0.0 7.8 184.2 1.5 37.2 18.7 10.7 27.8 11.2 420.2 1.2 74.0 0.0 1.2 61.5 152.4 14.8 50.1 227.8 260.9 455.8 211.1 388.9 0.0 0.0 2.8 28.5 189.4 187.6 12.0 346.7 220.4 74.7 32.8 214.5 1.3 211.2 0.5 0.3 3.3 4.8 419.4 192.8 10.3 3.7 1.3 27.4 2.1 164.3 30.7 146.3 1.3 1.2 15.5 26.1 13.1 135.8 490.6 5.0 28.6 BTAF1 "MOT1, TAF-172, TAF(II)170, TAF172, TAFII170" ENSG00000095564 "B-TFIID TATA-box binding protein associated factor 1" O14981 10 91923770-92030325 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070682 Supported Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Vesicles "HPA070682: AB_2686294" "unprognostic (2.41e-1)" "unprognostic (1.29e-1)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-1)" "prognostic favorable (5.07e-4)" "unprognostic (2.72e-1)" "unprognostic (9.28e-2)" "unprognostic (1.16e-1)" "unprognostic (7.34e-2)" "unprognostic (9.70e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.45e-2)" "unprognostic (1.10e-1)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" 20.4 13.2 5.2 20.1 7.3 32.1 19.2 8.5 8.6 18.4 5.9 20.4 16.2 20.7 21.1 17.2 23.4 15.2 14.4 6.1 5.5 11.8 15.4 19.1 32.0 6.1 5.3 25.4 18.1 14.7 13.3 13.7 6.0 16.8 15.9 34.3 19.2 12.7 14.8 50.4 22.0 14.0 5.9 22.0 18.4 17.9 5.8 21.7 17.3 9.2 25.5 20.1 19.9 10.4 28.9 13.8 31.7 38.7 16.5 25.8 15.8 16.5 19.6 16.0 23.7 19.1 17.2 30.8 10.3 16.3 9.9 30.4 21.5 14.6 23.8 21.2 23.2 21.9 35.7 20.0 16.8 33.3 22.0 18.4 18.5 24.3 35.1 34.3 15.6 25.9 18.2 34.5 16.6 12.6 25.8 21.0 14.4 8.3 10.8 20.6 19.7 14.5 14.9 17.5 12.2 14.3 15.8 8.0 20.3 20.8 16.2 21.9 16.9 14.3 11.4 19.5 23.7 39.7 19.6 24.9 22.4 30.1 3.8 4.4 2.7 1.5 2.5 1.9 2.2 2.5 1.9 1.8 2.1 3.1 2.3 1.8 1.9 2.2 3.6 4.9 1.6 1.4 5.2 7.3 8.5 8.6 6.1 5.5 6.1 5.3 6.0 5.9 5.8 10.4 18.3 19.2 31.5 58.4 29.5 21.7 12.1 7.3 21.6 26.7 16.2 11.9 13.6 7.2 14.6 20.2 45.9 6.6 34.8 7.9 1.9 6.8 12.9 33.3 28.0 15.6 16.2 13.9 78.5 6.6 9.8 17.3 35.2 46.6 24.1 22.4 8.9 8.7 7.1 18.5 66.4 7.1 6.1 9.7 19.8 5.1 11.8 27.1 5.4 67.5 16.4 13.9 14.4 68.3 91.5 6.7 6.3 11.7 52.1 15.7 9.6 3.3 24.9 35.5 6.6 25.7 22.8 24.7 12.2 20.4 29.8 14.6 24.7 11.4 9.3 16.4 BTG2 "APRO1, MGC126063, MGC126064, PC3, TIS21" ENSG00000159388 "BTG anti-proliferation factor 2" P78543 1 203305491-203309602 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Enteroendocrine cells: 965.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 161.8;HMC-1: 160.8;RT4: 131.3;U-266/70: 259.8;U-266/84: 141.2" "Low region specificity" "Detected in all" HPA002355 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "HPA002355: AB_1078304" "prognostic favorable (8.53e-4)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" "unprognostic (4.81e-3)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (2.47e-1)" "unprognostic (7.87e-3)" "unprognostic (4.72e-1)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.18e-2)" "unprognostic (4.46e-2)" "unprognostic (6.22e-2)" "unprognostic (4.34e-1)" "unprognostic (1.17e-1)" "unprognostic (2.86e-3)" 274.5 244.6 38.3 124.3 40.7 309.3 118.8 58.4 45.0 101.7 36.7 231.5 88.5 91.9 41.5 313.4 355.0 157.8 256.3 35.1 49.0 132.2 20.8 105.0 122.0 61.8 42.1 554.9 488.9 37.4 209.2 106.7 43.6 265.9 205.7 152.6 75.1 182.9 210.7 134.4 111.1 213.7 49.3 107.1 244.5 10.2 42.4 334.6 201.2 287.1 132.3 279.9 79.1 42.1 4.3 6.1 10.9 4.5 13.4 9.8 92.9 11.2 21.4 2.8 10.5 8.8 1.6 161.8 7.8 3.5 1.8 69.5 39.6 42.6 5.2 10.8 20.3 84.5 12.3 18.4 29.5 0.4 160.8 10.1 76.7 10.3 18.7 9.5 57.6 8.2 40.6 106.9 28.1 3.6 18.1 5.4 4.9 1.7 1.2 11.4 36.5 84.3 5.3 131.3 1.9 11.3 8.6 3.6 1.4 80.0 9.0 10.1 14.3 0.3 18.2 2.9 0.6 259.8 141.2 103.4 2.2 4.1 6.3 8.4 19.7 23.1 10.0 27.1 14.8 29.9 10.9 10.2 11.5 29.0 17.5 12.6 77.1 12.7 35.6 38.6 11.2 19.7 38.3 40.7 58.4 45.0 35.1 49.0 61.8 42.1 43.6 49.3 42.4 42.1 555.8 157.0 241.8 6.5 330.1 230.2 464.4 311.4 548.7 25.4 355.1 276.7 274.8 48.6 128.5 187.6 29.2 50.0 343.9 345.8 15.6 113.2 1.4 336.7 211.7 196.4 965.1 127.6 2.9 163.7 16.6 352.8 562.2 643.2 369.3 40.6 148.2 6.5 120.1 3.3 2.0 617.1 264.5 98.8 183.6 3.1 72.7 227.0 120.9 25.3 47.5 478.8 58.7 4.5 10.4 55.9 399.9 55.3 725.2 230.1 397.5 13.9 88.5 38.9 124.9 537.5 305.0 1.8 1.7 343.8 447.9 138.0 300.8 278.6 360.7 211.8 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 250.8;breast: 200.0" "Cell type enriched" "Detected in many" 6 "Adipocytes: 900.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "OE19: 9.9;U-698: 37.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favorable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 250.8 13.3 18.3 3.0 13.1 1.0 200.0 14.9 24.2 12.7 11.2 11.7 1.9 11.0 5.4 5.9 20.0 9.3 104.5 20.6 13.1 22.4 7.9 102.3 7.1 21.9 14.6 5.3 11.9 5.9 4.8 10.5 21.8 8.3 3.6 1.2 6.9 2.6 46.6 11.8 10.8 4.0 12.7 57.3 12.8 4.4 32.2 9.8 29.6 20.7 13.8 10.5 10.4 12.7 0.0 0.2 0.1 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.4 0.1 0.2 1.4 0.0 0.0 0.2 0.7 0.1 0.0 0.2 3.7 1.5 0.4 0.2 0.0 0.7 4.2 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.9 0.3 0.0 0.1 0.1 0.2 0.1 9.9 2.3 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.2 0.1 0.0 0.2 0.6 0.0 0.0 0.1 5.5 0.1 0.0 0.3 0.1 37.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 18.3 13.1 14.9 24.2 20.6 13.1 21.9 14.6 21.8 12.7 32.2 12.7 900.4 0.0 3.8 1.3 9.8 2.3 0.6 0.1 0.6 0.6 2.4 3.6 40.6 0.0 0.8 0.0 0.0 0.1 3.9 1.0 3.9 0.0 0.7 1.1 0.5 127.0 4.2 0.4 8.4 0.2 0.1 10.2 0.5 3.4 1.3 7.0 144.9 0.6 0.1 0.0 1.2 3.5 0.0 8.3 1.1 1.4 2.1 1.7 3.6 54.4 0.1 0.3 0.0 1.0 0.6 0.1 1.2 0.4 1.2 0.4 0.0 0.1 2.4 0.3 13.1 8.4 37.5 4.0 9.8 5.5 2.3 0.1 2.2 88.9 1.5 0.5 C11orf16 ENSG00000176029 "Chromosome 11 open reading frame 16" Q9NQ32 11 8920076-8933006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 6.2;fallopian tube: 12.9;lymphoid tissue: 6.2" "Group enriched" "Detected in some" 8 "Endometrial ciliated cells: 40.8;Ionocytes: 28.5;Respiratory ciliated cells: 110.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA040644 Uncertain "Endoplasmic reticulum,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "Endoplasmic reticulum" Vesicles "HPA040644: " "unprognostic (5.32e-3)" "unprognostic (1.03e-2)" "unprognostic (4.09e-3)" "prognostic favorable (3.32e-4)" "unprognostic (1.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.94e-5)" "unprognostic (6.40e-4)" "unprognostic (1.58e-2)" "unprognostic (9.99e-2)" "unprognostic (4.87e-2)" "unprognostic (1.05e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.71e-1)" "unprognostic (1.13e-3)" 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.3 0.1 1.0 6.2 0.0 0.0 0.3 0.0 0.0 12.9 0.0 0.0 0.3 0.7 0.3 0.0 2.6 0.0 1.3 2.3 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 2.2 0.6 6.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.1 0.3 0.7 1.3 2.3 0.8 1.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.1 0.0 0.0 7.1 5.5 0.0 0.1 0.0 0.0 0.0 0.0 1.6 40.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 28.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 110.8 0.0 0.0 0.0 1.5 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 C11orf53 MGC50104 ENSG00000150750 "Chromosome 11 open reading frame 53" Q8IXP5 11 111245726-111286401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "stomach 1: 3.4;testis: 5.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 14.3;Early spermatids: 38.1;Exocrine glandular cells: 56.6;Late spermatids: 12.4;Respiratory ciliated cells: 9.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "OE19: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA056128, HPA073101" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm Vesicles "HPA056128: AB_2683046, HPA073101: " "unprognostic (3.51e-2)" "unprognostic (3.60e-2)" "unprognostic (4.84e-2)" "unprognostic (5.84e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-3)" "unprognostic (5.60e-3)" "unprognostic (3.09e-1)" "unprognostic (2.50e-1)" "unprognostic (9.95e-2)" "unprognostic (8.66e-2)" "unprognostic (3.52e-2)" 0.9 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.1 0.0 1.4 0.9 0.9 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.5 0.6 1.3 0.4 0.7 0.0 0.3 1.0 0.0 2.1 0.0 1.8 0.0 1.2 0.0 0.0 0.0 3.4 5.5 0.0 0.4 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 0.1 0.1 14.3 3.3 0.0 0.0 0.0 0.1 1.5 0.0 1.9 38.1 0.0 1.4 0.0 7.7 0.0 0.1 56.6 0.1 1.9 3.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 3.0 8.2 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.2 0.3 4.0 0.0 9.9 0.0 0.0 0.1 0.6 1.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 4.4 C16orf72 "FLJ41272, PRO0149" ENSG00000182831 "Chromosome 16 open reading frame 72" Q14CZ0 16 9091644-9121635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 106.1" "Cell type enhanced" "Detected in all" "Late spermatids: 643.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041568, HPA067492" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 42: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "HPA041568: AB_10796677, HPA067492: AB_2685850" "unprognostic (3.98e-2)" "unprognostic (4.74e-2)" "unprognostic (5.87e-3)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.37e-1)" "unprognostic (3.17e-2)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (6.74e-2)" "unprognostic (8.64e-2)" "unprognostic (7.92e-3)" "unprognostic (2.03e-1)" "unprognostic (1.29e-2)" "unprognostic (6.64e-3)" "unprognostic (6.51e-2)" 20.0 17.4 15.7 18.2 17.8 106.1 17.2 14.9 20.3 15.9 14.0 14.9 14.8 15.2 17.3 19.6 12.8 19.0 15.8 18.8 16.7 18.6 26.8 17.5 20.1 14.1 15.8 14.2 18.6 22.3 9.8 17.1 14.9 15.9 15.0 20.8 14.2 14.7 32.4 17.0 13.6 16.8 13.8 20.9 15.8 17.3 16.8 19.4 18.8 27.8 22.0 17.8 15.2 16.8 17.3 18.9 29.6 27.1 34.4 26.7 15.5 33.2 27.6 18.8 19.3 15.9 22.0 30.8 18.6 38.6 14.8 19.8 27.5 29.4 39.2 20.3 15.4 20.7 27.2 33.6 44.4 26.3 23.2 40.7 45.3 31.5 44.7 30.1 33.1 31.7 31.6 45.7 33.6 24.9 23.5 23.3 36.1 17.7 16.5 39.6 36.1 33.1 24.6 31.3 19.1 21.4 39.9 27.8 35.1 27.4 32.1 26.6 38.3 36.6 24.0 47.6 21.7 51.7 48.0 42.5 32.6 23.2 30.3 5.5 2.8 3.2 3.7 3.1 4.2 2.5 3.1 2.6 2.2 3.0 3.5 3.2 10.9 2.3 3.4 2.8 2.7 1.7 15.7 17.8 14.9 20.3 18.8 16.7 14.1 15.8 14.9 13.8 16.8 16.8 65.3 48.1 37.2 17.6 47.5 76.9 45.4 13.0 78.6 43.6 81.6 53.8 39.3 35.8 19.1 22.0 87.6 29.6 76.0 45.8 19.6 28.1 210.0 75.7 75.1 52.5 48.2 21.7 27.6 29.4 35.7 42.9 35.2 115.7 18.3 51.9 38.6 59.5 32.5 43.7 28.2 35.1 8.2 83.8 65.6 643.5 24.5 83.5 32.0 28.1 49.0 41.8 33.0 24.6 33.3 38.9 37.7 27.1 59.2 52.0 44.5 36.8 15.9 51.2 32.9 78.0 56.3 41.5 22.3 84.5 64.4 57.1 58.8 35.3 34.9 70.1 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431426 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 173 "testis: 135.3" "Group enriched" "Detected in some" 25 "Early spermatids: 1057.0;Late spermatids: 524.2;Spermatocytes: 287.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Group enriched" "Detected in many" 4 "dendritic cells: 2.5;granulocytes: 1.0" "Cell line enriched" "Detected in some" 4 "MCF7: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044415 Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 74: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.3 0.1 0.3 0.0 0.1 0.6 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.4 0.3 0.0 0.1 0.1 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.5 0.1 135.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 5.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.2 1.0 0.0 0.0 2.5 0.0 0.0 0.3 0.1 0.2 0.7 0.2 0.4 0.6 0.4 0.4 0.2 0.4 0.6 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1057.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 524.2 9.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 287.9 24.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 170.0;Late spermatids: 100.8;Spermatocytes: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 23: Testis - Cell cycle regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.6 10.1 10.0 9.5 10.1 3.1 11.2 12.7 12.1 11.9 9.2 11.6 10.5 14.5 9.7 8.8 12.2 8.9 15.8 9.7 10.2 12.7 9.9 9.2 13.7 8.3 9.2 17.2 9.3 16.6 10.6 12.5 8.4 12.6 10.0 23.3 10.8 11.9 24.6 8.7 9.8 12.8 9.0 10.8 10.3 39.7 9.6 17.9 16.1 21.8 12.2 9.1 6.9 9.9 20.0 20.6 28.1 17.2 20.2 17.2 27.2 25.6 22.2 35.6 33.6 19.7 16.1 37.7 17.8 13.2 24.2 19.5 39.4 14.7 41.4 13.8 26.8 34.6 21.5 23.3 17.6 37.0 19.7 13.5 18.1 23.8 19.5 17.8 30.9 25.1 38.3 21.9 24.0 11.5 43.1 17.5 22.3 22.1 22.1 25.7 77.2 19.3 18.4 14.9 34.3 30.8 13.7 24.7 30.0 44.0 27.1 23.0 17.1 37.1 34.0 12.1 24.8 24.7 31.9 35.8 14.9 16.5 24.1 17.3 3.3 4.8 6.6 4.0 6.6 4.9 4.9 5.9 3.8 4.7 4.5 6.6 1.6 4.4 4.4 5.8 7.2 3.4 10.0 10.1 12.7 12.1 9.7 10.2 8.3 9.2 8.4 9.0 9.6 9.9 10.3 6.4 15.1 10.7 6.4 5.0 2.1 3.0 8.6 10.3 6.1 7.2 20.2 5.7 7.9 5.5 20.9 9.5 14.9 4.6 9.8 6.1 170.0 8.9 12.3 11.0 5.4 1.3 10.8 3.8 5.8 9.6 5.6 7.0 7.6 11.8 5.0 4.6 5.0 8.4 10.9 3.8 6.1 5.1 2.6 100.8 5.3 4.8 1.8 9.4 5.9 10.6 4.1 10.1 9.0 4.5 5.1 7.5 5.9 2.1 6.6 7.5 15.8 15.8 0.0 10.5 7.7 67.1 13.6 7.1 4.4 16.8 5.5 17.9 4.8 1.4 C18orf32 FLJ23458 ENSG00000177576 "Chromosome 18 open reading frame 32" Q8TCD1 18 49477243-49487252 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 238.5;Late spermatids: 233.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040921 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 34: Spermatids - Unknown function" Vesicles Nucleoplasm "HPA040921: AB_10795423" "unprognostic (5.83e-2)" "unprognostic (5.48e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-2)" "unprognostic (4.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.72e-1)" "unprognostic (2.80e-2)" "unprognostic (6.36e-2)" "unprognostic (4.36e-3)" "unprognostic (2.58e-3)" "unprognostic (2.76e-2)" "prognostic favorable (8.89e-9)" "unprognostic (1.02e-1)" "unprognostic (7.42e-2)" "unprognostic (1.28e-2)" "unprognostic (4.36e-2)" 41.5 66.7 10.8 5.6 13.8 6.8 39.8 15.3 20.0 34.9 8.3 46.0 6.1 35.6 5.6 32.3 34.5 6.6 59.3 11.3 13.5 79.6 86.8 46.5 7.9 14.8 13.0 38.8 47.0 18.5 67.9 6.9 14.0 39.4 10.2 24.6 43.7 8.4 37.9 27.8 39.9 7.3 13.4 39.2 58.1 40.9 13.1 8.5 43.9 7.2 10.4 38.8 32.6 18.7 4.3 3.2 14.4 13.3 12.3 8.8 8.6 5.5 7.6 6.0 6.8 0.5 3.7 4.9 8.6 7.9 9.0 11.1 5.1 10.6 12.6 11.3 4.1 4.2 2.3 5.4 11.2 5.1 11.2 9.9 21.0 5.0 6.1 16.0 12.2 10.1 4.1 11.4 9.9 1.9 4.6 2.5 4.7 4.9 5.9 4.0 3.6 3.8 7.1 5.0 10.7 12.3 5.1 3.4 4.4 19.8 3.1 2.3 13.1 9.6 5.0 1.7 6.9 13.4 24.1 9.1 5.2 5.9 7.1 27.4 8.4 25.8 8.4 8.8 8.7 8.9 6.9 7.7 6.6 7.4 6.6 8.4 41.4 6.2 11.3 9.5 8.2 10.3 10.8 13.8 15.3 20.0 11.3 13.5 14.8 13.0 14.0 13.4 13.1 18.7 20.2 44.8 29.2 0.0 50.8 5.5 4.6 21.2 39.3 35.0 26.2 15.0 5.5 31.5 22.4 23.9 43.8 22.9 33.8 92.9 39.2 87.5 238.5 38.1 21.0 17.5 95.5 20.2 0.0 82.7 17.7 28.7 63.2 30.3 45.6 5.3 23.6 40.4 22.1 18.5 0.0 57.3 32.6 38.0 12.0 233.1 17.1 48.1 23.2 0.0 73.9 41.4 34.0 0.0 0.0 92.3 77.5 10.1 83.0 5.6 92.7 57.2 42.4 36.3 19.7 10.3 22.7 12.7 13.9 58.4 7.7 38.7 43.4 4.5 40.8 5.2 C19orf81 ENSG00000235034 "Chromosome 19 open reading frame 81" C9J6K1 19 50649445-50659310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 2.4;testis: 6.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 20.2;Early spermatids: 30.7;Muller glia cells: 65.4;Rod photoreceptor cells: 29.3;Spermatocytes: 17.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HMC-1: 1.5;JURKAT: 1.2;K-562: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060238 Enhanced Approved Vesicles,Aggresome NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 5: Muller glia cells - Visual perception" "Vesicles, Aggresome" "HPA060238: AB_2684228" "unprognostic (2.29e-2)" "unprognostic (2.75e-2)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (3.39e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.48e-2)" "unprognostic (6.01e-4)" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (1.95e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.6 0.0 0.5 0.1 0.0 2.4 1.3 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.3 0.1 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.5 4.3 0.4 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.0 0.8 0.0 0.0 0.2 0.7 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 2.4 1.3 0.8 0.6 0.7 0.4 0.8 0.2 0.4 0.8 0.2 0.0 0.0 0.3 0.5 2.2 1.7 0.0 12.0 14.9 4.0 4.3 1.3 1.5 0.0 20.2 8.4 0.1 3.0 0.1 13.7 7.9 30.7 2.3 1.4 1.5 0.0 0.8 1.5 1.3 0.3 0.9 0.0 5.4 0.0 1.4 1.8 0.0 0.9 11.8 2.1 0.0 0.0 0.3 0.8 6.4 0.6 0.9 5.4 1.0 2.6 65.4 0.0 1.5 3.5 4.4 0.0 0.7 0.1 6.0 0.0 0.2 0.0 29.3 0.0 1.1 1.8 17.1 5.0 0.9 4.3 0.0 0.8 2.7 0.0 0.4 C1orf53 ENSG00000203724 "Chromosome 1 open reading frame 53" Q5VUE5 1 197902630-197907367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 15.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 64.6;Theca cells: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 8.9" "Lineage enriched" "Detected in many" 4 "monocytes: 8.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065352 Approved Vesicles,Aggresome NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles Aggresome "HPA065352: AB_2685477" "prognostic favorable (1.63e-4)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (2.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.90e-3)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (5.53e-3)" "unprognostic (9.85e-2)" "unprognostic (1.12e-1)" "unprognostic (8.58e-3)" "unprognostic (1.37e-1)" 1.7 9.4 2.6 0.5 2.1 0.8 1.4 1.9 3.6 1.5 5.1 2.8 1.8 1.0 3.1 3.0 0.9 0.8 6.7 2.7 2.2 5.1 15.1 1.9 0.5 2.3 2.6 2.3 2.7 0.4 5.0 0.8 2.1 1.4 1.3 0.5 2.3 0.4 3.7 0.9 1.9 0.8 1.8 1.6 1.8 3.1 3.3 0.3 2.7 1.4 0.3 1.2 1.5 2.5 4.4 6.0 0.4 2.1 3.7 10.5 3.3 7.5 5.4 6.2 3.1 5.4 3.7 8.5 11.8 8.5 1.4 2.0 2.2 1.4 0.6 2.7 15.8 5.0 3.7 8.6 1.0 11.2 6.8 7.1 4.8 1.9 0.8 5.0 2.2 1.8 1.4 2.1 4.7 7.9 0.6 10.1 4.7 6.9 8.7 1.1 3.4 3.1 10.1 6.9 18.4 14.4 9.5 1.6 3.2 2.3 4.5 4.3 5.1 7.2 8.0 10.2 5.2 3.6 2.6 2.2 5.2 3.6 9.0 0.0 2.7 0.0 0.3 8.9 0.0 0.0 0.1 0.6 2.1 0.1 0.3 0.3 0.0 0.0 4.4 0.6 0.1 0.9 2.6 2.1 1.9 3.6 2.7 2.2 2.3 2.6 2.1 1.8 3.3 2.5 0.5 9.6 10.6 0.3 1.6 2.5 4.1 13.1 4.0 2.2 16.3 20.8 11.7 18.6 15.1 22.0 0.0 18.9 0.3 14.8 19.6 9.9 15.7 16.2 6.7 2.0 7.8 4.8 2.0 13.8 10.2 5.5 4.1 12.1 1.3 8.6 2.2 64.6 9.5 3.3 1.5 12.6 14.2 4.1 1.8 2.7 14.0 4.7 8.8 0.0 2.6 11.5 4.1 1.0 0.8 9.3 8.8 10.5 6.0 6.7 10.8 25.8 12.2 3.9 0.0 1.4 6.1 8.6 4.5 12.4 2.8 11.8 1.1 55.8 16.6 5.7 C1QTNF4 "CTRP4, ZACRP4" ENSG00000172247 "C1q and TNF related 4" Q9BXJ3 11 47589667-47594411 "Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0;pituitary gland: 17.1" "Cell type enhanced" "Detected in many" "Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0" "Group enriched" "Detected in some" 4 "glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "REH: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041032 Approved Uncertain "Golgi apparatus,Vesicles" "Secreted in brain" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 14: REH - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus, Vesicles" "HPA041032: AB_10671170" "unprognostic (1.84e-3)" "unprognostic (1.58e-1)" "unprognostic (8.98e-4)" "unprognostic (8.19e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-3)" "unprognostic (6.78e-2)" "unprognostic (6.11e-2)" "unprognostic (6.35e-2)" "unprognostic (4.00e-1)" "unprognostic (4.91e-4)" "unprognostic (1.22e-1)" "unprognostic (8.22e-6)" "unprognostic (6.02e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (6.28e-2)" 1.7 1.5 7.9 0.0 33.0 1.1 2.2 13.2 17.6 5.3 0.0 3.9 0.1 5.8 0.0 0.5 4.2 0.0 1.0 7.5 1.1 1.4 0.9 0.7 0.0 6.0 4.9 12.0 0.4 0.7 17.1 0.0 2.1 2.8 0.0 0.1 1.1 0.1 0.9 1.8 1.5 0.1 1.0 1.0 1.5 5.8 6.7 0.0 1.5 0.0 0.0 1.3 2.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 33.0 13.2 17.6 7.5 1.1 6.0 4.9 2.1 1.0 6.7 3.4 2.4 0.0 0.0 18.9 0.0 2.4 6.5 0.2 0.0 15.8 1.3 25.8 0.7 1.5 0.3 3.7 16.7 1.3 0.1 0.2 3.9 0.1 11.3 0.8 21.2 4.5 0.0 2.5 15.5 0.2 2.7 20.7 0.5 0.6 0.0 31.3 2.5 0.2 3.3 5.0 17.8 0.1 0.0 0.3 3.0 51.7 46.0 0.7 10.6 4.7 0.0 54.5 0.0 5.0 8.0 0.1 0.1 38.4 0.0 4.3 0.1 0.6 0.6 24.7 26.3 12.8 8.5 13.5 44.5 0.3 1.8 3.6 0.6 39.0 0.2 2.4 C5AR1 "C5A, C5AR, C5R1, CD88" ENSG00000197405 "Complement C5a receptor 1" P21730 19 47290023-47322066 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 125.5;lymphoid tissue: 84.8" "Group enriched" "Detected in many" 4 "Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 394.0" "Group enriched" "Detected in many" 42 "granulocytes: 394.0;monocytes: 115.9" "Cell line enhanced" "Detected in some" "A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB002720, HPA014520, HPA048012" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" Vesicles "CAB002720: , HPA014520: AB_1846337, HPA048012: " "unprognostic (5.95e-2)" "prognostic favorable (4.71e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-1)" "unprognostic (4.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-2)" "unprognostic (4.41e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (9.55e-4)" "unprognostic (2.02e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.96e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.82e-2)" "unprognostic (6.54e-2)" 72.7 18.2 3.3 84.8 3.1 125.5 8.5 2.4 9.0 11.8 21.6 9.8 2.5 7.5 1.4 8.3 23.9 38.8 11.7 3.9 8.2 9.7 18.0 43.1 11.5 8.9 6.9 5.0 8.9 4.8 51.8 31.8 8.4 5.3 4.2 4.4 5.1 2.5 1.9 2.3 5.8 28.1 5.7 38.2 7.2 2.6 10.5 7.1 3.6 5.8 4.3 37.1 4.6 11.6 1.0 3.9 0.1 0.1 0.7 0.2 0.6 0.7 0.5 0.2 0.1 0.2 4.1 0.3 0.7 0.9 0.4 1.4 0.2 0.5 0.2 0.7 0.5 0.1 3.8 0.6 0.4 1.5 4.7 0.3 2.2 0.4 0.3 0.6 0.0 0.2 0.2 1.7 0.1 1.1 0.2 2.5 1.2 0.2 0.3 0.2 0.1 0.3 1.3 0.9 0.0 0.0 0.3 0.3 0.6 0.5 0.2 2.2 0.0 0.1 2.1 0.3 0.1 0.2 0.3 0.3 6.2 6.5 0.2 41.6 53.8 38.8 0.4 80.4 0.3 0.4 0.3 0.2 6.1 0.6 0.3 0.3 394.0 0.5 115.9 1.1 0.3 19.3 3.3 3.1 2.4 9.0 3.9 8.2 8.9 6.9 8.4 5.7 10.5 11.6 4.4 3.2 20.8 0.0 5.1 5.1 1.0 3.4 2.8 1.0 2.1 4.4 2.9 1.5 15.3 1.8 2.1 0.8 1.5 1.6 3.9 0.0 1.3 17.3 1.8 6.3 0.0 0.4 1.5 0.0 1.5 5.3 1.1 4.6 25.2 0.1 2.9 8.3 130.9 0.0 0.6 0.8 4.1 228.3 122.4 1.3 0.6 446.7 5.4 5.6 56.3 0.2 0.0 1.0 0.3 0.1 0.1 0.0 4.9 0.5 0.7 1.3 40.7 4.3 13.1 4.1 2.8 0.5 0.9 1.4 3.0 1.5 3.3 0.0 1.3 0.5 C8orf44-SGK3 ENSG00000288602 "C8orf44-SGK3 readthrough" 8 66667596-66860472 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Astrocytes: 17.3;Excitatory neurons: 23.5;Inhibitory neurons: 17.5;Microglial cells: 11.2;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 18.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 31.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006699, HPA027146" Approved Uncertain Nucleoplasm,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA006699: , HPA027146: AB_1856745" 4.1 3.1 5.2 3.1 5.5 6.1 6.3 5.3 7.2 4.5 3.5 3.5 2.8 5.6 11.5 2.1 7.3 3.7 4.4 5.1 6.3 4.2 3.1 3.4 5.7 4.6 4.8 7.9 2.2 2.9 3.8 4.7 5.1 5.8 9.1 4.2 6.1 4.1 6.9 2.6 4.9 3.9 5.1 4.3 6.6 4.8 5.7 7.6 3.7 5.4 2.6 7.5 6.9 2.4 3.5 2.6 5.8 7.0 1.7 2.3 4.3 5.2 5.8 2.8 8.7 9.8 1.3 5.3 4.1 4.4 5.5 3.1 8.2 8.5 8.3 9.3 7.2 5.5 4.6 5.3 6.0 9.2 9.1 3.3 7.3 9.0 5.3 10.7 9.7 5.6 4.8 2.1 4.6 3.7 3.5 6.6 3.8 3.7 2.4 2.4 5.0 2.0 3.4 3.8 2.9 1.3 3.9 5.3 7.0 3.5 5.1 2.6 2.5 2.2 2.2 5.7 3.8 4.8 4.7 6.0 1.4 31.0 9.8 6.2 4.0 4.1 4.9 7.6 4.5 5.1 7.2 6.1 7.0 5.0 6.9 5.2 2.7 6.9 7.0 4.2 5.2 5.5 5.3 7.2 5.1 6.3 4.6 4.8 4.7 3.9 4.8 7.5 0.0 0.0 0.0 17.3 0.9 0.0 0.0 0.1 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 23.5 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 11.2 0.1 0.5 0.0 15.6 18.0 0.0 1.1 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 1.4 0.1 0.0 0.6 0.0 0.0 0.0 CA11 "CARP2, CARPX1" ENSG00000063180 "Carbonic anhydrase 11" O75493 19 48637946-48646187 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 330.0;choroid plexus: 146.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 46.1;hTERT-RPE1: 47.1;SCLC-21H: 32.6;U-266/84: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041778 Approved Vesicles,Microtubules "Secreted in brain" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Microtubules" "HPA041778: AB_10794525" "unprognostic (1.39e-1)" "prognostic favorable (4.33e-4)" "unprognostic (2.59e-3)" "unprognostic (5.72e-2)" "unprognostic (1.54e-1)" "unprognostic (9.80e-3)" "unprognostic (6.02e-2)" "prognostic favorable (2.11e-5)" "unprognostic (3.79e-2)" "unprognostic (2.98e-1)" "prognostic favorable (8.60e-5)" "unprognostic (4.88e-2)" "unprognostic (8.64e-3)" "unprognostic (1.21e-1)" "unprognostic (7.15e-2)" "unprognostic (4.09e-3)" "unprognostic (1.75e-1)" 13.1 17.3 240.8 3.2 256.9 1.6 8.5 215.4 330.0 15.9 146.2 19.4 8.4 33.0 28.2 8.0 21.4 5.5 10.7 266.6 167.0 14.7 1.7 5.8 5.0 170.3 169.2 48.8 5.9 58.0 37.2 1.1 172.2 14.0 2.5 30.0 8.9 13.5 9.2 14.3 9.3 18.2 163.8 6.1 13.0 6.4 180.5 6.6 12.1 7.4 5.3 9.2 12.2 231.9 2.0 12.7 22.9 46.1 3.1 1.2 0.6 1.5 14.9 1.5 3.3 3.1 15.7 7.5 1.7 1.7 4.2 4.9 9.4 4.6 1.3 1.6 13.5 3.3 7.2 0.2 3.0 0.3 9.8 5.4 9.2 1.4 2.0 47.1 1.8 19.8 6.1 20.5 0.7 5.0 4.1 1.4 9.9 7.5 4.7 2.6 0.9 16.1 10.1 0.4 32.6 18.2 1.7 1.6 2.7 6.1 6.3 0.8 0.2 3.9 14.2 0.1 0.4 18.9 33.9 1.3 5.7 4.3 2.0 0.0 0.4 0.0 1.5 0.5 1.5 1.0 1.2 1.2 0.7 1.3 1.5 1.3 0.0 1.3 0.0 1.9 1.5 0.7 240.8 256.9 215.4 330.0 266.6 167.0 170.3 169.2 172.2 163.8 180.5 231.9 5.1 3.2 8.1 11.1 9.3 7.1 9.1 13.2 12.5 81.0 15.5 12.1 5.4 21.5 9.6 31.3 16.7 0.7 9.8 3.9 25.4 11.5 15.0 6.7 6.3 6.7 13.1 3.6 47.0 10.0 0.4 11.6 5.6 7.9 6.3 3.1 8.9 47.5 6.0 28.6 18.1 6.4 16.2 20.4 26.4 7.9 22.1 6.8 8.8 5.6 5.6 50.4 12.3 7.1 6.8 3.4 2.9 26.7 4.3 4.3 20.7 38.7 7.5 30.8 6.6 4.2 8.9 1.3 4.9 5.9 10.9 0.4 6.9 8.7 5.2 6.4 CA4 "CAIV, Car4, RP17" ENSG00000167434 "Carbonic anhydrase 4" P22748 17 60149942-60170899 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Disease variant, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 263.6" "Group enriched" "Detected in many" 16 "Adipocytes: 704.2;Distal enterocytes: 1289.3;Paneth cells: 2368.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 7.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "neutrophil: 99.5" "Lineage enriched" "Detected in single" 995 "granulocytes: 99.5" "Cell line enhanced" "Detected in single" "OE19: 1.1" "Region enriched" "Detected in all" 5 "cerebellum: 300.3" "Low region specificity" "Detected in all" "HPA011089, HPA017258" Enhanced Uncertain Vesicles,Cytosol NA NA 190000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Vesicles "HPA011089: AB_1845996, HPA017258: AB_1845997" "unprognostic (2.07e-2)" "unprognostic (7.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.78e-3)" "unprognostic (8.42e-2)" "unprognostic (1.19e-1)" "unprognostic (3.19e-2)" "unprognostic (5.84e-2)" "unprognostic (7.76e-2)" "unprognostic (9.74e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-2)" "unprognostic (2.68e-3)" "unprognostic (8.59e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-2)" 83.0 2.3 17.8 3.1 18.8 19.5 80.9 86.8 34.2 12.7 13.9 263.6 3.8 6.0 51.9 1.0 5.0 38.3 55.2 22.8 13.9 47.6 0.7 87.2 0.6 13.4 17.8 6.2 31.8 16.9 15.7 8.6 22.8 8.2 172.6 0.1 10.4 36.9 30.5 3.8 11.2 2.7 12.7 16.0 10.0 1.3 15.1 1.6 74.6 42.3 0.1 6.2 5.6 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.5 0.0 0.0 0.0 0.0 0.1 17.8 18.8 86.8 34.2 22.8 13.9 13.4 17.8 22.8 12.7 15.1 14.9 704.2 0.0 2.4 1.3 1.5 1.5 0.3 0.0 2.2 0.0 2.3 2.5 9.1 0.0 0.6 14.7 0.0 0.0 1.2 1289.3 33.2 11.7 0.5 0.6 13.0 88.3 19.3 0.0 3.8 0.2 0.0 4.4 0.0 0.2 11.4 23.2 1.4 0.0 0.6 0.0 1.4 24.6 0.0 0.0 1.2 0.1 0.6 1.1 0.0 23.4 0.0 0.1 0.0 1.0 0.4 0.1 2368.3 0.0 1.2 0.1 14.9 72.4 0.7 0.0 6.6 5.0 23.4 0.1 0.0 0.1 1.1 0.0 2.4 0.4 41.7 0.3 CACNA1H Cav3.2 ENSG00000196557 "Calcium voltage-gated channel subunit alpha1 H" O95180 16 1153106-1221771 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 107.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.8;Late spermatids: 15.5;Peritubular cells: 25.9;Sertoli cells: 26.3;Smooth muscle cells: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 17.9;AN3-CA: 25.4;MCF7: 48.3;OE19: 16.0;T-47d: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039125 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Vesicles" "HPA039125: AB_10795578" "unprognostic (1.66e-3)" "unprognostic (2.10e-1)" "unprognostic (4.07e-2)" "unprognostic (1.21e-3)" "unprognostic (1.37e-2)" "unprognostic (2.15e-1)" "unprognostic (4.39e-2)" "unprognostic (2.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" "prognostic favorable (3.12e-5)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (1.93e-2)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (5.55e-2)" 13.6 28.0 13.6 5.2 24.5 0.1 7.6 2.1 12.1 26.3 0.0 107.7 6.4 57.3 2.6 7.1 37.8 10.3 9.3 11.0 8.1 14.1 13.4 11.8 0.7 3.0 3.8 80.1 4.6 3.6 45.9 2.1 2.9 28.0 2.4 1.8 1.9 27.5 6.2 19.4 22.3 15.6 3.7 0.7 27.5 19.4 13.5 0.5 11.0 3.0 0.2 57.0 17.1 0.2 0.0 17.9 3.0 25.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 10.4 0.1 0.0 11.0 3.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.0 3.0 4.9 0.0 0.0 48.3 0.0 0.0 9.4 16.0 3.6 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.9 1.0 13.9 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 24.5 2.1 12.1 11.0 8.1 3.0 3.8 2.9 3.7 13.5 0.2 1.3 0.0 0.0 1.0 0.0 1.5 0.1 0.0 0.0 22.8 0.3 0.1 2.7 4.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.7 7.2 0.2 5.3 2.2 10.8 0.0 2.6 0.0 0.1 1.3 0.5 0.2 4.5 0.0 0.4 7.8 0.1 0.0 0.7 1.0 2.0 0.0 0.3 15.5 8.4 0.2 0.0 0.0 0.0 0.8 0.0 0.5 0.1 0.4 0.4 25.9 0.0 7.2 0.0 0.7 0.0 1.5 26.3 0.4 22.4 3.4 5.1 0.0 3.4 0.0 0.2 0.3 0.1 1.3 CACNB3 CACNLB3 ENSG00000167535 "Calcium voltage-gated channel auxiliary subunit beta 3" P54284 12 48813794-48828941 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.2" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.8" "Lineage enriched" "Detected in single" 10 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 75.9;U-937: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059515 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus, Vesicles" "HPA059515: AB_2684047" "unprognostic (1.77e-2)" "unprognostic (4.84e-2)" "unprognostic (2.16e-3)" "unprognostic (2.12e-2)" "unprognostic (8.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.06e-1)" "unprognostic (3.60e-2)" "unprognostic (3.27e-2)" "unprognostic (2.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.04e-1)" "unprognostic (5.44e-3)" "unprognostic (6.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" 10.1 3.9 67.9 2.8 69.9 1.3 9.0 56.8 84.2 33.7 44.1 18.1 4.1 31.1 8.5 21.5 19.6 7.2 8.4 72.6 56.7 12.4 1.9 11.8 1.8 50.2 56.2 43.7 4.5 5.1 12.3 5.8 53.4 13.7 8.2 4.7 13.0 9.1 2.8 11.5 10.8 23.1 49.9 6.1 9.2 8.6 59.6 7.6 9.6 5.9 4.1 14.5 20.2 58.7 17.3 13.2 21.1 46.1 26.8 18.0 12.9 16.8 39.4 25.6 14.5 4.5 13.4 2.2 21.5 30.7 4.4 17.2 21.6 19.5 10.1 18.4 5.9 8.5 11.7 0.6 11.0 1.7 9.1 11.7 10.6 10.2 5.5 75.9 31.1 18.6 1.2 7.2 16.9 42.6 22.1 2.2 13.3 18.1 10.9 24.0 5.0 6.6 19.9 31.6 32.9 31.8 5.5 37.1 12.0 18.6 25.2 7.7 27.3 15.5 21.7 7.7 9.5 7.1 3.5 0.7 12.9 109.9 5.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.6 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.8 0.2 67.9 69.9 56.8 84.2 72.6 56.7 50.2 56.2 53.4 49.9 59.6 58.7 5.6 3.2 4.3 1.0 0.5 2.9 3.2 5.9 4.0 3.2 8.7 5.7 2.8 1.5 5.1 1.8 4.2 0.8 2.1 12.6 1.9 9.5 1.0 10.0 22.0 5.9 10.2 0.8 15.1 4.3 10.4 7.9 6.1 7.1 1.3 12.0 3.6 0.2 1.6 0.0 4.5 9.5 16.2 0.6 2.9 2.7 13.4 2.4 1.8 3.7 3.7 1.0 2.1 2.0 1.1 10.4 4.6 10.9 1.3 2.9 8.7 0.7 9.4 1.0 0.0 1.5 12.2 1.6 8.1 9.6 5.1 1.1 3.5 6.1 14.4 1.9 CADPS2 CAPS2 ENSG00000081803 "Calcium dependent secretion activator 2" Q86UW7 7 122318411-122886759 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 682.7;Microglial cells: 180.8;Oligodendrocyte precursor cells: 111.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 96.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 43.5;Karpas-707: 56.3;OE19: 63.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 159.9" HPA056398 Approved Nucleoplasm,Vesicles NA NA "Cluster 21: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "HPA056398: AB_2683117" "unprognostic (1.93e-1)" "unprognostic (5.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.67e-3)" "unprognostic (8.69e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (1.33e-1)" "unprognostic (4.07e-1)" "unprognostic (4.33e-2)" "unprognostic (3.93e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.01e-7)" "unprognostic (9.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.71e-2)" "unprognostic (3.45e-2)" 10.3 21.1 9.2 4.5 16.3 0.1 18.3 96.2 30.9 29.8 5.8 10.7 12.6 35.0 30.3 4.5 11.0 15.6 10.2 14.2 14.4 38.3 13.2 18.0 3.5 4.9 40.1 9.9 26.0 12.0 13.8 6.0 7.9 19.4 10.7 7.2 48.3 18.5 2.4 4.0 10.0 21.7 6.2 6.7 20.0 4.0 17.4 4.9 18.3 7.8 3.8 9.3 8.5 18.7 0.0 0.1 3.4 0.0 5.1 5.2 0.3 0.5 13.5 2.9 13.4 0.1 12.6 0.0 0.0 6.4 0.4 0.1 0.4 1.9 1.3 0.0 11.1 4.4 0.1 25.1 16.9 0.0 0.2 5.5 2.4 2.3 1.7 11.8 43.5 0.0 0.0 56.3 0.2 30.9 0.0 0.1 12.6 63.6 21.4 0.0 0.0 23.2 0.6 14.3 20.5 0.0 0.6 24.4 1.2 3.2 9.5 0.1 12.5 4.7 3.1 0.1 8.9 16.8 0.7 0.0 18.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 16.3 96.2 30.9 14.2 14.4 4.9 40.1 7.9 6.2 17.4 18.7 29.3 9.6 43.9 85.2 3.1 2.2 7.9 7.3 10.2 0.6 36.7 22.4 12.9 11.5 14.4 40.5 0.0 0.4 0.5 4.3 17.6 4.4 8.5 4.8 13.5 24.7 4.8 0.0 682.7 11.1 0.5 13.0 42.3 11.2 1.3 10.1 14.3 12.5 0.4 3.3 14.2 13.2 10.2 3.1 1.4 6.8 9.6 0.6 3.6 180.8 0.0 27.2 0.0 111.1 11.0 4.8 3.7 10.1 15.7 13.4 5.7 7.9 9.4 1.5 0.0 6.9 6.2 0.7 4.2 6.2 1.4 0.3 0.7 11.3 8.0 8.5 CALCOCO1 "calphoglin, Cocoa, KIAA1536" ENSG00000012822 "Calcium binding and coiled-coil domain 1" Q9P1Z2 12 53708517-53727745 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 109.6;hTERT-RPE1: 146.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038313, HPA038314" Approved Enhanced Vesicles,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 55: Plasma cells - Humoral immune response" Cytosol Vesicles "HPA038313: AB_10675794, HPA038314: AB_10672587" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" "unprognostic (3.11e-2)" "unprognostic (8.42e-2)" "unprognostic (3.03e-1)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (9.66e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-3)" "unprognostic (8.01e-2)" "unprognostic (2.80e-1)" "unprognostic (5.63e-3)" "unprognostic (9.88e-3)" 125.7 71.3 81.0 25.0 92.7 35.0 115.3 93.5 100.3 102.4 95.0 163.1 31.0 105.3 69.1 71.2 101.7 55.6 142.9 82.0 81.9 73.8 57.0 98.3 33.8 85.2 81.4 110.9 108.3 65.6 80.2 50.3 87.1 90.6 35.4 47.6 119.8 55.5 264.2 180.8 88.3 53.2 78.1 91.0 126.5 49.5 82.7 36.3 89.2 120.6 37.5 125.0 96.4 88.7 12.1 13.8 20.4 26.8 109.6 71.5 13.1 26.4 56.2 19.4 26.6 6.7 52.7 4.9 23.7 61.3 10.0 15.8 8.2 22.3 20.7 20.1 17.1 9.9 31.5 5.4 53.3 4.2 22.0 99.8 58.2 20.3 19.8 146.7 35.2 22.0 8.1 46.7 34.2 5.2 13.5 15.9 4.2 10.9 15.1 13.6 11.3 17.2 31.9 8.4 11.7 21.0 15.1 8.3 26.7 42.5 24.6 13.0 41.2 10.0 13.0 9.5 3.8 42.5 12.8 1.8 46.1 4.9 12.8 85.2 19.6 76.7 26.1 22.4 18.7 14.5 17.8 20.8 11.6 17.1 15.7 17.6 72.0 20.2 23.7 8.8 33.4 23.8 81.0 92.7 93.5 100.3 82.0 81.9 85.2 81.4 87.1 78.1 82.7 88.7 33.0 35.3 14.4 18.9 19.8 32.4 19.0 16.7 30.1 34.3 32.8 27.6 11.7 25.8 16.8 22.0 35.5 23.8 26.0 13.6 5.9 16.7 40.7 27.1 19.4 23.4 28.6 32.0 31.1 11.7 8.8 29.2 16.8 17.5 7.6 29.1 31.8 17.9 15.9 26.9 33.3 18.7 24.4 26.0 15.3 54.0 47.5 28.6 19.6 11.2 21.9 25.3 64.9 20.6 22.6 22.0 17.5 41.3 53.5 20.1 25.9 14.0 26.5 44.6 19.7 28.6 29.5 24.2 9.3 16.7 50.7 45.6 27.3 27.5 13.0 26.4 CALCOCO2 "MGC17318, NDP52" ENSG00000136436 "Calcium binding and coiled-coil domain 2" Q13137 17 48831018-48866522 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 1127.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022989, HPA023019, HPA023195" Enhanced Supported Vesicles,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol Vesicles "HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916" "unprognostic (3.71e-1)" "unprognostic (2.87e-1)" "unprognostic (3.84e-2)" "unprognostic (3.37e-2)" "unprognostic (4.90e-2)" "unprognostic (4.46e-2)" "unprognostic (2.05e-1)" "unprognostic (2.28e-1)" "unprognostic (3.88e-1)" "unprognostic (2.15e-1)" "unprognostic (2.41e-1)" "unprognostic (4.03e-2)" "unprognostic (3.52e-2)" "unprognostic (1.06e-1)" "unprognostic (3.80e-2)" "unprognostic (7.57e-2)" "unprognostic (5.65e-2)" 117.9 59.2 36.5 55.3 43.8 62.9 95.3 41.6 50.8 81.0 72.3 101.0 68.1 69.2 61.0 88.6 82.2 66.2 139.1 35.3 45.3 75.7 120.3 91.4 53.2 48.7 42.0 86.6 56.6 76.8 46.6 63.3 49.2 55.6 101.5 76.4 52.5 72.5 158.4 68.2 75.4 87.8 39.0 68.8 71.6 136.3 41.0 74.4 75.3 170.3 67.1 80.9 76.9 52.0 126.0 79.4 33.1 64.0 241.2 173.7 95.0 120.2 160.0 135.9 151.3 150.8 80.6 42.5 117.0 146.5 115.9 68.2 81.4 101.7 162.6 193.3 66.9 40.7 48.0 59.1 276.8 137.4 196.8 258.1 148.1 144.3 103.9 129.0 101.3 130.7 74.9 124.3 119.2 36.8 119.5 73.6 10.3 278.9 97.7 77.8 161.7 81.0 52.2 39.2 13.1 27.9 37.6 24.3 106.0 66.6 154.2 76.5 97.7 147.1 44.9 91.0 85.8 110.4 165.1 30.0 89.2 69.0 61.4 108.9 115.1 115.5 56.6 121.5 54.2 54.1 49.9 58.9 67.1 46.7 50.5 55.8 132.8 105.0 132.3 33.6 107.2 89.7 36.5 43.8 41.6 50.8 35.3 45.3 48.7 42.0 49.2 39.0 41.0 52.0 166.2 115.4 98.1 20.5 42.1 36.6 73.3 40.9 40.9 16.8 34.7 32.4 169.1 37.1 48.4 33.1 50.1 50.2 48.6 124.5 37.2 47.2 1127.4 37.4 89.7 104.6 50.4 40.8 31.0 42.2 45.3 79.1 31.6 44.0 100.0 29.8 110.3 58.9 27.6 8.4 21.2 44.7 24.4 119.2 54.3 233.3 70.2 70.7 26.6 28.1 57.4 45.9 64.9 26.7 27.3 37.7 54.6 74.1 56.2 57.6 81.5 48.9 28.4 72.7 72.3 69.6 76.2 152.5 32.7 55.6 46.9 81.3 54.6 96.3 66.1 66.1 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 11.3;brain: 44.3;lymphoid tissue: 24.7" "Cell type enhanced" "Detected in some" "Astrocytes: 88.8;Excitatory neurons: 130.6;Inhibitory neurons: 212.7;Oligodendrocyte precursor cells: 44.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Karpas-707: 44.5" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" No No "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.1 11.3 12.2 0.0 18.5 0.6 0.2 44.3 15.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 25.4 40.6 0.0 0.2 0.0 0.0 27.9 17.0 0.1 1.0 0.0 0.5 0.0 30.2 0.2 0.1 1.9 0.0 1.1 0.0 3.5 0.0 0.0 15.2 0.0 0.0 3.2 8.3 24.7 0.1 0.0 0.0 0.0 3.2 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 44.5 0.0 0.0 0.1 0.0 6.0 0.0 0.0 7.1 0.0 0.8 0.0 0.0 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 7.2 0.1 0.0 7.0 7.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 18.5 44.3 15.0 25.4 40.6 27.9 17.0 30.2 15.2 8.3 26.5 0.0 0.0 0.0 88.8 0.0 2.3 0.4 0.0 0.0 3.8 0.0 0.6 5.6 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.8 0.1 0.1 0.3 0.0 2.1 130.6 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.4 0.4 0.1 0.0 212.7 1.5 0.0 0.3 0.7 7.0 0.0 0.1 0.0 14.0 0.0 0.2 1.0 44.7 15.7 0.0 0.1 0.7 0.0 0.2 0.0 0.1 0.0 0.8 0.0 6.1 0.2 8.8 12.8 0.0 9.8 0.1 0.2 0.2 0.1 0.1 CAPN9 "GC36, nCL-4" ENSG00000135773 "Calpain 9" O14815 1 230747384-230802003 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 22.2;stomach 1: 60.3" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 25.6;Gastric mucus-secreting cells: 93.8;Intestinal goblet cells: 71.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 7.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "OE19: 10.7;SCLC-21H: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020398, CAB033483, HPA062050" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 4: Stomach - Digestion" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "Golgi apparatus" "CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: " "unprognostic (2.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.60e-2)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.49e-2)" "unprognostic (3.36e-2)" "unprognostic (2.30e-2)" "unprognostic (4.61e-2)" "unprognostic (3.44e-2)" "unprognostic (9.10e-2)" "unprognostic (1.60e-1)" "unprognostic (5.97e-5)" "unprognostic (1.51e-1)" "unprognostic (2.08e-1)" "unprognostic (4.60e-2)" "unprognostic (2.16e-1)" 0.0 0.6 1.4 0.9 2.2 0.0 0.4 1.3 1.2 0.4 0.0 13.7 6.6 0.2 0.5 0.2 2.5 0.6 0.4 1.1 1.4 0.0 0.0 7.5 0.0 2.1 1.7 0.6 0.2 1.0 0.0 0.0 1.8 0.6 22.2 5.0 11.3 0.1 0.2 0.1 11.7 0.5 1.9 0.0 60.3 0.2 1.7 0.1 0.1 0.1 0.0 2.0 0.1 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.5 10.7 0.0 0.4 0.0 0.0 0.0 0.1 14.7 0.0 0.0 0.4 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 1.3 1.2 1.1 1.4 2.1 1.7 1.8 1.9 1.7 3.4 0.0 25.6 3.0 0.3 0.1 0.0 0.6 0.7 0.0 0.0 0.6 0.3 6.0 0.0 3.2 0.0 0.0 0.1 0.0 4.1 0.0 0.2 5.2 1.5 0.1 0.1 3.0 0.0 0.4 0.2 0.0 0.4 93.8 0.5 2.5 0.1 0.0 0.0 0.1 0.0 0.4 71.8 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.6 1.7 5.0 0.0 0.2 0.5 3.3 0.1 8.2 1.7 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.1 1.5 CASP10 "FLICE-2, MCH4" ENSG00000003400 "Caspase 10" Q92851 2 201182898-201229406 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 71.3;NK-cells: 44.3;Paneth cells: 44.5;Plasma cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 25.3" "Low region specificity" "Detected in all" "CAB003780, HPA017059" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 1: K-562 - Erythropoiesis" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "CAB003780: AB_289592, HPA017059: AB_1846040" "unprognostic (4.01e-2)" "unprognostic (8.24e-2)" "unprognostic (4.80e-1)" "unprognostic (1.28e-3)" "unprognostic (4.74e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.68e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.05e-7)" "unprognostic (3.23e-2)" "unprognostic (2.19e-2)" "unprognostic (4.49e-2)" "unprognostic (1.38e-2)" 8.8 2.4 5.7 9.2 5.5 19.5 6.5 4.5 5.8 4.0 4.4 13.2 21.8 3.3 6.2 8.8 5.4 7.4 6.7 4.7 5.1 8.1 6.2 11.5 8.9 6.0 5.0 1.6 4.8 2.3 1.3 9.6 5.8 3.9 13.4 1.3 5.4 3.1 4.9 5.7 18.4 5.1 5.6 22.6 10.2 1.2 7.3 8.7 5.3 2.8 10.4 9.0 5.1 5.4 4.4 3.5 0.3 0.4 0.1 0.3 7.5 0.7 4.6 0.4 1.8 4.6 9.8 0.5 7.0 2.5 1.7 2.9 0.2 2.3 1.3 2.1 4.8 12.2 4.0 15.1 1.6 8.3 12.7 0.5 2.0 5.3 0.4 0.3 25.3 5.1 14.9 17.4 0.4 0.3 15.9 7.8 0.6 6.0 2.4 8.8 0.5 18.4 8.7 6.2 0.2 0.1 4.1 0.2 1.9 3.0 0.2 7.8 10.0 0.4 0.8 3.4 0.2 18.7 12.1 0.5 4.5 6.3 0.2 5.9 11.7 0.7 6.4 16.5 5.6 8.2 5.2 3.6 6.5 7.7 7.2 6.4 2.1 8.5 19.3 6.6 1.2 7.2 5.7 5.5 4.5 5.8 4.7 5.1 6.0 5.0 5.8 5.6 7.3 5.4 20.7 19.2 10.0 0.3 15.8 6.0 2.7 10.6 5.2 0.0 1.3 0.9 1.8 8.6 9.4 9.2 0.0 1.1 20.5 71.3 1.9 16.2 1.2 7.7 7.4 29.7 2.4 14.9 0.3 10.4 0.7 4.2 26.5 12.0 7.6 0.8 26.4 7.1 9.4 0.0 0.5 21.6 4.1 26.6 17.5 0.0 0.6 16.2 7.2 33.7 22.0 0.5 44.3 0.0 0.9 8.6 44.5 0.0 49.7 2.5 26.1 8.7 24.4 0.4 0.0 2.9 2.2 0.1 0.1 6.6 4.5 0.4 12.9 4.1 16.4 10.3 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733802-8841808 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 182.7;tongue: 72.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 94.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 0.4 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 5.7 0.1 0.1 27.4 0.1 0.1 0.0 0.0 0.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 2.5 0.2 182.7 0.2 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 72.8 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 11.0 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 CAVIN1 "cavin-1, CGL4, PTRF" ENSG00000177469 "Caveolae associated protein 1" Q6NZI2 17 42402449-42423256 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "RNA-binding, rRNA-binding" "Congenital generalized lipodystrophy, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 575.1;Alveolar cells type 1: 429.5;Breast myoepithelial cells: 154.9;Cytotrophoblasts: 159.8;Endothelial cells: 217.4;Smooth muscle cells: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 1105.9;fHDF/TERT166: 796.6;TIME: 920.9;U-138 MG: 912.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049838, HPA074213" Supported Supported "Vesicles,Plasma membrane" NA NA 440000 "Cluster 11: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" Vesicles "HPA049838: AB_2680907, HPA074213: AB_2686674" "unprognostic (1.59e-1)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.36e-4)" "unprognostic (1.56e-1)" "unprognostic (1.76e-3)" "unprognostic (6.33e-3)" "unprognostic (1.72e-1)" "unprognostic (1.04e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (7.18e-3)" "unprognostic (2.36e-1)" "unprognostic (3.44e-3)" "unprognostic (4.24e-3)" "unprognostic (3.21e-2)" "unprognostic (2.07e-3)" "prognostic unfavorable (5.87e-4)" 397.8 65.3 42.6 69.1 47.2 3.7 295.3 55.8 40.9 239.9 50.6 314.0 30.8 344.3 56.8 101.0 207.5 78.1 220.9 35.4 49.7 66.4 21.0 202.8 30.0 68.8 55.0 162.5 28.4 26.5 34.8 151.3 60.1 181.5 50.7 3.6 84.2 215.4 144.8 161.9 104.1 242.3 53.5 109.0 132.8 22.6 47.2 16.6 112.4 92.7 24.0 255.4 192.3 58.0 315.9 264.8 5.5 69.8 342.3 409.6 6.9 1105.9 477.8 432.2 340.5 134.6 20.1 0.5 216.3 796.6 177.4 509.7 46.8 331.6 351.0 1.1 9.5 137.5 154.8 66.1 215.8 0.3 1.2 283.0 120.5 340.8 115.8 230.2 592.3 0.4 95.5 1.3 187.9 5.0 7.4 1.6 25.8 48.1 1.8 0.6 173.3 0.6 186.1 1.6 0.4 2.0 371.9 6.4 91.7 145.2 29.8 2.0 920.9 912.0 429.5 330.9 407.9 0.8 0.9 1.6 270.7 0.5 104.8 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 42.6 47.2 55.8 40.9 35.4 49.7 68.8 55.0 60.1 53.5 47.2 58.0 575.1 429.5 117.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 55.4 154.9 0.0 0.0 50.8 23.9 0.0 159.8 3.4 0.0 3.9 45.6 0.0 11.7 130.4 217.4 0.0 0.0 0.0 4.4 11.3 114.2 0.0 16.9 63.1 116.3 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.5 0.0 0.0 0.5 0.0 0.0 1.1 3.6 0.0 0.0 0.0 211.7 0.0 0.0 0.0 0.0 77.2 4.5 6.6 0.0 0.0 CBS HIP4 ENSG00000160200 "Cystathionine beta-synthase" P35520 21 43053191-43076943 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Allosteric enzyme, Lyase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 174.9;pancreas: 99.0" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.3;Cardiomyocytes: 4.9;Hepatocytes: 3.6;Ionocytes: 2.0;Melanocytes: 5.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 51 "neutrophil: 5.0" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.0" "Cell line enhanced" "Detected in many" "BEWO: 177.5;HAP1: 172.8;HHSteC: 224.1;MCF7: 197.7;RPMI-8226: 197.4" "Low region specificity" "Detected in all" HPA001223 Supported Approved Nucleoli,Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (4.86e-2)" "unprognostic (1.48e-2)" "unprognostic (6.81e-2)" "unprognostic (1.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.68e-4)" "unprognostic (3.62e-1)" "unprognostic (6.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.50e-2)" "unprognostic (2.13e-1)" "unprognostic (1.61e-2)" "unprognostic (6.73e-3)" "unprognostic (2.62e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" 6.6 2.8 42.5 1.0 39.5 0.2 3.4 58.5 55.3 12.3 29.3 4.8 3.0 4.5 0.0 2.0 5.8 1.2 7.7 41.4 40.3 3.8 174.9 10.2 2.7 42.5 44.6 30.3 99.0 2.5 8.8 1.2 42.7 12.7 0.9 2.5 19.9 1.1 1.1 2.3 7.0 2.3 38.4 1.7 16.5 2.0 48.1 0.7 17.4 1.2 1.4 11.6 6.2 45.4 30.0 17.0 31.3 113.4 48.9 31.5 177.5 39.5 10.0 15.6 15.4 53.7 1.5 0.1 19.2 67.2 0.3 1.5 172.8 13.2 3.1 0.0 20.5 12.3 73.1 63.8 224.1 7.9 19.1 21.7 1.4 16.0 16.4 13.2 38.6 85.6 138.7 118.1 11.1 197.7 16.1 0.1 20.3 65.7 29.4 0.0 0.2 197.4 0.5 15.5 57.8 85.1 78.5 5.4 44.4 18.4 27.0 91.2 5.4 0.8 42.5 0.3 4.8 34.8 30.2 41.2 19.0 11.0 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 42.5 39.5 58.5 55.3 41.4 40.3 42.5 44.6 42.7 38.4 48.1 45.4 0.2 0.0 0.5 0.7 0.0 0.4 0.0 2.3 0.0 0.2 0.5 0.1 4.9 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.2 0.8 1.2 0.0 0.1 0.0 0.1 0.0 3.6 0.2 0.0 0.0 0.0 2.0 0.0 1.4 0.0 0.9 0.2 5.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.2 1.7 0.1 0.1 0.1 0.0 0.3 0.6 0.0 0.6 0.0 1.0 0.1 0.1 0.0 0.2 0.1 CBSL ENSG00000274276 "Cystathionine beta-synthase like" P0DN79 21 6444869-6468040 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 88.1;pancreas: 48.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 14 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 105.1;NTERA-2: 246.2;U-266/70: 75.7" HPA001223 Supported Approved Nucleoli,Vesicles NA NA 510000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 5: NTERA-2 - Transcription" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (2.39e-1)" "unprognostic (1.54e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-3)" "unprognostic (6.49e-2)" "unprognostic (1.42e-2)" "unprognostic (1.28e-2)" "unprognostic (6.62e-3)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (7.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (3.17e-3)" "unprognostic (8.44e-2)" "unprognostic (2.46e-1)" "unprognostic (3.61e-1)" 3.8 1.2 0.9 0.8 0.8 0.1 1.7 1.6 1.3 7.5 0.3 2.3 2.0 1.8 1.4 1.0 5.6 1.0 4.4 0.6 0.9 1.6 88.1 4.8 0.1 1.3 1.6 14.7 48.5 2.2 4.4 0.8 1.1 6.1 0.0 1.1 4.6 8.9 0.6 1.2 3.7 0.0 0.6 1.2 8.2 1.0 1.6 0.2 12.3 0.0 0.4 5.0 3.1 1.3 0.1 0.0 36.3 105.1 0.0 0.0 1.4 23.3 15.2 8.9 29.3 0.2 18.2 0.0 0.1 0.0 17.1 12.1 0.2 13.5 5.6 0.0 35.4 0.0 0.0 0.0 1.0 0.0 16.1 12.8 51.5 0.1 23.1 0.0 0.2 0.8 0.7 41.5 0.3 0.0 18.9 2.6 246.2 0.5 0.0 0.3 0.0 0.3 40.5 0.0 38.7 58.5 0.0 3.4 44.9 0.0 0.1 0.1 0.0 2.7 0.0 17.3 4.4 75.7 29.6 0.3 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.8 1.6 1.3 0.6 0.9 1.3 1.6 1.1 0.6 1.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CC2D1B "Freud-2, KIAA1836" ENSG00000154222 "Coiled-coil and C2 domain containing 1B" Q5T0F9 1 52345723-52366205 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 10.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027500, HPA031426" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "HPA027500: AB_10600693, HPA031426: AB_2673876" "unprognostic (1.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.38e-2)" "unprognostic (2.50e-2)" "unprognostic (5.85e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (3.39e-2)" "unprognostic (4.75e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-2)" "unprognostic (2.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-2)" "unprognostic (1.87e-1)" 13.4 15.0 14.5 8.7 18.0 5.0 12.6 17.3 15.9 10.4 13.5 13.0 8.0 11.0 9.2 16.7 10.0 7.0 13.3 13.1 16.0 18.9 17.2 17.8 12.1 19.1 17.7 13.3 15.6 10.2 19.5 7.5 18.6 13.7 6.5 4.0 12.7 7.1 29.1 12.0 15.0 5.5 17.4 17.9 12.8 16.7 17.1 11.0 17.7 11.7 9.7 12.2 12.0 19.5 12.4 17.2 7.8 12.2 28.1 10.7 18.3 15.6 27.3 19.9 15.0 11.5 10.1 7.7 12.9 18.2 43.6 8.3 10.1 21.6 9.0 14.2 11.1 8.5 13.6 9.7 22.6 11.8 19.8 15.9 19.3 22.2 16.9 19.3 12.4 12.2 14.7 8.2 22.2 8.5 12.4 9.7 15.2 12.5 19.2 7.9 14.7 11.3 21.0 17.2 8.5 8.0 15.2 22.7 22.7 20.0 8.0 17.4 14.9 22.9 12.6 12.6 17.9 11.7 11.5 9.9 30.3 12.7 28.8 10.4 1.1 2.8 2.3 0.6 1.9 1.7 1.8 1.8 1.1 1.2 1.4 2.0 1.6 1.9 0.5 1.1 1.6 1.3 14.5 18.0 17.3 15.9 13.1 16.0 19.1 17.7 18.6 17.4 17.1 19.5 6.7 9.6 13.4 4.6 7.5 3.2 3.3 3.4 5.2 5.6 3.9 2.7 5.6 4.3 7.6 11.0 0.0 9.0 9.0 10.2 3.9 10.0 3.7 6.7 4.1 5.8 6.0 2.5 4.6 12.7 10.3 3.9 14.8 9.6 15.8 6.7 9.7 8.2 11.6 1.7 4.6 5.7 2.0 6.9 1.5 2.4 3.4 8.0 1.8 2.8 5.9 6.5 8.2 2.0 5.9 12.2 9.1 6.4 6.7 3.8 8.6 5.3 5.4 4.9 0.0 5.1 4.1 16.6 8.8 4.9 3.1 15.7 8.9 5.8 4.9 3.5 CCDC115 "ccp1, FLJ30131, MGC12981" ENSG00000136710 "Coiled-coil domain containing 115" Q96NT0 2 130337933-130342699 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034598 Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane" Vesicles "HPA034598: AB_10601697" "prognostic favorable (7.59e-4)" "unprognostic (1.28e-2)" "unprognostic (1.10e-3)" "unprognostic (6.80e-3)" "unprognostic (3.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.20e-2)" "unprognostic (8.13e-3)" "unprognostic (2.63e-1)" "unprognostic (4.29e-1)" "unprognostic (2.87e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (7.83e-2)" "unprognostic (2.16e-1)" "unprognostic (3.16e-2)" 27.8 25.1 25.3 18.0 25.8 24.8 25.4 26.4 28.0 33.7 21.7 25.3 21.2 29.5 32.3 31.1 29.9 19.9 18.4 25.2 26.6 29.8 17.8 26.6 29.8 26.8 25.3 41.6 20.2 40.2 22.9 13.8 26.3 24.0 19.3 15.8 29.1 27.7 12.9 39.3 24.2 17.7 26.1 26.1 24.1 10.4 25.4 23.3 30.3 12.3 26.0 26.8 28.1 27.5 22.5 10.5 13.3 8.1 27.2 30.7 16.3 10.5 28.2 22.4 26.1 24.4 48.5 25.7 36.6 18.3 11.4 20.7 10.8 19.2 16.1 33.4 20.2 20.2 5.4 27.3 22.7 20.8 40.2 26.2 44.2 14.6 8.1 21.8 23.7 24.3 19.8 22.6 27.7 20.7 38.5 37.5 17.2 11.2 26.4 29.4 14.2 24.1 18.8 18.6 12.4 22.8 12.3 22.4 24.2 8.7 24.5 25.3 18.6 10.1 10.4 18.5 8.3 12.4 13.0 19.7 22.9 22.1 13.5 129.9 94.6 154.8 80.8 136.0 71.8 96.3 85.1 85.8 95.2 98.9 81.1 74.8 33.3 80.6 174.9 73.8 103.6 132.8 25.3 25.8 26.4 28.0 25.2 26.6 26.8 25.3 26.3 26.1 25.4 27.5 37.5 19.2 28.3 3.6 43.6 51.9 42.3 104.2 40.5 25.9 43.3 41.9 13.9 35.8 50.8 77.3 10.4 76.7 35.1 29.9 105.7 47.4 1.4 14.5 16.9 30.8 27.6 13.5 8.7 42.7 36.6 30.6 21.4 20.3 53.3 22.7 33.2 21.4 63.5 23.5 12.3 35.6 99.7 45.5 60.7 4.5 42.6 49.4 53.4 5.6 97.3 48.4 49.4 10.1 12.2 27.5 49.1 52.3 16.9 14.9 51.9 65.9 24.3 27.6 46.0 29.2 31.7 9.0 24.0 42.4 70.0 26.4 51.3 39.1 41.6 30.0 CCDC122 FLJ31846 ENSG00000151773 "Coiled-coil domain containing 122" Q5T0U0 13 43823909-43879740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 148.5;Spermatocytes: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034233, HPA054995, HPA061456" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Nucleoplasm "CAB034233: AB_2228702, HPA054995: AB_2682665, HPA061456: AB_2684527" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (1.07e-1)" "unprognostic (1.67e-2)" "unprognostic (1.39e-2)" "unprognostic (1.68e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (5.28e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-3)" "unprognostic (2.74e-1)" "unprognostic (1.16e-2)" "unprognostic (2.14e-2)" "unprognostic (3.79e-2)" "unprognostic (1.32e-1)" "unprognostic (6.75e-2)" 2.3 2.9 1.7 1.9 2.9 0.9 3.8 1.4 2.0 2.7 0.7 2.9 1.7 4.1 5.3 2.1 4.4 3.1 4.6 1.5 1.9 3.0 2.4 2.0 2.7 2.5 2.2 6.1 3.6 4.0 3.2 3.1 2.5 4.9 3.5 0.6 3.2 2.4 1.1 4.0 2.5 3.3 1.7 2.9 3.1 4.1 2.2 2.1 4.9 0.3 2.7 2.9 2.0 4.9 2.2 1.8 0.8 0.0 0.6 4.0 2.3 5.7 6.4 3.0 3.3 3.0 7.6 3.8 3.2 3.4 4.9 3.4 0.7 0.8 3.9 5.7 2.8 1.6 1.0 1.6 8.1 0.9 0.4 10.4 6.7 4.2 10.9 2.5 1.4 1.4 0.0 1.1 4.0 2.6 0.6 0.6 0.9 0.5 2.1 0.9 0.0 2.1 4.5 1.2 2.0 3.1 4.0 0.1 3.4 4.3 0.6 0.6 7.1 0.2 0.8 4.9 0.0 0.0 0.0 1.8 2.7 0.1 2.9 3.5 0.6 1.1 0.5 0.6 0.6 1.0 0.7 0.5 0.5 1.3 0.5 0.5 1.4 1.4 1.1 1.2 0.7 0.4 1.7 2.9 1.4 2.0 1.5 1.9 2.5 2.2 2.5 1.7 2.2 4.9 5.6 9.6 11.7 8.5 5.2 3.1 8.9 6.1 9.6 1.9 10.5 12.1 11.1 10.0 8.5 7.3 0.0 17.5 1.7 4.5 19.6 13.1 2.8 14.3 11.3 6.7 18.0 6.1 15.8 10.1 11.6 9.2 4.6 8.3 1.3 13.8 5.7 4.9 2.0 10.1 24.7 9.4 0.0 2.2 2.7 2.3 17.7 3.9 1.8 21.5 0.8 12.7 0.0 28.6 148.5 7.6 2.9 7.9 1.3 8.3 6.4 12.0 19.1 0.6 0.0 7.4 6.7 43.2 26.3 5.5 3.8 7.9 2.9 14.0 7.1 6.4 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 9.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 54.2;Early spermatids: 59.1;Rod photoreceptor cells: 49.4;Spermatocytes: 165.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "basal ganglia: 2.4;cerebellum: 7.6;cerebral cortex: 6.9;hippocampal formation: 4.9;white matter: 3.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.5;TIME: 8.5" "HPA022996, HPA047220, HPA047851, HPA066260" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 6: Brain - Smell perception" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 1.3 1.3 0.6 2.1 2.4 4.2 1.5 7.6 6.9 1.1 0.0 1.7 0.7 3.5 2.5 0.8 1.6 1.2 1.2 4.9 0.0 0.5 1.1 1.3 1.7 0.8 0.0 4.5 2.7 0.4 1.6 2.7 0.8 1.5 0.9 7.4 1.2 1.0 1.0 2.5 1.0 1.6 0.0 1.8 1.5 9.1 0.0 3.3 0.8 2.3 1.2 1.6 0.9 3.9 0.5 3.4 0.8 2.1 3.0 9.5 0.4 0.2 0.0 0.2 0.2 4.4 0.1 0.5 2.8 6.2 0.2 5.3 4.4 0.3 0.2 3.2 0.2 0.4 0.5 0.3 0.2 0.7 2.7 1.7 0.1 2.1 0.2 0.9 0.1 0.1 0.4 0.3 2.0 0.1 0.0 1.1 0.6 0.9 0.4 1.4 0.2 0.1 0.1 4.1 1.1 1.2 0.6 0.2 1.2 1.5 3.4 0.1 8.5 0.7 0.4 4.6 1.4 5.7 6.3 0.2 0.3 6.2 1.6 0.2 0.1 0.0 0.5 0.1 0.3 0.2 0.5 0.3 0.1 0.1 0.9 0.5 0.2 0.2 0.4 0.2 0.5 0.0 0.6 2.4 7.6 6.9 4.9 0.0 0.8 0.0 0.8 0.0 0.0 3.9 5.9 0.0 14.9 15.7 3.1 4.0 6.4 1.9 0.0 40.8 4.5 2.5 2.8 2.8 2.9 0.0 54.2 4.9 6.4 1.7 0.0 1.8 59.1 8.0 25.8 9.1 1.2 1.7 21.2 0.0 7.1 9.7 2.0 10.4 26.0 6.2 3.6 2.0 4.2 33.7 19.8 2.4 2.0 6.8 7.7 6.5 7.2 6.3 5.4 1.0 3.6 7.1 6.2 17.1 4.0 1.7 3.8 9.1 1.7 8.6 1.2 1.1 3.9 49.4 6.6 11.7 10.2 165.9 36.1 0.2 3.7 1.9 6.9 22.2 2.1 4.6 CCDC22 "CXorf37, JM1" ENSG00000101997 "Coiled-coil domain containing 22" O60826 X 49235470-49250520 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport, Ubl conjugation pathway" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000229, HPA000888, HPA075980" Uncertain Approved Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 4: Macrophages - Innate immune response" "Endoplasmic reticulum, Vesicles" "HPA000229: , HPA000888: AB_1078420, HPA075980: " "unprognostic (1.24e-2)" "unprognostic (1.96e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-1)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.68e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (4.57e-3)" "unprognostic (3.61e-2)" "unprognostic (4.99e-2)" "unprognostic (6.99e-2)" "unprognostic (2.57e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-3)" 10.3 12.3 9.4 10.1 10.0 18.6 10.3 9.9 10.8 11.7 8.8 12.1 10.4 12.2 5.3 14.2 11.3 6.4 12.8 9.4 9.2 12.3 12.9 10.7 15.0 10.8 9.4 11.2 14.2 8.7 11.2 6.9 10.1 13.5 5.2 4.7 12.3 8.7 17.2 13.8 13.4 6.0 9.6 20.5 12.9 3.8 10.0 13.6 11.0 7.7 8.5 11.9 11.1 10.8 18.8 16.0 9.6 33.5 8.8 8.9 20.4 10.9 7.9 12.0 13.6 16.3 16.0 6.9 15.9 9.7 14.3 15.0 10.6 18.0 4.9 18.1 23.6 7.3 15.6 15.5 14.7 20.8 12.4 8.2 15.2 15.9 8.6 6.1 11.9 13.7 14.7 11.8 8.6 58.3 15.3 24.4 11.2 9.5 23.2 22.0 15.6 30.1 9.4 9.4 11.4 8.8 16.7 19.4 15.0 9.8 30.2 20.2 13.3 15.4 16.5 19.2 11.6 21.2 12.6 12.5 16.8 38.5 12.3 8.6 37.0 23.8 18.3 30.9 20.1 18.9 18.8 21.3 38.2 16.8 16.7 19.6 2.8 10.8 27.1 15.1 21.8 28.0 9.4 10.0 9.9 10.8 9.4 9.2 10.8 9.4 10.1 9.6 10.0 10.8 8.6 0.0 4.4 3.3 15.0 5.6 9.6 13.0 6.2 11.6 7.4 6.1 2.4 15.7 12.0 11.0 6.2 15.2 11.2 12.5 15.6 13.9 0.3 5.8 4.6 7.8 6.7 8.6 3.7 7.3 14.8 7.6 7.1 6.9 11.4 8.6 11.0 7.2 32.0 1.7 2.9 18.2 8.2 14.4 11.9 0.4 8.1 13.8 7.2 1.9 18.0 9.9 9.2 1.0 4.2 8.6 7.6 7.5 10.2 6.2 15.6 12.1 5.6 8.0 6.6 9.1 9.5 0.1 0.9 8.0 6.7 20.2 13.3 11.0 15.7 8.3 CCDC32 "C15orf57, MGC20481" ENSG00000128891 "Coiled-coil domain containing 32" Q9BV29 15 40528683-40565057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.5;Hofbauer cells: 72.0;Syncytiotrophoblasts: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041688 Uncertain Approved "Nuclear speckles,Vesicles" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Vesicles "HPA041688: AB_10796779" "unprognostic (7.10e-2)" "unprognostic (1.04e-1)" "unprognostic (9.86e-3)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (4.25e-5)" "unprognostic (4.03e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.70e-2)" "unprognostic (2.34e-1)" "unprognostic (1.23e-2)" "unprognostic (5.77e-2)" "unprognostic (3.72e-1)" "unprognostic (1.18e-1)" "unprognostic (2.20e-1)" "unprognostic (6.47e-2)" 16.0 20.5 16.2 17.0 14.8 20.2 15.5 13.9 18.1 16.0 16.9 17.3 17.0 14.6 17.3 9.3 18.2 17.8 18.1 18.3 17.1 22.8 13.0 14.2 28.7 16.1 17.6 25.0 17.9 20.0 13.6 21.3 18.6 13.9 19.8 15.1 13.0 14.9 15.5 10.3 14.9 15.4 15.6 21.5 18.0 8.3 18.2 19.4 20.9 11.1 25.8 19.2 12.1 16.2 15.4 10.8 14.1 22.8 28.8 29.9 8.4 12.0 17.8 20.9 21.8 16.4 20.9 5.6 32.9 18.0 30.2 28.3 13.8 13.8 14.8 35.0 16.2 62.6 18.1 20.6 19.6 24.0 31.5 25.4 14.1 16.3 11.0 19.8 26.7 22.0 35.0 36.9 16.1 13.3 11.2 20.4 5.6 35.3 13.6 19.1 18.5 19.1 39.6 36.3 15.8 15.5 17.9 18.5 9.3 16.6 19.6 43.4 29.8 19.5 17.0 34.1 17.5 21.1 21.1 18.4 20.7 37.2 27.8 58.2 32.4 33.9 32.6 34.2 25.9 147.1 35.6 35.3 43.0 167.2 35.8 30.7 34.0 29.1 35.7 57.6 50.6 42.1 16.2 14.8 13.9 18.1 18.3 17.1 16.1 17.6 18.6 15.6 18.2 16.2 32.1 12.8 13.4 0.0 24.6 0.0 0.0 0.0 0.0 0.0 18.6 20.8 0.0 0.0 9.9 20.2 0.0 80.5 19.6 0.0 29.4 27.0 0.0 22.7 13.7 10.2 0.0 0.0 0.0 29.2 32.5 11.3 0.0 14.4 6.3 15.5 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 10.3 0.0 0.0 0.0 0.0 38.3 0.0 0.0 7.8 0.0 0.0 30.0 12.4 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 81.4 10.1 35.0 0.0 0.0 CCDC65 "CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28" ENSG00000139537 "Coiled-coil domain containing 65" Q8IXS2 12 48904110-48931840 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 26.6;testis: 37.3" "Cell type enhanced" "Detected in many" "Early spermatids: 151.1;Endometrial ciliated cells: 92.7;Respiratory ciliated cells: 155.7;Spermatocytes: 85.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 8.7;MAIT T-cell: 9.1;memory CD4 T-cell: 7.5;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.6;naive CD8 T-cell: 6.2;T-reg: 4.8" "Lineage enriched" "Detected in single" 11 "T-cells: 9.1" "Cell line enhanced" "Detected in many" "HeLa: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038520, HPA057573" Uncertain Approved "Vesicles,Centriolar satellite" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "Centriolar satellite" "HPA038520: AB_10672714, HPA057573: AB_2683473" "unprognostic (3.06e-2)" "unprognostic (1.17e-1)" "unprognostic (4.22e-2)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.43e-2)" "unprognostic (2.86e-2)" "unprognostic (5.79e-3)" "unprognostic (3.23e-1)" "unprognostic (9.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.03e-4)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (6.16e-2)" 0.4 0.4 1.5 0.7 2.3 1.4 0.4 0.0 2.8 1.4 3.4 0.4 0.3 1.1 2.8 0.3 26.6 1.2 0.3 3.2 0.3 1.8 0.3 2.9 1.0 1.4 2.3 0.8 0.8 1.4 2.1 0.1 1.3 0.4 0.0 7.1 0.3 0.4 0.4 1.5 0.5 0.1 0.5 1.1 0.4 37.3 1.5 0.2 2.5 0.0 0.3 0.2 0.3 0.3 0.6 2.5 1.1 2.2 0.0 0.0 1.1 0.6 0.0 0.3 1.0 3.1 1.4 0.9 0.8 0.0 0.3 0.7 0.0 0.0 0.4 1.4 1.1 1.4 4.4 1.1 0.1 1.1 1.2 0.0 0.0 0.6 0.0 1.7 0.0 0.7 0.6 0.3 0.0 1.5 0.3 1.5 2.5 0.9 0.6 0.8 0.5 1.0 2.0 1.6 0.6 1.0 0.7 0.9 0.8 1.7 2.3 1.0 1.0 0.8 0.8 0.9 0.5 1.1 1.2 0.8 0.9 0.9 0.2 0.0 0.0 0.0 8.7 0.0 9.1 0.2 7.5 7.3 0.0 0.5 4.6 6.2 0.1 0.8 0.0 0.0 4.8 2.9 1.5 2.3 0.0 2.8 3.2 0.3 1.4 2.3 1.3 0.5 1.5 0.3 0.9 0.0 1.1 2.0 0.6 0.9 0.2 6.2 0.0 1.2 0.4 0.5 0.5 0.0 13.8 0.0 12.5 0.1 6.5 0.0 7.9 1.0 151.1 92.7 3.0 0.6 0.0 2.7 7.2 0.6 0.1 0.8 0.5 4.2 0.0 0.5 0.0 0.5 0.0 0.0 4.0 0.0 12.2 0.0 0.8 22.7 1.5 0.3 1.8 1.0 0.2 2.2 33.0 2.0 0.8 0.3 0.0 2.2 1.0 0.2 0.0 3.4 155.7 11.5 0.0 0.5 3.6 85.9 4.8 0.0 0.1 0.1 7.3 0.5 0.0 0.1 CCDC93 FLJ10996 ENSG00000125633 "Coiled-coil domain containing 93" Q567U6 2 117915478-118014133 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054183 Approved Enhanced "Vesicles,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" Vesicles "Plasma membrane" "HPA054183: AB_2682408" "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.02e-2)" "unprognostic (3.32e-2)" "unprognostic (2.47e-3)" "prognostic unfavorable (2.97e-6)" "unprognostic (2.51e-1)" "unprognostic (8.12e-2)" "unprognostic (8.99e-2)" "unprognostic (1.52e-3)" "unprognostic (8.56e-2)" "unprognostic (4.87e-1)" "unprognostic (1.79e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (2.40e-2)" 10.2 14.5 9.3 10.4 8.5 21.7 9.6 9.6 12.7 9.1 15.0 11.3 11.9 8.2 9.8 7.4 9.3 7.1 21.3 8.4 9.4 9.8 7.8 11.8 10.3 9.7 9.0 13.3 13.0 15.9 16.1 8.1 10.3 7.6 10.6 26.0 9.1 8.4 12.9 11.0 12.8 8.1 8.4 12.1 9.1 12.1 11.5 10.1 11.9 10.3 10.1 8.6 8.1 8.5 18.7 8.1 22.0 19.4 31.2 21.3 18.5 21.8 14.2 14.0 14.3 17.7 11.7 15.9 14.5 17.1 24.9 15.8 12.8 11.2 18.1 20.8 13.0 20.1 15.5 23.9 13.7 22.1 22.0 14.6 11.5 21.9 25.9 19.4 15.0 18.9 11.1 11.0 15.8 8.1 14.0 23.8 9.9 13.4 13.0 17.6 17.2 10.7 11.5 19.6 17.4 10.3 14.2 10.6 15.1 19.6 8.9 13.5 21.2 23.9 20.0 20.4 15.3 14.3 16.0 24.7 13.8 16.1 14.2 2.9 1.6 1.8 2.1 2.1 2.0 1.6 1.5 1.8 1.2 1.4 2.0 1.7 1.7 1.7 1.3 0.5 0.7 1.0 9.3 8.5 9.6 12.7 8.4 9.4 9.7 9.0 10.3 8.4 11.5 8.5 17.4 19.2 28.2 61.0 28.6 17.6 14.6 11.2 9.6 32.0 12.4 10.0 43.0 7.2 17.5 1.8 47.9 12.6 31.9 21.5 9.8 24.0 4.5 14.9 15.2 16.5 16.7 9.9 57.1 16.7 8.5 14.7 11.7 17.0 15.2 25.1 12.8 6.0 15.2 20.2 60.6 11.4 10.2 16.3 15.9 10.6 13.7 19.9 3.6 32.8 19.9 13.8 20.6 53.3 37.9 32.0 11.9 14.3 19.4 13.9 17.1 9.4 16.3 36.0 6.6 21.4 15.0 46.0 31.1 10.1 16.1 12.9 24.3 12.8 14.0 15.0 CCL15 "HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3" ENSG00000275718 "C-C motif chemokine ligand 15" Q16663 17 35996440-36001553 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 83.0;liver: 31.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2" "Cancer enhanced" "Detected in many" "liver cancer: 11.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Hep G2: 35.4;OE19: 28.7" HPA058608 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 3270000 11000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" Vesicles "HPA058608: AB_2683776" "unprognostic (1.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.31e-2)" "unprognostic (1.40e-1)" "unprognostic (8.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" "unprognostic (2.41e-2)" "unprognostic (1.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-2)" "prognostic favorable (3.02e-4)" 0.2 0.4 0.1 7.8 0.1 0.1 0.4 0.1 0.3 0.3 0.0 59.7 37.6 0.1 0.0 0.2 9.6 9.2 0.0 0.1 0.1 10.0 31.6 2.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 83.0 0.0 0.1 0.1 0.0 0.1 62.0 1.4 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 4.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 28.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.5 0.0 0.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.1 7.2 5.0 0.0 0.0 0.0 0.0 262.6 0.0 0.0 0.0 12.2 0.1 0.7 71.8 0.0 0.0 0.7 0.0 0.0 0.0 0.1 8.9 0.0 2.5 40.2 0.1 0.0 0.0 208.3 2.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 380.6 0.0 0.0 0.0 461.4 61.3 76.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 138.2 0.2 CCL2 "GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF" ENSG00000108691 "C-C motif chemokine ligand 2" P13500 17 34255218-34257203 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 756.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1152.5;Ductal cells: 3382.2;Exocrine glandular cells: 919.2;Prostatic glandular cells: 889.0;Skeletal myocytes: 994.7;Smooth muscle cells: 1507.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 7.5;eosinophil: 3.0" "Group enriched" "Detected in many" 6 "granulocytes: 3.0;monocytes: 7.5" "Group enriched" "Detected in many" 4 "BJ hTERT+: 1902.2;HMC-1: 2427.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "midbrain: 9.9;spinal cord: 39.4" "CAB013676, HPA019163" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 323000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" Vesicles "CAB013676: , HPA019163: AB_1846179" "unprognostic (6.43e-2)" "unprognostic (4.14e-2)" "unprognostic (4.78e-2)" "unprognostic (5.57e-2)" "unprognostic (2.37e-3)" "unprognostic (8.64e-2)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.19e-1)" "unprognostic (9.33e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (4.51e-4)" "unprognostic (1.33e-1)" "unprognostic (2.50e-2)" "unprognostic (1.81e-1)" "unprognostic (4.92e-2)" 390.9 129.8 15.6 167.2 15.1 96.5 76.8 14.7 26.8 20.4 24.4 169.5 41.2 30.2 15.0 47.1 85.6 256.5 305.8 16.0 21.1 229.5 161.1 405.1 78.4 32.7 16.5 19.3 141.6 34.6 70.5 39.1 21.9 153.1 103.5 11.5 47.0 45.4 19.6 40.3 80.3 150.7 21.4 73.2 121.2 12.1 43.3 142.7 84.4 47.0 16.6 756.1 36.3 25.3 0.1 15.3 40.4 0.0 110.7 94.5 0.3 116.6 1902.2 243.3 516.8 7.1 0.2 0.3 90.4 27.6 3.8 64.0 4.3 0.1 122.9 0.6 0.9 0.2 13.5 0.0 3.5 0.4 2427.9 105.9 0.0 50.6 2.9 162.6 112.4 0.0 6.5 20.2 0.0 0.0 0.7 19.6 5.8 0.0 0.4 0.6 3.3 20.9 354.7 0.0 0.1 8.1 0.3 6.0 3.3 108.4 4.6 2.5 6.4 129.0 5.7 3.6 0.7 1.2 0.5 0.1 75.7 37.6 84.3 0.0 7.5 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 1.6 15.6 15.1 14.7 26.8 16.0 21.1 32.7 16.5 21.9 21.4 43.3 25.3 218.3 182.7 126.5 2.0 3.6 568.6 866.2 595.3 1152.5 0.1 23.5 50.9 29.5 92.9 120.7 138.0 0.0 2.7 2.2 0.0 0.0 3382.2 0.0 8.4 37.8 577.2 0.0 0.0 0.7 919.2 3.6 840.5 5.6 11.4 353.0 0.1 50.3 0.4 439.1 0.0 0.1 0.0 6.1 8.9 408.5 0.4 12.2 593.1 213.5 8.4 37.8 13.8 0.0 0.0 0.1 781.2 0.0 1.5 2.9 889.0 0.0 67.7 27.7 0.7 131.5 994.7 1507.0 0.4 0.3 13.0 222.8 4.5 44.3 1.7 0.1 40.6 CCN2 "CTGF, IGFBP8" ENSG00000118523 "Cellular communication network factor 2" P29279 6 131948176-131951372 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Cell adhesion, DNA synthesis" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 101.2;Cardiomyocytes: 38.7;Extravillous trophoblasts: 47.1;Fibroblasts: 261.8;Smooth muscle cells: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "naive B-cell: 8.1" "Lineage enriched" "Detected in single" 81 "B-cells: 8.1" "Cell line enhanced" "Detected in many" "EFO-21: 1605.0;HUVEC TERT2: 1377.0;TIME: 2874.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005123, HPA031074, HPA031075" Approved Approved "Golgi apparatus,Vesicles" "Secreted in other tissues" No No 1010000 5900000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Vesicles" "CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248" "unprognostic (2.87e-1)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (5.68e-2)" "unprognostic (9.79e-2)" "unprognostic (1.82e-2)" "unprognostic (3.38e-1)" "unprognostic (4.96e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.27e-3)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.62e-1)" "unprognostic (1.77e-2)" "unprognostic (3.84e-3)" 265.9 107.5 18.9 168.0 18.8 2.0 206.4 16.3 34.0 531.0 31.5 148.8 43.7 418.5 34.4 271.9 243.8 441.4 371.8 25.8 14.2 235.7 82.9 226.3 73.6 18.8 32.1 77.0 194.0 43.0 44.8 198.2 20.2 364.6 136.1 2.4 138.2 154.3 51.8 155.1 151.2 576.3 14.2 569.1 182.6 24.7 20.8 49.5 464.7 61.9 14.9 324.0 102.5 18.2 4.6 7.5 126.8 3.7 279.9 158.5 1.8 373.1 178.2 226.8 119.4 0.2 12.2 0.6 1605.0 482.7 185.0 6.2 4.2 26.4 211.3 2.5 3.5 0.2 55.7 137.3 109.6 0.3 0.5 232.2 5.9 163.9 40.2 340.7 1377.0 0.0 0.4 0.3 650.8 2.5 0.5 1.2 61.8 41.3 21.7 32.6 6.0 0.7 81.9 0.4 0.5 0.8 38.3 62.2 18.3 308.5 6.1 3.1 2874.4 311.6 242.4 397.8 694.0 11.5 1.7 4.1 42.5 0.7 399.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.9 18.8 16.3 34.0 25.8 14.2 18.8 32.1 20.2 14.2 20.8 18.2 101.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 17.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 47.1 261.8 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.4 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 CD47 "IAP, MER6, OA3" ENSG00000196776 "CD47 molecule" Q08722 3 108043091-108091862 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 589.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016055, HPA044659" Approved Supported "Vesicles,Plasma membrane" NA NA 49000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" Vesicles "CAB016055: AB_627086, HPA044659: AB_2679040" "unprognostic (3.54e-2)" "unprognostic (4.74e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.49e-2)" "unprognostic (2.14e-1)" "unprognostic (2.05e-3)" "unprognostic (8.77e-3)" "unprognostic (7.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.69e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (7.37e-2)" "unprognostic (3.78e-1)" "prognostic favorable (7.29e-5)" "unprognostic (1.83e-1)" 51.8 64.9 39.2 116.4 47.9 232.2 89.3 64.4 63.5 57.4 30.4 89.0 74.6 53.0 92.4 93.9 100.5 86.7 59.5 47.2 41.9 44.4 71.4 154.6 137.9 53.1 40.5 46.1 41.5 27.2 34.6 80.1 48.5 122.2 99.3 285.7 105.3 55.7 57.9 59.8 79.3 55.4 50.9 100.1 104.2 59.0 49.2 79.1 91.2 22.8 161.7 110.1 52.4 76.4 303.3 49.9 108.0 62.1 130.3 122.6 147.9 106.0 139.4 70.8 126.0 2.1 159.1 129.6 180.0 90.7 216.5 201.0 52.2 98.7 91.7 81.5 35.8 311.6 45.9 3.9 73.8 227.4 467.6 85.7 58.1 71.6 53.6 118.5 73.4 132.6 85.1 323.6 108.5 148.1 268.5 77.0 46.7 298.4 133.6 154.2 69.3 187.8 185.3 115.8 69.7 37.9 63.6 111.7 124.4 56.5 227.4 85.8 76.5 210.9 40.9 120.7 79.4 124.2 100.8 208.0 131.5 119.8 65.6 185.2 119.2 232.8 178.1 244.2 155.6 191.6 209.7 192.0 181.6 188.7 149.2 169.0 145.4 232.6 339.2 133.3 334.5 296.9 39.2 47.9 64.4 63.5 47.2 41.9 53.1 40.5 48.5 50.9 49.2 76.4 72.3 368.6 157.4 98.6 192.9 165.3 311.7 504.4 101.3 102.9 119.0 93.1 51.9 110.1 205.7 93.8 95.9 169.9 218.6 36.5 15.6 589.6 81.5 157.2 17.0 76.5 63.8 112.6 219.2 412.5 85.5 119.1 36.2 120.4 57.7 250.0 83.6 34.2 186.4 122.8 129.3 70.8 148.5 79.6 200.7 52.2 34.2 121.5 117.4 39.4 100.5 51.7 219.4 107.1 150.4 344.7 92.6 48.5 143.8 439.0 53.7 16.3 162.2 229.7 65.7 47.1 85.4 111.5 19.6 97.1 140.1 121.2 160.8 80.6 94.3 321.3 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736479 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 1445.2;Prostatic glandular cells: 1678.0;Urothelial cells: 1531.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 3747.5;U-2197: 3049.9" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 58000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favorable (1.39e-10)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 517.4 248.3 284.5 209.6 310.8 198.8 555.9 329.0 365.1 305.5 542.2 255.1 120.7 290.7 971.7 478.9 368.1 475.3 608.3 288.2 359.7 577.4 339.8 553.5 148.8 327.9 340.2 228.5 353.6 706.1 250.3 485.6 340.9 256.8 271.4 130.7 693.6 443.2 529.3 282.8 167.9 380.0 330.5 131.8 422.7 127.7 337.0 167.7 308.1 915.0 288.6 550.5 325.5 315.6 297.2 278.4 77.6 212.0 1697.1 1314.9 46.8 1765.7 1778.5 408.9 451.9 129.7 822.1 23.9 291.5 1802.5 475.5 314.0 141.0 1589.9 561.1 475.5 218.2 31.3 846.7 193.1 483.2 183.4 94.8 631.8 387.2 343.3 1550.6 1104.9 2475.5 109.3 207.9 585.9 2575.4 282.7 79.9 70.3 43.5 541.8 1421.8 30.1 232.1 227.8 1304.4 510.0 54.3 79.5 576.2 243.7 298.2 218.0 187.5 18.1 3747.5 838.6 235.5 3049.9 595.9 273.8 558.8 30.4 734.2 1.3 1556.9 164.9 22.3 209.6 50.9 7.9 64.8 63.9 104.9 56.6 95.4 59.6 68.2 41.4 134.3 92.5 4.8 49.9 298.2 53.5 284.5 310.8 329.0 365.1 288.2 359.7 327.9 340.2 340.9 330.5 337.0 315.6 728.0 272.4 247.2 32.3 39.1 286.0 1103.2 951.4 82.0 51.3 434.9 270.0 315.5 444.7 569.7 242.8 33.3 553.5 29.2 344.6 164.4 1445.2 129.4 94.3 91.6 792.6 166.6 206.0 25.1 618.3 407.2 303.5 109.6 115.6 139.4 88.2 585.0 185.7 486.7 47.1 29.9 112.8 722.2 139.4 374.2 61.6 237.3 88.2 1270.0 54.4 161.7 198.3 26.8 32.6 22.2 1195.7 392.2 204.7 149.7 1678.0 41.7 208.2 1042.5 56.2 276.1 159.1 410.7 130.6 31.2 83.7 284.4 836.6 52.4 139.5 104.9 1531.0 CD68 "DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1" ENSG00000129226 "CD68 molecule" P34810 17 7579491-7582111 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 358.0;lymphoid tissue: 370.7" "Cell type enhanced" "Detected in many" "Hofbauer cells: 1820.4;Kupffer cells: 701.2;Langerhans cells: 341.5;Macrophages: 791.2;Proximal enterocytes: 335.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 3255.5;intermediate monocyte: 3655.9;non-classical monocyte: 3740.6" "Group enriched" "Detected in all" 11 "dendritic cells: 1378.6;monocytes: 3740.6" "Cell line enhanced" "Detected in all" "ASC diff: 472.0;U-87 MG: 751.0" "Low region specificity" "Detected in all" "CAB000051, CAB000066, HPA048982, CAB072861, CAB072862" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" "CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587" "unprognostic (2.16e-2)" "unprognostic (1.47e-2)" "unprognostic (6.46e-2)" "unprognostic (1.49e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.75e-4)" "unprognostic (2.83e-2)" "unprognostic (1.31e-1)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (1.14e-5)" "unprognostic (1.58e-1)" "unprognostic (8.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.65e-2)" 139.6 78.3 10.4 236.1 9.8 266.2 72.6 11.2 33.4 77.8 14.6 88.8 279.5 26.7 9.0 126.4 43.1 161.1 38.9 8.2 26.7 50.6 156.7 358.0 217.3 45.5 31.2 19.4 22.1 14.2 8.9 173.1 36.0 13.1 91.9 4.8 52.6 19.8 23.0 24.8 240.2 79.0 16.1 370.7 87.5 15.2 58.5 44.2 22.7 21.3 84.2 149.3 50.6 31.6 243.4 48.6 3.2 3.5 472.0 177.6 2.1 75.6 203.9 97.8 113.4 10.1 71.3 2.9 84.2 220.8 174.6 10.6 1.2 47.6 65.9 2.2 9.0 38.8 13.2 59.0 42.0 19.2 207.8 57.1 9.8 205.4 150.4 162.6 26.3 4.3 15.7 24.2 95.5 2.2 1.7 17.2 2.8 63.1 36.0 3.3 4.5 144.4 20.9 10.9 1.6 3.0 63.2 31.3 72.1 2.2 1.6 146.1 82.4 123.7 8.0 125.7 100.1 1.4 2.1 1.9 751.0 46.4 64.0 243.5 3255.5 21.4 9.1 3655.9 11.1 80.2 4.1 6.2 817.3 59.0 5.8 5.1 219.4 18.7 3740.6 1378.6 6.5 3324.3 10.4 9.8 11.2 33.4 8.2 26.7 45.5 31.2 36.0 16.1 58.5 31.6 10.4 0.0 19.7 1.3 20.5 15.7 39.0 58.8 3.4 0.2 7.2 9.8 0.0 12.8 53.2 5.5 0.0 8.9 110.3 22.5 5.9 82.1 0.8 8.3 11.3 15.9 4.9 6.6 0.3 156.8 58.1 45.6 29.6 18.7 43.6 0.9 16.4 23.9 1820.4 0.0 0.4 15.8 16.2 701.2 341.5 2.1 6.5 791.2 39.2 5.6 179.2 0.3 7.2 0.0 0.1 121.0 86.1 1.9 8.5 33.3 335.3 50.2 20.6 1.0 26.3 8.7 11.7 0.5 1.2 12.4 14.3 33.4 10.8 0.5 28.9 99.9 CD83 "BL11, HB15" ENSG00000112149 "CD83 molecule" Q01151 6 14117256-14136918 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 209.6" "Cell type enhanced" "Detected in many" "B-cells: 668.5;Langerhans cells: 1390.2;Macrophages: 539.4;monocytes: 513.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 79.1;HDLM-2: 71.9;U-698: 121.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002509, HPA041454, HPA073595" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Vesicles "Golgi apparatus" "CAB002509: AB_563641, HPA041454: AB_2677489, HPA073595: " "unprognostic (2.22e-3)" "unprognostic (1.92e-2)" "unprognostic (1.22e-1)" "unprognostic (6.39e-2)" "unprognostic (5.83e-2)" "unprognostic (3.02e-2)" "unprognostic (1.00e-2)" "unprognostic (9.05e-3)" "unprognostic (9.05e-2)" "unprognostic (3.91e-2)" "unprognostic (7.37e-2)" "unprognostic (6.68e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.30e-1)" "unprognostic (7.07e-2)" "unprognostic (1.40e-2)" "unprognostic (2.46e-2)" 10.2 19.9 14.7 34.9 13.9 209.6 7.0 16.1 17.9 26.2 23.0 5.2 4.6 7.3 4.0 4.5 5.1 17.0 4.8 15.6 19.2 18.7 14.9 39.9 51.3 20.2 16.6 16.5 4.2 6.6 7.2 9.2 21.0 8.3 9.2 5.0 19.5 13.8 1.3 5.0 11.5 6.9 16.7 20.1 5.7 5.2 21.0 38.0 5.3 2.9 70.2 15.5 15.4 21.6 18.1 0.8 12.7 17.7 18.2 4.2 0.4 5.1 17.6 8.3 14.4 1.3 11.6 79.1 14.6 1.3 16.8 2.0 4.8 5.5 27.0 71.9 7.6 10.6 21.4 2.1 0.6 15.8 16.5 4.8 2.3 8.0 2.6 2.5 0.2 26.4 2.4 0.0 0.8 6.5 12.6 29.7 5.3 3.2 3.7 12.1 28.1 10.9 6.0 17.2 2.8 5.2 1.0 0.6 13.5 7.3 3.0 12.3 0.4 12.8 8.1 1.9 12.0 0.7 0.2 121.5 2.8 21.6 19.7 0.0 3.1 2.0 4.4 19.0 4.8 19.7 4.0 3.7 9.0 31.0 2.8 3.3 2.2 5.0 29.3 3.2 6.2 4.4 14.7 13.9 16.1 17.9 15.6 19.2 20.2 16.6 21.0 16.7 21.0 21.6 41.3 19.2 77.9 5.2 668.5 49.5 16.0 10.0 41.5 4.2 26.5 46.4 30.9 2.8 8.2 11.0 6.2 1.5 100.4 5.4 3.9 0.9 0.9 29.0 24.1 39.1 24.0 3.0 5.6 1.6 2.4 31.1 11.2 74.8 238.8 8.1 2.9 1.1 145.6 1.7 6.1 7.3 4.1 83.0 1390.2 1.9 0.3 539.4 44.4 13.1 513.6 3.5 1.0 2.5 1.3 2.1 0.4 0.0 20.4 26.2 1.7 17.7 4.9 2.7 0.0 17.2 17.0 2.1 10.2 17.2 38.5 2.7 69.2 21.0 11.6 3.5 CD84 "hCD84, mCD84, SLAMF5" ENSG00000066294 "CD84 molecule" Q9UIB8 1 160541095-160579516 "CD markers, Predicted membrane proteins" "Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.2" "Cell type enhanced" "Detected in many" "granulocytes: 187.1;Hofbauer cells: 91.1;Kupffer cells: 177.0;Macrophages: 90.6;monocytes: 76.4;T-cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 23.8;HEL: 45.3;HL-60: 13.1;HMC-1: 49.7;MOLT-4: 12.9;U-698: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063316, HPA068020, HPA070502" Enhanced Enhanced "Vesicles,Plasma membrane" NA NA 35000000 "Cluster 46: Basophils - DNA binding" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane" Vesicles "HPA063316: , HPA068020: , HPA070502: AB_2686274" "unprognostic (4.38e-2)" "unprognostic (6.16e-3)" "unprognostic (1.00e-2)" "unprognostic (8.16e-2)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (3.84e-1)" "unprognostic (2.54e-2)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (8.26e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" 3.3 2.4 1.9 19.4 2.1 7.9 2.7 2.3 2.4 2.8 1.9 3.2 2.4 1.4 0.9 2.2 1.1 6.2 1.4 1.7 1.9 0.8 5.2 7.8 24.2 5.2 3.1 1.5 2.0 0.9 0.4 7.1 4.5 1.1 4.5 0.2 1.4 3.4 0.4 1.3 4.6 4.0 3.8 15.2 3.6 1.9 5.2 9.9 1.1 0.7 13.2 4.7 0.8 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 45.3 0.1 0.0 0.0 13.1 49.7 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 0.1 0.0 0.0 12.9 9.7 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 30.8 0.0 2.9 0.0 32.7 9.6 15.0 8.2 8.0 6.5 6.3 7.0 10.1 7.1 6.0 4.0 7.4 1.2 1.4 3.2 4.1 10.5 8.8 1.9 2.1 2.3 2.4 1.7 1.9 5.2 3.1 4.5 3.8 5.2 7.2 1.3 0.0 6.4 0.0 27.4 2.4 0.7 0.0 0.6 0.2 0.6 1.5 1.2 2.8 1.3 0.0 0.0 0.5 20.5 0.2 0.0 0.1 0.9 0.5 0.2 4.2 0.0 21.5 0.1 0.2 0.5 1.2 2.6 0.2 187.1 0.1 3.3 1.1 91.1 0.0 0.2 0.1 0.0 177.0 42.2 1.5 0.6 90.6 5.4 34.7 76.4 0.0 4.1 0.0 0.1 0.0 0.0 0.0 10.8 0.9 0.3 0.3 0.7 0.2 0.0 1.6 1.5 0.1 0.4 0.5 2.4 1.0 46.8 2.9 0.2 0.6 CD93 "C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4" ENSG00000125810 "CD93 molecule" Q9NPY3 20 23079360-23086324 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 137.6" "Cell type enhanced" "Detected in many" "Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5" "Group enriched" "Detected in many" 41 "dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009300, HPA012368" Enhanced Approved "Vesicles,Plasma membrane" NA NA 550000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 32: U-937 - Innate immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Vesicles, Plasma membrane" "HPA009300: AB_1846342, HPA012368: AB_1846341" "unprognostic (2.05e-1)" "unprognostic (2.85e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (2.31e-1)" "unprognostic (2.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.77e-1)" "unprognostic (4.51e-1)" "unprognostic (3.74e-2)" "unprognostic (2.61e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (2.74e-4)" "unprognostic (8.81e-3)" "unprognostic (6.13e-2)" "unprognostic (4.49e-2)" "unprognostic (3.11e-2)" 81.4 11.9 2.7 43.5 2.6 16.4 41.0 2.8 6.5 23.9 6.5 13.8 9.8 17.8 6.1 19.0 23.4 39.7 34.3 2.7 3.5 25.6 16.3 64.6 14.0 5.4 4.3 6.2 13.2 10.8 6.6 137.6 5.4 11.3 12.1 1.4 9.7 10.9 24.2 12.2 14.5 43.5 4.0 23.4 13.0 4.6 7.1 9.3 21.4 34.4 10.6 41.3 12.8 3.5 0.2 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 346.0 0.0 0.9 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.9 0.2 27.8 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 105.3 442.2 0.0 0.1 0.1 0.5 0.0 0.0 0.3 0.0 593.5 0.1 0.0 25.8 0.4 0.3 16.8 0.0 0.0 0.2 0.1 9.1 0.0 0.0 0.0 27.8 0.1 7.5 1.2 0.5 9.9 2.7 2.6 2.8 6.5 2.7 3.5 5.4 4.3 5.4 4.0 7.1 3.5 321.5 3.2 7.4 0.0 2.4 15.0 1.0 0.0 6.2 0.0 1.0 1.8 14.3 5.7 3.7 0.0 0.0 0.2 5.0 0.0 0.0 0.5 0.4 0.4 0.7 309.2 0.0 1.3 0.0 0.0 0.5 9.8 0.5 0.4 5.1 0.0 162.8 1.9 19.9 0.0 0.2 0.0 0.0 156.4 52.5 0.8 1.8 102.4 8.8 4.7 131.8 0.2 6.2 0.0 0.1 0.1 0.0 27.8 2.1 4.1 0.0 0.3 3.0 0.1 19.7 5.7 8.0 0.0 0.2 1.6 10.1 0.4 2.4 3.0 0.0 4.0 CDC25B ENSG00000101224 "Cell division cycle 25B" P30305 20 3786772-3806121 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 7.2;NK-cells: 18.1;T-cells: 28.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038892, HPA038893, HPA075215" Enhanced Uncertain "Vesicles,Mitotic spindle" Yes Yes "Cluster 20: T-cells - T-cell receptor" "Cluster 64: Macrophages - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Mitotic spindle" "HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: " "unprognostic (4.69e-2)" "unprognostic (5.74e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (4.76e-4)" "unprognostic (1.13e-1)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.31e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.94e-13)" "unprognostic (1.15e-1)" "unprognostic (2.38e-1)" "unprognostic (3.94e-1)" "unprognostic (9.46e-2)" 29.2 15.6 30.5 28.8 32.4 29.4 25.1 39.2 33.2 41.7 23.2 37.6 14.4 35.0 9.4 27.1 31.5 17.9 16.3 27.6 32.5 31.3 24.8 78.4 47.6 31.3 29.9 37.4 12.8 3.8 45.7 31.1 30.2 25.4 11.3 7.8 16.7 8.9 10.5 21.8 41.2 14.2 27.4 56.1 30.1 12.4 30.9 44.7 41.8 6.3 32.8 35.8 30.2 35.8 129.6 273.2 36.5 60.0 43.8 43.0 19.3 63.3 95.3 103.1 75.9 49.2 182.9 91.3 27.5 65.4 253.5 183.5 50.6 105.8 50.2 36.2 54.4 49.4 88.5 59.6 178.4 38.6 25.0 41.1 85.0 95.4 115.7 35.6 58.4 44.2 33.3 232.7 63.1 105.5 119.0 57.7 27.3 90.9 116.9 62.0 102.6 67.5 73.2 12.2 25.8 56.9 148.6 140.8 78.1 31.7 48.1 20.4 48.6 55.1 66.2 101.5 85.0 57.8 97.8 36.8 28.1 38.0 54.6 3.9 2.4 0.0 22.7 3.4 21.3 5.8 22.6 23.3 2.4 7.2 18.6 21.6 0.3 18.1 1.7 1.3 28.2 11.2 30.5 32.4 39.2 33.2 27.6 32.5 31.3 29.9 30.2 27.4 30.9 35.8 14.0 9.6 21.7 18.6 21.7 11.2 6.0 10.9 7.4 14.4 4.8 5.5 8.6 8.6 4.5 7.3 2.1 11.9 30.6 5.8 0.0 9.9 0.7 2.7 20.6 27.1 7.8 32.6 39.2 4.8 17.7 15.7 17.3 5.4 1.3 11.5 14.3 13.7 30.4 3.3 38.0 10.4 12.2 14.8 9.4 1.1 7.2 12.4 17.8 6.5 8.8 8.3 44.3 22.6 13.2 15.0 4.3 9.1 49.6 6.0 5.5 11.1 3.7 2.6 0.0 26.5 14.0 2.3 12.3 10.3 11.2 3.6 36.4 7.1 10.9 4.4 CDH24 CDH11L ENSG00000139880 "Cadherin 24" Q86UP0 14 23047062-23057538 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 11.7;Astrocytes: 9.1;Bipolar cells: 8.2;Endothelial cells: 8.8;Enteroendocrine cells: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074551 Approved Vesicles,Cytosol NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol Vesicles "HPA074551: " "unprognostic (2.30e-1)" "unprognostic (3.06e-2)" "unprognostic (4.15e-3)" "unprognostic (6.21e-2)" "unprognostic (1.27e-1)" "unprognostic (9.18e-2)" "unprognostic (6.68e-3)" "unprognostic (2.71e-2)" "unprognostic (5.97e-3)" "unprognostic (3.55e-1)" "unprognostic (4.18e-2)" "unprognostic (5.97e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.37e-2)" "unprognostic (8.85e-2)" 4.3 2.4 4.9 1.2 3.8 1.2 3.6 3.8 4.7 5.9 1.7 2.7 1.1 8.6 1.1 4.0 4.3 4.2 2.0 9.4 4.3 2.9 0.5 3.3 1.3 4.0 3.9 2.4 2.1 2.2 1.9 1.6 3.9 3.1 1.7 1.7 3.1 1.6 0.7 2.9 2.4 4.0 2.3 2.4 2.0 1.7 3.8 3.7 4.6 0.5 0.9 2.6 4.1 5.3 4.6 4.5 18.3 20.9 4.4 2.2 10.1 8.4 5.4 7.0 9.0 5.7 6.1 0.3 6.7 9.2 1.8 25.8 8.0 7.1 5.6 7.1 6.7 1.0 12.7 1.9 4.9 13.2 0.3 17.3 2.3 7.6 5.0 8.5 11.5 4.2 2.9 11.0 6.1 12.9 1.0 8.8 4.6 4.7 10.2 22.9 6.1 8.4 2.0 3.8 52.9 14.2 19.7 10.4 1.1 5.0 9.3 1.9 10.7 6.9 26.0 2.8 6.3 3.5 1.1 0.3 7.2 3.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 3.8 3.8 4.7 9.4 4.3 4.0 3.9 3.9 2.3 3.8 5.3 11.7 0.0 0.0 9.1 0.3 1.5 0.8 0.5 3.4 8.2 2.1 1.1 2.0 0.0 0.5 1.8 0.0 2.3 0.9 1.9 1.9 0.5 0.4 0.6 2.1 8.8 10.7 0.0 2.6 0.5 2.5 1.7 1.1 1.0 0.0 4.3 2.5 0.0 0.6 0.0 1.7 1.7 0.0 0.0 0.3 1.0 0.0 0.1 1.8 2.8 0.1 4.4 0.0 5.5 0.2 0.6 0.3 0.0 0.3 0.8 0.2 0.5 0.5 0.8 0.0 0.2 1.5 1.1 2.5 2.0 2.3 1.9 0.7 2.5 2.1 0.9 CDK5R1 "Nck5a, p35, p35nck5a" ENSG00000176749 "Cyclin dependent kinase 5 regulatory subunit 1" Q15078 17 32486993-32491253 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 63.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Early spermatids: 21.2;Excitatory neurons: 36.6;Inhibitory neurons: 31.6;Late spermatids: 18.9" "Cancer enhanced" "Detected in many" "melanoma: 14.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "SCLC-21H: 58.1;SH-SY5Y: 15.6;SK-MEL-30: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000252 Approved Nucleoplasm,Vesicles NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "HPA000252: AB_2665953" "unprognostic (1.08e-1)" "unprognostic (9.13e-2)" "unprognostic (1.79e-2)" "unprognostic (3.65e-1)" "unprognostic (1.97e-1)" "unprognostic (8.09e-2)" "unprognostic (2.74e-5)" "unprognostic (1.81e-2)" "unprognostic (3.32e-1)" "unprognostic (2.18e-1)" "unprognostic (5.90e-2)" "unprognostic (5.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "unprognostic (7.92e-2)" "unprognostic (8.81e-2)" "unprognostic (1.03e-1)" 0.8 2.8 37.8 7.1 50.8 5.4 1.2 11.0 63.5 1.5 0.0 0.9 1.4 0.9 0.2 7.5 0.7 0.9 1.1 53.4 21.1 0.8 1.0 0.8 13.9 3.2 10.5 2.6 1.4 0.7 6.9 0.6 4.5 0.6 0.8 10.4 1.1 0.5 2.3 1.9 3.6 0.6 3.5 12.1 1.6 7.2 21.7 4.2 0.5 0.8 14.1 0.8 3.1 34.2 3.9 2.2 9.8 3.1 1.1 1.8 1.1 2.4 1.4 2.9 3.7 5.7 0.9 1.9 2.2 2.0 2.4 1.8 3.8 2.4 3.8 0.7 7.3 0.7 1.1 2.3 0.5 1.3 1.9 1.1 5.8 2.9 2.4 1.1 2.1 6.9 3.9 2.2 6.2 1.6 3.4 1.5 6.2 1.4 2.1 2.9 5.9 7.1 1.4 1.7 58.1 15.6 2.3 1.3 43.8 1.4 2.5 4.4 2.2 4.0 5.9 1.6 6.3 1.1 1.5 1.9 3.4 5.6 9.7 0.0 0.3 0.4 0.8 0.3 0.6 0.2 1.1 0.4 0.0 0.1 1.5 0.9 1.2 0.2 0.1 0.6 0.1 0.6 37.8 50.8 11.0 63.5 53.4 21.1 3.2 10.5 4.5 3.5 21.7 34.2 1.7 0.0 1.5 6.5 13.1 1.5 0.5 1.0 7.4 15.9 3.7 2.3 3.6 0.0 0.8 0.0 45.9 0.6 10.1 0.3 0.0 0.2 21.2 1.1 1.3 1.2 0.0 0.0 36.6 0.6 0.3 1.2 0.5 1.5 0.0 1.6 0.7 0.7 0.9 1.7 31.6 1.4 2.0 3.5 0.5 18.9 0.0 1.3 3.6 2.8 2.0 18.4 10.3 9.5 11.9 1.2 1.2 0.7 0.9 1.2 0.4 1.5 1.0 6.3 0.0 2.9 3.1 6.7 4.3 8.8 1.3 1.1 7.1 1.9 1.1 0.5 CDKL1 KKIALRE ENSG00000100490 "Cyclin dependent kinase like 1" Q00532 14 50326265-50416461 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 23.4;Excitatory neurons: 46.2;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 25.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059605, HPA065919" Uncertain Enhanced Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Vesicles "HPA059605: AB_2684080, HPA065919: AB_2685578" "unprognostic (4.12e-3)" "unprognostic (3.22e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.02e-1)" "unprognostic (3.23e-3)" "unprognostic (9.36e-3)" "unprognostic (2.63e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (5.53e-8)" "unprognostic (1.21e-1)" "unprognostic (7.96e-2)" "unprognostic (9.39e-3)" "unprognostic (3.31e-3)" 13.5 3.6 3.4 4.9 4.4 3.6 3.5 1.4 9.0 13.9 3.7 8.8 13.2 13.9 3.2 5.2 15.4 5.2 2.3 5.5 2.3 19.4 1.6 6.5 6.5 2.0 2.1 13.8 1.3 1.2 0.6 6.5 2.9 5.9 6.6 20.2 2.8 9.0 7.1 13.5 6.9 8.5 2.9 7.0 4.9 2.0 1.8 1.9 7.9 1.0 2.6 6.9 6.6 8.1 7.7 4.9 3.5 4.3 5.3 6.1 2.3 2.2 3.2 1.9 2.0 4.0 5.9 6.1 2.8 3.2 3.2 5.9 0.8 0.3 1.9 8.9 3.1 12.2 4.6 3.9 6.2 9.7 5.3 1.5 3.0 3.2 8.0 2.4 6.7 10.3 3.3 4.8 1.1 2.5 2.8 4.7 1.9 2.6 3.9 3.3 3.8 3.1 5.3 6.6 4.6 3.4 4.2 18.3 2.1 1.3 2.4 6.2 4.0 6.7 4.1 7.1 5.0 2.4 1.8 2.9 1.7 8.7 7.6 3.2 1.4 2.6 3.5 1.4 3.1 2.6 2.3 3.2 0.8 3.0 1.9 1.9 0.7 2.3 0.2 0.8 2.4 1.3 3.4 4.4 1.4 9.0 5.5 2.3 2.0 2.1 2.9 2.9 1.8 8.1 3.2 19.2 9.9 6.5 3.0 3.1 4.1 0.2 3.4 0.7 0.4 0.5 0.5 0.0 2.6 11.0 0.0 0.1 2.3 7.2 5.9 1.4 0.4 23.4 9.6 3.3 1.8 6.1 46.2 1.8 0.1 7.6 1.1 4.9 1.3 3.2 6.4 0.3 0.4 0.0 20.6 2.1 2.0 0.9 1.5 1.5 9.0 1.5 0.0 7.5 0.8 0.9 2.1 46.8 25.4 1.9 4.8 3.4 0.2 3.1 4.9 8.0 20.4 0.7 0.0 4.0 4.6 0.0 0.3 4.7 2.7 0.3 4.2 3.6 5.2 2.2 CDKL3 NKIAMRE ENSG00000006837 "Cyclin dependent kinase like 3" Q8IVW4 5 134286350-134371047 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.2" "Group enriched" "Detected in many" 6 "Early spermatids: 342.0;Late spermatids: 295.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027751 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Vesicles" "HPA027751: AB_10601256" "unprognostic (4.70e-2)" "unprognostic (2.15e-2)" "unprognostic (2.35e-1)" "unprognostic (1.48e-1)" "unprognostic (1.43e-1)" "unprognostic (3.98e-2)" "unprognostic (3.43e-3)" "unprognostic (5.93e-2)" "unprognostic (2.12e-3)" "unprognostic (1.49e-1)" "unprognostic (8.47e-4)" "unprognostic (2.82e-1)" "unprognostic (9.85e-4)" "unprognostic (8.33e-2)" "unprognostic (4.88e-2)" "unprognostic (7.10e-3)" "unprognostic (3.43e-3)" 0.7 0.8 2.5 0.5 2.8 0.2 0.6 2.5 4.4 0.8 1.3 0.8 0.5 1.1 0.6 0.6 1.2 0.6 2.7 2.4 2.7 1.5 0.8 0.5 0.7 2.9 2.6 0.7 0.5 1.0 0.6 0.4 3.0 0.7 0.6 4.2 0.4 0.8 3.4 0.6 0.6 1.5 3.1 0.7 0.5 16.2 2.8 0.9 1.2 3.3 0.9 0.6 0.5 5.0 0.5 1.3 1.7 1.2 2.7 2.4 0.7 1.7 1.4 0.7 1.7 1.2 0.8 1.3 1.0 1.1 3.3 0.5 1.5 1.0 1.2 1.6 1.0 0.8 1.7 1.9 1.7 0.3 0.5 1.1 2.5 2.2 0.6 1.2 0.7 3.4 1.1 0.7 1.9 0.6 1.2 4.6 1.2 0.3 0.5 1.9 0.6 0.4 0.9 0.5 2.5 0.8 1.8 0.1 2.1 1.8 1.0 0.9 0.5 1.4 0.3 1.9 0.5 1.8 2.5 2.9 2.1 1.4 1.1 0.0 0.3 0.3 0.3 0.4 1.4 0.5 0.4 0.9 1.0 0.3 1.3 1.3 0.0 0.6 0.1 0.5 0.9 0.4 2.5 2.8 2.5 4.4 2.4 2.7 2.9 2.6 3.0 3.1 2.8 5.0 4.1 0.0 3.7 50.6 2.0 10.8 6.4 18.8 4.0 13.3 4.5 5.8 2.2 2.8 9.9 5.5 4.2 3.1 3.2 0.5 9.8 3.5 342.0 7.5 6.4 4.6 3.0 4.8 41.6 5.1 1.8 6.2 1.5 3.7 3.8 7.0 3.6 2.3 3.6 6.7 52.0 1.5 18.3 2.1 19.4 295.3 5.0 2.8 10.6 16.9 2.4 10.8 3.1 32.6 50.7 1.5 1.6 9.1 1.4 4.3 1.3 9.5 12.9 9.7 0.0 6.3 7.9 35.3 17.2 1.7 11.1 4.5 3.4 6.2 0.9 3.8 CDKN1B "KIP1, P27KIP1" ENSG00000111276 "Cyclin dependent kinase inhibitor 1B" P46527 12 12715058-12722369 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 182.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003691, CAB021888, HPA059086" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900" "unprognostic (5.67e-2)" "unprognostic (9.76e-2)" "prognostic favorable (5.15e-4)" "unprognostic (6.90e-3)" "unprognostic (5.84e-3)" "unprognostic (1.03e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (4.04e-2)" "unprognostic (1.11e-1)" "unprognostic (2.85e-3)" "unprognostic (9.23e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (8.39e-4)" "unprognostic (1.23e-1)" "unprognostic (8.68e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" 53.4 44.7 53.6 40.1 70.6 68.1 50.2 73.4 81.3 55.3 43.1 43.9 44.5 41.0 24.5 29.1 47.3 24.6 32.9 47.9 58.9 30.2 35.2 38.9 55.3 58.6 58.3 66.1 23.9 34.4 24.4 41.0 61.2 35.9 32.5 55.3 36.3 33.4 81.4 45.4 40.7 24.8 55.1 55.1 30.0 25.8 58.3 71.8 33.7 63.4 39.9 32.0 44.5 91.2 37.1 16.6 94.5 16.6 32.0 18.0 46.1 31.5 53.8 46.0 56.4 47.7 40.4 0.3 12.5 19.6 16.6 34.2 44.9 16.7 41.1 62.4 31.5 28.8 46.5 53.2 42.5 24.5 18.6 19.8 35.3 15.2 44.0 107.8 27.8 54.5 31.5 101.6 16.6 45.9 32.7 35.3 38.0 32.1 16.8 25.2 30.9 63.1 22.5 38.6 35.6 58.4 48.9 34.8 65.8 33.7 18.6 54.6 19.1 22.6 34.9 20.7 33.3 86.1 59.4 33.2 28.2 36.6 22.5 6.2 3.8 8.6 5.9 3.5 6.1 6.8 7.7 7.2 3.6 5.0 8.0 6.1 20.9 7.3 5.5 3.9 12.3 4.0 53.6 70.6 73.4 81.3 47.9 58.9 58.6 58.3 61.2 55.1 58.3 91.2 64.2 44.8 29.3 6.2 126.2 52.6 20.7 21.0 115.5 45.6 39.5 30.1 39.1 21.5 27.1 9.2 27.1 42.9 92.5 32.3 15.6 10.8 70.0 31.2 35.8 51.1 45.7 70.5 8.1 9.3 47.6 39.3 25.5 34.3 31.0 21.3 47.2 30.7 26.8 10.1 13.4 41.4 24.4 55.3 66.0 67.7 55.9 65.1 74.7 23.4 31.6 182.9 60.8 6.0 29.5 10.1 21.3 26.7 121.2 30.3 33.4 16.9 36.4 29.4 92.1 20.2 53.5 7.7 10.8 102.3 52.6 39.0 166.1 20.9 41.9 22.7 CEBPA "C/EBP-alpha, CEBP" ENSG00000245848 "CCAAT enhancer binding protein alpha" P49715 19 33299934-33302534 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 98.7;liver: 194.7;skin 1: 118.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 91.6;Hepatocytes: 106.5;Hofbauer cells: 87.0;Suprabasal keratinocytes: 171.8;Syncytiotrophoblasts: 212.3" "Cancer enhanced" "Detected in all" "liver cancer: 70.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 16.0;classical monocyte: 7.1;intermediate monocyte: 12.3;myeloid DC: 5.1;non-classical monocyte: 15.7" "Group enriched" "Detected in many" 15 "dendritic cells: 5.1;granulocytes: 16.0;monocytes: 15.7" "Cell line enhanced" "Detected in many" "BEWO: 196.9;Hep G2: 110.9;NB-4: 114.1;THP-1: 407.7;U-937: 130.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052734, HPA065037, HPA067937" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 43: THP-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927" "unprognostic (1.80e-1)" "unprognostic (7.62e-3)" "unprognostic (2.09e-3)" "unprognostic (2.21e-2)" "unprognostic (3.38e-1)" "unprognostic (3.99e-2)" "unprognostic (1.94e-1)" "unprognostic (2.43e-3)" "unprognostic (5.95e-2)" "unprognostic (3.96e-2)" "unprognostic (3.09e-1)" "unprognostic (9.45e-2)" "unprognostic (8.02e-3)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (2.72e-2)" 98.7 2.9 16.2 5.7 17.9 22.6 67.7 18.3 26.9 8.7 10.4 21.0 21.2 2.9 0.8 20.9 4.3 3.0 2.8 15.7 18.8 3.6 194.7 25.5 9.1 27.4 22.4 1.3 9.7 26.8 2.6 16.0 21.3 8.8 11.5 0.6 9.8 3.4 19.1 118.7 20.8 2.5 25.7 7.7 12.5 1.0 24.5 4.1 6.5 4.5 6.3 8.7 14.8 34.8 2.5 5.1 0.1 7.1 55.8 0.0 196.9 0.1 1.5 0.1 0.0 24.8 0.1 0.0 3.0 0.0 1.1 9.4 5.8 0.6 0.0 35.8 7.2 0.1 0.1 110.9 0.9 36.6 42.1 2.2 25.4 0.0 0.2 0.0 0.0 2.8 2.4 0.0 0.0 12.7 0.2 114.1 5.0 61.8 2.7 0.0 0.4 1.1 0.2 17.7 0.4 1.7 0.7 0.5 0.8 6.2 13.7 407.7 0.1 0.1 0.8 0.1 0.9 0.4 0.0 0.2 0.0 130.9 0.0 16.0 7.1 0.0 0.8 12.3 0.7 0.0 0.1 0.5 5.1 0.1 0.2 0.4 2.5 0.0 15.7 0.2 0.0 2.1 16.2 17.9 18.3 26.9 15.7 18.8 27.4 22.4 21.3 25.7 24.5 34.8 5.4 16.0 37.8 0.0 2.8 37.3 20.8 3.3 22.2 0.7 6.2 12.2 0.4 57.2 5.1 0.0 0.0 40.3 14.4 91.6 3.9 0.5 0.0 0.8 0.8 4.9 4.2 5.7 1.9 5.8 44.3 9.5 12.8 1.3 1.3 0.0 2.2 106.5 87.0 0.0 0.3 24.8 4.1 35.0 27.4 0.2 3.1 42.9 5.4 17.8 28.2 8.4 6.2 1.0 0.4 1.9 30.6 1.5 2.0 15.1 42.5 4.9 5.1 0.5 0.0 4.1 3.1 0.2 0.7 29.7 171.8 212.3 5.0 0.3 51.5 12.2 CEBPZ "CBF2, CTF2" ENSG00000115816 "CCAAT enhancer binding protein zeta" Q03701 2 37201612-37231596 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 282.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052065 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles Nucleoplasm "HPA052065: AB_2681715" "unprognostic (1.64e-2)" "unprognostic (1.20e-1)" "unprognostic (3.00e-3)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.88e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (2.94e-5)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (2.66e-1)" "prognostic unfavorable (8.13e-4)" "unprognostic (2.65e-2)" "unprognostic (5.36e-2)" "unprognostic (4.19e-2)" "unprognostic (8.76e-2)" "unprognostic (2.05e-1)" "unprognostic (8.01e-2)" 21.1 27.8 10.3 18.9 11.5 31.3 26.2 15.8 12.8 17.9 11.9 19.5 17.4 20.1 19.9 20.5 17.2 16.7 15.3 9.8 11.8 25.3 27.1 19.3 24.6 10.9 11.0 23.9 20.6 22.3 10.2 23.0 11.4 19.7 20.0 24.4 16.3 15.6 36.3 17.9 18.1 16.9 10.8 19.9 17.4 38.4 11.1 24.0 22.4 24.4 24.4 26.6 12.6 14.2 61.2 46.6 46.9 26.1 45.2 48.6 39.9 57.0 39.2 47.2 50.5 74.5 45.1 111.5 49.4 33.8 64.4 51.0 122.8 58.5 60.2 71.8 53.9 104.0 47.5 60.9 35.8 105.7 44.9 37.3 56.4 62.8 63.4 31.1 43.3 27.8 114.8 49.8 48.6 31.8 61.5 82.4 153.3 81.0 43.2 48.6 76.3 84.3 45.3 56.9 49.9 80.7 47.5 57.6 65.5 67.6 41.8 45.9 35.5 45.8 52.3 41.3 79.1 55.5 62.0 88.1 40.8 95.6 51.2 34.8 16.8 16.3 23.8 21.7 30.0 29.6 24.7 23.4 17.6 30.0 31.1 26.1 6.1 26.1 22.3 25.6 21.4 14.6 10.3 11.5 15.8 12.8 9.8 11.8 10.9 11.0 11.4 10.8 11.1 14.2 73.4 86.6 82.9 15.0 91.6 107.1 109.2 64.4 83.1 45.5 50.4 54.1 34.4 47.1 81.9 49.7 43.8 54.7 93.4 36.7 107.6 56.1 282.1 56.0 87.2 60.5 44.2 66.7 15.6 62.5 37.4 67.4 52.5 67.5 73.4 44.7 43.9 76.4 35.1 43.7 19.3 56.6 44.7 37.0 36.1 43.3 60.9 44.6 21.4 15.0 54.1 57.1 63.8 18.6 21.4 54.9 30.2 50.8 67.7 79.0 30.2 89.1 54.2 95.5 52.6 94.3 68.3 186.7 99.3 56.8 101.2 45.0 87.7 62.1 64.2 80.9 CECR2 KIAA1740 ENSG00000099954 "CECR2 histone acetyl-lysine reader" Q9BXF3 22 17359949-17558149 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.5;retina: 15.6;skeletal muscle: 21.8" "Cell type enhanced" "Detected in many" "Astrocytes: 109.4;Cone photoreceptor cells: 168.9;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 137.7;Rod photoreceptor cells: 94.1" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.5;HAP1: 14.4;K-562: 8.3;NTERA-2: 22.8;SCLC-21H: 10.1;SuSa: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002943 Approved Approved Nucleoplasm,Vesicles No No "Cluster 54: Non-specific - Microtubule organization" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Vesicles "HPA002943: AB_1078496" "unprognostic (2.46e-2)" "unprognostic (4.10e-2)" "unprognostic (7.99e-2)" "unprognostic (1.92e-3)" "unprognostic (7.48e-3)" "unprognostic (2.46e-3)" "unprognostic (2.49e-1)" "unprognostic (6.67e-2)" "unprognostic (8.18e-2)" "unprognostic (3.94e-1)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (8.13e-6)" "unprognostic (1.13e-1)" "unprognostic (1.59e-1)" "unprognostic (6.56e-2)" "unprognostic (1.94e-2)" 0.7 0.4 5.2 0.2 12.8 0.5 1.0 22.5 8.3 1.4 1.2 1.2 0.2 2.3 0.6 0.4 1.7 0.2 3.4 5.3 8.0 1.3 7.6 2.6 0.1 9.8 9.0 2.9 2.6 0.0 6.4 1.0 8.7 1.0 0.3 15.6 0.9 0.2 21.8 0.9 0.5 0.9 5.4 0.4 0.5 3.5 9.8 0.2 2.2 10.6 0.2 1.3 1.0 12.7 0.2 0.1 15.5 5.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.7 0.1 14.4 0.0 0.0 0.0 7.2 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.5 8.3 0.0 0.0 0.1 0.0 0.5 22.8 0.0 0.0 1.8 1.0 0.1 0.0 5.1 10.1 0.0 0.0 0.2 0.9 9.0 1.6 2.5 0.1 0.1 3.4 0.0 0.0 5.8 1.4 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 12.8 22.5 8.3 5.3 8.0 9.8 9.0 8.7 5.4 9.8 12.7 1.9 6.4 10.6 109.4 0.3 0.0 1.1 0.2 0.0 22.1 0.7 0.6 11.8 0.0 0.8 1.8 168.9 10.1 0.0 0.0 0.0 0.1 6.3 6.3 6.2 2.0 0.0 0.0 2.3 0.2 2.5 3.1 0.0 17.2 0.0 3.5 4.2 10.7 0.7 5.0 4.3 0.0 0.0 0.3 0.3 4.0 1.2 1.4 0.0 34.7 0.2 18.3 0.0 120.1 137.7 0.1 0.0 1.2 0.8 1.8 0.0 1.4 0.9 94.1 6.6 33.9 3.2 1.9 15.9 0.1 0.1 33.0 0.2 0.4 0.0 3.6 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 71.3;Muller glia cells: 150.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 55.1;NB-4: 99.8;U-937: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 5: Muller glia cells - Visual perception" "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favorable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favorable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favorable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 13.6 13.0 31.8 10.0 38.9 3.4 31.1 26.6 37.1 35.9 18.7 17.7 6.3 21.5 61.5 64.3 21.3 11.2 14.8 35.3 25.2 27.8 57.7 19.4 19.9 36.9 30.5 22.0 89.1 29.0 22.2 1.9 30.8 32.9 3.9 36.9 55.0 17.6 3.1 47.7 15.2 12.0 26.8 17.7 26.8 11.5 30.7 13.1 51.9 5.3 20.4 18.4 32.7 44.0 0.4 2.1 2.1 25.0 0.8 0.2 1.7 3.1 8.4 3.7 1.7 19.5 1.7 40.0 27.4 0.0 9.6 13.6 16.4 0.4 1.7 35.5 12.4 7.6 0.1 55.1 31.6 0.0 21.3 12.3 20.7 8.8 18.9 10.5 0.3 17.7 5.9 1.2 0.0 0.8 2.6 99.8 25.4 0.2 8.7 49.1 0.8 3.0 6.3 0.0 9.3 12.2 4.3 0.7 14.5 16.7 18.8 8.8 0.2 2.9 7.8 18.6 0.1 24.5 21.1 32.0 0.1 61.9 2.8 12.3 7.1 27.4 7.5 3.9 5.7 19.8 4.3 4.6 4.1 17.7 3.9 3.8 22.4 22.4 2.4 3.9 5.5 5.8 31.8 38.9 26.6 37.1 35.3 25.2 36.9 30.5 30.8 26.8 30.7 44.0 3.2 6.4 10.7 27.1 31.2 18.0 13.2 12.0 15.4 24.5 47.0 28.8 4.1 22.8 22.2 1.8 18.8 3.4 17.2 0.2 7.9 20.0 1.7 7.9 11.2 8.6 23.9 4.0 38.3 30.5 0.9 15.7 3.1 7.6 12.7 14.4 8.2 71.3 16.4 11.8 24.4 1.3 8.2 7.1 7.2 7.3 14.3 6.7 26.6 16.9 19.6 150.3 27.8 47.7 48.1 9.4 2.5 16.1 12.4 40.6 0.4 44.6 27.8 29.5 6.6 6.9 13.8 1.0 1.6 20.6 25.9 2.9 15.7 2.7 2.5 11.9 CFAP94 "CASC1, FLJ10921, LAS1, PPP1R54" ENSG00000118307 "Cilia and flagella associated protein 94" Q6TDU7 12 25108289-25195162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 12.4;fallopian tube: 14.0;testis: 22.9" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.9;Fibroblasts: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "T-47d: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039662, HPA040141" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 24: Non-specific - Transcription regulation" Cytosol Vesicles "HPA039662: AB_10795468, HPA040141: " "unprognostic (6.42e-3)" "unprognostic (1.26e-2)" "unprognostic (1.95e-2)" "unprognostic (2.04e-3)" "unprognostic (4.62e-1)" "unprognostic (1.85e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (2.22e-1)" "unprognostic (3.91e-2)" "unprognostic (6.21e-4)" "unprognostic (2.54e-2)" "prognostic favorable (3.13e-4)" "unprognostic (2.01e-1)" "unprognostic (8.74e-3)" "unprognostic (7.16e-2)" "unprognostic (1.19e-1)" 0.2 0.7 1.6 0.2 2.3 0.6 1.5 0.9 2.0 2.0 12.4 0.3 0.0 1.6 6.0 0.5 14.0 0.7 0.4 2.1 2.3 2.7 0.0 1.9 0.4 5.7 6.0 1.2 0.7 3.3 4.0 0.1 4.2 1.0 0.0 5.1 0.7 1.1 0.1 1.0 0.1 0.3 4.0 0.2 0.6 22.9 3.0 0.4 4.1 0.0 0.1 0.2 0.2 2.5 0.1 0.3 0.4 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.3 0.0 1.0 1.1 0.3 0.0 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.4 0.0 1.1 0.6 0.4 0.0 0.0 0.2 0.5 0.2 0.1 0.0 0.4 0.1 0.0 1.0 0.1 0.6 0.2 0.1 0.0 0.1 0.5 1.3 0.0 0.0 0.1 0.8 0.5 0.1 0.4 0.2 0.9 0.3 0.2 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.6 0.0 0.2 0.0 0.9 0.1 0.2 1.3 0.3 0.2 0.3 0.0 0.1 1.6 2.3 0.9 2.0 2.1 2.3 5.7 6.0 4.2 4.0 3.0 2.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CFDP1 "BCNT, CENP-29, CP27, p97, SWC5, Yeti" ENSG00000153774 "Craniofacial development protein 1" Q9UEE9 16 75293698-75433503 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 493.3;Paneth cells: 745.2;Proximal enterocytes: 612.2;Proximal tubular cells: 637.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041316, HPA048242" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA041316: AB_10794371, HPA048242: AB_2680327" "unprognostic (1.45e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-1)" "unprognostic (4.88e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (9.63e-5)" "unprognostic (5.81e-3)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.61e-2)" "unprognostic (1.42e-1)" "unprognostic (7.37e-2)" "unprognostic (2.85e-2)" "unprognostic (6.54e-2)" "unprognostic (1.36e-1)" "unprognostic (4.92e-3)" "unprognostic (1.25e-1)" 45.0 51.0 57.4 24.0 58.0 35.0 45.2 60.8 75.3 69.1 57.9 47.5 30.4 58.6 62.3 41.2 55.6 29.7 36.8 57.1 61.7 64.5 43.1 37.3 27.1 58.8 59.3 83.1 41.2 30.8 57.1 63.1 58.8 39.9 40.2 49.6 39.4 38.1 35.7 42.4 36.4 51.0 56.7 30.2 34.7 59.5 59.6 57.0 45.0 34.9 35.8 44.8 50.7 60.8 65.0 47.6 158.9 59.2 141.2 156.3 47.2 63.2 74.1 83.0 119.1 82.5 86.6 61.3 91.1 79.3 92.7 71.5 123.3 101.9 164.9 26.4 58.6 63.0 46.6 177.2 97.3 69.2 51.6 98.4 85.5 100.2 121.4 144.6 91.5 114.0 91.3 28.3 93.9 149.0 102.2 152.6 77.1 110.0 24.8 182.7 64.3 108.5 93.1 35.5 94.5 79.4 105.7 22.3 92.5 136.4 91.8 121.6 53.8 59.2 63.1 63.2 40.8 54.4 89.2 228.6 59.3 89.9 53.3 61.3 45.5 60.8 31.2 47.8 44.5 33.6 42.7 34.7 48.8 35.4 38.7 36.5 38.1 28.5 46.2 48.7 68.5 25.8 57.4 58.0 60.8 75.3 57.1 61.7 58.8 59.3 58.8 56.7 59.6 60.8 87.4 38.5 57.5 37.5 45.5 57.9 116.3 135.9 47.3 87.2 89.5 103.4 34.7 91.5 111.2 115.8 116.7 119.0 50.5 493.3 197.6 79.1 133.7 197.7 118.5 97.6 82.2 78.9 49.5 94.9 114.0 82.9 61.2 121.3 28.5 194.5 62.8 153.9 77.1 62.2 50.5 219.2 59.0 53.1 44.5 69.7 125.2 51.1 33.8 45.9 64.8 60.8 84.5 49.8 75.6 92.4 745.2 112.5 42.3 116.9 612.2 637.6 205.3 112.5 98.6 55.3 88.2 311.2 178.0 49.5 65.6 154.9 51.6 103.5 120.0 130.4 CGRRF1 "CGR19, RNF197" ENSG00000100532 "Cell growth regulator with ring finger domain 1" Q99675 14 54509812-54539292 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 145.4;Spermatocytes: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002930 Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Vesicles "HPA002930: AB_1078507" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (5.61e-2)" "unprognostic (4.38e-1)" "unprognostic (1.01e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.58e-2)" "unprognostic (2.63e-1)" "unprognostic (7.29e-2)" "unprognostic (2.64e-3)" "prognostic favorable (2.57e-8)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.48e-1)" "unprognostic (1.74e-1)" 9.9 9.2 20.5 3.9 21.1 7.9 11.9 22.2 25.8 9.6 21.2 11.7 5.3 11.0 13.8 5.9 11.2 5.9 12.3 20.2 21.2 14.5 7.8 7.5 6.0 21.2 21.4 10.0 13.1 12.8 12.7 7.0 21.2 11.3 6.9 13.6 8.5 10.9 19.3 4.2 8.5 8.6 22.1 8.5 9.7 22.3 20.9 5.6 12.7 12.5 5.3 10.1 7.5 22.3 10.4 8.6 9.7 8.6 16.7 10.6 7.3 9.5 10.2 14.6 15.2 8.7 11.7 5.9 11.9 8.2 15.8 9.1 10.8 8.4 18.5 11.9 8.7 8.3 1.7 10.6 20.1 4.6 4.4 10.9 16.7 11.0 18.1 9.6 10.6 9.3 3.3 7.6 13.6 19.0 4.9 7.2 6.0 9.5 15.3 10.8 12.3 2.9 11.8 13.3 6.4 6.3 8.3 3.9 16.1 8.7 11.3 4.2 9.3 18.2 14.3 7.2 8.7 5.0 6.4 8.5 10.0 5.6 12.0 61.9 12.4 22.6 19.1 15.4 18.7 18.2 19.9 20.2 10.4 19.4 20.0 18.6 12.5 20.3 19.0 9.0 22.3 19.7 20.5 21.1 22.2 25.8 20.2 21.2 21.2 21.4 21.2 22.1 20.9 22.3 20.3 9.6 11.5 21.5 22.6 7.6 17.4 26.7 16.5 18.6 18.3 18.7 22.1 14.3 17.3 16.5 10.4 14.7 21.8 17.5 23.5 21.6 145.4 13.7 15.1 20.3 10.7 4.2 14.2 16.9 11.5 22.3 5.6 13.1 29.2 12.7 18.9 10.6 17.0 11.8 13.8 9.1 28.5 14.8 10.3 41.5 16.8 24.8 16.0 12.2 15.5 29.4 16.5 17.1 24.3 17.7 13.1 22.6 11.5 16.8 15.6 27.3 22.6 15.9 19.7 17.0 25.0 112.2 36.0 10.0 3.4 12.0 24.0 12.3 11.0 14.0 CHEK1 CHK1 ENSG00000149554 "Checkpoint kinase 1" O14757 11 125625665-125676255 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.7;lymphoid tissue: 20.7;seminal vesicle: 29.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;Erythroid cells: 34.5;Extravillous trophoblasts: 35.6;Spermatocytes: 48.9;Spermatogonia: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 6.2" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 6.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044364 Supported Nucleoplasm,Vesicles NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Vesicles "HPA044364: AB_2678913" "unprognostic (6.74e-2)" "unprognostic (3.63e-1)" "prognostic favorable (3.62e-4)" "unprognostic (5.54e-2)" "unprognostic (2.17e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.70e-6)" "unprognostic (3.95e-3)" "unprognostic (1.26e-3)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.10e-6)" "unprognostic (1.75e-1)" "prognostic unfavorable (1.04e-8)" "unprognostic (2.89e-2)" "unprognostic (2.64e-1)" "unprognostic (8.16e-2)" "unprognostic (1.33e-1)" 1.6 1.3 0.7 8.2 1.0 25.7 2.6 0.6 1.3 1.7 0.5 7.9 6.8 1.7 6.7 4.1 1.1 1.7 0.9 0.7 0.9 2.2 2.1 1.3 14.9 0.7 0.8 1.8 2.0 13.2 1.7 4.8 0.8 1.6 8.7 0.7 1.5 29.8 0.6 3.6 7.3 3.4 0.6 2.2 2.6 8.9 1.2 20.7 1.0 1.3 13.9 3.3 2.1 0.8 48.5 37.0 81.1 47.4 13.5 28.9 35.7 61.1 28.7 41.6 40.1 88.0 100.3 120.7 63.5 24.9 53.7 52.6 54.2 33.2 50.1 81.4 24.8 224.2 27.2 44.7 4.3 121.1 39.6 15.7 6.0 47.6 36.0 19.9 44.7 84.1 117.3 102.7 51.4 23.8 181.3 65.0 86.1 77.1 33.2 104.7 74.4 67.2 37.9 63.2 50.5 53.6 45.2 35.4 15.2 57.3 93.9 40.6 28.4 51.0 47.3 29.6 60.8 21.9 45.4 187.5 20.5 86.6 67.6 1.7 0.2 0.0 0.4 0.1 0.2 0.7 1.6 0.4 0.6 0.3 0.4 0.3 1.1 0.3 0.1 0.7 6.2 0.4 0.7 1.0 0.6 1.3 0.7 0.9 0.7 0.8 0.8 0.6 1.2 0.8 1.1 3.2 0.5 1.6 5.5 6.2 3.9 5.8 5.2 1.7 3.9 6.0 4.6 32.9 4.1 7.3 0.0 17.3 6.0 4.5 3.9 3.4 7.8 5.5 8.0 3.5 1.8 34.5 3.3 1.1 35.6 5.3 6.1 9.9 0.0 21.1 3.6 1.2 11.1 0.0 2.5 9.2 2.0 0.0 5.2 3.1 1.5 3.2 0.0 2.8 3.2 2.8 3.1 1.5 1.6 2.9 3.9 1.2 17.7 3.1 8.0 9.4 2.5 1.7 0.0 3.1 7.8 48.9 49.8 9.5 4.8 7.8 5.1 4.8 16.7 3.0 CHI3L1 "GP39, YK-40, YKL40" ENSG00000133048 "Chitinase 3 like 1" P36222 1 203178931-203186704 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Inflammatory response" Antimicrobial "Asthma, Cancer-related genes, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 232.4;brain: 239.4;liver: 447.8" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 88.7;Ductal cells: 88.9;Hepatocytes: 61.8;Hofbauer cells: 317.5" "Cancer enriched" "Detected in all" 8 "glioma: 1313.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 495 "neutrophil: 470.4" "Lineage enriched" "Detected in single" 495 "granulocytes: 470.4" "Cell line enhanced" "Detected in some" "ASC diff: 322.9;ASC TERT1: 712.9;HSkMC: 637.0;THP-1: 1068.4;U-138 MG: 303.5;U-87 MG: 303.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 10 "olfactory bulb: 16.0" HPA077365 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 25100000 180000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 15: Liver - Metabolism" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" Vesicles "HPA077365: " "unprognostic (2.11e-3)" "unprognostic (1.21e-1)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.01e-3)" "unprognostic (8.81e-2)" "unprognostic (2.09e-1)" "unprognostic (1.48e-1)" "unprognostic (4.46e-2)" "unprognostic (1.30e-1)" "unprognostic (7.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-2)" "unprognostic (3.43e-2)" "unprognostic (1.14e-2)" "unprognostic (9.39e-3)" 79.8 2.0 58.9 138.9 75.9 232.4 62.8 55.3 94.7 30.5 56.8 6.5 0.4 19.5 1.0 14.4 23.4 3.0 9.8 47.4 129.6 60.9 447.8 38.4 32.4 239.4 112.8 6.6 13.8 0.2 134.5 10.1 135.6 13.7 2.0 50.9 99.4 0.9 21.0 75.6 16.8 6.8 70.0 13.9 9.7 1.0 156.4 12.4 15.0 1.0 36.9 97.8 9.1 70.8 0.8 0.0 0.0 0.3 322.9 712.9 0.0 0.0 0.2 0.0 0.0 75.3 0.2 0.1 1.2 0.4 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 8.3 0.3 0.3 637.0 0.0 1.9 0.3 30.8 0.0 0.0 0.0 1.0 0.2 0.3 0.0 5.8 2.7 0.0 0.0 0.0 0.1 15.4 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.2 0.0 1068.4 0.0 303.5 1.6 0.0 0.4 2.3 41.9 0.3 303.7 1.2 0.2 0.0 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 470.4 0.0 0.9 0.0 0.0 1.3 58.9 75.9 55.3 94.7 47.4 129.6 239.4 112.8 135.6 70.0 156.4 70.8 0.7 6.4 42.8 20.5 0.1 4.2 47.1 88.7 0.0 0.1 29.8 21.5 1.0 2.8 17.3 27.6 0.0 1.3 0.6 0.0 0.0 88.9 0.0 4.8 2.2 2.1 0.0 0.4 1.1 0.0 1.1 18.6 0.0 7.2 0.0 0.0 0.0 61.8 317.5 0.0 0.1 0.0 6.1 0.8 0.4 0.0 0.9 23.7 14.2 0.0 1.0 45.1 0.0 0.0 0.1 2.0 0.0 0.0 1.4 4.2 0.0 0.2 3.4 2.8 0.0 1.0 2.3 0.0 0.0 1.5 1.1 0.8 0.9 0.0 0.0 2.2 CHIC2 BTL ENSG00000109220 "Cysteine rich hydrophobic domain 2" Q9UKJ5 4 54009789-54064605 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 348.7;Suprabasal keratinocytes: 373.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 365.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA026784, HPA076603" Uncertain Enhanced "Vesicles,Plasma membrane" NA Yes "Cluster 38: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 30: Epithelial cell lines - Translation" "Cluster 28: Keratinocytes - Keratinization" "Vesicles, Plasma membrane" "HPA026782: AB_1846654, HPA026784: AB_2732433, HPA076603: AB_2732317" "unprognostic (4.56e-2)" "unprognostic (2.24e-3)" "unprognostic (3.47e-3)" "unprognostic (9.58e-2)" "unprognostic (1.49e-1)" "unprognostic (2.25e-2)" "unprognostic (7.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (2.94e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (2.89e-1)" "unprognostic (1.77e-1)" "unprognostic (4.56e-2)" "unprognostic (9.40e-2)" 20.8 15.9 9.1 12.9 8.5 27.1 18.1 12.6 9.6 16.0 12.1 12.4 12.3 12.3 10.3 27.4 12.1 20.5 15.1 8.6 9.2 14.2 20.3 19.7 14.7 8.6 8.5 13.0 9.9 6.5 9.3 13.5 9.0 12.9 8.9 5.9 15.2 5.7 9.8 27.5 13.2 10.5 7.8 17.3 12.9 39.6 9.2 21.9 11.9 6.6 13.3 15.1 18.1 9.7 25.4 4.6 12.8 11.9 21.5 16.8 13.1 34.6 36.1 20.1 20.3 18.1 22.0 21.4 29.5 22.0 17.2 7.7 17.9 25.1 22.0 11.9 9.5 11.7 4.2 13.6 65.1 19.2 23.4 22.6 19.8 30.3 45.3 38.3 30.0 22.2 13.0 15.4 40.6 7.1 22.3 30.7 8.7 11.2 16.9 14.3 7.3 8.4 23.3 8.1 19.7 18.3 8.3 12.2 26.6 18.3 6.1 26.8 51.3 25.2 19.9 36.6 21.4 18.4 9.5 17.2 18.7 18.7 18.7 365.5 79.3 171.5 60.1 64.7 57.7 41.3 60.0 68.6 55.9 40.1 54.6 59.6 325.0 74.2 68.3 47.0 81.5 77.9 9.1 8.5 12.6 9.6 8.6 9.2 8.6 8.5 9.0 7.8 9.2 9.7 58.1 6.4 7.3 35.6 42.5 348.7 95.5 61.0 68.3 8.1 61.6 33.5 4.1 15.7 25.9 7.3 8.4 27.8 57.8 27.2 17.6 42.8 55.4 64.1 58.0 64.3 25.8 72.6 39.7 28.0 38.7 80.8 32.6 34.2 36.3 36.8 38.6 23.9 24.7 13.5 40.2 21.9 40.7 36.4 144.2 13.4 17.1 50.3 67.6 49.6 32.6 9.0 28.8 74.4 23.2 61.8 42.1 24.5 40.2 85.1 41.9 29.2 56.0 7.2 19.7 53.9 45.1 163.5 89.9 97.4 373.8 47.7 65.8 39.8 21.0 135.9 CHST7 "C6ST-2, C6ST2" ENSG00000147119 "Carbohydrate sulfotransferase 7" Q9NS84 X 46573765-46598496 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 35.3" "Cell type enhanced" "Detected in many" "Langerhans cells: 45.4;monocytes: 55.5;Peritubular cells: 60.2;Sertoli cells: 52.6;Skeletal myocytes: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 18.5" "Group enriched" "Detected in many" 10 "granulocytes: 10.9;monocytes: 10.2;T-cells: 18.5" "Cell line enhanced" "Detected in many" "EFO-21: 22.8;NTERA-2: 20.5;PC-3: 17.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003919, HPA030503" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 9800 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Vesicles" "HPA003919: AB_10601258, HPA030503: " "unprognostic (3.16e-1)" "prognostic favorable (7.20e-4)" "unprognostic (1.11e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" "unprognostic (7.85e-2)" "unprognostic (9.82e-3)" "unprognostic (3.52e-2)" "unprognostic (2.61e-1)" "unprognostic (2.81e-1)" "unprognostic (2.39e-3)" "unprognostic (6.71e-2)" "unprognostic (1.19e-1)" "unprognostic (8.85e-3)" "unprognostic (8.28e-2)" "unprognostic (1.50e-1)" "unprognostic (4.39e-2)" 13.2 3.4 5.4 1.7 7.3 2.5 7.5 6.4 7.0 11.2 3.7 3.7 0.8 5.8 0.4 2.5 4.9 1.9 17.4 5.4 7.1 4.0 7.5 3.6 1.8 6.1 7.3 35.3 2.0 1.2 4.2 2.0 6.0 4.1 0.8 0.9 3.5 1.4 4.4 7.3 4.0 1.4 4.7 10.2 3.4 2.1 8.0 1.4 5.8 3.9 0.7 4.5 7.7 4.0 5.5 4.7 3.9 3.5 10.8 7.5 0.2 7.6 5.4 2.0 2.6 1.2 2.1 0.0 22.8 3.1 1.3 4.1 3.8 1.3 1.7 3.2 8.1 1.1 0.3 4.1 16.6 1.9 0.1 2.5 1.1 3.8 3.1 3.4 6.2 2.5 0.0 4.7 1.5 2.6 0.7 2.4 20.5 0.4 17.0 3.6 3.2 10.3 5.5 0.2 8.8 3.4 1.1 0.2 0.9 9.6 1.3 0.4 1.4 6.1 0.6 3.3 3.5 11.0 2.4 1.7 6.8 0.1 0.4 2.4 2.2 0.7 1.5 7.1 1.4 1.2 5.8 2.8 1.2 0.6 1.2 1.1 10.9 0.6 10.2 0.8 18.5 1.9 5.4 7.3 6.4 7.0 5.4 7.1 6.1 7.3 6.0 4.7 8.0 4.0 33.8 0.0 3.1 22.9 2.5 12.4 2.0 4.8 1.2 0.8 2.2 3.7 7.4 10.0 2.6 1.8 0.0 5.3 11.5 1.7 1.9 2.8 0.0 3.6 20.8 16.3 0.0 0.0 0.9 2.5 4.3 23.6 0.0 1.6 0.0 19.7 15.7 4.5 11.5 3.3 4.1 2.9 0.0 14.2 45.4 0.3 19.0 14.1 14.2 4.7 55.5 5.2 4.1 13.0 1.0 1.8 1.5 60.2 4.7 6.7 0.7 2.1 1.9 0.8 52.6 43.1 11.2 0.5 1.3 1.3 13.2 1.4 9.9 11.4 0.9 3.3 CIC KIAA0306 ENSG00000079432 "Capicua transcriptional repressor" Q96RK0 19 42268537-42295797 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026388, HPA044341, HPA064725" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm Vesicles "CAB026388: , HPA044341: AB_2678901, HPA064725: AB_2685335" "unprognostic (2.02e-2)" "unprognostic (4.08e-1)" "unprognostic (1.41e-2)" "unprognostic (3.54e-3)" "unprognostic (3.67e-1)" "unprognostic (4.17e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-1)" "unprognostic (4.87e-1)" "unprognostic (1.85e-2)" "unprognostic (1.72e-3)" "unprognostic (3.10e-1)" "unprognostic (4.23e-2)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (1.88e-2)" "unprognostic (1.56e-1)" 41.9 41.5 43.3 23.4 36.1 31.8 42.7 40.7 47.4 53.8 2.3 45.6 15.6 62.3 8.7 34.3 49.1 16.1 35.4 36.3 27.7 41.7 44.6 40.8 24.2 39.5 27.8 70.1 39.4 12.2 58.7 12.6 35.7 40.5 5.8 13.5 35.4 18.7 45.2 47.2 36.9 16.0 17.4 46.9 38.6 74.6 29.4 21.0 44.3 15.3 13.5 39.6 37.5 32.5 31.8 56.7 26.4 34.4 16.6 30.7 10.7 22.8 22.5 22.9 20.9 18.5 21.4 26.7 20.8 21.8 19.6 16.6 14.6 38.9 7.6 61.9 19.6 22.2 44.7 23.0 20.1 11.8 50.9 36.7 25.5 24.4 15.5 24.8 19.2 15.9 21.8 52.5 13.3 31.9 25.1 25.6 16.2 12.6 5.8 21.5 21.2 14.3 20.5 25.3 33.6 27.1 23.7 15.7 21.6 8.3 18.3 25.8 27.5 52.0 43.7 15.9 33.2 41.0 29.8 18.1 37.9 19.4 32.6 0.0 0.5 0.1 0.7 0.8 0.5 0.5 0.3 0.5 0.5 0.6 0.2 0.4 1.1 0.2 0.6 0.6 0.1 0.6 43.3 36.1 40.7 47.4 36.3 27.7 39.5 27.8 35.7 17.4 29.4 32.5 27.8 0.0 3.0 15.7 13.7 25.9 12.8 16.2 27.9 38.3 20.7 16.9 7.8 21.5 7.1 9.2 20.9 6.9 9.1 14.2 3.9 13.4 5.1 14.6 14.9 20.3 14.8 8.4 8.0 15.3 5.1 11.2 17.9 22.3 12.0 11.1 13.9 19.2 11.9 42.1 9.0 10.1 10.2 18.0 23.6 3.3 21.8 15.3 24.9 7.5 13.0 18.4 8.2 4.0 10.3 16.9 11.2 18.0 10.4 11.3 10.6 6.2 8.0 18.8 26.3 19.9 17.6 19.4 20.2 16.5 19.5 13.0 13.2 14.2 10.6 11.9 CLCF1 "BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6" ENSG00000175505 "Cardiotrophin like cytokine factor 1" Q9UBD9 11 67364168-67374177 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 41.8;Glandular and luminal cells: 104.9;Pancreatic endocrine cells: 56.2;Prostatic glandular cells: 56.4;Urothelial cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 57.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA042444 Uncertain Approved "Nuclear bodies,Vesicles" "Secreted to blood" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" "Nuclear bodies, Vesicles" "HPA042444: AB_10794527" "unprognostic (2.68e-1)" "unprognostic (7.87e-3)" "unprognostic (6.21e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.47e-2)" "unprognostic (5.08e-2)" "unprognostic (2.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (2.37e-1)" 16.2 6.0 1.3 8.0 0.5 13.7 5.3 0.0 1.5 13.9 0.9 13.4 1.4 16.6 1.0 4.4 17.1 17.7 8.8 1.0 0.6 19.0 4.2 9.3 5.3 1.4 0.5 6.7 6.5 0.2 6.5 4.2 0.4 7.2 1.7 1.4 9.1 1.8 1.5 2.6 9.4 8.3 0.0 8.1 11.2 1.9 2.1 0.7 9.7 1.9 4.4 18.1 7.6 0.2 15.1 31.4 2.2 9.7 4.2 5.8 0.0 20.9 11.6 14.4 7.0 5.1 40.3 9.1 17.1 26.8 17.5 10.3 0.4 10.7 6.3 0.5 0.3 0.1 23.9 4.0 13.6 1.9 2.4 7.6 2.6 15.0 6.5 27.4 3.1 0.0 3.5 0.4 15.0 12.0 0.1 6.8 8.1 18.9 28.8 0.9 4.8 0.5 22.7 0.8 0.1 1.6 57.8 2.2 1.3 4.4 1.3 2.5 12.5 27.6 11.6 35.4 31.5 2.0 0.1 1.0 35.4 1.8 11.1 0.0 0.9 15.2 10.5 3.4 6.2 10.8 4.8 8.3 1.3 13.8 0.1 3.5 0.3 0.2 10.5 0.0 1.1 3.2 1.3 0.5 0.0 1.5 1.0 0.6 1.4 0.5 0.4 0.0 2.1 0.2 4.2 16.0 4.8 1.3 10.6 3.7 25.9 6.5 1.8 0.0 14.5 2.4 0.8 25.8 9.6 7.3 0.0 0.4 10.0 3.8 1.9 24.0 1.8 41.8 19.4 6.2 1.2 0.0 0.7 11.8 0.6 14.0 5.1 104.9 3.8 2.1 2.9 1.0 1.2 0.0 0.5 2.3 6.1 0.3 10.7 4.7 3.4 6.7 8.8 1.0 6.5 1.7 3.1 0.5 0.1 56.2 14.3 0.0 9.5 56.4 0.2 5.2 1.7 0.3 0.0 32.6 10.4 0.3 0.9 1.6 4.4 0.1 9.7 0.1 1.5 65.2 CLDN7 "CEPTRL2, CPETRL2, Hs.84359" ENSG00000181885 "Claudin 7" O95471 17 7259903-7263983 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 341.3;intestine: 341.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1391.1;Pancreatic endocrine cells: 822.1;Paneth cells: 1276.4;Proximal enterocytes: 1390.9;Urothelial cells: 975.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 84.1;CACO-2: 90.2;CAPAN-2: 173.2;HaCaT: 364.9;MCF7: 129.8;OE19: 139.6;SK-BR-3: 150.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB013063, HPA014703, HPA073662" Enhanced Approved "Vesicles,Cell Junctions" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "Cell Junctions" "CAB013063: , HPA014703: AB_1846873, HPA073662: " "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (4.12e-2)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (3.41e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-3)" "unprognostic (8.34e-2)" "unprognostic (4.89e-3)" "unprognostic (1.62e-2)" "prognostic favorable (8.96e-11)" "prognostic favorable (4.09e-4)" "unprognostic (1.87e-1)" "prognostic favorable (1.85e-4)" "unprognostic (1.62e-1)" 6.7 8.0 0.4 17.6 0.4 0.2 31.2 0.5 0.6 47.3 0.4 341.0 146.7 4.8 43.9 341.3 41.3 27.4 2.7 0.4 0.4 123.8 40.2 61.8 0.8 0.6 0.5 1.5 108.5 49.0 31.1 14.2 0.6 44.5 128.6 1.1 169.2 30.0 1.5 13.1 248.9 6.2 0.5 5.7 5.2 1.9 0.6 2.4 76.7 0.0 21.2 40.5 96.3 0.9 10.8 1.1 0.2 0.3 0.0 0.6 84.1 0.3 0.3 0.0 0.0 90.2 173.2 0.1 3.2 0.4 0.4 364.9 0.1 11.2 0.0 0.1 1.9 0.1 2.4 0.0 6.5 0.1 0.8 1.5 17.3 0.0 0.6 0.0 8.1 0.1 1.0 0.3 0.1 129.8 0.1 1.2 0.6 139.6 3.4 0.2 0.0 2.5 0.1 0.0 20.4 0.4 1.1 150.2 0.0 6.6 55.0 1.3 16.8 0.2 0.6 0.7 0.2 0.1 0.3 0.1 1.2 0.0 0.3 0.0 0.3 0.0 0.5 0.8 1.3 0.1 0.3 0.8 0.4 0.9 0.9 1.7 0.0 0.7 0.0 0.0 0.3 0.5 0.4 0.4 0.5 0.6 0.4 0.4 0.6 0.5 0.6 0.5 0.6 0.9 4.4 112.2 55.6 0.0 7.4 2.0 295.4 316.3 66.6 0.7 200.4 102.4 0.6 240.2 550.3 321.8 8.4 281.3 3.1 1391.1 39.2 787.5 0.1 210.1 26.6 9.0 326.8 4.0 0.0 790.0 342.7 5.2 15.3 225.5 5.7 0.1 3.6 41.2 33.7 0.0 0.0 741.7 362.2 4.1 6.4 0.2 1.2 11.0 24.9 1.9 11.0 1.6 0.0 0.0 0.0 822.1 1276.4 0.0 0.5 406.5 1390.9 78.6 498.5 6.7 0.0 0.2 38.6 0.4 3.5 366.1 2.6 588.9 10.2 1.0 691.9 975.8 CLDN9 ENSG00000213937 "Claudin 9" O95484 16 3012923-3014505 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.8;pituitary gland: 25.2" "Cell type enhanced" "Detected in some" "Cholangiocytes: 15.7;Ductal cells: 9.5;Endometrial ciliated cells: 8.6;Pancreatic endocrine cells: 8.1;Respiratory ciliated cells: 18.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 4.7;CAPAN-2: 7.3;MCF7: 24.2;SCLC-21H: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA076613 Supported "Vesicles,Cell Junctions" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Cell Junctions" Vesicles "HPA076613: AB_2686808" "unprognostic (7.93e-2)" "unprognostic (1.40e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (2.24e-6)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.13e-1)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "unprognostic (8.97e-3)" "unprognostic (4.51e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.55e-2)" 0.3 0.2 3.3 0.2 4.4 2.7 0.2 10.8 5.6 0.3 2.4 0.5 0.7 0.0 0.0 0.1 1.2 0.2 1.7 3.3 3.6 1.5 5.2 1.2 0.0 5.3 4.0 0.0 6.4 1.4 25.2 0.1 5.6 0.3 0.0 1.9 0.6 0.0 1.2 0.2 0.5 0.0 3.7 2.3 0.5 0.3 4.1 0.3 0.4 0.1 0.0 0.2 0.1 5.2 4.7 0.2 0.0 2.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 7.3 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.0 24.2 0.0 2.0 0.1 0.3 0.2 0.0 0.0 0.2 0.2 0.1 20.8 0.0 0.6 0.9 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.4 10.8 5.6 3.3 3.6 5.3 4.0 5.6 3.7 4.1 5.2 0.0 0.0 0.0 0.0 0.0 0.1 2.6 1.4 0.0 1.3 1.1 0.4 0.3 15.7 2.3 0.0 0.0 0.3 0.0 0.6 0.0 9.5 0.1 8.6 0.3 0.1 1.8 0.0 0.8 1.7 0.9 0.1 0.0 2.7 0.0 0.0 0.4 0.3 0.1 0.0 0.4 0.4 2.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 3.4 8.1 1.5 0.0 0.0 1.2 0.4 0.1 18.1 0.7 0.0 0.0 0.6 0.1 0.2 0.0 0.4 1.1 0.1 0.0 0.6 1.8 CLEC16A "Gop-1, KIAA0350" ENSG00000038532 "C-type lectin domain containing 16A" Q2KHT3 16 10944564-11182186 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 130.9;Early spermatids: 118.7;Excitatory neurons: 93.3;Inhibitory neurons: 135.1;Late spermatids: 84.8;Oligodendrocyte precursor cells: 69.4;Oligodendrocytes: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HDLM-2: 110.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035814, HPA035815, HPA061385" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 43: Testis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Vesicles" "HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: AB_2684498" "unprognostic (3.41e-1)" "unprognostic (4.58e-2)" "unprognostic (7.36e-2)" "unprognostic (1.56e-2)" "unprognostic (3.44e-1)" "unprognostic (1.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.22e-3)" "unprognostic (4.54e-2)" "unprognostic (7.78e-3)" "unprognostic (2.08e-1)" "unprognostic (3.49e-1)" "prognostic favorable (2.92e-6)" "unprognostic (2.69e-1)" "unprognostic (1.79e-1)" "unprognostic (8.22e-2)" "unprognostic (3.03e-1)" 10.2 12.8 12.1 7.2 13.4 13.2 9.4 16.7 17.3 11.2 23.6 9.5 8.2 9.0 6.9 13.9 9.4 4.8 14.6 11.3 11.1 16.6 16.2 12.8 9.3 13.8 14.5 8.2 8.9 11.7 17.3 7.0 13.8 11.3 5.9 11.5 9.1 5.7 17.5 14.2 10.8 6.2 9.7 12.4 10.4 46.8 21.0 10.9 13.3 8.3 8.8 9.1 10.4 11.7 11.6 12.1 9.0 11.9 14.8 10.3 8.0 11.7 11.4 9.6 12.5 13.5 21.1 22.8 26.6 14.3 10.6 10.1 11.6 21.7 12.3 110.3 12.5 10.4 16.4 14.4 10.4 11.5 21.5 12.3 10.4 15.9 13.4 8.8 13.3 12.4 17.6 13.8 11.5 19.0 18.2 9.1 7.2 10.0 9.5 24.6 7.6 13.5 20.1 8.4 11.5 15.3 16.8 17.1 9.1 10.4 12.1 17.7 14.2 12.4 16.1 18.3 10.4 9.7 9.2 18.7 15.5 16.4 13.1 2.7 1.9 1.4 2.2 1.5 1.3 1.7 1.8 1.5 1.5 2.8 2.1 1.8 2.6 1.8 3.0 2.0 1.4 1.1 12.1 13.4 16.7 17.3 11.3 11.1 13.8 14.5 13.8 9.7 21.0 11.7 7.1 16.0 10.0 130.9 12.8 7.1 3.7 5.9 11.4 11.7 5.2 5.1 5.9 8.6 8.8 3.7 37.5 3.4 5.5 12.1 0.0 6.0 118.7 7.5 6.0 6.1 7.7 8.6 93.3 6.4 2.6 6.2 9.2 8.0 8.2 5.7 9.7 12.6 4.8 11.8 135.1 7.9 6.1 5.4 6.2 84.8 5.6 6.8 3.6 40.3 8.6 3.9 4.1 69.4 72.9 6.5 4.0 8.6 8.8 3.5 10.3 3.5 8.9 18.3 0.0 7.4 4.5 27.1 8.4 13.4 8.2 3.8 8.6 3.3 6.7 4.9 CLINT1 "CLINT, ENTH, EPNR, KIAA0171" ENSG00000113282 "Clathrin interactor 1" Q14677 5 157785743-157859145 "Plasma proteins, Predicted intracellular proteins, Transporters" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "basophil: 749.5" "Lineage enriched" "Detected in all" 10 "granulocytes: 749.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043280, HPA056947" Supported Supported Nucleoplasm,Vesicles NA NA 540000 "Cluster 46: Basophils - DNA binding" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Vesicles Nucleoplasm "HPA043280: AB_10793944, HPA056947: AB_2683283" "unprognostic (1.92e-2)" "unprognostic (6.93e-2)" "prognostic favorable (2.95e-4)" "unprognostic (7.23e-2)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (2.53e-1)" "unprognostic (8.13e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.88e-5)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.56e-1)" 28.6 34.4 10.3 42.8 11.9 101.1 31.4 10.6 14.8 36.4 17.7 53.9 68.3 26.4 54.2 72.0 37.8 61.4 34.2 11.8 12.7 70.4 89.5 36.3 49.4 11.8 11.9 26.9 49.3 113.2 17.8 47.1 11.4 29.5 53.4 16.0 50.8 42.4 53.1 39.7 55.7 31.9 11.0 31.0 69.2 20.3 12.4 50.7 56.0 41.0 73.8 64.5 38.8 11.4 65.6 91.7 64.3 59.8 86.3 71.0 91.6 89.7 87.5 83.4 115.9 128.7 100.0 121.3 100.3 82.6 112.0 95.8 87.1 100.4 120.7 57.9 70.4 80.6 80.4 65.2 85.5 112.9 105.6 52.5 75.6 94.7 105.6 53.6 80.0 69.6 70.6 66.1 69.9 56.7 88.7 60.5 67.8 63.6 93.9 78.8 96.9 103.0 84.8 115.4 56.6 62.1 64.5 111.7 87.4 81.2 76.4 78.0 83.7 74.6 56.3 69.5 89.4 76.1 77.9 154.4 61.0 126.2 67.5 749.5 46.5 179.7 43.6 49.2 75.2 47.5 41.4 43.7 62.7 46.2 35.9 38.8 17.6 58.6 53.4 48.5 66.2 53.1 10.3 11.9 10.6 14.8 11.8 12.7 11.8 11.9 11.4 11.0 12.4 11.4 68.6 60.9 132.9 25.1 76.0 57.1 83.7 69.4 80.2 21.6 74.4 44.2 103.9 105.8 137.8 68.0 8.4 45.1 73.8 73.5 95.9 93.4 4.1 116.5 82.4 52.8 54.5 54.9 31.9 64.0 71.9 71.8 119.3 141.9 84.7 40.2 21.0 86.8 30.5 11.8 29.0 78.9 38.7 42.9 87.8 5.6 47.2 73.0 35.6 28.1 94.1 25.5 73.2 39.2 31.4 53.7 62.6 28.6 158.3 92.5 50.3 94.5 148.5 19.0 39.5 67.2 61.9 44.2 40.2 156.3 78.3 68.3 65.5 82.0 99.0 271.5 CLOCK "bHLHe8, KAT13D, KIAA0334" ENSG00000134852 "Clock circadian regulator" O15516 4 55427903-55546909 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001867, HPA027565" Supported Enhanced Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA001867: AB_1078537, HPA027565: AB_1846975" "unprognostic (1.30e-2)" "unprognostic (9.02e-2)" "unprognostic (4.25e-3)" "unprognostic (2.48e-1)" "unprognostic (3.94e-2)" "unprognostic (2.00e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (3.01e-2)" "unprognostic (5.96e-2)" "unprognostic (4.07e-2)" "unprognostic (8.31e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "unprognostic (7.16e-2)" 5.5 6.1 3.7 4.2 4.2 1.3 5.9 8.9 5.4 8.0 5.5 5.1 4.9 6.9 5.7 9.2 5.3 4.3 7.5 4.7 5.3 6.5 5.5 4.6 2.9 2.8 3.7 6.2 5.1 10.3 5.5 5.5 3.3 6.2 5.7 11.6 4.6 6.1 9.8 6.8 5.6 7.1 3.8 4.5 6.9 14.1 3.8 3.0 10.1 9.2 3.7 5.6 6.8 5.0 20.0 9.1 7.5 11.6 11.8 11.5 3.6 18.7 16.4 12.9 12.7 5.1 14.8 5.1 9.9 22.8 10.3 15.9 9.5 15.4 23.2 6.9 3.1 4.4 9.4 6.7 10.3 7.0 4.7 6.7 15.8 18.8 18.7 10.4 13.1 4.6 10.1 10.1 21.3 10.6 4.0 4.1 5.0 16.3 9.4 2.5 8.7 3.3 11.0 10.9 7.6 6.2 13.5 16.7 8.9 6.2 5.7 4.2 17.1 18.4 19.5 6.0 26.6 9.1 7.5 3.1 15.6 5.8 14.6 0.0 0.7 0.2 0.7 0.7 1.3 0.4 0.9 0.8 1.1 0.7 0.4 0.6 0.2 0.9 0.7 0.5 0.9 0.4 3.7 4.2 8.9 5.4 4.7 5.3 2.8 3.7 3.3 3.8 3.8 5.0 32.2 41.7 27.7 49.3 15.2 31.1 21.8 28.5 27.9 63.4 21.5 14.9 55.2 14.3 27.4 14.7 43.8 11.3 11.9 21.5 1.9 13.6 34.5 34.2 39.9 32.1 39.7 3.8 95.9 16.5 6.8 28.0 25.0 32.0 3.8 16.6 28.9 27.7 11.6 33.7 114.6 18.5 18.3 17.0 26.1 16.9 23.9 16.9 10.6 70.3 14.0 26.7 19.6 82.0 93.1 28.3 13.2 36.1 18.5 34.0 29.6 19.7 25.2 41.4 13.1 36.5 28.2 64.9 72.5 55.1 37.5 5.2 14.0 21.7 15.6 51.6 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 18.2;brain: 26.7;ovary: 64.7" "Cell type enriched" "Detected in many" 4 "Excitatory neurons: 552.2" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 32.7;SCLC-21H: 14.5;SuSa: 42.7;THP-1: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" Yes No 130000 "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: AB_2684615" "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 18.2 4.8 17.3 0.3 15.3 0.0 8.8 0.0 26.7 4.2 0.0 1.4 0.5 5.1 0.7 1.0 4.7 2.1 6.1 23.4 0.0 4.3 0.8 1.1 2.7 13.3 3.1 64.7 1.6 0.8 0.9 0.9 9.1 5.3 0.8 2.7 1.3 1.1 1.6 2.0 1.3 6.8 0.0 0.1 1.0 0.6 0.0 0.7 2.8 2.2 0.2 1.6 3.2 15.6 0.0 0.0 5.1 0.0 2.2 0.6 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.1 0.0 32.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 2.1 0.0 0.0 0.0 42.7 2.2 9.4 0.0 1.0 0.5 1.4 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 15.3 0.0 26.7 23.4 0.0 13.3 3.1 9.1 0.0 0.0 15.6 2.1 0.0 0.0 18.3 0.0 0.5 0.3 0.0 8.6 1.8 10.9 2.2 8.0 0.0 0.6 3.7 0.0 0.2 0.1 0.0 1.9 0.2 39.8 0.5 8.9 0.8 0.0 0.0 552.2 0.2 0.0 9.1 0.0 0.2 0.0 25.0 2.2 0.0 0.1 0.0 111.5 0.0 0.0 0.3 1.5 31.1 28.0 0.8 0.0 5.6 0.0 0.8 0.0 108.6 29.4 0.0 0.0 0.7 0.0 5.0 0.0 32.3 3.0 3.8 0.0 28.3 13.7 0.8 0.8 0.4 0.0 0.0 0.7 0.5 0.0 0.3 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15675012 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "kidney: 486.4" "Cell type enriched" "Detected in some" 16 "Proximal tubular cells: 885.4" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.5;hTERT-HME1: 5.2;RPTEC TERT1: 8.5;SuSa: 5.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Endoplasmic reticulum, Vesicles" "HPA048543: AB_2680436" "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favorable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favorable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.5 0.8 0.5 0.0 0.6 0.3 2.0 0.7 0.8 1.0 16.6 0.6 1.3 1.5 3.1 0.6 2.4 3.7 1.1 0.7 0.6 486.4 61.5 1.7 0.4 0.6 0.5 3.2 5.3 10.5 0.6 0.5 0.6 1.5 0.3 1.2 0.8 1.3 0.1 1.2 0.4 0.4 0.4 0.2 10.9 1.0 0.5 0.8 4.1 0.1 0.3 0.8 0.4 0.9 2.3 1.8 1.1 0.3 0.7 1.0 0.7 0.0 0.0 0.1 0.1 0.1 0.5 0.1 1.6 0.2 0.2 8.5 0.7 2.3 0.0 0.3 0.7 0.2 0.0 0.8 1.0 0.0 0.0 0.2 2.0 0.3 5.2 0.6 0.0 2.1 0.5 0.4 0.2 2.8 0.1 0.3 2.9 0.8 2.6 0.2 0.3 0.9 8.5 0.1 1.1 1.0 0.6 0.1 1.8 5.1 0.6 0.2 0.0 0.2 0.4 0.3 0.0 0.4 0.2 0.3 0.6 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.1 0.1 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.7 0.8 0.7 0.6 0.6 0.5 0.6 0.4 0.5 0.9 0.1 0.0 4.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 3.0 3.2 0.0 0.0 1.8 27.6 0.0 2.1 0.0 0.0 54.8 25.1 0.0 2.8 0.6 0.1 0.0 0.0 0.0 0.6 0.5 0.3 0.0 3.3 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 885.4 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 3.7 0.5 0.0 0.0 CLUAP1 "CFAP22, FAP22, FLJ13297, IFT38, KIAA0643" ENSG00000103351 "Clusterin associated protein 1" Q96AJ1 16 3500976-3539048 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 215.5;Endometrial ciliated cells: 119.2;Respiratory ciliated cells: 181.3;Rod photoreceptor cells: 116.8;Spermatocytes: 150.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036976, HPA044191" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Vesicles "HPA036976: AB_10602209, HPA044191: AB_2678852" "unprognostic (1.78e-1)" "unprognostic (9.28e-3)" "unprognostic (1.21e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.57e-1)" "unprognostic (3.67e-1)" "unprognostic (4.53e-2)" "unprognostic (3.63e-2)" "unprognostic (2.04e-1)" "unprognostic (8.44e-2)" "unprognostic (3.13e-1)" "unprognostic (6.94e-3)" "unprognostic (5.11e-3)" "unprognostic (8.43e-2)" "unprognostic (2.07e-1)" "unprognostic (8.94e-3)" "unprognostic (1.12e-2)" 9.7 10.7 11.1 5.9 12.6 3.9 14.7 14.2 14.5 21.1 17.8 11.0 4.2 24.2 16.0 11.1 31.8 10.6 11.4 11.2 11.6 18.6 7.7 12.1 7.4 10.4 12.7 24.6 12.2 31.4 11.7 10.6 9.1 17.0 9.8 28.9 9.1 19.9 9.9 5.6 5.4 20.2 9.8 6.6 9.0 40.0 12.0 12.4 22.0 11.6 6.0 10.8 7.8 10.4 15.7 18.3 20.8 28.9 31.4 32.0 11.0 19.9 26.7 31.4 23.7 5.1 31.3 8.2 16.5 33.7 18.8 16.8 14.7 23.6 26.2 6.6 13.1 6.9 10.3 10.5 36.7 12.5 7.2 21.1 25.4 29.1 29.4 33.1 17.2 16.4 21.7 1.0 23.6 19.3 12.0 14.0 21.5 6.6 11.1 25.9 14.3 15.7 45.7 4.9 23.2 19.8 11.6 8.8 14.3 16.0 18.7 28.8 11.5 20.8 13.8 17.1 15.0 12.8 10.9 2.2 8.0 7.3 15.3 6.2 3.6 1.2 6.2 4.2 12.1 7.3 17.8 10.8 6.8 6.1 26.9 18.4 1.3 9.0 2.4 6.6 10.3 5.8 11.1 12.6 14.2 14.5 11.2 11.6 10.4 12.7 9.1 9.8 12.0 10.4 14.5 22.4 20.5 17.0 3.5 5.6 12.3 29.1 14.8 41.0 13.4 13.8 11.7 11.5 30.6 14.7 108.4 20.7 7.5 3.3 43.0 24.3 215.5 119.2 49.7 12.4 17.5 4.6 23.6 8.0 7.7 21.9 6.6 26.4 5.1 28.1 13.6 9.2 10.4 38.7 26.3 7.9 18.3 4.9 5.7 63.4 31.4 5.0 3.6 5.6 18.1 40.7 12.3 11.1 10.3 8.6 5.3 33.1 3.5 9.4 5.3 34.6 181.3 116.8 6.6 24.7 22.7 150.0 58.4 6.4 4.1 9.3 12.1 36.7 9.0 6.5 CLUH "CLU1, KIAA0664" ENSG00000132361 "Clustered mitochondria homolog" O75153 17 2689386-2712663 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "CACO-2: 266.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031505, HPA044346" Uncertain Supported "Nuclear bodies,Vesicles" NA NA 5500 "Cluster 7: Monocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 39: CACO-2 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "Nuclear bodies" "HPA031505: AB_2673912, HPA044346: AB_10962153" "unprognostic (3.48e-2)" "unprognostic (3.97e-2)" "unprognostic (9.02e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (2.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.84e-1)" "unprognostic (2.69e-2)" "unprognostic (5.64e-2)" "unprognostic (5.11e-2)" "prognostic favorable (1.92e-5)" "unprognostic (4.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-2)" "unprognostic (6.26e-2)" 30.8 56.7 13.8 18.1 12.7 14.3 28.5 16.3 18.3 19.8 19.7 45.9 46.6 21.3 1.9 67.7 19.2 15.4 80.8 14.5 11.2 50.6 135.0 19.6 14.6 14.6 13.2 17.0 50.4 15.6 20.3 9.0 15.3 24.7 13.2 7.2 32.1 11.8 127.8 47.5 34.2 8.5 9.3 25.2 35.1 25.2 17.3 6.4 25.2 52.9 11.1 29.6 29.2 11.2 69.5 131.9 8.9 33.3 20.2 14.1 99.9 34.9 13.0 41.9 31.0 266.2 30.0 122.6 41.5 19.4 26.9 127.6 45.3 52.9 14.7 43.6 86.4 68.0 112.2 93.9 17.1 53.7 44.1 22.6 29.7 48.9 24.7 9.4 20.5 43.3 81.8 42.2 11.7 79.8 69.6 58.0 28.2 35.8 67.8 104.7 37.0 70.8 26.0 117.3 43.9 32.6 40.0 129.4 44.4 6.6 72.7 31.3 33.7 33.7 44.9 92.2 80.5 18.2 22.9 49.7 35.4 73.2 41.6 0.0 2.2 0.0 1.7 3.1 1.3 2.2 1.0 0.9 2.4 2.2 2.3 2.1 0.2 0.6 2.0 2.7 1.5 0.9 13.8 12.7 16.3 18.3 14.5 11.2 14.6 13.2 15.3 9.3 17.3 11.2 5.8 6.4 20.9 20.9 6.5 30.5 12.0 11.7 16.5 18.5 23.5 22.7 42.1 41.5 16.7 18.4 22.9 9.7 7.6 47.8 11.7 18.4 1.8 12.7 10.8 8.5 25.8 22.1 9.9 18.3 8.2 6.8 22.4 24.6 1.3 18.1 6.8 122.1 13.1 8.4 11.4 38.8 14.2 10.3 6.3 4.0 5.0 7.9 21.4 4.7 7.4 6.5 2.1 7.5 6.2 19.6 21.2 6.0 11.7 22.9 39.2 35.1 14.1 17.1 6.6 12.3 11.3 8.6 17.5 42.4 35.5 8.2 7.2 43.3 68.3 22.5 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376773-23379772 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 182.4;choroid plexus: 49.5" "Cell type enhanced" "Detected in some" "Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 20.8" "Lineage enriched" "Detected in many" 19 "granulocytes: 20.8" "Cell line enriched" "Detected in some" 7 "HEL: 91.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 540000 "Cluster 34: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.1 1.0 75.6 0.5 119.1 8.2 0.9 123.8 101.7 2.8 49.5 5.8 0.5 0.8 1.1 1.2 1.2 2.1 22.7 73.9 85.2 0.5 0.3 1.5 0.2 150.9 106.2 0.8 0.2 0.1 0.6 0.7 135.2 2.1 0.8 2.3 2.2 3.2 3.1 0.7 1.7 0.8 113.4 2.8 1.4 0.1 110.2 0.1 0.5 0.9 0.0 1.2 2.6 182.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 91.8 0.0 0.0 0.2 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.2 20.8 0.7 0.9 0.1 0.4 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 4.2 0.0 0.0 1.0 0.4 30.0 75.6 119.1 123.8 101.7 73.9 85.2 150.9 106.2 135.2 113.4 110.2 182.4 0.5 0.0 0.0 6.5 0.4 1.0 0.1 0.0 1.2 0.2 1.3 5.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.4 0.0 0.0 93.7 5.4 0.0 1.5 32.0 0.0 20.6 106.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 3.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 CMTR1 "FTSJD2, ISG95, KIAA0082, MTr1" ENSG00000137200 "Cap methyltransferase 1" Q8N1G2 6 37433219-37482827 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 253.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029954, HPA029979, HPA029980" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094" "unprognostic (1.33e-1)" "unprognostic (2.12e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.00e-1)" "unprognostic (3.72e-1)" "unprognostic (1.68e-2)" "unprognostic (6.43e-3)" "unprognostic (2.95e-2)" "unprognostic (9.17e-2)" "unprognostic (5.24e-3)" "unprognostic (1.50e-3)" "unprognostic (3.00e-3)" "unprognostic (3.27e-2)" "unprognostic (9.72e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-2)" 20.1 22.1 21.0 19.2 21.2 30.9 19.5 20.3 22.9 23.6 18.6 26.8 18.1 23.1 17.4 16.9 22.4 15.1 25.1 20.7 22.0 19.4 21.8 20.4 25.3 21.5 21.0 28.0 22.1 27.5 26.0 24.9 20.3 21.9 15.2 28.5 21.7 18.4 30.1 23.2 23.2 20.4 20.2 28.8 21.9 62.9 23.5 30.9 20.3 23.4 25.6 21.6 20.0 20.2 23.5 21.9 31.0 50.7 34.2 31.1 37.4 27.5 37.7 68.1 75.9 33.3 15.3 48.6 30.5 40.7 63.8 25.7 39.7 28.4 51.7 33.8 35.2 26.8 26.8 37.2 26.3 38.9 17.6 27.1 20.9 37.6 26.7 35.7 32.2 44.3 60.6 34.5 36.3 38.5 49.8 34.6 15.6 15.7 20.7 39.0 36.7 28.1 22.0 28.2 34.2 25.6 30.8 23.4 40.2 22.1 39.8 29.7 30.0 40.7 30.3 16.3 31.1 39.3 21.8 253.0 16.0 40.1 45.6 4.2 5.4 3.5 4.9 7.1 4.1 5.5 4.3 5.2 5.1 3.8 4.7 3.9 3.3 5.6 5.5 4.2 6.1 4.6 21.0 21.2 20.3 22.9 20.7 22.0 21.5 21.0 20.3 20.2 23.5 20.2 11.3 9.6 9.2 5.9 12.0 3.6 3.9 4.0 8.6 14.2 6.3 5.5 10.4 8.6 11.5 7.3 33.3 18.0 15.4 5.3 0.0 4.5 20.2 7.7 15.4 9.6 8.4 6.5 15.1 8.5 8.0 8.8 11.7 8.9 3.8 24.9 7.9 10.1 7.5 11.8 13.9 8.4 4.1 7.5 2.3 11.3 7.8 9.5 3.6 14.0 11.5 8.8 7.2 10.6 14.2 8.5 3.3 6.8 12.4 4.3 4.7 4.0 11.2 11.9 6.6 8.5 13.5 16.8 10.6 5.8 4.7 20.8 11.5 22.0 6.9 3.6 CNGB1 "CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45" ENSG00000070729 "Cyclic nucleotide gated channel subunit beta 1" Q14028 16 57882340-57971128 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Olfaction, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "retina: 600.2" "Group enriched" "Detected in some" 8 "Cone photoreceptor cells: 331.5;Rod photoreceptor cells: 1111.1" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.5;RPMI-8226: 1.8;SCLC-21H: 5.0;SiHa: 2.9;SK-BR-3: 1.4" "Region enhanced" "Detected in some" "hypothalamus: 4.5" "HPA039159, HPA060355" Approved Vesicles,Cytosol No NA "Cluster 77: Retina - Visual perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol Vesicles "HPA039159: AB_10795579, HPA060355: " "unprognostic (5.52e-3)" "unprognostic (4.51e-3)" "unprognostic (1.06e-1)" "unprognostic (2.73e-3)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (8.56e-4)" "unprognostic (3.08e-1)" "unprognostic (9.84e-2)" "unprognostic (2.83e-1)" "unprognostic (2.14e-4)" "unprognostic (5.42e-2)" "unprognostic (1.01e-3)" "unprognostic (5.20e-2)" "unprognostic (1.88e-1)" "unprognostic (4.57e-2)" "unprognostic (9.07e-2)" 0.1 2.5 15.5 1.1 13.2 0.2 0.0 0.0 20.4 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.1 0.3 0.0 24.5 24.8 0.0 0.1 0.1 0.2 2.8 3.2 0.0 0.5 0.0 0.2 0.4 4.4 0.0 0.4 600.2 0.0 0.1 0.0 0.2 0.6 0.1 2.4 0.1 0.0 0.4 36.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.0 0.5 0.0 0.0 1.3 0.0 0.1 0.0 0.3 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.6 5.0 0.0 2.9 1.4 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.2 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 15.5 13.2 0.0 20.4 24.5 24.8 2.8 3.2 4.4 2.4 36.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.4 0.0 61.6 0.3 0.0 1.1 0.0 0.1 0.0 331.5 6.9 0.0 0.0 0.0 0.4 1.6 0.9 0.1 4.2 0.0 0.0 3.2 0.4 0.9 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.4 25.2 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 89.5 0.0 1.0 0.1 0.2 1.1 0.0 0.0 0.2 0.0 0.3 0.0 1111.1 0.0 0.1 0.2 0.5 0.7 0.0 0.0 1.4 0.1 0.1 0.0 0.2 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798800-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 42.4" "Group enriched" "Detected in many" 5 "Early spermatids: 70.5;Late spermatids: 124.8;Respiratory ciliated cells: 47.0;Spermatocytes: 150.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.9;ASC diff: 1.6;SiHa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA072363 Approved Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 78: Testis - Spermatogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Vesicles "HPA072363: " "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.3 0.2 0.9 0.0 0.9 0.1 1.8 1.2 1.9 0.1 0.1 0.8 0.1 0.1 1.4 0.0 0.7 0.0 0.1 0.9 1.0 1.5 0.0 0.5 0.0 1.0 0.9 0.4 1.0 0.3 0.0 0.1 0.9 1.3 1.9 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.8 0.1 3.3 42.4 0.8 0.0 0.3 0.6 0.0 0.2 0.0 1.9 2.9 0.3 0.2 0.5 1.6 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.5 0.1 0.3 0.0 0.8 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.9 1.2 1.9 0.9 1.0 1.0 0.9 0.9 0.8 0.8 1.9 1.2 3.2 4.6 2.3 1.0 0.4 0.5 0.4 0.0 1.7 5.5 2.2 1.1 1.5 2.1 0.0 0.0 0.3 1.2 1.4 5.9 0.2 70.5 5.4 1.7 0.8 0.0 2.7 1.9 0.4 0.4 1.9 4.1 1.6 6.3 0.2 0.4 1.1 0.3 6.7 1.6 5.3 4.1 1.0 0.7 124.8 2.5 1.1 0.0 0.0 0.2 1.0 0.0 2.0 1.1 0.4 0.4 1.2 0.7 5.6 0.9 0.5 47.0 0.7 6.6 1.0 1.7 150.2 17.1 0.0 0.6 0.3 0.9 0.5 2.7 2.3 COG4 "COD1, DKFZP586E1519" ENSG00000103051 "Component of oligomeric golgi complex 4" 16 70480568-70523560 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040924, HPA042539" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" Vesicles "HPA040924: AB_2677203, HPA042539: AB_2678044" "unprognostic (1.30e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (6.08e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (1.64e-5)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "unprognostic (3.02e-1)" "unprognostic (3.35e-1)" "unprognostic (1.99e-2)" "unprognostic (1.79e-1)" 17.8 22.0 25.3 12.8 27.2 14.2 15.7 27.8 27.0 20.2 29.0 20.3 10.5 17.4 11.1 30.1 19.7 12.8 25.7 25.3 26.5 16.9 16.9 18.3 15.4 26.9 26.3 18.8 10.6 27.9 19.0 19.8 26.6 14.4 16.6 14.5 17.1 16.5 67.7 23.8 16.3 19.2 25.9 17.9 17.4 19.2 27.7 22.3 15.9 49.4 17.7 18.5 20.7 28.3 37.3 59.9 47.1 31.3 62.6 43.7 53.0 41.0 53.7 51.0 43.9 48.3 66.7 25.0 57.7 64.9 35.5 53.4 60.8 65.3 70.9 21.5 36.7 23.1 59.8 47.5 36.7 15.3 15.0 51.9 41.9 66.1 40.6 59.7 51.7 31.6 55.9 18.1 57.6 75.9 25.1 23.4 45.2 50.4 30.9 46.8 31.2 57.4 42.3 31.0 43.9 45.5 80.7 30.5 24.3 48.0 77.9 26.4 49.7 46.3 29.1 35.3 29.8 19.1 26.2 78.0 50.7 15.8 46.1 20.6 26.4 23.8 19.7 28.8 14.4 11.8 19.3 17.9 32.8 14.6 16.9 15.7 13.8 14.4 34.4 15.2 24.4 25.1 25.3 27.2 27.8 27.0 25.3 26.5 26.9 26.3 26.6 25.9 27.7 28.3 13.6 16.0 16.0 21.9 11.0 9.1 12.1 22.6 11.4 24.5 9.2 8.0 23.3 2.8 21.1 3.7 14.6 47.7 13.1 20.8 9.8 23.4 3.1 11.9 13.0 16.8 12.6 12.6 10.9 16.0 26.8 16.5 18.8 13.4 8.8 28.7 16.8 17.8 24.7 8.4 13.0 18.0 24.4 14.1 8.9 6.7 14.6 11.1 8.8 7.5 14.7 29.3 12.3 19.6 19.1 17.6 21.0 19.2 12.3 6.3 21.7 13.8 18.5 29.9 32.9 14.0 18.6 37.5 25.7 13.1 10.7 39.0 12.9 37.3 19.4 8.9 COL12A1 COL12A1L ENSG00000111799 "Collagen type XII alpha 1 chain" Q99715 6 75084326-75206267 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Endometrial stromal cells: 44.3;Excitatory neurons: 52.9;Fibroblasts: 99.7;Leydig cells: 60.3;Sertoli cells: 46.0;Smooth muscle cells: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "fHDF/TERT166: 1432.1;SiHa: 846.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 29.1" "HPA009143, HPA010021" Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA 9100000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles Cytosol "HPA009143: AB_1847095, HPA010021: " "unprognostic (2.60e-2)" "unprognostic (2.80e-3)" "unprognostic (7.92e-2)" "unprognostic (8.27e-3)" "unprognostic (1.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (3.47e-3)" "unprognostic (1.38e-1)" "unprognostic (4.30e-1)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "prognostic unfavorable (1.69e-9)" "unprognostic (1.03e-3)" "unprognostic (1.81e-1)" "unprognostic (3.16e-3)" "unprognostic (1.92e-2)" 105.1 15.7 2.2 16.0 1.9 0.0 65.4 0.8 2.7 112.8 0.4 74.9 8.7 124.5 5.5 36.2 42.2 20.9 25.5 1.0 1.2 25.9 3.5 24.6 7.2 1.8 4.8 123.2 5.9 5.0 4.8 1.8 0.6 20.8 17.2 0.4 16.1 42.4 14.4 48.9 40.6 72.1 0.6 11.4 18.1 4.6 2.0 5.5 19.3 12.5 4.2 26.3 45.8 0.8 0.2 2.2 11.5 0.2 270.2 162.0 28.3 275.4 229.3 186.2 257.3 27.5 0.7 0.0 27.7 1432.1 3.9 59.2 0.5 28.7 174.6 0.2 1.4 0.2 101.1 0.1 97.9 0.3 0.2 234.9 5.0 42.2 50.6 173.6 32.0 0.1 0.0 0.0 29.4 0.2 0.1 0.2 6.4 0.0 15.3 0.1 23.1 0.2 8.9 14.4 0.0 0.0 846.1 21.2 0.3 15.5 131.8 0.5 0.2 78.5 97.0 41.5 91.4 0.1 0.1 0.4 26.4 0.3 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 0.8 2.7 1.0 1.2 1.8 4.8 0.6 0.6 2.0 0.8 14.2 76.9 5.1 2.3 0.0 20.6 0.6 12.7 5.2 0.4 4.7 7.1 4.1 0.0 4.7 3.7 0.0 0.6 0.0 0.0 0.0 1.4 24.1 6.3 44.3 11.0 0.0 0.0 52.9 4.6 1.3 99.7 2.6 14.1 1.3 0.1 3.3 0.0 0.8 0.0 32.4 0.0 0.0 0.3 18.4 14.7 60.3 1.8 21.4 38.4 0.0 0.0 0.0 19.6 1.2 6.7 0.0 13.2 0.1 1.7 0.0 0.9 1.7 0.0 46.0 20.0 48.6 0.3 0.6 0.6 13.1 0.7 2.5 1.4 0.1 0.3 COL1A1 OI4 ENSG00000108821 "Collagen type I alpha 1 chain" P02452 17 50184101-50201632 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 1331.8;gallbladder: 1211.3" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 2044.3;Fibroblasts: 1944.4;Leydig cells: 556.0;Smooth muscle cells: 1024.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 1689.5;BJ: 3428.1;fHDF/TERT166: 5206.1;HSkMC: 2490.3;U-138 MG: 2687.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 115.9" "HPA011795, HPA012111" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 80000000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum" Vesicles "HPA011795: AB_1847088, HPA012111: " "unprognostic (1.61e-1)" "unprognostic (3.60e-3)" "unprognostic (8.29e-2)" "unprognostic (5.52e-2)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.01e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-2)" "unprognostic (8.53e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (7.19e-12)" "unprognostic (2.74e-2)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (3.87e-3)" 312.1 39.9 1.8 272.8 5.3 4.5 184.9 1.3 15.9 1331.8 12.0 223.2 37.7 531.4 23.4 110.2 234.1 1211.3 126.6 1.5 1.9 34.7 29.7 139.0 78.1 3.2 1.4 377.3 39.8 14.1 80.5 503.5 2.0 137.5 46.5 0.4 51.3 98.6 21.2 362.0 86.6 801.2 2.2 46.9 109.9 38.2 17.3 14.4 50.8 13.0 21.1 616.3 342.2 6.7 6.0 5.0 16.4 3.2 702.9 1689.5 29.2 3428.1 915.8 826.6 517.6 64.2 14.6 0.6 7.8 5206.1 5.7 9.1 8.3 3.4 150.1 5.2 6.1 0.4 92.2 4.2 1309.3 1.2 0.8 2490.3 45.7 1016.2 4.6 126.9 0.5 4.8 2.2 0.4 425.4 8.5 1.4 1.0 17.0 10.7 10.5 6.1 2.1 2.7 3.9 0.2 2.0 8.8 5.6 5.0 0.2 245.4 39.8 0.6 1.5 2687.4 562.6 405.0 16.2 2.8 5.9 0.7 200.1 1.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.3 1.3 15.9 1.5 1.9 3.2 1.4 2.0 2.2 17.3 6.7 66.9 9.6 13.8 0.0 2.1 188.0 12.4 31.6 10.8 0.2 9.1 10.0 12.5 5.7 13.2 7.3 0.0 45.7 1.7 1.4 0.0 13.3 1.9 64.6 2044.3 33.4 3.0 0.0 0.1 4.2 45.5 1944.4 17.9 49.2 2.5 8.1 378.0 3.4 67.6 0.0 0.3 5.4 6.1 0.3 318.1 18.2 556.0 13.1 188.5 12.2 0.0 2.5 0.0 0.0 0.0 23.8 0.3 268.1 1.3 10.7 0.1 0.7 9.8 0.2 78.9 74.8 1024.9 4.0 2.6 4.3 163.5 111.8 29.4 57.3 2.9 9.1 COL22A1 ENSG00000169436 "Collagen type XXII alpha 1 chain" Q8NFW1 8 138588235-138914041 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pituitary gland: 44.0" "Cell type enhanced" "Detected in some" "Early spermatids: 39.6;Excitatory neurons: 13.0;Late spermatids: 33.7;Muller glia cells: 25.5" "Cancer enhanced" "Detected in many" "testis cancer: 9.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 29.5;RT4: 12.2;SCLC-21H: 8.1;U-2 OS: 6.8" "Low region specificity" "Detected in many" HPA024830 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 44: HDLM-2 - Immune response" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Endoplasmic reticulum" "HPA024830: AB_1847102" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (2.88e-2)" "unprognostic (4.19e-6)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.05e-2)" "unprognostic (5.57e-3)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.01e-1)" "unprognostic (9.24e-2)" "unprognostic (5.74e-2)" "unprognostic (3.62e-2)" "unprognostic (3.66e-15)" "unprognostic (2.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (1.09e-1)" 0.1 7.6 0.6 0.6 1.0 0.0 0.0 2.9 0.5 0.8 0.4 1.0 0.3 1.9 0.2 0.1 0.4 0.3 0.2 0.3 1.4 1.9 0.0 0.0 0.5 2.9 1.2 0.2 0.1 1.4 44.0 0.0 0.6 3.0 0.1 5.2 0.9 2.4 0.7 0.0 0.4 1.6 4.3 0.2 2.2 1.1 2.0 2.1 0.2 1.1 1.2 0.9 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 12.2 8.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 2.9 0.5 0.3 1.4 2.9 1.2 0.6 4.3 2.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 3.7 2.5 0.0 0.3 0.2 0.3 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 39.6 0.1 0.2 0.8 0.0 0.0 13.0 0.2 0.0 0.2 0.0 0.6 0.0 0.6 0.0 0.0 5.9 0.0 0.8 0.0 8.2 0.0 0.0 33.7 0.3 0.3 0.0 1.0 0.6 25.5 0.0 0.5 0.3 3.0 0.0 0.0 0.0 4.8 0.0 0.1 0.2 1.6 0.0 0.1 0.3 2.1 1.7 0.0 0.0 0.0 0.0 0.0 0.1 1.9 COL4A3 ENSG00000169031 "Collagen type IV alpha 3 chain" Q01955 2 227164624-227314792 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Alport syndrome, Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 52.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 169.9;Bipolar cells: 62.1;Cone photoreceptor cells: 398.2;Muller glia cells: 143.1;Oligodendrocyte precursor cells: 84.9" "Group enriched" "Detected in some" 6 "lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 7 "B-cells: 1.0" "Cell line enhanced" "Detected in some" "HeLa: 18.8;hTERT-RPE1: 14.5;Karpas-707: 9.9;RPTEC TERT1: 11.0;U-266/70: 9.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042064 Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 20: HeLa - Mitochondria" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Endoplasmic reticulum" "HPA042064: AB_10794410" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (9.28e-6)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.84e-2)" "unprognostic (7.07e-3)" "unprognostic (2.30e-1)" "unprognostic (9.09e-3)" "unprognostic (9.30e-2)" "unprognostic (3.02e-2)" "prognostic favorable (2.51e-7)" "unprognostic (1.78e-1)" "unprognostic (3.10e-2)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" 0.6 11.5 1.9 2.1 1.8 0.3 1.0 1.5 1.7 0.4 21.5 0.8 0.7 1.2 16.3 1.0 2.1 3.2 8.9 1.4 2.0 30.5 0.6 15.0 2.9 3.3 3.1 3.9 5.0 0.2 16.2 0.2 2.7 6.0 1.0 52.9 1.2 9.9 22.2 0.5 6.7 0.8 1.6 7.2 1.8 1.7 6.3 0.4 20.5 15.2 5.6 1.4 1.2 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.0 0.0 0.3 1.1 0.1 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 1.2 0.0 9.9 0.0 0.4 0.0 0.1 1.4 0.0 0.0 0.1 0.0 3.2 11.0 2.3 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 9.0 3.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.8 1.5 1.7 1.4 2.0 3.3 3.1 2.7 1.6 6.3 2.2 0.5 169.9 31.7 3.9 14.0 0.1 0.1 0.1 0.6 62.1 0.1 0.9 2.6 1.5 9.3 42.3 398.2 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.2 2.4 0.0 0.0 5.5 1.0 0.0 4.6 0.5 0.3 1.3 22.8 0.4 0.2 0.0 1.7 14.1 0.0 0.0 0.0 0.3 0.3 8.4 0.3 1.8 13.1 0.0 143.1 0.0 84.9 3.6 1.0 0.0 12.0 8.0 0.1 0.0 1.9 0.1 11.9 13.1 11.7 3.6 0.4 0.0 0.3 0.3 0.0 1.2 0.1 0.0 0.0 COL4A5 "ASLN, ATS" ENSG00000188153 "Collagen type IV alpha 5 chain" P29400 X 108439838-108697545 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 102.9" "Cell type enriched" "Detected in many" 9 "Oligodendrocytes: 713.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 87.7;HHSteC: 95.0;HUVEC TERT2: 92.8;TIME: 88.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077177 Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" Vesicles "HPA077177: " "unprognostic (2.58e-2)" "unprognostic (2.57e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.97e-2)" "unprognostic (7.27e-2)" "unprognostic (2.70e-1)" "unprognostic (2.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.61e-2)" "unprognostic (1.06e-1)" 7.4 5.6 25.2 2.3 57.4 0.0 8.1 38.2 40.8 38.1 20.0 5.8 3.8 59.2 25.4 9.6 37.5 18.2 10.9 27.0 33.7 16.9 2.4 8.5 1.2 47.7 43.1 23.0 3.8 16.8 19.7 14.5 47.4 37.0 5.6 6.1 7.4 32.9 7.6 26.4 6.3 47.2 36.4 5.5 34.5 6.0 45.3 2.7 10.5 4.4 1.0 47.6 22.7 102.9 4.5 26.7 47.2 14.9 18.0 10.6 0.3 2.8 11.7 14.2 23.2 24.0 1.9 4.2 0.0 2.0 8.6 21.7 13.2 45.2 17.8 6.7 11.7 3.4 87.7 2.9 95.0 0.0 13.5 49.2 53.6 17.4 37.2 45.2 92.8 0.0 0.2 0.1 13.9 2.0 0.1 0.5 14.0 0.0 16.0 0.1 0.0 0.2 35.9 26.7 0.0 0.0 70.2 2.2 6.0 65.6 12.9 0.0 88.8 9.5 2.8 6.4 4.0 1.9 0.0 0.0 8.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 57.4 38.2 40.8 27.0 33.7 47.7 43.1 47.4 36.4 45.3 102.9 1.0 6.4 7.3 72.5 0.0 26.9 29.7 29.4 17.1 0.5 14.8 14.7 10.0 2.8 14.2 20.2 0.0 0.7 0.0 0.0 0.0 0.4 0.1 7.4 45.4 4.6 0.0 0.0 1.1 0.9 0.4 12.3 3.1 5.7 1.3 2.0 4.2 0.5 0.4 0.0 1.5 0.2 6.1 0.3 2.1 1.7 20.2 0.6 1.8 20.6 0.0 11.1 0.0 3.5 713.9 0.4 0.0 36.9 0.0 18.1 0.0 0.1 8.2 0.6 6.6 2.4 18.3 0.4 0.9 4.2 15.9 0.7 1.1 21.5 0.1 24.7 COL6A3 ENSG00000163359 "Collagen type VI alpha 3 chain" P12111 2 237324003-237414207 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Congenital muscular dystrophy, Disease variant, Dystonia, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 391.3" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 355.2;Fibroblasts: 567.9;Leydig cells: 315.1;Smooth muscle cells: 197.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 3311.7;ASC TERT1: 4227.5;BJ hTERT+: 1279.6;HSkMC: 2705.3" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Region enriched" "Detected in many" 4 "spinal cord: 12.0" "HPA010007, HPA010080" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 1000000000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Endoplasmic reticulum" Vesicles "HPA010007: , HPA010080: AB_1078550" "unprognostic (8.94e-2)" "unprognostic (7.24e-2)" "unprognostic (6.60e-2)" "unprognostic (3.82e-1)" "unprognostic (3.90e-2)" "unprognostic (2.37e-1)" "unprognostic (5.34e-2)" "unprognostic (2.87e-2)" "unprognostic (8.20e-3)" "unprognostic (2.55e-2)" "unprognostic (1.33e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (5.57e-11)" "unprognostic (1.54e-2)" "unprognostic (2.50e-2)" "unprognostic (3.51e-2)" "unprognostic (1.84e-3)" 150.8 8.3 0.1 126.5 1.0 0.4 74.5 0.2 3.0 212.6 5.2 94.8 22.9 156.3 10.2 44.1 91.8 236.4 61.2 2.4 0.1 5.7 10.3 65.8 30.7 0.6 0.1 123.8 21.1 17.3 2.8 132.9 0.7 47.7 51.7 0.0 45.2 55.4 32.5 35.7 46.6 391.3 0.8 19.0 41.5 15.6 1.8 24.8 38.1 62.3 16.1 188.4 62.7 0.9 0.2 0.5 0.6 0.0 3311.7 4227.5 60.9 815.6 1279.6 167.0 188.2 0.0 0.1 4.5 0.1 818.7 67.4 0.6 0.7 0.9 98.8 2.0 0.1 0.0 0.0 0.0 669.9 0.0 0.4 2705.3 0.0 596.3 1.8 7.8 0.2 0.0 0.1 0.6 6.2 0.0 0.1 0.2 0.5 0.0 7.4 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 17.3 0.0 0.4 2.9 19.0 45.1 27.6 142.4 1.0 0.0 0.1 859.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.2 3.0 2.4 0.1 0.6 0.1 0.7 0.8 1.8 0.9 48.2 0.0 10.5 0.3 0.6 61.1 0.5 0.5 1.8 1.0 2.5 2.9 10.6 1.5 3.8 0.0 0.0 4.5 1.2 0.0 0.0 0.9 5.4 11.0 355.2 17.6 0.0 0.0 0.8 0.0 6.2 567.9 6.6 8.7 1.3 1.8 25.4 1.8 8.1 0.0 0.4 0.0 0.0 1.3 85.4 9.6 315.1 5.5 72.9 29.0 2.2 1.1 1.0 0.0 0.3 2.4 0.0 103.4 2.0 0.9 0.0 0.2 1.0 2.3 32.9 19.2 197.7 1.5 1.3 3.3 61.5 5.7 9.3 48.7 0.0 1.0 COL7A1 "EBD1, EBDCT, EBR1" ENSG00000114270 "Collagen type VII alpha 1 chain" Q02388 3 48564073-48595329 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 98.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 72.5;Basal respiratory cells: 59.3;Basal squamous epithelial cells: 67.2;Endometrial stromal cells: 45.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 41.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 65.7;HaCaT: 63.5;HBEC3-KT: 100.6;HDLM-2: 97.8;HeLa: 146.2;SiHa: 82.8" "CAB016357, HPA018877, HPA042420" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 6000 "Cluster 41: Basophils - Cellular respiration" "Cluster 31: Skin - Epidermis development" "Cluster 20: HeLa - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum" Vesicles "CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990" "unprognostic (2.69e-2)" "unprognostic (4.11e-1)" "unprognostic (1.35e-1)" "unprognostic (3.47e-1)" "unprognostic (4.93e-2)" "prognostic favorable (6.31e-4)" "unprognostic (7.56e-2)" "unprognostic (1.25e-2)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.74e-2)" "unprognostic (0.00e+0)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (3.86e-2)" 0.8 1.1 1.4 3.8 1.0 0.1 4.9 2.8 2.1 24.3 0.4 2.9 1.7 12.1 6.7 21.8 6.4 4.0 3.2 0.3 6.5 7.4 1.3 1.7 1.2 7.0 3.2 3.4 0.4 0.0 2.5 1.6 3.0 34.2 0.9 1.4 11.5 12.2 3.5 98.2 4.1 2.5 2.6 6.5 2.1 3.6 6.5 1.2 0.5 0.6 1.3 6.6 29.2 0.6 0.2 25.4 1.2 0.5 9.2 12.3 31.0 65.7 40.8 16.9 10.0 0.4 0.5 0.1 2.0 15.0 15.4 63.5 0.0 100.6 3.1 97.8 0.5 0.2 146.2 4.3 25.6 0.0 0.4 19.9 58.8 34.4 26.8 23.1 0.0 0.7 0.5 0.7 2.0 0.3 0.0 0.9 3.1 1.3 1.3 0.5 2.2 0.2 9.2 0.2 0.2 0.2 82.8 0.1 0.8 3.7 1.3 0.3 0.0 5.6 3.2 3.2 50.1 1.8 1.8 0.1 49.0 0.4 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 2.8 2.1 0.3 6.5 7.0 3.2 3.0 2.6 6.5 0.6 0.4 0.0 0.0 10.7 0.2 72.5 24.1 59.3 67.2 17.7 1.0 10.2 6.6 0.0 10.6 11.0 10.4 1.4 0.1 0.6 0.0 0.9 11.8 3.1 45.3 1.4 1.8 0.0 6.8 0.7 1.0 8.3 1.1 4.0 0.0 0.8 0.4 0.7 1.6 8.4 11.6 0.7 0.0 0.3 4.2 6.3 5.0 0.8 8.8 8.4 0.1 2.6 0.0 4.0 4.4 15.6 0.1 5.7 0.0 5.7 0.2 0.3 2.5 12.9 0.0 2.0 13.4 2.6 1.5 11.3 24.2 1.2 0.8 5.0 0.2 5.8 COL9A2 "EDM2, MED" ENSG00000049089 "Collagen type IX alpha 2 chain" Q14055 1 40300489-40317813 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease variant, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.2;pituitary gland: 108.1" "Cell type enhanced" "Detected in many" "Muller glia cells: 295.4;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 128.1" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 3.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.2;granulocytes: 3.2" "Group enriched" "Detected in many" 4 "HDLM-2: 98.6;Hep G2: 27.6;HMC-1: 90.3;THP-1: 105.0" "Low region specificity" "Detected in all" "HPA056316, HPA075286" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 510000 "Cluster 52: Eosinophils - Transcription" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 5: Muller glia cells - Visual perception" Vesicles Nucleoplasm "HPA056316: AB_2683099, HPA075286: AB_2732288" "unprognostic (1.42e-2)" "unprognostic (3.54e-2)" "unprognostic (8.94e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (4.46e-2)" "unprognostic (1.83e-3)" "unprognostic (2.06e-2)" "unprognostic (9.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (2.26e-1)" "unprognostic (1.16e-3)" "unprognostic (4.28e-2)" "unprognostic (2.56e-1)" "unprognostic (5.89e-2)" "unprognostic (1.71e-2)" 2.2 3.4 42.6 3.7 71.5 10.9 5.9 58.9 51.1 12.1 21.6 6.5 5.8 5.0 1.7 1.6 11.4 8.5 2.2 38.2 49.7 24.6 0.9 4.3 5.9 65.9 74.1 1.3 2.3 21.0 108.1 1.1 66.2 13.7 3.1 23.1 16.3 24.2 0.2 4.6 10.4 1.4 52.0 9.8 16.5 2.6 58.6 1.8 12.2 0.3 3.1 12.1 2.0 86.2 12.0 0.3 1.8 0.8 2.6 1.3 7.8 0.0 0.0 0.6 1.3 0.4 6.8 3.4 10.0 0.3 0.0 2.0 0.1 0.0 0.3 98.6 1.4 2.0 0.8 27.6 1.5 0.9 90.3 4.8 0.0 0.1 0.0 0.7 0.0 1.5 0.1 19.8 0.0 2.7 1.2 2.1 2.2 0.0 1.2 2.3 0.0 6.9 0.0 14.3 1.4 2.3 0.1 11.8 1.3 6.6 15.0 105.0 0.1 0.0 11.6 0.2 0.4 1.4 0.2 3.4 1.0 12.3 0.6 0.0 0.1 3.2 0.0 0.2 0.0 0.2 0.1 0.0 1.2 0.2 0.0 0.0 0.5 0.2 0.3 0.1 0.1 0.0 42.6 71.5 58.9 51.1 38.2 49.7 65.9 74.1 66.2 52.0 58.6 86.2 0.5 0.0 3.3 26.1 10.8 1.0 3.0 8.5 0.0 2.0 7.1 9.7 1.0 7.2 10.0 25.8 0.0 3.2 2.5 7.2 0.0 11.7 0.2 13.6 0.9 0.6 12.7 0.4 0.3 0.8 0.6 2.1 26.0 20.0 26.1 1.6 1.1 0.0 3.4 0.0 0.3 6.6 2.0 0.3 22.4 0.9 2.1 6.4 1.8 3.7 22.1 295.4 1.0 62.4 128.1 4.9 9.6 0.0 4.0 6.1 5.0 0.3 12.9 10.9 0.0 1.3 1.8 3.4 6.2 0.2 0.6 1.4 2.7 1.8 13.4 13.4 COLGALT2 "C1orf17, GLT25D2, KIAA0584" ENSG00000198756 "Collagen beta(1-O)galactosyltransferase 2" Q8IYK4 1 183929854-184037729 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 50.6" "Cell type enhanced" "Detected in many" "Astrocytes: 53.5;Excitatory neurons: 79.9;Inhibitory neurons: 71.5;Late spermatids: 76.2;Oligodendrocyte precursor cells: 115.1;Oligodendrocytes: 359.3" "Cancer enhanced" "Detected in many" "glioma: 11.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 30 "basophil: 11.1" "Lineage enriched" "Detected in single" 30 "granulocytes: 11.1" "Cell line enhanced" "Detected in many" "Hep G2: 17.1;OE19: 13.8;SK-MEL-30: 18.6;U-251 MG: 18.0;WM-115: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031749, HPA031750" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 17: WM-115 - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Vesicles "HPA031749: AB_10599298, HPA031750: AB_10611252" "unprognostic (5.44e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-5)" "unprognostic (2.08e-1)" "unprognostic (4.41e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-1)" "unprognostic (2.00e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (5.13e-9)" "unprognostic (1.53e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (3.80e-2)" 1.7 6.4 15.7 0.8 29.3 1.1 1.5 22.7 18.6 1.0 0.0 4.3 0.5 1.8 3.1 0.7 2.8 2.3 11.4 16.5 17.3 0.8 0.2 3.7 0.3 26.8 24.0 1.3 2.3 0.5 2.2 0.1 28.7 5.3 0.9 3.5 2.9 2.2 8.8 0.3 1.0 1.7 20.2 0.5 1.9 3.5 25.8 0.3 3.3 6.3 0.5 1.8 1.5 50.6 0.1 0.0 5.7 0.4 3.0 4.4 0.1 1.8 0.7 0.8 1.0 2.8 0.2 0.0 0.5 4.4 1.1 0.0 5.6 0.0 1.4 6.6 3.3 0.4 0.0 17.1 0.1 6.0 0.1 2.6 0.0 0.8 0.1 8.4 0.0 0.2 5.7 7.2 6.1 0.2 0.3 0.3 3.9 13.8 0.0 0.5 0.0 0.0 0.0 1.2 2.2 3.5 0.3 0.0 18.6 3.7 0.0 0.3 0.1 0.7 0.7 0.1 18.0 10.8 0.1 0.1 0.5 2.8 22.5 11.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 15.7 29.3 22.7 18.6 16.5 17.3 26.8 24.0 28.7 20.2 25.8 50.6 0.1 0.0 0.0 53.5 0.0 0.4 0.5 0.0 0.0 4.4 0.3 0.3 3.5 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.6 40.3 0.2 0.5 0.9 0.0 1.3 79.9 0.0 0.0 9.9 1.5 0.5 0.0 0.2 0.0 0.1 0.3 0.0 71.5 0.1 0.0 0.3 9.5 76.2 2.1 0.9 1.8 4.7 0.0 5.7 8.2 115.1 359.3 1.2 0.0 4.1 1.9 0.2 0.0 0.3 0.0 0.4 13.1 2.3 3.1 0.3 1.3 0.0 0.4 0.0 4.5 0.4 0.0 0.4 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941371-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 885.9;Syncytiotrophoblasts: 648.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 818.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" NA NA 43000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 15: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favorable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favorable (5.67e-4)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 78.1 180.7 99.3 39.6 108.9 71.8 85.5 114.4 140.4 105.3 119.6 80.1 55.0 76.9 47.7 198.0 65.2 60.3 81.7 96.6 107.4 94.2 292.3 93.3 49.7 117.4 107.9 107.4 74.0 61.5 48.7 116.9 117.3 87.2 20.7 17.2 133.7 70.5 98.6 119.7 64.1 38.3 109.2 63.6 99.8 51.7 102.7 26.9 59.1 49.9 26.0 86.9 124.1 124.3 131.3 131.7 15.0 128.3 141.2 122.5 6.0 143.9 178.8 120.3 133.6 112.1 148.6 51.7 62.7 208.9 48.6 172.9 23.6 152.0 26.2 115.1 163.4 92.5 65.1 267.1 265.1 155.0 35.3 159.2 180.7 104.3 101.3 116.6 113.2 82.0 383.2 109.4 100.6 818.5 63.4 267.9 32.4 361.1 42.9 88.2 127.9 72.8 129.0 404.5 60.4 53.8 47.7 405.7 125.7 7.6 84.0 436.6 137.5 212.7 82.2 71.0 109.6 37.5 18.0 41.2 236.0 211.3 152.5 62.2 312.2 59.6 77.9 218.1 64.0 56.8 52.6 62.6 251.5 57.8 45.5 51.7 12.0 73.5 151.5 291.4 72.6 178.6 99.3 108.9 114.4 140.4 96.6 107.4 117.4 107.9 117.3 109.2 102.7 124.3 99.1 125.0 88.1 22.9 33.1 102.1 231.9 248.1 188.4 73.4 174.9 218.4 41.9 104.4 162.7 152.6 10.4 885.9 80.1 53.0 320.8 201.0 4.6 59.1 72.2 86.7 84.5 70.0 16.8 193.0 113.5 103.1 46.4 46.9 71.7 95.7 77.1 262.0 311.4 25.2 17.2 97.7 191.2 177.0 107.7 13.3 134.2 137.0 240.1 20.6 137.0 158.7 41.2 25.1 45.7 170.2 108.8 179.8 45.5 132.4 179.9 73.8 135.8 43.2 138.1 143.3 113.1 8.4 5.7 236.4 123.5 648.5 41.8 222.0 122.3 206.6 COPS2 "ALIEN, CSN2, TRIP15" ENSG00000166200 "COP9 signalosome subunit 2" P61201 15 49106068-49155661 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016867, HPA018271, HPA061071" Approved Supported "Vesicles,Cytokinetic bridge" Yes No 190000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" Vesicles "Cytokinetic bridge" "HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424" "unprognostic (3.47e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (1.86e-1)" "unprognostic (7.84e-3)" "unprognostic (1.04e-1)" "unprognostic (6.77e-2)" "unprognostic (2.49e-2)" "unprognostic (6.09e-2)" "unprognostic (3.86e-3)" "unprognostic (1.42e-1)" "unprognostic (4.35e-3)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (5.62e-2)" "unprognostic (1.10e-3)" 61.7 43.4 24.8 34.4 28.5 124.5 67.0 35.0 36.8 61.9 25.3 43.2 43.3 58.4 44.0 63.2 43.2 53.7 61.5 26.1 30.4 60.8 57.6 35.0 45.5 30.9 27.7 76.7 54.0 65.7 26.4 45.0 32.8 45.2 41.6 32.2 40.0 47.0 92.6 35.5 37.2 56.5 35.2 32.0 36.4 51.0 27.5 49.6 61.8 112.1 48.8 59.0 35.3 41.7 92.0 53.1 111.6 94.4 134.2 189.9 76.7 157.3 149.8 135.4 123.5 113.0 49.1 151.1 105.2 152.2 108.7 131.9 160.3 130.9 148.0 103.3 64.5 141.0 105.4 91.7 102.6 134.7 70.7 161.2 104.3 110.4 193.3 149.3 144.0 82.5 184.4 78.8 149.3 49.5 72.3 67.3 72.6 128.4 68.9 78.2 105.2 227.7 143.5 136.5 108.4 78.6 90.7 96.4 127.8 129.4 95.6 133.3 93.4 132.1 71.0 249.6 167.9 71.0 196.3 191.0 123.4 215.1 109.4 11.7 17.9 12.2 13.1 23.5 24.4 14.6 19.7 19.2 21.0 13.9 24.8 16.2 7.4 16.6 22.9 13.3 28.4 16.0 24.8 28.5 35.0 36.8 26.1 30.4 30.9 27.7 32.8 35.2 27.5 41.7 72.8 76.9 56.1 14.4 50.0 87.1 57.1 90.8 80.8 23.2 47.6 59.3 104.3 27.1 69.8 23.9 10.4 56.1 48.2 18.5 54.8 40.3 28.2 56.7 91.6 53.6 20.8 50.1 35.2 29.9 71.0 79.6 36.2 94.0 52.6 39.3 46.1 32.5 43.9 33.7 36.1 25.1 32.6 47.5 44.9 21.6 55.3 46.1 35.6 19.7 49.3 24.8 27.8 21.6 48.7 35.9 21.6 53.4 63.5 53.0 41.0 84.8 47.4 19.7 19.7 74.6 109.0 93.1 43.3 63.2 98.9 131.9 54.0 58.6 34.6 64.4 CPQ "LDP, PGCP" ENSG00000104324 "Carboxypeptidase Q" Q9Y646 8 96645242-97149654 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 225.9" "Cell type enhanced" "Detected in all" "Astrocytes: 150.2;Oligodendrocytes: 299.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 250.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 116.1;ASC TERT1: 131.4;hTERT-RPE1: 108.2;Karpas-707: 97.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023235, HPA024490" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 51000000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 1: Thyroid gland - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Vesicles" "HPA023235: AB_1855257, HPA024490: AB_1855258" "unprognostic (4.04e-2)" "unprognostic (5.46e-2)" "unprognostic (4.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "unprognostic (3.98e-3)" "unprognostic (5.24e-2)" "unprognostic (2.92e-2)" "unprognostic (2.67e-2)" "unprognostic (9.19e-2)" "unprognostic (2.38e-3)" "unprognostic (6.16e-3)" "prognostic favorable (5.40e-5)" "unprognostic (6.74e-3)" "unprognostic (8.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" 46.2 35.9 22.6 25.4 33.9 31.8 34.7 28.0 26.7 75.1 20.6 39.6 29.3 46.0 36.2 25.9 39.8 57.8 51.8 21.6 27.0 80.5 70.0 32.3 22.8 32.6 27.5 87.4 46.7 60.7 25.6 39.2 33.2 40.2 33.1 16.8 32.8 54.2 13.3 20.6 35.0 64.7 25.9 31.3 32.1 13.9 30.3 8.2 225.9 33.2 17.0 46.3 38.6 38.6 0.6 2.1 2.1 0.1 116.1 131.4 0.5 35.3 55.6 12.8 26.5 2.0 0.9 0.4 27.2 59.0 15.7 1.0 2.4 2.8 12.0 31.4 4.4 28.4 1.5 17.7 25.6 4.9 37.0 69.6 6.5 15.0 3.7 108.2 6.0 0.1 27.1 97.0 29.4 1.2 0.5 14.1 2.5 0.2 5.2 4.3 0.0 0.6 26.7 13.2 2.4 0.3 10.2 0.4 28.2 25.8 12.3 28.6 21.3 51.9 4.9 0.8 11.5 7.9 0.9 0.3 32.2 21.6 33.5 32.0 71.3 45.1 27.3 49.6 27.6 5.4 20.3 24.0 51.8 7.4 17.6 24.6 250.5 25.9 47.5 14.8 22.2 40.6 22.6 33.9 28.0 26.7 21.6 27.0 32.6 27.5 33.2 25.9 30.3 38.6 46.6 12.8 12.5 150.2 11.7 19.4 25.7 21.3 9.6 12.7 12.1 27.9 27.2 42.9 13.9 47.8 29.2 12.1 40.8 9.3 17.6 22.7 5.0 6.6 43.3 27.1 13.8 7.2 24.0 10.7 1.8 123.8 10.7 8.6 38.0 43.1 51.0 48.3 54.0 10.1 31.3 7.9 24.4 56.0 44.9 9.0 72.4 39.4 78.2 131.2 33.7 43.4 39.1 44.7 299.6 11.7 9.5 73.0 11.9 12.4 42.4 56.0 9.7 16.3 52.6 71.1 67.8 5.6 3.4 2.8 13.1 6.0 23.8 38.6 12.2 13.5 CPSF2 "CPSF100, KIAA1367" ENSG00000165934 "Cleavage and polyadenylation specific factor 2" Q9P2I0 14 92121969-92172145 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024238 Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Vesicles "HPA024238: AB_1847200" "unprognostic (2.31e-1)" "unprognostic (9.80e-2)" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (4.95e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.34e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.33e-2)" "unprognostic (6.68e-2)" "unprognostic (8.78e-3)" "unprognostic (2.44e-1)" "unprognostic (2.91e-1)" "unprognostic (8.75e-2)" "unprognostic (4.90e-2)" 14.8 14.5 7.3 24.9 9.7 11.5 11.8 9.3 10.1 13.7 13.0 16.1 14.7 15.0 15.0 18.3 11.7 15.0 13.1 6.8 8.9 13.6 19.7 14.7 21.0 9.5 9.2 12.6 14.9 18.2 10.7 16.7 10.6 15.6 16.8 13.9 13.6 14.1 27.1 11.1 14.4 17.8 8.5 18.6 17.4 26.0 8.5 27.3 18.3 25.6 24.8 16.6 12.3 12.2 48.1 46.9 47.0 48.6 23.9 21.1 69.5 60.7 59.0 55.1 54.3 41.4 64.9 51.3 38.9 65.1 37.2 69.2 65.2 55.2 79.2 83.3 22.4 75.4 46.1 39.5 70.5 76.3 60.6 34.7 46.2 52.5 93.8 36.5 52.2 54.5 68.8 62.9 62.1 69.6 88.3 26.8 53.3 76.8 42.3 86.0 72.7 45.9 37.5 67.1 51.7 34.7 71.7 39.9 51.1 41.9 82.9 47.4 56.3 43.9 27.7 33.4 52.4 37.6 66.2 103.0 53.0 58.9 69.7 16.6 12.9 9.3 7.8 11.7 10.4 7.6 6.9 8.4 11.3 4.0 6.1 8.6 4.4 11.1 9.8 7.3 12.1 9.5 7.3 9.7 9.3 10.1 6.8 8.9 9.5 9.2 10.6 8.5 8.5 12.2 14.2 28.9 31.8 23.2 22.9 10.3 15.2 15.1 15.9 12.7 13.4 9.5 27.1 10.0 25.5 7.3 29.2 24.0 19.8 14.6 13.7 18.0 28.2 24.3 30.0 22.9 13.8 33.0 13.6 24.0 22.7 20.0 17.3 16.8 30.4 26.2 20.7 27.2 24.8 11.8 17.5 17.3 12.2 32.9 8.8 11.2 19.0 31.1 3.6 19.7 41.2 16.9 27.8 18.6 27.9 23.8 14.0 23.0 35.4 29.9 12.5 16.3 34.1 22.7 32.9 19.6 23.2 61.7 41.3 27.2 12.8 25.3 22.8 26.6 18.2 20.2 CPSF4 "CPSF30, NAR" ENSG00000160917 "Cleavage and polyadenylation specific factor 4" O95639 7 99438922-99457373 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049094, HPA066470" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Vesicles "HPA049094: AB_2680626, HPA066470: AB_2685672" "unprognostic (4.03e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (1.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.84e-2)" "unprognostic (2.28e-2)" "unprognostic (3.15e-1)" "unprognostic (3.73e-3)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (4.23e-2)" 20.4 19.0 31.4 13.8 30.8 20.1 19.2 29.9 35.1 18.7 23.6 16.7 14.0 16.8 11.7 20.4 15.7 11.3 17.4 30.1 30.4 17.3 20.2 15.4 23.7 35.5 31.6 18.8 29.9 8.3 18.4 16.7 32.1 19.1 10.7 7.2 19.8 12.3 36.1 20.4 16.1 11.1 30.4 22.0 20.0 32.0 32.3 16.1 13.9 18.0 19.9 16.0 17.4 30.4 40.0 33.9 55.4 44.9 22.4 25.5 66.8 25.8 31.5 38.8 50.5 56.0 52.0 56.4 34.2 25.2 48.2 34.0 39.1 40.5 35.4 41.9 41.6 27.0 41.4 54.4 117.2 49.4 33.3 46.8 34.0 40.7 60.4 28.1 35.8 40.1 70.8 64.8 36.2 95.6 99.6 88.9 51.3 53.0 47.7 40.8 37.0 66.8 24.2 36.1 43.3 50.6 29.4 60.9 61.6 58.2 25.3 51.8 20.0 36.5 50.1 64.3 50.0 59.9 68.6 83.3 28.1 48.1 44.1 1.2 3.4 2.6 3.3 3.0 4.4 8.2 5.0 6.1 4.1 8.4 6.3 5.6 1.3 4.4 2.1 5.4 8.2 3.0 31.4 30.8 29.9 35.1 30.1 30.4 35.5 31.6 32.1 30.4 32.3 30.4 11.6 6.4 8.9 6.2 11.2 8.8 16.4 10.6 9.6 4.6 11.9 10.3 10.4 14.3 8.6 1.8 10.4 55.9 17.7 8.7 15.6 15.6 3.0 4.9 9.3 11.0 7.7 15.6 10.7 17.1 33.1 12.7 5.1 5.3 12.7 27.0 8.2 8.2 21.5 6.7 14.7 10.6 14.2 10.1 13.5 7.8 27.4 8.7 8.8 5.6 18.5 10.7 14.4 6.0 8.1 13.9 6.0 17.3 14.7 28.6 10.1 20.2 4.3 6.9 19.7 23.7 16.4 20.9 19.8 9.3 9.2 45.4 10.7 25.1 12.6 14.9 CREG1 CREG ENSG00000143162 "Cellular repressor of E1A stimulated genes 1" O75629 1 167529117-167553805 "Predicted secreted proteins" "Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 545.7;Kupffer cells: 559.7;monocytes: 322.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 55.4;classical monocyte: 128.4;eosinophil: 75.7;intermediate monocyte: 75.7;myeloid DC: 89.9;neutrophil: 43.7;non-classical monocyte: 72.3" "Group enriched" "Detected in all" 6 "dendritic cells: 89.9;granulocytes: 75.7;monocytes: 128.4" "Cell line enhanced" "Detected in all" "RPMI-8226: 1237.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056390 Approved Vesicles,Microtubules "Secreted to blood" NA NA 520000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" Microtubules Vesicles "HPA056390: AB_2683113" "unprognostic (3.25e-1)" "unprognostic (2.00e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-3)" "unprognostic (4.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.55e-1)" "unprognostic (5.02e-2)" "unprognostic (2.07e-3)" "unprognostic (8.54e-2)" "unprognostic (8.65e-2)" "unprognostic (1.21e-1)" "unprognostic (8.24e-3)" "unprognostic (2.99e-1)" "unprognostic (4.63e-2)" "unprognostic (3.78e-3)" "unprognostic (3.16e-1)" 130.5 127.7 37.5 79.0 41.1 125.9 109.7 39.0 45.9 76.8 47.8 77.1 60.3 61.8 109.7 91.7 70.9 128.2 82.2 36.5 40.4 132.1 295.2 99.1 98.9 46.0 39.1 84.2 70.7 75.4 64.8 110.8 44.4 62.9 82.7 80.0 104.5 74.6 71.4 109.8 63.0 77.9 45.7 136.9 61.4 50.1 49.3 35.5 125.8 78.2 63.5 116.3 63.3 61.2 93.5 41.5 21.1 43.5 325.8 89.8 53.0 39.2 17.8 30.7 39.8 67.8 104.4 101.7 112.2 43.6 57.2 143.3 24.3 84.9 20.9 140.3 82.3 41.5 31.1 37.9 111.5 93.6 295.2 94.5 250.5 35.6 38.7 42.7 10.3 35.9 218.5 405.0 42.6 39.2 19.6 95.9 22.8 214.0 63.9 32.5 58.8 1237.2 54.7 64.9 14.0 25.7 98.1 132.8 112.8 70.1 175.5 252.7 19.1 8.0 39.6 126.2 25.9 79.4 168.4 67.7 131.6 96.0 16.3 55.4 128.4 75.7 5.1 75.7 8.0 4.3 7.5 6.5 89.9 2.1 16.6 8.8 43.7 11.0 72.3 6.2 3.9 57.6 37.5 41.1 39.0 45.9 36.5 40.4 46.0 39.1 44.4 45.7 49.3 61.2 44.7 35.3 90.1 5.9 15.3 44.1 49.1 23.1 56.9 17.9 61.7 63.8 55.7 65.8 32.2 55.2 89.6 91.5 18.3 15.6 23.5 36.0 27.6 33.9 19.3 34.2 29.3 124.8 24.7 39.7 41.7 78.4 21.9 64.1 29.9 62.0 48.2 90.3 545.7 15.2 22.1 44.5 14.2 559.7 57.6 27.4 43.5 213.8 24.9 26.2 322.8 30.5 6.2 10.1 14.6 21.0 31.5 28.6 27.8 34.0 46.3 60.6 18.5 31.5 13.1 43.2 40.8 65.5 42.0 86.3 51.1 126.7 17.3 38.9 50.4 44.0 CREM hCREM-2 ENSG00000095794 "CAMP responsive element modulator" Q03060 10 35126791-35212958 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 216.6" "Cell type enhanced" "Detected in all" "dendritic cells: 819.1;Early spermatids: 2013.6;Langerhans cells: 1094.0;Late spermatids: 814.3;T-cells: 612.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 103.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001818, CAB018352" Enhanced Supported Nucleoplasm,Vesicles NA NA "Cluster 13: T-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "CAB018352: AB_673599, HPA001818: AB_1078566" "unprognostic (1.78e-1)" "unprognostic (6.26e-3)" "unprognostic (7.09e-2)" "unprognostic (2.51e-2)" "unprognostic (6.22e-3)" "unprognostic (9.27e-3)" "unprognostic (1.16e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" "unprognostic (8.98e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (4.44e-2)" "unprognostic (4.19e-1)" "unprognostic (1.66e-2)" "unprognostic (1.52e-1)" 54.9 137.4 31.9 51.0 34.3 22.0 27.1 31.3 39.2 26.4 38.6 24.5 8.9 30.3 11.4 17.6 29.2 44.5 50.5 33.6 42.9 58.8 60.5 30.5 17.6 36.7 35.5 60.6 16.0 24.5 59.5 100.3 36.0 32.0 13.6 23.5 13.4 23.3 30.0 9.0 15.9 24.5 34.1 25.3 20.7 216.6 35.8 29.3 22.3 31.3 16.9 60.5 19.1 33.5 24.8 39.0 32.3 33.2 22.2 23.0 32.2 31.8 24.8 19.6 27.0 4.6 10.2 42.0 30.2 18.7 21.2 5.6 28.0 20.8 28.5 103.8 20.6 14.9 25.7 18.6 26.5 3.6 15.2 20.4 25.9 38.3 11.7 17.2 55.3 31.1 44.3 16.9 30.4 20.0 26.1 10.8 9.6 9.2 88.6 16.0 16.9 7.8 34.8 9.7 7.5 20.4 15.1 13.1 88.7 36.5 7.2 11.0 74.0 14.9 19.1 41.4 21.3 7.4 10.9 14.6 35.6 33.1 13.0 5.3 3.5 11.5 11.5 5.5 14.6 7.0 12.6 10.4 4.1 6.8 9.0 10.4 9.7 10.2 4.2 12.4 16.2 8.5 31.9 34.3 31.3 39.2 33.6 42.9 36.7 35.5 36.0 34.1 35.8 33.5 98.7 19.2 47.9 42.7 301.8 143.4 58.0 30.9 18.8 18.3 32.1 32.4 62.3 20.0 33.2 165.5 6.2 98.7 819.1 16.8 97.8 40.6 2013.6 32.6 27.6 118.7 69.0 5.7 50.1 44.4 109.1 140.6 29.0 44.2 347.7 14.5 17.9 37.6 120.6 10.1 34.3 17.9 32.6 61.4 1094.0 814.3 26.1 286.1 247.3 30.0 187.4 39.0 65.9 113.1 34.9 30.6 19.7 32.7 109.4 49.5 15.3 64.2 46.1 19.5 46.0 45.5 232.8 464.7 156.8 15.9 108.4 230.0 612.4 46.4 13.6 52.7 CRYGA "CRY-g-A, CRYG1, CRYG5" ENSG00000168582 "Crystallin gamma A" P11844 2 208160740-208163589 "Predicted intracellular proteins" "Eye lens protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Oligodendrocyte precursor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043386 Supported Uncertain Vesicles,Cytosol NA NA "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.49e-1)" 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.7 0.6 0.3 0.2 0.3 0.2 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGB CRYG2 ENSG00000182187 "Crystallin gamma B" P07316 2 208142573-208146158 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "Early spermatids: 1.1" "Group enriched" "Detected in some" 6 "ovarian cancer: 1.1;testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "hippocampal formation: 3.3;hypothalamus: 2.2;thalamus: 2.0" HPA043386 Supported Approved Vesicles,Cytosol NA NA "Cluster 29: Early spermatids - Spermatogenesis" "Vesicles, Cytosol" "HPA043386: " "unprognostic (6.73e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGC CRYG3 ENSG00000163254 "Crystallin gamma C" P07315 2 208128137-208129828 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.7" "Group enriched" "Detected in some" 13 "Early spermatids: 1.9;Granulosa cells: 3.7;Late spermatids: 3.2;Spermatocytes: 2.1;Spermatogonia: 2.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8;ovarian cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "hippocampal formation: 3.2;hypothalamus: 1.5;thalamus: 1.2" "Group enriched" "Detected in some" 14 "cerebral cortex: 1.2;hippocampal formation: 1.5" HPA043386 Supported Approved Vesicles,Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.89e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGD CRYG4 ENSG00000118231 "Crystallin gamma D" P07320 2 208121607-208124524 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "ovary: 8.0" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 140.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "HEL: 10.0" "Not detected" "Not detected" "HPA041269, HPA043386" Supported Approved Vesicles,Cytosol NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cytosol" "HPA041269: AB_2732491, HPA043386: " "unprognostic (4.49e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.5 0.0 0.4 1.3 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.6 0.0 0.0 0.0 0.0 0.5 0.7 8.0 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.8 0.5 0.6 0.5 0.7 0.6 0.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.1 0.0 4.6 0.3 0.0 0.1 0.9 0.0 0.0 0.0 140.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 34.5 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.9 0.1 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 CSF1R "C-FMS, CD115, CSFR, FMS" ENSG00000182578 "Colony stimulating factor 1 receptor" P07333 5 150053291-150113372 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 113.3;placenta: 103.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 103.2;Hofbauer cells: 340.4;Kupffer cells: 291.2;Langerhans cells: 73.4;Macrophages: 196.3;Microglial cells: 134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 444.6;non-classical monocyte: 646.9" "Lineage enriched" "Detected in many" 5 "monocytes: 646.9" "Group enriched" "Detected in some" 4 "BEWO: 123.0;SK-BR-3: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008970, HPA012323" Uncertain Supported "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1600000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" "Vesicles, Plasma membrane" "CAB008970: , HPA012323: AB_1848977" "unprognostic (3.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (9.83e-2)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (9.37e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.72e-2)" "unprognostic (4.61e-2)" 51.3 31.0 19.6 75.1 17.1 5.6 19.3 20.2 21.4 21.6 19.3 21.9 24.3 12.1 5.8 21.0 17.2 40.6 16.6 19.8 33.8 7.1 27.5 36.6 54.4 41.4 35.5 12.7 9.9 11.8 5.7 103.3 40.1 9.1 21.5 1.5 10.1 20.8 3.2 13.4 37.3 41.9 36.6 113.3 21.0 7.0 40.6 14.3 6.0 11.8 21.7 42.6 3.8 67.6 4.5 0.2 0.0 0.0 1.9 0.4 123.0 0.2 0.2 0.0 0.0 3.8 0.0 5.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.2 1.1 3.0 0.0 6.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 6.1 0.1 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.2 0.2 0.0 47.8 0.0 1.9 0.0 20.7 0.0 0.8 0.2 0.1 3.3 0.0 0.3 0.1 6.6 2.6 0.0 3.0 138.4 4.0 0.6 444.6 0.6 0.3 0.2 0.4 139.0 0.2 0.3 0.2 21.6 0.2 646.9 11.1 0.5 132.7 19.6 17.1 20.2 21.4 19.8 33.8 41.4 35.5 40.1 36.6 40.6 67.6 2.0 0.0 3.8 0.0 4.3 2.8 0.0 0.0 1.2 0.0 0.5 2.3 3.1 4.3 0.0 0.0 0.0 6.2 2.8 0.0 0.0 0.0 4.8 0.0 0.1 10.5 0.0 2.5 0.4 0.0 103.2 2.2 1.5 0.2 2.5 8.3 2.9 1.5 340.4 0.0 0.5 0.3 0.0 291.2 73.4 5.4 1.8 196.3 3.6 134.9 39.4 0.0 1.0 1.5 0.3 0.1 1.7 0.0 1.0 0.0 0.0 0.1 0.7 0.5 13.1 1.2 2.0 2.2 0.2 0.4 1.3 26.4 1.3 2.2 0.2 0.0 CSK ENSG00000103653 "C-terminal Src kinase" P41240 15 74782057-74803198 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 169.3" "Cell type enhanced" "Detected in all" "B-cells: 130.9;dendritic cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011203, HPA026488, HPA028425" Approved Approved Enhanced Vesicles,Cytosol No No 150000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Vesicles, Cytosol" "CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899" "unprognostic (1.05e-1)" "prognostic favorable (5.14e-5)" "unprognostic (2.59e-3)" "prognostic favorable (8.22e-4)" "unprognostic (4.15e-2)" "unprognostic (4.11e-2)" "unprognostic (1.87e-1)" "unprognostic (2.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-1)" "unprognostic (4.12e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.74e-4)" "prognostic favorable (1.07e-4)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" 21.4 19.9 23.4 89.1 26.2 50.6 19.4 26.5 26.7 26.8 18.2 33.6 36.7 22.4 8.0 98.5 20.0 22.9 29.3 22.5 23.9 21.3 48.8 32.0 169.3 31.0 29.8 19.0 17.2 15.8 21.1 17.6 31.6 24.8 19.5 6.9 31.6 14.1 14.8 36.7 59.9 18.7 29.1 127.9 30.0 19.2 28.2 68.5 19.5 15.8 106.3 33.0 32.8 28.4 62.2 85.6 41.2 68.1 38.5 29.2 35.3 40.7 38.8 75.7 53.6 78.9 56.0 275.7 52.6 37.0 70.2 62.9 87.2 82.1 21.2 134.7 107.8 233.8 29.5 80.2 53.3 123.6 285.1 41.7 39.6 54.0 48.1 37.9 58.1 127.5 68.7 93.1 45.7 104.6 89.7 72.7 51.2 55.7 60.6 98.0 35.4 201.9 34.9 135.6 68.1 47.2 52.8 109.5 72.3 26.2 75.5 179.5 50.7 91.1 47.8 72.5 71.7 49.6 108.7 283.8 47.1 232.5 63.1 88.7 68.0 176.1 74.3 146.8 63.4 95.6 63.6 73.9 76.6 113.6 48.3 57.0 130.8 58.6 169.8 44.3 106.2 79.5 23.4 26.2 26.5 26.7 22.5 23.9 31.0 29.8 31.6 29.1 28.2 28.4 21.3 3.2 9.2 8.5 130.9 9.3 8.2 7.6 13.1 16.6 16.7 17.1 11.5 12.8 9.3 9.2 6.2 7.5 99.1 40.6 1.9 9.3 15.8 10.0 15.1 15.3 9.5 29.2 5.3 14.0 13.7 11.3 27.0 15.3 26.6 19.0 12.5 34.3 50.7 28.6 10.0 23.2 6.1 91.2 44.9 3.3 9.0 85.1 8.8 23.4 86.9 6.4 90.6 3.5 4.7 21.2 18.4 8.2 56.7 13.9 27.5 8.0 9.3 5.1 6.6 6.9 18.1 5.7 12.5 49.4 9.1 5.6 90.3 21.5 27.5 14.9 CSRNP1 "AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1" ENSG00000144655 "Cysteine and serine rich nuclear protein 1" Q96S65 3 39141855-39154562 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 193.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 17.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 64.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045207, HPA058463" Supported Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "HPA045207: AB_10967202, HPA058463: AB_2683726" "unprognostic (2.90e-2)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (1.46e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.07e-4)" "prognostic unfavorable (6.47e-4)" "unprognostic (2.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" 88.9 55.8 13.6 34.0 13.7 193.1 51.7 17.2 22.5 34.7 15.4 35.6 12.0 30.2 6.4 61.7 79.8 67.5 49.9 12.8 18.0 29.2 67.3 80.8 14.9 21.3 16.2 41.5 39.4 23.5 43.3 25.0 15.7 32.7 15.4 5.8 21.3 18.5 36.9 57.1 26.4 64.1 18.3 20.3 48.0 14.7 17.1 34.9 33.8 19.0 8.7 51.6 27.7 15.4 4.4 9.7 2.5 4.8 4.7 4.9 7.8 15.9 22.1 13.0 10.6 13.7 4.0 14.4 3.3 12.1 9.3 4.9 3.0 21.0 6.4 21.6 4.0 16.4 8.0 10.5 5.8 4.1 15.7 2.3 11.3 20.4 3.2 11.6 17.8 3.9 12.7 24.9 10.7 13.9 0.8 6.7 11.4 7.4 8.1 6.8 10.4 23.7 10.3 15.9 7.0 1.1 8.7 64.2 5.5 14.5 7.2 7.5 9.0 6.6 28.2 5.6 11.9 6.3 5.8 6.6 14.4 5.2 8.4 0.1 3.0 3.8 1.7 5.9 2.1 3.6 1.6 2.0 3.3 3.7 2.0 1.3 17.1 2.6 11.0 4.2 2.7 2.3 13.6 13.7 17.2 22.5 12.8 18.0 21.3 16.2 15.7 18.3 17.1 15.4 200.8 48.1 66.3 6.8 75.0 103.2 88.1 40.2 153.1 1.4 121.1 95.8 15.8 37.1 31.2 11.0 0.0 19.7 86.3 77.3 9.8 37.6 54.4 119.6 65.2 92.8 59.3 13.2 3.5 38.5 43.0 98.1 75.4 199.4 96.5 4.2 73.9 40.7 38.7 0.0 1.5 54.7 22.4 36.7 165.2 46.8 1.5 94.5 69.4 4.7 14.8 7.6 7.2 1.5 1.3 49.2 60.9 4.1 74.3 49.4 54.1 6.0 21.0 1.7 13.1 154.4 103.9 0.6 4.7 85.7 79.6 90.7 132.4 8.9 38.0 38.9 CST3 ENSG00000101439 "Cystatin C" P01034 20 23626706-23638473 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 4217.6" "Cell type enriched" "Detected in all" 4 "Langerhans cells: 18746.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4" "Group enriched" "Detected in all" 9 "dendritic cells: 7959.0;monocytes: 6424.5" "Cell line enhanced" "Detected in many" "ASC diff: 1733.4;ASC TERT1: 1179.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000118, HPA013143" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1040000000 2800000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 41: Macrophages - Immune response" "Golgi apparatus, Vesicles" "CAB000118: , HPA013143: AB_1847417" "unprognostic (3.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.83e-4)" "unprognostic (8.53e-2)" "unprognostic (4.06e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.46e-2)" "unprognostic (3.72e-1)" "unprognostic (2.29e-3)" "unprognostic (3.51e-2)" "unprognostic (1.85e-1)" "unprognostic (1.16e-1)" "unprognostic (2.97e-1)" "unprognostic (5.01e-2)" "prognostic favorable (8.77e-4)" 1046.2 707.6 3041.2 262.3 3117.9 170.8 900.3 2823.3 4217.6 587.8 3094.8 788.7 389.6 708.3 875.9 557.1 802.7 583.0 1275.3 2976.3 2707.6 517.4 833.6 595.8 463.5 3258.4 3096.2 575.8 944.1 320.0 670.1 165.9 2939.3 773.9 416.9 46.9 2008.0 441.5 749.0 497.1 800.3 367.6 3028.1 723.7 979.9 761.3 3302.7 418.9 658.8 517.4 208.1 703.0 618.4 2883.1 155.2 328.2 75.4 175.8 1733.4 1179.8 145.3 261.4 350.7 170.3 137.7 625.1 219.7 0.8 241.0 345.2 221.3 496.2 69.6 499.9 51.9 0.9 253.5 157.6 61.1 1082.9 621.2 7.5 251.0 919.0 415.9 226.6 241.5 352.5 268.5 18.5 147.6 4.0 239.5 234.4 1.5 162.2 103.5 461.9 752.2 5.7 96.4 215.2 708.0 328.3 84.7 98.2 191.1 54.6 343.3 107.7 156.5 548.2 702.0 163.4 119.0 231.6 97.7 157.1 6.2 1.8 138.0 339.5 184.0 48.1 4967.5 33.2 66.9 6424.5 25.5 23.1 18.3 45.8 7959.0 13.6 16.9 31.1 809.3 191.4 4297.7 4427.4 13.6 4250.8 3041.2 3117.9 2823.3 4217.6 2976.3 2707.6 3258.4 3096.2 2939.3 3028.1 3302.7 2883.1 662.4 115.4 168.8 849.5 93.8 942.9 571.1 568.2 213.9 152.4 660.2 512.1 240.7 1361.2 514.5 641.9 29.2 476.8 603.3 1889.9 414.8 489.9 46.2 441.1 795.0 728.2 882.1 252.1 4.5 783.6 308.7 3026.2 981.7 631.0 359.9 687.0 491.9 2563.0 1816.7 48.8 11.2 1360.6 691.7 4301.1 18746.6 184.3 2132.6 4542.6 1563.5 87.1 2025.6 248.7 99.9 263.9 6.0 1458.5 2342.1 1790.4 67.9 786.0 4301.1 1098.6 364.4 36.3 2195.7 1417.0 846.2 125.5 400.6 461.5 822.0 469.0 117.4 208.1 1039.4 1079.7 CSTF2T "CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64" ENSG00000177613 "Cleavage stimulation factor subunit 2 tau variant" Q9H0L4 10 51695486-51699595 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039216, HPA062021" Approved Enhanced Nucleoplasm,Vesicles No No "Cluster 15: NK-cells - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Vesicles "HPA039216: AB_10795462, HPA062021: AB_2684662" "unprognostic (2.60e-2)" "unprognostic (3.75e-2)" "unprognostic (2.93e-2)" "unprognostic (2.17e-1)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (5.92e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.31e-1)" "unprognostic (1.96e-1)" 13.5 13.2 10.6 17.4 13.1 13.6 11.7 13.4 13.4 11.0 11.2 10.4 11.7 11.7 10.3 9.0 14.8 10.2 14.4 10.4 11.5 11.9 12.6 9.6 19.6 13.3 12.6 17.9 12.3 18.0 6.0 11.9 13.1 11.9 10.6 13.8 10.7 9.3 22.2 10.9 11.6 12.2 13.9 17.6 11.1 9.5 12.0 21.5 11.5 22.8 19.4 12.4 6.3 18.4 16.2 18.9 27.9 29.4 38.5 26.2 1.9 22.5 20.7 25.4 24.7 25.3 23.2 46.5 12.7 19.7 15.4 24.8 21.2 23.6 22.9 27.1 24.0 26.8 19.9 4.7 18.6 10.5 23.6 38.0 18.0 22.4 25.8 16.1 19.3 26.9 29.3 25.6 22.2 13.9 42.9 16.8 10.3 19.7 40.3 33.7 56.2 9.9 19.6 13.4 23.3 30.1 18.8 19.4 20.4 28.9 36.2 19.2 20.7 16.2 22.1 15.1 28.5 32.5 13.0 32.9 33.7 24.1 14.3 2.8 4.1 4.5 3.5 3.8 4.9 1.7 2.6 2.8 4.3 3.0 4.4 4.0 1.1 10.9 2.8 2.7 4.6 2.9 10.6 13.1 13.4 13.4 10.4 11.5 13.3 12.6 13.1 13.9 12.0 18.4 13.4 9.6 7.5 2.9 15.8 9.1 7.1 15.7 12.5 18.2 8.7 5.6 14.3 8.6 11.1 9.2 8.4 24.1 13.7 7.5 23.5 16.4 1.7 9.2 13.5 17.7 6.1 17.7 4.6 15.3 14.6 12.4 9.7 7.8 20.3 10.9 17.9 16.7 15.4 20.2 5.7 8.7 10.2 14.8 8.3 2.7 23.9 8.9 0.0 3.7 22.5 13.2 33.0 3.0 19.3 13.9 6.1 19.9 7.1 4.1 9.3 13.6 17.8 13.7 6.6 16.1 9.1 37.0 15.7 8.5 6.5 6.2 17.2 12.0 11.2 5.1 CTDP1 FCP1 ENSG00000060069 "CTD phosphatase subunit 1" Q9Y5B0 18 79679803-79754510 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cataract, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 113.1;Late spermatids: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032641, HPA040394, HPA070389" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Vesicles "CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155" "unprognostic (1.71e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" "prognostic favorable (6.43e-4)" "unprognostic (2.64e-2)" "unprognostic (7.99e-2)" "unprognostic (3.47e-3)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (1.15e-1)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "prognostic favorable (5.51e-5)" "unprognostic (5.16e-2)" "unprognostic (8.58e-2)" "unprognostic (2.85e-2)" "unprognostic (4.74e-2)" 9.3 7.4 3.8 7.2 3.9 13.7 8.9 3.3 4.2 7.8 4.1 11.1 7.2 10.4 1.4 10.7 8.1 4.0 7.2 3.3 3.3 7.9 9.5 9.3 8.7 5.3 4.2 5.0 9.0 3.3 6.9 4.2 4.0 8.2 3.1 1.5 9.5 3.9 11.9 20.5 10.9 3.1 3.3 13.5 9.9 22.2 4.0 6.5 8.0 3.1 3.7 9.6 8.6 4.4 13.4 14.0 7.7 11.0 6.0 5.0 25.9 9.6 6.1 7.6 7.5 9.4 8.0 17.2 4.2 5.6 9.1 16.4 6.6 8.8 3.1 16.9 12.4 8.5 6.6 12.9 8.7 37.6 20.5 8.4 8.3 8.1 3.8 4.6 9.2 12.2 11.2 8.1 3.0 11.5 25.4 29.5 12.7 4.2 19.1 20.7 10.1 20.0 5.6 13.1 12.0 12.4 10.2 9.8 13.9 5.8 8.0 21.7 12.9 12.9 19.4 5.3 9.7 7.4 27.6 16.1 11.0 18.8 9.3 0.0 0.4 3.2 0.5 0.4 0.4 0.2 0.4 0.8 0.6 0.1 0.5 0.3 1.0 1.1 0.4 0.1 0.1 0.2 3.8 3.9 3.3 4.2 3.3 3.3 5.3 4.2 4.0 3.3 4.0 4.4 7.4 0.0 4.1 3.6 9.2 8.5 5.0 4.0 11.4 9.5 7.7 6.5 3.8 4.3 4.5 3.7 14.6 8.8 24.2 20.0 1.9 5.4 113.1 18.6 8.0 7.5 6.0 13.5 7.7 7.2 8.0 4.8 19.9 24.0 7.0 7.8 6.4 5.7 8.8 23.5 6.6 16.6 6.1 7.5 9.5 123.2 7.8 13.8 7.2 6.5 6.5 6.5 19.6 3.0 8.9 10.2 14.9 10.5 15.2 11.8 10.0 6.8 9.6 14.8 0.0 5.9 7.4 18.0 10.5 10.5 10.1 19.0 18.3 8.0 11.7 12.6 CTDSPL "C3orf8, HYA22, PSR1, RBSP3, SCP3" ENSG00000144677 "CTD small phosphatase like" O15194 3 37861880-37984469 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 170.4;Excitatory neurons: 189.3;Inhibitory neurons: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 132.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048325 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA048325: AB_2680359" "unprognostic (7.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (6.48e-3)" "unprognostic (1.73e-1)" "unprognostic (3.35e-2)" "unprognostic (1.66e-3)" "unprognostic (4.30e-2)" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-3)" "unprognostic (1.20e-1)" "prognostic favorable (6.22e-14)" "unprognostic (3.48e-2)" "unprognostic (6.84e-2)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" 21.1 9.2 19.4 6.3 20.6 10.0 28.1 24.3 23.2 20.3 17.1 33.4 14.3 20.2 14.0 23.8 17.9 29.3 29.4 18.8 17.3 39.7 21.5 27.2 4.1 19.2 17.7 19.6 15.8 12.0 10.7 31.7 16.6 26.5 30.2 3.2 27.1 31.3 21.2 52.9 17.6 23.2 18.1 17.3 31.7 10.6 19.5 7.2 14.0 19.9 5.5 26.4 19.1 17.3 44.5 18.9 7.6 24.0 29.2 41.0 57.2 30.0 37.0 20.1 23.5 27.4 35.3 0.2 17.9 36.9 8.4 36.3 19.2 56.1 16.0 0.1 15.1 27.2 18.8 63.1 26.4 0.0 6.4 21.5 132.3 21.2 25.5 22.4 28.2 12.0 8.9 0.0 33.7 13.7 11.1 0.1 31.5 17.7 2.7 12.3 14.9 0.2 63.3 28.7 6.3 19.9 16.5 28.7 33.5 30.5 28.1 7.3 23.2 14.4 20.4 27.3 19.1 0.6 0.2 0.2 15.8 14.8 27.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 2.1 19.4 20.6 24.3 23.2 18.8 17.3 19.2 17.7 16.6 18.1 19.5 17.3 26.8 67.3 27.6 170.4 1.2 30.1 17.0 17.7 27.9 10.1 25.7 59.4 42.2 65.8 25.7 23.9 0.0 34.7 1.0 35.6 23.5 14.2 21.5 7.6 17.6 22.4 45.2 7.8 189.3 4.7 9.9 32.4 10.2 27.2 1.3 15.7 22.9 18.1 7.2 10.1 126.3 18.5 2.0 13.3 6.5 51.3 71.7 11.3 8.8 22.5 1.4 9.5 1.0 87.4 48.8 14.2 17.9 98.2 0.4 15.5 9.1 19.7 12.4 1.7 26.3 55.4 40.4 10.0 16.9 17.7 28.7 9.4 2.0 65.8 42.0 14.4 CTNS "CTNS-LSB, PQLC4, SLC66A4" ENSG00000040531 "Cystinosin, lysosomal cystine transporter" O60931 17 3636459-3663103 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Protein transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 35.5;Late spermatids: 29.3;Theca cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 34.3;granulocytes: 27.9;monocytes: 10.4" "Cell line enhanced" "Detected in all" "HDLM-2: 144.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046947 Supported "Vesicles,Intermediate filaments" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 4: Macrophages - Innate immune response" "Vesicles, Intermediate filaments" "HPA046947: AB_2679872" "unprognostic (1.64e-1)" "unprognostic (1.70e-1)" "unprognostic (1.21e-1)" "unprognostic (8.25e-2)" "unprognostic (8.39e-2)" "prognostic favorable (7.33e-4)" "unprognostic (1.28e-2)" "unprognostic (8.02e-2)" "unprognostic (1.94e-1)" "unprognostic (6.62e-3)" "prognostic favorable (6.39e-5)" "unprognostic (8.40e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-1)" "unprognostic (5.64e-2)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 10.3 19.5 9.5 10.0 17.0 10.2 9.6 13.5 12.1 20.3 12.1 8.3 12.2 11.3 6.4 8.7 10.3 13.1 10.5 10.8 10.3 15.2 15.9 11.6 10.0 16.5 16.8 12.1 27.0 13.6 9.6 12.9 18.0 10.8 7.2 6.8 12.0 11.6 15.3 19.2 11.0 8.6 10.9 12.1 15.0 24.8 13.2 8.8 9.2 7.4 9.5 9.1 9.4 28.0 17.6 37.0 22.6 18.2 34.5 16.9 13.0 19.6 28.8 21.1 26.0 21.0 16.0 10.2 17.8 11.6 55.9 40.1 19.8 12.1 12.6 144.3 33.7 10.8 32.2 19.3 46.5 8.0 81.3 23.8 14.2 20.2 15.4 28.1 22.2 18.7 12.6 15.9 16.6 15.1 7.8 7.9 9.8 12.2 16.8 16.4 9.3 23.0 15.3 16.2 3.9 17.2 19.2 24.4 20.3 19.0 17.1 7.7 24.2 17.2 11.6 40.3 13.3 12.4 20.0 4.2 28.1 7.8 11.8 27.9 10.4 21.8 3.0 6.9 4.9 5.8 4.0 5.7 9.7 4.9 4.5 5.5 3.1 5.2 7.1 34.3 4.3 7.3 9.5 17.0 13.5 12.1 10.8 10.3 16.5 16.8 18.0 10.9 13.2 28.0 4.4 3.2 2.2 6.5 4.8 1.7 3.5 2.5 4.0 1.6 6.3 5.0 5.2 5.7 2.7 12.9 10.4 6.1 5.2 3.6 0.0 6.7 35.5 5.7 4.4 5.3 2.4 4.0 3.4 6.4 7.1 6.0 7.7 4.3 8.2 6.7 9.3 7.6 25.2 5.0 3.4 2.5 4.1 7.2 5.9 29.3 9.6 12.1 5.4 3.7 10.0 6.5 3.1 5.5 11.1 6.4 3.3 12.8 4.5 6.5 3.2 9.5 7.0 3.9 6.6 3.7 3.5 19.7 8.7 2.9 2.4 8.5 3.3 30.9 1.8 3.2 CTSB ENSG00000164733 "Cathepsin B" P07858 8 11842524-11869533 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 1446.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1" "Group enriched" "Detected in all" 6 "dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1" "Cell line enhanced" "Detected in all" "BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000457, HPA018156, HPA048998" Enhanced Supported Nucleoli,Vesicles "Secreted to blood" NA NA 100000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 4: Macrophages - Innate immune response" Vesicles Nucleoli "CAB000457: , HPA018156: AB_1846069, HPA048998: " "unprognostic (5.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.38e-2)" "unprognostic (2.17e-2)" "unprognostic (2.98e-3)" "unprognostic (5.96e-2)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" "unprognostic (2.82e-2)" "unprognostic (1.06e-1)" "unprognostic (7.61e-2)" "unprognostic (8.30e-2)" "unprognostic (2.85e-1)" "unprognostic (7.39e-2)" "unprognostic (4.12e-2)" "prognostic favorable (5.76e-4)" "prognostic unfavorable (9.02e-4)" 443.9 304.5 65.6 399.7 71.2 87.0 249.0 65.9 77.2 583.2 101.0 312.4 120.8 379.2 116.9 421.6 368.4 230.6 447.0 64.7 95.5 420.6 497.2 428.9 289.6 100.4 90.8 169.1 135.4 79.6 156.8 253.2 107.4 255.5 159.3 33.6 437.3 156.6 237.4 184.7 260.2 316.1 91.9 521.1 194.3 33.2 204.5 60.9 1150.7 99.3 104.0 431.9 477.8 159.2 66.6 283.4 4.0 94.9 657.3 754.5 128.3 885.0 1607.5 258.4 299.5 10.3 294.4 1.5 32.2 1436.1 419.3 279.5 65.3 157.1 195.6 25.9 52.6 58.8 10.0 397.1 479.2 7.7 73.7 296.4 532.2 327.2 427.3 611.5 33.4 20.2 81.7 260.7 194.6 62.5 6.5 23.1 16.3 839.7 91.3 33.6 39.3 202.7 2.6 121.1 4.9 68.6 165.1 68.6 514.6 110.1 97.8 68.7 922.4 766.5 111.9 129.9 259.3 182.7 178.5 4.8 432.5 22.9 249.4 390.6 610.1 90.6 26.3 467.3 35.4 44.1 79.0 31.5 287.4 38.8 48.3 21.5 97.8 31.3 307.6 410.1 78.7 703.7 65.6 71.2 65.9 77.2 64.7 95.5 100.4 90.8 107.4 91.9 204.5 159.2 87.7 109.0 171.4 17.6 54.8 54.7 441.6 563.2 54.7 55.2 94.1 74.5 320.1 165.8 331.7 114.0 41.7 279.4 122.4 147.9 27.4 294.6 15.6 105.8 240.1 163.0 154.7 210.2 36.2 238.2 341.7 155.0 44.4 183.5 179.4 105.9 204.2 239.5 2744.5 58.9 42.8 94.2 158.7 1774.9 436.5 18.5 76.4 1224.3 161.9 70.3 373.1 117.4 24.7 19.1 12.9 363.9 154.0 92.9 47.3 295.5 198.6 351.8 180.8 40.0 39.5 39.4 149.9 10.8 21.0 160.3 40.5 649.6 56.0 32.1 139.6 321.4 CTSL "CTSL1, FLJ31037" ENSG00000135047 "Cathepsin L" P07711 9 87724051-87731469 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 563.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1081.6;Extravillous trophoblasts: 1012.3;Hepatic stellate cells: 580.4;Hofbauer cells: 1105.7;Macrophages: 537.2;Syncytiotrophoblasts: 1543.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 128.1;non-classical monocyte: 195.2" "Lineage enriched" "Detected in many" 12 "monocytes: 195.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 2305.0;HSkMC: 1061.0" "Low region specificity" "Detected in all" "CAB000459, HPA070413" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 17000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" "CAB000459: AB_2292484, HPA070413: " "unprognostic (1.05e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.19e-3)" "unprognostic (8.12e-3)" "prognostic unfavorable (5.15e-5)" "unprognostic (2.09e-1)" "unprognostic (3.15e-1)" "unprognostic (6.80e-2)" "unprognostic (3.21e-1)" "prognostic favorable (4.34e-4)" "unprognostic (5.64e-3)" "unprognostic (2.26e-2)" "unprognostic (1.72e-1)" "unprognostic (7.11e-3)" 232.4 86.6 49.2 136.0 55.4 84.8 110.0 52.9 67.5 69.5 67.9 110.3 39.7 108.1 81.6 33.3 108.4 85.0 112.5 47.0 52.3 207.3 333.5 154.9 101.1 54.4 54.0 96.4 61.9 151.1 69.5 563.6 57.5 68.2 58.8 32.3 77.6 91.7 71.9 39.8 57.1 125.2 52.4 124.4 71.4 80.1 112.2 33.0 76.1 79.8 49.4 209.8 48.0 59.6 88.1 423.0 32.6 55.3 514.0 2305.0 198.4 267.2 781.8 232.2 300.6 43.0 86.3 0.0 128.9 355.4 754.0 67.5 49.8 86.0 198.4 1.9 37.8 18.1 111.2 105.1 352.6 0.1 51.4 1061.0 138.9 373.7 134.9 186.6 194.9 0.0 162.5 0.7 326.6 115.6 0.5 9.9 67.7 128.6 77.5 21.6 21.5 0.6 158.6 39.0 42.8 50.6 62.1 133.5 312.3 177.9 14.5 97.9 296.9 190.8 104.7 750.6 125.9 18.5 84.1 0.9 692.6 0.2 67.9 0.3 13.5 0.6 0.3 128.1 0.0 0.0 6.6 0.1 7.9 0.1 16.7 1.3 0.5 0.2 195.2 0.3 1.7 10.1 49.2 55.4 52.9 67.5 47.0 52.3 54.4 54.0 57.5 52.4 112.2 59.6 86.1 41.7 52.9 15.3 11.2 37.7 82.1 58.0 15.4 43.8 12.2 33.4 96.8 87.2 46.4 75.4 18.8 1081.6 0.3 16.3 27.4 91.8 5.3 48.1 119.9 110.0 11.5 251.2 18.6 93.4 1012.3 261.7 10.2 27.6 29.7 63.6 580.4 122.6 1105.7 13.5 24.0 8.5 20.3 206.9 105.4 17.4 156.9 537.2 64.0 14.0 16.2 79.5 0.0 17.6 31.7 67.2 5.6 187.3 1.9 34.5 8.0 138.3 67.3 45.4 92.1 176.9 136.3 207.4 60.5 6.8 34.0 1543.6 10.8 30.8 11.7 44.8 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832158-122846175 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1631 "pancreas: 2414.2" "Cell type enriched" "Detected in some" 6 "Exocrine glandular cells: 266.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 1.9;U-937: 1.2" "Not detected" "Not detected" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles No No "Cluster 25: Pancreas - Digestion" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663" "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.4 0.2 0.2 0.2 0.3 0.8 0.4 0.2 0.5 0.6 0.2 0.6 0.5 0.4 0.4 0.5 0.4 0.0 0.4 0.3 0.2 0.9 0.2 0.5 0.2 0.2 0.2 1.0 2414.2 0.0 1.4 0.1 0.4 0.7 0.0 0.4 0.5 0.0 0.1 0.7 0.9 0.0 0.2 1.1 0.4 1.0 0.2 0.3 0.5 0.0 0.0 0.5 0.5 0.3 0.3 0.5 0.1 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.7 0.0 0.1 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.1 0.2 0.3 0.3 0.3 1.0 0.1 0.4 0.3 0.4 0.4 0.0 0.0 0.4 0.0 0.4 0.1 0.4 0.2 0.3 0.0 0.3 0.5 0.4 0.6 0.5 0.0 0.5 0.2 0.0 0.0 0.4 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.7 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 2.8 0.1 0.1 0.1 0.0 0.4 0.0 266.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.0 0.0 0.1 0.0 0.3 0.3 6.7 0.3 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.0 43.6 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.7 0.2 0.0 0.1 0.0 0.7 0.1 0.2 0.1 CXCL16 "CXCLG16, SR-PSOX, SRPSOX" ENSG00000161921 "C-X-C motif chemokine ligand 16" Q9H2A7 17 4733533-4739928 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 4051.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 63.3;intermediate monocyte: 107.5;myeloid DC: 38.2;neutrophil: 103.2;non-classical monocyte: 141.6" "Group enriched" "Detected in many" 7 "dendritic cells: 38.2;granulocytes: 103.2;monocytes: 141.6" "Cell line enhanced" "Detected in many" "A-431: 86.5;CACO-2: 63.5;CAPAN-2: 58.4;HaCaT: 97.9;T-47d: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053253, HPA066315" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1100000 6800000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 83: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "HPA053253: AB_2682091, HPA066315: AB_2685657" "unprognostic (4.64e-3)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (3.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (4.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.78e-2)" "unprognostic (4.74e-2)" "unprognostic (2.37e-2)" "unprognostic (2.48e-2)" "unprognostic (2.60e-1)" 27.6 18.1 18.7 56.0 19.4 70.4 29.3 20.0 30.7 19.8 20.8 21.9 45.7 11.7 15.3 24.6 24.0 54.0 7.8 17.4 23.0 19.6 52.6 106.0 23.7 32.5 22.7 10.5 20.8 61.8 14.4 31.1 27.9 16.3 25.8 10.2 47.1 14.4 2.6 21.8 39.3 17.6 25.2 43.8 41.2 112.6 28.7 12.5 10.5 3.3 17.9 60.6 14.3 34.2 86.5 12.4 0.4 44.7 0.7 3.1 11.5 1.1 8.9 11.2 15.6 63.5 58.4 0.1 10.0 1.5 8.6 97.9 20.0 14.1 5.3 8.9 14.8 0.4 1.7 29.5 8.5 0.1 15.8 0.7 26.6 5.9 1.3 7.4 3.1 0.9 0.4 0.7 0.8 20.9 0.3 1.8 0.4 42.1 7.2 1.2 0.0 13.2 30.4 15.8 0.4 1.4 17.6 11.3 5.5 2.3 57.4 1.4 0.4 1.5 6.8 2.2 5.3 3.0 3.9 0.1 0.5 2.9 2.4 0.6 63.3 16.7 0.5 107.5 0.7 9.5 1.1 0.8 38.2 13.0 0.8 1.2 103.2 0.6 141.6 16.0 0.1 29.2 18.7 19.4 20.0 30.7 17.4 23.0 32.5 22.7 27.9 25.2 28.7 34.2 9.7 73.7 46.6 1.6 17.4 70.1 130.4 133.4 40.5 2.6 64.8 50.3 0.8 58.6 132.4 40.5 2.1 3.4 11.1 28.1 3.9 151.0 795.4 22.1 4.1 25.4 30.9 2.7 0.1 145.9 2.5 14.2 36.7 32.7 74.1 2.3 132.1 9.0 196.4 3.3 0.3 32.2 44.7 231.6 406.3 4051.5 24.5 270.6 26.6 15.0 556.1 13.2 1.0 5.0 1.2 188.1 44.5 30.1 2.2 277.2 51.3 17.4 62.4 1.3 19.7 3.4 14.4 22.7 11.5 33.7 76.4 2.9 11.7 1.6 23.7 272.7 CXorf38 MGC39350 ENSG00000185753 "Chromosome X open reading frame 38" Q8TB03 X 40626921-40647561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 61.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050120 Approved Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 57: B-cells - Immune response" "Vesicles, Cytosol" "HPA050120: AB_2681024" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "unprognostic (2.91e-1)" "unprognostic (6.98e-2)" "unprognostic (1.37e-1)" "unprognostic (3.15e-1)" "unprognostic (1.48e-3)" "unprognostic (7.59e-2)" "unprognostic (1.46e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (1.23e-1)" "unprognostic (1.71e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.73e-2)" "prognostic favorable (1.44e-8)" 9.0 8.2 5.1 11.5 5.9 10.5 8.2 5.8 5.3 8.0 4.5 7.6 8.3 7.3 4.6 6.1 10.0 6.4 4.8 4.9 5.3 8.1 8.0 10.2 16.1 6.2 5.6 9.5 6.0 9.5 4.8 6.8 6.3 6.3 7.7 5.7 6.5 6.1 5.0 7.9 9.7 5.8 5.8 14.4 6.6 2.1 5.9 13.2 11.1 4.1 13.4 7.2 7.0 7.0 11.3 5.9 6.2 4.9 6.5 10.8 3.3 7.5 10.5 9.1 9.1 7.7 15.8 18.5 6.4 11.2 15.2 7.4 7.6 12.5 8.3 25.7 11.4 12.5 7.1 4.6 10.8 22.0 18.6 9.6 9.0 12.7 12.5 8.7 10.4 15.8 5.3 13.7 17.0 10.5 15.4 16.7 5.6 8.2 12.8 12.7 13.2 14.4 10.7 17.0 7.0 9.6 15.1 7.5 8.9 11.6 11.4 10.1 13.0 11.9 6.8 8.7 6.5 14.7 5.5 7.9 15.4 11.4 8.0 9.3 16.0 22.1 9.2 15.8 9.7 6.9 8.7 7.4 14.2 9.6 7.6 7.8 19.7 7.3 25.1 5.9 10.9 10.3 5.1 5.9 5.8 5.3 4.9 5.3 6.2 5.6 6.3 5.8 5.9 7.0 19.8 9.6 9.1 10.1 26.9 3.6 11.3 6.3 10.8 12.6 10.5 8.0 6.4 18.6 7.6 16.5 18.8 9.2 48.3 15.1 7.9 27.7 1.0 25.2 15.0 14.0 7.3 6.3 11.9 30.1 9.7 8.9 9.7 21.6 17.1 16.5 10.4 10.8 36.6 15.2 13.1 12.7 8.2 30.7 9.8 1.3 9.6 29.5 3.6 8.4 61.9 10.2 41.2 12.1 17.8 40.5 17.2 5.3 16.4 14.7 15.8 14.4 7.8 7.6 6.6 13.5 9.2 6.5 7.4 9.7 5.4 8.2 31.2 20.6 13.3 28.3 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348754-61362283 "Predicted membrane proteins" "Electron transport, Transport" "Oxidoreductase, Translocase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 251.4" "Cell type enhanced" "Detected in all" "dendritic cells: 145.1;Melanocytes: 320.2;Theca cells: 128.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 314.5;naive B-cell: 386.6;plasmacytoid DC: 841.4" "Group enriched" "Detected in all" 9 "B-cells: 386.6;dendritic cells: 841.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoli,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles Nucleoli "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 19.5 251.4 10.2 32.6 11.5 26.0 17.3 10.5 10.7 17.1 17.4 33.3 19.2 24.1 18.7 19.6 30.4 27.5 12.3 11.0 10.1 15.3 31.0 21.3 70.3 13.0 13.7 27.1 24.4 21.5 13.8 17.3 12.6 20.9 27.8 11.4 21.8 19.8 26.1 76.0 27.8 18.8 12.3 49.7 20.8 13.6 12.1 28.1 18.5 17.7 70.4 22.9 16.2 14.0 50.2 80.6 13.4 40.6 67.8 41.9 11.3 26.0 37.3 29.8 28.9 22.6 54.3 98.1 42.1 46.2 24.0 67.5 13.6 72.2 20.1 64.5 28.5 18.3 53.6 16.5 32.0 24.9 42.3 63.4 95.7 65.3 30.0 25.0 44.1 46.1 55.5 57.3 51.2 53.3 45.7 11.4 24.5 44.7 51.9 52.2 14.0 72.6 35.2 48.1 16.2 26.1 54.7 71.5 60.5 9.6 58.6 29.3 31.7 34.2 17.8 34.2 35.6 34.3 49.9 56.8 50.6 44.2 46.4 19.4 66.4 35.5 31.0 53.8 28.6 314.5 22.1 29.2 63.5 386.6 23.5 24.6 21.8 31.5 64.0 841.4 23.6 84.8 10.2 11.5 10.5 10.7 11.0 10.1 13.0 13.7 12.6 12.3 12.1 14.0 13.0 6.4 22.8 6.8 96.2 28.3 18.3 86.6 19.9 15.9 19.6 18.7 1.9 10.0 30.0 12.9 31.3 49.9 145.1 53.6 11.7 26.2 53.6 15.4 12.0 13.5 19.2 14.1 4.3 38.8 39.5 16.4 21.4 7.5 8.8 13.0 15.4 21.0 51.4 18.5 4.1 28.9 22.4 23.8 21.2 14.2 20.8 47.9 320.2 8.4 57.1 23.7 28.8 5.5 7.2 26.6 48.9 20.7 10.5 15.9 55.6 13.7 72.0 56.2 13.1 14.8 15.8 7.2 11.5 18.4 24.0 39.5 18.7 128.9 30.7 16.2 CYB5A CYB5 ENSG00000166347 "Cytochrome b5 type A" P00167 18 74250846-74291973 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 889.6;liver: 2472.0" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6" "Cancer enhanced" "Detected in all" "liver cancer: 43.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 1117.0;RT4: 513.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006333, HPA047548, HPA058547" Enhanced Enhanced Vesicles,Cytosol No No 1400000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Cytosol" "CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750" "unprognostic (1.88e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.23e-4)" "unprognostic (1.08e-2)" "unprognostic (1.41e-1)" "unprognostic (9.14e-2)" "prognostic favorable (4.15e-4)" "unprognostic (7.79e-3)" "unprognostic (1.11e-1)" "unprognostic (3.33e-2)" "unprognostic (2.68e-2)" "unprognostic (1.65e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (4.64e-2)" "unprognostic (8.54e-2)" 309.5 109.6 38.4 31.2 39.7 25.3 253.5 42.2 45.2 86.0 37.6 146.5 438.2 44.9 176.2 78.1 81.9 301.2 84.8 37.5 38.8 889.6 2472.0 356.6 43.7 43.1 39.7 223.9 461.3 236.0 58.5 81.8 41.9 95.9 103.4 10.3 59.1 122.8 41.4 118.4 381.7 46.7 40.8 75.6 194.8 57.9 40.0 51.6 42.5 42.1 35.2 155.5 68.3 43.5 78.8 130.8 67.4 0.6 1117.0 198.2 89.5 52.6 113.8 111.0 163.8 156.2 82.7 95.6 36.7 97.6 54.4 170.6 0.1 73.1 86.9 179.8 91.7 34.9 65.6 418.1 174.6 67.3 44.1 334.1 57.4 63.0 32.3 66.0 63.6 85.8 58.6 35.0 93.7 140.9 38.3 80.5 30.4 110.0 86.8 93.6 21.9 2.3 111.9 513.2 190.4 79.7 51.4 137.1 65.8 56.6 271.5 63.7 57.9 0.6 85.8 26.6 68.1 24.6 109.2 30.3 67.0 19.2 64.3 4.1 29.5 7.5 51.3 36.3 116.2 93.7 55.6 60.2 53.7 112.7 54.5 68.6 3.7 36.3 45.7 47.8 48.8 43.2 38.4 39.7 42.2 45.2 37.5 38.8 43.1 39.7 41.9 40.8 40.0 43.5 169.7 637.8 1371.0 11.4 76.0 98.0 82.1 368.6 50.7 9.9 345.8 213.2 90.7 836.4 1053.2 842.4 4.2 229.3 29.4 197.0 2156.1 239.4 7.5 163.1 76.6 119.9 164.2 180.0 13.1 504.6 169.8 141.4 208.9 345.6 39.9 55.0 177.4 3376.3 97.4 8.4 12.6 236.5 457.7 128.6 72.9 26.7 158.1 60.8 90.7 10.3 224.1 39.2 32.0 14.1 22.7 266.7 358.9 149.7 33.4 142.0 1856.4 3630.6 619.5 14.0 52.6 49.6 85.0 15.3 42.0 141.2 223.9 44.5 52.6 1123.6 329.9 220.7 CYP2C18 "CPCI, CYP2C, CYP2C17, P450IIC17" ENSG00000108242 "Cytochrome P450 family 2 subfamily C member 18" P33260 10 94683729-94736190 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 102.8;liver: 197.0;stomach 1: 67.2" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 68.8;Hepatocytes: 124.0;Proximal enterocytes: 62.5;Squamous epithelial cells: 22.8" "Cancer enhanced" "Detected in many" "liver cancer: 18.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.2;OE19: 1.9" "Not detected" "Not detected" HPA074424 Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Plasma membrane" "HPA074424: " "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-1)" "unprognostic (9.78e-2)" "unprognostic (2.28e-1)" "unprognostic (4.22e-3)" "unprognostic (1.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (6.81e-3)" 0.3 0.0 0.0 1.6 0.1 0.0 0.3 0.2 0.1 5.3 0.0 5.9 102.8 0.1 0.0 30.9 0.0 16.3 0.0 0.1 0.0 0.3 197.0 0.8 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 2.5 0.0 5.4 0.0 0.0 4.4 83.1 0.1 0.1 0.0 67.2 0.1 0.1 0.3 0.0 0.0 7.1 0.2 9.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.0 3.3 0.0 0.3 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.1 17.2 3.2 0.0 0.0 0.1 0.0 6.7 0.0 1.5 0.0 0.6 0.1 0.0 0.0 2.7 0.5 6.9 0.2 0.1 68.8 1.3 0.0 0.0 1.8 124.0 0.0 0.0 0.8 2.1 2.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 9.1 3.9 0.0 0.3 0.0 62.5 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.3 22.8 1.7 1.5 0.1 0.1 5.7 0.0 CYP2C8 CPC8 ENSG00000138115 "Cytochrome P450 family 2 subfamily C member 8" P10632 10 95036772-95069497 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 359 "liver: 2156.6" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 1834.2" "Cancer enriched" "Detected in some" 82 "liver cancer: 102.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013547, HPA013970, HPA015066, HPA074424" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 62: Liver - Hemostasis" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Plasma membrane" "HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: " "unprognostic (3.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (1.09e-2)" "unprognostic (1.80e-3)" "unprognostic (4.29e-2)" "unprognostic (1.03e-1)" "unprognostic (3.38e-1)" "prognostic favorable (9.82e-4)" "unprognostic (2.85e-1)" "unprognostic (1.44e-3)" "unprognostic (2.63e-1)" "unprognostic (7.88e-2)" "unprognostic (1.39e-1)" "unprognostic (4.05e-4)" 0.3 1.8 1.7 0.0 1.9 0.2 0.3 1.4 2.1 0.3 1.4 0.4 0.2 0.1 0.3 0.1 1.1 4.6 0.3 1.8 2.2 1.4 2156.6 0.4 0.1 1.7 2.2 0.1 1.7 0.5 3.1 0.1 1.8 0.6 0.0 3.1 0.2 0.3 0.2 0.1 1.1 0.0 1.4 1.0 6.0 4.0 2.1 0.2 0.9 0.0 0.1 0.2 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.9 1.4 2.1 1.8 2.2 1.7 2.2 1.8 1.4 2.1 1.8 0.0 0.0 0.0 1.6 8.9 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.2 147.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 7.3 0.9 0.1 2.0 1.8 57.5 4.5 0.2 0.0 0.1 0.0 0.2 0.0 0.6 52.8 1834.2 0.0 5.0 3.7 0.1 0.0 70.9 0.0 7.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 1.2 0.5 1.2 0.0 0.0 0.1 1.0 0.8 0.9 1.7 0.0 0.0 0.3 2.1 0.6 0.0 0.0 0.0 3.3 0.0 0.2 0.2 CYP2C9 "CYP2C10, P450IIC9" ENSG00000138109 "Cytochrome P450 family 2 subfamily C member 9" P11712 10 94938658-94990091 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 1719.9" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 1704.9" "Cancer enriched" "Detected in some" 41 "liver cancer: 118.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015066, CAB016123, HPA074424" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Plasma membrane" "CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: " "unprognostic (3.37e-1)" "unprognostic (5.68e-2)" "unprognostic (9.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "prognostic favorable (2.83e-6)" "unprognostic (2.37e-1)" "unprognostic (2.05e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-4)" "unprognostic (7.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.45e-2)" "unprognostic (1.24e-2)" 0.2 0.0 0.0 0.4 0.0 0.2 0.1 0.1 0.0 1.2 0.0 2.7 87.8 0.0 0.0 7.7 0.0 7.9 0.0 0.0 0.0 4.3 1719.9 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 2.3 46.2 0.1 0.0 0.5 18.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.6 0.2 1.8 0.0 0.0 0.0 1.5 0.0 7.6 0.0 0.8 0.7 1.1 0.0 16.0 0.0 0.7 0.0 0.2 44.4 7.4 0.0 0.0 26.7 1704.9 0.0 0.0 0.1 1.4 0.0 34.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.6 0.0 0.1 0.0 65.3 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.1 1.9 0.0 2.7 0.0 CYP3A4 CYP3A3 ENSG00000160868 "Cytochrome P450 family 3 subfamily A member 4" P08684 7 99756960-99784248 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 3796.2" "Group enriched" "Detected in some" 40 "Hepatocytes: 2612.9;Proximal enterocytes: 1685.2" "Cancer enriched" "Detected in some" 240 "liver cancer: 351.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0" "Low region specificity" "Detected in all" "CAB033671, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 85: Liver - Metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 2: Hepatocytes - Metabolism" Cytosol Vesicles "CAB033671: AB_782375, HPA072245: , HPA075539: " "unprognostic (4.55e-2)" "unprognostic (8.95e-2)" "unprognostic (8.08e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.37e-2)" "unprognostic (7.07e-3)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" "unprognostic (4.92e-2)" "unprognostic (3.78e-2)" "unprognostic (6.42e-2)" "unprognostic (1.89e-8)" "unprognostic (2.59e-1)" "unprognostic (1.75e-2)" "unprognostic (9.79e-2)" "unprognostic (6.82e-2)" 0.3 3.8 0.1 1.1 0.3 0.0 0.3 0.0 0.8 0.1 0.0 4.6 797.6 0.6 0.2 0.4 0.1 0.6 0.1 0.1 0.0 4.9 3796.2 0.1 0.9 0.0 0.0 0.1 43.4 0.0 1.0 0.0 0.0 0.2 2.2 0.4 0.3 0.0 2.4 1.9 853.0 0.0 0.0 0.1 1.1 1.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.8 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 2.2 0.2 0.0 0.0 0.0 0.8 3.4 0.0 0.1 1.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.3 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 2.2 0.4 0.8 0.2 0.0 0.0 0.0 0.0 0.4 32.9 0.0 0.0 0.0 0.3 0.0 5.6 0.0 0.1 0.4 0.0 0.0 1.4 0.0 26.7 0.6 0.9 0.0 0.0 0.0 0.1 0.0 0.0 30.0 2612.9 0.0 0.0 0.6 29.6 2.0 52.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.1 38.9 0.0 0.0 0.6 1685.2 3.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.9 0.1 2.3 0.5 16.1 1.1 CYP3A43 ENSG00000021461 "Cytochrome P450 family 3 subfamily A member 43" Q9HB55 7 99828013-99866102 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 44.7" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Early spermatids: 7.5;Excitatory neurons: 3.9;granulocytes: 2.5;Hepatocytes: 6.4;Late spermatids: 3.3;Spermatocytes: 2.4" "Cancer enriched" "Detected in single" 18 "liver cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA066463, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 85: Liver - Metabolism" "Cluster 15: Hepatocytes - Hemostasis" Cytosol Vesicles "HPA066463: AB_2685670, HPA072245: , HPA075539: " "unprognostic (1.20e-3)" "unprognostic (4.74e-2)" "unprognostic (3.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.52e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.68e-2)" "unprognostic (1.44e-1)" "unprognostic (2.38e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.23e-2)" "unprognostic (6.46e-2)" "unprognostic (5.90e-2)" "unprognostic (3.10e-1)" "unprognostic (6.37e-4)" 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 44.7 0.1 0.1 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.2 0.1 0.3 0.2 0.1 0.2 0.0 0.1 0.1 0.8 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.6 0.0 0.3 0.4 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.2 0.0 0.0 3.9 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 6.4 0.1 1.7 1.9 0.0 0.0 0.6 1.9 3.3 0.0 0.2 0.0 1.0 0.0 0.2 0.0 0.5 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.7 0.1 2.4 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.2 CYP3A5 "CP35, P450PCN3, PCN3" ENSG00000106258 "Cytochrome P450 family 3 subfamily A member 5" P20815 7 99648194-99679998 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 177.7;liver: 276.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 377.4;Distal enterocytes: 382.7;Gastric mucus-secreting cells: 506.6;Hepatocytes: 454.5;Paneth cells: 451.6;Proximal enterocytes: 1074.6;Urothelial cells: 380.4" "Cancer enhanced" "Detected in many" "liver cancer: 38.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 9.7;Hep G2: 7.9;OE19: 28.3" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (2.13e-1)" "unprognostic (4.36e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.73e-1)" "prognostic favorable (3.72e-5)" "unprognostic (1.37e-3)" "unprognostic (1.21e-2)" "unprognostic (7.29e-3)" "unprognostic (3.85e-1)" "unprognostic (4.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" "unprognostic (2.39e-4)" "unprognostic (6.58e-3)" 3.3 14.4 0.1 3.8 0.4 0.6 6.5 0.8 0.9 5.1 0.4 28.4 127.3 3.1 3.0 22.1 3.1 32.7 1.0 0.3 0.0 10.6 276.1 9.2 1.4 0.6 0.0 0.8 47.0 0.0 0.9 0.4 0.4 21.6 21.0 0.7 2.9 5.7 0.9 20.5 177.7 1.1 0.0 0.8 86.5 0.4 0.0 2.1 1.0 0.0 3.2 10.4 13.1 0.5 1.6 3.3 1.6 1.9 0.4 0.6 0.5 1.5 0.0 0.0 0.0 9.7 7.4 1.0 1.5 0.0 1.2 1.2 0.0 0.0 0.0 1.8 1.2 1.2 0.7 7.9 0.1 2.0 0.6 0.0 2.1 0.0 0.0 1.4 0.0 0.9 3.3 2.0 0.0 0.3 2.6 3.8 0.4 28.3 0.8 0.6 1.6 2.2 0.4 1.5 1.2 1.7 0.9 0.8 3.2 1.6 0.5 0.7 1.2 1.8 1.6 1.6 1.2 1.0 2.6 1.7 1.6 2.6 1.5 0.4 0.3 0.4 0.4 0.3 0.9 0.2 0.6 0.6 0.2 0.1 0.4 0.5 0.5 0.4 0.2 0.3 0.5 0.2 0.1 0.4 0.8 0.9 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.5 0.9 12.8 14.8 1.3 4.8 46.1 112.7 31.0 59.7 13.7 1.1 0.4 1.3 377.4 27.3 3.7 12.5 1.7 1.7 382.7 0.0 63.4 2.0 3.1 2.2 6.3 54.6 21.7 8.6 50.7 1.2 8.5 506.6 10.3 10.1 1.8 8.2 454.5 0.6 8.4 11.0 140.5 6.1 9.5 4.5 0.5 2.5 4.1 3.6 2.8 4.9 4.0 10.3 7.1 6.5 80.1 451.6 2.6 6.4 156.3 1074.6 10.8 12.1 21.6 0.0 2.5 3.4 15.1 6.4 107.3 59.0 1.5 7.5 3.1 139.8 380.4 CYP3A7 "CP37, P450-HFLA" ENSG00000160870 "Cytochrome P450 family 3 subfamily A member 7" P24462 7 99705036-99735196 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "liver: 304.9" "Group enriched" "Detected in some" 17 "Cholangiocytes: 85.8;Hepatocytes: 60.5" "Cancer enriched" "Detected in some" 43 "liver cancer: 38.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.3;Hep G2: 2.5;HHSteC: 1.4" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (8.10e-3)" "unprognostic (1.45e-1)" "unprognostic (3.12e-1)" "unprognostic (5.47e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (8.28e-2)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-11)" "unprognostic (2.02e-2)" "unprognostic (5.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.34e-3)" 0.2 0.9 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.2 0.5 0.3 0.3 0.1 0.0 6.5 0.0 0.0 0.1 8.5 304.9 2.4 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.1 0.0 0.2 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.1 85.8 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.3 60.5 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 3.8 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 1.3 0.0 0.2 CYP3A7-CYP3A51P ENSG00000282301 "CYP3A7-CYP3A51P readthrough" 7 99684957-99735102 "Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 12.7" "Group enriched" "Detected in some" 10 "Cholangiocytes: 4.3;Hepatocytes: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA "Cluster 85: Liver - Metabolism" "Cluster 15: Hepatocytes - Hemostasis" Cytosol Vesicles "HPA072245: , HPA075539: " 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 1.1 0.1 0.0 0.0 1.5 12.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DACT3 "DAPPER3, MGC15476, RRR1" ENSG00000197380 "Dishevelled binding antagonist of beta catenin 3" Q96B18 19 46647551-46661182 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 23.9;Oligodendrocytes: 27.2;Smooth muscle cells: 22.9" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 10.5;SH-SY5Y: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043053 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles Nucleoplasm "HPA043053: AB_10794769" "unprognostic (2.35e-1)" "unprognostic (3.08e-1)" "unprognostic (5.30e-3)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.66e-1)" "unprognostic (2.03e-2)" "unprognostic (3.27e-2)" "unprognostic (2.03e-4)" "unprognostic (1.70e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.97e-8)" "unprognostic (1.59e-2)" "unprognostic (4.03e-2)" "unprognostic (3.54e-3)" "prognostic unfavorable (6.66e-4)" 9.1 3.3 42.1 5.9 42.0 1.4 5.4 41.1 54.4 34.7 3.6 53.9 3.9 48.2 14.3 7.4 37.4 7.2 27.5 48.6 33.4 5.9 2.6 14.0 1.1 45.4 40.1 17.0 1.1 1.9 4.1 1.7 39.9 19.7 6.7 5.8 1.7 24.6 2.2 4.1 13.0 31.6 34.7 6.8 18.0 18.7 46.3 0.5 4.8 2.9 0.9 39.0 15.9 58.0 0.2 0.2 5.6 5.3 1.9 1.5 0.5 3.1 5.2 1.0 1.5 0.2 0.3 0.5 2.0 10.5 1.0 0.3 3.6 0.1 1.0 0.3 1.9 1.2 0.8 0.2 2.7 0.1 2.1 4.9 0.1 1.3 0.1 0.6 0.4 0.7 1.8 1.8 0.9 0.4 0.2 1.4 2.2 0.0 0.8 4.6 1.3 0.3 0.2 0.3 2.1 24.6 0.4 0.2 0.4 5.7 0.4 0.5 0.4 2.6 3.2 2.6 0.5 1.6 0.5 0.8 0.5 0.8 1.9 2.6 0.3 0.3 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.5 0.2 0.2 1.6 0.7 0.2 0.3 0.2 0.1 42.1 42.0 41.1 54.4 48.6 33.4 45.4 40.1 39.9 34.7 46.3 58.0 1.9 6.4 5.5 13.7 0.2 2.3 1.5 0.0 0.0 16.5 1.0 2.4 17.8 1.5 0.7 0.0 2.1 5.4 0.5 0.3 0.0 0.0 23.9 0.4 9.3 3.1 1.8 0.0 9.2 0.0 2.6 7.4 0.0 0.8 6.3 0.5 1.8 0.2 1.1 1.7 16.7 0.2 2.0 1.6 9.2 8.6 7.8 1.4 3.6 7.5 1.2 9.2 2.1 15.1 27.2 0.1 1.2 14.7 0.1 1.0 0.2 0.3 0.2 6.3 6.6 2.3 22.9 2.3 2.5 0.4 3.3 9.9 1.0 4.3 0.2 1.0 DAPK2 "DRP-1, MGC119312" ENSG00000035664 "Death associated protein kinase 2" Q9UIK4 15 63907036-64072033 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 50.2;thyroid gland: 41.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 86.6;Late spermatids: 112.5;Oligodendrocytes: 99.9;Proximal enterocytes: 64.0" "Cancer enriched" "Detected in many" 15 "thyroid cancer: 30.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 94.3;eosinophil: 213.0;neutrophil: 65.9" "Lineage enriched" "Detected in many" 25 "granulocytes: 213.0" "Cell line enhanced" "Detected in many" "ASC diff: 10.6;HaCaT: 9.2;HMC-1: 18.3;MCF7: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071581 Supported "Golgi apparatus,Vesicles" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA071581: AB_2686421" "unprognostic (3.20e-2)" "unprognostic (4.07e-2)" "unprognostic (4.23e-2)" "unprognostic (1.95e-3)" "unprognostic (2.88e-2)" "unprognostic (1.30e-2)" "unprognostic (2.32e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.04e-1)" "unprognostic (3.18e-1)" "unprognostic (9.21e-2)" "unprognostic (8.51e-2)" "unprognostic (4.77e-7)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (3.20e-3)" "unprognostic (9.07e-2)" 12.5 2.2 5.9 2.7 7.6 15.9 8.8 5.9 8.1 6.7 4.3 9.8 20.6 1.6 0.2 3.3 1.7 1.5 28.0 5.5 6.7 4.5 2.0 20.0 3.1 6.2 6.8 0.9 2.7 0.9 1.6 0.4 6.6 5.1 6.6 0.4 7.5 3.6 50.2 8.1 21.3 1.7 6.0 7.8 9.9 3.1 6.6 1.5 41.9 19.6 2.6 2.4 9.5 9.5 3.1 2.3 6.1 1.5 10.6 0.5 0.0 2.1 6.7 1.1 1.2 1.0 1.6 0.2 0.7 6.7 3.7 9.2 3.8 0.1 0.6 0.2 0.2 1.3 4.5 0.1 0.1 0.1 18.3 1.1 7.9 0.4 0.2 7.0 0.7 0.1 0.4 0.1 0.7 9.7 0.0 0.4 0.7 3.1 2.2 2.9 0.0 0.3 0.0 3.2 0.4 0.3 0.4 1.2 0.0 1.5 5.2 0.4 0.4 0.9 1.0 1.4 1.8 0.6 0.2 0.0 0.0 3.0 0.3 94.3 0.2 213.0 2.1 0.1 0.9 1.3 0.6 2.2 0.2 0.4 0.0 1.4 65.9 2.7 0.1 8.6 0.1 1.3 5.9 7.6 5.9 8.1 5.5 6.7 6.2 6.8 6.6 6.0 6.6 9.5 24.9 86.6 22.3 5.2 4.8 11.6 7.0 8.7 0.6 0.1 9.4 7.4 46.2 1.5 14.6 0.0 0.0 0.1 22.6 45.2 1.9 9.1 25.3 3.0 1.6 6.4 8.4 0.8 15.9 35.6 0.2 8.7 16.3 7.8 15.2 1.3 5.7 1.3 0.4 5.0 2.1 17.0 6.1 1.3 0.8 112.5 3.1 3.2 0.0 15.0 0.3 2.1 2.1 11.1 99.9 9.4 30.6 5.7 0.4 12.0 64.0 0.3 2.8 0.3 13.1 7.6 4.5 2.6 4.9 0.5 4.1 0.1 14.9 1.9 19.6 14.0 DBF4B "ASKL1, chifb, DRF1, FLJ13087, ZDBF1B" ENSG00000161692 "DBF4 zinc finger B" Q8NFT6 17 44708608-44752264 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.0;Horizontal cells: 30.3;Oligodendrocytes: 30.9;Spermatocytes: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048465, HPA077959" Approved Supported Nucleoplasm,Vesicles NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Vesicles "HPA048465: AB_2680405, HPA077959: " "unprognostic (2.44e-1)" "unprognostic (1.26e-1)" "unprognostic (6.37e-2)" "unprognostic (2.15e-3)" "unprognostic (1.62e-1)" "unprognostic (6.13e-2)" "unprognostic (1.53e-4)" "unprognostic (7.61e-2)" "unprognostic (1.54e-2)" "unprognostic (4.08e-2)" "unprognostic (8.43e-3)" "unprognostic (1.83e-1)" "unprognostic (4.23e-6)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.57e-1)" "unprognostic (1.39e-1)" 0.9 0.7 1.1 1.2 1.1 2.0 1.3 1.2 1.8 1.5 0.5 1.9 0.6 1.9 3.5 1.4 1.8 0.7 0.8 1.1 1.0 1.6 0.6 0.8 1.5 1.1 1.0 1.7 0.9 0.8 1.7 0.9 1.1 2.3 1.2 2.9 1.1 1.3 0.6 2.0 1.5 1.5 0.8 1.6 1.3 5.1 1.2 1.9 2.7 0.4 1.3 1.6 1.3 1.2 3.7 7.7 5.7 4.2 0.5 1.1 4.9 3.9 1.7 8.1 7.9 3.3 3.1 5.5 2.1 1.3 7.2 3.6 5.0 1.7 9.3 9.2 8.2 7.0 6.2 4.3 0.2 4.8 5.9 0.5 0.6 4.4 1.4 1.8 4.1 9.3 8.9 5.6 4.4 4.0 7.1 2.9 2.5 7.7 4.0 6.2 6.6 2.3 1.8 2.2 3.1 3.4 3.8 1.2 2.9 6.1 3.9 3.1 1.8 2.8 5.2 3.6 7.2 2.6 3.5 7.2 2.1 4.1 4.3 0.0 0.1 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.1 1.1 1.1 1.2 1.8 1.1 1.0 1.1 1.0 1.1 0.8 1.2 1.2 2.1 0.0 1.1 15.0 4.0 0.6 2.6 1.2 1.2 30.0 1.5 1.3 1.1 0.0 2.1 5.5 12.5 4.2 5.8 0.6 0.0 0.3 8.1 2.0 2.2 2.8 4.2 5.5 11.4 0.8 1.4 2.3 1.5 1.1 3.8 9.6 3.3 0.3 1.4 30.3 11.0 0.3 0.0 1.3 3.1 7.4 1.2 2.5 5.4 5.6 1.4 7.2 2.1 7.5 30.9 0.2 0.2 3.0 3.4 2.0 0.7 0.5 1.9 15.7 0.0 4.5 2.0 35.7 16.5 1.9 0.1 1.4 1.4 5.3 1.1 2.3 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636363-133659329 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 272.7;brain: 236.6" "Cell type enriched" "Detected in some" 6 "Hepatic stellate cells: 10.0" "Cancer enhanced" "Detected in some" "liver cancer: 1.7" "Region enriched" "Detected in many" 8 "pons: 236.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 346 "SH-SY5Y: 1826.4" "Region enriched" "Detected in some" 6 "pons and medulla: 22.1" "Region enriched" "Detected in single" 26 "pons: 18.5" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA 1600000000 "Cluster 32: T-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 2.8 272.7 0.1 1.0 0.2 0.2 0.1 0.0 0.8 0.4 0.0 0.1 0.4 0.3 0.2 0.1 0.3 0.3 0.5 0.3 0.2 1.3 36.1 0.8 2.3 9.8 29.4 0.4 4.3 0.0 1.4 1.4 236.6 0.4 0.0 0.1 0.6 0.2 0.1 0.2 0.6 0.0 0.0 0.9 0.4 0.2 0.6 0.2 0.4 0.0 0.0 0.4 1.1 1.0 0.0 0.0 0.1 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 3.2 0.9 0.1 0.0 0.0 0.3 5.2 4.7 0.0 0.0 2.1 1826.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 0.3 0.2 9.8 29.4 236.6 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 DBNL "ABP1, HIP-55, SH3P7" ENSG00000136279 "Drebrin like" Q9UJU6 7 44044640-44069456 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Endocytosis, Immunity, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 338.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020265, HPA027735" Enhanced Supported "Vesicles,Plasma membrane" NA NA 3500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 3: Monocytes - Immune response regulation" "Vesicles, Plasma membrane" "HPA020265: AB_1850723, HPA027735: AB_10603790" "unprognostic (9.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.12e-5)" "unprognostic (2.25e-1)" "unprognostic (6.18e-3)" "unprognostic (1.83e-1)" "unprognostic (5.88e-2)" "unprognostic (8.92e-2)" "unprognostic (5.76e-3)" "unprognostic (5.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (1.46e-1)" "unprognostic (9.51e-2)" 58.1 51.6 44.2 62.8 45.1 76.6 51.3 41.7 50.4 72.4 39.9 54.6 34.7 56.0 20.2 189.0 47.8 47.2 49.2 45.8 45.2 50.7 51.1 57.8 99.6 46.2 44.8 38.0 44.3 38.4 47.8 34.9 48.4 57.0 30.6 9.4 57.5 38.0 34.3 59.9 64.7 44.8 44.3 119.5 54.7 20.8 44.6 64.8 47.6 16.4 89.1 60.3 92.0 43.4 57.6 89.1 60.5 56.6 77.0 49.7 46.0 95.9 93.6 111.5 91.5 90.0 82.5 132.3 70.0 126.1 133.6 101.9 35.6 130.6 40.7 70.6 38.9 51.9 73.8 52.4 78.5 75.8 70.3 46.6 53.3 107.1 35.2 71.5 74.1 83.9 63.8 49.3 105.5 91.5 136.5 85.3 43.1 72.9 73.0 69.4 48.1 64.5 69.8 90.5 65.6 89.8 69.6 121.5 24.4 43.8 94.0 99.4 121.1 82.7 75.5 49.5 113.6 102.7 49.4 81.2 78.3 83.2 183.8 263.3 377.1 295.0 190.3 422.7 148.3 253.9 138.0 155.0 362.5 261.7 136.5 145.1 357.4 192.4 437.9 376.6 183.1 558.8 44.2 45.1 41.7 50.4 45.8 45.2 46.2 44.8 48.4 44.3 44.6 43.4 49.9 44.8 36.2 10.7 105.4 17.6 34.1 62.9 19.4 33.0 26.7 24.0 30.6 25.8 42.2 31.3 35.5 78.9 101.6 58.5 45.0 87.0 10.3 30.7 39.3 44.8 37.8 45.8 7.4 73.2 146.4 39.3 54.6 50.7 65.9 42.3 32.5 22.5 176.0 40.4 6.7 50.0 38.7 129.6 48.6 10.6 37.0 113.4 55.2 7.5 338.3 42.5 112.3 5.5 11.4 105.9 74.0 33.8 50.2 31.5 49.0 33.6 21.6 38.6 6.6 29.0 54.6 24.4 12.8 64.4 26.7 87.3 69.5 51.9 44.0 51.1 DCAF15 "C19orf72, MGC99481" ENSG00000132017 "DDB1 and CUL4 associated factor 15" Q66K64 19 13952492-13961449 "Predicted intracellular proteins" "Immunity, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068351 Approved Vesicles,Mitochondria NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Mitochondria Vesicles "HPA068351: AB_2685977" "unprognostic (6.91e-2)" "unprognostic (6.55e-3)" "unprognostic (3.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.95e-1)" "unprognostic (1.89e-2)" "unprognostic (1.83e-3)" "unprognostic (9.72e-2)" "unprognostic (8.03e-2)" "unprognostic (1.21e-1)" "prognostic favorable (7.97e-4)" "unprognostic (1.98e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (7.97e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" 17.6 10.7 5.9 10.3 6.0 20.5 18.1 7.1 7.9 18.7 4.7 18.1 6.9 17.0 4.3 24.0 16.7 4.5 18.6 6.0 5.6 16.2 13.9 18.6 13.5 5.6 5.2 15.5 13.7 7.1 16.5 7.3 5.2 17.0 5.2 3.6 16.1 5.3 22.9 30.2 23.4 5.1 4.9 33.4 14.0 44.7 5.6 14.6 17.0 8.6 10.8 15.6 21.6 5.4 18.9 11.5 29.5 16.2 3.1 4.5 13.5 12.7 8.8 26.1 25.9 20.4 7.9 17.3 14.4 12.3 15.4 16.7 18.9 12.0 9.2 21.0 33.8 21.3 21.0 21.4 6.5 17.8 30.2 5.9 10.9 19.3 8.6 9.4 13.1 27.4 22.9 24.8 11.6 28.7 32.0 33.0 35.2 12.7 17.8 29.2 10.4 11.8 14.1 14.3 18.8 19.3 11.4 8.1 10.7 12.1 10.5 22.7 9.2 17.8 13.1 28.3 24.1 17.4 20.7 18.3 11.4 25.8 15.6 0.2 0.3 0.9 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.4 0.1 0.3 0.6 0.1 0.2 0.4 0.6 0.2 5.9 6.0 7.1 7.9 6.0 5.6 5.6 5.2 5.2 4.9 5.6 5.4 19.5 0.0 0.0 6.8 19.7 4.8 10.5 6.9 8.6 17.3 8.9 10.7 2.9 10.0 3.8 9.2 8.4 13.7 24.4 9.6 1.9 11.0 5.0 7.0 7.8 10.9 7.7 9.4 5.2 10.3 15.1 7.5 13.7 7.0 1.3 15.0 7.1 3.4 15.7 15.2 3.4 5.7 4.1 8.1 7.0 9.5 18.3 14.3 1.8 8.4 13.8 9.2 16.5 7.1 5.5 9.9 9.6 12.0 18.3 6.4 4.5 4.7 3.9 13.9 6.6 6.0 7.9 35.6 19.9 10.0 9.8 13.8 21.2 10.4 7.9 8.9 DCHS2 "CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ" ENSG00000197410 "Dachsous cadherin-related 2" Q6V1P9 4 154231742-154491799 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.7" "Cell type enhanced" "Detected in some" "Astrocytes: 63.0;Early spermatids: 20.7;Excitatory neurons: 30.3;Horizontal cells: 25.2;Inhibitory neurons: 13.2;Late spermatids: 19.4;Microglial cells: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "U-2 OS: 4.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA064159 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 9: U-2 OS - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Plasma membrane" "HPA064159: AB_2685201" "unprognostic (1.38e-2)" "unprognostic (1.51e-1)" "unprognostic (5.74e-3)" "unprognostic (5.93e-2)" "unprognostic (7.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (1.61e-1)" "unprognostic (2.53e-3)" "unprognostic (1.62e-1)" "unprognostic (1.06e-3)" "unprognostic (3.13e-1)" "unprognostic (2.62e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-3)" 0.0 0.1 0.6 0.0 0.8 0.0 0.1 0.3 0.5 0.9 0.0 1.7 0.0 1.4 0.0 0.0 0.9 0.1 0.0 0.4 0.8 0.1 0.0 0.1 0.0 0.5 1.3 0.7 0.0 0.0 0.6 0.0 0.3 0.4 0.0 0.1 0.1 0.2 0.0 0.2 0.3 0.1 0.7 0.0 1.2 1.1 1.1 0.0 0.0 0.0 0.0 0.6 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.3 0.5 0.4 0.8 0.5 1.3 0.3 0.7 1.1 1.4 0.0 0.0 0.0 63.0 0.0 0.4 0.2 0.8 0.0 0.4 0.8 0.6 1.9 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.7 0.1 0.5 0.3 6.7 0.0 30.3 0.0 0.0 1.8 3.6 0.0 0.0 1.2 0.0 0.0 0.1 25.2 13.2 0.1 0.0 0.0 0.7 19.4 0.6 0.0 0.0 13.1 0.0 0.2 0.0 6.6 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.2 0.0 0.3 0.5 1.7 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 DCLK3 "DCAMKL3, DCDC3C, KIAA1765" ENSG00000163673 "Doublecortin like kinase 3" Q9C098 3 36712422-36764349 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;testis: 2.8" "Cell type enriched" "Detected in some" 6 "Early spermatids: 53.8" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.2" "Region enhanced" "Detected in some" "basal ganglia: 3.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040685, HPA053234" Approved Approved Vesicles,Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol Vesicles "HPA040685: AB_2732487, HPA053234: " "unprognostic (9.09e-3)" "unprognostic (1.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.66e-2)" "unprognostic (2.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.96e-2)" "unprognostic (1.86e-2)" "unprognostic (2.05e-1)" "unprognostic (7.07e-2)" "unprognostic (6.11e-5)" "unprognostic (7.94e-3)" "unprognostic (5.80e-2)" "unprognostic (3.25e-3)" "unprognostic (1.36e-2)" 0.5 0.1 0.9 0.4 3.9 0.1 0.2 0.1 1.8 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.2 1.0 0.3 0.0 0.0 0.1 1.5 0.1 0.0 0.9 0.1 0.1 0.3 1.4 0.0 0.0 2.8 0.7 1.3 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.9 0.1 1.8 0.8 0.7 0.3 0.2 0.0 1.4 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 53.8 0.1 0.1 0.5 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 0.4 8.9 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.1 3.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCP1B FLJ31638 ENSG00000151065 "Decapping mRNA 1B" Q8IZD4 12 1946053-2004535 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 36.2;Early spermatids: 55.2;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in all" 5 "T-cells: 27.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039709 Approved Supported Vesicles,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 5: NTERA-2 - Transcription" "Cluster 64: Astrocytes - Nervous system maintenance" "Vesicles, Cytosol" "HPA039709: AB_10672901" "unprognostic (9.60e-2)" "unprognostic (7.19e-3)" "unprognostic (4.37e-3)" "unprognostic (2.13e-1)" "unprognostic (7.00e-2)" "unprognostic (1.08e-1)" "unprognostic (8.94e-2)" "unprognostic (3.26e-1)" "unprognostic (3.13e-1)" "unprognostic (1.53e-2)" "unprognostic (5.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" "unprognostic (3.98e-2)" "unprognostic (1.46e-1)" "unprognostic (1.84e-2)" "unprognostic (7.42e-2)" 9.2 16.4 3.4 3.4 3.4 1.6 8.8 3.0 3.6 15.0 3.9 26.2 3.0 21.9 5.8 6.6 13.8 4.0 4.5 3.2 3.6 7.9 10.0 7.9 4.8 2.9 3.0 13.1 9.0 5.5 13.6 3.7 2.9 14.4 5.0 5.0 7.7 6.7 10.5 8.1 10.2 9.2 2.9 9.2 11.9 20.7 3.5 6.7 9.4 5.1 4.6 18.2 10.9 3.1 0.1 3.8 6.9 5.3 8.5 10.7 11.5 4.7 9.2 5.8 7.1 0.6 6.0 9.4 1.6 6.9 5.0 0.0 4.6 5.0 5.1 15.8 5.0 3.9 3.0 5.6 11.3 5.6 4.5 8.1 8.1 5.2 4.5 12.0 9.6 7.2 2.5 3.7 7.1 4.5 7.8 4.6 15.0 3.4 1.4 4.6 3.3 1.7 6.8 0.0 1.0 5.0 4.0 3.3 3.4 15.4 3.4 5.1 5.7 2.8 10.0 6.4 4.9 3.1 2.5 6.5 6.6 3.8 7.1 5.3 2.9 0.3 10.0 4.2 12.5 5.1 10.3 9.8 5.4 4.9 7.8 10.2 0.5 5.9 5.0 2.6 27.3 5.5 3.4 3.4 3.0 3.6 3.2 3.6 2.9 3.0 2.9 2.9 3.5 3.1 4.9 6.4 4.6 36.2 6.4 0.9 4.1 7.5 5.2 6.4 4.0 5.0 2.5 1.5 5.7 7.3 10.4 6.5 5.1 4.0 13.7 7.3 55.2 6.6 8.7 5.8 2.4 3.0 24.3 4.2 4.8 7.6 8.2 2.8 5.7 12.2 3.3 5.9 5.7 6.7 28.9 4.6 14.2 3.5 0.9 19.8 5.6 3.7 1.8 17.8 6.5 4.1 2.1 37.7 35.3 4.9 5.8 9.4 5.8 3.0 8.1 7.2 5.2 7.0 0.0 3.7 7.1 23.6 10.2 4.5 2.4 2.9 8.6 10.3 5.1 2.9 DCT TYRP2 ENSG00000080166 "Dopachrome tautomerase" P40126 13 94436811-94479682 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Melanin biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "skin 1: 107.4" "Cell type enriched" "Detected in some" 23 "Melanocytes: 3552.1" "Cancer enriched" "Detected in some" 215 "melanoma: 155.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 272 "SK-MEL-30: 257.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA010742, HPA010743, HPA010800, CAB017634" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Cluster 61: Skin - Cornification" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" Vesicles "CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520" "unprognostic (5.99e-2)" "unprognostic (1.67e-2)" "unprognostic (1.54e-2)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" "unprognostic (3.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.81e-2)" "unprognostic (6.07e-2)" "unprognostic (1.81e-1)" "unprognostic (3.64e-3)" "unprognostic (1.06e-2)" "unprognostic (6.18e-5)" "unprognostic (6.97e-2)" "unprognostic (9.87e-2)" "unprognostic (1.22e-3)" "unprognostic (2.42e-1)" 0.4 0.4 0.6 0.0 1.0 0.1 3.0 0.4 0.7 0.2 0.2 0.3 0.0 0.3 0.9 0.0 0.9 0.1 0.1 0.6 0.6 0.2 0.2 0.1 0.0 0.6 0.6 0.4 0.4 0.0 1.6 0.0 0.5 0.3 0.0 0.9 1.5 0.3 0.4 107.4 0.1 0.1 0.6 0.1 0.1 0.6 0.6 0.5 0.2 0.1 0.0 0.2 0.3 0.5 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 257.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.4 0.7 0.6 0.6 0.6 0.6 0.5 0.6 0.6 0.5 0.0 0.0 0.0 23.5 0.0 152.3 0.1 0.0 0.0 1.0 0.3 0.5 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.5 0.1 1.2 0.0 0.0 16.1 0.2 0.0 1.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 25.5 23.8 0.9 0.0 3552.1 1.9 0.0 3.5 0.0 6.6 2.4 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.5 1.0 0.5 0.8 0.0 33.4 0.0 0.9 0.1 0.0 0.0 DCUN1D4 KIAA0276 ENSG00000109184 "Defective in cullin neddylation 1 domain containing 4" Q92564 4 51843000-51916837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 111.9;Oligodendrocytes: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036483, HPA036484" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 15: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Vesicles Nucleoplasm "HPA036483: AB_10670719, HPA036484: AB_10671843" "unprognostic (3.16e-2)" "unprognostic (2.65e-1)" "unprognostic (2.77e-3)" "unprognostic (1.41e-1)" "unprognostic (5.61e-2)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (1.37e-1)" "unprognostic (8.47e-3)" "unprognostic (1.61e-3)" "unprognostic (3.88e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-3)" "unprognostic (2.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.10e-3)" "unprognostic (1.40e-1)" 14.0 17.8 14.5 7.3 14.1 2.8 9.8 14.4 20.3 13.3 8.1 15.0 5.9 13.6 11.5 10.4 12.7 11.4 12.1 13.4 17.3 14.9 28.9 9.1 7.5 16.0 16.2 16.0 9.1 9.5 15.7 6.9 17.2 12.0 8.5 15.7 13.4 16.9 11.8 7.7 9.7 17.3 14.2 9.4 13.3 17.0 18.9 6.5 13.2 11.4 6.1 16.9 10.9 16.4 10.6 18.9 25.5 36.7 25.6 27.5 9.8 31.1 23.2 18.0 15.9 11.8 12.1 8.1 20.1 35.2 23.5 11.2 31.0 19.8 27.8 4.9 9.5 13.8 14.9 28.7 54.9 20.4 17.9 25.1 23.7 19.6 17.9 27.0 19.2 7.4 15.6 5.9 35.3 15.2 24.1 13.6 14.5 21.1 15.1 11.4 12.2 4.4 23.1 12.4 14.4 15.6 13.1 17.8 28.9 13.9 18.4 12.3 28.8 24.0 19.7 19.7 25.7 11.1 18.1 7.3 16.6 18.8 14.4 6.8 3.6 8.8 5.7 3.3 8.5 3.6 6.4 6.5 2.5 2.4 6.0 6.8 1.4 3.7 2.4 1.5 3.2 4.4 14.5 14.1 14.4 20.3 13.4 17.3 16.0 16.2 17.2 14.2 18.9 16.4 13.1 6.4 14.1 86.2 9.7 37.2 19.2 16.5 16.5 23.3 18.1 11.7 40.6 14.3 13.2 16.5 16.7 5.0 9.8 14.9 13.7 10.6 76.3 10.7 16.1 17.9 6.7 11.8 90.9 12.2 8.5 23.1 21.9 10.0 13.3 18.9 17.2 35.8 8.2 30.3 88.6 7.2 12.2 7.3 18.4 111.9 14.9 7.2 32.0 51.5 5.3 14.9 15.5 69.4 131.4 13.3 10.9 25.9 6.3 17.2 8.9 24.1 18.1 17.8 0.0 13.4 20.8 24.6 25.5 17.3 33.2 3.4 11.1 12.4 8.9 15.0 DEFA5 "DEF5, HD-5" ENSG00000164816 "Defensin alpha 5" Q01523 8 7055304-7056739 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 768 "intestine: 9759.8" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 1740.2;Undifferentiated cells: 1753.0" "Cancer enhanced" "Detected in many" "cervical cancer: 181.1;colorectal cancer: 147.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 28.3;NB-4: 24.2;RPMI-8226: 26.6;SH-SY5Y: 19.6;U-2197: 8.5" "HPA015309, HPA015775, CAB069919" Enhanced Approved Vesicles,Midbody "Secreted to digestive system" Yes NA 110000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" Vesicles Midbody "CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594" "prognostic favorable (9.44e-5)" "unprognostic (3.91e-2)" 0.3 0.4 0.1 12.7 0.1 0.2 0.5 0.1 0.5 0.0 0.1 56.6 5185.1 3.9 0.1 0.8 0.0 0.0 0.4 0.1 0.2 0.2 1.1 0.4 6.0 0.1 0.2 0.4 0.8 0.0 1.1 0.0 0.2 0.7 0.2 0.1 0.7 0.0 0.3 0.3 9759.8 0.1 0.1 0.4 0.9 0.8 0.2 0.4 0.3 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 2.5 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.1 325.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 399.9 0.0 0.0 0.0 1740.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.0 1753.0 0.0 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 258.9;Excitatory neurons: 188.2;Inhibitory neurons: 175.8;Late spermatids: 88.5;Microglial cells: 178.0;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 145.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 12.1;granulocytes: 20.4;monocytes: 21.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Approved Vesicles,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 28: BEWO - Transcription regulation" "Cluster 64: Astrocytes - Nervous system maintenance" "Vesicles, Cytosol" "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favorable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 8.5 8.3 8.2 10.3 8.3 27.0 7.1 2.7 10.3 7.9 6.8 10.6 11.3 8.3 4.6 7.7 8.7 7.2 7.3 8.1 6.2 11.4 10.8 6.9 9.0 5.6 6.0 7.9 6.2 11.9 10.2 11.3 4.9 7.7 9.6 10.3 6.1 7.6 8.4 6.9 12.6 9.9 4.8 14.2 6.9 9.5 6.4 7.1 10.8 4.8 6.2 7.6 6.5 5.7 29.0 16.7 14.7 28.0 9.8 15.3 68.3 27.4 41.0 22.9 19.6 23.0 12.5 23.1 5.5 22.3 30.1 15.9 12.6 19.9 22.2 9.8 9.7 10.9 39.1 17.1 13.2 13.2 7.0 14.2 17.6 18.9 32.2 8.0 20.6 21.8 30.3 17.2 18.7 16.5 15.8 19.1 29.4 33.1 25.2 24.3 14.4 19.5 11.4 10.1 31.1 25.3 22.1 14.4 16.9 9.6 19.8 32.8 9.7 24.5 9.4 28.9 14.6 26.0 21.7 16.0 20.6 25.9 16.5 20.4 21.1 4.3 1.8 14.6 0.9 1.7 1.3 0.8 12.1 1.8 0.8 1.0 12.8 0.8 12.8 1.9 0.6 5.3 8.2 8.3 2.7 10.3 8.1 6.2 5.6 6.0 4.9 4.8 6.4 5.7 6.4 0.0 1.5 258.9 10.0 5.1 2.6 2.5 1.8 16.1 4.8 4.3 7.7 7.2 1.7 16.5 16.7 10.0 6.8 25.3 5.9 4.3 35.1 5.0 8.2 10.5 12.0 20.2 188.2 5.1 32.2 7.6 20.9 3.9 4.5 8.8 7.5 14.5 18.0 32.0 175.8 7.6 2.0 21.4 8.2 88.5 14.6 18.7 3.6 178.0 18.7 11.6 5.2 165.4 145.2 6.1 9.5 11.3 13.1 5.3 18.3 16.0 2.9 13.1 0.0 6.7 5.9 3.8 1.4 3.8 2.8 8.8 5.3 4.5 7.8 3.9 DENND3 KIAA0870 ENSG00000105339 "DENN domain containing 3" A2RUS2 8 141117278-141195808 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 106.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 157.0;Microglial cells: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 34.6;neutrophil: 39.8" "Group enriched" "Detected in many" 5 "granulocytes: 39.8;monocytes: 10.0" "Cell line enhanced" "Detected in many" "HDLM-2: 64.6;HeLa: 89.5;U-937: 58.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024491, HPA041668" Approved Approved Vesicles,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 20: HeLa - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Cytosol" "HPA024491: AB_2671581, HPA041668: " "unprognostic (2.27e-1)" "unprognostic (9.62e-2)" "unprognostic (9.47e-3)" "unprognostic (1.66e-1)" "unprognostic (6.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (7.07e-3)" "unprognostic (2.71e-2)" "unprognostic (2.25e-2)" "unprognostic (7.74e-2)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (4.51e-2)" "unprognostic (5.42e-2)" 42.8 8.9 21.7 27.2 18.8 106.4 28.2 12.2 28.4 22.9 14.7 36.2 5.7 17.8 2.1 7.5 19.1 13.6 24.9 19.9 17.7 21.5 6.5 57.9 28.6 33.6 24.7 15.1 7.6 4.1 10.0 15.1 25.7 16.9 7.8 3.7 18.2 8.5 13.8 15.6 23.7 8.3 22.7 43.9 15.8 6.1 21.2 7.1 20.6 11.7 25.1 12.4 17.6 31.4 16.4 14.8 1.0 3.1 4.4 6.4 2.4 8.5 27.4 3.8 3.0 4.6 15.3 4.2 22.8 17.5 7.5 7.8 4.2 10.0 2.7 64.6 3.6 17.3 89.5 1.4 3.9 17.2 2.4 0.5 5.1 4.2 5.3 9.2 21.1 7.8 0.2 40.7 2.9 5.2 2.6 24.1 1.1 3.2 16.6 2.9 0.8 16.6 14.8 5.6 4.7 3.0 1.8 1.3 1.1 7.3 6.8 27.6 16.7 0.7 6.8 10.6 0.3 8.0 37.0 1.3 2.6 58.6 1.0 24.3 5.4 34.6 0.8 8.0 0.8 5.0 0.6 0.3 4.1 4.3 0.1 0.2 39.8 2.7 10.0 0.1 0.2 3.5 21.7 18.8 12.2 28.4 19.9 17.7 33.6 24.7 25.7 22.7 21.2 31.4 49.0 157.0 35.2 2.6 39.7 15.7 7.6 11.7 7.4 4.5 6.3 2.0 10.1 10.0 18.8 22.0 4.2 0.7 29.5 18.3 1.9 3.5 6.1 15.1 8.1 31.7 4.8 5.7 53.9 3.5 0.6 4.8 16.8 14.5 10.8 1.9 16.4 0.3 24.4 1.7 5.2 7.9 4.1 55.6 22.2 2.8 1.5 39.7 8.8 79.6 33.0 0.7 21.6 1.5 1.1 11.0 9.9 0.7 38.8 20.3 1.5 2.7 15.1 0.5 39.5 2.1 21.5 8.7 8.5 2.9 9.1 0.5 12.5 0.6 4.1 6.3 DENND5A "FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1" ENSG00000184014 "DENN domain containing 5A" Q6IQ26 11 9138825-9265959 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 287.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052923, HPA055009" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Vesicles" "HPA052923: AB_2681989, HPA055009: AB_2682669" "unprognostic (5.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" "unprognostic (1.28e-2)" "unprognostic (4.03e-1)" "unprognostic (3.48e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (1.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "unprognostic (5.15e-2)" "unprognostic (3.10e-1)" "prognostic unfavorable (1.14e-6)" "unprognostic (9.86e-3)" "unprognostic (1.03e-1)" "unprognostic (4.32e-1)" "unprognostic (1.40e-2)" 45.8 23.5 72.4 23.2 90.5 21.7 36.3 85.0 80.7 36.1 45.5 44.2 5.8 38.5 14.1 17.4 37.5 23.3 58.0 65.1 85.4 25.5 15.7 46.1 16.8 81.5 86.6 30.2 23.2 18.5 20.5 28.8 77.0 24.5 12.9 34.7 19.5 40.0 26.7 17.3 20.2 47.5 74.9 31.4 23.7 15.8 87.3 28.0 22.0 33.7 15.9 40.4 25.1 81.3 18.8 23.3 63.7 56.1 113.0 92.0 61.7 69.2 99.8 85.7 104.5 16.4 13.6 0.0 30.5 129.0 82.4 12.7 64.3 22.5 111.4 73.0 30.9 6.2 32.2 34.5 61.0 34.4 13.9 76.8 11.5 51.1 74.6 59.7 83.8 21.9 33.6 0.3 101.9 11.0 19.4 15.1 19.7 3.2 28.6 34.2 46.1 0.3 41.6 13.4 15.9 32.1 65.8 29.7 27.2 70.4 15.7 24.6 59.2 63.0 41.0 78.7 47.3 1.4 0.4 18.7 63.4 14.1 51.9 4.4 5.0 5.7 0.1 6.3 0.6 1.8 1.3 1.3 4.6 0.2 3.8 1.9 10.8 1.0 9.2 1.1 0.0 1.9 72.4 90.5 85.0 80.7 65.1 85.4 81.5 86.6 77.0 74.9 87.3 81.3 34.1 19.2 14.5 43.8 7.4 21.7 19.3 10.3 10.2 9.7 15.3 13.8 33.2 14.3 8.0 14.7 60.5 15.9 6.4 0.3 0.0 7.3 1.1 26.3 31.8 31.3 6.6 7.8 47.7 6.7 20.1 27.1 3.1 57.8 2.5 11.6 21.4 10.9 21.8 13.5 74.2 2.2 4.1 36.3 63.4 2.0 21.5 48.9 19.6 68.4 41.1 11.6 3.1 136.2 287.1 8.4 1.4 20.7 0.9 32.5 0.1 10.3 4.8 10.5 26.3 34.4 31.6 7.9 12.3 6.3 8.2 11.2 6.3 16.0 0.8 15.0 DEPP1 "C10orf10, DEPP, FIG, Fseg" ENSG00000165507 "DEPP1 autophagy regulator" Q9NTK1 10 44970981-44978809 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 889.5;breast: 697.2" "Cell type enhanced" "Detected in many" "Adipocytes: 192.0;Ductal cells: 146.3;Exocrine glandular cells: 113.0;Glandular and luminal cells: 87.1;Syncytiotrophoblasts: 300.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 143.2;HDLM-2: 106.7;HHSteC: 258.2;HSkMC: 201.6;HUVEC TERT2: 165.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013687, HPA037818, HPA037819" Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Mitochondria Vesicles "CAB013687: , HPA037818: , HPA037819: AB_2675685" "unprognostic (3.99e-2)" "unprognostic (4.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-3)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (4.25e-1)" "unprognostic (5.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.89e-2)" "prognostic unfavorable (2.29e-6)" "unprognostic (2.30e-3)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.74e-1)" 889.5 48.4 62.3 19.4 71.4 4.5 697.2 59.5 71.8 153.0 50.3 145.7 16.7 168.5 16.5 65.7 334.2 68.5 260.6 55.5 71.9 95.4 131.6 508.6 63.0 175.9 72.3 297.8 349.7 23.0 85.2 76.5 93.4 82.6 12.0 28.2 119.7 22.8 165.8 165.0 94.8 68.8 101.6 32.8 104.6 19.3 87.4 25.2 200.5 52.2 47.6 177.6 139.1 90.6 30.2 0.2 0.5 0.4 143.2 69.5 7.4 0.2 10.2 0.4 1.8 1.1 11.2 0.0 1.6 13.5 7.1 1.2 1.2 9.1 0.7 106.7 4.0 0.1 0.1 11.0 258.2 0.1 0.1 201.6 0.4 0.1 1.4 24.9 165.0 0.0 0.2 63.2 0.6 0.0 0.1 1.7 0.2 0.6 0.9 5.1 1.7 25.7 0.5 10.9 5.6 0.3 0.0 1.3 5.8 17.0 0.2 7.0 1.6 7.8 5.6 0.5 7.3 1.7 2.8 0.4 44.2 2.6 4.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.4 62.3 71.4 59.5 71.8 55.5 71.9 175.9 72.3 93.4 101.6 87.4 90.6 192.0 0.0 24.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 47.0 27.8 0.0 0.0 6.2 31.3 0.0 53.8 1.4 0.0 37.2 146.3 0.0 61.3 33.2 60.0 0.0 0.0 0.0 113.0 14.7 79.3 0.0 87.1 0.0 8.4 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 65.0 0.0 0.0 0.5 0.0 0.0 25.5 5.8 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 300.2 1.8 0.8 0.0 0.0 DGAT2 ENSG00000062282 "Diacylglycerol O-acyltransferase 2" Q96PD7 11 75759512-75801535 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 476.0;breast: 133.6;liver: 331.8;skin 1: 151.5" "Cell type enhanced" "Detected in many" "Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5" "Cancer enhanced" "Detected in many" "liver cancer: 19.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "eosinophil: 137.7;neutrophil: 348.6" "Lineage enriched" "Detected in many" 16 "granulocytes: 348.6" "Cell line enhanced" "Detected in many" "ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 22.0" HPA013351 Approved Vesicles,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 21: OE19 - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" "Vesicles, Cytosol" "HPA013351: AB_1847630" "unprognostic (2.28e-1)" "unprognostic (3.69e-1)" "unprognostic (9.38e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.63e-1)" "unprognostic (4.99e-2)" "unprognostic (1.10e-2)" "unprognostic (7.59e-2)" "unprognostic (4.46e-1)" "unprognostic (4.12e-3)" "unprognostic (2.87e-1)" "unprognostic (2.99e-1)" "unprognostic (1.49e-7)" "unprognostic (2.03e-1)" "unprognostic (2.85e-1)" "unprognostic (2.74e-2)" "unprognostic (5.60e-2)" 476.0 5.1 5.8 19.4 11.7 7.2 133.6 2.9 6.1 2.6 5.3 9.0 14.5 1.2 1.8 24.1 2.1 5.8 11.7 5.7 6.4 3.4 331.8 5.6 4.0 3.7 3.9 1.8 4.6 2.1 1.6 1.5 5.5 2.2 4.9 0.6 10.5 1.6 4.1 151.5 16.5 2.8 3.4 15.0 12.8 38.1 6.9 4.3 8.8 5.6 18.2 21.3 12.6 5.1 13.3 6.4 0.4 11.2 80.4 6.4 1.0 1.3 1.7 1.6 1.0 46.6 13.5 21.1 16.8 0.3 11.9 0.5 1.8 6.5 4.4 62.5 1.2 1.5 4.0 64.9 0.9 7.4 7.2 26.8 33.6 7.3 10.6 4.4 1.2 20.9 1.2 27.6 0.7 8.5 5.1 16.7 3.6 124.0 31.5 0.0 0.1 24.8 1.2 35.8 22.6 1.4 12.3 1.9 2.9 2.7 4.4 26.6 1.6 14.1 7.0 0.3 9.1 16.3 40.0 28.8 10.2 23.7 25.3 19.4 22.1 137.7 0.0 4.4 0.4 7.4 0.4 0.0 6.1 7.6 0.1 0.2 348.6 0.0 5.0 1.8 0.0 5.7 5.8 11.7 2.9 6.1 5.7 6.4 3.7 3.9 5.5 3.4 6.9 5.1 3.2 6.4 5.4 0.3 5.0 1.1 0.9 3.0 0.6 0.9 5.2 7.0 3.5 0.0 2.7 0.0 2.1 0.5 0.3 0.6 0.0 1.7 259.3 3.3 0.2 0.5 1.2 2.7 2.9 0.5 0.1 0.7 10.7 0.2 0.0 2.1 2.9 116.4 2.2 1.7 1.3 4.8 0.0 4.1 13.1 64.1 2.1 4.2 1.8 0.0 4.0 0.4 0.0 0.0 1.0 3.7 2.2 0.7 0.9 2.8 1.2 2.2 3.4 0.0 6.6 0.6 1.0 53.9 53.5 0.3 8.0 0.8 0.5 0.2 3.0 15.7 DGKG DAGK3 ENSG00000058866 "Diacylglycerol kinase gamma" P49619 3 186105668-186362234 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell type enhanced" "Detected in many" "Astrocytes: 223.0;Excitatory neurons: 111.0;Inhibitory neurons: 63.5;Oligodendrocyte precursor cells: 334.8" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 2.1;eosinophil: 1.2;intermediate monocyte: 1.2;myeloid DC: 1.5;neutrophil: 2.6;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 7 "dendritic cells: 1.5;granulocytes: 2.6;monocytes: 2.1" "Cell line enhanced" "Detected in some" "HDLM-2: 23.9;HL-60: 7.7;U-266/84: 9.4;U-87 MG: 14.3;U-937: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036577 Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Plasma membrane" "HPA036577: AB_10672358" "unprognostic (2.23e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-2)" "unprognostic (3.24e-5)" "unprognostic (2.70e-1)" "unprognostic (6.09e-4)" "unprognostic (1.21e-3)" "unprognostic (3.80e-2)" "unprognostic (5.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.94e-1)" "unprognostic (5.09e-2)" "unprognostic (8.05e-7)" "unprognostic (3.47e-3)" "unprognostic (7.19e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-3)" 1.6 4.2 14.2 0.8 17.4 9.3 1.1 28.2 11.9 2.2 0.0 3.2 1.4 1.2 8.0 4.6 4.1 0.9 9.1 20.4 3.6 1.3 0.8 3.8 0.9 20.1 6.5 1.2 0.5 5.7 6.0 7.8 20.8 1.3 0.8 1.7 0.8 1.8 1.8 0.8 1.7 2.4 0.6 0.9 2.1 0.3 9.6 0.5 1.8 1.0 0.8 3.4 1.7 13.2 3.2 4.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 2.7 0.0 3.3 0.2 0.0 0.0 0.0 23.9 0.0 3.2 0.0 3.5 0.0 7.7 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.6 0.0 0.4 0.4 0.1 0.1 2.6 0.4 0.0 1.4 1.7 0.0 2.6 0.0 0.0 0.6 0.0 0.9 0.0 2.0 0.0 0.1 4.9 0.0 0.0 0.8 2.4 2.9 0.0 9.4 0.0 14.3 7.0 2.6 0.0 2.1 1.2 0.0 1.2 0.0 0.3 0.0 0.0 1.5 0.1 0.0 0.0 2.6 0.0 1.5 0.2 0.0 0.7 14.2 17.4 28.2 11.9 20.4 3.6 20.1 6.5 20.8 0.6 9.6 13.2 0.1 0.0 1.7 223.0 3.1 0.4 0.2 0.0 0.6 0.1 0.1 0.4 19.4 1.5 0.0 1.8 0.0 0.1 0.0 0.0 0.0 1.4 2.6 0.3 0.1 5.0 0.0 0.4 111.0 1.2 0.0 0.5 0.5 0.1 0.0 0.3 22.1 0.0 2.1 1.7 63.5 0.1 0.0 3.2 1.4 4.2 1.8 3.4 0.0 12.2 5.2 6.8 0.0 334.8 7.8 1.0 0.1 0.4 0.2 0.4 0.1 0.9 0.0 0.1 13.1 1.8 14.5 0.0 0.2 0.4 0.4 0.1 0.1 0.9 0.1 0.4 DGKH DGKeta ENSG00000102780 "Diacylglycerol kinase eta" Q86XP1 13 42040036-42256578 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enhanced" "Detected in all" "Prostatic glandular cells: 137.8;Urothelial cells: 147.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 25.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039533, HPA040355, HPA061538" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 10: Brain - Neuronal signaling" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Plasma membrane" Vesicles "HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: " "unprognostic (2.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.55e-3)" "unprognostic (7.62e-2)" "unprognostic (1.04e-2)" "unprognostic (9.60e-2)" "unprognostic (7.00e-3)" "unprognostic (4.37e-2)" "unprognostic (1.86e-1)" "unprognostic (2.41e-1)" "unprognostic (3.43e-3)" "unprognostic (1.03e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (1.43e-2)" 3.7 1.3 4.5 2.0 25.8 1.3 3.5 8.7 5.4 4.4 0.0 3.7 1.5 6.4 6.9 4.1 4.3 2.5 3.0 7.3 4.4 3.3 1.0 7.8 2.2 0.0 7.4 2.8 1.0 0.7 2.6 4.5 0.4 2.8 3.3 2.6 3.0 2.1 1.5 3.2 2.7 4.0 0.2 1.7 2.6 2.3 9.7 2.7 2.5 2.2 1.3 5.3 4.6 2.8 5.6 6.6 4.3 3.6 1.9 4.2 0.5 3.4 2.7 2.2 2.8 0.6 4.7 4.3 4.1 3.7 8.3 11.8 3.8 7.7 3.3 3.4 12.4 7.6 3.6 0.4 2.4 3.3 2.0 1.6 7.7 4.3 17.0 3.4 9.9 5.3 3.0 2.9 3.8 5.1 3.4 1.7 1.9 5.2 4.3 5.0 3.8 2.9 7.4 16.7 2.5 2.6 3.1 4.0 3.0 1.8 3.4 8.9 9.8 4.1 3.8 4.5 4.7 1.5 1.5 4.8 2.4 2.9 3.1 0.6 0.3 0.1 0.2 0.2 0.2 0.1 0.4 0.4 0.0 0.2 0.2 0.4 0.9 0.1 0.1 0.3 0.3 0.1 4.5 25.8 8.7 5.4 7.3 4.4 0.0 7.4 0.4 0.2 9.7 2.8 64.8 22.4 20.1 8.8 1.9 61.7 58.1 61.1 15.9 44.5 13.6 8.9 8.5 24.3 44.7 11.0 4.2 3.7 2.2 29.0 1.9 11.3 25.9 64.1 26.0 50.8 47.4 2.7 85.4 7.2 2.2 17.5 15.3 46.2 7.6 5.7 23.2 3.2 6.8 1.7 60.2 18.7 14.2 5.6 43.1 20.1 3.4 8.0 8.8 56.2 8.6 18.8 1.0 54.3 11.0 27.6 19.2 9.1 6.2 137.8 13.1 8.4 91.8 2.6 26.3 16.2 54.1 3.8 3.8 19.7 33.1 2.9 13.0 11.5 22.0 147.3 DHRS4 "FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2" ENSG00000157326 "Dehydrogenase/reductase 4" Q9BTZ2 14 23953734-23969279 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.21e-2)" "unprognostic (2.59e-1)" "unprognostic (3.46e-2)" "unprognostic (3.79e-3)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (7.35e-3)" "unprognostic (1.61e-3)" "unprognostic (2.66e-1)" "unprognostic (1.19e-2)" "unprognostic (1.06e-2)" "unprognostic (7.65e-2)" "prognostic favorable (4.55e-6)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.03e-1)" "unprognostic (5.68e-2)" 34.1 45.8 8.6 10.4 9.2 6.9 34.5 8.8 9.7 30.5 10.1 43.5 34.0 27.1 5.2 45.8 23.6 5.9 49.1 8.3 8.6 92.0 109.7 28.0 10.2 9.2 8.6 33.0 40.3 8.8 19.3 5.3 9.2 31.9 13.5 3.9 31.2 8.4 62.2 44.7 38.6 8.3 8.6 32.2 33.7 37.9 9.0 9.6 25.4 14.0 8.5 30.5 33.1 9.5 15.1 29.6 10.4 17.2 16.6 18.5 0.1 27.4 15.3 11.5 9.1 6.5 16.5 13.3 14.3 14.6 7.6 18.1 8.6 12.3 10.1 34.6 16.5 7.8 23.5 36.6 9.5 11.6 45.2 18.0 14.8 9.2 20.8 12.3 14.4 19.6 11.8 30.4 15.8 52.3 21.1 10.7 9.9 18.9 30.3 33.8 18.0 41.4 12.1 17.1 19.9 16.1 27.7 17.6 13.8 6.8 16.0 14.6 25.5 13.3 13.8 13.9 9.0 22.8 22.8 3.5 11.8 12.6 13.6 5.4 54.4 6.0 18.0 45.8 21.4 21.5 20.3 18.2 47.4 18.5 20.1 19.5 2.3 18.1 25.5 39.4 19.4 36.2 8.6 9.2 8.8 9.7 8.3 8.6 9.2 8.6 9.2 8.6 9.0 9.5 16.6 16.0 30.5 6.2 12.5 12.5 10.4 15.7 55.2 5.1 22.2 31.9 35.4 17.2 21.3 14.7 0.0 9.6 17.8 34.2 78.2 6.4 50.4 13.1 11.6 14.6 19.2 20.8 2.6 9.8 6.0 23.7 34.7 7.8 13.9 10.5 20.0 68.1 30.4 6.7 2.1 50.1 8.2 29.2 13.5 66.1 11.1 35.9 5.4 3.7 33.2 18.1 47.4 4.0 5.0 5.3 22.3 17.3 24.6 11.2 51.8 235.4 23.2 1.8 6.6 13.5 18.1 59.4 1.9 61.6 13.4 3.8 18.1 22.9 71.8 9.0 DHRS4L2 SDR25C3 ENSG00000187630 "Dehydrogenase/reductase 4 like 2" Q6PKH6 14 23969874-24006408 "Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 136.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 204.2;Proximal enterocytes: 326.4;Proximal tubular cells: 581.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" "Secreted - unknown location" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.41e-2)" "unprognostic (2.83e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (6.02e-2)" "unprognostic (3.97e-3)" "unprognostic (7.34e-2)" "prognostic favorable (3.21e-4)" "unprognostic (1.57e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-3)" "unprognostic (6.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (3.65e-2)" 27.2 39.5 28.8 14.6 29.6 11.5 30.5 28.3 38.4 26.9 30.8 34.7 34.4 19.7 12.8 38.4 18.6 10.6 45.9 28.5 27.8 122.5 136.2 22.5 14.6 29.3 28.7 25.2 34.0 24.5 16.7 10.0 28.7 32.5 26.6 6.7 24.7 20.7 50.7 37.1 42.0 18.4 28.6 29.3 27.9 41.4 29.4 16.9 21.5 28.5 16.5 26.0 26.1 29.9 18.7 29.0 4.9 24.4 46.2 47.9 0.6 17.3 34.3 24.8 18.4 8.4 22.5 12.6 11.5 35.3 16.0 20.6 22.3 29.1 20.6 43.3 13.3 3.1 24.8 52.4 34.0 15.3 47.9 50.0 36.4 16.3 23.7 17.0 29.5 40.0 10.1 44.9 26.7 61.5 40.4 16.5 9.7 45.9 31.8 64.9 19.9 38.2 35.6 23.7 26.0 15.7 24.5 21.5 15.0 10.3 25.2 24.5 20.8 12.9 13.4 15.4 8.8 25.5 21.1 3.8 11.1 23.7 18.8 4.8 56.3 6.9 19.4 47.2 20.1 21.9 20.9 22.2 45.4 17.4 21.0 19.1 2.6 17.2 29.3 37.4 21.8 33.6 28.8 29.6 28.3 38.4 28.5 27.8 29.3 28.7 28.7 28.6 29.4 29.9 39.3 16.0 29.6 10.4 17.8 27.8 46.1 56.8 27.9 9.9 45.5 54.4 17.2 47.1 34.3 25.8 2.1 21.2 22.9 37.9 127.2 40.0 20.7 20.6 20.1 32.0 37.3 24.2 7.3 55.7 7.3 36.4 13.3 16.5 17.7 31.8 50.0 204.2 146.1 11.8 6.7 61.7 42.7 55.9 42.8 35.4 43.8 41.9 51.6 10.3 65.0 79.5 35.0 10.1 8.5 30.4 54.9 37.2 10.8 32.5 326.4 581.7 28.6 8.3 32.9 24.2 32.7 17.2 1.7 42.1 40.2 13.0 21.3 37.5 78.1 42.4 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358219-40378621 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 17.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.0;Distal enterocytes: 16.8;Horizontal cells: 18.5;Intestinal goblet cells: 18.2;Proximal enterocytes: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.2;HaCaT: 6.6;SCLC-21H: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Vesicles" "HPA059903: AB_2684156" "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.2 0.7 5.1 0.4 4.7 0.3 0.1 17.6 5.7 0.3 0.0 1.5 1.1 0.2 0.1 0.1 0.2 0.2 0.1 3.6 3.9 0.0 0.1 0.1 0.4 5.5 1.6 0.3 0.3 0.1 1.3 0.2 5.8 0.1 1.2 1.6 0.3 0.4 0.1 0.3 1.2 0.3 0.4 0.2 1.2 0.7 4.5 0.2 1.4 0.0 0.0 0.1 0.1 1.9 1.3 0.5 0.3 2.0 0.1 0.0 0.7 0.2 0.1 0.8 1.2 1.9 0.6 0.2 1.3 0.8 4.2 6.6 0.2 1.1 0.5 0.1 0.4 0.3 0.4 0.1 0.0 0.4 1.1 1.4 0.0 0.2 0.1 0.2 0.4 0.7 0.5 0.8 1.1 0.3 0.2 0.3 0.3 1.7 0.9 0.2 0.3 0.4 0.2 1.7 13.4 1.9 0.2 0.1 0.2 0.3 0.3 0.2 0.4 0.9 0.7 0.2 0.2 0.2 0.1 0.2 0.3 0.5 1.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.2 0.0 0.0 5.1 4.7 17.6 5.7 3.6 3.9 5.5 1.6 5.8 0.4 4.5 1.9 0.9 3.2 3.6 1.0 0.5 0.0 1.9 0.0 0.0 19.0 0.8 1.3 1.7 1.5 4.4 3.7 10.4 0.2 0.2 16.8 0.0 0.4 1.3 0.3 0.6 1.4 9.6 2.7 5.1 0.4 0.3 1.6 5.1 0.5 8.8 0.4 0.4 0.4 1.0 18.5 7.0 18.2 0.0 0.6 0.0 1.8 1.2 1.1 0.0 1.0 0.3 2.3 4.1 4.0 0.3 0.3 3.2 0.0 0.3 1.2 12.1 0.2 2.2 7.6 0.0 3.1 0.8 4.1 6.1 0.0 0.0 0.3 1.1 0.8 8.6 1.1 DLG1 "dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97" ENSG00000075711 "Discs large MAGUK scaffold protein 1" Q12959 3 197042560-197299330 "Predicted intracellular proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 422.9;Oligodendrocytes: 1542.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016307, HPA069593" Supported Uncertain "Vesicles,Plasma membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 38: EFO-21 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "Plasma membrane" "CAB016307: AB_2092015, HPA069593: " "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.79e-2)" "unprognostic (4.56e-3)" "unprognostic (3.54e-2)" "unprognostic (8.56e-2)" "unprognostic (8.90e-3)" "unprognostic (2.97e-1)" "unprognostic (5.98e-2)" "unprognostic (2.33e-1)" "unprognostic (2.41e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-3)" "unprognostic (3.56e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (3.07e-1)" 20.7 14.5 26.4 14.7 57.0 16.2 18.4 33.2 36.4 23.8 15.4 24.2 24.0 19.7 11.6 37.6 16.1 17.1 19.4 25.4 29.3 27.6 25.9 18.0 14.7 36.9 43.3 23.3 17.2 31.7 14.4 21.3 34.8 15.9 26.3 38.8 20.2 18.6 25.2 18.8 25.4 21.2 19.9 13.0 22.9 15.5 50.3 27.1 43.3 28.2 20.6 20.3 20.5 73.5 128.0 20.0 40.3 75.7 34.2 36.2 40.7 52.2 46.2 49.2 59.0 60.4 59.8 41.5 127.1 47.7 95.7 86.4 39.3 76.4 97.7 10.9 22.5 35.2 31.1 40.5 35.2 35.0 33.3 27.8 43.3 49.1 101.3 163.1 64.8 32.2 26.7 51.4 125.6 41.5 51.3 12.9 35.3 71.1 35.4 26.7 51.6 26.8 51.9 55.3 19.7 32.3 72.9 49.5 49.4 46.7 108.8 26.0 62.5 127.5 33.5 36.1 79.9 76.0 50.6 50.6 50.3 51.8 40.0 2.5 0.7 1.2 0.8 0.7 1.3 1.6 1.3 0.9 0.8 1.2 1.3 1.3 2.4 1.1 0.4 1.1 1.0 0.8 26.4 57.0 33.2 36.4 25.4 29.3 36.9 43.3 34.8 19.9 50.3 73.5 24.0 25.6 25.7 113.3 28.5 53.3 52.3 45.5 40.5 42.0 29.6 23.0 25.6 35.8 44.6 49.7 95.9 48.9 25.2 72.4 5.9 22.8 12.9 51.8 37.4 28.1 28.9 17.5 422.9 20.2 19.5 27.7 51.5 68.5 12.0 29.9 27.8 54.6 14.9 37.0 117.8 34.4 28.5 26.4 26.0 19.2 28.6 19.2 37.4 165.8 18.3 71.9 43.3 257.3 1542.2 30.3 48.0 25.6 34.1 52.3 50.6 20.8 66.3 101.7 13.1 40.5 25.5 31.2 37.9 66.7 70.8 25.0 30.6 29.3 38.8 106.8 DLG2 "chapsyn-110, PPP1R58, PSD-93, PSD93" ENSG00000150672 "Discs large MAGUK scaffold protein 2" Q15700 11 83455012-85627922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 88.4" "Group enriched" "Detected in many" 4 "Excitatory neurons: 3292.3;Inhibitory neurons: 2602.7;Oligodendrocyte precursor cells: 2331.8;Oligodendrocytes: 4213.8" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 8.2;SH-SY5Y: 8.1;T-47d: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021307, HPA023896, CAB072341" Enhanced Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 6: T47d - Mammary gland" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" Vesicles "CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353" "unprognostic (2.61e-3)" "unprognostic (2.81e-2)" "unprognostic (4.05e-2)" "unprognostic (9.03e-2)" "unprognostic (3.25e-1)" "unprognostic (1.09e-1)" "unprognostic (9.44e-3)" "unprognostic (7.78e-2)" "unprognostic (4.32e-1)" "unprognostic (4.61e-2)" "unprognostic (9.28e-3)" "unprognostic (4.84e-1)" "unprognostic (7.66e-6)" "unprognostic (2.92e-2)" "unprognostic (2.41e-1)" "unprognostic (6.52e-2)" "unprognostic (8.89e-2)" 1.6 11.0 29.5 1.1 48.7 0.3 2.1 3.6 55.8 1.8 0.0 2.3 1.2 2.9 4.1 7.5 5.7 2.1 3.0 64.4 18.1 3.6 2.8 1.7 1.1 13.5 8.2 5.7 3.3 7.3 10.0 2.4 10.3 4.0 1.4 25.4 3.1 4.6 0.8 20.2 1.2 2.2 11.9 2.5 1.5 8.1 10.5 7.3 15.5 0.7 2.9 1.7 2.6 88.4 0.6 0.3 0.9 0.5 0.6 0.7 8.2 0.2 0.5 0.4 0.3 7.4 1.1 1.3 1.3 0.4 0.5 0.8 2.3 0.7 0.4 0.8 0.9 1.3 5.0 0.2 0.1 0.4 1.1 0.5 0.5 1.0 1.0 0.4 0.5 1.9 1.2 3.5 0.7 0.9 0.6 1.3 6.0 0.8 1.3 1.4 2.0 0.9 0.4 0.3 5.9 8.1 0.8 5.1 0.4 7.2 21.2 0.0 0.3 2.2 1.8 2.1 0.3 0.8 2.9 5.6 0.8 0.7 0.2 0.0 0.0 0.2 0.1 0.0 0.5 0.1 0.1 0.2 0.0 0.6 0.6 0.2 0.0 0.0 0.1 0.5 0.0 0.0 29.5 48.7 3.6 55.8 64.4 18.1 13.5 8.2 10.3 11.9 10.5 88.4 7.0 3.2 10.4 742.8 1.3 3.3 3.6 0.3 9.1 298.1 4.4 5.2 8.3 2.8 1.8 7.3 275.2 7.9 1.8 1.5 9.8 0.7 21.5 1.3 2.7 3.6 4.2 0.0 3292.3 0.4 0.5 7.4 1.1 2.4 0.0 1.6 2.2 4.6 4.0 23.5 2602.7 1.1 0.0 0.3 0.0 16.4 7.8 0.8 1.8 487.2 0.6 11.0 0.0 2331.8 4213.8 0.4 0.1 6.4 0.1 2.0 0.6 2.7 0.9 48.2 6.6 7.1 4.1 11.3 3.2 6.2 8.5 2.1 1.7 12.1 0.9 0.8 DLGAP1 "DAP-1, GKAP, SAPAP1" ENSG00000170579 "DLG associated protein 1" O14490 18 3496032-4455307 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.4" "Group enriched" "Detected in many" 7 "Excitatory neurons: 2145.5;Inhibitory neurons: 3599.2;Oligodendrocyte precursor cells: 1264.6" "Cancer enhanced" "Detected in many" "glioma: 2.4" "Region enhanced" "Detected in many" "cerebral cortex: 39.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 10.7;HAP1: 3.7;U-2197: 3.3;U-87 MG: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078234 Approved Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Cytosol" "HPA078234: " "unprognostic (2.50e-3)" "unprognostic (7.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.98e-1)" "unprognostic (1.07e-2)" "unprognostic (3.63e-3)" "unprognostic (2.73e-2)" "unprognostic (1.97e-2)" "unprognostic (2.93e-3)" "unprognostic (5.49e-3)" "unprognostic (5.87e-4)" "unprognostic (2.18e-1)" "unprognostic (2.78e-3)" "unprognostic (3.10e-2)" "unprognostic (4.93e-3)" "unprognostic (8.93e-2)" "unprognostic (9.68e-2)" 0.4 4.3 8.3 0.2 18.3 0.0 1.5 4.4 39.4 0.6 0.0 0.3 0.1 0.7 8.2 0.2 6.5 4.1 0.4 24.0 0.0 1.2 0.1 0.7 0.2 0.0 0.0 1.9 0.2 0.0 2.4 0.6 0.0 2.9 0.2 3.2 1.9 10.1 0.1 0.2 0.2 0.3 0.0 0.5 0.1 3.7 0.0 0.1 0.5 0.4 0.1 0.5 0.6 7.4 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.7 0.0 0.2 1.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 1.4 0.8 1.2 0.0 0.1 0.0 0.8 0.2 0.0 0.0 0.0 0.0 1.0 3.3 0.0 0.2 0.0 0.1 2.3 0.0 0.9 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 18.3 4.4 39.4 24.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 1.5 0.0 4.6 309.8 0.3 0.8 0.3 0.3 5.7 23.6 6.6 2.8 3.1 7.2 0.1 1.8 0.0 0.1 0.1 0.4 0.0 0.2 11.4 31.7 8.3 1.9 3.0 0.0 2145.5 0.2 0.1 1.8 0.5 94.6 0.0 0.0 2.2 0.0 0.2 0.0 3599.2 1.7 0.0 0.0 0.7 13.8 0.6 0.6 12.4 72.1 0.1 0.2 0.0 1264.6 31.0 0.2 0.1 0.4 0.0 3.5 0.0 5.4 4.4 1.4 0.0 0.7 2.2 12.9 4.8 1.6 0.1 0.3 0.8 0.1 0.1 0.1 DMPK "DM, DM1, DM1PK, DMK, MDPK, MT-PK" ENSG00000104936 "DM1 protein kinase" Q09013 19 45769709-45782552 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 44.1;Sertoli cells: 59.2;Smooth muscle cells: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 85.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "spinal cord: 8.7" "HPA007164, HPA008905" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 38: Heart - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol Vesicles "HPA007164: AB_1078687, HPA008905: AB_1078685" "unprognostic (7.44e-2)" "unprognostic (2.66e-1)" "unprognostic (1.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.29e-1)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-1)" "prognostic favorable (9.39e-5)" "unprognostic (1.93e-1)" "unprognostic (1.60e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (4.24e-3)" 24.2 68.3 22.1 17.5 24.0 3.0 19.1 22.2 33.1 42.8 25.6 121.5 15.8 92.7 5.3 33.4 61.2 13.9 171.3 21.8 21.6 20.3 8.8 29.8 5.2 24.0 23.8 31.1 34.3 2.9 37.9 8.8 22.3 56.4 4.8 4.1 18.6 37.6 173.6 12.3 34.6 59.9 21.9 17.8 51.7 13.2 23.8 4.2 21.7 143.2 1.3 69.1 34.3 21.3 11.7 16.7 13.5 10.7 13.4 12.9 10.5 26.1 22.2 10.5 8.8 2.2 6.6 2.9 2.8 32.9 9.2 15.1 3.0 1.5 2.2 12.4 16.6 0.8 22.6 1.4 12.6 0.1 5.4 22.8 8.0 6.4 1.7 24.2 3.6 2.1 8.6 8.0 15.4 13.7 1.6 3.8 8.8 4.8 3.3 5.0 85.1 6.4 4.7 11.5 10.2 13.5 13.6 27.6 9.3 4.8 28.6 5.5 8.4 9.2 10.4 8.3 15.0 16.8 11.5 2.9 9.5 1.3 13.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 24.0 22.2 33.1 21.8 21.6 24.0 23.8 22.3 21.9 23.8 21.3 10.5 0.0 2.2 44.1 3.7 8.0 8.1 3.8 5.7 5.7 9.6 9.9 3.7 4.3 3.2 3.7 8.4 2.7 4.2 4.7 1.9 2.7 1.5 8.7 8.6 7.9 10.1 0.4 16.4 17.3 2.0 8.4 8.2 6.3 0.0 9.7 9.3 1.5 0.8 5.0 12.4 8.2 8.2 1.6 9.8 1.8 7.2 0.8 7.2 10.3 0.4 2.6 5.2 26.7 10.0 5.8 4.5 23.3 3.1 4.0 3.8 31.7 7.1 7.4 59.2 27.6 34.9 7.2 6.4 10.1 6.8 1.6 4.5 5.4 5.1 4.6 DNAJA3 "hTid-1, TID1" ENSG00000103423 "DnaJ heat shock protein family (Hsp40) member A3" Q96EY1 16 4425805-4456775 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016095, HPA040875, HPA044229" Approved Supported Vesicles,Mitochondria NA NA 16000 "Cluster 22: NK-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Vesicles "CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (2.86e-3)" "unprognostic (2.91e-2)" "unprognostic (4.17e-1)" "unprognostic (5.18e-2)" "unprognostic (1.60e-1)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (3.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.27e-2)" "prognostic favorable (1.79e-4)" "unprognostic (4.17e-2)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.92e-1)" 18.9 44.3 15.7 11.8 16.3 6.4 18.3 17.5 18.7 19.9 15.3 25.2 17.5 18.6 6.8 27.8 18.0 8.1 43.6 16.0 16.8 26.7 65.7 15.8 13.3 16.5 16.1 20.7 26.5 23.9 20.2 12.3 17.2 18.7 12.6 8.7 20.2 12.4 90.5 22.7 21.2 10.4 16.6 19.3 23.9 23.6 17.5 11.5 18.7 48.3 11.9 23.8 20.5 16.8 26.4 53.7 16.1 33.1 20.5 18.8 34.6 34.2 22.9 45.1 36.1 40.2 38.7 50.2 32.9 20.3 31.3 38.4 55.7 39.7 24.8 42.2 35.8 25.4 48.8 40.4 50.8 47.5 24.4 22.6 46.6 40.0 66.1 20.5 20.4 36.7 63.1 39.7 27.8 60.9 39.6 33.8 35.6 48.2 43.2 51.5 27.6 92.7 32.5 28.0 43.7 17.3 38.2 77.6 62.0 13.7 46.7 38.3 22.2 35.8 24.5 80.1 44.4 38.5 56.6 69.7 17.9 45.0 39.8 1.4 5.3 3.2 10.3 8.7 12.4 12.1 9.6 9.8 7.6 10.0 12.9 10.4 0.8 11.1 6.9 5.4 10.8 10.5 15.7 16.3 17.5 18.7 16.0 16.8 16.5 16.1 17.2 16.6 17.5 16.8 10.9 12.8 8.1 11.4 23.7 15.7 18.5 12.6 25.0 23.0 14.8 10.8 36.3 14.3 13.0 25.8 10.4 42.8 8.2 17.9 45.0 21.8 62.6 8.9 13.5 13.3 17.5 18.7 19.4 12.2 34.3 13.6 18.8 10.0 12.7 17.9 8.9 46.1 16.6 23.5 20.4 17.5 16.2 10.1 7.0 30.5 19.3 10.0 21.4 6.5 15.2 18.5 16.5 10.6 15.2 13.9 15.5 22.2 19.9 28.9 21.5 25.9 9.2 23.2 13.1 14.2 14.2 50.5 33.7 23.5 16.9 28.5 17.5 29.8 32.7 16.7 DNAJC13 "KIAA0678, RME8" ENSG00000138246 "DnaJ heat shock protein family (Hsp40) member C13" O75165 3 132417502-132539032 "Human disease related genes, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036923, HPA036924" Approved Supported Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" Vesicles Cytosol "HPA036923: AB_10672480, HPA036924: AB_2675386" "unprognostic (3.35e-3)" "unprognostic (7.47e-2)" "unprognostic (9.16e-2)" "unprognostic (1.20e-2)" "unprognostic (9.71e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (3.68e-2)" "unprognostic (3.38e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (8.36e-4)" "unprognostic (1.92e-1)" "unprognostic (4.81e-3)" "unprognostic (2.15e-1)" "unprognostic (1.71e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" 11.7 9.4 5.9 12.4 6.5 15.5 11.4 6.0 6.3 12.9 8.2 14.4 10.9 13.8 11.7 10.7 9.9 9.9 12.9 5.9 6.9 16.0 9.8 11.3 11.0 7.7 6.9 11.7 6.8 12.6 5.9 15.4 7.1 10.8 14.3 10.7 9.1 12.1 12.5 9.8 10.4 16.7 6.3 12.2 9.7 7.8 7.5 12.0 15.7 14.2 10.6 12.4 10.3 7.8 31.0 18.0 22.2 10.9 54.3 46.7 13.7 32.3 62.5 31.4 33.8 20.4 18.2 15.7 20.5 46.3 41.1 24.1 22.1 24.3 43.5 18.3 6.4 20.6 17.1 13.6 27.6 21.1 18.3 34.2 16.4 28.5 35.1 22.7 44.6 26.0 11.4 25.6 43.7 24.1 16.8 9.1 12.7 26.7 15.8 15.9 16.5 13.0 27.7 32.4 7.9 11.9 31.6 16.7 36.1 19.0 24.7 17.8 40.9 34.7 17.8 33.3 13.9 14.8 15.7 21.5 36.8 13.6 25.2 2.0 2.6 0.4 0.8 2.2 0.7 1.0 0.9 0.7 2.8 0.4 0.6 0.8 0.5 0.7 4.0 1.4 0.4 0.8 5.9 6.5 6.0 6.3 5.9 6.9 7.7 6.9 7.1 6.3 7.5 7.8 16.8 12.8 21.9 45.7 14.4 6.6 7.3 7.3 6.8 10.8 8.9 7.2 47.2 8.6 11.3 12.9 33.3 7.9 13.2 21.5 1.9 9.0 1.7 10.3 31.3 17.1 14.4 12.8 48.7 9.1 7.7 20.2 16.8 18.7 12.0 18.9 13.2 8.5 20.5 67.3 48.7 12.5 0.0 34.2 9.2 3.6 15.2 26.5 28.4 60.0 25.1 13.3 6.2 46.8 64.7 11.7 12.5 21.4 13.9 10.5 17.0 18.7 13.1 11.5 6.6 22.3 19.7 5.3 13.7 15.4 7.5 5.1 10.8 22.5 13.4 11.0 DNM1L "DRP1, DVLP, DYMPLE, HDYNIV, VPS1" ENSG00000087470 "Dynamin 1 like" O00429 12 32679200-32745650 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Biological rhythms, Endocytosis, Necrosis" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009952, HPA039324" Approved Enhanced Vesicles,Cytosol NA NA 2000000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol Vesicles "CAB009952: AB_2093533, HPA039324: AB_2676443" "unprognostic (2.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (5.09e-1)" "unprognostic (4.06e-2)" "prognostic unfavorable (6.27e-6)" "unprognostic (8.68e-2)" "unprognostic (2.25e-2)" "unprognostic (1.04e-2)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (7.48e-2)" "unprognostic (1.57e-2)" 23.2 23.2 25.3 23.5 27.5 40.0 21.1 27.7 32.3 18.4 15.7 24.0 18.6 23.6 23.9 28.6 19.8 17.5 38.9 28.4 26.1 27.9 14.2 16.7 20.9 22.5 22.0 20.0 13.5 40.5 25.3 23.9 23.6 27.0 22.7 44.9 16.0 28.7 43.8 18.3 16.8 32.0 22.2 18.8 17.3 36.0 21.6 21.4 22.4 57.2 24.8 29.9 18.5 26.6 66.8 62.3 64.3 68.3 51.2 52.7 123.2 72.0 55.4 67.2 61.7 80.6 48.0 87.3 50.0 65.8 66.9 57.8 69.2 80.3 79.3 46.6 57.6 102.3 57.2 48.2 41.7 72.5 50.1 48.6 37.4 70.7 66.1 63.5 81.1 41.4 74.4 37.5 75.3 21.7 29.1 61.7 138.2 41.0 30.8 48.6 125.0 61.5 56.5 79.1 57.1 59.3 76.3 51.8 56.7 129.4 59.7 49.0 74.0 57.3 54.4 135.3 68.2 26.1 75.8 86.3 55.6 47.0 43.5 7.4 10.0 3.2 5.6 15.6 6.9 7.0 6.2 6.1 18.8 6.0 7.3 8.4 1.8 8.1 15.6 5.6 7.3 7.9 25.3 27.5 27.7 32.3 28.4 26.1 22.5 22.0 23.6 22.2 21.6 26.6 42.5 38.5 38.4 82.6 36.0 30.0 34.7 28.0 44.3 80.9 32.5 29.2 82.8 20.0 33.3 25.8 131.3 30.0 53.8 26.7 31.3 34.8 63.9 38.8 55.8 42.0 30.5 28.4 139.4 25.1 63.7 41.0 23.9 59.4 50.7 48.8 26.4 16.0 30.8 126.2 150.0 24.9 34.6 27.5 30.7 78.0 26.8 43.3 14.2 44.0 45.6 59.0 34.0 99.5 121.7 45.7 14.4 30.5 48.5 42.8 11.4 23.3 22.8 164.8 19.7 55.0 55.5 79.3 52.3 39.6 27.6 36.0 42.2 26.0 31.5 36.4 DOLPP1 LSFR2 ENSG00000167130 "Dolichyldiphosphatase 1" Q86YN1 9 129081111-129090438 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 29.1;Proximal enterocytes: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019179 Approved Approved "Vesicles,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 45: Enterocytes - Digestion" Vesicles "Intermediate filaments" "HPA019179: AB_1847827" "unprognostic (1.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.89e-1)" "unprognostic (6.12e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-2)" "unprognostic (3.18e-1)" "unprognostic (3.10e-2)" "unprognostic (6.96e-2)" "unprognostic (7.12e-2)" "unprognostic (1.65e-1)" "unprognostic (4.37e-3)" "unprognostic (7.59e-3)" "unprognostic (2.38e-2)" "unprognostic (1.35e-1)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" 5.6 11.4 12.2 6.3 13.4 8.1 5.8 13.0 13.8 6.6 8.7 15.5 26.2 5.3 6.0 19.2 5.5 5.8 4.6 12.1 12.5 6.0 22.4 5.0 6.6 13.3 13.4 5.2 10.4 8.7 6.2 7.6 14.3 8.5 12.5 3.8 9.9 4.7 4.9 10.5 22.6 5.3 13.1 7.8 10.8 8.1 13.5 10.1 5.4 4.8 6.6 6.0 8.3 15.2 8.7 33.6 31.4 29.6 10.3 9.1 36.2 20.9 12.2 39.3 22.0 42.9 28.4 16.7 18.2 13.0 30.2 61.8 32.6 17.8 16.6 19.9 20.6 22.0 22.3 34.5 18.8 23.0 26.4 9.5 24.4 25.5 20.3 8.9 17.5 30.7 37.3 16.2 11.4 44.7 26.5 24.8 27.4 64.7 28.2 30.8 25.3 31.2 14.2 14.1 35.9 24.2 27.1 24.1 9.4 18.4 44.8 15.0 14.5 33.5 16.4 33.4 29.0 20.3 41.6 25.3 15.3 4.6 22.8 7.9 8.2 12.6 10.2 10.5 25.2 11.4 12.6 12.6 10.5 7.7 12.5 11.9 1.7 11.2 11.0 15.8 13.6 8.9 12.2 13.4 13.0 13.8 12.1 12.5 13.3 13.4 14.3 13.1 13.5 15.2 3.1 6.4 6.3 4.2 3.9 2.3 3.0 6.9 1.2 3.7 7.3 5.2 2.1 10.0 6.3 1.8 6.2 18.8 2.8 29.1 1.9 7.1 0.5 3.9 5.0 3.4 3.6 13.0 3.1 9.6 14.2 3.9 10.2 5.4 5.7 3.8 5.3 18.3 7.5 3.3 4.4 10.1 6.1 2.9 1.9 0.5 2.1 2.7 5.4 1.0 4.2 8.6 6.2 3.5 6.4 6.6 16.2 4.1 6.7 3.8 42.0 4.1 3.2 3.7 0.0 3.1 4.0 6.3 9.7 11.0 4.0 16.4 4.4 8.1 13.5 4.1 DOP1A "dJ202D23.2, DOPEY1, KIAA1117" ENSG00000083097 "DOP1 leucine zipper like protein A" Q5JWR5 6 83067666-83171350 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.7;Cardiomyocytes: 9.8;Cytotrophoblasts: 4.8;dendritic cells: 5.9;Hofbauer cells: 4.1;Plasma cells: 3.8;Syncytiotrophoblasts: 3.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027902, HPA027904" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "HPA027902: AB_10600003, HPA027904: AB_10600877" "unprognostic (7.18e-2)" "unprognostic (3.91e-1)" "unprognostic (6.11e-2)" "unprognostic (6.05e-3)" "unprognostic (8.21e-3)" "unprognostic (1.36e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-2)" "unprognostic (2.84e-1)" "unprognostic (2.47e-1)" "prognostic favorable (7.36e-4)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" 5.2 4.9 5.0 6.2 5.7 4.9 10.9 8.7 6.4 8.9 3.5 8.0 7.9 10.4 7.4 7.1 9.4 7.2 9.0 5.1 4.2 6.9 6.2 6.8 7.2 3.8 3.7 13.8 9.1 11.6 7.7 6.0 3.7 9.6 8.8 24.0 9.5 10.7 6.3 13.6 8.9 7.5 5.0 8.2 7.2 12.7 4.1 10.6 13.6 9.4 7.5 6.2 5.0 11.0 4.2 3.0 9.8 8.9 8.7 9.1 4.6 7.0 5.9 4.7 6.8 6.4 1.0 8.2 4.9 7.7 5.9 5.5 10.0 7.6 5.9 7.2 11.3 6.8 4.2 2.4 4.7 10.1 6.9 7.3 10.4 6.6 17.0 6.2 7.0 12.6 14.4 5.9 5.1 3.9 3.0 4.5 2.0 3.1 6.1 8.2 7.4 3.0 6.1 11.7 17.6 3.2 5.2 3.3 1.3 7.0 5.3 5.7 11.8 5.9 2.1 6.0 5.5 7.3 5.7 4.6 3.2 4.6 4.7 0.0 0.3 0.4 0.5 0.4 0.4 0.6 0.4 1.1 0.7 0.4 0.8 0.4 0.0 0.4 0.3 0.3 0.4 0.4 5.0 5.7 8.7 6.4 5.1 4.2 3.8 3.7 3.7 5.0 4.1 11.0 5.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 4.8 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 3.4 0.8 0.0 0.0 0.0 DPP7 "DPP2, DPPII" ENSG00000176978 "Dipeptidyl peptidase 7" Q9UHL4 9 137110546-137115177 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 997.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 232.0;THP-1: 218.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021282, CAB025541, HPA059381" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted - unknown location" NA NA 1600000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999" "unprognostic (1.15e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (6.78e-3)" "unprognostic (1.25e-1)" "unprognostic (8.33e-2)" "unprognostic (7.49e-2)" "unprognostic (6.10e-2)" "unprognostic (2.28e-2)" "unprognostic (5.71e-3)" "prognostic favorable (8.31e-5)" "unprognostic (7.99e-2)" "unprognostic (1.46e-2)" "unprognostic (2.56e-2)" "unprognostic (1.72e-1)" "unprognostic (2.15e-1)" "unprognostic (1.02e-1)" 60.2 98.8 42.1 28.0 43.2 45.8 56.8 43.4 64.9 45.4 83.6 65.3 28.4 46.3 16.7 46.0 53.6 31.3 116.4 43.8 52.0 58.7 70.0 57.3 41.7 53.4 48.0 37.7 82.8 54.3 112.3 26.7 45.7 81.1 7.3 8.0 92.3 46.2 52.8 56.6 51.7 12.8 45.6 79.0 69.4 75.3 48.3 19.8 83.7 21.4 14.4 59.3 48.0 49.2 28.0 43.1 3.5 3.6 51.1 40.5 5.7 42.2 66.2 26.6 17.4 41.0 22.2 56.2 44.4 27.2 1.2 60.3 30.7 8.2 1.3 54.8 2.1 26.4 63.6 1.3 113.5 69.1 135.5 50.0 31.7 11.6 24.1 38.3 35.1 65.8 57.5 41.2 18.0 76.4 35.7 65.7 14.8 99.9 42.8 52.8 0.5 232.0 43.3 30.5 67.7 46.7 47.8 122.6 118.9 0.8 43.5 218.1 44.1 67.4 23.5 43.4 29.5 51.7 31.8 14.9 80.9 41.1 31.1 40.2 194.8 59.2 148.8 176.2 151.8 86.6 131.4 127.9 190.6 83.4 117.1 106.2 12.0 95.0 110.6 276.6 173.6 204.1 42.1 43.2 43.4 64.9 43.8 52.0 53.4 48.0 45.7 45.6 48.3 49.2 80.5 54.5 80.9 54.9 96.8 67.0 103.2 109.2 59.7 74.5 90.3 82.2 66.5 94.4 76.8 53.3 35.5 55.2 129.2 28.2 37.2 121.0 288.7 35.9 40.7 58.2 88.1 35.9 31.4 68.1 115.3 97.2 33.6 47.3 74.3 178.7 64.6 77.1 315.7 121.1 27.9 32.3 107.8 171.7 106.2 997.8 155.4 150.1 167.2 9.4 165.5 123.9 122.6 16.6 26.4 58.2 54.3 169.2 190.2 108.5 97.3 84.9 75.4 83.6 52.6 57.4 58.4 106.2 46.2 47.3 64.9 51.4 115.4 19.0 43.1 90.4 DPYSL4 "CRMP3, DRP-4, ULIP4" ENSG00000151640 "Dihydropyrimidinase like 4" O14531 10 132186948-132205759 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;heart muscle: 33.7;retina: 15.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 64.9;Cardiomyocytes: 20.1;Cone photoreceptor cells: 58.4;Horizontal cells: 33.7;Oligodendrocytes: 18.4" "Cancer enhanced" "Detected in many" "glioma: 13.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.2;AN3-CA: 70.0;SH-SY5Y: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049066 Approved Approved Vesicles,Mitochondria NA NA "Cluster 32: T-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 62: Horizontal cells - Visual perception" "Vesicles, Mitochondria" "HPA049066: AB_2680619" "unprognostic (6.27e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "unprognostic (1.81e-1)" "unprognostic (3.95e-1)" "unprognostic (5.99e-2)" "unprognostic (8.36e-5)" "unprognostic (1.72e-1)" "unprognostic (8.91e-2)" "unprognostic (1.08e-2)" "unprognostic (3.81e-2)" "unprognostic (6.36e-2)" "unprognostic (7.47e-6)" "unprognostic (3.04e-3)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.11e-4)" 1.3 2.2 18.4 0.7 18.6 0.1 1.5 10.3 25.9 2.5 2.4 1.6 0.1 3.3 0.7 0.6 1.5 0.7 33.7 20.3 12.6 0.6 0.3 1.2 0.3 14.8 15.0 5.3 0.9 0.0 10.4 0.2 15.1 4.9 0.0 15.9 2.6 2.0 2.0 1.2 0.9 1.1 12.1 1.2 1.3 7.9 16.4 0.0 1.0 0.2 0.2 1.0 1.3 18.1 0.1 15.2 53.2 70.0 0.1 0.4 0.0 4.6 0.6 2.9 0.6 0.0 0.4 0.0 1.8 2.4 5.1 0.0 10.4 10.3 0.3 0.0 2.0 0.0 0.1 5.7 9.3 0.0 10.6 4.7 4.9 1.7 0.2 0.9 5.4 0.0 0.0 0.5 7.7 4.5 0.0 0.0 9.1 0.9 5.1 0.0 0.0 8.7 0.0 1.1 8.3 72.0 1.7 0.1 9.7 3.1 0.2 0.1 9.0 13.1 21.7 0.0 12.8 0.1 3.9 0.0 22.0 0.0 1.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.3 0.1 0.0 0.0 0.1 18.4 18.6 10.3 25.9 20.3 12.6 14.8 15.0 15.1 12.1 16.4 18.1 0.3 0.0 0.0 7.2 0.1 0.5 0.5 0.1 0.6 64.9 0.4 0.6 20.1 0.0 0.1 0.0 58.4 0.0 0.1 0.0 0.0 0.3 5.3 0.1 5.0 1.2 1.8 0.0 12.2 0.0 0.1 2.7 2.0 0.3 0.0 0.7 0.0 0.0 0.2 33.7 13.6 0.0 0.0 0.0 0.8 9.0 4.1 0.1 1.8 0.0 0.1 7.5 0.0 12.1 18.4 0.5 0.0 4.5 0.0 0.7 0.0 0.0 0.0 13.8 0.0 1.0 5.7 7.0 5.2 0.3 0.1 0.0 0.5 4.5 0.0 0.2 DRAM2 "MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154" ENSG00000156171 "DNA damage regulated autophagy modulator 2" Q6UX65 1 111117163-111140203 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018036, HPA061701" Supported Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus, Vesicles" "HPA018036: AB_1858134, HPA061701: AB_2684590" "unprognostic (9.38e-3)" "unprognostic (1.58e-2)" "unprognostic (2.16e-3)" "unprognostic (5.22e-2)" "unprognostic (1.12e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (3.45e-5)" "unprognostic (6.57e-3)" "prognostic unfavorable (6.43e-4)" "unprognostic (2.69e-1)" "unprognostic (4.37e-3)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (1.77e-3)" 38.0 23.1 13.9 33.1 14.5 17.9 26.8 17.7 19.9 23.1 22.7 26.7 28.6 17.7 17.6 15.0 30.1 36.4 23.7 13.5 15.2 26.5 24.9 25.0 55.3 15.6 14.9 24.3 25.6 28.3 4.6 41.2 16.2 17.8 30.7 16.9 25.8 16.7 16.6 17.9 26.3 17.0 15.5 45.3 23.4 10.3 15.0 27.8 22.0 23.6 50.3 29.4 4.2 17.8 38.0 12.9 24.0 10.8 57.3 56.2 23.4 28.7 29.9 24.7 24.9 12.5 38.2 28.7 17.2 25.6 12.1 37.4 30.5 24.0 31.9 26.8 25.6 16.8 18.4 16.4 41.4 19.4 15.4 38.5 41.4 18.3 38.4 53.6 29.9 29.1 34.1 19.6 30.1 19.6 16.6 28.8 14.5 43.3 13.2 11.1 40.0 14.0 42.5 25.8 19.1 18.2 16.8 52.4 80.1 33.1 16.7 84.6 24.8 20.6 13.8 16.2 18.9 25.7 9.6 29.8 33.4 34.7 29.6 41.7 47.3 11.5 14.2 61.0 19.4 65.7 17.5 15.3 45.1 54.1 22.3 19.0 7.2 25.0 49.8 28.6 17.7 35.5 13.9 14.5 17.7 19.9 13.5 15.2 15.6 14.9 16.2 15.5 15.0 17.8 34.5 12.8 12.0 17.3 146.2 47.0 54.4 82.5 34.1 11.6 53.6 43.9 29.7 32.9 53.1 44.1 2.1 98.1 38.9 41.2 43.0 59.2 8.5 51.7 19.5 36.4 13.2 28.6 20.6 46.6 102.3 39.2 24.5 17.6 23.6 18.5 42.8 26.0 183.1 20.2 31.7 45.7 77.3 189.4 97.8 7.8 33.5 110.3 81.8 39.4 89.0 27.1 56.7 31.7 42.6 41.9 64.3 24.8 54.7 46.3 88.4 80.4 95.8 10.1 39.5 26.4 32.5 4.7 14.6 40.8 53.0 73.3 38.6 26.3 43.7 70.1 DUSP22 "JKAP, JSP1, MKPX, VHX" ENSG00000112679 "Dual specificity phosphatase 22" Q9NRW4 6 291630-351355 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 270.6;U-266/70: 130.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031394 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 37: B-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Vesicles" "HPA031394: AB_10604114" "unprognostic (7.34e-3)" "unprognostic (7.94e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (9.08e-3)" "unprognostic (2.48e-1)" "unprognostic (9.06e-2)" "unprognostic (5.56e-3)" "unprognostic (3.10e-2)" "unprognostic (3.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.97e-2)" "unprognostic (3.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" 36.9 16.4 25.6 27.7 29.1 23.7 33.0 27.4 28.8 31.6 21.2 47.8 22.5 28.9 12.2 45.7 25.9 21.3 42.1 25.1 27.1 32.4 32.7 38.5 32.4 32.3 28.5 19.6 40.8 13.2 21.2 27.3 30.3 23.2 16.1 7.8 30.4 15.1 52.3 41.4 33.7 22.0 28.0 43.9 32.7 44.9 29.3 15.0 28.1 37.7 30.5 30.3 36.8 42.7 13.7 8.3 17.3 25.9 19.5 21.5 22.8 9.9 8.0 8.6 10.3 8.8 15.1 28.4 23.3 10.3 18.3 9.4 21.9 18.3 6.1 68.6 25.1 19.3 7.1 24.7 9.9 7.0 24.4 16.2 54.1 6.2 11.3 14.1 24.8 24.0 18.3 92.2 7.2 8.2 10.3 25.1 10.4 10.0 18.7 20.2 11.7 270.6 16.2 5.8 29.7 11.6 8.5 3.4 29.6 37.4 17.6 8.9 34.2 7.7 10.1 7.8 6.0 130.0 98.6 40.0 3.0 19.0 17.7 36.4 32.5 13.6 8.6 26.5 6.2 40.4 6.7 9.1 33.5 33.3 6.1 8.8 21.8 5.9 25.1 28.8 15.9 19.6 25.6 29.1 27.4 28.8 25.1 27.1 32.3 28.5 30.3 28.0 29.3 42.7 45.5 16.0 21.3 5.5 53.7 26.5 22.0 33.3 14.2 5.7 19.4 17.5 40.8 10.0 30.7 5.5 0.0 10.8 51.1 11.7 21.5 24.2 13.4 18.6 8.2 33.4 9.5 8.2 8.5 51.4 7.7 21.9 15.3 12.9 33.0 8.8 21.8 25.0 30.1 0.0 6.1 14.7 32.6 38.6 43.0 20.5 15.5 47.1 46.2 21.5 78.4 14.9 36.0 7.1 25.9 29.2 12.4 9.4 59.7 16.5 23.2 18.2 39.7 3.2 26.3 11.6 22.8 34.5 73.8 42.5 37.1 6.6 21.3 6.8 15.4 27.9 EBF1 "COE1, EBF, OLF1" ENSG00000164330 "EBF transcription factor 1" Q9UH73 5 158695916-159099916 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.7" "Cell type enhanced" "Detected in many" "Adipocytes: 79.8;Fibroblasts: 108.4;Leydig cells: 285.5;Microglial cells: 255.8;Peritubular cells: 121.5;Sertoli cells: 98.6;Smooth muscle cells: 138.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "memory B-cell: 12.1;naive B-cell: 10.2" "Lineage enriched" "Detected in single" 24 "B-cells: 12.1" "Cell line enhanced" "Detected in many" "ASC diff: 30.0;HSkMC: 26.7;REH: 82.6;U-2197: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061169 Approved Nucleoplasm,Vesicles NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 14: REH - Unknown function" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Vesicles "HPA061169: AB_2684441" "unprognostic (7.86e-2)" "unprognostic (3.08e-2)" "unprognostic (7.29e-2)" "unprognostic (4.70e-2)" "unprognostic (2.63e-1)" "unprognostic (1.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.60e-1)" "unprognostic (5.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (9.62e-7)" "prognostic unfavorable (7.80e-4)" "unprognostic (5.75e-2)" "unprognostic (5.81e-2)" "unprognostic (4.37e-3)" 37.7 2.8 4.6 3.8 5.0 3.3 20.5 16.4 5.0 14.6 3.9 5.1 1.1 10.5 4.1 3.5 12.5 8.1 7.9 3.8 5.0 3.3 0.4 4.3 9.4 9.8 7.5 8.5 1.7 1.6 2.4 10.8 7.1 4.8 3.2 2.0 4.7 4.4 4.7 7.6 5.5 7.7 11.6 4.7 3.5 4.0 5.3 2.5 7.5 7.4 9.2 10.4 10.3 4.9 0.0 0.5 12.8 0.0 30.0 11.9 0.2 0.3 0.0 0.7 1.7 0.0 0.0 11.9 0.0 4.0 2.4 0.1 0.5 0.1 0.2 2.8 0.2 0.0 3.5 0.0 1.0 0.1 0.3 26.7 0.0 11.4 0.4 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.1 0.2 1.2 0.0 0.0 82.6 0.6 0.2 0.0 0.0 6.8 1.7 0.7 0.3 0.0 0.2 0.0 0.1 0.0 15.3 1.8 17.5 0.3 0.0 0.1 11.1 10.2 1.2 13.0 0.5 0.0 0.1 0.0 0.0 0.0 12.1 0.0 0.0 0.0 10.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 4.6 5.0 16.4 5.0 3.8 5.0 9.8 7.5 7.1 11.6 5.3 4.9 79.8 0.0 0.5 5.2 76.3 12.2 0.3 0.0 1.8 5.9 0.8 1.9 5.0 0.0 0.7 1.8 0.0 0.2 0.2 0.1 0.0 3.9 28.2 1.5 54.2 56.3 0.0 0.4 0.4 0.0 0.3 108.4 1.5 1.4 0.0 0.0 4.6 2.2 0.8 0.0 1.6 0.1 0.0 0.3 16.6 21.7 285.5 1.9 14.2 255.8 9.3 1.9 0.0 3.0 0.9 0.1 0.0 121.5 7.7 0.7 0.0 0.1 0.9 2.3 98.6 4.6 138.8 2.7 1.3 1.6 7.0 0.4 5.0 10.7 0.0 1.7 EBF3 "COE3, DKFZp667B0210" ENSG00000108001 "EBF transcription factor 3" Q9H4W6 10 129835233-129973053 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.9;brain: 16.9" "Group enriched" "Detected in some" 5 "Adipocytes: 29.6;Endothelial cells: 13.1;Fibroblasts: 14.9;Skeletal myocytes: 33.5;Smooth muscle cells: 11.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 16.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;HAP1: 13.6;LHCN-M2: 25.4;NB-4: 35.7;RH-30: 13.2;SCLC-21H: 28.7;THP-1: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061169 Approved Nucleoplasm,Vesicles NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Vesicles "HPA061169: AB_2684441" "unprognostic (2.96e-1)" "unprognostic (3.78e-2)" "unprognostic (8.63e-3)" "unprognostic (2.60e-2)" "unprognostic (7.68e-2)" "unprognostic (4.50e-3)" "unprognostic (8.53e-6)" "unprognostic (2.93e-2)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.63e-1)" "unprognostic (4.16e-3)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (9.49e-2)" "unprognostic (4.58e-2)" 23.9 0.6 0.3 1.0 0.1 0.1 13.7 1.4 0.2 4.1 0.4 2.7 0.2 2.3 0.8 1.4 4.8 2.4 9.4 0.1 2.7 0.5 0.5 0.2 6.9 6.5 8.5 1.0 1.3 2.1 0.9 2.5 3.8 2.4 0.5 1.9 3.0 1.1 7.9 3.3 1.0 1.5 16.9 0.2 1.6 1.6 3.2 1.3 7.3 7.7 1.0 3.3 5.5 1.1 0.0 0.0 0.6 0.1 12.5 10.3 0.1 0.8 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.5 0.0 0.0 13.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 2.4 0.0 0.0 0.0 0.7 0.0 0.0 25.4 0.0 0.0 35.7 0.0 0.0 0.0 0.3 13.2 0.0 0.0 0.1 28.7 0.4 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 1.3 8.7 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.4 0.2 0.1 2.7 6.5 8.5 3.8 16.9 3.2 1.1 29.6 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.0 1.8 0.3 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.1 13.1 0.0 0.0 0.9 0.0 0.0 14.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.5 0.4 0.3 0.4 0.0 1.9 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.7 0.0 33.5 11.7 0.0 3.4 0.1 0.9 0.0 0.2 0.1 0.0 0.1 EDA "ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED" ENSG00000158813 "Ectodysplasin A" Q92838 X 69616067-70039472 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Developmental protein" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Microglial cells: 84.3;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.2;MAIT T-cell: 1.3" "Group enriched" "Detected in many" 5 "monocytes: 1.2;T-cells: 1.3" "Cell line enhanced" "Detected in many" "EFO-21: 5.2;Hep G2: 17.9;OE19: 5.1;RPMI-8226: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA037972, HPA037973" Supported "Vesicles,Lipid droplets" "Secreted - unknown location" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 89: Fibroblasts - ECM organization" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 50: Fibroblasts - ECM organization" Vesicles "Lipid droplets" "HPA037972: AB_2675761, HPA037973: AB_2675762" "unprognostic (3.76e-2)" "unprognostic (8.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.59e-3)" "unprognostic (7.85e-2)" "unprognostic (1.25e-4)" "unprognostic (4.33e-4)" "unprognostic (5.03e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-2)" "unprognostic (2.01e-1)" "prognostic favorable (1.04e-9)" "unprognostic (8.63e-4)" "unprognostic (7.64e-2)" "unprognostic (9.85e-2)" "unprognostic (2.79e-1)" 4.2 8.5 2.4 0.7 3.0 0.1 2.8 2.2 2.6 4.9 5.2 2.6 0.5 3.0 3.2 1.5 3.8 2.0 10.4 2.1 2.4 3.7 2.1 3.2 0.8 3.2 2.8 4.9 4.2 9.7 1.3 1.8 3.0 3.4 1.1 0.3 2.2 2.2 1.7 4.2 1.1 2.1 2.3 1.4 3.8 1.2 3.1 1.2 6.0 2.0 0.6 2.3 3.9 4.6 0.0 0.6 0.3 2.8 0.5 0.0 0.2 0.0 0.1 0.0 0.0 1.3 0.1 0.3 5.2 0.2 0.2 0.5 3.8 1.4 0.0 0.0 4.5 0.0 0.0 17.9 1.0 0.0 1.1 1.8 1.3 0.0 0.9 0.0 0.5 3.5 0.0 4.9 0.0 1.2 0.0 0.0 2.8 5.1 0.3 0.0 1.2 6.0 0.1 0.0 1.5 0.0 0.1 0.3 0.1 2.0 0.3 0.1 0.5 1.7 2.2 2.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.1 2.4 3.0 2.2 2.6 2.1 2.4 3.2 2.8 3.0 2.3 3.1 4.6 3.3 3.2 0.5 21.2 0.3 3.8 2.6 2.0 6.8 0.2 0.9 1.5 12.1 0.0 1.1 5.5 0.0 0.2 0.1 1.0 0.0 1.3 21.3 4.6 1.2 2.2 1.8 0.0 17.9 1.3 0.2 6.0 5.6 12.2 0.0 0.5 11.0 1.2 4.1 0.0 9.6 0.6 0.0 4.8 1.2 9.2 4.7 2.8 1.8 84.3 0.1 1.3 0.0 30.2 45.9 1.1 0.1 2.2 0.2 2.3 0.4 3.1 1.3 0.1 6.6 10.7 5.4 1.7 3.5 3.2 4.1 0.0 2.1 0.4 0.9 1.5 EEPD1 KIAA1706 ENSG00000122547 "Endonuclease/exonuclease/phosphatase family domain containing 1" Q7L9B9 7 36153254-36301538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 46.9" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 88.0;Oligodendrocytes: 175.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 51.8;neutrophil: 46.4" "Group enriched" "Detected in many" 6 "granulocytes: 51.8;T-cells: 23.0" "Cell line enhanced" "Detected in many" "HDLM-2: 18.3;PC-3: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053668 Approved "Nuclear speckles,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear speckles" Vesicles "HPA053668: AB_2682223" "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.54e-3)" "unprognostic (5.21e-3)" "unprognostic (1.14e-1)" "unprognostic (4.76e-1)" "unprognostic (1.19e-2)" "unprognostic (3.75e-2)" "unprognostic (7.89e-2)" "unprognostic (8.77e-2)" "unprognostic (7.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (4.59e-2)" 19.5 5.2 9.8 4.0 12.5 8.1 18.3 10.6 14.2 10.2 7.3 12.0 9.9 7.7 3.6 7.1 7.3 11.7 11.1 10.4 10.6 5.9 24.0 8.1 4.6 12.0 12.8 8.5 11.5 2.2 4.4 4.0 12.7 12.5 3.8 1.5 4.1 3.4 46.9 12.8 11.5 5.6 10.3 10.8 17.0 5.3 13.0 12.8 3.1 12.8 3.0 10.9 9.1 19.2 2.2 5.9 1.8 5.6 16.2 3.5 0.1 1.5 7.2 1.1 2.0 1.2 4.5 5.9 1.8 2.2 16.8 2.4 2.4 2.8 1.0 18.3 4.0 0.7 0.5 11.0 1.5 0.9 5.5 7.3 1.7 0.7 0.4 4.5 0.1 4.4 7.3 0.6 1.2 2.3 6.1 14.6 8.2 7.4 22.4 1.6 2.0 1.3 3.6 4.7 4.4 3.1 0.5 0.8 2.2 3.2 1.8 7.0 0.5 2.2 6.5 1.5 1.7 4.3 5.1 0.0 5.4 3.8 1.4 23.1 5.9 51.8 3.0 3.6 5.2 0.3 23.0 6.6 3.2 0.0 5.0 1.5 46.4 3.9 1.6 2.9 11.6 4.2 9.8 12.5 10.6 14.2 10.4 10.6 12.0 12.8 12.7 10.3 13.0 19.2 32.4 0.0 0.5 30.0 1.3 2.7 14.7 1.8 1.8 4.2 4.9 7.2 4.0 34.3 2.1 0.0 20.9 0.2 0.9 10.8 5.9 26.2 17.4 8.4 3.0 14.8 9.6 1.3 28.4 7.4 0.3 4.0 20.9 7.2 8.9 0.9 3.9 16.9 25.3 6.7 88.0 6.2 0.0 5.8 5.5 3.6 5.0 9.8 3.6 45.0 3.8 2.0 0.0 1.5 175.4 16.9 12.6 16.6 0.7 8.7 19.4 1.9 2.6 1.4 6.6 2.1 6.6 0.7 5.4 4.2 4.0 0.5 3.3 6.4 6.2 10.2 EFHB "CFAP21, FLJ25200" ENSG00000163576 "EF-hand domain family member B" Q8N7U6 3 19879472-19947025 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.5;fallopian tube: 17.1;testis: 15.5" "Group enriched" "Detected in many" 4 "Early spermatids: 77.2;Endometrial ciliated cells: 49.9;Late spermatids: 25.7;Respiratory ciliated cells: 93.6;Spermatocytes: 32.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "RPTEC TERT1: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA034835 Approved Vesicles,Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol Vesicles "HPA034835: " "unprognostic (9.70e-2)" "unprognostic (2.71e-2)" "unprognostic (2.37e-1)" "unprognostic (2.33e-2)" "unprognostic (1.20e-2)" "unprognostic (9.56e-3)" "unprognostic (1.51e-5)" "unprognostic (4.43e-2)" "unprognostic (3.66e-1)" "unprognostic (1.51e-1)" "unprognostic (4.92e-2)" "unprognostic (5.47e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (9.35e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" 0.5 0.7 1.6 0.1 1.5 0.2 0.9 1.0 1.4 0.9 2.6 0.2 0.0 1.1 0.6 0.4 17.1 0.6 0.2 1.4 1.6 1.0 0.2 2.0 0.2 6.5 5.0 1.5 0.2 0.4 0.4 0.4 3.4 0.4 0.3 0.8 0.2 0.5 0.2 0.4 0.2 0.5 3.7 0.5 0.2 15.5 1.6 0.3 0.5 0.2 0.3 0.3 0.2 2.2 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 19.5 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 1.5 1.0 1.4 1.4 1.6 6.5 5.0 3.4 3.7 1.6 2.2 1.0 0.0 1.1 5.5 0.3 0.1 0.5 1.9 0.6 0.8 1.8 1.4 0.3 5.7 12.4 3.7 2.1 0.9 1.6 0.5 5.9 0.3 77.2 49.9 1.8 0.7 1.2 3.6 1.7 0.2 0.5 1.3 0.0 1.8 3.8 1.8 1.8 0.6 0.5 1.7 2.2 0.2 4.1 1.3 0.3 25.7 2.5 1.0 0.0 1.9 0.2 5.3 0.0 3.0 1.7 0.6 0.1 2.2 0.0 0.3 1.2 8.3 93.6 0.8 0.0 3.6 1.7 32.7 4.3 0.1 0.1 0.8 0.3 1.0 0.4 0.3 EFNA5 "AF1, EPLG7, LERK7" ENSG00000184349 "Ephrin A5" P52803 5 107376894-107670937 "Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Astrocytes: 291.2;Excitatory neurons: 798.5;Inhibitory neurons: 373.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 35.2;RPTEC TERT1: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013282, HPA054047" Approved Approved Vesicles,Cytosol NA Yes 10000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Cytosol" "CAB013282: AB_2533353, HPA054047: AB_2682355" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.15e-3)" "unprognostic (3.98e-3)" "unprognostic (2.74e-2)" "unprognostic (8.91e-4)" "unprognostic (9.46e-3)" "unprognostic (4.92e-1)" "unprognostic (2.28e-3)" "unprognostic (1.26e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.92e-7)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (1.27e-1)" 4.1 1.1 4.5 2.0 6.5 0.1 4.0 1.3 13.6 10.1 0.0 2.3 0.8 1.1 2.0 7.1 2.9 2.7 6.8 3.1 10.2 3.4 0.3 2.4 0.8 0.9 0.3 4.0 0.5 2.5 2.7 2.4 0.6 4.3 2.3 2.5 5.6 4.7 0.5 9.7 0.8 2.2 0.0 5.3 2.5 1.4 2.1 1.4 1.0 1.4 2.5 3.5 4.8 5.4 12.7 22.2 35.2 0.0 16.7 14.2 3.6 0.3 6.3 4.5 11.6 0.2 13.9 0.0 20.5 2.4 7.1 13.1 19.4 18.0 3.6 0.0 12.9 0.1 11.9 0.0 3.1 0.6 0.0 16.0 15.4 0.0 14.4 3.9 13.8 0.0 0.0 0.0 8.3 12.0 0.0 0.0 4.6 0.1 1.9 0.0 16.9 0.4 50.9 15.5 5.8 14.7 6.0 8.9 3.8 11.2 3.9 2.2 0.2 28.3 5.0 17.4 7.1 1.2 0.0 8.3 12.4 0.8 31.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.4 0.1 0.7 0.0 0.0 0.0 0.1 4.5 6.5 1.3 13.6 3.1 10.2 0.9 0.3 0.6 0.0 2.1 5.4 1.1 9.6 24.4 291.2 0.0 15.9 22.5 18.5 6.2 4.3 11.8 8.5 30.6 11.5 26.0 14.7 0.0 20.3 3.3 4.3 23.5 1.7 1.8 3.2 14.8 8.2 12.0 0.0 798.5 1.3 3.3 16.9 5.6 6.3 0.0 0.1 9.7 0.0 1.7 6.7 373.1 8.5 18.3 0.3 7.0 3.7 18.3 0.4 8.8 37.5 3.6 4.7 2.1 26.2 8.7 13.9 4.9 21.8 1.7 14.1 0.0 0.1 19.6 1.4 0.0 1.3 3.7 0.1 4.0 14.9 24.2 3.8 2.2 2.3 5.9 23.1 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164595-32168281 "Metabolic proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Granulosa cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 3.2;SK-MEL-30: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Nuclear speckles" "HPA061173: AB_2684443" "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 13.3 7.2 3.8 0.5 3.5 1.1 13.6 3.6 5.7 23.4 4.1 19.8 0.6 10.0 0.8 12.3 16.3 3.0 14.2 3.9 3.9 16.3 7.4 9.4 0.3 3.8 3.9 31.2 5.1 0.4 8.2 2.9 3.7 16.9 0.5 0.0 7.9 1.4 3.8 12.8 8.8 0.3 3.8 7.9 10.2 4.4 4.1 0.6 8.7 2.5 0.2 13.5 17.2 3.8 0.2 0.1 0.4 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.5 0.0 0.3 3.2 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.2 0.7 0.5 0.0 0.0 0.6 1.0 1.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 3.4 0.0 1.0 0.7 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.5 3.6 5.7 3.9 3.9 3.8 3.9 3.7 3.8 4.1 3.8 1.2 6.4 4.1 0.0 0.3 1.5 0.6 0.3 4.6 1.5 0.5 0.3 0.1 0.0 1.6 1.8 2.1 0.8 0.6 0.2 0.0 0.4 0.1 1.0 1.9 1.7 0.0 1.7 0.0 0.2 0.4 1.5 4.6 1.3 0.0 10.4 3.3 0.3 0.2 0.0 0.0 1.1 0.0 0.6 1.6 0.2 3.7 0.7 0.0 0.0 0.0 0.9 3.1 0.0 0.0 0.3 0.2 1.2 2.1 0.7 0.4 0.1 1.6 1.5 0.0 2.0 1.5 0.5 0.4 4.0 2.3 0.8 0.9 1.5 1.3 0.5 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2;skin 1: 45.6" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 284.3;Glandular and luminal cells: 116.6;granulocytes: 108.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 47.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.5;HMC-1: 9.5;MCF7: 31.9;SK-MEL-30: 22.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "amygdala: 19.3;basal ganglia: 52.5;cerebral cortex: 47.8;hippocampal formation: 41.3;olfactory bulb: 33.7" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles NA NA "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favorable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 29.0 24.5 7.7 19.0 9.9 10.1 10.3 0.6 47.2 9.5 0.0 4.6 1.5 5.6 0.4 5.9 17.3 30.0 12.1 16.1 0.0 5.8 2.9 5.8 11.4 5.1 0.0 15.3 4.5 13.8 6.8 1.0 2.0 14.4 3.2 4.5 3.1 0.9 1.9 45.6 3.9 12.5 1.3 3.3 6.5 5.4 0.0 19.5 8.4 3.2 5.9 14.8 3.6 5.8 0.2 0.0 0.2 0.3 1.8 5.5 0.1 0.6 0.6 0.0 0.1 0.1 0.0 0.1 0.1 1.3 0.4 0.5 0.2 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 9.5 0.6 0.2 0.2 0.0 0.8 0.1 0.2 0.3 0.1 0.0 31.9 0.0 0.2 0.1 2.2 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.1 0.5 0.0 22.5 0.3 1.4 0.1 0.0 0.3 0.1 0.2 0.4 0.4 0.1 0.0 0.9 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.7 9.9 0.6 47.2 16.1 0.0 5.1 0.0 2.0 1.3 0.0 5.8 80.2 6.4 11.2 0.3 46.7 23.1 31.9 43.8 39.3 2.3 73.0 68.2 47.1 0.0 12.2 0.0 0.0 1.3 9.3 3.5 0.0 3.3 18.4 47.1 52.7 36.5 284.3 0.0 16.0 4.2 1.3 33.9 35.2 116.6 108.7 21.8 37.5 0.5 4.7 0.0 0.9 19.2 8.2 19.0 20.3 11.6 3.1 27.8 21.4 3.7 0.0 5.1 0.0 1.0 0.7 4.5 2.2 0.4 3.7 16.1 0.2 0.1 5.7 1.3 0.0 41.3 35.9 0.3 0.2 16.5 50.0 9.7 11.5 6.5 7.0 9.8 EHBP1L1 "DKFZp762C186, TANGERIN" ENSG00000173442 "EH domain binding protein 1 like 1" Q8N3D4 11 65576046-65592650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 255.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 79.1;Kupffer cells: 79.7;Macrophages: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039479, HPA073476" Enhanced Approved "Vesicles,Plasma membrane" NA NA 110000 "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Vesicles, Plasma membrane" "HPA039479: AB_10795678, HPA073476: " "unprognostic (1.87e-2)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.84e-1)" "unprognostic (2.41e-3)" "unprognostic (2.35e-1)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.36e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.10e-3)" "unprognostic (5.02e-2)" "unprognostic (3.50e-2)" "unprognostic (1.10e-1)" 27.2 9.9 7.5 51.9 6.2 59.7 21.5 5.9 9.4 35.9 7.3 108.1 26.0 56.1 5.7 45.4 48.0 18.0 45.6 7.1 6.3 17.7 10.8 39.6 30.7 9.8 8.1 19.6 8.1 4.1 9.8 16.3 7.7 45.2 12.2 0.4 22.9 39.5 255.7 22.6 46.6 32.8 8.0 73.3 41.0 7.3 9.4 14.5 13.0 70.7 16.6 71.3 40.8 9.0 40.6 41.0 1.3 21.8 10.5 26.4 8.2 31.4 22.9 14.8 7.8 13.7 34.9 14.0 52.4 45.8 41.2 55.9 7.6 29.7 3.4 39.3 1.2 32.4 51.0 12.0 10.0 7.1 30.1 22.7 19.8 37.2 6.8 26.9 15.2 20.8 50.5 55.9 13.8 34.5 12.4 27.5 1.8 15.1 34.8 33.6 0.2 46.8 13.7 20.0 0.9 17.2 17.4 15.2 32.9 3.0 21.9 33.7 26.3 40.3 42.9 57.3 0.6 98.5 66.6 7.3 60.2 18.8 23.9 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 7.5 6.2 5.9 9.4 7.1 6.3 9.8 8.1 7.7 8.0 9.4 9.0 33.1 0.0 6.9 6.2 23.9 10.1 8.5 2.9 15.9 1.4 12.2 14.2 22.0 7.2 7.4 1.8 0.0 3.4 27.3 79.1 0.0 3.6 0.2 11.9 12.2 26.0 4.2 61.6 4.4 5.1 1.4 13.8 61.2 14.2 2.5 5.3 18.9 5.7 32.6 0.0 2.2 16.3 2.0 79.7 33.9 1.7 11.5 67.6 7.2 15.0 49.1 0.7 20.6 1.5 1.3 27.8 53.0 38.0 19.5 11.6 19.5 0.4 8.6 1.1 26.3 27.3 30.7 2.7 5.9 15.3 14.8 2.6 23.2 23.0 21.9 17.0 EIF2B3 "EIF-2B, EIF2Bgamma" ENSG00000070785 "Eukaryotic translation initiation factor 2B subunit gamma" Q9NR50 1 44850522-44986722 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024213, HPA024218, HPA024219" Supported Supported Vesicles,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Vesicles, Cytosol" "HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069" "unprognostic (2.12e-2)" "unprognostic (7.49e-2)" "unprognostic (4.37e-3)" "unprognostic (5.14e-2)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (4.55e-2)" "unprognostic (1.14e-2)" "unprognostic (7.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (5.38e-2)" "unprognostic (6.98e-2)" "unprognostic (7.80e-2)" "unprognostic (5.69e-3)" "unprognostic (2.73e-2)" 23.6 27.2 11.4 11.6 10.9 10.9 21.9 13.2 15.6 18.7 10.1 17.5 8.6 17.0 12.5 17.4 16.3 9.6 40.6 11.2 11.6 15.4 24.7 13.5 14.3 11.9 12.1 18.2 16.9 30.0 15.8 9.7 12.8 15.0 13.4 19.0 25.1 13.7 77.0 17.6 10.7 19.4 11.0 14.9 14.2 19.3 11.2 13.3 12.5 48.0 14.5 17.7 17.1 14.0 35.4 26.9 30.9 25.5 36.3 43.1 36.2 56.1 42.2 56.5 52.9 39.0 20.7 90.6 39.9 43.2 45.0 20.6 65.3 48.6 69.5 32.5 58.1 44.3 29.3 38.4 46.2 71.2 24.3 29.3 25.8 61.0 69.9 26.5 52.8 30.1 106.1 31.6 62.3 23.1 69.7 30.2 42.0 38.8 52.7 54.7 51.3 65.7 28.7 15.7 53.2 20.5 55.1 63.8 37.4 40.7 24.7 32.8 28.3 35.9 42.9 53.4 73.7 31.6 37.9 68.9 27.9 59.5 43.1 1.6 23.4 3.9 18.6 37.2 22.8 14.8 18.3 21.1 37.0 18.9 22.9 23.6 2.1 25.5 33.1 25.3 17.6 21.4 11.4 10.9 13.2 15.6 11.2 11.6 11.9 12.1 12.8 11.0 11.2 14.0 13.9 6.4 22.0 24.8 15.8 13.8 19.0 33.0 10.8 15.1 15.8 16.8 79.2 15.7 24.9 5.5 20.9 25.1 12.1 4.5 29.4 18.9 26.1 17.0 23.0 14.4 3.6 15.3 39.9 15.8 22.6 22.6 13.7 11.5 25.9 21.1 3.9 22.6 24.8 21.9 44.5 7.0 20.3 10.7 11.2 11.3 26.4 15.4 17.8 26.2 30.1 21.7 10.3 29.1 35.7 13.7 6.9 25.2 22.6 17.1 5.7 23.1 34.2 21.8 26.3 19.7 45.4 45.5 23.6 17.1 14.9 14.9 13.5 40.4 9.4 13.9 ELAVL4 "HUD, PNEM" ENSG00000162374 "ELAV like RNA binding protein 4" P26378 1 50024029-50203772 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 52.8" "Group enriched" "Detected in some" 4 "Early spermatids: 155.5;Excitatory neurons: 158.7;Inhibitory neurons: 109.7;Late spermatids: 159.4;Oligodendrocyte precursor cells: 75.4" "Cancer enriched" "Detected in some" 4 "glioma: 2.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Cell line enriched" "Detected in some" 17 "SH-SY5Y: 157.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004442, HPA043047" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "CAB004442: AB_627765, HPA043047: AB_2732502" "unprognostic (1.25e-1)" "unprognostic (6.63e-3)" "unprognostic (4.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (3.83e-4)" "unprognostic (4.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.75e-1)" "unprognostic (3.75e-3)" "unprognostic (7.91e-2)" "unprognostic (2.39e-3)" "unprognostic (7.83e-2)" "unprognostic (2.81e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-2)" 0.1 11.2 13.9 2.4 18.0 0.0 0.2 7.4 52.8 0.0 0.0 2.2 1.4 0.0 0.0 0.2 0.1 0.1 0.2 20.0 18.5 0.1 0.1 0.3 0.2 36.5 14.0 0.0 2.3 0.0 3.4 0.2 31.7 0.1 2.8 3.9 0.2 0.1 0.0 0.4 2.2 1.1 2.0 0.2 1.0 8.5 11.4 0.9 0.0 0.0 0.2 0.1 0.2 17.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.2 157.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 13.9 18.0 7.4 52.8 20.0 18.5 36.5 14.0 31.7 2.0 11.4 17.4 0.1 0.0 0.0 7.2 0.1 0.8 0.0 0.0 0.0 3.9 0.1 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 155.5 0.0 0.0 0.3 32.9 0.0 158.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 109.7 0.1 4.1 4.0 5.0 159.4 1.5 3.1 1.8 22.5 0.0 1.5 0.0 75.4 5.9 0.3 0.0 0.4 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.1 8.9 11.8 0.0 0.9 0.1 0.2 0.0 0.1 0.1 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427479 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 18.2;retina: 6.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 45.5;Excitatory neurons: 11.6;Inhibitory neurons: 16.2;Oligodendrocyte precursor cells: 36.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 18.2;basal ganglia: 13.8;cerebral cortex: 17.5;hippocampal formation: 16.6;white matter: 4.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 12.0;CAPAN-2: 11.2;GAMG: 12.3;RPMI-8226: 11.7;RPTEC TERT1: 21.5;U-2 OS: 24.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 56: Bipolar cells - Visual perception" "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 0.0 0.6 18.2 0.0 13.8 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 16.6 0.9 0.2 0.2 0.6 0.0 2.7 2.7 0.0 0.2 0.0 0.0 0.0 1.9 0.6 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.1 1.7 2.2 2.2 0.0 0.0 0.0 0.0 0.0 4.8 12.0 4.9 0.0 0.0 0.0 0.9 0.0 5.3 2.8 1.2 0.1 1.9 11.2 0.2 6.8 3.8 12.3 8.2 0.6 1.1 0.1 0.2 0.1 0.0 5.7 0.0 0.2 0.0 0.1 0.9 0.1 0.4 1.6 4.5 0.4 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.3 7.1 10.6 0.1 0.1 11.7 21.5 0.1 1.0 0.0 4.9 6.2 0.0 0.1 0.0 0.1 0.5 0.0 24.1 0.2 3.5 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 13.8 0.0 17.5 16.6 0.9 2.7 2.7 1.9 2.8 2.2 4.8 0.1 0.0 5.1 1.3 0.5 0.1 0.0 0.9 0.0 45.5 0.0 0.0 0.0 1.5 0.2 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.2 0.0 0.0 11.6 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 3.3 16.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 1.9 0.0 0.9 0.0 36.7 0.9 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.6 2.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOVL3 CIG-30 ENSG00000119915 "ELOVL fatty acid elongase 3" Q9HB03 10 102226299-102229589 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 30.5" "Cell type enhanced" "Detected in some" "Adipocytes: 2.5;Breast myoepithelial cells: 3.2;Skeletal myocytes: 5.0;Spermatogonia: 3.4;Theca cells: 2.2" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 10 "classical monocyte: 7.1;intermediate monocyte: 2.4;myeloid DC: 2.0;non-classical monocyte: 5.9" "Group enriched" "Detected in many" 10 "dendritic cells: 2.0;monocytes: 7.1" "Cell line enhanced" "Detected in many" "ASC diff: 9.5;ASC TERT1: 9.4;HSkMC: 13.9;NB-4: 11.6;SiHa: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA036236 Enhanced Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Cytosol" "HPA036236: AB_10601550" "unprognostic (1.52e-2)" "unprognostic (6.76e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (6.25e-5)" "unprognostic (8.23e-3)" "unprognostic (9.82e-2)" "unprognostic (2.17e-4)" "unprognostic (4.27e-2)" "unprognostic (2.28e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (5.36e-3)" "unprognostic (2.66e-9)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" 3.2 0.7 1.0 0.3 0.8 1.8 3.5 0.5 1.3 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.2 1.0 0.4 0.8 0.0 1.0 0.1 0.4 0.9 0.1 0.0 0.1 0.0 0.9 0.4 0.2 0.1 0.1 0.3 0.1 0.2 30.5 0.2 0.0 0.4 0.8 0.1 1.2 0.4 0.0 0.0 0.3 0.0 0.2 0.3 0.5 3.2 0.2 0.2 7.8 9.5 9.4 2.8 0.1 0.3 0.4 0.5 0.5 3.0 0.0 0.3 0.0 0.0 0.1 5.9 0.1 0.5 0.0 0.0 0.2 0.4 0.8 0.3 0.0 0.1 13.9 1.6 3.6 0.0 0.0 0.0 0.9 0.1 3.5 0.8 0.0 0.0 11.6 0.1 1.1 1.0 0.0 5.1 0.0 2.0 0.1 0.0 0.4 22.6 0.9 0.7 0.6 8.1 2.7 0.0 1.5 0.0 0.3 0.3 0.5 7.2 0.0 3.4 6.5 0.0 0.0 7.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 5.9 0.0 0.0 1.7 1.0 0.8 0.5 1.3 1.0 0.4 0.4 0.9 0.4 0.4 0.4 0.5 2.5 0.0 1.1 0.0 0.2 0.4 0.5 0.6 0.6 0.0 1.1 3.2 0.3 0.0 0.5 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 0.0 1.3 1.9 0.0 0.0 0.3 0.0 0.7 1.3 0.0 0.2 0.0 0.0 1.4 0.4 0.2 0.0 0.0 0.2 0.0 1.5 0.8 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 5.0 1.2 0.1 3.4 0.6 0.1 0.3 0.3 2.2 0.2 0.1 EML6 FLJ42562 ENSG00000214595 "EMAP like 6" Q6ZMW3 2 54723499-54972025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.3;retina: 13.9" "Cell type enhanced" "Detected in many" "Astrocytes: 145.0;Excitatory neurons: 372.7;Inhibitory neurons: 265.1;Oligodendrocyte precursor cells: 95.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 10.9;SCLC-21H: 34.0;U-698: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062808, HPA068759" Uncertain Approved Vesicles,Mitochondria NA NA "Cluster 10: Basophils - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Mitochondria Vesicles "HPA062808: AB_2684872, HPA068759: AB_2686027" "unprognostic (1.06e-1)" "unprognostic (6.89e-4)" "unprognostic (7.83e-2)" "unprognostic (9.96e-2)" "unprognostic (6.24e-2)" "unprognostic (3.26e-4)" "unprognostic (5.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (6.27e-2)" "unprognostic (6.85e-6)" "unprognostic (5.00e-1)" "unprognostic (5.81e-2)" "unprognostic (6.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (5.13e-3)" 0.3 3.0 1.6 4.0 1.8 0.7 0.7 1.4 3.8 0.2 0.2 0.7 0.7 0.3 1.1 0.5 0.4 0.2 0.1 2.2 2.1 1.7 0.5 0.4 7.0 1.3 1.4 0.1 0.8 1.9 3.2 1.4 1.3 0.6 0.8 13.9 0.5 0.5 1.0 0.9 2.0 0.4 0.6 2.6 0.5 1.3 1.4 0.6 2.6 0.5 10.3 0.6 0.4 2.9 0.7 2.0 0.2 1.5 1.0 0.3 2.0 0.2 0.3 0.2 0.2 0.8 0.3 10.9 0.2 0.7 0.4 0.3 1.4 0.5 0.4 1.0 0.4 0.6 0.9 5.1 0.0 0.3 0.0 0.1 0.1 0.6 1.1 0.2 0.2 6.2 0.0 2.0 0.0 1.1 2.1 0.4 0.5 0.2 2.3 0.9 0.7 0.8 0.1 1.4 34.0 4.2 0.5 0.1 0.0 0.2 0.1 0.1 0.3 0.4 2.1 0.5 0.6 7.8 2.2 35.0 1.8 3.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.8 1.4 3.8 2.2 2.1 1.3 1.4 1.3 0.6 1.4 2.9 0.9 0.0 1.1 145.0 7.3 3.7 1.9 0.6 1.8 28.0 1.1 0.8 2.0 0.0 3.5 3.7 56.3 0.4 0.4 0.5 0.0 0.2 24.6 2.9 0.6 1.3 2.4 0.0 372.7 0.4 0.6 1.0 2.0 1.2 0.0 0.8 1.4 0.6 1.3 38.7 265.1 3.6 0.0 1.0 2.3 11.2 0.6 0.6 0.0 19.7 0.0 14.3 1.0 95.5 30.2 0.1 0.1 0.7 8.4 1.6 1.1 0.7 7.0 32.7 0.0 2.2 1.5 5.1 2.6 0.6 4.4 0.1 0.8 0.9 0.4 2.3 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 2037.4;Macrophages: 699.2;Melanocytes: 1117.1" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 1472.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.31e-7)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 107.7 85.6 37.6 115.8 37.4 325.1 68.8 37.9 41.0 149.6 36.9 166.7 36.9 143.9 60.7 37.1 96.2 72.5 100.9 38.6 53.8 51.8 29.1 141.0 86.1 52.1 43.9 110.8 18.4 17.1 21.4 67.1 46.9 61.3 65.5 9.2 41.8 90.1 21.7 61.6 81.6 202.9 44.2 91.8 65.3 33.5 43.7 45.2 43.2 43.7 94.7 132.8 106.9 48.4 73.8 739.3 44.9 127.1 691.3 1081.5 1.2 490.7 898.0 627.6 560.7 73.5 265.0 6.9 107.5 1101.0 296.4 12.1 45.5 54.6 390.4 241.3 20.5 335.0 192.0 43.3 572.4 160.2 338.9 586.1 12.2 635.3 436.3 455.5 277.9 66.1 237.4 616.1 1019.5 10.1 25.1 1472.4 55.4 12.1 196.9 22.1 150.1 355.7 554.6 0.4 1.8 2.0 225.2 1.2 131.2 77.2 2.7 253.1 456.6 574.7 236.5 435.8 388.1 287.6 426.6 20.1 339.2 232.5 402.5 2401.3 980.4 1402.3 1324.0 1173.0 1117.1 570.1 1425.3 1327.0 688.7 467.9 818.8 948.4 1094.0 854.5 1148.4 516.9 1631.4 1971.4 37.6 37.4 37.9 41.0 38.6 53.8 52.1 43.9 46.9 44.2 43.7 48.4 66.5 0.0 4.5 5.5 338.0 278.0 75.4 161.0 48.3 2.3 14.7 22.9 5.4 21.5 21.8 33.1 0.0 14.9 375.9 1.5 5.9 72.0 6.5 18.9 255.1 118.6 6.0 94.8 0.2 11.2 26.0 371.3 23.0 15.1 257.0 8.5 128.2 7.2 589.0 0.0 0.3 4.1 42.7 458.8 2037.4 21.3 335.5 699.2 1117.1 6.5 444.5 64.6 565.4 0.0 0.7 114.3 28.2 217.0 334.9 285.5 1.7 9.3 14.6 5.0 105.2 193.0 278.7 16.2 6.7 10.6 189.9 20.2 441.4 29.1 4.9 44.4 EPC1 Epl1 ENSG00000120616 "Enhancer of polycomb homolog 1" Q9H2F5 10 32267751-32378798 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 149.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028931 Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Vesicles" "HPA028931: " "unprognostic (6.94e-2)" "unprognostic (3.03e-2)" "unprognostic (9.93e-2)" "unprognostic (9.43e-2)" "unprognostic (5.73e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.80e-2)" "unprognostic (3.83e-3)" "unprognostic (7.43e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.02e-4)" "unprognostic (4.40e-2)" "unprognostic (1.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-3)" 14.4 9.6 12.5 13.9 13.7 149.7 19.4 21.2 14.5 17.5 12.0 15.9 11.5 20.6 15.8 11.1 14.8 12.8 11.9 12.4 12.0 11.9 13.8 14.7 21.5 12.4 12.7 23.4 14.4 14.6 10.3 11.7 13.0 15.0 16.1 19.3 15.0 10.3 22.7 13.8 12.9 16.8 12.5 18.6 13.9 14.4 12.4 31.9 16.8 23.4 17.6 15.2 14.1 16.2 12.0 9.6 21.4 17.9 10.6 14.1 12.4 12.2 6.9 15.6 12.8 10.7 15.1 21.8 8.0 13.6 8.2 12.1 12.1 10.4 10.8 15.9 19.4 18.0 13.5 19.2 11.4 14.1 24.7 12.9 15.8 9.3 7.3 13.9 12.8 18.3 18.8 27.7 12.6 12.9 21.5 10.1 5.3 11.4 8.4 27.7 18.3 11.2 12.1 10.9 18.7 17.8 11.4 8.3 20.1 11.8 8.6 18.7 11.6 9.3 22.7 7.8 10.6 11.3 12.2 35.6 10.0 21.1 8.4 65.8 15.3 36.3 18.9 10.2 16.0 27.4 16.9 15.0 9.1 30.9 17.5 16.1 46.8 13.4 13.2 27.4 21.1 7.7 12.5 13.7 21.2 14.5 12.4 12.0 12.4 12.7 13.0 12.5 12.4 16.2 103.8 41.7 50.9 133.2 166.8 28.6 85.0 54.0 78.6 101.4 69.6 84.3 32.4 52.9 49.2 40.5 68.8 34.9 182.6 55.5 9.8 51.5 11.8 54.1 86.7 70.1 98.6 74.9 108.0 43.6 40.7 71.8 58.1 65.8 85.4 74.9 58.5 35.8 35.2 114.4 106.7 63.9 50.8 55.7 46.8 13.1 94.8 84.4 40.9 134.0 75.4 57.3 148.3 161.9 131.8 49.9 52.3 68.1 139.4 71.6 50.4 20.5 44.1 85.8 98.6 134.9 82.5 77.8 58.3 62.9 24.9 46.1 175.3 56.5 51.0 72.4 EPN3 "FLJ20778, MGC129899" ENSG00000049283 "Epsin 3" Q9H201 17 50532682-50543750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;stomach 1: 37.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 77.9;Distal enterocytes: 27.6;Gastric mucus-secreting cells: 44.9;Intestinal goblet cells: 24.9;Squamous epithelial cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 28.6;HBEC3-KT: 40.3;MCF7: 66.4;OE19: 62.8;RT4: 50.2;SK-BR-3: 25.8;T-47d: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055546, HPA063224" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 6: T47d - Mammary gland" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles Nucleoplasm "HPA055546: AB_2682844, HPA063224: AB_2684964" "unprognostic (1.91e-2)" "unprognostic (1.99e-2)" "unprognostic (2.41e-1)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (2.06e-1)" "unprognostic (5.70e-3)" "unprognostic (7.62e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.66e-3)" "unprognostic (1.00e-2)" "prognostic favorable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (1.16e-1)" "unprognostic (4.90e-1)" "unprognostic (3.52e-3)" 0.2 8.9 2.3 0.8 1.3 0.6 2.3 6.4 6.0 6.5 1.2 7.1 6.8 0.4 3.2 35.9 7.5 5.9 7.1 0.7 2.1 6.0 0.1 0.3 0.0 11.5 5.4 13.5 23.0 21.2 0.8 4.2 13.6 9.9 4.4 0.2 11.1 5.6 0.1 30.5 3.2 0.1 0.5 0.0 37.3 2.8 13.4 3.2 1.1 0.0 3.7 5.5 12.9 1.8 20.5 0.3 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 14.7 12.1 0.0 0.2 0.0 0.1 28.6 0.0 40.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.2 0.1 21.8 0.1 3.0 0.0 0.0 0.1 0.0 0.0 0.0 66.4 0.3 0.0 0.0 62.8 0.4 0.0 0.0 0.1 0.2 50.2 0.4 0.0 0.0 25.8 0.0 0.4 57.4 0.2 1.5 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.3 6.4 6.0 0.7 2.1 11.5 5.4 13.6 0.5 13.4 1.8 0.2 0.0 0.0 0.0 0.4 2.3 4.4 4.1 10.8 2.9 6.5 3.4 5.4 8.6 8.3 18.4 0.0 77.9 0.0 27.6 5.9 9.2 1.0 3.8 0.6 0.4 3.6 0.0 1.0 11.5 7.4 0.8 44.9 5.5 0.0 3.1 0.0 0.0 5.9 0.0 1.7 24.9 2.0 0.0 0.0 2.1 2.8 0.5 0.0 1.0 0.6 0.6 0.0 0.0 0.0 3.4 10.3 0.0 1.3 4.9 2.1 0.3 4.3 0.9 0.0 0.0 0.8 0.0 0.5 30.0 5.5 10.7 0.2 12.4 19.3 7.8 EPS15 "AF-1P, MLLT5" ENSG00000085832 "Epidermal growth factor receptor pathway substrate 15" P42566 1 51354263-51519266 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Host-virus interaction, Protein transport, Transport" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 314.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008451, CAB010164, HPA061431" Approved Enhanced Vesicles,Cytosol "Intracellular and membrane" NA NA 65000 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Vesicles, Cytosol" "CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662" "unprognostic (1.45e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (1.05e-2)" "unprognostic (7.72e-3)" "unprognostic (3.99e-1)" "unprognostic (1.42e-1)" "unprognostic (4.96e-3)" "unprognostic (9.26e-2)" "unprognostic (4.13e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.41e-1)" "unprognostic (5.36e-2)" "unprognostic (8.73e-3)" "unprognostic (2.13e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" 31.9 35.1 40.3 25.5 48.2 20.7 25.6 38.8 55.7 23.9 25.7 19.1 15.8 22.8 17.6 21.0 18.3 26.1 26.5 43.9 39.1 24.5 26.4 26.9 46.0 38.6 44.1 28.8 14.7 29.0 15.5 31.5 40.7 26.7 20.5 23.4 16.7 20.9 47.6 24.2 17.7 24.3 40.1 34.1 21.3 46.9 45.0 27.6 25.3 40.5 45.6 22.8 20.9 57.2 35.4 10.4 22.0 20.8 49.6 49.2 54.5 24.2 37.9 19.4 28.4 14.4 19.2 71.8 24.3 38.1 39.5 32.7 28.7 23.1 29.1 81.8 18.0 64.1 16.9 17.1 46.7 36.9 56.4 40.3 21.0 34.0 45.7 33.5 36.5 25.2 40.4 31.7 29.8 17.5 29.9 19.8 30.2 24.6 16.7 24.1 33.3 15.9 25.5 43.2 15.0 20.9 28.8 50.4 42.1 60.2 20.5 25.7 51.1 18.0 19.1 36.3 20.5 37.6 41.0 47.6 26.6 41.0 16.1 18.8 10.4 12.1 9.4 10.7 14.2 15.6 11.2 14.9 10.8 9.0 6.6 9.6 7.8 10.8 13.0 7.1 19.0 8.7 40.3 48.2 38.8 55.7 43.9 39.1 38.6 44.1 40.7 40.1 45.0 57.2 51.5 35.3 41.0 142.4 78.3 43.0 32.1 16.4 30.1 18.1 28.2 15.6 59.8 24.3 22.7 44.1 31.3 22.8 65.0 28.5 19.6 15.2 27.0 22.1 50.1 43.3 28.8 81.0 77.1 19.0 18.9 52.5 41.3 35.6 24.6 36.0 61.4 37.7 83.4 28.6 60.6 30.7 12.2 80.9 61.9 61.7 65.9 67.0 103.2 110.5 57.6 38.4 27.8 29.7 314.1 23.3 19.8 48.2 78.4 62.1 20.7 28.1 31.9 26.6 39.5 45.1 38.0 74.4 44.5 33.8 51.0 28.5 74.3 28.5 21.4 50.8 ERGIC1 "ERGIC-32, ERGIC32, KIAA1181, NET24" ENSG00000113719 "Endoplasmic reticulum-golgi intermediate compartment 1" Q969X5 5 172834251-172952683 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 247.8;Intestinal goblet cells: 202.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018666, HPA018900" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Vesicles" "HPA018666: AB_1848241, HPA018900: AB_1848242" "unprognostic (8.86e-2)" "unprognostic (3.50e-2)" "unprognostic (3.44e-2)" "unprognostic (5.71e-2)" "unprognostic (7.96e-2)" "unprognostic (2.46e-2)" "unprognostic (9.53e-3)" "unprognostic (7.02e-3)" "unprognostic (2.06e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "unprognostic (1.74e-2)" "unprognostic (1.67e-1)" "unprognostic (3.86e-2)" "unprognostic (9.28e-2)" "unprognostic (3.22e-2)" 67.3 147.8 33.4 49.1 31.2 44.9 60.3 47.4 35.4 127.2 26.7 97.7 79.5 67.4 75.3 55.0 72.4 50.2 60.9 35.8 31.8 66.1 193.2 77.8 40.8 41.4 36.4 56.9 80.6 50.7 48.5 47.9 38.1 146.8 102.7 21.6 97.6 69.8 92.3 46.7 79.4 64.1 33.0 69.2 107.1 25.3 41.3 83.1 75.2 91.9 55.0 58.3 54.3 34.0 120.2 112.8 95.0 211.6 353.3 262.0 51.9 239.5 179.3 105.5 97.4 159.5 120.4 114.8 166.9 406.4 181.7 43.2 68.5 316.8 123.3 92.0 67.5 70.7 156.1 86.1 258.9 33.3 21.6 223.8 128.6 155.8 143.8 173.8 171.0 117.8 42.6 156.8 177.1 150.4 96.5 57.6 56.0 283.7 101.4 327.4 62.9 358.5 245.2 68.6 52.9 96.0 82.7 234.7 120.6 91.1 98.0 37.4 132.4 171.3 69.1 165.9 99.2 246.8 294.0 47.5 236.9 78.3 76.2 3.7 7.5 19.2 3.1 10.5 5.2 9.3 1.6 2.1 6.1 6.2 1.0 2.3 30.6 14.3 14.3 3.1 1.0 5.1 33.4 31.2 47.4 35.4 35.8 31.8 41.4 36.4 38.1 33.0 41.3 34.0 41.9 57.7 29.5 22.9 62.0 22.8 32.1 22.7 14.8 37.2 51.2 35.1 32.9 68.6 29.4 49.7 16.7 20.7 44.3 83.6 21.5 101.9 11.5 36.2 48.0 33.5 26.0 25.9 35.4 60.8 90.3 47.2 49.5 77.9 23.5 64.4 37.5 247.8 41.1 21.9 41.8 202.9 36.7 77.0 105.2 33.8 65.0 54.8 7.2 30.0 91.1 39.0 36.0 47.7 30.6 86.9 59.3 58.3 96.2 74.2 95.0 38.5 28.4 12.6 39.5 56.1 41.1 1.9 10.5 27.2 26.9 9.0 25.1 103.5 73.3 47.8 ERI1 "3'HEXO, THEX1" ENSG00000104626 "Exoribonuclease 1" Q8IV48 8 9002147-9116746 "Predicted intracellular proteins" "RNA-mediated gene silencing, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033838, HPA055548, HPA056074" Uncertain Approved Vesicles,Microtubules NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules Vesicles "CAB033838: AB_2098575, HPA055548: AB_2682845, HPA056074: AB_2683029" "unprognostic (2.49e-1)" "unprognostic (1.13e-1)" "prognostic favorable (8.05e-5)" "unprognostic (1.96e-2)" "unprognostic (2.79e-2)" "unprognostic (2.61e-3)" "unprognostic (1.08e-3)" "unprognostic (2.90e-1)" "unprognostic (5.50e-2)" "unprognostic (1.49e-1)" "unprognostic (1.25e-3)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.27e-2)" "unprognostic (3.57e-1)" "unprognostic (8.75e-2)" "unprognostic (2.36e-2)" 5.3 3.1 3.1 6.5 3.8 13.0 4.8 3.7 4.1 4.3 3.5 3.8 4.7 4.7 2.5 4.3 3.9 3.9 2.8 3.0 3.5 4.2 4.4 5.1 7.4 4.5 3.9 4.2 3.0 4.2 2.5 6.7 3.7 3.2 4.6 11.3 3.8 3.2 2.4 3.2 3.8 5.1 3.8 5.0 3.6 9.1 3.8 6.9 2.9 2.7 7.4 6.2 3.5 4.1 32.3 19.9 17.2 13.1 13.4 21.7 23.5 27.4 14.4 19.6 24.1 14.8 14.4 36.7 7.0 15.7 32.7 11.2 15.1 18.5 27.3 15.1 10.8 20.3 15.8 11.5 13.7 15.6 28.6 12.9 6.1 16.3 14.4 10.9 26.8 21.6 23.3 22.6 22.8 10.5 47.2 19.3 20.0 24.2 12.1 20.1 25.1 13.7 25.2 45.6 2.4 18.8 16.4 12.5 13.8 12.1 9.3 13.9 23.2 20.7 21.4 39.5 21.6 4.9 18.1 31.9 15.3 22.2 16.5 6.4 4.6 3.4 4.2 5.1 4.3 5.3 4.9 4.4 3.9 3.9 3.8 3.6 3.3 6.0 3.5 2.9 9.8 3.5 3.1 3.8 3.7 4.1 3.0 3.5 4.5 3.9 3.7 3.8 3.8 4.1 9.2 3.2 8.1 17.6 9.7 18.2 9.6 6.7 3.4 17.4 8.6 5.0 5.7 2.8 10.1 3.7 14.6 25.3 11.3 7.4 3.9 9.0 46.9 14.8 14.4 8.6 3.6 18.7 11.4 12.0 27.6 9.1 8.6 23.3 8.2 7.7 11.4 4.8 13.5 5.0 9.7 5.2 8.2 9.7 15.9 16.7 6.5 12.9 10.6 9.4 11.9 8.0 6.2 9.5 16.7 11.2 5.6 9.1 11.2 6.3 4.3 8.2 9.1 21.6 13.1 7.8 7.5 43.6 45.6 6.1 10.1 20.8 11.7 5.9 6.8 3.8 ERICH2 ENSG00000204334 "Glutamate rich 2" A1L162 2 170783786-170798971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 163.9" "Cell type enriched" "Detected in many" 7 "Early spermatids: 2216.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "hTCEpi: 61.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory bulb: 33.1" HPA061010 Approved "Nucleoli fibrillar center,Vesicles" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoli fibrillar center" Vesicles "HPA061010: " "unprognostic (1.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.26e-1)" "prognostic favorable (9.49e-4)" "unprognostic (7.57e-3)" "unprognostic (6.61e-2)" "unprognostic (9.62e-3)" "unprognostic (6.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-2)" "unprognostic (1.12e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (8.98e-7)" "unprognostic (1.03e-1)" "unprognostic (5.28e-3)" "unprognostic (7.35e-2)" "unprognostic (2.76e-1)" 1.4 1.8 5.8 0.2 6.3 0.0 4.3 6.0 7.3 6.2 15.0 0.8 0.1 4.9 3.6 0.6 9.5 1.8 3.9 5.4 7.0 3.5 5.4 12.1 0.3 5.2 5.7 2.2 2.9 7.9 1.4 0.4 5.3 2.2 0.7 6.9 2.5 2.2 1.1 0.6 0.3 1.3 5.0 0.1 3.9 163.9 5.7 0.3 18.6 3.5 0.6 1.1 0.9 5.3 9.5 0.0 0.1 7.7 0.0 0.0 0.4 0.0 0.0 1.5 3.1 7.9 1.9 0.0 0.3 0.0 3.4 0.2 2.0 0.7 0.1 1.3 2.0 4.1 0.0 0.1 7.8 0.4 0.5 1.2 61.5 0.0 14.1 0.2 0.0 1.5 9.2 0.0 0.0 3.3 0.0 0.8 9.5 11.3 1.6 0.0 1.5 0.0 4.4 0.2 1.1 2.0 5.6 0.1 2.4 1.8 1.3 1.3 0.0 2.0 1.7 0.0 0.9 0.0 0.0 0.0 7.7 3.8 6.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 6.3 6.0 7.3 5.4 7.0 5.2 5.7 5.3 5.0 5.7 5.3 0.2 6.4 24.4 8.1 0.1 0.3 0.6 1.7 0.0 1.6 1.0 2.0 2.0 2.8 2.3 1.8 0.0 0.0 0.0 0.1 13.7 0.9 2216.6 25.7 3.6 0.9 7.7 0.0 4.4 1.8 0.2 1.0 0.0 1.3 0.0 0.7 0.0 2.5 0.0 0.0 12.7 1.6 2.0 0.0 0.0 302.9 9.6 0.9 0.0 1.9 0.0 2.0 0.0 6.6 4.0 1.3 0.0 7.5 0.0 0.2 0.0 0.7 21.5 0.5 6.6 0.8 1.0 39.1 10.8 0.0 0.1 0.0 0.1 0.2 0.4 0.1 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293638 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7" "Cell type enhanced" "Detected in many" "Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles NA Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 45: Enterocytes - Digestion" Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.01e-5)" "prognostic unfavorable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favorable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.4 0.2 0.0 2.4 0.0 8.5 0.5 0.0 0.0 3.5 0.0 1.5 3.9 0.2 0.0 15.4 0.2 0.4 0.1 0.0 0.0 0.9 0.6 0.4 4.4 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.1 1.4 0.0 2.0 0.1 0.0 2.6 4.3 0.7 0.0 1.0 0.9 6.2 0.1 10.7 0.1 0.0 4.9 0.6 5.9 0.0 27.8 23.6 27.6 21.1 0.6 1.9 17.5 15.9 8.6 28.8 19.2 15.8 22.7 49.9 9.5 6.8 17.4 20.2 32.6 9.9 14.3 13.7 32.8 30.6 24.1 11.1 0.1 19.5 25.2 0.6 0.6 15.5 7.6 2.8 15.4 22.2 42.6 41.0 9.1 29.2 30.6 16.4 22.5 14.5 12.9 29.3 30.2 21.4 4.2 11.6 18.9 15.8 11.9 20.4 10.1 13.0 36.9 12.7 8.2 14.5 27.2 11.9 25.5 32.5 29.7 31.9 8.2 19.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.3 0.6 0.9 0.3 0.5 0.6 0.0 1.0 1.3 0.9 0.0 0.4 3.7 0.0 1.9 0.6 2.7 0.0 0.2 0.8 0.2 0.8 1.0 3.5 1.3 0.7 0.0 2.3 1.1 3.6 0.7 0.0 4.4 0.7 6.8 2.6 0.0 0.4 2.7 22.4 0.6 2.1 1.2 0.0 1.3 0.0 1.0 0.0 0.0 0.0 0.0 0.5 1.5 1.3 0.4 2.1 0.4 22.6 6.6 0.2 0.0 0.0 0.4 0.9 5.5 4.1 7.4 0.6 0.3 0.4 0.1 2.8 0.4 ESR1 "ER-alpha, Era, ESR, NR3A1" ENSG00000091831 "Estrogen receptor 1" P03372 6 151656691-152129619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 83.8;endometrium 1: 110.9;fallopian tube: 64.9" "Cell type enhanced" "Detected in many" "Breast glandular cells: 86.6;Endometrial ciliated cells: 77.9;Endometrial stromal cells: 79.9;Glandular and luminal cells: 98.9;Hepatocytes: 52.1;Horizontal cells: 62.2;Skeletal myocytes: 56.7" "Cancer enhanced" "Detected in many" "breast cancer: 40.2;endometrial cancer: 24.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "MCF7: 46.0;T-47d: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000037, HPA000449, HPA000450, CAB055099, CAB072858" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 6: T47d - Mammary gland" "Cluster 44: Endometrium - Transcription" Vesicles Nucleoplasm "CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754" "unprognostic (8.28e-2)" "unprognostic (3.02e-2)" "unprognostic (1.43e-2)" "prognostic favorable (5.47e-7)" "unprognostic (4.79e-1)" "unprognostic (2.43e-3)" "unprognostic (4.10e-5)" "unprognostic (9.92e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (7.35e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-2)" "unprognostic (7.91e-3)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.52e-1)" 4.2 1.8 3.2 1.5 1.3 0.8 29.1 2.9 1.3 83.8 3.2 0.9 0.4 110.9 1.2 0.5 64.9 1.2 1.8 0.6 6.7 2.8 16.9 2.0 1.6 0.4 0.5 9.0 1.0 0.2 6.6 0.4 0.3 6.1 0.5 3.5 0.9 9.8 5.8 1.1 0.8 50.4 0.2 1.7 0.6 2.3 5.9 1.0 3.4 2.6 2.3 2.1 46.9 0.3 0.6 0.0 0.1 0.1 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.6 0.0 0.0 0.0 1.2 0.1 46.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.7 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.2 57.4 0.0 0.1 0.2 0.2 0.5 0.0 5.2 1.1 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.2 1.3 2.9 1.3 0.6 6.7 0.4 0.5 0.3 0.2 5.9 0.3 0.6 0.0 1.1 1.3 2.3 1.0 1.7 0.0 0.0 3.9 86.6 16.4 4.4 0.0 1.0 0.0 8.4 0.1 0.4 0.1 1.9 0.0 40.1 77.9 79.9 2.7 1.8 0.0 4.5 0.2 0.1 11.3 0.0 98.9 2.5 36.9 5.0 52.1 0.9 62.2 5.4 0.0 0.0 4.0 3.1 10.3 4.1 2.5 1.8 1.0 0.2 2.4 0.0 25.1 0.6 0.1 0.0 2.2 8.5 0.6 0.0 3.7 1.3 4.6 0.0 56.7 11.7 1.8 1.3 0.4 1.7 0.1 2.2 4.8 0.1 6.8 ESR2 "ER-beta, Erb, NR3A2" ENSG00000140009 "Estrogen receptor 2" Q92731 14 64084232-64338112 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 6.1" "Cell type enhanced" "Detected in many" "Early spermatids: 61.4;Granulosa cells: 26.6;Late spermatids: 93.7;Rod photoreceptor cells: 35.6;Spermatocytes: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 4.2;U-266/70: 9.8;U-698: 16.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 6.1" "HPA068406, CAB079300" Enhanced Supported Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 71: Testis - DNA repair" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Vesicles "CAB079300: , HPA068406: " "unprognostic (7.63e-3)" "unprognostic (2.28e-3)" "unprognostic (8.27e-3)" "unprognostic (5.41e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (8.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.65e-1)" "unprognostic (3.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.66e-1)" "unprognostic (4.21e-2)" "unprognostic (5.89e-2)" 1.5 6.1 1.2 1.2 0.6 1.0 0.9 3.0 0.8 1.4 3.5 0.9 1.0 1.2 0.4 0.7 1.0 0.5 0.6 0.5 0.9 1.5 0.7 0.6 2.1 0.7 0.6 5.4 2.1 0.1 0.8 0.2 1.0 1.5 1.0 2.0 0.8 0.2 1.4 1.0 1.3 0.3 0.3 1.8 1.0 5.7 1.7 2.5 0.6 0.2 1.6 1.1 0.6 0.9 0.8 0.4 0.7 0.6 0.0 0.1 1.5 0.2 0.0 0.1 0.1 0.3 0.9 3.1 0.1 0.1 0.4 1.0 0.8 0.0 0.1 0.7 0.4 0.3 1.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.2 0.3 1.1 0.5 4.2 0.2 0.8 0.5 0.2 0.7 0.6 0.4 0.5 0.4 0.3 0.1 1.3 2.2 0.6 0.4 0.2 1.1 0.4 0.7 0.1 0.5 0.4 1.0 0.2 0.1 9.8 3.1 16.4 0.2 0.1 0.8 0.3 0.1 0.5 0.3 0.2 0.2 0.5 0.2 0.4 0.0 0.7 0.4 0.3 0.6 0.2 0.3 1.1 0.2 0.1 1.2 0.6 3.0 0.8 0.5 0.9 0.7 0.6 1.0 0.3 1.7 0.9 0.9 6.4 0.0 6.8 5.5 0.3 2.2 0.4 2.8 1.6 0.3 0.1 0.9 4.3 0.9 0.0 6.2 0.7 5.2 0.1 0.0 0.3 61.4 3.5 0.9 3.0 0.0 0.4 12.4 0.7 0.5 2.2 0.0 4.9 1.3 26.6 1.1 0.1 0.1 0.0 17.9 0.8 0.0 0.0 0.3 93.7 0.9 0.2 1.8 7.5 0.1 0.9 6.2 10.6 7.6 0.5 0.1 1.2 16.6 3.8 0.4 0.1 1.7 35.6 0.0 1.5 1.4 28.0 1.4 0.5 0.1 1.1 3.0 16.4 0.8 1.8 ETV3 PE-1 ENSG00000117036 "ETS variant transcription factor 3" P41162 1 157121191-157138474 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 361.2;monocytes: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004794, HPA073211" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm Vesicles "HPA004794: AB_1078761, HPA073211: " "unprognostic (1.65e-1)" "unprognostic (2.37e-1)" "unprognostic (3.78e-2)" "unprognostic (4.39e-2)" "unprognostic (7.59e-2)" "unprognostic (5.23e-2)" "unprognostic (1.38e-2)" "unprognostic (3.30e-1)" "unprognostic (2.36e-2)" "unprognostic (5.37e-2)" "unprognostic (1.34e-2)" "unprognostic (8.02e-2)" "unprognostic (7.26e-3)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" "unprognostic (8.97e-2)" "unprognostic (6.65e-2)" 13.7 7.7 6.6 11.1 6.6 24.0 12.1 7.9 20.1 8.3 5.3 8.7 15.1 9.3 7.5 15.6 7.8 12.7 7.4 8.3 8.1 6.6 6.6 12.6 10.1 7.7 6.5 11.5 6.4 23.9 5.0 12.8 7.0 10.2 9.5 5.7 9.2 8.5 9.4 31.5 14.6 10.1 7.1 10.0 10.0 9.4 7.4 10.8 7.9 8.8 12.5 17.6 11.4 7.1 11.9 11.4 11.6 10.1 17.3 11.3 9.9 10.9 11.4 10.5 9.7 12.2 11.6 14.2 13.4 13.4 5.6 18.0 12.8 16.7 13.8 31.0 8.1 11.9 12.2 6.7 10.3 19.0 18.1 12.5 19.2 15.7 13.3 8.5 11.1 8.8 13.9 10.2 12.0 15.7 5.8 10.7 38.6 16.9 8.7 8.7 13.8 16.3 8.1 43.9 9.8 19.0 11.9 28.1 29.5 20.7 14.4 20.7 18.8 13.5 11.9 13.2 13.7 24.6 13.5 16.7 15.5 10.9 45.2 6.3 4.6 3.3 4.5 4.2 6.2 2.1 3.9 4.5 4.5 2.4 3.9 3.5 5.4 4.2 4.2 1.2 3.3 2.6 6.6 6.6 7.9 20.1 8.3 8.1 7.7 6.5 7.0 7.1 7.4 7.1 22.9 35.3 16.2 3.6 20.4 70.4 18.4 20.2 71.7 2.3 18.2 14.4 9.4 5.7 24.3 12.9 10.4 7.5 37.2 22.1 0.0 6.4 9.4 18.1 18.0 19.4 10.7 5.9 8.1 6.3 9.0 16.3 15.3 29.5 22.2 6.4 15.4 8.3 8.7 1.7 6.9 12.5 10.2 13.2 361.2 7.3 4.1 69.0 16.0 5.6 97.0 3.9 10.3 6.0 4.4 10.4 13.4 4.5 25.3 16.5 16.0 3.2 29.7 6.3 13.1 16.4 15.4 10.2 9.4 64.2 78.7 14.9 40.4 6.0 14.4 51.4 EVA1A "FAM176A, FLJ13391, TMEM166" ENSG00000115363 "Eva-1 homolog A, regulator of programmed cell death" Q9H8M9 2 75469302-75569722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 191.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 41.7;Cytotrophoblasts: 43.3;Hepatocytes: 78.1;Proximal tubular cells: 77.3;Syncytiotrophoblasts: 124.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 85.7;U-138 MG: 110.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008055 Approved Supported "Vesicles,Plasma membrane" NA Yes "Cluster 85: Liver - Metabolism" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Plasma membrane" "HPA008055: AB_1080308" "unprognostic (2.72e-1)" "unprognostic (2.61e-2)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.60e-2)" "unprognostic (5.02e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "prognostic favorable (5.67e-4)" "unprognostic (7.33e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.80e-4)" "unprognostic (8.19e-2)" "unprognostic (4.37e-2)" "unprognostic (2.43e-2)" "unprognostic (9.07e-2)" 1.1 0.5 0.2 1.1 0.9 0.1 3.4 0.6 0.5 9.8 0.2 0.7 1.7 2.8 9.6 0.4 3.7 1.2 1.6 0.2 0.3 20.0 191.6 20.7 0.4 1.1 0.5 0.5 23.8 7.6 1.1 17.3 0.9 0.9 0.7 0.5 8.9 2.2 1.2 2.7 1.8 2.0 0.7 10.8 0.6 2.9 0.8 5.1 1.8 1.6 0.3 0.8 0.8 0.8 1.0 14.5 1.5 0.4 3.1 21.2 1.4 68.0 45.3 59.2 30.1 0.5 1.2 0.1 6.3 85.7 54.2 9.4 1.7 14.4 36.8 0.0 1.1 0.0 2.5 45.7 2.2 0.0 0.1 15.0 8.3 73.2 33.3 59.0 37.2 0.0 0.0 0.0 46.1 0.0 0.1 0.0 3.3 0.2 23.5 7.9 0.1 0.0 32.5 0.5 0.9 1.6 6.2 0.4 53.7 2.2 0.2 0.3 31.0 110.3 46.3 2.0 71.9 0.7 0.1 0.3 62.5 0.0 59.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.5 0.2 0.3 1.1 0.5 0.9 0.7 0.8 0.8 6.1 41.7 35.4 1.0 0.9 2.8 13.7 14.3 3.4 1.2 11.7 12.3 0.3 1.5 23.0 11.0 0.0 43.3 0.4 0.1 27.4 30.5 12.2 13.3 1.4 4.8 1.8 0.0 1.1 16.1 25.9 4.7 0.0 11.4 0.0 0.0 2.2 78.1 3.5 0.0 0.9 1.1 4.1 0.8 1.2 9.4 0.3 0.6 28.4 2.8 0.1 0.0 0.0 1.5 0.9 9.7 0.0 0.7 0.0 12.3 0.5 77.3 1.7 0.1 0.0 2.2 9.0 2.2 0.9 1.1 0.9 124.8 1.1 0.0 1.6 10.5 EVI5 NB4S ENSG00000067208 "Ecotropic viral integration site 5" O60447 1 92508696-92792404 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027339 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 15: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" Vesicles "HPA027339: AB_1848308" "unprognostic (1.23e-1)" "unprognostic (2.84e-1)" "unprognostic (4.29e-3)" "unprognostic (1.65e-1)" "unprognostic (4.94e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-3)" "unprognostic (7.43e-2)" "unprognostic (1.12e-1)" "unprognostic (9.11e-2)" "unprognostic (9.04e-3)" "unprognostic (2.25e-1)" "unprognostic (6.15e-2)" "unprognostic (8.30e-2)" "unprognostic (5.40e-1)" "unprognostic (6.38e-2)" "unprognostic (2.35e-2)" 5.7 8.1 5.9 4.5 8.3 2.7 4.4 8.5 5.8 5.9 8.2 4.8 4.3 6.4 4.6 4.0 5.1 5.8 7.1 4.2 7.7 5.0 16.4 7.1 3.2 8.1 6.2 3.8 3.8 7.9 3.9 12.1 6.8 5.3 5.5 4.9 4.5 5.6 2.9 5.0 4.0 7.1 8.6 4.5 6.4 9.6 6.3 1.3 6.6 3.6 3.3 5.5 3.8 10.9 5.4 5.9 9.1 8.9 14.5 18.2 8.6 12.2 18.5 8.2 9.4 10.4 1.4 2.4 16.8 14.0 15.2 6.1 8.6 9.0 14.6 0.2 3.3 4.3 5.6 6.2 14.2 3.1 4.8 11.5 7.2 14.2 8.5 23.9 17.9 0.2 7.7 3.8 13.9 2.7 0.3 3.6 2.6 3.5 4.8 2.2 21.7 3.2 6.3 15.5 3.4 7.0 14.4 7.4 16.6 9.8 3.6 7.1 11.8 9.1 6.6 12.2 8.1 5.5 3.4 3.8 6.0 5.0 7.6 0.9 2.7 2.8 0.1 1.9 0.0 1.2 0.1 0.0 1.3 1.2 0.0 0.0 3.4 0.1 2.9 0.8 0.0 0.4 5.9 8.3 8.5 5.8 4.2 7.7 8.1 6.2 6.8 8.6 6.3 10.9 27.2 60.9 29.9 91.4 18.7 43.5 29.3 23.0 18.2 24.5 20.5 17.7 51.8 22.8 32.3 16.5 25.0 48.4 7.5 22.9 17.6 27.9 3.0 67.8 39.4 31.2 22.1 11.4 158.4 29.9 26.0 42.5 42.3 26.2 13.3 21.9 43.2 52.4 32.2 30.3 149.3 27.0 14.2 54.0 27.0 5.8 28.3 45.1 26.6 114.3 48.9 28.5 5.2 112.6 199.6 68.4 19.3 54.2 28.8 28.1 21.8 20.1 46.9 25.4 13.1 51.4 56.4 37.4 42.4 21.2 50.0 65.5 5.5 60.9 20.0 32.1 EVL RNB6 ENSG00000196405 Enah/Vasp-like Q9UI08 14 99971449-100144236 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 402.4;NK-cells: 591.2;Rod photoreceptor cells: 438.0;T-cells: 373.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 291.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018849, HPA019536, CAB033987" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Vesicles, Cytosol" "CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180" "unprognostic (1.12e-3)" "unprognostic (5.03e-3)" "unprognostic (6.46e-3)" "unprognostic (2.70e-1)" "unprognostic (2.65e-1)" "unprognostic (2.27e-3)" "unprognostic (3.65e-2)" "unprognostic (2.35e-1)" "unprognostic (2.06e-1)" "unprognostic (6.35e-3)" "prognostic favorable (4.07e-6)" "unprognostic (3.50e-3)" "prognostic unfavorable (4.14e-6)" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-3)" "unprognostic (2.43e-1)" 38.8 31.3 130.5 91.9 135.1 50.1 58.1 105.0 185.5 44.4 66.3 46.6 29.2 64.8 49.5 30.6 63.7 42.0 53.0 136.9 108.8 42.6 90.3 63.2 159.0 103.1 110.1 51.6 40.8 19.7 98.6 29.1 106.1 52.1 24.2 204.6 41.2 32.0 33.2 41.0 69.9 62.0 92.5 107.7 43.3 31.6 115.5 179.4 37.9 28.8 126.2 43.1 32.8 121.2 15.2 14.2 107.1 30.3 22.4 58.5 59.7 18.9 26.5 14.2 18.7 0.8 11.4 30.9 24.9 19.2 10.5 0.4 49.0 36.3 16.8 30.4 32.6 51.9 11.5 8.4 18.0 16.2 116.7 31.6 18.9 9.1 35.8 29.3 38.3 117.3 25.5 2.3 15.7 22.7 291.7 89.6 19.7 13.1 21.8 65.4 58.7 5.5 17.2 0.6 120.8 73.1 14.3 22.0 7.2 24.6 17.7 47.4 27.7 11.2 16.5 66.9 12.8 55.3 44.1 87.9 14.9 27.1 19.7 2.3 2.6 27.4 20.2 13.9 15.1 9.6 22.6 19.2 4.3 13.2 26.3 24.4 0.6 18.0 16.5 0.8 41.4 10.6 130.5 135.1 105.0 185.5 136.9 108.8 103.1 110.1 106.1 92.5 115.5 121.2 26.4 28.9 42.3 45.1 155.2 20.8 22.2 10.8 12.0 125.4 70.4 50.5 4.7 22.8 14.2 12.9 402.4 22.6 215.3 1.0 31.3 12.9 4.2 40.1 51.9 47.5 8.4 31.1 119.9 14.0 12.0 30.5 20.4 26.2 17.1 45.1 39.3 102.2 144.8 77.4 121.1 3.7 8.2 82.5 76.6 12.0 24.8 92.5 26.6 100.2 42.0 89.1 591.2 86.0 66.1 11.6 2.9 49.7 53.3 17.4 2.6 14.2 41.9 438.0 6.6 29.8 33.9 14.1 28.4 8.7 31.4 14.6 373.3 13.5 3.8 15.9 EXOC3L1 "EXOC3L, FLJ35539, FLJ35587" ENSG00000179044 "Exocyst complex component 3 like 1" Q86VI1 16 67184379-67190185 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 44.7" "Cell type enhanced" "Detected in many" "Adipocytes: 26.4;Endothelial cells: 19.6;Granulosa cells: 20.8;Hepatic stellate cells: 28.9;Leydig cells: 15.5;Peritubular cells: 18.4;Theca cells: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;HUVEC TERT2: 3.5;SCLC-21H: 6.4;SuSa: 2.1;TIME: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA029574 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Cluster 64: Macrophages - Immune response" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Vesicles, Plasma membrane" "HPA029574: AB_10602495" "unprognostic (1.15e-2)" "unprognostic (4.91e-2)" "unprognostic (6.87e-3)" "unprognostic (2.09e-3)" "unprognostic (2.33e-1)" "unprognostic (2.46e-2)" "unprognostic (6.77e-2)" "unprognostic (3.98e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-2)" "unprognostic (6.48e-3)" "unprognostic (2.88e-1)" "unprognostic (6.64e-3)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.35e-1)" 6.4 4.6 0.5 1.8 0.5 0.0 4.1 1.0 0.8 2.6 0.0 1.6 0.9 2.8 0.1 1.3 1.8 1.1 5.4 0.5 0.5 7.3 2.1 10.0 1.4 0.8 0.2 3.6 1.6 0.8 2.0 5.9 1.1 2.4 0.4 0.2 1.6 0.6 2.1 1.2 1.7 0.9 0.1 44.7 1.5 2.1 0.4 0.1 7.1 0.8 0.2 1.7 1.3 0.1 0.1 0.0 0.7 0.2 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.8 0.1 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 3.5 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.4 0.8 0.7 0.1 0.0 0.1 6.4 0.8 0.8 0.1 0.0 2.1 0.6 0.0 2.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.5 1.0 0.8 0.5 0.5 0.8 0.2 1.1 0.1 0.4 0.1 26.4 0.0 0.0 0.3 0.3 0.9 2.1 2.8 5.7 1.5 3.0 5.2 1.6 0.0 0.4 3.7 0.0 0.6 0.2 4.6 7.9 1.0 2.0 0.1 0.3 19.6 1.2 2.7 0.1 3.7 4.3 2.6 1.5 0.4 0.0 20.8 28.9 1.4 0.8 3.3 0.3 3.4 2.0 1.9 0.2 5.5 15.5 1.8 0.0 1.0 4.0 0.3 0.0 1.0 0.0 0.6 3.1 18.4 0.0 0.4 8.9 0.2 0.3 0.9 0.0 0.3 1.1 4.0 8.6 1.2 2.0 0.8 0.2 32.5 2.7 1.6 EXOC6 "DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p" ENSG00000138190 "Exocyst complex component 6" Q8TAG9 10 92826831-93059493 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 164.2" "Cell type enhanced" "Detected in all" "Excitatory neurons: 181.7;Microglial cells: 146.1;Oligodendrocyte precursor cells: 157.3;Rod photoreceptor cells: 177.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 30.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036285, HPA059111" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles Nucleoplasm "HPA036285: AB_10673617, HPA059111: AB_2683907" "unprognostic (1.41e-1)" "unprognostic (1.39e-3)" "unprognostic (5.20e-2)" "unprognostic (2.65e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (1.16e-3)" "unprognostic (7.21e-3)" "unprognostic (3.84e-1)" "unprognostic (2.70e-1)" "unprognostic (1.66e-1)" "unprognostic (8.13e-2)" "prognostic favorable (4.66e-4)" "unprognostic (2.12e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (6.41e-2)" 8.7 14.4 5.9 8.2 7.5 12.9 8.0 7.7 8.6 6.5 8.0 9.6 8.1 6.1 5.7 4.2 5.8 10.1 7.1 8.2 6.0 6.4 10.1 10.7 9.5 3.4 2.4 3.9 10.0 6.3 6.1 37.4 3.7 8.6 10.2 164.2 5.6 4.3 31.8 5.0 9.5 7.7 3.3 9.1 7.0 9.9 6.1 8.5 28.4 19.7 8.2 10.1 3.5 7.1 19.8 24.3 25.7 16.8 1.3 1.6 9.1 9.0 24.9 8.1 9.7 9.1 16.5 22.5 19.0 4.3 6.6 12.3 20.8 5.7 10.1 20.1 20.9 35.1 8.3 11.7 9.6 36.4 30.6 2.2 3.0 7.2 4.8 14.6 113.8 14.6 29.2 14.5 4.0 10.7 15.3 23.2 3.5 40.2 7.0 22.5 11.2 11.6 17.4 13.2 8.5 11.9 9.2 9.2 11.8 6.4 18.2 18.8 22.4 0.6 8.2 7.5 14.7 10.8 12.4 18.1 2.8 41.6 9.3 6.2 4.9 15.2 3.0 3.9 3.0 6.7 3.4 2.8 5.1 6.6 2.7 3.2 30.6 2.8 3.9 11.1 3.3 2.4 5.9 7.5 7.7 8.6 8.2 6.0 3.4 2.4 3.7 3.3 6.1 7.1 28.3 16.0 16.7 33.6 27.6 3.3 10.7 8.6 3.4 40.2 9.8 6.5 12.0 20.0 15.0 16.5 39.6 22.9 24.1 14.3 5.9 28.3 5.4 8.8 3.0 53.1 25.6 39.2 181.7 15.4 7.8 7.8 13.7 16.5 10.8 24.3 77.1 14.2 21.4 23.5 100.3 16.6 14.2 18.2 12.5 12.6 4.4 18.9 5.4 146.1 22.8 27.1 19.6 157.3 84.7 14.1 10.3 14.7 13.8 14.1 10.8 8.4 10.0 177.8 13.1 13.6 9.0 25.0 25.5 4.9 4.8 20.5 18.4 29.8 11.9 15.8 EXTL1 "EXTL, MGC70794" ENSG00000158008 "Exostosin like glycosyltransferase 1" Q92935 1 26019884-26036464 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.2;skeletal muscle: 12.7;tongue: 29.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 15.3;Breast glandular cells: 8.8;Excitatory neurons: 22.7;Horizontal cells: 10.1;Melanocytes: 7.2;Oligodendrocyte precursor cells: 10.6" "Cancer enriched" "Detected in some" 13 "melanoma: 21.7" "Group enriched" "Detected in many" 11 "amygdala: 10.3;basal ganglia: 9.8;cerebral cortex: 14.2;hippocampal formation: 11.5;white matter: 6.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "WM-115: 150.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010726, HPA037749" Uncertain Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 79000 "Cluster 47: Non-specific - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 30: Mammary glandular cells - Lactation" Centrosome Vesicles "HPA010726: , HPA037749: AB_10805350" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (8.16e-3)" "unprognostic (1.47e-2)" "unprognostic (2.47e-2)" "unprognostic (6.14e-3)" "unprognostic (3.78e-2)" "unprognostic (1.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (1.44e-2)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-3)" "unprognostic (2.27e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-2)" 0.2 1.0 10.3 0.0 9.8 0.0 0.8 0.0 14.2 0.4 0.0 1.0 0.1 3.6 0.1 0.5 0.7 0.3 3.5 11.5 0.0 0.4 0.0 0.2 0.2 0.1 0.6 1.1 1.5 0.0 0.9 0.3 0.4 0.4 0.0 0.8 0.5 0.2 12.7 2.3 0.3 1.3 0.0 3.5 0.3 0.6 0.9 0.0 0.2 29.8 0.0 0.3 0.4 6.9 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.2 0.6 0.0 0.2 2.4 0.2 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 150.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 9.8 0.0 14.2 11.5 0.0 0.1 0.6 0.4 0.0 0.9 6.9 0.1 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 15.3 8.8 1.8 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.0 22.7 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.0 0.1 10.1 5.1 0.0 0.0 0.0 0.3 0.6 1.5 0.0 7.2 2.8 0.0 0.4 0.0 10.6 1.9 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.4 0.4 0.2 0.2 0.0 0.0 1.0 0.0 1.1 0.1 0.1 FAAP24 "C19orf40, FLJ46828, MGC32020" ENSG00000131944 "FA core complex associated protein 24" Q9BTP7 19 32972209-32978229 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 14.6;Spermatocytes: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041168 Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Vesicles "HPA041168: AB_10960496" "unprognostic (1.18e-2)" "unprognostic (1.22e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (6.52e-2)" "unprognostic (2.73e-1)" "unprognostic (2.58e-3)" "unprognostic (3.76e-2)" "unprognostic (1.88e-2)" "unprognostic (3.98e-2)" "unprognostic (2.82e-3)" "unprognostic (3.54e-2)" "prognostic unfavorable (4.00e-7)" "unprognostic (4.37e-3)" "unprognostic (5.30e-1)" "unprognostic (2.31e-3)" "unprognostic (2.15e-1)" 1.7 1.4 0.8 2.6 0.7 3.5 1.8 1.2 1.1 1.0 1.1 1.7 1.8 1.3 2.4 1.8 1.4 2.3 0.7 0.8 0.6 1.2 1.4 1.4 3.1 1.4 0.6 2.5 0.9 0.4 0.8 1.6 1.0 4.8 2.5 0.5 1.2 1.1 0.5 2.8 2.2 1.5 0.4 2.4 1.4 6.2 0.9 2.6 1.8 0.2 3.5 1.5 1.2 2.2 6.0 15.0 5.7 9.3 3.2 6.3 4.9 7.7 8.2 14.5 18.8 10.3 9.7 7.0 11.2 3.2 11.4 4.2 11.7 5.9 11.5 19.4 5.4 15.3 5.8 7.6 1.7 5.2 7.5 3.5 3.5 9.0 5.3 2.3 5.9 11.2 8.2 7.1 11.1 6.7 11.6 7.1 2.6 8.7 6.7 10.2 5.1 3.9 2.9 3.6 5.9 4.9 8.7 9.9 6.1 6.2 6.6 13.7 3.5 14.2 6.6 6.2 7.2 5.5 12.4 9.6 10.1 11.9 9.6 15.3 5.7 8.8 3.2 6.9 3.8 6.4 4.0 4.9 3.6 6.2 3.6 5.2 13.9 7.1 7.8 6.9 5.6 3.2 0.8 0.7 1.2 1.1 0.8 0.6 1.4 0.6 1.0 0.4 0.9 2.2 1.7 3.2 1.1 0.0 3.0 0.0 3.3 0.0 1.8 1.5 3.9 3.6 0.5 2.8 1.3 3.7 2.1 11.1 6.5 1.2 1.9 1.6 7.2 4.4 3.0 2.1 1.2 7.4 0.0 8.0 14.6 3.1 0.5 6.3 1.3 7.1 3.6 0.4 8.2 5.0 0.0 2.4 0.0 5.1 0.0 12.3 3.4 3.5 0.0 0.0 7.0 0.6 2.1 0.0 0.0 4.2 2.4 3.4 2.6 3.2 3.5 1.0 0.0 1.0 0.0 2.7 2.2 22.6 8.3 2.7 0.0 5.1 2.5 5.8 2.7 2.6 FAM166C "C2orf70, LOC339778" ENSG00000173557 "Family with sequence similarity 166 member C" A6NJV1 2 26562585-26579532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.6;testis: 26.6" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062453 Enhanced Approved "Nuclear membrane,Vesicles" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 21: OE19 - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear membrane, Vesicles" "HPA062453: AB_2684769" "unprognostic (5.44e-2)" "unprognostic (9.30e-3)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (1.99e-2)" "unprognostic (9.40e-6)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (6.49e-4)" "unprognostic (4.58e-2)" "unprognostic (1.52e-1)" "unprognostic (2.98e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-3)" "unprognostic (7.08e-3)" 0.1 0.1 0.8 0.1 0.7 0.0 0.2 0.5 0.6 0.3 4.1 0.6 0.1 0.2 0.3 0.1 7.6 0.0 0.4 0.8 2.5 1.0 0.0 0.4 0.0 2.0 2.0 0.0 0.7 0.1 0.7 0.0 1.2 0.2 0.4 0.1 1.9 0.2 0.1 0.1 0.1 0.1 1.5 0.0 4.8 26.6 2.9 0.0 1.1 0.0 0.0 0.1 0.0 1.0 4.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 3.7 0.0 0.9 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 0.6 0.8 2.5 2.0 2.0 1.2 1.5 2.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM177A1 C14orf24 ENSG00000151327 "Family with sequence similarity 177 member A1" Q8N128 14 35044907-35113130 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 637.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053222, HPA055440" Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 170000 "Cluster 1: Neutrophils - Mixed function" "Cluster 78: Testis - Spermatogenesis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 24: Non-specific - Transcription regulation" Vesicles Nucleoplasm "HPA053222: AB_2682083, HPA055440: AB_2682817" "unprognostic (6.86e-2)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (4.64e-3)" "unprognostic (6.28e-2)" "unprognostic (7.79e-2)" "prognostic favorable (8.51e-5)" "unprognostic (1.12e-2)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (1.69e-1)" "unprognostic (8.28e-2)" "unprognostic (1.91e-1)" 45.3 43.2 36.8 30.0 50.1 49.6 38.2 45.3 46.5 44.2 36.9 81.5 57.2 29.4 29.6 49.7 26.8 37.7 78.1 39.0 51.3 61.3 77.0 68.6 20.2 52.4 50.6 28.2 49.4 30.6 47.4 27.3 49.1 63.1 71.5 31.3 43.4 36.1 48.3 41.3 54.6 42.3 45.0 23.6 42.5 86.2 47.0 21.6 48.0 32.8 23.2 46.7 37.7 57.0 63.4 51.2 38.0 31.3 64.6 64.6 46.7 101.3 55.8 52.4 57.1 52.2 82.6 25.1 68.1 98.9 71.1 65.8 47.1 58.5 66.7 73.5 28.8 19.5 63.8 179.5 79.4 30.7 44.9 58.5 75.3 63.5 49.5 76.7 60.6 46.7 47.7 79.8 102.5 91.5 38.0 28.1 30.9 100.9 65.2 21.9 52.7 35.9 95.2 68.7 52.1 45.9 119.3 94.2 81.3 75.2 87.2 23.9 71.3 67.5 59.2 76.6 53.2 59.3 79.8 31.2 42.3 20.5 68.0 79.9 43.9 79.2 31.0 36.7 36.5 45.0 40.3 35.7 34.8 35.8 31.7 31.4 167.5 32.6 31.9 50.8 60.0 30.4 36.8 50.1 45.3 46.5 39.0 51.3 52.4 50.6 49.1 45.0 47.0 57.0 126.7 240.4 176.3 6.5 87.4 160.7 199.4 200.4 83.6 35.8 119.0 118.4 147.8 67.2 168.1 104.8 27.1 71.0 322.2 329.3 119.3 121.9 637.1 235.5 86.6 116.4 133.8 36.0 10.7 249.6 118.0 80.5 107.0 426.4 82.3 43.1 82.5 235.6 75.5 23.5 13.4 189.5 144.5 61.1 130.9 505.9 54.0 85.4 149.4 8.4 125.1 45.3 48.4 9.0 28.4 364.6 220.1 53.0 133.3 211.4 273.7 347.2 177.8 45.5 46.0 65.2 106.2 189.3 106.8 93.1 171.5 123.3 215.7 30.4 224.2 229.5 FAM78A "C9orf59, FLJ00024" ENSG00000126882 "Family with sequence similarity 78 member A" Q5JUQ0 9 131258076-131276510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.7;testis: 31.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 55.7;Early spermatids: 90.6;Granulosa cells: 167.2;Late spermatids: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.3;HEL: 38.6;HL-60: 38.7;NB-4: 60.7;THP-1: 53.5;U-937: 35.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021472, HPA023914" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Vesicles" "HPA021472: AB_1848411, HPA023914: AB_1848412" "unprognostic (5.16e-2)" "prognostic favorable (3.67e-4)" "unprognostic (3.65e-2)" "unprognostic (2.07e-2)" "unprognostic (2.71e-1)" "prognostic favorable (2.00e-4)" "unprognostic (3.24e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-2)" "unprognostic (5.83e-1)" "unprognostic (5.84e-2)" "unprognostic (6.79e-2)" "unprognostic (1.59e-3)" "unprognostic (2.61e-3)" "unprognostic (7.42e-2)" "unprognostic (2.61e-2)" "unprognostic (2.39e-1)" 2.9 2.0 3.8 13.8 5.6 21.7 1.7 3.6 6.3 1.4 1.8 2.4 2.7 1.5 0.3 1.7 1.3 3.1 26.5 5.1 3.7 1.6 1.5 6.1 24.5 5.6 4.1 1.4 1.1 1.1 1.2 5.3 4.9 1.4 1.6 4.6 2.7 0.9 53.7 1.2 8.9 1.8 4.6 21.6 3.8 31.9 5.8 21.1 1.6 20.2 14.9 3.5 1.1 5.7 0.7 0.3 2.5 5.6 1.7 0.5 39.3 0.3 0.3 0.5 0.2 0.3 0.2 17.1 0.2 0.3 0.8 0.1 16.0 0.2 0.1 4.4 1.4 38.6 0.6 0.3 0.6 38.7 1.5 0.4 0.8 0.0 0.1 0.5 22.2 10.8 13.8 4.7 0.5 6.0 1.7 60.7 2.6 0.3 0.6 4.0 2.3 23.7 0.2 0.1 1.5 2.1 2.3 0.8 2.4 0.9 1.4 53.5 0.6 2.3 2.4 1.3 0.1 3.4 1.9 9.7 0.3 35.9 0.6 0.5 9.7 17.6 9.2 12.6 7.4 14.2 8.9 10.1 6.0 15.9 11.0 9.3 9.8 3.1 9.9 2.7 9.5 8.7 3.8 5.6 3.6 6.3 5.1 3.7 5.6 4.1 4.9 4.6 5.8 5.7 3.2 0.0 1.5 0.0 15.5 0.9 0.0 0.0 0.0 55.7 0.4 0.5 17.6 0.0 0.0 1.8 0.0 1.1 19.0 0.0 0.0 0.1 90.6 0.1 0.2 6.8 0.0 3.4 5.0 0.0 37.6 3.1 0.5 0.1 1.3 167.2 6.4 0.5 25.7 0.0 1.7 0.0 0.0 21.7 10.6 120.3 5.0 14.8 1.8 15.9 15.6 0.8 30.9 1.0 0.1 0.1 0.0 3.4 12.0 0.0 0.0 0.2 0.0 1.8 0.0 0.6 6.3 2.2 1.2 0.0 0.9 1.4 17.4 1.0 0.0 0.1 FAM78B ENSG00000188859 "Family with sequence similarity 78 member B" Q5VT40 1 166057426-166167001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 87.6;Excitatory neurons: 55.4;Horizontal cells: 82.4;Inhibitory neurons: 85.0;Oligodendrocyte precursor cells: 45.8" "Cancer enhanced" "Detected in many" "melanoma: 3.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HDLM-2: 8.6;RT4: 4.9;SK-MEL-30: 10.1;U-2 OS: 2.6;WM-115: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052789, HPA073246" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA052789: AB_2681949, HPA073246: AB_2686588" "unprognostic (7.38e-3)" "unprognostic (1.14e-3)" "unprognostic (7.96e-2)" "unprognostic (3.16e-2)" "unprognostic (3.77e-2)" "unprognostic (3.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-3)" "unprognostic (3.25e-2)" "unprognostic (1.69e-3)" "unprognostic (3.87e-2)" "unprognostic (1.87e-11)" "unprognostic (7.41e-2)" "unprognostic (2.09e-1)" "unprognostic (5.41e-2)" "unprognostic (2.69e-2)" 0.7 0.2 0.9 0.0 0.7 0.0 0.5 0.5 2.6 1.1 0.0 0.5 0.2 0.7 0.0 0.4 0.2 0.1 0.6 1.0 0.1 0.2 0.7 0.2 0.1 0.6 0.1 0.3 0.4 0.1 0.5 0.0 0.1 0.4 0.1 0.8 0.3 0.1 0.7 0.5 0.1 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.4 0.1 0.1 0.8 0.5 0.5 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 8.6 0.0 0.0 0.1 0.3 0.2 0.0 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 4.9 0.8 0.5 0.0 0.1 10.1 0.0 0.3 0.2 0.1 0.6 2.6 0.0 0.1 0.0 0.0 0.0 0.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.5 2.6 1.0 0.1 0.6 0.1 0.1 0.2 0.1 0.5 1.2 0.0 1.7 5.5 0.4 0.5 0.5 0.0 1.8 15.5 1.0 0.8 9.9 2.8 0.0 0.0 87.6 0.0 0.0 0.4 1.9 0.7 2.5 0.1 1.7 1.6 0.0 0.0 55.4 0.2 0.0 1.6 0.0 0.1 0.0 1.1 0.4 1.6 0.0 82.4 85.0 0.6 0.0 0.3 0.6 2.6 1.2 0.1 1.8 5.6 0.6 2.2 0.0 45.8 5.7 0.3 0.3 0.7 0.0 0.2 0.1 1.3 0.0 12.9 0.0 4.5 1.0 0.6 4.4 0.6 0.1 0.0 0.7 0.4 1.1 0.2 FAM83E FLJ20200 ENSG00000105523 "Family with sequence similarity 83 member E" Q2M2I3 19 48599961-48615076 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.7;salivary gland: 28.5;stomach 1: 37.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 22.8;Early spermatids: 26.0;Gastric mucus-secreting cells: 74.9;Intestinal goblet cells: 26.9;Paneth cells: 16.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 2.9;OE19: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049305, HPA075968" Uncertain Approved Vesicles,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" Cytosol Vesicles "HPA049305: AB_2680705, HPA075968: " "unprognostic (1.36e-1)" "unprognostic (9.81e-3)" "unprognostic (3.83e-2)" "unprognostic (7.39e-2)" "unprognostic (4.77e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (2.26e-2)" "unprognostic (3.18e-1)" "unprognostic (2.71e-1)" "unprognostic (8.00e-2)" "unprognostic (9.31e-2)" "unprognostic (7.05e-8)" "unprognostic (5.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.70e-1)" "unprognostic (8.90e-3)" 0.1 0.1 0.2 3.7 0.3 0.4 1.4 0.8 0.5 10.6 0.2 32.7 30.0 1.1 0.1 7.0 3.9 6.4 0.2 0.3 0.2 0.8 0.3 8.0 0.2 0.1 0.1 0.0 1.2 0.0 0.2 0.6 0.2 3.2 16.6 0.2 28.5 0.4 2.7 1.9 30.0 1.0 0.0 0.2 37.4 2.2 0.2 0.1 0.1 0.0 1.3 1.2 4.1 0.5 0.4 0.4 0.0 0.7 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.3 2.9 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.4 0.1 0.1 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.6 0.1 0.8 1.1 9.4 0.9 0.2 0.1 0.3 0.0 0.2 0.5 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.2 0.0 0.2 0.5 0.1 0.1 0.2 0.1 1.0 0.1 0.2 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.8 0.5 0.3 0.2 0.1 0.1 0.2 0.0 0.2 0.5 0.0 9.6 13.4 1.3 0.4 0.0 1.4 0.8 0.6 0.0 1.8 0.8 2.1 8.6 6.5 1.8 0.0 0.1 0.3 22.8 0.0 0.1 26.0 4.8 0.5 0.2 5.4 0.0 0.3 1.1 0.1 0.2 74.9 5.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 26.9 2.0 0.0 0.0 9.3 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.3 1.6 16.5 0.0 0.4 3.3 12.7 0.0 5.1 0.0 0.0 0.2 0.2 0.8 0.5 2.3 0.0 0.1 0.3 0.1 12.8 6.9 FAM98B FLJ38426 ENSG00000171262 "Family with sequence similarity 98 member B" Q52LJ0 15 38454127-38487710 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008320, HPA008502" Enhanced Supported Nucleoplasm,Vesicles NA NA 20000 "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA008320: AB_1848419, HPA008502: AB_1848420" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-2)" "unprognostic (1.54e-2)" "unprognostic (3.09e-2)" "unprognostic (9.25e-3)" "unprognostic (1.74e-1)" "unprognostic (4.69e-2)" "unprognostic (2.18e-1)" "unprognostic (3.15e-1)" "unprognostic (3.15e-2)" "unprognostic (1.51e-2)" "unprognostic (2.26e-1)" "unprognostic (4.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" 12.7 11.4 9.5 12.8 10.2 9.8 12.9 16.4 12.6 9.7 7.2 15.4 9.6 13.3 9.0 9.0 8.1 7.0 12.4 10.8 10.9 13.1 7.8 8.1 13.8 9.4 9.7 11.2 6.1 19.3 6.4 12.0 10.0 12.1 11.6 19.8 6.3 10.0 13.8 8.8 10.0 9.5 10.1 11.2 9.5 8.5 9.6 28.6 11.7 16.3 13.3 11.9 7.0 12.6 30.7 16.2 77.7 40.0 14.1 25.7 37.9 38.6 28.2 37.4 37.5 35.8 14.4 21.1 41.4 32.2 37.9 31.8 47.4 39.5 52.2 21.8 25.7 62.6 33.9 27.8 20.4 59.8 34.6 23.9 24.1 33.3 38.5 27.4 38.9 45.7 45.6 25.7 36.0 13.8 50.7 31.8 42.0 34.8 22.3 53.3 42.0 17.7 32.8 39.9 47.8 48.9 42.5 27.0 19.8 34.6 33.0 36.6 32.7 42.1 51.5 28.2 44.0 47.6 46.1 78.3 23.1 38.9 44.8 2.3 0.5 1.4 2.8 0.4 2.4 1.6 2.8 2.3 0.6 1.9 3.4 2.6 0.4 2.2 0.6 1.4 1.9 0.4 9.5 10.2 16.4 12.6 10.8 10.9 9.4 9.7 10.0 10.1 9.6 12.6 17.9 16.0 21.4 16.3 16.8 14.7 12.7 14.1 14.2 36.8 15.2 11.6 48.9 12.8 18.1 16.5 16.7 30.6 16.4 11.0 7.9 16.4 3.4 19.1 21.5 16.9 12.6 16.6 22.5 19.8 22.4 16.6 16.8 17.0 13.3 18.4 16.8 13.1 12.6 20.2 20.5 22.6 12.2 15.8 12.2 2.5 12.5 10.9 5.4 18.7 21.4 18.5 21.6 12.1 23.8 14.3 9.8 17.0 18.2 12.4 11.1 12.7 18.8 27.9 6.6 21.5 16.2 27.2 17.1 19.7 14.8 21.5 15.3 14.7 19.3 14.1 FANCL "FAAP43, FLJ10335, PHF9, Pog" ENSG00000115392 "FA complementation group L" Q9NW38 2 58159243-58241372 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 188.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033842, HPA036685, HPA036686" Supported Approved "Nuclear bodies,Vesicles" NA Yes "Cluster 19: B-cells - Humoral immune response" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Vesicles "CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844" "unprognostic (3.02e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-3)" "unprognostic (6.24e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.81e-7)" "unprognostic (4.71e-2)" "unprognostic (2.63e-2)" "unprognostic (1.31e-2)" "unprognostic (3.50e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.12e-7)" "unprognostic (1.50e-1)" "unprognostic (1.39e-1)" "unprognostic (9.08e-3)" "prognostic favorable (7.80e-5)" 8.5 35.3 39.4 11.0 49.5 15.1 19.5 35.3 39.4 18.6 27.2 12.1 11.5 19.9 18.4 11.5 13.9 12.0 13.0 34.1 45.1 12.2 21.7 9.6 14.8 51.6 40.3 24.8 14.5 14.0 44.3 12.5 55.4 14.7 14.8 24.6 18.7 10.7 9.1 17.9 12.8 13.5 40.9 16.8 13.1 19.1 41.2 13.2 17.1 9.1 12.6 11.7 14.6 68.6 48.6 35.0 69.4 34.0 11.9 15.1 36.9 34.8 21.5 33.8 43.5 30.9 59.4 33.4 43.8 11.4 46.3 27.5 39.0 26.4 56.0 78.8 61.7 54.8 49.5 42.1 13.0 53.3 29.0 11.8 12.4 24.8 9.7 29.9 27.0 23.5 51.9 29.6 23.2 24.6 18.9 65.8 75.2 77.4 7.2 35.2 52.5 26.1 29.9 47.2 78.1 39.3 49.5 20.2 33.8 37.0 18.7 35.4 15.9 30.0 45.0 22.3 39.0 30.4 20.6 19.7 63.7 35.7 46.6 3.2 3.0 4.9 3.7 5.6 3.0 9.1 3.2 4.2 5.9 9.3 1.0 2.3 0.8 7.6 4.3 5.3 4.8 2.2 39.4 49.5 35.3 39.4 34.1 45.1 51.6 40.3 55.4 40.9 41.2 68.6 16.7 19.2 20.0 18.6 9.4 10.3 13.9 26.1 11.4 16.6 12.5 15.4 16.4 8.6 16.1 9.2 4.2 29.1 4.8 7.2 11.7 9.7 2.5 11.1 15.8 14.8 9.0 14.5 45.0 4.2 14.0 12.2 15.3 6.2 10.8 25.8 13.2 12.5 10.9 8.4 38.4 15.0 30.5 6.3 4.6 3.6 10.8 7.0 26.6 34.7 6.8 22.8 3.1 81.4 188.9 4.6 13.3 14.3 9.7 6.2 21.7 5.7 23.2 18.7 13.1 10.8 12.4 52.6 37.9 9.5 6.8 7.4 5.6 13.2 16.0 9.3 FBXL6 FBL6 ENSG00000182325 "F-box and leucine rich repeat protein 6" Q8N531 8 144355431-144359376 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008867 Approved Nucleoplasm,Vesicles Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" Nucleoplasm Vesicles "HPA008867: AB_2668161" "unprognostic (2.97e-2)" "unprognostic (3.30e-2)" "unprognostic (1.13e-3)" "unprognostic (3.13e-1)" "unprognostic (9.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.29e-3)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.43e-2)" "unprognostic (9.04e-2)" "unprognostic (9.73e-2)" "prognostic unfavorable (4.49e-10)" "unprognostic (3.93e-2)" "unprognostic (1.44e-1)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" 4.6 4.8 2.3 1.4 2.3 2.0 4.9 2.5 3.2 4.3 2.5 8.0 4.6 3.5 0.6 7.2 3.1 1.0 4.1 2.3 2.2 4.6 10.8 3.9 1.8 2.5 2.4 2.1 8.1 1.6 3.8 1.8 2.4 4.2 1.8 0.5 5.1 1.6 4.2 6.6 7.8 0.7 2.4 6.8 5.5 5.2 2.6 1.5 3.3 0.3 1.2 4.6 4.3 2.3 9.0 3.0 2.1 13.3 2.7 0.7 3.8 4.4 5.1 4.5 3.1 3.2 3.9 4.1 5.3 2.2 2.2 5.8 2.4 6.1 1.0 7.6 3.0 8.2 1.6 7.9 4.0 2.1 8.4 1.2 5.5 2.5 6.6 1.2 3.7 6.7 3.8 6.6 1.7 16.7 6.0 1.9 2.6 9.8 8.3 6.7 2.4 14.0 6.0 3.0 3.1 3.0 5.1 8.0 7.7 1.2 13.2 3.7 3.3 2.2 8.1 10.8 5.4 2.5 2.1 3.0 3.4 5.1 2.9 0.0 0.1 0.6 0.4 0.4 0.3 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.3 1.6 0.7 0.0 0.0 2.3 2.3 2.5 3.2 2.3 2.2 2.5 2.4 2.4 2.4 2.6 2.3 17.9 6.4 2.0 4.6 10.1 5.7 6.0 2.1 7.4 9.9 13.2 12.8 1.1 7.2 4.6 0.0 14.6 8.3 17.3 18.2 5.9 5.2 1.9 5.2 6.8 5.9 2.4 3.0 7.4 6.2 11.6 5.2 13.7 7.8 1.3 7.7 6.8 6.7 6.9 1.7 5.6 19.4 2.0 4.7 7.6 1.6 5.3 9.0 5.4 4.7 2.6 7.9 6.2 2.0 2.7 7.5 10.8 1.9 20.1 8.2 43.7 8.1 2.0 9.0 0.0 5.1 13.6 5.0 7.8 14.8 6.7 3.8 10.7 9.9 17.3 6.3 FBXW12 "Fbw12, FBXO35" ENSG00000164049 "F-box and WD repeat domain containing 12" Q6X9E4 3 48372219-48401259 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "pancreas: 6.1" "Group enriched" "Detected in some" 4 "Early spermatids: 12.4;Late spermatids: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037491, HPA037492" Uncertain Approved Vesicles,Cytosol NA NA "Cluster 25: Pancreas - Digestion" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol Vesicles "HPA037491: AB_2675504, HPA037492: AB_2675505" "unprognostic (5.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-2)" "unprognostic (8.56e-2)" "unprognostic (2.17e-1)" "unprognostic (9.48e-2)" "unprognostic (2.95e-1)" "unprognostic (1.21e-3)" "unprognostic (6.96e-3)" "unprognostic (2.36e-1)" "unprognostic (6.29e-3)" "unprognostic (1.43e-1)" "unprognostic (1.29e-1)" "unprognostic (8.81e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.1 6.1 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.5 0.6 0.4 0.1 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.4 0.6 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536092 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.9" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 201.8;Excitatory neurons: 529.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 23.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 14.2 9.5 37.9 15.0 43.1 19.8 14.2 54.3 66.9 8.7 6.7 9.5 7.8 8.6 24.3 14.3 15.6 9.2 24.7 48.2 23.0 6.7 11.2 11.4 16.1 17.1 20.9 9.1 12.8 7.8 9.2 9.4 18.1 7.8 10.3 18.0 11.8 7.5 26.0 63.1 10.4 9.1 11.8 16.2 13.0 22.8 29.4 14.7 10.3 19.7 20.3 11.9 10.7 47.4 9.8 8.0 19.1 14.2 12.2 9.4 16.2 13.4 12.9 8.5 8.1 15.7 12.0 24.7 3.9 13.7 6.5 5.2 16.9 30.9 12.1 16.2 8.0 11.9 10.7 10.9 12.7 29.2 10.6 14.8 45.7 15.2 24.4 8.4 15.2 20.5 19.2 25.7 10.8 13.7 34.9 10.6 9.7 8.0 6.1 32.2 8.0 5.3 9.8 17.0 12.7 10.2 8.5 11.3 7.5 21.6 6.4 12.6 15.6 11.3 12.6 5.4 8.2 79.0 47.5 24.4 9.4 9.2 8.3 23.5 2.7 1.6 4.0 3.0 2.7 2.8 3.1 2.7 1.6 1.8 3.4 2.5 4.8 7.1 2.2 2.1 2.9 1.3 37.9 43.1 54.3 66.9 48.2 23.0 17.1 20.9 18.1 11.8 29.4 47.4 29.5 9.6 22.9 80.0 48.1 201.8 36.5 29.9 120.1 74.9 32.1 30.9 61.8 12.8 15.1 9.2 31.3 10.9 54.7 22.2 3.9 14.3 17.4 37.7 37.3 36.1 14.5 30.1 529.6 13.5 39.9 27.2 21.4 61.6 15.8 19.1 17.9 18.3 10.5 11.8 186.5 16.4 32.6 18.8 47.0 10.2 15.2 33.7 28.4 172.4 28.0 37.0 35.0 102.5 99.8 18.7 18.2 11.3 174.5 36.3 8.9 7.5 11.9 41.4 13.1 33.2 25.5 74.1 87.2 57.0 174.9 31.2 46.2 18.7 14.9 70.5 FIG4 "ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3" ENSG00000112367 "FIG4 phosphoinositide 5-phosphatase" Q92562 6 109690609-109878098 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.5;Oligodendrocyte precursor cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017823, HPA068859" Approved Supported "Vesicles,Lipid droplets" NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Lipid droplets" "CAB017823: , HPA068859: AB_2686049" "prognostic unfavorable (5.91e-4)" "unprognostic (4.12e-2)" "prognostic favorable (8.42e-4)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.73e-4)" "unprognostic (7.06e-2)" "unprognostic (2.69e-1)" "unprognostic (8.67e-2)" "unprognostic (3.44e-3)" "unprognostic (4.22e-2)" "prognostic favorable (8.19e-4)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (5.45e-2)" "unprognostic (2.00e-2)" 9.3 10.2 5.5 7.1 7.2 5.6 8.1 5.9 7.7 8.2 12.9 10.1 5.0 8.5 7.8 9.4 7.2 7.6 7.7 6.0 8.8 9.5 6.1 13.4 10.1 6.4 7.3 8.2 7.5 17.4 11.9 8.8 8.9 7.7 9.5 10.8 10.7 7.8 10.6 7.6 9.1 10.3 5.6 13.8 8.7 8.2 6.1 12.3 9.3 8.3 10.1 9.2 8.4 7.0 8.3 8.4 11.7 14.9 11.8 17.2 7.8 9.9 14.1 8.3 23.2 4.6 7.2 23.2 5.8 18.9 14.9 5.2 12.6 8.5 20.7 13.3 16.5 10.9 5.9 5.5 11.4 9.5 10.0 8.8 9.9 12.8 10.6 22.8 18.3 13.9 6.8 8.8 12.7 6.8 12.0 8.4 5.9 12.0 4.7 7.9 6.1 7.3 13.3 18.4 12.8 11.7 7.1 10.7 21.1 15.6 6.0 23.1 11.2 4.2 3.8 5.4 9.5 3.4 2.6 7.9 27.3 8.5 4.6 15.4 24.9 14.2 8.8 24.5 7.7 18.9 6.3 8.5 19.2 21.2 7.5 7.5 7.4 10.0 15.2 8.1 9.4 11.7 5.5 7.2 5.9 7.7 6.0 8.8 6.4 7.3 8.9 5.6 6.1 7.0 4.9 16.0 9.0 24.5 15.7 4.6 7.1 7.3 5.2 8.8 5.4 3.3 6.7 2.8 6.9 9.2 2.1 13.4 9.5 7.0 5.9 9.8 18.0 7.5 5.3 5.2 10.2 3.0 49.5 11.4 7.0 6.0 8.2 7.9 8.8 8.6 7.1 4.1 23.3 1.7 32.4 8.6 8.2 19.2 6.8 17.7 3.4 17.3 8.8 29.0 16.4 8.5 11.3 46.8 37.4 7.6 6.3 6.8 6.5 4.0 6.3 8.2 9.1 7.6 0.0 5.1 6.6 5.5 12.1 8.3 4.4 12.3 9.3 5.6 6.4 8.9 FLOT2 "ECS-1, ECS1, ESA, ESA1, M17S1" ENSG00000132589 "Flotillin 2" Q14254 17 28879335-28897733 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001396, CAB004395, HPA071038" Supported Supported "Vesicles,Plasma membrane" NA NA 170000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 44: HDLM-2 - Immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "Plasma membrane" Vesicles "CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: " "unprognostic (6.04e-2)" "unprognostic (8.76e-3)" "unprognostic (3.01e-1)" "unprognostic (8.92e-2)" "unprognostic (4.15e-3)" "unprognostic (2.17e-2)" "unprognostic (4.36e-3)" "unprognostic (2.12e-1)" "unprognostic (5.21e-2)" "unprognostic (1.20e-1)" "unprognostic (9.98e-2)" "unprognostic (2.80e-1)" "unprognostic (4.12e-3)" "unprognostic (2.64e-2)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (2.20e-2)" 60.2 46.4 38.4 56.8 38.6 97.1 56.2 28.1 47.6 42.8 45.2 58.9 21.0 39.1 21.2 69.3 46.8 27.0 63.5 41.1 42.5 71.4 98.4 59.5 68.2 45.9 37.1 37.7 38.8 30.0 22.3 58.4 41.3 67.8 27.2 20.3 61.7 51.6 51.6 38.2 53.0 35.3 37.5 122.7 44.6 10.4 47.1 47.8 39.6 44.1 63.6 78.8 49.6 36.1 55.5 90.8 69.6 60.2 33.6 44.2 76.6 42.5 57.9 60.9 71.3 96.0 45.7 76.9 79.3 47.6 42.0 63.3 76.5 69.7 25.9 245.5 91.4 92.7 80.5 70.3 43.6 76.8 15.2 53.3 53.6 49.3 66.9 64.1 97.4 21.8 89.0 65.6 28.9 83.5 21.2 54.0 61.4 48.6 24.6 32.6 70.6 189.3 92.0 166.9 61.9 103.3 99.8 69.6 77.5 66.7 72.3 136.3 81.5 21.4 38.2 35.2 65.0 36.5 68.2 39.5 59.9 72.3 40.7 171.9 106.0 213.2 98.8 96.6 72.6 98.5 74.6 84.5 144.3 118.1 55.3 69.0 415.2 78.5 110.2 38.8 97.6 143.2 38.4 38.6 28.1 47.6 41.1 42.5 45.9 37.1 41.3 37.5 47.1 36.1 34.2 22.4 21.9 12.7 46.8 12.6 27.1 20.6 29.6 6.9 24.9 30.1 32.9 22.8 16.5 20.2 10.4 96.6 20.5 29.0 15.6 39.3 13.0 25.8 13.2 37.0 25.8 49.2 17.0 31.1 68.9 14.8 23.0 27.6 6.3 15.6 48.9 45.1 44.4 5.0 19.2 25.9 10.2 43.3 22.6 42.3 10.8 31.1 8.8 22.5 75.2 10.7 35.0 16.1 11.0 32.2 16.5 8.6 27.8 14.8 14.8 26.7 19.1 12.4 19.7 7.1 13.4 1.6 6.9 42.4 9.2 37.1 32.5 4.2 32.0 26.7 FMO4 FMO2 ENSG00000076258 "Flavin containing dimethylaniline monoxygenase 4" P31512 1 171314183-171342084 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 48.6;liver: 61.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Hepatocytes: 22.1;Oligodendrocytes: 18.5;Proximal enterocytes: 16.5;Proximal tubular cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 5.7;HSkMC: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049100, HPA072438" Approved Approved Vesicles,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Cytosol" "HPA049100: AB_2680629, HPA072438: " "unprognostic (1.83e-2)" "unprognostic (1.17e-1)" "unprognostic (6.18e-2)" "unprognostic (3.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.13e-1)" "prognostic favorable (1.09e-4)" "prognostic favorable (7.45e-4)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (5.99e-2)" "unprognostic (2.90e-1)" "prognostic favorable (6.96e-4)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-3)" "unprognostic (1.95e-1)" 3.7 2.6 2.2 1.9 3.1 0.9 4.1 2.8 3.0 3.3 3.1 5.0 5.4 2.7 6.3 2.3 3.5 4.9 5.2 2.1 2.6 48.6 61.3 3.2 2.9 3.1 2.8 3.8 2.4 4.7 1.9 2.3 3.3 3.1 4.8 0.7 2.0 2.2 1.0 3.4 9.2 2.0 2.6 3.1 5.0 1.7 3.1 3.6 3.2 2.1 3.3 2.4 2.9 3.5 0.1 0.1 0.3 0.4 4.1 3.4 0.2 0.8 3.7 1.1 1.2 0.6 5.3 3.7 5.7 0.1 2.0 0.2 0.7 1.0 1.6 1.6 0.8 0.0 0.0 0.0 0.6 0.7 0.8 6.6 2.4 0.4 1.0 0.4 0.2 1.7 0.2 2.3 0.5 0.7 1.6 1.3 0.4 0.9 1.2 0.4 0.4 2.1 2.6 0.0 0.1 0.0 1.2 1.0 2.4 4.1 2.2 1.0 0.1 0.9 0.3 1.0 0.7 2.9 1.0 2.2 1.8 1.1 0.8 0.2 1.0 0.3 0.9 1.6 0.7 1.2 0.8 1.3 0.9 1.8 1.2 0.9 0.1 1.7 1.1 1.2 2.1 0.8 2.2 3.1 2.8 3.0 2.1 2.6 3.1 2.8 3.3 2.6 3.1 3.5 2.2 0.0 2.6 7.2 3.2 2.8 4.6 5.0 2.8 0.0 2.3 2.0 3.7 2.8 3.7 9.2 0.0 2.8 0.6 7.1 29.4 2.3 5.7 3.8 1.7 1.4 1.2 0.0 0.1 1.4 1.2 6.6 8.2 1.7 1.3 1.5 2.9 22.1 3.7 0.0 0.1 3.2 2.0 5.9 1.3 1.3 1.5 2.7 5.4 2.8 1.6 1.8 1.0 0.0 18.5 1.1 0.7 0.4 1.1 0.9 16.5 49.5 7.3 0.0 0.0 1.8 2.1 0.3 0.5 1.9 1.6 1.9 1.7 2.0 2.8 1.8 FNBP1 "FBP17, KIAA0554" ENSG00000187239 "Formin binding protein 1" Q96RU3 9 129887187-130043194 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 317.7;Langerhans cells: 402.9;monocytes: 433.2;Oligodendrocytes: 522.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 137.7;JURKAT: 143.2;MOLT-4: 140.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019635, HPA019691, HPA022119, HPA067742" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Plasma membrane" Vesicles "HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: " "unprognostic (2.86e-1)" "unprognostic (2.59e-3)" "unprognostic (1.22e-2)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (1.43e-2)" "unprognostic (6.30e-3)" "unprognostic (9.10e-2)" "unprognostic (2.90e-1)" "unprognostic (6.17e-2)" "unprognostic (9.26e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (8.45e-5)" "unprognostic (6.84e-2)" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.21e-1)" 21.8 11.9 51.2 57.8 73.7 40.6 16.4 77.4 53.4 32.5 22.2 107.3 15.0 50.0 17.0 39.4 34.8 27.8 15.1 47.0 62.5 16.4 18.4 25.4 78.1 67.6 69.1 22.1 8.1 10.7 17.7 16.3 65.8 41.4 29.6 12.6 16.3 44.1 24.1 25.9 37.6 46.8 55.9 60.9 29.6 17.3 69.9 111.0 33.4 13.2 74.3 68.4 26.8 86.6 42.5 19.3 34.9 40.8 21.0 25.8 29.5 23.7 20.2 17.6 14.7 20.3 16.2 82.9 20.4 44.5 20.8 20.7 33.0 21.6 17.6 137.7 9.8 22.8 22.8 13.8 35.8 62.3 75.1 18.7 9.3 32.6 19.5 25.6 26.1 143.2 5.4 1.1 16.4 34.0 140.1 60.8 27.5 5.7 32.6 31.9 28.3 24.1 22.1 23.0 5.5 17.6 43.3 42.9 16.5 33.3 30.0 28.3 31.9 16.6 20.7 30.5 15.0 16.4 64.4 3.8 20.0 42.2 25.2 13.2 5.1 9.6 10.8 5.6 9.3 12.7 9.7 10.3 5.8 7.7 8.9 8.6 9.3 6.0 6.5 6.9 10.9 4.5 51.2 73.7 77.4 53.4 47.0 62.5 67.6 69.1 65.8 55.9 69.9 86.6 27.2 35.3 25.2 317.7 180.4 33.1 21.3 12.8 21.6 20.2 42.5 24.6 14.8 15.7 29.8 22.0 52.1 18.6 217.2 28.3 19.6 22.6 1.7 46.2 38.8 38.3 18.1 31.3 65.6 17.3 24.5 38.8 26.5 78.7 80.4 9.2 71.0 18.4 43.6 28.6 107.8 8.7 20.3 221.2 402.9 5.5 46.6 131.1 76.5 95.5 433.2 42.8 223.5 69.4 522.1 21.8 19.8 51.6 147.9 67.8 0.2 15.0 42.3 29.5 59.2 19.9 41.0 26.5 45.4 26.7 41.1 63.9 233.7 7.1 16.2 42.3 FOSB "AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291" ENSG00000125740 "FosB proto-oncogene, AP-1 transcription factor subunit" P53539 19 45467995-45475179 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 45.6" "Immune cell enhanced" "Detected in some" "neutrophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010267, HPA054663" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB010267: AB_640583, HPA054663: AB_2682562" "unprognostic (7.22e-2)" "unprognostic (9.74e-2)" "unprognostic (2.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.30e-3)" "unprognostic (9.43e-2)" "unprognostic (2.04e-2)" "unprognostic (2.99e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (4.99e-3)" "unprognostic (8.72e-2)" "unprognostic (4.45e-2)" "unprognostic (4.04e-2)" 394.7 121.6 2.1 118.4 5.5 433.8 91.7 35.7 45.6 150.3 4.8 37.6 24.8 46.6 3.9 187.7 404.1 347.1 48.9 11.1 7.8 34.7 85.5 113.5 67.7 1.5 1.6 274.4 126.3 46.2 27.3 57.8 1.5 118.5 78.4 10.7 76.8 29.6 3.3 267.8 63.1 353.7 0.8 21.8 104.4 8.8 1.2 152.2 316.0 81.3 1.6 213.9 11.0 3.8 0.4 0.6 0.1 0.3 1.2 0.3 1.8 2.3 1.0 0.7 0.7 0.5 1.0 2.0 0.4 1.5 11.4 0.8 0.5 1.6 0.5 0.3 0.7 0.6 0.8 0.4 0.8 1.1 13.3 0.5 8.1 1.7 1.9 0.4 0.9 2.3 0.8 6.8 0.2 0.2 0.2 1.2 0.4 1.0 0.4 0.5 0.1 1.4 0.6 1.3 3.1 0.4 1.4 9.6 1.2 1.9 0.5 0.8 0.1 0.5 0.6 1.1 0.7 5.1 0.8 0.5 1.1 0.8 1.3 0.9 1.2 1.0 0.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.1 2.1 5.5 35.7 45.6 11.1 7.8 1.5 1.6 1.5 0.8 1.2 3.8 1048.7 685.9 761.3 2.6 445.7 380.5 533.4 162.4 865.6 50.6 1627.1 1523.2 177.8 370.3 174.4 11.0 135.5 237.5 359.6 551.1 1.9 145.5 10.1 667.9 1204.4 442.6 877.0 68.6 1.3 74.2 301.9 788.2 911.3 1541.3 830.4 239.3 393.7 77.9 210.3 8.4 0.3 898.4 42.7 345.2 353.4 11.3 240.2 797.3 172.5 1.0 16.3 186.1 1.0 0.0 0.3 111.6 457.3 59.5 503.4 307.3 417.8 2.7 111.5 217.6 302.4 2234.0 608.8 3.3 4.5 476.3 380.9 396.9 481.8 174.2 616.5 208.5 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109734 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 44.0;salivary gland: 11.4" "Cell type enriched" "Detected in some" 4 "Ionocytes: 132.2" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Group enriched" "Detected in some" 5 "MCF7: 1.4;SuSa: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Supported Nucleoli,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 12: NES - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Vesicles "HPA071469: AB_2686403" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.5 0.1 0.0 0.1 3.0 0.0 0.0 11.4 1.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.5 0.2 0.0 0.0 7.6 6.5 0.3 0.0 0.3 1.8 0.0 0.0 0.1 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 132.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.2 0.0 0.0 0.0 FOXN2 HTLF ENSG00000170802 "Forkhead box N2" P32314 2 48314637-48379295 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 54.0;brain: 53.3" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 152.3;Oligodendrocytes: 282.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003485 Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Vesicles "HPA003485: AB_1078905" "unprognostic (5.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.65e-3)" "prognostic favorable (3.85e-4)" "unprognostic (4.00e-1)" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (8.95e-2)" "unprognostic (2.59e-1)" "unprognostic (5.15e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (2.24e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-2)" "unprognostic (1.12e-2)" 17.9 5.5 13.3 15.4 30.3 54.0 8.0 25.3 19.0 7.7 4.2 7.7 8.3 6.7 4.2 9.3 5.5 9.7 8.6 13.9 16.3 6.6 19.8 9.5 19.4 24.1 21.0 5.9 8.9 9.5 3.0 13.4 21.9 5.0 8.0 3.4 5.5 4.2 4.8 3.6 10.3 9.8 20.0 18.1 7.9 6.3 19.2 14.9 6.9 6.4 17.1 10.6 3.9 53.3 13.1 19.5 22.2 19.6 17.2 12.7 24.3 14.4 15.8 11.9 13.2 17.3 15.9 28.4 18.7 17.0 14.5 16.2 13.7 16.5 17.2 22.3 11.7 56.1 13.3 17.4 30.0 30.9 42.1 11.4 6.9 12.9 22.3 9.6 12.8 11.6 26.6 32.7 19.5 10.1 34.4 20.3 16.8 9.8 10.2 17.0 46.5 23.2 10.2 16.5 12.4 12.6 6.9 13.2 24.9 7.5 5.7 18.0 15.0 16.0 16.1 15.2 15.2 17.8 14.2 40.5 13.9 27.5 22.2 120.9 32.4 129.6 24.0 26.2 27.4 21.2 23.1 22.4 33.6 20.6 17.2 17.7 40.8 25.7 36.4 20.8 28.8 17.2 13.3 30.3 25.3 19.0 13.9 16.3 24.1 21.0 21.9 20.0 19.2 53.3 22.1 0.0 7.4 66.6 31.3 15.6 27.5 10.0 15.4 6.7 5.4 5.6 11.1 14.3 6.1 1.8 0.0 6.7 28.3 7.0 5.9 6.0 4.8 8.9 17.2 21.8 2.4 22.5 28.1 5.4 32.1 13.3 14.3 13.3 22.8 1.2 20.7 19.7 17.9 13.5 25.2 8.0 8.2 39.5 47.3 4.7 12.2 44.4 12.4 35.6 44.1 7.8 26.8 152.3 282.0 11.0 7.1 11.3 31.0 35.2 11.3 4.8 3.3 3.6 6.6 17.8 27.4 22.7 13.1 11.9 21.2 16.6 38.3 2.8 8.9 35.9 FRAT1 ENSG00000165879 "FRAT regulator of WNT signaling pathway 1" Q92837 10 97319271-97321915 "Predicted intracellular proteins" "Wnt signaling pathway" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 25.2;Early spermatids: 31.3;Kupffer cells: 26.1;Late spermatids: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 8.7;neutrophil: 10.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB046472, HPA055258" Approved Approved Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 6: T47d - Mammary gland" "Cluster 31: Spermatids - Spermatogenesis" "Vesicles, Cytosol" "CAB046472: AB_1849131, HPA055258: AB_2682763" "unprognostic (1.48e-2)" "prognostic favorable (5.92e-4)" "unprognostic (3.54e-1)" "unprognostic (1.13e-2)" "unprognostic (1.45e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.11e-2)" "unprognostic (4.44e-3)" "unprognostic (5.73e-2)" "unprognostic (2.50e-2)" "unprognostic (6.36e-3)" "unprognostic (1.89e-1)" "prognostic favorable (6.36e-5)" "unprognostic (6.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.43e-2)" 3.2 2.9 2.6 5.0 2.6 10.6 2.4 3.8 3.5 2.5 1.8 3.2 4.4 2.6 1.0 2.4 3.0 1.2 3.1 2.8 3.1 2.1 11.8 3.3 3.8 3.6 3.4 2.4 3.9 2.0 2.1 1.2 3.1 4.0 1.9 1.9 3.7 1.6 3.8 4.2 4.5 1.5 2.9 12.6 4.8 10.9 3.9 4.1 2.0 2.6 2.4 2.3 2.1 2.6 0.7 1.3 1.4 6.7 1.8 0.9 1.5 0.8 2.9 0.5 0.6 0.2 0.8 4.5 1.5 0.5 1.0 2.0 1.1 1.4 0.1 4.0 2.0 3.8 0.8 1.8 0.6 1.4 4.0 0.8 2.0 0.2 0.9 2.7 1.2 6.1 1.6 3.1 0.4 4.2 4.0 7.9 1.9 4.8 5.5 3.3 0.3 2.9 0.5 1.0 0.7 2.2 1.0 2.1 1.5 1.4 7.7 5.4 1.1 0.3 0.4 1.0 0.3 2.9 1.7 1.5 0.5 7.0 0.0 0.9 2.0 8.7 0.5 1.3 0.4 0.5 0.4 0.7 1.0 0.5 0.7 0.5 10.1 0.2 1.5 0.6 0.3 0.5 2.6 2.6 3.8 3.5 2.8 3.1 3.6 3.4 3.1 2.9 3.9 2.6 4.1 3.2 5.8 1.0 5.8 1.1 1.1 0.9 1.2 25.2 2.9 1.9 3.3 5.7 0.9 1.8 0.0 0.6 16.8 6.0 0.0 1.4 31.3 5.8 1.6 4.0 4.2 4.2 0.7 2.0 1.7 1.5 2.0 4.1 0.0 5.0 3.3 15.6 3.9 3.3 1.6 4.9 4.1 26.1 1.8 85.2 1.2 15.5 3.6 0.0 12.5 4.9 13.4 0.5 0.7 1.1 2.3 1.9 1.1 2.5 3.8 1.0 3.3 8.4 0.0 3.4 1.7 1.2 0.6 1.6 1.6 2.3 9.0 4.7 2.8 2.2 FSTL1 "FRP, FSL1, OCC-1, OCC1, tsc36" ENSG00000163430 "Follistatin like 1" Q12841 3 120392293-120450993 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 352.1;Fibroblasts: 521.9;Leydig cells: 327.4;Peritubular cells: 270.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "basophil: 12.0" "Lineage enriched" "Detected in single" 14 "granulocytes: 12.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 1782.4;BJ: 2156.3;fHDF/TERT166: 2692.9;HBF TERT88: 1741.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035251, HPA040815" Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 34000000 "Cluster 34: Basophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Cytosol" "HPA035251: AB_10601906, HPA040815: AB_2732489" "unprognostic (2.60e-1)" "unprognostic (1.59e-3)" "unprognostic (8.84e-2)" "unprognostic (4.54e-3)" "unprognostic (4.10e-2)" "unprognostic (1.35e-1)" "unprognostic (9.88e-2)" "unprognostic (3.05e-2)" "unprognostic (1.19e-2)" "unprognostic (3.88e-2)" "unprognostic (3.54e-2)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (4.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.05e-2)" "unprognostic (4.47e-3)" 432.4 134.3 20.5 116.3 18.1 2.2 166.1 22.8 22.7 279.9 83.0 156.4 37.1 157.5 50.8 126.1 150.6 257.0 242.7 20.6 22.8 45.4 35.7 120.7 50.3 28.5 44.6 90.3 37.3 35.5 25.7 442.0 23.1 188.3 90.4 29.8 59.3 184.4 31.8 64.2 69.1 409.6 22.7 63.1 68.6 33.5 22.7 24.2 78.8 89.8 38.8 260.4 104.3 20.6 81.0 21.2 222.9 91.8 1304.4 1782.4 1.3 2156.3 1208.9 1374.5 1211.0 0.1 178.5 0.8 178.8 2692.9 112.8 20.5 68.6 270.0 1741.5 1.1 32.5 0.4 159.8 0.3 286.0 1.2 0.9 1362.7 8.5 884.5 192.7 612.1 811.6 11.2 0.5 0.3 227.6 0.5 22.6 2.0 181.3 0.4 181.9 0.7 92.7 1.0 150.4 1.7 39.2 93.5 764.6 13.6 76.5 462.6 23.5 6.2 986.8 507.4 479.8 268.0 323.8 1.0 1.1 2.3 177.4 0.9 67.0 12.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 2.6 20.5 18.1 22.8 22.7 20.6 22.8 28.5 44.6 23.1 22.7 22.7 20.6 76.9 64.1 9.4 56.5 1.1 64.1 31.9 36.4 10.2 2.3 25.6 24.6 127.5 8.6 42.5 23.9 0.0 114.4 2.5 0.9 0.0 62.6 2.3 44.4 176.7 111.4 3.0 3.6 9.6 5.8 352.1 521.9 3.1 23.0 1.3 66.5 142.5 17.4 20.6 1.7 16.2 0.2 8.2 10.8 91.6 9.8 327.4 11.5 110.3 30.0 9.9 116.1 0.0 9.5 0.9 117.8 0.7 270.8 0.9 108.4 0.0 5.5 74.9 4.3 59.2 62.5 129.3 1.5 4.4 2.2 48.2 54.7 7.1 47.5 0.9 65.3 FTO "ALKBH9, KIAA1752, MGC5149" ENSG00000140718 "FTO alpha-ketoglutarate dependent dioxygenase" Q9C0B1 16 53701692-54158512 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase, Transferase" "Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 173.3;Excitatory neurons: 226.1;Inhibitory neurons: 240.7;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 282.5;Respiratory ciliated cells: 182.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017123, HPA041086, HPA068695" Enhanced Supported Vesicles,Cytosol No No 540000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol Vesicles "CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117" "unprognostic (9.74e-2)" "unprognostic (2.49e-1)" "unprognostic (9.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.88e-2)" "unprognostic (6.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-1)" "unprognostic (4.30e-3)" "unprognostic (6.11e-3)" 24.4 33.6 31.8 12.5 36.6 8.2 36.3 30.1 37.7 25.8 31.0 22.2 7.7 26.9 21.4 17.2 25.3 21.6 27.1 35.2 39.5 25.0 17.4 36.8 15.0 29.2 31.3 27.2 20.7 40.6 26.2 20.1 31.9 20.0 14.1 38.4 18.9 23.9 33.1 21.4 12.5 29.9 30.5 16.4 15.0 8.3 33.8 17.0 27.5 23.0 14.8 21.9 18.5 43.9 15.1 26.8 35.0 35.9 67.3 50.4 11.5 35.6 32.2 29.3 8.5 16.8 19.3 34.4 38.2 46.3 16.6 21.7 32.4 34.9 42.5 16.0 25.5 15.5 33.6 31.7 46.2 12.5 17.1 55.9 36.5 26.6 32.5 36.6 44.1 25.1 15.2 8.4 48.1 11.8 28.0 19.2 18.1 15.5 17.5 42.2 52.9 32.3 44.6 12.3 43.0 29.7 40.4 23.6 10.8 33.7 31.1 29.3 42.4 36.4 23.9 19.8 22.1 15.9 13.9 35.0 33.9 22.9 28.7 14.9 17.9 9.7 25.6 22.7 32.4 17.6 24.4 25.9 23.8 17.4 22.5 24.4 2.9 26.4 16.5 9.5 26.6 23.1 31.8 36.6 30.1 37.7 35.2 39.5 29.2 31.3 31.9 30.5 33.8 43.9 15.1 80.1 62.0 173.3 10.3 12.4 10.0 8.6 13.6 22.8 69.1 39.5 22.3 15.7 54.4 7.3 12.5 9.3 10.2 4.8 7.9 9.0 39.1 11.0 18.3 17.4 6.6 9.7 226.1 5.7 7.4 23.1 9.7 9.9 25.9 16.8 11.0 13.8 9.2 16.8 240.7 6.6 10.2 9.0 13.2 69.9 14.3 11.8 10.6 134.0 5.5 19.6 10.3 210.6 282.5 5.5 5.0 15.1 18.7 6.0 4.5 15.8 182.7 14.1 13.1 21.6 16.8 3.5 3.4 11.0 9.1 5.1 12.9 17.8 6.3 7.9 FXYD6-FXYD2 ENSG00000255245 "FXYD6-FXYD2 readthrough" 11 117820163-117876667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 7.5;salivary gland: 4.5" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 97.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MOLT-4: 6.5;RPTEC TERT1: 7.3" "HPA068838, HPA075209" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear membrane, Vesicles" "HPA068838: AB_2686047, HPA075209: AB_2732285" 0.3 0.2 0.4 0.0 0.4 0.0 0.2 0.5 0.5 0.4 0.2 0.9 0.1 1.0 0.8 0.1 0.6 0.9 0.6 0.4 0.4 7.5 0.2 0.4 0.0 0.3 0.3 1.3 1.9 0.0 0.3 0.2 0.3 0.3 0.0 0.0 4.5 0.1 0.2 0.1 0.3 0.3 0.3 0.9 0.3 0.3 0.3 0.4 0.3 0.2 0.1 0.4 0.2 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.0 0.0 0.0 0.2 0.0 7.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.6 0.0 11.0 0.0 0.0 0.0 0.0 97.8 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.3 2.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 15.8 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 FZD3 ENSG00000104290 "Frizzled class receptor 3" Q9NPG1 8 28494205-28574267 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 14.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 98.0;Excitatory neurons: 155.9;Inhibitory neurons: 82.3;Rod photoreceptor cells: 87.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 9.3" "Group enriched" "Detected in many" 5 "dendritic cells: 9.3;T-cells: 2.3" "Cell line enhanced" "Detected in many" "AF22: 53.2;Karpas-707: 27.9;SCLC-21H: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024995, HPA042320" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles Nucleoplasm "CAB024995: , HPA042320: AB_2677948" "unprognostic (1.21e-1)" "unprognostic (1.73e-1)" "prognostic favorable (1.17e-4)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.57e-4)" "unprognostic (1.69e-2)" "unprognostic (4.26e-4)" "unprognostic (2.11e-1)" "prognostic favorable (3.71e-4)" "unprognostic (2.86e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-2)" "unprognostic (1.38e-1)" "unprognostic (4.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.09e-3)" 1.0 2.9 5.2 1.5 6.7 1.5 2.3 5.7 9.9 2.4 13.8 2.2 1.3 3.4 6.9 1.9 3.5 1.3 1.1 6.8 4.0 2.6 0.6 1.0 2.1 1.8 5.4 7.0 3.5 4.2 3.8 1.3 4.2 4.3 1.2 14.7 3.3 5.5 1.2 1.5 1.0 2.4 0.9 0.6 2.5 5.0 3.2 1.8 3.4 1.3 1.4 1.9 1.6 2.6 14.8 3.1 53.2 10.2 0.0 0.8 7.9 0.5 1.1 3.0 1.3 3.1 3.1 6.9 2.6 0.3 6.6 5.2 8.0 8.8 2.1 9.1 5.8 4.8 1.0 2.0 0.0 2.7 7.9 0.6 4.1 0.2 2.3 0.6 0.6 7.3 3.5 27.9 0.1 3.7 0.2 5.8 13.3 6.4 4.6 3.3 8.0 6.8 4.0 4.4 39.6 10.7 2.9 7.5 8.7 7.0 7.4 4.0 0.0 0.0 14.3 2.0 3.7 5.1 6.1 6.7 4.2 0.0 2.7 0.7 0.2 0.0 1.6 0.2 2.1 1.1 1.2 2.3 0.9 0.6 1.6 1.6 0.1 0.9 0.0 9.3 0.0 0.7 5.2 6.7 5.7 9.9 6.8 4.0 1.8 5.4 4.2 0.9 3.2 2.6 1.7 9.6 12.0 65.6 5.6 6.6 7.9 17.0 10.8 28.1 21.6 11.7 6.0 4.3 17.7 9.2 98.0 10.5 15.7 1.4 1.9 12.1 25.7 24.2 18.7 4.3 28.7 5.0 155.9 14.9 9.7 8.8 8.2 27.7 5.7 29.3 8.6 3.0 4.2 21.9 82.3 6.3 8.2 1.0 7.4 11.9 48.1 2.1 33.8 14.0 0.7 17.0 2.1 52.8 14.3 11.8 3.4 51.1 17.2 14.1 0.8 11.4 17.5 87.1 26.3 8.6 15.0 58.4 45.6 5.6 4.7 4.8 5.0 15.0 5.4 7.7 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor subunit delta" O14764 1 2019329-2030758 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 49.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 14.7;Excitatory neurons: 30.0;Horizontal cells: 13.5;Inhibitory neurons: 37.4;Spermatogonia: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HMC-1: 1.2;MCF7: 4.4;NB-4: 2.7;SH-SY5Y: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 6: Brain - Smell perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA044371: AB_2678916" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 0.3 1.5 12.8 0.0 16.9 0.0 0.5 49.6 40.5 0.1 0.1 0.2 0.0 0.3 0.1 0.3 0.2 0.4 0.7 14.7 5.4 0.7 0.2 0.9 0.2 14.3 18.1 0.2 0.1 0.7 2.7 0.1 20.2 0.2 0.0 1.4 0.3 0.0 0.3 0.4 0.2 0.3 1.0 0.3 0.1 3.6 29.7 0.1 0.9 0.4 0.0 0.2 0.2 14.7 0.0 0.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 2.7 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.8 16.9 49.6 40.5 14.7 5.4 14.3 18.1 20.2 1.0 29.7 14.7 1.0 3.2 3.6 4.9 0.1 0.5 0.0 0.0 0.0 14.7 0.3 0.0 0.9 0.0 6.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 3.4 0.0 0.0 30.0 0.0 0.3 0.5 0.0 0.2 2.5 0.3 0.0 0.0 0.1 13.5 37.4 0.0 0.0 0.0 0.3 0.2 0.0 0.9 0.0 8.4 0.0 1.4 0.0 3.0 4.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.4 1.6 0.0 0.0 4.8 0.1 11.3 0.1 0.0 0.3 0.4 0.2 0.1 0.1 GAK DNAJC26 ENSG00000178950 "Cyclin G associated kinase" O14976 4 849276-932373 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 134.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027405, HPA027459, HPA027463" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.24e-3)" "unprognostic (1.07e-1)" "unprognostic (3.50e-3)" "unprognostic (1.68e-1)" "unprognostic (7.07e-2)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (3.33e-3)" "prognostic favorable (1.70e-6)" "unprognostic (1.09e-3)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "prognostic favorable (7.41e-4)" 31.9 40.7 21.1 25.9 22.5 35.5 34.0 20.1 29.7 42.7 20.1 56.3 51.2 41.9 8.0 49.7 43.0 17.7 25.4 21.5 17.8 55.0 47.7 46.0 25.6 28.7 19.8 40.5 53.1 22.7 37.1 15.6 22.1 41.8 14.8 9.4 71.0 13.3 31.4 40.4 57.4 9.8 17.7 61.5 54.2 45.8 20.6 21.6 38.5 6.6 12.9 38.7 39.3 20.5 36.0 28.3 16.9 29.0 16.6 14.2 43.6 33.0 19.7 22.3 18.5 35.9 49.8 30.4 20.9 20.1 40.3 29.7 17.7 27.4 10.5 30.7 27.9 35.3 29.5 27.5 31.1 36.2 53.0 20.5 23.2 22.7 11.0 14.2 24.7 35.3 38.4 37.4 15.2 34.7 61.6 92.1 30.4 38.2 46.3 50.2 19.4 27.4 18.2 28.8 29.0 31.3 19.3 24.2 23.3 14.1 39.2 30.7 40.8 30.9 18.0 31.8 45.1 59.5 41.3 33.8 34.9 43.7 29.0 3.0 10.3 12.8 8.8 9.8 7.6 4.9 5.8 6.1 6.5 3.9 3.3 4.8 7.4 4.8 24.6 7.6 5.6 9.4 21.1 22.5 20.1 29.7 21.5 17.8 28.7 19.8 22.1 17.7 20.6 20.5 24.7 25.6 33.2 34.0 33.9 17.0 15.3 17.9 14.8 27.2 25.3 17.7 12.2 18.6 28.2 25.8 64.6 19.0 46.2 131.3 9.8 18.8 99.1 32.2 21.6 26.7 29.4 26.1 25.7 28.0 17.5 19.5 93.8 52.5 18.3 31.2 18.5 31.6 36.6 11.8 23.5 66.5 26.4 35.9 18.4 134.7 25.1 35.5 16.0 59.0 28.8 16.3 35.0 9.0 24.4 37.6 71.1 18.8 26.1 28.4 65.8 31.0 33.8 26.9 19.7 17.9 18.0 32.9 27.4 19.9 22.3 31.1 34.6 41.6 65.0 44.6 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "brain: 645.9;pituitary gland: 885.8" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3" "Cancer enhanced" "Detected in many" "testis cancer: 22.2" "Region enriched" "Detected in many" 13 "hypothalamus: 645.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6" "Region enhanced" "Detected in many" "hypothalamus: 82.6" "Low region specificity" "Detected in all" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 60000 200000 "Cluster 7: Monocytes - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 24: NB-4 - Immune response" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" Vesicles "CAB079779: , HPA049864: AB_2680922" "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 3.2 0.9 2.8 14.9 2.1 0.7 4.4 1.1 5.2 1.0 0.8 17.6 1.8 0.2 0.0 0.8 1.0 0.2 1.0 2.2 645.9 1.5 0.3 0.5 0.1 48.5 5.1 0.2 2.1 0.1 885.8 0.3 13.8 4.4 4.0 0.0 0.9 0.2 0.4 33.3 4.1 9.9 0.6 0.3 9.7 1.0 19.5 0.7 0.4 0.0 0.0 0.7 2.9 2.6 0.0 11.0 1.1 0.3 0.0 0.0 24.0 36.7 0.0 0.7 0.0 267.2 9.9 0.0 12.7 1.3 0.4 0.1 0.0 0.2 0.0 0.0 119.3 6.4 74.6 0.0 1.3 3.7 0.0 1.7 4.0 0.0 0.1 0.0 6.3 0.0 139.5 0.0 0.2 77.2 0.0 493.5 60.3 2.9 23.7 0.0 0.1 51.1 0.6 0.0 49.8 189.6 25.8 1.5 0.0 26.8 1.5 57.6 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.1 1.1 5.2 2.2 645.9 48.5 5.1 13.8 0.6 19.5 2.6 0.6 0.0 0.0 0.0 0.2 2.0 22.2 0.1 0.0 0.0 3.2 5.8 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.7 0.0 38.9 0.1 64.2 50.8 3.4 1.8 4.2 2.1 52.1 48.7 6.6 2.0 26.4 4.5 0.4 0.0 0.0 2.0 0.0 0.2 1.1 4.1 0.0 1.2 0.2 0.0 0.7 1.8 0.0 0.6 0.0 0.0 0.0 0.3 39.5 0.1 0.0 1.0 82.5 0.0 0.4 0.0 0.0 0.0 1.6 6.7 2.2 10.9 1.1 3.4 1.9 0.8 0.0 1.3 24.3 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574665 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.6;intestine: 24.4;kidney: 18.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 30.0;Muller glia cells: 35.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 53.6;Proximal enterocytes: 48.1;Proximal tubular cells: 24.6" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 27.6;CACO-2: 7.7;EFO-21: 14.6;K-562: 6.6;OE19: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001220, HPA077138" Approved Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 45: Intestine - Brush border" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles Nucleoplasm "HPA001220: AB_1078933, HPA077138: " "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 1.3 0.2 14.8 0.4 33.3 0.8 1.1 27.7 25.8 2.7 0.3 5.2 23.0 2.4 1.7 0.5 3.1 5.2 1.1 14.6 18.3 18.4 4.0 1.9 0.7 32.9 29.0 2.3 6.9 0.7 1.5 0.9 31.0 3.1 2.4 2.3 0.5 1.4 3.1 1.6 24.4 0.3 23.2 0.3 8.2 5.0 29.1 0.1 0.2 0.3 0.0 1.6 1.8 51.6 0.0 27.6 0.5 0.2 0.0 0.0 2.0 0.0 0.2 0.0 0.0 7.7 3.8 0.4 14.6 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.7 0.4 0.4 5.7 0.6 0.2 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.4 6.6 0.6 0.0 0.2 0.3 1.1 3.9 10.6 0.4 0.2 0.0 0.7 1.1 0.1 0.3 1.8 0.0 0.4 0.2 0.7 0.2 0.2 0.8 0.2 0.2 0.3 0.0 2.4 1.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.3 0.1 0.1 0.5 0.0 0.0 0.6 0.0 0.0 14.8 33.3 27.7 25.8 14.6 18.3 32.9 29.0 31.0 23.2 29.1 51.6 0.5 0.0 0.0 2.3 0.3 0.4 0.1 0.0 0.0 0.8 0.6 3.3 0.6 30.0 0.0 3.7 0.0 0.1 0.0 14.0 15.6 7.0 1.1 1.1 0.3 0.3 10.9 2.7 2.0 11.1 0.1 0.3 5.1 2.4 0.0 0.9 0.0 1.6 0.1 0.0 1.9 5.7 0.0 0.3 0.3 0.8 1.5 0.2 0.0 0.0 0.0 35.3 0.0 26.7 53.6 5.0 8.8 2.2 0.1 0.4 48.1 24.6 0.1 1.3 0.0 2.1 0.3 12.4 14.3 0.0 0.3 0.3 0.2 0.0 7.6 0.1 GALNT16 "GalNAc-T16, GALNTL1, KIAA1130" ENSG00000100626 "Polypeptide N-acetylgalactosaminyltransferase 16" Q8N428 14 69259277-69357033 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8;heart muscle: 45.0" "Cell type enhanced" "Detected in many" "Astrocytes: 16.6;Cardiomyocytes: 46.7;Excitatory neurons: 27.6;Fibroblasts: 24.0;Inhibitory neurons: 23.8;Smooth muscle cells: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.5;ASC diff: 11.7;hTEC/SVTERT24-B: 17.0;hTERT-RPE1: 17.2;SCLC-21H: 8.7;U-2 OS: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059136, HPA075325" Approved Approved Vesicles,Cytosol NA NA 370000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Cytosol" "HPA059136: AB_2683919, HPA075325: " "unprognostic (9.71e-3)" "unprognostic (7.47e-2)" "unprognostic (4.02e-1)" "unprognostic (2.30e-2)" "unprognostic (6.71e-2)" "unprognostic (5.72e-3)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-4)" "unprognostic (1.31e-2)" "prognostic favorable (5.23e-6)" "unprognostic (5.38e-3)" "unprognostic (3.34e-2)" "unprognostic (3.93e-2)" "unprognostic (7.96e-5)" 14.4 11.6 25.7 2.0 24.4 0.1 12.0 14.7 28.4 7.6 6.5 6.5 2.2 7.3 2.8 3.6 5.6 3.4 45.0 27.0 35.5 7.7 2.0 3.4 3.2 19.6 22.5 2.1 4.3 2.5 4.7 0.4 19.9 4.0 2.2 1.3 23.5 4.6 4.4 7.5 3.7 8.6 16.4 12.1 3.2 3.5 40.8 2.2 4.9 5.8 1.3 3.1 5.0 21.3 0.0 0.8 8.5 0.3 11.7 5.3 0.0 1.3 0.1 1.5 2.3 0.4 0.0 0.0 0.2 1.4 0.8 0.0 3.0 0.0 0.3 0.1 6.0 0.0 0.2 0.5 0.1 0.0 0.5 0.5 0.0 17.0 0.0 17.2 0.9 0.0 0.0 0.0 2.8 0.5 0.0 0.0 1.7 0.0 0.1 0.0 4.8 0.0 0.5 0.0 8.7 3.0 1.8 0.4 0.0 0.3 0.3 0.0 0.1 1.7 19.9 2.2 2.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 24.4 14.7 28.4 27.0 35.5 19.6 22.5 19.9 16.4 40.8 21.3 4.0 0.0 0.0 16.6 0.0 4.1 0.4 0.0 0.0 2.8 3.1 3.0 46.7 0.0 0.0 0.0 2.1 0.1 0.2 0.0 3.9 0.1 9.7 0.2 0.4 1.7 0.0 0.0 27.6 0.0 0.0 24.0 0.5 0.2 0.0 0.3 0.0 0.0 0.2 0.0 23.8 0.1 0.0 0.0 6.1 11.2 0.9 0.3 3.6 5.6 0.0 0.1 0.0 8.0 1.6 0.0 0.0 3.8 0.0 0.5 0.1 0.1 0.0 0.8 6.6 10.1 14.8 0.6 2.1 0.3 3.3 0.0 0.3 11.2 0.6 0.4 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" Q9NY28 12 4720400-4851927 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 31.3;testis: 13.5" "Group enriched" "Detected in some" 6 "Early spermatids: 95.2;Intestinal goblet cells: 47.0;Late spermatids: 150.2" "Group enriched" "Detected in some" 4 "colorectal cancer: 1.2;glioma: 1.8;pancreatic cancer: 0.8;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 23.4;U-266/84: 7.6" "Not detected" "Not detected" "HPA012638, HPA073461" Supported Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA No "Cluster 22: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 2: Karpas-707 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: AB_2686604" "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 0.4 0.6 3.2 1.8 3.3 0.0 0.6 2.7 5.1 0.5 2.0 14.0 5.7 0.3 0.1 0.1 0.6 0.0 2.5 3.2 2.8 0.4 0.2 0.3 0.2 3.4 3.2 0.7 0.2 0.0 2.8 0.1 3.3 0.4 31.3 0.2 0.4 0.3 0.1 0.2 12.6 0.8 2.9 0.5 0.5 13.5 3.3 0.0 0.2 0.0 0.0 0.4 0.3 4.1 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 23.4 0.0 0.0 0.0 0.1 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 3.2 3.3 2.7 5.1 3.2 2.8 3.4 3.2 3.3 2.9 3.3 4.1 0.1 6.4 0.5 1.3 0.5 0.0 0.0 0.1 0.6 2.1 0.1 2.3 4.5 0.0 0.0 0.0 0.0 0.0 1.5 1.8 0.0 0.0 95.2 0.5 0.1 0.5 6.6 0.0 1.1 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 47.0 0.0 0.0 0.0 150.2 1.5 0.1 0.0 3.7 0.2 0.5 0.0 15.1 7.4 0.2 0.6 2.6 0.0 0.1 1.0 1.0 0.0 0.6 6.6 0.7 0.1 12.3 8.3 0.0 0.0 0.0 0.8 0.3 2.2 0.0 GARNL3 "bA356B19.1, DKFZp761J1523" ENSG00000136895 "GTPase activating Rap/RanGAP domain like 3" Q5VVW2 9 127224265-127393660 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 77.1;Excitatory neurons: 178.4;Inhibitory neurons: 184.7;Microglial cells: 48.7;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 165.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "OE19: 5.3;SH-SY5Y: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028757, HPA074886" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 21: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Nucleoplasm "HPA028757: AB_2294383, HPA074886: AB_2732270" "unprognostic (3.15e-2)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (3.40e-2)" "unprognostic (3.12e-2)" "unprognostic (1.19e-3)" "unprognostic (5.58e-3)" "unprognostic (3.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (6.88e-4)" "unprognostic (2.22e-1)" "unprognostic (3.23e-7)" "unprognostic (6.39e-2)" "unprognostic (6.60e-2)" "unprognostic (7.04e-3)" "unprognostic (1.78e-5)" 3.1 6.0 5.7 0.3 5.7 0.0 4.4 11.6 6.0 6.0 2.0 2.9 1.8 7.4 5.2 4.4 5.4 3.7 11.3 6.9 5.2 2.1 1.8 2.4 1.3 4.7 4.5 4.5 2.1 6.6 2.0 1.4 5.8 6.2 1.9 1.3 5.0 4.0 1.5 2.8 1.8 6.7 4.6 1.8 1.8 2.9 4.2 0.6 5.7 1.8 1.3 4.6 3.3 11.2 0.5 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.3 0.1 1.0 1.2 0.3 0.0 1.0 0.1 0.4 0.6 1.8 0.0 0.1 0.0 0.8 0.0 1.9 1.2 0.4 0.4 0.1 0.1 1.5 0.0 0.0 1.5 0.7 1.9 0.8 0.7 0.1 0.5 0.0 0.3 0.4 5.3 1.6 0.1 1.1 3.4 1.9 2.5 1.2 3.9 0.8 2.7 0.4 0.6 0.9 0.0 0.0 0.2 1.0 0.0 0.4 2.3 2.4 1.0 0.4 0.5 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 5.7 5.7 11.6 6.0 6.9 5.2 4.7 4.5 5.8 4.6 4.2 11.2 1.3 0.0 0.0 77.1 0.5 2.7 1.7 0.4 2.8 8.0 3.1 4.3 6.8 4.3 2.0 3.7 0.0 0.6 0.2 0.9 1.9 0.3 2.2 1.0 21.1 1.5 1.2 0.4 178.4 0.6 0.1 4.8 5.6 1.2 0.0 2.4 1.8 2.5 0.8 1.7 184.7 0.8 0.0 1.3 1.9 1.0 7.5 1.3 1.8 48.7 0.0 4.0 0.0 45.2 165.3 0.4 1.6 3.4 0.5 3.3 0.6 1.8 0.1 1.0 0.0 7.1 4.0 3.5 3.9 2.7 2.0 0.3 0.7 1.0 0.8 1.2 GCG "GLP-1, GLP1, GLP2, GRPP" ENSG00000115263 Glucagon P01275 2 162142882-162152404 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "pancreas: 1943.6" "Cell type enriched" "Detected in some" 23 "Enteroendocrine cells: 5457.0" "Cancer enriched" "Detected in some" 209 "pancreatic cancer: 428.4" "Region enriched" "Detected in single" 55 "medulla oblongata: 6.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 133.4;U-2 OS: 186.8;U-698: 44.5" "Region enriched" "Detected in single" 10 "pons and medulla: 3.5" "Region enriched" "Detected in some" 5 "spinal cord: 13.7" "CAB000040, HPA036760, HPA036761" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to blood" NA NA 127000 420000 "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Endoplasmic reticulum" Vesicles "CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297" "unprognostic (3.13e-3)" "unprognostic (9.99e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" 20.3 0.1 0.0 3.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 84.4 3.4 0.6 0.0 5.3 0.0 4.1 2.5 0.0 0.0 41.9 0.0 0.2 3.5 6.2 0.0 0.1 1943.6 0.0 0.0 0.1 0.1 0.8 151.9 0.0 0.3 0.0 0.0 37.2 130.2 0.8 0.0 0.2 41.2 0.0 0.0 0.4 0.6 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.4 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 186.8 0.2 12.1 0.0 5.6 44.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.2 0.0 0.0 0.3 0.1 5457.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 91.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 230.9 8.5 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 22.9 0.0 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 75.5;intestine: 142.9;salivary gland: 55.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5" "Group enriched" "Detected in many" 4 "colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favorable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.2 0.7 0.2 11.9 0.2 0.5 0.4 0.6 0.4 19.2 0.2 142.9 97.5 2.0 0.0 15.8 4.2 75.5 0.1 0.2 0.1 17.9 0.4 0.7 0.9 0.1 0.4 0.1 2.1 0.9 0.1 0.1 0.2 1.2 123.2 0.1 55.8 0.3 0.2 0.3 123.3 4.6 0.0 0.1 25.8 4.3 0.2 1.3 2.1 0.0 10.6 9.1 29.9 0.4 0.1 147.4 0.0 0.2 0.0 1.0 0.2 0.1 7.7 0.0 0.0 6.3 6.0 0.6 24.6 0.0 9.5 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.5 30.3 0.0 0.2 0.2 0.3 3.5 0.7 0.0 0.1 0.0 0.2 0.0 0.4 1.4 0.6 0.1 0.2 0.2 75.9 0.3 0.4 0.0 0.6 10.2 1.2 0.2 0.2 0.0 0.2 0.4 0.1 0.1 0.0 0.1 0.2 0.4 7.3 0.1 0.2 0.5 0.8 8.9 0.3 0.1 0.9 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.2 0.1 0.3 0.1 0.0 0.2 0.2 0.6 0.4 0.2 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.0 0.0 2.2 0.0 1.0 0.0 18.3 8.9 0.0 0.0 0.5 0.0 0.7 11.5 40.5 104.8 0.0 0.0 0.1 360.1 0.0 92.6 9.8 23.3 8.6 0.3 7.8 0.0 0.0 14.9 0.0 0.2 27.5 75.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 26.9 8.2 0.6 0.0 19.2 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 58.4 163.2 0.0 0.1 8.0 85.5 4.4 9.8 0.0 6.6 0.6 1.5 3.0 0.3 1.4 0.0 0.0 0.8 0.0 48.5 52.4 GDNF "ATF1, ATF2, HFB1-GDNF" ENSG00000168621 "Glial cell derived neurotrophic factor" P39905 5 37812677-37840041 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes, Disease variant, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 8.2;skeletal muscle: 10.1" "Cell type enhanced" "Detected in some" "Fibroblasts: 3.3;Skeletal myocytes: 11.5;Spermatogonia: 3.4;Theca cells: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 41.4;SuSa: 12.6;U-87 MG: 12.6;WM-115: 46.5" "Region enhanced" "Detected in single" "basal ganglia: 2.8" "Low region specificity" "Detected in some" "CAB005210, HPA070283" Supported Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" Vesicles Nucleoplasm "CAB005210: AB_2247684, HPA070283: AB_2686246" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (3.54e-2)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (5.33e-2)" "unprognostic (1.92e-1)" "unprognostic (3.71e-2)" "unprognostic (2.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.10e-1)" "unprognostic (1.16e-4)" "unprognostic (2.04e-1)" "unprognostic (8.86e-2)" "unprognostic (1.05e-1)" "unprognostic (4.42e-2)" 0.1 0.4 2.3 1.6 1.5 0.1 0.3 5.8 1.4 0.8 0.0 8.2 1.4 1.3 2.5 0.9 0.9 0.9 0.8 0.6 1.6 0.9 0.7 0.0 0.1 0.7 3.1 3.6 0.0 0.0 0.1 5.0 1.0 1.3 2.4 0.3 0.2 4.5 10.1 1.3 2.0 2.1 0.2 0.4 1.6 0.4 6.1 0.1 0.1 4.3 0.0 0.7 0.8 2.9 0.0 0.0 0.1 0.1 1.8 1.0 0.0 5.5 3.4 1.1 1.6 0.0 0.1 0.1 0.0 7.4 0.1 0.2 0.0 0.1 2.2 0.0 0.2 0.0 0.4 0.5 0.2 0.1 0.1 1.8 0.1 41.4 0.0 1.4 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.1 0.4 0.1 0.0 0.1 9.0 0.0 0.0 0.2 0.5 0.0 0.3 0.2 2.7 12.6 0.1 0.0 0.0 5.5 0.0 1.4 6.2 4.0 0.0 0.0 12.6 0.0 46.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 1.5 5.8 1.4 0.6 1.6 0.7 3.1 1.0 0.2 6.1 2.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.6 0.6 0.0 0.3 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.1 3.3 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.7 0.1 0.0 0.0 11.5 1.8 0.9 3.4 0.0 0.3 0.1 0.0 2.6 0.0 0.5 GGT7 "D20S101, dJ18C9.2, GGTL3, GGTL5" ENSG00000131067 "Gamma-glutamyltransferase 7" Q9UJ14 20 34844720-34872856 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 60.9;Inhibitory neurons: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013204, HPA013339" Approved Approved Nucleoplasm,Vesicles NA NA 1900000 "Cluster 30: Non-specific - Translation" "Cluster 80: Striated muscle - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Nucleoplasm "HPA013204: AB_1850347, HPA013339: AB_2668816" "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (1.26e-5)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.46e-3)" "unprognostic (2.49e-2)" "unprognostic (3.49e-1)" "unprognostic (1.16e-2)" "unprognostic (3.34e-3)" "unprognostic (3.61e-2)" "unprognostic (5.00e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-1)" "unprognostic (5.50e-2)" "unprognostic (2.00e-1)" 13.2 13.8 37.0 11.8 35.8 5.5 15.4 43.4 43.8 25.6 53.2 19.1 16.0 19.3 29.1 10.1 21.1 18.2 22.3 38.6 33.3 24.9 16.8 14.4 18.2 34.3 28.9 24.1 27.1 22.9 40.5 13.7 33.6 24.8 14.9 22.7 30.8 22.6 67.5 17.9 20.1 14.9 22.5 15.4 22.1 10.1 32.0 15.8 28.8 13.8 13.6 19.7 18.0 35.4 5.2 7.7 38.5 39.5 29.7 26.4 34.2 21.7 21.9 17.5 26.0 40.6 25.5 0.0 25.1 17.1 17.8 3.6 16.8 9.5 11.5 1.8 29.9 15.9 16.0 21.3 26.5 0.8 24.9 38.5 10.6 19.7 9.1 52.2 1.5 20.3 12.0 2.8 12.2 9.1 4.2 8.1 8.9 9.1 3.8 0.1 26.3 25.9 25.3 7.7 22.4 26.1 11.2 17.6 28.2 14.4 13.5 14.2 0.6 59.8 23.6 5.7 12.6 29.6 4.2 1.9 70.4 1.5 22.4 1.4 2.8 1.5 6.9 2.0 2.0 6.1 5.8 2.6 2.5 5.4 11.5 8.2 0.3 3.0 0.7 1.4 5.1 1.8 37.0 35.8 43.4 43.8 38.6 33.3 34.3 28.9 33.6 22.5 32.0 35.4 2.0 3.2 2.7 23.2 6.4 7.4 18.1 14.8 9.1 40.2 9.6 5.8 1.9 32.9 11.1 18.4 12.5 24.2 2.2 14.2 0.0 16.1 3.2 3.3 7.6 2.1 10.8 1.7 60.9 5.6 12.3 14.0 23.4 4.5 2.5 9.0 1.4 12.1 4.5 40.4 58.0 15.2 38.7 3.2 4.4 1.8 12.5 3.2 10.6 17.8 2.8 9.7 4.1 31.2 25.5 6.3 17.8 7.9 1.9 9.3 11.9 6.1 7.2 19.3 6.6 16.0 9.4 13.9 15.5 5.7 4.3 16.8 7.2 17.0 17.9 13.9 GIGYF1 "GYF1, PERQ1" ENSG00000146830 "GRB10 interacting GYF protein 1" O75420 7 100679507-100694250 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 100.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020999, HPA023995" Enhanced Approved Vesicles,Microtubules NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles Microtubules "HPA020999: AB_2111744, HPA023995: AB_1855221" "unprognostic (3.82e-3)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (2.67e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.42e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.43e-2)" "unprognostic (8.06e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.35e-5)" "unprognostic (3.66e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (1.89e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-3)" 25.7 25.9 21.1 15.6 21.1 30.5 26.9 27.7 24.1 36.1 21.3 26.5 15.8 34.9 11.0 19.1 30.2 10.4 22.4 19.5 17.3 27.3 23.1 22.6 18.9 20.9 18.8 43.4 36.1 13.5 41.9 11.4 18.7 28.5 8.0 8.8 29.6 13.7 26.5 33.5 30.7 11.2 16.2 39.1 25.1 32.2 21.4 17.2 32.8 16.7 11.3 23.5 23.6 24.0 16.5 16.8 26.1 38.2 12.3 9.6 46.6 15.3 12.4 9.4 10.8 9.8 27.6 22.9 19.2 11.1 19.0 19.4 12.9 15.3 5.8 24.4 26.4 15.9 48.5 14.3 12.2 18.1 26.1 15.1 12.2 12.0 17.0 15.3 9.5 26.4 44.8 21.9 8.7 37.5 32.1 100.1 32.0 6.5 20.1 51.2 13.9 23.1 6.9 14.8 23.3 36.7 19.8 31.2 18.2 17.6 14.2 30.2 14.7 26.8 32.9 44.7 14.2 17.8 8.4 12.3 15.6 35.9 16.2 2.2 1.3 1.2 2.4 1.2 1.8 1.3 1.6 1.5 0.5 1.9 1.4 1.5 4.5 1.3 1.3 2.0 0.9 0.5 21.1 21.1 27.7 24.1 19.5 17.3 20.9 18.8 18.7 16.2 21.4 24.0 26.5 3.2 7.8 19.9 18.1 31.7 11.0 5.8 8.0 25.5 25.5 20.6 8.3 32.9 5.8 18.4 18.8 12.0 31.2 19.5 15.6 11.5 1.0 12.2 24.3 17.5 18.6 9.9 18.1 9.4 10.7 17.8 18.8 17.5 5.7 26.5 22.5 19.0 11.4 52.2 17.7 22.8 6.1 25.5 19.8 3.8 24.5 15.6 17.8 29.0 12.5 15.3 20.6 14.6 22.6 11.8 18.0 18.0 10.5 16.7 20.4 9.9 5.0 28.0 32.9 33.2 19.6 16.4 36.0 6.8 22.4 16.3 20.5 12.9 16.1 10.2 GIMAP4 "FLJ11110, HIMAP4, IAN1, IMAP4" ENSG00000133574 "GTPase, IMAP family member 4" Q9NUV9 7 150567369-150573953 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 127.7" "Cell type enhanced" "Detected in many" "Adipocytes: 182.3;Endothelial cells: 195.2;Hepatic stellate cells: 222.0;Kupffer cells: 197.2;Macrophages: 110.0;monocytes: 176.0;NK-cells: 344.0;T-cells: 186.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 26 "HUVEC TERT2: 326.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019135, HPA019137, HPA027198" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" "Vesicles, Cytosol" "HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599" "unprognostic (5.03e-2)" "unprognostic (3.30e-3)" "unprognostic (4.08e-2)" "prognostic favorable (7.63e-4)" "unprognostic (1.72e-1)" "unprognostic (1.73e-2)" "unprognostic (7.00e-2)" "unprognostic (2.40e-2)" "unprognostic (1.87e-2)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.65e-1)" "unprognostic (3.32e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-1)" 46.1 18.3 15.0 75.1 15.6 4.2 31.8 16.2 21.2 19.7 16.3 21.2 16.5 23.0 9.6 12.0 18.7 24.6 31.3 14.3 16.0 17.3 29.9 50.8 127.7 19.2 18.0 7.7 6.7 9.6 6.0 48.7 18.0 10.2 22.4 1.5 11.2 13.3 17.5 8.4 25.0 38.3 18.8 115.6 18.0 4.2 16.4 30.5 21.1 48.1 85.1 31.1 11.6 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 326.4 3.4 0.1 0.3 0.0 0.0 0.4 0.2 0.4 0.0 0.0 12.7 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.5 370.2 5.2 325.8 390.9 404.2 3.0 408.0 402.8 122.1 1.3 424.3 361.9 339.7 263.4 320.4 5.3 312.1 776.9 15.0 15.6 16.2 21.2 14.3 16.0 19.2 18.0 18.0 18.8 16.4 18.7 182.3 3.2 12.4 0.3 7.3 6.8 0.2 0.0 3.4 0.1 2.2 4.7 9.9 5.7 1.8 11.0 0.0 0.6 82.6 0.0 0.0 0.2 0.6 0.3 0.4 195.2 0.0 9.7 0.5 0.2 0.8 9.0 2.0 0.3 6.3 0.0 222.0 3.7 96.4 0.0 0.1 0.0 0.0 197.2 20.9 1.7 5.0 110.0 10.6 18.7 176.0 0.2 344.0 0.0 0.1 0.1 0.0 0.0 14.7 0.4 0.0 1.9 0.7 0.4 13.1 3.9 7.9 0.0 0.8 1.1 6.1 0.8 186.2 0.8 0.0 0.3 GIMAP7 "IAN7, MGC27027" ENSG00000179144 "GTPase, IMAP family member 7" Q8NHV1 7 150514872-150521073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 170.1" "Cell type enhanced" "Detected in many" "Adipocytes: 265.8;Endothelial cells: 263.3;Hepatic stellate cells: 267.4;Kupffer cells: 156.8;monocytes: 140.8;NK-cells: 632.4;T-cells: 255.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "monocytes: 666.6;NK-cells: 1121.0;T-cells: 2269.3" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 92.9;MOLT-4: 78.6" "Not detected" "Not detected" "HPA020266, HPA020268" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus, Vesicles" "HPA020266: AB_1849680, HPA020268: AB_1849682" "unprognostic (4.85e-3)" "unprognostic (1.65e-3)" "unprognostic (6.11e-2)" "unprognostic (1.32e-2)" "unprognostic (3.71e-1)" "prognostic favorable (7.43e-4)" "prognostic favorable (8.98e-5)" "unprognostic (6.49e-3)" "unprognostic (5.24e-2)" "unprognostic (6.12e-3)" "unprognostic (2.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.07e-3)" "unprognostic (2.07e-1)" "unprognostic (3.14e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" 49.8 15.0 16.3 73.6 17.4 6.6 37.4 17.1 21.3 19.2 16.0 20.3 21.1 27.8 19.8 12.6 21.5 22.1 40.1 15.5 17.2 20.9 20.4 61.0 170.1 19.0 17.8 7.4 7.6 10.5 5.6 31.5 19.1 10.9 23.3 1.2 13.7 12.0 27.8 9.3 40.1 33.6 17.6 124.3 22.0 4.5 18.0 52.5 28.2 56.1 99.2 29.6 13.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 92.9 9.4 0.0 0.0 0.0 0.0 78.6 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.7 656.5 9.6 1184.0 595.9 1164.2 6.5 1762.9 1440.6 286.3 6.5 2269.3 1597.2 52.5 1121.0 666.6 16.3 1076.9 2581.7 16.3 17.4 17.1 21.3 15.5 17.2 19.0 17.8 19.1 17.6 18.0 17.6 265.8 0.0 13.2 0.3 13.1 2.4 0.4 0.0 2.8 0.0 2.8 5.6 14.6 5.7 0.6 1.8 0.0 0.2 125.1 0.2 0.0 0.5 1.3 0.9 0.6 263.3 0.0 17.0 0.0 0.7 0.0 8.0 3.1 0.7 13.9 0.0 267.4 5.3 15.5 0.0 0.0 0.1 0.0 156.8 10.6 2.0 2.5 54.9 1.8 22.5 140.8 0.4 632.4 0.5 0.1 0.4 1.2 0.4 19.3 0.2 0.0 1.7 0.7 0.4 0.0 6.0 9.4 0.2 0.9 1.1 3.3 0.4 255.9 0.9 0.2 0.0 GJB3 "CX31, DFNA2, EKV" ENSG00000188910 "Gap junction protein beta 3" O75712 1 34781214-34786369 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 77.8;skin 1: 145.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 138.4;Basal prostatic cells: 71.9;Basal respiratory cells: 43.6;Pancreatic endocrine cells: 119.8;Prostatic glandular cells: 63.4;Squamous epithelial cells: 91.9;Suprabasal keratinocytes: 170.6;Urothelial cells: 171.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 58.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 88.8;CAPAN-2: 121.7;HaCaT: 99.4;HBEC3-KT: 84.9;hTCEpi: 136.8;OE19: 54.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA074472 Supported "Vesicles,Cell Junctions" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Vesicles, Cell Junctions" "HPA074472: AB_2686694" "unprognostic (1.34e-3)" "unprognostic (2.30e-1)" "unprognostic (2.84e-2)" "unprognostic (5.22e-3)" "unprognostic (3.82e-2)" "unprognostic (2.00e-2)" "unprognostic (1.21e-4)" "prognostic unfavorable (4.56e-4)" "unprognostic (2.30e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (4.50e-2)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-2)" "unprognostic (2.46e-2)" 0.3 0.2 1.3 1.7 0.6 0.0 5.5 1.1 1.0 8.9 0.0 4.2 0.2 0.3 2.8 77.8 1.1 7.0 0.1 0.6 0.0 0.5 1.5 0.6 0.5 0.2 0.0 0.1 0.3 0.0 0.1 1.4 0.1 4.0 5.0 0.0 8.9 1.7 0.6 145.0 1.3 0.1 0.0 0.0 5.9 0.8 0.1 0.8 0.2 0.0 12.9 11.9 26.4 0.2 88.8 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 121.7 0.0 11.6 0.1 0.1 99.4 0.0 84.9 0.0 0.1 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 136.8 0.0 35.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.4 54.2 22.3 0.0 0.0 0.0 40.8 33.0 0.0 0.0 13.1 0.9 0.0 0.1 1.0 0.1 0.0 0.1 5.7 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 1.1 1.0 0.6 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 3.2 0.0 0.0 0.0 138.4 71.9 43.6 16.5 0.0 2.0 1.3 0.4 1.5 15.5 5.5 0.0 0.3 0.0 18.3 0.0 14.6 0.0 4.1 0.4 1.7 1.8 0.0 0.2 7.3 0.2 1.7 3.1 8.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 6.1 0.0 12.5 0.0 0.0 0.4 14.2 0.0 0.0 0.0 0.0 0.0 0.0 119.8 8.1 0.0 0.0 63.4 0.5 0.0 10.1 0.0 0.0 0.0 2.1 0.1 0.3 91.9 170.6 0.1 0.5 0.0 19.1 171.0 GLB1 "EBP, ELNR1" ENSG00000170266 "Galactosidase beta 1" P16278 3 32996609-33097202 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 857.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008382, HPA040610, HPA069503" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2700000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" Vesicles "Golgi apparatus" "CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142" "unprognostic (1.51e-2)" "unprognostic (3.66e-2)" "unprognostic (5.02e-3)" "unprognostic (9.66e-3)" "unprognostic (9.61e-3)" "unprognostic (1.04e-1)" "unprognostic (2.31e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.08e-1)" "prognostic favorable (1.14e-5)" "unprognostic (3.05e-1)" "unprognostic (2.33e-1)" "unprognostic (2.20e-1)" "unprognostic (5.85e-2)" 22.0 36.1 12.1 27.8 13.0 21.9 20.5 12.5 14.8 33.4 16.0 43.5 43.0 21.9 103.6 15.4 28.2 32.0 15.5 12.5 14.8 46.0 48.2 42.7 25.8 14.3 12.9 21.4 30.8 59.4 18.5 53.8 15.4 23.2 45.6 14.9 25.3 29.3 7.7 15.8 31.0 30.6 12.4 24.4 35.5 13.5 13.5 17.5 52.8 10.8 23.0 31.8 16.2 15.1 37.4 63.6 39.8 48.3 241.9 123.7 857.2 59.1 157.6 73.7 95.1 91.3 86.5 17.9 50.9 120.9 53.9 35.1 38.1 75.5 53.7 104.9 33.0 69.9 35.3 47.4 124.3 50.5 69.9 144.9 70.2 67.0 39.2 144.1 116.5 24.7 64.3 67.0 81.8 44.6 29.6 31.6 26.4 78.0 27.0 24.7 26.4 86.6 78.4 54.4 12.0 40.3 75.0 120.2 74.4 69.3 80.3 130.2 67.7 46.8 32.2 65.2 50.1 53.2 87.9 5.9 99.6 71.2 36.7 43.9 146.2 86.4 29.2 125.8 40.4 37.9 34.3 31.8 166.5 35.6 17.9 21.8 56.6 26.0 92.1 35.1 77.1 91.9 12.1 13.0 12.5 14.8 12.5 14.8 14.3 12.9 15.4 12.4 13.5 15.1 8.7 19.2 25.3 39.2 18.6 6.0 13.6 60.1 10.8 11.3 11.5 7.5 9.1 34.3 43.3 27.6 6.2 100.1 14.1 41.9 27.4 53.5 24.8 18.7 16.0 17.4 16.9 20.6 46.7 35.4 55.3 29.2 26.0 27.1 26.6 20.6 19.6 39.7 79.5 5.0 46.0 23.5 40.7 43.9 13.9 5.0 15.2 41.7 14.2 23.4 64.6 16.5 10.3 27.2 24.2 28.1 43.4 21.1 19.8 9.9 36.2 33.1 31.0 16.2 13.1 12.9 16.3 1.0 6.6 10.1 3.4 49.1 18.7 51.0 32.0 12.1 GLB1L2 ENSG00000149328 "Galactosidase beta 1 like 2" Q8IW92 11 134331874-134378341 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 160.6" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 182.0" "Cancer enhanced" "Detected in many" "prostate cancer: 21.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.2;NK-cell: 3.1" "Group enriched" "Detected in many" 24 "NK-cells: 3.1;T-cells: 3.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 49.9;HaCaT: 52.6;OE19: 123.6;SCLC-21H: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054808, HPA059955" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 21: OE19 - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm Vesicles "HPA054808: AB_2682608, HPA059955: AB_2684178" "unprognostic (2.63e-2)" "unprognostic (9.77e-3)" "unprognostic (2.32e-2)" "unprognostic (2.20e-2)" "unprognostic (8.07e-2)" "unprognostic (1.54e-1)" "unprognostic (5.98e-2)" "unprognostic (2.08e-2)" "unprognostic (1.51e-1)" "unprognostic (8.31e-2)" "unprognostic (1.67e-1)" "unprognostic (1.48e-1)" "unprognostic (4.73e-2)" "unprognostic (1.22e-2)" "unprognostic (2.64e-1)" "unprognostic (3.88e-3)" "unprognostic (1.01e-1)" 1.5 2.1 3.0 2.6 2.1 0.3 7.0 0.1 7.7 5.9 14.7 27.6 5.7 33.9 2.1 3.5 25.6 2.8 1.2 8.5 0.3 20.7 0.6 3.6 0.6 1.0 0.8 13.7 10.6 25.0 14.1 1.5 1.0 34.5 11.7 160.6 9.1 25.2 1.0 9.4 4.0 4.4 0.1 0.6 9.0 8.3 0.7 0.5 22.7 0.2 0.6 6.7 5.0 1.3 16.0 1.6 8.2 4.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 13.3 49.9 0.0 16.3 0.0 6.8 52.6 25.2 0.4 0.0 0.0 23.9 0.0 6.7 0.6 2.2 0.0 28.4 0.3 0.7 0.0 0.0 0.0 0.1 7.6 26.3 0.0 0.0 15.3 4.4 3.0 4.7 123.6 18.2 0.0 0.0 1.5 14.1 11.0 34.9 13.1 11.4 14.2 0.0 1.2 18.4 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.1 0.0 3.1 0.0 0.0 0.0 3.2 0.0 1.2 0.0 0.6 1.2 0.0 0.1 0.9 1.4 0.0 3.1 0.0 0.0 0.0 0.5 3.0 2.1 0.1 7.7 8.5 0.3 1.0 0.8 1.0 0.1 0.7 1.3 0.2 0.0 1.8 0.3 0.4 2.2 5.2 1.0 1.8 6.2 7.2 7.9 1.6 1.5 2.5 0.0 41.7 0.2 3.4 19.5 0.0 2.5 2.1 7.9 22.1 1.2 9.0 0.0 1.6 2.4 1.0 3.6 4.1 2.2 0.0 41.9 0.0 0.2 0.2 5.0 1.2 5.9 0.0 0.0 0.3 6.8 1.2 0.3 5.4 1.0 0.0 10.8 1.0 1.0 0.3 2.2 6.3 0.7 2.2 8.1 3.0 8.4 10.1 182.0 0.0 3.7 2.3 2.6 4.6 1.9 0.9 0.1 2.5 3.4 11.5 2.7 GLDN "CLOM, COLM, colmedin, CRG-L2, UNC-122" ENSG00000186417 Gliomedin Q6ZMI3 15 51341655-51408005 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 84.8" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 510.8" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.7;MCF7: 1.3;SuSa: 1.8;U-266/70: 3.3;U-266/84: 2.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050873, HPA059441" Uncertain Supported "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA 410000 "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Plasma membrane" "HPA050873: , HPA059441: AB_2684018" "unprognostic (5.04e-2)" "unprognostic (2.57e-2)" "unprognostic (5.15e-5)" "unprognostic (3.21e-3)" "unprognostic (2.82e-2)" "unprognostic (2.33e-1)" "unprognostic (2.07e-4)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (3.30e-2)" "unprognostic (3.15e-1)" "unprognostic (2.14e-2)" "unprognostic (9.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (3.80e-3)" "unprognostic (1.37e-1)" 18.5 2.3 18.1 1.6 51.1 0.7 9.7 35.0 28.6 1.8 0.0 3.5 0.2 0.5 0.5 0.5 1.2 3.4 5.0 15.5 31.2 0.4 0.1 8.7 0.2 47.6 48.9 0.5 0.5 0.4 0.6 3.9 56.4 2.4 6.4 1.3 1.4 0.7 1.0 5.0 0.6 0.6 26.0 2.9 2.1 0.2 41.7 0.1 0.8 0.9 0.2 1.5 1.5 84.8 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.5 0.8 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.1 0.0 3.3 2.9 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 18.1 51.1 35.0 28.6 15.5 31.2 47.6 48.9 56.4 26.0 41.7 84.8 40.1 0.0 2.6 2.0 0.0 6.2 0.0 0.3 0.0 9.2 0.2 0.3 8.4 0.0 0.1 0.0 0.0 5.2 0.0 47.0 0.0 0.0 0.0 0.0 0.1 3.7 1.2 0.0 7.4 0.0 0.6 7.9 4.6 0.2 0.0 4.5 0.0 0.2 4.9 0.0 17.2 1.7 0.0 14.9 9.5 0.0 0.3 16.1 3.6 42.2 0.0 0.3 0.0 2.0 510.8 0.1 28.6 0.0 0.0 0.1 0.0 0.1 0.9 0.8 0.0 4.7 9.8 0.1 0.1 0.0 4.0 100.4 0.6 0.4 5.1 1.6 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391089-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 46.8" "Group enriched" "Detected in many" 7 "Early spermatids: 254.0;Spermatocytes: 306.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 4.2;SK-BR-3: 5.6;U-2 OS: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Vesicles "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.0 2.7 5.1 0.8 5.2 0.3 2.4 6.5 5.9 2.1 2.5 0.9 0.6 2.3 3.7 1.0 3.1 1.0 2.3 5.5 5.0 2.0 1.5 1.2 0.7 4.0 4.3 7.1 2.6 4.1 2.6 0.9 4.4 1.5 0.4 3.0 1.0 3.0 2.3 1.9 0.8 1.1 4.0 1.6 0.7 46.8 4.7 1.3 2.4 1.6 0.4 0.9 0.9 6.3 0.2 0.4 0.2 0.4 2.9 1.6 0.5 0.4 0.3 0.1 0.2 0.1 0.3 0.2 1.0 0.3 0.7 0.1 0.0 0.1 0.3 0.6 0.2 0.1 0.6 4.2 2.1 0.4 0.0 0.5 0.9 0.4 1.5 2.5 0.1 0.1 0.2 0.5 0.8 0.1 0.4 0.3 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 0.7 0.3 0.5 5.6 1.7 0.2 1.7 0.1 0.8 0.6 7.6 0.9 0.3 0.7 0.7 0.2 0.2 0.2 0.5 0.7 0.0 0.1 0.3 0.0 0.1 0.3 0.3 0.5 0.1 0.3 0.5 0.9 0.6 0.3 0.1 0.7 1.0 0.2 5.1 5.2 6.5 5.9 5.5 5.0 4.0 4.3 4.4 4.0 4.7 6.3 1.5 0.0 3.1 15.0 0.3 0.9 4.6 1.7 3.4 5.6 2.9 3.0 4.0 1.5 1.8 0.0 0.0 1.7 1.5 0.1 9.8 0.6 254.0 4.9 1.4 1.5 0.0 0.4 7.4 0.0 0.2 3.0 1.1 0.5 1.3 1.4 0.0 0.2 0.6 1.7 13.3 0.1 0.0 0.3 0.3 39.0 7.5 0.7 0.0 10.3 0.0 6.7 0.0 27.2 28.1 0.1 0.0 5.7 0.1 1.2 0.1 1.4 14.1 2.0 6.6 5.6 1.9 306.8 19.4 0.3 0.4 0.4 0.6 2.1 0.3 2.1 GLIPR2 "C9orf19, GAPR-1" ENSG00000122694 "GLI pathogenesis related 2" Q9H4G4 9 36136536-36163913 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 188.5;Langerhans cells: 203.6;Macrophages: 117.6;monocytes: 203.0;NK-cells: 180.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 71.6;HDLM-2: 72.9;TIME: 127.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029478 Approved Uncertain Vesicles,Microtubules NA NA 19000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 4: Macrophages - Innate immune response" Vesicles Microtubules "HPA029478: AB_10670038" "unprognostic (1.57e-2)" "unprognostic (5.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-2)" "unprognostic (1.33e-2)" "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (1.84e-2)" "unprognostic (4.26e-2)" "unprognostic (3.21e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (6.54e-7)" "unprognostic (6.57e-3)" "unprognostic (4.94e-1)" "unprognostic (1.02e-1)" "unprognostic (2.43e-2)" 38.5 20.9 17.6 52.7 22.8 73.8 32.4 21.0 22.6 45.9 14.1 73.7 14.7 77.8 15.1 18.6 36.9 24.1 24.2 17.2 19.3 8.8 6.9 62.6 29.9 24.8 22.1 13.3 5.6 2.5 4.9 8.8 22.3 38.3 33.1 2.7 15.3 39.3 7.7 12.2 32.2 63.8 22.8 41.3 25.3 3.4 26.7 18.7 15.8 11.1 19.2 38.8 27.4 27.6 3.7 2.9 20.9 22.3 71.6 33.3 2.4 32.9 20.0 7.8 14.1 1.3 0.3 0.2 10.2 30.9 19.7 0.2 7.9 1.1 4.7 72.9 6.4 8.8 6.2 0.4 27.9 5.7 28.3 23.4 1.0 44.5 7.8 14.0 62.5 22.6 0.4 5.0 17.4 7.9 27.9 15.2 20.1 0.3 10.7 18.9 44.1 1.0 1.6 1.8 5.6 11.3 4.4 2.2 3.6 42.2 2.3 24.0 127.3 10.7 24.8 9.6 28.0 7.8 2.2 12.7 11.0 35.0 2.5 268.6 360.9 540.3 168.4 162.5 89.1 24.4 114.3 108.2 208.3 24.5 47.0 74.7 657.0 125.5 124.9 18.5 132.2 414.0 17.6 22.8 21.0 22.6 17.2 19.3 24.8 22.1 22.3 22.8 26.7 27.6 11.9 3.2 25.4 4.6 22.3 13.4 2.5 14.7 1.8 0.3 46.9 19.0 2.6 2.8 30.9 5.5 0.0 3.8 66.9 14.7 0.0 21.2 0.7 1.8 33.9 13.3 8.4 58.7 1.1 1.3 3.3 54.3 11.7 2.1 52.6 1.9 16.1 0.9 188.5 0.0 0.8 42.4 14.2 83.2 203.6 2.3 18.0 117.6 62.2 2.8 203.0 21.4 180.2 3.0 28.6 5.2 16.1 25.9 22.8 16.0 4.0 1.1 64.3 0.5 46.0 44.7 43.2 0.9 6.4 0.9 10.2 3.4 75.5 10.9 45.3 3.3 GLRX2 "bA101E13.1, GRX2" ENSG00000023572 "Glutaredoxin 2" Q9NS18 1 193090866-193106114 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 17 "Early spermatids: 796.4;Late spermatids: 1841.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 240.2" "Low region specificity" "Detected in all" "HPA023087, HPA057224" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "HPA023087: AB_1849778, HPA057224: AB_2683373" "unprognostic (4.80e-2)" "unprognostic (3.77e-2)" "unprognostic (8.04e-2)" "unprognostic (2.33e-1)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "unprognostic (2.40e-3)" "unprognostic (5.11e-2)" "unprognostic (3.21e-2)" "unprognostic (2.38e-2)" "unprognostic (1.10e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (3.30e-7)" "unprognostic (6.23e-2)" "unprognostic (1.73e-1)" "unprognostic (6.21e-2)" "unprognostic (4.48e-2)" 16.1 22.3 16.0 7.9 16.5 9.5 12.4 17.0 28.7 10.2 15.4 14.4 11.7 8.2 10.7 16.7 7.2 6.9 37.0 16.5 18.2 16.2 25.9 9.8 5.2 17.3 15.8 6.2 9.6 5.5 8.4 7.5 17.9 17.9 9.0 2.5 11.1 8.4 37.6 12.9 10.6 8.7 15.9 9.8 12.9 30.2 16.8 3.8 7.2 24.8 7.3 13.9 11.7 17.2 47.2 57.8 14.6 32.8 52.2 33.9 24.0 67.2 29.8 55.6 45.9 36.3 44.2 20.0 36.1 28.6 67.1 44.4 17.5 39.4 56.7 45.6 30.4 40.4 39.0 42.6 55.9 32.8 39.0 23.1 33.8 76.5 38.4 21.6 35.7 13.7 60.8 21.9 68.4 66.3 26.9 60.6 16.8 75.6 38.2 23.7 22.9 48.3 53.7 31.4 13.8 12.4 26.9 81.2 240.2 21.6 35.2 37.5 21.6 42.8 11.2 93.7 70.5 42.6 48.7 41.4 40.8 38.1 61.2 13.6 18.8 26.6 12.7 23.1 14.2 13.2 13.4 11.7 22.5 10.8 11.7 13.4 9.6 16.1 30.0 9.2 18.6 14.5 16.0 16.5 17.0 28.7 16.5 18.2 17.3 15.8 17.9 15.9 16.8 17.2 24.2 9.6 10.1 5.5 14.8 18.2 21.1 39.1 14.2 7.2 21.7 23.6 62.8 12.8 21.5 16.5 6.2 39.2 19.5 25.8 29.4 41.1 796.4 16.1 24.2 18.7 13.8 15.6 11.3 41.4 41.6 25.2 14.8 17.7 46.9 16.4 11.0 30.3 44.2 1.7 10.1 26.5 32.6 15.0 26.9 1841.1 17.4 26.8 26.6 5.6 25.9 9.9 28.8 5.0 10.1 38.3 31.5 18.0 20.5 39.2 40.3 74.3 13.9 11.5 6.6 15.5 36.2 12.3 25.4 21.3 19.9 24.8 14.0 33.1 24.1 20.5 GLT8D2 FLJ31494 ENSG00000120820 "Glycosyltransferase 8 domain containing 2" Q9H1C3 12 103988987-104064183 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012740, HPA026904, HPA070791" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Vesicles" "HPA012740: , HPA026904: AB_1849731, HPA070791: " "unprognostic (4.02e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (9.53e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-3)" "unprognostic (2.57e-1)" "unprognostic (1.25e-1)" "unprognostic (7.55e-2)" "unprognostic (5.03e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (1.58e-6)" "prognostic unfavorable (7.92e-4)" "unprognostic (7.15e-2)" "unprognostic (7.70e-3)" "unprognostic (7.03e-3)" 16.9 10.9 4.2 5.2 4.9 1.5 19.5 2.6 5.1 29.6 11.2 17.6 5.8 27.4 21.6 7.5 22.3 35.8 15.4 4.8 3.7 4.3 2.7 10.2 6.0 2.9 3.1 41.6 4.5 6.6 9.6 9.4 3.1 13.3 11.4 1.0 7.7 16.0 3.2 4.1 7.7 21.8 2.8 1.6 8.4 6.8 3.7 2.2 26.3 11.5 5.8 20.8 18.9 4.4 0.3 0.6 0.7 22.2 28.3 69.3 0.5 32.0 89.4 8.3 10.5 0.4 0.2 0.9 1.8 37.5 0.4 0.1 0.4 11.9 7.0 1.6 10.0 0.6 11.2 0.2 12.7 0.9 0.5 63.2 0.7 10.0 13.8 51.9 4.4 0.6 0.4 1.3 36.5 0.3 0.8 0.5 2.7 0.1 6.7 1.0 33.6 0.2 45.5 0.4 1.3 1.7 33.5 0.8 0.4 2.4 6.0 0.5 0.7 13.2 6.2 1.3 1.9 3.9 0.8 0.3 1.0 0.7 1.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 4.9 2.6 5.1 4.8 3.7 2.9 3.1 3.1 2.8 3.7 4.4 8.0 0.0 4.6 2.9 0.3 2.8 4.2 2.4 0.0 0.8 1.0 26.3 3.9 1.5 0.1 0.0 2.1 4.1 0.4 0.0 0.0 0.1 41.2 0.6 8.3 7.5 1.8 0.0 10.2 0.0 0.8 55.9 1.1 0.4 0.0 0.1 20.7 0.3 0.6 0.0 10.5 1.3 0.0 0.6 2.8 11.5 55.9 0.4 3.6 4.7 0.6 0.5 0.0 1.0 2.6 0.3 0.0 51.9 1.2 1.4 0.0 0.0 0.1 0.5 6.6 25.2 18.0 1.1 1.1 0.2 2.4 1.4 0.6 10.7 0.0 0.1 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease variant, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 224.7;Hofbauer cells: 100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 30.9;dendritic cells: 39.6;monocytes: 40.4" "Cell line enhanced" "Detected in all" "BEWO: 207.1;HBEC3-KT: 291.8;hTCEpi: 287.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 19000000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Vesicles, Cytosol" "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 17.4 20.5 29.3 30.0 39.7 20.6 28.0 38.9 31.1 30.8 17.9 19.7 15.8 15.1 30.8 56.2 15.4 23.4 26.2 27.1 34.3 11.4 24.8 39.0 61.4 42.6 37.9 21.3 14.9 28.3 6.6 57.9 44.3 21.1 26.3 11.7 17.0 17.9 7.2 81.8 16.3 20.0 39.0 36.0 15.8 11.6 36.2 72.3 13.0 10.5 77.9 40.3 49.5 46.7 22.3 14.8 15.1 71.7 98.0 48.2 207.1 35.0 75.1 19.0 25.6 30.3 26.1 71.9 35.1 26.9 51.1 60.0 16.7 291.8 27.2 41.4 10.5 11.7 16.8 37.9 23.7 19.1 117.1 65.4 287.0 24.4 16.4 26.0 27.6 85.1 11.4 30.7 30.1 9.6 38.4 18.0 10.2 11.4 32.3 17.7 7.1 46.3 18.4 43.3 3.9 13.4 29.1 133.0 58.3 52.0 30.7 22.5 24.6 46.0 17.6 38.3 10.6 75.2 96.8 187.0 53.1 30.1 19.4 7.6 40.4 2.4 3.7 13.6 2.7 30.9 4.3 3.9 39.6 29.8 6.1 4.8 8.7 4.4 3.4 28.0 5.4 18.6 29.3 39.7 38.9 31.1 27.1 34.3 42.6 37.9 44.3 39.0 36.2 46.7 5.8 16.0 23.0 5.5 25.0 14.9 18.5 63.2 26.7 5.8 5.4 15.5 30.9 0.0 29.7 18.4 2.1 53.6 8.3 4.4 1.9 7.2 0.5 5.7 6.8 7.3 3.6 5.0 2.2 8.1 224.7 10.2 10.7 7.7 69.6 16.3 8.6 24.2 100.8 6.7 2.7 5.4 10.2 55.7 32.5 1.6 8.1 67.8 8.8 2.8 52.5 8.0 7.2 3.5 9.5 6.0 4.7 13.9 28.8 6.7 6.2 5.4 19.9 3.7 0.0 7.9 6.9 1.8 4.2 45.6 23.9 52.5 5.6 6.4 6.7 36.5 GNG2 ENSG00000186469 "G protein subunit gamma 2" P59768 14 51826195-51979342 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 113.4" "Cell type enhanced" "Detected in many" "dendritic cells: 251.8;Early spermatids: 714.4;Late spermatids: 1146.4;NK-cells: 246.1" "Cancer enhanced" "Detected in all" "glioma: 15.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 77.2;fHDF/TERT166: 140.2;MOLT-4: 112.5;SH-SY5Y: 89.2;WM-115: 249.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003534, CAB018380" Uncertain Supported Approved "Vesicles,Plasma membrane" NA NA 170000 "Cluster 46: Basophils - DNA binding" "Cluster 65: Brain - Ion transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Plasma membrane" Vesicles "CAB018380: AB_631547, HPA003534: AB_1079004" "unprognostic (6.11e-2)" "unprognostic (5.78e-3)" "unprognostic (2.06e-3)" "unprognostic (6.55e-2)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (5.72e-2)" "unprognostic (1.24e-1)" "prognostic favorable (1.64e-4)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.90e-6)" "unprognostic (9.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (3.59e-2)" 51.3 22.0 38.5 41.1 44.8 64.0 21.0 0.8 55.4 11.9 10.9 24.1 15.2 12.2 5.1 14.1 5.8 17.3 13.5 54.1 75.2 7.5 12.7 19.0 47.7 10.6 20.5 14.4 7.3 3.5 14.9 19.5 27.2 10.6 19.6 15.0 8.1 9.0 5.6 7.8 21.2 19.8 13.6 61.7 15.9 113.4 46.4 62.0 5.7 13.1 45.4 22.2 5.3 22.2 0.0 3.1 77.2 48.6 11.6 15.0 1.2 12.9 15.9 6.1 4.9 6.4 0.2 0.2 1.8 140.2 8.9 0.3 10.4 0.0 4.2 36.4 1.2 0.0 0.7 0.0 6.0 7.4 0.3 25.1 0.0 6.2 0.5 32.2 0.0 67.9 0.0 6.5 39.7 0.0 112.5 12.0 41.1 0.0 9.5 39.4 6.1 2.0 6.4 0.0 11.5 89.2 0.3 0.1 34.5 2.7 0.0 0.3 0.0 18.7 3.1 0.3 9.9 0.2 0.0 5.5 15.5 39.2 249.0 379.4 64.0 177.1 162.8 111.9 110.5 38.1 88.9 134.2 65.8 36.2 55.5 98.5 185.2 25.2 177.3 28.0 143.2 158.6 38.5 44.8 0.8 55.4 54.1 75.2 10.6 20.5 27.2 13.6 46.4 22.2 11.6 6.4 7.2 3.3 101.3 11.5 0.4 0.0 2.2 18.7 1.5 1.9 1.0 1.5 0.0 3.7 2.1 0.6 251.8 0.8 1.9 0.2 714.4 0.5 2.7 11.7 175.8 20.4 66.2 0.0 0.6 23.9 11.7 0.8 32.3 0.2 11.0 0.9 51.1 0.0 59.6 2.4 0.0 94.1 60.0 1146.4 9.9 84.0 55.2 24.4 33.3 0.7 246.1 96.0 3.2 0.5 0.1 6.0 62.7 0.2 0.1 0.9 0.0 2.2 39.5 10.2 12.2 11.2 4.6 1.3 6.7 0.7 191.5 2.2 0.5 0.2 GNPDA1 "GNPDA, GNPI, GPI, HLN, KIAA0060" ENSG00000113552 "Glucosamine-6-phosphate deaminase 1" P46926 5 141991749-142013041 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 127.2;Proximal tubular cells: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 382.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 930000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: AB_2679857" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (6.79e-2)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (8.89e-3)" "prognostic unfavorable (2.60e-6)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.09e-1)" "unprognostic (1.58e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "unprognostic (5.82e-2)" "unprognostic (9.66e-2)" "unprognostic (2.05e-3)" 18.8 38.4 26.9 17.3 28.8 8.1 20.9 26.2 35.2 26.7 27.7 19.7 29.5 28.7 51.9 13.6 18.4 22.3 17.3 28.1 30.8 76.4 16.6 17.6 22.7 27.0 27.7 31.8 11.3 27.9 20.5 22.2 29.3 22.2 21.9 17.7 14.6 28.3 26.4 14.8 22.5 29.2 27.0 30.9 14.5 18.8 29.7 24.9 27.8 25.7 19.8 33.3 17.1 30.7 42.6 61.0 23.2 115.8 77.1 51.9 54.6 32.6 78.7 84.7 95.8 91.3 49.2 0.2 72.9 23.6 382.3 44.0 109.9 98.0 74.8 32.9 46.5 31.3 33.1 65.5 137.2 86.4 39.2 63.5 56.9 54.5 144.8 63.2 91.6 80.6 37.3 110.1 93.0 27.2 66.8 9.8 88.0 62.8 121.4 25.5 76.3 94.3 81.8 114.8 20.6 54.0 65.0 67.8 127.9 67.5 54.6 26.5 43.3 50.9 33.3 76.9 47.5 61.2 126.9 47.1 74.2 29.3 45.0 0.3 48.6 7.1 37.2 59.1 77.9 19.4 30.0 34.2 51.7 11.1 35.3 38.8 12.7 15.8 56.3 29.6 27.6 40.2 26.9 28.8 26.2 35.2 28.1 30.8 27.0 27.7 29.3 27.0 29.7 30.7 10.5 9.6 14.9 10.7 8.2 6.0 40.8 20.9 21.1 11.6 12.6 17.8 12.6 12.8 20.1 18.4 8.4 26.7 11.1 6.9 35.2 29.3 1.1 5.8 19.8 14.6 15.0 9.9 11.5 14.2 48.6 22.8 7.7 9.6 12.0 30.8 15.4 7.4 127.2 6.7 12.7 6.2 12.2 60.2 10.7 3.6 19.9 48.5 14.2 12.2 23.5 40.5 15.5 7.1 11.5 21.6 7.1 26.7 7.8 32.9 19.4 102.3 8.0 7.9 0.0 10.4 11.7 10.4 17.0 17.6 7.4 29.7 16.6 64.8 9.1 34.7 GNPDA2 SB52 ENSG00000163281 "Glucosamine-6-phosphate deaminase 2" Q8TDQ7 4 44682200-44726588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 820000 "Cluster 44: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: AB_2679857" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (3.29e-1)" "unprognostic (1.55e-3)" "unprognostic (1.02e-1)" "unprognostic (1.33e-1)" "unprognostic (9.57e-2)" "unprognostic (9.75e-3)" "unprognostic (1.03e-1)" "unprognostic (1.28e-3)" "unprognostic (4.18e-2)" "unprognostic (6.86e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" 13.1 12.6 9.6 9.8 10.8 8.4 14.5 21.9 13.3 13.9 7.5 12.3 7.9 16.6 14.0 10.1 12.6 10.5 17.5 10.8 9.9 13.8 4.0 10.0 12.6 9.5 9.8 22.6 8.2 13.0 12.8 6.7 9.9 14.7 8.2 18.5 9.2 15.2 11.3 9.7 8.5 16.5 10.4 11.8 9.1 11.6 9.8 13.2 18.1 10.1 10.5 12.0 10.0 12.5 15.7 10.9 11.4 9.7 17.8 24.7 3.9 27.1 30.3 17.9 16.7 5.6 19.1 13.6 15.5 23.4 29.8 5.3 10.6 26.3 19.7 18.4 11.9 19.3 16.6 9.2 18.8 20.8 17.7 28.5 18.1 17.9 13.1 22.6 26.5 18.1 12.2 17.9 33.6 0.7 25.2 11.6 5.5 10.4 19.5 16.3 24.3 8.0 17.3 9.5 19.5 15.8 12.1 7.0 27.2 5.4 14.9 12.1 25.9 23.7 22.6 38.5 31.6 23.0 38.7 19.7 38.6 14.3 21.3 9.3 2.4 5.0 9.7 3.6 11.2 12.2 9.0 9.3 3.7 10.5 11.2 10.8 1.1 9.8 4.9 2.8 10.7 4.7 9.6 10.8 21.9 13.3 10.8 9.9 9.5 9.8 9.9 10.4 9.8 12.5 18.4 9.6 4.6 17.0 19.8 12.5 8.9 18.6 8.0 15.6 9.2 8.1 14.1 2.8 9.4 14.7 8.4 1.2 15.7 3.0 15.6 13.3 30.3 7.9 21.9 14.4 6.7 6.5 29.1 15.1 1.1 22.0 7.1 8.5 15.8 8.5 11.4 1.6 4.8 13.5 29.2 4.4 18.3 3.7 8.7 5.0 16.1 4.2 8.8 8.4 4.3 19.8 13.4 31.2 20.4 14.2 2.9 23.7 6.3 5.2 2.9 13.2 8.0 18.2 13.1 14.3 20.0 34.4 29.9 5.7 10.7 0.5 13.7 20.0 4.4 5.2 GOLPH3 "GOPP1, GPP34, MIDAS, Vps74" ENSG00000113384 "Golgi phosphoprotein 3" Q9H4A6 5 32124716-32174319 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044564, HPA055841" Approved Supported "Golgi apparatus,Vesicles" NA NA 23000 "Cluster 26: Non-specific - Mitochondria" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 28: BEWO - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus, Vesicles" "HPA044564: AB_10795169, HPA055841: AB_2682940" "unprognostic (1.64e-2)" "unprognostic (1.66e-1)" "unprognostic (9.27e-2)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-2)" "unprognostic (1.89e-2)" "unprognostic (8.19e-2)" "unprognostic (2.95e-2)" "unprognostic (7.48e-2)" "unprognostic (2.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (1.11e-1)" "unprognostic (1.52e-2)" 50.1 38.3 28.5 41.9 29.2 20.8 50.0 29.8 34.5 56.2 32.9 76.6 46.3 41.6 58.7 43.1 41.0 77.7 38.4 26.5 29.6 61.5 110.1 50.7 49.2 30.2 29.5 51.5 62.6 54.9 29.8 68.4 29.9 75.3 60.2 19.8 64.8 50.4 37.3 32.8 49.3 52.3 29.1 39.5 52.9 27.0 29.7 43.9 48.0 57.0 52.4 60.5 41.3 32.3 57.7 37.9 59.9 65.5 111.3 106.1 171.6 77.8 103.3 71.5 67.7 51.9 101.3 51.7 75.0 105.7 69.3 52.8 75.1 54.9 89.7 67.7 44.9 56.9 119.9 99.4 89.4 88.8 64.0 81.3 77.1 70.3 80.1 65.8 57.9 33.6 60.5 121.8 80.4 58.0 57.1 115.3 51.8 78.0 38.5 52.8 86.4 53.8 89.9 72.1 45.6 51.0 180.8 186.9 79.4 75.6 76.4 97.1 56.5 62.7 58.5 49.7 55.6 136.1 179.3 62.5 56.3 125.8 76.4 6.8 8.0 19.2 7.8 10.6 6.8 11.5 8.4 10.1 8.9 16.0 9.9 7.2 7.9 8.5 10.5 6.9 13.2 4.2 28.5 29.2 29.8 34.5 26.5 29.6 30.2 29.5 29.9 29.1 29.7 32.3 33.9 60.9 49.2 26.8 53.3 70.0 44.5 30.0 51.2 13.5 59.6 30.7 31.7 88.6 42.8 44.1 10.4 67.3 52.0 72.6 52.8 58.0 5.2 46.3 35.8 46.2 52.0 50.5 47.9 44.1 111.6 51.7 57.6 71.3 14.5 16.8 59.3 153.6 54.4 13.5 45.8 86.3 40.7 63.7 56.2 16.1 50.7 49.1 44.4 43.1 48.7 20.2 36.0 53.8 60.1 49.7 35.1 57.2 120.0 83.9 59.8 59.8 49.1 10.0 39.5 30.8 52.1 15.4 25.1 68.2 73.6 110.0 45.6 50.4 50.2 80.7 GOLT1B "CGI-141, GOT1, YMR292W" ENSG00000111711 "Golgi transport 1B" Q9Y3E0 12 21501781-21518408 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055909, HPA066383" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 5: NTERA-2 - Transcription" "Cluster 55: Plasma cells - Humoral immune response" Vesicles Nucleoplasm "HPA055909: AB_2682967, HPA066383: AB_2685667" "unprognostic (1.22e-2)" "unprognostic (3.07e-3)" "unprognostic (1.84e-1)" "unprognostic (3.65e-1)" "unprognostic (3.45e-1)" "unprognostic (5.37e-3)" "prognostic unfavorable (1.99e-8)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.83e-10)" "unprognostic (3.13e-1)" "unprognostic (2.14e-1)" "unprognostic (6.78e-2)" "unprognostic (1.04e-1)" 17.5 22.1 12.7 16.9 14.1 25.8 18.5 13.4 18.9 18.0 12.7 13.4 10.6 14.6 15.6 13.6 12.5 13.9 14.8 13.9 15.1 15.5 18.8 17.6 15.0 13.2 14.6 10.9 21.6 11.9 19.0 29.0 13.8 16.1 14.8 14.1 16.1 13.2 15.5 12.9 11.3 17.7 13.9 12.4 14.2 10.6 14.7 11.2 15.9 11.8 14.1 17.8 12.2 16.3 31.2 30.0 28.5 36.5 56.5 83.2 46.1 126.5 48.2 40.4 63.3 45.4 48.1 19.4 29.8 66.6 71.0 30.1 23.4 27.2 69.5 29.4 22.8 29.7 19.6 32.8 61.0 37.0 36.8 44.2 50.1 44.9 85.6 67.7 35.8 24.4 18.6 21.1 59.2 30.7 17.3 62.1 75.7 27.8 23.5 14.0 65.0 39.4 32.2 18.7 7.2 23.1 49.0 20.6 70.4 90.2 28.2 39.4 40.6 46.5 49.5 57.1 67.2 20.3 45.9 51.8 63.6 35.5 64.2 48.0 26.6 20.8 22.1 31.4 26.6 22.7 25.8 24.4 27.0 25.9 23.3 23.8 7.2 21.6 29.4 29.4 28.0 27.6 12.7 14.1 13.4 18.9 13.9 15.1 13.2 14.6 13.8 13.9 14.7 16.3 23.4 9.6 15.6 15.0 38.9 46.7 23.4 42.7 27.3 27.6 20.4 11.2 18.9 22.8 36.8 16.5 10.4 29.0 34.9 13.8 27.4 31.6 3.4 10.9 26.3 28.7 13.1 22.9 70.4 33.4 72.4 45.7 15.3 21.7 21.5 10.3 16.8 23.2 41.0 18.5 49.3 31.7 38.7 23.6 65.1 5.2 17.4 35.4 53.4 14.0 26.0 17.5 18.6 25.1 25.4 38.6 15.4 19.9 75.8 49.0 8.7 21.7 18.2 7.7 13.1 24.6 39.3 23.7 32.4 22.8 63.9 64.0 39.1 9.6 14.6 44.9 GPC6 ENSG00000183098 "Glypican 6" Q9Y625 13 93226807-94408020 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 163.2;Excitatory neurons: 333.6;Inhibitory neurons: 496.1;Oligodendrocyte precursor cells: 691.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 62.5;HSkMC: 70.8;hTERT-RPE1: 64.3;SuSa: 39.5;U-87 MG: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA017671 Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 420000 "Cluster 48: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA017671: AB_1849833" "unprognostic (5.24e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" "unprognostic (9.76e-2)" "unprognostic (1.72e-1)" "unprognostic (5.50e-2)" "unprognostic (1.28e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.33e-2)" "unprognostic (3.71e-2)" "unprognostic (2.53e-3)" "unprognostic (6.21e-3)" "unprognostic (7.42e-2)" "unprognostic (3.36e-1)" "unprognostic (3.35e-3)" 9.1 2.2 0.8 8.9 1.9 0.1 2.2 1.7 1.5 3.6 1.1 6.3 2.3 2.4 2.4 5.2 4.1 17.0 6.2 1.3 3.1 7.7 17.7 3.5 0.4 1.7 2.4 7.3 1.6 1.8 2.9 1.3 2.3 6.2 6.5 5.6 3.1 15.1 0.6 1.1 4.3 7.8 2.0 2.2 5.4 2.0 1.9 1.7 1.7 1.9 0.9 11.6 2.4 2.1 0.0 4.7 10.2 4.5 62.5 19.5 0.0 7.2 0.0 4.9 6.4 0.0 0.0 0.2 0.0 16.0 0.0 0.0 5.7 1.2 9.1 0.0 4.1 0.0 0.1 20.2 37.8 0.1 0.1 70.8 0.5 11.7 8.1 64.3 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.1 6.4 0.0 3.4 0.0 1.6 0.1 5.5 0.0 4.1 16.8 0.0 1.9 0.0 39.5 14.0 0.0 0.0 26.9 22.6 25.4 12.3 15.9 0.1 0.0 52.8 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 1.9 1.7 1.5 1.3 3.1 1.7 2.4 2.3 2.0 1.9 2.1 0.6 0.0 0.5 163.2 0.0 0.6 0.5 0.5 0.6 50.3 0.6 1.9 1.7 4.3 0.7 7.3 10.4 0.2 0.0 0.1 0.0 0.3 6.7 1.6 25.9 1.1 0.0 0.0 333.6 0.0 0.1 31.2 0.0 3.1 0.0 36.0 5.7 41.2 0.5 0.0 496.1 0.1 2.0 1.3 1.0 5.0 4.7 0.5 1.8 31.9 0.0 2.7 0.0 691.6 13.2 0.1 0.0 1.9 0.1 1.6 0.0 14.5 0.0 115.0 0.0 34.4 20.9 4.2 2.7 0.5 0.4 0.1 0.7 11.9 0.1 0.2 GPHN KIAA1385 ENSG00000171723 Gephyrin Q9NQX3 14 66507407-67181803 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" "Multifunctional enzyme, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.4" "Group enriched" "Detected in many" 4 "Astrocytes: 493.0;Excitatory neurons: 686.5;Inhibitory neurons: 866.7;Oligodendrocyte precursor cells: 576.1;Oligodendrocytes: 597.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003116, CAB004419, HPA024694" Enhanced Approved Vesicles,Cytosol NA NA 6900 "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Cytosol "CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616" "unprognostic (8.37e-2)" "unprognostic (2.53e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-1)" "unprognostic (5.14e-2)" "unprognostic (4.89e-3)" "unprognostic (8.29e-2)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (2.23e-1)" "unprognostic (2.49e-2)" "unprognostic (8.54e-2)" "prognostic favorable (5.25e-12)" "unprognostic (9.81e-2)" "unprognostic (2.27e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (4.61e-5)" 13.8 11.1 35.5 3.5 36.0 2.6 13.4 48.4 54.1 9.7 20.9 11.8 7.4 9.9 11.6 12.2 11.1 6.2 17.1 36.1 37.6 25.3 62.4 9.3 3.8 32.7 35.3 8.9 23.9 11.7 13.6 3.6 32.3 11.3 10.1 23.1 9.4 6.6 24.5 15.2 9.0 6.2 32.4 6.7 14.7 6.2 34.6 5.8 11.9 13.8 4.3 11.4 10.7 39.5 39.9 8.8 13.7 15.9 14.2 17.5 9.5 11.1 5.7 12.7 12.2 2.8 17.9 0.0 1.8 7.7 5.5 13.1 17.0 19.9 18.9 15.0 14.9 15.8 9.4 22.3 7.8 9.1 15.8 13.3 13.8 2.9 16.0 4.8 11.8 13.8 9.3 14.2 7.1 19.2 11.9 22.2 5.0 28.3 17.0 0.0 32.5 13.2 16.7 7.5 25.8 10.3 10.2 31.6 12.4 3.3 18.5 11.5 6.7 14.1 24.8 11.3 13.0 22.8 9.1 0.3 10.5 0.8 11.2 0.0 0.7 0.3 2.0 1.2 3.2 1.2 2.5 1.7 1.1 1.9 1.7 1.6 0.0 1.3 1.0 1.5 3.0 0.7 35.5 36.0 48.4 54.1 36.1 37.6 32.7 35.3 32.3 32.4 34.6 39.5 11.5 6.4 13.1 493.0 11.8 4.7 9.2 5.8 27.9 34.3 12.4 6.7 12.7 8.6 10.8 1.8 52.1 3.9 3.5 8.6 13.7 4.0 3.8 7.2 13.5 10.7 6.0 7.6 686.5 5.3 2.3 8.7 19.9 13.6 0.0 3.9 15.7 47.6 3.7 43.7 866.7 15.0 8.2 5.8 1.7 5.0 11.1 4.5 1.8 148.0 1.3 8.9 1.0 576.1 597.5 3.1 7.8 5.7 15.1 11.5 7.1 20.1 2.4 34.9 0.0 12.5 11.8 11.8 8.9 26.7 5.8 2.1 7.9 9.0 10.4 6.5 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favorable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 29.9 45.2 26.9 18.8 29.3 26.2 32.7 29.7 27.2 36.8 29.9 39.9 32.9 31.6 31.6 39.6 40.1 32.2 22.5 24.2 29.4 42.1 34.4 32.4 23.2 28.9 28.1 34.5 46.7 49.0 23.2 22.2 27.5 34.4 28.1 27.8 57.5 40.2 18.4 31.2 36.6 26.3 27.7 33.3 35.8 25.5 29.1 23.5 41.3 20.5 27.8 31.0 32.9 27.8 33.5 35.9 21.7 42.6 83.0 44.8 24.4 25.6 77.0 34.7 36.7 22.2 37.5 15.8 46.4 52.4 41.6 28.1 24.7 53.3 17.8 64.1 28.4 25.7 37.7 29.6 81.3 16.7 33.7 48.7 100.2 33.5 67.2 45.9 41.3 37.9 26.4 102.7 35.6 23.3 29.5 24.0 15.6 60.2 31.5 23.7 24.7 61.0 72.7 32.6 0.2 23.4 25.9 41.8 38.7 18.4 39.9 40.0 34.4 19.7 12.5 63.2 27.6 66.2 39.3 11.4 68.0 52.9 21.7 79.3 116.1 123.0 82.6 109.7 75.2 48.2 65.2 70.4 84.6 49.9 45.9 52.8 178.4 80.9 130.5 30.0 81.2 132.7 26.9 29.3 29.7 27.2 24.2 29.4 28.9 28.1 27.5 27.7 29.1 27.8 40.8 9.6 14.5 12.7 26.3 26.5 43.7 107.4 21.1 28.3 42.7 33.0 8.0 45.8 59.7 36.8 22.9 58.7 31.1 76.4 37.2 87.7 38.0 30.8 23.6 32.7 21.7 6.9 5.4 110.1 37.2 27.4 39.3 44.1 26.0 15.0 40.7 26.7 57.1 21.9 6.0 57.6 81.4 30.3 46.7 94.9 23.6 42.4 30.2 5.6 50.3 46.0 42.2 7.5 9.6 83.3 83.7 18.4 27.8 29.1 121.2 55.0 39.8 43.0 39.5 22.2 26.4 34.3 19.9 27.2 31.8 58.6 38.9 28.3 47.1 36.1 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12891559-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 201.9;urinary bladder: 130.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 939.1;Club cells: 357.8;Distal enterocytes: 477.9;Pancreatic endocrine cells: 600.7;Paneth cells: 359.8;Urothelial cells: 1252.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 355.6;A549: 285.7;CAPAN-2: 1347.4;HaCaT: 351.2;SiHa: 492.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: AB_2679685" "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavorable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 31.5 3.7 1.2 11.5 0.9 1.8 9.6 1.0 1.4 35.4 3.4 56.4 18.7 8.9 0.4 23.0 9.8 24.9 18.9 1.8 0.8 9.0 1.8 201.9 0.2 2.7 4.5 21.4 2.7 0.9 2.5 13.5 1.0 10.2 48.4 1.6 23.5 1.3 0.7 5.8 20.9 5.1 0.5 0.4 33.6 1.5 2.1 0.3 55.5 0.6 4.4 130.8 30.6 1.8 355.6 285.7 0.1 1.3 3.4 1.5 18.4 105.2 39.5 66.2 49.4 49.1 1347.4 0.1 8.6 83.3 67.2 351.2 1.0 50.1 101.7 0.4 4.3 0.2 105.4 2.2 23.8 0.1 0.3 1.8 66.5 27.5 6.7 82.3 40.9 0.0 0.5 0.3 2.9 251.7 0.2 0.3 1.6 130.0 43.5 0.2 6.7 0.3 133.6 69.6 0.5 0.6 492.0 36.8 15.9 52.3 10.9 1.0 4.0 2.6 83.9 156.1 4.3 0.2 0.3 0.3 34.6 0.3 2.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.2 0.9 1.0 1.4 1.8 0.8 2.7 4.5 1.0 0.5 2.1 1.8 10.0 939.1 200.2 0.0 1.0 12.5 329.6 202.8 4.6 0.1 80.6 41.7 1.9 11.5 357.8 46.0 0.0 3.8 1.5 477.9 0.0 46.9 0.1 91.8 54.1 15.8 8.3 0.0 0.2 72.1 11.7 108.5 176.9 288.1 10.1 0.2 8.6 0.2 1.6 0.0 0.4 43.5 61.1 0.3 18.0 0.4 13.4 9.6 51.6 0.0 0.6 3.5 0.0 0.0 0.1 600.7 359.8 10.1 0.5 320.1 114.0 0.2 86.3 0.4 0.0 23.0 38.8 1.5 0.3 22.7 9.1 1.1 4.9 0.7 110.4 1252.7 GPRIN1 "GRIN1, KIAA1893" ENSG00000169258 "G protein regulated inducer of neurite outgrowth 1" Q7Z2K8 5 176595802-176610156 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.1;pituitary gland: 8.1;retina: 6.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 12.8;Excitatory neurons: 7.5;Horizontal cells: 21.9;Inhibitory neurons: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 56.5;SCLC-21H: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036478, HPA070892" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 44: HDLM-2 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" Vesicles "HPA036478: AB_2675145, HPA070892: AB_2686321" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.41e-2)" "unprognostic (5.66e-2)" "unprognostic (6.54e-3)" "unprognostic (3.06e-1)" "unprognostic (4.76e-6)" "prognostic unfavorable (6.83e-6)" "unprognostic (1.11e-1)" "unprognostic (1.45e-1)" "unprognostic (2.59e-3)" "unprognostic (1.56e-3)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.24e-3)" "unprognostic (5.60e-2)" "unprognostic (2.21e-1)" "unprognostic (3.32e-3)" 0.5 1.6 16.9 0.8 15.9 0.2 0.3 6.8 19.5 0.3 0.0 1.1 3.8 0.4 0.0 0.8 0.1 0.3 0.4 22.1 15.7 0.6 0.4 0.4 0.8 4.3 3.5 0.0 0.6 0.1 8.1 0.3 5.1 0.2 0.4 6.9 0.3 0.0 0.3 1.0 3.2 0.7 3.3 0.4 0.8 1.5 14.8 0.9 0.2 0.2 1.1 0.3 0.2 6.6 7.5 7.9 9.8 14.1 2.1 4.6 8.3 9.8 5.1 7.5 9.7 9.6 4.8 17.0 19.6 5.3 22.0 6.5 6.3 6.8 6.5 56.5 4.3 0.3 4.1 3.4 0.9 0.4 4.2 2.3 5.1 8.1 1.2 1.5 5.5 3.8 9.1 24.0 6.3 19.7 1.8 0.0 9.9 5.0 15.4 31.7 10.9 10.1 8.4 7.7 59.5 34.1 11.4 3.2 17.7 1.2 7.4 6.5 6.8 13.8 16.0 5.3 14.5 0.4 2.3 4.8 11.9 0.8 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 15.9 6.8 19.5 22.1 15.7 4.3 3.5 5.1 3.3 14.8 6.6 0.4 0.0 0.0 0.3 0.5 2.4 0.1 0.3 0.6 12.8 0.4 0.3 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.3 1.9 0.4 0.0 0.5 0.6 1.0 1.8 0.0 7.5 1.8 0.9 0.4 0.0 1.2 0.0 0.3 0.0 0.0 0.9 21.9 8.0 0.3 0.0 0.0 0.3 0.0 0.3 0.2 0.0 1.9 0.1 1.1 1.0 2.5 0.3 1.6 0.1 0.0 0.8 0.2 0.0 0.3 0.4 3.1 0.0 1.5 0.3 0.7 2.7 0.4 1.4 0.1 0.3 0.4 0.2 0.1 GRHL1 "LBP-32, MGR, TFCP2L2" ENSG00000134317 "Grainyhead like transcription factor 1" Q9NZI5 2 9951693-10002277 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 119.6;skin 1: 87.7;vagina: 66.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Cytotrophoblasts: 61.9;Extravillous trophoblasts: 80.5;Suprabasal keratinocytes: 132.7;Syncytiotrophoblasts: 184.6;Urothelial cells: 104.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "eosinophil: 2.2" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "BEWO: 212.3;RT4: 41.4;SK-BR-3: 112.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005798, HPA006420" Enhanced Supported Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Vesicles "HPA005798: AB_1079026, HPA006420: AB_1079025" "unprognostic (2.26e-3)" "unprognostic (5.80e-2)" "unprognostic (8.35e-2)" "unprognostic (7.33e-3)" "unprognostic (2.70e-1)" "unprognostic (2.76e-2)" "unprognostic (4.43e-3)" "unprognostic (6.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-4)" "unprognostic (3.66e-1)" "unprognostic (3.40e-1)" "unprognostic (4.04e-2)" "unprognostic (2.14e-1)" 4.5 1.3 2.2 1.2 2.3 8.7 39.8 0.8 2.8 31.0 1.0 1.5 1.2 1.0 7.3 119.6 2.2 3.0 2.5 2.7 2.5 4.0 12.2 5.0 1.0 0.8 1.5 0.4 4.2 29.0 3.6 26.7 0.9 11.4 1.0 11.4 44.7 7.3 1.1 87.7 0.7 0.7 0.6 0.8 3.7 3.2 4.3 0.9 2.9 0.4 26.1 13.9 66.9 1.7 10.9 0.2 1.2 3.0 0.4 0.5 212.3 1.0 1.5 0.7 1.2 0.9 7.5 1.4 0.4 0.1 1.5 6.5 13.0 1.4 3.1 3.2 5.9 0.3 2.3 4.3 0.3 0.7 1.2 0.4 5.5 6.0 0.0 0.0 1.1 2.3 2.2 4.1 0.0 14.3 2.2 1.7 0.8 3.5 2.5 0.9 1.0 1.9 1.4 41.4 2.4 1.6 2.0 112.3 2.7 17.4 13.7 0.4 1.2 0.6 2.6 3.3 1.3 2.7 1.7 1.5 0.6 1.7 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.2 1.7 2.2 2.3 0.8 2.8 2.7 2.5 0.8 1.5 0.9 0.6 4.3 1.7 2.2 3.2 8.1 3.9 1.2 40.0 23.1 10.7 2.8 25.5 37.1 19.9 2.1 1.5 31.1 20.2 62.6 61.9 1.3 1.2 0.0 2.9 6.4 4.5 1.3 4.2 3.5 0.0 14.6 9.1 80.5 5.4 3.1 9.6 10.2 0.4 2.5 7.7 7.7 11.8 6.0 0.8 4.1 1.0 15.7 3.0 0.0 10.6 21.4 1.9 1.0 1.1 0.0 4.0 1.0 5.7 0.1 0.4 1.0 31.5 0.1 2.4 18.6 11.5 0.0 3.0 3.7 9.6 5.1 35.2 132.7 184.6 2.1 0.1 1.2 104.6 GRIK1 "GluK1, GLUR5" ENSG00000171189 "Glutamate ionotropic receptor kainate type subunit 1" P39086 21 29536933-29940033 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "adrenal gland: 12.5;brain: 32.6;retina: 38.2" "Group enriched" "Detected in some" 10 "Inhibitory neurons: 2260.1;Oligodendrocyte precursor cells: 862.5" "Cancer enriched" "Detected in some" 5 "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014623, HPA073879" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" Vesicles "HPA014623: AB_1850305, HPA073879: " "unprognostic (1.39e-1)" "unprognostic (6.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.04e-2)" "unprognostic (1.03e-3)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.12e-3)" "unprognostic (1.25e-1)" "unprognostic (8.77e-2)" "unprognostic (4.89e-3)" "unprognostic (1.20e-3)" "unprognostic (1.47e-8)" "unprognostic (2.09e-1)" "unprognostic (2.68e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-3)" 0.2 12.5 7.5 0.2 6.6 0.1 1.8 2.4 6.0 0.8 0.0 0.3 0.0 0.1 2.0 0.3 0.0 0.1 0.0 8.4 12.3 0.0 0.1 0.1 0.1 30.0 11.2 0.3 0.0 0.0 0.2 0.4 32.6 2.4 0.5 38.2 0.0 0.1 0.1 0.8 0.4 0.1 2.6 0.1 0.2 0.5 9.7 0.0 0.0 0.0 0.0 0.4 0.4 2.9 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.5 6.6 2.4 6.0 8.4 12.3 30.0 11.2 32.6 2.6 9.7 2.9 0.1 0.0 0.0 27.4 0.0 0.3 0.0 0.0 0.0 149.8 2.3 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.1 1.2 0.4 0.0 0.0 29.8 0.0 0.0 0.7 0.0 0.2 0.0 148.8 0.0 0.0 0.1 1.7 2260.1 0.0 0.0 0.0 0.4 13.2 0.3 0.2 3.6 10.3 0.0 2.5 0.0 862.5 8.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.9 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.1 33.8 0.1 0.0 GRIPAP1 "DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3" ENSG00000068400 "GRIP1 associated protein 1" Q4V328 X 48973720-49002264 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 212.7;Rod photoreceptor cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000282, HPA000615" Approved Approved Vesicles,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 58: Brain - Synaptic function" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "Vesicles, Cytosol" "HPA000282: AB_1079022, HPA000615: AB_1079023" "unprognostic (3.34e-1)" "unprognostic (2.86e-3)" "unprognostic (3.24e-3)" "unprognostic (3.93e-3)" "unprognostic (2.68e-1)" "unprognostic (1.23e-1)" "unprognostic (3.97e-3)" "unprognostic (1.01e-2)" "unprognostic (5.26e-2)" "unprognostic (3.65e-1)" "unprognostic (1.69e-3)" "unprognostic (1.06e-2)" "prognostic unfavorable (3.92e-7)" "unprognostic (4.24e-3)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "prognostic favorable (4.63e-7)" 17.2 23.8 30.6 23.6 31.7 35.3 16.6 28.0 35.5 19.6 19.6 19.3 19.0 17.5 24.7 19.3 19.3 13.3 15.3 31.4 30.4 20.6 22.0 21.3 25.4 29.2 29.6 19.9 15.4 22.9 33.6 15.6 29.9 19.0 15.4 48.1 16.7 15.5 18.4 24.4 21.9 14.7 23.1 28.1 19.4 19.7 30.1 26.1 20.9 12.9 24.1 18.0 17.5 32.2 27.9 43.6 30.7 64.3 18.1 13.8 27.7 22.4 27.6 28.3 26.7 23.7 24.0 42.1 12.6 22.3 30.4 39.0 38.5 24.5 22.6 49.3 19.7 34.0 59.8 25.2 31.1 36.7 58.3 14.4 34.5 37.7 27.8 26.2 26.1 35.6 25.2 54.3 26.3 51.5 32.2 49.3 36.3 19.8 23.5 35.3 46.1 33.8 28.0 34.1 27.0 30.0 47.6 18.8 28.4 44.4 42.6 72.5 31.3 14.9 23.2 30.7 18.5 33.0 27.6 29.6 25.9 54.9 25.9 32.5 14.6 21.3 10.1 13.3 8.6 11.3 10.4 9.7 12.0 13.6 8.9 9.5 25.9 15.7 13.0 12.4 9.0 9.5 30.6 31.7 28.0 35.5 31.4 30.4 29.2 29.6 29.9 23.1 30.1 32.2 22.6 9.6 25.1 13.7 28.6 8.2 15.5 25.2 10.8 67.6 11.6 9.1 13.9 22.8 26.7 18.4 212.7 21.2 30.1 25.8 29.4 15.5 9.3 23.8 19.3 21.2 21.7 17.2 32.1 18.4 9.9 14.4 26.0 26.3 43.1 31.2 18.5 18.5 17.2 69.0 32.9 22.4 34.6 27.0 18.7 14.4 17.1 28.5 7.2 10.3 32.7 25.3 33.0 18.1 17.7 18.4 30.6 19.2 22.2 16.9 23.9 19.1 25.5 169.4 19.7 16.9 17.8 11.5 10.1 16.6 14.2 26.1 25.1 35.8 16.5 19.5 GSPT1 "eRF3a, ETF3A, GST1" ENSG00000103342 "G1 to S phase transition 1" P15170 16 11868128-11916082 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052488, HPA074588" Approved Approved Vesicles,Cytosol NA NA 210000 "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol Vesicles "HPA052488: AB_2681849, HPA074588: " "unprognostic (4.13e-2)" "unprognostic (1.66e-1)" "prognostic favorable (2.10e-5)" "unprognostic (1.64e-1)" "unprognostic (2.05e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (7.94e-4)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "unprognostic (1.74e-1)" "unprognostic (1.41e-3)" "unprognostic (1.65e-1)" "prognostic favorable (3.06e-5)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-3)" "unprognostic (3.13e-2)" 60.8 57.5 22.3 49.5 24.7 76.3 46.0 24.4 33.3 42.0 27.4 56.0 33.8 34.5 46.6 67.9 30.1 35.2 53.4 23.9 24.5 53.6 76.3 47.7 55.4 25.0 23.1 33.3 62.2 62.7 27.5 50.0 26.2 47.8 59.6 35.3 41.0 41.8 127.0 43.5 34.3 46.9 25.0 40.2 49.8 68.7 23.1 56.3 57.7 97.8 82.0 85.7 39.6 29.3 220.1 212.9 116.1 161.0 164.2 169.3 167.5 238.0 245.9 187.1 185.4 153.1 197.8 295.7 303.9 207.5 130.1 164.3 297.8 220.3 312.9 142.4 153.6 202.0 163.1 325.5 137.9 258.7 103.5 133.5 170.0 212.0 288.3 122.4 210.4 146.2 331.7 148.7 220.0 211.2 219.8 134.0 232.9 163.0 120.1 256.4 200.5 345.6 184.7 189.3 186.4 99.6 342.0 256.3 144.2 164.3 222.4 122.6 163.3 206.8 129.5 151.5 190.3 146.6 233.2 253.8 145.4 258.1 128.5 1.4 5.8 7.7 6.3 11.1 8.8 7.9 8.1 7.7 7.0 6.5 8.2 8.1 1.9 7.2 9.9 3.8 10.5 4.3 22.3 24.7 24.4 33.3 23.9 24.5 25.0 23.1 26.2 25.0 23.1 29.3 69.4 76.9 160.2 39.5 92.3 242.2 232.0 47.1 170.8 47.7 95.0 61.6 123.4 57.2 69.1 86.5 50.1 76.1 94.5 88.1 103.7 58.9 94.9 109.0 95.6 74.4 66.6 328.5 61.6 63.4 118.3 77.2 81.1 153.9 24.7 93.2 43.5 77.9 75.2 52.2 47.0 107.2 32.6 60.8 116.3 51.6 47.8 80.9 64.0 35.6 50.1 43.6 25.7 38.7 42.9 73.0 66.9 47.4 166.2 271.0 38.3 120.3 52.7 41.5 59.2 94.6 123.0 138.3 83.5 198.5 257.7 102.1 132.1 128.1 114.1 270.4 GSTM2 GST4 ENSG00000213366 "Glutathione S-transferase mu 2" P28161 1 109668022-109709551 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 61.0;Plasma cells: 28.4;Squamous epithelial cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 116.0;HSkMC: 115.6" "Low region specificity" "Detected in all" "CAB040547, HPA055972, HPA055973" Approved Supported Vesicles,Cytosol NA NA 1200000 "Cluster 26: Non-specific - Mitochondria" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" Cytosol Vesicles "CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (2.51e-3)" "unprognostic (1.28e-1)" "unprognostic (2.04e-2)" "unprognostic (2.57e-2)" "unprognostic (2.20e-1)" "unprognostic (5.04e-2)" "unprognostic (7.31e-2)" "prognostic favorable (9.70e-5)" "unprognostic (1.51e-2)" "unprognostic (7.43e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-1)" "unprognostic (1.48e-3)" "unprognostic (1.07e-2)" "unprognostic (1.87e-1)" "unprognostic (2.32e-1)" "unprognostic (2.14e-1)" 73.7 84.4 92.3 11.9 109.9 10.7 81.2 86.7 104.6 165.9 111.5 115.2 26.3 70.6 43.7 61.6 102.7 22.0 99.7 93.5 104.7 86.8 35.6 45.2 14.3 94.3 97.1 240.9 54.5 53.6 113.7 9.3 91.9 159.0 17.7 25.1 55.2 80.7 218.4 88.2 65.5 34.2 93.9 52.6 88.3 41.9 105.2 15.9 97.9 108.4 12.6 108.3 144.5 90.6 0.0 3.5 37.8 38.9 44.0 116.0 7.2 24.5 42.6 22.1 28.0 6.7 0.0 0.7 25.5 61.1 18.0 0.2 3.1 0.2 28.6 1.5 0.8 14.0 0.4 9.3 29.6 1.1 25.2 115.6 1.0 32.7 0.0 58.5 16.1 11.6 4.2 0.7 48.5 0.3 19.5 24.6 6.7 0.7 32.4 23.8 0.1 0.2 6.6 0.5 8.1 18.7 0.0 1.0 13.0 21.7 38.6 7.0 0.2 24.3 1.2 35.3 1.9 11.9 19.0 1.3 36.7 0.5 0.3 1.8 3.8 29.6 3.1 6.3 3.1 8.8 8.8 3.4 23.0 6.2 34.4 15.1 2.2 18.0 4.1 29.8 9.4 10.8 92.3 109.9 86.7 104.6 93.5 104.7 94.3 97.1 91.9 93.9 105.2 90.6 2.0 0.0 4.8 16.0 4.5 4.8 2.4 0.9 20.5 1.5 4.5 4.3 61.0 2.8 11.5 3.7 0.0 0.5 6.1 0.4 0.0 0.2 1.9 2.8 10.3 5.8 0.0 10.9 1.5 0.0 0.2 19.2 14.8 2.7 2.5 4.4 1.8 0.8 1.5 3.3 2.6 1.3 2.0 0.8 2.3 10.4 15.5 3.4 5.4 11.2 0.7 7.2 8.2 12.5 0.7 0.1 0.0 10.5 28.4 0.8 0.4 1.2 9.9 0.3 6.6 5.6 13.6 0.3 0.8 27.0 2.8 0.5 5.1 4.0 0.7 1.6 HACL1 "2-HPCL, HPCL, PHYH2" ENSG00000131373 "2-hydroxyacyl-CoA lyase 1" Q9UJ83 3 15560699-15601852 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 117.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 117.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035496, HPA035497, HPA073760" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles Nucleoplasm "HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633" "unprognostic (6.64e-3)" "unprognostic (2.82e-2)" "unprognostic (2.24e-3)" "unprognostic (3.82e-1)" "unprognostic (4.08e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (6.31e-2)" "unprognostic (8.27e-3)" "unprognostic (5.23e-2)" "unprognostic (3.30e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.62e-2)" "unprognostic (2.66e-1)" "unprognostic (3.23e-2)" "unprognostic (9.07e-2)" 14.4 12.0 7.5 8.2 7.8 11.6 14.6 10.4 10.5 9.1 7.9 10.0 56.6 8.3 16.6 7.5 10.8 8.8 11.0 7.6 7.0 26.0 51.8 9.7 14.1 7.4 7.2 7.5 15.2 20.0 7.8 7.8 7.0 10.8 12.0 12.2 9.1 9.1 17.6 10.6 27.7 9.5 7.4 11.4 13.2 26.7 6.8 13.9 20.4 10.6 14.5 10.3 6.4 10.0 15.1 28.6 8.2 30.7 13.4 12.4 82.3 14.2 22.0 26.6 26.3 27.3 14.3 14.6 9.7 18.7 10.5 10.4 18.7 25.3 23.8 13.6 36.4 25.4 17.7 24.7 20.3 30.5 23.1 13.7 16.2 37.9 16.6 8.3 31.4 18.3 24.0 21.2 22.9 28.7 14.0 12.6 19.7 19.7 29.7 14.4 21.5 19.6 26.4 20.2 9.6 12.3 22.4 19.0 25.2 12.8 8.5 25.4 22.5 14.1 14.6 17.4 24.7 27.2 50.9 28.5 27.1 26.4 17.2 117.3 16.0 18.3 14.4 20.1 21.2 15.4 15.5 18.0 16.0 21.2 14.8 16.1 3.4 24.1 24.2 10.2 19.8 13.0 7.5 7.8 10.4 10.5 7.6 7.0 7.4 7.2 7.0 7.4 6.8 10.0 12.4 9.6 17.3 34.9 22.1 10.3 12.0 13.5 20.5 19.3 9.1 10.2 6.4 14.3 15.6 11.0 29.2 27.2 15.7 6.1 13.7 16.0 66.6 12.6 6.0 12.3 9.1 8.2 67.4 25.2 18.0 12.0 11.2 5.4 13.3 12.7 8.9 24.3 13.2 13.5 55.8 7.5 10.2 9.3 8.1 56.8 23.3 8.8 12.4 25.3 19.3 24.8 8.2 40.7 38.8 14.5 11.2 15.4 21.4 9.0 41.9 39.7 29.8 38.3 6.6 9.0 11.2 51.1 24.4 8.6 7.1 18.9 19.4 15.1 10.6 7.9 HAND2 "bHLHa26, dHand, Hed, Thing2" ENSG00000164107 "Heart and neural crest derivatives expressed 2" P61296 4 173524969-173530229 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 60.5" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 100.3;Endometrial stromal cells: 317.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.5;stomach cancer: 4.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 24 "SH-SY5Y: 410.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019591, CAB025576" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm Vesicles "CAB025576: , HPA019591: AB_2670199" "unprognostic (4.11e-2)" "unprognostic (7.50e-3)" "unprognostic (2.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.95e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-2)" "unprognostic (2.56e-1)" "unprognostic (2.44e-1)" "unprognostic (1.35e-1)" "unprognostic (3.27e-2)" "unprognostic (4.95e-2)" "unprognostic (1.56e-1)" "unprognostic (6.39e-3)" 4.9 28.0 0.0 5.4 0.0 0.0 2.1 0.5 0.0 22.2 0.0 60.5 2.5 33.4 0.3 1.0 16.0 16.2 36.8 0.0 0.0 0.1 5.5 0.0 0.2 0.0 0.0 15.3 4.1 0.0 0.1 20.9 0.2 1.3 4.4 0.0 0.8 1.0 0.2 1.5 11.0 27.3 0.0 1.1 22.1 0.4 0.0 0.4 1.5 1.1 0.8 12.4 5.3 0.0 0.0 0.1 0.0 0.0 16.6 7.7 0.3 2.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 17.3 0.0 0.1 1.7 0.0 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 410.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.3 4.1 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.2 0.0 0.1 0.1 100.3 2.8 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.6 0.2 9.0 317.1 2.7 0.0 0.0 0.0 0.4 1.4 30.4 0.0 5.3 0.0 0.0 6.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 2.3 0.9 39.4 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.9 0.1 0.3 0.2 0.3 2.3 1.3 0.6 0.0 0.0 HAO2 "GIG16, HAOX2" ENSG00000116882 "Hydroxyacid oxidase 2" Q9NYQ3 1 119368779-119394130 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "kidney: 303.7;liver: 425.6" "Group enriched" "Detected in some" 7 "Hepatocytes: 256.8;Proximal tubular cells: 450.1" "Group enriched" "Detected in some" 26 "liver cancer: 25.6;renal cancer: 11.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050355 Uncertain Vesicles,Cytosol NA NA "Cluster 81: Kidney & Liver - Metabolism" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol Vesicles "HPA050355: " "unprognostic (1.13e-1)" "unprognostic (1.68e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (6.22e-2)" "unprognostic (5.33e-3)" "unprognostic (2.80e-2)" "unprognostic (3.27e-1)" "unprognostic (3.15e-1)" "unprognostic (3.17e-1)" "unprognostic (1.41e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.92e-4)" "unprognostic (9.66e-2)" "unprognostic (1.79e-1)" "unprognostic (2.89e-2)" "unprognostic (5.14e-4)" 0.0 0.6 0.2 0.1 0.6 0.0 0.6 0.1 0.6 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 303.7 425.6 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.1 0.4 0.2 0.1 0.3 23.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.6 0.2 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.7 0.0 11.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 0.6 0.0 13.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 4.2 256.8 0.1 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 450.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 HDHD3 "C9orf158, MGC12904" ENSG00000119431 "Haloacid dehalogenase like hydrolase domain containing 3" Q9BSH5 9 113373419-113376999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 156.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 214.0;Exocrine glandular cells: 156.4;Paneth cells: 208.6;Proximal enterocytes: 254.0;Proximal tubular cells: 275.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 73.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020427, HPA024158, HPA024585" Enhanced Enhanced Nucleoli,Vesicles NA NA "Cluster 24: B-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoli Vesicles "HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565" "unprognostic (1.30e-1)" "prognostic favorable (2.72e-4)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (8.24e-3)" "unprognostic (1.57e-2)" "unprognostic (6.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (5.87e-2)" "prognostic favorable (3.54e-7)" "unprognostic (2.16e-2)" "unprognostic (1.84e-1)" "unprognostic (4.68e-1)" "unprognostic (1.19e-3)" 12.2 156.4 16.8 11.1 18.0 8.4 19.5 16.2 19.3 19.9 14.5 59.7 82.9 13.4 14.9 42.1 16.5 17.8 22.4 15.8 17.7 56.3 122.8 10.2 10.2 15.7 17.0 19.9 53.0 68.4 23.1 5.0 16.2 30.4 35.9 8.0 52.2 16.1 8.8 28.3 68.5 7.7 15.7 17.6 50.1 7.0 18.5 6.7 38.7 5.7 7.6 17.6 21.1 15.5 7.4 20.8 4.4 12.3 10.7 4.7 37.0 5.4 10.1 8.6 9.3 38.3 36.1 16.2 6.6 3.0 17.0 28.3 7.0 8.3 2.9 22.9 16.1 22.4 12.5 24.1 12.5 1.4 16.6 7.4 17.4 7.0 19.7 9.9 4.5 14.9 18.0 4.0 4.1 48.3 10.4 6.5 9.9 73.7 16.1 8.5 0.0 13.2 11.0 15.4 11.1 7.0 9.3 39.4 14.0 9.5 24.8 4.7 4.5 1.7 0.1 1.4 1.9 9.7 20.2 6.8 2.1 0.1 1.3 0.2 3.7 8.2 12.4 2.1 14.0 14.8 14.2 11.5 6.1 16.6 14.5 11.1 2.4 8.2 0.2 14.1 17.1 8.5 16.8 18.0 16.2 19.3 15.8 17.7 15.7 17.0 16.2 15.7 18.5 15.5 4.1 9.6 10.1 24.5 19.7 9.9 20.6 26.6 10.8 10.3 38.6 31.2 15.8 80.1 32.6 23.9 10.4 29.4 11.7 214.0 86.1 84.8 0.2 20.9 6.4 9.4 40.3 15.4 9.2 156.4 16.5 8.6 112.7 22.3 7.6 122.4 9.7 85.4 20.6 1.7 10.4 80.4 28.5 6.5 3.7 2.0 14.3 6.9 10.6 6.5 13.7 12.1 15.5 5.5 4.9 104.8 208.6 9.1 9.3 23.7 254.0 275.1 33.3 13.8 6.6 5.5 11.1 0.3 6.0 42.9 14.6 31.6 14.0 26.0 94.6 51.4 HEATR4 MGC48595 ENSG00000187105 "HEAT repeat containing 4" Q86WZ0 14 73478484-73558947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.4;testis: 11.5" "Cell type enhanced" "Detected in some" "Astrocytes: 27.4;Early spermatids: 85.5;Excitatory neurons: 19.8;Inhibitory neurons: 16.9;Late spermatids: 29.3;Oligodendrocyte precursor cells: 13.0" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "cerebellum: 6.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.2;SCLC-21H: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003642, HPA079348" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles Cytosol "HPA003642: AB_1079376, HPA079348: " "unprognostic (5.25e-2)" "unprognostic (2.45e-3)" "unprognostic (2.85e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-2)" "unprognostic (2.60e-2)" "unprognostic (3.50e-1)" "unprognostic (8.09e-2)" "unprognostic (3.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (5.50e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" 0.5 0.5 0.2 0.8 0.2 0.9 0.4 6.4 1.0 0.7 0.0 0.4 1.9 1.0 0.3 0.6 0.6 0.8 0.6 0.8 0.0 0.4 0.8 0.5 1.6 0.0 0.0 1.0 0.9 0.2 0.5 0.3 0.1 0.4 0.1 2.9 0.8 0.1 1.9 3.6 0.8 0.1 0.0 1.0 0.7 11.5 0.1 0.0 1.0 0.0 0.0 0.3 0.5 0.8 0.7 0.8 0.3 0.5 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.5 0.0 0.8 0.2 0.2 0.0 2.2 0.2 0.9 0.3 0.2 0.7 0.4 0.4 0.3 0.0 1.1 2.4 0.3 0.8 1.1 1.2 0.5 1.3 0.1 0.4 0.1 0.9 0.7 0.1 0.6 0.2 0.1 0.5 0.2 0.1 0.2 0.1 0.1 0.4 0.1 0.2 0.5 0.5 0.3 0.0 0.6 0.5 0.5 0.3 0.3 0.0 0.2 0.2 0.1 0.2 0.2 6.4 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.2 0.0 1.5 27.4 0.2 0.3 0.5 0.1 0.0 0.8 0.3 0.3 0.8 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 85.5 0.3 0.3 0.4 0.0 0.0 19.8 0.0 0.2 0.5 0.0 0.9 0.0 0.4 0.0 0.6 0.1 0.0 16.9 0.2 0.0 0.0 1.0 29.3 0.6 0.3 0.0 3.7 0.0 0.6 0.0 13.0 6.8 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.0 0.9 0.7 11.1 1.6 0.0 0.9 0.1 0.4 0.1 0.0 0.1 HEBP1 "HBP, HEBP" ENSG00000013583 "Heme binding protein 1" Q9NRV9 12 12974870-13000265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 242.9" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 837.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056417, HPA075277" Approved Approved Nucleoplasm,Vesicles NA NA 290000 "Cluster 14: Monocytes - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" Vesicles Nucleoplasm "HPA056417: AB_2683122, HPA075277: AB_2686741" "unprognostic (1.65e-1)" "unprognostic (2.31e-2)" "unprognostic (9.28e-2)" "unprognostic (5.67e-3)" "unprognostic (4.45e-3)" "unprognostic (5.42e-3)" "unprognostic (2.70e-1)" "unprognostic (2.44e-1)" "unprognostic (6.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.94e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.71e-2)" "unprognostic (1.64e-1)" "unprognostic (4.02e-2)" "unprognostic (4.43e-2)" 72.5 108.1 43.1 21.0 49.6 57.9 66.6 48.0 46.0 54.8 47.3 44.5 242.9 43.8 17.4 42.6 49.9 41.4 58.5 40.9 46.0 69.1 145.8 54.6 28.2 52.5 46.5 80.0 75.9 50.2 27.8 34.6 49.9 42.4 21.7 15.2 43.7 36.8 39.3 59.6 165.7 38.7 49.9 58.5 45.1 29.8 46.8 19.5 122.6 37.7 21.4 51.2 50.3 53.5 74.2 46.2 29.3 54.8 229.6 167.6 20.5 65.0 91.0 60.2 79.7 29.8 26.6 21.2 25.2 128.8 51.9 64.7 37.6 54.2 69.1 3.0 30.0 12.0 51.0 74.2 159.1 22.3 11.3 134.7 47.9 80.7 101.9 187.0 124.3 25.1 13.6 19.4 103.9 48.1 18.3 34.9 42.5 71.5 30.0 40.2 85.3 22.1 50.8 74.1 16.6 14.8 85.6 41.1 86.5 84.2 21.3 33.6 140.2 45.7 53.1 72.6 36.2 16.4 14.4 7.9 73.2 38.5 18.8 15.6 65.7 17.2 9.6 49.4 13.5 11.5 16.5 10.4 51.2 11.8 20.6 12.1 21.0 18.7 69.8 25.3 9.7 25.9 43.1 49.6 48.0 46.0 40.9 46.0 52.5 46.5 49.9 49.9 46.8 53.5 120.1 54.5 21.3 2.0 14.9 37.5 56.2 38.3 39.9 43.0 73.3 95.8 26.7 115.8 19.8 57.0 4.2 36.2 14.5 56.5 99.7 89.5 33.8 8.6 27.4 80.4 20.4 174.4 1.5 100.3 27.1 68.6 28.5 14.6 1.3 31.6 162.4 121.7 82.0 6.7 1.7 45.3 18.3 85.4 43.1 13.0 89.2 53.7 62.2 0.0 78.1 44.2 10.3 4.5 3.5 71.1 90.5 94.0 8.0 79.8 837.6 93.0 7.0 6.7 52.6 35.7 40.8 13.8 7.5 44.5 36.1 26.3 14.5 84.3 93.6 54.3 HECTD4 "C12orf51, FLJ34154, KIAA0614" ENSG00000173064 "HECT domain E3 ubiquitin protein ligase 4" 12 112160188-112382439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 141.8;Excitatory neurons: 190.4;Inhibitory neurons: 180.0;Oligodendrocyte precursor cells: 109.1;Oligodendrocytes: 138.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041062, HPA045473" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 71: Testis - DNA repair" "Cluster 15: RT4 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Nucleoplasm "HPA041062: AB_2677281, HPA045473: AB_2679338" "unprognostic (9.27e-2)" "unprognostic (2.35e-1)" "unprognostic (6.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.38e-1)" "prognostic favorable (2.97e-4)" "unprognostic (3.52e-2)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.95e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.89e-1)" "unprognostic (1.58e-2)" "unprognostic (4.51e-3)" 6.7 6.5 6.3 3.1 6.1 14.2 6.8 15.6 6.9 10.0 3.4 11.3 2.0 9.5 4.0 11.0 8.4 3.1 6.8 5.9 2.0 7.5 7.6 7.8 3.8 1.0 0.8 8.5 8.8 6.1 11.7 4.1 1.3 10.5 3.6 10.8 7.9 4.0 8.0 10.7 7.6 4.2 0.4 7.6 10.0 6.8 1.2 6.5 13.5 5.6 4.1 8.8 9.7 6.7 5.1 9.2 7.7 6.1 8.7 7.4 3.2 3.2 3.6 4.8 4.0 8.6 1.3 5.2 3.2 6.7 5.4 4.6 10.8 4.3 3.9 7.0 9.4 8.6 10.7 3.8 2.6 6.1 6.3 4.7 4.8 7.3 5.1 8.7 7.7 9.6 10.2 3.9 4.5 4.4 6.7 7.7 3.3 5.7 7.1 8.3 4.2 3.3 2.4 8.8 12.8 8.0 9.2 7.5 2.8 7.2 5.3 6.7 11.0 5.2 4.0 5.7 4.6 11.8 5.7 6.5 4.1 3.3 2.9 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.2 0.3 0.0 0.0 6.3 6.1 15.6 6.9 5.9 2.0 1.0 0.8 1.3 0.4 1.2 6.7 14.7 19.2 20.8 96.9 15.7 11.5 8.4 8.3 18.8 54.3 15.1 11.7 20.1 12.8 9.4 12.9 141.8 10.9 15.2 14.6 0.0 8.0 7.0 23.9 25.9 14.2 27.6 47.4 190.4 8.7 5.2 11.2 23.9 32.2 8.2 17.9 15.7 15.2 6.6 80.8 180.0 14.2 8.2 11.1 6.7 6.3 11.5 12.6 7.2 66.5 11.1 17.7 14.4 109.1 138.8 10.3 9.0 15.8 15.8 12.8 9.2 5.6 16.0 53.8 0.0 19.3 14.6 25.0 7.8 22.1 14.9 8.9 12.9 12.4 14.0 9.0 HEG1 "HEG, KIAA1237" ENSG00000173706 "Heart development protein with EGF like domains 1" Q9ULI3 3 124965710-125055997 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 90.1;Cardiomyocytes: 90.5;Cone photoreceptor cells: 264.8;Endothelial cells: 121.5;Hepatic stellate cells: 130.3;Microglial cells: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 174.1;HHSteC: 241.5;hTERT-RPE1: 351.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010952, HPA011559" Approved Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 510000000 "Cluster 15: NK-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Plasma membrane" "HPA010952: AB_2668389, HPA011559: AB_1850580" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.48e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (9.80e-2)" "unprognostic (1.69e-1)" "unprognostic (8.33e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.11e-2)" "unprognostic (4.99e-2)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.16e-4)" 30.1 9.9 19.3 19.2 23.2 1.9 14.8 27.0 15.0 20.8 28.3 11.9 8.0 19.2 6.2 16.1 13.2 38.9 67.3 14.3 22.7 15.2 7.5 55.1 16.5 32.0 28.1 12.4 31.6 16.1 3.6 33.4 28.6 13.9 12.2 46.8 7.7 14.6 14.3 5.2 9.4 25.4 27.3 17.9 9.8 13.5 30.3 8.6 52.2 24.2 15.7 30.0 10.1 30.6 7.0 7.1 54.7 4.2 73.2 58.7 21.1 64.9 90.1 72.6 83.5 58.5 1.0 2.8 43.8 174.1 52.3 15.3 7.4 31.6 97.9 6.5 3.7 1.3 42.3 8.4 241.5 1.8 80.6 77.8 10.1 87.4 21.5 351.3 69.3 5.0 0.1 1.0 25.7 1.3 2.8 0.1 10.1 0.1 5.5 4.8 41.0 0.2 14.6 1.2 1.0 5.6 134.8 10.6 6.4 55.1 24.2 4.3 93.9 37.7 41.3 150.5 29.1 6.9 19.7 0.4 76.8 6.5 82.4 1.1 0.1 0.0 1.9 1.7 1.1 0.5 0.6 1.7 0.4 0.3 1.2 0.8 0.0 3.9 1.9 0.4 0.2 0.5 19.3 23.2 27.0 15.0 14.3 22.7 32.0 28.1 28.6 27.3 30.3 30.6 90.1 86.6 5.8 28.7 4.9 5.0 8.0 25.4 6.8 6.1 2.4 5.7 90.5 7.2 6.5 27.6 264.8 1.8 19.2 0.5 0.0 32.0 7.0 4.0 20.1 121.5 0.0 6.1 0.9 6.4 65.3 44.8 1.1 2.2 26.6 24.9 130.3 3.5 6.8 1.7 14.9 0.5 4.1 18.4 7.3 9.4 5.0 7.1 7.2 92.8 4.0 6.0 35.0 13.0 57.6 6.4 0.1 13.9 8.6 5.2 0.8 1.3 1.0 66.8 0.0 24.0 28.7 1.0 1.1 2.7 4.4 3.3 14.2 3.1 0.1 1.3 HEXA ENSG00000213614 "Hexosaminidase subunit alpha" P06865 15 72340924-72376420 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 234.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018082, HPA054583" Supported Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 20000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" Vesicles Cytosol "HPA018082: , HPA054583: AB_2682531" "unprognostic (1.51e-2)" "unprognostic (1.73e-2)" "unprognostic (3.41e-1)" "prognostic favorable (5.63e-8)" "unprognostic (6.58e-2)" "unprognostic (1.32e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (3.75e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (9.98e-2)" "unprognostic (3.98e-1)" "unprognostic (7.05e-3)" "unprognostic (3.02e-2)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" 49.8 56.1 18.3 37.6 21.1 110.0 58.5 20.4 21.6 73.8 28.5 55.1 49.8 42.6 164.6 24.8 47.8 76.7 54.3 19.9 20.1 90.1 79.4 84.2 54.2 23.0 21.3 39.3 30.6 54.0 26.3 102.0 24.6 45.3 67.0 32.1 45.0 53.3 22.1 21.8 41.2 59.5 21.7 54.7 45.1 35.6 27.0 38.1 76.5 33.2 42.4 71.6 19.7 29.9 39.8 66.4 27.8 53.8 223.6 253.1 39.7 54.8 274.1 115.3 182.8 34.6 282.7 32.9 50.9 110.0 59.9 77.1 74.5 34.6 72.5 26.5 30.0 41.4 60.4 60.9 172.9 99.9 113.1 216.7 101.3 50.4 89.3 210.3 107.4 48.4 65.1 197.6 156.0 33.9 21.7 50.0 16.0 128.9 0.3 22.3 60.6 75.3 129.1 61.6 23.8 26.4 136.5 126.6 307.3 56.1 23.4 123.9 54.1 171.9 70.7 160.1 59.3 104.7 151.8 33.4 62.1 130.4 85.3 24.2 84.6 60.1 43.8 35.7 38.7 41.1 28.8 38.9 98.0 38.0 22.5 33.2 8.1 51.3 13.3 37.3 28.2 63.0 18.3 21.1 20.4 21.6 19.9 20.1 23.0 21.3 24.6 21.7 27.0 29.9 68.9 64.1 62.4 19.9 46.3 22.2 33.3 94.3 19.4 42.4 28.6 30.4 26.9 30.0 68.0 66.2 106.3 150.2 54.2 36.6 60.7 88.3 20.6 27.2 30.2 50.8 47.2 19.1 22.7 38.0 68.0 78.7 42.8 40.6 29.9 49.9 43.5 42.9 234.3 26.9 24.7 46.3 81.4 92.8 75.0 13.7 74.3 118.1 94.3 24.4 60.3 38.4 82.4 20.6 26.7 39.1 74.6 44.8 37.7 33.0 68.5 66.7 37.5 56.9 46.0 24.5 31.7 24.3 32.3 13.5 15.6 157.6 36.7 45.2 50.6 27.5 HEXIM1 "CLP-1, EDG1, HIS1, MAQ1" ENSG00000186834 "HEXIM P-TEFb complex subunit 1" O94992 17 45148475-45152099 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 467.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008926, CAB011625" Supported Enhanced Nucleoplasm,Vesicles NA NA "Cluster 10: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB011625: AB_2233058, HPA008926: AB_1079048" "unprognostic (2.82e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (2.39e-1)" "unprognostic (2.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (2.89e-3)" "unprognostic (1.26e-2)" 16.8 32.6 16.3 13.2 15.4 36.3 17.0 16.2 16.5 17.2 16.5 22.5 17.7 19.6 15.9 24.2 21.3 14.3 15.0 14.8 16.8 21.1 26.8 17.3 12.8 17.0 19.1 14.4 19.7 14.1 19.2 25.2 16.0 24.2 10.2 9.0 19.2 19.8 33.2 22.6 24.9 13.0 17.7 25.6 23.1 21.6 19.7 15.4 20.1 21.6 12.4 19.7 17.6 14.2 35.7 111.1 22.8 33.0 36.7 19.6 55.3 30.9 27.8 25.0 27.8 52.6 49.3 15.5 93.1 32.7 12.1 28.2 13.8 30.4 20.0 32.2 32.9 48.2 65.8 65.0 32.0 30.3 61.4 23.0 25.5 18.6 8.1 62.6 12.7 26.8 21.5 36.6 19.0 47.8 31.9 34.9 20.9 32.9 33.4 13.1 19.9 19.2 66.5 62.1 12.2 9.2 46.6 52.0 52.2 23.0 54.2 23.5 24.3 25.1 34.6 14.6 58.5 33.1 11.4 10.0 23.0 28.1 29.1 16.2 4.0 6.8 4.2 6.1 2.4 3.0 4.2 3.7 3.3 3.2 3.7 3.9 10.0 3.7 7.3 3.4 3.8 2.2 16.3 15.4 16.2 16.5 14.8 16.8 17.0 19.1 16.0 17.7 19.7 14.2 210.3 73.7 111.8 7.2 76.1 84.5 75.0 57.7 157.1 25.1 127.0 215.9 59.7 87.2 60.5 25.8 22.9 134.8 114.3 250.4 7.9 35.0 2.2 88.8 66.1 91.3 52.8 82.1 10.7 23.6 70.1 99.2 94.3 137.9 125.9 16.5 42.5 40.5 42.1 15.2 12.9 122.0 54.9 33.9 83.2 3.0 35.1 83.0 53.4 9.4 38.4 27.7 28.8 7.1 8.2 25.3 127.1 43.6 44.1 52.1 184.9 53.8 45.7 24.8 26.3 249.2 128.2 2.6 7.9 126.7 71.5 467.5 111.1 16.9 92.2 34.4 HFM1 "FLJ36760, FLJ39011, MER3, SEC63D1" ENSG00000162669 "Helicase for meiosis 1" A2PYH4 1 91260766-91404856 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Meiosis "Helicase, Hydrolase" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 9.3;testis: 13.8" "Cell type enhanced" "Detected in some" "Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035036, HPA035557" Supported "Golgi apparatus,Vesicles" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA035036: AB_2797224, HPA035557: AB_10696507" "unprognostic (1.35e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-1)" "unprognostic (2.83e-4)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (7.43e-3)" "unprognostic (1.79e-1)" "unprognostic (7.75e-2)" "unprognostic (7.97e-2)" "unprognostic (1.76e-4)" "unprognostic (2.81e-2)" "unprognostic (1.06e-2)" "unprognostic (2.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.77e-4)" "unprognostic (9.59e-2)" 0.4 0.3 1.0 0.1 1.0 0.2 0.4 5.1 1.0 0.9 0.0 0.5 0.3 2.3 1.1 0.1 0.8 0.2 0.6 0.7 1.6 0.7 0.1 0.2 0.1 1.7 1.6 3.9 0.7 0.1 9.3 0.5 1.1 0.6 0.3 4.5 0.5 1.1 1.5 0.1 0.2 0.9 1.1 0.4 0.2 13.8 1.6 0.1 1.6 1.1 0.2 0.4 0.3 1.3 0.0 0.1 5.2 2.8 0.0 0.1 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.3 0.1 1.6 0.0 0.0 0.2 1.0 0.0 0.0 0.0 1.7 2.1 0.0 0.0 0.7 1.4 0.0 0.5 0.0 0.0 0.5 0.5 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 5.1 1.0 0.7 1.6 1.7 1.6 1.1 1.1 1.6 1.3 0.2 0.0 1.1 50.9 0.0 0.0 0.0 0.0 0.6 3.9 0.1 0.3 3.1 0.0 0.0 0.0 6.2 0.5 0.0 0.0 0.0 0.4 17.8 0.2 1.9 0.4 0.0 2.5 17.6 0.2 0.2 0.6 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 38.4 0.0 0.0 0.0 0.0 5.0 4.1 0.0 0.0 10.3 0.0 2.4 0.0 90.5 9.5 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 6.2 0.0 2.0 1.4 58.9 15.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 HMOX2 HO-2 ENSG00000103415 "Heme oxygenase 2" P30519 16 4474690-4510347 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 515.3;Late spermatids: 2001.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025464, HPA040611" Supported Approved Vesicles,Cytosol NA NA 12000 "Cluster 20: T-cells - T-cell receptor" "Cluster 43: Testis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Vesicles, Cytosol" "CAB025464: , HPA040611: AB_10961034" "unprognostic (3.33e-1)" "unprognostic (3.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.91e-4)" "unprognostic (2.74e-1)" "unprognostic (4.27e-2)" "unprognostic (6.23e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (3.60e-1)" "unprognostic (7.74e-3)" "unprognostic (9.87e-2)" "prognostic favorable (8.98e-6)" "unprognostic (3.51e-2)" "unprognostic (4.14e-2)" "unprognostic (1.65e-2)" "unprognostic (2.64e-1)" 63.0 51.3 43.7 23.2 51.9 18.3 55.7 56.9 55.2 47.1 36.2 41.0 34.8 35.8 22.5 84.5 35.9 26.9 149.9 47.7 50.0 71.2 109.5 46.6 33.2 55.8 49.2 25.6 39.7 38.6 43.8 17.9 57.1 34.5 25.1 22.5 44.1 14.1 37.9 44.4 42.6 22.7 44.7 67.8 100.2 152.2 54.3 24.3 41.9 32.3 36.3 33.2 49.0 53.5 82.9 38.2 20.5 45.6 65.8 31.5 33.8 53.9 26.5 48.3 43.7 48.3 55.5 36.9 64.0 55.7 34.6 51.5 75.4 126.9 48.4 51.5 48.4 27.5 35.2 63.3 43.7 56.8 44.4 48.7 41.7 55.7 37.6 37.9 83.7 46.9 44.7 18.1 44.5 114.3 48.7 58.4 34.2 81.1 35.7 54.3 33.7 84.4 72.3 51.8 34.4 19.4 43.1 95.1 66.4 33.9 58.2 36.3 91.7 25.7 39.9 120.3 30.1 24.3 30.0 78.0 16.5 52.5 35.2 87.6 37.1 252.6 166.3 46.5 142.1 69.8 153.8 168.5 73.6 66.8 145.5 151.6 125.1 99.0 35.7 39.2 155.4 142.3 43.7 51.9 56.9 55.2 47.7 50.0 55.8 49.2 57.1 44.7 54.3 53.5 33.8 35.3 41.5 7.8 37.2 54.8 35.7 73.5 19.4 29.3 26.4 29.1 70.6 32.9 54.5 36.8 20.9 75.3 59.8 70.7 129.1 79.7 515.3 38.6 30.9 53.4 31.8 14.3 23.0 90.7 69.6 39.4 89.7 53.3 19.7 38.8 75.0 93.0 67.2 28.6 21.6 37.6 85.5 23.9 52.9 2001.6 45.4 30.6 62.2 5.6 29.3 53.9 141.1 9.5 32.9 114.9 70.7 56.1 47.1 37.7 110.8 239.3 39.9 27.8 72.3 14.6 58.0 199.7 149.8 28.2 51.6 38.4 88.3 47.4 48.9 28.7 HNF1B "HNF1beta, LFB3, MODY5, TCF2, VHNF1" ENSG00000275410 "HNF1 homeobox B" P35680 17 37686431-37745105 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.1;pancreas: 33.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 78.6;Collecting duct cells: 57.0;Distal tubular cells: 45.0;Ductal cells: 42.0;Early spermatids: 32.3;Glandular and luminal cells: 41.7;Pancreatic endocrine cells: 31.7;Proximal tubular cells: 38.2" "Cancer enhanced" "Detected in many" "renal cancer: 32.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 139.3" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in single" "HPA002083, CAB068192" Enhanced Supported Nucleoplasm,Vesicles NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Nucleoplasm Vesicles "CAB068192: AB_2665649, HPA002083: AB_1080232" "unprognostic (2.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (5.29e-3)" "unprognostic (5.29e-2)" "unprognostic (3.00e-2)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-1)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "prognostic favorable (6.00e-4)" "unprognostic (7.06e-2)" "unprognostic (2.26e-1)" "unprognostic (7.49e-2)" "prognostic favorable (2.51e-6)" 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.7 0.0 9.9 6.9 1.5 7.5 0.0 5.7 15.1 0.0 0.0 0.1 61.1 12.9 6.8 0.0 0.0 0.0 0.0 33.0 3.5 0.0 0.0 0.0 2.3 7.1 0.0 0.0 4.4 0.0 0.0 8.6 0.1 0.0 0.0 8.2 3.9 0.1 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 2.2 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 139.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.6 14.1 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.6 78.6 1.9 57.0 0.0 0.0 0.0 15.4 45.0 42.0 32.3 18.5 3.6 0.4 14.4 0.0 0.2 25.4 0.0 0.2 13.7 41.7 5.7 0.0 0.0 5.1 0.1 0.0 0.2 13.5 0.0 0.3 0.0 11.6 0.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.1 31.7 11.4 0.0 0.0 2.6 14.3 38.2 3.7 0.0 0.0 0.0 0.3 3.0 2.5 0.0 0.0 0.0 0.6 0.0 20.4 2.7 HOOK2 HK2 ENSG00000095066 "Hook microtubule tethering protein 2" Q96ED9 19 12763003-12872740 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 291.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 83.7;RT4: 100.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043519, HPA050351" Approved Supported Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 15: RT4 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Vesicles, Cytosol" "HPA043519: AB_2678525, HPA050351: AB_2681102" "unprognostic (4.26e-1)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "unprognostic (1.16e-1)" "unprognostic (4.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.25e-3)" "unprognostic (3.06e-2)" "unprognostic (2.52e-2)" "unprognostic (1.75e-3)" "prognostic unfavorable (7.59e-5)" "prognostic favorable (3.28e-4)" "unprognostic (3.27e-3)" "unprognostic (5.74e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-2)" 40.0 20.6 15.8 10.3 15.1 4.1 45.8 15.5 21.0 31.4 14.3 35.8 52.0 15.1 46.8 55.5 27.0 20.9 63.3 14.8 15.2 54.9 46.8 24.0 7.1 15.3 14.3 24.9 98.1 38.4 113.8 14.2 15.5 53.1 25.0 13.4 59.3 26.8 70.7 56.2 43.1 10.7 12.7 18.0 41.8 24.7 14.8 7.5 96.2 34.0 13.3 25.1 39.3 15.5 38.5 9.7 11.3 8.0 12.5 11.5 40.5 11.9 5.6 6.5 8.3 33.3 44.2 7.5 20.8 11.5 5.7 48.6 12.0 34.3 6.8 19.7 8.8 7.5 21.1 11.0 5.9 4.2 10.2 14.0 32.4 8.3 13.4 15.0 3.9 14.6 12.6 5.7 13.6 83.7 4.3 7.8 4.8 24.9 10.2 12.1 7.1 18.6 13.4 100.5 28.1 14.5 8.7 25.7 7.3 11.5 35.3 9.1 7.2 12.6 8.5 19.7 4.2 20.6 23.9 4.5 13.4 14.2 9.3 0.2 0.8 0.0 1.4 1.3 0.9 1.7 1.8 0.6 1.3 1.2 3.0 1.9 1.0 1.3 0.8 0.6 0.4 1.1 15.8 15.1 15.5 21.0 14.8 15.2 15.3 14.3 15.5 12.7 14.8 15.5 14.8 19.2 38.0 25.1 34.4 50.5 99.8 135.0 158.8 117.7 84.4 62.9 29.6 75.8 84.5 82.8 100.1 85.0 11.9 137.2 43.0 77.5 9.2 26.2 21.0 18.6 63.0 11.1 28.9 45.4 40.2 24.2 140.2 39.3 12.6 30.7 22.1 24.4 16.6 63.9 43.3 93.9 118.0 11.1 21.6 9.1 27.1 20.4 28.4 6.5 19.7 26.6 10.3 17.1 10.6 46.7 98.0 26.7 30.1 131.6 291.7 45.4 49.3 84.5 13.1 24.5 25.4 73.9 26.1 82.1 65.5 128.1 27.9 42.1 95.6 87.1 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102686 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 3.8;Enteroendocrine cells: 4.8;Hepatic stellate cells: 6.4;Squamous epithelial cells: 6.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 16 "medulla oblongata: 4.5;pons: 3.3;spinal cord: 4.7;white matter: 4.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 14.5;HaCaT: 6.2;RPTEC TERT1: 4.9" "Region enriched" "Detected in single" 36 "pons and medulla: 5.8" "Group enriched" "Detected in some" 17 "medulla oblongata: 4.2;pons: 1.1;spinal cord: 3.0" HPA078220 Approved Nucleoplasm,Vesicles Yes NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Vesicles" "HPA078220: AB_2686880" "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 1.9 1.0 0.0 0.6 0.0 0.0 1.6 0.0 0.0 1.6 0.0 3.3 0.9 2.0 5.1 2.3 4.1 1.0 0.2 0.0 0.0 4.4 0.2 1.7 0.2 4.5 0.2 0.6 0.3 5.7 0.0 0.0 3.3 1.7 1.8 0.0 0.0 2.1 0.7 1.6 2.6 0.9 4.7 1.2 2.2 0.1 0.1 1.8 0.8 3.0 0.6 2.0 0.9 4.3 1.1 0.6 4.0 14.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.6 3.4 0.1 1.5 0.1 1.8 6.2 0.2 0.0 0.0 0.0 2.0 0.0 0.1 0.2 1.8 0.1 0.3 0.8 0.0 3.1 3.1 0.0 2.5 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.9 1.0 0.7 0.0 4.9 0.5 0.9 0.0 0.2 0.0 0.9 0.2 0.0 0.0 2.5 0.0 0.2 1.1 0.5 0.0 0.0 0.1 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 3.3 4.7 0.1 4.3 1.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 23.3 0.0 1.2 3.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.1 1.3 2.5 4.8 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.4 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 1.1 0.5 0.0 0.0 0.0 1.0 1.9 0.0 0.0 6.3 0.3 0.0 0.1 0.0 1.7 0.7 HPSE "HPA, HPSE1, HSE1" ENSG00000173083 Heparanase Q9Y251 4 83292461-83335153 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Cell adhesion" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hofbauer cells: 16.4;Kupffer cells: 41.5;Macrophages: 20.2;monocytes: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "classical monocyte: 27.2;neutrophil: 18.5" "Group enriched" "Detected in many" 4 "granulocytes: 18.5;monocytes: 27.2" "Cell line enhanced" "Detected in many" "Karpas-707: 39.8;OE19: 40.1;TIME: 25.8" "Region enhanced" "Detected in some" "olfactory bulb: 3.7" "Low region specificity" "Detected in all" "CAB009813, HPA055344" Supported Nucleoplasm,Vesicles "Secreted to extracellular matrix" No No 6500000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 2: Karpas-707 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm Vesicles "CAB009813: AB_2120854, HPA055344: " "unprognostic (6.57e-2)" "unprognostic (1.22e-2)" "unprognostic (9.13e-2)" "unprognostic (5.92e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.24e-2)" "unprognostic (5.65e-2)" "unprognostic (7.06e-2)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (9.62e-3)" "unprognostic (3.27e-1)" "unprognostic (2.78e-1)" "unprognostic (3.04e-3)" "unprognostic (4.15e-2)" "unprognostic (3.70e-3)" 3.4 4.5 0.8 6.6 0.9 2.3 1.0 0.6 1.7 2.4 0.4 5.9 2.1 2.7 0.2 9.9 3.9 2.7 0.8 0.9 0.9 1.6 2.4 3.2 4.5 1.8 1.0 4.5 0.8 5.6 1.2 2.1 1.3 0.6 6.4 0.2 9.7 0.6 0.3 5.3 2.8 1.9 1.8 6.0 2.0 5.7 2.7 2.0 0.7 0.3 3.9 3.0 3.3 3.6 13.5 0.6 0.1 1.7 3.2 0.9 0.1 1.5 8.2 3.6 16.5 0.0 11.0 0.4 2.3 4.2 20.8 12.3 16.8 2.5 6.5 1.4 1.7 4.2 9.0 0.2 1.4 2.5 8.4 1.8 5.1 2.4 15.4 1.4 18.1 2.4 0.1 39.8 1.5 2.8 0.2 0.3 0.7 40.1 2.6 0.0 0.4 0.6 10.2 0.3 9.3 0.0 17.7 9.8 1.4 2.6 1.5 3.8 25.8 1.5 4.6 1.4 1.7 0.5 6.2 0.2 9.9 11.4 2.7 0.4 27.2 0.0 1.4 10.1 1.0 0.2 2.7 1.0 3.0 0.3 1.7 1.6 18.5 2.3 1.5 0.1 5.2 7.9 0.8 0.9 0.6 1.7 0.9 0.9 1.8 1.0 1.3 1.8 2.7 3.6 0.3 6.4 4.4 0.0 0.7 3.4 3.0 3.3 2.8 0.0 0.3 0.5 0.6 0.0 5.6 1.8 0.0 0.5 2.4 10.1 0.0 1.9 0.6 2.3 3.7 1.0 6.6 2.7 0.8 1.3 2.9 1.4 4.1 13.2 0.0 0.4 2.9 0.6 16.4 0.0 3.8 2.8 0.0 41.5 3.0 0.3 0.6 20.2 0.0 7.5 33.9 0.0 3.1 0.0 0.1 1.1 6.7 0.0 0.7 1.7 4.1 0.0 2.8 0.0 0.0 0.1 1.2 0.2 1.0 4.0 3.7 1.5 6.2 1.4 4.6 3.7 HSD17B13 "SCDR9, SDR16C3" ENSG00000170509 "Hydroxysteroid 17-beta dehydrogenase 13" Q7Z5P4 4 87303789-87322886 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "liver: 573.7" "Cell type enhanced" "Detected in many" "Adipocytes: 100.0;Club cells: 42.9;Hepatocytes: 131.3;Respiratory ciliated cells: 34.0;Urothelial cells: 57.0" "Cancer enriched" "Detected in some" 26 "liver cancer: 52.9" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "NB-4: 1.4" "Not detected" "Not detected" HPA029125 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Golgi apparatus" "HPA029125: AB_10601580" "unprognostic (2.49e-1)" "unprognostic (7.46e-2)" "unprognostic (7.02e-2)" "unprognostic (1.86e-4)" "unprognostic (4.74e-2)" "unprognostic (8.44e-2)" "prognostic favorable (2.94e-4)" "prognostic favorable (7.80e-4)" "unprognostic (4.97e-1)" "unprognostic (2.22e-2)" "unprognostic (1.00e-1)" "unprognostic (2.46e-1)" "unprognostic (7.18e-4)" "unprognostic (3.62e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-3)" 9.4 0.3 0.6 0.2 0.6 1.4 6.4 2.4 1.0 2.7 0.1 0.7 0.4 2.7 0.2 0.2 1.0 0.2 0.4 0.6 0.5 0.4 573.7 3.6 0.2 0.8 0.5 0.5 1.8 0.1 0.2 0.8 0.9 4.5 0.4 0.8 0.2 0.2 0.3 6.5 0.7 4.2 0.4 0.7 0.3 0.4 0.5 0.3 0.2 0.1 0.1 1.2 7.8 0.9 0.0 0.1 0.2 0.2 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.4 0.2 0.7 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.1 0.0 0.1 1.4 0.1 0.4 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.2 1.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.2 0.1 0.6 0.1 0.0 0.1 0.1 0.0 0.6 0.6 2.4 1.0 0.6 0.5 0.8 0.5 0.9 0.4 0.5 0.9 100.0 3.2 6.4 1.6 0.0 2.5 22.6 0.3 0.0 0.2 0.2 0.3 0.3 4.3 42.9 1.8 0.0 0.1 0.4 1.0 0.0 0.1 2.7 0.4 0.5 2.4 1.8 5.3 3.7 0.4 0.3 0.8 0.0 0.1 0.0 0.2 1.8 131.3 0.2 0.0 3.0 0.5 0.0 2.4 0.4 2.7 0.0 0.7 0.0 0.0 0.3 0.3 0.0 1.5 2.8 0.1 1.4 0.4 0.1 4.7 0.2 0.5 34.0 0.1 0.0 0.7 0.4 0.0 0.9 0.2 0.4 0.0 0.7 0.2 0.7 57.0 HSD17B6 "HSE, RODH, SDR9C6" ENSG00000025423 "Hydroxysteroid 17-beta dehydrogenase 6" O14756 12 56752161-56787790 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "liver: 1804.3" "Cell type enriched" "Detected in many" 11 "Hepatocytes: 1969.3" "Cancer enriched" "Detected in many" 5 "liver cancer: 170.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 13.4;U-266/84: 18.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059141 Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 32: T-cells - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 16: U-266 - Nucleosome" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Vesicles" "HPA059141: AB_2683922" "unprognostic (7.70e-2)" "unprognostic (8.76e-2)" "unprognostic (5.08e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-2)" "prognostic favorable (6.32e-4)" "unprognostic (1.06e-2)" "unprognostic (3.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (2.50e-10)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-1)" 8.5 2.5 13.1 6.9 16.2 0.5 0.7 13.4 18.9 28.0 9.4 24.7 3.2 20.9 1.6 9.9 6.5 9.1 0.8 12.3 12.6 2.5 1804.3 63.2 0.8 12.0 14.6 6.0 0.6 0.5 0.6 5.4 11.5 51.2 7.6 0.8 0.4 69.2 0.4 1.2 4.8 13.1 12.4 47.5 5.7 23.3 13.7 0.9 31.4 0.5 0.9 36.7 14.6 12.8 0.3 0.8 1.9 0.4 1.9 1.4 2.3 4.1 3.5 1.9 1.9 0.4 0.4 12.0 1.7 0.5 0.5 0.3 6.1 1.1 1.1 7.7 2.2 3.7 1.2 0.6 1.2 1.9 6.0 1.0 0.4 1.2 0.6 0.6 0.0 10.3 1.1 13.4 0.9 2.4 5.6 1.3 7.5 0.7 0.7 7.4 0.8 2.9 0.2 1.4 11.0 2.3 2.0 3.6 0.9 0.7 0.6 1.5 0.3 0.9 0.8 4.0 1.0 11.7 18.0 7.8 1.3 6.9 0.6 0.0 0.0 0.0 1.0 0.2 1.2 0.7 0.8 0.8 0.2 0.3 1.1 0.7 0.0 0.0 0.5 0.7 1.0 0.3 13.1 16.2 13.4 18.9 12.3 12.6 12.0 14.6 11.5 12.4 13.7 12.8 0.4 173.1 130.6 21.2 6.1 1.3 3.1 0.6 0.6 0.4 0.7 0.6 0.2 27.1 9.3 0.0 0.0 1.4 0.4 0.0 0.0 0.1 4.6 0.7 3.5 1.3 0.0 29.5 1.4 0.0 2.6 5.0 0.0 0.1 0.0 1.6 26.0 1969.3 0.4 0.0 2.1 0.4 0.0 40.2 0.3 4.5 12.5 0.5 0.0 1.0 1.0 1.3 0.0 3.0 5.5 0.1 0.0 1.5 0.8 16.1 0.0 0.3 1.5 0.6 13.1 0.6 3.5 16.4 11.4 1.2 1.6 0.4 2.2 36.0 0.7 1.1 HSPA1L "HSP70-HOM, hum70t" ENSG00000204390 "Heat shock protein family A (Hsp70) member 1 like" P34931 6 31809619-31815283 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "testis: 63.2" "Group enriched" "Detected in many" 22 "Early spermatids: 212.5;Late spermatids: 560.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.1;EFO-21: 1.5;HEK 293: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA043285, HPA052504" Enhanced Approved Nucleoplasm,Vesicles NA NA 53000000 "Cluster 83: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" Vesicles Nucleoplasm "HPA043285: AB_10962482, HPA052504: AB_2681854" "unprognostic (1.80e-1)" "unprognostic (8.70e-2)" "unprognostic (2.52e-3)" "unprognostic (6.97e-4)" "unprognostic (2.69e-2)" "unprognostic (1.17e-2)" "unprognostic (4.24e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "prognostic favorable (1.02e-4)" "unprognostic (5.26e-3)" "unprognostic (9.96e-2)" "prognostic favorable (4.63e-4)" "unprognostic (4.48e-2)" "unprognostic (4.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-3)" 1.2 1.4 0.0 0.0 0.2 0.1 0.9 1.4 0.3 1.5 0.0 1.8 0.1 1.8 0.0 0.6 2.4 0.0 1.4 0.1 0.2 1.5 1.2 1.3 0.0 0.2 0.2 2.2 0.9 0.0 1.7 0.0 0.3 1.1 0.0 0.1 1.0 0.0 3.9 1.0 1.5 0.0 0.2 2.4 1.3 63.2 0.4 0.0 1.5 0.1 0.0 1.6 1.1 0.6 0.1 1.1 0.1 0.4 0.3 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.5 0.0 0.4 0.4 0.1 0.0 0.1 0.3 4.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.3 0.1 0.2 0.2 0.2 0.3 0.2 0.4 0.6 4.2 0.0 1.1 2.9 3.5 0.9 1.3 0.4 2.2 2.6 1.9 2.0 4.5 0.0 0.9 0.0 8.4 0.6 1.4 1.4 0.0 0.7 212.5 2.0 0.7 2.2 1.8 3.2 0.6 0.2 0.6 1.3 0.0 1.3 0.0 0.9 1.8 1.1 1.3 3.3 0.8 1.4 0.0 4.4 2.5 560.9 5.0 2.1 5.4 2.8 4.1 3.6 1.0 0.5 2.0 0.4 1.4 2.2 1.9 0.9 0.9 0.6 2.2 2.8 0.0 0.8 2.9 17.0 8.7 1.7 0.1 0.4 3.8 0.9 1.5 0.3 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 320.2;skeletal muscle: 170.4" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 342.0;Distal tubular cells: 238.7;Extravillous trophoblasts: 509.9;Spermatocytes: 578.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 75.4;BEWO: 114.4;BJ hTERT+: 99.0;CAPAN-2: 52.9;SCLC-21H: 101.4" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA 63000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 70: Brain - Nervous system development" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: AB_2681854" "prognostic favorable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 9.8 6.5 83.9 7.5 161.2 0.7 6.4 148.0 116.3 12.5 84.2 94.1 5.5 51.6 18.6 42.3 17.0 5.3 39.7 88.5 96.0 73.0 4.2 14.2 3.8 170.1 122.9 5.6 8.8 7.8 15.2 61.5 174.9 10.8 9.5 1.2 16.4 4.5 170.4 31.7 29.6 28.7 128.5 20.2 18.5 121.0 125.3 3.0 2.7 60.6 5.0 42.9 16.0 320.2 30.4 75.4 11.4 0.2 8.1 0.7 114.4 42.3 99.0 16.6 27.3 2.9 52.9 7.4 16.8 46.4 3.6 33.6 0.0 2.2 10.1 4.3 5.8 0.1 4.0 0.2 7.9 0.2 10.0 3.7 1.7 2.4 0.1 4.1 1.1 0.5 0.0 6.0 8.4 13.5 0.5 0.4 8.4 11.7 9.1 6.0 0.0 0.1 26.1 4.6 101.4 5.8 1.8 3.7 0.1 3.9 2.9 3.1 1.6 0.3 0.2 3.7 0.2 7.6 0.2 0.2 9.2 0.1 11.4 0.3 0.0 0.0 0.5 0.1 0.0 0.2 0.4 0.2 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.0 1.0 0.1 83.9 161.2 148.0 116.3 88.5 96.0 170.1 122.9 174.9 128.5 125.3 320.2 74.7 0.0 5.2 18.6 21.1 54.0 31.2 35.1 342.0 1.9 37.5 57.1 39.1 5.7 8.8 132.4 0.0 42.5 30.8 29.2 238.7 8.3 35.7 56.4 63.8 59.6 28.1 0.0 0.5 5.6 509.9 40.7 83.6 54.5 13.3 1.4 32.2 0.8 15.7 0.0 1.1 63.4 24.4 3.1 25.7 27.3 8.7 24.0 30.2 6.5 0.0 14.2 0.0 2.5 157.4 5.5 15.6 7.5 7.1 7.5 8.5 1.5 4.6 2.4 26.3 48.6 66.2 578.6 77.1 175.8 42.3 75.9 29.8 4.5 12.9 11.3 HSPA6 HSP70B' ENSG00000173110 "Heat shock protein family A (Hsp70) member 6" P17066 1 161524540-161526894 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 242.2;lung: 94.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 335.3;Langerhans cells: 478.8;Macrophages: 213.7;Prostatic glandular cells: 180.1;Smooth muscle cells: 235.6;T-cells: 391.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebral cortex: 242.2" "Immune cell enriched" "Detected in many" 7 "neutrophil: 317.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 317.9" "Cell line enriched" "Detected in some" 7 "Karpas-707: 50.7" "Low region specificity" "Detected in all" "CAB017452, HPA028549, HPA052504" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" Vesicles Nucleoplasm "CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854" "unprognostic (3.90e-2)" "unprognostic (2.05e-1)" "unprognostic (5.87e-2)" "unprognostic (2.59e-1)" "unprognostic (2.40e-1)" "unprognostic (6.36e-3)" "prognostic unfavorable (7.26e-4)" "unprognostic (4.61e-2)" "unprognostic (1.29e-1)" "unprognostic (1.93e-1)" "unprognostic (1.68e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" 26.2 15.7 11.3 9.9 16.3 3.6 3.6 22.1 242.2 2.9 24.7 9.3 1.7 1.7 0.7 7.3 3.8 8.7 31.7 12.9 12.4 27.2 33.0 94.4 2.3 15.1 12.4 46.8 5.9 1.1 23.8 20.5 28.7 3.3 1.7 1.8 3.3 5.0 3.8 8.4 5.1 2.3 13.8 63.5 34.5 2.4 15.5 1.3 12.8 3.6 1.7 18.5 10.9 20.1 0.8 1.5 0.0 0.3 0.0 1.1 1.0 0.6 0.5 0.2 0.4 0.5 0.7 0.2 2.2 0.2 0.8 0.4 0.5 0.4 0.3 0.5 0.1 0.3 1.4 0.0 0.0 0.1 3.3 0.2 1.0 0.5 0.0 0.0 0.0 0.2 0.6 50.7 0.0 0.0 0.3 1.3 0.1 0.3 5.4 0.0 0.1 0.7 0.0 0.3 0.1 0.0 0.2 0.9 3.1 0.1 0.4 0.7 0.2 0.1 0.5 0.4 3.6 6.9 0.4 0.0 1.3 1.3 2.3 6.5 35.1 13.4 6.4 44.1 1.0 0.2 0.7 3.4 12.2 0.0 0.0 1.6 317.9 8.3 37.7 0.2 0.0 11.8 11.3 16.3 22.1 242.2 12.9 12.4 15.1 12.4 28.7 13.8 15.5 20.1 14.0 9.6 9.3 0.3 23.8 29.3 335.3 4.4 5.2 42.5 8.7 36.2 11.1 0.0 12.2 5.5 127.2 1.8 12.8 25.3 0.0 0.4 3.2 16.2 16.4 36.7 71.0 24.0 0.0 0.0 11.2 98.8 30.1 26.2 2.5 0.0 3.9 0.3 76.0 10.1 0.0 71.0 4.1 47.8 478.8 1.1 5.6 213.7 103.2 1.0 15.8 36.1 5.2 0.0 0.1 0.3 16.5 0.0 104.1 180.1 0.0 1.5 17.1 36.9 0.0 11.1 235.6 2.9 0.6 16.5 21.7 18.3 391.3 3.6 67.3 92.7 HSPA8 "HSC70, HSC71, HSP73, HSPA10" ENSG00000109971 "Heat shock protein family A (Hsp70) member 8" P11142 11 123057489-123063230 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation" "Chaperone, Hydrolase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 2455.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002056, HPA052504" Uncertain Approved Nucleoplasm,Vesicles NA Yes 140000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Vesicles "CAB002056: , HPA052504: AB_2681854" "unprognostic (2.28e-3)" "unprognostic (1.19e-3)" "prognostic favorable (6.14e-6)" "unprognostic (1.75e-1)" "unprognostic (1.84e-2)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.65e-3)" "unprognostic (3.82e-1)" "unprognostic (9.64e-2)" "unprognostic (2.93e-1)" "unprognostic (3.22e-1)" "prognostic favorable (3.81e-4)" "unprognostic (2.53e-1)" "unprognostic (1.83e-1)" "unprognostic (2.74e-1)" "unprognostic (7.16e-2)" 539.8 604.9 456.3 542.1 498.1 442.4 448.9 591.6 887.9 326.6 571.4 435.8 506.9 367.3 614.7 554.2 498.5 508.6 892.4 535.1 614.9 850.5 763.2 480.1 685.0 564.8 564.2 421.4 1238.1 593.8 501.9 487.1 620.0 411.2 525.8 531.5 404.1 439.8 1519.0 224.4 453.5 508.4 554.2 520.3 676.7 395.0 559.8 628.6 422.6 1508.5 879.6 866.0 302.4 656.8 1369.6 2077.3 1370.5 1176.5 1259.4 1337.4 1775.6 2730.9 1550.4 3373.2 2004.8 3151.7 1787.3 2318.5 1614.6 1591.9 2337.3 1835.9 4091.6 1027.2 3323.5 1955.4 605.9 2570.4 881.5 1532.0 347.5 2418.0 1757.1 721.8 1594.5 1045.0 320.7 1753.4 1845.6 321.7 2727.8 1147.0 2704.5 1235.5 2507.0 1761.3 2063.2 3463.3 1874.0 2214.4 962.2 1281.3 1665.1 1008.4 1371.8 1023.9 1980.4 2110.5 763.6 1491.1 1837.1 901.9 1767.0 1621.1 1246.1 1404.5 2402.7 740.6 1985.0 1890.9 1791.1 3316.9 1970.0 517.7 592.3 587.8 1245.4 1159.8 1499.6 1009.2 1441.8 1366.1 656.1 752.2 1367.5 1326.5 201.8 1110.7 1255.0 465.5 1761.7 3439.4 456.3 498.1 591.6 887.9 535.1 614.9 564.8 564.2 620.0 554.2 559.8 656.8 795.5 192.3 228.2 72.5 576.3 282.3 2455.6 315.3 507.6 206.7 454.5 380.1 396.3 278.8 352.8 130.6 127.2 926.1 740.3 513.1 528.3 589.0 49.8 404.1 380.1 512.8 519.8 551.7 33.4 628.8 1032.6 609.7 366.0 366.5 434.8 633.8 249.9 223.9 810.9 181.7 45.6 511.1 303.2 359.8 1060.8 58.2 222.4 590.6 528.3 35.6 530.9 307.4 639.5 28.1 50.3 513.8 552.1 270.0 573.6 779.5 823.0 1002.2 465.7 278.1 243.3 416.3 893.1 248.9 419.2 590.6 284.6 1512.1 1123.5 430.3 632.0 1171.5 HYKK "AGPHD1, LOC123688" ENSG00000188266 "Hydroxylysine kinase" A2RU49 15 78507564-78537372 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Late spermatids: 33.7;Proximal enterocytes: 37.0;Proximal tubular cells: 39.4;Skeletal myocytes: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Lineage enriched" "Detected in single" 6 "T-cells: 3.0" "Cell line enhanced" "Detected in many" "HEK 293: 22.2;U-266/84: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040706 Approved Approved Vesicles,Aggresome NA NA "Cluster 32: T-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles Aggresome "HPA040706: AB_10795528" "unprognostic (9.26e-2)" "unprognostic (1.98e-4)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (2.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (2.73e-1)" "unprognostic (5.16e-2)" "unprognostic (6.24e-3)" "unprognostic (6.37e-2)" "unprognostic (3.44e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-3)" "unprognostic (3.90e-2)" 4.5 4.8 2.8 1.0 3.1 1.3 4.5 2.2 3.2 5.6 1.6 4.6 7.3 3.8 5.9 2.8 4.3 2.4 5.3 2.7 2.2 12.3 5.7 2.1 2.0 2.0 2.0 6.1 6.8 4.8 3.5 0.7 1.8 4.1 3.4 2.6 3.5 4.1 6.2 2.8 7.2 3.6 1.6 1.3 5.1 5.3 2.3 1.9 4.5 5.4 1.7 3.9 3.8 2.9 4.3 6.3 1.0 11.3 2.3 5.3 2.7 1.5 2.7 3.7 4.2 2.2 4.9 3.1 1.4 2.5 6.3 5.2 10.0 3.3 3.5 1.5 22.2 1.7 3.8 5.6 6.0 0.5 1.9 4.8 6.4 1.4 2.7 1.8 2.7 13.8 4.0 8.4 2.2 5.0 4.2 1.0 0.7 9.8 8.3 2.4 12.4 2.7 7.1 5.1 1.3 1.6 2.9 8.6 10.9 1.9 9.5 0.4 1.9 2.4 1.8 4.3 4.4 12.9 24.2 0.2 3.2 0.2 3.4 0.4 0.1 0.2 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.1 3.0 0.6 0.3 0.1 0.0 0.3 0.5 0.4 2.8 3.1 2.2 3.2 2.7 2.2 2.0 2.0 1.8 1.6 2.3 2.9 4.1 12.8 4.1 4.6 1.4 3.6 7.7 4.5 6.2 2.0 4.5 9.8 6.7 0.0 2.9 7.3 2.1 7.3 1.5 2.8 29.4 2.5 14.0 2.7 3.3 4.1 4.2 1.3 2.8 7.9 4.4 5.4 5.1 1.5 0.0 2.4 6.8 7.1 0.8 0.0 2.7 3.9 2.0 1.0 0.9 33.7 5.3 1.0 7.2 2.8 0.3 7.5 0.0 0.5 1.1 2.9 3.6 3.8 1.7 3.7 37.0 39.4 3.5 1.9 0.0 28.1 4.0 5.4 8.0 4.9 1.6 3.4 1.6 3.9 5.7 4.7 ICA1 "ICA69, ICAp69" ENSG00000003147 "Islet cell autoantigen 1" Q05084 7 8113184-8262687 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 594.7;Late spermatids: 867.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "T-reg: 29.9" "Lineage enriched" "Detected in many" 9 "T-cells: 29.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.1;MCF7: 42.5;OE19: 48.4;RT4: 49.4;SCLC-21H: 66.1;SH-SY5Y: 105.8;SK-BR-3: 52.1;T-47d: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017646, HPA061452" Approved Supported Vesicles,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 25: Pancreas - Digestion" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Vesicles, Cytosol" "HPA017646: AB_1851382, HPA061452: AB_2684525" "unprognostic (1.39e-1)" "unprognostic (1.37e-1)" "unprognostic (3.74e-1)" "unprognostic (6.83e-3)" "unprognostic (9.49e-2)" "unprognostic (8.57e-3)" "unprognostic (1.37e-2)" "unprognostic (3.54e-1)" "unprognostic (7.61e-2)" "unprognostic (3.42e-1)" "unprognostic (5.84e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.23e-8)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (4.08e-2)" 15.8 10.4 11.3 5.7 16.2 23.8 21.1 21.5 21.8 16.4 1.2 22.8 13.6 6.8 13.6 9.5 13.7 11.1 44.3 13.4 9.3 16.0 8.8 11.2 13.5 8.0 9.5 1.7 62.7 20.9 19.8 8.2 9.3 22.1 23.5 2.9 37.1 4.9 2.8 12.8 17.8 5.6 5.1 12.4 30.5 24.2 13.3 5.0 14.1 3.3 9.6 13.8 7.4 15.3 0.0 1.5 1.7 0.2 0.2 0.0 4.2 0.0 0.0 0.6 0.2 1.0 47.1 0.3 5.2 0.1 0.9 0.0 0.8 1.9 0.0 0.0 6.8 9.1 0.9 0.0 0.4 9.1 1.8 0.0 3.0 0.0 0.0 0.5 31.5 8.2 26.4 0.0 0.0 42.5 0.4 0.0 9.9 48.4 0.4 0.0 0.0 19.5 19.0 49.4 66.1 105.8 0.0 52.1 0.7 11.6 43.4 14.3 19.8 0.0 0.9 0.2 1.0 14.1 7.5 0.0 0.0 6.9 10.3 1.0 2.4 0.2 0.3 0.8 0.6 0.4 5.4 0.4 2.4 0.7 0.3 0.2 3.4 0.9 0.4 0.6 29.9 1.3 11.3 16.2 21.5 21.8 13.4 9.3 8.0 9.5 9.3 5.1 13.3 15.3 73.4 28.9 24.4 6.5 1.6 20.5 16.2 7.1 9.1 10.4 42.8 28.7 43.2 22.8 20.1 22.0 6.2 2.7 2.1 28.2 43.0 38.4 594.7 34.2 5.8 44.1 77.2 16.4 132.1 74.8 0.8 4.5 56.1 65.4 8.2 11.2 42.1 1.3 23.9 0.0 138.0 80.5 44.7 8.1 9.3 867.0 7.5 9.6 14.2 60.0 6.3 0.8 3.1 49.3 3.9 59.8 53.1 3.0 1.7 53.8 23.8 8.3 17.8 1.7 6.6 1.2 5.6 13.9 9.6 18.4 8.9 2.2 9.5 4.7 41.8 42.7 IFI30 "GILT, IFI-30, IP-30, IP30, MGC32056" ENSG00000216490 "IFI30 lysosomal thiol reductase" P13284 19 18173162-18178117 "Predicted intracellular proteins, Predicted membrane proteins" Immunity Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 572.7;lymphoid tissue: 708.3" "Cell type enhanced" "Detected in many" "Hofbauer cells: 155.9;Kupffer cells: 205.4;Langerhans cells: 139.3;Macrophages: 426.2;monocytes: 144.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 9509.8;eosinophil: 3890.4;intermediate monocyte: 14243.6;myeloid DC: 5699.9;non-classical monocyte: 9865.9" "Group enriched" "Detected in all" 8 "dendritic cells: 5699.9;granulocytes: 3890.4;monocytes: 14243.6" "Cell line enhanced" "Detected in many" "Daudi: 655.7;RPMI-8226: 717.7;SK-BR-3: 457.4;U-266/84: 794.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA026650 Enhanced Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 110000 "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Vesicles, Cytosol" "HPA026650: AB_10602237" "unprognostic (4.66e-2)" "unprognostic (1.25e-4)" "unprognostic (2.35e-3)" "unprognostic (7.40e-2)" "unprognostic (1.76e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-3)" "unprognostic (2.40e-1)" "unprognostic (4.01e-2)" "unprognostic (9.19e-3)" "unprognostic (3.04e-1)" "unprognostic (1.19e-1)" "unprognostic (7.29e-11)" "unprognostic (3.50e-1)" "unprognostic (1.62e-2)" "unprognostic (3.39e-2)" "unprognostic (9.59e-3)" 132.4 121.0 18.4 708.3 20.8 283.8 58.6 20.3 104.5 40.8 48.7 129.0 197.3 22.2 26.9 38.7 57.3 109.6 31.2 18.0 23.3 80.3 148.2 572.7 370.7 32.0 24.9 14.8 61.3 75.0 27.9 128.8 40.5 31.6 148.0 2.6 66.3 22.0 12.6 55.0 153.6 165.0 26.8 385.3 112.2 16.0 69.4 91.9 54.2 9.0 221.0 215.7 19.6 49.8 115.5 59.2 0.4 37.9 11.2 19.9 102.6 11.8 17.2 34.6 91.8 132.3 193.1 655.7 96.6 39.7 175.2 85.1 69.9 30.1 3.7 182.5 55.2 8.1 98.1 188.9 111.8 20.1 46.9 70.4 60.4 59.8 19.7 4.4 2.0 23.8 96.8 394.8 16.6 217.3 9.9 2.5 21.2 380.6 68.7 65.8 4.5 717.7 101.1 3.7 5.3 8.0 200.5 457.4 11.3 7.4 31.6 8.8 4.2 55.2 34.2 120.7 12.0 14.6 794.7 368.5 154.1 133.5 8.5 106.9 9509.8 3890.4 40.8 14243.6 38.8 952.6 28.5 31.1 5699.9 708.1 19.7 24.3 2102.8 70.2 9865.9 173.2 41.5 11082.7 18.4 20.8 20.3 104.5 18.0 23.3 32.0 24.9 40.5 26.8 69.4 49.8 6.4 9.6 38.8 0.0 54.2 3.6 2.5 2.1 2.2 0.4 8.6 13.2 1.1 4.3 18.3 12.9 0.0 5.6 4.0 8.3 1.9 1.8 0.3 2.5 1.7 8.4 0.0 4.6 0.1 1.1 14.8 8.1 6.6 4.1 13.9 0.2 3.6 1.3 155.9 0.0 0.1 14.9 2.0 205.4 139.3 0.2 0.3 426.2 5.4 1.0 144.1 0.7 5.2 0.0 0.1 1.2 3.4 0.0 47.7 4.6 5.9 5.4 8.9 0.7 0.0 2.6 1.8 0.2 0.7 3.7 3.3 12.0 9.6 1.5 9.6 1.2 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;parathyroid gland: 5.1;placenta: 6.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 33.3;Cytotrophoblasts: 104.8;Early spermatids: 37.6;Late spermatids: 98.6;Syncytiotrophoblasts: 41.3" "Group enriched" "Detected in many" 5 "glioma: 2.2;testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 105.8;CACO-2: 27.4;Hep G2: 87.8;SuSa: 41.9" "Low region specificity" "Detected in many" HPA015713 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 12: NES - Nervous system development" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.0 0.2 2.3 0.0 2.0 0.0 0.8 4.3 3.2 1.0 0.0 0.4 0.0 0.7 0.1 0.0 0.6 0.1 0.1 2.6 1.9 0.2 0.0 0.0 0.0 2.4 2.7 0.8 0.0 5.1 1.9 6.0 2.4 0.1 0.0 1.0 0.0 0.1 0.1 0.1 0.1 0.2 1.6 0.0 0.2 2.8 3.0 1.4 0.9 0.0 0.0 0.1 0.4 1.9 0.0 0.0 105.8 4.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 27.4 0.2 0.0 0.3 0.0 0.0 0.0 7.2 0.0 0.0 0.0 1.0 0.0 0.2 87.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 16.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 2.2 1.5 0.1 0.1 0.0 41.9 3.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.0 4.3 3.2 2.6 1.9 2.4 2.7 2.4 1.6 3.0 1.9 0.1 0.0 0.0 15.3 0.0 0.0 0.2 0.0 0.0 4.1 2.2 1.0 0.6 0.0 0.0 1.8 33.3 104.8 0.0 0.4 0.0 0.0 37.6 0.4 4.8 1.0 0.0 0.0 2.8 0.0 4.3 3.0 0.0 0.6 0.0 0.1 0.0 0.0 7.2 0.0 7.0 0.0 0.0 0.0 0.0 98.6 0.6 0.1 0.0 1.0 0.0 3.7 0.0 16.1 8.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.7 0.4 1.3 11.0 0.0 0.0 41.3 0.1 0.1 0.2 0.0 IGF2R "CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI" ENSG00000197081 "Insulin like growth factor 2 receptor" P11717 6 159969082-160113507 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 69.5" "Cell type enhanced" "Detected in many" "NK-cells: 264.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009661, HPA011332" Supported Enhanced "Golgi apparatus,Vesicles" NA NA 190000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus, Vesicles" "CAB009661: AB_2122795, HPA011332: AB_1846276" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (2.92e-5)" "unprognostic (5.83e-2)" "unprognostic (1.72e-1)" "unprognostic (4.15e-1)" "unprognostic (3.25e-1)" "unprognostic (7.32e-3)" "unprognostic (2.32e-1)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.37e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.08e-4)" 20.3 21.9 1.8 11.4 3.7 13.3 16.0 3.9 4.3 15.2 11.7 17.4 7.4 19.3 4.8 16.7 13.9 10.7 21.8 3.2 4.2 14.8 23.9 22.2 8.2 4.3 3.6 17.0 16.6 14.3 9.5 15.3 3.8 11.0 11.6 3.2 18.4 6.7 69.5 16.5 14.7 16.0 3.2 23.2 15.5 7.7 4.8 15.9 14.5 27.2 7.8 15.3 16.5 5.9 20.8 18.1 32.6 44.6 108.4 76.4 36.9 30.1 80.4 30.3 52.8 28.3 37.2 7.3 30.9 38.4 101.7 25.4 27.0 140.0 52.0 47.7 19.4 3.6 30.0 32.1 49.2 20.7 31.2 52.7 45.4 57.6 144.8 65.4 19.2 36.0 42.2 48.2 46.4 10.1 8.8 13.4 13.1 19.3 23.2 23.2 20.6 46.1 29.9 20.8 11.3 25.4 45.0 34.5 44.8 41.4 15.7 49.4 25.3 27.0 27.9 57.3 60.4 16.7 40.2 9.1 49.0 23.7 38.9 0.5 1.0 0.8 1.1 0.3 0.4 0.2 0.5 0.4 0.2 0.2 0.5 0.7 4.4 0.7 0.4 1.3 0.2 0.3 1.8 3.7 3.9 4.3 3.2 4.2 4.3 3.6 3.8 3.2 4.8 5.9 44.7 48.1 47.3 34.6 16.7 22.2 10.0 16.0 17.1 13.0 20.2 14.7 33.6 24.3 22.1 16.5 20.9 7.5 107.0 46.2 0.0 29.3 7.5 25.8 38.7 29.6 22.3 9.5 33.0 19.4 12.3 29.9 16.8 39.7 3.8 41.7 28.9 63.4 22.2 15.2 34.2 18.4 12.2 59.4 12.8 5.2 47.5 37.6 12.4 31.9 65.9 11.7 264.7 30.7 40.0 40.8 17.2 38.4 35.9 17.1 23.2 23.6 12.2 15.1 65.7 63.7 32.6 10.9 10.4 28.9 19.7 9.3 38.8 38.8 20.9 16.7 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38406528-38424454 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "thyroid gland: 16.5" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.8;Excitatory neurons: 2.5;Hofbauer cells: 1.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 2.5;Spermatogonia: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 360.4;NTERA-2: 104.2;RH-30: 97.5;SCLC-21H: 334.3;SH-SY5Y: 332.6;SuSa: 241.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051354 Uncertain Uncertain Nucleoplasm,Vesicles "Secreted to blood" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 0.8 1.5 2.4 0.5 4.2 0.5 0.1 3.4 2.8 0.2 1.4 0.5 0.9 0.7 0.1 0.3 0.3 0.6 1.3 2.6 2.0 0.2 0.3 0.8 0.2 1.5 2.3 0.1 0.9 0.0 1.1 0.6 1.7 0.4 0.3 0.3 0.1 1.6 0.2 0.2 0.6 1.1 1.0 0.1 1.6 2.1 2.8 2.9 16.5 0.0 0.1 0.5 0.1 1.8 0.0 8.6 360.4 0.4 0.0 0.0 0.2 2.4 0.0 0.5 0.3 0.1 0.2 0.1 1.3 0.3 0.0 0.1 44.0 0.0 0.5 0.0 2.7 0.1 1.2 0.2 0.0 1.7 1.2 0.4 0.0 0.0 0.0 0.2 0.0 1.6 0.2 0.2 2.5 0.1 0.3 0.2 104.2 0.5 0.7 0.1 97.5 0.9 0.0 0.2 334.3 332.6 6.4 0.5 0.0 241.3 2.3 2.3 0.4 0.1 7.7 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.7 0.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.2 0.1 0.0 2.4 4.2 3.4 2.8 2.6 2.0 1.5 2.3 1.7 1.0 2.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.3 0.6 0.1 0.0 1.8 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 IL13RA1 "CD213a1, IL-13Ra, NR4" ENSG00000131724 "Interleukin 13 receptor subunit alpha 1" P78552 X 118727133-118794535 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 199.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 10.9;eosinophil: 12.2;myeloid DC: 17.2;neutrophil: 29.2" "Group enriched" "Detected in many" 7 "dendritic cells: 17.2;granulocytes: 29.2;monocytes: 10.9" "Cell line enhanced" "Detected in many" "HDLM-2: 181.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001587 Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 17000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" Vesicles Nucleoplasm "HPA001587: AB_1079133" "unprognostic (5.14e-3)" "unprognostic (4.72e-2)" "unprognostic (7.12e-2)" "unprognostic (7.75e-2)" "unprognostic (8.81e-3)" "unprognostic (3.82e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.44e-1)" "unprognostic (1.90e-1)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.82e-2)" "unprognostic (5.08e-2)" 51.9 34.3 15.9 40.3 16.2 7.1 41.5 18.1 17.3 27.1 20.4 52.1 48.5 31.9 26.2 53.5 35.8 39.3 20.2 14.6 22.3 33.7 120.3 48.9 25.4 26.0 20.3 37.5 22.3 22.2 15.4 32.8 24.6 22.5 61.6 25.6 34.7 27.1 31.4 20.6 60.8 40.6 22.2 29.9 35.8 16.6 19.6 16.0 29.8 55.9 34.5 31.6 27.4 24.6 31.6 37.2 17.4 48.0 39.0 113.5 33.1 63.3 86.2 29.2 37.6 21.8 55.0 0.1 111.4 86.6 84.8 29.1 19.0 26.6 32.3 181.0 16.5 5.1 30.9 55.8 23.4 0.6 13.0 104.1 23.5 40.0 48.8 87.9 61.8 0.0 16.6 3.3 41.9 44.8 0.1 8.5 16.1 57.8 38.6 0.1 43.3 0.2 43.6 32.9 6.5 6.0 102.3 35.5 24.7 22.8 22.8 28.9 79.3 56.7 26.7 99.7 50.5 0.7 16.8 0.3 125.6 16.1 24.6 0.2 10.9 12.2 0.0 2.7 0.1 2.9 0.0 0.0 17.2 2.5 0.0 0.0 29.2 0.1 1.1 2.9 0.1 2.9 15.9 16.2 18.1 17.3 14.6 22.3 26.0 20.3 24.6 22.2 19.6 24.6 36.0 70.5 48.5 1.0 20.2 17.2 37.1 17.2 18.2 2.1 32.4 26.3 11.5 37.1 46.0 29.5 16.7 8.1 2.8 61.9 9.8 36.1 38.1 25.8 34.0 58.8 93.2 4.8 0.3 98.3 31.9 38.7 38.7 27.3 0.0 13.6 78.9 149.0 41.2 0.0 2.0 138.4 16.2 124.8 140.6 7.3 24.2 120.4 21.4 73.1 199.7 43.7 2.1 0.0 6.9 87.9 27.0 18.8 1.3 42.3 70.8 25.2 49.7 11.2 32.9 14.4 26.2 7.5 28.9 37.2 12.1 9.4 2.7 7.1 29.5 30.8 IL17RB "CRL4, EVI27, IL17BR, IL17RH1" ENSG00000056736 "Interleukin 17 receptor B" Q9NRM6 3 53846568-53865794 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9;kidney: 59.8;liver: 33.3" "Cell type enhanced" "Detected in many" "Astrocytes: 48.3;Enteroendocrine cells: 29.2;Oligodendrocyte precursor cells: 37.7;Proximal tubular cells: 78.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 20.2;Hep G2: 59.5;OE19: 46.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005482 Enhanced Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 7: Kidney - Transmembrane transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Plasma membrane" "HPA005482: AB_1234567" "unprognostic (1.85e-3)" "unprognostic (4.22e-3)" "unprognostic (1.60e-3)" "unprognostic (2.86e-2)" "unprognostic (1.42e-2)" "unprognostic (6.20e-3)" "unprognostic (1.62e-2)" "unprognostic (6.09e-3)" "unprognostic (1.30e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" "unprognostic (4.27e-2)" "prognostic favorable (6.61e-4)" "unprognostic (8.10e-2)" "unprognostic (6.97e-2)" "unprognostic (5.29e-1)" "unprognostic (7.15e-3)" 0.9 2.0 20.2 2.3 21.4 0.5 5.7 22.7 28.9 18.1 16.6 6.8 5.8 5.1 0.7 1.7 3.3 2.4 2.7 19.4 20.2 59.8 33.3 3.8 2.5 18.7 19.9 1.5 7.8 1.1 4.2 0.9 19.0 2.4 6.9 4.8 4.9 0.6 1.3 2.2 5.9 0.8 18.9 1.2 3.6 2.5 23.2 0.3 2.9 0.2 0.7 0.8 1.3 23.6 1.5 3.1 4.5 3.4 0.1 0.0 7.1 3.1 0.1 0.1 0.0 20.2 1.4 4.6 1.0 1.0 1.7 0.8 12.2 0.0 0.0 1.6 3.5 6.0 6.1 59.5 0.0 5.6 3.2 0.0 0.0 0.0 0.0 3.8 0.0 1.6 4.9 2.1 0.1 4.2 0.9 2.3 12.1 46.2 2.6 1.7 1.9 5.3 1.4 5.3 6.4 3.7 10.1 2.4 1.9 3.3 9.2 2.0 2.5 3.0 3.3 2.6 3.9 4.7 5.6 2.9 2.7 3.3 1.7 1.3 0.2 0.0 0.2 0.2 0.1 0.1 0.6 0.2 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.3 0.9 0.1 20.2 21.4 22.7 28.9 19.4 20.2 18.7 19.9 19.0 18.9 23.2 23.6 0.2 0.0 4.1 48.3 0.2 0.3 2.0 0.0 0.0 0.1 8.2 4.4 4.1 17.2 1.3 0.0 0.0 1.4 0.3 4.3 9.8 4.8 1.0 0.5 1.0 0.2 29.2 0.0 0.5 1.6 1.0 0.6 4.6 1.7 2.5 0.4 0.4 13.1 0.1 0.0 2.5 8.7 2.0 0.0 1.1 0.7 1.2 1.2 0.0 1.9 0.0 4.4 0.0 37.7 4.3 1.8 3.0 0.4 0.0 4.4 2.9 78.0 0.0 0.1 0.0 0.3 0.5 0.4 1.0 0.0 0.1 0.4 0.9 0.0 10.2 0.6 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 225.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 109.2;Hepatocytes: 295.8;Oligodendrocyte precursor cells: 298.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "eosinophil: 23.8;neutrophil: 95.0" "Lineage enriched" "Detected in many" 15 "granulocytes: 95.0" "Cell line enriched" "Detected in many" 4 "SK-MEL-30: 247.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 350000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 2: Hepatocytes - Metabolism" "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.29e-4)" 6.2 2.9 4.0 11.4 1.1 20.3 4.3 0.0 8.7 4.4 0.5 2.2 1.8 4.0 2.6 13.1 5.4 12.1 3.9 4.6 3.1 3.3 225.8 8.2 2.7 2.4 3.7 3.0 3.9 1.5 1.2 37.0 3.3 3.9 2.2 2.4 5.2 3.4 1.3 11.9 2.2 6.4 1.5 5.4 4.5 1.3 5.5 4.6 4.0 2.1 4.8 9.4 5.5 3.3 13.3 3.0 5.5 0.8 9.5 7.7 10.0 5.8 11.9 13.4 13.2 5.8 29.3 2.2 59.2 16.4 31.1 34.1 3.0 57.6 18.7 2.5 3.6 2.9 5.3 14.5 19.6 20.2 9.5 10.3 23.1 19.7 59.2 27.8 6.0 5.9 0.4 0.2 6.4 6.5 1.7 9.4 8.5 6.0 6.0 9.5 8.2 4.8 5.3 14.8 1.0 0.0 26.3 15.0 247.1 5.2 9.6 14.6 7.9 10.3 10.4 32.1 26.6 5.0 0.2 0.5 17.2 18.0 60.9 11.7 3.8 23.8 1.8 4.3 3.3 2.1 2.1 2.3 3.8 2.1 2.0 1.3 95.0 0.3 6.3 0.6 2.1 1.4 4.0 1.1 0.0 8.7 4.6 3.1 2.4 3.7 3.3 1.5 5.5 3.3 3.5 0.0 14.7 6.5 6.8 44.7 16.5 45.8 68.9 6.5 2.5 4.7 5.5 40.0 22.8 3.7 8.4 8.5 3.6 1.8 0.0 7.7 4.4 8.6 3.8 8.0 5.4 4.4 44.3 7.5 109.2 7.3 7.1 12.3 7.6 0.7 7.5 295.8 7.8 0.0 63.3 1.4 4.1 33.7 17.7 0.6 4.4 28.8 8.8 53.4 5.0 1.0 6.2 298.6 1.5 19.7 0.8 2.6 5.3 11.5 0.7 1.1 8.7 0.6 0.0 18.0 5.1 0.1 0.6 30.9 37.2 24.2 5.2 1.4 1.1 14.3 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 110.7;skin 1: 163.3;vagina: 66.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 36.8;Basal respiratory cells: 115.8;Basal squamous epithelial cells: 60.9;Club cells: 43.0;Early spermatids: 57.0;Late spermatids: 28.8;Squamous epithelial cells: 56.5;Suprabasal keratinocytes: 38.1" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 86.0;HBEC3-KT: 140.0;HHSteC: 91.8;hTCEpi: 555.6;hTERT-HME1: 102.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol NA NA "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles Cytosol "HPA063914: AB_2732709" "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 2.3 0.2 0.1 0.0 0.2 0.0 10.3 0.1 0.6 24.3 0.1 0.6 0.0 0.2 0.0 110.7 0.4 0.0 0.6 0.1 0.1 0.2 5.4 0.5 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.4 0.2 2.2 0.5 0.0 13.6 0.2 1.0 163.3 0.4 0.0 0.1 0.3 0.5 3.7 0.2 2.0 0.5 0.9 9.5 1.3 66.2 0.2 27.2 0.0 0.1 0.4 15.4 64.9 2.6 0.6 1.8 0.3 1.2 2.7 3.4 0.2 14.9 9.7 1.0 86.0 0.0 140.0 0.7 0.4 0.0 0.3 19.5 0.0 91.8 0.2 0.2 11.5 555.6 4.5 102.6 0.7 0.1 0.1 0.3 0.1 0.0 0.0 0.6 0.0 0.4 2.4 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 54.6 0.0 2.8 4.7 0.5 0.9 0.0 0.2 1.8 0.5 0.5 0.1 0.2 0.2 8.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.7 0.0 0.0 0.7 0.0 36.8 1.7 115.8 60.9 0.0 0.3 0.5 0.4 0.0 43.0 0.0 0.0 1.7 0.8 0.8 0.0 0.9 57.0 0.7 0.4 0.9 0.0 0.0 1.0 0.2 1.4 3.9 0.0 0.8 0.0 0.2 0.0 2.2 0.4 0.0 1.2 0.7 10.2 0.3 6.6 28.8 0.3 0.6 3.6 1.0 1.7 0.0 1.0 1.0 0.2 1.0 0.1 0.7 0.4 1.3 0.2 0.3 5.5 0.0 0.0 0.6 3.6 1.7 1.9 56.5 38.1 1.6 0.6 0.2 0.5 5.3 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851357-55922854 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.6;lymphoid tissue: 2.1;testis: 1.8" "Cell type enhanced" "Detected in some" "Early spermatids: 2.2;Late spermatids: 1.2;Spermatocytes: 2.5;Syncytiotrophoblasts: 1.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 26.3;HBEC3-KT: 10.3;HHSteC: 9.5;hTERT-HME1: 11.5;U-2 OS: 16.8;U-87 MG: 20.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles Nucleoplasm "HPA051532: , HPA068114: AB_2732779" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.1 1.8 0.0 2.1 0.0 0.6 0.1 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.1 0.4 0.5 0.2 0.5 0.3 0.1 0.0 0.2 0.0 0.0 0.4 26.3 0.0 0.0 10.3 2.2 0.0 0.1 0.0 0.0 0.0 9.5 0.0 0.0 7.3 2.9 4.8 11.5 0.6 4.1 0.1 0.0 0.4 1.4 0.0 0.0 1.2 0.0 0.0 6.8 0.0 1.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.5 2.0 0.5 16.8 0.0 0.8 0.0 0.0 0.0 20.8 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.3 0.3 0.0 0.0 0.3 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.1 2.5 0.6 0.0 0.1 1.1 0.0 0.7 0.0 0.0 IL33 "C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV" ENSG00000137033 "Interleukin 33" O95760 9 6215786-6257983 "Predicted intracellular proteins, Predicted secreted proteins" Transcription Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 120.7" "Cell type enhanced" "Detected in many" "Endothelial cells: 141.8;Fibroblasts: 87.5;Hepatic stellate cells: 499.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 53.6;U-2197: 162.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007057, HPA022899, HPA024426" Supported Supported Nucleoplasm,Vesicles "Secreted to blood" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Vesicles "CAB007057: , HPA022899: , HPA024426: AB_1845820" "prognostic favorable (4.42e-4)" "unprognostic (8.36e-2)" "unprognostic (5.67e-3)" "unprognostic (7.67e-3)" "unprognostic (4.27e-1)" "unprognostic (1.63e-1)" "unprognostic (2.59e-3)" "unprognostic (2.66e-3)" "unprognostic (3.18e-1)" "unprognostic (2.05e-1)" "unprognostic (1.43e-1)" "unprognostic (8.08e-2)" "unprognostic (1.58e-3)" "unprognostic (4.70e-3)" "unprognostic (4.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.85e-3)" 38.7 16.7 9.2 44.6 9.3 0.2 27.2 7.0 12.1 56.2 6.4 24.8 8.8 50.0 15.9 24.5 25.9 33.4 40.9 8.5 10.8 5.0 36.7 53.0 47.1 7.8 8.3 5.0 3.4 3.7 5.7 61.1 7.1 30.0 19.4 2.0 18.9 31.5 6.1 44.0 15.6 50.8 8.3 20.5 33.6 5.8 10.8 13.1 12.6 13.8 43.0 120.7 21.2 8.6 0.0 0.0 0.0 0.0 0.3 1.4 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.1 16.9 0.3 0.0 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.9 0.7 0.3 0.4 53.6 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 162.9 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 9.3 7.0 12.1 8.5 10.8 7.8 8.3 7.1 8.3 10.8 8.6 63.5 6.4 7.2 39.5 1.0 24.2 17.0 73.9 27.3 0.0 9.4 4.1 5.8 4.3 77.8 0.0 0.0 0.0 0.1 2.2 0.0 3.0 0.5 12.4 7.1 141.8 10.7 8.0 0.2 7.9 0.0 87.5 48.4 20.6 1.3 0.0 499.4 5.0 0.1 0.0 0.1 0.2 2.0 20.8 10.2 1.6 20.5 1.7 1.8 1.0 0.0 9.5 0.0 0.5 0.1 12.1 0.2 12.4 0.2 5.2 0.0 0.0 62.1 0.1 0.0 65.5 11.5 0.0 0.4 3.3 48.4 0.1 1.2 0.1 1.1 4.9 IL37 "FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7" ENSG00000125571 "Interleukin 37" Q9NZH6 2 112912971-112918882 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 136.8" "Cell type enriched" "Detected in some" 26 "Ionocytes: 73.2" "Cancer enriched" "Detected in some" 6 "lung cancer: 6.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.7;PC-3: 5.9;RT4: 3.2" "HPA054371, HPA057950" Uncertain Supported Nucleoplasm,Vesicles "Secreted to blood" NA NA 76700 "Cluster 48: NK-cells - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Vesicles" "HPA054371: AB_2682465, HPA057950: AB_2683561" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" "unprognostic (3.71e-5)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.09e-2)" "unprognostic (1.28e-2)" "unprognostic (9.54e-2)" "unprognostic (8.26e-3)" "unprognostic (3.95e-2)" "unprognostic (1.66e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-2)" 0.1 0.0 0.0 0.2 0.0 0.2 16.7 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.1 0.4 136.8 0.1 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.0 0.1 0.2 2.7 0.2 0.2 0.2 0.3 0.0 0.2 0.1 0.2 0.1 0.1 0.4 0.8 0.1 0.0 1.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.2 0.2 5.9 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 73.2 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.8 0.0 0.1 0.0 0.0 0.0 ILVBL "209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535" ENSG00000105135 "IlvB acetolactate synthase like" A1L0T0 19 15114984-15125786 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 148.2;Syncytiotrophoblasts: 253.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067682 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Golgi apparatus, Vesicles" "HPA067682: AB_2685885" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.04e-2)" "unprognostic (2.53e-1)" "unprognostic (3.83e-1)" "unprognostic (5.60e-2)" "unprognostic (1.77e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.91e-8)" "unprognostic (4.65e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (2.40e-1)" 29.7 45.5 22.7 13.9 27.5 15.5 27.5 30.9 25.1 29.7 32.8 46.2 50.1 24.3 14.4 40.9 22.6 25.5 73.7 21.4 25.5 41.6 56.8 19.2 15.5 29.2 25.3 28.3 42.5 65.8 34.4 19.2 26.3 24.2 18.6 13.8 27.7 23.2 18.7 43.4 43.7 13.7 24.8 17.6 41.1 25.5 25.2 10.5 48.0 25.0 10.6 28.5 30.6 32.3 68.8 41.0 34.4 40.7 43.8 29.7 39.6 31.6 42.2 37.2 47.5 65.5 162.1 29.7 61.1 34.2 22.3 50.6 20.9 38.5 10.8 27.5 41.1 43.7 41.3 72.4 70.1 37.2 37.0 44.6 43.9 21.7 28.3 30.4 35.0 29.6 17.9 37.6 29.3 159.0 24.9 29.6 31.9 54.9 58.8 36.0 31.1 46.5 32.3 33.6 28.4 38.3 18.8 81.2 62.1 13.2 37.2 31.2 37.7 55.9 30.7 71.0 45.1 26.1 29.2 15.1 35.9 35.8 43.1 22.7 22.2 5.5 21.1 31.8 24.0 11.9 17.7 22.0 26.3 12.9 22.9 23.6 2.5 23.7 30.3 19.1 20.2 23.3 22.7 27.5 30.9 25.1 21.4 25.5 29.2 25.3 26.3 24.8 25.2 32.3 28.0 25.6 11.7 18.3 12.7 12.7 26.8 53.8 22.2 95.3 18.0 14.9 36.1 62.9 43.0 25.8 27.1 84.2 15.8 67.8 19.6 48.4 6.2 9.9 13.4 23.2 44.4 12.6 4.9 50.6 148.2 21.4 40.2 13.0 11.4 29.0 26.7 59.3 43.2 18.5 8.3 60.6 28.5 12.1 9.5 6.5 25.7 15.8 83.6 5.6 6.8 48.0 7.2 9.0 15.7 32.3 68.4 19.9 17.2 18.6 123.0 50.4 26.1 36.8 19.7 14.7 21.2 20.3 20.8 25.0 16.2 253.4 11.8 48.2 73.2 23.4 INHA ENSG00000123999 "Inhibin subunit alpha" P05111 2 219569162-219575711 "Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 75.6;ovary: 104.4;testis: 95.3" "Cell type enhanced" "Detected in some" "Granulosa cells: 254.3;Syncytiotrophoblasts: 331.0;Theca cells: 75.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.5;HEL: 4.5;SK-BR-3: 9.9;SuSa: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB000047, HPA019141, HPA048834" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Golgi apparatus" "CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: " "unprognostic (8.90e-3)" "unprognostic (2.91e-2)" "unprognostic (2.82e-1)" "unprognostic (7.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.45e-1)" "unprognostic (3.57e-1)" "unprognostic (9.61e-3)" "unprognostic (4.15e-3)" "unprognostic (6.71e-2)" "unprognostic (3.73e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (4.85e-2)" "unprognostic (7.20e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" 1.2 75.6 3.4 0.2 3.7 0.1 1.4 2.7 4.8 2.0 2.2 0.9 0.2 2.0 2.2 0.8 3.0 0.4 16.3 3.5 3.2 3.1 0.7 0.8 0.1 3.4 2.9 104.4 12.3 0.7 6.6 11.3 3.5 3.1 0.0 1.9 1.5 1.1 0.8 2.1 0.4 0.4 2.5 0.4 0.7 95.3 3.4 0.0 3.3 0.0 0.0 1.0 1.8 3.0 0.4 0.2 0.0 1.9 0.6 0.1 3.5 0.3 0.2 0.5 0.2 0.3 3.2 0.0 0.2 0.7 0.5 2.0 0.2 0.5 0.0 0.0 0.6 4.5 1.8 2.4 0.3 0.0 0.0 0.6 0.8 0.0 0.5 1.4 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.1 1.2 0.1 0.9 0.1 0.2 0.0 0.5 0.2 0.3 0.8 1.1 9.9 0.3 4.9 0.5 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.7 2.7 4.8 3.5 3.2 3.4 2.9 3.5 2.5 3.4 3.0 0.1 0.0 0.0 5.9 0.0 0.0 0.1 0.8 0.0 2.7 0.3 0.3 2.2 0.0 0.1 7.3 2.1 11.8 0.0 0.0 0.0 2.8 0.8 0.5 0.5 0.2 0.0 0.0 5.9 8.9 35.5 1.2 0.0 0.5 0.0 254.3 0.7 0.1 2.6 6.7 6.9 0.0 0.0 0.3 0.0 5.0 4.1 0.2 0.0 0.0 0.0 3.7 0.0 1.0 0.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 3.4 0.6 0.0 0.0 331.0 0.0 75.6 0.0 0.0 INKA1 "C3orf54, FAM212A" ENSG00000185614 "Inka box actin regulator 1" 3 49803261-49805030 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 24.1" "Cell type enhanced" "Detected in some" "Adipocytes: 19.9;Breast myoepithelial cells: 9.7;Endothelial cells: 8.4;Hofbauer cells: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 59.6;memory B-cell: 65.9;naive B-cell: 64.4" "Group enriched" "Detected in many" 7 "B-cells: 65.9;granulocytes: 59.6" "Cell line enhanced" "Detected in many" "HEL: 68.5;HMC-1: 45.1;NB-4: 38.5;THP-1: 42.1;U-937: 34.9" "Low region specificity" "Detected in all" HPA041879 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 32: U-937 - Innate immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Vesicles" "HPA041879: AB_10797269" "unprognostic (1.36e-1)" "unprognostic (2.99e-2)" "unprognostic (6.97e-2)" "unprognostic (7.95e-2)" "unprognostic (1.34e-1)" "prognostic favorable (1.96e-4)" "unprognostic (2.70e-2)" "unprognostic (4.35e-2)" "unprognostic (7.28e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-3)" "unprognostic (4.61e-2)" "unprognostic (1.90e-3)" "unprognostic (4.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.40e-2)" 5.1 2.3 4.8 2.0 5.0 3.5 4.1 5.2 7.6 6.2 2.8 3.2 0.8 4.7 1.4 19.7 2.8 1.5 5.2 5.3 5.5 5.8 1.1 5.4 4.1 6.2 5.3 2.2 1.3 0.5 2.1 3.1 5.7 6.4 0.5 0.2 4.9 2.1 11.7 24.1 4.3 1.8 5.8 6.7 2.4 2.9 6.5 1.6 2.1 2.3 3.9 5.5 10.3 7.0 1.3 1.1 1.5 1.1 1.8 4.1 0.0 3.0 1.9 1.4 1.7 0.1 0.0 14.9 0.4 2.2 1.5 8.7 0.5 10.4 0.1 2.6 0.0 68.5 0.7 0.2 2.6 10.4 45.1 5.4 14.5 2.9 2.6 0.9 6.1 1.0 4.7 1.2 1.2 0.6 0.9 38.5 1.1 0.0 5.8 13.9 0.8 3.3 0.1 16.9 0.8 5.3 2.7 0.5 1.5 0.4 0.3 42.1 3.8 7.3 0.9 3.4 1.3 1.7 1.7 1.2 3.2 34.9 1.8 59.6 2.4 11.6 1.3 5.9 0.3 65.9 1.5 1.8 0.7 64.4 2.2 3.6 1.3 0.0 8.5 9.3 1.6 6.4 4.8 5.0 5.2 7.6 5.3 5.5 6.2 5.3 5.7 5.8 6.5 7.0 19.9 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 1.0 9.7 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.7 0.0 0.5 1.6 8.4 0.0 0.0 0.0 1.2 0.7 3.0 0.0 0.1 0.0 0.1 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.1 0.4 0.5 0.0 0.0 INMT ENSG00000241644 "Indolethylamine N-methyltransferase" O95050 7 30697985-30757602 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Detoxification "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 205.8" "Group enriched" "Detected in many" 7 "Endothelial cells: 150.4;Hepatic stellate cells: 268.4;Leydig cells: 285.2;Peritubular cells: 455.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CACO-2: 16.7;HHSteC: 6.7" HPA061343 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Vesicles" "HPA061343: AB_2684483" "unprognostic (1.70e-1)" "unprognostic (4.36e-2)" "unprognostic (5.26e-2)" "unprognostic (6.78e-3)" "unprognostic (1.59e-1)" "unprognostic (3.39e-4)" "prognostic favorable (5.72e-4)" "unprognostic (3.08e-2)" "unprognostic (3.94e-2)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (9.07e-2)" "unprognostic (4.97e-2)" "unprognostic (1.62e-2)" "unprognostic (1.43e-2)" "unprognostic (9.71e-2)" "unprognostic (1.58e-2)" 64.5 51.2 3.1 2.7 6.0 0.7 10.2 7.9 13.1 6.4 9.3 9.5 2.8 16.0 25.4 15.0 43.8 8.3 75.6 7.6 8.7 20.0 23.3 205.8 7.6 9.6 6.0 17.7 11.3 5.7 7.8 33.7 5.6 29.6 4.6 0.5 9.1 48.0 14.4 4.2 8.5 25.7 2.5 13.0 12.7 15.8 4.8 1.7 21.3 13.2 4.0 11.1 7.2 16.6 0.0 0.1 0.0 0.1 1.5 2.1 0.3 0.2 2.1 0.0 0.0 16.7 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 6.7 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.2 0.2 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.5 0.1 0.6 0.0 0.6 0.1 0.0 1.0 0.0 0.6 0.2 0.0 0.7 0.3 0.0 0.2 0.1 0.3 1.6 0.2 0.2 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.5 0.1 0.3 0.1 0.2 3.1 6.0 7.9 13.1 7.6 8.7 9.6 6.0 5.6 2.5 4.8 16.6 39.4 0.0 3.6 0.0 1.0 2.2 0.1 0.0 1.2 0.0 0.4 0.6 10.0 7.2 2.5 0.0 0.0 0.7 0.3 0.0 0.0 0.0 2.3 0.1 0.8 150.4 1.2 8.0 0.0 0.0 0.4 38.2 0.0 0.0 0.0 0.9 268.4 5.1 0.8 0.0 0.0 0.2 0.0 16.6 4.4 16.0 285.2 0.7 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 455.5 1.5 0.2 0.0 0.1 0.7 0.0 32.9 5.0 19.6 1.3 1.3 0.4 2.3 1.8 1.3 0.2 0.0 0.4 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294414 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.5" "Cell line enhanced" "Detected in many" "Karpas-707: 54.9;U-266/70: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" NA Yes 190000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles "Plasma membrane" "HPA036302: AB_2675048, HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 13.0 22.6 12.5 2.8 16.8 5.6 13.0 17.3 12.8 14.6 18.8 15.0 10.0 18.4 6.3 4.1 16.9 8.2 26.3 10.0 12.2 21.8 33.0 7.2 2.3 18.3 16.3 39.9 64.2 13.0 16.3 7.4 18.7 15.2 10.4 6.5 16.9 9.9 23.5 11.5 12.2 11.5 14.1 48.2 12.5 5.4 16.6 2.7 14.5 13.3 3.5 12.3 9.2 22.5 6.2 3.2 3.6 5.7 18.8 6.1 11.1 3.5 2.9 1.6 1.6 8.4 7.0 9.0 8.2 6.8 4.0 1.6 8.9 1.4 1.2 0.0 6.4 0.0 2.3 22.6 8.2 4.3 6.7 10.0 4.5 0.2 4.9 4.2 3.8 4.8 9.5 54.9 1.8 3.2 3.1 7.8 3.3 3.8 5.2 29.0 2.1 7.6 0.1 27.8 6.6 5.2 6.5 3.8 3.3 6.4 1.4 21.6 3.6 3.4 2.1 8.2 5.1 40.4 23.9 20.2 4.3 7.3 0.0 2.7 8.6 5.9 0.2 8.8 0.3 0.8 0.3 0.1 9.8 1.1 0.7 0.1 1.9 1.0 12.5 8.2 0.0 1.6 12.5 16.8 17.3 12.8 10.0 12.2 18.3 16.3 18.7 14.1 16.6 22.5 75.6 48.1 34.7 64.9 10.6 64.9 63.6 34.7 8.0 40.4 134.0 76.2 92.1 137.2 83.3 62.5 79.2 17.8 6.7 124.1 15.6 55.1 4.7 26.8 106.8 123.9 163.6 25.0 68.3 78.7 53.7 43.7 20.4 42.1 3.8 168.4 255.2 246.0 9.2 38.7 100.8 97.3 32.6 49.0 31.1 9.0 96.3 35.0 51.6 62.8 24.2 31.6 0.0 62.8 183.5 50.7 68.8 245.3 21.8 107.9 122.9 114.1 65.3 23.6 59.2 37.6 44.2 5.2 3.6 3.2 68.8 38.3 4.7 81.4 65.2 130.0 IPO9 "FLJ10402, Imp9" ENSG00000198700 "Importin 9" Q96P70 1 201829149-201884291 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059540 Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 70000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Cytosol Vesicles "HPA059540: " "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.44e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (4.11e-5)" "unprognostic (8.92e-3)" "unprognostic (2.23e-3)" "unprognostic (2.52e-1)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (5.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (5.78e-4)" 17.0 18.2 17.8 12.0 17.8 10.1 16.5 18.0 22.5 18.9 16.4 15.9 9.2 19.2 18.2 15.7 15.2 9.2 15.9 18.8 17.6 17.4 26.9 17.9 13.7 17.3 16.7 17.2 17.9 14.8 20.7 14.5 16.8 17.5 13.9 23.7 12.3 10.8 14.0 17.7 15.1 16.7 15.0 19.6 14.3 14.4 17.8 16.2 19.3 10.7 16.7 16.6 15.0 17.1 45.4 46.9 63.0 51.4 35.7 24.1 47.1 34.2 34.3 55.6 53.8 75.6 38.4 26.8 18.9 32.9 48.8 41.0 43.0 47.2 47.9 24.5 38.1 20.0 75.2 57.2 27.2 26.2 31.4 26.7 21.3 60.2 48.5 37.1 56.7 36.0 40.5 24.6 40.4 45.1 30.5 34.2 63.4 40.6 15.2 32.2 65.8 26.6 30.7 71.0 53.3 60.5 37.5 58.7 30.8 96.6 43.1 32.8 31.1 52.1 46.6 29.5 63.5 18.1 12.0 31.5 25.9 30.5 39.8 10.1 10.1 8.7 9.9 13.2 8.6 9.5 9.5 10.9 12.6 8.5 7.6 8.3 2.3 10.2 13.8 6.6 9.5 7.8 17.8 17.8 18.0 22.5 18.8 17.6 17.3 16.7 16.8 15.0 17.8 17.1 25.7 22.4 45.6 48.0 22.1 15.8 14.9 14.3 13.6 57.9 14.5 14.7 23.6 10.0 20.4 7.3 60.5 27.8 17.6 7.5 1.9 16.9 8.0 9.2 28.9 27.3 11.3 28.6 60.1 18.7 20.8 25.4 16.3 11.2 11.4 32.6 23.2 18.1 19.5 75.7 60.7 16.3 10.2 17.6 21.5 8.8 20.2 13.3 14.2 36.5 21.6 38.1 26.8 46.8 50.6 17.6 10.6 28.2 18.2 16.4 8.9 9.0 10.5 56.5 39.5 35.4 26.1 42.0 37.3 16.4 14.2 22.6 17.0 26.0 17.0 12.5 IQGAP2 ENSG00000145703 "IQ motif containing GTPase activating protein 2" Q13576 5 76403285-76708132 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 113.1" "Cell type enhanced" "Detected in many" "Early spermatids: 1011.9;Late spermatids: 351.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 21.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 74.2;Hep G2: 61.7;HMC-1: 211.8;RPMI-8226: 81.6;U-937: 57.0" "Region enhanced" "Detected in many" "hippocampal formation: 30.5" "Low region specificity" "Detected in all" "CAB004241, HPA037403, HPA037404" Uncertain Approved "Vesicles,Plasma membrane" NA NA 3700000 "Cluster 18: Basophils - Vesicular transport" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Vesicles, Plasma membrane" "CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460" "unprognostic (9.46e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (9.03e-3)" "unprognostic (8.85e-2)" "prognostic favorable (5.65e-4)" "unprognostic (5.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "prognostic favorable (9.44e-12)" "unprognostic (3.29e-2)" "unprognostic (9.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.27e-2)" 7.9 12.2 0.8 11.7 0.6 25.0 27.1 0.5 0.7 19.6 2.4 25.7 56.5 3.3 9.5 2.8 3.4 18.6 2.9 0.4 0.9 35.2 113.1 9.9 14.4 2.2 2.5 8.9 25.7 44.3 1.1 30.7 1.9 15.2 23.0 23.9 34.6 15.4 0.3 2.7 31.4 4.3 1.4 13.2 39.1 51.1 2.4 7.3 28.6 1.3 8.2 6.5 1.5 2.4 0.0 9.6 31.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 74.2 0.1 0.7 2.7 0.0 2.7 0.2 12.1 0.0 0.1 8.6 12.0 27.6 6.8 61.7 0.2 15.7 211.8 0.0 0.0 0.0 0.0 0.0 1.2 14.9 24.6 21.4 0.0 0.0 13.5 42.4 14.8 25.4 0.3 4.9 0.1 81.6 0.0 0.1 0.6 3.2 17.3 0.9 0.1 31.4 0.0 9.3 0.4 0.0 0.5 0.0 0.3 19.8 0.0 18.7 0.1 57.0 3.0 21.3 3.1 1.9 4.5 2.5 3.7 0.5 4.7 3.9 2.9 0.2 1.8 3.3 6.0 4.3 3.4 7.7 6.2 1.4 0.8 0.6 0.5 0.7 0.4 0.9 2.2 2.5 1.9 1.4 2.4 2.4 9.1 12.8 12.2 0.7 27.3 4.7 21.5 2.4 0.0 6.7 68.9 34.5 3.5 107.2 9.1 35.0 108.4 14.2 230.3 96.2 7.9 44.5 1011.9 43.8 3.3 7.7 9.1 76.3 2.3 66.7 1.2 22.0 99.4 37.5 94.9 8.7 18.5 235.7 65.9 1.7 19.0 52.9 61.1 132.6 63.3 351.0 7.5 141.3 16.0 47.8 63.4 14.0 114.4 0.5 1.1 18.7 37.5 5.3 148.3 21.5 87.1 65.2 16.1 121.8 0.0 3.9 3.5 25.5 11.4 1.2 3.8 7.3 112.1 82.7 43.7 6.5 IQSEC2 "BRAG1, IQ-ArfGEF, KIAA0522, MRX1, MRX18, MRX78" ENSG00000124313 "IQ motif and Sec7 domain ArfGEF 2" Q5JU85 X 53225828-53321350 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 58.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 54.0;Late spermatids: 41.6;Proximal enterocytes: 42.1;Proximal tubular cells: 52.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 10.4;plasmacytoid DC: 10.6" "Group enriched" "Detected in many" 16 "dendritic cells: 10.6;monocytes: 10.4" "Cell line enhanced" "Detected in many" "A549: 47.3;GAMG: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003973, HPA076533" Approved "Vesicles,Lipid droplets" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 47: Non-specific - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Lipid droplets" "HPA003973: AB_2280343, HPA076533: " "unprognostic (1.85e-1)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (1.32e-1)" "unprognostic (4.66e-3)" "unprognostic (6.02e-2)" "unprognostic (2.80e-1)" "unprognostic (3.78e-2)" "unprognostic (2.82e-1)" "unprognostic (9.05e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.56e-2)" "unprognostic (1.75e-1)" "unprognostic (4.30e-2)" "prognostic favorable (2.38e-4)" 10.8 18.8 18.3 5.8 22.4 2.4 9.9 9.8 32.3 9.7 0.0 14.9 12.5 12.0 4.4 9.5 10.7 6.1 11.2 35.8 0.0 19.4 1.9 8.7 2.8 2.4 0.1 7.6 9.0 14.1 10.9 3.8 2.8 12.0 7.1 3.0 14.9 8.8 58.7 8.9 14.2 7.3 0.3 5.3 10.4 9.9 0.2 3.4 9.7 34.0 3.4 12.1 9.8 14.2 4.8 47.3 1.8 4.4 6.5 13.1 5.3 7.7 13.4 6.2 10.9 1.2 18.2 0.3 12.4 18.3 58.5 6.4 1.7 7.7 4.4 4.8 8.3 5.4 20.8 1.3 14.2 0.2 2.8 9.8 11.8 16.1 9.0 14.4 8.5 0.1 17.3 5.3 12.4 11.2 0.0 1.0 14.6 14.2 21.0 3.5 3.7 6.0 9.0 10.1 1.9 1.8 18.0 11.0 7.5 8.3 15.7 2.3 9.5 5.6 10.6 3.1 3.5 1.5 0.2 0.2 34.6 3.5 3.1 0.1 10.4 0.5 0.0 3.7 0.1 0.2 0.0 0.0 5.4 0.1 0.1 0.0 0.6 0.0 2.0 10.6 0.0 2.3 18.3 22.4 9.8 32.3 35.8 0.0 2.4 0.1 2.8 0.3 0.2 14.2 8.4 6.4 5.9 15.0 1.4 4.0 6.7 11.5 7.4 1.5 12.2 9.5 4.0 12.8 9.3 14.7 0.0 8.0 2.0 21.1 21.5 5.2 18.0 5.4 3.5 6.2 3.6 0.8 54.0 7.1 6.5 6.6 8.2 4.7 3.8 9.1 6.4 0.9 14.7 0.0 25.7 9.7 8.2 12.0 5.0 41.6 1.5 14.1 10.6 17.8 11.9 5.0 0.0 9.5 2.5 5.5 12.6 2.2 1.0 7.0 42.1 52.4 7.6 0.1 0.0 2.7 8.4 0.8 1.5 9.3 3.8 4.5 1.5 2.5 10.7 14.6 IRX4 ENSG00000113430 "Iroquois homeobox 4" P78413 5 1877413-1887236 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 15.8;heart muscle: 14.3;skin 1: 22.5;vagina: 12.2" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 48.6;Basal squamous epithelial cells: 50.7;Breast myoepithelial cells: 15.6;Prostatic glandular cells: 13.3;Squamous epithelial cells: 26.5;Suprabasal keratinocytes: 20.2" "Group enriched" "Detected in many" 5 "cervical cancer: 5.4;head and neck cancer: 7.3;lung cancer: 1.8;prostate cancer: 6.9;testis cancer: 7.3" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 41.8;HaCaT: 16.3;HBEC3-KT: 8.1;MCF7: 8.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "medulla oblongata: 1.2;pons: 1.5" HPA064094 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Vesicles" "HPA064094: " "unprognostic (1.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (1.53e-1)" "unprognostic (1.35e-1)" "unprognostic (7.52e-2)" "unprognostic (7.54e-2)" "unprognostic (4.26e-1)" "unprognostic (1.70e-2)" 0.2 0.0 0.0 0.0 0.0 0.1 3.2 0.7 0.0 3.7 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 14.3 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.9 0.0 1.2 9.9 0.0 0.0 9.5 0.0 0.6 22.5 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 12.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 16.3 0.0 8.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 8.3 1.1 0.1 0.1 4.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 3.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.8 0.7 1.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 48.6 2.8 0.1 50.7 0.0 1.4 15.6 6.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 1.1 26.5 20.2 3.7 0.0 0.0 0.0 1.7 ISOC1 CGI-111 ENSG00000066583 "Isochorismatase domain containing 1" Q96CN7 5 129094749-129114028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 156.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070307 Approved "Endoplasmic reticulum,Vesicles" NA NA 1900000 "Cluster 44: Non-specific - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" "Endoplasmic reticulum, Vesicles" "HPA070307: AB_2686249" "unprognostic (1.67e-1)" "unprognostic (4.46e-2)" "unprognostic (1.29e-1)" "unprognostic (6.42e-3)" "unprognostic (3.87e-2)" "unprognostic (1.91e-1)" "unprognostic (6.32e-2)" "unprognostic (1.90e-1)" "unprognostic (2.47e-1)" "unprognostic (4.19e-2)" "unprognostic (2.00e-2)" "unprognostic (4.18e-1)" "unprognostic (7.09e-3)" "unprognostic (2.49e-1)" "unprognostic (2.65e-1)" "unprognostic (1.65e-2)" "unprognostic (1.32e-2)" 27.8 28.0 11.9 12.8 12.2 12.6 25.5 11.9 13.7 57.2 11.4 19.6 32.1 102.7 21.0 22.1 27.2 15.6 65.7 11.1 16.0 33.6 100.2 14.0 14.6 15.9 16.4 17.1 19.9 15.7 20.5 15.3 13.8 19.7 21.7 14.8 28.4 8.9 17.1 23.5 28.3 64.9 13.8 10.0 20.4 11.1 15.2 18.9 13.3 16.4 16.8 21.3 19.2 15.2 27.7 21.4 21.7 33.5 35.0 18.5 95.7 11.7 10.0 13.1 23.1 75.5 38.2 19.6 28.3 6.9 40.0 14.7 46.5 35.2 24.2 107.5 52.8 39.0 20.9 55.7 24.7 15.6 13.6 12.2 10.5 20.5 17.7 9.4 31.6 30.6 43.0 33.2 11.6 110.2 29.2 25.3 33.5 26.4 57.8 41.5 63.2 19.3 32.9 55.4 36.6 156.9 33.7 42.3 21.6 19.7 34.9 13.0 13.4 14.8 28.1 11.9 38.3 27.5 22.9 32.7 16.5 48.4 17.0 64.0 25.2 38.0 54.0 25.0 61.4 47.7 50.3 57.7 31.5 49.4 43.9 51.8 30.9 61.4 25.3 29.0 69.0 48.9 11.9 12.2 11.9 13.7 11.1 16.0 15.9 16.4 13.8 13.8 15.2 15.2 58.1 12.8 17.2 6.5 18.9 131.8 42.4 28.5 88.2 12.4 33.6 19.8 70.6 34.3 19.3 20.2 10.4 74.7 26.3 19.9 125.2 22.2 1.6 23.5 30.1 16.9 31.8 21.0 1.7 28.1 71.8 33.9 17.3 24.9 18.4 51.0 5.3 84.7 23.9 0.0 5.6 26.6 30.5 8.8 41.0 4.2 13.7 14.3 28.4 4.7 18.9 52.9 18.6 6.0 9.2 16.3 29.8 19.2 36.9 38.5 45.7 96.2 10.6 6.5 0.0 33.7 15.9 6.5 38.1 53.7 84.1 50.9 26.4 79.3 32.8 37.8 ITCH AIP4 ENSG00000078747 "Itchy E3 ubiquitin protein ligase" Q96J02 20 34363241-34540748 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 139.7;Oligodendrocytes: 260.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021126, HPA049032, CAB072824, CAB072825" Supported Enhanced Nucleoplasm,Vesicles No No "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607" "unprognostic (2.51e-1)" "unprognostic (6.95e-2)" "unprognostic (1.25e-3)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (9.29e-3)" "unprognostic (1.94e-1)" "unprognostic (3.89e-3)" "unprognostic (1.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.24e-1)" "unprognostic (3.23e-2)" "unprognostic (2.21e-1)" 19.5 16.2 13.7 18.1 27.1 27.3 20.0 19.6 17.7 24.5 17.7 21.6 20.2 19.4 16.6 42.8 15.7 17.0 20.2 14.7 15.9 23.3 55.6 18.7 21.4 19.8 20.0 18.8 16.5 23.1 7.8 25.6 21.0 19.6 23.5 25.6 18.7 19.9 17.2 14.0 20.9 21.5 15.9 20.4 20.9 38.5 20.2 23.2 26.3 21.7 25.7 30.6 14.8 45.7 55.5 34.6 35.2 25.9 38.3 57.4 42.7 43.5 52.0 56.2 54.0 101.5 83.8 26.7 42.1 55.6 73.9 66.2 54.9 92.3 66.2 20.8 17.9 78.3 28.2 59.3 43.9 32.6 34.4 31.7 46.2 44.4 72.2 49.8 41.7 40.6 45.5 45.7 46.2 26.5 49.2 18.8 16.9 35.6 44.2 40.9 76.3 63.6 34.7 91.2 21.4 16.4 82.0 32.7 51.0 33.9 38.3 31.1 39.5 61.5 36.0 42.8 33.3 36.2 40.5 40.0 41.0 21.6 38.0 4.6 6.7 7.0 12.0 7.0 12.5 9.2 4.2 6.1 4.9 7.8 3.7 5.7 20.2 7.6 4.9 14.3 5.8 4.3 13.7 27.1 19.6 17.7 14.7 15.9 19.8 20.0 21.0 15.9 20.2 45.7 26.1 12.8 21.8 56.5 33.1 15.0 23.9 11.7 25.6 19.5 15.1 8.5 25.0 12.8 25.6 31.3 25.0 17.5 46.1 28.8 5.9 12.8 59.0 26.5 34.6 20.7 12.0 26.5 85.0 16.3 21.2 24.2 33.1 36.1 19.0 17.9 18.2 53.0 15.8 15.2 72.3 16.9 10.2 24.3 26.7 139.7 22.4 31.4 26.6 68.4 30.0 38.2 43.3 79.4 260.0 22.6 23.7 15.4 50.3 25.8 21.1 26.8 23.5 26.0 13.1 21.4 22.0 40.6 25.5 30.4 16.2 46.9 30.8 12.3 11.9 40.6 ITIH5 MGC10848 ENSG00000123243 "Inter-alpha-trypsin inhibitor heavy chain 5" 10 7559270-7666998 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 112.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 282.7;Fibroblasts: 111.3;Microglial cells: 160.2;Smooth muscle cells: 110.1;Syncytiotrophoblasts: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038305 Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Vesicles "HPA038305: AB_10670662" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "unprognostic (3.11e-3)" "unprognostic (6.80e-2)" "unprognostic (1.80e-1)" "unprognostic (5.84e-3)" "unprognostic (1.63e-1)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (2.90e-1)" "unprognostic (5.80e-3)" "unprognostic (6.11e-2)" "unprognostic (1.36e-1)" "unprognostic (6.79e-3)" "unprognostic (2.00e-2)" "unprognostic (4.50e-2)" "unprognostic (3.48e-2)" 112.7 3.7 17.9 19.4 18.6 0.2 53.3 19.7 23.2 17.4 28.6 62.7 13.9 24.3 6.3 21.4 10.5 27.7 16.8 14.7 18.0 16.4 1.6 22.4 12.5 18.9 18.1 21.2 15.0 6.3 5.4 86.9 19.7 24.0 16.8 3.5 9.5 46.6 17.8 12.0 21.6 28.8 15.7 3.4 24.0 6.2 22.5 3.8 24.5 22.5 13.4 51.4 15.3 15.2 0.0 0.0 0.0 0.1 0.0 0.0 7.0 18.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.5 14.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 0.1 0.0 0.0 0.0 102.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 18.6 19.7 23.2 14.7 18.0 18.9 18.1 19.7 15.7 22.5 15.2 74.9 3.2 2.7 1.3 0.2 11.3 3.0 0.1 6.8 2.7 1.6 17.3 8.7 8.6 3.7 0.0 2.1 282.7 0.8 0.1 0.0 25.7 2.0 18.7 1.5 58.8 0.0 0.0 0.5 0.4 70.2 111.3 0.0 34.1 2.5 0.5 1.8 0.1 20.7 0.0 0.7 0.0 8.2 1.2 19.6 2.2 5.3 3.6 14.2 160.2 1.1 21.9 0.0 1.5 1.0 0.3 0.0 15.4 0.9 1.8 0.2 2.1 0.7 3.2 78.9 32.3 110.1 1.7 7.7 0.7 8.8 221.9 3.0 0.3 0.0 1.6 ITM2B "BRI, BRI2, BRICD2B, E25B, E3-16" ENSG00000136156 "Integral membrane protein 2B" Q9Y287 13 48232612-48270357 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Amyloidosis, Deafness, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 4375.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 4375.2" "Cell line enhanced" "Detected in all" "HMC-1: 731.2;RPTEC TERT1: 1718.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029292, HPA071992" Enhanced Enhanced "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 5800000 "Cluster 5: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus, Vesicles" "HPA029292: AB_10601917, HPA071992: AB_2686480" "unprognostic (4.66e-2)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.00e-1)" "unprognostic (4.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "unprognostic (9.88e-2)" "unprognostic (2.42e-1)" "unprognostic (5.89e-2)" "unprognostic (2.87e-2)" "prognostic favorable (3.73e-5)" "unprognostic (4.38e-2)" "unprognostic (4.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.22e-1)" 510.2 367.4 286.9 172.5 301.0 125.6 323.8 328.6 489.0 416.1 406.6 260.1 289.2 388.8 1171.8 399.9 305.4 257.5 381.0 320.1 339.2 1306.3 391.2 376.1 236.7 334.9 308.0 507.2 179.6 233.7 290.5 573.8 304.4 312.5 191.4 174.4 408.7 386.2 164.7 399.6 287.4 232.5 373.6 435.2 312.8 121.4 308.8 188.3 386.1 206.2 187.4 305.1 402.2 394.8 67.6 51.8 73.1 116.3 348.5 254.5 119.2 215.0 202.2 87.5 100.6 29.1 248.3 16.6 168.8 121.6 48.5 214.1 61.3 107.0 107.4 69.9 147.3 137.9 29.0 99.0 138.5 140.6 731.2 113.4 149.1 45.1 62.0 375.7 131.2 78.3 24.5 90.9 174.8 29.6 200.4 310.1 266.0 116.5 103.6 100.1 100.5 73.6 1718.9 268.6 26.2 119.5 154.5 110.2 111.0 306.0 74.0 119.4 180.5 62.9 73.8 95.7 85.4 72.9 59.6 2.5 78.0 75.3 155.3 3091.4 864.5 2737.9 387.4 661.3 512.5 235.3 523.1 476.4 428.9 245.3 551.3 466.8 4375.2 356.5 692.7 196.2 563.4 1723.5 286.9 301.0 328.6 489.0 320.1 339.2 334.9 308.0 304.4 373.6 308.8 394.8 1380.0 695.5 300.4 174.6 408.6 862.4 1661.1 2606.2 1006.2 653.1 460.1 573.5 384.8 722.0 1121.9 1991.8 187.7 1164.3 448.2 754.2 545.9 910.2 23.6 751.8 802.2 1166.2 283.3 307.0 114.2 682.9 2362.8 1334.0 302.8 1177.2 578.0 421.2 1319.7 557.3 2117.8 353.3 142.6 503.2 1129.1 1569.8 900.6 76.7 1867.0 1381.5 681.3 252.0 1415.7 1634.9 425.3 174.4 237.9 515.7 788.3 2011.6 445.4 922.5 1259.3 2748.9 795.6 219.4 1222.7 602.4 1022.9 143.6 256.4 1384.6 1149.6 1471.5 723.2 665.5 440.9 1613.4 ITPKA "IP3-3KA, IP3KA" ENSG00000137825 "Inositol-trisphosphate 3-kinase A" P23677 15 41493393-41503551 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5;intestine: 18.1" "Cell type enhanced" "Detected in some" "Distal enterocytes: 51.4;Early spermatids: 45.4;Gastric mucus-secreting cells: 34.1;Late spermatids: 166.4;Proximal enterocytes: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 11 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "Hep G2: 33.6;OE19: 18.2" "Low region specificity" "Detected in all" HPA040454 Enhanced Approved Approved "Vesicles,Plasma membrane" No No "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 31: Spermatids - Spermatogenesis" Vesicles "Plasma membrane" "HPA040454: AB_10672897" "unprognostic (5.91e-2)" "unprognostic (2.16e-3)" "unprognostic (4.19e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.58e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.76e-9)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-3)" "unprognostic (2.10e-2)" 0.2 7.3 21.4 0.7 26.7 0.4 0.2 13.8 36.5 1.3 10.9 10.7 17.6 0.3 0.1 0.3 0.5 0.2 2.6 28.7 12.4 0.2 1.7 0.5 0.1 10.9 12.0 0.3 1.9 2.0 0.4 0.3 11.6 0.8 2.7 0.3 1.4 0.3 4.4 0.4 18.1 0.3 11.3 0.2 10.9 10.4 12.1 0.0 0.2 0.0 0.0 0.6 0.9 20.4 7.1 1.9 0.3 7.9 0.0 2.5 14.3 4.3 3.4 2.8 2.9 16.3 0.3 0.0 3.5 0.4 6.3 0.8 3.4 0.3 0.2 6.6 4.3 9.9 4.7 33.6 12.6 3.4 0.5 0.2 0.2 2.7 0.8 1.6 0.2 1.3 12.9 1.9 1.0 4.7 0.3 6.5 0.9 18.2 5.6 1.7 1.4 0.6 0.3 0.4 0.7 1.5 3.2 0.0 0.3 0.0 0.9 5.0 0.3 6.9 7.1 7.7 11.8 1.0 10.8 0.0 12.6 13.2 2.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.4 26.7 13.8 36.5 28.7 12.4 10.9 12.0 11.6 11.3 12.1 20.4 0.1 0.0 0.0 3.3 0.5 0.1 0.3 0.1 0.0 0.0 0.3 0.0 1.4 0.0 0.1 0.0 0.0 0.6 0.1 51.4 0.0 0.1 45.4 0.3 2.4 0.5 0.0 0.8 23.7 0.7 0.5 0.3 34.1 0.3 0.0 1.0 0.4 0.3 0.2 0.0 0.8 12.0 0.0 0.0 0.0 166.4 2.5 0.4 0.0 1.9 0.0 7.9 0.0 1.5 2.9 0.8 16.1 1.5 0.1 0.1 35.8 0.1 0.1 0.2 6.6 0.3 0.5 14.4 4.9 0.0 0.0 0.1 0.4 0.1 18.7 0.2 ITSN2 "KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP" ENSG00000198399 "Intersectin 2" Q9NZM3 2 24202864-24360536 "Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036475 Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 36: HEL - Hemostasis" "Cluster 10: Non-specific - Unknown function" "Vesicles, Plasma membrane" "HPA036475: AB_10670718" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (1.24e-1)" "unprognostic (5.95e-2)" "unprognostic (4.64e-1)" "prognostic favorable (2.98e-4)" "unprognostic (3.32e-2)" "unprognostic (3.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.66e-1)" "unprognostic (2.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.72e-2)" "unprognostic (2.41e-2)" "unprognostic (2.12e-2)" 23.1 21.4 11.0 35.8 11.1 73.6 15.3 6.6 12.3 22.1 17.5 19.5 17.6 19.5 12.9 36.7 15.4 19.0 20.0 10.3 10.3 21.2 27.4 27.0 53.3 12.1 12.5 16.4 67.0 18.7 16.2 24.7 11.8 17.8 20.1 16.0 18.4 15.0 23.3 26.5 22.4 18.0 9.4 43.3 24.7 15.2 15.3 30.0 50.7 18.9 50.9 22.2 24.5 15.7 41.2 19.7 4.8 14.2 13.6 18.1 43.5 24.5 22.8 11.1 13.2 19.2 21.4 63.6 21.2 20.4 32.7 18.2 21.9 15.5 18.3 50.8 21.0 86.1 12.6 21.4 22.9 44.7 47.6 14.2 17.7 19.4 33.7 21.1 35.3 23.7 25.0 46.7 17.6 16.9 18.4 21.7 8.9 24.9 19.1 22.8 55.7 19.0 19.6 76.0 3.3 9.9 19.4 20.6 29.5 19.2 14.1 23.7 49.1 23.6 20.6 19.6 22.9 50.6 60.4 65.0 18.8 40.4 21.0 69.6 30.4 56.2 31.1 37.0 32.8 68.7 26.8 27.7 28.7 73.1 27.4 24.6 112.8 26.5 59.3 18.9 31.2 20.3 11.0 11.1 6.6 12.3 10.3 10.3 12.1 12.5 11.8 9.4 15.3 15.7 62.6 96.1 103.3 64.6 143.2 51.7 82.0 21.7 41.5 23.7 21.9 20.2 70.5 22.8 48.5 29.5 20.9 26.1 88.6 42.5 17.6 53.0 4.3 42.8 21.5 62.8 24.5 33.2 114.7 75.5 35.3 40.7 53.0 62.1 103.9 30.4 39.3 27.8 42.4 13.5 98.2 28.6 26.4 93.1 111.1 7.6 30.1 102.2 24.9 132.1 107.1 16.0 105.0 104.0 140.5 88.3 48.4 18.0 85.2 74.9 40.1 27.0 35.3 33.2 13.1 54.2 40.3 95.6 58.8 36.4 58.1 24.2 94.9 28.3 24.6 116.6 JAG2 ENSG00000184916 "Jagged canonical Notch ligand 2" Q9Y219 14 105140982-105168824 "Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 56.1;Basal respiratory cells: 30.9;Basal squamous epithelial cells: 27.3;Breast myoepithelial cells: 26.4;Endothelial cells: 34.2;Horizontal cells: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 62.6;HBEC3-KT: 21.0;SCLC-21H: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025481, HPA030636, HPA050567" Approved Supported Vesicles,Cytosol NA NA 370000 "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles Cytosol "CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178" "unprognostic (6.74e-2)" "unprognostic (4.49e-2)" "unprognostic (4.28e-2)" "unprognostic (6.97e-3)" "unprognostic (3.50e-1)" "unprognostic (2.13e-2)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-2)" "unprognostic (2.62e-1)" "unprognostic (1.67e-2)" "unprognostic (9.19e-2)" "unprognostic (8.47e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.39e-1)" "unprognostic (2.17e-1)" 7.2 1.0 4.0 1.3 3.6 0.1 9.6 0.9 5.0 4.6 0.5 3.1 1.1 5.3 0.4 8.8 5.3 1.8 12.8 3.5 7.4 4.3 0.9 5.1 0.7 4.6 4.4 1.5 6.8 1.5 17.4 3.0 6.8 8.1 0.2 0.8 7.8 2.8 9.7 19.5 4.0 1.1 2.5 2.0 3.0 3.2 6.5 1.6 4.7 2.8 0.6 5.2 6.8 1.6 16.8 6.7 0.4 1.7 0.0 0.0 20.0 0.2 0.1 0.0 0.0 5.6 20.1 0.0 13.8 0.0 0.1 62.6 4.0 21.0 0.0 2.3 9.7 0.0 20.0 0.0 0.2 0.1 3.9 0.2 9.9 0.0 2.3 0.2 5.1 0.9 4.1 0.0 0.0 7.6 0.0 0.0 2.0 2.1 2.3 5.3 3.9 7.2 0.1 4.4 31.4 1.0 5.6 1.3 0.2 0.3 15.8 2.5 17.2 0.1 1.7 0.0 0.2 0.9 0.1 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.6 0.9 5.0 3.5 7.4 4.6 4.4 6.8 2.5 6.5 1.6 56.1 6.4 3.2 1.0 0.2 23.3 7.6 30.9 27.3 2.7 3.8 26.4 6.7 2.8 7.6 0.0 25.0 2.2 2.2 2.7 0.0 3.9 0.1 16.5 0.9 34.2 0.0 0.0 12.1 2.7 1.0 1.8 2.0 7.4 0.0 1.1 7.9 0.6 0.7 26.9 9.9 3.6 4.1 0.8 2.9 1.0 1.5 1.1 7.2 15.0 1.3 0.6 1.0 0.5 1.1 3.3 2.1 0.7 0.9 4.4 8.2 0.3 11.5 4.8 0.0 3.7 3.7 0.8 13.5 6.0 6.8 1.4 3.4 0.3 2.7 1.5 JCAD KIAA1462 ENSG00000165757 "Junctional cadherin 5 associated" Q9P266 10 30012803-30115494 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Adipocytes: 106.8;Endothelial cells: 30.3;Granulosa cells: 72.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 29.3;HUVEC TERT2: 29.9;LHCN-M2: 24.9;TIME: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017956 Enhanced Approved "Vesicles,Cell Junctions" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cell Junctions" "HPA017956: AB_1852408" "unprognostic (1.78e-1)" "unprognostic (8.33e-2)" "unprognostic (5.37e-2)" "unprognostic (8.07e-2)" "unprognostic (6.32e-2)" "unprognostic (7.09e-2)" "unprognostic (9.36e-2)" "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (3.08e-2)" "prognostic unfavorable (2.54e-4)" "prognostic unfavorable (2.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.34e-2)" 31.2 7.5 13.5 5.2 21.2 0.1 13.0 5.1 13.0 6.5 3.1 36.0 1.4 17.3 7.5 5.9 12.5 10.4 18.3 10.8 7.2 6.7 1.8 24.2 3.5 12.5 8.4 10.9 16.9 4.9 4.5 33.6 10.1 7.8 3.9 13.1 2.4 9.5 9.9 3.7 3.7 17.3 7.3 0.9 4.5 14.0 13.3 6.1 13.6 14.8 1.8 18.3 4.4 8.1 15.3 6.7 5.9 0.0 3.7 0.9 8.6 8.1 8.5 1.2 2.0 2.6 0.1 0.0 0.6 29.3 1.7 0.3 1.6 0.5 3.3 1.7 3.6 0.0 0.0 0.1 16.0 0.0 1.0 9.1 0.2 19.9 1.5 0.5 29.9 0.4 0.0 0.0 24.9 0.5 0.0 0.7 1.2 0.9 10.2 0.0 3.3 0.0 1.2 0.3 0.8 0.1 0.3 0.1 0.0 8.4 0.0 1.4 67.8 14.9 3.6 4.7 0.7 6.2 0.8 0.0 3.5 10.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 21.2 5.1 13.0 10.8 7.2 12.5 8.4 10.1 7.3 13.3 8.1 106.8 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 16.4 0.0 1.3 8.5 30.3 0.0 0.0 0.0 0.4 0.9 2.2 0.0 0.8 1.3 72.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.4 0.2 7.1 0.0 0.0 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: AB_2686429" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 25.9 34.9 23.6 17.7 26.5 22.9 32.5 29.5 30.3 23.0 34.2 29.6 17.3 30.5 26.4 17.8 31.2 30.8 25.9 22.9 30.2 44.5 34.0 30.7 25.2 30.1 29.8 25.8 20.7 56.6 28.6 33.8 31.3 29.9 29.5 34.7 25.4 27.0 17.1 17.9 24.0 27.7 28.7 23.0 24.4 30.4 26.1 22.1 34.6 21.1 20.7 26.4 16.2 32.0 54.8 68.0 57.3 46.8 40.9 59.0 42.8 85.9 76.6 52.6 62.9 21.8 108.1 27.7 75.6 85.5 55.3 40.0 41.2 52.8 72.1 82.8 24.0 30.3 38.5 42.3 56.0 45.6 53.6 60.9 56.6 45.9 32.6 82.1 55.7 35.8 25.4 54.9 100.7 54.1 25.6 37.8 31.2 45.9 60.4 31.4 73.6 27.9 92.1 59.3 23.7 40.9 82.8 68.4 45.1 40.0 66.4 32.3 72.4 54.9 65.6 53.0 58.0 21.7 45.5 32.7 80.7 33.2 68.0 86.3 59.3 82.3 34.4 74.8 34.3 36.1 37.0 37.0 51.9 34.1 38.9 36.5 89.4 50.2 83.0 70.5 47.0 57.8 23.6 26.5 29.5 30.3 22.9 30.2 30.1 29.8 31.3 28.7 26.1 32.0 25.5 22.4 31.2 29.7 23.6 30.0 32.8 132.9 54.1 30.3 31.6 27.1 10.2 41.5 66.3 46.0 18.8 64.2 42.0 27.4 7.9 45.4 174.5 43.3 31.7 26.9 31.2 40.8 30.3 54.8 64.8 37.4 27.5 20.9 34.9 28.0 26.4 41.9 57.8 28.6 26.8 26.7 89.5 60.3 31.4 61.2 35.4 40.4 48.0 19.7 34.2 40.1 29.9 28.1 34.5 51.4 21.3 31.6 50.2 26.3 22.4 53.0 110.6 30.3 13.1 27.5 58.8 85.1 41.1 30.7 29.1 29.8 27.6 30.3 24.6 20.9 JMJD4 FLJ12517 ENSG00000081692 "Jumonji domain containing 4" Q9H9V9 1 227730425-227735411 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 74.0;Late spermatids: 204.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027260, HPA052861" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane" Vesicles "HPA027260: AB_10602608, HPA052861: AB_2681975" "unprognostic (1.80e-1)" "unprognostic (1.37e-1)" "unprognostic (4.86e-2)" "unprognostic (2.29e-1)" "unprognostic (1.43e-1)" "unprognostic (2.86e-1)" "unprognostic (1.23e-1)" "unprognostic (6.19e-2)" "unprognostic (1.74e-2)" "unprognostic (4.31e-2)" "unprognostic (8.69e-3)" "unprognostic (8.68e-3)" "prognostic unfavorable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (2.82e-1)" "unprognostic (2.05e-1)" "unprognostic (4.68e-1)" 6.8 12.8 8.5 4.8 7.9 3.6 7.1 7.7 9.4 6.2 8.1 6.2 4.3 8.1 4.8 6.8 7.0 4.1 7.4 8.6 8.4 7.4 11.9 5.2 6.9 9.0 9.2 7.9 9.6 5.8 10.0 4.0 9.3 9.7 2.4 1.6 8.7 5.6 10.2 6.0 6.2 4.2 8.3 9.0 5.9 14.8 8.6 6.5 6.4 4.7 4.4 6.8 4.6 8.9 18.4 26.4 8.4 9.3 9.0 5.1 31.0 11.3 11.6 17.0 10.4 22.6 15.2 24.3 16.8 10.7 9.1 18.1 5.8 17.9 2.0 13.2 29.4 14.9 13.3 17.8 15.8 15.7 7.1 9.0 11.1 16.2 11.8 6.7 8.8 17.5 19.7 7.8 8.3 15.4 19.5 8.3 14.6 13.9 42.2 17.8 10.3 21.9 10.1 16.7 16.4 11.1 10.8 37.4 14.5 4.3 30.2 16.9 7.7 8.6 8.8 10.6 21.0 14.5 5.0 9.3 8.6 7.6 24.1 3.2 7.2 2.8 11.1 7.4 12.2 8.7 8.4 7.7 6.6 8.6 13.1 11.4 0.7 14.3 4.1 13.2 10.2 8.0 8.5 7.9 7.7 9.4 8.6 8.4 9.0 9.2 9.3 8.3 8.6 8.9 7.0 6.4 7.2 4.6 7.9 4.1 8.0 8.6 1.8 14.0 16.6 13.2 3.7 4.3 7.4 7.3 0.0 13.1 7.2 8.8 5.9 21.7 74.0 5.2 11.0 6.9 9.0 13.9 4.4 28.9 14.0 9.7 10.7 4.9 7.0 12.7 6.8 14.5 16.9 11.8 3.3 6.9 2.0 7.6 2.1 204.9 11.5 6.1 12.4 2.8 11.0 12.2 13.4 3.0 2.1 23.7 5.6 4.1 14.7 11.0 12.9 12.5 7.7 14.7 6.6 6.7 8.2 36.1 7.5 7.4 4.7 9.6 7.3 13.3 7.3 7.5 KANSL3 "FLJ10081, KIAA1310, NSL3, Rcd1" ENSG00000114982 "KAT8 regulatory NSL complex subunit 3" Q9P2N6 2 96593170-96642787 "Metabolic proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035017, HPA035018" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 52: Non-specific - Ribosome" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Vesicles "HPA035017: AB_2674414, HPA035018: AB_10601763" "unprognostic (2.19e-1)" "unprognostic (6.94e-2)" "unprognostic (5.62e-2)" "unprognostic (8.72e-3)" "unprognostic (3.28e-1)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (6.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.02e-1)" "unprognostic (3.01e-2)" "unprognostic (2.99e-2)" "unprognostic (2.04e-3)" "unprognostic (3.28e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-3)" "unprognostic (4.99e-3)" 11.8 9.9 1.9 8.6 2.4 14.9 12.3 1.6 3.1 13.7 8.1 11.8 7.2 15.0 7.7 8.9 12.5 6.9 10.7 2.9 2.6 8.8 6.4 9.9 8.2 2.1 2.9 15.1 9.8 15.1 8.8 9.0 2.3 11.2 6.9 6.3 12.5 14.7 33.9 10.8 12.0 10.6 3.3 10.1 9.8 12.8 3.3 13.1 12.9 21.1 8.9 13.0 10.8 2.3 13.1 7.9 26.0 19.4 10.6 6.4 11.4 9.7 15.2 20.1 21.4 15.1 7.8 18.1 14.6 16.2 14.7 8.2 18.8 9.4 17.5 12.8 14.8 26.0 8.1 16.2 15.0 17.4 9.0 15.0 5.8 12.8 11.4 12.0 11.0 21.0 18.6 12.8 12.8 6.9 32.3 13.5 12.5 6.7 12.8 26.2 16.5 10.6 12.4 12.7 26.8 16.9 12.3 11.8 11.8 14.7 11.4 5.5 15.9 13.5 11.8 9.8 8.9 10.1 6.7 15.7 7.0 19.9 12.2 2.4 1.3 0.5 2.8 1.5 2.1 1.6 1.7 2.9 0.7 1.5 1.2 2.3 0.2 3.1 1.3 0.7 1.1 1.7 1.9 2.4 1.6 3.1 2.9 2.6 2.1 2.9 2.3 3.3 3.3 2.3 11.6 44.8 30.8 29.0 10.5 4.6 9.9 8.1 9.1 15.0 14.8 12.2 23.8 10.0 18.8 11.0 43.8 8.1 10.0 15.0 3.9 10.5 13.4 13.0 13.7 12.1 13.1 6.7 35.6 9.6 4.3 12.7 17.3 13.5 18.3 33.1 15.7 12.7 8.1 15.2 36.2 18.4 10.2 12.5 5.6 28.6 9.9 11.2 7.2 16.9 13.7 10.2 9.2 29.7 37.3 13.2 7.9 12.8 10.6 10.3 10.7 5.8 13.1 29.5 13.1 16.0 13.6 23.3 9.7 11.3 6.5 11.1 14.2 18.3 15.6 10.1 KDR "CD309, FLK1, VEGFR, VEGFR2" ENSG00000128052 "Kinase insert domain receptor" P35968 4 55078481-55125595 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6" "Cancer enhanced" "Detected in all" "renal cancer: 27.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 74.8;TIME: 83.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004028, HPA073577" Enhanced Approved "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA 11000000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Nuclear membrane" "CAB004028: AB_2212507, HPA073577: " "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (9.65e-2)" "unprognostic (1.97e-1)" "unprognostic (9.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.78e-3)" "unprognostic (2.59e-2)" "unprognostic (1.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.79e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (4.00e-2)" "unprognostic (2.30e-1)" "unprognostic (3.22e-1)" "unprognostic (1.86e-1)" 41.6 11.7 2.7 4.3 3.8 0.0 26.1 2.8 4.1 14.8 10.4 6.3 2.2 39.5 2.9 4.0 17.9 5.6 20.6 2.1 2.8 15.7 9.2 23.5 2.8 3.2 3.6 5.2 6.2 8.6 11.0 30.9 3.5 11.7 1.0 16.4 5.3 10.0 6.5 5.9 7.5 7.5 3.3 4.4 8.4 1.8 4.5 1.0 34.4 4.6 1.0 8.6 7.5 3.4 0.0 0.0 4.4 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.5 0.0 0.0 0.9 0.0 0.0 0.4 0.2 74.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.8 2.8 4.1 2.1 2.8 3.2 3.6 3.5 3.3 4.5 3.4 157.8 0.0 4.9 0.0 1.4 2.5 0.5 0.1 1.8 11.7 1.3 2.5 9.4 1.5 18.4 0.0 0.0 0.1 0.8 0.0 0.0 0.5 0.8 0.4 2.6 143.8 0.0 2.7 0.1 0.0 0.1 8.3 0.0 0.8 2.5 0.0 158.1 3.3 0.4 0.0 1.3 0.0 0.0 10.6 2.1 0.9 0.0 1.2 7.2 7.5 0.0 206.6 0.0 0.0 6.1 0.5 0.0 0.4 1.3 0.5 0.0 0.0 3.9 7.9 0.0 0.9 7.5 0.3 0.9 0.8 2.7 0.1 0.6 1.6 0.0 1.4 KHK ENSG00000138030 Ketohexokinase P50053 2 27086747-27100762 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "intestine: 121.2;kidney: 104.4;liver: 180.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7" "Group enriched" "Detected in all" 7 "liver cancer: 62.2;renal cancer: 32.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 32.8;Hep G2: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007040 Enhanced Approved Vesicles,Cytosol NA NA 620000 "Cluster 39: Non-specific - mRNA processing" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol Vesicles "HPA007040: AB_1079185" "unprognostic (8.44e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.62e-8)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "unprognostic (3.08e-2)" "unprognostic (3.13e-2)" "unprognostic (1.67e-2)" "unprognostic (2.50e-2)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (1.68e-2)" "unprognostic (2.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.44e-1)" "unprognostic (1.02e-2)" 2.2 4.6 4.2 3.0 4.3 1.7 2.0 7.1 5.9 2.6 1.2 4.2 112.4 3.8 0.6 2.4 4.3 1.3 1.4 4.8 3.9 104.4 180.5 1.6 1.9 5.4 4.0 3.6 9.4 2.6 1.4 0.5 5.5 1.6 1.2 1.5 4.4 1.4 3.8 2.4 121.2 1.9 3.6 2.0 2.9 3.2 3.8 0.7 1.1 2.0 1.2 1.8 2.3 4.7 25.0 18.5 2.8 11.0 2.0 0.5 2.5 1.7 1.1 2.3 1.4 9.0 5.3 3.7 5.8 0.1 2.6 10.7 9.4 3.1 0.8 8.8 17.2 32.8 5.2 48.0 1.1 4.6 3.7 0.1 1.3 2.7 0.2 1.2 2.1 5.1 5.9 6.1 0.2 16.0 5.4 3.6 4.0 22.3 7.2 18.9 1.4 20.9 2.7 3.0 10.2 15.8 3.6 6.2 6.9 1.0 2.7 2.0 1.9 0.7 3.6 1.6 6.5 7.5 14.4 6.3 3.0 10.7 1.8 0.0 5.4 0.3 4.1 3.1 5.5 3.8 6.6 6.0 4.9 3.6 4.7 5.8 0.5 4.9 1.4 6.1 4.7 4.9 4.2 4.3 7.1 5.9 4.8 3.9 5.4 4.0 5.5 3.6 3.8 4.7 6.5 3.2 3.7 1.6 6.8 3.6 2.6 0.8 6.8 3.6 4.7 5.8 1.8 20.0 1.0 40.5 2.1 4.1 1.3 7.4 129.1 3.2 1.2 0.1 0.6 5.5 6.0 15.6 3.4 3.0 3.6 2.4 3.6 0.3 4.5 2.9 9.7 428.5 8.3 6.7 2.7 89.6 4.1 11.9 2.0 6.2 1.8 10.8 8.8 0.0 1.9 9.8 4.1 2.5 2.3 2.1 95.7 1.5 8.0 0.7 1858.7 1019.7 0.0 5.4 0.0 5.0 5.0 1.1 5.8 4.6 6.8 9.4 6.8 0.8 82.6 2.2 KIAA0895L LOC653319 ENSG00000196123 "KIAA0895 like" Q68EN5 16 67175599-67184040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 74.3;Early spermatids: 84.9;Horizontal cells: 107.7;Late spermatids: 198.4;Rod photoreceptor cells: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065996 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA065996: AB_2685593" "unprognostic (8.71e-2)" "unprognostic (1.54e-1)" "unprognostic (8.11e-3)" "unprognostic (2.89e-2)" "unprognostic (2.15e-1)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (4.89e-3)" "unprognostic (2.90e-1)" "prognostic favorable (3.16e-4)" "unprognostic (3.74e-2)" "unprognostic (2.67e-3)" "unprognostic (3.93e-2)" "unprognostic (2.82e-1)" "unprognostic (3.61e-1)" "unprognostic (1.00e-3)" 14.6 25.1 19.9 4.9 20.1 3.4 11.5 25.6 26.6 21.5 12.4 11.8 6.5 21.1 7.5 12.4 30.8 6.0 11.7 21.0 18.8 19.2 9.3 14.5 2.1 21.2 17.3 39.7 11.7 6.6 46.1 5.7 21.3 17.1 5.2 29.2 10.8 4.1 5.1 9.3 11.2 7.1 15.9 16.2 14.4 23.5 17.7 4.1 25.3 2.2 1.7 15.5 13.3 20.4 3.1 5.0 19.0 11.9 3.6 8.2 12.3 7.9 1.6 3.6 3.4 5.1 3.1 5.7 5.0 3.3 3.0 11.6 5.4 4.5 2.3 5.2 7.1 8.3 15.6 4.7 2.8 3.8 16.2 4.7 2.0 4.5 1.7 13.4 6.0 12.2 8.6 5.3 4.6 5.1 8.6 6.4 4.1 3.1 8.2 23.0 9.1 11.1 6.3 7.3 21.6 18.0 9.4 4.7 2.6 9.0 10.2 6.4 7.0 11.8 8.4 5.8 3.4 6.6 5.9 6.0 15.3 5.7 6.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 19.9 20.1 25.6 26.6 21.0 18.8 21.2 17.3 21.3 15.9 17.7 20.4 5.3 3.2 7.9 29.4 1.3 2.9 3.8 7.0 7.4 74.3 6.3 6.9 3.3 8.6 8.8 7.3 43.8 3.9 2.3 6.6 3.9 5.6 84.9 6.7 14.9 5.8 13.1 1.7 23.6 2.5 6.7 5.4 10.7 10.8 4.5 18.6 7.1 4.3 4.2 107.7 28.9 4.6 10.2 0.6 2.1 198.4 6.8 2.3 5.4 5.6 1.7 13.8 0.0 20.1 14.9 3.4 5.4 10.9 1.2 4.5 2.1 1.9 5.1 68.0 19.7 2.8 8.8 6.9 10.9 5.9 2.4 3.0 2.0 16.3 6.6 4.8 KIAA1210 ENSG00000250423 KIAA1210 Q9ULL0 X 119078635-119150579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 39.4;seminal vesicle: 19.8;testis: 30.9" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Endometrial stromal cells: 25.2;Granulosa cells: 11.1;Late spermatids: 11.5;Peritubular cells: 6.0" "Cancer enhanced" "Detected in single" "prostate cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.0" "Not detected" "Not detected" "HPA000551, HPA048322" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus, Vesicles" "HPA000551: AB_1079165, HPA048322: AB_2680358" "unprognostic (2.48e-1)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-1)" "unprognostic (2.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (5.69e-2)" "unprognostic (1.05e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.24e-1)" "unprognostic (6.26e-4)" 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 1.6 39.4 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 19.8 0.3 0.0 0.0 0.2 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.0 1.9 25.2 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.6 0.0 11.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 11.5 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.4 1.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376108-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 26.4;parathyroid gland: 33.5" "Group enriched" "Detected in some" 6 "Excitatory neurons: 366.9;Inhibitory neurons: 193.5" "Cancer enhanced" "Detected in many" "melanoma: 4.4" "Group enriched" "Detected in many" 141 "amygdala: 8.6;basal ganglia: 14.9;cerebral cortex: 26.4;hippocampal formation: 12.3;white matter: 7.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 42.4;U-138 MG: 53.8;WM-115: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles NA NA 160000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 17: WM-115 - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.2 0.4 8.6 0.2 14.9 0.0 0.7 0.0 26.4 0.1 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.3 0.1 12.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.3 33.5 0.7 1.1 0.0 0.0 0.1 0.9 0.3 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.7 0.3 0.2 7.9 0.1 1.9 6.1 0.2 1.0 6.5 0.0 24.7 14.4 3.8 2.1 0.0 0.6 18.7 0.3 21.9 19.2 1.4 0.9 7.3 5.7 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.1 6.4 11.0 13.4 16.9 0.5 0.2 20.5 15.1 0.0 0.2 0.0 1.4 0.0 9.1 0.0 1.6 0.0 0.0 9.6 2.2 2.2 0.3 0.0 6.2 0.2 0.0 0.0 42.4 53.8 11.8 1.3 19.6 0.0 0.0 0.0 14.7 0.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 14.9 0.0 26.4 12.3 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.2 0.0 0.0 18.3 0.1 2.0 0.6 0.6 0.0 5.6 2.2 2.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.8 1.1 0.2 0.1 0.7 0.0 0.0 366.9 0.0 0.2 1.0 0.0 0.6 0.0 0.2 5.0 0.2 0.3 3.3 193.5 0.0 0.0 0.0 0.9 1.2 0.0 0.1 17.8 18.7 0.0 0.1 0.0 40.2 7.2 1.2 0.0 0.4 0.0 1.2 0.0 0.1 0.1 0.4 0.0 0.1 1.8 0.0 1.8 0.6 0.3 0.0 0.0 0.1 0.0 0.7 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180912897-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 25.3" "Group enriched" "Detected in many" 13 "Bipolar cells: 95.3;Cone photoreceptor cells: 131.3;Rod photoreceptor cells: 176.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SH-SY5Y: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: AB_2684585" "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 5.7 1.2 3.8 1.3 3.9 0.4 4.0 15.4 6.1 7.2 4.3 8.4 2.4 8.1 1.3 3.5 6.1 2.5 7.7 4.9 2.4 6.2 0.5 3.6 1.2 3.6 3.2 5.8 1.7 0.3 1.8 2.8 2.9 4.8 0.6 25.3 3.2 2.1 2.0 2.5 2.9 3.1 2.8 2.5 3.2 1.7 4.0 0.3 6.1 0.4 0.4 7.4 4.2 5.3 1.7 0.8 1.4 3.0 4.3 10.5 4.8 3.3 3.8 1.6 0.9 1.6 1.7 0.7 3.0 4.1 0.8 3.2 0.3 0.1 0.5 0.9 1.3 2.4 0.6 2.2 5.9 1.5 1.7 5.0 0.1 0.2 0.1 2.7 2.2 2.5 2.1 1.1 1.4 1.4 2.1 0.6 3.3 0.5 0.4 1.1 17.8 2.5 2.6 1.6 12.2 44.7 1.0 1.1 7.3 1.4 1.3 2.1 5.2 3.4 2.5 4.0 1.3 2.3 3.2 1.6 0.4 1.2 2.3 1.3 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 3.8 3.9 15.4 6.1 4.9 2.4 3.6 3.2 2.9 2.8 4.0 5.3 1.0 0.0 1.8 9.8 0.5 0.4 0.8 0.8 0.6 95.3 0.5 0.6 3.5 1.5 1.3 1.8 131.3 0.3 0.5 0.0 1.9 0.4 4.6 0.8 3.6 2.1 0.0 0.0 5.0 0.2 0.4 3.3 0.0 2.2 1.3 1.6 1.8 0.1 1.8 3.3 1.5 0.0 0.0 0.3 0.4 1.8 7.8 0.5 3.6 1.0 1.0 10.0 0.0 4.5 1.4 0.7 0.0 5.7 0.1 0.4 0.2 1.8 0.1 176.0 6.6 8.4 2.4 0.6 0.6 0.2 0.3 0.3 0.4 0.6 0.1 0.0 KISS1R "AXOR12, GPR54, HOT7T175" ENSG00000116014 "KISS1 receptor" Q969F8 19 917287-921005 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 8.5" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 41.9" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 15.7;RPMI-8226: 37.4;SCLC-21H: 7.4;SH-SY5Y: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA007156, HPA071913" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 30: Non-specific - Translation" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 25: RPMI-8226 - Immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" "Plasma membrane" Vesicles "HPA007156: , HPA071913: AB_2686471" "unprognostic (1.54e-1)" "unprognostic (3.01e-2)" "unprognostic (9.42e-2)" "unprognostic (2.15e-1)" "unprognostic (8.46e-3)" "unprognostic (9.23e-2)" "unprognostic (1.65e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (7.17e-2)" "prognostic unfavorable (3.33e-6)" "unprognostic (1.87e-1)" "unprognostic (8.09e-3)" "unprognostic (1.05e-1)" "unprognostic (2.05e-2)" 0.0 0.0 2.9 0.1 1.8 0.0 0.0 0.9 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 3.8 0.3 0.1 0.1 0.1 4.0 2.2 0.0 1.3 0.3 1.1 0.1 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.0 0.4 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 4.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.7 0.0 0.0 0.3 0.1 0.0 0.6 1.2 0.4 1.0 0.0 37.4 0.0 0.0 7.4 20.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 2.9 1.8 0.9 3.4 1.3 3.8 4.0 2.2 3.9 1.0 8.5 0.8 0.1 0.0 0.0 0.0 1.0 0.1 0.1 0.5 0.0 1.1 1.2 1.4 0.5 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 41.9 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.7 0.0 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.3 1.8 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.0 0.0 4.2 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.3 0.3 0.3 1.6 0.9 0.2 0.1 0.2 KLHL12 C3IP1 ENSG00000117153 "Kelch like family member 12" Q53G59 1 202891116-202928636 "Predicted intracellular proteins" "ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 140.7;Late spermatids: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071324 Supported "Vesicles,Centriolar satellite" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Vesicles, Centriolar satellite" "HPA071324: AB_2686389" "unprognostic (1.69e-2)" "unprognostic (2.84e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-3)" "unprognostic (3.35e-2)" "unprognostic (1.15e-2)" "unprognostic (9.11e-2)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (2.20e-3)" "unprognostic (6.22e-2)" "unprognostic (6.01e-2)" "unprognostic (3.32e-1)" "unprognostic (4.87e-2)" 13.3 15.8 26.4 14.6 26.8 18.8 17.3 24.7 27.8 13.8 23.9 19.4 14.5 14.9 22.7 15.8 18.4 12.3 20.4 27.5 29.8 21.8 16.2 15.0 19.0 24.6 26.5 17.7 16.3 21.2 15.2 15.6 27.6 19.3 23.4 24.6 13.7 13.6 14.3 13.5 14.8 17.3 24.6 17.1 16.0 44.8 28.5 20.4 19.8 18.3 22.4 14.2 13.1 26.4 20.4 24.5 30.2 34.3 46.2 34.2 35.6 24.1 28.0 29.7 27.0 23.3 33.0 57.8 18.5 27.7 29.8 25.8 40.5 33.8 32.3 29.9 17.6 20.1 19.5 23.6 33.4 42.3 31.7 33.0 43.0 25.7 56.1 23.5 26.8 56.9 51.5 36.7 41.3 28.0 35.6 20.4 43.4 25.8 18.3 36.5 52.8 37.0 26.1 25.7 22.5 25.8 29.9 27.6 33.2 54.7 49.2 29.4 22.0 29.0 20.2 7.1 21.7 26.4 22.5 48.0 28.6 29.9 28.3 7.5 10.1 15.6 6.9 12.3 10.2 7.1 6.9 8.3 10.5 6.7 7.3 7.9 10.1 8.3 13.2 6.1 11.1 9.2 26.4 26.8 24.7 27.8 27.5 29.8 24.6 26.5 27.6 24.6 28.5 26.4 7.0 6.4 11.5 12.7 13.3 5.4 9.4 8.9 6.2 11.2 8.5 5.7 16.6 12.8 9.2 16.5 12.5 11.9 9.3 17.6 23.5 12.1 140.7 8.6 7.8 7.8 10.8 15.8 14.9 8.9 12.1 9.3 5.6 7.4 3.8 15.0 8.6 7.8 17.2 5.0 19.3 13.2 6.1 15.9 5.6 88.1 8.4 12.9 5.4 14.0 16.8 11.3 10.3 11.1 18.6 11.4 10.1 8.2 9.3 8.7 11.6 15.9 8.2 10.2 6.6 6.9 7.6 26.0 44.9 9.2 6.7 11.1 11.5 9.5 12.5 7.2 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207561-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 125.4;Oligodendrocytes: 144.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 7.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 65: Brain - Ion transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 11.8 11.8 35.3 12.1 50.9 21.4 13.0 26.7 55.8 5.9 14.3 7.2 5.3 7.7 13.5 19.7 9.9 10.7 5.5 78.4 34.7 15.4 27.1 14.2 11.2 33.2 35.7 4.1 7.8 9.5 16.3 7.7 30.8 8.2 6.7 8.8 20.0 10.0 4.7 6.4 6.5 10.7 33.3 14.6 8.3 6.1 35.5 6.3 12.3 6.8 9.5 15.2 8.8 45.2 16.1 14.7 9.8 10.1 14.1 12.9 10.2 21.3 16.7 10.7 11.7 8.9 11.5 16.3 5.1 10.9 19.2 10.5 16.1 10.4 13.9 27.2 6.0 14.1 12.8 12.9 12.9 14.2 19.3 10.7 30.5 9.8 37.1 18.5 25.9 6.1 6.4 33.0 16.1 6.0 0.4 4.0 6.0 8.9 6.5 5.6 7.0 5.1 18.1 14.9 49.1 8.1 13.5 4.5 13.0 18.1 3.3 15.1 37.0 8.4 17.6 9.6 14.0 21.5 16.3 13.2 10.1 9.7 16.9 1.8 0.9 1.3 0.5 1.0 0.3 0.3 0.3 0.3 0.8 0.8 0.9 1.0 7.2 0.3 1.2 0.4 0.5 0.4 35.3 50.9 26.7 55.8 78.4 34.7 33.2 35.7 30.8 33.3 35.5 45.2 19.0 6.4 17.9 33.3 10.7 6.0 13.1 8.0 4.6 8.9 13.2 10.9 4.7 8.6 9.7 22.0 14.6 4.3 8.3 7.5 27.4 8.7 1.9 8.3 6.6 14.6 15.5 2.1 125.4 12.9 9.4 5.2 8.2 13.5 9.5 4.0 25.7 35.6 8.3 32.0 33.0 6.2 8.2 42.5 13.9 1.7 4.1 22.7 5.4 39.4 13.5 5.8 1.0 43.2 144.5 9.6 7.4 4.5 6.3 11.9 5.4 19.0 10.9 7.3 0.0 11.9 7.2 3.3 7.4 7.7 7.5 3.7 9.2 3.9 3.9 20.1 KRT222 "KA21, KRT222P, MGC45562" ENSG00000213424 "Keratin 222" Q8N1A0 17 40654665-40665181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;retina: 8.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 53.9;Excitatory neurons: 25.9;Horizontal cells: 28.6;Inhibitory neurons: 24.4;Muller glia cells: 46.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 9.7" "HPA054586, HPA068724, HPA069774" Enhanced Approved "Vesicles,Lipid droplets" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Lipid droplets" "HPA054586: AB_2682532, HPA068724: , HPA069774: AB_2686195" "unprognostic (2.72e-2)" "unprognostic (4.08e-2)" "unprognostic (1.92e-1)" "unprognostic (2.43e-1)" "unprognostic (1.26e-2)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.12e-2)" "unprognostic (5.59e-1)" "unprognostic (2.04e-1)" "unprognostic (1.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-1)" "unprognostic (7.41e-2)" 1.2 2.7 4.8 0.1 5.5 0.0 0.3 6.1 9.7 0.4 0.0 0.5 0.4 0.5 5.0 0.3 0.3 3.3 0.3 5.0 4.0 0.5 2.8 0.2 0.1 3.8 3.5 0.1 0.5 0.7 1.8 0.0 3.9 1.1 0.5 8.0 0.2 1.4 0.0 0.1 0.9 0.5 1.8 1.8 0.3 0.3 4.1 0.4 0.7 0.1 0.1 0.3 0.4 5.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 5.5 6.1 9.7 5.0 4.0 3.8 3.5 3.9 1.8 4.1 5.1 1.5 0.0 0.5 1.3 0.0 0.1 0.8 0.0 1.8 53.9 1.0 0.6 0.5 10.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.4 0.0 0.1 4.3 0.0 0.0 25.9 0.2 0.2 2.5 0.0 0.0 2.5 0.0 2.2 3.5 0.0 28.6 24.4 0.2 0.0 0.3 0.3 0.6 6.5 0.0 0.0 2.8 0.0 46.7 0.0 1.5 2.1 0.1 0.0 0.7 0.0 0.1 1.2 2.7 0.0 8.9 0.0 0.0 0.2 0.2 1.2 0.9 0.0 0.1 0.1 0.0 0.1 0.1 KRT34 "Ha-4, KRTHA4" ENSG00000131737 "Keratin 34" O76011 17 41377650-41382403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "skin 1: 66.6" "Group enriched" "Detected in some" 8 "Early spermatids: 5.4;Late spermatids: 15.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BJ: 201.8" "Not detected" "Not detected" "HPA055194, HPA072208" Enhanced Approved Nucleoplasm,Vesicles NA NA 170000000 "Cluster 61: Skin - Cornification" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA055194: AB_2682733, HPA072208: AB_2686494" "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (9.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.86e-3)" "unprognostic (5.12e-7)" "unprognostic (3.84e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 66.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 1.1 1.8 0.0 1.6 0.0 0.0 0.0 0.1 1.9 0.0 201.8 8.8 23.5 46.4 0.0 0.1 0.0 0.0 25.1 0.1 0.0 0.0 0.0 42.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 8.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.1 26.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.3 0.1 0.0 0.3 0.0 0.0 KSR1 "KSR, RSU2" ENSG00000141068 "Kinase suppressor of ras 1" Q8IVT5 17 27456470-27626438 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 101.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 73.0;Glandular and luminal cells: 50.3;Inhibitory neurons: 50.2;Oligodendrocyte precursor cells: 53.3;Oligodendrocytes: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 393.5;HEL: 140.5;HMC-1: 93.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009623, HPA011215, HPA011878" Uncertain Supported Vesicles,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" Cytosol Vesicles "CAB009623: AB_2265455, HPA011215: AB_1852649, HPA011878: " "unprognostic (2.03e-2)" "unprognostic (2.74e-1)" "unprognostic (2.60e-1)" "unprognostic (3.48e-3)" "unprognostic (2.90e-1)" "unprognostic (6.98e-2)" "unprognostic (1.92e-5)" "unprognostic (8.36e-3)" "unprognostic (1.32e-1)" "unprognostic (3.15e-2)" "unprognostic (1.12e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (1.00e-1)" "unprognostic (7.55e-2)" "unprognostic (1.74e-2)" "unprognostic (9.61e-2)" 22.6 17.5 19.6 19.9 22.0 16.7 15.6 17.4 35.8 36.9 13.2 13.1 8.1 26.5 9.9 29.8 20.8 21.4 13.6 33.1 19.3 40.7 6.5 26.2 14.3 28.6 20.2 26.4 101.4 7.3 15.1 44.9 23.0 15.6 8.5 19.4 8.4 18.5 30.0 21.6 15.2 20.0 17.5 22.5 9.3 25.3 22.9 11.6 31.0 14.0 14.6 14.6 23.1 26.7 4.6 18.1 11.1 5.8 9.2 6.5 64.7 4.2 9.1 6.2 7.2 55.0 0.8 4.4 9.5 8.0 40.8 2.8 11.0 2.5 3.7 393.5 12.1 140.5 19.3 23.0 16.0 1.8 93.0 8.1 4.0 17.8 0.5 25.3 34.8 6.1 75.0 0.5 3.6 4.4 2.1 5.4 8.3 4.0 3.2 9.1 61.5 3.2 25.1 3.3 17.1 11.3 22.3 5.1 6.0 29.4 0.7 7.5 32.5 1.8 8.2 5.1 3.0 0.5 0.1 0.1 1.8 7.9 10.5 0.0 1.0 3.8 0.3 2.1 0.3 0.4 0.1 0.2 0.5 0.1 0.1 0.1 1.1 0.9 1.1 0.0 0.5 0.4 19.6 22.0 17.4 35.8 33.1 19.3 28.6 20.2 23.0 17.5 22.9 26.7 19.7 6.4 3.4 33.6 4.1 3.1 3.6 3.1 1.8 11.8 1.9 2.3 1.2 1.5 11.9 14.7 73.0 19.2 4.9 7.1 3.9 2.0 33.4 24.0 21.6 9.1 6.6 0.4 26.2 5.3 21.0 8.2 3.6 50.3 0.0 10.8 11.7 1.3 6.7 10.1 50.2 2.2 0.0 8.3 6.9 47.7 1.5 9.0 8.8 27.2 10.4 5.7 4.1 53.3 49.2 2.1 7.1 2.2 2.8 1.6 6.7 3.2 14.9 25.8 0.0 5.3 4.8 2.6 6.1 11.3 6.0 19.4 5.7 8.4 1.2 6.2 L3MBTL4 "FLJ35936, HsT1031" ENSG00000154655 "L3MBTL histone methyl-lysine binding protein 4" Q8NA19 18 5954706-6415237 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 160.4;Late spermatids: 85.8;Microglial cells: 78.7;Oligodendrocyte precursor cells: 191.5;Oligodendrocytes: 252.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 3.4;Karpas-707: 4.8;RPMI-8226: 11.6;SCLC-21H: 5.3;SH-SY5Y: 5.8;U-2 OS: 3.4" "Low region specificity" "Detected in some" "HPA064194, HPA069042" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Vesicles" "HPA064194: AB_2685208, HPA069042: AB_2686071" "unprognostic (1.33e-3)" "unprognostic (8.98e-2)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.70e-2)" "unprognostic (1.73e-1)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-2)" "unprognostic (5.08e-2)" "unprognostic (1.00e-1)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" 3.0 4.3 7.1 1.8 11.5 1.6 4.9 0.2 8.4 4.3 0.6 2.1 3.0 3.2 3.6 3.6 4.2 2.5 4.9 3.8 6.8 7.1 8.8 3.9 2.0 3.3 8.2 8.5 6.5 8.5 3.2 0.7 4.7 2.0 2.0 1.7 3.4 2.9 1.0 7.3 3.5 1.3 1.6 2.9 3.2 12.7 6.6 2.9 5.8 1.3 1.6 1.4 4.1 14.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 2.4 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 1.4 3.1 0.0 11.6 0.0 2.0 5.3 5.8 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 3.4 0.1 1.4 0.1 0.0 0.0 1.3 0.0 1.7 0.3 1.1 0.0 0.7 0.3 0.0 0.5 0.1 0.1 0.7 2.5 0.1 0.2 0.1 3.6 0.8 0.1 0.0 0.5 7.1 11.5 0.2 8.4 3.8 6.8 3.3 8.2 4.7 1.6 6.6 14.0 6.5 3.2 12.2 56.2 4.8 7.8 7.0 0.8 10.2 2.2 4.5 4.8 6.4 11.5 4.1 5.5 16.7 0.1 2.7 0.3 3.9 7.4 62.5 8.1 1.2 3.6 11.4 0.8 33.9 5.2 0.0 3.4 1.5 16.9 1.3 15.4 2.5 10.0 3.2 0.0 160.4 1.5 0.0 3.2 5.3 85.8 10.2 2.9 1.8 78.7 27.2 1.8 25.7 191.5 252.9 3.5 1.9 12.8 1.5 10.3 3.5 8.1 1.2 0.6 6.6 6.9 7.2 9.3 2.4 6.5 8.2 0.1 2.1 0.5 2.5 4.6 LAMB2 "LAMS, NPHS5" ENSG00000172037 "Laminin subunit beta 2" P55268 3 49121114-49133118 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 151.8;Leydig cells: 146.3;Peritubular cells: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 299.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000053, HPA001895, HPA050033, CAB078160" Supported Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA 25000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles Cytosol "CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: " "unprognostic (1.12e-2)" "unprognostic (4.40e-2)" "unprognostic (5.14e-3)" "unprognostic (1.10e-1)" "unprognostic (4.08e-1)" "unprognostic (4.01e-1)" "unprognostic (5.59e-2)" "unprognostic (6.80e-2)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (1.26e-1)" "unprognostic (4.96e-2)" "unprognostic (1.21e-3)" "unprognostic (1.78e-1)" "unprognostic (4.38e-2)" "unprognostic (6.20e-2)" "unprognostic (1.24e-2)" 75.2 73.2 12.8 18.2 14.2 2.6 58.2 15.1 14.9 68.0 47.7 63.1 24.6 72.7 25.5 31.9 63.8 62.2 169.1 13.1 14.5 41.3 31.7 55.1 16.9 20.0 14.8 94.4 32.7 104.7 15.4 99.0 15.4 50.4 18.0 11.7 40.3 81.0 67.5 40.9 32.5 80.2 14.1 29.8 48.4 21.4 17.3 6.7 60.2 70.0 12.8 52.2 55.9 13.5 15.7 38.7 34.4 122.0 196.3 201.5 31.1 131.9 161.8 73.8 75.7 18.3 52.0 0.2 44.4 299.0 38.3 49.3 30.0 47.6 52.3 0.1 9.5 6.9 63.4 32.1 132.5 0.3 0.3 176.9 69.4 61.6 62.1 184.3 75.9 0.0 4.1 0.1 61.4 30.3 0.1 0.3 15.1 20.7 32.0 0.2 16.6 0.5 53.5 19.1 0.2 20.4 74.9 42.9 68.3 57.5 93.4 0.9 126.9 82.2 34.9 28.5 35.4 0.1 0.4 0.4 39.1 0.3 57.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 14.2 15.1 14.9 13.1 14.5 20.0 14.8 15.4 14.1 17.3 13.5 83.7 118.6 53.5 26.1 2.4 31.2 13.9 33.6 33.0 1.7 39.4 40.5 151.8 37.1 43.6 55.2 6.2 11.3 0.9 3.6 5.9 26.4 3.5 15.4 24.4 77.8 0.0 0.4 0.2 9.4 6.4 120.1 50.4 27.2 1.3 88.9 94.9 49.9 10.4 8.4 0.4 3.1 32.6 10.1 31.1 12.3 146.3 7.5 42.7 15.9 3.5 46.7 2.1 1.0 0.6 14.1 14.9 140.7 0.5 10.2 16.4 28.6 11.2 2.6 118.3 80.8 92.3 4.3 8.6 14.2 24.4 9.4 3.8 27.6 5.6 9.3 LAMTOR2 "ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3" ENSG00000116586 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2" Q9Y2Q5 1 156054782-156058506 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 627.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004126 Approved Approved Nucleoplasm,Vesicles No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Vesicles" "HPA004126: AB_1849916" "unprognostic (2.09e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-2)" "unprognostic (4.52e-2)" "unprognostic (8.64e-2)" "unprognostic (3.90e-2)" "unprognostic (3.79e-1)" "unprognostic (1.66e-2)" "unprognostic (2.06e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (1.10e-6)" "unprognostic (2.47e-1)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (1.35e-1)" 64.3 84.4 81.9 41.6 81.4 57.1 57.7 83.9 98.9 44.8 83.0 62.0 51.5 42.3 76.7 75.2 52.1 43.8 96.1 81.6 84.7 91.0 164.3 53.8 56.3 81.6 82.5 26.7 87.8 74.4 44.6 37.5 82.0 50.9 56.5 18.0 59.3 44.0 88.6 57.8 53.7 48.9 82.2 65.7 78.1 26.6 85.8 56.1 44.7 70.2 52.0 53.6 46.7 85.8 63.9 142.3 65.4 90.9 131.9 106.7 72.3 55.7 94.4 68.8 78.1 65.9 106.1 94.0 94.4 108.7 60.0 91.5 67.7 151.1 38.7 78.4 103.0 54.9 96.2 88.6 104.4 78.0 86.5 126.1 93.4 73.1 93.3 94.4 142.6 137.3 50.8 68.1 100.9 128.7 80.6 111.4 69.4 250.9 212.1 67.5 48.7 138.7 152.5 93.2 25.3 145.3 70.4 195.1 116.3 104.1 136.5 227.9 96.6 57.5 52.4 83.4 53.0 101.6 166.5 56.2 102.2 87.3 62.9 281.8 465.8 376.2 172.2 446.9 169.8 290.6 188.2 188.7 537.2 249.4 142.6 152.8 231.8 207.0 363.2 284.1 298.3 389.7 81.9 81.4 83.9 98.9 81.6 84.7 81.6 82.5 82.0 82.2 85.8 85.8 102.5 57.7 46.5 3.6 64.5 48.4 59.5 190.3 43.3 29.4 129.9 123.2 113.5 114.4 120.2 108.5 6.2 146.3 73.9 247.5 387.4 193.0 44.5 113.2 78.7 92.6 126.1 48.0 4.5 179.3 203.1 67.5 68.3 105.0 107.3 56.7 86.7 322.1 416.1 6.7 5.4 164.7 197.4 188.9 150.1 89.0 47.2 165.0 158.3 5.6 297.4 92.8 94.7 4.5 5.8 183.2 267.4 50.8 76.8 80.2 317.8 627.2 144.1 30.5 32.9 38.9 124.6 25.5 33.9 99.4 80.0 77.2 64.2 83.3 166.9 97.7 LDHA ENSG00000134333 "Lactate dehydrogenase A" P00338 11 18394560-18408425 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease variant, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 2198.1;Basal respiratory cells: 2133.0;Extravillous trophoblasts: 2086.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015336, CAB069404" Uncertain Supported Vesicles,Cytosol NA NA 170000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol Vesicles "CAB015336: AB_2134947, CAB069404: " "unprognostic (8.83e-2)" "prognostic unfavorable (2.78e-5)" "unprognostic (3.81e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (4.66e-3)" "prognostic unfavorable (3.26e-8)" "prognostic unfavorable (2.27e-6)" "unprognostic (1.08e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.09e-6)" "unprognostic (1.76e-2)" "prognostic unfavorable (9.69e-9)" "unprognostic (4.15e-2)" "unprognostic (1.89e-1)" "unprognostic (3.07e-1)" "unprognostic (1.05e-2)" 444.5 358.1 64.3 139.5 68.4 184.6 330.4 54.0 72.1 203.1 58.4 278.5 158.1 151.1 43.8 450.6 189.2 75.5 361.2 68.4 73.7 440.2 729.2 242.0 97.2 73.6 74.9 149.7 171.5 26.6 95.9 113.9 94.9 170.1 117.4 443.8 267.5 81.8 947.5 468.6 296.6 124.2 58.5 185.3 181.1 95.2 67.4 115.3 180.8 500.3 146.5 266.2 314.4 65.9 1261.4 730.9 28.4 415.2 599.8 399.3 400.6 1186.1 1148.5 936.9 1366.4 324.5 196.6 909.3 380.3 1110.8 727.1 979.2 716.1 1715.1 2082.2 331.3 422.6 329.6 629.4 588.5 148.9 811.2 235.8 411.1 760.3 380.3 373.7 1670.8 550.8 292.3 462.8 431.7 1127.7 319.4 674.8 509.3 182.7 413.2 849.4 432.0 298.0 768.0 1546.6 284.5 220.5 279.3 642.7 518.6 230.8 431.4 241.7 192.9 546.9 1228.3 455.3 1094.7 14.3 348.0 545.1 899.4 1767.1 415.0 434.1 98.4 147.1 79.7 93.8 165.0 105.2 70.4 122.1 99.6 202.1 54.4 78.1 81.0 47.1 91.3 169.3 68.0 140.8 237.6 64.3 68.4 54.0 72.1 68.4 73.7 73.6 74.9 94.9 58.5 67.4 65.9 421.7 73.7 201.6 21.5 220.8 2198.1 475.6 2133.0 523.0 464.2 213.6 229.5 241.8 175.8 837.3 309.0 146.0 509.8 427.2 696.1 434.3 1293.9 204.4 180.0 317.4 492.8 45.6 123.2 38.7 1532.3 2086.2 544.4 163.6 485.8 262.9 205.3 205.6 514.4 659.3 514.8 33.5 285.1 649.0 224.4 1155.1 129.6 287.7 373.9 1177.5 20.6 973.4 444.2 170.0 9.5 12.6 1771.4 590.3 205.0 376.0 546.8 1765.0 682.5 178.1 481.4 190.7 251.6 706.3 195.5 44.0 422.9 1723.2 501.7 410.9 196.2 362.1 530.8 LECT2 "chm-II, chm2" ENSG00000145826 "Leukocyte cell derived chemotaxin 2" O14960 5 135922279-135954983 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "liver: 477.9" "Group enriched" "Detected in some" 15 "Early spermatids: 147.7;Hepatocytes: 100.7;Late spermatids: 55.8" "Cancer enriched" "Detected in single" 216 "liver cancer: 35.1" "Region enhanced" "Detected in some" "cerebellum: 6.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA043883, HPA058246" Enhanced Supported Vesicles,Cytosol "Secreted to blood" NA NA 26500000 5300000 "Cluster 17: Basophils - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 20: HeLa - Mitochondria" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol Vesicles "HPA043883: AB_2678714, HPA058246: " "prognostic favorable (4.16e-5)" "unprognostic (2.57e-2)" "unprognostic (3.52e-1)" 0.2 0.5 0.4 0.4 0.8 2.4 0.4 6.3 2.8 0.1 0.0 0.2 0.5 0.3 0.8 0.4 0.1 0.4 0.1 0.9 0.0 0.6 477.9 0.3 0.9 0.0 0.0 0.3 0.1 0.2 0.0 0.2 0.1 0.4 0.2 3.1 0.7 0.2 2.1 1.4 0.9 0.1 0.0 0.9 0.3 8.8 0.0 0.2 0.4 0.0 0.2 0.1 0.0 1.1 0.3 0.4 0.5 0.7 0.2 0.4 0.6 0.1 0.0 0.0 0.0 0.1 0.4 0.8 0.6 0.3 0.3 0.5 0.0 0.2 0.0 0.3 1.0 0.7 0.7 1.3 0.3 1.0 0.1 0.2 0.1 0.3 0.3 0.6 0.1 0.8 0.2 0.3 0.6 0.0 0.4 0.4 0.5 0.3 0.6 0.5 0.5 0.2 0.2 0.9 0.3 0.6 0.0 0.2 0.0 0.9 0.1 0.5 0.8 0.3 0.4 0.4 0.1 1.1 0.5 0.3 0.3 0.9 0.8 0.6 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.8 6.3 2.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 147.7 0.0 0.1 0.3 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 100.7 0.0 0.0 0.1 0.0 0.0 2.9 0.0 55.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 LGMN "LGMN1, PRSC1" ENSG00000100600 Legumain Q99538 14 92703807-92748679 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 1448.9;Macrophages: 346.1;Syncytiotrophoblasts: 416.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "plasmacytoid DC: 209.2" "Lineage enriched" "Detected in all" 12 "dendritic cells: 209.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 898.6;U-266/70: 462.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001426 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 2000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles Nucleoplasm "HPA001426: AB_1079247" "unprognostic (1.19e-1)" "unprognostic (1.16e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (3.50e-2)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "prognostic favorable (4.70e-4)" "unprognostic (8.06e-2)" "unprognostic (3.64e-2)" "unprognostic (7.18e-3)" "unprognostic (7.24e-2)" 173.7 44.4 37.6 82.2 38.6 20.6 69.7 31.7 60.8 52.6 51.2 102.5 110.4 30.8 36.8 64.5 36.6 145.8 85.3 40.0 40.3 205.9 111.1 107.3 177.0 35.6 37.3 33.0 37.9 247.0 24.9 262.1 42.4 51.9 105.9 19.7 56.4 32.2 50.4 32.7 97.6 65.0 35.9 202.2 107.0 29.8 62.8 52.8 93.2 50.4 54.9 144.7 52.1 49.4 33.2 47.5 30.8 57.4 94.3 76.0 108.4 70.3 67.0 71.7 84.2 36.9 58.6 18.2 101.5 116.5 44.3 81.5 0.0 60.8 33.7 1.6 36.2 1.2 24.4 42.8 27.7 1.0 2.7 54.2 29.1 68.4 39.4 21.3 82.1 33.7 7.4 150.9 5.2 45.2 8.9 1.2 15.1 208.2 32.1 8.4 27.1 898.6 59.2 129.1 33.6 23.2 97.9 59.4 53.0 66.8 43.9 0.6 47.2 35.3 44.8 64.5 21.8 462.5 58.0 25.0 20.0 0.2 69.1 1.9 1.6 0.1 0.8 3.1 1.6 17.0 5.1 1.3 19.3 14.5 15.2 9.0 1.6 3.7 1.0 209.2 9.7 7.0 37.6 38.6 31.7 60.8 40.0 40.3 35.6 37.3 42.4 35.9 62.8 49.4 34.9 57.7 128.0 8.8 33.9 23.1 37.5 36.0 22.2 10.6 31.2 37.6 29.8 42.9 48.1 31.3 93.8 181.8 24.5 64.2 9.8 61.3 1.3 79.4 23.5 38.3 36.5 22.7 19.2 50.6 140.2 63.8 73.4 177.7 8.8 17.6 276.3 46.4 1448.9 13.5 41.0 31.1 95.6 317.6 89.0 3.3 30.4 346.1 48.0 27.2 37.5 23.6 2.1 10.6 15.2 50.5 57.1 57.9 24.7 44.6 163.4 220.4 20.9 19.8 19.7 40.4 62.1 19.9 17.6 22.3 17.5 416.3 8.2 15.1 48.3 44.7 LGSN "GLULD1, LGS" ENSG00000146166 "Lengsin, lens protein with glutamine synthetase domain" Q5TDP6 6 63275951-63319983 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 2.0;liver: 3.8;placenta: 1.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.5;Inhibitory neurons: 3.7;Late spermatids: 4.4;Oligodendrocytes: 5.9;Proximal tubular cells: 5.6;Respiratory ciliated cells: 3.0" "Cancer enriched" "Detected in some" 4 "lung cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.2;BEWO: 3.3;CACO-2: 1.6;HeLa: 1.8;Karpas-707: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030957, HPA039983" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Vesicles" "HPA030957: AB_10670149, HPA039983: AB_2676784" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (1.12e-1)" "unprognostic (9.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (5.05e-4)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (2.13e-1)" "unprognostic (2.53e-2)" "unprognostic (4.51e-3)" "unprognostic (1.64e-3)" "unprognostic (1.31e-1)" "unprognostic (2.19e-1)" 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 2.0 3.8 0.2 0.0 0.3 0.1 0.0 0.3 0.0 0.0 1.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 0.0 2.2 0.0 1.1 1.9 0.1 1.2 2.0 0.0 0.1 0.0 0.0 3.5 0.2 0.5 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.3 0.0 3.7 0.7 0.0 0.3 0.0 4.4 0.3 0.1 0.0 1.9 0.0 0.0 0.0 1.5 5.9 0.0 0.3 0.0 0.1 0.2 0.1 5.6 3.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.4 0.1 0.1 0.8 0.2 LINGO4 LRRN6D ENSG00000213171 "Leucine rich repeat and Ig domain containing 4" Q6UY18 1 151800264-151805419 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 21.3;tongue: 5.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Melanocytes: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 1.8;hypothalamus: 1.0;midbrain: 2.7;pons and medulla: 4.0;thalamus: 1.4" "Region enriched" "Detected in many" 7 "spinal cord: 19.7" HPA060781 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus, Vesicles" "HPA060781: AB_2684361" "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.33e-3)" "unprognostic (1.96e-1)" "unprognostic (8.65e-2)" "unprognostic (3.16e-2)" "unprognostic (1.49e-5)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (2.39e-1)" "unprognostic (1.94e-4)" "unprognostic (6.92e-2)" "unprognostic (3.94e-4)" "unprognostic (3.84e-1)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.60e-2)" 0.0 2.0 0.1 0.1 0.1 0.0 0.1 4.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.1 0.7 0.1 0.7 0.3 0.5 0.3 1.1 0.2 0.2 2.8 1.6 0.0 0.4 0.5 1.4 0.0 3.9 0.7 0.1 0.1 0.6 0.2 21.3 0.6 0.2 0.0 1.3 0.1 0.4 0.6 1.6 1.2 0.6 5.6 0.2 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 0.2 0.3 0.5 2.8 1.6 3.9 1.3 1.6 2.1 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 LLGL2 "HGL, Hugl-2" ENSG00000073350 "LLGL scribble cell polarity complex component 2" Q6P1M3 17 75525080-75575209 "Predicted intracellular proteins" "Cell cycle, Cell division, Exocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 297.5;Pancreatic endocrine cells: 249.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.1" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;NK-cells: 2.1;T-cells: 3.1" "Cell line enhanced" "Detected in many" "CACO-2: 92.6;CAPAN-2: 134.2;MCF7: 132.1;OE19: 101.6;RT4: 92.9;SK-BR-3: 127.5;T-47d: 96.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA022913 Uncertain Supported Vesicles,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Vesicles "HPA022913: AB_1852930" "unprognostic (1.18e-1)" "unprognostic (4.18e-2)" "unprognostic (2.89e-2)" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "prognostic favorable (9.25e-4)" "unprognostic (2.60e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (3.49e-1)" "prognostic favorable (6.00e-5)" "unprognostic (6.22e-3)" "prognostic favorable (6.14e-9)" "unprognostic (1.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.15e-3)" "unprognostic (1.56e-2)" 3.9 7.8 2.7 14.2 6.0 4.6 9.0 6.2 3.6 16.3 9.5 64.5 54.5 4.1 24.0 55.5 14.9 21.3 3.4 2.1 4.1 56.7 26.9 27.6 5.1 6.0 5.9 4.9 74.5 17.3 11.2 6.3 6.2 14.7 28.4 10.4 43.4 12.5 1.3 34.1 55.4 1.9 4.0 24.5 64.2 6.9 4.5 2.3 17.8 0.9 5.7 9.6 25.9 9.8 60.1 54.7 0.3 10.4 0.0 0.0 22.7 0.4 0.6 1.1 0.6 92.6 134.2 4.0 13.6 0.2 5.0 73.7 10.1 10.1 0.2 5.1 18.1 4.0 16.1 35.1 0.6 0.6 8.5 0.0 13.6 0.2 2.1 1.3 2.0 5.8 7.9 5.4 0.0 132.1 3.5 7.1 7.4 101.6 21.2 6.9 0.2 14.9 28.4 92.9 22.1 4.5 11.8 127.5 4.0 12.2 96.6 9.4 0.5 0.2 0.6 0.2 1.0 6.4 9.3 1.8 0.4 0.3 2.7 0.0 0.1 0.1 3.1 0.3 0.7 0.3 0.7 2.1 0.1 0.3 0.1 1.2 0.1 2.1 0.1 1.1 0.5 0.4 2.7 6.0 6.2 3.6 2.1 4.1 6.0 5.9 6.2 4.0 4.5 9.8 7.7 89.8 51.6 3.6 9.0 10.6 34.7 17.3 12.0 15.5 28.8 20.1 3.8 74.4 40.5 90.1 166.8 3.7 44.7 297.5 31.3 84.1 0.6 88.7 7.2 9.0 95.1 0.8 1.1 138.9 8.5 3.5 158.5 87.7 22.2 7.2 4.6 25.0 6.0 8.4 0.8 113.0 32.6 3.8 6.0 1.0 4.7 4.7 3.6 5.6 5.5 28.1 50.4 0.5 49.9 249.4 159.8 4.1 16.1 37.6 84.5 47.0 53.9 117.5 6.6 1.3 6.4 1.5 18.9 27.5 21.7 4.4 21.8 7.5 136.1 89.7 LMAN1 "ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60" ENSG00000074695 "Lectin, mannose binding 1" P49257 18 59327823-59359265 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 502.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002320, CAB037163" Supported Supported "Endoplasmic reticulum,Vesicles" NA NA 18000000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "Endoplasmic reticulum" "CAB037163: AB_532237, HPA002320: AB_1079256" "unprognostic (5.64e-2)" "unprognostic (8.96e-3)" "unprognostic (4.20e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (1.65e-1)" "unprognostic (5.40e-3)" "unprognostic (1.16e-1)" "unprognostic (2.03e-1)" "unprognostic (2.40e-2)" "unprognostic (1.06e-1)" "unprognostic (5.79e-2)" "unprognostic (4.28e-2)" "unprognostic (5.37e-3)" "unprognostic (7.05e-2)" "unprognostic (3.71e-3)" 36.0 43.3 14.8 39.4 16.4 21.7 43.8 16.9 19.4 66.0 20.1 34.1 45.7 46.1 52.9 31.1 48.8 31.9 42.6 13.8 19.4 64.5 181.1 33.6 28.4 17.1 16.0 43.3 53.1 74.3 32.7 54.8 17.4 58.4 39.3 40.0 69.0 43.7 33.3 20.3 49.1 37.7 16.2 27.4 59.3 21.2 16.0 32.1 86.5 41.1 34.8 40.1 21.2 20.4 90.6 52.7 55.1 46.4 125.6 215.6 110.7 159.6 227.9 105.7 140.5 52.7 85.2 16.0 110.7 191.0 75.7 108.1 79.0 90.5 191.0 61.7 50.4 52.5 65.4 109.5 148.9 183.6 77.0 144.7 106.8 102.5 208.1 198.1 108.1 54.3 89.7 173.6 104.2 24.5 53.5 37.9 37.8 45.8 64.5 60.0 100.1 176.0 58.9 67.6 37.5 40.9 80.6 78.0 91.6 76.8 57.8 70.8 89.8 170.5 59.9 55.2 94.0 131.6 71.3 76.2 179.1 96.0 142.6 6.0 2.5 0.7 7.3 3.7 10.0 7.1 7.9 7.7 3.5 5.1 7.5 7.7 0.3 10.0 2.1 8.8 9.6 4.0 14.8 16.4 16.9 19.4 13.8 19.4 17.1 16.0 17.4 16.2 16.0 20.4 120.0 102.5 97.1 15.0 104.0 69.8 120.3 213.5 84.8 39.2 104.5 97.2 134.6 71.4 171.2 80.9 106.3 149.3 86.7 32.8 21.5 130.6 28.1 117.5 203.7 97.7 51.6 49.6 17.2 84.6 304.8 162.4 106.0 200.7 33.6 96.9 75.0 394.0 80.2 58.9 22.1 181.4 107.8 41.9 40.1 10.3 110.6 52.5 67.6 22.5 53.5 76.8 54.6 20.1 33.5 71.6 45.5 85.4 502.1 214.1 95.5 75.6 164.7 66.7 65.7 95.4 142.3 47.2 65.1 80.7 57.0 231.2 69.5 149.6 89.7 129.5 LRP1 "A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A" ENSG00000123384 "LDL receptor related protein 1" Q07954 12 57128483-57213361 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Endocytosis "Developmental protein, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 109.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4" "Group enriched" "Detected in many" 21 "dendritic cells: 1.6;monocytes: 4.3" "Cell line enhanced" "Detected in many" "ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004182, CAB018621, HPA022903" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 180000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles Nucleoplasm "CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426" "unprognostic (1.65e-1)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (5.00e-2)" "unprognostic (4.33e-2)" "unprognostic (3.98e-1)" "unprognostic (8.68e-2)" "unprognostic (1.70e-1)" "unprognostic (3.37e-3)" "unprognostic (1.48e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.29e-5)" 109.2 14.1 21.3 29.0 36.3 8.2 40.0 30.2 19.7 32.3 8.0 24.1 23.2 36.9 6.2 19.3 30.3 31.5 35.5 16.7 21.9 5.7 35.0 34.0 4.9 46.0 31.5 71.0 10.7 7.8 10.2 39.8 27.9 13.8 11.2 9.9 20.3 20.2 13.0 20.4 18.4 28.9 27.1 13.6 15.1 7.3 48.9 5.6 17.6 23.5 2.7 25.5 29.3 27.6 7.7 14.5 30.4 24.2 484.8 488.4 91.2 85.3 109.0 27.5 26.7 26.9 12.4 0.4 10.4 222.2 6.0 33.6 5.3 8.7 9.7 0.7 1.3 0.4 17.9 56.4 66.5 0.5 14.6 318.5 3.1 61.8 7.2 248.7 1.7 1.1 0.4 1.3 87.2 1.7 0.2 0.4 34.8 11.0 8.8 3.2 171.0 1.6 1.9 2.2 1.4 16.4 19.0 0.6 13.2 42.0 2.9 1.2 1.2 96.0 35.0 53.9 5.2 1.1 0.1 0.2 167.4 0.1 18.7 0.0 4.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 1.6 21.3 36.3 30.2 19.7 16.7 21.9 46.0 31.5 27.9 27.1 48.9 27.6 24.6 12.8 8.4 113.6 3.2 24.0 11.9 28.7 19.9 29.2 4.9 19.3 14.8 15.7 14.7 1.8 0.0 87.5 1.1 81.7 0.0 7.4 1.9 9.7 111.4 13.0 4.2 0.8 39.3 1.8 53.0 273.4 49.5 4.2 6.3 36.9 11.0 188.4 73.8 8.4 41.6 14.1 6.1 145.3 28.6 8.4 233.3 102.9 28.4 89.9 48.8 154.7 1.0 173.4 6.6 14.7 27.2 184.3 4.4 5.5 86.0 2.1 15.1 7.3 39.5 129.7 77.0 1.6 2.4 35.4 16.1 125.9 4.2 11.4 25.0 12.3 LRP11 "bA350J20.3, MANSC3" ENSG00000120256 "LDL receptor related protein 11" Q86VZ4 6 149818757-149864359 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 61.3;Respiratory ciliated cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017267 Approved "Vesicles,Plasma membrane" NA NA 1500000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" Vesicles "HPA017267: " "prognostic unfavorable (2.31e-8)" "unprognostic (3.85e-3)" "unprognostic (1.68e-1)" "unprognostic (1.30e-2)" "unprognostic (5.17e-2)" "unprognostic (4.25e-3)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.05e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (3.29e-1)" "unprognostic (2.63e-1)" "unprognostic (4.76e-2)" "unprognostic (2.47e-1)" "unprognostic (6.75e-2)" "unprognostic (1.34e-2)" "unprognostic (4.23e-2)" 14.5 18.0 25.2 5.3 25.8 1.4 11.8 18.7 31.5 17.2 13.8 13.1 11.7 11.4 16.4 28.6 22.3 11.3 10.8 26.7 23.3 20.3 10.0 13.6 2.9 23.6 24.9 16.5 19.8 42.8 17.6 12.5 25.0 25.5 12.3 13.5 20.1 13.0 5.2 20.6 9.1 12.0 19.7 4.1 16.3 8.0 26.0 2.4 22.9 4.8 5.9 18.0 20.8 25.0 26.5 22.9 17.2 15.0 37.8 67.2 3.5 27.7 52.1 18.5 22.4 7.3 52.9 0.2 36.7 43.3 79.4 69.4 19.2 47.1 13.3 43.7 19.4 13.3 74.3 30.4 22.6 13.2 0.8 42.8 93.1 23.0 46.5 52.5 28.9 11.8 26.8 11.0 22.3 45.4 0.5 1.3 10.4 52.0 19.6 14.5 25.5 6.4 33.9 53.8 22.4 15.6 86.7 46.3 17.0 8.5 38.8 26.4 21.1 22.6 4.8 48.4 21.3 0.1 8.7 6.3 40.9 12.9 13.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 25.2 25.8 18.7 31.5 26.7 23.3 23.6 24.9 25.0 19.7 26.0 25.0 7.3 6.4 2.8 17.6 0.5 11.3 14.3 17.9 5.7 12.2 10.2 6.0 8.8 12.8 18.3 20.2 2.1 2.1 0.5 7.7 5.9 6.5 27.0 61.3 6.4 7.4 29.4 5.5 42.5 22.7 1.8 20.5 15.3 16.5 0.0 12.4 9.3 9.5 3.6 8.4 44.3 5.0 16.2 1.9 6.2 31.7 16.4 1.7 14.2 11.2 0.1 6.0 0.0 17.6 40.1 19.7 4.2 14.7 0.6 22.2 4.0 7.0 107.7 5.5 0.0 10.0 11.7 14.7 10.4 14.9 14.3 5.6 1.8 15.7 13.2 23.6 LRP2 "DBS, gp330" ENSG00000081479 "LDL receptor related protein 2" P98164 2 169127109-169362534 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Hearing, Neurogenesis, Transport" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 70.5;kidney: 34.8;parathyroid gland: 44.7;retina: 29.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 87.6;Cytotrophoblasts: 63.2;Oligodendrocytes: 300.1;Proximal tubular cells: 283.9" "Cancer enhanced" "Detected in many" "renal cancer: 29.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 39.4;CACO-2: 64.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA005980, HPA064792" Enhanced Approved Vesicles,Mitochondria No NA 74000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Mitochondria" "HPA005980: AB_1079278, HPA064792: AB_2685353" "unprognostic (1.87e-1)" "unprognostic (1.04e-3)" "unprognostic (1.32e-3)" "unprognostic (3.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (1.64e-3)" "unprognostic (2.99e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (4.38e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.37e-1)" "unprognostic (4.21e-1)" "unprognostic (2.44e-2)" "unprognostic (1.62e-2)" 1.5 0.0 5.5 0.0 23.4 0.1 9.6 18.9 13.5 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.2 7.5 14.6 34.8 0.3 1.2 0.0 30.5 17.5 0.0 0.0 44.7 0.1 7.5 31.9 0.0 0.0 29.3 0.9 0.0 0.1 0.1 0.0 0.0 14.5 0.0 0.0 0.2 18.7 0.0 17.3 0.0 0.0 0.0 0.0 70.5 0.0 0.0 39.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 64.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 23.4 18.9 13.5 7.5 14.6 30.5 17.5 31.9 14.5 18.7 70.5 0.2 6.4 43.7 1.0 3.0 0.3 0.2 0.0 0.0 2.8 22.9 15.1 2.1 2.8 2.5 3.7 87.6 63.2 0.2 0.0 17.6 0.0 3.1 0.1 0.1 0.5 0.0 0.0 1.8 0.0 2.2 1.8 0.0 0.1 2.5 0.0 0.0 0.8 5.1 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 2.5 0.0 1.9 0.0 33.1 0.0 1.5 300.1 0.0 0.0 0.0 0.0 0.0 0.0 283.9 2.2 19.5 0.0 0.0 0.3 0.1 0.8 0.0 0.0 23.1 1.7 0.0 0.0 0.2 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355249-194369743 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 4.9;skin 1: 7.3" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "fHDF/TERT166: 120.6;U-87 MG: 62.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" NA NA 1700000 "Cluster 31: Skin - Epidermis development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 1.1 0.1 0.0 1.3 0.0 0.0 3.7 0.0 0.0 2.9 0.0 1.7 0.5 1.9 0.0 0.5 1.1 1.6 0.2 0.0 0.0 0.0 0.1 2.0 0.8 0.0 0.1 0.2 0.1 0.1 0.0 2.2 0.0 0.1 3.0 0.0 1.0 0.0 0.1 7.3 0.4 0.6 0.0 1.3 1.5 0.0 0.1 0.2 1.3 0.2 4.9 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.7 0.1 0.1 0.4 0.0 0.0 1.0 120.6 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 22.5 3.7 3.0 0.0 0.0 0.0 0.0 62.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 LRRC17 "H_RG318M05.3, P37NB" ENSG00000128606 "Leucine rich repeat containing 17" Q8N6Y2 7 102913000-102945111 "Predicted secreted proteins" Osteogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 76.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 31.3;Granulosa cells: 68.6;Leydig cells: 101.9;Peritubular cells: 31.6;Sertoli cells: 65.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 94 "eosinophil: 9.9" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.9" "Cell line enriched" "Detected in many" 5 "LHCN-M2: 1237.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073458 Approved "Vesicles,Cytokinetic bridge" "Secreted in other tissues" Yes NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Cytokinetic bridge" "HPA073458: " "unprognostic (1.77e-1)" "unprognostic (7.73e-2)" "unprognostic (4.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (4.46e-1)" "unprognostic (1.18e-1)" "unprognostic (9.76e-4)" "unprognostic (6.09e-3)" "unprognostic (2.26e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (8.57e-3)" "unprognostic (4.48e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.30e-4)" 8.1 2.4 1.6 1.1 1.7 0.2 12.9 1.6 2.4 22.5 1.7 2.7 1.6 15.7 12.1 6.0 17.3 27.4 13.2 1.7 1.6 2.8 3.5 3.2 2.1 1.6 1.7 76.2 2.3 2.0 2.4 0.6 1.5 5.6 3.3 1.8 2.7 3.2 2.1 3.0 2.3 6.0 1.6 3.3 6.9 5.0 2.3 6.2 3.8 2.8 1.0 4.4 5.8 1.6 0.0 0.0 58.8 0.5 6.0 29.4 0.1 1.6 18.2 0.6 2.8 0.0 0.2 0.0 3.4 1.5 7.3 0.1 0.0 0.0 4.3 0.0 1.4 0.1 0.0 0.1 8.3 0.5 0.2 28.1 0.7 21.5 0.0 141.1 140.9 0.6 0.0 0.1 1237.5 0.0 0.1 0.4 3.1 0.1 0.1 0.1 244.0 0.2 0.2 0.1 1.3 1.3 0.1 0.0 0.1 0.1 0.0 1.7 11.8 0.2 1.5 15.2 2.3 1.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.7 1.6 2.4 1.7 1.6 1.6 1.7 1.5 1.6 2.3 1.6 3.6 0.0 1.1 4.6 0.2 0.9 0.2 0.9 0.0 3.7 0.7 0.8 1.1 0.0 0.5 1.8 2.1 0.3 0.3 0.0 0.0 1.7 3.5 2.7 15.3 4.4 0.0 0.0 6.9 0.4 0.2 31.3 1.1 4.6 1.3 68.6 6.1 0.5 0.4 0.0 8.7 0.1 2.0 0.0 2.7 2.9 101.9 0.5 5.4 10.3 0.6 0.6 0.0 2.5 5.3 0.2 0.3 31.6 0.0 0.3 0.1 0.3 0.1 2.2 65.7 16.1 17.8 0.6 0.5 0.4 0.6 0.0 0.9 6.6 0.2 0.2 LRRC43 MGC35140 ENSG00000158113 "Leucine rich repeat containing 43" Q8N309 12 122167738-122203471 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 4.9;choroid plexus: 16.1;fallopian tube: 19.0;testis: 6.4" "Cell type enhanced" "Detected in some" "Early spermatids: 23.2;Endometrial ciliated cells: 21.8;Late spermatids: 43.5;Proximal tubular cells: 15.9;Respiratory ciliated cells: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.1;HSkMC: 1.3;HUVEC TERT2: 2.7;SCLC-21H: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA039425 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" Vesicles "HPA039425: AB_2676501" "unprognostic (6.42e-3)" "unprognostic (1.33e-1)" "unprognostic (2.71e-1)" "unprognostic (2.83e-3)" "unprognostic (2.48e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.56e-2)" "unprognostic (6.03e-5)" "unprognostic (1.19e-1)" "unprognostic (4.52e-3)" "unprognostic (2.61e-1)" "unprognostic (6.21e-4)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.39e-1)" "unprognostic (2.49e-1)" 0.5 0.3 2.1 0.0 2.7 0.5 0.3 1.5 2.2 1.1 16.1 0.3 0.5 0.7 1.8 0.1 19.0 0.9 0.7 2.3 2.7 2.1 0.1 1.6 0.0 3.5 4.9 0.3 0.6 1.9 2.2 0.1 2.8 0.7 0.1 0.6 1.1 1.2 0.1 0.3 0.1 0.2 3.7 0.3 0.2 6.4 2.9 0.0 1.6 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.7 0.2 0.2 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.1 0.0 0.2 1.3 0.0 0.4 0.0 0.0 2.7 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.1 0.0 0.3 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.9 0.2 0.2 0.0 0.2 2.1 2.7 1.5 2.2 2.3 2.7 3.5 4.9 2.8 3.7 2.9 1.4 0.0 6.4 0.0 4.6 0.1 0.0 0.1 1.0 0.0 0.4 0.3 0.3 0.5 0.0 2.7 1.8 4.2 0.1 1.7 0.2 1.9 0.1 23.2 21.8 0.4 0.1 0.0 0.8 3.5 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.0 2.8 0.0 2.0 0.0 0.3 43.5 0.6 0.3 0.0 1.0 0.0 0.9 2.1 2.0 0.7 0.0 0.0 0.4 0.1 0.1 0.0 15.9 35.2 0.1 0.0 0.1 0.5 8.2 1.2 0.0 0.0 0.1 0.5 0.0 0.1 0.1 LRRD1 IMAGE:4798971 ENSG00000240720 "Leucine rich repeats and death domain containing 1" A4D1F6 7 92141643-92179531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 16.5" "Group enriched" "Detected in some" 90 "Early spermatids: 258.1;Late spermatids: 869.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055670, HPA079440" Enhanced Approved Vesicles,Mitochondria NA NA "Cluster 17: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" Mitochondria Vesicles "HPA055670: , HPA079440: " "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (3.72e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (1.12e-1)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.27e-2)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" "unprognostic (1.77e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.13e-3)" 0.0 0.0 0.4 0.0 0.5 0.3 0.1 1.7 0.8 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.2 0.1 0.5 0.9 0.0 0.0 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.5 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.0 16.5 0.8 0.0 0.1 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.0 0.4 0.5 1.7 0.8 0.5 0.9 0.6 0.4 0.8 0.2 0.8 1.1 0.1 0.0 0.6 1.6 0.0 0.3 0.5 0.0 0.0 0.6 0.2 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.3 0.1 0.0 0.0 258.1 0.1 0.6 0.3 0.0 0.0 1.7 0.0 0.1 0.3 0.0 0.3 1.3 0.4 0.0 0.0 0.1 1.7 2.8 0.0 0.0 0.0 0.7 869.3 4.7 0.5 0.0 1.0 0.0 0.3 0.0 1.5 1.4 0.0 0.0 3.0 0.0 0.4 0.1 0.1 1.5 0.9 0.0 1.2 0.3 6.2 2.6 0.0 0.3 0.0 0.5 0.3 0.1 0.3 LSM8 YJR022W ENSG00000128534 "LSM8 homolog, U6 small nuclear RNA associated" O95777 7 118184144-118204035 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020116 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Vesicles" "HPA020116: AB_1853385" "unprognostic (1.02e-2)" "unprognostic (6.58e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.85e-4)" "unprognostic (3.33e-2)" "unprognostic (7.34e-2)" "unprognostic (1.13e-3)" "unprognostic (1.87e-2)" "unprognostic (1.79e-2)" "unprognostic (9.90e-2)" "unprognostic (5.14e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.46e-6)" "unprognostic (4.82e-2)" "unprognostic (1.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.00e-3)" 26.8 19.1 6.2 22.3 8.3 44.8 25.6 16.5 7.7 20.5 6.2 22.0 15.5 19.9 16.5 24.4 18.7 9.2 19.2 6.3 7.5 23.7 18.5 21.2 28.9 7.5 7.4 19.8 24.9 8.4 16.3 10.1 7.7 20.8 14.2 16.7 22.7 7.8 21.7 21.6 26.0 8.3 6.8 30.9 21.3 17.3 7.2 18.2 22.1 7.8 27.5 20.0 20.6 10.5 37.2 21.2 53.7 43.6 11.3 19.4 25.3 36.1 26.4 19.2 21.5 16.8 35.6 70.0 78.9 13.4 51.5 28.2 23.1 16.3 18.6 35.9 27.7 49.5 63.3 48.6 29.2 63.9 59.1 20.8 19.6 24.6 25.8 17.7 19.6 55.8 45.8 71.2 26.1 13.2 142.9 155.6 43.6 28.9 26.0 40.8 32.0 53.3 20.3 27.8 28.2 41.6 29.2 83.0 89.1 36.9 17.3 72.7 17.4 36.9 27.7 56.3 51.2 69.9 52.0 101.1 29.1 66.9 61.5 65.3 46.5 45.5 61.8 66.7 59.8 68.0 67.8 75.6 51.5 58.0 64.6 67.5 15.4 43.9 65.7 93.2 74.2 39.5 6.2 8.3 16.5 7.7 6.3 7.5 7.5 7.4 7.7 6.8 7.2 10.5 108.5 25.6 58.6 15.0 130.3 0.0 93.6 0.0 82.6 41.5 71.8 92.1 43.5 74.4 35.3 62.5 47.9 133.2 141.2 76.8 90.1 101.2 54.6 76.1 92.8 79.6 86.4 83.1 19.5 172.0 193.6 69.0 66.3 76.4 101.4 87.1 88.5 75.3 139.8 42.1 22.4 99.1 0.0 148.9 0.0 19.1 97.3 102.2 0.0 36.5 184.9 52.6 158.6 23.6 39.1 144.8 109.0 76.0 95.6 108.6 83.6 106.8 36.5 42.0 85.5 65.3 66.2 135.3 117.8 106.7 0.0 120.8 121.1 76.1 100.7 121.2 LSMEM1 "C7orf53, FLJ39575" ENSG00000181016 "Leucine rich single-pass membrane protein 1" Q8N8F7 7 112480853-112491062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 81.6" "Cell type enhanced" "Detected in many" "Early spermatids: 49.2;Glandular and luminal cells: 27.7;Late spermatids: 67.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HeLa: 8.7" "Group enriched" "Detected in many" 4 "amygdala: 1.4;basal ganglia: 1.0;cerebellum: 4.0;olfactory bulb: 3.3" "Low region specificity" "Detected in many" "HPA013753, HPA047988" Uncertain Supported Vesicles,Cytosol NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Cytosol Vesicles "HPA013753: AB_1848926, HPA047988: AB_2680229" "unprognostic (6.87e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-2)" "unprognostic (2.77e-2)" "unprognostic (1.38e-1)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (6.68e-2)" "unprognostic (3.54e-2)" "unprognostic (2.80e-3)" "unprognostic (1.47e-6)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.25e-2)" "unprognostic (3.42e-2)" 2.2 2.1 1.2 0.2 1.7 0.3 1.5 2.1 2.5 1.7 1.1 2.0 0.5 1.0 1.0 2.0 1.6 0.1 2.9 1.2 1.7 4.0 7.2 4.3 0.1 1.2 1.1 1.7 5.5 0.0 2.3 0.2 1.1 2.5 0.3 0.8 1.7 0.3 81.6 1.4 2.2 0.1 0.8 4.2 2.7 2.9 1.3 0.1 2.2 17.0 0.0 1.8 2.2 1.5 0.0 0.1 0.1 0.6 0.5 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.2 8.7 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.9 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.7 1.3 0.0 0.2 0.4 0.1 0.0 0.2 0.5 0.3 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 2.1 2.5 1.2 1.7 1.2 1.1 1.1 0.8 1.3 1.5 16.8 0.0 2.8 5.9 5.1 5.5 2.7 1.3 9.6 2.1 12.8 23.4 9.9 2.8 2.2 1.8 2.1 1.3 9.5 17.5 0.0 0.8 49.2 12.7 18.4 5.3 3.0 0.0 8.5 0.9 1.1 7.2 7.7 27.7 0.0 0.5 1.1 1.0 4.0 0.0 7.6 5.7 0.0 1.2 4.8 67.8 0.9 13.6 1.8 3.7 1.8 0.6 0.0 1.5 5.0 0.8 7.1 0.4 4.2 6.1 5.2 0.5 1.4 3.2 0.0 22.3 8.1 0.5 0.5 9.5 4.7 1.9 6.3 2.2 5.4 3.6 LURAP1 "C1orf190, FLJ25163, LRAP35a" ENSG00000171357 "Leucine rich adaptor protein 1" Q96LR2 1 46203334-46221256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Early spermatids: 140.9;Late spermatids: 335.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 5.4;RPTEC TERT1: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030060, HPA030061" Uncertain Supported Vesicles,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 21: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 31: Spermatids - Spermatogenesis" Cytosol Vesicles "HPA030060: AB_10599997, HPA030061: AB_10601990" "unprognostic (3.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.22e-3)" "unprognostic (8.82e-2)" "unprognostic (1.91e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.47e-2)" "unprognostic (2.44e-2)" "unprognostic (2.95e-2)" "unprognostic (4.14e-2)" "unprognostic (1.33e-1)" "prognostic favorable (8.81e-8)" "unprognostic (1.32e-2)" "unprognostic (2.80e-1)" "unprognostic (3.11e-2)" "unprognostic (2.39e-2)" 2.1 3.5 2.4 0.9 6.5 1.7 2.1 5.7 5.7 4.5 2.5 3.1 0.8 3.2 2.2 2.0 3.3 1.7 5.4 3.1 4.7 5.3 0.4 1.6 0.5 9.7 5.4 3.9 0.3 9.5 2.1 0.9 7.3 4.6 1.0 1.3 2.6 4.8 1.1 2.0 1.3 2.7 4.0 1.6 2.7 8.9 6.2 1.2 10.5 1.0 0.8 3.8 4.0 13.6 0.1 0.1 2.1 0.1 2.8 3.8 2.1 1.5 3.8 2.0 2.3 0.1 0.1 0.2 0.1 3.6 0.7 0.2 2.2 4.8 1.6 0.4 1.0 0.2 0.5 0.2 0.8 0.1 0.1 1.8 3.0 4.0 1.8 5.4 3.0 0.5 1.9 0.3 1.1 0.2 0.2 0.2 0.8 0.0 0.3 0.7 1.0 0.0 5.3 0.0 0.3 0.8 0.0 0.1 3.4 0.8 1.1 0.2 0.2 1.2 1.5 1.0 0.3 0.1 0.1 0.2 1.2 0.2 0.3 0.2 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.3 0.3 0.2 0.8 0.3 0.1 0.2 0.0 0.1 2.4 6.5 5.7 5.7 3.1 4.7 9.7 5.4 7.3 4.0 6.2 13.6 2.2 0.0 0.0 6.8 0.0 5.0 15.6 4.5 8.0 0.2 2.7 4.1 3.1 0.0 1.3 11.0 0.0 4.1 0.1 0.2 15.6 0.1 140.9 1.3 1.6 2.9 1.2 0.0 10.0 0.4 2.3 4.0 0.0 1.3 0.0 2.5 3.3 0.1 4.4 0.0 5.5 0.3 0.0 0.3 3.3 335.2 9.3 1.2 14.2 5.6 0.7 2.0 1.0 1.0 25.3 0.0 0.1 9.8 0.0 8.6 0.1 5.3 3.3 0.2 6.6 2.6 4.7 36.3 2.2 2.7 3.4 7.7 0.2 2.7 0.1 5.5 LYPD3 C4.4A ENSG00000124466 "LY6/PLAUR domain containing 3" O95274 19 43460787-43465608 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 1066.8;skin 1: 669.3;vagina: 487.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 504.7;Squamous epithelial cells: 811.7;Suprabasal keratinocytes: 2306.1;Syncytiotrophoblasts: 715.8;Urothelial cells: 642.9" "Cancer enhanced" "Detected in many" "cervical cancer: 158.5;head and neck cancer: 235.7" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 5.5" "Group enriched" "Detected in many" 9 "dendritic cells: 2.6;granulocytes: 2.1;T-cells: 5.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.5;HaCaT: 99.5;MCF7: 114.2;RT4: 108.2;SK-BR-3: 158.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041529, HPA041797, HPA077859" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA 7600000 "Cluster 32: T-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "Endoplasmic reticulum, Vesicles" "HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: " "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (2.80e-1)" "unprognostic (2.67e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (1.07e-3)" "unprognostic (5.13e-2)" "unprognostic (8.79e-2)" "unprognostic (1.11e-1)" "unprognostic (2.96e-3)" 1.7 3.5 0.7 1.7 0.8 6.6 32.1 0.6 1.0 259.1 1.4 1.1 0.5 7.6 1.8 1066.8 3.5 1.3 1.3 0.7 0.9 2.9 1.2 1.6 2.6 0.7 0.8 8.9 1.3 1.8 2.3 12.3 0.7 11.9 0.7 1.0 183.3 1.3 2.8 669.3 1.6 0.8 0.7 2.1 3.3 1.1 0.8 12.2 1.2 0.2 131.9 55.0 487.0 0.7 38.6 0.6 0.2 0.6 0.3 0.0 15.3 1.5 3.9 1.4 1.9 0.5 42.5 0.4 1.7 1.1 5.6 99.5 0.2 4.4 0.7 0.0 0.3 0.7 4.5 0.8 0.4 0.0 0.9 1.7 37.2 0.2 0.3 1.7 0.0 3.1 0.2 0.1 0.1 114.2 0.9 0.0 0.2 24.3 8.3 0.5 0.0 0.2 1.0 108.2 0.1 0.3 0.5 158.9 1.8 4.7 17.7 0.1 0.0 0.0 0.7 0.5 0.7 0.6 3.0 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.8 0.0 1.1 0.1 2.9 1.1 2.6 0.0 5.5 4.7 2.1 0.0 0.0 0.3 0.9 1.2 0.7 0.8 0.6 1.0 0.7 0.9 0.7 0.8 0.7 0.7 0.8 0.7 0.9 0.0 1.1 0.0 1.3 504.7 102.5 161.2 111.0 0.7 66.6 38.0 0.6 2.8 72.6 14.7 0.0 96.5 2.1 0.9 1.9 1.6 0.1 4.5 4.4 7.5 0.0 0.4 0.0 0.2 87.2 18.1 3.6 24.5 5.7 0.5 0.0 0.3 14.0 3.3 0.1 2.2 24.4 0.3 139.8 0.0 0.6 23.2 147.7 0.0 0.7 4.5 0.0 0.0 0.2 4.7 0.2 0.4 0.0 40.4 0.3 0.7 5.7 0.5 0.0 1.5 10.5 0.1 0.9 811.7 2306.1 715.8 9.6 0.5 1.1 642.9 MAK16 "MAK16L, RBM13" ENSG00000198042 "MAK16 homolog" Q9BXY0 8 33485182-33501262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044417, HPA050574" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Vesicles" "HPA044417: AB_2678935, HPA050574: AB_2681181" "unprognostic (2.10e-1)" "unprognostic (1.74e-1)" "unprognostic (8.48e-3)" "unprognostic (2.28e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.00e-4)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (8.04e-2)" "unprognostic (1.20e-1)" "unprognostic (6.74e-2)" "unprognostic (1.47e-1)" 9.9 6.2 4.7 9.3 4.8 9.2 8.9 5.1 5.7 6.6 4.1 5.7 5.4 7.2 5.1 8.0 5.9 6.5 7.0 4.5 6.4 7.2 9.0 5.6 11.1 5.3 6.3 7.5 9.3 5.9 4.5 7.8 5.8 6.1 6.5 4.0 5.6 5.6 8.4 7.4 5.0 7.7 5.3 6.5 5.4 5.6 5.5 8.8 8.5 8.0 10.8 12.2 5.1 6.0 14.1 19.3 13.2 30.6 15.2 18.1 19.9 25.0 16.2 26.4 24.6 28.5 12.0 49.7 23.8 22.1 22.5 18.3 45.6 27.8 35.0 10.8 12.3 46.9 13.2 25.6 22.9 19.3 27.4 19.1 24.8 34.8 40.4 9.4 19.6 33.5 59.5 27.5 22.0 16.1 68.9 22.4 71.4 34.4 13.2 23.9 20.1 22.2 22.2 23.7 33.6 26.7 15.5 21.1 30.4 16.2 14.7 19.5 17.8 24.9 19.3 32.6 28.9 13.8 16.4 50.4 15.3 39.7 27.0 0.0 2.4 0.6 3.2 5.0 3.6 2.0 3.2 2.8 2.9 2.5 4.0 4.3 0.4 4.4 7.9 3.0 2.6 2.3 4.7 4.8 5.1 5.7 4.5 6.4 5.3 6.3 5.8 5.3 5.5 6.0 12.8 16.0 9.7 3.6 12.8 15.6 15.2 5.6 13.1 5.1 7.9 9.0 12.9 10.0 11.3 9.2 2.1 11.5 7.8 3.9 7.9 10.6 1.8 9.8 19.8 12.7 1.8 15.8 5.8 7.8 15.8 15.8 8.2 10.5 9.5 10.8 5.3 7.3 8.7 10.1 6.0 6.7 6.1 5.3 4.7 1.3 9.0 7.8 1.8 2.8 7.7 2.9 10.3 7.1 4.7 11.5 5.0 7.5 12.1 15.3 4.1 10.2 10.5 5.1 6.6 17.6 14.4 13.8 19.2 12.7 14.9 7.5 9.9 13.8 7.4 12.3 MAN1C1 HMIC ENSG00000117643 "Mannosidase alpha class 1C member 1" Q9NR34 1 25616791-25786206 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 54.2;Excitatory neurons: 72.8;Hepatic stellate cells: 63.9;Hepatocytes: 57.8;Inhibitory neurons: 65.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 4.7" "Lineage enriched" "Detected in single" 5 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "AF22: 30.5;HSkMC: 108.9;U-266/70: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048352 Uncertain Uncertain Nucleoplasm,Vesicles NA NA 1800000 "Cluster 32: T-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Vesicles" "HPA048352: AB_2680368" "unprognostic (2.75e-1)" "unprognostic (5.45e-3)" "unprognostic (5.71e-3)" "unprognostic (2.05e-2)" "unprognostic (1.95e-1)" "unprognostic (8.90e-3)" "unprognostic (4.78e-2)" "prognostic favorable (7.55e-4)" "unprognostic (1.80e-1)" "unprognostic (5.70e-2)" "prognostic favorable (4.79e-4)" "unprognostic (2.51e-1)" "unprognostic (9.09e-3)" "unprognostic (3.18e-2)" "unprognostic (7.23e-2)" "unprognostic (7.44e-2)" "unprognostic (5.18e-2)" 12.5 11.6 13.3 9.4 15.2 2.2 6.2 16.6 16.1 19.6 27.3 10.0 4.5 14.5 7.5 7.0 9.7 18.6 10.1 15.9 16.9 25.4 29.6 9.2 12.4 45.1 23.2 17.3 3.6 24.0 17.1 21.1 26.1 17.6 4.6 11.0 5.7 17.9 4.6 8.1 6.1 19.9 29.4 19.3 7.3 4.2 16.4 10.5 26.0 5.5 9.4 12.3 9.1 37.8 0.1 0.4 30.5 6.4 22.4 17.2 8.6 0.4 5.8 1.4 0.4 0.6 0.2 0.1 0.3 2.3 3.9 0.4 3.0 0.3 0.6 9.8 1.3 0.6 0.5 0.1 2.6 5.2 12.0 108.9 0.5 0.7 0.0 0.4 0.1 1.2 0.1 1.3 0.0 1.6 0.0 5.8 7.8 0.1 0.2 0.6 18.9 0.6 0.2 0.7 17.7 0.6 0.7 4.7 1.5 5.5 2.4 3.6 0.1 0.0 1.6 20.1 0.7 31.7 0.1 0.1 4.6 10.7 1.5 0.3 0.9 0.4 0.3 0.6 0.5 0.2 2.1 0.9 0.3 0.5 4.7 2.7 0.6 0.4 0.8 0.2 0.5 0.7 13.3 15.2 16.6 16.1 15.9 16.9 45.1 23.2 26.1 29.4 16.4 37.8 5.8 3.2 3.2 18.3 2.0 6.6 2.9 3.6 5.2 23.5 1.1 1.5 7.0 4.3 7.3 22.0 54.2 10.6 1.6 0.5 9.8 1.0 0.3 0.4 8.1 8.4 3.0 2.7 72.8 3.8 0.9 23.3 1.1 0.6 2.5 0.3 63.9 57.8 24.8 21.9 65.8 0.1 16.2 19.0 4.3 2.1 27.1 6.8 1.8 39.4 3.3 17.8 3.1 25.1 21.7 1.4 0.3 22.2 2.2 2.0 0.0 23.3 2.2 4.4 6.6 17.0 7.1 0.2 2.9 1.0 5.3 42.7 6.9 0.7 0.2 1.9 MAN2B1 "LAMAN, MANB" ENSG00000104774 "Mannosidase alpha class 2B member 1" O00754 19 12646511-12666742 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 32.8;Plasma cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 201.8;intermediate monocyte: 178.8;myeloid DC: 158.8;non-classical monocyte: 138.4;plasmacytoid DC: 187.5" "Group enriched" "Detected in all" 5 "dendritic cells: 187.5;monocytes: 201.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041530, HPA053404" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 3200000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Vesicles" "HPA041530: AB_10795639, HPA053404: " "unprognostic (6.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.20e-2)" "unprognostic (5.48e-2)" "unprognostic (3.81e-1)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.84e-2)" "unprognostic (9.55e-2)" "unprognostic (1.95e-1)" "unprognostic (2.79e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.94e-5)" "unprognostic (4.00e-1)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.51e-1)" 35.8 21.4 5.3 54.6 6.4 83.6 24.8 6.6 5.9 19.6 18.5 30.3 31.0 21.8 9.0 19.8 19.9 28.4 16.0 4.9 7.4 17.3 23.7 46.8 52.1 10.3 6.7 16.7 39.7 16.6 9.9 24.6 9.5 20.5 22.6 1.6 35.2 14.9 12.1 28.9 33.6 20.2 8.9 70.1 32.7 6.4 9.7 23.1 16.3 9.4 39.3 35.6 16.7 12.4 52.4 26.3 26.4 31.3 85.8 57.3 74.0 37.9 79.2 33.1 32.4 21.3 21.4 56.9 44.9 30.4 9.4 40.1 13.6 25.6 15.7 28.5 41.6 19.8 13.6 34.9 43.5 131.6 130.2 68.5 49.2 18.5 23.3 35.6 31.7 21.1 25.6 41.9 17.8 40.9 17.9 74.2 21.9 26.2 32.8 40.8 36.1 28.8 38.9 59.8 8.2 25.5 37.7 32.0 63.0 15.8 49.4 80.0 42.0 44.8 18.4 44.0 36.2 55.4 65.5 28.0 30.4 127.5 51.2 12.2 201.8 29.7 31.9 178.8 35.4 32.9 28.9 29.0 158.8 26.4 15.4 15.9 29.4 13.2 138.4 187.5 30.7 150.3 5.3 6.4 6.6 5.9 4.9 7.4 10.3 6.7 9.5 8.9 9.7 12.4 1.6 6.4 7.5 8.5 25.1 3.6 2.0 2.7 14.2 2.6 1.9 1.0 0.9 2.8 2.0 1.8 0.0 2.5 20.5 2.0 1.9 1.7 3.7 1.4 2.5 3.1 1.8 9.4 7.8 2.3 2.8 7.2 20.9 1.3 1.3 3.4 1.8 0.8 8.4 0.0 6.4 0.9 0.0 15.4 24.7 11.1 3.7 32.8 1.8 17.8 11.0 1.5 9.2 3.5 13.4 1.5 2.5 4.5 78.1 2.5 3.8 1.5 3.9 4.0 13.1 2.3 2.0 0.6 1.6 11.5 3.3 2.7 9.4 2.7 2.0 2.0 MANSC1 "FLJ10298, LOH12CR3" ENSG00000111261 "MANSC domain containing 1" Q9H8J5 12 12326056-12350242 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 70.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "neutrophil: 98.3" "Lineage enriched" "Detected in many" 39 "granulocytes: 98.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 50.7;OE19: 54.3;RPTEC TERT1: 25.9" "Low region specificity" "Detected in all" "HPA007955, HPA007956" Approved Approved "Golgi apparatus,Vesicles" NA NA 44000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Vesicles" "HPA007955: AB_1079306, HPA007956: AB_1079305" "unprognostic (5.41e-3)" "unprognostic (3.10e-2)" "unprognostic (1.24e-1)" "unprognostic (5.46e-3)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-2)" "unprognostic (8.47e-2)" "unprognostic (9.18e-2)" "unprognostic (5.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.03e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.15e-2)" "unprognostic (4.46e-2)" "unprognostic (3.65e-1)" "unprognostic (1.03e-2)" 18.9 12.1 3.4 4.3 4.1 3.5 19.5 3.9 6.5 16.9 5.0 22.9 11.7 22.1 11.5 42.3 16.6 10.2 11.2 4.1 3.0 13.2 9.7 12.3 2.3 3.2 3.3 11.3 25.2 11.3 17.9 9.5 3.2 15.1 15.8 5.4 70.0 10.8 4.0 21.7 15.2 12.1 2.6 11.3 21.5 8.4 3.8 1.4 13.8 4.4 6.4 16.3 20.6 4.0 0.3 5.7 1.8 0.1 5.6 5.5 6.2 3.9 4.6 2.0 2.5 4.8 18.2 0.0 4.2 3.9 2.1 0.8 7.1 3.3 1.5 0.0 6.9 8.3 6.4 4.2 0.9 1.4 2.3 3.5 5.3 1.3 0.9 13.8 50.7 0.1 5.6 0.1 0.6 11.0 0.0 0.6 6.5 54.3 3.0 0.2 0.0 0.1 25.9 18.8 2.6 10.3 2.1 16.9 6.0 2.8 15.4 5.0 20.5 2.8 2.3 0.7 5.5 0.4 0.2 2.8 2.0 0.0 2.1 6.6 1.2 1.0 0.1 0.9 0.0 0.2 0.3 0.0 0.6 0.4 2.5 0.4 98.3 0.6 0.4 0.1 0.0 0.6 3.4 4.1 3.9 6.5 4.1 3.0 3.2 3.3 3.2 2.6 3.8 4.0 29.0 9.6 21.2 8.8 3.3 4.0 7.1 7.2 6.2 6.1 21.2 13.5 2.6 28.6 11.9 23.9 8.4 35.4 4.5 33.6 1.9 19.0 0.9 15.1 5.2 28.8 21.7 3.6 16.6 37.9 7.4 10.4 23.0 20.5 2.5 8.6 37.1 9.8 8.0 10.1 13.5 33.4 8.2 5.5 0.7 2.2 13.7 2.0 0.0 15.0 2.7 11.4 9.2 7.5 11.4 16.3 25.2 16.6 1.0 7.4 16.7 3.0 18.1 13.1 0.0 4.8 6.5 2.1 1.5 22.1 4.7 17.0 3.0 9.7 26.5 8.8 MAP1LC3B ATG8F ENSG00000140941 "Microtubule associated protein 1 light chain 3 beta" Q9GZQ8 16 87383953-87404779 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037216, HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (4.70e-3)" "unprognostic (2.89e-1)" "unprognostic (3.21e-1)" "unprognostic (9.70e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-2)" "unprognostic (4.98e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "prognostic favorable (2.77e-7)" "prognostic unfavorable (8.97e-4)" "unprognostic (9.66e-2)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" 92.0 82.9 108.4 37.5 112.9 245.6 72.9 123.7 135.3 46.1 110.7 46.2 25.5 52.6 44.7 45.0 48.2 57.0 102.7 105.2 130.1 71.3 50.3 50.9 52.5 131.5 132.0 43.3 37.1 74.2 51.1 75.6 140.8 43.6 47.1 125.9 49.2 49.3 195.2 62.5 36.9 66.6 120.5 44.4 42.3 51.8 126.5 54.9 63.5 176.7 51.4 57.3 42.0 123.8 56.9 33.7 63.8 59.2 188.5 145.3 41.9 111.4 130.1 88.0 59.9 56.0 42.4 37.7 82.0 155.7 97.5 50.8 95.2 72.3 125.3 49.9 81.0 39.4 40.2 94.4 313.4 28.3 40.0 194.9 234.8 137.0 326.0 131.1 101.1 57.2 107.4 79.0 150.4 61.5 48.4 64.0 66.1 27.7 81.2 76.2 42.2 37.6 119.0 28.4 53.0 60.3 174.8 29.4 230.8 85.2 48.0 34.0 134.1 94.7 59.7 86.4 65.3 99.4 131.5 137.7 133.9 68.3 69.6 312.5 86.8 198.1 78.6 81.6 80.5 72.5 75.8 81.1 69.2 58.2 58.4 62.0 214.3 104.7 85.3 75.1 108.2 109.2 108.4 112.9 123.7 135.3 105.2 130.1 131.5 132.0 140.8 120.5 126.5 123.8 523.1 89.8 90.5 15.7 185.3 221.0 203.1 176.2 301.7 70.4 183.9 227.3 180.7 72.9 117.2 77.3 52.1 130.6 242.7 309.1 262.2 310.9 222.1 283.6 235.9 191.7 132.2 364.2 29.2 134.8 140.2 177.7 96.4 530.5 131.1 49.3 80.7 70.1 206.4 87.5 41.4 137.3 238.0 150.9 268.5 269.7 90.7 262.2 188.5 19.7 207.0 194.3 143.2 14.6 26.9 322.8 407.6 89.1 202.0 209.3 217.4 236.9 133.5 124.0 59.2 129.5 168.2 361.2 206.7 221.8 213.5 631.5 221.6 85.7 122.4 294.5 MAP1LC3B2 ATG8G ENSG00000258102 "Microtubule associated protein 1 light chain 3 beta 2" A6NCE7 12 116548105-116576606 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 40.5;Langerhans cells: 33.4;Paneth cells: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.2" "HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles Nucleoplasm "HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (1.50e-1)" "unprognostic (6.94e-2)" "unprognostic (9.14e-2)" "unprognostic (3.89e-3)" "unprognostic (1.62e-1)" "unprognostic (1.22e-1)" "unprognostic (2.43e-3)" "unprognostic (3.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (1.11e-3)" "unprognostic (6.66e-3)" "unprognostic (1.65e-1)" "unprognostic (1.53e-2)" "unprognostic (3.42e-1)" 1.8 2.2 0.3 0.7 0.4 3.9 1.5 2.0 0.6 0.7 0.8 0.9 1.2 1.3 1.2 1.8 1.0 1.6 2.4 0.3 0.8 1.3 1.1 1.2 1.1 0.5 0.6 1.4 0.8 0.1 0.9 0.7 0.7 0.8 1.5 0.9 1.2 0.0 4.2 1.6 1.4 1.5 0.5 0.8 0.8 1.1 0.4 0.7 0.9 0.5 1.5 0.8 0.9 0.7 1.4 0.7 1.5 1.8 0.4 0.5 1.6 2.8 0.2 0.0 0.1 2.7 2.0 1.1 1.8 0.2 3.4 1.0 0.4 0.3 0.5 1.0 1.9 0.6 2.7 4.9 0.9 0.9 1.0 0.1 0.4 0.9 0.7 3.9 1.9 1.2 3.3 3.0 0.3 2.7 1.0 1.9 0.8 1.2 2.6 1.4 0.2 3.6 0.2 1.5 1.5 2.3 1.9 0.6 7.2 2.8 1.0 0.4 0.7 2.6 0.9 2.2 1.4 2.2 3.3 3.6 3.9 1.4 1.3 38.6 11.6 34.2 7.8 11.8 7.2 9.0 8.8 7.9 9.4 7.7 6.1 7.0 43.5 9.8 14.2 9.6 15.9 13.6 0.3 0.4 2.0 0.6 0.3 0.8 0.5 0.6 0.7 0.5 0.4 0.7 1.9 0.0 1.7 10.7 4.0 24.2 17.3 6.1 0.0 1.5 1.1 2.5 40.5 1.5 4.6 0.0 0.0 2.5 2.8 22.7 7.9 0.2 12.3 2.8 2.2 8.0 1.8 24.0 4.4 0.0 2.4 8.3 0.0 5.9 7.0 0.9 2.5 2.0 4.5 13.5 8.6 7.5 12.2 7.2 33.4 14.2 4.7 5.5 10.6 1.0 2.4 0.5 7.2 4.0 1.7 0.4 63.1 3.8 0.1 12.5 2.5 8.1 3.1 1.1 0.0 9.0 8.0 20.8 11.5 0.0 21.5 11.4 8.2 0.8 5.9 21.8 MARCO "SCARA2, SR-A6" ENSG00000019169 "Macrophage receptor with collagenous structure" Q9UEW3 2 118942194-118994660 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 94.9;lung: 199.6;lymphoid tissue: 87.9" "Cell type enriched" "Detected in many" 6 "Kupffer cells: 1269.8" "Cancer enhanced" "Detected in many" "lung cancer: 21.6" "Group enriched" "Detected in many" 4 "cerebral cortex: 4.1;thalamus: 12.6" "Group enriched" "Detected in some" 4 "classical monocyte: 33.7;intermediate monocyte: 56.5" "Lineage enriched" "Detected in many" 5 "monocytes: 56.5" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;THP-1: 2.5;U-2 OS: 2.6;U-266/70: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA063793 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 30000000 "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" Vesicles "HPA063793: AB_2685123" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (5.96e-3)" "unprognostic (3.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.58e-2)" "unprognostic (3.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (6.27e-3)" "unprognostic (5.13e-2)" "unprognostic (2.24e-3)" "unprognostic (1.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (6.55e-2)" 64.7 31.1 0.4 87.9 1.4 3.4 7.4 0.7 4.1 0.7 4.4 5.7 2.0 0.7 1.3 2.4 25.5 2.4 19.0 0.9 1.0 1.6 94.9 199.6 17.7 1.2 1.7 7.5 0.8 0.3 1.5 2.8 1.9 1.8 2.1 0.0 4.4 2.3 1.5 2.5 3.1 29.8 1.2 37.1 3.5 2.0 12.6 1.3 1.5 5.0 1.1 25.2 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 2.6 0.4 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.0 33.7 0.0 0.0 56.5 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.7 0.0 7.2 1.0 0.0 9.2 0.4 1.4 0.7 4.1 0.9 1.0 1.2 1.7 1.9 1.2 12.6 0.7 0.7 25.6 45.1 0.0 1.0 1.1 0.1 0.0 0.0 0.0 3.4 1.8 0.4 1.5 16.7 3.7 0.0 0.7 1.4 0.1 0.0 3.9 0.0 0.0 0.0 5.2 0.0 8.0 0.0 0.2 1.1 2.6 0.0 0.0 12.6 0.0 11.4 3.4 169.6 0.0 0.0 0.0 0.0 1269.8 46.4 0.1 0.0 199.3 0.0 2.8 23.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.5 0.1 0.0 0.2 13.1 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.9 1.9 4.1 0.0 0.0 0.1 MARF1 "KIAA0430, LKAP, LMKB, PPP1R34" ENSG00000166783 "Meiosis regulator and mRNA stability factor 1" Q9Y4F3 16 15594387-15643154 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 28.7;Breast glandular cells: 26.3;Endometrial stromal cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017992 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Vesicles" "HPA017992: AB_1852921" "unprognostic (2.33e-1)" "unprognostic (6.44e-3)" "unprognostic (8.84e-2)" "unprognostic (3.78e-2)" "unprognostic (1.28e-1)" "unprognostic (6.13e-3)" "unprognostic (2.35e-1)" "unprognostic (2.10e-2)" "unprognostic (2.47e-2)" "unprognostic (6.93e-2)" "unprognostic (8.44e-3)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (8.74e-2)" "unprognostic (7.94e-2)" 10.5 7.1 2.1 10.8 5.2 9.7 9.4 1.5 6.6 10.0 3.7 16.0 10.4 12.8 1.0 12.3 13.7 12.5 9.2 4.5 3.4 13.5 8.3 9.3 14.6 3.6 4.5 18.2 12.9 12.3 5.9 9.4 2.6 10.4 12.1 8.4 14.4 13.7 18.3 10.5 11.2 12.0 0.0 12.1 10.1 4.9 4.4 12.7 14.8 15.2 22.0 12.1 8.8 4.5 8.3 9.4 15.0 8.2 12.1 22.4 7.2 9.6 12.4 8.2 13.5 2.7 6.2 29.8 17.0 12.3 6.7 5.6 7.7 12.4 13.6 11.6 5.0 13.1 12.3 10.4 13.4 15.7 10.5 13.4 13.4 15.3 15.5 16.9 19.5 12.8 12.6 13.3 15.6 7.7 13.9 2.6 5.6 7.1 7.2 19.5 22.0 5.9 7.1 6.4 9.1 10.8 7.7 8.9 14.3 6.7 9.2 13.2 19.7 11.2 5.5 11.6 6.3 12.3 12.9 15.9 12.4 9.6 16.4 2.5 0.7 4.6 1.1 1.2 0.7 4.1 1.7 1.3 0.8 5.2 1.9 1.4 7.1 0.9 1.8 0.3 1.7 0.9 2.1 5.2 1.5 6.6 4.5 3.4 3.6 4.5 2.6 0.0 4.4 4.5 21.4 22.4 28.7 0.0 10.7 0.0 0.0 0.0 0.0 0.0 26.3 19.8 0.0 0.0 18.6 23.9 0.0 5.7 14.7 0.0 15.6 10.4 0.0 17.8 27.5 8.4 0.0 0.0 0.0 14.2 5.9 7.7 0.0 20.0 11.4 23.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 7.2 0.0 0.0 0.0 0.0 13.7 0.0 0.0 6.8 0.0 0.0 19.0 17.5 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 7.7 7.8 17.9 0.0 0.0 MARVELD3 MRVLDC3 ENSG00000140832 "MARVEL domain containing 3" Q96A59 16 71626161-71642114 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 150.1;Intestinal goblet cells: 68.2;Paneth cells: 102.9;Proximal enterocytes: 199.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 21.7;BEWO: 30.9;CACO-2: 23.6;CAPAN-2: 22.5;HaCaT: 21.4;MCF7: 40.8;RT4: 18.8;SK-BR-3: 18.5;T-47d: 26.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043514, HPA045471" Approved "Vesicles,Intermediate filaments" No NA "Cluster 17: Basophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 45: Enterocytes - Digestion" Vesicles "Intermediate filaments" "HPA043514: AB_10959475, HPA045471: " "unprognostic (1.18e-1)" "unprognostic (3.92e-1)" "unprognostic (9.92e-2)" "unprognostic (5.56e-2)" "unprognostic (1.03e-1)" "unprognostic (6.16e-3)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (2.54e-1)" "unprognostic (8.75e-3)" "unprognostic (3.29e-1)" "unprognostic (5.16e-2)" "prognostic favorable (6.80e-10)" "unprognostic (2.63e-3)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "unprognostic (2.43e-1)" 0.2 0.3 0.5 3.1 0.6 0.6 6.2 1.8 0.9 4.0 6.5 23.6 31.1 1.8 7.3 4.2 4.2 4.8 0.3 1.1 0.5 12.9 5.3 2.4 0.5 0.4 0.5 0.5 17.1 12.5 1.0 5.7 0.5 6.0 18.7 2.1 11.6 2.5 0.8 3.3 33.1 0.6 0.1 0.4 2.8 0.9 0.5 0.9 3.9 0.0 1.7 3.8 2.5 0.9 21.7 0.7 0.5 0.9 0.0 0.1 30.9 0.0 0.0 0.0 0.0 23.6 22.5 0.2 2.3 0.0 0.1 21.4 1.9 10.3 0.1 0.0 12.1 0.0 0.4 6.2 0.0 0.1 0.2 0.9 12.5 0.1 0.2 0.1 0.0 0.1 0.3 0.1 0.0 40.8 0.2 0.3 3.5 13.4 0.2 0.0 0.1 8.8 0.3 18.8 3.7 0.2 0.4 18.5 0.0 2.4 26.3 0.3 0.0 0.0 0.4 0.4 0.2 0.2 0.3 0.1 0.2 0.2 0.2 1.8 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.2 1.2 0.4 0.1 0.3 0.2 0.1 0.5 0.6 1.8 0.9 1.1 0.5 0.4 0.5 0.5 0.1 0.5 0.9 0.3 9.6 8.4 0.3 0.8 7.9 28.7 9.6 22.8 7.0 25.4 10.7 0.6 40.0 17.9 9.2 0.0 36.5 1.5 150.1 1.9 29.8 4.4 14.2 1.5 1.0 61.5 0.0 0.6 33.7 2.5 1.5 6.1 19.4 0.0 3.8 0.4 9.1 3.1 0.0 0.6 68.2 14.2 1.0 1.0 3.3 0.3 1.2 0.0 0.0 0.8 1.0 0.0 0.0 0.6 26.3 102.9 0.7 0.0 38.4 199.3 27.6 17.4 19.6 0.0 4.1 1.6 9.6 5.0 19.6 3.7 4.8 1.4 0.0 61.3 44.3 MAST1 "KIAA0973, SAST" ENSG00000105613 "Microtubule associated serine/threonine kinase 1" Q9Y2H9 19 12833951-12874952 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 37.7;pituitary gland: 23.3;retina: 15.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Region enhanced" "Detected in many" "cerebral cortex: 37.7" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 9 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028181, HPA073106" Enhanced Supported Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Cytosol "HPA028181: AB_10603872, HPA073106: AB_2732218" "unprognostic (6.32e-2)" "unprognostic (3.66e-2)" "unprognostic (3.93e-2)" "unprognostic (2.83e-5)" "unprognostic (1.72e-1)" "unprognostic (4.19e-2)" "unprognostic (2.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "unprognostic (8.89e-3)" "unprognostic (3.43e-2)" "unprognostic (3.84e-3)" "unprognostic (1.19e-1)" "unprognostic (7.04e-2)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" 0.0 2.2 6.5 0.3 12.1 0.3 0.1 7.3 37.7 0.2 0.0 1.2 0.3 0.0 0.0 0.2 0.1 0.2 0.2 8.3 2.4 0.1 0.6 0.1 0.1 11.2 1.1 0.3 0.6 0.5 23.3 0.0 9.5 0.2 0.1 15.4 0.2 0.0 0.0 3.7 0.4 0.0 0.0 0.1 0.6 5.0 1.2 0.8 0.1 0.0 0.0 0.2 0.3 3.0 3.6 1.6 1.5 23.3 0.0 0.0 1.9 0.2 0.1 0.3 0.9 0.8 1.5 5.8 2.6 0.0 3.9 0.1 6.8 0.1 0.1 4.1 4.5 0.5 5.8 2.6 0.0 1.3 1.2 0.5 0.1 0.8 0.7 1.3 0.0 15.2 5.2 3.0 0.0 0.8 2.4 0.6 6.9 0.6 7.2 15.9 4.6 8.3 0.3 0.2 40.5 20.2 0.8 1.4 4.3 1.2 3.8 2.1 0.0 2.8 4.2 3.1 0.8 16.7 14.5 3.7 5.1 3.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 6.5 12.1 7.3 37.7 8.3 2.4 11.2 1.1 9.5 0.0 1.2 3.0 0.5 0.0 2.4 7.8 0.2 0.9 1.6 0.6 0.6 24.7 0.8 2.5 1.0 0.0 0.3 0.0 43.8 0.6 0.4 0.6 0.0 0.4 14.0 0.2 0.2 1.3 0.0 0.0 64.7 0.5 0.6 1.3 0.0 0.3 1.3 0.5 1.1 0.5 0.2 15.2 70.3 0.1 0.0 1.0 1.2 8.2 0.6 0.7 5.4 6.5 0.1 3.7 0.0 22.1 3.0 0.3 2.5 1.2 0.0 1.0 0.9 0.2 1.0 20.4 0.0 2.0 0.5 8.0 5.2 0.7 1.4 0.3 1.0 0.4 0.7 1.2 MBD1 "CXXC3, PCM1" ENSG00000141644 "Methyl-CpG binding domain protein 1" Q9UIS9 18 50266882-50281774 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 97.4;Spermatocytes: 136.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009017, CAB036003, HPA068850" Approved Enhanced Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Vesicles" "CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121" "unprognostic (2.12e-2)" "unprognostic (5.05e-2)" "unprognostic (6.88e-2)" "unprognostic (5.01e-3)" "unprognostic (9.20e-2)" "unprognostic (6.85e-2)" "prognostic unfavorable (5.08e-6)" "unprognostic (5.91e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.96e-3)" "prognostic unfavorable (1.70e-6)" "unprognostic (7.06e-3)" "unprognostic (7.70e-2)" "unprognostic (7.05e-2)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 28.5 39.8 23.9 26.2 25.9 44.2 29.1 24.8 28.2 32.3 19.3 35.7 24.8 32.1 20.5 39.2 31.6 19.6 35.7 26.7 22.2 32.5 35.7 29.9 30.2 23.1 22.0 34.8 34.5 32.4 42.8 24.6 21.1 33.0 17.7 24.0 30.5 23.5 51.0 43.4 33.7 20.4 19.5 41.0 33.6 88.1 23.1 29.6 35.4 28.6 24.2 35.3 32.2 25.6 30.9 28.6 31.5 35.9 33.2 26.9 33.9 36.2 41.4 49.2 37.7 21.6 23.9 48.5 25.8 35.3 28.8 54.4 36.3 63.4 28.4 54.7 23.2 30.6 43.8 23.1 63.9 74.8 62.1 31.5 100.4 56.2 127.2 31.1 40.9 47.4 39.3 73.8 38.3 28.5 63.3 38.9 29.8 16.1 22.7 57.8 23.3 53.2 24.4 13.8 41.5 39.5 27.0 25.5 33.2 25.4 32.4 67.4 44.7 53.0 24.1 17.3 37.2 135.8 62.2 51.6 34.3 56.8 49.0 16.0 11.2 22.7 15.3 9.7 14.6 11.6 13.5 12.9 11.2 11.4 13.8 11.4 14.5 14.3 7.8 10.2 13.8 12.6 23.9 25.9 24.8 28.2 26.7 22.2 23.1 22.0 21.1 19.5 23.1 25.6 17.7 9.6 24.6 19.6 20.1 22.7 13.9 18.2 23.3 15.1 16.5 14.5 28.1 14.3 20.5 16.5 18.8 31.1 25.0 24.5 13.7 15.7 85.1 17.1 16.1 17.6 13.1 9.7 20.4 13.8 24.2 16.5 28.1 17.3 8.8 17.7 13.9 18.1 18.7 15.2 17.3 19.5 24.4 15.8 11.1 97.4 15.5 17.5 16.0 9.4 15.7 17.4 14.4 12.1 16.4 21.1 24.5 19.2 34.6 14.4 21.3 9.7 16.9 20.3 13.1 14.8 18.9 136.0 32.5 21.6 29.3 51.4 20.0 28.1 18.6 17.0 MBNL3 "CHCR, FLJ11316, MBLX39, MBXL" ENSG00000076770 "Muscleblind like splicing regulator 3" Q9NUK0 X 132369317-132489968 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.3;placenta: 170.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 328.3;Hepatocytes: 119.6;Syncytiotrophoblasts: 344.1" "Cancer enhanced" "Detected in all" "liver cancer: 13.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 123.8;Hep G2: 171.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001584 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 28: Placenta - Pregnancy" "Cluster 39: CACO-2 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Golgi apparatus" "HPA001584: AB_1079326" "unprognostic (3.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (1.87e-1)" "unprognostic (2.67e-3)" "unprognostic (8.74e-2)" "unprognostic (3.46e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-3)" "unprognostic (4.36e-3)" "unprognostic (1.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.43e-1)" "unprognostic (8.28e-2)" "unprognostic (2.37e-1)" 6.8 11.6 1.3 8.7 1.9 14.8 4.7 1.7 1.0 3.7 2.4 11.7 9.9 4.9 24.3 10.9 9.4 5.7 9.7 1.1 4.4 8.0 59.3 5.9 13.8 3.6 3.1 4.8 10.0 4.2 1.6 170.8 3.2 4.0 11.5 0.1 6.6 11.1 0.6 12.6 9.8 4.0 2.0 11.3 13.0 42.8 1.6 14.3 8.2 3.4 15.1 8.5 2.8 3.7 7.2 0.0 8.6 1.4 1.6 3.6 15.7 0.5 3.2 1.1 0.0 123.8 22.7 32.6 0.7 1.3 1.1 7.7 19.8 8.2 0.8 3.3 7.6 29.1 25.9 171.5 1.5 32.9 10.2 1.5 7.1 0.0 3.6 0.1 1.1 20.4 2.6 9.2 1.6 19.2 56.3 12.5 1.3 27.5 1.6 53.2 10.7 18.6 5.7 18.6 3.1 10.5 14.8 8.6 4.3 15.1 3.1 8.4 3.9 6.3 1.2 8.2 6.7 18.2 13.0 47.0 1.2 21.8 20.2 11.9 7.9 5.5 16.6 9.9 14.4 20.6 9.8 11.6 8.8 25.5 10.0 11.2 1.2 18.7 21.7 17.0 2.2 9.1 1.3 1.9 1.7 1.0 1.1 4.4 3.6 3.1 3.2 2.0 1.6 3.7 4.1 3.2 6.8 16.0 16.9 8.8 2.2 2.1 5.2 0.7 3.5 3.6 14.7 41.5 5.0 11.0 0.0 328.3 9.5 12.8 3.9 1.5 5.8 12.6 1.3 3.6 6.7 55.8 0.9 5.4 56.6 7.5 15.3 6.6 8.8 6.8 6.4 119.6 29.3 0.0 0.9 9.8 0.0 27.2 6.5 9.4 23.0 9.6 7.2 30.0 10.6 0.2 9.2 0.0 20.6 1.3 3.6 50.8 12.2 1.4 6.4 9.7 4.5 1.9 0.0 3.1 2.7 2.1 1.7 13.6 8.5 344.1 10.3 5.7 10.3 3.3 MED23 "CRSP130, CRSP3, DRIP130, MRT18, Sur2" ENSG00000112282 "Mediator complex subunit 23" Q9ULK4 6 131573966-131628242 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 72.0;Inhibitory neurons: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070341 Approved Nucleoplasm,Vesicles NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA070341: AB_2686257" "unprognostic (1.11e-2)" "unprognostic (4.66e-2)" "unprognostic (5.51e-3)" "unprognostic (1.80e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (6.62e-3)" "unprognostic (4.47e-1)" "unprognostic (1.64e-1)" "unprognostic (6.81e-3)" "unprognostic (1.44e-2)" "unprognostic (3.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (2.21e-1)" "unprognostic (2.44e-2)" "unprognostic (2.53e-2)" 7.7 10.5 3.4 11.5 3.7 22.0 14.3 9.8 5.0 12.0 3.7 10.6 11.4 13.3 10.6 8.5 11.0 8.9 6.5 3.5 3.6 10.3 7.9 9.9 14.8 2.4 2.8 14.2 10.7 18.3 6.0 11.0 3.1 11.7 12.4 11.5 12.7 11.6 7.4 11.5 10.6 10.4 2.7 12.8 11.6 10.5 3.5 18.0 14.4 10.1 15.3 10.1 7.8 6.4 7.2 7.8 18.2 23.0 22.1 16.8 16.7 17.6 19.8 16.0 23.0 8.2 9.8 15.9 12.5 18.2 15.4 12.6 9.9 11.4 24.7 18.1 13.8 16.6 14.9 14.0 16.0 27.8 27.1 14.9 13.3 17.7 17.8 18.6 20.1 16.9 21.7 16.2 17.0 11.0 21.3 17.4 8.7 12.3 7.8 18.9 11.4 9.6 12.2 10.4 13.6 12.3 12.6 17.4 11.6 20.9 4.8 19.3 20.4 11.8 13.3 19.0 16.2 17.0 12.3 22.6 14.5 12.6 16.1 4.9 4.5 7.6 5.5 4.6 8.3 4.7 5.5 6.2 5.6 4.2 5.5 5.1 3.6 12.9 3.3 2.9 6.6 3.9 3.4 3.7 9.8 5.0 3.5 3.6 2.4 2.8 3.1 2.7 3.5 6.4 16.3 19.2 9.6 24.8 21.5 9.2 6.3 11.9 13.6 23.7 15.5 10.9 6.5 8.6 15.7 23.9 16.7 8.7 23.7 15.5 3.9 7.6 2.1 14.8 14.7 13.9 14.4 12.0 72.0 7.7 6.8 12.5 14.3 16.6 14.0 18.3 14.3 12.4 8.1 11.8 67.1 17.4 6.1 17.6 9.5 3.2 14.3 12.8 5.4 36.5 16.9 7.7 21.6 42.3 60.8 9.1 14.9 10.1 19.4 10.7 14.7 8.5 13.4 24.4 13.1 13.8 10.2 13.5 5.3 12.0 8.7 7.8 20.7 14.6 14.3 12.8 MEF2C ENSG00000081189 "Myocyte enhancer factor 2C" Q06413 5 88717117-88904257 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 555.4;tongue: 246.8" "Cell type enhanced" "Detected in many" "B-cells: 471.5;Excitatory neurons: 735.7;Inhibitory neurons: 759.5;Microglial cells: 730.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 29.7;basal ganglia: 58.6;cerebral cortex: 75.3;hippocampal formation: 55.7" "Group enriched" "Detected in many" 4 "classical monocyte: 72.0;intermediate monocyte: 82.6;memory B-cell: 141.6;myeloid DC: 95.2;naive B-cell: 187.9;non-classical monocyte: 71.5;plasmacytoid DC: 100.3" "Group enriched" "Detected in many" 5 "B-cells: 187.9;dendritic cells: 100.3;monocytes: 82.6" "Cell line enhanced" "Detected in many" "Daudi: 103.6;HEL: 229.3;Karpas-707: 121.6;REH: 261.8;WM-115: 145.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 70.0;cerebral cortex: 253.1;hippocampal formation: 220.0;olfactory bulb: 66.8" "HPA005533, CAB068196, CAB068197" Enhanced Supported Nucleoplasm,Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Vesicles" "CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352" "unprognostic (2.74e-1)" "unprognostic (1.64e-2)" "unprognostic (2.37e-2)" "unprognostic (8.78e-2)" "unprognostic (9.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-2)" "unprognostic (3.52e-2)" "unprognostic (8.73e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (7.18e-3)" "unprognostic (1.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.42e-2)" 28.9 26.8 29.7 39.2 58.6 11.1 17.5 0.0 75.3 18.8 0.0 15.9 6.9 25.9 7.3 13.6 17.3 28.5 35.2 55.7 0.0 10.4 10.5 21.3 62.9 0.0 0.0 34.9 5.6 9.3 6.3 45.5 0.0 20.0 15.4 34.2 9.0 17.7 555.4 4.9 11.2 31.5 0.0 43.8 12.7 9.4 0.0 12.8 21.7 246.8 77.7 21.3 7.6 11.0 1.6 0.0 7.1 0.0 7.7 4.6 0.2 2.2 4.5 0.3 1.0 0.2 1.0 103.6 0.6 12.0 2.5 3.1 9.6 9.1 0.2 31.7 12.5 229.3 12.3 0.0 2.8 10.4 0.6 21.6 0.0 0.3 0.0 1.4 35.1 0.0 12.3 121.6 9.0 0.0 0.3 0.1 2.2 0.1 8.4 261.8 63.1 50.5 0.0 1.2 0.0 8.3 0.0 0.7 29.5 3.9 0.3 58.0 40.4 5.6 1.0 0.6 5.4 92.0 11.5 62.0 1.5 70.1 145.2 0.6 72.0 0.2 0.2 82.6 0.1 141.6 0.2 0.1 95.2 187.9 0.2 0.2 24.3 16.7 71.5 100.3 0.5 34.4 29.7 58.6 0.0 75.3 55.7 0.0 0.0 0.0 0.0 0.0 0.0 11.0 367.4 32.1 52.0 117.5 471.5 10.7 4.2 0.0 7.4 22.6 5.2 26.5 86.4 10.0 21.7 1.8 214.8 0.8 138.6 9.2 27.4 0.8 11.0 0.8 13.4 197.5 1.2 59.1 735.7 12.7 1.2 26.8 2.0 1.0 5.1 107.5 283.4 3.4 171.1 5.0 759.5 1.5 0.0 205.8 127.5 8.6 29.8 205.1 67.6 730.7 202.7 61.8 8.2 119.6 18.7 0.4 3.0 71.8 314.7 2.1 0.2 0.8 3.7 202.9 335.2 72.7 257.6 4.0 29.5 2.5 8.4 1.6 12.2 58.6 6.3 2.3 MEF2D ENSG00000116604 "Myocyte enhancer factor 2D" Q14814 1 156463727-156500779 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 170.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 211.3;U-266/70: 193.0;U-266/84: 214.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004807, HPA007114" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA004807: AB_1079354, HPA007114: AB_1079353" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.95e-1)" "unprognostic (8.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (9.96e-2)" "unprognostic (1.96e-2)" "unprognostic (1.97e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (9.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.45e-1)" 33.3 32.6 15.7 24.4 22.6 79.8 27.5 21.8 24.9 43.5 0.0 43.6 16.0 48.9 14.3 19.2 39.1 20.2 54.9 24.1 4.8 17.8 19.6 37.0 21.1 1.3 3.2 44.5 31.6 27.9 26.1 22.9 1.0 31.1 13.9 50.0 21.6 24.1 170.9 32.8 27.0 25.6 1.5 29.4 28.2 14.7 2.7 27.5 25.2 69.2 14.8 33.8 32.8 14.0 19.7 32.2 7.2 10.7 15.6 22.2 12.4 26.1 29.6 12.0 12.5 10.4 24.1 42.5 30.3 31.4 12.7 18.8 8.2 13.2 7.1 65.7 11.6 10.8 42.1 6.2 19.2 25.6 32.8 24.5 21.6 21.0 27.9 24.8 22.5 13.5 8.6 72.7 19.1 16.6 18.6 56.4 10.6 10.2 20.5 80.6 16.5 48.3 10.4 8.7 12.0 19.2 24.1 48.2 39.6 13.4 13.7 211.3 40.2 29.1 29.3 22.1 19.7 193.0 214.3 81.3 24.5 19.2 15.9 1.1 1.4 1.7 1.3 0.7 1.5 1.1 0.9 1.2 1.0 1.0 0.5 0.8 5.3 1.1 1.4 5.8 1.3 0.7 15.7 22.6 21.8 24.9 24.1 4.8 1.3 3.2 1.0 1.5 2.7 14.0 21.8 6.4 18.6 21.9 29.8 37.2 10.9 10.6 25.6 82.3 25.2 19.7 42.0 17.2 16.2 1.8 173.0 5.0 72.5 60.6 0.0 7.7 2.5 26.4 26.0 24.0 21.5 11.0 28.7 11.1 4.9 25.1 25.0 43.1 3.8 9.0 22.9 13.2 18.0 70.7 18.8 32.2 8.2 25.4 64.1 4.4 31.4 35.5 14.2 20.6 17.7 19.0 33.0 13.0 20.2 25.8 46.3 32.4 44.6 19.7 17.2 3.4 9.1 85.3 98.6 48.8 46.1 5.1 10.7 16.6 38.1 15.3 33.1 11.0 14.0 19.3 METTL7B "ALDI, MGC17301" ENSG00000170439 "Methyltransferase like 7B" Q6UX53 12 55681678-55684611 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1;heart muscle: 124.2;liver: 284.3" "Cell type enhanced" "Detected in some" "Hepatocytes: 83.9;Hofbauer cells: 72.7;Proximal enterocytes: 192.4;Proximal tubular cells: 55.6" "Cancer enhanced" "Detected in many" "glioma: 97.9;liver cancer: 97.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.5;myeloid DC: 7.0;naive B-cell: 1.7;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 45 "B-cells: 1.7;dendritic cells: 7.0;monocytes: 4.5" "Cell line enhanced" "Detected in many" "CACO-2: 28.4;CAPAN-2: 56.6;EFO-21: 41.3;Hep G2: 28.7;LHCN-M2: 47.0;OE19: 32.5;THP-1: 42.2;U-87 MG: 41.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA038644 Enhanced Approved Vesicles,Microtubules NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" Microtubules Vesicles "HPA038644: AB_2676130" "unprognostic (7.54e-2)" "unprognostic (7.15e-2)" "unprognostic (5.55e-2)" "unprognostic (3.07e-3)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-2)" "unprognostic (5.33e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-2)" "unprognostic (7.10e-2)" "prognostic favorable (2.37e-4)" "unprognostic (2.43e-1)" 2.1 1.7 5.5 1.8 5.9 1.2 0.9 4.9 10.8 0.4 5.9 28.5 59.6 0.4 133.1 0.1 3.1 11.7 124.2 13.1 5.9 52.1 284.3 1.6 2.3 8.4 5.5 0.1 2.9 0.2 3.1 10.9 5.0 0.3 23.6 1.3 0.5 0.8 7.4 0.9 55.3 2.1 5.7 4.3 4.2 0.7 11.6 0.2 3.3 10.0 0.5 1.3 0.1 7.7 0.4 21.8 0.1 0.5 4.3 15.3 0.3 0.8 3.2 0.2 1.4 28.4 56.6 11.6 41.3 1.2 1.1 0.1 4.1 0.3 0.8 0.0 5.4 1.2 3.2 28.7 0.0 0.6 0.0 4.0 0.0 1.0 0.0 4.2 0.0 0.0 0.2 0.0 47.0 20.2 0.0 0.4 5.7 32.5 2.7 0.0 1.5 2.7 0.5 0.1 0.1 0.3 2.2 0.0 3.9 0.2 3.8 42.2 0.0 3.1 3.5 0.4 2.9 0.0 0.6 3.5 41.9 9.9 0.2 0.0 0.8 0.0 0.0 4.5 0.0 0.5 0.0 0.0 7.0 1.7 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.4 5.5 5.9 4.9 10.8 13.1 5.9 8.4 5.5 5.0 5.7 11.6 7.7 0.0 0.0 1.5 0.7 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.1 26.5 22.8 0.6 0.0 0.0 0.5 0.0 29.0 3.9 3.9 0.0 0.1 0.0 0.5 1.2 4.0 0.7 5.1 0.5 2.0 2.6 0.2 0.0 0.8 1.1 83.9 72.7 0.0 0.1 14.0 0.0 17.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 4.6 20.7 1.2 0.0 0.1 192.4 55.6 0.0 0.0 0.0 7.8 0.6 0.0 0.1 0.0 0.0 0.7 0.3 0.1 22.2 0.1 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917799-127966034 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Vesicles Nucleoplasm "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favorable (2.21e-4)" 4.6 5.7 1.3 6.8 1.3 2.6 6.9 1.9 1.6 6.2 1.1 6.8 10.0 5.6 3.9 5.4 5.5 4.8 3.8 1.1 1.7 6.4 10.0 4.8 5.4 1.4 1.3 6.8 8.1 9.1 7.1 5.9 1.5 5.5 8.2 4.6 5.8 4.4 3.7 5.9 7.6 5.8 1.1 7.3 6.4 3.9 0.8 5.2 7.0 4.4 7.9 5.3 5.9 2.2 10.9 7.3 9.5 4.6 7.2 6.9 7.0 8.3 10.3 10.2 10.5 5.2 14.3 5.2 14.5 14.3 14.8 7.8 10.2 7.4 14.4 10.8 7.9 5.7 9.1 8.0 9.4 6.0 6.6 8.3 2.7 8.6 7.7 5.0 10.6 6.6 9.5 5.9 14.6 8.9 5.0 1.9 1.7 11.8 5.2 5.3 0.6 4.7 7.5 13.9 8.5 2.9 9.0 12.0 3.5 6.4 5.6 5.1 6.7 2.9 3.1 10.7 7.8 12.5 22.1 9.6 10.3 5.3 8.8 1.9 1.6 2.8 2.5 2.4 2.4 2.5 2.7 2.2 1.6 1.1 2.4 2.6 2.5 2.4 3.7 2.2 3.4 1.2 1.3 1.3 1.9 1.6 1.1 1.7 1.4 1.3 1.5 1.1 0.8 2.2 9.5 12.8 14.1 17.0 18.8 3.2 4.9 8.5 10.2 17.2 8.1 5.3 3.0 5.7 14.0 16.5 20.9 12.5 17.9 7.2 1.9 8.5 10.4 7.7 7.2 7.2 4.2 3.8 32.1 7.0 7.3 8.6 11.7 8.2 12.7 18.4 8.9 10.1 7.6 11.8 34.9 6.8 10.2 8.5 3.3 14.7 9.3 6.5 3.6 27.2 10.5 8.6 20.6 20.6 24.6 7.8 9.5 9.4 19.9 5.4 11.1 6.3 12.1 24.9 6.6 5.8 6.6 12.6 8.4 8.9 5.7 22.0 13.7 11.4 7.3 4.8 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 11.8;pancreas: 4.0;salivary gland: 5.9" "Group enriched" "Detected in some" 4 "Early spermatids: 27.4;Late spermatids: 18.2" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "OE19: 1.6;RH-30: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA055697 Enhanced Approved Vesicles,Cytosol NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" Vesicles Cytosol "HPA055697: AB_2682890" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.1 0.0 0.0 0.4 0.0 0.2 1.1 0.0 0.4 0.0 0.2 1.5 11.8 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.9 0.0 0.0 0.0 9.6 0.0 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 27.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 MGRN1 "KIAA0544, RNF156" ENSG00000102858 "Mahogunin ring finger 1" O60291 16 4616493-4690974 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 16.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007653, HPA008033" Approved Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 52: Non-specific - Transcription" Vesicles "Endoplasmic reticulum" "HPA007653: AB_1846304, HPA008033: " "unprognostic (2.27e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (4.24e-1)" "unprognostic (1.26e-2)" "unprognostic (9.96e-2)" "unprognostic (1.70e-1)" "unprognostic (4.03e-2)" "unprognostic (9.47e-2)" "unprognostic (6.41e-2)" "unprognostic (2.32e-1)" "unprognostic (9.06e-2)" "unprognostic (1.79e-1)" "unprognostic (5.04e-2)" 23.3 34.3 18.6 25.0 20.6 32.6 22.8 11.9 25.4 28.3 4.9 30.6 28.9 36.9 6.8 20.4 32.1 19.7 26.9 26.4 11.4 24.0 53.5 30.3 18.1 14.1 10.4 30.5 34.6 18.5 33.2 18.5 8.8 30.1 10.9 9.0 25.6 20.5 52.1 23.0 29.9 17.5 8.1 37.7 35.3 18.0 12.0 11.7 28.8 16.7 10.9 28.2 20.6 24.3 13.6 63.9 32.4 33.2 19.0 18.4 44.0 28.7 20.0 23.6 20.0 42.5 31.4 40.0 36.2 35.0 17.6 21.4 26.0 23.6 7.0 56.0 28.8 22.0 45.2 59.6 34.7 32.1 52.3 34.2 15.0 33.0 14.1 17.0 23.0 26.0 32.7 28.6 16.4 59.7 33.3 42.9 48.0 19.2 27.4 60.7 17.0 54.3 20.8 39.3 51.8 42.8 47.6 50.6 28.2 14.8 30.7 31.4 40.8 43.7 24.1 124.3 25.0 44.6 37.8 27.2 18.6 31.8 32.0 5.4 3.5 3.8 2.5 3.9 2.3 1.3 1.4 2.3 2.4 1.5 3.2 1.9 16.2 1.4 2.6 4.1 1.7 3.7 18.6 20.6 11.9 25.4 26.4 11.4 14.1 10.4 8.8 8.1 12.0 24.3 14.7 25.6 34.0 24.2 22.2 9.2 29.5 10.0 6.2 27.3 15.8 11.0 11.4 22.8 9.6 18.4 43.8 23.5 28.2 27.7 5.9 18.6 16.2 20.1 24.2 16.9 37.0 13.7 26.6 22.7 17.7 19.0 44.9 24.5 14.0 30.4 15.0 34.8 30.4 25.2 25.0 23.5 4.1 30.1 21.4 27.2 26.8 27.0 21.4 8.4 36.5 20.8 23.7 18.6 29.8 32.0 15.8 24.8 29.0 23.7 31.7 13.9 11.1 35.2 0.0 20.4 17.6 9.3 12.5 11.9 16.3 34.2 24.0 29.8 23.1 27.8 MIB1 "DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6" ENSG00000101752 "Mindbomb E3 ubiquitin protein ligase 1" Q86YT6 18 21704957-21870953 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "REH: 121.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019100, CAB037044" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 44: Endometrium - Transcription" "Plasma membrane" Vesicles "CAB037044: AB_1841007, HPA019100: AB_1853934" "unprognostic (1.38e-1)" "unprognostic (6.92e-2)" "unprognostic (7.29e-2)" "unprognostic (6.99e-2)" "unprognostic (5.66e-2)" "unprognostic (3.23e-2)" "unprognostic (8.45e-3)" "unprognostic (2.70e-1)" "unprognostic (5.42e-2)" "unprognostic (4.69e-2)" "unprognostic (3.78e-2)" "unprognostic (4.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.91e-3)" "unprognostic (1.73e-1)" "unprognostic (4.86e-2)" "unprognostic (1.85e-2)" 8.1 6.3 9.1 6.0 9.1 4.9 11.2 9.2 8.5 11.0 8.0 7.1 5.1 13.0 9.5 8.0 7.1 8.6 6.0 8.4 9.2 11.1 10.4 7.2 7.6 9.5 10.2 11.7 8.1 9.8 5.2 11.0 8.6 10.1 7.0 8.3 8.4 8.5 5.8 9.1 5.2 10.2 10.1 7.2 7.6 8.7 10.3 11.5 13.6 7.0 7.9 8.4 8.2 9.6 19.9 7.6 36.4 25.8 19.5 23.0 9.0 15.6 17.2 10.8 15.6 11.3 7.1 16.9 14.1 21.4 11.8 13.2 21.4 21.0 24.4 22.4 10.4 18.8 9.7 15.9 15.8 38.3 7.8 14.8 23.0 12.6 32.0 16.0 27.8 6.6 26.5 47.5 17.2 9.5 18.9 14.7 9.5 12.2 10.2 121.1 30.3 42.5 18.7 16.9 12.1 30.1 26.8 12.4 13.9 18.6 8.8 25.1 23.9 27.8 14.2 11.7 21.1 25.6 9.5 25.4 11.8 24.1 16.9 0.7 0.3 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.1 0.2 0.1 0.3 0.5 0.1 0.2 0.4 0.1 9.1 9.1 9.2 8.5 8.4 9.2 9.5 10.2 8.6 10.1 10.3 9.6 35.7 48.1 22.7 68.2 11.9 21.9 15.1 19.8 24.5 28.8 24.1 19.7 18.1 25.8 31.8 16.5 25.0 13.3 18.2 20.8 3.9 13.4 7.0 29.0 59.2 30.8 24.0 23.1 106.7 12.9 7.5 33.1 10.2 32.4 14.5 16.8 24.3 30.0 12.9 15.2 92.6 17.1 26.4 17.2 16.2 5.6 20.5 14.2 26.6 67.5 19.4 17.7 15.5 121.2 109.6 18.8 7.0 24.8 18.1 48.5 8.7 15.9 30.6 14.5 0.0 35.4 26.9 26.2 12.0 23.4 24.6 25.3 14.5 21.8 10.4 25.3 MINDY4 "C7orf67, FAM188B, FLJ22374" ENSG00000106125 "MINDY lysine 48 deubiquitinase 4" Q4G0A6 7 30771417-30892387 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Collecting duct cells: 12.9;Endometrial ciliated cells: 36.7;Endometrial stromal cells: 8.9;Respiratory ciliated cells: 18.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019475, HPA030129, HPA030130" Approved Supported Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Cytosol" "HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565" "unprognostic (2.96e-1)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.07e-1)" "unprognostic (6.01e-3)" "unprognostic (3.81e-2)" "unprognostic (5.25e-3)" "unprognostic (1.97e-1)" "unprognostic (5.59e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-1)" "unprognostic (9.55e-2)" "unprognostic (1.12e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" 6.7 3.7 2.1 1.2 3.5 2.4 4.4 0.4 4.2 5.7 10.6 4.6 1.3 5.4 8.4 2.9 11.5 5.6 4.7 1.9 1.8 4.9 2.1 9.5 1.2 2.8 4.5 8.9 3.4 4.8 5.6 3.3 2.2 5.9 2.1 2.1 3.1 8.1 2.3 3.2 2.2 5.9 1.8 1.2 3.2 9.0 2.4 1.2 6.7 3.5 0.9 4.3 3.7 2.5 2.4 6.0 3.1 9.5 2.7 10.3 4.5 3.5 6.0 2.6 2.2 0.0 4.4 0.0 3.9 2.3 3.6 2.6 2.1 2.0 2.5 0.0 3.5 1.9 3.2 0.0 3.3 2.7 1.3 5.3 3.1 7.7 1.5 0.2 3.8 1.7 19.2 1.1 2.2 0.0 1.5 0.8 8.9 8.5 1.4 0.4 0.0 0.6 7.1 1.2 5.7 7.7 2.3 12.5 1.3 3.5 6.4 2.0 2.3 0.1 1.4 2.7 1.5 2.5 3.5 0.0 4.9 0.1 11.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 2.1 3.5 0.4 4.2 1.9 1.8 2.8 4.5 2.2 1.8 2.4 2.5 5.2 9.6 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 1.8 12.9 0.0 2.3 0.5 0.0 3.9 2.8 0.0 36.7 8.9 2.3 0.0 0.0 0.0 1.3 4.1 2.7 0.0 3.9 2.5 4.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 2.4 18.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.2 4.1 0.0 0.0 MMP16 "C8orf57, DKFZp761D112, MT3-MMP" ENSG00000156103 "Matrix metallopeptidase 16" P51512 8 88032011-88328025 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.8" "Cell type enriched" "Detected in many" 5 "Oligodendrocyte precursor cells: 2402.1" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 29.4;HUVEC TERT2: 12.8;SH-SY5Y: 16.2;U-138 MG: 13.7;WM-115: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023693 Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 17: WM-115 - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol Vesicles "HPA023693: AB_1854025" "unprognostic (2.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.31e-2)" "unprognostic (2.39e-3)" "unprognostic (1.45e-3)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "unprognostic (9.42e-2)" "unprognostic (2.92e-1)" "unprognostic (2.09e-8)" "unprognostic (6.90e-3)" "unprognostic (1.16e-1)" "unprognostic (3.62e-1)" "unprognostic (2.19e-3)" 0.7 0.3 4.6 0.3 5.8 0.0 1.8 2.2 5.4 1.7 0.0 0.8 0.1 1.6 0.6 0.4 0.6 2.6 0.8 5.1 3.9 0.1 0.1 0.2 0.2 1.0 1.5 1.0 0.6 0.2 0.5 1.0 1.3 0.9 0.4 0.4 0.3 0.7 0.1 0.2 0.3 1.3 1.4 0.4 0.3 0.4 3.0 0.4 1.0 0.5 0.2 0.9 0.5 3.3 0.0 0.2 7.9 29.4 1.0 2.0 0.0 10.9 1.6 3.0 1.8 0.0 0.1 0.0 0.0 4.9 1.8 0.0 5.8 0.0 3.7 0.0 3.4 0.0 0.0 0.0 2.4 0.0 0.5 1.4 0.0 4.4 1.3 5.4 12.8 0.1 0.0 1.1 1.7 0.0 0.0 0.0 1.7 0.0 3.0 0.3 0.6 0.0 0.6 0.1 0.2 16.2 0.0 0.0 0.2 2.2 1.1 0.0 7.1 13.7 7.7 0.2 4.2 0.0 0.0 0.0 5.7 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 5.8 2.2 5.4 5.1 3.9 1.0 1.5 1.3 1.4 3.0 3.3 2.2 0.0 0.0 20.5 0.1 1.1 0.0 0.0 0.6 4.4 0.8 1.4 1.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 1.9 0.0 6.5 0.5 15.9 5.2 0.0 0.0 443.4 0.0 0.1 16.0 0.0 0.4 0.0 1.9 1.4 0.0 0.4 1.7 300.3 0.0 0.0 0.0 1.6 6.5 0.9 0.4 1.8 10.3 0.0 3.0 0.0 2402.1 13.0 0.1 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.7 2.9 0.0 1.1 0.2 0.1 0.0 0.2 3.4 0.0 0.1 MMP19 "MMP18, RASI-1" ENSG00000123342 "Matrix metallopeptidase 19" Q99542 12 55835433-55842966 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Angiogenesis, Collagen degradation, Differentiation" "Developmental protein, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 58.5" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 54.4;Fibroblasts: 52.8;Hofbauer cells: 30.8;Kupffer cells: 35.7;Langerhans cells: 100.7;Macrophages: 61.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "thalamus: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "BEWO: 75.6" "Region enriched" "Detected in many" 5 "olfactory bulb: 7.2" "Low region specificity" "Detected in all" HPA070804 Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 2100000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 41: Macrophages - Immune response" "Endoplasmic reticulum, Vesicles" "HPA070804: AB_2686315" "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (2.28e-2)" "unprognostic (2.42e-1)" "unprognostic (4.77e-3)" "unprognostic (4.77e-3)" "unprognostic (2.01e-2)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (8.56e-9)" "unprognostic (5.06e-3)" "unprognostic (1.28e-3)" "unprognostic (2.73e-2)" "unprognostic (4.00e-2)" 58.5 3.6 0.0 11.4 0.1 0.7 18.3 0.0 0.3 10.4 0.5 7.3 1.2 20.7 0.5 2.3 17.2 25.6 8.8 0.1 0.1 5.7 2.7 25.4 2.8 0.1 0.1 11.9 7.2 0.5 0.8 10.8 0.2 3.3 3.3 0.1 3.1 2.3 0.9 5.5 8.7 8.7 0.1 27.4 9.6 0.4 1.3 2.9 4.4 0.6 6.9 9.6 6.2 0.1 1.5 0.0 0.2 0.0 7.8 12.4 75.6 10.1 10.6 3.9 4.4 0.6 0.6 0.0 0.0 12.8 0.3 0.0 0.0 3.0 4.0 0.8 0.0 0.0 0.3 0.1 6.5 0.0 0.6 12.1 0.4 1.9 2.4 6.2 0.7 0.0 0.2 0.1 11.2 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.8 0.0 1.7 4.7 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.2 15.7 2.2 5.0 0.2 0.3 0.1 0.0 0.0 8.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.2 0.1 1.3 0.1 2.8 0.0 4.6 0.7 1.3 7.1 0.3 1.9 0.6 0.4 0.3 0.3 0.7 11.5 3.3 0.0 4.2 18.6 0.7 0.0 0.0 0.3 0.5 2.4 20.8 1.5 0.0 0.0 0.2 0.5 54.4 52.8 1.1 1.7 2.5 0.4 3.6 0.7 30.8 0.0 0.2 0.1 0.0 35.7 100.7 0.9 5.9 61.2 12.4 1.9 22.5 0.4 0.0 0.0 0.3 0.1 0.0 5.3 1.0 0.3 0.0 0.1 1.5 1.7 0.0 3.8 7.6 0.2 0.2 1.0 4.3 18.7 0.9 0.2 0.0 0.4 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530750 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 509.9;salivary gland: 267.9;urinary bladder: 211.2" "Cell type enriched" "Detected in many" 8 "Ductal cells: 8176.2" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 145.9;CAPAN-2: 815.9;EFO-21: 189.8;RPTEC TERT1: 350.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 2810000 35000 "Cluster 5: Breast - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: AB_2681452" "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavorable (2.53e-4)" "prognostic unfavorable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 3.8 0.1 0.0 2.0 0.0 0.3 168.7 0.0 0.3 13.3 0.0 1.6 0.6 97.4 27.9 21.3 91.2 509.9 0.2 0.0 0.0 140.2 3.4 31.6 1.9 0.0 0.0 0.7 85.2 0.0 0.3 0.8 0.0 54.0 1.0 0.0 267.9 34.9 0.1 32.4 0.6 4.8 0.0 0.2 7.3 0.6 0.4 3.3 0.4 0.0 29.3 211.2 1.7 0.0 0.2 145.9 0.0 0.4 0.0 0.0 0.2 0.0 2.1 0.1 0.1 1.9 815.9 0.0 189.8 0.0 0.0 1.1 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.6 1.0 0.1 0.2 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.5 11.8 0.0 0.0 0.0 0.0 350.1 1.0 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.1 0.0 0.7 3.0 0.0 1.6 0.1 0.6 0.4 1.0 5.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 86.6 43.3 0.0 1.5 1.0 382.2 135.4 1.2 0.0 124.2 93.7 0.7 100.1 401.2 1017.0 0.0 0.7 2.9 1.2 0.0 8176.2 6.1 62.1 3.3 8.8 0.0 0.0 0.0 209.4 0.3 3.4 0.0 124.6 2.5 0.0 0.0 0.0 98.0 0.0 0.0 0.0 38.7 0.6 0.3 10.3 11.8 12.6 0.0 0.0 65.2 0.0 0.0 0.0 0.0 850.9 0.0 0.0 0.1 603.3 0.0 33.9 72.6 0.0 0.0 0.0 31.4 0.1 0.2 17.0 2.4 0.8 3.6 0.0 2.3 840.8 MOSPD1 dJ473B4 ENSG00000101928 "Motile sperm domain containing 1" Q9UJG1 X 134887632-134915257 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 106.9;Endometrial ciliated cells: 80.3;Erythroid cells: 150.1;Late spermatids: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031158 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 13: T-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Vesicles" "HPA031158: AB_10603874" "unprognostic (2.23e-3)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.77e-1)" "unprognostic (3.36e-1)" "unprognostic (6.78e-3)" "unprognostic (5.15e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (6.20e-3)" "unprognostic (4.27e-2)" "unprognostic (6.45e-3)" "unprognostic (2.92e-2)" "unprognostic (2.01e-1)" "unprognostic (5.71e-2)" "unprognostic (1.15e-1)" 5.1 14.0 4.1 4.9 4.1 15.4 8.3 4.5 5.5 8.7 12.4 6.7 5.9 16.2 12.8 15.2 26.9 7.1 20.0 4.0 4.4 10.9 7.6 7.5 6.2 4.8 4.4 10.9 7.7 15.1 3.4 11.8 4.5 8.4 7.4 6.7 9.4 7.7 21.5 10.4 5.6 11.3 4.4 6.4 5.4 10.4 4.4 9.7 9.6 14.1 8.5 10.6 8.8 4.5 19.6 15.1 12.5 8.7 19.5 11.4 27.3 32.2 58.2 30.4 29.4 37.2 7.6 6.5 43.7 20.6 54.9 6.9 19.6 16.7 39.9 21.9 11.5 5.6 36.7 15.1 82.2 15.6 9.1 20.6 20.0 34.2 14.7 34.5 22.6 13.3 7.0 25.9 37.3 27.2 11.2 7.1 12.8 10.2 34.1 8.3 22.2 12.4 13.0 55.3 7.4 9.2 16.3 16.2 56.7 60.6 6.5 9.7 11.3 14.9 9.2 56.0 29.0 20.1 29.0 10.4 20.2 26.4 19.9 4.9 5.4 10.5 5.8 4.3 7.9 4.7 6.9 6.4 6.3 4.1 7.7 7.6 3.5 5.1 5.1 6.7 12.4 4.1 4.1 4.1 4.5 5.5 4.0 4.4 4.8 4.4 4.5 4.4 4.4 4.5 13.2 6.4 5.8 3.9 11.0 21.3 10.6 13.8 29.6 8.5 10.8 9.4 43.7 4.3 11.8 11.0 2.1 9.0 6.9 7.6 21.5 26.3 106.9 80.3 10.5 12.2 4.2 150.1 7.6 12.4 16.0 10.5 8.6 12.0 5.7 21.5 13.9 6.7 14.9 5.0 8.8 6.9 16.2 11.9 7.7 82.9 6.8 7.5 30.2 4.7 7.4 9.3 11.3 9.0 4.4 20.9 12.7 10.9 14.7 11.8 5.7 27.9 20.0 8.5 6.6 6.8 16.9 3.8 6.6 12.2 20.5 26.1 13.2 15.8 7.1 9.9 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269855-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "bone marrow: 4023.1" "Cell type enriched" "Detected in some" 30 "Erythroid cells: 87.4" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "classical monocyte: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 94 "HL-60: 3517.4;NB-4: 4589.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" No NA 576000000 24000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.5 0.4 0.8 0.6 0.6 4023.1 0.3 0.6 1.1 0.0 0.3 0.2 0.0 0.2 1.1 0.1 0.1 0.3 1.1 0.8 0.7 0.2 1.8 8.4 1.7 0.9 1.0 0.1 0.1 0.0 1.5 1.4 0.9 0.2 0.2 0.4 66.3 0.1 1.1 4.3 0.2 0.3 0.8 21.7 0.1 0.4 0.8 10.9 0.3 0.3 0.2 0.5 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3517.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4589.9 0.0 0.0 0.0 5.3 3.2 0.6 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 4.0 0.0 0.0 6.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.1 7.5 0.8 0.6 0.6 1.1 0.8 0.7 0.9 1.0 0.9 0.8 0.8 0.7 0.0 0.0 0.5 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.9 0.0 0.5 0.1 0.0 0.1 0.0 87.4 0.3 0.2 0.9 0.7 0.0 0.0 0.0 0.0 0.7 0.3 0.9 0.0 0.2 0.0 0.0 1.2 0.0 1.3 0.0 2.9 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.3 0.1 0.0 0.1 0.6 0.0 0.0 0.0 MPZL1 "FLJ21047, PZR" ENSG00000197965 "Myelin protein zero like 1" O95297 1 167721192-167791919 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 183.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 183.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026966, HPA063538" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "HPA026966: AB_10600931, HPA063538: AB_2685034" "unprognostic (6.54e-2)" "unprognostic (9.26e-3)" "unprognostic (4.59e-2)" "unprognostic (4.88e-1)" "unprognostic (2.18e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (4.27e-6)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.22e-1)" "unprognostic (3.41e-2)" "unprognostic (2.59e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.99e-7)" "unprognostic (3.55e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (4.21e-2)" 74.8 34.1 23.1 49.2 21.6 8.3 91.6 22.0 21.8 63.1 40.1 60.1 40.8 50.0 27.4 52.9 60.1 67.7 52.4 22.1 28.3 28.6 23.0 42.3 35.2 25.7 30.0 46.4 27.5 28.4 33.0 68.9 30.7 41.8 59.4 12.7 73.1 38.9 14.7 34.0 41.0 62.6 26.4 29.2 43.8 48.2 28.6 29.3 39.5 26.8 45.9 74.7 51.3 24.9 88.5 126.3 96.9 75.8 303.4 137.2 304.8 134.5 172.7 86.3 106.4 234.4 119.5 31.0 152.9 171.6 76.1 144.2 97.5 149.0 72.6 70.9 52.8 25.5 63.5 56.7 188.5 30.2 16.1 126.1 183.5 137.8 153.4 121.4 116.4 93.6 97.1 63.5 103.0 29.3 103.6 36.2 61.9 176.7 53.5 62.5 82.7 137.5 131.4 84.6 55.7 91.8 119.6 122.4 69.7 221.9 66.6 16.0 132.8 97.9 44.1 127.5 73.8 94.0 157.2 142.8 140.8 35.3 15.8 7.7 29.1 20.0 2.8 24.8 1.3 14.7 2.8 4.1 38.5 8.8 7.7 2.6 183.8 10.4 34.6 43.9 0.5 11.0 23.1 21.6 22.0 21.8 22.1 28.3 25.7 30.0 30.7 26.4 28.6 24.9 52.9 28.9 30.0 31.0 15.1 76.3 78.5 57.6 35.9 8.8 75.9 73.9 6.3 20.0 49.6 20.2 6.2 128.7 21.1 67.1 5.9 63.2 1.8 14.5 40.4 56.7 47.8 10.1 32.8 75.6 145.2 118.2 41.3 23.0 3.8 75.3 24.3 23.3 37.7 10.1 27.9 39.7 20.3 28.2 31.9 4.9 69.9 23.5 16.0 60.0 84.0 11.8 3.1 141.8 1.7 81.0 41.6 83.8 23.5 141.7 55.5 10.1 28.3 13.9 19.7 18.6 48.6 8.9 26.8 41.2 55.5 76.9 8.6 49.4 61.0 57.7 MRAP "B27, C21orf61, FALP" ENSG00000170262 "Melanocortin 2 receptor accessory protein" Q8TCY5 21 32291813-32314784 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 27 "adipose tissue: 75.6;adrenal gland: 166.5;breast: 44.2" "Group enriched" "Detected in some" 5 "Early spermatids: 16.1;Granulosa cells: 43.7;Horizontal cells: 43.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 1.5;HSkMC: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011024, HPA011093" Uncertain Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" Vesicles "HPA011024: AB_10599292, HPA011093: AB_10600889" "unprognostic (1.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.53e-1)" "unprognostic (1.11e-1)" "unprognostic (9.53e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.80e-2)" "unprognostic (4.12e-1)" "unprognostic (6.30e-6)" "unprognostic (3.32e-2)" "unprognostic (2.37e-1)" "unprognostic (1.18e-1)" "unprognostic (5.76e-2)" 75.6 166.5 0.1 1.8 0.1 0.0 44.2 0.0 0.5 0.1 0.8 1.2 0.2 0.0 0.0 0.1 0.0 0.6 2.0 0.1 0.0 0.3 2.4 1.0 0.1 0.2 0.0 2.0 0.7 0.0 0.1 1.7 0.1 0.0 0.2 1.0 2.0 0.0 0.2 1.3 3.5 0.1 0.0 0.0 0.6 0.5 0.0 0.1 0.7 0.2 0.0 1.4 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.7 0.2 0.4 0.2 0.8 0.2 0.5 0.0 1.9 0.1 0.5 0.7 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.1 1.3 0.0 0.0 0.0 43.7 0.0 1.7 0.1 43.7 0.6 0.0 0.0 0.0 0.0 6.6 0.6 0.1 0.0 0.0 0.0 0.3 0.0 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.6 1.6 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 MRAS "M-RAs, R-RAS3, RRAS3" ENSG00000158186 "Muscle RAS oncogene homolog" O14807 3 138347648-138405534 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 202.3;heart muscle: 132.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "non-classical monocyte: 25.0" "Lineage enriched" "Detected in many" 9 "monocytes: 25.0" "Cell line enhanced" "Detected in many" "BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042728 Approved Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol Vesicles "HPA042728: AB_10796582" "unprognostic (1.96e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.69e-1)" "unprognostic (5.32e-2)" "unprognostic (8.96e-2)" "unprognostic (3.85e-3)" "unprognostic (1.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (3.18e-3)" "unprognostic (1.78e-2)" "unprognostic (6.25e-2)" "unprognostic (2.21e-1)" "unprognostic (4.23e-2)" 91.9 67.7 112.7 10.8 130.6 1.7 46.7 118.2 105.5 17.3 48.9 24.2 3.3 28.7 7.1 7.9 26.4 12.0 132.9 105.6 132.8 22.9 5.5 18.4 5.2 126.1 135.9 48.6 5.7 8.2 17.7 10.6 112.9 15.3 4.1 15.9 13.4 15.0 80.4 12.2 8.7 23.2 110.3 12.2 12.0 9.6 202.3 4.9 26.4 48.0 3.3 29.1 12.1 97.8 0.8 7.9 15.8 24.5 59.6 29.2 40.0 92.9 16.0 7.3 8.2 3.3 3.1 0.3 113.7 70.4 18.6 0.1 9.0 1.8 6.1 7.7 3.1 0.5 4.8 20.1 15.9 0.0 1.9 41.5 5.9 0.7 1.4 13.6 1.3 0.0 10.7 0.8 31.4 3.7 0.0 20.4 19.1 0.0 2.7 1.1 33.8 0.2 30.4 2.0 18.6 42.0 62.8 0.7 45.9 10.9 16.1 37.7 0.6 23.7 25.3 24.3 2.4 0.1 1.0 1.2 21.4 0.1 11.4 0.2 2.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.8 25.0 0.1 0.0 0.8 112.7 130.6 118.2 105.5 105.6 132.8 126.1 135.9 112.9 110.3 202.3 97.8 8.9 9.6 1.5 54.2 0.8 2.2 3.0 3.4 1.2 5.6 28.8 34.8 121.7 2.8 3.5 9.2 10.4 20.1 0.2 0.0 58.7 8.6 11.6 1.0 21.4 14.5 1.8 0.0 25.5 3.2 3.2 23.0 2.0 1.5 6.3 35.2 12.8 1.6 26.3 28.6 20.6 0.0 2.0 15.1 18.4 40.0 23.3 18.2 28.4 20.6 12.2 24.3 0.0 28.6 11.0 3.8 0.0 34.3 0.1 3.3 0.0 27.5 1.3 9.6 6.6 20.8 18.9 7.3 18.6 0.4 1.0 14.4 0.8 59.1 0.0 0.6 MSH2 "COCA1, HNPCC, HNPCC1" ENSG00000095002 "MutS homolog 2" P43246 2 47403067-47663146 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 46.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009572, HPA066845, CAB070867" Approved Supported Nucleoplasm,Vesicles NA Yes 28000 "Cluster 48: NK-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Vesicles "CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" "unprognostic (2.89e-3)" "prognostic unfavorable (4.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.31e-3)" "prognostic unfavorable (1.72e-9)" "unprognostic (1.77e-1)" "unprognostic (7.09e-3)" "unprognostic (8.57e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (5.38e-2)" "unprognostic (3.29e-3)" "unprognostic (1.20e-3)" "unprognostic (5.74e-1)" "unprognostic (8.46e-2)" "unprognostic (1.48e-1)" 8.1 7.5 8.3 12.8 10.5 15.7 15.7 14.6 10.6 9.7 12.2 11.9 7.8 11.7 14.0 9.5 12.4 5.8 10.1 9.6 9.0 8.2 6.7 8.1 23.7 8.6 8.0 8.7 6.5 14.8 6.2 11.6 9.5 8.6 15.0 34.9 8.5 7.7 7.1 11.1 9.3 8.8 8.5 10.8 8.1 16.2 7.9 32.6 15.8 7.2 25.0 7.9 6.4 8.9 114.3 35.3 103.3 57.9 7.3 21.2 64.3 62.9 33.3 80.9 76.9 72.3 50.1 141.2 84.6 23.8 56.6 49.8 78.6 37.4 122.3 68.1 55.8 99.3 42.3 65.6 7.7 97.7 34.9 12.3 11.2 68.1 19.0 19.1 45.2 3.9 165.1 34.0 63.1 44.2 119.6 75.4 195.7 69.3 45.1 151.1 182.2 84.4 35.8 57.3 85.9 91.6 58.4 49.2 48.0 83.6 46.9 38.8 18.7 55.5 70.9 57.1 74.6 20.8 63.4 180.1 33.1 72.5 35.4 3.0 1.3 4.9 8.0 4.4 9.3 6.7 7.7 10.3 2.5 7.9 12.6 13.1 1.0 14.2 3.9 3.4 11.8 6.5 8.3 10.5 14.6 10.6 9.6 9.0 8.6 8.0 9.5 8.5 7.9 8.9 14.7 9.6 11.5 18.6 13.0 8.3 7.9 14.4 8.6 17.4 7.5 7.1 15.6 5.7 12.6 9.2 45.9 19.9 14.2 6.6 3.9 11.5 17.8 21.0 11.3 13.4 3.5 54.1 59.9 8.4 20.7 12.2 7.1 18.8 12.0 28.2 5.0 1.6 11.4 11.8 58.0 12.1 14.2 4.1 4.6 22.8 5.3 5.1 8.8 16.9 5.5 22.6 17.5 35.7 54.7 7.3 5.0 6.4 12.4 2.8 5.4 4.5 23.3 41.1 0.0 9.8 9.0 56.5 50.8 9.3 6.5 5.1 12.8 24.3 13.5 3.8 MSH5 G7 ENSG00000204410 "MutS homolog 5" O43196 6 31739677-31762676 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Meiosis" DNA-binding "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 18.8;Erythroid cells: 8.0;Gastric mucus-secreting cells: 10.7;Plasma cells: 10.7;Spermatocytes: 10.9;Spermatogonia: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 3.1;NB-4: 5.2" HPA062688 Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Vesicles "Endoplasmic reticulum" "HPA062688: AB_2684835" "unprognostic (3.21e-3)" "unprognostic (2.32e-2)" "unprognostic (2.05e-1)" "unprognostic (4.37e-2)" "unprognostic (4.51e-1)" "unprognostic (9.20e-4)" "unprognostic (7.67e-3)" "unprognostic (2.57e-2)" "unprognostic (1.45e-2)" "unprognostic (2.05e-3)" "unprognostic (4.59e-3)" "unprognostic (2.28e-2)" "unprognostic (5.19e-5)" "unprognostic (3.75e-2)" "unprognostic (8.83e-2)" "unprognostic (9.21e-2)" "unprognostic (9.34e-4)" 1.3 1.2 0.1 0.5 0.1 0.7 1.5 0.1 0.4 1.7 0.2 1.6 0.0 1.4 0.0 2.2 1.9 0.0 1.0 0.1 0.1 5.6 2.0 1.4 0.6 0.1 0.2 2.3 1.6 0.0 2.2 0.0 0.1 2.9 0.0 0.1 1.6 0.0 0.6 1.8 1.8 0.0 0.1 2.4 1.6 14.0 0.1 0.0 1.5 0.0 0.0 1.6 1.7 0.2 0.3 1.1 0.4 0.9 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.1 1.0 3.1 0.4 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.7 1.1 0.1 0.6 0.0 0.3 1.3 0.0 0.0 0.1 0.3 0.5 0.9 1.2 1.9 1.6 0.0 2.1 0.5 5.2 0.9 0.9 0.0 2.1 0.1 2.4 0.3 0.5 0.2 0.8 0.3 0.2 0.0 0.0 0.3 1.8 0.0 0.3 1.6 0.1 0.6 0.3 2.1 1.7 0.0 0.5 0.8 2.5 0.4 0.0 0.4 0.3 0.0 1.4 0.4 0.1 0.1 0.6 0.1 0.1 0.6 0.1 0.6 0.8 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.4 0.0 2.3 0.0 3.6 0.5 0.5 0.3 3.4 0.7 0.5 0.5 0.3 2.8 0.8 3.7 18.8 0.6 0.5 1.0 0.0 0.2 0.1 1.6 1.3 0.6 1.2 8.0 0.0 0.2 0.4 0.9 10.7 2.8 3.8 3.1 0.4 0.3 0.5 0.0 0.0 1.2 0.0 0.8 1.3 0.5 1.2 1.5 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.5 0.7 10.7 0.5 2.0 0.8 0.9 7.3 0.0 1.0 1.4 10.9 8.3 6.2 0.4 0.5 2.5 0.9 1.9 0.4 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760734-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 93.4;fallopian tube: 278.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 189.1;Alveolar cells type 2: 85.6;Club cells: 121.9;Glandular and luminal cells: 57.1;Paneth cells: 214.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 39 "dendritic cells: 5.9;monocytes: 1.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 513.4;EFO-21: 77.4;HeLa: 173.4;hTCEpi: 111.5;OE19: 96.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 9 "spinal cord: 1.7" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 17000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favorable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 93.4 0.2 0.7 1.1 1.0 3.2 0.5 0.6 1.5 15.9 0.3 8.9 7.1 6.2 24.1 7.1 278.2 16.4 8.4 0.7 0.8 6.5 0.2 71.8 0.2 1.9 1.2 3.7 0.9 0.1 0.7 2.7 1.3 3.8 4.0 0.7 39.3 9.9 0.0 1.4 2.9 3.4 1.0 0.4 13.0 1.1 1.2 0.8 0.2 0.0 27.2 2.9 2.9 1.0 0.4 2.1 0.0 1.0 0.0 0.0 2.3 0.3 7.7 8.7 2.0 7.4 513.4 0.0 77.4 0.7 0.1 1.3 0.0 0.7 0.7 0.2 0.3 0.0 173.4 5.9 4.4 0.2 0.1 0.0 111.5 0.0 2.0 7.8 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.1 0.6 96.4 0.8 0.2 0.2 0.6 2.4 0.1 0.1 0.0 29.7 0.1 0.0 0.1 0.7 0.0 0.0 0.4 12.1 0.1 0.0 0.3 0.3 0.4 0.0 0.0 0.6 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.3 0.7 1.0 0.6 1.5 0.7 0.8 1.9 1.2 1.3 1.0 1.2 1.0 0.0 189.1 85.6 0.0 0.0 0.3 3.0 49.0 0.0 1.4 0.3 0.3 1.6 52.9 121.9 25.8 0.0 0.2 0.0 4.1 0.0 9.3 1.6 35.8 3.3 0.7 3.0 0.0 0.0 0.9 0.0 4.6 0.0 57.1 0.0 0.0 0.4 0.1 2.9 0.0 0.0 1.6 22.4 1.0 1.9 7.4 4.7 3.7 1.8 1.0 4.4 0.0 0.0 0.0 0.0 33.0 214.4 0.0 1.4 3.3 1.7 0.1 54.2 0.6 0.0 0.0 2.8 0.6 0.7 0.5 0.1 0.1 1.3 0.0 3.1 50.8 MSMP "PC-3, PSMP" ENSG00000215183 "Microseminoprotein, prostate associated" Q1L6U9 9 35752990-35756613 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.5;choroid plexus: 1.1;pituitary gland: 1.5;placenta: 1.2" "Group enriched" "Detected in some" 50 "Early spermatids: 96.3;Late spermatids: 216.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 85.7;PC-3: 108.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055174 Uncertain Supported Vesicles,Cytosol "Secreted in other tissues" No No 30000 "Cluster 10: Basophils - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 34: Spermatids - Unknown function" Vesicles Cytosol "HPA055174: AB_2682726" 0.2 0.0 0.6 0.2 0.3 0.0 0.1 0.4 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.2 1.5 0.4 0.0 0.0 0.0 1.5 1.2 0.9 0.0 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 85.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.6 0.3 0.4 0.8 0.3 0.3 1.5 0.4 0.9 0.6 0.3 0.4 1.3 0.0 1.1 0.0 1.1 0.4 1.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 1.4 96.3 0.6 0.1 3.1 0.0 0.0 0.0 2.0 0.2 0.3 0.0 0.2 0.0 0.5 2.5 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.8 216.6 0.3 0.1 1.8 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.1 0.7 0.1 1.5 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.8 0.5 0.0 0.1 0.3 0.2 0.1 0.3 1.3 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 261.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.3;Excitatory neurons: 11.9;Inhibitory neurons: 9.7;Oligodendrocyte precursor cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 1.9 1.5 1.5 1.5 1.8 1.6 1.7 4.3 2.0 3.2 1.6 2.3 1.2 2.1 1.7 1.4 2.2 1.2 10.9 1.5 0.6 1.7 1.6 2.2 1.8 0.2 0.3 3.0 1.9 56.2 2.3 0.6 0.2 2.5 1.3 2.5 1.7 0.8 261.3 3.7 2.7 1.1 0.0 3.9 1.8 1.4 0.7 1.5 1.5 5.9 1.5 2.2 2.2 1.3 0.9 0.6 1.5 2.7 2.1 2.8 1.2 0.7 0.5 0.3 0.6 0.3 0.7 2.1 0.2 0.7 0.1 1.1 1.0 0.2 0.8 1.1 0.9 1.7 1.3 0.5 0.7 1.1 1.7 2.4 0.7 0.6 1.7 2.1 0.2 0.8 0.6 1.0 1.2 0.2 0.9 1.6 0.4 0.5 0.7 0.5 4.1 0.1 0.8 0.9 0.3 0.8 0.5 1.0 0.9 1.4 0.9 0.9 1.3 1.2 0.7 0.4 1.7 0.6 2.1 1.1 0.5 1.9 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.8 4.3 2.0 1.5 0.6 0.2 0.3 0.2 0.0 0.7 1.3 0.9 0.0 3.6 4.6 1.0 0.5 0.1 0.6 0.0 1.4 0.4 0.5 5.3 0.0 0.2 0.0 0.0 0.3 0.4 0.4 0.0 0.4 0.3 0.4 0.7 1.2 0.0 1.3 11.9 0.4 0.2 0.8 1.1 0.8 5.1 1.8 1.4 0.2 0.2 0.0 9.7 0.4 0.0 0.8 0.6 0.3 3.1 0.5 0.0 4.7 1.1 0.5 1.0 6.0 3.4 0.2 3.9 1.5 0.4 0.5 0.6 0.2 0.3 1.2 0.0 4.0 0.6 0.7 0.3 0.0 0.0 0.1 1.1 1.4 0.6 0.2 MTA3 KIAA1266 ENSG00000057935 "Metastasis associated 1 family member 3" Q9BTC8 2 42494569-42756947 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 137.0;Oligodendrocyte precursor cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039433 Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 63: T-cells - Adaptive immune response" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Vesicles "HPA039433: AB_10794747" "unprognostic (5.40e-2)" "unprognostic (4.89e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (4.13e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (7.55e-2)" "unprognostic (2.04e-1)" "unprognostic (5.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-2)" "unprognostic (9.03e-2)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (1.28e-2)" 11.8 41.8 16.4 5.6 18.9 1.6 14.9 9.1 19.4 18.5 7.1 16.6 7.8 16.8 27.5 21.8 16.1 10.0 12.4 21.9 14.9 13.6 7.9 8.8 10.7 12.3 13.9 29.2 18.8 17.3 15.1 15.3 18.8 14.4 13.2 9.3 13.6 16.8 9.1 19.1 11.4 12.0 11.7 7.8 16.8 21.0 16.1 70.4 12.6 9.9 14.5 15.3 17.8 14.8 13.0 16.6 20.1 14.3 17.4 28.0 46.6 7.4 18.6 21.7 19.2 22.2 26.2 45.4 12.6 22.1 15.9 8.2 51.6 25.2 34.2 14.1 21.0 6.7 8.8 36.4 21.9 5.0 29.0 29.5 29.1 13.4 16.6 28.1 30.4 23.9 16.5 6.1 25.7 27.8 30.3 22.0 84.4 20.8 9.7 18.4 18.9 0.0 25.7 12.1 12.3 37.1 13.5 45.5 17.8 61.6 23.2 7.0 14.2 8.9 12.1 7.2 8.1 11.5 4.7 63.5 12.6 5.7 11.1 2.5 0.9 0.0 1.7 0.6 2.6 1.2 2.0 2.9 1.5 1.3 4.4 3.0 0.2 1.8 0.9 0.4 1.1 1.5 16.4 18.9 9.1 19.4 21.9 14.9 12.3 13.9 18.8 11.7 16.1 14.8 12.7 12.8 12.5 60.4 10.8 15.3 21.1 33.0 15.4 0.0 24.6 19.6 12.5 15.7 25.7 22.0 0.0 58.5 5.1 19.1 17.6 22.9 10.7 44.5 23.1 13.1 9.6 2.5 137.0 28.0 42.0 21.7 31.1 32.3 12.0 72.3 20.7 13.3 12.4 0.0 81.8 20.0 50.8 6.6 7.1 26.0 33.8 5.2 17.8 53.4 6.9 0.0 9.2 106.1 65.9 20.2 21.8 39.9 10.9 17.7 25.2 33.1 18.4 0.0 13.1 15.8 35.9 25.5 41.1 24.5 18.3 59.9 12.6 44.5 21.5 17.3 MTHFSD FLJ12998 ENSG00000103248 "Methenyltetrahydrofolate synthetase domain containing" Q2M296 16 86530178-86555235 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041333 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Vesicles" "HPA041333: AB_10795006" "unprognostic (4.09e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (9.88e-5)" "unprognostic (2.66e-2)" "unprognostic (7.71e-2)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (6.24e-2)" "unprognostic (3.29e-1)" "unprognostic (4.05e-2)" "unprognostic (2.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.94e-3)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (4.77e-1)" "unprognostic (5.85e-3)" 7.2 8.2 5.3 8.7 6.5 6.3 10.4 6.3 6.2 9.2 7.6 8.7 7.4 9.6 10.6 10.1 13.0 8.4 7.9 5.2 5.1 7.6 7.9 8.3 11.7 6.4 6.2 11.5 9.9 11.8 9.3 8.1 6.4 10.2 10.5 6.6 11.0 8.1 11.3 12.7 8.6 8.3 6.1 10.6 9.7 17.7 6.4 10.6 11.0 8.3 11.7 8.9 8.8 9.6 15.7 14.6 14.2 12.3 11.8 18.0 17.0 15.3 11.1 19.0 9.4 13.0 25.8 14.2 16.3 13.4 10.2 21.4 15.8 15.0 17.7 9.4 12.8 12.9 20.0 12.0 16.0 10.1 6.9 11.4 23.4 24.4 20.9 16.4 11.5 20.5 26.9 0.0 13.9 19.8 12.6 15.0 9.3 12.9 18.3 38.6 8.0 11.2 11.1 9.4 13.8 9.5 34.7 6.8 12.6 14.1 34.5 10.3 11.9 18.3 15.7 12.2 15.1 11.1 14.7 41.6 16.7 15.8 18.2 5.9 4.8 2.4 4.7 3.5 5.0 4.6 5.2 4.9 6.0 3.4 4.2 5.0 1.9 6.3 4.3 2.7 4.5 4.8 5.3 6.5 6.3 6.2 5.2 5.1 6.4 6.2 6.4 6.1 6.4 9.6 6.4 6.4 5.9 10.4 6.4 1.1 2.7 4.2 1.2 0.0 6.8 7.1 4.4 2.8 4.7 5.5 0.0 7.9 5.6 7.2 11.7 5.2 35.6 7.4 5.9 4.6 4.2 7.4 6.6 4.2 4.5 4.5 2.6 4.9 4.5 9.4 5.7 3.4 6.1 0.0 7.1 5.3 2.0 5.5 2.0 18.8 6.5 4.3 3.6 3.7 4.7 0.0 6.2 5.5 13.5 3.6 3.6 8.2 4.1 2.6 5.3 4.4 8.2 0.0 6.6 2.2 5.5 11.4 4.0 4.5 1.4 7.7 3.8 5.7 5.5 2.0 MTOR "FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1" ENSG00000198793 "Mechanistic target of rapamycin kinase" P42345 1 11106535-11262551 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB069425, HPA071227" Approved Approved Vesicles,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 10: Non-specific - Unknown function" "Vesicles, Cytosol" "CAB069425: , HPA071227: AB_2686367" "unprognostic (3.18e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (2.45e-3)" "unprognostic (5.50e-2)" "unprognostic (2.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (8.24e-3)" "unprognostic (3.48e-2)" "unprognostic (1.88e-1)" "prognostic favorable (1.49e-5)" "unprognostic (1.27e-1)" "unprognostic (2.45e-1)" "unprognostic (6.60e-2)" "unprognostic (7.55e-2)" 16.3 19.4 18.2 13.5 19.0 14.0 16.8 18.4 20.1 15.2 18.6 22.8 11.0 17.5 21.8 18.3 14.6 9.0 23.6 19.7 17.7 24.1 27.6 15.2 15.3 16.5 21.2 14.2 18.3 20.6 21.8 11.8 18.4 19.8 16.0 26.9 16.5 13.8 36.4 17.1 19.6 13.8 14.6 21.2 18.7 33.8 22.7 19.2 17.8 17.8 15.9 17.1 14.9 18.7 28.5 25.2 33.3 25.4 39.4 18.6 16.6 23.4 22.3 30.6 29.9 26.0 25.5 31.4 19.6 27.8 18.8 33.1 45.3 35.8 39.3 25.2 33.2 41.7 53.8 33.4 24.7 41.1 29.7 24.0 26.8 43.7 44.0 14.5 39.3 29.6 47.4 26.1 21.6 32.4 28.5 31.2 25.3 29.6 23.5 28.2 39.2 21.0 27.2 25.3 33.4 24.5 50.1 26.8 31.2 36.5 21.8 24.0 42.3 26.5 23.9 20.5 31.8 25.5 25.5 60.5 19.1 43.6 28.6 0.3 1.1 1.3 1.9 2.4 1.6 1.4 1.1 1.0 1.6 1.1 1.3 1.1 0.8 1.1 1.3 1.2 2.4 1.0 18.2 19.0 18.4 20.1 19.7 17.7 16.5 21.2 18.4 14.6 22.7 18.7 9.2 16.0 11.8 40.8 10.0 3.4 5.2 7.6 8.6 0.0 7.7 7.5 25.1 2.8 10.3 9.2 0.0 7.9 9.8 9.4 1.9 8.5 42.0 13.8 16.1 11.0 10.3 14.3 43.8 6.2 7.2 9.2 16.8 18.6 13.3 12.9 5.3 13.4 6.9 0.0 49.2 7.8 6.1 8.2 4.1 36.1 7.8 9.1 8.8 36.5 9.2 0.0 10.3 38.2 37.4 10.4 5.4 8.2 17.2 8.9 7.0 4.5 6.3 0.0 39.5 11.4 12.1 49.3 37.4 15.6 5.7 9.9 9.8 15.3 10.0 5.7 MVB12B "C9orf28, FAM125B, FLJ00001" ENSG00000196814 "Multivesicular body subunit 12B" Q9H7P6 9 126326829-126507041 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 99.3" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 505.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043683, HPA049383" Approved "Golgi apparatus,Vesicles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Vesicles" "HPA043683: AB_2678616, HPA049383: AB_2680737" "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (6.82e-2)" "unprognostic (9.59e-3)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (4.45e-3)" "unprognostic (4.33e-1)" "unprognostic (1.05e-1)" "prognostic favorable (7.89e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-3)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (5.79e-2)" "unprognostic (1.12e-3)" 5.8 5.2 32.5 4.5 63.6 12.3 4.8 58.6 44.5 6.4 27.6 8.2 3.7 6.8 3.0 4.1 9.9 3.8 5.4 32.0 40.1 4.4 4.2 18.0 6.9 81.1 59.4 6.4 3.2 7.7 8.3 15.0 68.4 6.6 6.2 6.2 3.1 8.4 24.6 5.0 5.5 6.4 57.2 11.1 6.4 5.7 56.7 8.4 5.8 13.0 2.6 7.9 5.0 99.3 4.8 6.5 34.6 19.1 1.2 0.4 20.4 4.0 3.1 7.0 1.3 5.6 0.3 0.0 2.4 3.8 10.3 2.1 10.7 1.9 4.3 8.0 6.7 1.7 1.1 24.6 2.7 3.2 1.5 2.6 3.5 1.4 0.1 5.8 5.4 25.5 0.0 0.0 5.2 3.9 5.3 10.0 7.6 0.8 8.6 7.6 18.9 0.0 0.3 19.5 8.7 15.9 6.4 4.6 4.1 14.4 4.6 19.2 7.9 7.8 5.8 4.4 8.2 0.1 0.0 1.9 2.2 14.2 4.2 0.0 0.8 0.1 1.4 0.2 2.5 0.1 0.6 2.3 1.0 0.2 0.1 1.0 0.0 0.0 0.2 0.0 0.0 0.9 32.5 63.6 58.6 44.5 32.0 40.1 81.1 59.4 68.4 57.2 56.7 99.3 6.3 6.4 7.3 75.4 1.8 3.6 3.2 1.0 6.8 9.4 3.3 3.6 3.6 4.3 1.3 1.8 4.2 12.4 4.7 8.8 0.0 1.6 0.8 6.2 3.0 5.8 2.4 1.7 64.5 1.4 2.6 3.1 2.6 2.4 7.0 5.5 2.2 6.2 1.6 10.1 58.2 2.5 6.1 23.3 6.2 2.7 2.8 10.2 0.0 74.9 3.9 9.1 2.1 56.8 505.6 1.0 5.5 6.4 2.2 1.2 0.9 0.3 6.9 5.3 0.0 2.6 2.7 3.4 6.4 2.9 2.6 3.4 10.9 0.8 3.0 1.6 MVK "LRBP, MK" ENSG00000110921 "Mevalonate kinase" Q03426 12 109573255-109598125 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Kinase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.1" "Cell type enhanced" "Detected in all" "Early spermatids: 60.5;Horizontal cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016961, HPA044110" Approved Supported Vesicles,Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 15: Hepatocytes - Hemostasis" "Vesicles, Cytosol" "HPA016961: AB_1854220, HPA044110: " "unprognostic (3.10e-1)" "unprognostic (2.27e-2)" "unprognostic (1.85e-1)" "unprognostic (4.43e-2)" "unprognostic (3.66e-2)" "unprognostic (2.08e-2)" "unprognostic (4.30e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (8.23e-2)" "unprognostic (1.30e-1)" "unprognostic (6.43e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (3.88e-1)" "unprognostic (3.28e-1)" 7.9 29.8 12.7 6.1 13.7 8.3 14.7 16.7 15.0 14.5 9.6 11.2 13.9 7.3 10.2 45.5 6.3 5.3 9.4 11.1 13.2 32.1 69.1 11.4 6.9 36.1 15.5 10.7 10.0 11.5 11.6 5.4 38.6 12.3 8.6 7.3 13.7 7.0 12.1 33.3 9.8 5.0 15.3 6.7 11.8 28.5 15.3 4.2 15.1 8.8 9.1 9.5 20.1 24.4 30.1 25.0 29.9 13.7 11.2 27.3 14.4 9.5 21.7 30.0 32.8 31.4 33.8 17.7 7.8 11.7 48.1 36.0 31.6 50.0 13.2 19.0 18.1 9.9 15.7 53.7 31.5 11.1 13.0 27.2 42.1 48.8 13.6 12.6 20.9 19.0 18.7 17.4 13.6 34.5 12.0 34.6 22.6 14.9 32.3 10.5 22.1 37.0 67.4 40.9 25.1 18.7 19.8 58.7 14.0 11.0 59.7 21.1 14.1 13.2 14.5 12.0 12.8 13.3 20.6 28.2 16.1 29.2 16.6 1.0 6.9 4.0 12.6 6.5 11.3 9.4 7.4 12.4 8.6 14.1 10.9 8.3 1.6 11.0 4.6 7.0 7.6 6.4 12.7 13.7 16.7 15.0 11.1 13.2 36.1 15.5 38.6 15.3 15.3 24.4 6.1 12.8 12.4 6.8 8.3 4.7 5.2 39.7 4.6 12.4 13.1 11.0 5.7 11.5 25.8 14.7 18.8 33.0 7.3 10.4 21.5 15.6 60.5 5.8 2.3 7.1 9.0 4.8 5.1 18.1 15.3 6.8 9.7 5.1 1.3 14.7 6.4 32.7 15.6 62.2 5.2 7.8 10.2 3.4 2.2 42.5 8.1 4.8 7.2 3.7 10.3 10.6 10.3 4.0 15.3 13.2 3.2 7.2 4.1 5.5 16.4 52.4 13.5 12.2 6.6 4.0 8.2 33.9 16.8 12.0 8.5 47.9 6.1 44.8 11.1 4.6 MYBBP1A "FLJ37886, P160, PAP2, Pol5" ENSG00000132382 "MYB binding protein 1a" Q9BQG0 17 4538897-4555386 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005466 Supported Supported Nucleoli,Vesicles No No 47000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Vesicles "HPA005466: AB_2667327" "unprognostic (8.06e-2)" "unprognostic (2.33e-1)" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (7.81e-2)" "unprognostic (1.29e-1)" "unprognostic (1.57e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.84e-1)" "prognostic favorable (1.61e-4)" "unprognostic (3.88e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.78e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (8.12e-4)" "unprognostic (9.70e-2)" 12.3 11.0 3.8 13.4 3.8 11.4 15.9 1.3 7.6 13.3 0.8 11.9 9.6 14.6 4.6 17.0 15.2 6.2 11.0 5.0 4.2 9.8 10.8 11.4 13.8 5.2 4.9 14.1 24.4 6.7 12.7 5.2 3.5 17.1 5.1 3.8 18.9 10.1 27.9 22.0 12.9 7.3 2.1 14.0 12.4 8.1 3.4 7.4 11.2 8.0 8.7 14.9 13.8 3.8 60.1 90.0 11.9 56.2 15.4 17.1 40.8 39.8 17.5 39.5 30.8 67.1 24.4 80.4 47.2 23.9 19.8 74.2 50.1 61.3 19.0 40.3 133.8 38.8 58.3 62.2 25.2 45.5 34.7 25.7 34.6 58.8 29.1 11.0 26.6 45.0 64.2 37.1 18.2 51.4 54.2 19.5 56.0 19.1 48.0 69.8 19.7 54.0 9.8 45.5 25.5 48.5 40.8 29.7 28.2 8.6 27.5 19.1 34.3 35.1 31.5 32.7 118.6 32.1 26.5 34.4 32.5 53.9 45.3 0.0 1.9 0.3 2.8 1.6 3.4 2.9 2.3 3.1 2.9 1.7 2.5 2.8 0.1 2.4 3.4 2.1 1.0 2.7 3.8 3.8 1.3 7.6 5.0 4.2 5.2 4.9 3.5 2.1 3.4 3.8 13.4 9.6 14.5 4.6 13.1 12.9 6.8 7.1 12.0 8.2 12.9 14.4 4.1 8.6 13.3 3.7 12.5 2.9 5.8 9.2 0.0 7.7 0.5 6.7 15.3 17.0 11.4 7.2 11.3 12.7 5.4 10.2 10.7 8.5 5.1 12.2 8.6 7.8 6.5 10.1 6.1 8.0 4.1 4.5 6.8 0.6 5.6 6.3 3.6 7.5 3.8 3.8 6.2 3.5 6.5 8.2 4.5 12.0 13.7 13.9 4.6 3.2 12.2 6.2 6.6 10.8 12.9 2.6 11.1 12.8 11.9 1.1 9.7 13.8 12.4 6.2 MYCT1 "FLJ21269, MTLC" ENSG00000120279 "MYC target 1" Q8N699 6 152697895-152724567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.6" "Group enriched" "Detected in some" 5 "Adipocytes: 123.0;Endothelial cells: 141.3;Hepatic stellate cells: 230.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 33 "eosinophil: 30.7" "Lineage enriched" "Detected in single" 248 "granulocytes: 30.7" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 124.6;TIME: 104.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047992 Approved Nucleoplasm,Vesicles NA NA 120000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Vesicles "HPA047992: " "unprognostic (2.92e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (2.06e-1)" "unprognostic (6.73e-2)" "unprognostic (6.80e-2)" "unprognostic (4.64e-3)" "unprognostic (6.78e-2)" "unprognostic (9.90e-2)" "unprognostic (2.10e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.26e-3)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (3.36e-2)" 26.6 3.2 6.8 5.2 6.9 1.2 21.4 6.9 10.2 9.0 5.2 6.1 3.5 10.1 4.5 4.6 9.2 10.5 17.1 6.3 7.1 6.6 13.1 15.6 6.2 7.7 6.9 3.6 2.7 4.3 2.2 20.7 8.6 4.4 5.8 1.0 3.7 3.8 12.8 4.7 5.6 12.4 6.8 49.6 4.5 1.8 10.0 2.5 12.2 20.5 3.0 8.1 7.3 7.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 17.7 0.1 0.0 0.2 0.0 0.1 0.0 23.0 0.3 0.0 0.7 0.1 0.1 0.0 0.2 0.2 0.3 0.0 124.6 0.0 0.3 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.0 0.0 104.4 0.5 0.8 1.5 0.0 1.1 0.0 15.6 0.0 0.0 0.0 0.9 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.6 6.8 6.9 6.9 10.2 6.3 7.1 7.7 6.9 8.6 6.8 10.0 7.5 123.0 0.0 5.2 0.7 0.8 7.1 0.2 0.1 2.8 0.2 0.4 0.9 3.1 2.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 10.2 1.3 0.2 141.3 0.0 13.7 0.1 0.2 0.0 4.0 0.0 0.1 1.3 0.0 230.6 2.1 0.1 0.0 0.1 0.0 0.0 7.3 7.3 3.7 0.3 13.3 14.2 30.9 0.1 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.6 0.5 0.0 0.0 17.7 0.0 0.0 1.5 2.2 0.1 0.1 0.5 5.5 0.0 0.9 0.5 0.0 0.7 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294151-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 5.4;breast: 5.3;esophagus: 9.6;stomach 1: 6.0" "Cell type enriched" "Detected in many" 5 "Pancreatic endocrine cells: 199.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 172.8;A549: 83.5;CAPAN-2: 24.3;U-2 OS: 36.1" HPA012949 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 5.4 0.1 0.0 0.6 0.0 0.1 5.3 0.0 0.0 1.8 0.0 0.5 0.3 0.0 0.7 9.6 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.1 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.6 0.0 0.0 4.1 0.2 0.0 0.0 0.2 6.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 3.9 0.0 172.8 83.5 0.0 0.0 0.0 0.0 2.5 0.2 0.1 0.0 0.0 0.5 24.3 0.5 6.3 0.0 0.1 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.4 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.1 8.5 0.0 2.4 0.2 0.1 3.8 0.1 0.1 0.2 3.4 6.8 0.0 0.1 3.5 0.6 0.2 0.0 0.0 0.0 2.4 0.6 0.0 2.9 0.7 1.6 0.1 36.1 0.0 1.4 0.3 1.7 0.2 0.2 0.5 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.0 0.8 0.8 3.8 0.0 0.0 30.7 37.7 0.4 0.0 17.6 3.7 0.0 0.0 0.9 7.8 0.0 12.6 12.7 1.2 0.1 0.5 0.0 0.0 0.0 9.4 0.4 3.4 23.9 1.5 0.0 0.1 0.0 0.2 2.4 0.0 0.0 1.3 2.0 0.0 0.0 6.9 0.3 4.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 199.3 22.3 0.0 3.9 1.4 0.0 0.0 1.5 0.0 0.0 0.1 2.9 0.0 0.4 3.4 1.3 0.1 0.4 0.0 2.7 8.5 MYH15 KIAA1000 ENSG00000144821 "Myosin heavy chain 15" Q9Y2K3 3 108380368-108529322 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9;retina: 2.8;tongue: 1.8" "Cell type enhanced" "Detected in some" "Astrocytes: 14.0;Excitatory neurons: 8.8;Inhibitory neurons: 6.3;Muller glia cells: 8.0;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 10.6;Rod photoreceptor cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.4;Karpas-707: 2.3;PC-3: 5.1;SH-SY5Y: 1.8;U-87 MG: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA034871, HPA057915" Uncertain Approved Vesicles,Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 5: Muller glia cells - Visual perception" Cytosol Vesicles "HPA034871: AB_10669996, HPA057915: " "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.62e-1)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (7.84e-3)" "unprognostic (7.32e-2)" "unprognostic (1.89e-2)" "unprognostic (5.67e-2)" "unprognostic (6.67e-2)" "unprognostic (4.42e-2)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (8.41e-2)" "unprognostic (3.57e-2)" 0.1 0.2 1.5 0.1 1.9 0.1 0.0 1.4 1.4 0.1 0.6 0.4 0.4 0.0 0.3 0.0 0.1 0.2 0.4 1.5 1.7 0.0 0.0 0.3 0.1 1.7 1.5 0.0 0.0 0.0 0.9 0.0 1.5 0.2 0.3 2.8 0.1 0.0 0.2 0.5 0.6 0.0 1.5 0.2 0.1 0.6 1.6 0.1 0.1 1.8 0.0 0.0 0.0 1.6 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.9 0.1 0.2 0.0 0.4 0.0 0.1 0.0 4.4 0.0 0.1 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.0 2.3 1.2 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.5 1.2 0.2 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 1.9 1.4 1.4 1.5 1.7 1.7 1.5 1.5 1.5 1.6 1.6 0.0 0.0 0.5 14.0 0.3 0.0 0.1 0.0 0.0 1.7 0.0 0.0 2.3 0.0 0.0 0.0 2.1 0.0 0.1 0.4 0.0 0.2 3.0 1.0 0.1 0.1 0.0 0.0 8.8 0.2 0.0 0.6 0.0 0.1 0.0 0.5 0.0 0.0 0.1 1.7 6.3 1.1 0.0 0.0 0.3 0.9 0.0 0.1 1.8 1.0 0.0 8.0 0.0 5.0 10.6 0.5 0.0 0.0 1.6 0.4 0.1 0.1 0.0 5.1 0.0 0.1 0.6 1.1 0.6 0.0 0.1 0.0 0.1 0.5 1.2 0.1 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46702282-46790407 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 103.4;skeletal muscle: 46.5;tongue: 72.6" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 169.0;Endometrial ciliated cells: 44.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.9;HEL: 40.2;K-562: 6.5;SK-BR-3: 7.9" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.6;hippocampal formation: 5.1" "Region enriched" "Detected in single" 5 "hippocampal formation: 3.5" HPA073447 Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Vesicles "HPA073447: AB_2732225" "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 1.9 0.1 1.7 0.3 0.1 1.1 2.3 0.4 1.7 0.0 0.1 0.3 0.8 4.3 1.7 0.2 103.4 2.5 2.8 1.1 0.1 0.4 0.2 9.8 12.2 0.3 0.1 0.0 0.4 0.5 8.2 2.2 0.1 0.2 2.1 0.1 46.5 0.1 0.1 0.2 5.9 0.1 0.1 6.0 1.9 0.1 0.1 72.6 0.1 0.0 0.0 3.0 0.0 0.1 0.1 0.1 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 2.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 6.5 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.4 0.0 7.9 0.2 3.5 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.3 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 1.9 1.7 1.1 2.3 2.5 2.8 9.8 12.2 8.2 5.9 1.9 3.0 0.2 0.0 3.3 0.7 0.5 0.0 0.7 0.0 0.0 0.9 1.3 0.0 169.0 0.0 3.7 0.0 2.1 2.0 0.2 0.0 0.0 0.0 8.1 44.8 7.1 1.7 0.0 0.0 0.9 0.2 0.5 6.7 0.0 2.2 1.3 1.6 0.7 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 7.2 0.6 0.8 0.0 0.0 0.2 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.8 0.0 0.2 8.7 1.3 0.0 4.9 2.7 1.0 0.7 0.0 0.0 0.3 0.8 0.7 0.0 0.8 MYOF "FER1L3, KIAA1207" ENSG00000138119 Myoferlin Q9NZM1 10 93306429-93482334 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 123.4;Pancreatic endocrine cells: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 20.4;non-classical monocyte: 26.6" "Group enriched" "Detected in many" 57 "dendritic cells: 8.1;monocytes: 26.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 452.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014245 Enhanced Supported "Vesicles,Plasma membrane" NA NA 190000 "Cluster 51: Monocytes - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "Plasma membrane" "HPA014245: AB_1848495" "unprognostic (3.41e-2)" "unprognostic (3.85e-1)" "unprognostic (2.88e-2)" "unprognostic (7.44e-2)" "unprognostic (3.50e-2)" "unprognostic (8.57e-3)" "unprognostic (3.48e-2)" "unprognostic (7.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.55e-1)" "unprognostic (5.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.94e-2)" "unprognostic (9.17e-2)" "unprognostic (9.18e-2)" 31.7 8.1 2.9 20.6 4.1 1.5 43.3 5.0 2.5 56.4 37.4 22.4 5.3 27.5 7.1 36.4 36.9 26.6 13.8 3.4 4.1 10.9 2.9 32.2 4.4 8.9 6.8 9.8 5.9 23.8 3.8 55.2 8.1 27.5 29.3 0.9 19.7 31.4 3.6 56.1 9.0 44.3 6.2 6.5 13.4 2.2 5.4 5.1 35.7 6.2 9.1 62.0 29.4 6.2 228.9 206.3 21.4 14.6 159.4 318.4 62.0 190.3 452.7 110.1 109.2 51.1 177.1 0.0 76.9 353.7 116.2 350.0 1.8 204.7 82.6 1.4 0.9 0.0 80.8 2.1 55.2 0.0 0.2 183.0 71.6 77.7 323.8 289.4 299.7 0.0 0.0 0.5 275.6 39.4 0.1 0.9 1.6 72.0 171.6 0.0 15.8 0.1 314.3 281.5 0.1 0.0 130.4 29.7 46.1 83.1 141.5 4.7 378.5 167.3 11.8 111.3 113.9 0.2 0.3 0.3 128.2 2.6 201.0 0.0 5.4 0.0 0.0 20.4 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.3 0.0 26.6 2.8 0.2 1.6 2.9 4.1 5.0 2.5 3.4 4.1 8.9 6.8 8.1 6.2 5.4 6.2 42.5 60.9 52.5 1.6 1.2 23.7 63.0 101.4 39.3 0.1 48.4 34.3 9.2 14.3 91.5 22.0 0.0 56.6 3.8 74.1 1.9 54.8 0.6 50.9 45.9 28.8 1.8 0.0 2.7 33.7 23.7 38.1 23.0 123.4 1.3 1.7 35.7 0.4 22.9 0.0 0.8 29.6 42.7 29.2 20.2 0.6 5.9 28.5 8.8 60.0 12.8 0.1 0.0 2.0 0.7 153.7 22.2 9.1 0.8 86.7 0.6 1.5 60.7 0.8 6.6 15.9 39.6 0.1 0.3 53.4 30.7 51.2 1.9 8.3 18.7 100.7 NACC1 "BEND8, BTBD14B, BTBD30, NAC-1, NAC1" ENSG00000160877 "Nucleus accumbens associated 1" Q96RE7 19 13116862-13141147 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021238, HPA062245, CAB069927" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 47: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724" "unprognostic (2.19e-1)" "unprognostic (9.20e-3)" "unprognostic (2.67e-2)" "unprognostic (2.84e-2)" "unprognostic (2.62e-1)" "unprognostic (7.75e-2)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.93e-1)" "unprognostic (8.46e-2)" "unprognostic (2.40e-2)" "unprognostic (3.04e-2)" "unprognostic (7.35e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.74e-2)" 12.6 19.5 31.0 14.6 19.2 8.8 10.3 7.1 26.6 9.7 0.0 17.3 13.3 18.4 7.9 27.6 11.9 6.4 20.9 25.7 7.4 14.8 20.5 16.7 12.1 13.4 15.9 7.7 12.2 10.7 14.8 12.4 15.1 14.6 6.6 3.7 15.8 11.2 24.2 17.4 16.0 7.7 8.9 15.9 16.0 17.0 20.6 11.3 14.0 7.9 8.8 15.0 12.6 16.4 98.8 110.0 28.0 59.6 15.0 17.7 74.9 47.4 34.2 42.4 32.4 114.8 40.4 50.9 104.1 39.8 37.3 49.0 34.8 80.7 16.2 89.1 52.5 32.4 87.9 84.7 35.5 52.0 82.3 28.8 28.0 46.1 24.7 36.5 50.2 46.4 72.5 19.8 22.9 206.1 82.9 39.6 123.6 28.9 101.7 47.8 32.9 49.5 28.2 101.1 58.2 37.7 49.6 64.9 39.1 29.8 59.3 46.4 76.7 94.6 58.8 67.2 87.0 53.4 88.1 42.4 99.7 52.8 58.9 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 31.0 19.2 7.1 26.6 25.7 7.4 13.4 15.9 15.1 8.9 20.6 16.4 4.9 0.0 1.7 6.2 5.6 12.1 7.5 11.8 2.8 16.6 11.5 7.5 2.1 12.8 8.5 16.5 2.1 19.0 12.9 22.7 7.9 12.3 2.3 10.9 8.9 8.1 4.9 12.2 7.2 8.8 20.0 5.2 10.7 17.6 10.2 13.3 8.6 18.0 21.1 26.9 5.9 16.2 14.2 9.6 9.6 2.0 4.4 8.8 5.4 3.7 10.5 12.0 10.3 5.5 5.4 21.7 11.1 9.4 5.6 16.5 14.0 15.0 5.9 7.7 6.6 7.5 7.0 11.1 15.6 8.4 13.9 27.1 7.9 15.2 15.4 17.2 NADK FLJ13052 ENSG00000008130 "NAD kinase" O95544 1 1751232-1780457 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 506.2" "Group enriched" "Detected in all" 7 "granulocytes: 506.2;monocytes: 162.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048909, HPA053368" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm Vesicles "HPA048909: AB_2680553, HPA053368: AB_2682130" "unprognostic (1.29e-1)" "unprognostic (4.29e-1)" "unprognostic (7.07e-2)" "unprognostic (6.82e-2)" "unprognostic (1.98e-1)" "unprognostic (1.58e-2)" "unprognostic (3.32e-1)" "unprognostic (9.03e-2)" "unprognostic (7.81e-2)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (4.54e-3)" "unprognostic (1.40e-1)" "unprognostic (5.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" 53.6 81.8 24.8 37.5 26.6 100.7 44.7 22.1 29.0 28.6 27.8 45.1 38.0 30.9 13.3 29.9 36.1 23.3 28.7 24.1 24.3 30.2 134.0 40.3 41.2 25.4 24.6 37.2 38.9 17.2 26.4 26.0 25.0 32.9 25.4 10.9 40.2 17.4 19.6 28.3 43.3 19.8 24.5 93.1 43.2 27.5 26.5 16.4 31.7 19.2 26.6 32.3 27.1 23.8 41.6 39.3 34.4 50.7 47.8 34.5 44.2 40.9 35.5 45.6 40.3 42.1 74.2 54.5 30.4 30.5 14.7 34.6 37.3 32.5 20.3 53.5 59.1 44.7 65.0 73.6 46.2 63.4 72.1 40.6 28.9 28.4 40.3 24.8 44.9 42.6 55.9 75.8 34.4 47.4 48.1 54.8 23.5 69.4 43.8 60.4 29.4 113.1 39.7 33.9 46.2 35.2 45.8 99.2 43.7 20.3 34.2 43.6 43.8 33.1 23.7 34.6 37.5 67.1 32.7 121.8 32.7 69.3 17.6 84.2 141.3 329.7 7.4 158.6 8.8 10.8 4.3 5.9 45.9 12.1 2.8 4.1 506.2 3.8 162.6 37.9 7.0 82.9 24.8 26.6 22.1 29.0 24.1 24.3 25.4 24.6 25.0 24.5 26.5 23.8 29.0 12.8 30.7 14.4 27.2 9.8 15.7 11.2 13.6 7.9 21.4 17.9 6.8 25.8 21.6 14.7 16.7 24.5 46.8 57.8 15.6 19.1 14.9 18.7 22.2 20.8 22.8 15.8 10.2 29.4 26.3 18.7 52.0 22.8 2.5 21.2 22.5 94.3 36.6 6.7 10.4 38.7 16.2 58.4 13.7 26.7 37.6 45.0 8.8 9.4 67.3 5.7 27.8 10.6 11.1 28.7 34.6 34.6 26.0 34.7 28.6 24.3 13.5 17.7 13.1 12.6 18.2 12.4 22.4 19.5 12.8 42.8 15.4 44.2 31.0 27.5 NANOG "FLJ12581, FLJ40451" ENSG00000111704 "Nanog homeobox" Q9H9S0 12 7787794-7799146 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 8.4;Spermatocytes: 5.5" "Cancer enriched" "Detected in single" 1164 "testis cancer: 58.1" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;granulocytes: 1.5" "Cell line enriched" "Detected in some" 5 "NTERA-2: 125.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB019380, HPA072117" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 5: NTERA-2 - Transcription" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Vesicles "CAB019380: , HPA072117: " "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (8.59e-3)" "unprognostic (3.50e-1)" "unprognostic (3.46e-2)" "unprognostic (6.35e-2)" "unprognostic (1.10e-1)" "unprognostic (3.87e-1)" "unprognostic (4.51e-7)" "unprognostic (3.46e-2)" "unprognostic (2.09e-1)" "unprognostic (1.51e-1)" "unprognostic (3.85e-2)" 0.0 0.1 0.3 0.1 0.7 0.4 0.1 1.9 0.4 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.4 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.1 0.1 0.2 0.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 125.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.5 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.2 0.7 0.3 0.2 1.7 0.1 0.0 0.3 0.7 1.9 0.4 0.3 0.1 0.3 0.1 0.3 0.1 0.4 0.7 0.4 0.0 0.0 0.0 0.2 1.7 1.8 0.8 0.0 2.2 0.3 0.1 0.8 0.0 0.3 0.0 8.4 1.6 1.4 0.1 0.0 0.4 1.0 0.3 0.5 0.6 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.3 0.0 2.1 0.7 0.6 0.5 0.0 0.0 0.3 2.0 0.3 0.0 0.3 1.5 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.2 0.4 1.5 0.0 0.9 0.0 0.3 0.9 1.0 0.0 1.7 0.4 5.5 0.6 0.0 0.6 0.7 0.7 0.7 0.4 1.8 NANOGP8 ENSG00000255192 "Nanog homeobox retrogene P8" Q6NSW7 15 35083410-35085295 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 3.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 415 "testis cancer: 20.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 69 "NTERA-2: 33.2;SuSa: 11.6" HPA072117 Supported Nucleoplasm,Vesicles NA NA "Cluster 6: Brain - Smell perception" "Cluster 5: NTERA-2 - Transcription" Nucleoplasm Vesicles "HPA072117: " "unprognostic (1.58e-1)" "unprognostic (9.05e-3)" "unprognostic (1.48e-1)" "unprognostic (2.37e-1)" 0.1 0.1 0.7 0.0 3.7 0.2 0.1 2.1 1.8 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.5 0.2 0.1 0.1 0.0 0.3 0.2 0.2 0.2 0.0 0.2 0.0 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.7 1.2 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 3.7 2.1 1.8 0.2 0.5 0.3 0.2 0.4 0.2 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NECAP1 DKFZP566B183 ENSG00000089818 "NECAP endocytosis associated 1" Q8NC96 12 8076939-8097881 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053980, HPA063300" Uncertain Approved Vesicles,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" Vesicles Cytosol "HPA053980: AB_2682331, HPA063300: AB_2684981" "unprognostic (1.73e-2)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-3)" "unprognostic (1.03e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (5.79e-3)" "unprognostic (5.72e-3)" "unprognostic (1.03e-1)" "unprognostic (1.72e-2)" "unprognostic (1.89e-2)" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (5.94e-2)" 11.7 23.7 25.4 11.8 23.2 8.0 13.6 19.3 39.6 14.9 1.0 17.8 15.6 10.2 8.7 12.1 15.5 9.9 12.7 25.5 44.0 15.8 14.4 11.2 8.0 13.0 11.1 16.1 22.3 27.5 24.7 15.9 17.8 15.7 16.9 42.5 15.9 12.4 7.9 9.4 15.6 11.4 13.8 10.1 16.1 13.6 15.2 14.2 12.6 12.2 10.4 16.9 10.1 15.9 20.4 18.8 12.6 17.6 29.6 22.0 28.2 41.8 26.6 36.1 36.2 40.9 23.1 9.2 7.3 20.9 26.2 14.0 35.2 23.1 31.2 28.2 27.4 11.6 21.2 21.4 26.9 10.7 29.2 28.7 26.3 40.4 48.0 27.7 26.2 15.0 27.3 14.8 38.8 25.8 17.3 2.8 35.1 57.2 15.4 6.8 32.0 9.7 24.6 32.0 20.7 14.3 21.3 29.7 15.9 40.7 10.1 8.9 26.6 16.9 33.3 20.3 30.1 9.4 18.4 19.9 30.6 11.7 26.0 28.8 16.6 36.4 10.9 15.7 12.7 9.8 10.3 11.2 11.9 10.2 12.1 11.0 28.7 10.6 22.7 7.2 16.8 13.0 25.4 23.2 19.3 39.6 25.5 44.0 13.0 11.1 17.8 13.8 15.2 15.9 18.9 38.5 24.0 11.4 36.1 25.5 22.0 16.0 25.6 49.0 17.5 10.5 10.4 7.2 18.7 23.9 27.1 14.6 32.9 19.8 25.4 15.3 25.4 11.3 20.9 18.1 16.2 17.0 29.4 16.7 14.5 17.9 17.3 16.1 29.2 33.5 15.4 15.2 13.8 28.6 28.4 16.1 12.2 19.8 39.0 13.7 23.3 22.4 28.4 11.2 14.8 30.7 20.6 14.6 21.3 19.0 16.0 14.7 33.7 21.8 23.9 17.8 13.1 46.3 6.6 17.7 21.3 17.4 22.3 21.0 21.3 22.4 35.6 25.2 14.1 22.0 NEIL2 "FLJ31644, MGC2832, MGC4505, NEH2" ENSG00000154328 "Nei like DNA glycosylase 2" Q969S2 8 11769639-11787345 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 68.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA073029, HPA073916" Supported Nucleoplasm,Vesicles NA NA "Cluster 30: Non-specific - Translation" "Cluster 35: Non-specific - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm Vesicles "HPA073029: AB_2732216, HPA073916: AB_2732245" "unprognostic (1.52e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (9.88e-2)" "unprognostic (2.18e-2)" "unprognostic (5.72e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (5.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.29e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (4.05e-1)" 9.5 27.8 29.2 5.9 28.8 2.3 9.5 27.7 27.9 13.1 23.8 8.6 2.8 9.5 12.5 6.9 15.0 5.7 14.6 29.6 35.6 12.8 16.3 7.4 7.1 32.0 34.3 11.1 11.2 9.0 17.9 6.4 36.8 11.3 4.8 13.4 10.0 8.1 24.5 15.8 6.8 8.5 31.9 12.4 6.9 26.1 36.1 4.7 11.8 13.7 6.9 9.8 8.8 28.3 8.2 22.9 14.1 27.7 6.6 12.2 6.3 13.0 10.6 12.2 8.4 7.1 8.8 3.2 4.9 15.7 26.3 7.1 13.5 14.1 16.7 9.7 6.7 11.3 5.7 13.9 5.3 5.0 8.2 10.8 20.7 10.7 9.9 11.8 11.6 3.7 16.1 10.8 15.0 8.6 0.9 5.2 12.6 33.9 12.1 14.4 18.1 8.8 14.4 12.3 21.5 17.0 10.2 5.3 19.1 11.2 8.4 0.7 14.3 13.9 19.8 3.8 18.4 10.0 22.3 5.7 36.6 16.7 28.8 0.7 2.2 0.2 12.7 3.9 17.5 21.9 12.9 15.3 4.6 16.9 18.7 16.8 1.3 15.1 2.0 8.3 9.3 7.0 29.2 28.8 27.7 27.9 29.6 35.6 32.0 34.3 36.8 31.9 36.1 28.3 7.2 0.0 5.8 6.2 14.0 8.5 17.1 8.0 13.6 32.3 13.1 7.7 19.6 14.3 7.0 7.3 16.7 18.6 5.6 1.5 33.2 21.1 1.1 6.9 8.4 8.9 10.1 10.3 6.3 23.3 15.8 10.3 3.1 3.8 2.5 14.9 7.9 23.6 15.1 8.4 6.9 6.1 14.2 6.9 6.6 2.1 14.0 6.8 14.2 0.0 6.6 38.9 11.3 6.0 3.7 15.1 1.0 24.5 3.8 15.3 0.8 32.2 6.8 17.1 6.6 11.8 10.2 19.0 68.1 8.3 12.8 5.3 9.7 8.9 6.2 12.0 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 36.6;tongue: 20.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 87.6;Early spermatids: 123.5;Endometrial ciliated cells: 59.3;Excitatory neurons: 131.4;Inhibitory neurons: 130.2;Late spermatids: 61.7;Respiratory ciliated cells: 104.2" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 6.0;LHCN-M2: 8.2;U-2 OS: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favorable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.2 0.3 3.0 0.3 5.3 0.3 14.0 0.0 9.4 1.4 3.3 2.0 2.5 0.8 8.3 1.8 11.0 1.4 3.3 9.6 5.0 1.7 2.5 2.4 0.5 3.3 5.7 0.7 0.7 0.4 3.4 0.1 2.7 1.7 0.5 6.2 0.3 1.2 12.4 0.3 0.8 0.3 2.3 0.4 1.0 36.6 6.1 0.5 0.7 20.0 0.6 1.2 0.2 0.9 0.8 1.6 0.8 0.9 0.6 1.5 0.3 6.0 0.9 1.6 1.4 0.0 0.4 0.5 1.4 2.5 1.1 0.1 0.4 0.4 1.7 1.1 0.6 0.1 3.4 2.9 0.1 0.3 0.8 1.8 0.4 2.5 0.1 2.0 1.1 3.4 0.1 0.6 8.2 0.1 0.6 0.4 0.5 0.2 0.2 0.8 0.3 0.2 3.0 0.5 0.1 0.2 0.9 0.3 0.4 0.5 4.8 0.3 0.7 4.3 6.8 0.2 0.6 0.2 0.2 0.4 3.6 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 5.3 0.0 9.4 9.6 5.0 3.3 5.7 2.7 2.3 6.1 0.9 1.5 6.4 0.0 11.4 0.3 0.3 0.3 3.2 0.0 14.5 25.8 7.4 12.9 4.3 9.3 1.8 87.6 0.0 0.8 0.2 0.0 0.4 123.5 59.3 1.3 2.4 0.0 0.0 131.4 0.0 0.3 3.1 0.0 7.7 0.0 1.1 0.7 1.3 0.2 0.0 130.2 0.4 12.2 1.0 0.8 61.7 1.8 1.1 0.0 32.8 0.1 1.0 1.0 20.6 12.9 0.2 2.7 1.2 0.1 1.9 2.1 0.3 104.2 19.1 0.0 14.9 2.4 32.2 2.2 0.1 0.4 0.0 1.1 3.7 0.6 0.4 NET1 "ARHGEF8, NET1A" ENSG00000173848 "Neuroepithelial cell transforming 1" Q7Z628 10 5412557-5459056 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 242.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 252.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020068 Uncertain Approved Nucleoplasm,Vesicles Yes Yes "Cluster 32: T-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA020068: AB_2670348" "unprognostic (1.77e-2)" "unprognostic (1.87e-1)" "unprognostic (3.40e-1)" "unprognostic (4.05e-2)" "unprognostic (3.37e-3)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (8.27e-4)" "unprognostic (2.26e-1)" "unprognostic (5.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.46e-1)" 48.8 10.8 35.5 23.4 34.2 40.5 52.8 38.5 57.6 43.7 52.8 92.2 56.2 41.8 56.2 68.4 46.2 35.9 13.2 30.2 32.4 49.3 45.1 22.2 26.7 41.8 37.2 28.5 37.9 5.4 10.6 65.7 43.8 41.3 88.2 6.5 93.1 24.3 25.0 39.8 74.7 36.9 37.5 8.1 77.8 14.4 41.1 30.4 26.2 28.0 33.0 60.8 59.3 40.1 115.9 67.7 45.2 51.0 26.8 11.9 252.9 69.1 37.6 53.4 50.4 36.4 215.2 40.6 27.7 42.4 11.4 185.5 54.9 104.3 63.9 38.1 38.5 77.5 22.9 84.0 7.2 21.5 31.1 18.2 61.0 54.0 12.3 47.6 31.1 42.6 138.5 64.4 30.0 54.3 74.3 30.6 61.5 158.6 51.0 45.0 85.0 32.4 33.4 57.6 38.5 20.6 60.7 110.9 20.3 76.2 36.7 65.3 29.5 20.3 30.9 30.7 56.0 39.3 23.1 53.4 18.1 33.1 43.4 2.0 0.6 1.4 0.6 1.0 0.0 1.4 1.2 0.4 4.9 0.6 8.7 1.7 0.1 0.8 0.4 2.0 4.0 2.2 35.5 34.2 38.5 57.6 30.2 32.4 41.8 37.2 43.8 37.5 41.1 40.1 18.4 32.1 55.8 2.6 12.7 40.3 127.2 49.0 103.0 11.0 52.6 28.3 12.1 41.5 84.3 12.9 4.2 110.2 8.4 242.2 5.9 13.1 2.4 97.7 30.6 42.7 80.8 54.1 5.1 24.4 109.1 33.2 107.0 131.4 15.2 16.9 12.5 55.7 14.5 3.3 7.7 145.3 34.6 10.5 59.8 2.4 21.8 31.2 35.6 44.0 48.7 3.8 0.0 8.5 5.7 62.1 148.3 87.6 39.2 67.8 123.6 29.2 85.7 3.5 111.7 183.0 185.0 26.3 16.0 158.1 32.4 117.5 9.3 2.9 145.0 186.5 NEU1 NEU ENSG00000204386 "Neuraminidase 1" Q99519 6 31857659-31862905 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 197.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 3.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "GAMG: 5.4;U-266/84: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015634, HPA021506" Approved Supported "Vesicles,Cell Junctions" NA NA 180000 "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Vesicles "Cell Junctions" "HPA015634: AB_1854386, HPA021506: AB_1854385" "unprognostic (3.84e-2)" "unprognostic (7.47e-2)" "unprognostic (9.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-1)" "unprognostic (4.42e-3)" "unprognostic (1.38e-3)" "unprognostic (8.58e-3)" "unprognostic (7.49e-2)" "unprognostic (5.21e-2)" "unprognostic (4.44e-3)" "unprognostic (1.27e-1)" "unprognostic (2.70e-2)" "unprognostic (6.22e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (2.13e-3)" 23.9 57.2 0.7 0.4 0.8 0.0 22.4 2.5 1.2 21.2 1.2 25.1 0.7 19.5 0.0 14.9 16.8 1.0 22.5 0.7 0.6 43.7 29.9 28.9 0.3 0.8 0.5 20.3 35.9 0.3 33.0 0.2 0.8 26.5 0.0 1.6 38.6 0.0 21.3 20.1 24.3 0.1 0.3 25.3 29.8 8.2 1.0 0.0 31.8 0.0 0.0 23.2 16.2 1.7 0.3 0.2 0.8 1.4 1.8 0.4 0.7 0.2 0.2 0.3 0.3 1.5 0.6 0.7 0.4 0.1 5.4 0.3 2.2 0.0 0.4 2.5 0.3 0.6 0.9 1.2 1.4 0.9 1.8 1.0 0.2 1.4 0.7 0.2 0.6 0.9 1.1 1.2 0.5 0.3 0.6 0.0 0.6 0.5 0.4 0.9 0.4 0.9 1.0 0.4 0.7 0.4 0.2 0.3 0.7 0.9 0.9 0.5 0.7 1.1 0.8 0.7 0.6 3.7 9.6 0.9 1.7 0.4 0.4 1.3 0.3 0.4 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.6 0.2 0.3 3.0 0.3 0.2 0.3 0.2 0.1 0.7 0.8 2.5 1.2 0.7 0.6 0.8 0.5 0.8 0.3 1.0 1.7 65.7 25.6 46.3 5.2 57.0 34.3 48.5 45.0 39.9 26.4 87.7 55.8 29.0 51.5 54.8 47.8 25.0 62.8 100.5 83.7 9.8 114.2 0.8 29.3 53.5 42.8 113.5 4.6 6.3 59.6 57.8 73.8 32.6 60.8 67.9 17.4 30.7 34.5 170.9 10.1 7.6 39.9 79.3 63.0 65.9 1.4 27.7 93.0 71.2 9.4 25.8 48.8 9.2 5.0 4.0 34.4 88.1 23.3 81.7 89.0 115.0 59.9 29.2 32.7 26.3 60.8 43.7 5.4 10.0 29.3 41.6 197.0 81.7 40.3 41.1 34.6 NEU3 ENSG00000162139 "Neuraminidase 3" Q9UQ49 11 74988279-75018893 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Spermatocytes: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038729, HPA070381" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Vesicles "HPA038729: AB_2676179, HPA070381: " "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (2.55e-2)" "unprognostic (1.13e-3)" "unprognostic (2.95e-2)" "unprognostic (5.42e-2)" "unprognostic (1.63e-1)" "unprognostic (5.11e-2)" "unprognostic (3.91e-3)" "unprognostic (8.50e-2)" "prognostic favorable (5.98e-4)" "unprognostic (3.57e-3)" "unprognostic (3.80e-2)" "unprognostic (3.79e-1)" "unprognostic (2.38e-1)" "unprognostic (3.73e-1)" "unprognostic (1.84e-1)" 3.2 12.7 8.1 6.4 9.7 23.7 6.5 5.1 10.8 3.8 2.9 4.2 4.3 4.9 5.2 2.6 4.2 4.5 6.2 5.3 5.0 5.1 8.2 5.1 8.3 4.1 4.0 8.0 6.1 10.4 5.7 3.9 5.4 11.5 6.4 10.4 4.2 3.2 26.4 8.0 4.3 4.8 1.1 6.2 4.8 13.9 5.1 12.3 8.1 22.6 7.8 3.5 2.5 7.5 9.1 8.2 6.7 11.7 5.2 4.4 7.1 8.7 5.7 9.4 7.7 24.3 7.2 25.7 8.5 7.2 12.9 8.1 16.1 11.4 14.7 13.2 7.9 21.8 14.4 10.8 5.6 34.7 19.3 5.5 9.4 9.9 15.0 6.5 7.2 37.3 35.1 17.5 11.2 9.7 33.1 16.8 8.0 18.5 10.3 27.0 17.5 22.2 12.8 9.3 12.0 7.2 13.7 8.4 37.0 8.0 18.9 8.2 10.4 11.6 11.7 8.0 9.1 15.5 15.8 51.8 3.6 17.2 9.8 1.2 2.6 2.4 1.5 1.4 1.1 1.0 1.2 1.5 1.5 1.2 1.2 1.5 1.5 0.5 1.8 1.1 0.9 0.9 8.1 9.7 5.1 10.8 5.3 5.0 4.1 4.0 5.4 1.1 5.1 7.5 1.4 3.2 4.6 4.6 5.3 0.5 2.0 0.4 0.6 8.6 3.5 3.9 7.7 2.8 2.7 1.8 62.6 2.1 4.1 1.0 0.0 1.2 9.2 2.2 2.3 2.3 7.2 5.0 12.5 3.1 1.4 2.1 3.1 2.7 1.3 3.7 3.6 6.9 5.4 11.8 10.3 2.9 2.0 10.1 1.1 7.6 1.5 6.2 0.0 8.4 6.8 3.4 3.1 9.5 9.9 2.6 1.0 1.9 5.8 3.0 1.6 3.7 1.6 6.4 0.0 5.8 1.8 32.0 2.2 1.6 0.6 1.4 3.9 3.8 2.8 0.6 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152198-26187137 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7;placenta: 34.4" "Group enriched" "Detected in many" 14 "Cytotrophoblasts: 305.9;Syncytiotrophoblasts: 698.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 133.5;NTERA-2: 113.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 57: Non-specific - Angiogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nucleoplasm, Vesicles" "HPA055889: AB_2682958" "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavorable (7.58e-12)" "prognostic favorable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.6 3.1 4.2 10.6 7.3 2.5 2.2 19.5 19.7 1.5 2.3 6.3 8.0 2.2 0.2 2.4 1.6 4.3 1.4 6.3 4.8 2.5 1.6 4.8 8.0 7.0 4.6 1.1 4.8 0.4 1.3 34.4 7.2 1.4 4.8 5.1 3.2 0.6 2.7 7.3 5.7 1.0 5.1 7.6 7.3 1.4 6.3 5.9 1.0 0.2 7.0 4.8 1.5 10.8 40.9 3.5 1.6 4.0 0.0 0.0 133.5 7.9 15.2 15.0 27.3 26.2 68.8 3.0 51.2 0.8 57.5 8.6 6.0 13.4 33.7 27.9 8.5 5.7 7.0 19.8 10.5 5.0 52.3 1.3 1.6 6.2 2.3 22.4 35.0 11.3 8.6 69.9 3.0 5.5 3.5 8.8 113.9 11.1 13.9 5.0 0.4 20.5 20.5 40.5 12.3 14.7 0.2 3.2 1.2 37.5 1.9 3.0 76.0 1.4 2.3 0.6 32.6 42.0 72.2 3.4 0.2 17.5 53.1 0.0 0.2 0.0 0.1 0.2 0.3 0.2 0.4 0.2 0.6 0.2 0.2 0.1 0.1 0.2 0.0 0.2 0.6 0.1 4.2 7.3 19.5 19.7 6.3 4.8 7.0 4.6 7.2 5.1 6.3 10.8 14.6 6.4 2.8 3.9 4.6 1.8 4.2 12.7 5.2 1.4 3.1 2.3 1.9 14.3 6.9 11.0 0.0 305.9 1.6 6.1 0.0 13.0 1.0 6.1 1.8 7.6 1.2 12.0 3.8 5.3 33.9 2.8 14.3 6.4 27.9 35.2 2.2 0.3 24.3 0.0 4.4 6.6 12.2 15.6 17.2 0.3 0.0 16.7 1.8 2.8 11.1 1.1 4.1 1.5 11.6 15.6 4.1 0.0 18.2 10.4 2.7 0.5 8.9 1.9 0.0 2.9 2.7 0.6 7.1 5.5 1.6 698.6 9.0 4.8 9.8 6.7 NKX2-1 "BCH, NKX2A, TITF1, TTF-1, TTF1" ENSG00000136352 "NK2 homeobox 1" P43699 14 36516392-36521149 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "lung: 53.1;thyroid gland: 172.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 137.8;Alveolar cells type 2: 124.8" "Group enriched" "Detected in some" 39 "lung cancer: 30.9;thyroid cancer: 103.2" "Region enhanced" "Detected in many" "thalamus: 17.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SCLC-21H: 78.7" "Group enriched" "Detected in some" 5 "basal ganglia: 3.2;hypothalamus: 10.2" "Group enriched" "Detected in some" 13 "basal ganglia: 4.3;hypothalamus: 10.4" "CAB000078, CAB053633, HPA074316" Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus, Vesicles" "CAB000078: , CAB053633: AB_442138, HPA074316: " "unprognostic (3.79e-1)" "unprognostic (4.25e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" "unprognostic (1.26e-2)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.83e-2)" "unprognostic (4.18e-1)" 0.0 0.1 1.1 0.0 2.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 10.1 0.0 0.0 53.1 0.0 0.0 0.3 0.1 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 17.8 0.0 172.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 78.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.0 0.0 4.0 0.1 10.1 0.0 0.3 0.0 0.0 17.8 0.1 0.0 137.8 124.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 NLRC4 "CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf" ENSG00000091106 "NLR family CARD domain containing 4" Q9NPP4 2 32224453-32265732 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.3;lung: 6.2;lymphoid tissue: 11.4" "Cell type enhanced" "Detected in some" "Hofbauer cells: 11.9;Kupffer cells: 21.0;Macrophages: 14.5;Microglial cells: 10.3;monocytes: 18.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "classical monocyte: 49.3;intermediate monocyte: 56.9;myeloid DC: 32.2;neutrophil: 24.6;non-classical monocyte: 44.2" "Group enriched" "Detected in many" 32 "dendritic cells: 32.2;granulocytes: 24.6;monocytes: 56.9" "Cell line enhanced" "Detected in some" "HL-60: 3.1" "Not detected" "Not detected" "HPA006592, HPA075894" Uncertain Approved Vesicles,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Vesicles, Cytosol" "HPA006592: AB_2667620, HPA075894: " "unprognostic (7.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.25e-2)" "unprognostic (1.97e-1)" "unprognostic (8.88e-2)" "unprognostic (2.45e-2)" "unprognostic (1.17e-2)" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (6.33e-2)" "unprognostic (6.33e-2)" "unprognostic (6.03e-6)" "unprognostic (7.42e-2)" "unprognostic (2.06e-3)" "unprognostic (2.02e-2)" "unprognostic (1.63e-1)" 3.4 1.4 0.4 8.7 0.5 8.3 0.7 0.4 0.8 0.6 0.6 0.9 0.9 0.4 0.0 0.6 0.8 1.4 1.2 0.4 0.4 0.5 1.6 6.2 2.3 0.6 0.5 0.3 0.8 0.1 0.6 2.1 0.6 0.4 0.8 0.6 0.5 0.2 1.0 0.3 1.3 2.3 0.5 11.4 0.6 0.4 0.9 0.7 0.4 0.3 1.2 2.0 0.3 0.8 0.1 0.2 0.3 0.7 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.3 0.3 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.3 0.5 0.1 0.4 0.0 3.1 0.5 0.0 0.3 0.0 1.4 0.4 0.0 0.1 0.3 0.2 0.0 0.0 0.2 1.4 0.1 0.2 0.2 0.1 0.4 0.5 0.0 0.3 0.3 0.7 0.2 0.2 1.2 0.5 0.1 1.4 0.1 0.3 0.3 0.2 0.4 0.3 0.8 1.2 0.4 1.3 0.4 0.5 49.3 5.8 0.1 56.9 0.4 0.6 0.0 0.0 32.2 1.1 0.0 0.1 24.6 0.3 44.2 0.4 0.2 18.6 0.4 0.5 0.4 0.8 0.4 0.4 0.6 0.5 0.6 0.5 0.9 0.8 0.2 0.0 1.8 1.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 2.7 4.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 1.1 0.0 11.9 0.0 3.3 0.0 0.0 21.0 1.0 0.0 0.0 14.5 0.0 10.3 18.4 0.0 1.0 1.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.0 NLRP5 "CLR19.8, MATER, NALP5, PAN11, PYPAF8" ENSG00000171487 "NLR family pyrin domain containing 5" P59047 19 55999726-56061810 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "parathyroid gland: 22.4" "Cell type enhanced" "Detected in some" "Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "Karpas-707: 1.3;U-2 OS: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047260, HPA056271" Uncertain Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 9: U-2 OS - Unknown function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" Vesicles "HPA047260: , HPA056271: AB_2683083" "unprognostic (9.67e-2)" "unprognostic (2.22e-2)" "unprognostic (5.03e-1)" "unprognostic (7.78e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 22.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NMRK2 "ITGB1BP3, MIBP, NRK2" ENSG00000077009 "Nicotinamide riboside kinase 2" Q9NPI5 19 3933103-3942416 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 116 "heart muscle: 1438.4;skeletal muscle: 634.8;tongue: 722.1" "Cell type enriched" "Detected in some" 36 "Cardiomyocytes: 995.1" "Cancer enhanced" "Detected in some" "renal cancer: 32.8;testis cancer: 13.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 29.2;NTERA-2: 24.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049909, HPA054792, HPA072450" Approved Enhanced Nucleoplasm,Vesicles NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Vesicles "HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522" "unprognostic (3.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.18e-2)" "unprognostic (2.54e-1)" "unprognostic (1.03e-1)" "unprognostic (7.61e-2)" "unprognostic (3.30e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (5.38e-1)" 0.7 1.7 0.2 0.0 0.2 0.0 0.8 0.2 0.8 0.2 0.2 0.5 0.0 0.4 0.1 5.7 0.6 0.0 1438.4 0.2 0.4 1.9 0.3 2.1 0.0 0.3 0.4 0.5 0.6 0.0 1.7 0.1 0.1 2.6 0.1 0.0 8.0 0.8 634.8 0.7 0.5 0.0 0.2 0.1 0.6 0.5 0.2 0.0 0.6 722.1 0.0 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.8 0.2 0.4 0.3 0.4 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 995.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.4 0.0 0.0 0.2 0.0 0.6 26.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 24.6 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 NOS1AP "CAPON, KIAA0464" ENSG00000198929 "Nitric oxide synthase 1 adaptor protein" O75052 1 162069691-162370475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 22.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 204.3;Excitatory neurons: 142.3;Horizontal cells: 67.3;Inhibitory neurons: 107.6;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 82.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.9;HaCaT: 3.1;HEL: 4.6" "Low region specificity" "Detected in all" "CAB018582, HPA030066, HPA055561" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 36: HEL - Hemostasis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851" "unprognostic (7.04e-3)" "unprognostic (2.20e-1)" "unprognostic (1.79e-2)" "unprognostic (3.93e-2)" "unprognostic (1.58e-2)" "unprognostic (4.75e-2)" "unprognostic (2.07e-1)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.71e-1)" "unprognostic (2.15e-5)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (5.08e-3)" 0.4 2.8 16.3 0.1 20.1 1.8 1.2 8.0 16.2 0.6 0.0 1.3 0.6 0.5 0.2 0.7 0.6 0.6 0.8 22.2 2.4 0.9 3.1 0.4 0.0 3.0 2.1 0.2 0.9 0.5 0.8 0.4 0.4 0.7 1.1 3.6 1.5 1.4 0.2 1.1 0.7 0.4 0.0 0.0 1.4 1.8 5.5 0.1 0.1 0.2 0.2 0.6 0.4 21.5 3.9 0.0 1.8 1.1 0.0 0.0 0.2 0.3 0.4 0.5 0.4 0.9 1.0 0.0 2.2 0.1 0.6 3.1 0.6 0.1 0.1 0.1 1.7 4.6 0.6 1.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 1.0 0.6 0.4 0.0 0.1 2.1 0.3 0.0 1.3 0.6 1.5 0.0 0.7 0.1 0.9 1.4 1.4 0.9 0.8 0.1 0.6 0.5 1.1 0.2 0.4 0.0 0.4 0.0 0.6 2.2 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.3 20.1 8.0 16.2 22.2 2.4 3.0 2.1 0.4 0.0 5.5 21.5 4.4 0.0 0.5 5.9 0.4 2.9 6.1 0.7 0.6 11.6 14.1 21.5 2.3 2.8 1.5 22.0 204.3 0.2 0.4 7.9 9.8 1.0 36.8 4.5 3.5 3.6 6.7 2.7 142.3 1.2 0.3 1.3 9.7 7.9 0.0 8.0 3.3 21.2 0.1 67.3 107.6 10.2 0.0 0.8 0.4 12.4 4.4 0.2 0.0 43.1 0.0 13.4 1.0 79.9 82.9 0.7 5.3 7.2 0.1 6.8 3.9 0.6 1.7 3.8 6.6 0.9 1.1 2.0 2.2 2.3 2.0 0.5 0.5 1.9 5.3 7.8 NOSTRIN MGC20702 ENSG00000163072 "Nitric oxide synthase trafficking" Q8IVI9 2 168786539-168865514 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 167.0;Endothelial cells: 129.6;Hepatic stellate cells: 172.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 10.1;HEL: 41.9;K-562: 31.8;OE19: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044384, HPA076885" Approved Approved Vesicles,Cytosol NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol Vesicles "HPA044384: AB_2678922, HPA076885: " "unprognostic (4.74e-2)" "unprognostic (2.42e-1)" "unprognostic (8.73e-2)" "unprognostic (2.27e-1)" "unprognostic (3.15e-3)" "unprognostic (3.02e-6)" "unprognostic (4.89e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-4)" "unprognostic (5.47e-3)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.63e-1)" "unprognostic (1.75e-1)" "unprognostic (2.33e-1)" "unprognostic (6.47e-2)" "unprognostic (4.98e-2)" 32.6 20.4 6.1 4.6 5.8 0.3 31.4 5.0 7.6 17.5 4.2 15.3 14.0 14.9 4.3 5.1 16.4 14.0 16.1 4.9 5.6 32.6 7.3 30.8 4.6 6.6 6.0 10.6 22.6 3.8 3.8 25.4 6.5 13.3 16.4 0.8 48.9 6.8 5.1 7.3 14.3 12.8 5.5 5.5 23.0 14.4 6.6 1.9 13.5 3.6 3.0 8.1 11.3 5.0 0.0 3.6 1.1 0.0 0.0 0.0 10.1 0.4 0.0 0.0 0.0 6.3 6.5 0.1 4.3 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 41.9 1.8 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 31.8 0.0 0.0 0.1 0.1 0.1 0.1 20.5 0.3 0.4 1.9 0.0 3.4 1.6 0.0 0.1 0.2 1.9 0.0 0.2 0.5 0.0 0.0 0.0 0.7 0.2 0.6 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 5.8 5.0 7.6 4.9 5.6 6.6 6.0 6.5 5.5 6.6 5.0 167.0 9.6 10.3 2.0 1.6 1.0 0.6 0.3 0.6 0.1 20.0 11.0 7.1 15.7 3.3 3.7 0.0 18.9 0.4 57.3 13.7 8.0 26.6 16.3 3.3 129.6 11.4 2.7 0.4 21.8 7.0 6.1 41.3 23.2 0.0 72.4 172.5 1.0 1.6 0.0 0.5 35.9 0.0 6.3 0.9 60.9 8.7 1.2 24.9 55.3 0.7 1.6 0.0 2.0 0.0 17.7 53.4 5.7 0.2 3.3 43.1 59.0 1.5 0.3 72.3 1.3 11.3 13.7 1.8 0.4 0.4 26.3 0.9 71.9 20.7 1.2 NOXRED1 "C14orf148, FLJ32809" ENSG00000165555 "NADP dependent oxidoreductase domain containing 1" Q6NXP6 14 77394021-77423517 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 5.9;testis: 6.9" "Group enriched" "Detected in some" 25 "Early spermatids: 137.8;Late spermatids: 125.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA055658, HPA060408" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 34: Spermatids - Unknown function" Vesicles "Plasma membrane" "HPA055658: AB_2682878, HPA060408: " "unprognostic (1.92e-2)" "unprognostic (4.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (2.49e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (2.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.24e-2)" "unprognostic (1.29e-2)" "unprognostic (2.60e-1)" "unprognostic (5.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.07e-3)" 0.2 0.6 0.5 0.1 0.6 0.2 0.5 0.2 0.5 0.2 1.7 0.5 0.5 0.5 0.5 0.3 0.5 0.6 0.1 0.5 0.6 0.5 0.3 0.3 0.6 0.8 1.0 0.3 0.4 0.2 0.7 0.3 0.7 0.3 0.5 5.9 0.2 0.4 0.1 1.1 0.3 0.4 0.9 0.5 0.2 6.9 0.5 0.5 0.9 0.0 0.4 0.2 0.2 0.7 0.3 0.7 0.3 0.4 0.1 0.7 0.5 0.3 0.5 0.3 0.2 0.4 0.3 0.7 0.1 0.6 0.1 0.2 0.1 0.1 0.4 0.3 0.2 0.4 0.0 0.7 0.2 0.1 0.6 0.4 0.9 0.3 0.5 0.4 0.2 0.8 0.1 0.5 0.1 0.8 0.2 0.2 0.0 0.2 0.6 0.2 0.1 0.0 0.3 0.1 0.7 0.5 0.4 0.1 0.1 0.7 0.7 0.4 0.9 0.2 0.2 0.4 0.1 0.7 0.7 0.4 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.2 0.5 0.5 0.6 0.8 1.0 0.7 0.9 0.5 0.7 0.2 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 4.2 0.0 0.0 0.3 0.0 0.0 137.8 0.6 0.1 0.2 1.8 0.0 4.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 3.0 0.0 0.0 0.3 0.2 125.8 0.9 0.3 0.0 0.0 0.0 0.4 0.0 3.0 4.4 0.1 0.0 1.2 0.1 0.1 0.3 0.1 0.2 1.5 0.0 0.0 0.1 4.1 2.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586506 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease variant, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 110.6" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 70.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 273.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 17.5 76.7 35.1 16.9 69.6 42.6 20.0 55.3 47.8 16.7 28.6 13.7 14.5 16.7 15.0 20.5 13.4 15.3 11.5 41.1 44.3 16.8 15.2 29.0 20.4 73.3 55.8 16.0 11.9 72.6 15.0 27.8 66.6 13.1 12.0 28.0 36.8 13.2 22.9 24.3 17.8 15.1 49.8 17.1 20.4 13.7 55.8 12.2 11.8 14.1 15.6 15.8 18.0 110.6 21.5 41.4 17.8 29.3 55.8 44.6 40.7 37.3 81.1 38.8 84.3 28.1 30.7 18.4 28.0 55.0 132.8 59.3 22.6 63.2 35.2 15.0 17.9 6.8 35.7 63.2 79.2 25.0 28.5 42.2 61.3 81.7 273.2 76.8 40.3 20.7 20.1 47.5 44.2 32.4 10.6 14.9 12.5 24.4 37.3 15.3 28.1 45.0 88.8 51.9 7.5 14.5 44.6 62.0 54.3 27.7 15.9 19.5 50.0 81.1 15.3 32.4 32.3 29.7 97.1 12.2 177.7 21.8 37.1 4.4 9.0 8.8 29.7 8.7 20.5 5.0 12.4 20.7 4.0 6.7 5.5 15.0 7.9 10.5 13.8 70.9 17.4 10.6 35.1 69.6 55.3 47.8 41.1 44.3 73.3 55.8 66.6 49.8 55.8 110.6 18.4 25.6 56.1 32.7 9.6 9.3 34.1 16.5 8.0 6.7 10.5 9.4 4.4 11.5 21.8 9.2 18.8 15.1 61.0 24.8 0.0 11.2 1.2 23.3 12.2 16.4 3.6 2.5 23.8 15.1 7.8 13.0 15.3 53.9 10.8 31.6 6.8 9.8 28.9 3.3 20.2 7.3 2.0 11.9 6.5 1.5 9.0 21.0 12.4 59.0 7.2 15.1 25.7 39.2 182.0 34.4 22.6 10.5 15.6 41.5 8.3 5.4 10.0 12.7 0.0 10.3 14.4 13.9 25.1 17.6 14.5 23.8 19.1 52.4 7.6 64.0 NPL "C1orf13, DHDPS1, NPL1" ENSG00000135838 "N-acetylneuraminate pyruvate lyase" Q9BXD5 1 182789293-182830384 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 52.3;placenta: 45.2" "Cell type enhanced" "Detected in many" "Astrocytes: 170.1;Cytotrophoblasts: 123.1;Hofbauer cells: 481.5;Kupffer cells: 148.8;Microglial cells: 125.5;Proximal tubular cells: 141.0;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 423.2" "Group enriched" "Detected in many" 34 "granulocytes: 423.2;monocytes: 128.4" "Cell line enhanced" "Detected in many" "HEL: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028345, HPA075808" Enhanced Approved "Vesicles,Plasma membrane" NA NA 190000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "Plasma membrane" "HPA028345: AB_10610145, HPA075808: " "unprognostic (2.43e-2)" "unprognostic (5.71e-3)" "unprognostic (1.72e-2)" "unprognostic (1.06e-1)" "unprognostic (1.57e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (4.41e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.49e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.93e-2)" "unprognostic (2.35e-2)" "unprognostic (7.44e-2)" 12.7 5.8 16.7 19.2 20.8 18.9 5.5 19.3 22.9 4.3 11.1 6.9 2.8 1.7 29.9 10.0 3.3 13.0 2.6 12.7 15.6 52.3 20.8 14.5 32.5 19.6 20.1 1.4 2.8 3.3 1.7 45.2 18.9 2.3 9.1 1.9 4.2 6.2 1.7 8.4 4.4 7.5 15.8 28.7 5.0 5.1 27.0 6.2 2.6 2.8 14.7 15.5 5.1 22.0 3.4 0.6 1.0 0.0 2.8 2.8 0.9 1.1 2.1 1.2 0.6 0.0 1.4 9.0 1.5 0.0 0.0 1.3 1.9 2.4 0.3 0.0 1.5 14.2 0.4 0.1 1.5 5.4 8.1 2.2 9.1 0.2 0.0 0.1 0.1 10.1 10.9 13.8 2.1 1.1 0.3 3.5 11.0 7.0 1.1 1.4 0.7 11.0 0.2 7.4 3.1 4.6 5.0 0.3 4.7 1.1 2.9 8.7 0.2 1.1 2.4 0.7 0.1 9.8 12.7 9.0 2.4 9.5 3.6 25.5 128.4 104.1 5.5 118.2 4.8 1.8 4.5 4.9 7.6 6.3 3.5 4.9 423.2 0.3 96.6 1.5 8.1 65.4 16.7 20.8 19.3 22.9 12.7 15.6 19.6 20.1 18.9 15.8 27.0 22.0 2.9 0.0 5.5 170.1 4.9 6.1 4.0 8.6 1.8 7.6 1.5 4.4 2.9 2.8 4.8 7.3 2.1 123.1 2.2 2.3 19.6 1.2 19.1 0.4 0.6 3.5 1.8 45.5 7.5 2.4 6.1 2.5 3.1 0.2 5.7 0.5 72.8 3.9 481.5 6.7 13.5 1.4 6.1 148.8 11.5 27.0 0.9 91.7 10.6 125.5 40.1 2.8 5.2 22.1 21.0 1.3 0.3 0.4 0.7 1.6 0.9 141.0 1.7 2.8 0.0 1.7 1.7 16.5 8.9 16.5 7.1 107.4 3.1 3.4 1.6 4.3 NPPB ENSG00000120937 "Natriuretic peptide B" P16860 1 11857464-11858945 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 767 "heart muscle: 5154.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 351.7;Ductal cells: 266.6;Pancreatic endocrine cells: 86.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Group enriched" "Detected in some" 4 "basal ganglia: 3.4;cerebral cortex: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 135.5;CACO-2: 362.2;SuSa: 67.7" "Region enhanced" "Detected in single" "pons and medulla: 1.4" HPA077324 Approved Vesicles,Cytosol "Secreted to blood" NA NA 9680 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Vesicles Cytosol "HPA077324: " "unprognostic (3.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (4.23e-1)" "unprognostic (3.28e-2)" 1.0 0.3 0.3 0.1 3.4 0.0 0.7 0.4 1.8 0.3 0.1 0.3 0.0 0.3 0.3 0.2 0.0 0.6 5154.6 0.3 0.3 0.3 0.5 6.7 0.9 0.3 0.4 0.8 4.0 0.1 0.5 0.8 0.3 0.5 0.0 0.1 1.2 0.0 0.8 0.5 0.4 0.0 0.6 0.1 0.7 0.8 0.5 0.1 0.5 0.0 0.0 0.2 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 135.5 0.3 0.0 2.1 1.1 362.2 0.0 0.0 0.1 0.1 0.3 3.8 0.1 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 67.7 0.0 0.0 0.0 0.0 32.0 0.2 0.2 0.0 0.1 0.0 0.1 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.4 1.8 0.3 0.3 0.3 0.4 0.3 0.6 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 351.7 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 266.6 0.1 0.8 0.1 4.9 0.0 0.0 0.2 8.3 2.2 11.7 0.0 1.4 0.0 0.2 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.2 0.0 0.0 0.0 86.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 17.6 5.8 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.1 NR0B2 SHP ENSG00000131910 "Nuclear receptor subfamily 0 group B member 2" Q15466 1 26911489-26913975 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Receptor, Repressor" "Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.9;liver: 142.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 97.2;Distal tubular cells: 52.8;Exocrine glandular cells: 42.4;Gastric mucus-secreting cells: 90.2;Hepatocytes: 173.4;Proximal enterocytes: 49.8" "Cancer enriched" "Detected in many" 5 "liver cancer: 52.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 33 "Hep G2: 78.2" "Region enriched" "Detected in single" 6 "cerebellum: 1.7" "Not detected" "Not detected" HPA003983 Supported Nucleoplasm,Vesicles NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" Nucleoplasm Vesicles "HPA003983: " "unprognostic (2.99e-2)" "unprognostic (1.86e-1)" "unprognostic (1.95e-3)" "unprognostic (4.68e-3)" "unprognostic (9.21e-2)" "unprognostic (8.22e-2)" "unprognostic (3.97e-2)" "unprognostic (2.44e-2)" "unprognostic (1.83e-1)" "unprognostic (3.09e-1)" "unprognostic (2.11e-2)" "unprognostic (6.74e-3)" "unprognostic (1.04e-1)" "unprognostic (2.03e-1)" "unprognostic (4.12e-3)" "unprognostic (1.10e-2)" 0.0 21.4 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.5 76.9 0.0 0.0 0.0 0.0 10.1 12.9 0.0 0.0 33.8 142.4 2.4 0.0 0.0 0.0 0.0 30.6 1.6 0.3 0.0 0.1 0.0 0.4 0.2 0.0 0.0 2.7 0.0 26.5 0.0 0.0 11.5 26.4 1.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 78.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.3 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 15.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 8.4 97.2 0.7 12.9 0.0 0.0 0.0 0.9 52.8 31.3 0.4 0.1 0.0 0.2 24.4 8.0 0.0 42.4 0.0 0.3 90.2 0.0 0.0 3.0 2.5 173.4 0.1 28.6 0.0 7.6 16.2 3.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.2 0.3 0.0 0.2 0.0 49.8 0.1 0.0 0.4 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.3 0.1 11.0 0.2 NR1H2 "LXR-b, LXRb, NER, NER-I, RIP15, UNR" ENSG00000131408 "Nuclear receptor subfamily 1 group H member 2" P55055 19 50329653-50383388 "Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005446, HPA056838, HPA070212" Uncertain Enhanced Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Vesicles "HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234" "unprognostic (1.31e-1)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (1.34e-3)" "unprognostic (1.68e-1)" "unprognostic (5.24e-3)" "unprognostic (2.26e-2)" "unprognostic (9.69e-2)" "unprognostic (6.45e-2)" "unprognostic (5.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.88e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (5.12e-2)" "unprognostic (1.69e-3)" 59.6 61.4 43.2 37.1 45.6 143.4 57.9 43.1 53.3 61.1 41.3 78.7 43.1 67.3 10.8 56.0 63.6 28.4 89.6 40.7 45.0 63.9 61.0 66.4 33.9 55.8 47.3 56.9 49.8 32.1 40.6 26.3 48.5 63.7 11.9 9.4 46.9 37.9 132.1 60.7 55.1 20.3 44.4 56.7 60.2 31.8 48.4 21.4 56.5 36.7 16.7 77.1 58.3 47.8 56.2 124.1 12.1 32.4 34.5 36.4 42.0 75.8 53.4 38.4 41.7 25.8 48.9 34.8 67.1 39.4 31.7 46.8 7.8 34.1 9.5 89.9 57.6 32.5 41.8 26.4 63.7 58.2 84.0 34.8 45.2 39.3 27.3 37.7 33.4 24.7 51.7 65.4 20.8 53.2 39.3 40.5 25.5 32.2 94.4 22.8 35.8 57.2 30.4 54.3 14.9 50.6 50.9 54.0 46.7 6.6 37.9 42.5 53.9 54.3 45.3 58.4 66.8 82.5 79.3 26.4 108.6 36.5 53.8 159.1 123.9 232.4 90.4 125.4 89.3 112.3 89.9 86.2 121.3 117.7 90.8 81.4 194.8 85.9 146.4 103.9 89.0 129.3 43.2 45.6 43.1 53.3 40.7 45.0 55.8 47.3 48.5 44.4 48.4 47.8 50.7 28.9 30.7 3.6 70.7 43.0 89.3 53.2 32.5 37.9 33.4 27.3 29.6 37.1 31.1 31.3 14.6 64.5 57.0 82.1 64.6 63.6 15.5 31.9 19.5 50.0 20.8 58.9 5.9 72.6 53.3 40.2 37.2 33.8 50.2 25.1 36.8 20.7 51.3 37.0 5.5 45.5 46.8 37.0 48.3 9.5 45.4 54.5 60.5 4.7 65.2 46.8 65.9 0.5 6.9 74.3 89.6 53.4 47.5 91.0 93.5 61.8 21.7 25.4 39.5 45.5 50.2 34.6 25.9 27.9 45.7 140.0 54.8 27.7 35.7 109.0 NSMCE1 NSE1 ENSG00000169189 "NSE1 homolog, SMC5-SMC6 complex component" Q8WV22 16 27224994-27268772 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "granulocytes: 275.5;Late spermatids: 420.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041567, HPA043091" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA041567: AB_10964260, HPA043091: AB_10962722" "unprognostic (6.27e-2)" "unprognostic (8.17e-2)" "unprognostic (2.52e-2)" "unprognostic (2.48e-3)" "unprognostic (4.17e-1)" "unprognostic (4.52e-3)" "unprognostic (1.59e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.91e-2)" "unprognostic (1.40e-1)" "unprognostic (5.45e-3)" "unprognostic (3.58e-1)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 43.8 68.3 58.8 32.2 61.7 35.1 52.5 65.2 71.7 43.3 66.0 53.1 25.3 42.3 55.0 45.5 62.2 35.8 47.6 57.4 63.3 58.3 55.9 42.4 54.5 65.5 61.4 45.0 59.3 86.1 37.3 37.3 64.6 57.4 36.8 24.9 46.2 51.7 45.2 40.7 37.0 45.2 64.0 33.5 51.3 79.8 61.3 56.4 53.0 44.9 54.7 51.4 39.1 67.0 56.5 80.6 53.8 58.6 85.8 114.2 43.1 58.9 60.4 44.5 46.1 62.7 134.1 110.0 137.7 91.1 45.7 59.5 101.9 178.6 57.3 136.3 70.6 51.0 68.6 122.1 149.1 59.9 37.4 112.6 122.3 111.7 211.5 127.8 60.3 104.3 69.6 33.8 82.9 96.7 80.0 67.5 46.8 94.0 54.7 69.1 65.8 174.7 129.9 36.3 56.4 51.0 40.2 55.9 104.3 65.1 92.3 71.9 37.8 53.3 33.2 61.1 57.8 101.0 78.1 85.9 114.0 59.4 23.3 125.3 91.2 86.2 78.9 81.6 86.3 84.2 111.1 95.7 128.4 133.1 126.7 99.7 29.6 213.8 81.5 124.6 113.0 120.3 58.8 61.7 65.2 71.7 57.4 63.3 65.5 61.4 64.6 64.0 61.3 67.0 34.8 35.3 36.4 8.5 38.1 28.3 57.6 110.7 33.0 14.9 60.7 83.8 49.6 62.9 58.5 44.1 2.1 126.2 41.2 45.6 129.1 79.2 209.9 40.3 32.9 33.9 58.7 24.0 5.4 73.0 63.3 44.5 17.3 29.6 275.5 37.4 52.8 64.0 83.2 13.5 6.7 65.8 44.7 53.3 45.6 420.8 24.2 39.5 46.2 12.2 98.1 64.7 43.3 12.5 14.8 40.1 45.7 39.9 28.1 49.0 83.9 173.8 94.6 18.8 26.3 58.1 50.1 119.0 39.4 43.5 32.7 64.3 55.3 39.9 46.7 48.3 NTAQ1 "C8orf32, FLJ10204, WDYHV1" ENSG00000156795 "N-terminal glutamine amidase 1" Q96HA8 8 123416726-123470028 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Cardiomyocytes: 21.9;Cytotrophoblasts: 13.9;Extravillous trophoblasts: 23.0;Hofbauer cells: 13.2;Syncytiotrophoblasts: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024823, HPA053680" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "HPA024823: AB_1845773, HPA053680: AB_2682228" "unprognostic (9.97e-2)" "unprognostic (4.82e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (4.93e-5)" "unprognostic (1.69e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (1.19e-1)" "unprognostic (5.79e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "unprognostic (5.39e-2)" "unprognostic (7.46e-2)" "unprognostic (2.37e-1)" 7.1 10.9 16.2 5.1 16.7 5.9 13.5 16.3 24.0 12.8 15.5 7.5 4.3 8.1 8.9 6.9 7.5 6.7 20.1 14.8 17.8 13.0 6.8 6.8 7.4 17.0 17.9 18.2 9.6 11.0 10.5 6.8 17.4 10.2 7.9 14.9 6.9 8.8 16.0 7.7 4.4 9.5 15.8 5.2 8.5 12.7 20.0 7.1 12.8 17.6 10.1 8.8 7.2 17.7 26.6 26.9 39.2 18.1 15.3 40.9 14.5 19.1 21.3 23.4 26.1 15.8 17.8 19.7 19.8 23.8 32.7 12.8 25.8 29.7 31.4 53.1 15.8 25.6 13.2 22.4 21.2 12.7 10.9 24.1 16.0 29.3 32.8 27.1 22.6 41.2 18.8 29.0 33.5 84.3 30.2 14.4 12.3 65.6 20.5 13.5 20.0 20.4 31.1 22.6 18.6 34.1 20.7 109.0 35.8 44.5 17.6 12.2 9.8 26.5 46.2 19.7 26.4 17.4 38.1 24.1 18.8 14.1 19.1 16.3 5.7 2.1 6.2 8.7 7.4 5.0 7.3 7.7 9.0 4.1 6.2 6.9 1.5 16.0 3.8 5.2 10.6 4.6 16.2 16.7 16.3 24.0 14.8 17.8 17.0 17.9 17.4 15.8 20.0 17.7 5.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 13.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 23.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 10.0 0.3 0.0 0.0 0.0 NTRK1 "MTC, TRK, TRKA" ENSG00000198400 "Neurotrophic receptor tyrosine kinase 1" P04629 1 156815640-156881850 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 7.0;brain: 21.7" "Group enriched" "Detected in some" 10 "Bipolar cells: 22.8;granulocytes: 55.9;Horizontal cells: 57.2" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Group enriched" "Detected in many" 6 "cerebral cortex: 7.6;medulla oblongata: 19.8;pons: 21.7" "Immune cell enriched" "Detected in single" 116 "basophil: 94.5" "Lineage enriched" "Detected in single" 768 "granulocytes: 94.5" "Cell line enriched" "Detected in some" 4 "HMC-1: 82.1" "Region enhanced" "Detected in many" "basal ganglia: 8.4" "Region enriched" "Detected in single" 6 "basal ganglia: 4.1" "CAB004606, HPA035799, HPA076570" Approved Approved Vesicles,Cytosol NA NA 79000 "Cluster 38: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 62: Horizontal cells - Visual perception" "Vesicles, Cytosol" "CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: " "unprognostic (5.89e-3)" "unprognostic (7.56e-2)" "unprognostic (2.74e-2)" "unprognostic (5.99e-3)" "unprognostic (7.26e-2)" "unprognostic (1.43e-3)" "unprognostic (1.56e-1)" "unprognostic (7.42e-3)" "unprognostic (7.63e-2)" "unprognostic (1.35e-1)" "unprognostic (6.73e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-11)" "unprognostic (2.18e-3)" "unprognostic (3.79e-2)" "unprognostic (1.07e-1)" "unprognostic (4.89e-1)" 0.8 7.0 0.7 0.4 1.8 0.7 0.2 1.8 7.6 0.7 0.7 0.8 0.5 1.0 0.0 0.1 0.5 0.4 1.0 0.3 2.8 3.0 0.0 0.5 0.1 19.8 1.5 0.1 0.2 0.0 0.7 0.2 21.7 1.4 0.0 1.9 0.5 0.3 0.4 0.1 0.3 0.6 0.2 0.1 0.5 1.6 0.4 0.3 0.2 0.2 0.0 0.3 0.5 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 0.0 11.9 0.0 14.0 0.0 0.0 0.0 0.0 82.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 1.6 0.0 0.2 0.0 2.4 0.2 0.0 1.5 2.5 0.0 0.2 0.0 0.5 1.5 18.2 0.0 0.1 0.0 0.3 0.0 0.1 0.3 0.0 1.1 0.0 0.0 3.5 0.6 0.0 0.0 0.0 0.1 94.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.7 1.8 1.8 7.6 0.3 2.8 19.8 1.5 21.7 0.2 0.4 0.6 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 4.2 0.7 0.0 0.0 4.3 0.0 0.1 55.9 0.0 0.0 0.0 0.1 57.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.9 3.2 2.7 0.0 0.1 0.0 1.0 0.1 0.0 0.0 NUS1 "C6orf68, MGC7199, NgBR, TANGO14" ENSG00000153989 "NUS1 dehydrodolichyl diphosphate synthase subunit" Q96E22 6 117675469-117710727 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Angiogenesis, Differentiation, Lipid metabolism" "Developmental protein, Receptor, Transferase" "Congenital disorder of glycosylation, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027504 Supported Approved "Vesicles,Plasma membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "Plasma membrane" "HPA027504: AB_10603124" "unprognostic (1.21e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (1.09e-2)" "unprognostic (2.31e-1)" "unprognostic (1.21e-1)" "unprognostic (8.26e-3)" "unprognostic (1.42e-3)" "unprognostic (2.42e-2)" "unprognostic (8.62e-2)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (8.35e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-1)" "unprognostic (3.22e-2)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" 17.8 20.0 12.1 22.2 13.0 19.4 22.2 11.4 15.5 60.3 16.1 19.8 16.5 20.6 28.4 15.7 18.4 16.1 11.7 12.9 13.8 28.4 31.6 18.2 21.4 10.8 12.5 16.5 20.4 29.8 11.9 21.6 11.9 20.6 20.3 12.5 30.5 17.6 10.0 11.1 17.6 18.7 11.7 17.8 24.2 12.6 13.5 18.5 35.4 12.6 20.6 23.5 11.7 12.4 27.1 19.5 41.3 46.4 40.7 52.9 101.0 48.3 50.1 39.5 45.1 44.6 29.5 63.4 51.1 44.7 50.0 24.0 62.1 47.2 73.0 47.9 57.0 72.8 31.5 80.2 62.6 92.8 41.2 46.6 52.5 43.3 87.7 40.3 41.3 46.5 88.4 54.9 59.7 30.5 43.9 58.8 48.0 36.9 35.3 41.7 29.7 45.7 79.0 26.6 48.7 38.5 29.1 37.4 36.9 45.6 23.8 95.9 36.4 24.3 30.1 39.2 70.5 75.6 60.8 66.8 57.6 70.0 49.7 1.9 1.3 0.8 1.3 1.4 1.9 1.1 1.6 1.8 1.5 1.0 1.3 1.7 0.1 1.9 2.5 3.8 1.7 1.0 12.1 13.0 11.4 15.5 12.9 13.8 10.8 12.5 11.9 11.7 13.5 12.4 18.7 0.0 22.3 30.3 28.5 60.5 41.9 32.6 19.4 15.3 26.6 13.7 6.3 15.7 24.0 25.8 10.4 26.8 38.1 26.4 27.4 23.4 16.0 15.7 28.9 24.3 13.1 19.1 33.4 30.2 63.6 22.8 38.2 21.4 31.1 15.8 28.2 39.7 35.3 15.2 37.1 29.3 20.3 37.0 42.2 14.0 18.0 30.2 32.0 20.6 28.4 8.3 24.7 35.7 36.5 37.4 22.7 20.3 57.5 73.1 18.6 33.6 23.1 9.6 6.6 21.3 25.9 24.9 25.4 25.7 56.1 57.9 26.2 14.5 26.1 77.5 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101828231 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.2;tongue: 50.5" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 177.7;Plasma cells: 59.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 92.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 12000 "Cluster 20: T-cells - T-cell receptor" "Cluster 80: Striated muscle - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 7.8 6.4 13.6 11.7 23.2 12.5 6.0 20.1 18.7 7.6 1.3 5.3 3.5 8.1 3.3 6.1 7.4 6.5 18.4 12.4 21.0 3.3 3.5 9.4 16.7 21.6 21.3 7.1 2.5 20.7 6.8 6.7 24.2 8.3 4.6 11.3 3.5 9.8 73.2 2.0 5.0 10.6 16.5 12.5 5.0 7.4 23.7 13.1 5.9 50.5 14.2 7.2 4.5 34.8 19.8 29.9 25.1 9.2 26.6 26.9 5.7 21.7 27.2 25.4 36.6 7.0 2.0 29.3 62.6 24.4 30.4 4.1 28.3 23.2 31.2 36.7 8.9 22.7 19.0 19.3 35.0 19.4 19.9 15.6 3.9 21.1 7.8 33.1 27.8 27.3 4.7 92.0 42.5 10.6 26.2 4.6 14.6 1.0 18.6 11.5 30.7 12.7 18.8 5.1 19.6 23.4 9.3 2.2 16.7 14.9 4.3 27.2 24.5 28.0 33.7 3.3 23.0 43.0 47.5 34.0 23.9 83.7 5.4 8.0 16.5 20.1 14.6 13.0 10.0 10.8 16.0 15.2 14.2 6.4 21.6 17.6 8.6 8.9 12.7 8.8 20.8 14.1 13.6 23.2 20.1 18.7 12.4 21.0 21.6 21.3 24.2 16.5 23.7 34.8 24.1 25.6 5.1 11.4 19.2 3.7 2.2 2.3 6.2 26.1 9.8 9.0 49.4 4.3 2.3 0.0 8.4 0.7 12.8 1.0 0.0 2.6 1.4 2.9 11.8 17.2 7.2 0.0 34.1 2.6 1.6 10.0 1.5 1.9 13.3 46.0 40.4 1.8 6.8 48.8 35.2 0.6 4.1 19.1 10.0 1.8 9.3 11.0 7.2 9.4 26.3 22.7 23.7 44.2 177.7 2.9 0.1 7.5 59.6 1.0 0.8 0.8 3.1 17.1 19.7 14.9 8.3 11.8 15.1 3.8 3.0 0.7 16.2 20.0 0.9 1.1 NXPH3 NPH3 ENSG00000182575 "Neurexophilin 3" O95157 17 49575871-49583827 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4" "Cell type enhanced" "Detected in some" "Astrocytes: 14.0;Bipolar cells: 23.3;Fibroblasts: 7.6;Muller glia cells: 8.5;Peritubular cells: 14.3;Smooth muscle cells: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 11.4;BJ: 3.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 41.1" HPA073819 Approved "Vesicles,Mitotic spindle" "Secreted in brain" Yes NA "Cluster 21: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" Vesicles "Mitotic spindle" "HPA073819: " "unprognostic (2.39e-2)" "unprognostic (4.75e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-1)" "unprognostic (1.92e-1)" "unprognostic (3.30e-1)" "unprognostic (1.97e-1)" "unprognostic (8.01e-2)" "unprognostic (4.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-2)" "unprognostic (6.33e-2)" "unprognostic (4.62e-4)" "unprognostic (2.59e-2)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (5.05e-3)" 3.9 0.9 1.8 1.0 1.8 0.0 2.9 16.4 3.5 9.0 0.7 11.0 0.4 12.0 0.6 1.5 7.0 1.7 2.9 3.5 0.5 0.4 0.1 2.7 0.5 6.3 3.8 5.2 0.6 1.3 7.5 1.3 6.4 5.9 0.3 0.6 3.1 4.7 1.2 2.3 1.7 2.5 0.1 1.0 3.4 1.6 3.9 0.3 1.4 2.0 0.3 8.9 6.9 3.0 0.0 0.0 0.1 0.0 0.0 0.2 11.4 3.2 0.4 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.6 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.8 16.4 3.5 3.5 0.5 6.3 3.8 6.4 0.1 3.9 3.0 0.5 0.0 1.3 14.0 0.0 0.4 0.3 0.2 0.6 23.3 0.9 0.5 1.7 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 2.5 0.2 3.2 7.6 0.0 0.5 0.0 0.0 6.4 0.0 0.2 0.0 1.5 0.0 0.0 0.3 1.4 0.0 4.4 0.3 1.8 0.0 4.2 8.5 0.0 2.5 0.5 0.0 0.0 14.3 0.7 0.3 0.0 0.0 0.0 1.2 0.0 0.8 8.9 0.1 1.3 0.0 1.1 0.1 0.2 0.1 0.0 0.1 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.5;pituitary gland: 22.0" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Bipolar cells: 6.2;Excitatory neurons: 11.1;Granulosa cells: 5.6;Horizontal cells: 13.5;Inhibitory neurons: 10.3" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.8;HUVEC TERT2: 3.9;SH-SY5Y: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Golgi apparatus" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 2.1 2.5 6.4 0.3 8.4 0.1 1.6 0.0 22.5 2.9 0.0 1.3 0.2 4.6 0.0 1.1 2.2 0.2 0.7 11.4 2.9 1.9 0.4 0.3 0.1 6.6 0.6 5.3 0.9 0.0 22.0 0.3 6.8 2.0 0.1 1.9 0.9 0.9 0.1 1.4 0.8 0.5 0.0 0.8 0.8 9.1 2.0 0.1 0.7 0.1 0.0 0.6 2.0 8.2 0.0 1.1 3.0 1.4 2.0 1.2 0.2 0.1 1.0 0.1 0.4 0.4 0.2 0.0 1.0 0.3 7.8 0.1 0.6 0.1 0.0 1.4 0.2 0.1 0.3 0.2 1.4 0.0 0.8 1.3 0.0 0.4 0.5 0.3 3.9 0.2 0.5 0.1 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 9.4 0.3 0.2 1.0 1.1 0.1 0.0 1.4 0.0 1.9 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.4 0.0 22.5 11.4 2.9 6.6 0.6 6.8 0.0 2.0 8.2 3.2 0.0 0.0 9.4 0.0 0.1 0.2 0.1 0.6 6.2 0.3 1.9 1.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.2 0.4 1.4 0.0 0.8 11.1 0.0 0.0 0.9 0.0 0.4 0.0 5.6 0.7 0.0 0.1 13.5 10.3 0.1 0.0 0.0 0.7 0.7 2.5 0.1 0.0 2.8 0.0 3.3 0.0 2.5 0.6 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.5 0.7 1.3 2.6 0.2 0.1 0.0 0.1 0.8 0.0 0.0 OAZ1 "AZ1, AZI, MGC138338, OAZ" ENSG00000104904 "Ornithine decarboxylase antizyme 1" P54368 19 2269509-2273490 "Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009291 Uncertain Approved "Vesicles,Centriolar satellite" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 43: THP-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "Centriolar satellite" "HPA009291: AB_1079519" "unprognostic (2.37e-1)" "unprognostic (9.69e-3)" "unprognostic (1.72e-1)" "unprognostic (6.04e-3)" "unprognostic (9.41e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (3.75e-2)" "unprognostic (3.19e-2)" "unprognostic (6.22e-2)" "prognostic favorable (4.10e-5)" "unprognostic (3.58e-2)" "unprognostic (2.40e-1)" "unprognostic (8.37e-2)" "unprognostic (1.72e-1)" "unprognostic (2.44e-2)" "unprognostic (6.01e-2)" 201.8 252.4 114.7 170.0 125.3 330.3 177.6 107.3 189.7 143.2 111.9 204.3 161.5 134.3 91.4 167.2 151.5 109.0 289.8 132.7 121.1 203.4 172.7 194.2 244.7 119.7 122.1 139.9 209.8 46.5 173.4 134.2 117.0 150.9 77.8 36.4 226.8 89.2 525.6 177.4 197.7 85.1 116.0 294.9 188.3 67.5 120.1 68.0 144.6 123.4 138.3 170.7 152.7 113.9 577.1 117.7 88.3 152.7 181.1 287.5 228.9 400.4 275.4 197.9 269.7 169.5 181.2 389.7 210.6 187.6 78.3 163.1 87.7 120.8 129.6 523.1 303.3 301.2 108.7 267.3 184.6 425.7 456.4 192.6 207.3 74.8 112.7 177.8 227.4 141.3 297.8 439.1 226.1 210.8 357.1 442.7 291.5 83.5 210.7 291.3 176.1 519.0 184.3 164.0 207.9 220.2 264.0 236.7 464.8 70.6 198.4 890.0 293.1 140.2 173.9 610.5 427.8 423.8 188.0 468.9 636.6 660.5 217.3 1887.3 1649.6 1940.9 466.4 1685.5 469.7 962.1 506.3 502.1 1155.4 941.6 464.3 466.0 2063.4 366.1 2039.6 778.3 779.9 2803.0 114.7 125.3 107.3 189.7 132.7 121.1 119.7 122.1 117.0 116.0 120.1 113.9 492.6 365.4 510.0 54.5 1096.3 1476.0 1102.4 828.6 715.9 325.4 748.2 626.1 746.8 579.0 543.0 294.3 106.3 1065.2 1149.3 1018.3 1230.6 1043.4 95.1 452.9 335.6 591.2 613.7 1446.6 85.6 1018.2 1605.0 711.4 305.3 325.4 713.5 385.8 529.0 773.2 2248.7 222.1 78.6 816.9 547.3 2400.4 2984.5 286.7 558.6 2391.4 1136.6 60.0 2929.3 362.0 1001.1 46.3 62.2 1071.2 1388.3 477.3 1143.0 1314.8 1700.6 1540.0 553.2 285.5 460.2 487.9 821.8 251.8 256.5 751.8 1283.3 1683.5 911.1 666.9 733.6 1692.6 ODF2 "CT134, ODF84" ENSG00000136811 "Outer dense fiber of sperm tails 2" Q5BJF6 9 128455186-128501292 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 317.6" "Cell type enriched" "Detected in all" 4 "Late spermatids: 8228.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001874, HPA048841" Enhanced Supported Vesicles,Centrosome NA NA "Cluster 44: Non-specific - Transcription" "Cluster 83: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" Centrosome Vesicles "HPA001874: AB_1079522, HPA048841: AB_2680536" "unprognostic (4.54e-3)" "unprognostic (9.91e-2)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (6.11e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.88e-1)" "unprognostic (1.79e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.93e-2)" "unprognostic (9.23e-3)" "unprognostic (1.47e-1)" "unprognostic (1.62e-1)" "unprognostic (7.65e-2)" 14.3 11.8 9.6 22.1 9.8 31.1 14.2 17.9 13.5 20.4 40.1 15.7 10.3 21.9 11.0 12.4 22.6 13.2 14.4 11.1 10.7 14.1 16.4 14.4 25.6 13.4 16.1 15.1 13.2 15.3 30.8 15.9 11.6 16.1 15.1 14.9 12.9 14.7 8.9 19.3 13.7 20.5 9.7 20.5 13.7 317.6 11.7 34.8 13.2 5.3 26.6 17.0 14.4 9.9 44.2 52.2 85.3 97.7 33.3 39.6 68.6 72.3 33.7 58.9 30.8 51.8 31.6 78.6 26.7 59.2 45.7 112.7 62.9 43.1 59.4 52.2 29.3 69.8 84.9 43.8 19.3 76.2 84.5 32.8 26.9 62.6 43.9 36.5 52.0 58.8 83.9 42.9 56.3 134.9 81.5 92.7 33.4 89.7 37.2 73.6 82.0 60.9 30.7 33.6 51.2 43.6 67.8 64.0 22.9 38.3 59.8 54.8 49.9 73.1 44.6 84.9 71.7 79.6 123.9 55.9 33.4 68.4 64.8 21.6 9.2 10.3 11.4 13.4 13.6 8.2 10.2 12.2 8.8 7.0 7.2 9.3 3.0 12.0 17.8 8.3 8.1 10.1 9.6 9.8 17.9 13.5 11.1 10.7 13.4 16.1 11.6 9.7 11.7 9.9 14.2 6.4 6.8 9.8 14.4 16.7 16.7 7.4 19.9 9.8 11.2 9.5 10.6 11.5 8.5 7.3 10.4 13.1 13.7 4.6 11.7 10.6 1914.4 39.4 16.3 18.3 3.6 29.8 18.5 9.0 16.8 14.0 10.2 13.4 19.6 10.1 8.2 9.6 12.4 8.4 16.6 10.9 12.2 10.2 14.9 8228.0 42.6 12.9 10.6 12.2 11.1 8.6 9.2 14.1 9.8 7.4 3.2 33.8 16.1 16.1 3.0 6.9 46.6 8.9 13.1 11.1 16.7 268.1 58.3 13.8 13.2 33.2 16.8 11.4 7.6 12.9 OIP5 "CT86, hMIS18beta, MIS18B" ENSG00000104147 "Opa interacting protein 5" O43482 15 41309273-41332591 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.3;skeletal muscle: 10.3;testis: 20.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 45.9;Extravillous trophoblasts: 24.0;Spermatocytes: 110.6;Spermatogonia: 56.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA052271, HPA059602" Enhanced Supported "Nuclear speckles,Vesicles" NA Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear speckles" Vesicles "HPA052271: AB_2681780, HPA059602: AB_2684079" "unprognostic (5.17e-2)" "unprognostic (7.26e-2)" "unprognostic (3.07e-1)" "unprognostic (1.59e-2)" "unprognostic (6.94e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (9.34e-5)" "unprognostic (5.51e-2)" "unprognostic (0.00e+0)" "unprognostic (3.84e-2)" "unprognostic (2.02e-1)" "unprognostic (5.75e-2)" "unprognostic (2.86e-2)" 0.6 1.7 0.1 3.3 0.2 10.3 1.2 1.2 0.4 0.9 0.2 4.1 3.5 0.8 0.3 3.8 0.4 0.6 1.5 0.2 0.2 0.3 1.2 0.5 5.8 0.2 0.4 1.5 0.3 0.1 0.1 2.3 0.4 0.5 3.9 0.7 0.8 0.6 10.3 3.3 3.9 1.1 0.1 1.7 1.5 20.9 0.2 9.1 0.4 0.8 5.2 0.7 1.3 0.5 33.7 17.8 34.3 24.9 1.7 2.1 32.4 20.0 9.3 24.5 26.1 31.8 16.2 19.8 17.0 7.7 37.8 51.0 35.7 16.1 19.2 42.4 40.1 42.4 49.8 33.6 0.4 46.5 22.1 0.7 3.2 13.8 14.5 5.2 21.1 40.8 59.4 37.3 16.5 16.3 27.1 34.8 30.9 50.4 37.9 32.9 28.4 30.5 11.1 15.4 53.7 17.5 33.7 34.3 9.6 13.7 33.7 26.3 10.0 24.5 37.3 24.6 36.6 17.0 83.2 71.1 7.1 56.5 35.9 0.0 0.4 0.5 0.2 0.7 0.8 1.0 0.7 0.8 0.7 1.2 1.3 0.8 0.0 1.2 0.4 4.1 3.1 0.8 0.1 0.2 1.2 0.4 0.2 0.2 0.2 0.4 0.4 0.1 0.2 0.5 0.2 0.0 0.5 1.0 2.7 4.1 0.9 3.6 1.2 0.0 1.1 2.2 0.2 0.0 1.8 0.0 0.0 15.0 1.7 2.3 0.0 0.4 12.0 1.9 0.6 0.9 0.0 45.9 2.2 0.4 24.0 1.7 5.1 1.1 1.3 5.2 0.0 0.8 7.5 0.0 2.1 3.0 8.2 2.2 1.8 10.8 0.9 1.2 0.0 0.0 0.6 1.1 2.1 1.5 2.5 0.2 0.5 1.2 10.9 0.4 0.9 0.3 0.0 0.3 6.6 1.0 1.1 110.6 56.8 8.3 2.4 3.8 1.2 2.1 7.6 0.9 ORM1 ENSG00000229314 "Orosomucoid 1" P02763 9 114323056-114326475 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 193 "liver: 42973.6" "Cell type enriched" "Detected in some" 46 "Hepatocytes: 58657.7" "Cancer enriched" "Detected in many" 16 "liver cancer: 2506.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 47 "neutrophil: 193.9" "Lineage enriched" "Detected in many" 47 "granulocytes: 193.9" "Cell line enriched" "Detected in some" 12 "Hep G2: 1182.7" "CAB006265, HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 945000000000 61000000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" Vesicles "Golgi apparatus" "CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512" "unprognostic (3.85e-1)" "unprognostic (2.12e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (1.16e-1)" "unprognostic (4.85e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.35e-4)" "unprognostic (2.10e-1)" "unprognostic (4.38e-2)" "unprognostic (9.32e-3)" "unprognostic (4.51e-2)" 13.4 10.3 0.1 12.7 0.3 223.1 6.6 0.0 0.4 2.7 0.2 1.5 0.1 2.7 0.3 1.9 1.9 1.0 3.4 0.2 0.2 4.9 42973.6 24.4 0.7 0.4 0.2 1.6 8.1 0.0 1.4 1.3 0.1 57.6 0.0 1.1 1.4 0.0 2.0 1.7 2.3 0.3 0.2 51.3 19.2 2.7 0.1 1.2 2.8 0.3 0.1 1.6 2.2 0.2 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 3.4 0.6 1182.7 0.1 5.3 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.2 0.0 0.2 1.0 0.1 0.0 0.7 7.1 0.0 0.0 0.4 0.0 0.0 5.7 5.5 0.0 0.0 0.4 102.0 1.2 0.0 0.5 0.0 0.0 1.2 0.6 3.5 0.0 4.3 0.1 0.0 4.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 193.9 0.0 1.0 0.0 0.0 1.8 0.1 0.3 0.0 0.4 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.2 0.0 3.2 18.1 0.0 81.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1166.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 1.3 0.2 34.4 0.0 890.4 0.0 4.9 0.3 0.2 0.0 2.5 0.0 0.0 930.9 58657.7 0.1 0.0 0.0 0.0 0.0 1260.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 78.6 0.0 0.0 0.3 ORM2 "AGP-B, AGP-B', AGP2" ENSG00000228278 "Orosomucoid 2" P19652 9 114329869-114333251 "Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 327 "liver: 8873.2" "Cell type enriched" "Detected in some" 41 "Hepatocytes: 10792.5" "Cancer enriched" "Detected in many" 34 "liver cancer: 873.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 40 "neutrophil: 12.0" "Lineage enriched" "Detected in single" 40 "granulocytes: 12.0" "Cell line enriched" "Detected in some" 232 "Hep G2: 831.1" "HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 422000000 41000000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Golgi apparatus" "HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512" "unprognostic (6.77e-2)" "unprognostic (8.00e-2)" "unprognostic (1.19e-1)" "unprognostic (4.44e-3)" "unprognostic (1.18e-1)" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (9.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (1.23e-9)" "unprognostic (3.23e-1)" "unprognostic (6.80e-2)" "unprognostic (7.62e-2)" "unprognostic (9.15e-4)" 4.0 4.0 0.2 3.2 0.4 27.1 3.0 0.0 0.2 1.3 0.2 0.3 0.2 2.1 0.1 0.4 0.4 0.6 0.8 0.1 0.1 1.7 8873.2 5.8 1.1 0.2 0.3 0.3 2.1 0.0 0.2 0.2 0.1 23.6 0.1 3.6 0.3 0.0 0.4 0.4 0.4 0.1 0.2 7.3 21.9 1.4 0.1 0.5 0.3 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.0 831.1 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.1 1.1 0.4 2.5 0.0 0.3 1.9 0.1 0.0 0.3 0.1 0.0 2.6 2.0 0.2 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.6 2.2 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.2 0.1 0.1 0.2 0.3 0.1 0.2 0.1 0.2 0.0 0.0 10.5 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 263.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.6 1.1 0.1 7.0 0.0 141.7 0.0 6.0 0.0 0.0 15.8 1.3 0.0 0.0 162.8 10792.5 0.0 0.0 0.0 0.0 0.0 236.1 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.2 OSBPL8 "MST120, MSTP120, ORP8, OSBP10" ENSG00000091039 "Oxysterol binding protein like 8" Q9BZF1 12 76351797-76559809 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001309 Uncertain Approved Vesicles,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 36: HEL - Hemostasis" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Vesicles, Cytosol" "HPA001309: AB_1079530" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.77e-1)" "unprognostic (1.70e-1)" "unprognostic (5.20e-2)" "unprognostic (1.23e-1)" "unprognostic (6.55e-3)" "unprognostic (2.84e-1)" "unprognostic (7.88e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (5.63e-3)" "unprognostic (2.96e-1)" "unprognostic (1.16e-1)" "unprognostic (3.19e-3)" 24.2 13.5 18.1 24.3 43.3 32.5 21.1 9.7 22.5 22.6 12.3 11.2 9.3 22.3 7.7 24.4 10.5 18.4 14.0 15.3 13.7 36.4 19.2 19.6 30.9 11.7 13.4 17.4 14.0 13.0 5.6 18.2 14.0 14.9 11.7 14.2 13.5 12.7 10.7 28.7 13.0 18.9 9.1 26.7 16.0 16.6 13.1 33.7 14.3 11.5 32.0 19.1 10.2 16.6 36.5 22.8 49.7 35.5 67.5 94.8 31.6 54.7 76.3 34.2 31.1 33.2 14.6 50.8 30.4 65.3 21.5 14.9 37.2 31.6 51.3 43.6 33.3 136.0 21.0 19.8 41.7 87.2 53.1 50.4 58.7 51.2 63.3 61.8 30.0 29.1 95.0 22.7 57.3 25.0 58.8 41.4 24.3 13.2 22.6 30.4 67.7 29.3 26.4 30.3 27.2 28.4 46.7 16.6 34.0 38.9 13.0 52.4 70.6 55.0 27.5 57.5 29.7 22.7 38.4 54.6 21.0 47.9 32.8 134.8 50.8 74.1 29.2 37.4 27.9 45.3 31.2 24.6 46.9 40.8 27.9 23.2 195.7 36.0 44.5 54.9 41.1 31.8 18.1 43.3 9.7 22.5 15.3 13.7 11.7 13.4 14.0 9.1 13.1 16.6 63.5 57.7 58.3 54.5 87.8 116.2 65.7 39.6 114.9 49.7 68.4 55.5 42.5 25.8 36.1 51.5 89.6 34.8 111.3 13.6 60.7 53.9 47.4 29.0 102.6 68.7 9.5 63.5 246.3 55.2 28.7 98.0 28.5 44.1 254.8 36.3 52.1 45.9 77.1 42.1 248.6 25.8 40.7 98.0 127.0 22.1 65.9 142.0 35.6 79.6 149.3 50.2 125.7 113.6 92.9 104.0 28.3 82.8 56.8 54.6 23.9 180.2 37.4 37.3 46.0 79.3 83.1 66.2 129.9 89.9 124.5 48.2 105.3 58.4 20.0 62.4 OSBPL9 ENSG00000117859 "Oxysterol binding protein like 9" Q96SU4 1 51577179-51798427 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 216.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027378, HPA027397" Supported Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" Vesicles "HPA027378: AB_1854816, HPA027397: AB_1854817" "unprognostic (5.99e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-2)" "unprognostic (2.43e-3)" "unprognostic (3.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.85e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-3)" "unprognostic (1.58e-1)" "unprognostic (8.36e-3)" "unprognostic (8.61e-2)" "unprognostic (3.64e-2)" "unprognostic (7.53e-3)" "unprognostic (2.55e-1)" "unprognostic (4.95e-2)" "unprognostic (3.37e-1)" 27.5 38.1 17.9 18.1 23.8 30.1 32.6 26.3 23.5 25.5 28.3 20.8 17.4 31.1 31.0 17.7 23.3 17.6 37.0 17.6 23.9 42.8 60.8 27.5 25.9 25.0 21.8 30.5 33.3 60.0 21.1 21.8 26.6 27.8 19.1 53.5 22.0 22.4 70.0 19.6 21.7 24.2 23.0 27.2 34.3 28.4 22.2 21.8 24.7 35.2 33.0 23.7 24.7 32.2 66.3 31.7 69.0 11.2 38.1 17.9 90.7 30.1 50.8 54.9 60.0 53.0 46.6 105.8 54.4 34.1 120.9 26.9 59.2 57.4 76.9 71.9 41.9 77.4 62.7 104.7 36.9 81.7 35.5 44.7 55.0 56.8 31.4 66.8 68.9 52.1 154.4 31.1 26.7 45.4 20.3 92.5 97.0 26.8 15.1 58.2 102.8 110.5 74.0 47.4 31.8 45.2 22.4 79.6 93.7 154.7 38.0 82.8 22.9 11.6 51.2 17.2 58.1 80.2 52.5 120.4 39.3 32.8 23.0 52.7 12.2 30.5 20.1 9.9 28.9 32.6 19.7 20.8 25.0 23.9 21.0 22.2 16.9 16.3 9.4 23.2 20.5 16.4 17.9 23.8 26.3 23.5 17.6 23.9 25.0 21.8 26.6 23.0 22.2 32.2 32.5 80.1 56.8 75.4 39.2 17.7 33.8 25.7 34.1 102.0 34.2 33.0 47.9 38.6 50.5 46.0 41.7 89.2 30.4 20.5 125.2 47.6 40.7 36.3 46.3 30.1 29.8 35.7 64.8 47.8 50.2 48.6 54.0 52.9 33.6 75.7 18.2 61.7 40.1 26.9 113.0 18.3 38.7 22.7 16.0 38.3 62.4 25.3 65.8 63.7 50.1 43.8 29.9 62.8 216.4 41.9 14.3 50.0 81.4 38.5 26.4 59.7 32.1 35.3 46.0 36.9 62.9 32.3 18.9 26.9 18.9 75.5 32.0 52.2 21.2 27.4 OTUD6A "DUBA2, FLJ25831, HSHIN6" ENSG00000189401 "OTU deubiquitinase 6A" Q7L8S5 X 70062457-70064179 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 4.8" "Group enriched" "Detected in some" 17 "Spermatocytes: 64.1;Spermatogonia: 25.1" "Cancer enriched" "Detected in single" 57 "testis cancer: 2.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053304 Enhanced Approved Vesicles,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol Vesicles "HPA053304: AB_2682107" "unprognostic (1.58e-1)" 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 4.8 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.5 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.4 0.1 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.4 0.4 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.6 0.4 0.3 0.6 0.0 0.0 0.1 0.0 0.1 2.6 0.0 0.3 1.3 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.9 0.7 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.3 0.0 0.3 0.0 1.8 0.0 0.4 0.4 64.1 25.1 0.0 0.6 0.3 1.0 0.2 0.0 0.2 OTX2 ENSG00000165588 "Orthodenticle homeobox 2" P32243 14 56799905-56816693 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "choroid plexus: 108.8;retina: 279.9" "Group enriched" "Detected in some" 11 "Bipolar cells: 170.6;Cone photoreceptor cells: 168.9;Rod photoreceptor cells: 202.5" "Cancer enriched" "Detected in single" 27 "testis cancer: 11.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 249.6;hTERT-RPE1: 57.0;NTERA-2: 199.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA000633, HPA001123" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 77: Retina - Visual perception" "Cluster 5: NTERA-2 - Transcription" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Vesicles "HPA000633: AB_1079538, HPA001123: " "unprognostic (3.82e-1)" "unprognostic (2.56e-2)" "unprognostic (9.28e-2)" 0.0 0.0 4.1 0.0 1.3 0.0 0.0 8.5 0.5 0.0 108.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.9 2.6 0.0 0.0 0.0 0.0 0.2 8.7 0.0 0.0 0.0 2.5 0.0 2.0 0.0 0.0 279.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 12.8 0.0 0.0 0.8 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 249.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 199.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.3 8.5 0.5 5.9 2.6 0.2 8.7 2.0 0.1 12.8 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 170.6 0.0 0.0 0.3 0.0 0.0 0.0 168.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 202.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OVGP1 "CHIT5, MUC9" ENSG00000085465 "Oviductal glycoprotein 1" Q12889 1 111414319-111427735 "Plasma proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 134 "fallopian tube: 2071.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 9.7;Excitatory neurons: 10.4;Glandular and luminal cells: 12.0;Inhibitory neurons: 8.5;Syncytiotrophoblasts: 17.4" "Group enriched" "Detected in many" 13 "endometrial cancer: 58.7;ovarian cancer: 27.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 4.9;OE19: 6.4;SK-BR-3: 5.0" "Region enhanced" "Detected in many" "cerebellum: 5.9" "Not detected" "Not detected" "HPA031666, HPA062205" Enhanced Supported Vesicles,Microtubules "Secreted in female reproductive system" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Vesicles Microtubules "HPA031666: , HPA062205: AB_2684710" "unprognostic (1.52e-1)" "unprognostic (2.06e-2)" "unprognostic (3.35e-2)" "prognostic favorable (1.36e-4)" "unprognostic (8.39e-2)" "unprognostic (3.58e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-2)" "unprognostic (5.44e-2)" "unprognostic (3.82e-2)" "unprognostic (7.68e-3)" "unprognostic (2.58e-1)" "unprognostic (5.35e-3)" "unprognostic (2.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.86e-3)" "prognostic favorable (3.93e-5)" 4.1 1.6 7.6 1.1 7.8 1.9 3.5 8.0 10.6 3.8 5.8 3.4 1.1 15.4 5.1 3.0 2071.7 1.1 2.3 7.7 7.0 5.0 8.0 3.9 2.2 7.3 6.9 6.7 1.5 6.8 2.4 2.0 7.2 5.5 2.2 4.3 4.2 1.5 2.6 7.6 5.2 1.4 6.5 4.6 2.8 9.2 6.9 1.2 2.4 1.0 2.0 4.6 3.8 8.2 0.4 0.4 0.9 0.5 1.8 2.0 1.7 0.2 1.4 0.3 0.7 0.6 0.0 0.8 1.7 0.6 0.0 0.5 0.3 0.3 0.5 2.0 4.9 0.3 0.8 2.4 0.6 0.9 2.2 1.8 2.9 0.0 1.0 1.4 0.4 3.2 0.3 1.5 0.1 0.5 0.6 1.2 0.2 6.4 1.7 0.6 0.2 0.7 1.4 3.7 0.6 0.6 0.1 5.0 0.7 2.4 0.3 0.8 0.8 0.1 0.2 2.5 0.7 1.8 0.5 0.4 0.2 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 7.8 8.0 10.6 7.7 7.0 7.3 6.9 7.2 6.5 6.9 8.2 1.2 0.0 1.1 3.3 0.6 3.1 1.1 0.3 0.0 2.1 1.7 1.9 0.6 0.0 0.5 0.0 0.0 5.6 0.2 1.1 1.9 0.2 4.0 9.7 0.7 1.6 0.0 0.0 10.4 0.0 2.6 0.6 0.0 12.0 0.0 1.0 1.4 2.9 0.6 0.0 8.5 1.5 2.0 0.6 1.4 6.1 1.5 0.5 0.0 3.7 0.0 0.4 0.0 1.5 2.4 0.2 0.5 1.9 0.1 1.6 0.6 2.8 1.3 0.6 0.0 0.7 1.1 3.8 0.7 1.0 3.1 17.4 0.8 0.2 1.6 1.6 OXLD1 "C17orf90, MGC104712" ENSG00000204237 "Oxidoreductase like domain containing 1" Q5BKU9 17 81665036-81666635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056878, HPA057019" Uncertain Approved Vesicles,Cytosol NA NA 12000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Vesicles, Cytosol" "HPA056878: AB_2683265, HPA057019: AB_2683310" "unprognostic (1.08e-1)" "prognostic favorable (2.91e-4)" "unprognostic (1.37e-1)" "unprognostic (1.38e-1)" "unprognostic (9.03e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "unprognostic (1.92e-2)" "unprognostic (2.14e-1)" "unprognostic (7.60e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-1)" "unprognostic (3.06e-2)" "unprognostic (3.64e-1)" "unprognostic (8.71e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-2)" 11.4 16.7 8.4 3.2 8.3 6.3 12.6 8.5 15.2 7.7 7.9 10.0 4.5 7.9 0.0 11.0 8.4 1.2 15.4 8.1 8.9 14.2 18.0 7.4 3.9 8.9 8.7 5.5 14.8 1.5 6.6 1.7 8.6 11.1 0.2 0.1 10.6 1.9 16.4 14.3 9.8 1.3 9.0 11.7 15.4 29.7 8.9 0.6 8.9 0.0 0.7 10.0 7.5 9.3 15.2 56.0 0.5 12.6 3.2 0.3 9.5 7.3 0.2 0.1 1.4 14.9 14.1 4.7 12.6 0.0 7.8 13.1 0.0 10.0 0.0 7.7 29.4 4.2 26.1 37.2 22.9 3.0 11.1 4.8 6.8 2.9 3.1 0.7 5.3 22.3 7.3 7.2 1.1 38.3 10.7 12.4 6.9 7.9 24.9 9.7 0.4 20.5 2.9 8.2 2.4 11.2 3.1 19.0 27.6 0.2 27.4 17.1 4.5 10.8 7.2 12.2 8.4 19.8 7.9 6.5 14.6 11.3 11.0 18.6 23.6 18.4 23.5 20.8 25.1 26.4 31.9 27.0 22.9 28.6 33.5 26.0 17.1 35.5 22.6 31.2 30.6 23.8 8.4 8.3 8.5 15.2 8.1 8.9 8.9 8.7 8.6 9.0 8.9 9.3 17.9 32.1 17.1 7.5 26.1 8.5 21.5 48.6 21.6 19.9 40.3 40.0 16.2 30.0 26.1 23.9 6.2 37.1 24.8 43.4 72.4 38.1 85.7 29.9 25.6 19.2 21.7 38.1 8.3 47.9 28.8 20.6 28.1 26.9 14.0 26.1 23.6 55.0 44.2 23.5 7.7 35.5 50.8 34.2 11.1 34.6 33.2 21.0 16.0 5.6 41.2 41.3 47.4 7.5 12.6 43.9 41.5 23.7 19.7 40.4 63.4 89.3 36.0 30.9 26.3 11.9 18.5 95.7 20.4 35.8 8.5 27.9 29.5 56.5 31.6 26.6 P3H1 "GROS1, LEPRE1, LEPRECAN, MGC117314" ENSG00000117385 "Prolyl 3-hydroxylase 1" Q32P28 1 42746335-42767084 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 47.9;Extravillous trophoblasts: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 193.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012113, HPA016980" Approved Approved Nucleoli,Vesicles "Intracellular and membrane" NA NA 18000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 28: Placenta - Pregnancy" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" Vesicles Nucleoli "HPA012113: AB_2668626, HPA016980: AB_2669498" "unprognostic (3.24e-1)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (4.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.95e-7)" "unprognostic (5.41e-2)" "unprognostic (2.70e-3)" "unprognostic (9.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" "unprognostic (2.67e-2)" "unprognostic (1.60e-3)" 12.4 11.1 3.6 8.7 3.5 6.1 10.2 3.6 4.4 13.4 7.3 8.3 2.4 13.8 6.1 4.4 9.8 12.0 9.1 3.8 3.8 7.2 13.3 11.6 5.1 5.2 3.5 12.8 6.8 5.9 15.5 37.4 3.8 7.5 5.4 1.3 6.7 5.9 3.0 7.6 7.4 20.3 3.4 11.5 6.7 15.2 3.8 7.6 7.6 3.9 5.1 12.3 8.5 3.6 8.7 22.3 48.7 115.0 112.8 85.4 20.1 101.8 131.9 71.9 121.7 11.3 18.8 13.0 79.7 193.0 29.2 7.8 20.9 25.9 49.2 19.5 26.3 30.5 32.2 32.6 65.2 30.9 34.0 73.8 17.4 72.6 30.9 102.4 102.9 18.3 17.5 16.1 49.0 4.7 20.6 17.8 53.1 4.7 16.0 19.9 71.9 17.7 38.2 4.9 10.2 17.3 62.5 1.7 45.8 85.2 3.7 127.0 85.1 53.8 47.2 43.4 41.2 14.5 17.5 11.9 61.5 41.5 77.0 5.0 18.9 16.8 8.3 20.4 8.8 4.1 6.3 7.0 23.6 3.3 5.1 5.3 1.8 17.8 26.3 10.9 12.4 9.3 3.6 3.5 3.6 4.4 3.8 3.8 5.2 3.5 3.8 3.4 3.8 3.6 13.7 3.2 2.3 5.9 10.5 0.0 6.4 0.0 6.2 10.2 4.5 6.5 5.0 7.2 0.6 11.0 25.0 47.9 11.1 0.4 0.0 11.5 17.1 3.2 30.1 16.4 6.1 11.3 12.9 7.6 56.6 34.4 3.6 4.4 1.3 28.8 16.8 11.3 17.6 15.2 10.8 2.5 0.0 8.7 0.0 10.8 19.3 11.7 0.0 9.4 10.5 3.5 6.2 9.5 6.9 7.4 2.0 16.1 11.2 3.4 1.7 1.9 0.7 22.1 0.0 17.2 22.3 30.6 18.8 3.5 0.0 17.5 9.6 27.0 1.9 4.5 P3H4 "LEPREL4, NO55, SC65" ENSG00000141696 "Prolyl 3-hydroxylase family member 4 (inactive)" Q92791 17 41801947-41812604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 3.9;MAIT T-cell: 5.0;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.9;NK-cell: 8.5" "Group enriched" "Detected in many" 10 "NK-cells: 8.5;T-cells: 5.0" "Cell line enriched" "Detected in many" 13 "OE19: 1032.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022520 Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum, Vesicles" "HPA022520: " "unprognostic (9.11e-2)" "unprognostic (3.72e-3)" "unprognostic (3.66e-2)" "unprognostic (3.72e-2)" "unprognostic (8.69e-3)" "unprognostic (4.32e-2)" "unprognostic (2.16e-3)" "unprognostic (1.94e-1)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (4.48e-6)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (8.96e-2)" "unprognostic (1.96e-3)" 5.1 11.6 5.4 5.5 5.6 0.5 4.9 7.3 6.6 10.0 7.5 6.2 7.6 10.7 4.9 2.8 7.7 6.8 8.8 4.6 6.8 7.8 2.3 6.0 2.7 5.2 4.9 7.9 12.9 11.5 10.5 12.1 4.9 7.3 4.2 1.3 10.4 7.2 4.8 7.4 6.5 10.1 4.5 3.3 5.2 2.3 6.6 1.3 12.2 2.0 1.6 7.2 6.4 4.5 9.2 45.0 27.4 70.8 29.1 28.1 26.9 75.5 33.6 25.6 35.0 22.3 12.4 1.4 30.6 58.7 19.5 16.4 23.6 32.3 10.1 21.0 35.5 11.4 44.1 30.3 35.4 2.3 3.6 29.5 9.5 22.3 20.3 61.0 32.6 3.2 2.2 11.6 16.7 31.6 0.6 6.8 17.1 1032.2 25.2 25.3 30.1 31.4 16.5 2.7 13.2 29.0 13.3 81.2 28.9 18.1 46.8 7.4 34.3 24.5 35.7 46.2 34.1 10.7 2.6 0.2 37.7 11.1 38.5 0.0 0.2 0.0 3.9 0.0 5.0 0.6 2.5 2.7 0.2 0.6 3.0 3.9 0.0 8.5 0.0 0.0 0.7 1.5 5.4 5.6 7.3 6.6 4.6 6.8 5.2 4.9 4.9 4.5 6.6 4.5 7.3 0.0 7.8 12.1 1.5 0.0 5.4 0.0 6.2 3.6 11.6 10.8 10.7 11.5 1.8 5.5 8.4 10.8 3.6 7.2 7.9 21.6 0.5 2.7 25.3 11.0 2.4 7.0 6.4 6.5 27.3 26.6 16.8 7.7 1.3 17.7 11.0 1.9 2.8 26.9 4.4 13.0 0.0 1.2 0.0 0.8 21.1 1.0 0.0 4.7 1.2 9.6 13.4 6.0 1.5 7.1 9.5 20.7 2.8 9.6 26.8 5.9 0.7 2.7 19.7 13.1 16.7 2.7 10.0 1.9 0.0 5.3 3.2 19.1 9.8 2.0 P4HA2 C-P4Halpha(II) ENSG00000072682 "Prolyl 4-hydroxylase subunit alpha 2" O15460 5 132190147-132295315 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 115.6;Endometrial stromal cells: 96.9;Skeletal myocytes: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 324.2;U-87 MG: 323.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA016997, HPA027824, CAB062557" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" No No 13000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum, Vesicles" "CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402" "unprognostic (1.30e-3)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.56e-3)" "unprognostic (1.28e-3)" "unprognostic (2.08e-3)" "unprognostic (1.62e-3)" "unprognostic (1.16e-3)" "unprognostic (1.93e-3)" "unprognostic (2.83e-2)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (2.77e-7)" "unprognostic (2.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.12e-4)" 17.4 11.7 11.9 16.1 12.1 2.4 12.3 11.4 28.4 29.5 42.2 28.7 22.6 31.1 76.7 19.6 29.6 19.9 40.6 14.4 17.2 80.0 10.5 31.5 2.5 11.4 14.3 8.6 70.7 10.9 19.9 35.1 19.1 10.8 32.7 7.8 32.5 17.1 13.0 16.7 26.8 52.6 10.0 8.7 20.5 9.7 16.8 11.3 20.7 22.9 8.3 22.9 22.3 12.2 57.0 34.9 11.2 57.2 149.2 173.7 61.1 261.9 223.7 108.9 265.0 78.9 50.3 1.5 71.8 283.3 120.5 70.2 33.2 136.5 172.7 41.5 11.9 0.6 48.1 49.0 324.2 0.0 33.9 104.6 193.1 128.8 117.4 162.7 59.1 0.1 21.2 3.6 134.0 23.2 0.2 0.5 3.0 53.7 27.2 0.9 3.6 9.8 31.1 11.0 5.4 15.8 67.7 22.3 47.9 84.1 28.4 3.7 88.9 171.7 63.5 51.0 57.1 24.4 28.1 11.8 323.4 0.4 48.3 0.0 0.4 0.0 0.8 0.3 0.7 0.0 0.4 0.1 0.2 0.0 0.0 0.1 1.0 0.9 0.0 0.3 0.0 0.2 11.9 12.1 11.4 28.4 14.4 17.2 11.4 14.3 19.1 10.0 16.8 12.2 13.0 35.3 10.3 7.5 1.1 16.8 43.6 115.6 23.9 11.6 9.5 9.5 13.3 8.6 36.9 11.0 22.9 2.6 0.3 43.2 5.9 68.3 1.4 26.7 96.9 12.2 15.0 0.0 7.7 71.8 70.2 61.6 12.8 28.0 5.7 11.1 9.3 7.8 7.6 0.0 7.7 18.6 32.6 1.3 5.5 2.0 8.1 4.4 30.2 2.8 2.6 6.8 0.0 1.5 1.2 81.9 41.0 5.3 3.0 19.6 41.4 44.6 71.9 5.2 26.3 109.4 47.6 23.0 29.1 6.8 9.8 7.5 4.8 10.4 13.8 15.3 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989889-49007153 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 155.3;Respiratory ciliated cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 25: RPMI-8226 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favorable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favorable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 13.3 37.1 50.6 4.9 53.3 5.9 12.4 44.3 67.9 18.4 89.7 14.7 12.1 17.6 18.7 8.2 39.8 11.2 26.2 53.5 57.3 29.8 11.9 15.7 6.5 52.2 49.6 20.0 38.5 39.4 75.9 11.0 51.5 18.5 7.4 16.4 19.6 16.8 15.2 10.1 13.0 7.4 45.8 10.7 25.1 23.6 53.3 5.5 26.5 11.3 3.8 12.8 13.1 49.6 8.6 27.9 4.8 0.1 15.5 17.6 0.4 16.8 24.6 13.2 14.8 6.3 55.6 8.1 15.8 21.6 10.5 4.8 12.5 6.6 4.1 30.4 19.5 0.0 42.1 0.0 38.6 8.3 0.2 11.0 6.3 13.4 1.1 51.4 15.0 0.1 0.0 37.9 6.5 48.1 1.2 1.0 6.8 52.6 31.2 0.0 0.0 53.5 24.4 15.9 20.9 0.2 17.7 25.0 0.1 1.1 20.1 13.1 9.9 8.0 6.1 19.9 14.5 50.0 28.6 0.1 54.9 0.7 7.1 8.0 9.0 5.9 6.7 3.5 9.6 8.4 12.3 11.7 9.4 15.9 13.0 8.3 0.8 5.9 4.5 1.6 17.0 6.0 50.6 53.3 44.3 67.9 53.5 57.3 52.2 49.6 51.5 45.8 53.3 49.6 15.1 22.4 17.3 36.2 16.1 9.2 34.6 41.1 12.5 72.9 28.7 23.0 12.0 41.5 44.0 46.0 87.6 31.4 13.4 27.4 19.6 38.3 138.4 106.4 23.7 12.6 80.9 12.4 55.7 39.1 9.9 28.1 48.9 31.2 22.9 31.6 15.4 8.5 16.8 117.8 48.6 40.4 65.1 6.3 12.8 155.3 30.4 13.0 12.4 20.6 11.3 58.4 14.4 17.1 32.3 23.6 51.8 25.9 28.9 24.4 56.2 30.4 169.4 72.5 19.7 32.9 24.7 32.5 7.0 12.9 10.4 26.1 25.0 23.9 40.9 31.2 PACRGL "C4orf28, MGC29898" ENSG00000163138 "Parkin coregulated like" Q8N7B6 4 20696282-20752907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 211.7;Late spermatids: 88.4;Oligodendrocytes: 66.9;Spermatocytes: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054666 Approved Nucleoplasm,Vesicles NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Vesicles" "HPA054666: AB_2682564" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (6.90e-3)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-2)" "unprognostic (1.09e-2)" "unprognostic (2.97e-1)" "unprognostic (4.55e-2)" "unprognostic (2.20e-2)" "unprognostic (5.08e-2)" "unprognostic (3.35e-2)" "unprognostic (1.25e-2)" "unprognostic (6.74e-3)" "unprognostic (3.63e-2)" "unprognostic (1.07e-2)" "prognostic favorable (4.85e-4)" 7.6 8.5 9.6 5.7 10.1 4.0 16.0 3.6 11.9 8.2 16.6 8.5 6.6 12.9 14.3 9.2 13.5 9.6 9.2 11.9 11.4 8.2 4.5 7.3 7.9 6.5 7.3 13.5 7.0 11.1 8.0 7.4 5.4 10.5 8.6 15.0 7.0 10.1 7.2 14.7 7.8 10.1 6.5 7.1 7.7 28.1 12.1 5.4 15.1 8.1 6.3 9.2 7.7 12.1 12.5 8.9 16.8 12.1 23.7 21.9 8.0 15.9 11.9 13.4 17.5 8.9 28.2 11.9 11.5 8.7 24.1 6.4 9.3 10.9 24.3 4.3 8.6 8.4 16.1 13.7 11.8 17.6 8.9 14.4 18.8 17.9 17.4 14.5 14.9 12.2 13.9 7.6 12.7 9.1 18.1 17.0 20.3 11.0 12.3 9.4 18.4 7.4 12.9 7.8 25.4 17.9 12.5 5.6 12.2 9.4 11.5 10.0 12.0 14.4 13.5 20.0 22.6 8.0 2.5 11.3 21.7 10.9 25.5 0.0 1.5 0.7 1.3 2.4 2.9 2.0 1.4 1.3 2.7 1.8 2.2 1.5 0.6 2.3 2.0 3.5 1.9 1.4 9.6 10.1 3.6 11.9 11.9 11.4 6.5 7.3 5.4 6.5 12.1 12.1 6.7 9.6 6.4 37.9 4.9 13.6 10.6 6.8 13.1 5.8 8.2 7.0 5.4 8.6 8.6 7.3 4.2 5.5 4.9 5.5 7.9 9.7 211.7 15.8 8.6 7.4 9.0 5.7 48.0 9.1 6.9 9.7 6.6 4.8 2.5 7.9 7.5 3.1 4.2 5.0 44.9 5.9 6.1 4.9 4.0 88.4 13.1 4.6 5.4 31.9 3.3 9.7 3.1 35.7 66.9 8.7 9.1 12.4 2.1 9.7 5.5 6.2 27.1 12.1 13.1 9.2 7.3 90.6 30.3 9.0 10.5 5.9 3.6 9.3 6.7 8.0 PACSIN1 SDPI ENSG00000124507 "Protein kinase C and casein kinase substrate in neurons 1" Q9BY11 6 34466061-34535229 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 149.3;retina: 64.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 76.1;Cone photoreceptor cells: 81.3;dendritic cells: 24.9;Excitatory neurons: 49.9;Horizontal cells: 69.0;Inhibitory neurons: 47.6;Rod photoreceptor cells: 89.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "plasmacytoid DC: 15.8" "Lineage enriched" "Detected in many" 4 "dendritic cells: 15.8" "Cell line enhanced" "Detected in some" "MCF7: 12.1;RPMI-8226: 14.0;T-47d: 21.5;U-266/84: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009929, HPA028852, HPA055491" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 6: T47d - Mammary gland" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Vesicles" "CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834" "unprognostic (3.33e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.72e-2)" "unprognostic (2.47e-3)" "unprognostic (2.14e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (6.63e-2)" "unprognostic (3.95e-4)" "unprognostic (9.12e-2)" "unprognostic (3.02e-2)" "unprognostic (4.18e-2)" "unprognostic (9.90e-2)" "unprognostic (5.50e-2)" "unprognostic (9.33e-2)" 0.2 0.7 40.9 1.2 72.9 0.8 0.2 0.0 149.3 0.3 0.0 0.8 0.5 0.5 0.1 0.1 0.6 0.3 5.4 64.4 0.0 1.4 0.2 0.2 3.6 58.8 10.0 0.6 5.1 1.7 6.3 0.0 55.4 0.7 0.2 64.3 1.0 0.4 0.2 0.3 1.4 0.1 0.0 1.3 1.3 0.8 3.9 1.3 0.2 0.1 2.2 0.4 0.3 59.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 4.5 0.8 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 1.1 0.1 0.0 12.1 0.7 0.0 2.8 0.1 0.1 0.1 0.0 14.0 0.0 0.4 4.2 0.3 0.0 2.2 0.0 0.4 21.5 2.4 0.0 0.0 0.3 0.0 0.0 3.5 16.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.6 0.0 15.8 0.0 0.1 40.9 72.9 0.0 149.3 64.4 0.0 58.8 10.0 55.4 0.0 3.9 59.5 0.2 0.0 0.0 2.3 0.3 0.0 0.1 0.0 0.0 76.1 0.2 0.1 4.5 0.0 0.0 0.0 81.3 0.1 24.9 0.1 0.0 0.3 0.2 1.3 0.2 0.6 0.0 0.0 49.9 0.7 0.0 0.1 0.5 2.0 0.0 0.2 0.0 0.0 0.0 69.0 47.6 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 6.5 0.0 12.7 1.0 1.0 2.0 0.1 0.0 0.0 0.2 0.1 0.0 2.3 0.0 89.4 0.0 0.2 0.2 0.4 1.7 0.0 0.0 0.0 0.6 0.1 0.1 0.1 PADI3 PDI3 ENSG00000142619 "Peptidyl arginine deiminase 3" Q9ULW8 1 17249098-17284233 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 17.0;urinary bladder: 25.6" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Ionocytes: 6.1;Squamous epithelial cells: 1.1;Urothelial cells: 7.9" "Cancer enriched" "Detected in many" 4 "urothelial cancer: 48.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 14.0;RT4: 17.4;T-47d: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA043739 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" Vesicles Nucleoplasm "HPA043739: AB_10959466" "unprognostic (4.47e-2)" "unprognostic (9.32e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.05e-3)" "unprognostic (6.66e-2)" "unprognostic (3.10e-3)" "unprognostic (5.88e-2)" "unprognostic (2.06e-4)" "unprognostic (1.03e-1)" "unprognostic (3.47e-4)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.55e-11)" "unprognostic (2.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.64e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 17.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.9 3.4 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 25.6 3.6 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 14.0 0.0 1.4 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 17.4 0.0 0.0 0.0 2.5 0.1 0.1 12.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.0 7.9 PAG1 "CBP, PAG" ENSG00000076641 "Phosphoprotein membrane anchor with glycosphingolipid microdomains 1" Q9NWQ8 8 80967810-81112068 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 169.6;granulocytes: 124.5;Melanocytes: 140.5;Microglial cells: 166.8;Sertoli cells: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 35.4;HMC-1: 45.5;SK-MEL-30: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001632, HPA066527" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Vesicles, Plasma membrane" "HPA001632: AB_1079557, HPA066527: AB_2685685" "unprognostic (8.30e-2)" "unprognostic (3.84e-2)" "unprognostic (5.89e-2)" "unprognostic (4.79e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (3.71e-3)" "unprognostic (3.84e-2)" "unprognostic (3.73e-2)" "unprognostic (4.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.24e-6)" "unprognostic (2.12e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.80e-1)" "unprognostic (1.94e-3)" 3.9 3.1 3.4 9.0 3.5 12.3 2.0 14.8 4.0 1.8 4.3 9.2 7.6 1.9 2.2 1.6 1.8 7.1 4.7 2.8 3.7 1.7 4.7 14.9 14.5 4.5 4.5 1.2 14.9 0.9 2.0 16.0 4.9 2.6 8.7 5.0 3.7 2.1 1.3 4.3 9.0 3.0 4.9 9.1 4.4 0.7 5.2 10.4 1.8 2.1 14.0 4.8 2.6 5.6 0.1 0.1 4.8 0.2 8.9 8.5 0.1 2.0 15.5 1.0 1.9 0.3 0.1 35.4 0.2 0.5 7.6 1.5 0.1 1.8 0.9 0.9 4.5 20.8 0.3 0.0 9.1 3.4 45.5 4.1 1.2 8.9 8.2 0.9 0.0 6.2 0.2 0.1 14.8 0.3 12.6 0.3 0.4 8.1 1.4 9.5 2.4 0.1 1.6 7.6 1.0 1.7 0.0 0.3 36.1 0.8 1.2 3.5 0.3 1.1 0.6 0.0 1.2 5.7 1.6 12.3 9.7 11.7 8.5 13.1 1.4 2.0 2.5 6.4 6.1 2.0 6.2 4.4 1.9 1.6 4.9 3.8 2.3 1.7 14.6 4.1 7.2 2.7 3.4 3.5 14.8 4.0 2.8 3.7 4.5 4.5 4.9 4.9 5.2 5.6 6.2 0.0 12.4 40.8 37.0 31.5 3.9 5.2 0.6 39.7 2.2 2.2 15.4 10.0 14.0 3.7 0.0 0.8 39.0 169.6 0.0 4.0 3.5 0.6 4.4 10.9 3.6 3.8 57.5 6.5 26.2 24.3 8.2 1.1 124.5 97.0 12.5 10.3 27.1 63.9 60.0 23.2 6.1 73.6 26.2 2.1 2.5 79.1 140.5 166.8 40.8 34.9 19.6 82.4 75.3 2.0 62.1 7.9 38.4 7.7 109.3 0.4 0.8 3.2 124.9 32.3 37.1 0.2 3.0 3.8 22.6 2.3 78.1 11.8 27.4 13.7 PAGE4 "CT16.7, GAGEC1, PAGE-4" ENSG00000101951 "PAGE family member 4" O60829 X 49829260-49834264 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "epididymis: 871.9;placenta: 1023.1" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 13314.7;Syncytiotrophoblasts: 8524.1" "Group enriched" "Detected in some" 17 "liver cancer: 14.8;prostate cancer: 7.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 10.2;U-266/70: 11.7;U-266/84: 45.1" "Not detected" "Not detected" HPA023880 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Golgi apparatus" "HPA023880: AB_1854930" "unprognostic (8.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-3)" "unprognostic (5.37e-2)" 0.3 5.7 0.1 0.3 0.2 0.0 0.0 0.1 0.5 7.0 0.1 0.2 0.4 51.2 871.9 0.0 21.4 0.0 0.4 0.1 0.2 3.1 0.3 0.2 0.0 0.1 0.1 3.7 2.5 0.0 1.3 1023.1 0.1 171.8 0.0 0.0 0.6 77.2 2.3 0.0 0.3 24.2 0.0 0.3 0.2 5.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.0 0.1 11.7 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13314.7 0.0 0.0 0.0 0.0 4.4 1.9 72.5 25.9 0.0 0.0 0.0 0.0 905.4 72.5 0.0 1.9 0.0 0.0 0.0 0.0 1052.1 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 48.8 20.7 0.0 0.0 8524.1 0.3 0.0 0.0 0.1 PAH PH ENSG00000171759 "Phenylalanine hydroxylase" P00439 12 102836889-102958410 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Phenylalanine catabolism" "Allosteric enzyme, Monooxygenase, Oxidoreductase" "Disease variant, FDA approved drug targets, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "kidney: 496.6;liver: 1408.4" "Group enriched" "Detected in some" 6 "Cholangiocytes: 250.2;Hepatocytes: 807.7;Proximal tubular cells: 344.4" "Cancer enriched" "Detected in some" 17 "liver cancer: 94.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "Hep G2: 238.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028407, HPA031642" Enhanced Approved "Endoplasmic reticulum,Vesicles" No NA 40000 "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Endoplasmic reticulum, Vesicles" "HPA028407: AB_10601241, HPA031642: AB_2673974" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (4.47e-2)" "unprognostic (9.13e-3)" "unprognostic (5.19e-2)" "unprognostic (5.99e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.27e-1)" "unprognostic (6.60e-2)" "unprognostic (4.45e-3)" "unprognostic (1.94e-3)" "unprognostic (1.83e-1)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (1.64e-1)" "unprognostic (3.96e-2)" "unprognostic (1.68e-2)" 0.2 6.4 2.1 0.0 1.9 0.0 0.2 1.8 3.4 0.1 1.1 0.3 0.1 0.1 0.5 0.0 0.1 79.4 0.0 2.2 2.3 496.6 1408.4 0.0 0.1 2.8 2.3 0.1 9.2 0.8 3.0 0.0 2.3 1.5 0.0 2.4 0.1 0.1 0.0 0.0 0.1 0.0 2.6 0.3 0.4 3.3 2.5 0.7 0.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 238.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.2 1.0 0.1 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.9 1.8 3.4 2.2 2.3 2.8 2.3 2.3 2.6 2.5 2.8 0.0 0.0 0.0 1.0 2.7 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.5 250.2 0.0 5.5 0.0 0.0 0.0 0.0 21.5 2.4 66.8 0.0 0.1 1.1 1.8 21.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 807.7 0.0 3.3 2.3 0.0 0.0 22.2 0.0 15.7 0.6 1.8 0.0 0.0 0.0 0.6 0.0 4.5 0.0 0.0 0.0 1.2 0.0 0.4 0.0 344.4 0.0 0.2 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.1 PAK2 "PAK65, PAKgamma" ENSG00000180370 "P21 (RAC1) activated kinase 2" Q13177 3 196739857-196832647 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Growth regulation, Host-virus interaction" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB007794 Approved Approved Nucleoplasm,Vesicles NA NA 1700000 "Cluster 5: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Vesicles" "CAB007794: AB_562363" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.85e-2)" "unprognostic (7.97e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.36e-4)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.30e-3)" "unprognostic (4.57e-2)" "unprognostic (1.25e-2)" "unprognostic (1.70e-2)" "unprognostic (3.39e-1)" 31.8 18.1 21.2 34.6 24.9 28.1 19.5 25.0 21.7 21.1 19.8 25.6 23.0 21.9 16.0 26.5 20.5 23.8 24.0 19.5 24.6 22.1 33.8 26.3 40.9 26.7 23.4 19.8 18.5 32.6 8.4 33.3 27.7 20.1 26.6 17.4 14.5 18.9 28.3 16.6 22.5 27.0 24.8 43.5 20.9 15.1 23.0 45.1 19.7 25.9 39.4 34.1 16.0 34.1 140.7 49.1 67.6 49.8 47.1 61.9 100.0 69.1 57.0 73.7 66.8 117.5 70.1 89.4 192.7 70.8 75.1 70.2 72.5 66.2 113.6 39.9 35.2 132.2 52.1 92.5 95.0 130.2 122.0 49.6 53.1 66.2 139.2 78.1 74.3 97.3 65.0 107.5 72.9 146.7 124.8 67.2 40.5 74.7 73.4 112.4 38.6 80.9 64.8 96.7 39.6 44.7 92.8 64.7 52.7 51.9 227.0 92.6 76.9 60.9 33.6 64.3 103.1 72.5 138.9 216.4 50.4 127.6 59.1 37.3 20.0 48.0 10.9 23.2 14.7 11.2 12.7 12.6 25.4 11.3 9.1 10.9 47.6 12.2 21.2 9.3 20.7 14.9 21.2 24.9 25.0 21.7 19.5 24.6 26.7 23.4 27.7 24.8 23.0 34.1 164.9 80.1 40.2 37.9 142.8 97.4 89.2 41.8 96.2 42.6 59.7 47.5 59.3 62.9 45.1 82.8 52.1 50.3 135.1 69.6 33.2 71.5 57.1 107.9 112.6 104.0 44.9 72.3 32.2 59.0 101.4 68.9 58.1 96.1 148.8 70.9 66.0 138.6 104.3 55.5 38.9 46.4 57.0 160.5 115.9 75.5 60.9 169.6 33.8 46.9 183.2 63.7 140.1 37.2 61.3 100.4 52.1 45.5 100.0 149.4 58.2 85.2 76.4 45.0 39.5 86.0 75.9 24.5 43.0 103.2 86.2 34.9 139.1 96.3 51.0 124.1 PAPPA2 "PAPP-A2, PAPPE, PLAC3" ENSG00000116183 "Pappalysin 2" Q9BXP8 1 176463171-176845601 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 56.8" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 140.7;Extravillous trophoblasts: 71.9;Muller glia cells: 41.4;Oligodendrocytes: 37.6;Syncytiotrophoblasts: 74.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8;renal cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-87 MG: 19.8" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 5.6" "HPA018412, HPA018430" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted in female reproductive system" NA NA 2000000 "Cluster 28: Placenta - Pregnancy" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Endoplasmic reticulum, Vesicles" "HPA018412: AB_1854962, HPA018430: AB_1854961" "unprognostic (2.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-2)" "unprognostic (9.04e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (3.54e-2)" "unprognostic (1.29e-2)" "unprognostic (4.39e-2)" "unprognostic (2.85e-2)" "unprognostic (1.52e-4)" "unprognostic (1.85e-1)" "unprognostic (8.18e-4)" "unprognostic (4.35e-2)" 0.6 0.0 0.5 0.3 0.3 0.0 2.5 0.3 0.4 6.6 0.0 0.6 0.0 0.6 0.3 0.0 0.2 1.8 0.3 0.5 0.2 6.3 0.6 0.1 0.0 0.5 0.5 0.0 2.5 0.0 1.1 56.8 0.6 0.2 0.5 3.7 0.1 0.6 0.0 0.1 0.2 0.5 0.4 0.0 1.6 0.4 0.3 0.0 0.5 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 4.3 2.1 3.5 0.9 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.7 0.5 0.5 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.3 1.6 1.3 0.1 0.6 0.3 0.4 0.0 19.8 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.4 0.5 0.2 0.5 0.5 0.6 0.4 0.3 0.4 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 0.8 0.0 0.0 5.5 0.0 1.5 0.0 0.1 11.7 0.0 2.6 0.2 0.1 0.3 140.7 0.0 16.3 0.2 71.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.0 10.8 0.2 0.0 0.0 0.0 1.9 11.5 0.0 0.0 2.8 0.0 41.4 0.0 5.0 37.6 0.8 0.0 10.9 0.0 0.0 0.0 0.5 0.0 2.4 6.6 0.0 1.2 1.3 2.2 0.0 0.0 74.0 0.0 0.0 0.2 0.1 PAXIP1 "CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2" ENSG00000157212 "PAX interacting protein 1" Q6ZW49 7 154943687-155003124 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 12.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006694, HPA016950" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA006694: AB_1855011, HPA016950: AB_2669489" "unprognostic (2.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.14e-2)" "unprognostic (2.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (7.39e-3)" "unprognostic (2.65e-2)" "unprognostic (1.34e-3)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (3.28e-2)" "unprognostic (4.99e-3)" "unprognostic (3.98e-1)" "unprognostic (2.44e-3)" "unprognostic (2.30e-1)" 4.3 3.9 2.3 5.8 2.5 9.8 5.4 12.0 2.6 4.8 2.7 4.9 4.8 4.6 4.8 5.4 4.2 4.4 3.9 2.3 2.4 4.6 5.7 4.2 8.8 2.8 2.6 5.7 4.4 6.2 3.8 6.1 2.9 4.4 4.9 3.9 5.7 3.6 5.9 6.5 5.7 3.7 2.5 5.6 5.2 8.7 2.6 26.6 5.5 4.6 6.0 5.3 4.7 2.8 17.7 14.2 18.4 31.2 7.8 6.5 16.4 7.6 8.0 10.3 11.9 15.7 13.6 22.9 9.4 9.1 21.3 13.6 23.7 12.1 12.7 23.0 18.4 17.4 10.7 13.6 5.5 23.9 22.3 6.3 9.0 10.3 4.2 5.8 9.9 22.8 24.3 15.1 10.4 24.3 51.1 19.9 29.8 17.1 9.5 28.8 18.7 24.8 10.7 14.6 14.6 9.4 20.3 14.9 9.5 16.6 11.4 20.1 5.1 8.6 1.5 12.3 18.6 15.2 9.5 31.0 21.1 27.7 23.6 0.2 0.9 0.5 0.9 1.1 1.4 0.5 1.5 1.1 1.0 0.9 2.4 0.7 0.5 1.3 1.3 1.2 1.2 0.9 2.3 2.5 12.0 2.6 2.3 2.4 2.8 2.6 2.9 2.5 2.6 2.8 5.2 6.4 6.3 18.9 5.8 6.4 5.1 4.7 4.0 18.9 8.9 6.6 6.9 7.2 7.1 9.2 10.4 9.0 3.8 6.8 5.9 3.9 2.3 5.5 6.9 5.2 2.4 10.3 21.4 3.3 8.0 6.9 5.6 6.5 2.5 8.8 5.0 9.2 4.4 3.3 24.2 8.4 2.0 6.1 7.1 2.8 8.7 4.8 3.6 15.9 6.3 8.0 7.2 27.2 27.4 4.4 4.3 9.4 4.9 8.0 5.2 4.2 4.3 12.3 0.0 11.1 5.1 22.6 18.7 8.9 7.0 6.2 4.9 6.3 9.8 4.5 PBXIP1 HPIP ENSG00000163346 "PBX homeobox interacting protein 1" Q96AQ6 1 154944076-154956123 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 176.0;Muller glia cells: 221.4;Theca cells: 153.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "granulocytes: 183.9;NK-cells: 56.9;T-cells: 197.4" "Cell line enriched" "Detected in all" 7 "Karpas-707: 1100.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006949 Approved Approved Vesicles,Cytosol NA NA 26000 "Cluster 13: T-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Vesicles Cytosol "HPA006949: AB_1079572" "unprognostic (6.17e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (8.94e-2)" "unprognostic (2.16e-1)" "prognostic favorable (7.19e-4)" "unprognostic (1.62e-1)" "prognostic favorable (8.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.46e-1)" "prognostic favorable (2.64e-4)" "unprognostic (1.20e-2)" "prognostic favorable (9.22e-6)" "unprognostic (3.89e-1)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.26e-3)" 57.7 122.5 169.3 58.4 180.3 35.1 45.9 159.8 158.8 74.5 296.1 124.5 55.4 81.7 39.0 46.0 68.8 52.8 67.7 144.4 173.6 56.9 29.7 49.0 69.4 208.2 189.7 115.3 34.0 102.4 168.9 33.3 168.5 63.6 29.7 38.9 53.0 95.3 139.7 37.2 90.7 52.4 171.7 82.2 82.7 58.1 210.4 80.8 85.9 100.5 59.1 79.2 50.5 161.2 7.3 19.1 29.9 20.0 101.3 31.5 22.0 25.1 55.3 11.9 23.5 5.6 24.9 31.3 79.1 30.5 17.0 26.8 7.3 16.1 8.3 16.9 11.7 7.1 26.2 20.1 46.9 8.6 83.6 48.0 26.2 15.1 3.0 137.7 45.4 23.6 4.2 1100.7 29.8 11.1 17.6 27.5 11.4 19.3 14.4 20.2 43.1 69.7 32.9 14.1 4.9 37.6 32.5 10.2 26.7 56.1 31.0 36.6 42.9 11.8 8.6 7.6 7.8 149.4 133.9 7.7 42.2 12.4 9.6 129.4 10.3 183.9 41.9 14.8 116.3 36.0 112.4 66.9 9.1 23.6 72.9 46.2 95.2 56.9 29.7 16.2 197.4 61.5 169.3 180.3 159.8 158.8 144.4 173.6 208.2 189.7 168.5 171.7 210.4 161.2 24.5 67.3 77.9 56.8 43.0 10.1 24.0 22.4 13.1 23.8 17.6 19.7 38.5 38.6 31.1 42.3 16.7 19.5 48.2 21.0 0.0 46.0 142.1 12.9 25.9 23.8 83.7 22.3 1.5 18.5 24.0 35.9 19.9 10.5 51.9 30.3 28.9 19.4 14.7 1.7 1.2 20.9 69.2 20.2 13.8 176.0 64.3 16.8 26.6 7.5 25.5 221.4 39.1 3.5 1.6 22.4 29.3 129.1 49.0 10.5 56.0 9.9 23.9 8.8 52.6 83.9 50.6 8.8 13.9 6.3 11.5 27.1 116.2 153.3 15.9 13.9 PCDH20 "FLJ22218, PCDH13" ENSG00000280165 "Protocadherin 20" Q8N6Y1 13 61409685-61415522 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0;smooth muscle: 9.0" "Cell type enhanced" "Detected in some" "Club cells: 6.2;Excitatory neurons: 8.2;Inhibitory neurons: 7.9;Intestinal goblet cells: 5.3;Ionocytes: 6.1;Oligodendrocyte precursor cells: 32.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "RPTEC TERT1: 51.3" HPA062669 Approved "Vesicles,Cytokinetic bridge" Yes NA "Cluster 10: Brain - Neuronal signaling" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 68: Oligodendrocytes - Mixed function" Vesicles "Cytokinetic bridge" "HPA062669: AB_2732687" "unprognostic (2.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-1)" "unprognostic (7.83e-2)" "unprognostic (6.79e-4)" "unprognostic (2.32e-2)" "unprognostic (1.56e-1)" "unprognostic (5.34e-4)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.12e-1)" 0.5 1.1 3.0 0.3 4.4 0.0 0.9 1.0 11.2 2.3 0.0 3.1 0.9 3.1 2.6 0.7 0.5 0.6 3.5 18.0 3.7 0.8 1.3 3.3 0.0 1.5 4.6 0.3 0.1 0.0 0.5 0.4 1.3 1.0 1.7 0.0 0.7 1.0 0.4 1.0 1.0 9.0 2.3 1.2 1.0 0.1 2.8 0.8 0.2 0.7 0.0 0.6 0.5 2.3 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 51.3 0.0 0.7 1.9 0.0 3.6 0.5 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 4.4 1.0 11.2 18.0 3.7 1.5 4.6 1.3 2.3 2.8 2.3 0.0 3.2 0.5 2.3 0.0 0.1 0.1 3.6 0.0 0.0 0.0 0.0 0.6 0.0 6.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 8.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 7.9 5.3 6.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 32.6 1.0 0.1 2.3 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.2 PCDHB16 "KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a" ENSG00000272674 "Protocadherin beta 16" Q9NRJ7 5 141182387-141186226 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 14.9;Endometrial stromal cells: 10.0;Fibroblasts: 7.3;Horizontal cells: 8.4;Skeletal myocytes: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 19.4;LHCN-M2: 10.5;U-138 MG: 39.3;U-2197: 11.1;U-87 MG: 9.9" "Low region specificity" "Detected in all" HPA014668 Approved "Vesicles,Plasma membrane" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "HPA014668: AB_1855055" "unprognostic (3.44e-3)" "unprognostic (4.03e-2)" "unprognostic (8.14e-2)" "unprognostic (8.60e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-2)" "unprognostic (1.17e-1)" "unprognostic (4.03e-2)" "unprognostic (3.13e-2)" "unprognostic (7.55e-3)" "unprognostic (3.49e-2)" "unprognostic (9.57e-2)" "unprognostic (3.55e-2)" "unprognostic (7.49e-3)" "unprognostic (2.00e-2)" "unprognostic (7.92e-3)" "unprognostic (2.83e-3)" 3.1 1.9 1.2 1.2 0.9 0.2 2.4 2.1 1.8 2.6 0.0 1.6 0.5 4.5 4.8 0.7 2.2 2.0 2.5 1.6 0.8 2.0 1.0 2.4 0.6 2.0 1.0 6.7 1.9 4.3 2.3 1.2 1.2 1.7 0.9 2.2 1.8 0.9 1.0 1.3 0.9 2.7 1.5 1.1 0.9 1.4 1.3 0.4 1.7 3.3 0.2 1.6 1.5 2.2 0.1 0.3 1.0 19.4 7.8 5.2 0.6 0.8 3.8 0.0 0.3 0.1 0.3 0.0 5.0 0.9 2.1 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 3.3 0.1 0.2 0.1 2.0 10.5 0.4 0.0 0.1 1.5 0.0 0.2 0.1 2.8 0.0 0.6 0.2 0.7 2.6 0.3 0.6 3.9 0.5 7.9 0.0 0.6 39.3 1.7 11.1 2.7 0.1 0.1 0.0 9.9 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.2 0.9 2.1 1.8 1.6 0.8 2.0 1.0 1.2 1.5 1.3 2.2 6.4 3.2 1.5 0.0 0.0 0.8 0.1 1.0 0.0 14.9 1.2 2.4 1.9 5.7 0.6 1.8 0.0 0.0 0.0 0.0 1.9 0.8 1.2 0.6 10.0 4.8 1.8 0.0 0.0 4.7 0.0 7.3 0.5 0.4 0.0 0.2 2.2 0.1 0.1 8.4 0.0 0.0 4.1 0.3 0.9 1.5 4.7 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 1.7 0.0 5.7 0.1 0.1 0.0 0.7 0.2 1.6 0.0 7.6 5.9 2.9 0.3 0.5 1.4 0.0 0.2 0.4 0.0 0.0 PCDHB5 "DKFZp586B0217, PCDH-BETA5" ENSG00000113209 "Protocadherin beta 5" Q9Y5E4 5 141135206-141138615 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.2;Early spermatids: 8.2;Muller glia cells: 5.0;Spermatocytes: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.7;GAMG: 13.9;NTERA-2: 17.7;RH-30: 14.0;SCLC-21H: 16.4;SuSa: 21.7;T-47d: 17.6;U-138 MG: 32.4;U-2 OS: 14.1;WM-115: 14.7" "Low region specificity" "Detected in many" "HPA013191, HPA067473" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane" Vesicles "HPA013191: AB_1855059, HPA067473: " "unprognostic (2.21e-1)" "unprognostic (4.71e-2)" "unprognostic (4.05e-3)" "unprognostic (1.81e-1)" "unprognostic (2.84e-2)" "unprognostic (5.23e-2)" "unprognostic (2.27e-2)" "unprognostic (1.76e-1)" "unprognostic (9.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.06e-3)" "unprognostic (6.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.55e-3)" 1.4 1.6 2.2 0.4 1.7 0.0 1.6 1.1 3.2 3.4 0.0 1.4 0.2 4.2 3.5 0.7 2.8 1.8 1.9 2.8 0.6 2.4 0.7 1.7 0.2 2.5 1.6 5.9 4.7 2.7 3.2 0.4 1.3 2.9 0.3 2.4 2.2 2.1 1.1 0.6 0.6 2.1 1.7 0.7 1.0 3.1 1.8 0.4 2.5 0.6 0.1 1.6 1.3 2.3 0.0 1.0 18.7 0.3 1.3 0.8 0.2 0.4 0.1 0.3 0.3 0.0 0.0 0.0 9.6 0.0 13.9 0.0 9.8 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 1.0 0.7 0.0 0.0 0.1 3.8 0.9 0.0 0.7 0.1 0.0 0.0 0.1 0.0 17.7 0.0 0.0 0.0 14.0 0.0 0.0 0.0 16.4 0.5 0.0 0.2 6.1 21.7 17.6 4.3 0.0 32.4 14.1 5.3 0.0 0.0 0.0 0.0 1.7 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 1.1 3.2 2.8 0.6 2.5 1.6 1.3 1.7 1.8 2.3 1.9 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.6 5.2 0.9 2.2 1.1 1.5 1.8 1.8 0.0 0.0 0.0 0.0 0.0 2.5 8.2 0.5 4.3 1.1 0.0 0.0 0.0 3.6 0.0 1.5 0.0 0.2 0.0 0.5 0.4 0.4 0.0 3.3 0.0 0.0 0.0 0.0 0.0 3.8 3.1 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 2.2 0.0 4.5 0.0 1.1 0.0 0.5 0.1 0.7 0.0 2.1 2.7 13.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.6 PCED1B "FAM113B, MGC16044" ENSG00000179715 "PC-esterase domain containing 1B" Q96HM7 12 47079603-47236662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.1;lymphoid tissue: 36.0" "Cell type enhanced" "Detected in many" "Astrocytes: 30.3;Excitatory neurons: 32.4;Granulosa cells: 47.8;Hofbauer cells: 37.6;Microglial cells: 60.0;T-cells: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 63.3;K-562: 48.9;SK-BR-3: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043901 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 58: T-cells - T-cell receptor" "Golgi apparatus" Vesicles "HPA043901: AB_10959888" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (3.29e-3)" "unprognostic (1.47e-3)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.32e-2)" "unprognostic (5.13e-2)" "unprognostic (2.36e-3)" "unprognostic (7.74e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "prognostic unfavorable (4.55e-6)" "unprognostic (4.79e-2)" "unprognostic (3.74e-1)" "unprognostic (3.74e-2)" "prognostic favorable (5.36e-5)" 6.5 40.1 3.4 17.9 3.2 10.6 6.1 2.7 3.3 6.7 2.3 10.1 2.2 8.7 2.0 3.1 9.3 5.9 3.3 2.4 3.7 6.0 3.9 9.1 36.0 4.8 5.3 23.4 2.7 1.2 2.3 3.6 4.4 5.8 2.7 0.8 3.3 2.3 1.3 2.7 12.2 4.5 3.6 29.5 3.8 13.7 4.8 7.1 3.4 1.2 24.1 9.6 5.4 5.0 3.4 63.3 1.5 0.0 0.5 0.0 3.0 2.0 3.5 0.7 0.3 3.2 12.3 11.5 3.4 6.5 1.2 9.2 0.0 9.4 0.0 13.5 0.0 0.4 0.6 1.3 1.3 2.7 0.5 0.2 4.1 1.1 7.1 8.8 2.7 0.8 48.9 10.6 4.4 1.5 0.7 2.3 10.6 7.9 0.9 0.2 1.6 8.2 9.7 5.2 0.4 0.0 5.7 31.0 0.0 3.2 5.7 4.0 0.8 0.2 0.9 0.1 2.2 11.4 8.6 20.3 3.0 8.7 0.3 1.7 1.1 2.8 42.5 2.3 48.3 50.1 50.7 54.1 6.4 35.6 88.8 83.5 4.5 30.1 2.6 38.1 59.1 35.4 3.4 3.2 2.7 3.3 2.4 3.7 4.8 5.3 4.4 3.6 4.8 5.0 3.4 3.2 5.6 30.3 23.6 1.1 0.9 4.2 9.1 2.5 4.4 6.2 0.5 0.0 1.5 1.8 0.0 0.5 21.1 0.2 0.0 3.2 0.9 5.1 1.4 3.4 10.2 0.4 32.4 12.8 9.1 3.1 1.5 10.3 1.3 47.8 9.7 0.3 37.6 0.0 2.2 1.4 0.0 4.3 1.8 2.5 3.7 10.7 1.8 60.0 5.3 0.9 23.7 17.6 0.6 11.7 0.8 0.7 28.1 1.4 0.1 0.4 0.8 0.1 0.0 1.3 4.4 0.7 0.2 2.8 0.6 2.1 36.2 22.4 0.3 4.2 PCOLCE "PCPE, PCPE1" ENSG00000106333 "Procollagen C-endopeptidase enhancer" Q15113 7 100602363-100608175 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 81.1" "CAB017623, HPA042927" Approved Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 1300000000 "Cluster 22: NK-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "CAB017623: AB_2251882, HPA042927: AB_2678224" "unprognostic (4.14e-1)" "unprognostic (1.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.92e-1)" "unprognostic (1.70e-2)" "unprognostic (4.48e-2)" "unprognostic (1.33e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.16e-2)" "unprognostic (1.73e-1)" "unprognostic (6.13e-2)" "prognostic unfavorable (1.68e-5)" "unprognostic (1.04e-2)" "unprognostic (3.21e-2)" "unprognostic (1.63e-2)" "unprognostic (1.43e-2)" 101.5 45.5 2.4 51.5 3.8 0.6 72.6 3.5 10.2 162.8 4.6 30.5 7.8 81.7 11.0 26.9 80.6 112.5 110.8 2.3 2.5 21.9 59.7 72.4 41.3 3.0 2.4 47.7 20.6 10.3 31.2 59.5 2.9 45.5 16.7 0.2 24.9 33.5 16.9 45.0 21.6 59.9 3.1 13.8 22.9 13.7 3.6 10.5 49.1 32.7 17.4 86.4 86.7 2.5 0.2 0.5 2.2 3.0 321.5 879.0 2.4 355.5 663.0 161.1 142.7 14.5 0.8 1.1 1.2 404.5 0.5 0.2 0.0 1.2 15.9 2.5 2.5 0.3 6.1 19.8 82.1 0.1 3.5 973.2 0.3 86.3 0.6 0.4 0.1 1.7 8.3 2.0 0.7 2.1 0.6 3.3 72.2 0.0 4.2 1.0 1.5 0.8 0.4 0.6 1.1 689.9 0.2 2.4 1.6 8.2 2.0 0.0 3.5 391.8 107.6 1213.4 0.2 0.4 0.5 0.1 136.6 1.2 68.2 0.0 0.0 0.4 0.1 0.3 0.3 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.1 0.0 2.4 3.8 3.5 10.2 2.3 2.5 3.0 2.4 2.9 3.1 3.6 2.5 33.6 9.6 2.8 2.3 2.5 40.0 3.3 4.2 6.8 4.3 6.6 11.3 16.3 4.3 5.5 5.5 0.0 13.3 4.5 0.8 27.4 6.4 14.8 15.1 491.6 17.2 1.8 5.7 0.5 5.1 11.2 439.9 7.1 11.0 1.3 0.7 33.9 44.8 20.8 16.8 2.5 0.9 6.1 1.9 53.6 27.6 140.5 5.5 32.0 9.4 0.8 12.1 6.2 1.5 0.2 4.1 1.3 50.4 2.1 2.2 0.1 2.5 6.8 2.0 32.9 14.2 442.2 32.8 21.0 3.6 33.1 25.2 9.4 22.6 0.7 3.0 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 53.4;retina: 33.3;testis: 112.4" "Cell type enriched" "Detected in many" 4 "Late spermatids: 4139.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 53.4;white matter: 16.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 8.4;Karpas-707: 4.2;NB-4: 17.7" "Region enriched" "Detected in many" 44 "cerebellum: 2160.4" "Region enriched" "Detected in all" 28 "cerebellum: 552.9" HPA057428 Approved "Nuclear speckles,Vesicles" Yes NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 21: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear speckles" Vesicles "HPA057428: AB_2683436" "prognostic favorable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favorable (2.76e-5)" 0.4 1.6 0.4 1.1 0.6 3.7 5.5 53.4 2.3 2.1 0.0 0.6 1.4 0.9 3.3 2.0 2.4 2.3 2.2 0.5 0.0 8.0 3.7 2.2 3.0 0.1 3.5 0.1 5.4 1.1 1.4 0.4 5.5 5.9 0.3 33.3 16.3 1.9 0.2 7.0 1.6 0.0 0.1 3.0 3.1 112.4 0.0 3.1 5.7 0.0 1.4 0.9 1.6 16.8 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.6 0.7 1.1 0.0 0.0 1.3 0.0 0.2 0.0 0.8 0.6 2.6 2.8 0.1 0.0 0.3 8.4 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 4.2 0.0 0.3 0.3 17.7 0.4 0.3 0.0 0.8 0.2 0.7 0.8 0.1 0.1 0.0 1.4 1.4 0.0 0.4 3.7 3.4 0.2 0.0 0.5 0.4 0.0 1.4 0.7 0.2 0.0 2.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.1 0.1 0.1 0.2 0.3 0.2 0.3 0.8 0.2 0.0 0.6 0.0 1.7 0.4 0.6 53.4 2.3 0.5 0.0 0.1 3.5 5.5 0.1 0.0 16.8 0.1 0.0 2.3 0.0 0.2 0.8 1.1 1.4 0.0 734.7 7.7 5.8 0.0 2.8 1.8 5.5 22.9 0.2 2.7 0.7 9.8 0.8 836.5 1.0 0.1 2.6 0.0 0.0 0.0 0.2 0.1 0.1 0.0 1.5 1.3 1.3 0.0 0.5 0.4 23.5 0.0 0.4 0.0 0.8 1.3 4139.3 10.5 7.1 1.8 1.0 1.5 40.7 2.1 0.0 0.0 0.4 0.1 13.2 0.3 1.0 1.3 0.5 0.4 100.3 19.7 0.0 0.1 14.5 9.0 0.0 1.1 0.0 1.0 0.0 0.6 0.6 PDCD11 "ALG-4, KIAA0185, NFBP, RRP5" ENSG00000148843 "Programmed cell death 11" Q14690 10 103396626-103446294 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017924, CAB026472" Approved Supported "Nucleoli rim,Vesicles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoli rim" Vesicles "CAB026472: , HPA017924: AB_10601045" "unprognostic (1.34e-1)" "unprognostic (6.84e-2)" "unprognostic (1.48e-1)" "unprognostic (2.31e-2)" "unprognostic (1.80e-1)" "unprognostic (8.94e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.16e-1)" "unprognostic (6.49e-2)" "unprognostic (3.25e-2)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (1.77e-1)" "unprognostic (6.28e-2)" "unprognostic (5.59e-2)" 8.1 7.8 4.1 10.0 4.8 7.5 9.4 4.5 4.6 8.7 4.5 7.7 5.9 9.9 5.9 11.7 9.0 4.4 7.5 4.4 4.7 9.8 9.1 7.3 11.0 4.4 4.5 10.4 11.6 8.5 6.4 7.5 4.6 8.0 7.9 6.1 7.2 6.2 15.8 15.5 7.7 9.1 4.1 9.5 7.3 14.8 5.1 11.9 6.9 8.1 11.8 9.9 8.4 5.0 27.4 39.8 27.2 77.0 23.3 20.9 30.5 29.6 20.7 29.2 23.7 54.7 26.3 74.9 20.5 21.4 18.0 48.0 70.6 37.1 32.5 34.8 47.5 43.7 26.0 44.2 27.7 88.0 28.7 21.8 33.3 44.8 101.3 21.0 31.6 19.4 71.5 32.7 28.4 30.9 44.5 49.9 55.9 21.7 37.9 44.3 39.0 34.1 18.1 26.6 18.2 34.1 19.9 23.2 32.6 26.4 22.8 24.8 34.5 21.5 27.0 29.0 55.9 41.2 61.8 69.5 19.0 83.3 16.2 0.1 2.8 0.9 3.2 2.6 5.2 3.4 3.1 2.7 2.8 2.2 2.7 3.2 0.3 2.1 2.3 3.3 2.3 2.5 4.1 4.8 4.5 4.6 4.4 4.7 4.4 4.5 4.6 4.1 5.1 5.0 8.8 12.8 14.1 5.9 13.6 16.4 9.3 10.8 8.0 15.0 18.6 15.6 14.6 20.0 17.4 9.2 29.2 12.8 18.1 9.6 13.7 23.6 61.2 12.6 25.4 14.4 9.5 14.9 11.8 15.8 15.8 14.0 5.6 11.7 18.9 18.5 8.9 24.5 10.9 6.7 9.3 12.9 4.1 7.7 5.2 19.6 11.1 10.7 10.6 8.4 9.8 4.9 9.2 7.5 7.6 29.1 4.9 10.1 9.6 17.9 4.4 8.2 20.2 13.8 6.6 16.8 11.0 27.5 30.7 14.0 16.9 8.2 11.6 19.0 19.9 8.7 PDCD6IP "AIP1, Alix, Hp95" ENSG00000170248 "Programmed cell death 6 interacting protein" Q8WUM4 3 33798571-33869707 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 299.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011905, CAB016212, HPA051604" Approved Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 4100000 "Cluster 27: Non-specific - Gene expression" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles Centrosome "CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: " "unprognostic (1.53e-1)" "unprognostic (2.63e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.17e-1)" "unprognostic (2.75e-1)" "unprognostic (5.12e-2)" "unprognostic (7.76e-3)" "unprognostic (1.23e-2)" "unprognostic (3.29e-1)" "unprognostic (2.86e-1)" "unprognostic (3.88e-3)" "unprognostic (4.49e-2)" "prognostic favorable (3.90e-9)" "unprognostic (9.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.78e-1)" "unprognostic (1.11e-1)" 33.1 27.6 16.3 24.5 17.9 21.2 32.9 18.4 23.3 35.0 23.0 46.4 36.2 35.1 26.4 46.0 30.9 25.9 30.5 17.6 19.7 35.0 33.2 35.2 26.1 25.2 18.1 34.3 25.0 40.6 22.8 31.2 26.4 30.0 41.5 30.5 29.7 23.7 33.9 39.8 38.8 31.8 18.6 27.5 37.2 23.8 18.8 24.4 34.2 22.1 30.1 26.9 35.9 21.4 47.2 46.4 30.2 25.1 78.5 80.6 34.3 67.2 56.2 50.9 52.2 33.3 43.8 75.9 33.8 77.7 32.2 45.5 47.8 61.4 57.8 27.4 39.5 56.7 37.4 28.2 50.8 56.5 57.6 62.2 69.5 57.6 67.8 60.5 77.1 32.4 50.3 26.2 74.4 27.0 36.3 31.8 29.9 43.5 57.8 32.8 36.5 43.8 64.6 39.2 14.7 26.8 61.6 67.8 30.7 48.9 62.0 51.4 101.1 59.5 28.2 50.1 46.9 26.6 37.6 55.6 56.7 62.6 28.8 6.8 13.5 11.0 8.0 18.1 8.7 12.0 8.9 8.1 12.4 10.8 7.7 7.5 6.8 12.1 18.0 5.0 9.4 10.0 16.3 17.9 18.4 23.3 17.6 19.7 25.2 18.1 26.4 18.6 18.8 21.4 78.5 86.6 84.8 85.8 76.1 41.7 62.6 62.7 51.8 28.6 42.5 34.0 53.4 62.9 80.6 64.4 52.1 53.0 58.5 299.9 37.2 67.2 85.3 121.6 84.0 68.8 36.1 40.6 83.5 78.3 52.8 54.3 96.8 77.8 53.7 53.0 54.3 57.3 60.6 25.2 69.2 97.1 63.1 93.0 44.7 50.4 74.0 85.0 28.4 75.9 71.0 23.1 42.2 96.0 161.7 122.5 127.1 80.5 46.9 56.5 130.2 61.0 130.9 49.9 46.0 42.3 50.4 93.0 48.4 61.5 43.2 96.6 55.2 47.7 86.7 70.3 PDGFD "IEGF, MSTP036, SCDGF-B" ENSG00000170962 "Platelet derived growth factor D" Q9GZP0 11 103907189-104164379 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 106.5;ovary: 78.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;dendritic cells: 30.0;Ductal cells: 30.6;Fibroblasts: 44.3;Inhibitory neurons: 95.0;Microglial cells: 28.1;NK-cells: 46.4" "Cancer enhanced" "Detected in all" "renal cancer: 17.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 9.5;gdT-cell: 16.4;memory CD8 T-cell: 7.2;naive CD8 T-cell: 6.0;NK-cell: 17.1" "Group enriched" "Detected in many" 29 "granulocytes: 9.5;NK-cells: 17.1;T-cells: 16.4" "Group enriched" "Detected in many" 6 "ASC diff: 139.8;HHSteC: 42.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 39.4" "HPA046183, HPA066271" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 95000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA046183: AB_2679573, HPA066271: AB_2685645" "unprognostic (2.21e-1)" "unprognostic (9.35e-2)" "unprognostic (5.60e-2)" "unprognostic (1.72e-1)" "unprognostic (5.81e-2)" "unprognostic (8.83e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (2.26e-1)" "unprognostic (7.01e-3)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.19e-1)" "unprognostic (6.72e-2)" "unprognostic (3.57e-3)" 20.4 106.5 0.5 3.4 0.8 0.9 21.7 0.7 1.3 25.1 9.0 8.8 4.1 11.8 7.1 1.9 9.3 34.0 23.2 0.8 2.2 7.7 2.3 3.1 7.4 5.1 6.6 78.0 25.7 17.1 13.4 7.0 9.4 10.0 9.8 1.5 8.6 37.4 2.2 7.9 4.8 9.7 1.8 2.8 23.4 3.3 2.0 3.7 18.3 8.8 5.4 15.8 15.4 2.3 0.0 7.8 4.0 0.0 139.8 4.2 0.1 0.9 0.8 0.7 0.8 0.0 1.3 7.4 1.4 7.3 5.2 0.4 0.0 0.2 0.3 0.0 3.2 0.2 1.6 0.3 42.6 0.0 0.1 14.7 0.0 0.1 0.0 0.2 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 1.4 0.0 2.1 0.0 6.7 0.0 0.1 9.6 0.0 13.8 3.2 1.8 0.0 2.0 1.0 0.1 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.8 0.6 0.0 9.5 16.4 0.0 1.4 0.4 1.7 7.2 0.0 0.0 0.2 6.0 0.2 17.1 0.1 0.0 0.1 4.2 0.5 0.8 0.7 1.3 0.8 2.2 5.1 6.6 9.4 1.8 2.0 2.3 15.6 0.0 0.0 1.0 1.6 3.1 7.7 0.2 1.8 2.3 1.7 9.4 4.5 32.9 0.6 5.5 0.0 0.2 30.0 0.2 0.0 30.6 8.2 0.8 1.8 10.3 1.8 1.3 13.9 4.4 0.2 44.3 0.0 1.4 0.0 8.1 2.9 0.0 0.3 26.9 95.0 1.0 0.0 1.3 3.7 13.3 0.3 0.8 0.0 28.1 0.9 1.5 46.4 2.0 2.8 3.0 0.5 2.2 8.4 1.6 0.0 0.3 0.0 0.5 6.6 1.9 3.7 0.4 4.3 0.3 2.0 0.0 10.2 5.2 0.6 3.2 PDGFRB "CD140b, JTK12, PDGFR, PDGFR1" ENSG00000113721 "Platelet derived growth factor receptor beta" P09619 5 150113839-150155872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Chemotaxis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Sertoli cells: 1288.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "ASC diff: 1350.1;ASC TERT1: 462.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003842, CAB018144, HPA028499" Enhanced Supported "Golgi apparatus,Vesicles" NA NA 39000000 "Cluster 14: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "Golgi apparatus" "CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018" "unprognostic (4.75e-2)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.27e-1)" "unprognostic (5.61e-2)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (2.12e-2)" "unprognostic (2.57e-3)" "unprognostic (6.72e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.87e-8)" "unprognostic (3.13e-3)" "unprognostic (1.25e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (8.11e-4)" 171.2 25.1 25.4 27.5 27.2 0.7 106.3 20.5 33.3 155.9 43.5 41.6 11.9 101.1 24.2 24.1 89.6 124.5 75.7 22.1 23.2 49.7 13.4 98.3 27.5 22.1 24.6 105.5 20.8 21.9 23.0 113.3 22.8 56.2 14.1 6.3 34.5 43.3 38.1 65.0 37.9 68.9 19.4 41.4 27.9 18.4 27.7 8.7 66.5 44.1 13.8 58.3 98.6 21.6 0.1 0.3 8.3 0.4 1350.1 462.7 3.0 48.9 202.3 33.5 56.4 5.4 0.0 0.0 6.4 142.0 19.0 0.1 0.1 0.4 15.8 0.0 0.0 0.1 3.3 3.5 190.7 0.0 0.4 210.0 0.0 46.3 0.6 106.6 0.1 0.1 0.1 5.5 5.5 0.0 0.1 0.6 9.0 0.2 0.2 3.7 2.5 0.2 0.0 0.0 0.1 24.8 0.5 0.1 0.0 38.2 0.1 0.6 0.4 53.7 17.2 23.1 2.8 0.4 0.0 0.3 33.4 0.1 1.5 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.2 25.4 27.2 20.5 33.3 22.1 23.2 22.1 24.6 22.8 19.4 27.7 21.6 50.8 0.0 1.1 81.9 0.5 24.0 0.5 0.0 2.2 6.6 1.4 3.3 17.3 1.5 0.0 1.8 4.2 0.6 6.0 0.3 0.0 0.8 1.6 2.8 99.5 32.2 0.0 0.0 7.9 0.0 1.1 123.5 2.0 2.3 0.0 2.5 6.4 1.9 1.5 0.0 1.3 0.7 0.0 0.0 35.6 10.9 165.3 3.1 24.9 45.0 0.7 50.7 23.7 10.1 3.3 0.1 0.1 203.8 2.3 0.7 0.3 0.1 0.7 2.9 1288.5 6.6 288.3 1.9 1.6 0.8 15.3 0.8 4.8 4.0 0.4 1.1 PDXDC1 KIAA0251 ENSG00000179889 "Pyridoxal dependent decarboxylase domain containing 1" Q6P996 16 14974591-15139339 "Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 483.6;Late spermatids: 733.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047369, HPA049121, HPA051484" Approved Enhanced "Golgi apparatus,Vesicles" NA NA 9600 "Cluster 39: Non-specific - mRNA processing" "Cluster 71: Testis - DNA repair" "Cluster 6: T47d - Mammary gland" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus, Vesicles" "HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502" "unprognostic (3.67e-2)" "unprognostic (4.99e-1)" "unprognostic (1.97e-3)" "unprognostic (1.84e-1)" "unprognostic (9.08e-2)" "unprognostic (2.18e-1)" "unprognostic (6.47e-3)" "unprognostic (4.97e-2)" "unprognostic (2.43e-1)" "unprognostic (2.74e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "prognostic favorable (3.13e-4)" "unprognostic (4.58e-2)" "unprognostic (8.11e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-1)" 33.3 37.9 4.9 20.9 5.0 12.9 33.1 14.7 6.5 35.7 7.9 61.3 52.5 31.9 17.0 43.4 29.2 20.8 39.1 6.0 4.1 47.6 104.5 34.6 13.4 6.2 4.7 31.1 70.4 27.1 63.2 23.5 7.5 55.8 47.8 13.4 80.5 25.2 52.0 27.8 61.1 18.5 1.2 31.8 56.7 113.2 7.2 11.7 42.9 16.5 15.0 39.1 34.7 5.7 21.4 30.9 31.1 26.1 16.9 20.4 51.4 19.6 17.4 14.3 19.7 38.0 45.3 40.7 42.0 26.5 20.5 34.0 22.1 20.1 20.5 25.0 30.2 24.7 51.8 100.2 44.3 19.7 56.4 21.5 20.4 25.0 20.9 28.0 15.3 21.6 18.5 26.0 34.1 52.2 12.9 10.4 15.3 20.8 11.7 19.9 12.9 48.6 22.7 33.9 31.9 22.8 52.6 30.0 50.9 19.7 121.0 30.3 23.8 11.0 10.0 12.3 25.7 24.2 25.1 39.3 22.7 16.4 35.8 2.9 7.8 11.6 9.4 7.7 10.8 8.3 6.8 7.7 11.7 9.0 8.2 8.1 1.0 7.5 6.2 5.4 6.6 8.2 4.9 5.0 14.7 6.5 6.0 4.1 6.2 4.7 7.5 1.2 7.2 5.7 29.6 38.5 64.6 32.7 33.0 38.2 42.2 21.6 18.8 32.1 57.9 27.8 45.7 58.6 52.9 29.5 31.3 51.7 30.6 149.8 27.4 38.2 483.6 48.1 41.7 35.1 161.2 33.2 80.7 58.3 56.5 36.0 71.9 75.3 39.3 42.1 27.5 123.6 30.5 40.4 68.3 216.7 24.4 33.1 16.8 733.8 49.0 30.9 26.6 31.9 27.5 19.7 39.1 55.8 45.0 46.5 114.4 45.5 45.4 58.1 115.6 53.4 48.3 47.4 46.0 24.0 28.0 142.3 72.7 24.6 42.6 80.7 33.9 21.2 127.2 76.5 PEX11B ENSG00000131779 "Peroxisomal biogenesis factor 11 beta" O96011 1 145911350-145918717 "Disease related genes, Predicted membrane proteins" "Peroxisome biogenesis" "Peroxisome biogenesis disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017150, HPA050104" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 43: THP-1 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles Nucleoplasm "HPA017150: , HPA050104: AB_2681017" "unprognostic (4.59e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.29e-1)" "unprognostic (3.62e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.67e-4)" "prognostic favorable (6.85e-4)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (2.10e-1)" "unprognostic (8.48e-2)" "unprognostic (6.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (7.62e-3)" "unprognostic (4.28e-1)" 17.5 25.1 34.7 19.0 35.8 13.3 31.2 32.5 42.5 24.6 33.3 24.9 24.6 23.4 33.1 34.3 25.7 17.0 28.0 36.3 38.1 32.4 27.1 20.1 27.4 33.3 33.0 24.6 27.2 33.5 24.5 23.1 35.1 24.3 27.6 20.2 28.7 25.6 39.8 28.1 25.9 21.0 31.6 27.7 28.3 30.8 34.1 30.2 26.4 34.9 34.7 23.2 22.2 34.2 27.1 24.4 21.0 21.1 48.6 37.9 21.9 26.8 35.3 34.4 26.5 11.3 30.7 25.2 28.1 38.3 16.6 31.9 18.6 40.0 24.0 28.4 14.1 15.6 14.8 29.2 68.3 46.9 27.5 49.9 49.3 23.3 22.8 43.9 44.5 34.8 28.7 40.5 54.7 43.1 35.8 43.5 7.5 57.4 29.5 33.0 31.5 55.5 58.8 19.1 14.7 24.0 20.2 38.4 24.7 20.5 53.2 72.0 39.7 23.1 18.2 30.3 19.8 43.1 54.0 35.1 38.5 26.3 16.0 89.6 64.7 47.3 58.5 60.9 64.8 93.2 67.5 65.4 70.8 84.1 74.7 67.9 32.4 71.1 60.5 94.9 79.6 82.7 34.7 35.8 32.5 42.5 36.3 38.1 33.3 33.0 35.1 31.6 34.1 34.2 5.0 16.0 10.3 9.8 17.0 19.4 9.2 41.3 26.7 8.0 16.8 17.0 12.8 17.2 20.7 40.5 0.0 37.9 19.6 20.2 45.0 13.7 12.2 8.2 7.0 12.3 12.7 14.1 13.0 13.8 13.9 11.1 19.4 7.4 3.8 9.3 18.2 32.9 23.0 5.0 13.5 16.0 20.3 18.3 10.7 21.1 14.0 12.9 21.4 4.7 27.1 12.6 25.7 9.5 12.9 16.0 11.4 19.9 17.4 10.1 20.1 34.5 22.9 5.1 6.6 5.8 10.3 41.1 24.3 34.0 22.0 20.0 13.8 11.6 15.8 9.4 PEX7 "PTS2R, RD" ENSG00000112357 "Peroxisomal biogenesis factor 7" O00628 6 136822564-136913934 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049202 Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Vesicles" "HPA049202: AB_2680674" "unprognostic (1.36e-2)" "unprognostic (2.07e-2)" "prognostic favorable (1.61e-4)" "unprognostic (4.01e-3)" "unprognostic (2.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (6.88e-2)" "prognostic favorable (1.85e-10)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (2.52e-2)" "unprognostic (2.65e-1)" 5.2 14.8 4.6 2.0 4.8 3.8 11.9 6.0 5.2 6.8 5.1 7.9 5.3 4.2 17.2 7.3 8.7 4.5 11.7 4.2 4.2 15.6 9.1 4.9 3.2 4.3 4.4 5.0 26.9 17.1 6.0 4.1 4.5 10.4 8.4 6.9 10.6 6.4 10.7 11.2 4.7 3.3 4.4 3.3 15.6 10.0 4.7 3.7 11.0 9.8 3.3 5.4 6.7 5.5 4.4 4.3 4.4 6.2 6.6 9.8 2.4 6.1 8.9 7.5 7.4 4.9 6.0 1.5 11.3 8.3 8.5 5.3 3.3 13.8 9.8 5.7 7.5 6.4 4.3 0.9 13.9 8.1 5.3 9.6 13.1 5.4 7.9 8.7 5.4 12.0 13.0 5.2 10.6 13.4 3.5 7.9 5.0 13.9 8.3 4.8 3.4 5.7 17.4 6.4 8.3 10.6 6.5 9.0 8.4 4.9 5.8 7.7 2.5 4.8 1.7 7.3 5.3 6.9 5.1 0.0 4.2 6.4 4.9 2.9 1.3 2.2 0.7 1.0 0.7 1.5 1.3 1.6 2.3 1.0 2.4 1.5 0.9 1.6 1.9 1.8 2.3 0.9 4.6 4.8 6.0 5.2 4.2 4.2 4.3 4.4 4.5 4.4 4.7 5.5 4.9 3.2 9.4 10.7 6.3 12.1 14.9 16.5 9.1 9.1 19.5 13.8 18.7 11.5 14.7 11.0 8.4 19.6 2.3 11.6 60.7 16.5 12.5 18.7 6.4 5.6 10.3 15.8 12.4 22.7 21.0 6.8 10.2 11.1 14.0 7.9 6.1 7.0 12.4 0.0 14.7 21.8 30.5 5.7 6.2 10.2 9.0 6.4 14.2 5.6 11.9 20.8 4.1 17.6 19.9 16.7 13.2 9.8 3.7 16.0 15.0 38.3 16.1 9.9 6.6 5.7 8.2 30.6 16.7 15.4 18.2 17.1 6.6 24.3 17.2 17.4 PFN3 ENSG00000196570 "Profilin 3" P60673 5 177400109-177400661 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 25.7" "Group enriched" "Detected in some" 176 "Early spermatids: 666.2;Late spermatids: 1589.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038274 Approved Vesicles,Cytosol NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "Vesicles, Cytosol" "HPA038274: " "unprognostic (1.03e-2)" "unprognostic (1.13e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 666.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1589.2 6.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PGLYRP4 "PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67" ENSG00000163218 "Peptidoglycan recognition protein 4" Q96LB8 1 153330120-153348841 "Metabolic proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix: 8.5;esophagus: 8.2;skin 1: 15.1;vagina: 10.3" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 30.1;Club cells: 9.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.7;HDLM-2: 2.2;Karpas-707: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB025879 Approved "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Plasma membrane" "CAB025879: " "unprognostic (2.76e-2)" "unprognostic (1.19e-1)" "unprognostic (6.10e-2)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.46e-1)" "unprognostic (3.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.15e-1)" "unprognostic (1.81e-1)" "unprognostic (1.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 15.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 2.3 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 30.1 0.6 0.0 0.0 0.1 0.3 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.0 1.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 2.0 0.0 0.3 0.3 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 4.0 3.4 0.3 0.0 0.0 0.2 0.2 PHKA1 PHKA ENSG00000067177 "Phosphorylase kinase regulatory subunit alpha 1" P46020 X 72578814-72714319 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Muscle protein" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "parathyroid gland: 32.0;skeletal muscle: 102.6;tongue: 89.2" "Cell type enriched" "Detected in many" 4 "Astrocytes: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001081, HPA075355" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Vesicles, Cytosol" "HPA001081: AB_1079607, HPA075355: " "unprognostic (3.68e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (3.52e-1)" "unprognostic (5.48e-2)" "unprognostic (1.23e-2)" "unprognostic (9.64e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (2.18e-1)" "unprognostic (4.76e-1)" "unprognostic (9.45e-3)" "unprognostic (9.94e-2)" "unprognostic (2.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" 3.2 17.7 6.9 1.0 11.4 0.7 4.8 8.9 5.7 2.6 17.0 4.0 1.1 3.3 6.5 5.6 3.8 3.2 7.5 6.0 8.7 2.7 2.3 2.1 1.1 8.8 11.9 8.3 7.6 32.0 9.8 1.8 9.1 6.0 3.3 3.9 7.1 6.4 102.6 3.4 2.1 3.4 7.9 3.4 6.9 2.1 10.4 4.0 6.9 89.2 1.4 4.8 3.5 6.7 15.3 21.2 1.2 12.4 7.2 6.8 12.9 2.8 2.6 0.5 0.1 6.2 13.3 0.0 8.2 0.3 15.1 5.9 24.9 10.3 0.8 39.2 25.1 7.0 17.4 5.7 7.5 0.0 0.0 9.1 10.0 2.4 16.7 12.5 14.5 12.7 11.0 0.0 13.6 11.0 11.1 0.7 16.5 25.2 28.0 0.0 0.0 0.0 3.7 7.2 12.9 15.3 13.4 17.3 0.2 15.4 6.2 0.6 7.5 0.0 6.2 2.7 7.3 17.1 17.1 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 11.4 8.9 5.7 6.0 8.7 8.8 11.9 9.1 7.9 10.4 6.7 5.8 0.0 3.7 85.2 0.5 2.4 6.5 2.3 4.0 2.4 5.2 3.7 6.6 1.5 3.5 11.0 8.4 1.0 0.1 0.8 0.0 1.6 0.4 4.8 1.4 3.5 2.4 4.0 5.3 2.7 1.1 2.5 3.6 2.9 6.3 3.4 5.7 1.9 1.6 3.3 16.0 1.8 4.1 10.4 0.7 0.1 3.1 0.6 1.8 6.5 0.0 1.5 0.0 18.6 0.5 5.4 0.4 8.6 1.3 9.0 0.4 1.6 6.6 3.3 0.0 7.1 1.9 0.4 1.0 5.6 3.4 0.5 0.3 1.9 2.6 8.9 PHOSPHO2 MGC22679 ENSG00000144362 "Phosphatase, orphan 2" Q8TCD6 2 169694454-169701708 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 158.7;Spermatocytes: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034726, HPA034727" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 1: Thyroid gland - Transcription" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles Nucleoplasm "HPA034726: AB_10602191, HPA034727: AB_2674302" "unprognostic (1.98e-1)" "unprognostic (1.22e-1)" "unprognostic (7.56e-2)" "unprognostic (1.39e-3)" "unprognostic (1.30e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (3.82e-6)" "unprognostic (4.31e-2)" "unprognostic (2.11e-2)" "unprognostic (5.19e-2)" "unprognostic (1.40e-1)" "unprognostic (2.31e-1)" "prognostic favorable (9.53e-4)" "unprognostic (4.10e-1)" "unprognostic (2.60e-1)" "unprognostic (6.12e-2)" "unprognostic (7.53e-2)" 5.0 2.8 1.9 2.4 1.9 2.9 10.6 4.1 1.6 4.7 3.7 5.8 6.4 5.3 4.2 3.2 6.0 4.0 2.7 1.6 2.8 5.6 3.6 3.3 3.0 1.4 1.8 6.0 5.1 7.2 4.6 3.0 1.5 13.0 5.8 7.2 8.5 4.7 3.4 3.5 6.4 3.1 1.7 2.5 4.7 13.7 2.4 3.0 9.8 1.6 3.0 3.8 2.8 1.9 6.6 1.8 4.6 6.2 8.5 2.7 17.8 2.8 1.9 4.3 4.7 6.3 4.9 6.4 6.1 2.1 8.9 5.0 6.2 3.4 3.5 9.5 7.0 6.4 6.1 11.0 5.6 5.3 5.6 4.9 6.3 4.9 6.5 3.6 3.9 8.9 10.8 6.4 2.7 6.0 3.7 6.8 6.0 4.2 2.3 3.6 2.8 5.1 6.8 19.6 19.1 6.5 5.8 3.1 6.8 5.5 8.4 3.2 2.3 4.7 4.3 4.2 3.1 6.2 6.0 5.7 5.5 3.2 5.1 0.1 0.7 1.0 3.3 0.9 4.6 6.5 3.6 3.2 0.9 8.8 4.7 4.6 1.3 9.8 0.9 4.2 4.4 1.4 1.9 1.9 4.1 1.6 1.6 2.8 1.4 1.8 1.5 1.7 2.4 1.9 6.1 3.2 3.6 0.0 6.8 2.5 10.3 5.4 2.8 8.7 15.2 11.0 4.1 5.7 4.7 3.7 6.2 8.8 2.5 7.0 9.8 7.6 158.7 10.6 5.0 4.3 15.0 6.9 0.0 11.1 9.3 6.9 15.3 3.3 0.0 5.7 2.5 3.7 2.8 6.7 0.0 6.6 12.2 0.6 1.6 35.9 4.7 2.0 3.6 0.0 1.0 6.4 1.0 0.0 0.0 6.4 6.8 4.9 3.8 6.5 12.7 12.2 13.4 10.2 0.0 6.7 9.3 68.9 13.9 4.5 4.3 5.5 5.7 8.8 7.5 5.5 PI15 P25TI ENSG00000137558 "Peptidase inhibitor 15" O43692 8 74824534-74855029 "Predicted secreted proteins" "Developmental protein, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.4;prostate: 31.0;smooth muscle: 49.9" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 36.8;Breast glandular cells: 73.2;Breast myoepithelial cells: 13.6;Prostatic glandular cells: 19.3;Smooth muscle cells: 36.2;Urothelial cells: 15.7" "Group enriched" "Detected in many" 7 "breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 23.3;SH-SY5Y: 21.3;SK-MEL-30: 30.0;U-266/70: 7.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "spinal cord: 6.3" "HPA006593, HPA030057" Uncertain Approved Vesicles,Cytosol "Secreted in other tissues" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 35: Glandular cells - Unknown function" Vesicles Cytosol "HPA006593: AB_1078568, HPA030057: AB_10602143" "unprognostic (2.77e-1)" "unprognostic (1.57e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-2)" "unprognostic (3.22e-1)" "unprognostic (3.24e-1)" "unprognostic (2.94e-2)" "unprognostic (2.33e-3)" "unprognostic (1.87e-1)" "unprognostic (2.25e-1)" "unprognostic (3.65e-2)" "unprognostic (1.85e-2)" "unprognostic (8.63e-14)" "unprognostic (2.54e-3)" "unprognostic (1.34e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" 5.8 1.1 0.6 54.4 0.8 0.0 22.1 0.1 1.6 11.0 0.0 7.8 0.2 19.8 2.1 2.5 20.9 1.5 1.8 0.9 0.9 0.9 0.2 2.2 0.6 0.7 0.8 6.3 0.3 0.0 0.5 0.3 0.4 31.0 4.6 0.6 2.0 6.8 0.4 0.4 4.6 49.9 1.1 1.3 0.7 0.5 2.4 0.4 0.6 0.2 0.2 8.3 6.5 0.6 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.1 21.3 0.0 0.1 30.0 0.4 0.5 0.5 0.0 0.0 0.5 0.0 0.1 7.9 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.1 1.6 0.9 0.9 0.7 0.8 0.4 1.1 2.4 0.6 0.2 0.0 0.0 2.3 0.1 0.1 36.8 0.0 0.6 0.2 73.2 13.6 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.6 0.2 9.1 2.5 0.0 0.0 4.3 0.0 0.4 3.9 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.6 1.9 0.9 0.2 3.6 1.0 0.0 0.0 0.0 0.5 2.0 0.0 0.0 0.0 0.1 19.3 0.0 0.1 0.0 0.5 0.0 1.7 36.2 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.0 15.7 PIK3CD p110D ENSG00000171608 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta" O00329 1 9651731-9729114 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 60.9;lymphoid tissue: 50.4" "Cell type enhanced" "Detected in many" "dendritic cells: 44.0;granulocytes: 25.3;Kupffer cells: 35.2;Microglial cells: 29.0;NK-cells: 29.9;T-cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 153.3;NB-4: 65.9;REH: 68.9;THP-1: 65.4;U-937: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015420, HPA044953" Enhanced Approved "Vesicles,Cytokinetic bridge" Yes No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Cytokinetic bridge" "CAB015420: AB_831654, HPA044953: AB_2679153" "unprognostic (5.73e-3)" "unprognostic (2.75e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-2)" "unprognostic (4.71e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (2.78e-2)" "unprognostic (1.54e-2)" "unprognostic (3.46e-2)" "unprognostic (6.75e-2)" "unprognostic (8.65e-3)" "unprognostic (2.09e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (6.78e-2)" 7.2 3.1 6.8 33.4 6.3 60.9 3.9 6.1 7.5 6.2 6.4 5.4 5.2 4.9 1.7 4.9 6.1 7.0 3.3 7.0 5.3 6.4 3.5 12.0 46.9 7.3 6.6 7.0 3.0 2.9 2.8 4.2 7.8 4.6 3.4 0.6 5.1 2.7 1.2 3.0 17.2 4.7 6.6 50.4 5.7 4.0 9.3 24.3 5.5 3.5 32.0 7.4 5.1 8.5 8.1 5.2 0.4 1.4 1.3 1.1 0.7 12.1 24.5 26.0 21.1 0.3 3.3 21.5 4.9 9.8 12.4 2.4 2.0 11.0 16.2 153.3 0.4 2.4 1.3 9.0 5.1 56.0 18.7 4.3 4.5 29.2 9.8 11.4 3.8 14.9 8.0 0.1 15.0 0.6 5.4 65.9 2.2 0.3 1.4 68.9 13.0 0.7 10.9 0.0 1.7 1.5 2.7 4.9 11.9 6.8 0.8 65.4 9.8 7.7 7.9 0.2 11.5 4.9 4.9 30.1 16.7 78.6 4.4 18.0 23.5 40.2 21.6 23.0 22.6 12.8 16.3 19.9 22.5 13.6 20.9 23.1 63.2 25.9 29.2 25.7 13.3 38.3 6.8 6.3 6.1 7.5 7.0 5.3 7.3 6.6 7.8 6.6 9.3 8.5 1.7 9.6 13.4 2.0 22.2 1.5 2.2 1.8 4.0 0.7 2.0 1.7 3.1 0.0 1.1 0.0 2.1 0.3 44.0 0.1 1.9 3.9 3.0 2.0 1.7 2.7 0.0 10.3 6.7 2.0 0.5 2.9 0.0 1.0 25.3 4.2 3.6 0.0 14.7 0.0 13.4 0.1 0.0 35.2 6.0 2.8 1.2 23.1 3.6 29.0 19.3 2.5 29.9 1.0 1.1 11.3 0.0 1.5 8.2 4.1 0.2 3.8 3.3 1.3 6.6 2.0 4.7 1.5 3.4 2.9 1.1 0.3 37.1 1.5 0.2 2.1 PIK3R3 p55 ENSG00000117461 "Phosphoinositide-3-kinase regulatory subunit 3" Q92569 1 46040140-46133036 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 199.0;Endothelial cells: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 5.8" "Group enriched" "Detected in many" 9 "granulocytes: 5.8;monocytes: 2.4;T-cells: 2.3" "Cell line enhanced" "Detected in all" "RT4: 76.1" "Low region specificity" "Detected in all" "HPA005751, HPA071988" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 15: RT4 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles Nucleoplasm "HPA005751: AB_1855350, HPA071988: AB_2686479" "unprognostic (1.98e-1)" "unprognostic (3.75e-3)" "unprognostic (8.04e-2)" "prognostic favorable (1.93e-4)" "unprognostic (6.32e-2)" "prognostic favorable (3.62e-4)" "unprognostic (4.88e-2)" "unprognostic (3.33e-3)" "unprognostic (4.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (9.99e-3)" "unprognostic (2.87e-2)" "unprognostic (9.74e-2)" "unprognostic (6.71e-2)" "unprognostic (8.22e-3)" 31.2 12.2 13.0 7.2 11.2 0.7 28.0 35.9 14.8 15.3 14.0 7.5 3.2 15.9 10.3 7.1 10.1 10.7 35.2 11.4 14.9 16.2 4.0 18.5 6.2 16.7 17.3 4.1 4.7 12.1 8.5 13.3 16.8 12.0 4.9 17.9 12.5 6.1 12.0 6.4 8.6 11.5 15.5 11.2 9.9 25.4 15.9 10.8 14.2 18.5 5.3 14.8 7.4 11.4 10.9 3.6 47.4 24.4 4.6 2.0 15.2 6.3 4.6 8.2 10.1 2.1 3.2 14.3 18.9 2.5 9.9 6.4 16.9 5.8 5.3 11.1 15.0 9.3 41.8 1.6 1.5 8.3 11.8 5.8 3.3 8.7 3.2 7.8 17.3 32.8 3.5 10.0 11.8 16.7 33.4 5.1 16.9 3.1 9.6 42.0 12.7 17.0 20.4 76.1 34.4 24.9 20.5 53.5 5.7 28.5 14.9 7.3 32.4 8.7 8.0 1.5 6.2 14.1 15.8 8.5 6.9 10.9 4.5 0.0 0.2 5.8 2.0 0.3 1.9 0.3 0.4 1.8 0.0 0.0 0.1 1.1 0.0 0.0 2.4 0.3 2.3 0.6 13.0 11.2 35.9 14.8 11.4 14.9 16.7 17.3 16.8 15.5 15.9 11.4 199.0 0.0 8.4 15.7 3.1 2.5 5.4 42.1 14.8 48.3 32.0 30.1 21.1 0.0 28.8 18.4 45.9 4.4 13.9 21.7 0.0 0.6 11.8 13.9 21.0 83.3 7.8 5.9 26.2 1.2 1.1 16.2 55.5 26.2 9.5 6.1 0.0 0.0 1.7 3.3 55.9 8.6 38.7 0.0 4.4 19.9 1.2 8.4 5.4 60.9 0.9 33.5 3.1 22.1 7.1 1.4 1.5 7.9 10.1 7.2 4.5 4.2 26.7 42.8 0.0 13.3 18.0 35.9 31.7 8.0 1.8 1.4 15.7 19.2 6.6 5.0 PIK3R4 "p150, VPS15" ENSG00000196455 "Phosphoinositide-3-kinase regulatory subunit 4" Q99570 3 130678934-130746829 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036032, HPA036033" Approved Approved Vesicles,Microtubules NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Vesicles Microtubules "HPA036032: AB_10610281, HPA036033: AB_2674911" "unprognostic (7.50e-2)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (4.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (1.02e-3)" "unprognostic (7.26e-2)" "prognostic favorable (4.40e-6)" "unprognostic (8.25e-2)" "unprognostic (3.72e-1)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" 8.8 8.5 3.7 7.8 4.2 8.9 10.0 5.2 4.9 9.4 5.6 8.2 7.5 10.1 7.9 8.0 9.1 7.2 7.6 4.1 4.5 10.5 21.2 9.6 9.4 3.2 3.6 12.4 6.9 17.6 6.1 9.7 3.8 9.8 8.1 16.5 7.6 9.6 7.3 7.8 8.0 10.4 3.8 10.0 7.5 11.4 3.2 11.4 13.1 8.6 10.4 9.0 6.5 7.1 20.7 12.9 18.5 13.4 26.6 21.1 12.8 15.0 17.9 20.2 23.3 16.7 17.1 24.2 18.4 15.2 16.1 28.7 30.7 23.3 31.6 14.7 11.3 19.7 13.8 11.7 12.2 30.3 9.5 14.7 16.4 21.7 13.6 12.6 19.0 13.8 23.3 11.9 18.1 18.1 24.9 9.2 23.3 18.6 12.4 17.2 21.4 21.9 13.2 16.7 17.0 12.4 21.6 13.4 15.3 21.5 18.6 13.1 15.2 15.5 13.3 17.6 12.2 13.8 13.5 31.2 17.0 11.3 14.7 9.7 5.3 7.0 6.3 6.0 9.3 5.6 5.7 4.7 6.9 3.5 6.6 6.0 4.4 8.5 6.6 2.4 6.8 5.3 3.7 4.2 5.2 4.9 4.1 4.5 3.2 3.6 3.8 3.8 3.2 7.1 8.3 6.4 8.7 18.6 8.8 3.8 3.9 5.7 10.8 8.1 5.7 4.7 7.7 8.6 9.6 11.0 14.6 5.6 7.2 5.5 1.9 5.0 4.4 8.9 7.5 8.9 3.0 9.2 28.5 5.8 3.4 6.9 13.3 9.9 9.5 9.5 7.5 18.2 5.9 5.0 30.3 6.8 8.2 6.4 2.6 3.1 9.6 7.3 5.4 20.6 7.1 9.0 6.2 22.1 32.9 6.6 4.3 11.7 6.9 4.8 6.2 4.2 12.6 12.6 6.6 8.9 6.2 17.0 13.9 9.5 4.4 4.2 7.5 9.6 6.1 3.4 PIP5K1B "MSS4, STM7" ENSG00000107242 "Phosphatidylinositol-4-phosphate 5-kinase type 1 beta" O14986 9 68705240-69009176 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 97.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 127.4;Early spermatids: 100.0;Inhibitory neurons: 270.1;Muller glia cells: 120.2" "Group enriched" "Detected in many" 4 "colorectal cancer: 10.1;pancreatic cancer: 3.4;stomach cancer: 9.4;testis cancer: 3.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "eosinophil: 34.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 34.5" "Cell line enhanced" "Detected in some" "AF22: 43.8;HEL: 17.0;Hep G2: 13.4;OE19: 73.1;U-266/70: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009687 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Vesicles "HPA009687: AB_1855391" "unprognostic (2.02e-3)" "unprognostic (1.84e-2)" "unprognostic (3.77e-2)" "unprognostic (2.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-3)" "unprognostic (1.80e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-2)" "unprognostic (2.92e-2)" "prognostic favorable (1.03e-9)" "unprognostic (2.10e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" 4.2 11.9 5.6 6.0 5.3 16.1 4.9 18.4 8.1 6.3 97.3 31.2 34.8 7.5 1.7 1.2 6.0 4.0 32.2 12.3 10.7 7.8 0.3 12.9 2.6 7.9 11.2 1.0 8.6 13.7 6.6 6.5 6.3 3.1 29.1 38.0 16.4 9.6 2.9 2.3 30.8 2.9 4.0 2.6 26.1 24.7 11.4 1.0 1.2 5.1 3.6 3.3 2.5 3.7 0.0 0.0 43.8 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 4.6 0.0 3.6 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.8 17.0 0.3 13.4 0.0 0.9 4.4 0.0 2.0 0.0 0.0 0.0 0.1 0.5 0.9 9.3 0.3 1.1 0.1 0.2 2.3 73.1 1.4 1.4 0.1 0.3 0.3 3.4 0.9 0.1 0.0 0.1 0.5 1.0 0.2 0.1 0.1 0.0 0.4 0.1 0.0 17.0 3.5 2.3 0.0 3.1 0.0 5.6 0.5 34.5 0.0 0.0 0.0 4.7 0.3 0.1 0.1 5.4 0.7 0.1 1.7 0.0 0.2 1.4 1.6 0.3 5.6 5.3 18.4 8.1 12.3 10.7 7.9 11.2 6.3 4.0 11.4 3.7 3.6 35.3 34.4 28.7 19.2 0.6 3.2 0.5 0.6 5.1 4.7 3.3 61.6 2.8 2.8 5.5 2.1 21.3 0.0 127.4 27.4 1.6 100.0 12.8 13.6 3.3 37.0 53.6 84.7 14.0 1.3 3.1 40.2 27.5 5.7 3.8 1.4 0.0 3.9 0.0 270.1 32.6 14.2 1.0 1.3 47.6 2.5 5.6 5.4 60.0 2.6 120.2 0.0 80.9 6.4 5.2 46.6 1.5 43.2 2.5 39.2 1.4 6.5 3.3 26.3 2.5 32.2 39.0 4.5 0.7 0.3 8.8 2.1 0.9 29.7 9.8 PITPNA "PITPN, VIB1A" ENSG00000174238 "Phosphatidylinositol transfer protein alpha" Q00169 17 1517718-1562792 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol NA NA 190000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 10: Non-specific - Unknown function" Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (1.54e-1)" "unprognostic (6.63e-2)" "unprognostic (2.43e-1)" "prognostic favorable (2.29e-4)" "unprognostic (7.88e-2)" "unprognostic (8.89e-3)" "unprognostic (2.37e-1)" "unprognostic (1.37e-1)" "unprognostic (7.33e-2)" "unprognostic (3.17e-2)" "prognostic favorable (1.80e-6)" "unprognostic (7.41e-2)" "prognostic favorable (9.35e-4)" "unprognostic (1.72e-1)" "unprognostic (1.23e-1)" "unprognostic (8.10e-2)" "unprognostic (6.81e-3)" 42.5 36.8 41.7 61.0 45.4 93.6 41.7 46.6 56.2 50.7 51.0 47.2 56.7 55.3 58.8 76.6 65.9 45.4 39.1 43.8 50.5 40.0 39.0 46.9 40.4 62.4 45.4 32.1 33.9 60.8 33.1 50.2 58.4 54.2 55.6 47.6 84.1 61.7 24.7 93.2 88.9 54.3 41.9 42.4 40.5 44.8 52.2 33.2 64.7 22.7 57.1 51.9 41.8 43.0 64.9 70.5 70.5 61.0 72.1 78.8 110.7 68.9 75.8 70.6 50.9 78.7 25.7 81.8 62.4 94.0 45.4 79.5 64.2 68.4 97.0 68.3 69.2 44.7 61.4 37.0 70.6 31.1 51.6 58.9 90.6 70.5 73.1 74.4 118.4 67.1 63.3 44.9 74.8 36.5 80.1 28.5 49.3 103.4 34.1 63.8 27.2 46.9 70.5 73.5 25.2 55.2 83.2 59.1 51.4 70.5 52.2 24.7 113.8 44.8 39.5 126.4 95.5 27.2 49.8 28.8 77.4 47.9 58.4 3.7 2.4 3.2 2.1 2.7 4.0 4.3 3.1 2.8 3.5 3.1 2.9 2.6 8.0 3.7 1.9 2.7 5.2 1.7 41.7 45.4 46.6 56.2 43.8 50.5 62.4 45.4 58.4 41.9 52.2 43.0 29.3 35.3 35.0 28.7 14.1 31.0 17.5 12.0 12.0 36.4 30.0 30.2 23.9 17.2 17.1 25.8 8.4 43.4 26.9 41.2 13.7 16.0 12.0 50.5 48.4 31.4 22.1 15.6 42.4 18.5 47.3 19.1 13.3 36.5 19.0 16.8 34.6 30.2 40.5 40.4 46.3 27.7 10.2 29.9 49.7 16.8 12.5 36.4 19.6 36.5 36.6 40.2 13.4 12.1 16.0 26.0 22.9 21.8 15.7 33.0 78.0 16.3 21.7 18.4 6.6 18.8 45.1 35.8 34.7 37.8 41.8 120.0 14.9 24.7 25.3 27.0 PITPNB VIB1B ENSG00000180957 "Phosphatidylinositol transfer protein beta" P48739 22 27851669-27920134 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol NA NA 300000 "Cluster 44: Non-specific - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (9.29e-2)" "unprognostic (1.64e-1)" "unprognostic (4.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.34e-1)" "unprognostic (7.52e-3)" "unprognostic (4.78e-2)" "unprognostic (8.22e-3)" "unprognostic (1.56e-3)" "unprognostic (2.42e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (6.28e-2)" "unprognostic (2.89e-2)" "unprognostic (1.64e-1)" 42.2 27.1 27.9 33.3 30.4 21.6 33.0 30.9 34.1 31.7 22.6 53.1 21.9 31.5 28.6 52.5 29.3 35.4 35.8 32.2 31.6 25.2 56.9 32.1 34.6 29.5 31.8 30.0 28.3 24.0 22.5 49.2 30.5 27.5 30.1 18.1 24.7 37.0 21.3 30.3 28.1 44.2 29.1 27.7 35.3 19.4 31.9 33.4 24.8 21.7 41.1 54.2 36.6 30.5 94.1 39.8 71.5 53.8 62.3 74.7 54.5 88.8 77.4 95.5 91.7 63.4 43.1 64.7 46.0 86.0 70.5 96.6 103.0 88.7 133.2 111.1 97.4 66.1 62.0 58.5 66.9 152.5 102.6 67.2 85.0 115.7 119.6 62.9 94.4 44.8 95.3 130.5 88.5 50.0 64.9 74.7 54.4 97.8 52.1 81.6 112.9 95.6 79.1 87.6 83.6 104.7 60.8 72.7 75.7 75.9 39.4 53.7 93.2 94.9 138.9 72.9 94.2 53.0 66.7 125.2 81.6 74.1 82.2 36.0 18.6 18.6 30.9 21.7 34.0 35.2 29.7 32.3 24.9 30.9 28.4 28.0 16.7 27.4 21.2 22.2 40.8 26.0 27.9 30.4 30.9 34.1 32.2 31.6 29.5 31.8 30.5 29.1 31.9 30.5 97.0 28.9 32.4 57.8 44.3 96.0 128.9 40.8 65.4 24.1 37.4 33.4 57.8 35.8 48.4 31.3 14.6 39.7 45.9 26.1 37.2 49.0 21.4 55.4 72.5 62.4 25.2 15.8 51.8 50.2 52.3 65.9 32.6 79.8 21.5 37.0 30.7 45.8 27.3 32.0 45.7 26.7 24.4 23.6 42.2 6.9 32.0 35.1 26.6 68.4 55.6 17.4 48.4 60.8 67.0 66.7 21.1 48.2 54.2 97.5 17.2 29.6 22.8 16.1 26.3 57.9 76.7 44.0 35.4 60.9 82.1 48.6 42.3 46.9 24.0 112.9 PITPNM1 "DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1" ENSG00000110697 "Phosphatidylinositol transfer protein membrane associated 1" O00562 11 67491768-67506263 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Distal enterocytes: 69.9;Endometrial ciliated cells: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 91.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060227 Approved Supported Vesicles,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Vesicles "HPA060227: AB_2684226" "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" "unprognostic (1.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.83e-2)" "unprognostic (8.68e-2)" "unprognostic (8.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.77e-1)" "unprognostic (2.26e-2)" "unprognostic (4.61e-1)" "unprognostic (3.27e-2)" "unprognostic (2.32e-2)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (4.62e-2)" "unprognostic (5.69e-2)" 10.6 24.5 19.6 24.3 12.6 26.8 6.4 6.1 23.2 10.7 13.9 14.4 18.7 9.3 2.4 19.5 23.1 9.0 22.3 13.3 23.8 37.8 11.0 16.3 27.6 14.2 31.0 4.0 9.8 10.3 26.7 8.0 13.5 10.4 7.5 40.7 8.7 10.3 6.9 5.0 21.1 5.9 2.3 21.6 16.0 8.8 51.5 17.4 15.7 18.4 17.2 16.2 9.3 5.5 12.7 31.2 18.8 13.9 20.3 12.1 30.5 12.2 21.5 14.8 8.4 28.5 22.6 12.5 28.7 17.5 28.4 32.4 14.5 27.0 4.8 91.0 6.0 17.0 55.8 10.8 16.0 19.4 35.3 15.0 17.0 22.4 14.7 27.4 17.9 18.7 13.2 11.0 12.5 19.1 33.2 45.6 19.3 35.9 13.5 23.7 6.0 17.3 24.4 25.1 18.1 11.5 27.3 37.6 29.6 9.0 7.4 16.9 17.7 26.5 20.1 16.9 8.9 16.0 8.3 11.2 37.1 22.7 10.6 0.0 1.4 0.9 1.1 3.3 1.0 0.7 0.8 1.0 1.0 0.5 0.3 0.8 1.4 0.1 2.7 0.4 0.7 1.1 19.6 12.6 6.1 23.2 13.3 23.8 14.2 31.0 13.5 2.3 51.5 5.5 7.5 3.2 5.8 2.0 10.8 8.2 6.3 9.3 13.6 45.7 5.4 5.2 8.4 5.7 9.7 20.2 64.6 4.6 10.6 69.9 3.9 11.3 6.1 63.3 16.5 4.9 11.4 0.4 5.1 9.3 8.9 4.2 34.7 24.6 2.5 7.1 3.3 3.4 8.4 38.7 6.6 16.8 10.2 13.2 14.0 17.0 2.1 15.2 3.6 10.3 13.5 20.7 3.1 0.5 0.5 15.9 32.7 1.2 7.5 9.8 39.0 18.9 37.8 53.7 0.0 6.3 9.8 1.4 5.5 11.2 3.3 15.2 14.9 1.4 24.0 19.4 PLA2G15 "GXVPLA2, LLPL, LYPLA3" ENSG00000103066 "Phospholipase A2 group XV" Q8NCC3 16 68245304-68261058 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.3" "Cell type enhanced" "Detected in many" "Hofbauer cells: 116.0;Horizontal cells: 38.7;Kupffer cells: 37.1;Syncytiotrophoblasts: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041702, HPA041727" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 38000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Vesicles" "HPA041702: AB_10794486, HPA041727: AB_10793931" "unprognostic (3.47e-2)" "unprognostic (9.99e-2)" "unprognostic (1.54e-3)" "unprognostic (6.84e-3)" "unprognostic (1.38e-2)" "unprognostic (1.65e-2)" "unprognostic (4.12e-3)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.84e-2)" "unprognostic (2.56e-1)" "unprognostic (9.29e-2)" "unprognostic (2.45e-3)" "unprognostic (2.98e-2)" "unprognostic (5.40e-3)" "unprognostic (6.28e-2)" "unprognostic (3.47e-2)" 15.1 11.5 12.9 7.6 12.5 7.0 9.8 12.8 18.1 6.6 9.2 8.0 6.9 6.2 8.7 6.2 7.4 9.3 35.5 13.1 14.2 33.4 17.3 17.5 13.6 13.1 14.1 7.7 7.4 11.4 11.4 27.3 14.6 8.1 5.9 4.4 9.1 5.7 58.3 13.9 6.5 8.8 12.4 20.3 8.4 10.8 15.9 11.7 13.2 22.4 5.1 8.8 6.4 16.1 10.0 10.0 7.9 25.5 36.7 26.8 19.0 24.6 31.6 35.7 30.2 26.1 18.6 17.4 31.2 34.1 28.5 15.2 8.5 10.4 15.9 6.0 16.4 5.0 10.4 19.0 19.6 4.6 25.0 19.0 11.2 35.2 5.5 44.6 22.5 8.9 7.9 9.8 23.0 21.3 7.2 14.5 5.1 9.4 12.1 9.9 11.3 55.3 17.7 8.7 3.0 5.1 31.2 9.6 19.2 6.6 25.2 23.7 18.8 31.5 15.0 41.1 16.5 34.6 33.5 22.1 28.6 13.8 12.0 19.6 24.1 16.0 4.7 27.5 4.8 5.0 5.2 7.0 14.1 5.3 6.5 5.5 1.0 2.3 32.4 12.2 5.1 14.6 12.9 12.5 12.8 18.1 13.1 14.2 13.1 14.1 14.6 12.4 15.9 16.1 4.4 6.4 3.3 3.6 3.0 4.8 2.4 6.8 2.8 12.1 7.0 6.0 22.5 1.5 5.1 9.2 8.4 20.9 4.9 8.1 5.9 10.1 1.9 4.3 4.8 5.9 0.0 1.7 7.0 7.2 7.6 8.2 8.6 9.0 15.2 6.6 9.3 13.7 116.0 38.7 6.7 8.5 2.0 37.1 6.8 6.1 2.1 21.4 12.4 10.3 7.7 4.4 3.1 5.5 3.9 6.3 5.0 1.5 2.6 2.6 3.0 19.5 2.7 6.1 0.0 5.5 6.7 3.4 2.8 4.1 3.4 50.8 3.9 3.1 4.1 2.0 PLA2G4A "cPLA2-alpha, PLA2G4" ENSG00000116711 "Phospholipase A2 group IVA" P47712 1 186828949-186988981 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 87.2;seminal vesicle: 48.3" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1" "Group enriched" "Detected in many" 7 "dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4" "Cell line enhanced" "Detected in many" "HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010050, HPA050062, HPA054206" Approved Supported Vesicles,Cytosol NA NA 35000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Cytosol Vesicles "CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417" "prognostic favorable (9.07e-4)" "unprognostic (1.18e-1)" "unprognostic (2.03e-1)" "prognostic favorable (2.85e-4)" "unprognostic (5.55e-2)" "unprognostic (1.51e-3)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (2.63e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (2.96e-2)" "unprognostic (8.07e-2)" "unprognostic (1.58e-1)" "unprognostic (1.90e-2)" "unprognostic (4.26e-2)" 9.9 12.7 2.4 6.3 3.4 4.8 6.5 2.8 3.7 14.5 3.2 11.9 11.1 10.2 11.7 7.5 24.9 6.2 6.3 2.4 3.3 10.8 2.1 5.9 5.3 4.4 3.5 6.4 7.6 87.2 2.0 5.8 4.0 8.8 8.1 0.8 6.3 48.3 0.5 9.5 8.2 10.5 4.1 6.6 5.3 2.8 3.1 1.5 2.6 2.1 2.9 29.1 8.4 3.9 0.0 39.7 0.2 0.0 23.8 9.5 0.0 1.5 15.1 1.8 3.2 0.3 15.5 0.0 0.0 0.0 6.8 2.8 24.6 7.4 0.8 12.5 0.6 7.6 52.4 0.0 14.7 11.1 3.8 5.4 5.0 19.5 4.0 2.4 16.5 3.4 16.7 5.9 0.0 0.0 0.0 0.0 2.1 84.4 5.1 0.0 0.0 73.4 0.1 5.4 0.2 0.0 5.9 2.0 7.3 0.7 0.8 15.0 3.3 14.3 1.9 66.3 3.2 2.3 0.0 0.0 5.3 32.4 20.7 0.2 6.8 7.8 0.0 8.4 0.2 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.6 1.1 4.0 3.1 0.0 1.7 2.4 3.4 2.8 3.7 2.4 3.3 4.4 3.5 4.0 4.1 3.1 3.9 0.6 0.0 1.1 0.3 0.2 21.4 4.3 4.6 10.2 0.2 2.9 2.9 2.3 0.0 4.9 0.0 0.0 0.1 3.2 1.6 1.9 2.1 0.9 33.4 1.7 6.6 1.2 3.0 8.1 0.0 0.1 11.2 7.1 28.1 10.8 3.3 1.1 0.2 6.6 0.0 5.8 2.6 2.0 7.9 8.3 1.3 10.5 11.5 5.4 115.2 3.7 0.0 1.0 2.0 0.4 1.7 7.3 14.7 0.0 2.3 2.0 0.3 2.3 0.5 0.0 1.2 5.0 0.6 0.3 5.2 8.9 0.0 1.0 1.2 4.8 13.4 PLA2G4E FLJ45651 ENSG00000188089 "Phospholipase A2 group IVE" Q3MJ16 15 41981582-42051190 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 17.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 12.9;Basal keratinocytes: 18.1;Suprabasal keratinocytes: 44.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 11.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041105, HPA072562" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 31: Skin - Epidermis development" "Cluster 28: Keratinocytes - Keratinization" "Vesicles, Cytosol" "HPA041105: AB_2677300, HPA072562: " "unprognostic (2.98e-1)" "unprognostic (5.52e-1)" "unprognostic (2.60e-1)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.77e-1)" "unprognostic (4.22e-2)" "unprognostic (2.43e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-7)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (4.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 18.1 0.3 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 5.1 0.5 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 5.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 44.9 0.0 0.1 0.0 0.2 0.7 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 78.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 11.1;RT4: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 31: Skin - Epidermis development" "Cluster 21: OE19 - Mitochondria" "Cluster 11: Alveolar cells - Smell perception" Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: AB_2683226" "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.0 0.0 0.1 0.4 0.3 0.3 2.4 0.1 0.1 5.7 0.0 6.4 6.7 0.0 1.6 5.7 0.1 0.1 0.3 0.1 0.0 7.8 0.2 12.2 0.1 0.0 0.0 0.0 0.1 2.9 1.7 0.1 0.0 4.3 3.8 0.2 2.6 0.4 2.9 78.1 4.2 0.1 0.0 0.1 2.4 0.1 0.0 4.4 1.9 0.5 0.3 1.2 11.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 11.1 0.1 0.0 0.0 0.0 0.0 8.3 0.4 0.0 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 74.5 0.0 0.0 5.5 2.7 1.3 0.6 0.0 1.2 0.3 2.9 0.0 0.5 5.5 0.0 1.7 0.0 21.7 3.9 0.4 0.0 7.3 1.0 0.1 0.0 0.0 0.0 1.3 0.7 0.1 18.3 17.1 2.5 0.0 0.0 0.0 0.1 0.0 0.0 7.7 4.1 0.0 0.3 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.3 0.0 0.3 3.1 10.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 5.6 13.8 1.2 0.6 0.0 6.7 2.0 PLAC1 "CT92, OOSP2B, OOSP2L" ENSG00000170965 "Placenta enriched 1" Q9HBJ0 X 134565838-134764322 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "placenta: 27.9" "Cell type enhanced" "Detected in some" "Fibroblasts: 24.5;Leydig cells: 5.6;Peritubular cells: 7.9;Spermatocytes: 6.5;Spermatogonia: 11.0;Syncytiotrophoblasts: 10.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 20.1;hTCEpi: 15.6;hTERT-HME1: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000163, HPA063425" Enhanced Approved Vesicles,Cytosol "Secreted in female reproductive system" NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" Vesicles Cytosol "HPA000163: , HPA063425: AB_2685012" "unprognostic (2.93e-1)" "unprognostic (2.50e-3)" "unprognostic (2.89e-4)" "unprognostic (1.35e-7)" "unprognostic (3.83e-3)" "unprognostic (2.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.26e-1)" "unprognostic (2.01e-1)" "unprognostic (4.28e-2)" "unprognostic (1.48e-2)" "unprognostic (2.87e-2)" "unprognostic (3.33e-16)" "unprognostic (7.64e-3)" "unprognostic (4.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.9 0.0 1.2 0.0 0.2 1.2 0.3 0.4 1.1 0.0 2.0 0.3 0.1 1.8 0.3 0.5 20.1 0.0 0.1 0.3 2.3 0.0 0.0 0.9 15.6 0.1 6.3 0.1 2.4 0.2 0.1 1.7 0.1 1.0 0.0 0.3 0.0 1.3 2.6 0.0 0.3 3.7 0.0 0.0 3.0 0.0 0.0 3.7 0.7 2.2 0.1 0.0 0.0 0.5 0.8 0.2 0.0 0.4 0.1 0.3 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.3 0.0 2.8 24.5 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.9 0.0 0.0 0.0 0.0 0.7 5.6 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.5 0.1 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 11.0 0.0 0.0 10.7 0.0 2.1 0.0 0.0 PLAU "UPA, URK" ENSG00000122861 "Plasminogen activator, urokinase" P00749 10 73909177-73917496 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.8;urinary bladder: 128.5" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.0;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070796 Supported Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 647000 88000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Vesicles" "HPA070796: " "unprognostic (1.96e-2)" "unprognostic (2.99e-2)" "unprognostic (7.40e-2)" "prognostic favorable (3.38e-4)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.39e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (2.26e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.83e-1)" "unprognostic (3.37e-2)" "unprognostic (1.51e-2)" "unprognostic (1.77e-2)" 57.6 4.8 2.5 41.7 2.7 36.2 17.6 2.7 8.9 9.3 4.4 13.1 11.9 22.0 16.7 14.4 10.3 28.5 23.1 2.4 2.9 103.8 5.0 22.0 14.3 3.8 2.9 2.3 10.1 8.3 2.9 36.5 5.4 9.1 18.2 0.3 17.3 13.7 10.8 25.5 13.7 23.4 3.3 40.6 15.7 3.7 4.7 5.9 17.9 18.9 7.2 128.5 16.2 4.7 171.1 88.9 36.8 1.7 3.1 59.5 2.0 101.9 461.6 40.0 62.2 2.3 856.0 0.1 184.0 14.5 416.9 114.1 0.9 165.8 44.8 9.9 0.0 0.1 4.4 1.7 72.6 15.6 32.3 158.7 20.2 271.4 103.7 447.0 114.7 1.0 1.1 0.9 822.4 0.2 0.2 22.7 10.8 0.3 244.5 0.4 112.6 0.9 3100.7 130.6 0.1 0.2 0.3 4.0 2.4 25.4 1.2 22.9 300.6 3.5 20.3 21.6 869.8 0.2 1.3 1.6 216.0 25.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.1 0.0 0.0 2.0 0.0 0.1 2.5 2.7 2.7 8.9 2.4 2.9 3.8 2.9 5.4 3.3 4.7 4.7 29.0 3.2 4.6 0.3 1.4 37.3 635.9 237.3 19.9 0.0 3.0 24.4 2.5 0.0 103.6 29.5 0.0 28.0 1.6 0.6 68.4 62.7 0.5 50.7 22.2 46.4 3.5 0.0 0.2 21.3 21.7 69.7 0.0 68.9 31.1 0.1 3.9 0.0 39.8 0.0 0.3 0.1 140.4 4.0 33.1 1.3 2.5 53.4 7.2 4.7 23.8 0.0 0.0 0.5 0.2 613.9 0.3 0.0 0.5 695.0 0.0 1.4 35.4 0.0 6.6 27.6 65.2 0.0 0.2 60.6 29.5 17.5 4.7 0.6 1.7 869.6 PLD1 ENSG00000075651 "Phospholipase D1" Q13393 3 171600404-171810950 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 86.8" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 519.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004527, HPA042396, HPA066938" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 10: Basophils - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Nucleoplasm "CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: " "unprognostic (3.23e-1)" "unprognostic (3.27e-1)" "unprognostic (5.82e-2)" "unprognostic (5.13e-2)" "unprognostic (4.58e-1)" "unprognostic (4.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.46e-1)" "unprognostic (6.23e-2)" "unprognostic (8.02e-2)" "unprognostic (2.06e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.76e-6)" 7.8 26.4 9.2 6.6 24.7 7.8 7.5 18.4 13.6 10.4 4.5 14.6 46.9 6.2 2.8 33.0 6.4 86.8 24.4 10.5 14.3 12.0 33.7 4.7 9.1 24.8 22.0 24.2 21.2 1.6 2.3 10.7 23.5 3.4 14.7 0.5 13.8 6.0 2.5 29.2 43.9 4.8 14.7 15.7 8.2 5.0 19.0 4.1 3.7 6.8 10.8 5.1 12.4 41.4 4.5 7.2 3.7 1.4 11.2 12.6 7.7 2.3 9.9 3.5 4.3 1.1 6.4 0.0 17.0 0.9 24.0 15.2 0.6 2.0 5.7 3.6 3.2 4.2 11.5 26.1 4.9 7.3 18.9 4.9 10.9 4.2 2.0 10.0 57.5 1.2 2.8 0.0 0.9 1.3 0.0 6.4 0.8 11.9 5.1 0.2 1.5 0.1 8.9 1.8 0.1 0.1 7.9 4.7 31.1 5.1 9.0 9.7 50.7 1.5 5.7 4.0 2.5 9.6 8.2 0.1 6.7 8.6 1.9 8.3 1.8 2.3 0.3 1.1 2.6 0.0 0.2 0.6 0.6 0.0 0.0 0.1 1.0 2.2 0.4 0.0 0.8 0.6 9.2 24.7 18.4 13.6 10.5 14.3 24.8 22.0 23.5 14.7 19.0 41.4 7.7 0.0 4.7 2.0 0.9 7.1 3.4 11.0 10.8 0.4 4.9 5.6 33.6 57.2 11.1 1.8 0.0 3.0 1.9 37.5 3.9 8.4 13.1 1.0 4.8 7.4 4.2 6.3 8.9 3.4 3.7 15.7 27.0 1.3 27.9 10.4 6.4 15.9 20.0 0.0 12.1 23.6 6.1 13.2 2.4 9.5 10.5 10.2 12.4 98.4 5.4 0.0 1.0 12.5 519.6 2.4 18.3 4.5 3.4 0.7 38.3 48.0 9.9 0.1 19.7 3.8 8.4 6.1 5.3 93.5 34.9 2.3 2.3 12.1 17.8 4.7 PLEK2 ENSG00000100558 "Pleckstrin 2" Q9NYT0 14 67386984-67412167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 149.0;Pancreatic endocrine cells: 179.8;Suprabasal keratinocytes: 90.6;Theca cells: 107.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1" "Lineage enriched" "Detected in single" 7 "T-cells: 3.1" "Cell line enhanced" "Detected in many" "A-431: 91.0;CAPAN-2: 94.4;HBEC3-KT: 177.4;PC-3: 64.1;TIME: 69.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001208 Enhanced Uncertain Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles Cytosol "HPA001208: AB_1079631" "unprognostic (4.41e-3)" "unprognostic (3.77e-1)" "unprognostic (1.15e-1)" "unprognostic (6.23e-2)" "unprognostic (6.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.97e-1)" "unprognostic (9.21e-3)" "prognostic unfavorable (8.26e-5)" "unprognostic (1.06e-1)" "unprognostic (3.09e-3)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (8.98e-2)" "unprognostic (4.59e-2)" 0.8 51.1 0.3 5.5 0.3 12.7 3.9 0.8 0.6 3.9 0.1 25.1 29.6 1.5 32.4 16.4 1.7 3.9 0.3 0.4 0.2 9.7 29.7 1.6 0.2 0.3 0.2 0.6 7.9 7.0 1.3 1.5 0.3 7.7 28.7 0.1 6.8 4.2 0.3 26.5 32.6 1.3 0.2 0.6 20.6 3.1 0.4 22.9 23.5 0.2 5.5 12.1 7.9 0.4 91.0 13.4 0.0 0.1 0.0 1.0 8.4 17.9 2.7 4.2 5.2 48.8 94.4 0.0 17.3 2.5 0.2 42.4 0.1 177.4 9.6 0.1 0.7 0.0 19.4 0.4 3.8 0.0 0.0 1.9 12.3 4.6 55.4 0.0 14.8 0.0 0.4 0.4 3.0 28.9 0.0 0.2 0.3 57.4 64.1 0.0 0.1 14.0 30.0 2.4 0.7 0.2 17.0 7.9 5.2 0.9 11.6 0.9 69.3 0.0 54.1 0.3 0.4 0.3 0.2 0.3 10.7 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.4 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.8 0.6 0.4 0.2 0.3 0.2 0.3 0.2 0.4 0.4 0.1 0.0 1.1 1.0 0.6 149.0 29.0 69.9 37.0 0.0 4.9 6.0 0.5 10.0 11.8 5.5 0.0 1.0 0.0 25.0 3.9 42.1 0.1 2.3 0.2 2.0 8.4 16.0 0.8 46.3 5.5 4.2 37.2 2.2 0.0 24.0 0.0 11.5 6.8 0.0 0.6 68.5 26.4 1.3 57.1 0.3 0.3 7.4 21.4 0.0 5.2 0.0 0.0 0.5 0.3 179.8 23.9 0.0 0.0 15.8 47.9 3.2 4.5 0.0 0.0 0.0 4.6 0.4 2.3 21.2 90.6 1.5 1.3 107.7 54.8 25.5 PLEKHA6 "KIAA0969, PEPP3" ENSG00000143850 "Pleckstrin homology domain containing A6" Q9Y2H5 1 204218853-204377665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 111.0;Distal enterocytes: 66.6;Excitatory neurons: 102.6;Inhibitory neurons: 62.5;Oligodendrocyte precursor cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 60.3;BEWO: 94.6;CAPAN-2: 79.2;OE19: 80.9;RT4: 66.4;SK-BR-3: 58.4;T-47d: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028152, HPA028157, HPA054311" Enhanced Approved "Vesicles,Cell Junctions" NA NA "Cluster 45: Intestine - Brush border" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Cell Junctions" Vesicles "HPA028152: AB_10601048, HPA028157: , HPA054311: AB_2682446" "unprognostic (9.81e-3)" "unprognostic (3.05e-1)" "unprognostic (1.59e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.38e-2)" "unprognostic (9.01e-2)" "unprognostic (3.32e-1)" "unprognostic (9.60e-3)" "unprognostic (1.53e-1)" "unprognostic (5.02e-3)" "unprognostic (1.23e-1)" "unprognostic (8.22e-2)" "unprognostic (5.17e-2)" "prognostic favorable (3.57e-4)" 5.1 6.6 20.4 6.0 21.6 0.4 13.7 20.9 34.4 4.1 9.1 32.2 25.5 4.8 12.9 17.2 9.3 13.2 20.8 19.6 18.7 27.4 27.5 3.2 0.6 23.1 24.3 4.6 10.2 5.7 31.1 8.8 23.3 13.8 29.3 11.4 9.0 13.9 6.0 4.0 29.5 3.8 17.9 3.1 39.7 5.4 34.6 1.0 4.0 2.4 2.4 12.7 7.5 24.1 60.3 36.8 23.7 0.1 0.3 0.6 94.6 2.1 6.6 0.2 0.3 17.8 79.2 0.3 17.3 1.4 0.3 6.7 0.3 6.5 0.3 0.2 3.8 0.2 15.2 25.7 3.5 0.0 0.1 1.0 19.6 0.0 5.0 7.2 10.4 0.8 0.1 0.2 23.9 26.7 0.1 0.1 7.4 80.9 44.6 0.0 0.2 0.1 23.0 66.4 4.8 48.4 26.6 58.4 0.4 4.9 55.3 0.3 0.7 0.0 1.0 0.3 0.5 0.2 0.0 0.1 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 21.6 20.9 34.4 19.6 18.7 23.1 24.3 23.3 17.9 34.6 24.1 0.2 0.0 10.9 111.0 0.3 0.1 4.2 1.9 0.6 41.6 15.7 8.1 16.6 37.1 4.5 9.2 20.9 6.6 0.5 66.6 3.9 8.4 10.4 4.0 1.3 1.2 16.8 2.7 102.6 5.1 2.4 9.0 40.8 6.2 0.0 0.3 5.0 21.4 0.8 18.5 62.5 32.7 4.1 0.6 0.7 4.0 5.3 0.7 0.0 15.0 0.1 1.2 0.0 85.5 41.8 13.3 33.2 3.8 0.1 6.9 15.2 11.7 7.2 7.1 0.0 26.4 1.1 0.6 0.2 1.4 0.6 21.6 0.6 0.1 34.5 13.7 PLEKHM1 KIAA0356 ENSG00000225190 "Pleckstrin homology and RUN domain containing M1" Q9Y4G2 17 45435900-45490749 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Cell line enhanced" "Detected in many" "OE19: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025018, HPA039473" Approved Supported Nucleoli,Vesicles NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Vesicles Nucleoli "HPA025018: AB_1855465, HPA039473: AB_2676526" "unprognostic (1.52e-1)" "unprognostic (3.13e-2)" "unprognostic (4.29e-2)" "prognostic favorable (1.28e-6)" "unprognostic (8.71e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.20e-2)" "unprognostic (1.88e-1)" "unprognostic (2.93e-2)" "unprognostic (4.02e-1)" "unprognostic (3.93e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" 7.0 6.4 2.9 5.5 2.9 9.7 6.2 3.5 3.8 12.9 3.2 6.5 3.5 5.7 1.0 31.7 5.9 5.3 6.2 2.8 3.1 3.6 3.6 8.8 4.8 3.7 3.1 4.9 6.1 4.4 5.7 2.9 3.2 5.1 3.6 1.6 14.4 0.9 12.3 11.8 6.2 2.0 2.8 6.8 5.6 3.4 3.4 5.4 6.5 7.2 4.8 6.8 13.6 3.7 7.3 11.0 1.7 5.4 8.4 4.8 0.1 3.3 4.9 1.9 2.6 4.2 6.0 5.2 3.4 3.9 14.1 1.7 4.1 1.9 1.6 13.7 3.5 0.0 5.6 6.9 2.0 0.0 4.3 2.2 4.9 0.9 8.0 3.8 10.0 0.0 5.2 6.2 9.1 6.0 5.2 1.1 1.7 26.6 9.0 2.8 5.6 5.3 6.0 16.8 3.2 2.1 3.2 4.5 5.2 4.8 10.1 5.3 19.1 12.7 3.6 5.2 5.9 0.6 6.2 1.8 7.7 2.8 5.8 2.8 1.2 1.0 0.2 0.3 0.0 1.2 0.6 0.2 0.3 0.3 0.2 0.0 6.5 0.7 0.4 0.2 0.5 0.2 2.9 2.9 3.5 3.8 2.8 3.1 3.7 3.1 3.2 2.8 3.4 3.7 12.6 12.8 18.1 7.8 17.5 18.0 18.1 10.3 6.8 10.4 11.7 8.4 8.7 15.7 12.7 12.9 16.7 4.8 24.3 25.6 5.9 8.1 4.3 24.9 11.1 12.1 13.8 10.8 13.5 8.2 4.7 12.1 19.9 27.9 1.3 5.4 12.8 8.1 9.1 16.8 13.3 13.0 4.1 27.9 15.2 2.0 7.2 21.1 7.2 9.4 13.7 7.3 14.4 7.5 20.8 18.3 17.7 7.9 22.9 27.2 8.6 10.5 11.9 8.2 0.0 17.7 7.6 7.6 3.7 10.0 16.3 8.6 18.5 9.3 12.2 43.1 PLEKHM3 "DAPR, PLEKHM1L" ENSG00000178385 "Pleckstrin homology domain containing M3" Q6ZWE6 2 207821288-208025527 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 99.1;Inhibitory neurons: 70.5;Microglial cells: 36.5;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 86.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035046 Uncertain Approved Vesicles,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 23: Testis - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol Vesicles "HPA035046: AB_10603128" "unprognostic (3.62e-1)" "unprognostic (1.58e-2)" "unprognostic (8.27e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (4.77e-2)" "unprognostic (6.06e-2)" "unprognostic (8.20e-2)" "unprognostic (4.13e-2)" "unprognostic (2.92e-3)" "unprognostic (2.17e-1)" "unprognostic (1.09e-1)" "unprognostic (4.86e-4)" "unprognostic (2.42e-1)" "unprognostic (3.12e-1)" "unprognostic (5.72e-2)" "unprognostic (1.33e-2)" 2.9 4.1 2.3 1.3 2.6 4.3 2.4 0.4 2.9 2.7 0.0 3.1 0.9 2.5 0.9 1.6 2.0 1.4 2.9 2.8 2.1 1.9 3.1 2.9 1.5 2.0 2.6 3.1 2.2 4.0 2.5 1.4 2.2 2.5 1.5 8.3 2.2 1.4 2.4 2.6 1.9 1.9 0.2 1.9 2.2 1.7 1.3 2.2 3.6 1.6 1.4 1.9 2.5 2.0 0.7 0.7 1.6 0.9 2.7 2.7 2.5 1.5 1.6 1.2 1.1 0.9 0.7 0.6 1.5 1.8 1.2 0.8 1.7 2.2 1.6 1.2 2.6 1.3 2.2 1.3 1.6 1.4 0.7 2.2 2.6 1.3 1.6 1.9 1.3 2.1 0.8 1.7 1.5 0.4 1.7 0.9 1.6 0.5 0.8 1.3 1.4 1.3 0.6 0.9 3.5 1.8 1.4 0.1 1.5 2.7 0.4 1.1 1.8 1.9 1.1 1.1 1.0 2.0 2.4 0.6 2.2 0.8 1.4 1.3 0.8 0.4 0.9 0.3 0.3 0.9 0.8 0.8 0.7 0.6 1.0 0.8 2.6 0.9 0.7 0.7 0.5 0.2 2.3 2.6 0.4 2.9 2.8 2.1 2.0 2.6 2.2 0.2 1.3 2.0 6.3 19.2 21.7 29.0 2.7 0.0 0.2 0.1 0.6 3.1 4.1 3.7 1.2 1.5 5.6 1.8 12.5 0.3 4.1 1.2 0.0 3.1 2.5 4.1 6.3 2.3 0.0 4.0 99.1 3.4 0.5 3.0 2.0 4.7 0.0 25.0 0.4 0.6 0.6 6.7 70.5 0.1 0.0 1.0 2.4 5.2 0.3 3.8 0.0 36.5 4.6 2.3 0.0 45.2 86.9 3.5 1.6 0.0 2.0 0.2 1.1 4.9 0.8 9.6 0.0 1.7 3.8 0.4 0.7 1.1 0.1 0.1 2.5 6.9 0.5 0.1 PLEKHS1 "bA211N11.2, C10orf81, FLJ23537" ENSG00000148735 "Pleckstrin homology domain containing S1" Q5SXH7 10 113751262-113783429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 30.5;cervix: 63.6;intestine: 43.9;pancreas: 36.9;salivary gland: 57.0" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 35.1;Club cells: 70.7;Endometrial ciliated cells: 33.8;Exocrine glandular cells: 31.1;Ionocytes: 38.7;Proximal enterocytes: 42.1;Respiratory ciliated cells: 157.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.1;OE19: 53.5;RT4: 22.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA037583 Approved Vesicles,Centrosome NA NA "Cluster 4: Stomach - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Centrosome Vesicles "HPA037583: AB_10671762" "unprognostic (2.64e-1)" "unprognostic (1.64e-2)" "unprognostic (2.74e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (2.63e-2)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (8.43e-2)" "unprognostic (6.82e-2)" "unprognostic (2.57e-1)" "unprognostic (1.21e-2)" "unprognostic (0.00e+0)" "unprognostic (4.00e-3)" "unprognostic (2.19e-1)" "unprognostic (2.27e-1)" "prognostic favorable (1.03e-4)" 0.3 0.1 0.0 7.3 0.0 0.3 30.5 0.0 0.3 63.6 0.0 3.6 43.9 1.8 3.9 1.0 9.4 2.7 0.4 0.0 0.0 0.9 0.1 6.7 0.2 0.2 0.0 0.1 36.9 0.1 0.2 0.1 0.0 6.0 4.7 0.4 57.0 3.3 0.0 0.8 38.7 0.5 0.0 0.2 8.8 0.9 0.0 0.1 0.1 0.0 2.8 1.5 0.0 0.1 0.2 1.4 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.1 0.7 0.2 10.1 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 53.5 0.0 0.2 6.4 0.3 1.7 22.3 0.1 0.2 0.1 1.4 0.0 0.0 6.3 0.0 0.0 0.2 0.2 0.2 0.5 4.7 0.2 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 3.2 3.2 0.3 0.0 0.1 0.3 35.1 0.0 0.0 16.6 8.3 0.4 0.0 70.7 0.0 0.0 0.0 0.1 6.7 0.0 4.9 13.2 33.8 0.3 0.5 0.0 0.0 0.2 31.1 0.0 0.6 3.1 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 5.6 38.7 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.2 2.8 0.4 0.0 1.4 42.1 0.3 157.3 0.0 0.0 0.3 3.7 0.2 0.1 0.6 0.0 0.0 0.3 0.0 12.1 0.5 PLIN5 "LSDA5, LSDP5, MLDP, OXPAT" ENSG00000214456 "Perilipin 5" Q00G26 19 4522531-4535224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 202.0;skeletal muscle: 149.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 47.1;Astrocytes: 53.8;Cardiomyocytes: 39.8;Hepatic stellate cells: 42.1;Hepatocytes: 140.5" "Cancer enhanced" "Detected in many" "liver cancer: 9.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "neutrophil: 13.9" "Lineage enriched" "Detected in single" 20 "granulocytes: 13.9" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;BEWO: 3.2;RT4: 3.1;SH-SY5Y: 2.8;T-47d: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA077050 Supported "Vesicles,Lipid droplets" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 6: T47d - Mammary gland" "Cluster 15: Hepatocytes - Hemostasis" "Vesicles, Lipid droplets" "HPA077050: " "prognostic favorable (7.68e-4)" "unprognostic (1.01e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (8.56e-4)" "unprognostic (1.24e-2)" "unprognostic (6.06e-3)" "prognostic favorable (2.81e-4)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.63e-1)" "unprognostic (1.54e-1)" "prognostic favorable (1.97e-4)" "unprognostic (3.18e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "prognostic favorable (2.16e-4)" 41.9 6.4 10.8 3.5 11.2 5.2 29.3 6.9 9.6 7.5 12.8 5.4 1.5 2.7 3.9 3.4 12.6 2.0 62.7 8.5 8.1 30.1 202.0 9.3 0.5 8.4 9.2 90.8 112.2 1.5 18.9 0.2 6.9 17.6 0.6 0.9 61.0 3.9 149.2 8.0 5.3 0.5 6.8 8.2 58.9 3.3 9.4 0.4 9.8 24.7 1.0 11.2 2.7 6.4 0.2 0.1 0.5 2.3 1.7 0.1 3.2 0.1 0.1 0.1 0.0 0.2 0.5 0.1 0.7 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.4 0.3 0.4 0.4 0.0 0.0 0.0 0.2 0.2 0.1 0.7 0.2 0.1 0.6 0.1 0.4 0.4 0.3 0.3 0.1 0.1 2.1 0.2 3.1 0.3 2.8 0.2 0.4 0.0 0.2 6.3 0.4 0.3 0.3 0.3 0.2 0.2 0.3 0.1 0.1 0.2 0.6 0.1 1.9 0.4 0.8 0.3 0.3 0.2 0.3 0.2 0.2 0.1 0.4 0.3 0.3 13.9 0.6 0.3 0.3 0.1 0.1 10.8 11.2 6.9 9.6 8.5 8.1 8.4 9.2 6.9 6.8 9.4 6.4 6.0 9.6 47.1 53.8 1.6 0.5 18.4 2.3 4.0 1.2 9.2 1.9 39.8 35.8 11.5 1.8 0.0 0.4 0.1 11.9 9.8 8.7 1.5 20.8 1.4 7.4 0.0 2.7 1.1 12.3 0.5 1.3 16.3 5.1 3.8 18.7 42.1 140.5 0.5 0.0 1.8 6.9 4.1 6.9 0.5 0.3 0.3 2.5 0.0 5.6 0.1 8.1 0.0 11.1 2.0 4.8 1.3 2.6 0.5 6.6 0.5 11.1 10.4 1.2 13.1 25.8 1.8 6.2 6.6 0.5 1.0 1.4 1.1 20.5 8.8 11.5 PLOD1 "LH1, LLH, PLOD" ENSG00000083444 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1" Q02809 1 11934205-11975538 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 236.8;Sertoli cells: 105.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049137, HPA055799" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 3600000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 15: Liver - Metabolism" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" Vesicles Nucleoplasm "HPA049137: AB_2680649, HPA055799: AB_2682924" "unprognostic (1.00e-1)" "unprognostic (2.69e-3)" "unprognostic (9.21e-3)" "unprognostic (5.43e-2)" "unprognostic (7.53e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.13e-3)" "unprognostic (1.23e-1)" "unprognostic (1.79e-1)" "unprognostic (4.15e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.91e-12)" "unprognostic (2.79e-1)" "unprognostic (7.12e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.43e-4)" 58.1 34.6 46.3 35.2 51.2 16.1 41.2 48.6 56.6 65.4 46.4 47.3 37.7 65.0 30.5 21.3 51.1 42.0 71.2 44.5 47.4 45.5 78.1 44.4 15.4 49.6 50.8 54.4 39.0 36.9 29.6 83.8 52.4 34.7 23.2 10.6 75.9 40.6 40.5 27.2 35.6 78.4 44.8 31.5 35.5 11.6 52.2 7.9 34.9 41.6 12.9 42.4 36.0 53.1 112.5 91.4 51.3 239.7 343.4 190.6 39.0 330.4 436.1 170.4 287.1 105.2 71.5 63.1 339.5 367.3 125.9 93.4 75.6 115.6 115.6 66.2 78.3 34.0 136.6 137.3 212.5 21.9 162.7 234.0 59.7 206.2 81.9 573.3 305.0 14.8 97.6 30.9 180.2 71.1 5.7 58.6 22.9 115.4 131.6 25.8 100.0 141.0 98.7 24.3 19.2 77.7 137.3 97.4 164.8 80.4 48.3 55.9 298.7 190.1 141.6 236.3 161.9 71.4 123.7 38.7 425.1 75.5 316.8 0.0 40.3 2.0 17.3 34.4 3.1 1.7 3.0 8.4 32.7 3.4 1.2 6.4 35.5 5.4 32.3 4.9 2.0 22.6 46.3 51.2 48.6 56.6 44.5 47.4 49.6 50.8 52.4 44.8 52.2 53.1 19.4 0.0 7.9 9.4 3.7 7.0 8.0 22.8 8.0 5.7 17.9 17.5 18.3 8.6 8.6 11.0 2.1 39.7 8.7 14.8 3.9 30.3 1.0 11.0 62.2 33.9 8.4 3.0 4.2 9.8 236.8 47.5 17.3 24.8 0.0 20.4 36.8 37.1 46.3 6.7 5.8 12.5 4.1 26.5 8.3 2.4 44.4 16.3 10.6 15.9 17.9 7.9 15.5 3.0 9.8 22.4 15.4 24.5 19.4 8.0 41.5 16.7 4.5 3.1 105.2 77.2 47.3 0.5 3.3 7.4 5.1 33.7 5.5 37.1 16.6 3.9 PLPP7 "C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3" ENSG00000160539 "Phospholipid phosphatase 7 (inactive)" Q8NBV4 9 131289459-131359022 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 91.2;skeletal muscle: 210.1;tongue: 74.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 18.8;Horizontal cells: 8.4;Leydig cells: 5.0;Skeletal myocytes: 7.0" "Cancer enhanced" "Detected in many" "glioma: 5.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 11.1;ASC diff: 11.4;ASC TERT1: 8.6;SCLC-21H: 11.3;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070252 Uncertain Approved Nucleoplasm,Vesicles No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" Vesicles Nucleoplasm "HPA070252: AB_2686242" "unprognostic (2.19e-1)" "unprognostic (3.07e-1)" "unprognostic (3.07e-2)" "unprognostic (2.71e-1)" "unprognostic (8.78e-2)" "unprognostic (7.03e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.65e-1)" "unprognostic (3.96e-3)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (3.69e-2)" "unprognostic (1.10e-2)" "unprognostic (7.85e-2)" "unprognostic (9.72e-3)" 4.8 9.7 10.0 1.1 11.5 0.4 4.9 16.4 13.9 6.3 1.4 9.6 0.7 6.4 0.6 2.5 5.1 2.1 91.2 10.6 9.1 4.2 0.3 2.1 0.5 11.0 10.7 8.7 2.3 1.2 4.7 0.5 11.1 4.9 0.5 4.0 3.4 2.5 210.1 1.4 3.1 2.7 8.8 2.4 3.1 5.0 11.7 0.4 1.8 74.4 0.3 6.7 4.0 11.0 0.0 0.0 2.2 11.1 11.4 8.6 2.3 1.7 1.2 0.3 0.0 0.0 0.0 0.0 0.3 4.5 2.4 0.0 0.2 0.0 0.1 0.0 1.9 0.0 0.1 3.6 2.8 0.0 0.0 2.9 0.0 3.1 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 11.3 8.7 0.0 0.1 0.0 0.3 0.3 2.8 0.1 0.1 0.7 0.5 0.0 0.0 0.4 0.0 1.9 0.0 1.8 0.0 2.6 0.0 0.0 1.7 0.0 0.4 0.0 0.0 2.3 0.5 0.2 0.2 0.0 1.3 1.5 1.0 0.0 0.9 10.0 11.5 16.4 13.9 10.6 9.1 11.0 10.7 11.1 8.8 11.7 11.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.8 0.1 0.0 0.0 0.0 0.0 1.8 2.1 0.1 0.1 0.0 1.9 0.0 1.4 0.1 1.7 1.4 0.0 1.3 0.0 0.6 0.7 4.1 0.0 0.1 0.0 0.8 1.1 0.0 0.5 8.4 0.0 0.0 0.0 0.3 0.0 1.7 5.0 2.2 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.3 0.0 3.8 0.7 0.0 0.0 2.3 0.0 3.7 0.0 7.0 3.0 0.0 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 PMF1 ENSG00000160783 "Polyamine modulated factor 1" Q6P1K2 1 156212993-156240042 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Vesicles "HPA034583: AB_2674234, HPA071854: AB_2686459" "unprognostic (1.17e-2)" "unprognostic (3.76e-3)" "unprognostic (2.58e-2)" "unprognostic (5.67e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (6.44e-2)" "unprognostic (1.32e-1)" "unprognostic (3.13e-1)" "unprognostic (1.26e-2)" "unprognostic (1.41e-2)" "unprognostic (9.29e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "unprognostic (1.62e-2)" 39.3 39.6 33.5 29.6 35.9 73.7 42.8 35.1 39.5 47.2 33.0 38.3 30.6 42.6 24.4 50.0 34.8 26.0 69.7 33.3 34.7 56.6 62.3 38.8 46.8 37.1 34.9 42.9 39.4 56.3 34.9 29.9 36.5 47.2 26.8 16.8 42.9 27.1 113.3 54.2 36.7 28.6 35.0 52.5 43.6 15.1 34.9 45.6 50.7 89.7 39.7 39.4 41.7 38.6 68.2 82.5 86.8 66.1 16.1 33.5 67.3 34.6 48.7 91.4 75.4 101.6 95.3 62.2 73.3 44.5 31.6 44.4 88.1 57.7 47.0 44.6 104.6 46.3 59.3 91.8 33.3 65.8 61.3 30.2 57.2 41.2 43.0 36.3 69.9 44.7 69.9 70.1 45.0 138.2 69.2 84.7 151.5 99.6 72.2 75.2 46.3 123.6 97.2 50.5 79.0 99.5 57.4 65.4 45.6 63.2 106.1 79.7 40.7 39.4 50.5 44.4 69.4 52.0 58.1 123.7 31.9 63.1 55.7 18.4 85.7 40.5 43.9 60.6 39.6 54.0 43.0 41.4 70.0 45.6 41.5 42.0 59.9 49.5 55.2 95.9 75.5 77.7 33.5 35.9 35.1 39.5 33.3 34.7 37.1 34.9 36.5 35.0 34.9 38.6 25.5 19.2 25.1 0.0 38.2 49.8 87.2 108.6 3.4 12.3 39.5 33.4 11.9 51.5 57.4 75.4 12.5 136.3 63.4 21.5 176.1 98.0 5.3 22.1 26.3 41.5 49.1 13.2 0.0 99.0 115.7 34.7 8.6 36.5 45.0 50.3 47.2 56.7 80.5 8.4 0.0 46.6 61.1 40.3 43.9 6.0 39.1 34.2 85.4 0.0 59.6 71.2 43.3 0.0 0.0 81.6 52.1 28.2 11.7 51.5 44.7 120.1 15.6 28.8 26.3 36.6 35.7 14.7 33.4 7.6 51.0 157.5 47.3 66.1 52.5 83.8 PMF1-BGLAP ENSG00000260238 "PMF1-BGLAP readthrough" 1 156212982-156243332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Proximal tubular cells: 2.5;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles NA NA "Cluster 24: B-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 59: Non-specific - Transcription" Nucleoplasm Vesicles "HPA034583: AB_2674234, HPA071854: AB_2686459" "unprognostic (8.15e-2)" "unprognostic (1.80e-1)" "unprognostic (8.56e-4)" "unprognostic (1.65e-2)" "unprognostic (4.01e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (4.66e-2)" "unprognostic (1.28e-1)" "unprognostic (8.52e-3)" "unprognostic (1.85e-4)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.31e-3)" "unprognostic (2.36e-1)" 7.0 9.0 6.8 2.2 7.1 4.6 5.0 7.6 11.5 10.8 7.3 9.5 2.8 6.7 5.1 5.2 7.3 3.6 16.2 6.8 7.3 8.6 7.6 4.9 3.4 6.8 6.7 10.0 5.7 3.8 10.3 4.7 6.8 11.0 1.6 4.9 7.7 4.1 13.3 4.3 4.6 2.9 6.8 6.5 6.5 3.5 6.9 3.0 8.7 10.0 2.5 6.8 7.2 8.4 8.9 8.4 11.6 7.8 3.0 7.4 5.2 7.8 5.0 7.5 6.0 6.6 7.9 7.7 12.8 7.0 3.1 6.0 10.8 10.1 3.5 13.4 18.4 5.3 8.5 12.5 14.5 5.3 9.3 9.7 9.3 7.0 6.2 6.9 7.3 7.0 5.4 12.4 5.0 11.1 4.7 11.3 23.7 5.9 16.1 8.7 4.5 11.4 4.8 4.2 7.9 10.3 5.2 2.0 13.6 10.0 11.8 20.9 7.9 3.7 3.8 4.6 7.0 7.4 9.4 11.5 4.7 6.9 7.5 2.3 5.7 3.1 2.8 3.9 2.9 2.7 4.6 4.3 4.2 7.7 6.2 3.6 6.4 3.0 4.3 4.4 5.6 5.7 6.8 7.1 7.6 11.5 6.8 7.3 6.8 6.7 6.8 6.8 6.9 8.4 0.6 0.0 1.5 0.3 1.3 0.0 0.5 0.1 1.8 0.0 0.5 0.4 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 3.9 0.4 0.0 0.4 1.1 0.3 0.0 1.3 0.2 0.0 0.2 1.1 0.5 0.4 0.0 0.6 0.7 0.5 0.4 0.0 0.3 0.3 0.0 0.6 0.0 0.1 1.5 0.8 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.1 0.1 0.4 2.4 0.1 0.4 2.5 1.5 0.0 6.6 0.3 0.6 0.3 0.5 2.2 0.0 1.0 1.3 0.2 0.6 0.3 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629185-127672802 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6;pituitary gland: 59.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 96.3;Early spermatids: 73.5;Horizontal cells: 82.4;Late spermatids: 153.1;Spermatogonia: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 118.1;SCLC-21H: 167.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "CAB024934: , HPA042265: AB_2677920" "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.8 17.3 45.0 2.7 39.9 1.8 8.8 34.1 50.9 2.9 1.9 9.4 7.2 4.4 2.3 4.2 4.3 4.5 4.1 42.3 65.6 7.2 1.6 2.0 2.2 49.2 50.9 11.2 13.5 5.3 59.0 1.0 54.6 13.1 8.2 21.6 24.9 2.0 3.2 7.6 6.7 1.8 32.9 2.0 14.1 30.8 53.6 1.9 5.5 1.8 2.7 3.1 2.8 40.5 0.3 13.8 37.5 89.2 0.0 0.0 55.2 4.3 0.2 7.9 1.6 28.7 1.5 34.0 33.3 0.6 12.1 0.2 30.9 0.0 0.7 0.2 63.3 0.7 30.9 29.3 1.2 78.1 75.7 1.5 6.6 0.2 0.0 20.9 2.2 0.2 45.6 0.2 2.9 17.6 0.3 0.3 56.2 7.9 66.6 0.2 1.0 118.1 10.9 3.9 167.0 94.0 40.9 86.3 77.2 3.7 22.0 39.2 0.4 0.2 17.2 1.5 27.3 0.2 0.0 26.9 0.9 50.1 25.1 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.6 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.6 0.5 0.1 45.0 39.9 34.1 50.9 42.3 65.6 49.2 50.9 54.6 32.9 53.6 40.5 1.6 0.0 1.1 10.4 3.4 5.5 3.7 1.3 9.1 96.3 17.5 18.4 0.5 4.3 1.7 9.2 31.3 2.2 4.4 14.3 1.9 6.8 73.5 8.7 2.5 2.2 63.5 5.5 21.3 20.1 5.9 8.2 25.0 12.3 1.3 9.5 0.7 0.7 1.3 82.4 57.7 23.2 4.1 1.3 2.8 153.1 8.7 1.6 21.4 5.6 8.1 19.0 6.2 29.1 12.5 12.9 16.7 5.7 10.4 9.9 10.8 2.9 1.7 49.9 6.6 3.8 9.8 20.4 80.4 10.0 5.5 1.5 3.3 7.5 21.8 3.1 POGLUT3 "KDELC2, MGC33424" ENSG00000178202 "Protein O-glucosyltransferase 3" Q7Z4H8 11 108472112-108498384 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 6.8;Cardiomyocytes: 13.1;Cytotrophoblasts: 27.6;Extravillous trophoblasts: 14.5;Fibroblasts: 14.7;Hofbauer cells: 18.0;Syncytiotrophoblasts: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039315, HPA039817, HPA066134" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 32: U-937 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Vesicles "HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624" "unprognostic (1.29e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-1)" "unprognostic (7.65e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.04e-2)" "unprognostic (3.49e-3)" "unprognostic (1.49e-1)" "unprognostic (6.00e-3)" "unprognostic (4.08e-3)" "unprognostic (1.66e-3)" "unprognostic (1.85e-2)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (6.27e-5)" 24.6 13.2 5.0 17.3 5.0 7.6 16.2 4.6 5.4 33.6 7.0 16.8 9.4 35.0 27.3 21.0 23.0 21.7 15.2 4.2 5.9 15.6 13.2 16.0 10.4 5.5 6.1 36.5 8.3 25.2 5.4 32.7 5.4 28.4 16.9 5.8 13.9 28.4 5.5 13.7 11.2 37.1 5.3 12.4 11.3 5.8 5.5 16.4 12.1 13.9 9.5 22.5 18.8 6.0 10.9 12.4 46.5 47.8 76.5 88.5 44.8 47.0 43.7 66.0 71.1 58.9 78.1 0.1 28.6 61.6 73.1 7.9 35.6 1.2 69.3 19.4 27.4 18.1 12.1 27.2 30.8 47.7 0.2 51.1 14.6 35.0 1.0 40.1 56.6 0.3 41.5 0.3 101.0 7.9 30.9 27.2 20.3 11.5 34.8 1.5 72.5 0.2 12.3 30.3 9.7 29.5 89.1 6.2 13.3 21.4 42.3 18.0 56.8 127.0 24.9 10.8 49.7 0.4 0.1 0.3 32.6 48.9 103.1 0.1 0.1 0.0 2.0 0.7 1.7 0.2 1.0 1.7 0.5 0.3 1.0 1.5 0.1 1.9 0.4 1.0 0.9 0.5 5.0 5.0 4.6 5.4 4.2 5.9 5.5 6.1 5.4 5.3 5.5 6.0 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 27.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 14.5 14.7 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 21.2 0.5 0.0 0.0 0.0 POP7 "RPP2, RPP20" ENSG00000172336 "POP7 homolog, ribonuclease P/MRP subunit" O75817 7 100706121-100707486 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021007 Uncertain Supported Nucleoli,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoli, Vesicles" "HPA021007: AB_10963575" "unprognostic (3.19e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-2)" "unprognostic (1.80e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.98e-2)" "unprognostic (2.28e-1)" "unprognostic (3.12e-2)" "unprognostic (9.50e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (6.21e-2)" "unprognostic (6.73e-2)" 25.6 31.7 30.1 18.1 31.6 33.9 26.6 33.4 38.6 24.2 23.8 27.9 19.3 27.7 11.0 34.0 21.3 9.8 37.6 32.3 30.8 25.8 67.1 18.2 17.3 30.1 27.8 18.1 31.3 16.6 22.8 16.6 30.8 22.6 9.2 9.6 29.0 13.5 69.0 50.2 22.3 12.1 29.4 22.7 26.4 12.5 29.1 15.6 16.8 31.9 12.0 25.4 24.9 33.9 115.7 115.3 47.2 78.4 25.1 23.9 92.0 65.6 32.4 73.7 73.1 159.8 71.0 97.5 105.1 30.0 81.4 70.4 70.1 79.5 36.8 82.7 212.4 44.9 75.0 166.5 42.1 69.2 49.8 27.6 30.2 76.2 74.8 20.9 41.6 68.9 157.4 77.8 39.8 330.4 158.0 232.9 135.2 77.8 164.4 123.6 50.0 159.4 45.3 65.2 90.4 92.3 54.5 156.2 78.7 42.0 50.0 66.2 41.3 92.0 117.7 191.0 127.6 34.0 99.4 175.8 61.0 115.1 104.6 106.3 63.2 72.4 54.7 64.7 50.7 60.3 54.6 54.3 55.3 47.7 49.5 52.0 39.0 78.9 70.3 51.2 69.8 62.5 30.1 31.6 33.4 38.6 32.3 30.8 30.1 27.8 30.8 29.4 29.1 33.9 30.5 19.2 17.0 2.9 29.7 105.0 32.0 57.2 56.3 26.1 61.6 64.1 27.9 37.1 31.5 35.0 6.2 148.2 25.8 51.8 93.9 75.4 2.1 31.2 32.3 37.2 40.2 50.1 5.2 87.4 181.3 37.3 25.0 35.1 17.7 32.4 33.5 99.0 66.1 32.0 6.0 61.7 67.1 27.3 40.7 7.9 42.0 22.4 56.9 2.8 38.7 41.8 41.2 4.0 5.8 92.2 47.6 37.2 55.1 75.6 69.8 86.1 27.8 21.3 46.0 29.8 52.2 9.2 45.5 74.7 119.2 139.3 27.2 39.9 55.8 43.5 POU2F2 "OCT2, OTF2" ENSG00000028277 "POU class 2 homeobox 2" P09086 19 42086110-42196585 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" "B-cells: 225.5;Kupffer cells: 119.6;Langerhans cells: 104.4;Macrophages: 105.0;monocytes: 137.6;Plasma cells: 96.7;Spermatocytes: 75.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 94.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 52.3;Daudi: 113.0;hTEC/SVTERT24-B: 42.7;U-266/70: 75.5;U-266/84: 80.2;U-698: 88.4;U-87 MG: 41.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002513, HPA049056, HPA062096, HPA064404, HPA073998" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Vesicles" "CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: " "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-2)" "unprognostic (8.89e-2)" "unprognostic (6.77e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-2)" "unprognostic (3.34e-1)" "unprognostic (8.39e-2)" "unprognostic (2.09e-1)" "unprognostic (1.52e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (7.57e-11)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (2.61e-2)" "unprognostic (1.54e-1)" 2.6 2.8 6.1 28.0 5.9 8.4 1.7 15.5 10.6 1.1 3.8 4.3 3.1 1.2 1.5 2.0 1.6 3.4 0.8 5.8 15.4 1.4 2.0 3.8 52.1 8.0 9.1 0.8 1.7 0.3 2.0 3.8 9.4 3.0 3.0 1.9 2.6 3.1 1.1 1.4 14.0 2.9 5.8 27.5 5.0 9.2 14.0 6.5 1.5 0.5 48.3 7.1 1.2 6.7 0.9 1.5 1.8 0.1 0.0 2.9 0.5 8.2 52.3 5.1 10.0 0.5 1.4 113.0 2.8 2.9 0.9 1.0 0.6 8.6 23.2 0.3 0.5 2.7 0.3 0.1 0.6 1.1 2.2 2.2 1.6 42.7 2.8 0.4 3.2 2.4 1.3 25.4 1.1 0.8 0.3 6.1 0.4 0.2 0.6 1.3 0.2 0.4 0.2 0.5 1.8 0.8 0.4 0.7 0.8 0.7 0.1 14.1 3.9 22.0 2.3 0.2 1.1 75.5 80.2 88.4 41.3 2.8 3.1 2.6 28.3 0.5 3.1 51.5 2.7 29.3 4.4 4.0 20.9 33.0 2.3 3.3 4.3 1.7 94.9 3.4 7.2 14.4 6.1 5.9 15.5 10.6 5.8 15.4 8.0 9.1 9.4 5.8 14.0 6.7 2.7 0.0 7.0 0.7 225.5 7.8 8.3 14.1 4.6 63.5 7.2 7.6 3.7 2.8 3.2 0.0 6.2 0.9 29.3 2.8 0.0 1.4 15.2 4.0 1.1 7.3 9.5 10.7 19.7 2.8 0.8 2.7 1.5 8.5 6.3 0.5 4.2 1.1 49.5 1.7 10.0 1.6 4.1 119.6 104.4 9.8 0.9 105.0 8.8 32.8 137.6 1.9 37.0 4.5 1.0 3.5 0.1 0.4 96.7 3.8 2.8 0.4 2.4 6.6 0.0 1.7 5.0 75.1 28.8 13.3 8.8 3.7 31.7 0.6 1.0 5.0 PPARG "NR1C3, PPARG1, PPARG2, PPARgamma" ENSG00000132170 "Peroxisome proliferator activated receptor gamma" P37231 3 12287368-12434356 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 165.1" "Cell type enhanced" "Detected in many" "Adipocytes: 284.1;Extravillous trophoblasts: 217.8;Granulosa cells: 232.9;Urothelial cells: 239.6" "Cancer enhanced" "Detected in all" "urothelial cancer: 33.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 198.7;ASC TERT1: 113.7;BEWO: 247.5;CAPAN-2: 111.6;HSkMC: 118.9;PC-3: 112.0;RT4: 157.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB004282, HPA051239, HPA063663" Approved Enhanced Nucleoplasm,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Vesicles" "CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081" "unprognostic (7.35e-3)" "unprognostic (3.27e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-2)" "unprognostic (2.41e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (3.41e-5)" "unprognostic (9.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.59e-8)" "unprognostic (1.51e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-3)" "prognostic favorable (5.52e-5)" 165.1 3.9 4.0 8.7 3.0 3.0 74.3 3.2 4.7 9.7 0.6 48.7 23.6 7.0 1.2 6.2 7.0 10.5 14.6 4.0 2.7 14.3 17.1 28.5 4.9 3.7 3.5 14.5 2.8 7.9 0.5 43.6 3.4 5.5 40.6 1.0 5.7 1.7 5.2 6.2 15.1 8.7 3.2 12.0 35.5 6.9 3.5 4.1 13.2 8.1 2.1 67.7 9.1 5.0 44.0 38.6 0.0 0.2 198.7 113.7 247.5 3.7 44.7 5.4 2.1 7.8 111.6 0.0 0.1 4.0 72.9 17.3 14.4 0.7 1.0 106.4 20.3 0.0 8.1 10.3 51.8 0.2 0.1 118.9 9.7 9.8 37.5 20.6 0.7 1.0 0.0 0.0 8.3 11.0 0.1 0.8 0.7 99.2 112.0 0.0 0.0 0.2 30.6 157.5 0.1 1.2 18.8 6.7 2.2 6.7 0.0 34.2 35.0 7.8 10.6 4.6 0.2 0.0 0.1 0.3 3.2 0.5 1.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 3.0 3.2 4.7 4.0 2.7 3.7 3.5 3.4 3.2 3.5 5.0 284.1 3.2 7.2 1.6 0.6 1.0 50.5 0.4 4.6 0.9 1.9 2.8 9.2 1.5 2.5 5.5 0.0 110.4 1.8 93.4 1.9 1.1 4.9 5.2 1.4 26.1 8.4 0.0 39.3 0.7 217.8 12.3 83.1 20.8 8.9 232.9 25.7 3.4 49.9 0.0 74.1 21.3 0.0 19.4 4.8 2.2 4.1 19.1 3.6 38.4 1.8 0.6 0.0 6.6 1.2 17.3 84.1 0.0 1.6 42.1 17.0 14.3 1.5 0.2 13.1 1.9 31.3 10.9 22.8 4.6 1.1 88.9 2.2 0.8 24.5 239.6 PPFIA3 "KIAA0654, LPNA3, MGC126567, MGC126569" ENSG00000177380 "PTPRF interacting protein alpha 3" O75145 19 49119544-49151026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 45.0;skin 1: 42.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 40.8;Horizontal cells: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 23.1;PC-3: 36.1;SK-BR-3: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043567, HPA050340" Enhanced Uncertain "Nucleoli fibrillar center,Vesicles" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "Nucleoli fibrillar center, Vesicles" "HPA043567: AB_2678558, HPA050340: AB_2681096" "prognostic unfavorable (3.09e-4)" "unprognostic (4.70e-2)" "unprognostic (5.14e-3)" "prognostic favorable (8.65e-4)" "unprognostic (3.46e-1)" "prognostic favorable (6.46e-7)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.27e-1)" "unprognostic (8.36e-2)" "unprognostic (9.41e-3)" "unprognostic (5.21e-3)" "unprognostic (8.52e-2)" "unprognostic (1.00e-2)" "unprognostic (1.22e-2)" "unprognostic (1.52e-1)" "unprognostic (3.92e-2)" "unprognostic (1.32e-1)" 2.0 4.5 16.4 0.8 18.8 0.2 2.7 11.7 28.6 4.6 0.0 6.6 3.0 2.2 0.3 14.1 1.9 0.6 3.1 18.2 11.4 3.1 2.7 2.9 0.8 10.1 8.7 1.3 4.7 2.1 45.0 0.4 9.9 5.6 1.0 3.7 5.3 0.6 1.4 42.3 3.7 0.4 3.5 2.2 2.4 4.2 11.7 2.4 2.8 0.2 1.1 1.4 8.1 16.6 3.3 3.3 3.3 8.0 0.1 0.0 6.0 0.4 0.4 1.5 2.2 2.2 1.3 7.3 4.3 0.4 2.4 1.7 5.0 0.7 0.4 7.9 10.8 4.6 3.5 1.7 0.4 1.9 11.4 0.4 1.8 1.0 0.5 0.7 0.0 12.1 9.0 11.2 0.1 14.2 2.3 3.2 1.4 23.1 36.1 7.6 6.5 3.6 0.5 1.6 7.2 9.5 1.3 29.7 3.3 0.0 16.5 4.4 0.7 1.7 6.1 1.1 0.2 21.0 18.2 5.4 1.7 7.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 18.8 11.7 28.6 18.2 11.4 10.1 8.7 9.9 3.5 11.7 16.6 15.7 0.0 0.6 8.5 0.8 7.1 8.0 3.5 11.4 40.8 10.4 6.1 4.2 8.6 3.0 5.5 14.6 0.5 3.6 19.3 19.6 2.7 1.2 1.3 3.6 15.2 26.5 2.7 19.9 4.4 2.1 3.4 3.6 2.4 0.0 2.7 23.2 8.6 2.5 43.7 21.5 26.3 8.2 2.2 2.4 1.7 5.6 2.7 16.0 2.8 0.0 16.2 0.0 10.6 2.7 1.9 13.7 3.8 1.2 18.2 15.0 4.6 0.9 17.9 0.0 0.6 5.5 2.5 5.9 8.7 11.8 0.5 0.7 13.2 20.4 6.3 PPP1R21 "CCDC128, FLJ16566, KLRAQ1" ENSG00000162869 "Protein phosphatase 1 regulatory subunit 21" Q6ZMI0 2 48440598-48515391 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 99.6;Oligodendrocytes: 190.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036791, HPA036792" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Nucleoplasm "HPA036791: AB_10671713, HPA036792: AB_2675317" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.83e-4)" "unprognostic (1.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.78e-3)" "unprognostic (1.44e-2)" "unprognostic (7.46e-2)" "unprognostic (3.00e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.13e-1)" "prognostic favorable (4.59e-6)" "unprognostic (9.23e-2)" "unprognostic (1.93e-1)" "prognostic favorable (9.87e-4)" "unprognostic (6.60e-2)" 9.3 10.6 10.6 10.5 13.4 9.9 8.5 8.2 13.4 8.5 10.7 8.8 7.9 12.7 19.6 12.1 14.5 10.8 10.1 9.7 9.4 28.1 11.6 11.2 13.3 11.1 11.0 13.4 8.1 33.5 9.6 12.8 10.2 11.4 10.6 12.0 5.7 10.6 5.7 10.5 9.9 13.0 8.7 13.0 9.0 9.4 11.7 13.9 21.4 4.8 12.2 9.5 7.6 18.9 17.3 8.2 6.8 8.5 17.1 12.5 18.3 10.0 11.0 6.1 7.2 4.5 10.6 11.8 16.4 14.2 11.7 9.3 5.8 9.1 12.4 15.1 4.8 12.6 7.2 10.8 11.6 5.5 9.8 15.9 8.1 11.0 13.2 15.1 15.3 5.9 5.2 19.2 16.7 9.5 10.9 9.5 17.7 12.3 8.4 9.1 18.8 13.1 11.9 10.8 9.2 5.7 19.0 4.8 18.1 18.2 8.6 9.0 13.9 6.4 7.8 5.6 8.0 14.3 4.1 10.5 10.2 12.5 8.6 18.6 4.7 8.1 3.7 5.4 2.9 5.4 4.3 4.4 5.0 6.8 6.4 5.5 11.6 3.8 4.8 3.1 4.6 2.3 10.6 13.4 8.2 13.4 9.7 9.4 11.1 11.0 10.2 8.7 11.7 18.9 14.5 22.4 16.5 37.5 23.6 10.5 32.9 8.6 13.6 9.1 6.9 6.7 11.0 14.3 9.2 25.8 2.1 21.7 8.5 11.7 5.9 11.0 3.9 10.2 11.5 10.9 18.7 10.3 99.6 8.4 16.3 15.0 25.5 12.3 12.0 12.4 10.8 13.6 35.2 28.6 49.6 10.7 10.2 26.1 12.2 5.7 12.2 19.3 12.4 44.0 24.3 21.2 19.6 69.9 190.3 12.2 9.3 20.7 19.4 17.0 10.7 59.3 20.0 6.8 13.1 9.6 14.2 9.8 10.8 17.4 14.1 27.1 20.5 12.1 8.4 27.2 PPP1R3F Hb2E ENSG00000049769 "Protein phosphatase 1 regulatory subunit 3F" Q6ZSY5 X 49269793-49301461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 27.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 38.6;Horizontal cells: 48.8;Oligodendrocytes: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "T-reg: 9.4" "Lineage enriched" "Detected in single" 12 "T-cells: 9.4" "Cell line enhanced" "Detected in many" "GAMG: 13.6;HDLM-2: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000244, HPA000918" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 35: T-regs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Vesicles" "HPA000244: AB_2665949, HPA000918: AB_2268692" "unprognostic (6.69e-2)" "unprognostic (2.87e-2)" "unprognostic (4.98e-4)" "unprognostic (1.83e-2)" "unprognostic (6.48e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.91e-2)" "unprognostic (2.89e-1)" "prognostic favorable (1.85e-6)" "unprognostic (5.99e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (7.96e-2)" "unprognostic (1.55e-1)" 3.1 4.0 13.9 2.4 14.9 1.5 3.2 14.0 18.3 5.7 8.1 7.4 1.3 5.8 5.8 4.2 7.1 1.5 18.1 15.2 14.1 4.1 3.4 3.3 2.7 14.7 13.5 8.2 2.6 1.1 15.5 1.0 17.2 5.6 0.6 9.7 3.1 1.4 27.5 3.3 3.5 1.3 12.5 4.0 3.4 4.2 14.1 1.3 5.3 12.8 1.4 6.7 4.6 19.1 2.1 4.7 2.9 3.6 2.4 1.8 2.3 2.8 1.8 1.3 2.2 3.0 1.8 2.2 0.6 0.6 13.6 3.6 0.9 0.5 0.9 13.2 4.4 0.2 4.0 0.3 1.5 0.6 1.5 1.4 1.4 1.5 0.5 2.2 0.1 2.8 0.6 0.9 0.9 6.2 1.2 2.5 9.8 0.1 5.8 6.1 3.2 1.1 1.4 1.1 3.8 3.7 0.9 0.1 6.2 4.5 3.3 2.3 2.5 4.1 1.0 3.0 2.0 3.6 4.4 1.5 1.6 5.2 4.8 0.0 0.2 0.0 0.2 0.3 0.6 0.3 1.8 0.6 0.2 0.0 1.5 0.6 0.0 0.3 0.7 0.2 9.4 0.3 13.9 14.9 14.0 18.3 15.2 14.1 14.7 13.5 17.2 12.5 14.1 19.1 2.1 0.0 0.5 14.0 2.8 1.9 2.4 1.0 4.0 38.6 2.5 3.4 16.8 0.0 0.7 3.7 8.4 1.1 1.7 0.3 7.9 0.3 0.1 3.6 2.8 2.2 3.0 0.8 9.6 0.2 0.1 3.8 0.0 2.0 0.0 4.3 3.3 1.1 0.7 48.8 10.7 0.1 0.0 0.6 1.8 0.7 4.7 1.5 0.0 3.7 0.2 11.9 0.0 12.5 34.3 0.4 0.1 3.0 2.0 2.2 0.0 7.6 2.6 17.8 0.0 4.0 3.9 2.0 8.5 7.3 1.3 1.2 5.6 2.4 0.2 2.3 PPP5C "PP5, PPP5" ENSG00000011485 "Protein phosphatase 5 catalytic subunit" P53041 19 46347087-46392981 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022641, HPA029065, HPA056933" Approved Supported Vesicles,Cytosol NA NA 120000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" "Vesicles, Cytosol" "CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278" "unprognostic (8.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.44e-1)" "unprognostic (6.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.29e-1)" "unprognostic (1.04e-2)" "unprognostic (8.25e-2)" "unprognostic (5.56e-2)" "unprognostic (2.20e-2)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.37e-1)" 27.4 37.5 27.7 17.7 29.3 14.2 26.3 28.4 36.5 28.0 27.7 31.3 16.8 34.9 9.8 30.4 31.7 13.3 56.4 29.8 28.6 29.1 32.7 28.0 19.7 32.3 28.2 24.7 23.7 32.5 36.6 15.8 33.3 23.7 15.4 14.4 23.0 18.2 58.9 27.5 25.9 20.8 26.2 33.5 33.6 16.9 30.3 20.5 26.2 45.7 15.0 27.7 26.3 28.5 61.9 114.9 66.0 50.1 48.3 50.9 30.6 75.4 59.6 88.2 78.2 82.4 47.9 94.3 39.9 54.0 48.4 49.9 86.2 88.5 24.7 65.9 120.5 76.4 80.9 59.4 54.5 106.6 52.8 47.8 40.9 62.1 45.9 34.2 77.2 79.3 76.0 47.3 49.4 67.5 59.5 203.4 50.2 109.6 61.7 89.0 56.6 76.5 52.8 81.8 93.1 69.7 62.6 78.8 26.9 28.6 49.7 67.8 65.5 38.3 64.3 29.1 79.1 38.0 93.0 111.5 41.7 89.4 65.9 0.0 10.3 3.0 27.8 18.0 17.8 15.1 12.8 22.0 16.8 11.7 12.2 16.8 0.2 22.0 23.4 11.7 14.3 15.4 27.7 29.3 28.4 36.5 29.8 28.6 32.3 28.2 33.3 26.2 30.3 28.5 28.1 6.4 12.5 22.9 16.5 9.4 16.6 20.9 19.9 19.7 13.1 13.5 5.6 44.3 14.2 16.5 16.7 26.4 12.3 25.2 33.2 29.9 1.2 31.3 25.2 19.6 14.9 11.6 18.5 19.5 36.2 17.6 26.0 19.6 4.5 18.6 24.3 24.9 21.6 16.8 23.2 17.0 22.4 12.3 8.2 3.2 17.4 11.9 16.0 11.2 12.1 21.0 17.5 17.6 14.5 26.4 17.0 18.4 25.5 12.1 16.3 21.4 14.6 17.9 39.5 14.6 19.9 26.6 32.0 20.8 13.2 25.7 20.4 23.1 25.0 11.7 PPP6R2 "dJ579N16.1, KIAA0685, SAP190, SAPS2" ENSG00000100239 "Protein phosphatase 6 regulatory subunit 2" O75170 22 50343304-50445090 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030656, CAB034919" Uncertain Supported Vesicles,Cytosol NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Vesicles, Cytosol" "CAB034919: AB_2183817, HPA030656: AB_10602926" "unprognostic (1.24e-1)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (1.70e-5)" "unprognostic (2.17e-1)" "unprognostic (3.79e-3)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-2)" "prognostic favorable (7.51e-4)" "unprognostic (6.89e-2)" "unprognostic (1.42e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (7.77e-3)" 21.9 35.6 23.5 20.9 27.3 21.4 23.2 24.3 32.2 23.7 19.2 28.5 24.5 25.4 11.5 28.3 23.8 18.0 36.7 25.4 19.7 29.6 72.4 25.2 27.3 26.9 22.2 24.8 29.0 21.4 41.0 14.8 21.8 31.4 11.8 12.6 27.9 17.1 65.8 27.6 28.7 14.0 18.2 32.4 30.1 62.7 26.0 25.8 30.8 31.7 16.5 23.9 22.3 25.8 30.9 17.8 27.3 34.8 19.7 21.0 24.4 30.1 31.9 31.5 31.7 15.0 18.7 36.9 14.5 30.0 17.4 24.6 16.9 22.4 11.8 19.3 30.9 19.8 37.7 37.7 25.6 46.9 52.1 31.2 23.8 19.0 10.1 24.8 27.8 30.8 20.5 31.5 23.2 50.0 32.3 33.9 11.3 19.5 21.9 44.8 20.9 24.3 23.1 36.1 17.0 23.1 31.0 47.6 25.0 10.1 17.2 35.2 32.5 29.3 26.4 24.6 20.3 33.6 8.7 32.7 30.6 22.6 41.2 4.0 8.6 5.8 9.0 9.4 10.4 7.9 6.2 9.6 8.8 8.4 5.9 7.9 13.7 5.9 6.8 11.0 13.3 8.5 23.5 27.3 24.3 32.2 25.4 19.7 26.9 22.2 21.8 18.2 26.0 25.8 28.5 22.4 20.6 79.0 32.0 8.8 14.4 12.9 22.8 43.7 25.5 21.8 19.2 37.1 17.1 27.6 56.3 17.3 39.9 39.8 31.3 19.3 84.0 30.8 39.0 18.1 26.9 19.8 83.0 32.5 11.8 15.3 35.2 34.8 31.8 23.9 18.9 65.1 16.0 65.6 80.8 23.0 16.2 25.3 8.8 48.6 19.6 23.4 10.6 61.8 32.1 25.0 50.4 52.8 59.9 33.3 29.0 19.9 42.0 19.4 27.0 23.6 17.9 43.2 26.3 16.9 18.7 78.5 47.1 17.9 8.5 28.5 28.4 17.8 25.2 17.5 PPT1 "CLN1, INCL, PPT" ENSG00000131238 "Palmitoyl-protein thioesterase 1" P50897 1 40072710-40097260 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 251.9;Kupffer cells: 315.8;Langerhans cells: 328.8;Macrophages: 271.3;monocytes: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 1254.3;eosinophil: 624.2;intermediate monocyte: 1006.3;myeloid DC: 1091.1;neutrophil: 683.9;non-classical monocyte: 815.7" "Group enriched" "Detected in all" 4 "dendritic cells: 1091.1;granulocytes: 683.9;monocytes: 1254.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 1082.7;THP-1: 1449.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021546 Supported Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 240000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" "HPA021546: AB_1855667" "unprognostic (5.02e-2)" "unprognostic (2.73e-1)" "unprognostic (1.64e-1)" "unprognostic (2.06e-3)" "unprognostic (6.68e-2)" "unprognostic (2.83e-2)" "prognostic unfavorable (6.98e-8)" "unprognostic (1.39e-1)" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (8.16e-2)" "unprognostic (2.39e-1)" "unprognostic (5.20e-3)" "unprognostic (1.75e-1)" "unprognostic (2.30e-1)" "unprognostic (2.93e-2)" "unprognostic (2.08e-2)" 69.8 59.4 92.9 92.7 95.6 117.5 95.7 100.4 135.9 70.1 106.1 50.5 32.1 72.7 60.1 45.1 55.4 57.1 45.3 93.6 101.2 75.8 54.1 128.5 93.9 97.0 96.7 68.6 42.6 79.2 39.0 74.8 99.6 73.4 58.8 89.4 56.8 63.2 21.3 40.3 39.2 95.3 101.6 177.0 45.1 37.6 99.1 78.0 60.0 37.1 75.1 79.1 34.7 113.5 115.6 62.5 93.7 81.0 106.5 92.1 209.8 68.4 127.9 153.0 183.3 350.1 270.5 140.1 118.1 65.2 112.2 209.5 154.9 112.7 163.6 186.4 151.4 100.3 127.2 155.5 137.5 233.7 158.9 103.1 107.5 108.7 126.4 79.7 190.9 108.8 167.7 247.0 80.6 168.1 109.8 88.3 258.3 163.9 93.8 116.0 263.7 226.1 89.2 152.0 114.1 96.9 247.9 1082.7 298.6 111.7 199.3 1449.6 85.2 100.7 147.1 70.7 174.9 161.2 383.8 133.9 109.4 408.7 155.5 85.7 1254.3 624.2 122.2 1006.3 137.9 118.8 171.5 131.3 1091.1 118.6 227.0 168.3 683.9 100.3 815.7 101.8 204.1 1586.9 92.9 95.6 100.4 135.9 93.6 101.2 97.0 96.7 99.6 101.6 99.1 113.5 45.2 28.9 47.7 19.9 33.3 39.6 77.1 30.8 34.7 46.6 55.3 37.5 15.7 41.5 40.0 38.6 16.7 51.7 28.9 4.7 5.9 59.0 64.8 13.8 46.4 49.6 19.9 40.1 28.4 42.1 66.5 56.6 14.8 18.2 84.9 34.6 47.5 9.3 251.9 25.2 39.2 8.1 20.3 315.8 328.8 87.6 31.4 271.3 67.6 31.9 227.2 120.3 28.8 27.6 22.7 22.2 6.0 39.5 34.2 42.4 3.2 18.5 32.3 37.0 19.7 30.5 49.3 17.5 33.0 19.1 27.3 41.2 43.5 39.4 11.4 35.6 PRAF2 "JM4, Yip6a" ENSG00000243279 "PRA1 domain family member 2" O60831 X 49071161-49074002 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 163.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002859, HPA005504, CAB011655" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum" Vesicles "CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340" "unprognostic (1.50e-1)" "prognostic favorable (7.42e-4)" "unprognostic (1.17e-2)" "unprognostic (1.32e-2)" "unprognostic (4.29e-1)" "unprognostic (3.67e-1)" "prognostic unfavorable (1.66e-6)" "prognostic favorable (2.81e-4)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "prognostic favorable (4.88e-6)" "unprognostic (8.39e-3)" "prognostic unfavorable (5.83e-6)" "unprognostic (4.96e-2)" "unprognostic (1.69e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" 26.5 38.7 66.9 15.6 67.3 8.2 23.2 67.2 82.5 43.2 63.8 32.3 6.1 51.5 163.4 11.7 36.0 14.8 32.0 66.7 72.1 26.3 11.5 29.7 12.8 69.4 73.8 37.7 10.5 29.2 74.5 11.4 73.9 26.4 11.1 21.6 13.9 35.8 12.1 14.7 17.8 43.6 66.1 21.7 21.9 28.2 71.1 21.5 27.7 9.0 14.9 33.1 26.0 69.8 17.0 35.0 40.0 51.5 140.4 84.7 5.0 59.1 61.9 39.7 43.2 2.0 5.3 1.7 14.0 129.3 32.6 15.5 1.6 32.3 43.6 31.3 45.4 13.4 43.0 1.8 143.2 8.8 25.0 108.3 27.0 75.0 54.0 80.9 61.6 41.3 2.1 4.6 69.5 31.4 56.6 10.6 22.5 8.3 2.3 30.8 21.9 3.8 60.0 5.0 26.6 66.3 49.5 25.5 35.2 35.1 25.0 6.2 37.8 30.1 39.6 65.6 17.5 71.7 19.8 13.4 72.7 15.3 48.1 47.0 13.0 18.5 38.6 15.0 43.2 32.0 41.6 33.9 14.9 30.2 36.7 40.1 34.1 39.0 11.2 5.9 68.4 26.0 66.9 67.3 67.2 82.5 66.7 72.1 69.4 73.8 73.9 66.1 71.1 69.8 21.5 12.8 10.0 7.5 8.7 7.6 14.9 34.8 11.4 23.1 8.0 10.7 5.8 11.5 16.3 11.0 12.5 3.3 13.2 2.2 11.7 16.7 3.4 6.8 31.6 30.9 10.2 5.2 5.8 5.7 13.4 29.9 4.1 9.2 15.9 13.4 33.5 3.6 6.1 16.8 7.0 4.7 40.7 5.7 11.3 6.0 38.2 6.6 14.2 5.6 5.6 29.2 16.5 3.5 9.9 4.1 0.8 41.3 10.5 10.1 1.5 18.5 17.7 8.6 19.7 13.2 33.4 14.7 4.5 5.0 7.4 9.7 17.5 36.3 1.5 9.3 PREX1 "KIAA1415, P-REX1" ENSG00000124126 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1" Q8TCU6 20 48624252-48827999 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 52.5;brain: 78.1" "Cell type enhanced" "Detected in many" "Astrocytes: 87.1;dendritic cells: 84.0;Kupffer cells: 104.7;Macrophages: 76.5;Microglial cells: 95.5;NK-cells: 90.6;Oligodendrocytes: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 157.9;SK-BR-3: 162.2;T-47d: 145.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001927 Supported Supported Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" "Vesicles, Cytosol" "HPA001927: AB_1079674" "unprognostic (8.07e-2)" "unprognostic (3.16e-2)" "unprognostic (2.15e-2)" "unprognostic (2.55e-1)" "unprognostic (7.47e-2)" "prognostic favorable (8.56e-4)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (5.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.70e-2)" "unprognostic (5.86e-3)" "unprognostic (6.84e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" 14.8 10.6 32.8 37.4 56.4 52.5 15.0 43.2 47.2 12.3 1.2 7.0 6.3 4.0 1.4 6.4 4.7 13.0 6.7 32.1 42.0 4.8 5.2 26.8 36.6 52.1 52.0 2.5 5.3 6.9 7.6 11.7 53.8 4.8 6.0 3.9 5.3 3.4 6.6 3.5 12.7 7.7 43.5 42.9 8.8 6.0 45.3 9.8 9.4 8.6 21.8 12.3 3.2 78.1 2.3 6.1 78.4 0.0 1.3 5.7 27.2 2.7 3.5 11.2 2.8 0.4 0.3 16.4 49.5 7.2 21.4 1.0 4.1 0.2 7.5 3.7 2.0 2.4 8.8 0.0 4.6 9.0 51.1 6.3 0.0 25.7 0.0 7.6 68.4 7.2 0.2 0.6 14.8 157.9 0.2 24.7 3.1 8.1 6.4 24.1 22.8 9.8 0.5 0.0 16.5 2.4 14.7 162.2 17.8 4.4 145.0 67.4 77.2 4.5 15.6 0.2 4.6 0.9 3.5 20.1 72.4 17.8 24.3 4.5 1.9 2.2 3.7 2.2 2.2 1.5 2.0 3.2 1.6 1.4 0.3 1.1 9.2 1.8 2.0 1.3 7.3 2.0 32.8 56.4 43.2 47.2 32.1 42.0 52.1 52.0 53.8 43.5 45.3 78.1 43.2 3.2 6.6 87.1 35.4 2.5 0.3 0.4 1.2 0.3 40.0 21.5 3.7 2.8 2.6 1.8 8.4 0.7 84.0 0.9 0.0 0.2 3.5 3.5 4.7 24.5 1.2 14.1 13.3 1.2 4.4 10.3 4.1 6.2 1.3 0.7 20.7 1.9 32.1 0.0 4.6 1.8 0.0 104.7 28.2 2.9 0.9 76.5 8.8 95.5 47.1 19.4 90.6 49.3 190.2 0.1 1.0 0.4 23.3 0.7 0.3 0.2 4.5 0.7 0.0 18.1 3.3 2.2 11.6 0.4 2.4 9.3 63.9 41.2 4.5 0.7 PRICKLE2 DKFZp686D143 ENSG00000163637 "Prickle planar cell polarity protein 2" Q7Z3G6 3 64092236-64445476 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 114.3;Excitatory neurons: 185.5;Inhibitory neurons: 232.4;Microglial cells: 112.4;Oligodendrocyte precursor cells: 103.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.1;ASC TERT1: 14.9;HSkMC: 22.1;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035493 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Vesicles "HPA035493: AB_10696504" "unprognostic (2.87e-1)" "unprognostic (4.31e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.92e-1)" "unprognostic (3.83e-2)" "unprognostic (3.03e-2)" "unprognostic (6.35e-2)" "unprognostic (1.32e-3)" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (9.04e-3)" "unprognostic (1.77e-1)" 20.8 3.0 14.1 3.9 14.9 0.3 8.0 3.4 15.8 16.4 9.1 18.4 2.3 17.3 6.8 7.7 11.7 8.8 5.6 28.5 10.0 3.8 3.1 10.6 0.8 4.4 8.9 8.4 3.8 5.4 5.6 5.6 6.2 7.3 4.6 10.1 4.9 13.8 1.9 4.3 5.9 16.6 6.3 1.4 8.1 1.7 11.7 1.0 6.9 3.9 1.0 12.4 8.8 9.3 0.0 4.7 1.3 0.1 24.1 14.9 0.0 3.5 4.5 2.8 4.2 8.3 0.1 0.0 0.5 3.4 7.6 0.1 0.0 3.2 2.8 3.3 0.1 0.0 0.5 0.1 6.7 0.0 0.0 22.1 4.0 8.2 3.5 8.4 1.7 0.0 0.0 1.8 3.9 4.6 0.0 0.1 3.0 0.0 0.1 0.0 0.2 0.1 4.5 11.7 1.2 0.2 0.0 0.9 0.1 7.7 1.6 0.1 0.1 11.9 5.4 2.9 6.9 3.7 0.0 0.7 15.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.1 14.9 3.4 15.8 28.5 10.0 4.4 8.9 6.2 6.3 11.7 9.3 12.4 0.0 10.9 114.3 1.5 6.2 4.1 7.3 7.4 25.6 4.3 8.4 6.2 1.5 7.3 3.7 64.6 1.4 0.3 1.6 0.0 2.7 15.1 24.7 47.5 9.5 0.0 0.0 185.5 0.4 0.4 20.3 0.0 8.7 0.0 5.2 33.5 1.7 4.1 16.8 232.4 0.6 4.1 1.2 1.8 3.5 9.9 0.6 5.4 112.4 0.0 7.5 1.0 103.5 26.4 0.7 0.3 23.0 0.2 0.9 0.0 6.2 7.6 4.4 13.1 14.6 14.3 2.0 1.0 6.2 3.0 4.9 0.6 6.6 1.1 2.7 PRKG1 "PGK, PKG, PKG1, PRKG1B, PRKGR1B" ENSG00000185532 "Protein kinase cGMP-dependent 1" Q13976 10 50990888-52298423 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 36.1" "Cell type enhanced" "Detected in many" "Astrocytes: 778.3;Excitatory neurons: 244.9;Inhibitory neurons: 473.0;Microglial cells: 188.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 36 "basophil: 7.3" "Lineage enriched" "Detected in single" 49 "granulocytes: 7.3" "Cell line enhanced" "Detected in many" "AN3-CA: 14.3;BJ hTERT+: 19.2;fHDF/TERT166: 16.1;U-138 MG: 11.2;U-87 MG: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007699, CAB009629" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Cytosol" "CAB009629: AB_2170663, HPA007699: AB_1079677" "unprognostic (3.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.44e-2)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (5.54e-1)" "unprognostic (2.23e-1)" "unprognostic (4.94e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (3.40e-1)" "unprognostic (9.26e-2)" "unprognostic (5.50e-3)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (3.78e-4)" 7.0 8.3 6.4 2.7 7.2 0.6 3.1 1.4 6.9 10.3 12.4 5.5 2.4 10.3 3.5 5.2 5.2 7.0 14.1 6.6 10.7 3.8 1.7 6.8 1.2 5.1 4.6 4.2 1.7 9.6 1.3 10.1 3.2 6.4 5.3 3.6 4.0 8.1 25.8 1.0 3.4 14.6 5.3 2.5 3.3 1.8 12.2 1.5 7.0 36.1 0.9 5.4 4.2 2.7 0.1 0.2 1.7 14.3 6.5 6.0 0.1 5.4 19.2 2.1 2.6 0.1 0.9 0.3 0.0 16.1 2.0 0.1 0.0 0.1 1.7 0.0 5.0 1.0 0.3 0.0 5.5 0.0 0.1 8.1 0.1 4.8 0.1 0.6 0.0 0.0 0.0 0.1 5.3 0.1 0.0 0.0 4.1 0.0 2.5 0.0 3.9 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.1 2.0 0.1 0.0 0.0 11.2 1.9 5.9 3.7 1.5 0.8 0.0 10.0 0.0 2.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 6.4 7.2 1.4 6.9 6.6 10.7 5.1 4.6 3.2 5.3 12.2 2.7 10.5 16.0 10.8 778.3 0.3 0.9 1.7 0.0 7.4 5.9 2.8 9.4 31.4 0.0 0.0 3.7 0.0 1.0 0.3 2.9 0.0 2.4 56.0 0.4 14.7 7.1 0.0 3.4 244.9 3.6 1.2 24.2 0.5 0.5 4.5 0.1 5.0 0.0 0.4 0.0 473.0 4.2 0.0 0.0 2.2 53.0 32.6 5.3 3.6 188.3 0.0 23.6 0.0 24.6 8.0 4.8 14.1 39.5 0.1 0.5 3.2 0.2 0.9 1.3 39.5 3.9 69.9 0.9 0.9 1.6 0.6 2.2 0.2 7.9 3.6 1.0 PRPS2 ENSG00000101911 "Phosphoribosyl pyrophosphate synthetase 2" P11908 X 12791355-12824222 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 147.8;parathyroid gland: 182.0" "Group enriched" "Detected in many" 7 "Leydig cells: 1431.5;Peritubular cells: 1995.0;Sertoli cells: 624.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051269, HPA067599, CAB070417" Enhanced Approved "Nuclear speckles,Vesicles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Vesicles "Nuclear speckles" "CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869" "unprognostic (7.50e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.09e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (4.75e-2)" "unprognostic (6.98e-2)" "unprognostic (2.64e-3)" "unprognostic (4.44e-3)" "unprognostic (1.81e-1)" "unprognostic (7.83e-2)" "unprognostic (2.20e-1)" "unprognostic (1.50e-1)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" 11.0 46.0 6.3 24.5 7.3 24.2 19.7 1.9 12.0 54.5 2.5 30.3 14.0 32.8 26.5 16.1 29.7 28.1 5.4 6.9 2.9 28.0 26.1 13.1 36.8 3.0 6.5 147.8 62.8 182.0 3.4 6.1 2.2 21.9 31.3 1.3 27.9 84.0 2.1 21.9 15.8 24.3 4.4 15.6 32.5 131.1 8.8 44.6 18.1 4.2 31.5 22.5 21.2 6.4 114.2 63.7 22.1 40.3 26.7 31.8 14.6 54.4 26.8 53.1 51.1 46.3 78.7 34.9 24.2 23.5 45.3 79.9 43.1 53.7 61.5 89.7 108.0 41.7 49.6 43.3 24.7 77.3 38.9 30.5 35.0 39.1 51.7 26.9 22.1 86.8 30.4 39.8 45.2 68.5 117.6 34.7 49.9 81.0 107.3 61.5 102.7 79.5 33.0 81.7 46.1 33.6 64.9 2.1 38.9 30.2 58.8 32.4 24.9 41.8 32.0 162.5 55.5 103.6 41.3 76.8 44.4 39.4 67.4 25.9 20.1 9.4 17.2 19.4 19.9 27.8 25.0 16.4 28.2 30.6 31.7 23.0 8.0 24.3 12.3 19.9 22.6 28.2 6.3 7.3 1.9 12.0 6.9 2.9 3.0 6.5 2.2 4.4 8.8 6.4 12.2 3.2 8.7 0.7 25.4 64.0 48.5 16.2 41.5 0.6 53.1 15.9 2.0 11.5 12.4 55.2 0.0 1.1 18.5 21.1 72.4 19.3 12.1 24.7 62.5 14.5 21.8 28.4 14.8 39.2 7.3 25.8 31.1 26.4 27.9 16.2 10.4 13.7 24.4 0.0 6.3 27.9 8.2 21.4 44.3 65.8 1431.5 20.7 40.9 3.7 18.2 1.2 18.6 3.5 5.1 24.6 17.4 1995.0 30.7 52.2 6.0 10.4 20.3 0.2 624.5 9.4 19.2 10.3 8.1 29.2 43.8 0.4 27.2 179.2 50.2 36.9 PRR15 ENSG00000176532 "Proline rich 15" Q8IV56 7 29563835-29567293 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 62.6;intestine: 81.4;stomach 1: 49.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 263.0;Granulosa cells: 194.2;Proximal enterocytes: 122.4;Respiratory ciliated cells: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.7;HaCaT: 45.1;OE19: 97.7;RT4: 34.5;SK-BR-3: 74.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA040996, HPA048121" Enhanced Uncertain "Vesicles,Cell Junctions" NA NA "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "Cell Junctions" "HPA040996: AB_2677241, HPA048121: AB_2680271" "unprognostic (5.46e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "prognostic favorable (6.37e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (3.69e-3)" "unprognostic (1.25e-1)" "prognostic favorable (1.83e-6)" "unprognostic (1.30e-2)" "unprognostic (5.71e-2)" "unprognostic (2.33e-3)" "unprognostic (1.58e-2)" 6.5 0.7 0.6 4.8 0.4 1.1 9.2 0.1 0.7 62.6 0.0 81.4 72.3 18.1 21.6 1.0 9.0 7.8 1.3 0.4 1.0 16.9 0.3 2.3 0.4 0.6 0.4 5.9 3.0 1.4 3.0 4.8 0.5 2.5 52.6 0.0 7.5 3.1 0.2 0.3 72.4 2.3 0.6 0.2 49.3 0.9 1.3 0.1 1.1 0.0 0.7 16.6 0.5 0.6 16.8 23.3 0.0 0.0 8.7 10.7 29.3 0.7 1.1 0.4 0.2 20.5 38.7 0.0 4.1 5.5 0.6 45.1 4.9 0.0 0.0 0.0 3.3 1.3 4.5 22.7 2.8 0.0 0.1 0.1 7.3 0.0 1.7 0.0 0.1 1.5 0.0 0.0 0.0 3.9 0.6 3.2 3.5 97.7 18.5 0.1 0.0 21.4 26.5 34.5 0.5 0.3 2.3 74.9 0.0 12.8 5.4 0.0 19.9 0.5 0.0 0.1 0.9 1.8 3.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.1 0.7 0.4 1.0 0.6 0.4 0.5 0.6 1.3 0.6 1.8 0.0 0.5 0.0 0.4 0.1 1.2 11.0 0.0 0.0 10.0 7.1 0.5 12.8 16.4 38.6 0.0 14.2 0.2 263.0 29.4 6.9 0.8 31.3 2.3 1.2 8.4 0.0 0.1 21.8 9.9 1.3 16.8 34.7 0.0 194.2 0.4 0.2 2.7 0.0 0.0 45.3 26.4 0.0 0.3 0.1 1.5 2.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 14.4 58.5 2.2 0.1 3.0 122.4 14.4 63.1 0.0 0.0 0.0 7.8 0.0 0.4 1.2 0.0 6.3 0.6 0.4 56.9 23.3 PRSS1 TRY1 ENSG00000204983 "Serine protease 1" P07477 7 142749468-142753076 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1923 "pancreas: 341429.7" "Cell type enriched" "Detected in some" 28 "Exocrine glandular cells: 57138.3" "Cancer enriched" "Detected in many" 224 "pancreatic cancer: 1920.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "OE19: 10.6;RPMI-8226: 4.5;U-2 OS: 2.8" "CAB025487, CAB025538, HPA062452, HPA063471" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 100000000000 "Cluster 35: T-regs - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Vesicles "Endoplasmic reticulum" "CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017" "unprognostic (6.55e-5)" "unprognostic (5.28e-1)" "unprognostic (7.58e-2)" "prognostic unfavorable (6.41e-6)" "unprognostic (8.26e-2)" "prognostic favorable (7.05e-4)" "unprognostic (1.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-1)" "prognostic favorable (4.91e-4)" "unprognostic (3.12e-1)" 45.2 9.9 0.0 4.7 0.0 0.0 25.7 0.0 0.0 19.9 0.0 11.2 54.5 8.9 0.8 15.2 5.6 0.0 51.0 0.0 0.0 9.6 29.7 6.4 6.5 0.0 0.0 177.5 341429.7 0.1 10.3 13.9 0.0 15.2 0.0 0.0 44.2 4.2 8.9 12.1 12.7 0.0 0.0 13.4 77.1 6.9 0.0 0.0 6.4 0.0 0.0 4.7 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 100.7 0.0 0.1 0.0 3.6 0.0 0.0 0.0 57138.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 119.4 0.6 0.0 0.0 0.0 1985.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.2 0.2 PRSS2 TRY2 ENSG00000275896 "Serine protease 2" P07478 7 142760398-142774564 "Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 452 "pancreas: 239420.0" "Cell type enriched" "Detected in some" 11 "Exocrine glandular cells: 108258.7" "Cancer enriched" "Detected in many" 72 "pancreatic cancer: 3463.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 4.1;T-reg: 2.9" "Group enriched" "Detected in many" 8 "granulocytes: 4.1;T-cells: 2.9" "Cell line enhanced" "Detected in some" "OE19: 21.0;RPMI-8226: 67.5;U-2 OS: 15.2" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 890000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 25: Pancreas - Digestion" "Cluster 25: RPMI-8226 - Immune response" "Cluster 1: Pancreatic cells - Digestion" Vesicles "Endoplasmic reticulum" "HPA062452: AB_2684768, HPA063471: AB_2685017" "prognostic favorable (2.32e-4)" "unprognostic (3.80e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-3)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-3)" "unprognostic (1.48e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (3.50e-1)" "unprognostic (5.36e-3)" "unprognostic (1.18e-1)" 65.1 12.5 0.1 0.2 0.1 3.2 25.4 0.0 0.1 27.6 0.0 12.6 358.5 11.4 0.0 18.2 9.6 0.1 25.0 0.0 0.0 9.4 32.2 8.2 1.3 0.0 0.0 64.9 239420.0 0.0 13.4 8.1 0.0 17.2 0.0 0.0 25.4 0.9 10.1 11.3 529.2 0.1 0.0 16.9 54.7 8.6 0.0 0.9 8.3 0.0 0.0 7.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.4 4.4 0.5 0.0 0.0 0.0 1.9 0.0 21.0 0.0 0.0 0.0 67.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.9 3.8 0.0 2.9 0.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.9 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 378.7 0.0 0.4 0.1 11.4 0.0 0.0 0.0 108258.7 0.0 0.3 4.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 348.9 0.0 0.0 0.0 0.0 9565.7 8.9 0.0 0.1 0.0 60.0 0.1 0.0 0.0 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 85.4 0.2 PRSS3 "PRSS4, TRY3, TRY4" ENSG00000010438 "Serine protease 3" P35030 9 33750679-33799231 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 268 "pancreas: 31113.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1022.9;Exocrine glandular cells: 2040.4;Pancreatic endocrine cells: 478.8;Paneth cells: 969.9;Proximal enterocytes: 1127.1" "Group enriched" "Detected in many" 7 "colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 104 "basophil: 158.7" "Lineage enriched" "Detected in many" 104 "granulocytes: 158.7" "Group enriched" "Detected in many" 5 "OE19: 316.6;PC-3: 852.5" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 700000000 "Cluster 38: Basophils - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "Endoplasmic reticulum" "HPA062452: AB_2684768, HPA063471: AB_2685017" "unprognostic (6.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.18e-1)" "unprognostic (1.64e-1)" "unprognostic (3.29e-2)" "unprognostic (5.89e-3)" "unprognostic (1.38e-1)" "unprognostic (2.06e-3)" "unprognostic (1.10e-2)" "unprognostic (8.94e-2)" "unprognostic (7.75e-4)" "unprognostic (5.46e-3)" "unprognostic (2.13e-1)" "unprognostic (8.79e-2)" "unprognostic (4.96e-1)" 3.8 4.6 23.5 7.2 29.3 0.6 1.7 25.8 35.4 30.8 16.9 87.0 92.6 0.4 0.0 116.2 0.3 22.8 6.3 28.2 25.6 3.7 12.4 0.6 0.7 25.0 24.5 12.9 31113.6 0.0 0.7 1.7 25.7 1.1 77.8 0.3 20.9 0.3 0.5 79.7 105.4 3.1 19.4 0.7 22.8 5.1 25.6 0.8 0.4 0.0 15.2 4.2 56.9 24.7 12.0 13.7 0.7 0.0 0.2 5.9 0.1 33.6 7.7 4.1 1.6 34.3 3.0 0.0 0.2 14.9 0.2 15.0 0.0 31.7 10.1 0.4 0.2 0.0 1.1 0.0 2.7 0.0 0.0 0.2 0.0 10.8 110.2 0.3 68.8 0.2 0.0 0.0 0.0 0.2 0.7 0.4 0.2 316.6 852.5 0.0 0.0 0.0 0.0 1.7 0.3 81.2 0.2 0.0 0.0 0.5 0.0 0.0 78.3 0.0 0.0 12.8 0.0 0.0 0.0 0.1 18.1 0.0 0.1 158.7 0.0 0.0 0.2 1.5 1.2 0.0 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.3 23.5 29.3 25.8 35.4 28.2 25.6 25.0 24.5 25.7 19.4 25.6 24.7 0.1 0.0 0.0 0.7 1.9 57.1 0.6 1.3 0.0 0.2 0.1 2.8 1.0 47.1 1.2 1.8 0.0 0.0 0.1 1022.9 3.9 43.2 31.4 0.0 0.0 3.2 192.6 0.0 32.8 2040.4 0.0 0.8 39.3 0.0 8.9 0.0 0.7 4.2 0.0 0.0 4.7 146.4 0.0 0.3 12.1 79.7 1.5 1.2 7.2 3.7 5.7 0.0 0.0 3.5 1.2 478.8 969.9 0.7 0.3 12.1 1127.1 14.7 0.1 0.2 0.0 0.0 1.7 0.5 0.9 1.1 134.1 0.1 2.1 0.0 329.0 56.2 PRTN3 "ACPA, AGP7, C-ANCA, MBT, P29, PR-3" ENSG00000196415 "Proteinase 3" P24158 19 840999-848175 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "bone marrow: 2098.1" "Cell type enriched" "Detected in some" 17 "Erythroid cells: 26.5" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 8 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.0" "Cell line enriched" "Detected in some" 6 "THP-1: 2054.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005938, CAB017558" Enhanced Approved Vesicles,Cytosol "Secreted to blood" NA NA 390000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Vesicles "CAB017558: AB_2172317, HPA005938: AB_1855764" "unprognostic (2.81e-2)" "unprognostic (2.10e-1)" "unprognostic (3.83e-3)" "unprognostic (4.20e-1)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (9.98e-3)" "unprognostic (3.67e-2)" "unprognostic (8.62e-6)" "unprognostic (5.31e-2)" "unprognostic (2.00e-1)" "unprognostic (5.14e-2)" 0.8 0.2 0.6 0.0 0.7 2098.1 0.4 0.2 1.3 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.6 0.6 0.4 0.3 2.8 11.7 0.4 0.3 0.4 0.1 0.1 0.2 1.3 0.6 0.4 0.3 0.0 0.0 1.6 0.0 0.3 1.3 0.0 0.0 0.2 38.2 0.1 0.2 0.6 7.1 0.4 0.0 0.0 0.0 0.1 0.4 1.2 0.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 343.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2054.4 0.0 0.0 0.0 0.2 0.9 0.0 0.2 0.3 0.0 14.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 9.9 0.6 0.7 0.2 1.3 0.6 0.4 0.3 0.4 0.4 0.2 0.6 0.4 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.8 1.3 0.4 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 26.5 0.4 0.0 0.9 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.5 0.0 0.1 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 PSMB10 "beta2i, LMP10, MECL1, MGC1665" ENSG00000205220 "Proteasome 20S subunit beta 10" P40306 16 67934506-67936864 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 122.3" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 173.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 183.4;RPMI-8226: 169.4;THP-1: 171.3;U-266/70: 189.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030224, HPA030225, CAB034384" Enhanced Approved Vesicles,Cytosol NA NA 1400000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" Cytosol Vesicles "CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231" "unprognostic (1.18e-2)" "unprognostic (1.90e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-3)" "unprognostic (2.00e-1)" "unprognostic (1.85e-2)" "unprognostic (7.22e-2)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (8.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" "unprognostic (2.97e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-2)" "prognostic favorable (5.44e-4)" 26.3 26.9 5.7 81.8 6.0 71.3 24.9 6.9 8.8 18.9 6.6 51.6 110.5 18.4 5.7 22.8 30.4 31.2 16.2 5.6 8.0 35.1 37.1 42.2 122.3 12.6 7.4 14.6 15.0 6.3 13.2 23.1 8.6 28.9 22.9 0.4 65.1 22.4 6.8 18.1 95.8 14.0 9.5 102.7 62.5 5.3 7.8 61.9 23.6 3.5 37.5 36.4 18.6 11.7 31.8 26.9 0.7 2.2 6.7 17.2 99.6 10.8 42.3 38.5 50.6 13.9 148.5 111.9 23.4 13.2 12.9 47.9 0.0 13.4 2.9 50.3 1.9 39.2 7.6 16.4 65.7 78.5 115.2 26.9 8.4 15.2 1.5 12.1 20.6 32.1 3.6 48.2 9.0 42.6 140.7 84.9 1.0 1.1 10.2 183.4 8.3 169.4 31.6 52.5 0.9 2.3 31.1 67.5 17.2 0.4 14.5 171.3 32.0 21.2 6.6 9.7 15.3 189.8 43.9 88.4 57.1 97.9 47.0 539.5 714.6 571.1 511.7 787.1 376.4 402.6 397.9 437.3 594.8 390.2 326.2 364.6 786.2 588.6 607.4 604.4 495.9 1155.7 5.7 6.0 6.9 8.8 5.6 8.0 12.6 7.4 8.6 9.5 7.8 11.7 24.7 22.4 26.8 4.6 72.9 17.2 14.3 101.2 26.2 1.0 15.8 13.8 1.6 28.6 43.9 18.4 0.0 29.5 66.2 80.8 23.5 58.5 14.0 17.6 20.1 22.8 16.3 32.6 3.4 104.3 30.0 23.4 110.6 12.3 51.9 7.2 37.1 10.2 87.4 0.0 5.0 74.6 52.9 81.9 66.4 35.9 30.1 88.5 48.0 9.4 123.3 3.0 112.3 2.5 7.3 51.2 139.7 21.1 110.5 12.1 173.5 69.4 83.9 1.1 19.7 10.3 26.6 16.4 7.5 24.1 9.9 22.6 93.9 16.9 79.5 24.8 PSMB8 "beta5i, D6S216E, LMP7, PSMB5i, RING10" ENSG00000204264 "Proteasome 20S subunit beta 8" P28062 6 32840717-32844679 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046995, HPA050327" Enhanced Approved "Vesicles,Cytokinetic bridge" Yes No 2700000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Cytokinetic bridge" "HPA046995: AB_2679896, HPA050327: AB_2681088" "prognostic favorable (5.08e-4)" "unprognostic (4.22e-2)" "unprognostic (2.39e-2)" "prognostic favorable (7.16e-4)" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (7.78e-2)" "unprognostic (1.09e-1)" "unprognostic (5.71e-2)" "unprognostic (1.17e-2)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (1.97e-3)" "unprognostic (7.11e-3)" 62.7 76.9 3.3 11.2 3.4 9.8 56.5 3.3 7.3 42.7 3.4 79.9 12.9 41.3 3.2 59.5 41.6 5.8 34.2 3.4 3.5 63.7 99.2 78.2 18.2 4.3 3.4 32.1 29.5 8.2 26.6 4.4 3.7 45.2 20.4 0.7 44.2 6.4 14.4 58.0 93.9 8.9 4.0 150.4 57.0 5.9 3.6 13.5 40.8 0.1 17.2 41.3 48.1 4.1 15.1 3.9 0.3 0.0 5.1 13.1 11.2 4.9 22.9 29.1 39.3 0.0 20.9 45.7 9.4 10.5 25.5 8.1 6.8 16.6 8.0 19.2 0.0 27.6 5.9 0.3 30.3 5.2 7.5 14.9 10.3 12.9 6.8 1.9 18.1 11.8 1.1 8.1 6.1 0.1 12.9 11.7 0.1 0.0 7.3 29.3 1.3 24.1 21.3 4.9 0.8 0.2 8.6 10.4 8.5 0.1 7.0 41.0 4.3 8.8 7.6 7.8 0.6 21.0 15.9 11.2 2.2 27.7 9.0 56.8 70.3 94.6 58.1 88.0 51.2 73.4 49.1 61.1 67.5 71.1 34.8 49.6 90.2 63.0 78.2 58.5 81.2 156.0 3.3 3.4 3.3 7.3 3.4 3.5 4.3 3.4 3.7 4.0 3.6 4.1 237.0 38.5 55.8 2.9 162.0 84.4 64.1 183.7 54.7 1.8 85.3 92.5 8.7 71.4 103.2 62.5 0.0 2.7 211.2 219.9 86.1 219.4 0.6 63.2 74.9 158.5 65.7 45.0 0.1 247.6 18.3 60.7 93.8 81.5 50.7 51.4 114.5 75.0 165.9 6.7 0.5 243.8 120.1 143.5 94.9 1.9 39.1 128.2 56.9 10.3 214.3 39.9 279.1 3.0 0.7 179.6 287.9 30.5 153.2 100.1 319.8 78.9 103.2 3.0 39.5 33.2 56.8 0.4 1.2 60.5 79.6 2.7 181.6 110.9 222.6 121.6 PSME3IP1 "C16orf94, FAM192A, NIP30, PIP30" ENSG00000172775 "Proteasome activator subunit 3 interacting protein 1" Q9GZU8 16 57152466-57186116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 82.3;Cytotrophoblasts: 56.7;Extravillous trophoblasts: 59.5;Hofbauer cells: 64.6;Syncytiotrophoblasts: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054382, HPA059652" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "HPA054382: AB_2682469, HPA059652: AB_2684095" "unprognostic (1.69e-2)" "unprognostic (5.20e-2)" "unprognostic (1.36e-1)" "unprognostic (9.20e-3)" "unprognostic (4.69e-3)" "unprognostic (2.45e-2)" "unprognostic (1.01e-2)" "unprognostic (2.22e-1)" "unprognostic (6.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.41e-1)" "unprognostic (4.19e-1)" "unprognostic (3.00e-1)" "unprognostic (3.87e-3)" "unprognostic (4.14e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-3)" 48.8 50.2 80.5 72.9 93.9 151.0 66.7 85.8 99.0 52.4 83.8 75.4 67.6 54.1 64.7 63.5 54.1 47.3 59.2 78.4 89.7 66.3 62.6 57.6 94.8 91.7 87.3 54.6 55.3 76.7 65.3 56.0 87.3 64.7 87.5 75.2 55.2 50.3 79.0 90.3 76.1 52.3 87.9 93.3 62.6 96.8 85.8 85.0 71.5 66.0 96.5 53.3 56.1 103.7 119.3 148.6 163.6 109.8 70.3 86.2 153.4 138.3 102.3 166.3 107.1 141.3 122.5 179.2 150.6 105.8 84.2 155.9 114.4 137.9 167.1 80.3 92.1 125.0 141.6 148.3 101.0 154.8 170.8 86.6 134.8 158.2 127.4 101.8 121.0 134.4 170.1 56.5 110.8 88.2 169.4 143.2 105.1 88.0 111.3 205.6 236.9 174.5 113.1 96.4 116.3 133.9 250.2 105.2 92.7 113.0 87.1 105.9 120.2 122.0 102.3 90.2 103.7 133.2 113.1 228.6 125.0 109.7 119.6 170.3 78.3 124.1 47.6 93.0 46.8 83.1 45.8 44.7 90.0 77.8 47.0 49.1 107.6 57.1 123.4 62.4 69.2 68.1 80.5 93.9 85.8 99.0 78.4 89.7 91.7 87.3 87.3 87.9 85.8 103.7 16.9 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.3 0.0 0.0 0.0 0.0 56.7 10.2 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 59.5 16.8 0.0 0.0 0.0 0.0 0.0 0.0 64.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 53.1 1.5 0.0 0.0 0.0 PTGS1 "COX1, PGHS-1, PTGHS" ENSG00000095303 "Prostaglandin-endoperoxide synthase 1" P23219 9 122370530-122395703 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 108.3;skin 1: 152.5;urinary bladder: 175.0" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 109.9;Glandular and luminal cells: 191.9;granulocytes: 208.0;Hepatic stellate cells: 61.8;Macrophages: 55.3;Suprabasal keratinocytes: 58.7" "Cancer enhanced" "Detected in all" "ovarian cancer: 53.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 28.9" "Group enriched" "Detected in many" 6 "dendritic cells: 20.0;granulocytes: 28.9;monocytes: 13.1" "Cell line enhanced" "Detected in many" "ASC diff: 113.7;ASC TERT1: 89.5;BJ: 115.2;BJ hTERT+: 156.0;HEL: 73.6;HMC-1: 298.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002834, CAB020315" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2100000 "Cluster 2: Granulocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" Vesicles "CAB020315: , HPA002834: AB_1079711" "unprognostic (4.20e-1)" "unprognostic (6.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (5.88e-2)" "unprognostic (2.00e-2)" "unprognostic (1.22e-3)" "unprognostic (3.32e-1)" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (4.03e-2)" "unprognostic (1.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (9.35e-4)" 12.8 2.9 3.1 10.5 3.2 9.0 6.7 4.2 4.8 5.8 5.5 108.3 10.8 6.1 2.2 67.3 43.2 9.6 12.6 7.4 5.5 9.3 3.0 11.3 4.6 6.5 5.2 2.0 1.8 2.0 4.8 2.2 6.3 21.1 24.2 0.7 4.3 6.1 2.1 152.5 17.7 16.1 6.7 8.0 20.5 0.9 7.0 2.2 3.2 4.0 11.6 175.0 15.9 11.9 0.3 0.5 0.4 0.0 113.7 89.5 0.0 115.2 156.0 1.0 1.1 0.0 0.2 4.2 5.4 19.7 0.3 7.1 0.4 10.5 0.9 0.0 0.2 73.6 0.6 0.0 32.9 5.2 298.4 46.1 1.2 5.7 0.3 0.0 42.3 0.1 0.1 0.3 2.3 0.0 0.2 6.6 1.6 0.0 0.5 0.3 1.4 8.6 14.7 0.0 0.5 0.6 0.6 9.5 0.2 0.5 0.3 8.4 1.0 0.7 0.6 1.7 0.1 0.3 0.2 0.0 0.4 31.6 0.3 28.9 12.1 23.3 0.0 13.1 0.0 2.4 0.0 0.0 20.0 3.5 0.1 0.0 5.2 2.8 10.2 1.4 0.2 21.9 3.1 3.2 4.2 4.8 7.4 5.5 6.5 5.2 6.3 6.7 7.0 11.9 0.9 0.0 6.6 0.0 5.9 9.9 2.6 7.7 0.0 0.1 1.1 1.4 1.6 4.3 2.2 42.3 0.0 0.1 0.2 0.1 0.0 0.6 0.1 109.9 10.4 24.7 1.8 18.7 0.8 0.5 0.3 10.7 2.0 191.9 208.0 0.1 61.8 0.8 26.1 0.0 0.5 0.6 4.1 15.5 20.7 0.3 1.5 55.3 3.6 16.9 11.7 0.0 7.2 1.0 0.1 0.6 0.6 0.0 0.3 2.8 0.0 0.0 0.8 0.1 0.0 1.4 3.6 0.0 0.2 18.2 58.7 0.4 3.4 0.1 1.0 0.8 PTGS2 COX2 ENSG00000073756 "Prostaglandin-endoperoxide synthase 2" P35354 1 186671791-186680922 "Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 116.7;seminal vesicle: 127.4;urinary bladder: 162.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 342.9;Fibroblasts: 270.7;granulocytes: 347.6;Langerhans cells: 305.6;Macrophages: 173.1;Urothelial cells: 151.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 16 "neutrophil: 11.7" "Lineage enriched" "Detected in single" 16 "granulocytes: 11.7" "Cell line enriched" "Detected in many" 4 "BJ hTERT+: 405.5" "Region enhanced" "Detected in many" "hippocampal formation: 15.1" "Low region specificity" "Detected in many" "CAB000113, HPA001335" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 41: Macrophages - Immune response" "Endoplasmic reticulum, Vesicles" "CAB000113: , HPA001335: AB_1079712" "unprognostic (1.36e-3)" "unprognostic (9.97e-3)" "unprognostic (3.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (5.96e-2)" "unprognostic (9.50e-2)" "unprognostic (9.03e-3)" "unprognostic (2.81e-1)" "unprognostic (3.24e-2)" "unprognostic (3.07e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (8.04e-3)" "unprognostic (4.38e-2)" "unprognostic (8.89e-2)" "unprognostic (3.74e-2)" 17.0 7.9 1.4 13.9 2.5 116.7 3.0 1.1 4.1 62.2 2.7 14.9 2.6 8.9 0.7 6.9 5.1 31.6 11.7 1.9 1.4 10.2 8.0 34.3 8.9 2.0 1.6 2.6 2.2 5.6 3.1 8.4 1.5 25.0 9.9 0.3 1.2 127.4 0.4 1.6 3.6 12.2 1.9 2.8 14.8 0.2 1.8 5.2 3.2 6.5 0.6 162.5 2.2 2.6 0.0 21.8 0.1 0.0 2.5 2.1 0.0 93.4 405.5 0.6 3.6 15.0 17.2 0.0 0.0 0.1 2.5 12.2 0.0 7.6 1.3 0.0 0.0 0.8 2.2 0.0 13.2 0.0 0.2 0.8 2.7 11.3 28.7 1.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 5.5 1.5 0.0 1.0 0.0 0.9 2.7 0.0 0.1 1.5 19.3 0.6 13.5 0.6 0.2 0.0 0.0 27.7 0.4 2.3 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 11.7 0.0 0.4 0.0 0.0 0.0 1.4 2.5 1.1 4.1 1.9 1.4 2.0 1.6 1.5 1.9 1.8 2.6 5.2 342.9 77.7 0.0 7.4 118.8 59.1 72.8 12.5 0.0 2.6 12.8 2.5 0.0 79.7 0.0 0.0 0.2 4.2 0.3 0.0 0.8 0.2 50.0 9.9 31.1 1.2 3.6 3.8 0.2 0.3 270.7 2.0 98.9 347.6 3.8 13.6 0.2 12.1 0.0 1.0 1.0 8.2 21.0 305.6 0.0 0.0 173.1 35.6 3.7 3.4 0.1 0.0 0.0 0.1 4.9 0.1 0.0 2.0 122.6 0.2 0.3 13.1 0.3 0.0 1.8 12.8 0.1 0.4 3.3 28.4 0.5 10.8 3.7 1.2 151.6 PTPRA "HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA" ENSG00000132670 "Protein tyrosine phosphatase receptor type A" P18433 20 2864184-3039076 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029412, CAB034366, HPA069480" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 37: B-cells - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles Nucleoplasm "CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141" "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" "unprognostic (4.58e-2)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.62e-1)" "unprognostic (5.43e-3)" "unprognostic (5.34e-2)" "unprognostic (1.55e-1)" "unprognostic (3.24e-1)" "unprognostic (7.33e-2)" "unprognostic (1.16e-1)" "prognostic favorable (3.29e-6)" "unprognostic (1.25e-1)" "unprognostic (4.02e-1)" "unprognostic (1.60e-2)" "unprognostic (4.19e-1)" 48.8 36.6 83.9 31.9 89.3 39.6 47.4 84.2 96.1 56.4 59.5 41.6 31.0 53.0 36.7 46.1 52.7 43.7 29.5 87.7 83.5 44.2 28.6 45.4 38.9 74.7 81.9 55.8 31.2 81.9 44.8 60.8 78.3 46.3 40.6 61.5 36.3 41.9 16.9 45.8 32.7 52.4 76.3 39.4 34.5 43.4 92.6 59.6 65.5 30.7 44.3 46.6 38.9 81.1 74.0 44.2 124.7 38.4 134.4 243.3 26.5 54.1 105.1 65.5 79.6 53.1 99.5 48.1 41.6 73.1 66.1 77.2 51.0 77.4 73.4 74.7 32.7 68.5 18.3 68.0 48.1 69.5 31.1 109.8 78.2 54.4 56.8 80.3 92.0 67.7 69.9 59.7 65.8 30.4 80.8 78.3 48.3 66.0 35.0 61.0 60.5 60.3 55.1 56.2 68.7 65.7 52.3 87.8 81.4 54.0 55.2 58.7 66.5 58.1 28.6 65.6 48.5 43.4 64.7 62.7 26.9 64.5 55.7 5.7 2.8 4.8 6.1 2.9 4.9 5.3 4.0 4.4 2.1 2.6 4.0 4.8 3.3 4.0 4.3 3.2 4.9 2.3 83.9 89.3 84.2 96.1 87.7 83.5 74.7 81.9 78.3 76.3 92.6 81.1 87.0 22.4 19.2 128.6 46.7 15.8 34.0 15.0 34.7 88.9 49.0 43.9 10.1 54.3 24.5 46.0 31.3 35.3 111.7 39.8 27.4 14.8 17.0 62.0 109.0 39.7 44.3 42.3 138.2 15.8 40.5 67.5 25.0 55.3 22.9 60.3 43.5 33.6 39.4 70.7 136.4 27.9 24.4 37.6 20.4 17.2 60.3 40.1 37.4 52.5 29.9 88.3 110.2 102.5 147.5 16.6 30.2 48.9 58.6 32.9 27.1 23.6 26.6 60.5 39.5 53.3 61.8 68.7 84.1 32.9 17.2 32.7 59.7 41.4 30.4 31.5 PTPRC "CD45, GP180, LCA, T200" ENSG00000081237 "Protein tyrosine phosphatase receptor type C" P08575 1 198638457-198757476 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Hydrolase, Protein phosphatase" "Cancer-related genes, Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 208.6;lymphoid tissue: 329.9" "Cell type enhanced" "Detected in many" "B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000052, HPA000440, CAB002800, CAB056154, CAB068221" Enhanced Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 24000000 "Cluster 14: Monocytes - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Vesicles" "CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377" "unprognostic (1.51e-2)" "unprognostic (1.24e-2)" "unprognostic (5.10e-3)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (3.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.08e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (6.41e-2)" "unprognostic (7.06e-2)" 32.8 11.6 3.8 248.5 3.3 208.6 13.9 4.4 4.3 14.9 6.9 26.4 27.4 11.3 5.6 15.1 8.4 45.7 7.3 3.5 5.6 7.0 29.6 68.6 329.9 12.9 8.6 5.7 5.6 4.0 2.9 23.5 11.5 11.6 30.5 2.0 13.8 6.6 4.6 5.7 42.9 25.3 7.9 202.5 37.9 5.5 6.9 306.9 7.0 7.6 251.2 62.1 5.2 14.7 0.4 0.0 0.2 0.2 0.0 0.0 0.8 0.3 0.3 0.1 0.0 0.0 0.1 209.9 0.3 0.7 0.2 0.3 0.0 0.2 0.4 0.6 0.0 118.0 0.2 0.1 0.0 108.1 0.7 0.0 0.0 0.3 0.0 0.4 0.5 266.4 2.4 3.3 0.3 0.1 161.1 65.0 0.5 0.2 0.2 4.6 0.4 0.3 0.1 0.1 1.2 1.8 0.1 0.4 0.5 0.2 0.3 87.0 1.3 0.0 0.8 0.8 0.4 93.7 91.2 123.4 0.1 94.5 0.4 226.1 480.0 521.4 634.4 885.8 541.8 249.0 437.0 618.1 385.8 245.8 489.8 494.1 844.3 506.9 1015.8 57.4 508.6 1340.6 3.8 3.3 4.4 4.3 3.5 5.6 12.9 8.6 11.5 7.9 6.9 14.7 12.6 44.8 62.3 0.7 525.2 15.8 0.9 0.0 4.0 0.3 6.0 9.3 4.6 5.7 14.2 1.8 0.0 0.6 1026.4 1.0 0.0 0.7 2.4 2.3 2.3 15.1 1.2 58.8 0.7 0.0 0.9 17.2 46.9 2.7 246.5 0.1 14.6 6.9 96.0 0.0 1.7 0.4 0.0 334.9 214.5 3.5 1.2 534.1 21.4 201.4 554.9 0.1 769.3 2.5 0.7 0.1 0.8 0.0 474.2 1.1 0.1 2.5 11.7 0.2 6.6 7.4 6.7 0.3 0.6 1.8 15.2 0.8 1049.1 5.4 0.9 0.8 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase receptor type D" P23468 9 8314246-10612723 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.8" "Group enriched" "Detected in many" 12 "Excitatory neurons: 4579.7;Inhibitory neurons: 1152.9;Oligodendrocyte precursor cells: 1170.2;Oligodendrocytes: 3151.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 21.1;HAP1: 4.3;HSkMC: 6.3;RH-30: 8.1;SCLC-21H: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 20000000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA054829: AB_2682618" "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favorable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 2.1 0.6 10.8 0.3 24.7 0.1 0.9 12.2 26.2 5.6 0.0 3.3 1.8 2.4 0.2 0.6 2.2 1.0 2.5 14.4 7.2 6.6 3.6 4.6 0.0 14.6 10.1 12.1 1.3 18.7 4.3 5.3 19.1 1.9 2.5 6.4 0.5 0.6 0.9 0.7 5.0 1.0 10.4 0.4 0.9 1.6 17.6 0.7 3.4 0.8 0.0 2.2 3.4 70.8 0.0 0.1 21.1 0.0 0.3 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 2.7 3.6 0.5 0.0 0.0 0.0 0.1 6.3 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.6 0.0 3.4 0.0 3.2 2.3 8.1 0.0 1.8 0.0 4.8 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 24.7 12.2 26.2 14.4 7.2 14.6 10.1 19.1 10.4 17.6 70.8 0.5 0.0 3.2 199.2 0.1 0.5 0.4 3.2 6.2 134.2 0.3 0.1 6.5 27.1 1.8 5.5 16.7 0.3 0.0 16.4 0.0 3.6 15.8 0.8 15.0 1.2 35.4 0.0 4579.7 0.0 0.3 15.5 0.5 1.0 0.0 9.2 1.4 13.5 1.3 5.0 1152.9 13.2 0.0 0.8 0.0 6.5 15.8 1.6 0.0 85.3 0.1 36.1 0.0 1170.2 3151.1 0.2 9.2 0.0 2.7 2.1 18.3 26.3 0.2 7.8 0.0 4.0 5.8 2.4 3.2 0.4 0.9 0.3 0.8 6.0 8.7 0.1 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 88.4;skin 1: 31.9" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 2714.3" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" NA NA 3400000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavorable (9.36e-4)" 1.6 1.6 66.0 1.2 64.2 0.0 4.0 57.2 88.4 1.8 21.5 4.4 0.6 0.1 0.8 7.9 0.3 0.7 1.3 64.0 64.1 0.1 0.1 1.2 0.0 60.9 62.9 0.7 2.7 0.0 2.3 0.2 62.4 1.0 1.1 19.0 3.4 0.7 0.1 31.9 1.0 1.3 63.7 1.0 13.8 0.3 58.6 0.2 0.1 0.3 2.6 0.9 2.3 72.4 0.1 0.0 425.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 27.7 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 126.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 5.4 15.2 0.1 0.0 0.0 0.1 0.0 0.0 0.7 10.9 5.6 0.0 0.6 0.0 193.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 66.0 64.2 57.2 88.4 64.0 64.1 60.9 62.9 62.4 63.7 58.6 72.4 0.1 0.0 1.5 625.2 0.2 25.2 8.6 82.2 44.9 18.3 5.6 12.2 1.3 0.0 39.7 0.0 4.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 37.7 0.7 0.1 1.3 9.2 0.0 0.0 10.1 0.0 0.0 0.1 65.6 72.0 0.0 0.0 0.0 1.6 0.7 0.3 0.1 19.6 22.5 0.0 90.4 0.0 2714.3 3.6 0.9 0.3 0.0 1.2 1.8 0.0 0.1 16.9 6.6 0.0 1.2 1.7 0.1 1.6 14.8 21.5 0.3 0.2 0.5 0.0 7.8 QRSL1 "DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA" ENSG00000130348 "Glutaminyl-tRNA amidotransferase subunit QRSL1" Q9H0R6 6 106629578-106668417 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Ligase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "memory B-cell: 86.4;naive B-cell: 71.0" "Lineage enriched" "Detected in all" 7 "B-cells: 86.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029585, HPA029587" Approved Approved Vesicles,Centrosome NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" Vesicles Centrosome "HPA029585: AB_10599823, HPA029587: AB_10602311" "unprognostic (1.86e-3)" "unprognostic (5.58e-2)" "unprognostic (6.19e-3)" "unprognostic (3.45e-1)" "unprognostic (2.11e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.97e-5)" "unprognostic (8.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (4.03e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.06e-1)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.46e-1)" 5.0 5.7 4.0 8.6 5.2 6.4 7.4 4.7 5.0 4.8 5.8 8.2 7.8 6.3 6.1 5.7 5.4 4.8 10.1 4.1 4.5 9.3 7.8 4.6 15.9 4.6 4.5 5.6 6.0 9.4 4.3 5.7 5.0 5.3 9.1 8.4 6.1 5.6 19.4 5.9 8.9 5.8 4.1 10.5 6.7 6.6 4.5 8.2 9.2 21.3 15.5 5.7 4.9 7.4 9.0 9.1 12.3 17.8 7.8 9.7 17.3 10.0 10.2 13.1 13.0 10.7 7.1 29.7 8.9 11.2 13.5 15.5 18.6 12.1 16.4 14.2 14.1 14.5 9.7 11.1 12.2 33.2 12.5 9.6 18.6 14.0 20.6 9.9 9.5 18.4 26.8 9.4 11.0 10.1 10.7 16.1 12.9 15.6 10.5 28.9 15.8 7.5 14.3 10.2 10.7 11.0 8.0 18.4 15.3 10.7 12.1 25.3 9.3 9.2 7.6 10.0 15.7 5.4 8.3 17.2 12.6 22.1 14.0 5.0 6.4 1.0 6.4 9.6 6.3 86.4 7.1 5.6 10.7 71.0 6.6 6.4 1.6 7.0 13.0 8.5 8.5 5.7 4.0 5.2 4.7 5.0 4.1 4.5 4.6 4.5 5.0 4.1 4.5 7.4 9.0 19.2 12.5 20.2 64.6 4.0 8.4 12.8 6.2 14.9 10.3 6.1 24.8 7.2 9.3 11.0 16.7 21.5 12.3 11.0 17.6 15.4 15.5 28.2 12.0 10.8 17.4 13.7 14.6 18.4 23.0 9.9 15.3 14.8 18.9 15.3 8.2 14.6 12.9 3.3 18.9 11.2 14.2 12.4 6.1 8.4 8.4 10.0 8.8 12.2 18.3 9.9 19.6 22.6 26.5 14.2 8.3 9.1 13.2 9.3 12.2 19.5 19.9 19.1 0.0 10.0 10.0 25.6 14.2 12.2 5.4 12.3 14.3 21.1 18.7 8.9 QSOX1 QSCN6 ENSG00000116260 "Quiescin sulfhydryl oxidase 1" O00391 1 180154869-180204030 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Extravillous trophoblasts: 1616.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 1918.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056243 Supported "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 2600000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" "Golgi apparatus" Vesicles "HPA056243: AB_2683077" "unprognostic (1.13e-1)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.49e-2)" "unprognostic (2.00e-2)" "unprognostic (2.73e-1)" "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.07e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (1.86e-5)" "unprognostic (3.25e-1)" "unprognostic (2.14e-1)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" 84.8 84.9 35.8 52.1 39.4 115.5 53.2 42.7 47.3 81.7 41.1 100.1 67.5 75.2 70.2 178.4 82.3 150.3 244.9 41.5 43.4 73.8 81.7 200.0 16.3 50.0 40.7 196.1 136.3 21.0 60.2 158.9 43.2 92.3 80.9 15.2 105.6 57.5 91.2 58.6 85.7 60.0 44.0 61.9 178.3 172.9 42.6 12.1 31.9 46.0 19.6 174.1 108.7 57.7 441.4 62.0 14.8 181.0 179.1 367.8 712.5 456.5 456.6 381.6 267.1 7.3 137.7 6.8 276.7 367.8 52.6 93.7 17.6 123.5 185.0 26.4 28.0 14.1 33.6 19.4 1918.6 48.6 129.2 197.9 55.5 408.0 484.3 499.9 569.4 32.1 20.2 66.3 255.3 76.4 10.4 89.7 49.4 302.6 174.6 19.7 33.0 11.8 63.1 123.6 51.9 52.6 133.8 179.8 91.9 32.2 33.0 226.3 678.3 473.8 187.5 322.0 392.9 48.3 84.4 12.2 180.9 153.9 146.0 16.2 53.1 20.6 14.0 29.9 10.2 5.4 9.1 9.6 39.2 3.2 8.1 8.0 40.2 16.9 28.6 8.0 11.5 28.6 35.8 39.4 42.7 47.3 41.5 43.4 50.0 40.7 43.2 44.0 42.6 57.7 36.6 57.7 101.6 8.5 7.7 13.8 27.4 81.2 7.4 11.5 86.2 47.9 48.3 51.5 112.5 71.7 25.0 19.5 10.7 138.1 0.0 230.4 49.2 49.2 19.4 41.7 46.2 6.9 17.2 130.1 1616.7 78.0 136.6 80.4 25.4 27.1 89.3 4.3 68.6 6.7 17.0 185.7 132.2 45.2 35.3 20.1 177.7 48.9 44.4 8.4 49.7 53.5 10.3 24.6 23.9 249.8 165.6 71.1 12.8 35.7 9.0 9.1 47.8 6.7 32.9 13.6 31.3 30.2 32.7 10.2 9.9 154.3 13.9 13.9 89.9 68.0 RAB11A YL8 ENSG00000103769 "RAB11A, member RAS oncogene family" P62491 15 65726054-65891989 "Predicted intracellular proteins" "Cell cycle, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 969.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013097, HPA051697, HPA060686" Approved Enhanced "Vesicles,Centriolar satellite" No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Vesicles, Centriolar satellite" "CAB013097: AB_2533987, HPA051697: AB_2732569, HPA060686: AB_2684342" "unprognostic (4.15e-2)" "unprognostic (5.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.74e-3)" "unprognostic (6.85e-2)" "unprognostic (6.07e-2)" "unprognostic (3.17e-2)" "unprognostic (7.12e-2)" "unprognostic (8.60e-2)" "unprognostic (4.83e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (4.29e-2)" "prognostic favorable (1.46e-5)" "unprognostic (9.93e-2)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (1.21e-1)" 140.0 231.6 79.7 123.9 86.4 126.0 150.1 83.4 105.0 159.3 78.5 223.8 139.8 117.4 130.9 480.0 146.1 185.1 156.3 86.1 97.4 162.9 124.1 148.1 141.2 87.0 83.0 104.9 107.6 192.5 106.8 214.4 101.3 150.3 224.2 99.0 195.1 126.2 119.6 288.5 158.9 149.2 87.2 183.9 216.2 201.8 86.0 143.6 155.3 109.6 246.0 269.8 232.2 86.7 285.2 330.3 330.1 240.8 294.7 275.0 431.1 297.0 300.4 264.4 313.0 305.8 497.4 370.7 295.8 342.6 262.3 429.0 525.0 393.2 248.2 243.7 314.9 445.3 219.9 274.1 224.7 211.5 254.0 282.8 438.1 260.2 214.7 281.7 595.2 197.8 364.5 214.3 378.1 283.7 209.9 167.3 275.9 1057.4 185.9 176.3 250.5 346.3 716.1 734.7 237.4 251.9 214.0 335.6 286.5 387.8 445.0 243.0 453.7 208.4 296.4 203.1 267.8 112.2 289.5 288.8 193.7 353.5 228.8 183.5 154.8 235.2 56.7 133.9 58.8 78.8 85.3 68.6 137.1 64.1 78.9 63.6 232.8 71.3 154.6 87.6 109.5 340.2 79.7 86.4 83.4 105.0 86.1 97.4 87.0 83.0 101.3 87.2 86.0 86.7 155.7 57.7 57.8 15.3 90.2 192.2 180.2 375.2 134.3 42.3 107.5 69.6 89.5 105.8 245.4 187.6 33.3 326.4 76.0 313.4 346.3 360.6 413.1 119.3 72.7 260.7 206.2 91.1 31.3 337.0 340.4 96.9 149.9 194.5 74.9 75.9 235.2 88.4 239.2 57.2 27.7 227.4 244.1 114.8 214.2 80.9 97.3 148.1 186.7 42.2 217.8 137.9 65.9 25.6 21.9 391.1 277.0 86.5 72.1 187.6 205.8 271.5 240.0 36.1 46.0 45.2 161.5 407.5 95.3 225.5 284.4 969.3 96.6 97.6 209.2 360.8 RAB11B H-YPT3 ENSG00000185236 "RAB11B, member RAS oncogene family" Q15907 19 8389981-8404434 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 334.5" "Low region specificity" "Detected in all" HPA054396 Approved "Vesicles,Centriolar satellite" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" "Vesicles, Centriolar satellite" "HPA054396: AB_2682474" "unprognostic (5.81e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.13e-2)" "unprognostic (1.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (4.78e-2)" "prognostic favorable (7.58e-5)" "unprognostic (1.23e-1)" "prognostic favorable (2.06e-4)" "unprognostic (3.66e-1)" "unprognostic (3.87e-1)" "unprognostic (8.85e-2)" "unprognostic (3.29e-3)" 102.1 96.7 97.6 59.2 113.2 68.7 113.8 118.5 131.4 105.3 67.4 99.1 76.5 101.3 23.0 95.2 97.3 51.2 167.9 91.7 102.0 129.3 133.8 98.2 58.8 130.9 121.8 107.6 129.7 49.0 115.7 53.9 127.7 111.7 23.4 38.2 104.3 49.3 119.6 101.8 97.2 27.8 108.1 118.7 118.0 64.5 120.4 44.1 210.0 36.6 28.2 99.5 94.2 127.3 93.1 115.3 83.1 75.9 43.7 39.9 64.8 54.6 36.8 39.5 42.0 79.4 74.3 54.1 147.7 47.3 53.1 70.8 29.4 78.7 13.1 109.3 142.4 57.5 97.8 98.0 42.4 67.6 102.6 59.5 49.1 44.6 29.6 51.2 50.1 71.7 62.4 137.2 42.2 92.8 116.7 334.5 117.9 44.6 111.3 75.2 56.2 91.0 43.6 130.1 91.4 118.7 67.7 53.8 71.5 33.8 67.9 75.0 98.0 146.2 85.4 114.0 86.2 145.3 101.7 64.1 109.4 75.3 100.6 47.6 44.4 100.7 44.7 45.5 30.6 39.6 40.3 46.8 45.4 41.3 38.1 36.6 65.7 53.7 55.2 59.1 43.0 39.6 97.6 113.2 118.5 131.4 91.7 102.0 130.9 121.8 127.7 108.1 120.4 127.3 74.0 19.2 25.7 21.2 68.3 62.1 86.2 115.1 75.7 60.1 85.0 79.8 18.1 71.4 59.5 95.6 14.6 152.2 52.4 148.4 127.2 93.8 44.3 58.2 43.2 70.7 114.7 63.1 15.1 94.9 166.7 71.3 99.4 51.0 29.9 56.5 76.1 62.2 109.6 67.3 18.7 112.4 118.0 62.8 52.7 38.0 86.3 62.6 71.2 15.9 76.9 104.1 59.8 8.5 41.3 82.3 154.7 76.3 78.0 81.1 135.5 113.9 59.3 36.0 92.1 50.1 121.0 64.5 38.7 69.8 69.3 209.9 63.3 46.4 92.8 104.6 RAB11FIP2 "KIAA0941, nRip11, Rab11-FIP2" ENSG00000107560 "RAB11 family interacting protein 2" Q7L804 10 118004916-118046941 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037726 Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Vesicles Nucleoplasm "HPA037726: AB_10672390" "unprognostic (1.97e-1)" "unprognostic (1.68e-2)" "unprognostic (3.61e-1)" "unprognostic (4.45e-2)" "unprognostic (1.30e-1)" "unprognostic (5.58e-2)" "unprognostic (2.17e-2)" "unprognostic (3.34e-2)" "unprognostic (1.83e-2)" "unprognostic (2.15e-1)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favorable (9.69e-5)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (2.17e-1)" 8.6 6.6 5.2 6.6 7.0 13.8 6.9 4.8 8.5 10.2 2.4 8.2 3.6 18.8 28.5 6.3 11.8 8.3 6.1 7.1 3.4 12.2 5.4 7.6 6.9 2.8 4.6 9.9 5.6 6.3 4.3 8.2 2.2 10.8 4.9 10.3 4.8 24.7 5.0 5.9 5.5 19.5 3.7 6.6 17.2 7.8 5.3 6.2 11.4 7.5 5.5 7.6 6.2 6.1 7.1 8.8 7.3 9.3 11.9 15.0 7.8 13.8 15.8 8.3 8.6 7.4 7.4 14.5 10.8 14.0 6.1 4.8 10.1 6.1 12.8 3.8 10.9 5.1 9.1 5.1 17.2 9.7 5.5 14.8 11.3 11.6 25.4 11.0 5.1 9.3 3.9 12.1 10.9 2.5 7.5 7.3 6.2 3.1 6.2 6.4 26.0 4.9 12.4 5.6 1.7 13.5 9.8 3.9 17.3 8.7 3.0 8.9 7.7 11.2 8.9 13.3 13.8 8.9 7.8 9.4 11.5 16.4 7.0 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.4 0.4 0.2 0.3 0.1 0.1 0.5 0.1 0.0 5.2 7.0 4.8 8.5 7.1 3.4 2.8 4.6 2.2 3.7 5.3 6.1 16.7 57.7 31.5 79.7 17.7 10.3 8.8 4.4 12.5 28.1 10.1 10.7 25.8 24.3 6.0 42.3 29.2 11.6 15.1 5.5 7.9 12.6 16.5 13.1 31.0 14.1 14.5 17.4 63.8 18.7 7.9 29.1 14.8 15.7 3.8 28.0 11.4 8.6 11.4 38.7 57.9 6.6 4.1 23.0 12.2 6.6 33.5 16.2 23.2 34.7 19.4 26.0 15.5 53.8 82.9 16.6 4.7 28.6 17.0 11.1 5.4 18.1 7.3 31.4 26.3 34.0 25.8 14.9 21.2 9.2 9.5 5.2 12.9 19.2 6.5 6.4 RAB11FIP5 "GAF1, KIAA0857, pp75, RIP11" ENSG00000135631 "RAB11 family interacting protein 5" Q9BXF6 2 73073382-73156721 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.7" "Cell type enhanced" "Detected in many" "Early spermatids: 86.2;Late spermatids: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036406, HPA036407" Enhanced Enhanced "Vesicles,Centriolar satellite" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Vesicles, Centriolar satellite" "HPA036406: AB_2675105, HPA036407: AB_10669778" "unprognostic (1.49e-1)" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-3)" "unprognostic (3.26e-2)" "unprognostic (1.58e-3)" "unprognostic (4.08e-3)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.87e-4)" "unprognostic (3.23e-3)" "unprognostic (1.45e-1)" "prognostic favorable (2.26e-5)" "unprognostic (1.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "unprognostic (9.66e-3)" 8.0 5.3 5.2 2.3 4.7 0.5 7.5 2.3 19.8 6.9 0.0 6.5 2.0 10.6 1.5 5.8 7.5 3.7 6.6 6.0 6.2 11.7 2.3 6.8 1.0 17.4 6.2 6.9 7.4 12.2 5.4 1.7 16.1 5.1 0.8 0.8 7.5 3.3 11.5 8.2 3.4 3.2 4.2 14.3 5.9 44.7 11.6 0.4 5.1 3.0 0.9 6.7 5.8 6.0 20.0 8.8 0.6 6.2 6.7 7.9 11.1 28.6 15.9 10.1 8.0 6.9 4.4 0.0 15.3 16.3 10.7 8.1 4.1 8.6 4.4 38.1 11.1 7.8 4.0 4.2 7.8 0.0 1.4 9.5 8.9 12.5 8.3 9.3 13.5 3.6 6.0 3.6 7.1 0.6 0.1 0.2 4.8 3.2 15.0 7.1 7.8 18.3 8.7 2.7 2.8 2.9 10.0 3.3 4.3 2.1 2.2 0.5 35.4 24.4 13.2 17.3 15.0 13.8 4.3 0.1 18.0 8.5 2.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 5.2 4.7 2.3 19.8 6.0 6.2 17.4 6.2 16.1 4.2 11.6 6.0 12.1 6.4 3.6 4.6 1.3 25.5 8.3 6.7 12.5 4.4 13.0 6.9 12.0 12.8 3.7 20.2 0.0 1.2 5.5 7.7 27.4 12.1 86.2 6.1 3.2 20.4 1.8 0.0 11.1 18.4 12.2 9.0 3.1 12.8 0.0 34.5 16.8 6.1 2.1 6.7 11.5 2.5 2.0 1.3 8.1 171.6 14.3 1.9 8.8 7.5 1.0 7.4 1.0 1.0 1.3 22.7 2.7 8.6 6.1 13.4 0.4 46.9 5.0 2.6 26.3 7.2 6.2 39.8 6.6 5.1 17.6 14.8 4.5 6.4 4.6 16.4 RAB15 ENSG00000139998 "RAB15, member RAS oncogene family" P59190 14 64945814-64973226 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 51.3;Inhibitory neurons: 28.0;Intestinal goblet cells: 35.2" "Cancer enhanced" "Detected in all" "testis cancer: 83.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "HAP1: 128.1;RH-30: 151.2;RT4: 116.1;SK-BR-3: 116.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041177 Uncertain Approved "Vesicles,Centriolar satellite" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Centriolar satellite" "HPA041177: AB_10794547" "unprognostic (9.80e-2)" "unprognostic (1.42e-2)" "unprognostic (1.53e-1)" "unprognostic (4.94e-2)" "unprognostic (6.29e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (7.14e-2)" "unprognostic (3.12e-1)" "unprognostic (4.25e-2)" "unprognostic (2.79e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-2)" "unprognostic (2.82e-2)" 2.8 4.9 30.0 6.2 35.0 0.8 8.4 28.2 43.2 7.3 13.4 13.5 12.7 4.2 5.6 4.3 4.7 6.2 33.4 38.9 22.6 19.3 21.2 9.9 3.8 21.2 20.7 2.2 12.6 39.4 9.6 16.1 28.6 10.9 20.2 5.8 36.5 4.6 10.0 7.2 13.1 11.8 17.2 2.8 10.9 1.7 25.5 7.7 6.7 1.2 3.0 17.9 5.0 31.5 10.9 57.0 20.3 20.3 4.5 6.4 57.6 6.7 9.3 13.5 11.8 26.8 28.4 0.6 3.9 16.5 6.2 10.9 128.1 1.3 9.5 3.6 6.2 12.3 1.1 23.5 0.6 0.6 7.5 4.4 2.5 5.9 1.2 3.5 42.6 29.2 0.4 2.0 23.9 61.8 15.2 11.3 45.8 65.6 8.2 18.5 151.2 1.0 15.8 116.1 65.4 12.7 3.4 116.7 15.0 23.6 33.2 11.8 11.2 11.5 49.0 5.5 8.7 0.6 0.4 5.8 2.4 0.3 8.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.9 0.1 0.0 30.0 35.0 28.2 43.2 38.9 22.6 21.2 20.7 28.6 17.2 25.5 31.5 1.7 6.4 3.9 5.9 0.8 2.5 3.2 1.3 0.6 2.9 12.4 7.4 22.2 4.3 4.2 16.5 0.0 24.7 5.0 5.5 3.9 7.9 0.5 6.6 2.8 3.7 1.2 0.0 51.3 12.2 16.0 2.0 2.6 13.6 1.3 4.1 4.6 8.7 2.7 11.8 28.0 35.2 0.0 0.3 1.3 1.1 0.3 0.9 0.0 4.7 1.0 2.0 1.0 10.6 4.9 13.0 5.5 1.5 0.2 5.6 2.9 5.9 1.3 2.9 0.0 2.4 5.2 0.9 0.4 1.6 1.1 17.9 1.5 1.5 12.0 14.1 RAB20 FLJ20429 ENSG00000139832 "RAB20, member RAS oncogene family" Q9NX57 13 110523066-110561722 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 91.3;Hofbauer cells: 105.0;Kupffer cells: 92.1;Macrophages: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 60.9;SK-BR-3: 85.7;T-47d: 54.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002882, HPA052111, HPA068647" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" "HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013" "unprognostic (5.59e-3)" "unprognostic (1.30e-1)" "unprognostic (3.48e-1)" "unprognostic (1.42e-3)" "unprognostic (1.30e-1)" "unprognostic (3.82e-2)" "unprognostic (1.14e-2)" "unprognostic (5.99e-2)" "unprognostic (9.43e-2)" "unprognostic (2.06e-2)" "unprognostic (9.41e-2)" "unprognostic (2.65e-1)" "prognostic favorable (8.57e-4)" "unprognostic (6.96e-2)" "unprognostic (4.32e-2)" "unprognostic (2.28e-2)" "prognostic favorable (4.48e-4)" 31.1 55.4 5.7 21.7 5.5 25.3 23.4 5.6 7.9 11.7 9.6 20.7 27.6 6.9 4.8 4.6 11.5 18.0 21.4 5.2 7.0 26.1 51.4 30.7 16.4 7.0 6.0 20.5 24.2 6.2 9.7 22.8 6.8 12.1 14.3 2.6 10.7 5.0 5.8 4.6 25.3 7.6 6.6 44.5 28.6 10.6 7.4 3.9 22.0 2.3 5.1 20.6 6.7 8.4 20.1 2.9 1.9 3.8 12.4 3.3 31.3 1.7 6.2 8.1 12.5 47.9 39.9 0.0 13.9 1.7 10.8 7.5 3.8 12.3 4.2 22.5 3.0 19.8 3.6 22.6 7.8 2.8 5.7 6.9 2.0 4.2 1.2 6.3 3.1 3.3 3.8 0.0 1.8 24.0 0.1 29.0 4.0 60.9 8.5 1.9 0.1 9.0 14.2 26.3 0.5 2.1 3.8 85.7 27.4 6.2 54.4 30.5 2.3 2.0 4.2 0.2 2.7 0.1 0.0 0.2 27.7 38.9 4.2 7.8 35.5 7.1 1.0 33.3 1.3 3.5 2.8 0.9 15.8 2.8 6.5 2.3 26.3 0.0 26.6 0.8 0.9 11.2 5.7 5.5 5.6 7.9 5.2 7.0 7.0 6.0 6.8 6.6 7.4 8.4 18.6 19.2 20.4 4.2 10.6 4.5 10.9 14.1 10.8 0.2 12.8 13.0 5.0 48.6 16.2 25.8 0.0 34.6 1.8 31.1 31.3 60.3 1.6 20.7 2.6 10.3 18.0 0.0 0.4 67.9 91.3 11.5 15.3 23.2 21.0 41.1 53.6 34.5 105.0 0.0 0.4 23.9 28.5 92.1 19.9 1.6 3.7 100.5 7.2 8.4 16.2 7.4 0.0 4.5 0.1 36.4 17.2 6.4 0.4 8.0 48.1 68.9 20.4 2.0 13.1 6.2 26.2 1.0 13.2 1.9 3.0 20.0 3.6 7.2 24.0 11.1 RAB29 "RAB7L, RAB7L1" ENSG00000117280 "RAB29, member RAS oncogene family" O14966 1 205767986-205775482 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.1" "Cell type enhanced" "Detected in many" "dendritic cells: 82.3;monocytes: 76.4;NK-cells: 129.8;Proximal tubular cells: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020822, HPA026303" Approved Supported Vesicles,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Cytosol" "CAB020822: , HPA026303: AB_1856016" "unprognostic (5.38e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.82e-5)" "unprognostic (9.50e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.60e-2)" "unprognostic (3.14e-1)" "unprognostic (5.50e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-1)" "unprognostic (1.53e-1)" "unprognostic (8.20e-3)" "unprognostic (1.42e-1)" 13.5 14.4 12.5 20.4 14.1 7.1 14.1 14.3 12.1 8.7 10.5 12.6 10.6 8.3 23.8 7.8 6.2 16.9 13.1 12.3 14.3 73.1 19.4 13.5 35.1 15.9 12.9 7.9 9.2 25.5 5.9 7.2 15.8 13.8 10.1 6.8 19.8 13.9 6.4 5.5 12.4 14.8 14.3 24.3 10.4 4.6 15.3 12.1 33.4 6.0 28.0 15.7 5.7 17.0 20.4 18.6 2.8 13.1 52.5 29.8 9.7 14.1 43.2 28.9 34.4 5.6 28.7 21.6 13.6 24.3 34.6 11.2 32.8 37.3 26.4 88.3 15.3 16.4 7.3 9.5 25.4 16.1 23.2 29.0 24.6 23.3 32.8 24.0 37.2 19.8 16.2 24.2 41.2 7.6 17.7 8.3 13.1 25.4 14.0 3.7 43.1 17.5 33.6 27.7 4.4 12.5 10.0 45.0 37.8 10.3 22.0 13.2 38.7 29.7 15.0 43.5 20.6 39.4 87.0 11.5 30.1 26.3 22.5 92.4 22.6 62.3 92.2 43.8 86.9 50.8 51.0 79.5 33.4 45.8 37.2 63.5 8.8 94.1 53.9 10.4 53.3 51.3 12.5 14.1 14.3 12.1 12.3 14.3 15.9 12.9 15.8 14.3 15.3 17.0 16.3 19.2 17.7 11.1 61.2 0.0 6.3 0.0 13.6 2.1 19.5 16.0 19.3 21.5 6.2 31.3 0.0 12.0 82.3 1.9 29.4 18.7 5.1 2.0 6.3 18.6 4.9 10.8 7.8 10.1 6.4 11.2 10.7 3.5 13.3 9.2 14.6 33.7 32.8 0.0 10.2 3.7 0.0 30.1 0.0 4.1 14.3 34.0 0.0 10.3 76.4 26.5 129.8 10.6 9.8 8.3 4.8 20.7 34.8 10.7 9.5 187.7 2.9 2.0 6.6 10.0 6.7 3.8 11.8 9.3 0.0 2.9 51.7 19.7 5.5 6.9 RAB5A RAB5 ENSG00000144566 "RAB5A, member RAS oncogene family" P20339 3 19947097-19985175 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Endocytosis, Phagocytosis, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004567, HPA049354" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Vesicles" "CAB004567: AB_628191, HPA049354: AB_2680725" "unprognostic (2.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.58e-2)" "unprognostic (4.72e-1)" "unprognostic (3.85e-1)" "unprognostic (5.58e-2)" "unprognostic (1.40e-2)" "unprognostic (6.75e-2)" "unprognostic (7.12e-2)" "unprognostic (5.97e-2)" "unprognostic (1.83e-3)" "unprognostic (4.68e-2)" "unprognostic (2.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.33e-1)" "unprognostic (2.45e-1)" "unprognostic (8.36e-2)" 35.7 27.3 39.2 27.0 39.9 41.4 33.2 42.1 49.5 30.5 36.6 29.7 29.6 22.7 42.4 42.3 21.1 32.2 36.3 38.6 43.1 33.6 42.8 29.5 24.3 42.7 42.5 19.9 27.2 53.8 20.5 49.2 42.2 30.7 30.5 35.4 35.8 28.8 29.1 36.0 28.2 28.0 44.0 24.2 32.6 18.0 41.1 28.9 41.1 30.3 29.1 35.4 29.7 46.1 29.8 26.8 38.5 26.4 65.8 57.8 38.9 51.3 59.7 47.8 55.0 31.9 45.7 21.8 30.3 56.7 27.6 18.4 29.0 38.2 55.7 37.9 24.1 31.9 24.9 31.1 82.2 45.0 38.1 53.6 71.0 56.1 81.9 59.9 61.6 28.5 37.1 34.1 57.9 46.2 34.8 31.9 48.4 40.8 42.6 25.8 27.2 32.2 98.9 38.8 12.0 39.6 36.9 45.3 60.3 57.0 35.4 35.8 61.6 34.5 30.1 44.4 44.2 42.0 73.5 28.6 55.0 40.4 57.1 28.7 18.0 31.3 7.9 19.6 10.6 7.9 9.3 9.6 18.1 5.8 8.5 8.1 36.0 20.3 26.3 11.8 10.9 11.5 39.2 39.9 42.1 49.5 38.6 43.1 42.7 42.5 42.2 44.0 41.1 46.1 114.8 60.9 45.1 33.0 43.6 170.0 129.5 48.8 62.0 34.0 57.0 35.9 57.0 27.1 52.6 42.3 31.3 74.7 44.2 68.7 103.7 52.2 21.2 45.9 44.4 72.4 62.0 55.3 33.7 45.3 67.2 65.2 66.3 72.0 85.0 39.1 41.7 39.3 54.2 15.2 31.4 59.4 65.1 44.4 158.8 15.9 36.7 60.9 83.6 28.1 43.1 86.1 41.2 65.9 44.1 65.2 55.9 35.3 50.7 109.7 49.4 62.3 48.1 36.8 52.6 86.5 72.4 24.6 27.1 65.0 188.0 164.3 60.6 37.1 41.5 151.0 RABEP2 "FLJ23282, FRA" ENSG00000177548 "Rabaptin, RAB GTPase binding effector protein 2" Q9H5N1 16 28904421-28936526 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047641 Approved Supported Vesicles,Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 57: B-cells - Immune response" "Vesicles, Cytosol" "HPA047641: AB_2680111" "unprognostic (4.93e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-2)" "unprognostic (7.06e-2)" "unprognostic (1.44e-1)" "prognostic favorable (5.84e-4)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (1.26e-3)" "unprognostic (5.86e-2)" "prognostic favorable (1.24e-6)" "unprognostic (7.50e-2)" "unprognostic (8.20e-2)" "unprognostic (1.08e-1)" "unprognostic (5.92e-3)" 7.3 21.5 7.3 25.1 8.8 11.5 9.3 8.2 9.2 11.0 10.7 15.0 16.8 8.4 2.7 18.7 7.0 6.6 16.8 6.5 7.9 19.2 10.6 10.1 46.7 10.7 8.5 6.3 17.9 11.5 16.4 5.3 8.4 28.6 4.6 3.5 17.5 7.0 6.5 23.6 28.3 3.4 7.9 47.9 14.4 6.2 8.2 5.3 13.9 3.2 9.4 12.5 12.3 8.5 13.5 21.1 5.6 10.5 3.3 4.7 10.1 15.5 9.2 10.9 10.7 15.9 12.0 27.7 23.7 6.5 4.4 17.8 2.2 9.9 2.1 9.5 9.9 10.5 17.0 21.7 6.5 7.7 32.1 7.9 8.0 13.5 2.4 6.3 15.5 7.4 4.9 9.7 8.5 31.9 9.5 17.8 7.3 5.4 11.4 33.6 5.1 17.4 7.5 17.5 8.6 11.1 7.6 34.8 7.0 1.2 27.6 15.9 27.5 16.4 8.4 12.1 15.6 15.3 5.0 20.7 17.3 18.2 12.6 0.9 2.8 2.4 3.5 2.9 2.4 12.1 2.5 3.2 3.7 15.0 2.2 2.1 0.7 5.5 3.3 2.2 2.2 2.8 7.3 8.8 8.2 9.2 6.5 7.9 10.7 8.5 8.4 7.9 8.2 8.5 11.5 3.2 10.0 4.9 42.4 5.1 14.7 14.6 17.6 11.1 13.3 11.0 1.9 11.5 12.9 20.2 35.5 26.1 21.0 35.0 17.6 16.0 0.7 9.2 8.2 14.2 17.3 6.5 4.8 20.9 7.1 9.0 23.0 10.0 18.4 12.1 7.9 4.2 12.4 15.2 6.5 33.7 18.3 8.4 11.3 1.3 4.1 10.5 10.6 9.4 11.6 8.6 22.6 5.0 8.4 20.0 44.1 6.4 21.4 15.4 32.3 11.6 8.0 43.4 13.1 7.9 9.6 4.3 6.0 16.6 8.4 22.0 14.5 22.6 26.7 19.0 RABL2A ENSG00000144134 "RAB, member of RAS oncogene family like 2A" Q9UBK7 2 113627229-113643396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.8" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.6" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (7.76e-3)" "unprognostic (7.79e-3)" "unprognostic (7.00e-2)" "unprognostic (2.94e-2)" "unprognostic (1.99e-1)" "unprognostic (4.23e-2)" "unprognostic (4.89e-2)" "unprognostic (6.77e-3)" "unprognostic (6.61e-2)" "unprognostic (7.36e-2)" "unprognostic (5.78e-3)" "unprognostic (4.29e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.89e-2)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (3.19e-5)" 2.5 1.2 2.7 1.3 2.9 0.9 2.8 2.3 3.4 3.8 4.6 3.3 1.3 4.4 3.6 1.5 19.8 1.6 2.4 3.0 2.5 2.0 1.9 2.7 1.0 2.6 4.8 5.0 1.5 1.3 2.9 0.8 3.2 2.7 1.0 6.6 2.1 2.0 1.3 2.5 1.8 2.1 3.3 1.7 1.9 5.3 2.9 3.0 3.5 1.4 1.9 2.6 2.8 2.7 2.1 3.7 5.0 4.0 4.1 5.8 3.7 2.0 1.6 2.9 2.0 3.3 1.4 3.1 8.5 0.7 2.0 2.3 2.5 0.3 1.9 4.1 4.7 1.6 0.1 0.4 3.3 0.6 1.1 2.1 4.3 0.5 1.2 4.2 2.1 4.6 1.5 0.8 1.7 1.8 10.6 0.7 2.8 1.9 1.3 2.0 1.9 1.3 2.1 0.5 2.0 7.0 1.9 2.2 1.9 1.5 0.4 3.0 0.5 0.4 0.6 0.7 1.4 2.9 3.4 0.8 5.8 2.3 1.0 0.0 4.3 2.4 6.2 7.1 6.9 8.9 9.0 6.5 7.1 8.2 7.5 5.7 0.5 12.8 7.1 9.1 4.9 5.4 2.7 2.9 2.3 3.4 3.0 2.5 2.6 4.8 3.2 3.3 2.9 2.7 4.2 9.6 8.1 13.4 6.4 4.5 5.6 8.1 5.2 7.6 6.4 8.0 9.5 2.8 12.1 7.3 10.4 3.4 6.3 4.9 13.7 7.6 16.3 36.9 5.6 3.4 7.2 3.0 30.2 3.1 2.9 6.8 5.6 2.8 11.4 9.9 5.3 4.4 3.6 16.8 20.5 4.3 4.1 3.2 3.5 14.5 8.1 3.1 7.2 3.7 5.7 7.3 9.2 7.1 19.4 3.6 3.2 7.2 0.8 2.9 7.2 6.8 123.2 16.8 0.0 5.9 8.1 22.3 9.6 3.6 4.8 2.5 6.0 4.4 4.1 3.6 RABL2B ENSG00000079974 "RAB, member of RAS oncogene family like 2B" Q9UNT1 22 50767501-50783662 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 99.4;Respiratory ciliated cells: 188.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (1.86e-3)" "prognostic favorable (5.58e-4)" "unprognostic (7.85e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (3.14e-1)" "unprognostic (6.97e-2)" "unprognostic (7.33e-2)" "unprognostic (1.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.71e-3)" "unprognostic (7.43e-3)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (8.37e-3)" 13.2 12.9 18.1 18.6 18.8 14.4 15.8 18.1 22.4 23.9 73.6 16.5 12.5 21.7 90.3 13.3 66.6 14.5 10.2 23.3 17.0 17.7 12.2 21.8 23.1 23.3 33.2 22.5 16.3 14.6 26.7 11.6 17.9 16.2 16.7 30.2 16.8 16.9 8.8 22.2 15.6 15.6 21.9 19.3 14.5 23.1 20.1 21.6 28.2 4.6 20.3 17.0 15.7 18.5 23.0 20.4 34.1 26.7 37.3 29.6 25.0 16.7 18.5 13.2 18.1 5.8 19.7 14.7 14.7 24.1 21.6 29.5 15.8 19.6 14.2 13.3 23.2 12.8 40.2 15.1 15.4 36.1 13.0 25.3 26.2 17.5 21.9 39.2 15.0 26.0 9.9 17.9 26.7 28.8 18.2 15.9 13.2 14.0 15.0 30.1 19.8 16.1 25.9 22.4 14.6 26.5 20.5 17.8 13.4 23.4 17.7 11.2 23.2 12.6 25.1 10.9 11.4 15.2 7.4 7.2 23.8 8.8 18.1 1.8 14.4 13.1 21.4 23.5 15.5 15.2 16.4 17.3 15.7 19.2 18.7 18.3 5.4 15.9 28.4 18.0 18.6 14.7 18.1 18.8 18.1 22.4 23.3 17.0 23.3 33.2 17.9 21.9 20.1 18.5 6.2 12.8 13.4 14.4 16.8 5.4 13.4 13.3 15.9 15.2 13.3 11.8 5.1 12.8 24.1 22.0 31.3 12.1 16.2 10.6 13.7 21.3 25.7 99.4 11.2 7.2 5.4 9.9 25.7 10.8 11.1 11.4 9.7 8.6 3.8 22.1 5.3 8.9 12.0 16.8 18.9 8.0 22.4 10.1 6.9 24.2 14.0 8.4 17.8 4.7 14.4 13.9 36.0 7.1 15.1 10.4 4.9 10.9 8.0 7.3 8.6 16.3 188.6 40.0 6.6 15.0 14.8 38.8 27.0 8.8 5.7 6.7 16.0 11.9 10.7 6.5 RAD1 "HRAD1, REC1" ENSG00000113456 "RAD1 checkpoint DNA exonuclease" O60671 5 34905260-34918989 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006692 Approved Approved Nucleoplasm,Vesicles NA Yes "Cluster 6: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Vesicles" "HPA006692: AB_2667645" "prognostic unfavorable (6.30e-4)" "unprognostic (1.85e-2)" "unprognostic (9.40e-2)" "unprognostic (1.98e-3)" "unprognostic (2.00e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (1.06e-5)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.61e-3)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (3.12e-3)" 3.5 8.1 3.2 4.8 3.5 8.4 5.8 3.9 4.6 6.8 5.3 4.1 4.9 5.6 5.4 4.9 3.9 4.6 8.9 3.8 4.6 5.1 4.3 7.5 8.9 3.5 2.7 5.7 4.4 5.1 3.5 8.1 3.2 6.8 4.3 8.7 4.9 4.8 10.9 6.7 4.8 4.6 1.9 4.9 4.8 7.9 3.4 6.3 6.3 8.6 6.2 5.2 4.7 3.8 8.5 10.2 12.3 20.5 7.9 9.4 17.2 15.1 12.0 13.0 10.6 12.2 12.3 25.0 5.2 11.2 15.7 8.4 12.6 7.6 14.4 10.1 12.7 12.9 34.0 8.0 11.9 16.5 11.9 7.8 7.3 13.9 9.3 6.1 6.2 11.0 22.7 13.2 11.2 10.2 19.6 13.9 15.4 6.0 15.7 17.1 24.0 8.6 6.7 9.0 12.4 13.3 30.0 19.9 13.3 7.6 12.5 14.8 6.2 17.9 13.3 9.7 14.4 7.9 13.8 20.3 11.1 28.6 12.5 7.4 2.9 6.5 5.3 2.8 6.9 8.6 5.8 7.6 3.1 9.1 8.2 6.8 1.6 4.5 2.8 6.9 4.9 2.6 3.2 3.5 3.9 4.6 3.8 4.6 3.5 2.7 3.2 1.9 3.4 3.8 11.5 22.4 43.2 5.9 18.3 29.2 20.2 29.3 13.1 25.3 23.9 18.4 25.7 14.3 21.3 20.2 27.1 82.3 20.4 11.9 19.6 18.1 22.0 13.1 16.6 14.1 13.1 28.2 6.6 22.5 54.4 18.7 6.1 12.0 21.5 39.1 10.0 14.8 23.4 23.5 9.0 12.7 30.5 12.0 19.3 16.8 25.1 13.1 17.8 6.5 12.7 23.9 9.2 7.5 9.1 17.8 13.8 21.8 18.0 21.9 13.4 16.4 14.6 35.6 13.1 19.6 19.4 72.5 58.6 15.6 28.6 80.6 22.3 27.4 13.0 25.8 RAET1G ULBP5 ENSG00000203722 "Retinoic acid early transcript 1G" Q6H3X3 6 149916878-149923121 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.4;esophagus: 15.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 42.9;Club cells: 14.8;Ionocytes: 12.2;Respiratory ciliated cells: 23.3;Squamous epithelial cells: 8.9;Urothelial cells: 8.1" "Group enriched" "Detected in many" 4 "cervical cancer: 4.5;head and neck cancer: 4.7;lung cancer: 1.2;thyroid cancer: 1.5;urothelial cancer: 4.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 29.5;hTCEpi: 22.6;SiHa: 11.9;U-87 MG: 9.3" "HPA062673, HPA066741" Supported "Vesicles,Plasma membrane" "Secreted - unknown location" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 20: HeLa - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Plasma membrane" "HPA062673: , HPA066741: " "unprognostic (4.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-3)" "unprognostic (1.49e-1)" "unprognostic (4.61e-3)" "prognostic unfavorable (5.35e-4)" "unprognostic (3.05e-1)" "unprognostic (1.57e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.33e-1)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" "unprognostic (8.85e-2)" "unprognostic (9.11e-2)" 2.8 8.4 0.4 0.4 0.3 0.0 0.6 0.0 0.4 4.1 0.0 0.2 0.1 0.3 0.7 15.1 0.6 0.7 0.6 0.4 0.3 0.9 0.1 0.5 0.1 0.3 0.6 0.7 0.1 0.2 0.3 0.1 0.1 0.7 0.1 0.1 3.7 1.0 0.2 2.7 0.2 0.6 0.0 0.1 0.4 0.3 0.7 0.0 0.4 0.1 1.1 1.8 6.0 0.0 1.0 1.4 0.0 1.7 2.3 1.7 0.0 0.8 3.0 1.3 1.9 0.0 1.5 0.0 0.6 1.7 1.4 2.7 0.9 5.3 1.1 0.3 1.6 0.5 29.5 0.0 0.7 0.0 0.0 3.3 22.6 3.5 1.7 1.5 0.3 0.7 0.3 0.2 0.6 1.3 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 1.0 3.2 0.3 0.3 11.9 0.5 0.0 0.1 0.4 0.4 1.6 0.6 0.5 1.6 0.8 0.0 0.0 0.0 9.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.4 0.3 0.3 0.6 0.1 0.0 0.7 0.0 1.4 0.0 0.0 0.0 0.0 3.1 5.1 42.9 2.8 0.0 0.4 0.4 0.1 1.5 14.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.4 0.1 1.3 0.0 0.0 0.0 1.3 0.0 1.9 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 12.2 0.0 0.7 0.1 0.9 0.0 3.6 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 23.3 0.0 0.0 0.2 1.1 0.0 0.3 8.9 1.7 0.1 0.3 0.5 0.0 8.1 RAET1L ENSG00000155918 "Retinoic acid early transcript 1L" Q5VY80 6 150018334-150025532 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 58.1;vagina: 17.3" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 6.4;Basal prostatic cells: 11.3;Basal respiratory cells: 6.4;Prostatic glandular cells: 7.1;Squamous epithelial cells: 7.2;Suprabasal keratinocytes: 17.0;Urothelial cells: 8.1" "Group enriched" "Detected in many" 4 "cervical cancer: 4.8;head and neck cancer: 10.1;lung cancer: 4.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 14.3" HPA066741 Supported "Vesicles,Plasma membrane" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Vesicles, Plasma membrane" "HPA066741: " "unprognostic (1.80e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (1.84e-1)" "unprognostic (4.24e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.09e-4)" "unprognostic (8.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (7.48e-2)" "unprognostic (1.46e-2)" "unprognostic (2.49e-1)" "unprognostic (1.29e-1)" "unprognostic (5.14e-2)" "unprognostic (7.43e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 5.2 0.3 17.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.2 0.0 0.7 14.3 0.3 0.4 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.4 0.0 0.0 0.0 2.6 0.7 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 11.3 6.4 1.2 0.0 0.4 0.3 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.8 0.5 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.1 0.0 0.2 0.9 0.0 0.0 0.0 0.4 0.0 0.1 7.2 17.0 0.0 0.0 0.0 0.1 8.1 RALY "HNRPCL2, P542" ENSG00000125970 "RALY heterogeneous nuclear ribonucleoprotein" Q9UKM9 20 33993646-34108308 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040971, HPA043614" Enhanced Enhanced Nucleoplasm,Vesicles NA NA 9400 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 39: CACO-2 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA040971: AB_2677230, HPA043614: AB_2678581" "unprognostic (2.06e-1)" "unprognostic (9.54e-3)" "unprognostic (3.72e-2)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.06e-1)" "unprognostic (1.27e-1)" "unprognostic (3.66e-1)" "unprognostic (4.20e-2)" "unprognostic (8.59e-2)" "unprognostic (3.29e-2)" "unprognostic (2.88e-2)" "unprognostic (8.61e-3)" "unprognostic (1.64e-2)" "unprognostic (8.80e-2)" 109.7 65.4 72.1 90.4 83.2 189.2 98.2 82.6 79.3 108.9 81.8 127.2 109.8 96.9 41.6 119.6 84.8 70.7 143.2 67.6 77.4 104.4 68.3 117.4 116.9 87.8 81.9 101.2 78.2 62.1 55.6 77.6 84.2 88.3 87.6 55.0 105.3 64.3 178.4 114.6 117.7 70.1 83.7 109.6 101.9 116.5 80.9 161.7 125.5 106.0 99.9 99.3 98.4 100.7 250.4 138.1 247.6 193.9 115.3 110.3 210.1 172.9 136.0 215.1 183.0 375.8 204.0 204.3 238.7 140.6 290.9 259.4 135.8 252.7 119.2 132.2 119.3 468.3 81.4 375.4 147.8 236.2 215.0 122.4 141.6 161.9 175.4 160.7 203.0 245.6 201.7 300.9 135.8 185.9 589.3 266.6 137.5 306.0 277.2 344.4 360.6 250.7 126.7 135.4 235.8 266.6 271.8 248.4 376.6 125.8 256.2 234.4 167.5 414.4 270.7 212.3 206.6 310.7 308.3 353.5 213.0 169.9 201.3 139.3 110.7 221.3 138.8 137.1 100.2 96.5 122.2 150.4 135.3 99.6 107.8 104.0 173.3 186.1 195.5 110.0 141.4 165.3 72.1 83.2 82.6 79.3 67.6 77.4 87.8 81.9 84.2 83.7 80.9 100.7 91.8 54.5 61.3 23.2 98.3 79.2 126.9 102.3 74.6 24.2 74.9 67.8 63.4 58.6 61.7 55.2 18.8 161.3 118.3 287.4 127.2 149.1 48.1 36.4 48.5 92.1 93.0 87.9 19.3 160.5 227.7 78.2 70.8 66.9 59.7 69.7 76.8 39.8 159.6 8.4 14.6 143.2 95.6 112.2 118.1 46.7 65.6 96.9 115.6 50.6 151.3 62.6 163.7 15.6 57.1 190.3 270.7 62.1 206.4 157.5 220.7 107.3 38.8 36.3 111.7 47.7 97.7 106.6 121.1 103.7 80.7 171.4 117.2 51.6 178.6 176.2 RASA4 "CAPRI, GAPL, KIAA0538" ENSG00000105808 "RAS p21 protein activator 4" O43374 7 102573807-102616756 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 254.9;tongue: 88.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 73.9;Enteroendocrine cells: 71.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 48.9" HPA043010 Uncertain Approved "Vesicles,Cell Junctions" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 56: Bipolar cells - Visual perception" Vesicles "Cell Junctions" "HPA043010: AB_2678267" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (8.93e-3)" "unprognostic (1.69e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (3.44e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (4.62e-3)" "unprognostic (4.19e-2)" "unprognostic (4.81e-2)" "unprognostic (8.87e-3)" "unprognostic (2.47e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" 38.9 17.5 22.9 10.8 18.8 6.0 31.2 22.7 23.0 37.4 3.6 29.8 10.9 37.7 4.7 10.8 28.4 6.3 14.5 22.5 22.8 29.2 2.6 22.1 13.8 21.5 25.9 25.2 12.3 12.8 24.2 13.0 17.3 23.4 4.0 13.3 12.9 18.0 254.9 17.3 21.6 7.5 17.2 16.8 16.1 5.4 22.7 4.8 17.3 88.6 7.1 26.0 29.0 16.3 1.1 1.5 14.1 2.6 1.8 5.8 0.6 16.3 7.6 4.3 4.9 6.1 3.1 9.9 11.9 24.0 0.3 12.7 0.6 0.1 1.7 1.7 2.4 3.2 4.1 1.0 2.1 2.0 4.4 6.4 1.4 1.4 0.4 18.7 2.7 6.5 5.9 17.0 1.4 4.0 8.6 7.1 1.0 6.6 7.3 17.5 2.9 16.5 0.4 5.0 12.7 25.3 2.3 2.3 1.9 7.5 1.1 5.7 3.0 48.9 22.3 4.9 4.1 28.9 18.5 7.7 4.3 4.5 5.9 0.4 7.9 0.2 1.3 8.6 3.0 3.2 2.4 1.8 10.9 2.9 2.5 1.5 1.8 1.4 1.1 9.2 3.3 3.8 22.9 18.8 22.7 23.0 22.5 22.8 21.5 25.9 17.3 17.2 22.7 16.3 26.8 12.8 10.9 15.0 8.3 3.8 4.5 1.3 0.6 73.9 2.0 3.0 1.1 2.8 5.2 3.7 16.7 0.2 7.2 5.9 13.7 1.1 0.4 3.3 13.0 24.9 71.8 5.7 5.6 0.7 0.2 5.0 3.1 2.9 1.3 13.6 3.3 1.4 6.0 28.6 6.6 11.8 0.0 11.6 22.8 0.3 8.4 13.3 1.8 4.7 14.2 9.4 6.2 5.5 1.4 1.7 2.8 7.9 4.0 2.9 19.9 8.4 6.2 11.7 13.1 21.3 10.0 3.4 3.3 1.3 3.4 0.4 6.4 5.6 2.9 4.1 RASA4B ENSG00000170667 "RAS p21 protein activator 4B" C9J798 7 102479976-102517777 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 130.9" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Bipolar cells: 3.3;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.2;intermediate monocyte: 2.0;myeloid DC: 3.3;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 6 "dendritic cells: 3.3;monocytes: 2.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 15.1;U-138 MG: 17.0;U-2 OS: 14.9" "Low region specificity" "Detected in all" HPA043010 Uncertain Approved "Vesicles,Cell Junctions" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" Vesicles "Cell Junctions" "HPA043010: AB_2678267" "unprognostic (1.05e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-2)" "unprognostic (1.55e-1)" "unprognostic (2.10e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" "unprognostic (2.31e-1)" "unprognostic (5.44e-4)" "unprognostic (1.18e-2)" "unprognostic (3.77e-2)" "unprognostic (4.37e-3)" "unprognostic (1.10e-1)" 14.0 5.8 6.5 4.2 6.1 2.2 10.8 6.3 7.9 13.3 3.0 11.9 6.4 16.5 1.3 2.8 9.7 3.7 4.7 6.2 8.0 6.4 0.8 6.0 4.7 7.8 8.3 9.6 2.4 5.2 5.8 4.9 6.7 8.1 1.8 5.3 4.5 7.6 130.9 5.5 7.8 3.8 6.6 5.9 4.9 2.1 7.6 1.9 3.8 19.2 2.8 9.5 9.5 7.5 0.2 1.4 3.7 0.5 1.3 2.9 0.2 6.8 4.4 2.2 3.6 0.5 1.1 3.4 7.3 8.6 0.7 9.1 0.0 0.0 1.1 0.5 1.6 0.5 2.7 0.8 1.2 0.3 0.5 2.9 0.8 0.1 0.2 10.4 0.9 1.7 0.9 9.8 0.7 3.0 2.9 1.9 0.3 1.7 1.9 2.8 1.5 4.6 0.1 0.9 3.1 15.1 1.0 0.5 0.5 3.0 1.0 2.0 2.0 17.0 14.9 1.8 0.6 3.5 2.9 2.4 2.3 0.9 2.8 0.0 2.2 0.0 0.3 2.0 0.2 0.1 0.3 0.1 3.3 0.2 0.3 0.4 0.3 0.0 0.4 2.1 0.3 1.2 6.5 6.1 6.3 7.9 6.2 8.0 7.8 8.3 6.7 6.6 7.6 7.5 0.6 0.0 0.6 2.9 1.1 0.4 0.2 0.0 1.2 3.3 0.1 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.9 0.1 0.0 0.1 0.3 1.8 2.4 0.4 0.5 0.2 0.0 0.3 5.6 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.8 1.3 0.0 0.6 0.9 0.0 0.3 1.0 0.0 1.0 0.6 0.6 0.0 1.5 0.0 0.1 0.0 0.0 2.5 0.2 1.3 0.3 0.1 0.6 0.0 0.5 0.8 0.3 0.0 0.3 1.1 0.1 1.6 0.3 0.0 0.2 RASGEF1B "FLJ31695, GPIG4" ENSG00000138670 "RasGEF domain family member 1B" Q0VAM2 4 81426393-82044244 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 118.7;granulocytes: 107.0;Langerhans cells: 282.6;Macrophages: 141.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 11.9;memory B-cell: 9.7;naive B-cell: 12.4;non-classical monocyte: 20.6;plasmacytoid DC: 28.0" "Group enriched" "Detected in all" 5 "B-cells: 12.4;dendritic cells: 28.0;monocytes: 20.6" "Cell line enhanced" "Detected in some" "CACO-2: 13.4;Daudi: 16.1;Karpas-707: 11.1;NTERA-2: 7.9;OE19: 9.2;SCLC-21H: 7.3;SuSa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044574 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm Vesicles "HPA044574: AB_10794292" "unprognostic (3.24e-1)" "prognostic favorable (6.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "prognostic favorable (1.49e-5)" "unprognostic (4.42e-2)" "unprognostic (6.31e-2)" "unprognostic (4.43e-1)" "unprognostic (4.85e-2)" "unprognostic (1.13e-2)" "unprognostic (3.88e-2)" "prognostic favorable (4.21e-6)" "unprognostic (4.19e-3)" "unprognostic (1.44e-2)" "unprognostic (3.19e-2)" "unprognostic (6.04e-2)" 13.8 6.4 8.9 11.0 20.1 32.5 8.3 12.8 9.4 8.8 17.0 6.5 13.6 3.5 12.3 11.3 8.0 12.0 4.3 8.0 9.3 9.4 41.8 19.8 10.7 37.6 12.5 2.5 2.8 5.4 7.5 13.0 39.0 4.2 7.1 12.5 9.9 2.1 2.9 24.3 13.9 5.9 10.0 11.2 14.7 2.4 18.4 14.2 3.4 2.3 9.8 6.0 5.3 20.2 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 13.4 0.3 16.1 0.0 0.0 0.1 0.3 1.1 0.1 0.0 0.1 2.5 1.4 1.0 0.6 0.5 0.3 0.7 0.2 0.6 0.0 0.5 0.1 0.0 2.8 0.2 11.1 0.0 0.6 5.5 0.5 7.9 9.2 3.6 1.6 0.1 6.4 0.5 0.2 7.3 0.1 0.0 2.3 0.1 7.3 1.1 0.0 0.0 0.0 0.5 0.5 0.1 0.1 0.0 5.1 1.2 0.2 0.2 0.8 3.0 0.4 1.9 11.9 2.1 9.7 1.6 1.6 2.7 12.4 2.8 2.7 1.1 3.8 20.6 28.0 0.5 1.2 8.9 20.1 12.8 9.4 8.0 9.3 37.6 12.5 39.0 10.0 18.4 20.2 9.6 28.9 15.9 1.3 118.7 58.9 7.9 4.4 23.9 11.7 22.7 13.2 9.1 15.7 11.1 14.7 37.5 33.2 71.2 13.2 13.7 3.1 0.5 44.5 4.8 10.8 26.8 0.0 3.6 4.0 2.4 9.1 30.1 38.0 107.0 0.6 102.1 45.9 39.5 3.3 2.8 12.8 16.2 64.2 282.6 1.5 0.9 141.4 62.2 10.3 2.9 1.0 2.1 26.7 25.5 3.0 9.6 1.9 33.5 10.2 9.2 12.9 34.0 4.9 0.0 5.9 17.7 0.8 3.2 10.4 56.7 11.2 56.3 0.5 8.1 11.5 RASSF10 ENSG00000189431 "Ras association domain family member 10" A6NK89 11 13009316-13012119 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 6.0;skin 1: 6.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 64.3;Distal tubular cells: 25.4;Gastric mucus-secreting cells: 17.9;Squamous epithelial cells: 60.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 8.9;CAPAN-2: 7.8;HaCaT: 12.6;HMC-1: 6.2;RPTEC TERT1: 11.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040406 Approved Vesicles,Cytosol NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Vesicles Cytosol "HPA040406: AB_2732485" "unprognostic (6.71e-2)" "unprognostic (5.12e-2)" "unprognostic (5.06e-2)" "unprognostic (2.41e-3)" "unprognostic (6.25e-3)" "prognostic favorable (2.76e-4)" "unprognostic (3.43e-3)" "unprognostic (8.04e-2)" "unprognostic (5.89e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (4.12e-5)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (2.88e-1)" "unprognostic (1.65e-2)" 0.3 0.0 0.4 0.0 0.8 0.0 1.3 0.2 0.5 0.6 0.3 0.4 1.2 0.1 0.1 6.0 3.0 0.3 0.3 0.2 0.3 3.4 0.0 1.2 0.0 0.7 1.0 0.0 0.0 2.1 0.1 0.0 0.7 0.6 0.4 0.0 4.6 0.2 0.7 6.6 0.5 0.0 1.0 0.0 3.6 0.5 0.1 0.5 0.1 0.2 0.5 1.1 1.5 0.5 0.4 8.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.8 0.0 0.5 0.0 0.3 12.6 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 2.2 0.0 1.3 0.0 0.0 11.9 1.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.5 0.2 0.3 0.7 1.0 0.7 1.0 0.1 0.5 2.0 0.0 5.1 0.7 0.1 0.0 6.3 0.0 64.3 0.0 5.8 8.0 0.9 0.0 2.5 1.8 0.0 0.2 0.0 0.9 25.4 0.6 0.0 6.0 1.1 1.4 2.4 0.0 0.0 0.2 0.0 0.2 17.9 11.1 1.3 0.0 3.9 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.3 0.5 0.0 1.9 0.0 0.9 0.0 0.0 0.0 11.5 1.2 0.0 0.0 1.9 0.0 4.5 7.3 0.0 0.0 0.5 0.3 0.0 0.8 60.0 0.0 0.0 0.2 0.0 5.5 3.5 RBP5 CRBPIII ENSG00000139194 "Retinol binding protein 5" P82980 12 7115736-7128889 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 443.5;liver: 324.2" "Cell type enriched" "Detected in many" 8 "Proximal tubular cells: 3197.2" "Group enriched" "Detected in all" 8 "liver cancer: 70.1;renal cancer: 126.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.0;Hep G2: 13.4;K-562: 26.3" HPA038723 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Vesicles "HPA038723: AB_2676175" "unprognostic (5.70e-3)" "unprognostic (7.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.87e-2)" "unprognostic (1.39e-3)" "unprognostic (2.49e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.04e-1)" "unprognostic (2.65e-1)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-2)" "unprognostic (3.33e-2)" "unprognostic (4.22e-1)" "prognostic favorable (3.68e-4)" 6.4 11.7 0.0 15.0 0.1 1.6 5.1 0.3 0.3 11.2 0.2 8.5 4.6 8.6 3.2 3.8 8.1 5.9 1.4 0.0 0.0 443.5 324.2 3.8 31.2 0.5 0.3 4.9 5.2 1.3 6.2 0.3 0.3 10.0 4.9 0.8 3.7 5.0 0.7 2.4 20.6 5.4 0.0 97.1 5.2 2.2 0.2 14.2 7.9 0.0 21.4 7.4 4.6 0.0 0.9 1.3 0.0 0.3 0.0 0.0 0.2 1.1 0.0 0.0 0.2 1.1 1.2 1.0 0.3 0.0 0.1 1.2 0.1 0.0 0.0 1.6 0.0 6.0 3.9 13.4 0.0 0.2 0.9 0.2 0.0 0.0 0.0 2.4 0.0 0.6 26.3 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.1 1.2 0.0 0.2 1.4 0.9 0.0 0.6 0.5 0.7 0.7 0.6 0.5 2.8 0.4 0.3 0.1 0.0 0.3 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.5 0.3 0.3 0.0 0.2 0.0 4.9 0.0 0.6 0.7 15.2 1.5 0.5 0.1 0.0 1.2 1.3 1.3 0.1 5.7 0.1 80.9 0.0 0.1 0.3 0.1 352.1 0.2 4.1 0.3 1.7 28.8 0.0 0.0 2.1 0.4 0.0 8.2 0.0 0.5 0.0 0.2 8.9 361.1 0.1 5.0 1.1 0.0 0.0 8.1 2.6 6.7 2.5 16.6 0.0 1.9 0.0 1.4 0.0 0.5 0.1 0.2 0.0 0.4 0.1 0.5 0.0 3197.2 0.9 1.7 0.0 0.1 4.3 0.7 0.4 0.2 2.3 0.0 7.3 2.4 0.1 0.3 RCN3 RLP49 ENSG00000142552 "Reticulocalbin 3" Q96D15 19 49528003-49546962 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 54.7;Fibroblasts: 105.1;Leydig cells: 38.2;Peritubular cells: 44.8;Smooth muscle cells: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 6.8" "Group enriched" "Detected in many" 9 "granulocytes: 2.5;NK-cells: 1.8;T-cells: 6.8" "Cell line enhanced" "Detected in many" "AN3-CA: 166.6;ASC diff: 283.3;ASC TERT1: 175.4;BJ: 353.8;BJ hTERT+ SV40 Large T+ RasG12V: 179.6;fHDF/TERT166: 304.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043134, HPA050402" Uncertain Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" No No 1600000 "Cluster 32: T-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum" Vesicles "HPA043134: AB_2678332, HPA050402: AB_2681114" "unprognostic (7.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.77e-3)" "unprognostic (8.87e-2)" "unprognostic (3.36e-3)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (1.16e-1)" "unprognostic (7.47e-2)" "unprognostic (9.75e-2)" "unprognostic (2.85e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (5.80e-12)" "unprognostic (5.26e-2)" "unprognostic (3.90e-2)" "unprognostic (1.56e-2)" "unprognostic (4.20e-3)" 67.9 35.3 15.8 33.6 17.2 6.8 48.2 15.5 24.1 78.8 23.5 43.5 39.9 47.4 4.4 11.4 41.4 25.2 56.7 16.0 19.1 41.2 62.3 40.8 8.7 17.4 17.0 50.0 16.4 3.9 20.7 31.1 19.0 32.4 11.4 1.4 19.1 12.1 11.7 25.3 43.2 25.7 16.8 65.9 23.4 17.2 24.5 4.0 26.4 7.5 4.1 43.2 46.3 18.8 3.2 4.3 2.7 166.6 283.3 175.4 1.9 353.8 86.5 122.0 179.6 4.2 1.3 1.3 19.5 304.0 1.3 0.3 6.8 0.5 49.2 0.1 2.5 19.5 1.5 9.1 105.7 0.1 43.0 119.5 0.2 93.2 0.4 3.2 43.8 2.3 8.7 1.0 87.8 2.9 0.1 2.0 1.4 8.8 24.5 0.5 3.9 4.0 1.4 0.0 1.7 10.5 0.3 1.1 0.3 2.8 1.3 11.5 121.4 1.7 52.4 135.3 0.1 14.9 44.5 2.6 7.9 9.6 13.4 0.0 0.2 1.6 0.7 0.0 0.7 0.4 1.7 0.6 0.4 0.2 6.8 2.3 2.5 1.8 0.3 0.2 1.6 1.1 15.8 17.2 15.5 24.1 16.0 19.1 17.4 17.0 19.0 16.8 24.5 18.8 12.0 0.0 6.1 4.6 2.8 18.6 0.6 2.9 3.4 0.8 1.7 3.3 2.1 1.5 0.8 1.8 0.0 2.5 1.4 10.5 1.9 1.6 2.2 1.5 54.7 10.6 1.2 0.0 1.0 0.5 5.0 105.1 6.6 1.6 1.3 7.0 27.1 3.7 22.6 1.7 1.1 7.6 0.0 11.4 23.2 3.0 38.2 11.9 10.6 10.3 3.1 0.6 0.0 1.5 0.8 1.5 7.9 44.8 4.8 0.9 13.1 0.6 0.9 0.8 13.1 37.5 66.5 6.5 6.8 2.8 13.9 6.2 2.2 17.2 8.0 0.4 RELN "PRO1598, RL" ENSG00000189056 Reelin P78509 7 103471381-103989658 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein, Hydrolase, Protease, Serine protease" "Disease variant, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 64.4" "Group enriched" "Detected in some" 8 "Hepatic stellate cells: 128.5;Inhibitory neurons: 372.4" "Cancer enhanced" "Detected in many" "liver cancer: 5.7" "Region enriched" "Detected in many" 10 "cerebellum: 64.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.2;PC-3: 8.6;SCLC-21H: 11.1;SH-SY5Y: 13.7;TIME: 33.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 110.0" HPA077891 Approved "Golgi apparatus,Vesicles" "Secreted in brain" NA NA 30000000 "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Vesicles "HPA077891: " "unprognostic (1.42e-1)" "unprognostic (2.93e-3)" "unprognostic (4.31e-2)" "unprognostic (1.29e-4)" "unprognostic (1.30e-1)" "unprognostic (6.95e-2)" "unprognostic (1.85e-1)" "unprognostic (8.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-2)" "unprognostic (3.31e-3)" "unprognostic (3.86e-1)" "unprognostic (2.02e-2)" "unprognostic (1.43e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.06e-2)" 1.3 1.8 2.0 0.6 1.8 0.0 2.7 64.4 3.8 1.5 0.6 0.8 0.2 0.4 0.1 0.8 2.8 0.7 1.7 3.3 6.4 0.4 13.4 0.5 0.4 2.6 4.2 0.4 0.1 0.0 0.5 0.0 6.3 0.6 0.9 2.9 0.8 0.9 0.2 0.6 0.9 0.7 3.9 0.3 0.5 0.7 0.5 0.0 1.7 1.1 0.2 0.7 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 2.1 0.0 0.1 0.0 0.0 4.3 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 1.9 0.0 0.0 0.0 11.1 13.7 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.8 64.4 3.8 3.3 6.4 2.6 4.2 6.3 3.9 0.5 0.5 1.0 0.0 0.0 9.1 0.5 0.6 0.0 0.0 0.6 30.2 0.5 0.4 5.1 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 13.6 0.1 0.0 8.3 0.0 7.0 2.6 1.2 0.1 7.5 0.0 0.1 0.0 0.0 128.5 3.3 0.2 0.0 372.4 0.0 0.0 5.3 2.2 6.1 0.0 0.1 0.0 2.8 0.0 0.2 0.0 3.0 10.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.8 0.7 0.1 0.8 0.0 0.6 0.3 0.4 0.0 0.0 0.0 RFC3 "MGC5276, RFC38" ENSG00000133119 "Replication factor C subunit 3" P40938 13 33818069-33966558 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 285.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030149 Approved Supported Nucleoplasm,Vesicles No Yes "Cluster 27: Non-specific - Gene expression" "Cluster 63: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Vesicles" "HPA030149: AB_10602921" "unprognostic (3.86e-2)" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-2)" "unprognostic (5.76e-2)" "unprognostic (3.07e-3)" "unprognostic (3.32e-2)" "unprognostic (4.93e-2)" "unprognostic (9.02e-3)" "unprognostic (4.49e-1)" "unprognostic (6.46e-2)" "unprognostic (4.05e-2)" "unprognostic (5.24e-3)" "unprognostic (4.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.08e-2)" "unprognostic (2.86e-1)" 5.3 13.8 2.6 12.9 2.4 19.5 12.8 8.7 2.6 5.7 1.7 9.0 8.5 10.6 4.3 6.7 8.3 4.6 6.1 2.7 2.5 5.1 7.4 5.4 24.3 2.7 2.2 7.8 4.8 5.1 2.6 10.8 2.8 6.3 11.6 5.9 5.5 4.1 3.5 7.5 7.9 7.6 3.7 6.6 6.5 12.8 2.6 24.1 6.5 4.4 23.4 5.7 4.6 2.5 49.0 51.1 86.4 69.5 6.5 10.0 47.5 66.6 29.2 85.5 73.7 63.0 72.2 179.8 26.8 25.3 53.2 72.5 111.6 45.9 112.0 71.5 68.9 105.0 54.4 68.0 7.5 127.2 48.3 9.8 5.8 74.5 49.9 14.1 28.9 63.7 75.1 44.2 51.4 56.1 108.8 58.1 104.2 101.2 42.1 40.3 103.4 41.1 25.4 42.7 45.1 79.2 49.4 65.3 33.4 45.7 52.2 66.8 15.5 45.1 49.7 57.1 70.9 24.9 36.7 285.3 32.4 73.7 86.6 1.5 4.4 7.2 3.2 6.1 3.7 5.8 3.9 3.3 6.1 5.5 5.0 4.5 0.9 2.5 5.3 2.5 6.3 3.1 2.6 2.4 8.7 2.6 2.7 2.5 2.7 2.2 2.8 3.7 2.6 2.5 9.3 9.6 6.2 5.9 11.2 12.2 6.9 6.9 7.4 16.5 8.9 10.5 7.5 1.5 8.6 3.7 8.4 29.6 5.1 3.0 3.9 7.3 8.4 7.0 7.9 9.4 6.1 43.8 30.2 8.9 39.3 7.5 3.1 7.7 1.3 17.8 8.9 7.2 11.9 8.4 20.3 4.3 4.1 6.7 4.0 7.9 6.2 6.5 8.8 34.7 6.4 5.4 1.0 33.7 18.0 5.4 1.5 4.5 21.0 2.7 1.1 5.4 3.8 12.2 6.6 7.9 29.8 52.6 43.2 9.2 7.0 16.4 6.6 9.2 10.1 3.3 RFX1 EF-C ENSG00000132005 "Regulatory factor X1" P22670 19 13961530-14007039 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 144.2;Late spermatids: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048722, HPA052966" Approved Enhanced Nucleoplasm,Vesicles NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "HPA048722: AB_2680500, HPA052966: " "unprognostic (6.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.55e-3)" "unprognostic (2.63e-1)" "unprognostic (5.45e-2)" "prognostic favorable (2.42e-4)" "unprognostic (2.62e-1)" "unprognostic (1.71e-1)" "unprognostic (2.88e-1)" "unprognostic (1.61e-2)" "prognostic favorable (4.92e-4)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-2)" "unprognostic (2.96e-1)" "unprognostic (1.50e-1)" "unprognostic (1.56e-2)" 5.8 6.1 1.2 2.0 1.2 2.4 6.4 4.3 2.4 9.8 0.5 6.0 2.3 7.0 0.8 7.7 7.4 1.3 7.4 1.3 1.6 7.2 8.7 6.6 1.7 1.1 1.1 8.8 7.8 2.2 16.6 1.5 0.7 8.0 0.5 1.1 7.3 1.6 7.9 7.4 7.1 0.6 0.5 9.2 6.7 22.1 2.0 1.7 9.9 0.8 1.0 5.9 7.7 0.8 3.3 3.2 1.7 2.1 1.0 1.2 5.1 1.8 1.1 2.0 1.7 3.3 3.2 1.8 3.6 0.9 1.7 4.2 1.2 1.2 0.7 2.0 7.0 2.1 3.8 3.0 1.8 2.1 4.3 0.9 1.3 1.8 1.0 1.7 1.5 1.5 5.5 1.9 1.0 4.8 3.9 4.6 3.9 1.7 4.8 3.4 1.8 2.6 1.9 1.7 6.9 3.7 3.0 2.6 2.6 0.9 2.9 2.2 1.8 3.4 2.8 3.8 3.1 4.7 2.3 1.2 2.7 2.0 3.1 0.2 1.1 0.6 0.4 0.4 0.4 1.0 0.5 0.5 0.6 1.1 0.5 0.6 3.7 1.1 0.7 1.2 0.3 0.4 1.2 1.2 4.3 2.4 1.3 1.6 1.1 1.1 0.7 0.5 2.0 0.8 26.1 16.0 8.9 3.6 25.9 5.6 8.8 8.7 10.8 29.6 25.9 21.1 11.2 14.3 11.3 22.0 35.5 9.7 34.4 24.0 9.8 11.9 144.2 14.3 31.2 13.4 16.7 29.9 12.0 9.6 12.7 14.5 14.3 25.2 11.4 10.2 20.3 17.5 10.7 23.5 10.2 19.5 10.2 24.5 12.0 119.2 25.7 17.2 1.8 10.3 15.4 13.4 14.4 4.5 4.9 9.7 14.0 27.8 19.9 6.8 13.8 17.4 4.6 46.7 13.1 25.8 13.1 33.9 20.5 7.8 7.5 19.0 20.4 8.3 15.6 6.7 RFX3 ENSG00000080298 "Regulatory factor X3" P48380 9 3218297-3526004 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.3;choroid plexus: 40.7" "Cell type enhanced" "Detected in many" "Astrocytes: 394.4;Early spermatids: 182.8;Excitatory neurons: 333.6;Inhibitory neurons: 208.8;Microglial cells: 188.3;Oligodendrocyte precursor cells: 256.9;Oligodendrocytes: 179.6;Respiratory ciliated cells: 150.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 26.4;HDLM-2: 16.2;SCLC-21H: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035689 Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Vesicles "HPA035689: AB_10671224" "prognostic favorable (1.47e-4)" "unprognostic (8.78e-2)" "unprognostic (1.18e-1)" "unprognostic (5.52e-2)" "unprognostic (2.27e-2)" "unprognostic (1.50e-1)" "unprognostic (8.26e-3)" "unprognostic (3.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (7.58e-3)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-1)" "unprognostic (2.52e-1)" "unprognostic (8.89e-3)" 3.0 1.9 10.0 2.0 14.6 6.3 3.3 21.7 31.3 4.2 40.7 2.6 2.2 3.2 2.7 1.4 11.5 2.2 2.0 27.6 11.0 2.1 1.6 4.2 3.4 14.0 21.3 3.7 2.4 3.3 4.4 2.7 8.2 3.0 2.4 9.0 2.2 1.8 3.2 2.4 2.8 1.5 17.6 3.0 3.1 21.2 13.2 6.3 2.7 1.5 3.7 2.2 2.9 11.8 2.5 3.3 26.4 6.4 1.0 1.1 2.6 1.0 2.9 2.3 1.7 1.0 3.1 3.9 1.1 1.4 1.8 1.4 6.5 2.8 3.9 16.2 1.8 7.3 3.6 2.2 1.3 1.5 1.0 1.6 1.3 2.7 4.4 4.4 4.0 5.0 1.4 3.9 2.4 1.9 4.7 5.4 7.0 2.1 1.4 4.9 1.8 1.0 3.6 1.9 14.1 6.2 1.5 0.8 2.4 5.1 1.3 3.9 2.5 1.7 3.8 0.9 1.6 1.3 0.6 7.8 1.8 1.7 1.8 2.4 2.2 4.7 5.9 3.3 3.6 4.1 5.3 4.7 2.2 5.1 3.6 4.5 6.1 4.0 1.0 3.2 7.2 2.7 10.0 14.6 21.7 31.3 27.6 11.0 14.0 21.3 8.2 17.6 13.2 11.8 15.7 6.4 7.7 394.4 20.9 5.0 8.0 6.4 6.2 24.7 7.7 6.2 6.9 2.8 23.2 3.7 25.0 2.0 11.3 2.4 0.0 3.9 182.8 89.4 16.1 18.5 141.1 7.4 333.6 2.5 2.7 7.3 7.1 11.2 6.3 8.4 15.0 1.0 3.1 38.7 208.8 9.4 6.1 7.3 5.7 120.8 7.2 8.6 1.8 188.3 5.4 14.5 5.2 256.9 179.6 4.2 4.9 7.5 8.1 6.1 2.9 2.2 150.3 24.7 0.0 22.8 11.4 8.9 5.2 4.9 6.3 1.4 12.2 5.9 6.0 3.9 RFX5 ENSG00000143390 "Regulatory factor X5" P48382 1 151340640-151347326 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018519, HPA079241" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm Vesicles "HPA018519: AB_1856209, HPA079241: " "unprognostic (1.17e-3)" "unprognostic (1.62e-1)" "unprognostic (2.61e-1)" "unprognostic (3.21e-2)" "unprognostic (2.68e-2)" "unprognostic (2.49e-2)" "unprognostic (3.73e-2)" "unprognostic (2.09e-3)" "unprognostic (2.99e-2)" "unprognostic (1.96e-1)" "unprognostic (8.29e-2)" "unprognostic (4.42e-2)" "unprognostic (5.66e-3)" "unprognostic (2.00e-3)" "unprognostic (3.43e-2)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" 18.4 25.6 13.3 43.3 13.7 24.0 14.9 17.8 13.2 18.2 11.7 22.7 31.6 22.0 13.1 18.3 18.4 23.4 18.3 12.3 16.8 18.3 13.1 27.9 67.7 17.1 17.6 10.1 9.6 22.1 18.1 12.4 18.5 20.4 28.1 14.6 16.0 25.1 17.0 13.1 26.1 31.8 15.4 50.7 19.6 15.5 15.7 50.5 23.7 23.8 71.8 26.5 11.4 13.3 37.7 41.8 57.6 32.8 27.6 24.0 12.6 17.8 30.0 43.6 57.7 13.7 50.9 145.2 63.9 21.5 42.6 59.5 24.9 34.4 31.9 177.4 39.7 54.8 89.4 23.0 17.7 48.9 59.4 25.2 18.8 28.8 13.2 35.7 39.9 92.0 26.8 88.3 33.8 34.2 78.7 36.2 41.9 30.5 21.2 97.1 32.3 80.1 42.0 49.1 20.4 60.0 35.7 55.0 52.8 69.2 51.6 114.3 39.9 23.8 25.1 11.8 33.7 110.9 118.2 168.6 37.8 26.4 31.3 5.6 22.6 11.5 17.4 28.2 15.3 47.9 13.9 17.4 47.4 53.3 10.9 12.2 3.1 31.4 30.8 25.1 28.5 21.5 13.3 13.7 17.8 13.2 12.3 16.8 17.1 17.6 18.5 15.4 15.7 13.3 8.4 9.6 7.5 4.9 32.0 6.6 12.5 11.4 14.2 7.6 9.4 6.5 5.1 8.6 12.1 7.3 0.0 8.8 16.9 3.8 9.8 15.7 8.4 7.5 6.3 9.9 4.2 16.6 3.2 9.2 3.4 6.1 5.6 12.8 24.1 9.4 10.8 7.3 12.4 1.7 7.0 5.1 10.2 18.5 15.7 17.9 5.0 13.3 5.4 8.4 40.8 7.2 21.6 3.0 2.4 8.6 2.7 9.8 9.5 14.1 11.2 10.7 7.4 2.7 6.6 5.3 5.7 15.5 7.5 14.2 6.1 3.4 13.7 15.7 7.3 14.6 RGPD1 RGP1 ENSG00000187627 "RANBP2 like and GRIP domain containing 1" P0DJD0 2 86907953-87013976 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix: 8.6;placenta: 6.8;testis: 15.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.3;Early spermatids: 2.5;Excitatory neurons: 4.3;granulocytes: 3.8;Inhibitory neurons: 4.0;Microglial cells: 2.8;Oligodendrocytes: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.6;MOLT-4: 10.7;NTERA-2: 3.1;RPMI-8226: 2.4;SuSa: 5.3" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (8.24e-2)" "unprognostic (6.05e-2)" "unprognostic (6.41e-2)" "unprognostic (1.39e-2)" "unprognostic (9.06e-2)" "unprognostic (6.28e-2)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.88e-5)" "unprognostic (2.23e-1)" "unprognostic (2.22e-2)" "unprognostic (5.36e-3)" "unprognostic (1.99e-2)" 0.1 0.1 0.2 0.1 0.2 0.0 0.1 2.0 0.4 8.6 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.2 1.5 0.3 0.1 1.6 0.3 1.5 6.8 1.2 0.1 0.0 2.1 0.2 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.3 15.4 0.6 0.9 0.2 0.0 0.5 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 10.7 0.2 3.1 0.1 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.7 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.0 0.4 0.1 0.6 1.5 0.3 1.2 0.1 0.6 0.3 0.1 0.0 0.5 1.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 2.5 0.0 0.0 0.5 0.0 0.4 4.3 0.0 0.0 0.8 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 2.8 0.0 0.2 0.0 1.5 1.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.2 0.8 0.0 0.0 0.3 1.0 0.0 0.0 0.0 RGPD2 "RANBP2L2, RGP2" ENSG00000185304 "RANBP2 like and GRIP domain containing 2" P0DJD1 2 87755960-87825952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 7.0;dendritic cells: 5.1;Early spermatids: 5.5;Excitatory neurons: 4.3;Late spermatids: 6.7;Plasma cells: 7.5;T-cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "T-reg: 9.6" "Lineage enriched" "Detected in single" 11 "T-cells: 9.6" "Cell line enhanced" "Detected in some" "BEWO: 11.0;JURKAT: 5.4;MOLT-4: 13.3;NTERA-2: 5.4;SuSa: 15.2;THP-1: 5.2" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.26e-2)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.05e-1)" "unprognostic (7.46e-3)" "unprognostic (1.71e-1)" "unprognostic (1.72e-2)" "unprognostic (4.10e-2)" "unprognostic (4.24e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-6)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (5.09e-2)" "unprognostic (2.59e-1)" 1.8 2.8 0.8 1.3 0.7 8.9 1.4 2.6 1.4 10.5 1.6 1.7 2.0 1.4 0.4 0.9 3.2 0.4 1.2 0.6 0.6 1.2 9.6 2.6 2.2 1.7 0.8 2.6 7.9 0.3 5.8 9.5 2.0 1.7 0.7 3.4 1.3 0.7 1.0 1.2 3.7 0.5 0.4 3.2 2.7 16.6 1.0 5.6 1.8 0.3 2.5 0.8 1.6 0.7 0.0 0.0 0.6 0.0 0.0 0.0 11.0 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 2.6 0.2 0.0 0.1 0.0 5.4 4.0 0.3 0.0 0.4 13.3 0.0 5.4 2.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 2.7 4.5 0.1 0.0 15.2 0.0 5.2 0.1 0.8 0.1 0.0 0.0 2.5 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.3 0.6 2.1 0.4 0.0 0.8 1.0 0.2 0.3 0.1 0.0 0.0 9.6 0.3 0.8 0.7 2.6 1.4 0.6 0.6 1.7 0.8 2.0 0.4 1.0 0.7 0.9 0.0 1.1 1.0 4.0 0.1 0.0 0.0 0.0 0.5 0.1 0.3 7.0 0.0 0.0 0.0 0.0 0.4 5.1 0.2 0.0 0.1 5.5 1.7 2.3 0.7 0.0 0.0 4.3 0.2 0.6 0.9 0.5 0.7 0.0 0.2 0.4 0.3 0.1 0.0 3.4 0.0 0.0 0.0 0.4 6.7 0.0 1.7 0.0 1.9 0.0 0.0 0.0 1.5 2.2 0.1 0.0 0.0 7.5 0.1 0.0 0.1 0.8 1.7 0.0 1.0 0.8 2.5 0.6 0.0 0.0 1.0 4.5 0.1 0.0 0.0 RGPD3 RGP3 ENSG00000153165 "RANBP2 like and GRIP domain containing 3" A6NKT7 2 106391290-106468413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 6.9" "Cell type enriched" "Detected in some" 4 "Early spermatids: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 1.5;MOLT-4: 4.6;RPMI-8226: 1.4" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (5.51e-2)" "unprognostic (6.61e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (6.86e-2)" "unprognostic (3.10e-1)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.44e-1)" "unprognostic (4.74e-3)" "unprognostic (5.05e-2)" "unprognostic (3.70e-1)" "unprognostic (3.42e-1)" "unprognostic (1.34e-1)" 0.2 0.1 0.4 0.1 0.4 0.4 0.2 0.4 0.5 0.1 0.9 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 0.4 0.7 0.7 0.2 0.1 1.0 0.6 0.2 0.2 0.2 0.5 0.2 1.1 0.2 0.1 0.9 0.2 0.2 0.2 0.3 0.1 0.1 0.4 0.6 0.1 6.9 0.7 1.9 0.1 0.1 0.2 0.3 0.1 0.5 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.5 0.1 0.6 0.1 0.2 0.1 0.0 1.5 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.4 0.3 0.0 0.2 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.4 0.5 0.4 0.4 1.0 0.6 1.1 0.4 0.7 0.5 0.0 0.0 1.1 1.6 0.1 0.1 0.1 0.0 0.0 1.6 0.0 0.0 2.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.1 0.1 0.5 0.0 0.0 2.4 0.2 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.3 4.4 0.0 0.1 0.0 1.9 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.4 3.2 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2 like and GRIP domain containing 4" Q7Z3J3 2 107826892-107892544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 5.8;Early spermatids: 10.4;Late spermatids: 3.1;Spermatocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 77: Retina - Visual perception" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.8 0.0 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.1 1.0 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.3 3.7 0.5 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.1 0.2 0.2 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.0 0.3 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.3 0.2 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RGPD5 "BS-63, DKFZp686I1842, RGP5" ENSG00000015568 "RANBP2 like and GRIP domain containing 5" Q99666 2 109792758-109857705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.50e-2)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.23e-1)" "unprognostic (4.23e-2)" "unprognostic (3.19e-1)" "unprognostic (3.19e-3)" "unprognostic (3.19e-1)" 10.2 8.3 12.0 5.8 16.4 13.8 10.3 5.9 21.9 8.1 8.1 8.2 7.4 10.4 17.5 5.4 7.6 7.2 8.9 16.5 14.7 7.3 6.8 10.3 6.0 3.5 3.4 13.0 13.5 14.7 8.2 11.1 4.3 12.3 7.2 22.3 7.0 9.6 6.5 11.6 7.4 7.4 2.7 6.4 7.0 41.2 12.6 3.8 14.4 9.7 5.3 7.5 3.9 14.0 24.3 7.8 26.0 19.5 7.7 8.0 1.2 19.3 16.1 13.8 11.2 20.9 7.8 0.6 12.4 11.7 14.6 8.0 14.3 7.0 17.3 3.7 6.4 18.5 4.1 10.2 8.8 1.5 3.1 8.5 9.5 13.3 14.2 14.5 9.4 7.6 8.8 5.4 10.7 4.5 4.0 0.6 12.7 3.0 9.9 4.3 14.4 0.1 10.4 13.7 31.9 4.5 10.0 1.5 14.0 16.5 0.5 5.4 15.6 14.3 21.1 1.0 14.1 12.2 0.5 0.6 11.7 0.2 4.6 5.4 2.0 2.5 1.9 1.0 3.6 1.7 1.5 2.1 1.4 4.2 2.0 2.1 5.5 2.0 1.2 2.5 1.9 0.6 12.0 16.4 5.9 21.9 16.5 14.7 3.5 3.4 4.3 2.7 12.6 14.0 12.9 3.2 11.8 0.0 9.0 3.4 5.0 0.8 2.8 17.7 2.5 1.4 13.8 0.0 3.7 12.9 16.7 2.4 15.9 1.7 0.0 1.7 4.1 12.3 12.0 7.4 5.3 0.0 7.3 1.0 1.8 7.4 5.1 18.6 0.0 9.4 4.2 0.9 1.8 3.3 4.5 1.4 0.0 2.9 6.5 1.7 2.5 6.6 1.8 1.0 0.9 3.8 0.0 0.0 0.2 1.5 1.7 1.2 10.7 5.5 1.7 0.4 2.6 20.3 0.0 9.7 7.8 4.1 2.9 1.2 3.3 4.4 12.4 1.6 1.0 7.3 RGPD6 RGP6 ENSG00000183054 "RANBP2 like and GRIP domain containing 6" Q99666 2 110513802-110577222 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 9.6;Alveolar cells type 2: 17.1;Club cells: 8.1;Excitatory neurons: 10.7;Inhibitory neurons: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 11.5;SCLC-21H: 10.5" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 11: Alveolar cells - Smell perception" "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.11e-2)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" "unprognostic (4.14e-4)" "unprognostic (2.04e-1)" 12.9 8.4 5.0 0.7 2.3 6.3 13.3 6.3 6.4 13.3 6.4 11.5 1.5 9.7 0.9 7.4 12.2 0.0 12.9 2.3 4.9 9.5 14.0 14.4 2.3 4.5 1.5 15.2 18.1 2.0 22.9 1.8 2.8 14.8 0.6 1.9 9.7 0.1 14.7 17.2 12.0 1.0 3.9 9.6 11.8 31.9 2.5 0.7 14.2 2.1 0.7 10.8 10.7 7.6 7.0 2.6 1.2 2.0 0.0 0.5 2.9 1.3 0.0 0.8 0.1 5.7 1.5 0.4 4.2 2.5 3.4 5.2 0.2 2.4 0.0 1.6 11.5 6.8 0.9 1.0 0.1 2.2 0.3 0.4 1.5 1.3 3.1 1.0 0.0 2.1 2.7 2.0 0.0 3.7 1.8 0.0 7.6 1.4 6.7 2.6 4.1 0.0 2.6 0.7 10.5 4.8 1.1 0.2 3.1 4.1 0.1 0.4 1.5 1.4 4.0 0.4 6.0 3.8 0.4 0.5 2.6 0.0 2.5 4.7 1.5 2.0 1.6 0.8 2.4 2.0 2.3 1.7 1.0 3.1 2.3 1.4 4.7 1.5 1.8 2.2 0.5 0.3 5.0 2.3 6.3 6.4 2.3 4.9 4.5 1.5 2.8 3.9 2.5 7.6 0.1 9.6 17.1 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.1 0.1 1.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 10.7 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.3 0.3 0.0 0.5 1.8 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.3 RGPD8 "RanBP2alpha, RANBP2L1" ENSG00000169629 "RANBP2 like and GRIP domain containing 8" O14715 2 112368369-112434488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 15.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Early spermatids: 24.3;Excitatory neurons: 9.8;Late spermatids: 10.1;Microglial cells: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 16.2;hTEC/SVTERT24-B: 13.4" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 36: HEL - Hemostasis" "Cluster 59: Non-specific - Transcription" "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.62e-1)" "unprognostic (7.61e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-3)" "unprognostic (3.17e-3)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.57e-1)" "unprognostic (9.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-2)" 4.3 1.8 2.7 2.8 3.6 10.6 4.5 8.6 7.6 2.8 4.5 2.1 1.6 3.1 5.4 1.4 2.2 2.9 1.8 3.7 3.5 2.4 5.1 3.3 2.4 2.2 2.4 3.2 3.0 2.2 2.6 3.3 1.9 2.6 2.3 7.9 2.5 2.9 1.7 3.8 2.1 2.6 1.1 3.0 1.7 15.6 2.6 3.2 2.4 2.2 3.0 2.6 1.6 5.5 6.1 2.6 4.3 2.6 1.6 3.6 0.1 2.4 1.9 2.3 1.5 5.3 0.4 0.0 1.7 4.0 2.0 2.9 12.3 1.7 2.4 8.7 4.0 16.2 4.5 4.1 2.2 0.1 0.2 0.6 2.2 13.4 3.4 5.7 1.9 2.8 8.4 0.4 3.6 2.5 8.7 2.1 3.0 0.9 3.7 0.0 0.5 0.1 1.3 2.5 2.7 0.5 8.1 0.1 1.7 3.0 1.2 6.8 8.9 1.3 1.8 6.9 4.4 0.0 0.0 0.0 0.5 2.9 0.3 1.3 0.4 0.4 1.0 0.3 1.4 0.5 0.7 0.9 0.4 0.6 1.0 0.6 0.3 0.5 0.8 0.7 0.4 0.3 2.7 3.6 8.6 7.6 3.7 3.5 2.2 2.4 1.9 1.1 2.6 5.5 1.0 9.6 3.6 1.6 2.8 0.4 0.4 0.2 5.2 0.8 0.3 0.3 8.0 1.5 1.9 0.0 2.1 0.2 0.7 0.1 0.0 0.5 24.3 0.6 0.5 1.5 0.0 2.5 9.8 1.1 0.1 2.2 2.6 0.6 5.1 0.6 0.7 0.2 0.4 0.0 7.0 0.4 0.0 0.6 0.8 10.1 0.3 2.0 0.0 9.4 2.3 0.4 0.0 7.5 5.2 0.9 0.0 0.0 2.4 0.0 0.0 0.1 6.7 0.7 0.0 0.9 0.9 6.8 2.7 2.7 0.0 0.4 3.1 0.0 0.0 0.3 RGS5 ENSG00000143248 "Regulator of G protein signaling 5" O15539 1 163111121-163321791 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Sertoli cells: 5114.5;Smooth muscle cells: 1592.3" "Cancer enhanced" "Detected in all" "renal cancer: 226.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 1303.0;OE19: 692.4;SH-SY5Y: 4234.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001821 Supported Supported Vesicles,Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol Vesicles "HPA001821: AB_1079806" "unprognostic (3.75e-1)" "unprognostic (3.93e-3)" "unprognostic (2.31e-1)" "unprognostic (6.91e-2)" "unprognostic (2.50e-2)" "unprognostic (1.32e-3)" "unprognostic (1.65e-2)" "unprognostic (7.38e-2)" "unprognostic (3.54e-3)" "unprognostic (2.19e-1)" "unprognostic (1.53e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.81e-3)" "unprognostic (7.05e-2)" "unprognostic (6.08e-2)" "unprognostic (1.41e-1)" 138.1 312.4 75.5 29.7 87.2 0.1 58.4 84.2 136.5 160.5 73.1 95.7 64.5 73.7 63.1 71.8 65.5 142.7 238.2 65.9 90.7 88.1 34.1 55.5 33.8 95.6 89.1 19.5 30.6 83.3 45.4 19.9 108.2 75.1 42.9 15.3 27.8 190.0 116.5 21.8 75.8 278.0 68.8 16.7 93.5 40.5 99.6 21.2 164.7 236.8 39.4 136.1 60.5 83.7 0.4 0.0 62.9 8.0 1.3 3.0 2.6 1.1 4.4 2.0 1.3 5.3 1.6 0.5 9.2 1.1 0.7 0.4 0.8 0.8 3.3 3.0 1.0 1.3 0.9 0.1 2.6 0.8 0.7 2.0 1.9 2.1 2.6 14.3 1303.0 0.3 0.2 1.2 4.7 0.0 0.9 2.2 38.7 692.4 1.4 0.4 0.1 3.6 0.7 0.0 5.2 4234.9 0.9 0.0 1.5 185.8 0.0 1.3 5.3 1.0 2.3 0.9 2.0 1.5 1.2 0.4 1.4 0.2 2.9 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.5 0.2 0.1 0.2 0.4 0.4 0.1 0.2 0.1 0.0 0.2 0.1 75.5 87.2 84.2 136.5 65.9 90.7 95.6 89.1 108.2 68.8 99.6 83.7 458.3 3.2 5.6 61.4 1.7 17.1 6.0 1.0 0.6 1.8 9.8 12.1 0.0 0.0 7.3 1.8 4.2 1.5 2.4 0.3 1.9 1.0 32.7 3.4 11.6 353.7 0.0 0.0 24.4 1.1 0.8 43.0 223.3 8.1 1.3 0.9 0.0 0.0 1.2 0.0 60.5 0.2 0.0 0.0 26.3 17.0 6.8 11.9 23.2 80.6 0.6 2.6 0.0 25.1 69.7 3.9 0.2 2.6 0.4 12.7 0.2 2.5 5.9 5.8 5114.5 44.9 1592.3 5.7 1.7 5.2 12.6 1.2 5.8 5.5 0.2 7.0 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 325.2;Rod photoreceptor cells: 480.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 9.7;MAIT T-cell: 2.5;memory CD8 T-cell: 6.8;naive CD8 T-cell: 3.2;NK-cell: 4.0" "Group enriched" "Detected in many" 42 "NK-cells: 4.0;T-cells: 9.7" "Cell line enhanced" "Detected in some" "HDLM-2: 25.9;HEL: 11.7;hTERT-RPE1: 4.7;SuSa: 4.1" "Region enriched" "Detected in all" 9 "basal ganglia: 248.1" "Region enriched" "Detected in all" 10 "basal ganglia: 110.0" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 44: HDLM-2 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: AB_2668943" "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favorable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 0.8 1.5 6.2 1.2 23.5 0.2 0.8 4.3 9.4 1.6 3.8 8.5 1.1 1.7 2.5 1.5 10.3 1.0 0.8 5.1 9.3 2.4 2.3 5.1 2.1 5.3 5.9 2.6 1.4 5.5 12.1 1.2 6.9 4.6 1.3 1.3 1.3 3.3 0.1 1.4 3.8 1.4 5.2 1.7 3.8 0.4 7.4 0.6 0.6 0.3 3.0 2.9 2.8 4.6 0.4 0.0 1.3 0.1 0.1 0.2 0.0 0.1 2.6 0.0 0.3 0.2 0.0 1.2 1.8 0.0 0.0 0.1 0.0 0.1 0.1 25.9 0.6 11.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.2 4.1 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 9.7 0.0 2.5 0.0 0.8 6.8 0.0 0.0 0.0 3.2 0.1 4.0 0.0 0.1 0.0 1.7 6.2 23.5 4.3 9.4 5.1 9.3 5.3 5.9 6.9 5.2 7.4 4.6 1.3 3.2 1.5 33.3 0.4 0.4 1.4 0.9 0.6 25.0 7.8 14.5 0.4 0.0 1.3 1.8 325.2 0.0 27.5 0.1 3.9 8.9 0.6 2.5 1.8 2.6 59.7 0.0 2.3 3.1 0.1 5.8 1.1 4.2 0.0 3.3 1.1 0.0 0.1 52.2 2.3 2.3 0.0 0.0 3.0 2.4 0.9 2.9 1.8 1.9 19.4 39.2 18.6 2.5 1.2 2.7 0.1 4.9 6.3 0.1 0.1 14.2 0.8 480.2 0.0 0.5 1.9 0.1 0.4 0.0 0.1 0.1 10.3 12.8 0.6 0.3 RHOH "ARHH, TTF" ENSG00000168421 "Ras homolog family member H" Q15669 4 40191053-40246967 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 62.9;lymphoid tissue: 98.2" "Cell type enhanced" "Detected in many" "B-cells: 273.0;dendritic cells: 90.5;granulocytes: 141.8;NK-cells: 64.9;Plasma cells: 183.1;T-cells: 223.6" "Cancer enhanced" "Detected in many" "breast cancer: 4.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 126.3;HMC-1: 92.5;JURKAT: 123.7;MOLT-4: 179.4;U-266/70: 65.5;U-266/84: 56.8;U-698: 116.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030345, HPA061314" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus, Vesicles" "HPA030345: AB_10601607, HPA061314: " "unprognostic (4.00e-2)" "unprognostic (1.83e-4)" "unprognostic (1.24e-2)" "unprognostic (2.22e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-3)" "unprognostic (1.16e-1)" "unprognostic (2.73e-2)" "unprognostic (2.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.07e-2)" "unprognostic (1.38e-1)" "unprognostic (3.31e-6)" "unprognostic (2.96e-1)" "unprognostic (3.91e-2)" "unprognostic (4.46e-2)" "unprognostic (2.44e-2)" 2.2 0.9 0.7 36.4 0.6 62.9 13.2 0.5 0.8 2.9 0.6 6.3 4.8 1.6 0.9 2.9 1.5 6.4 0.7 0.6 0.8 1.2 2.7 5.7 86.0 1.1 1.3 0.9 1.4 0.4 0.7 0.9 0.9 2.7 5.6 0.0 3.9 0.9 0.6 1.2 20.6 1.5 1.0 42.6 8.2 0.7 0.8 98.2 1.8 0.3 85.2 10.6 1.6 1.0 0.2 0.4 0.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 126.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 2.6 0.0 18.8 0.1 0.0 0.0 21.1 92.5 1.5 0.0 0.0 0.0 0.1 0.1 123.7 1.4 1.2 0.0 0.0 179.4 13.3 2.3 0.0 0.4 19.1 0.3 4.3 0.0 0.0 0.1 0.1 0.3 0.8 0.2 0.1 5.7 0.5 0.5 0.0 0.5 0.1 0.2 65.5 56.8 116.3 0.1 4.4 0.1 210.3 1.1 168.7 112.2 0.8 99.3 164.3 176.9 151.1 1.9 212.1 274.3 220.5 8.4 74.2 1.2 26.1 268.4 124.1 0.7 0.6 0.5 0.8 0.6 0.8 1.1 1.3 0.9 1.0 0.8 1.0 2.9 3.2 9.9 0.3 273.0 7.1 1.4 0.3 1.8 0.0 11.1 6.7 1.1 1.5 2.9 0.0 0.0 0.1 90.5 0.3 0.0 0.1 0.6 0.6 0.5 2.3 0.0 23.4 0.3 0.0 0.2 3.6 9.7 1.0 141.8 0.0 1.8 0.2 2.2 0.0 0.3 0.4 0.0 4.4 16.2 0.7 0.0 28.4 56.9 8.4 11.3 0.0 64.9 0.5 0.1 0.0 0.1 0.0 183.1 1.4 0.0 0.4 1.0 0.0 0.0 2.0 2.0 0.3 0.2 0.3 7.0 0.3 223.6 0.1 0.3 2.0 RHOQ "ARHQ, RASL7A, TC10" ENSG00000119729 "Ras homolog family member Q" P17081 2 46541806-46584688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 189.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 1.5;classical monocyte: 2.5;eosinophil: 4.2;intermediate monocyte: 2.7;memory B-cell: 1.7;myeloid DC: 1.6;naive B-cell: 2.4;neutrophil: 4.8;non-classical monocyte: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 164.0;ASC TERT1: 132.0;SK-MEL-30: 150.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044938 Approved Vesicles,Cytosol No No "Cluster 24: B-cells - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 41: Macrophages - Immune response" "Vesicles, Cytosol" "HPA044938: AB_2679149" "unprognostic (1.24e-1)" "unprognostic (1.30e-2)" "unprognostic (5.82e-2)" "unprognostic (2.07e-2)" "unprognostic (3.61e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.60e-5)" "unprognostic (2.01e-2)" "unprognostic (9.24e-2)" "unprognostic (2.11e-2)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (3.88e-3)" "unprognostic (1.39e-2)" "unprognostic (1.87e-1)" "unprognostic (7.68e-2)" "unprognostic (3.52e-2)" 96.9 35.7 34.8 30.1 40.1 12.4 64.8 38.9 41.4 59.6 43.9 67.0 11.0 53.2 67.7 18.9 59.3 26.7 196.8 34.3 44.7 44.3 22.6 56.0 23.8 40.9 44.2 40.8 28.6 50.4 29.5 28.6 38.9 50.6 13.5 27.7 32.7 36.5 162.4 28.1 35.3 38.4 39.2 42.7 32.8 10.1 36.8 9.9 39.1 181.3 19.1 62.8 44.7 43.5 12.3 12.4 21.0 28.6 164.0 132.0 3.7 32.8 84.1 16.2 24.4 6.2 4.1 28.7 34.0 58.5 52.4 5.8 20.6 9.8 29.3 10.2 15.3 8.2 9.8 20.9 81.8 8.8 10.7 118.1 17.3 20.1 22.5 39.0 19.3 3.1 12.1 44.0 35.2 8.1 6.9 17.9 20.8 8.9 14.4 5.3 34.5 10.1 23.1 22.4 15.3 50.3 11.6 16.4 150.8 32.9 9.0 20.7 13.2 50.1 44.8 49.3 14.1 48.5 17.7 28.4 73.6 22.1 18.4 1.5 2.5 4.2 0.4 2.7 0.3 1.7 0.2 0.4 1.6 2.4 0.0 0.3 4.8 0.3 1.9 0.6 0.3 0.7 34.8 40.1 38.9 41.4 34.3 44.7 40.9 44.2 38.9 39.2 36.8 43.5 27.9 57.7 22.4 65.3 38.1 22.4 31.0 18.1 11.4 21.1 30.4 22.4 189.2 14.3 22.1 20.2 10.4 14.6 32.2 1.0 17.6 21.4 30.8 22.1 90.2 23.4 6.0 2.1 12.8 32.0 3.6 82.8 4.1 24.6 12.0 12.1 17.5 12.2 44.5 121.1 27.7 5.5 8.2 90.9 77.8 11.4 35.4 90.7 42.7 68.4 55.1 52.9 15.5 52.3 41.5 22.4 0.3 42.5 42.0 41.2 0.2 30.1 18.8 24.2 46.0 54.2 82.3 2.3 4.5 6.8 19.7 25.9 17.0 10.9 1.9 31.9 RIMBP3 "KIAA1666, RIMBP3.1, RIMBP3A" ENSG00000275793 "RIMS binding protein 3" Q9UFD9 22 18605815-18611919 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "brain: 35.7;choroid plexus: 24.5;testis: 28.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 3.0;THP-1: 3.2" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Cluster 30: Non-specific - Translation" "Cluster 70: Brain - Nervous system development" "Cluster 43: THP-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.55e-2)" "unprognostic (3.95e-3)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.29e-2)" "unprognostic (9.81e-3)" "unprognostic (1.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" "unprognostic (6.06e-3)" "unprognostic (9.58e-2)" "unprognostic (8.49e-3)" "unprognostic (7.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.69e-3)" "unprognostic (7.95e-2)" 0.1 0.2 7.9 0.4 10.8 0.1 0.0 35.7 22.0 0.1 24.5 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 11.0 11.7 0.0 0.0 0.2 0.8 14.9 10.1 0.1 0.1 0.3 0.1 0.2 26.2 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 19.6 0.7 0.2 28.4 13.5 1.0 0.4 0.0 0.5 0.0 0.0 32.4 0.4 1.3 0.5 0.4 0.7 0.3 0.0 0.5 1.4 0.6 0.7 0.0 0.0 0.3 0.6 0.2 0.4 0.3 0.3 0.0 0.1 1.4 0.4 0.6 0.3 0.5 0.0 2.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 1.1 0.2 0.3 0.5 0.6 3.0 1.7 0.6 0.6 0.1 1.2 1.6 0.2 0.1 0.1 0.8 0.1 1.2 0.0 0.2 0.1 0.1 3.2 0.1 1.0 0.7 0.5 0.3 0.0 0.4 0.3 0.5 0.7 1.1 0.0 0.2 0.2 0.1 0.1 0.4 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.3 0.0 0.0 0.2 0.3 7.9 10.8 35.7 22.0 11.0 11.7 14.9 10.1 26.2 19.6 13.5 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RIMBP3B ENSG00000274600 "RIMS binding protein 3B" A6NNM3 22 21383374-21389478 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 49 "brain: 41.3;choroid plexus: 18.4;testis: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.2;RH-30: 1.1;THP-1: 2.1" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 43: THP-1 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (3.78e-1)" "unprognostic (3.54e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.28e-1)" "unprognostic (5.35e-2)" "unprognostic (4.37e-1)" "unprognostic (3.61e-4)" "unprognostic (1.69e-2)" "unprognostic (7.11e-2)" 0.0 0.1 8.2 0.4 12.8 0.0 0.0 41.3 19.1 0.0 18.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 10.4 13.6 0.0 0.0 0.1 0.3 16.5 12.6 0.0 0.1 0.2 0.0 0.2 19.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.2 0.2 0.0 13.6 13.2 0.4 0.1 0.0 0.2 0.0 0.0 29.6 0.0 0.5 0.1 0.1 0.3 0.2 0.1 0.1 0.4 0.2 0.2 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.2 0.9 1.2 0.1 0.2 0.1 0.8 1.1 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.0 2.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.2 0.6 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.2 0.1 8.2 12.8 41.3 19.1 10.4 13.6 16.5 12.6 19.2 16.2 13.2 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RIMBP3C ENSG00000183246 "RIMS binding protein 3C" A6NJZ7 22 21545678-21551461 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 6.1" "Cell type enhanced" "Detected in some" "Early spermatids: 30.7;Late spermatids: 49.4;Spermatocytes: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.74e-1)" "unprognostic (4.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (8.30e-2)" "unprognostic (4.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.15e-3)" "unprognostic (6.23e-2)" "unprognostic (2.17e-6)" "unprognostic (3.04e-1)" "unprognostic (3.29e-1)" "unprognostic (3.76e-6)" "unprognostic (1.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 49.4 0.6 0.1 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RINL FLJ45909 ENSG00000187994 "Ras and Rab interactor like" Q6ZS11 19 38867830-38878275 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 32.5;NK-cells: 45.3;Skeletal myocytes: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 14.2;Karpas-707: 24.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042083, HPA042103" Uncertain Approved Nucleoplasm,Vesicles No No "Cluster 37: B-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Vesicles" "HPA042083: AB_10793977, HPA042103: AB_10797380" "unprognostic (1.30e-1)" "prognostic favorable (6.49e-5)" "unprognostic (7.38e-2)" "unprognostic (1.75e-2)" "unprognostic (6.05e-2)" "prognostic favorable (1.64e-4)" "unprognostic (2.61e-2)" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (5.95e-2)" "unprognostic (1.85e-1)" "unprognostic (7.90e-2)" "unprognostic (3.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (3.17e-2)" "unprognostic (6.40e-3)" 5.3 2.5 2.2 5.3 2.7 2.8 4.2 2.6 2.8 2.8 2.9 3.9 1.6 2.0 0.9 6.3 3.3 1.7 3.5 2.1 2.3 6.1 7.8 4.3 9.7 2.6 2.1 1.5 13.2 2.7 7.2 1.6 2.9 2.5 1.4 2.5 5.3 1.1 2.3 3.6 8.4 1.0 1.9 15.8 4.2 1.1 2.2 3.9 5.1 0.9 7.6 4.6 3.7 2.2 0.0 1.8 0.4 0.2 0.7 0.3 2.8 0.4 0.3 0.4 0.4 1.9 9.2 9.1 3.1 0.4 0.1 0.2 1.7 2.4 0.5 1.7 0.6 10.1 2.6 4.8 1.9 6.4 14.2 2.0 0.4 1.2 0.5 0.3 3.5 5.1 1.8 24.6 0.0 1.6 1.6 4.3 0.8 5.2 0.3 1.2 0.1 6.5 1.7 0.2 3.2 1.3 4.2 6.7 3.6 0.4 0.8 7.7 2.6 0.1 1.9 0.5 0.1 9.1 9.3 6.3 0.7 2.8 0.5 5.3 1.1 1.6 10.3 2.5 6.5 17.4 6.9 7.7 2.0 21.9 5.3 6.4 3.0 5.2 2.5 16.0 8.1 3.6 2.2 2.7 2.6 2.8 2.1 2.3 2.6 2.1 2.9 1.9 2.2 2.2 6.7 3.2 7.7 0.0 22.4 3.2 5.3 2.9 4.6 4.0 5.8 4.7 3.5 8.6 2.3 3.7 8.4 13.9 32.5 0.6 7.9 7.3 0.5 2.8 1.6 6.9 7.2 9.0 2.2 7.3 7.1 4.3 5.1 6.3 15.2 1.3 8.2 7.5 9.3 0.0 1.6 0.7 14.2 6.8 2.7 1.3 3.1 4.3 10.6 1.0 10.5 6.2 45.3 3.5 0.6 5.1 1.7 2.6 14.8 2.3 0.6 12.7 1.3 10.6 0.0 30.3 2.3 2.7 4.4 6.4 3.8 4.1 24.6 5.0 1.3 3.6 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20802855 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "pancreas: 9121.6" "Cell type enhanced" "Detected in many" "Adipocytes: 826.6;Alveolar cells type 1: 929.5;Alveolar cells type 2: 818.4;Gastric mucus-secreting cells: 821.1;Hepatic stellate cells: 650.3;Hofbauer cells: 1583.4;Intestinal goblet cells: 663.8;Macrophages: 632.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 9.7;myeloid DC: 20.3" "Group enriched" "Detected in many" 9 "dendritic cells: 20.3;monocytes: 9.7" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 286.8;OE19: 67.4;RT4: 114.2;TIME: 179.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 1100000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 4: Macrophages - Innate immune response" Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 694.2 501.3 336.6 131.3 466.1 6.2 353.3 404.4 556.1 203.9 294.9 378.4 176.7 139.4 112.0 194.0 232.0 406.4 377.7 351.3 380.9 253.0 54.5 775.9 187.8 438.9 408.3 190.6 9121.6 60.6 43.9 897.4 403.7 83.9 425.2 3.1 168.0 149.7 127.6 118.1 201.8 285.6 357.3 353.1 1003.5 977.5 465.4 177.6 119.7 280.6 68.8 374.7 107.9 533.7 0.0 1.4 0.5 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 6.7 0.0 0.3 1.7 0.0 2.2 0.6 0.0 1.4 0.0 0.1 0.1 5.3 0.1 0.8 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 286.8 0.0 31.4 0.4 0.0 0.0 0.3 2.0 1.2 67.4 0.0 0.2 0.1 1.5 0.2 114.2 1.2 1.4 0.0 0.8 0.3 2.0 0.3 0.1 179.3 0.0 2.7 1.8 0.3 0.6 0.1 0.1 4.6 0.1 3.8 1.6 9.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 20.3 0.1 0.0 0.0 0.1 0.0 0.0 5.0 0.0 2.4 336.6 466.1 404.4 556.1 351.3 380.9 438.9 408.3 403.7 357.3 465.4 533.7 826.6 929.5 818.4 1.6 11.1 35.6 1.0 1.9 15.9 0.1 6.2 11.7 59.8 27.1 174.0 16.5 0.0 12.9 5.7 261.8 0.0 8.8 20.0 3.8 1.9 581.7 48.7 28.0 0.5 315.2 14.6 58.4 821.1 3.4 25.2 103.8 650.3 7.9 1583.4 1.7 0.8 663.8 8.2 267.9 197.5 57.1 32.0 632.8 40.9 36.5 3.4 0.8 0.0 1.0 232.3 286.8 246.7 10.9 7.5 1.4 81.7 0.9 34.9 2.7 98.6 20.7 31.4 16.4 6.6 16.6 28.1 25.9 10.6 392.8 162.9 3.8 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 278.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 619.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 619.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favorable (2.91e-4)" 26.7 15.2 7.7 40.3 7.5 52.3 16.3 7.7 9.7 17.7 12.3 15.7 16.8 12.4 16.3 35.5 16.9 18.9 12.5 7.6 8.9 16.3 26.6 30.5 18.3 9.9 8.5 15.9 22.3 17.9 10.4 21.8 9.6 12.6 15.8 7.8 18.3 10.1 8.5 25.6 18.2 12.9 8.5 53.1 19.1 15.8 9.1 15.2 12.2 9.4 19.6 29.1 22.7 10.9 19.9 11.4 8.8 11.3 31.6 31.3 49.7 24.0 31.8 32.1 35.8 29.0 51.6 6.1 28.3 23.9 42.9 39.0 12.5 24.6 29.7 16.9 16.6 12.4 9.9 50.0 42.1 13.4 19.2 28.9 40.0 37.9 25.1 24.7 58.9 13.0 10.7 18.0 32.4 16.9 18.8 14.0 6.1 27.1 20.0 11.5 14.2 23.4 38.0 48.0 11.5 8.5 14.4 36.0 37.2 9.5 9.7 17.8 39.6 16.2 9.1 24.5 5.3 35.5 22.5 0.2 5.2 18.6 12.2 44.0 73.6 90.3 43.8 118.1 41.8 13.2 40.0 45.3 27.9 8.5 28.2 30.2 619.9 15.3 134.1 52.5 53.8 69.8 7.7 7.5 7.7 9.7 7.6 8.9 9.9 8.5 9.6 8.5 9.1 10.9 19.9 48.1 48.1 44.7 55.2 76.9 78.1 63.5 54.7 20.4 29.7 15.9 13.0 41.5 48.4 55.2 56.3 65.2 112.4 53.1 1.9 59.1 97.9 41.8 31.9 30.0 8.5 22.7 82.8 42.2 73.0 53.5 37.2 63.1 39.2 17.3 27.1 46.2 85.9 8.4 71.6 31.7 12.2 278.6 144.2 37.2 30.7 209.0 40.9 50.6 116.5 11.6 61.8 34.7 59.6 54.3 52.3 19.5 125.5 73.5 45.9 25.8 44.8 20.7 59.2 40.5 30.1 36.6 40.3 128.3 91.6 128.1 115.7 23.8 32.8 154.1 RNF157 KIAA1917 ENSG00000141576 "Ring finger protein 157" Q96PX1 17 76142465-76240493 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 86.9;retina: 59.0;skeletal muscle: 73.9;testis: 31.4;tongue: 43.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 114.1;Cone photoreceptor cells: 189.7;Excitatory neurons: 64.6;Horizontal cells: 180.0;Inhibitory neurons: 92.7;Rod photoreceptor cells: 70.9" "Cancer enhanced" "Detected in many" "glioma: 11.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.2;T-cells: 5.8" "Cell line enhanced" "Detected in many" "HDLM-2: 100.9;U-266/70: 50.6;U-266/84: 45.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021854, HPA021991, HPA023922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus" Vesicles "HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202" "unprognostic (4.21e-1)" "unprognostic (4.62e-2)" "unprognostic (1.55e-2)" "unprognostic (2.63e-3)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.07e-3)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-3)" "unprognostic (4.02e-1)" "unprognostic (8.26e-2)" "unprognostic (8.69e-3)" "unprognostic (2.28e-1)" "unprognostic (2.75e-2)" "unprognostic (1.38e-1)" 13.6 3.3 36.4 3.7 39.1 2.2 4.9 34.1 86.9 1.4 9.8 9.8 9.6 1.4 3.4 1.0 1.8 1.3 6.4 56.9 34.5 5.8 2.5 1.4 5.2 59.7 41.9 1.2 3.4 14.6 6.3 1.6 61.1 1.9 7.0 59.0 1.9 1.5 73.9 1.0 10.3 1.8 34.1 3.5 3.9 31.4 51.5 2.8 3.4 43.7 2.7 3.0 1.0 58.1 0.2 7.1 29.3 10.7 8.8 4.4 13.4 0.3 8.9 1.9 1.3 3.3 3.1 0.0 4.2 0.5 6.9 0.2 26.0 0.1 1.6 100.9 8.9 0.0 2.9 4.7 1.7 1.4 10.9 2.4 0.1 3.7 0.1 1.5 0.2 4.7 16.0 0.3 3.6 8.0 4.4 0.8 4.8 5.5 21.1 0.0 0.3 0.1 3.4 3.2 5.1 24.0 5.3 0.1 11.5 6.5 0.7 5.1 0.2 1.9 2.3 14.4 9.6 50.6 45.5 0.1 0.8 0.1 15.1 2.2 0.2 0.3 1.6 0.1 3.4 0.2 3.4 2.7 0.1 0.4 5.8 3.9 1.2 0.7 0.2 0.3 1.3 1.0 36.4 39.1 34.1 86.9 56.9 34.5 59.7 41.9 61.1 34.1 51.5 58.1 2.8 3.2 3.3 33.3 1.5 2.0 0.8 0.2 0.6 114.1 0.8 0.9 9.0 11.5 1.3 1.8 189.7 0.6 5.0 5.3 0.0 1.9 27.8 0.6 3.7 4.4 2.4 5.5 64.6 1.1 0.4 3.1 0.0 1.5 0.0 0.9 0.7 4.3 0.4 180.0 92.7 7.4 0.0 0.8 6.0 29.1 11.5 1.1 1.8 3.7 1.4 35.9 8.2 62.8 35.0 0.1 3.4 13.9 2.1 0.9 19.3 9.1 0.7 70.9 0.0 2.9 1.3 22.7 25.0 0.0 2.3 0.3 15.5 1.3 18.2 1.5 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865432-124881471 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 6.4" "Cell type enhanced" "Detected in many" "Astrocytes: 32.3;Muller glia cells: 45.3" "Cancer enhanced" "Detected in many" "glioma: 5.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "AF22: 18.4" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Low region specificity" "Detected in many" HPA071053 Approved "Vesicles,Plasma membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.8 1.8 0.5 0.0 0.3 0.2 1.9 0.0 3.2 0.7 0.0 1.3 0.3 0.8 0.0 0.7 2.0 0.0 1.8 0.7 0.2 1.6 0.4 1.1 0.1 0.9 0.9 6.4 0.7 0.0 0.8 0.2 0.2 1.4 0.0 0.2 1.2 0.0 0.5 0.7 0.9 0.8 0.2 1.6 0.6 1.2 1.7 0.0 1.4 0.0 0.0 0.7 1.2 0.9 0.0 0.0 18.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 1.1 0.0 0.0 1.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.0 0.6 0.9 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.0 3.2 0.7 0.2 0.9 0.9 0.2 0.2 1.7 0.9 13.2 0.0 7.3 32.3 0.4 2.9 14.5 16.2 4.0 1.9 5.9 10.9 2.7 1.5 5.9 12.9 0.0 0.2 8.5 2.1 0.0 9.3 0.4 0.4 0.5 11.4 3.5 2.1 6.9 0.8 0.2 19.0 0.5 0.7 8.9 19.0 7.5 0.3 1.6 0.0 2.3 2.4 10.2 1.6 20.1 0.6 13.4 8.0 3.6 11.2 1.6 45.3 8.2 4.5 9.2 1.2 2.5 8.2 0.7 8.2 1.0 0.8 0.6 2.1 0.0 14.3 4.4 10.1 10.8 2.3 1.0 0.1 3.6 3.5 2.7 6.5 RPL7A "L7A, SURF3, TRUP" ENSG00000148303 "Ribosomal protein L7a" P62424 9 133348218-133351426 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046794 Approved Nucleoli,Vesicles NA NA 490000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Nucleoli Vesicles "HPA046794: AB_2732534" "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (8.83e-3)" "unprognostic (1.07e-3)" "unprognostic (4.17e-3)" "unprognostic (7.95e-2)" "prognostic unfavorable (8.99e-4)" "unprognostic (1.98e-1)" "unprognostic (8.88e-2)" "prognostic unfavorable (3.60e-5)" "unprognostic (4.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (4.06e-2)" "unprognostic (1.92e-2)" "unprognostic (9.89e-2)" 1864.3 2099.0 555.5 499.0 565.3 1295.5 1857.6 551.6 615.8 2259.5 549.3 1694.1 544.2 1635.0 1065.1 2717.9 1828.7 498.1 1316.3 539.3 556.2 1385.9 1390.8 1257.4 1006.5 570.3 558.1 3860.4 4112.2 606.1 1325.3 534.3 570.5 1665.0 909.8 237.3 1758.0 610.4 1999.9 2751.6 1419.1 767.3 588.2 1542.6 1762.7 692.1 563.8 1108.8 1287.3 862.8 1354.0 1718.9 2072.4 577.6 738.0 1094.6 1223.6 1227.0 2101.3 3459.0 1165.5 904.3 1835.4 1592.3 882.0 1676.1 941.1 2286.8 542.9 1587.3 858.2 1754.6 1831.4 2172.0 1273.6 977.8 1036.3 807.6 1533.7 1656.6 1389.2 1932.4 915.0 3509.5 3187.7 1154.6 1984.2 2581.3 2055.4 1579.3 1573.5 1170.9 1855.9 2494.0 1509.9 2010.8 1336.2 3265.2 1067.1 1307.0 1533.0 2946.8 2077.6 925.6 1144.0 1009.2 739.8 1878.6 1209.1 1008.0 2050.7 2009.1 1133.2 1042.8 746.6 950.3 1094.7 453.3 975.5 1410.1 814.8 1328.8 830.2 115.2 309.8 65.6 395.1 280.0 583.3 624.2 535.6 488.8 452.9 544.4 591.3 560.4 43.6 433.2 255.0 449.1 453.7 959.4 555.5 565.3 551.6 615.8 539.3 556.2 570.3 558.1 570.5 588.2 563.8 577.6 2135.7 519.2 830.9 22.5 3484.9 3244.6 4561.0 2878.3 4056.7 324.7 4450.1 8182.0 389.0 1720.0 1397.0 597.7 143.9 3617.6 2668.7 1136.8 2122.9 2037.3 1992.4 1277.7 3110.1 1843.9 1503.3 2592.1 30.3 4412.9 5135.5 1931.5 1701.4 1613.2 851.9 3717.2 1779.5 1292.4 2514.0 131.2 28.5 2769.2 876.9 2202.6 2161.8 4012.3 3736.3 2023.9 1511.9 22.5 2569.6 1085.1 2398.6 22.6 34.9 2672.7 2176.1 1929.6 3366.8 4776.6 2603.2 2708.5 569.1 516.9 966.3 2340.4 2271.5 1087.3 793.2 6499.1 3980.6 3307.4 2539.1 5934.2 3443.7 5327.8 RPRD2 "FLJ32145, HSPC099, KIAA0460" ENSG00000163125 "Regulation of nuclear pre-mRNA domain containing 2" Q5VT52 1 150363091-150476566 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 132.9;Inhibitory neurons: 133.8;Oligodendrocyte precursor cells: 136.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061693 Approved Approved Nucleoplasm,Vesicles NA NA 66000 "Cluster 44: Non-specific - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Vesicles" "HPA061693: AB_2684587" "unprognostic (1.68e-1)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (7.25e-2)" "unprognostic (5.67e-3)" "unprognostic (3.79e-2)" "unprognostic (1.75e-2)" "unprognostic (9.03e-2)" "unprognostic (1.50e-1)" "unprognostic (3.93e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-1)" "unprognostic (1.10e-3)" "unprognostic (1.11e-1)" "unprognostic (1.71e-1)" "unprognostic (7.92e-2)" "unprognostic (1.38e-1)" 10.8 11.4 6.1 10.8 7.4 13.7 12.0 17.4 11.0 16.0 3.2 13.2 10.6 18.9 14.2 14.0 21.1 10.7 13.2 7.3 8.1 16.0 11.4 12.9 13.6 4.2 5.3 29.8 14.5 19.2 10.7 9.8 4.3 14.3 14.5 17.4 14.0 16.2 24.5 12.8 12.1 17.8 3.8 14.0 11.9 14.1 7.7 19.5 23.0 22.8 15.7 12.7 11.3 7.9 24.6 18.4 23.9 24.3 24.3 20.5 22.6 17.4 20.7 18.8 18.4 16.1 29.4 38.8 19.5 21.4 10.4 26.6 34.0 25.9 20.4 17.9 14.2 22.3 21.2 19.5 17.4 33.8 26.3 21.8 19.3 26.2 34.4 20.9 23.5 23.2 22.1 40.9 19.3 35.4 29.8 10.9 30.0 30.9 20.6 27.0 17.7 39.4 27.7 22.4 25.4 25.6 35.6 30.0 22.6 21.2 23.7 29.5 21.7 17.3 17.8 14.6 24.9 24.9 29.5 28.7 17.2 24.8 17.4 5.8 2.9 3.5 5.6 1.8 5.1 5.4 5.3 4.5 2.6 5.2 6.1 6.2 1.4 3.9 7.3 3.1 7.0 2.4 6.1 7.4 17.4 11.0 7.3 8.1 4.2 5.3 4.3 3.8 7.7 7.9 18.7 19.2 25.9 97.3 30.8 15.4 10.5 17.1 25.0 35.0 22.0 19.8 27.6 17.2 24.5 33.1 16.7 14.0 27.2 20.6 7.9 14.6 11.0 31.8 30.1 21.6 25.8 16.8 132.9 12.9 9.1 23.4 16.8 33.5 17.7 28.5 26.0 27.1 14.7 11.8 133.8 22.1 18.3 22.6 10.5 6.6 37.9 16.6 10.6 56.2 18.6 22.9 27.8 136.2 112.2 14.1 17.7 39.9 29.6 16.4 21.6 30.8 29.9 29.8 32.9 37.1 20.6 21.1 21.3 26.4 14.6 10.0 27.6 27.3 22.3 16.9 RPTOR "KIAA1303, KOG1, Mip1, raptor" ENSG00000141564 "Regulatory associated protein of MTOR complex 1" Q8N122 17 80544819-80966371 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 46.0;Excitatory neurons: 70.1;Inhibitory neurons: 66.3;Microglial cells: 32.8;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013514, HPA064306" Approved Enhanced Vesicles,Lysosomes NA NA "Cluster 35: T-regs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Lysosomes" "CAB013514: AB_2533523, HPA064306: AB_2685240" "unprognostic (5.09e-3)" "unprognostic (1.01e-1)" "unprognostic (1.79e-1)" "unprognostic (1.90e-1)" "unprognostic (1.38e-1)" "unprognostic (9.75e-2)" "unprognostic (3.34e-3)" "unprognostic (1.17e-2)" "unprognostic (9.63e-2)" "unprognostic (8.80e-2)" "unprognostic (4.40e-3)" "unprognostic (8.46e-2)" "unprognostic (6.03e-2)" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-2)" "unprognostic (1.77e-2)" 5.9 4.6 3.5 4.4 3.3 4.1 3.6 2.0 4.4 4.3 0.1 5.7 4.8 5.6 1.8 4.5 4.5 2.9 6.1 3.8 2.6 3.1 3.4 4.2 3.3 3.3 2.8 4.8 5.5 5.3 4.0 3.6 3.3 4.5 2.4 2.6 4.6 5.0 14.1 5.1 4.5 4.6 2.0 3.8 4.4 4.0 3.5 4.4 3.6 7.0 2.7 5.4 3.6 3.2 16.2 34.7 6.8 12.9 9.5 7.0 15.5 12.7 9.5 17.9 12.4 21.5 13.8 13.3 10.1 12.9 13.8 11.6 10.5 15.7 8.9 5.6 19.6 20.8 16.8 21.2 8.9 19.8 15.3 12.3 9.9 17.3 9.1 5.9 16.6 15.7 24.9 4.6 8.6 8.8 12.4 7.8 7.4 9.2 24.0 10.2 12.9 11.2 4.6 17.8 13.4 17.4 14.4 22.9 14.9 6.6 16.3 14.5 9.6 37.1 17.8 11.6 15.7 8.9 3.9 12.6 22.4 10.1 23.6 0.0 0.1 0.0 0.5 0.3 0.3 0.2 0.2 0.3 0.4 0.1 0.2 0.2 0.0 0.1 0.2 0.0 1.0 0.4 3.5 3.3 2.0 4.4 3.8 2.6 3.3 2.8 3.3 2.0 3.5 3.2 4.3 0.0 3.9 46.0 8.5 3.2 3.0 2.4 4.6 6.8 4.2 3.3 4.5 5.7 1.6 5.5 4.2 4.4 7.2 3.8 1.9 3.6 6.7 3.9 5.4 4.3 6.0 4.8 70.1 3.8 5.9 4.8 8.2 4.9 2.5 7.5 2.2 7.5 4.7 11.8 66.3 3.1 6.1 5.7 3.2 10.9 3.1 6.7 1.8 32.8 1.7 4.3 2.1 50.8 66.2 4.7 3.5 5.3 9.4 4.5 4.6 2.7 2.0 7.0 0.0 5.5 4.1 4.5 3.5 5.1 3.0 4.4 9.3 6.0 5.6 3.8 RRAGA "FIP-1, RAGA" ENSG00000155876 "Ras related GTP binding A" Q7L523 9 19049427-19051025 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Supported Approved "Golgi apparatus,Vesicles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (6.30e-2)" "unprognostic (4.65e-1)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (6.74e-2)" "unprognostic (2.17e-2)" "unprognostic (2.11e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (3.13e-1)" "unprognostic (2.65e-1)" "unprognostic (1.74e-2)" "unprognostic (4.88e-2)" "unprognostic (2.10e-3)" "unprognostic (1.05e-1)" 79.3 73.7 73.6 39.6 75.1 30.2 72.8 77.5 82.5 67.3 74.6 74.0 38.6 94.8 77.4 62.1 74.7 49.7 87.1 76.7 83.5 67.7 68.3 51.9 46.4 73.5 74.2 83.0 46.7 47.6 68.7 71.0 77.5 58.1 45.6 39.7 53.3 73.8 128.9 72.5 57.1 82.7 80.2 52.9 57.1 40.2 78.1 53.2 57.1 104.5 47.9 70.7 58.0 84.5 115.2 92.7 74.9 78.4 263.8 167.0 51.5 112.7 134.4 96.2 117.7 35.8 34.7 22.6 61.1 190.8 86.7 42.8 64.8 106.6 101.2 97.7 72.8 145.3 122.6 139.0 172.8 20.3 52.7 148.8 101.3 82.2 55.7 132.4 116.1 36.9 33.4 32.1 202.5 72.5 56.2 118.8 41.9 59.5 70.6 43.0 48.8 32.6 147.9 98.8 61.4 76.6 61.9 55.5 60.4 67.5 71.3 54.0 91.0 116.2 44.6 83.6 85.3 22.5 39.4 51.6 127.9 30.8 43.1 155.3 85.6 147.8 74.5 98.0 72.7 49.4 77.1 74.6 81.0 50.4 70.1 69.8 58.9 81.9 109.3 58.2 100.0 107.8 73.6 75.1 77.5 82.5 76.7 83.5 73.5 74.2 77.5 80.2 78.1 84.5 84.3 25.6 27.7 16.0 35.0 61.1 123.7 138.8 50.7 47.8 43.2 57.9 51.8 41.5 63.8 53.3 18.8 130.9 28.1 32.9 105.7 95.9 92.5 74.0 70.6 86.5 17.5 38.1 17.5 61.4 98.6 80.3 28.1 47.2 33.6 38.0 71.4 61.9 64.6 48.8 20.0 29.8 81.4 37.1 33.2 28.3 93.8 39.2 56.9 20.6 51.0 95.4 49.4 21.1 29.6 52.3 44.3 103.0 24.0 50.8 51.4 130.1 75.4 37.0 32.9 65.3 79.1 113.8 22.9 47.7 59.2 121.4 37.3 61.6 34.8 74.8 RRAGB ENSG00000083750 "Ras related GTP binding B" Q5VZM2 X 55717749-55758774 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 72.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (2.01e-1)" "unprognostic (2.82e-3)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.44e-2)" "prognostic favorable (3.31e-5)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (3.64e-6)" "unprognostic (8.89e-3)" "unprognostic (1.56e-2)" "unprognostic (1.31e-2)" "unprognostic (2.71e-3)" "unprognostic (2.74e-2)" "unprognostic (3.35e-2)" "unprognostic (6.21e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" 12.6 14.8 13.1 7.1 13.4 8.2 14.7 11.0 12.9 14.0 9.9 12.3 6.9 18.5 34.7 8.9 20.5 13.0 15.2 13.5 14.2 16.2 8.0 11.1 8.3 11.2 14.0 22.2 8.0 23.1 14.9 11.4 12.5 16.4 9.6 17.1 8.9 18.0 12.0 12.1 8.8 17.3 12.4 11.3 9.6 9.2 15.2 10.2 22.9 15.9 8.7 12.0 10.0 12.5 11.9 8.9 10.0 7.6 34.7 32.2 2.6 10.3 19.0 9.1 12.2 5.2 7.7 3.5 72.6 14.4 7.6 7.5 9.1 5.8 8.4 6.5 12.7 5.2 12.1 10.5 24.6 8.4 8.0 38.4 21.9 6.8 8.8 36.8 12.3 9.3 7.3 8.1 15.3 8.8 4.5 11.7 10.4 3.2 14.4 17.0 11.1 10.0 13.9 15.3 10.0 8.9 14.2 4.4 15.6 25.4 12.9 8.8 6.8 11.2 5.2 10.4 5.6 11.1 16.4 6.7 8.5 18.2 5.0 7.1 4.7 4.1 5.0 6.7 7.5 6.8 6.5 6.9 7.3 10.4 7.4 7.5 1.4 6.5 3.9 4.6 7.5 4.0 13.1 13.4 11.0 12.9 13.5 14.2 11.2 14.0 12.5 12.4 15.2 12.5 14.5 12.8 17.4 22.9 16.0 8.7 15.3 16.1 19.4 20.4 9.7 10.2 16.4 4.3 10.4 18.4 14.6 7.4 6.8 4.9 27.4 9.8 1.8 14.3 16.1 12.7 4.2 11.1 32.4 5.0 5.5 15.6 10.7 11.9 17.1 16.7 5.7 2.6 7.3 20.2 29.6 5.1 8.2 5.4 7.8 2.9 9.9 7.9 5.4 23.4 7.8 27.0 2.1 28.6 38.2 4.3 10.8 15.4 6.4 9.0 7.3 19.3 10.4 25.6 0.0 17.9 16.6 7.7 14.6 11.2 7.7 4.8 11.8 26.9 6.9 6.9 RRAGC "FLJ13311, GTR2" ENSG00000116954 "Ras related GTP binding C" Q9HB90 1 38838198-38859772 "Disease related genes, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 224.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018247, HPA055489" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Vesicles" "HPA018247: AB_1856475, HPA055489: AB_2682832" "unprognostic (2.04e-2)" "unprognostic (1.58e-1)" "unprognostic (2.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.40e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (9.97e-9)" "unprognostic (2.14e-1)" "unprognostic (3.61e-2)" "unprognostic (4.98e-2)" "unprognostic (2.23e-2)" "unprognostic (1.71e-1)" "unprognostic (5.13e-2)" "unprognostic (6.38e-2)" "unprognostic (2.69e-1)" "unprognostic (2.77e-1)" "unprognostic (3.82e-2)" 37.0 16.9 18.0 16.6 19.2 30.2 25.2 20.0 19.4 17.1 16.4 21.5 18.7 16.1 14.0 24.9 13.9 17.7 21.6 17.6 20.4 24.5 18.5 19.3 20.5 20.4 21.3 21.6 14.2 24.0 10.0 28.5 21.3 14.9 17.0 16.1 14.2 16.9 17.4 29.8 16.2 21.9 19.5 17.3 15.1 17.5 19.8 18.8 16.7 18.9 21.8 19.0 18.1 21.3 37.0 16.6 21.3 23.3 110.7 74.6 33.0 33.7 68.6 44.8 47.2 12.7 23.9 23.0 18.9 52.6 71.8 21.7 40.1 22.2 36.8 37.6 28.3 22.1 19.2 14.7 135.6 26.0 23.9 66.7 55.2 48.0 61.9 35.4 47.5 24.5 22.9 44.9 65.7 10.2 19.0 14.7 27.2 15.9 28.0 18.1 37.6 15.6 31.6 42.5 11.1 16.5 27.0 20.0 73.2 47.5 18.3 19.5 42.5 54.3 22.4 60.0 29.2 35.0 60.5 26.8 50.5 29.1 28.8 0.5 2.4 5.5 1.7 2.3 2.9 3.3 2.6 2.2 2.3 3.6 2.2 2.1 5.9 1.7 1.8 8.4 2.5 1.6 18.0 19.2 20.0 19.4 17.6 20.4 20.4 21.3 21.3 19.5 19.8 21.3 31.2 32.1 28.0 6.5 42.1 111.9 47.1 19.2 40.9 20.0 31.0 25.0 22.2 24.3 16.1 12.9 12.5 84.9 38.4 30.3 11.7 55.7 56.3 32.0 26.6 34.3 14.4 24.0 7.4 48.1 57.7 39.4 12.2 42.9 16.5 16.9 35.7 14.2 72.1 38.7 8.3 10.3 20.3 34.4 65.0 49.8 30.7 49.2 53.4 9.4 63.3 43.4 10.3 7.5 15.8 47.0 14.0 37.2 20.1 47.3 21.5 30.4 15.0 22.8 19.7 28.1 37.5 24.7 28.5 46.1 140.5 224.1 23.3 18.6 12.2 51.1 RUBCN "KIAA0226, rubicon, rundataxin" ENSG00000145016 "Rubicon autophagy regulator" Q92622 3 197668867-197749727 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Endocytosis, Immunity, Phagocytosis" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 67.5;Plasma cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050908, HPA054497" Approved Supported Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Vesicles, Cytosol" "HPA050908: , HPA054497: AB_2682507" "unprognostic (2.91e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.34e-3)" "unprognostic (1.46e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (9.91e-5)" "unprognostic (1.99e-1)" "unprognostic (6.71e-2)" "unprognostic (2.86e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (2.22e-2)" "unprognostic (2.92e-2)" "unprognostic (1.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.23e-1)" 8.3 7.5 16.2 11.6 16.3 8.5 7.2 10.5 17.0 9.2 4.4 10.4 7.3 8.8 4.0 12.0 8.5 7.2 11.4 17.0 19.0 7.7 5.6 11.8 15.3 20.0 17.8 10.7 9.1 6.8 15.8 5.8 15.9 7.4 5.7 10.9 7.3 7.2 8.9 9.1 13.1 7.8 14.5 19.2 8.1 14.6 23.7 8.8 7.1 8.1 16.1 8.9 8.4 17.4 30.9 7.4 8.2 16.2 14.4 8.3 8.6 13.8 9.2 17.0 14.2 12.7 8.4 33.6 26.7 15.8 16.1 17.0 15.0 8.0 13.6 9.3 13.9 21.6 13.4 4.9 8.4 12.0 18.0 7.0 9.6 14.8 17.6 7.9 10.7 14.4 12.3 87.7 11.5 24.4 15.7 7.5 7.1 8.8 23.2 14.9 8.6 22.6 9.6 13.9 34.3 7.9 10.2 19.8 10.8 5.5 29.2 8.1 13.7 9.9 9.9 27.8 18.9 36.5 34.2 27.0 13.6 22.4 8.7 0.8 2.6 17.5 3.7 3.9 2.4 7.7 3.1 4.7 1.6 8.5 2.2 3.2 2.9 1.8 4.8 16.6 4.4 1.7 16.2 16.3 10.5 17.0 17.0 19.0 20.0 17.8 15.9 14.5 23.7 17.4 8.5 6.4 11.2 0.0 33.9 0.0 6.0 0.0 8.0 21.0 7.3 7.0 0.0 7.2 4.3 12.9 18.8 1.8 28.9 3.8 1.9 5.8 21.7 4.8 6.2 6.7 0.0 5.7 0.0 6.4 3.7 4.8 7.1 9.8 2.5 6.1 9.3 3.5 9.2 21.9 0.0 3.7 0.0 16.3 0.0 16.4 5.0 18.7 0.0 0.0 67.5 15.0 14.4 0.0 0.0 8.5 1.5 6.4 48.3 8.9 5.8 2.7 0.7 14.3 6.6 9.7 6.8 34.1 21.3 5.6 0.0 6.4 15.9 4.9 2.8 12.3 RUNDC3B "RPIB9, RPIP9" ENSG00000105784 "RUN domain containing 3B" Q96NL0 7 87627548-87832296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 7.3;brain: 6.3;liver: 5.6" "Group enriched" "Detected in many" 4 "Excitatory neurons: 167.5;Inhibitory neurons: 170.9;Microglial cells: 108.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.2;HEK 293: 1.0;SCLC-21H: 2.7;SH-SY5Y: 1.2;U-138 MG: 1.0;U-266/70: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056968, HPA057155, HPA075760" Uncertain Uncertain Vesicles,Cytosol NA NA "Cluster 45: Intestine - Brush border" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Vesicles "HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: " "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" "unprognostic (2.12e-1)" "unprognostic (1.83e-1)" "unprognostic (2.20e-2)" "unprognostic (1.77e-3)" "unprognostic (1.19e-2)" "unprognostic (4.16e-2)" "unprognostic (2.56e-1)" "unprognostic (1.19e-1)" "unprognostic (9.42e-5)" "unprognostic (4.44e-1)" "prognostic favorable (2.62e-6)" "unprognostic (1.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.32e-1)" "unprognostic (9.55e-2)" 0.4 7.3 3.1 0.1 2.9 0.0 0.6 6.3 3.9 1.4 0.0 1.3 2.8 1.9 0.6 0.5 1.0 0.9 0.7 2.0 3.7 1.9 5.6 0.4 0.2 2.5 1.5 1.2 0.1 0.3 0.2 0.0 2.2 0.6 1.5 1.7 0.3 0.4 0.1 0.5 2.5 2.1 0.8 0.1 0.1 1.9 4.0 0.1 0.2 0.1 0.2 0.5 0.3 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.0 0.0 0.5 0.4 0.0 0.5 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 2.7 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.9 6.3 3.9 2.0 3.7 2.5 1.5 2.2 0.8 4.0 1.3 15.3 0.0 0.0 5.5 0.6 4.8 0.1 0.1 2.2 7.9 1.0 1.1 2.5 7.2 0.1 0.0 6.2 0.5 0.9 12.2 1.9 1.1 4.6 5.6 0.5 30.8 0.0 2.7 167.5 0.2 0.8 1.1 0.0 2.0 0.0 0.7 1.4 18.9 0.1 11.8 170.9 2.9 0.0 0.0 2.3 1.7 4.1 0.6 3.6 108.7 0.2 0.7 4.1 15.1 5.7 0.6 6.5 1.5 0.1 0.2 18.2 11.6 0.2 8.0 0.0 0.3 2.0 21.2 18.8 0.4 3.0 1.2 0.8 1.6 4.2 0.1 RUNX1 "AML1, AMLCR1, CBFA2, PEBP2A2" ENSG00000159216 "RUNX family transcription factor 1" Q01196 21 34787801-36004667 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 175.5;Glandular and luminal cells: 155.8;Microglial cells: 195.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 23.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.9" "Cell line enhanced" "Detected in many" "HEL: 251.3;HMC-1: 145.3;JURKAT: 226.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA004176, HPA037912" Enhanced Enhanced Nucleoplasm,Vesicles No No "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Vesicles "HPA004176: AB_1078412, HPA037912: AB_2675733" "unprognostic (4.06e-3)" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (1.52e-1)" "unprognostic (5.15e-3)" "unprognostic (2.62e-1)" "unprognostic (5.87e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-3)" "unprognostic (2.33e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.44e-15)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (6.17e-2)" "unprognostic (5.47e-2)" 14.8 3.8 2.9 20.3 2.1 45.5 27.1 2.6 4.0 15.3 5.1 6.7 5.1 3.3 3.1 9.2 4.7 16.0 6.3 2.8 3.2 4.6 7.0 22.4 11.3 6.0 4.3 6.3 4.0 1.5 5.1 8.5 6.5 13.5 6.5 0.3 39.2 3.5 18.9 11.6 6.8 9.2 4.9 10.2 16.9 3.8 9.1 28.2 4.8 1.4 9.9 20.8 12.8 7.9 50.9 3.8 0.1 0.3 12.5 16.0 32.0 28.1 28.4 15.3 11.6 2.5 37.7 24.9 1.8 24.9 25.5 45.0 3.0 33.6 21.4 38.7 3.8 251.3 10.1 11.6 22.9 29.4 145.3 30.9 19.8 46.6 45.6 21.2 8.8 226.3 17.3 14.1 32.7 10.7 119.3 46.5 2.2 27.4 14.5 119.2 84.6 15.3 20.7 19.9 1.4 0.0 28.9 7.2 10.5 6.8 14.7 67.8 37.0 25.1 32.4 37.8 42.8 46.4 20.7 23.3 31.2 63.4 37.4 23.9 3.1 7.1 3.4 1.4 3.2 4.1 3.0 3.2 0.9 3.6 4.5 3.7 3.4 1.5 4.7 3.4 4.5 2.2 2.9 2.1 2.6 4.0 2.8 3.2 6.0 4.3 6.5 4.9 9.1 7.9 6.2 54.5 35.4 1.6 27.0 41.6 52.7 61.2 54.7 2.3 175.5 94.6 3.2 28.6 60.8 20.2 0.0 2.1 39.5 18.7 1.9 39.7 19.4 89.6 21.5 9.2 6.0 47.3 3.5 28.1 21.4 49.2 84.6 155.8 17.7 29.2 4.6 5.4 68.4 0.0 3.2 12.4 28.5 77.0 122.5 27.1 4.7 84.4 28.4 195.8 42.2 0.5 39.1 1.5 1.6 101.0 15.8 4.5 27.7 43.6 8.3 1.6 78.6 0.8 0.0 111.3 51.2 29.0 28.0 53.7 20.2 2.5 41.6 2.7 17.0 75.3 SALL2 "Hsal2, KIAA0360, ZNF795" ENSG00000165821 "Spalt like transcription factor 2" Q9Y467 14 21521080-21537216 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.1" "Cell type enhanced" "Detected in many" "Astrocytes: 13.4;Bipolar cells: 13.9;Horizontal cells: 13.5;Muller glia cells: 11.2;Oligodendrocyte precursor cells: 10.6" "Cancer enhanced" "Detected in many" "glioma: 16.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 109.2;NTERA-2: 85.7;SuSa: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004162 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 12: NES - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Vesicles Nucleoplasm "HPA004162: AB_2667155" "unprognostic (5.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (4.58e-3)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "prognostic favorable (1.23e-4)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "unprognostic (5.28e-3)" "unprognostic (2.03e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" 3.9 5.4 40.2 1.4 37.7 0.2 5.5 43.2 31.0 13.1 16.6 13.3 1.7 13.5 6.3 2.9 12.7 3.2 5.4 29.4 43.7 6.2 0.9 4.5 1.7 41.3 45.2 17.2 4.3 20.6 27.0 1.2 36.9 7.0 2.1 16.9 3.1 9.2 1.5 2.6 6.7 9.5 39.2 2.8 6.0 1.6 49.1 6.5 10.5 2.8 1.7 8.7 6.3 28.7 0.1 2.4 109.2 24.2 1.9 1.6 0.0 2.1 2.7 7.1 7.2 2.3 1.2 0.1 2.2 3.2 3.1 0.2 24.5 2.7 10.0 2.0 12.5 0.0 0.7 2.2 3.2 0.0 0.1 7.3 0.9 3.4 0.0 18.4 2.2 10.9 16.6 0.0 6.2 2.1 16.0 0.1 85.7 0.1 0.5 14.3 2.3 0.0 8.3 11.6 30.4 17.3 0.0 0.6 0.3 36.2 9.2 0.2 0.0 0.9 11.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.5 0.5 0.1 40.2 37.7 43.2 31.0 29.4 43.7 41.3 45.2 36.9 39.2 49.1 28.7 0.8 3.2 3.6 13.4 0.0 0.6 0.6 1.1 8.0 13.9 3.4 2.8 0.9 2.8 1.5 5.5 8.4 0.1 0.2 0.0 1.9 1.8 0.3 0.5 3.2 1.0 0.0 0.4 2.5 0.0 0.1 3.9 0.0 0.4 0.0 7.2 2.5 0.1 0.1 13.5 9.3 0.0 4.1 0.0 0.3 0.7 5.0 0.2 0.0 0.0 0.0 11.2 0.0 10.6 2.6 0.3 0.0 6.0 0.2 0.4 0.0 0.8 0.0 2.8 0.0 3.9 3.0 0.0 0.5 1.0 0.6 0.1 0.8 3.9 0.0 0.1 SAMD11 MGC45873 ENSG00000187634 "Sterile alpha motif domain containing 11" Q96NU1 1 923923-944575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 266.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 11 "NK-cells: 1.3" "Cell line enhanced" "Detected in many" "HEK 293: 87.6;HeLa: 142.1;SCLC-21H: 71.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030110 Approved Nucleoplasm,Vesicles NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Vesicles" "HPA030110: " "unprognostic (9.96e-2)" "unprognostic (1.75e-1)" "unprognostic (4.11e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-2)" "unprognostic (2.42e-1)" "unprognostic (9.28e-2)" "unprognostic (6.90e-2)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.62e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.35e-5)" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (3.26e-2)" "unprognostic (1.18e-1)" 3.8 9.0 3.6 3.3 4.5 1.0 1.8 6.0 8.8 7.4 7.2 4.9 5.1 9.6 9.4 1.9 17.6 3.2 13.2 5.6 9.0 19.7 4.3 3.9 2.1 23.4 10.5 3.3 1.4 1.6 27.6 0.3 10.9 16.9 1.1 24.5 2.0 19.5 0.8 0.8 5.4 4.1 8.8 17.1 4.9 4.7 8.3 0.1 4.7 0.3 0.4 14.0 7.9 10.1 0.3 8.0 0.1 7.4 0.4 0.1 2.0 9.2 0.5 0.6 0.3 0.4 2.4 0.0 19.0 26.0 5.1 15.3 8.8 0.0 0.0 0.8 87.6 0.0 142.1 0.4 1.9 0.0 0.9 5.3 0.0 0.1 0.0 12.1 0.0 0.2 3.5 0.0 0.2 8.4 0.0 0.1 3.8 0.5 0.8 0.7 1.4 5.6 1.2 0.0 71.1 20.9 23.8 12.3 0.2 6.1 12.8 0.5 1.4 3.8 14.4 0.2 2.6 1.3 0.0 0.3 5.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 3.6 4.5 6.0 8.8 5.6 9.0 23.4 10.5 10.9 8.8 8.3 10.1 0.1 0.0 1.8 12.1 0.3 0.4 0.1 0.3 0.6 25.5 0.7 0.4 0.9 2.8 1.9 3.7 29.2 0.2 0.1 0.2 0.0 1.0 3.9 20.1 43.9 6.1 26.5 0.0 0.1 0.4 0.9 17.0 2.0 6.4 0.0 3.8 4.6 0.2 0.3 35.3 0.2 1.0 0.0 0.6 0.0 12.1 0.9 0.7 0.0 1.0 0.0 25.8 0.0 0.0 0.1 1.6 2.6 4.1 0.4 2.1 0.0 0.3 0.1 266.9 0.0 0.2 4.1 1.5 26.0 0.1 0.6 0.1 0.6 0.0 0.2 0.3 SAMD9 "C7orf5, FLJ20073, KIAA2004" ENSG00000205413 "Sterile alpha motif domain containing 9" Q5K651 7 93099513-93118023 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.1" "Cell type enhanced" "Detected in many" "dendritic cells: 92.7;Distal enterocytes: 104.6;NK-cells: 109.2;Paneth cells: 171.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 28.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 66.7;GAMG: 66.0" "Low region specificity" "Detected in all" "HPA021318, HPA021319" Approved Supported Vesicles,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Vesicles "HPA021318: AB_2183383, HPA021319: AB_1856554" "unprognostic (3.66e-2)" "unprognostic (5.35e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (8.96e-2)" "unprognostic (1.38e-1)" "unprognostic (7.48e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (4.76e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (8.31e-5)" "unprognostic (6.00e-2)" "prognostic unfavorable (8.40e-7)" "unprognostic (5.91e-2)" "unprognostic (1.37e-2)" "unprognostic (2.18e-2)" "unprognostic (3.64e-1)" 4.1 3.6 1.1 13.2 1.0 9.9 3.5 1.1 1.0 8.0 1.4 11.0 7.5 3.5 2.9 39.1 3.0 7.2 2.4 1.1 1.6 3.2 3.7 7.7 15.8 2.8 1.5 5.8 1.6 1.0 0.9 7.0 2.0 2.0 11.3 0.3 4.3 2.4 0.6 1.9 7.7 4.0 2.9 17.7 10.7 1.0 2.1 20.7 2.0 2.3 15.9 7.0 8.3 2.5 28.5 3.6 1.0 0.2 12.0 15.2 0.3 10.9 45.2 51.0 66.7 0.2 30.9 11.9 16.8 27.1 66.0 32.6 0.1 10.0 17.1 40.5 1.3 17.3 18.0 0.0 5.4 19.5 23.1 6.8 14.1 16.8 4.6 2.8 7.7 13.1 1.2 28.6 10.9 0.1 29.2 15.9 0.1 0.0 7.9 9.5 9.2 13.5 0.3 3.6 4.4 0.4 8.4 3.3 9.1 0.1 1.0 9.5 33.8 11.8 4.2 36.0 6.0 16.9 3.4 10.8 12.3 11.2 12.1 21.8 4.2 15.7 8.3 8.1 7.7 5.6 6.4 7.3 3.6 5.9 6.7 6.1 17.8 8.8 12.8 2.5 8.8 3.2 1.1 1.0 1.1 1.0 1.1 1.6 2.8 1.5 2.0 2.9 2.1 2.5 43.9 9.6 3.7 0.7 53.4 2.3 8.2 40.2 4.0 1.4 4.4 5.1 1.2 5.7 33.7 14.7 0.0 1.9 92.7 104.6 0.0 23.5 0.1 21.1 18.5 29.0 3.0 19.4 0.4 12.3 7.1 14.6 37.8 7.0 43.6 21.8 12.1 1.2 11.5 6.7 1.5 34.9 20.3 29.9 9.6 0.7 15.2 32.7 3.6 21.5 41.6 2.2 109.2 2.0 2.4 50.4 171.0 12.4 35.9 7.0 12.6 2.3 37.5 0.1 13.1 14.4 12.6 0.2 0.0 21.1 1.8 0.4 69.4 25.4 5.6 34.3 SAPCD1 "C6orf26, NG23" ENSG00000228727 "Suppressor APC domain containing 1" Q5SSQ6 6 31762996-31764851 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 28.3" "Cell type enriched" "Detected in single" 15 "Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.4;U-2 OS: 1.1;U-937: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071699 Approved "Vesicles,Cell Junctions" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "Cell Junctions" "HPA071699: AB_2686433" "unprognostic (9.25e-4)" "unprognostic (1.32e-1)" "unprognostic (3.41e-2)" "unprognostic (3.28e-1)" "unprognostic (9.34e-2)" "unprognostic (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (8.16e-3)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "unprognostic (8.15e-10)" "unprognostic (2.65e-2)" "unprognostic (4.45e-1)" "unprognostic (3.57e-1)" "unprognostic (7.98e-5)" 2.7 1.1 0.4 0.0 0.4 0.2 2.5 0.5 0.9 2.4 0.4 3.7 0.0 2.5 0.1 2.5 3.9 0.0 1.2 0.4 0.3 7.4 3.1 2.0 0.6 0.4 0.5 3.8 2.1 0.0 6.1 0.1 0.4 6.0 0.2 1.2 2.3 0.1 1.0 28.3 3.9 0.1 0.4 4.8 2.6 3.6 0.4 0.2 2.2 0.0 0.1 2.5 2.2 0.4 0.4 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.5 0.0 0.3 0.2 0.0 0.1 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.7 0.4 0.2 0.2 0.2 0.5 0.0 0.1 0.7 1.4 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.2 0.1 0.0 0.3 0.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.7 0.1 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.9 0.4 0.3 0.4 0.5 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCAMP2 ENSG00000140497 "Secretory carrier membrane protein 2" O15127 15 74843730-74873365 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014699, HPA019194" Approved Supported "Golgi apparatus,Vesicles" NA NA 71000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "HPA014699: AB_1856605, HPA019194: AB_1856604" "unprognostic (1.74e-1)" "unprognostic (1.27e-2)" "unprognostic (2.05e-1)" "unprognostic (5.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.53e-2)" "unprognostic (7.23e-2)" "unprognostic (9.73e-3)" "unprognostic (7.26e-2)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.40e-1)" "unprognostic (1.79e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-2)" 43.1 46.7 27.8 40.3 32.8 51.5 40.7 31.9 31.2 40.5 38.8 76.0 75.7 36.9 36.9 103.4 47.4 35.4 32.4 26.1 29.8 44.9 42.0 49.6 47.9 40.7 30.9 26.5 54.5 85.6 29.4 48.9 36.7 35.5 72.7 4.7 92.7 32.4 34.2 68.3 80.1 33.6 33.6 66.8 64.9 36.2 33.3 33.0 38.3 18.9 53.4 38.1 49.4 35.4 44.7 57.3 24.2 37.6 72.0 37.2 72.0 45.0 56.6 46.9 50.1 83.0 102.6 36.5 57.8 68.1 67.7 157.8 72.3 55.9 19.4 145.8 71.1 92.8 31.2 57.6 54.3 48.0 170.9 48.0 97.6 44.4 32.0 37.0 46.0 42.0 31.3 67.5 33.3 68.1 24.6 55.3 24.1 111.0 36.6 42.6 22.3 126.4 54.0 63.1 24.9 25.0 36.7 64.3 42.4 35.4 88.5 76.3 43.4 40.2 23.9 43.8 53.0 46.1 73.2 37.6 37.8 112.2 30.2 118.3 111.3 90.0 94.1 106.9 76.1 80.8 85.3 95.9 81.8 70.9 69.4 75.8 74.4 83.8 119.3 128.7 105.3 120.8 27.8 32.8 31.9 31.2 26.1 29.8 40.7 30.9 36.7 33.6 33.3 35.4 36.0 73.7 31.7 17.9 49.5 17.5 41.7 40.5 19.4 6.8 28.0 24.8 14.4 24.3 53.1 40.5 2.1 156.9 63.4 116.8 15.6 67.4 132.3 30.8 22.0 36.2 37.3 29.0 7.7 92.8 61.9 37.2 54.0 40.6 79.2 31.3 26.4 27.7 164.7 6.7 6.1 77.5 42.7 78.3 44.5 56.2 32.0 77.0 32.0 21.5 56.9 41.4 63.8 12.1 17.9 96.1 75.5 23.0 73.1 54.0 105.7 48.1 52.6 8.4 26.3 25.6 35.8 47.1 35.3 39.6 22.3 136.4 55.1 40.0 64.2 58.5 SCG2 "CHGC, SgII, SN" ENSG00000171951 "Secretogranin II" P13521 2 223596940-223602361 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 360.1;brain: 426.2;pituitary gland: 269.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 212.4;Enteroendocrine cells: 283.4;Inhibitory neurons: 109.9;Ionocytes: 138.4" "Group enriched" "Detected in many" 8 "glioma: 70.0;pancreatic cancer: 52.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 53.3;HSkMC: 45.9;hTERT-RPE1: 46.5;SCLC-21H: 47.6;SH-SY5Y: 20.7;WM-115: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011893, HPA075062" Enhanced Supported Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 330000 "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Golgi apparatus" Vesicles "HPA011893: AB_1856656, HPA075062: AB_2732277" "unprognostic (2.93e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-3)" "unprognostic (6.82e-4)" "unprognostic (2.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.77e-3)" "unprognostic (6.73e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "prognostic favorable (5.58e-4)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.01e-10)" "unprognostic (2.47e-3)" "unprognostic (4.02e-1)" "unprognostic (1.57e-2)" "unprognostic (1.90e-3)" 9.2 360.1 49.2 30.2 78.4 0.4 0.5 17.1 54.7 1.5 2.2 10.6 47.7 3.5 0.4 0.6 0.2 4.0 1.7 21.7 426.2 0.6 0.2 3.3 0.4 118.3 195.4 6.1 28.3 0.5 269.0 1.1 250.9 3.5 13.0 40.6 0.3 1.2 0.3 1.0 21.3 12.8 77.4 0.2 17.9 0.2 130.7 0.1 6.4 0.8 0.1 0.8 1.3 30.3 0.0 3.1 10.3 8.5 2.3 53.3 0.2 0.5 2.0 4.0 10.1 0.4 1.0 0.0 0.9 0.7 6.2 0.2 0.2 0.0 5.0 0.1 0.5 0.0 0.6 0.0 0.5 0.7 4.6 45.9 0.2 5.8 2.0 46.5 0.0 0.0 0.2 0.4 5.1 0.3 0.0 0.2 7.3 0.1 0.2 0.0 0.3 0.3 0.9 0.1 47.6 20.7 0.0 0.5 2.5 1.6 0.0 0.1 0.1 5.4 2.2 0.2 3.6 0.1 0.0 0.3 1.6 0.1 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 78.4 17.1 54.7 21.7 426.2 118.3 195.4 250.9 77.4 130.7 30.3 0.0 6.4 0.0 12.7 0.0 0.0 0.4 2.8 0.0 212.4 0.0 0.0 0.1 0.0 1.3 0.0 2.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.2 6.7 283.4 0.0 27.7 0.2 0.0 2.3 0.0 0.1 0.0 0.0 0.7 0.0 0.1 8.4 109.9 14.7 138.4 0.3 0.3 0.0 0.6 0.0 1.8 3.7 0.0 11.6 0.0 34.2 8.2 14.8 6.2 0.4 0.0 2.1 0.1 0.1 0.7 14.6 0.0 1.8 1.7 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.5 0.8 SCRN3 FLJ23142 ENSG00000144306 "Secernin 3" Q0VDG4 2 174395730-174429575 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034689, HPA034690" Approved Approved Vesicles,Cytosol NA NA 27000 "Cluster 1: Neutrophils - Mixed function" "Cluster 8: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Cytosol" "HPA034689: AB_2674282, HPA034690: AB_10670574" "unprognostic (5.39e-3)" "unprognostic (4.58e-2)" "unprognostic (2.06e-2)" "unprognostic (3.58e-1)" "unprognostic (1.91e-1)" "unprognostic (1.89e-1)" "unprognostic (9.89e-2)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (5.85e-2)" "unprognostic (8.81e-2)" "unprognostic (1.30e-1)" "unprognostic (6.62e-3)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" 16.4 16.4 11.8 9.9 14.4 5.2 13.5 14.7 16.0 9.5 7.0 12.9 18.5 11.9 11.4 16.2 10.4 11.2 26.0 10.8 13.6 20.2 22.0 12.2 11.4 14.6 13.4 13.2 14.7 27.7 14.0 13.1 13.6 15.2 13.2 22.8 11.0 12.5 40.5 13.8 14.3 14.0 12.9 11.8 12.4 10.6 14.1 12.4 20.3 35.8 12.1 10.4 8.3 18.5 15.9 9.7 25.8 22.8 18.8 21.1 13.7 24.1 19.0 18.2 22.0 9.6 11.4 3.0 15.6 24.2 14.0 15.5 19.3 21.1 23.9 34.8 17.8 29.7 21.1 7.5 27.8 22.8 15.0 23.5 25.4 34.4 24.5 20.4 21.8 16.7 20.2 11.1 25.0 18.0 18.9 22.2 12.0 35.4 41.0 9.3 25.7 17.5 21.2 16.5 16.0 44.5 16.6 16.2 30.7 26.4 21.8 21.7 15.7 20.9 10.9 25.6 21.0 29.4 32.8 0.5 22.9 11.2 21.8 7.2 5.2 2.2 4.8 3.3 3.4 8.6 5.1 4.6 5.1 11.0 7.8 6.3 20.0 6.9 4.3 8.0 5.6 2.6 11.8 14.4 14.7 16.0 10.8 13.6 14.6 13.4 13.6 12.9 14.1 18.5 7.8 9.6 15.6 18.6 7.0 3.6 12.1 23.7 12.5 12.8 7.9 6.3 22.8 4.3 12.5 9.2 10.4 10.7 3.8 8.4 13.7 9.1 5.1 9.4 8.3 6.0 6.0 11.6 21.0 9.8 6.3 6.9 11.2 5.4 8.8 9.5 8.6 8.7 9.3 18.5 26.3 7.3 20.3 5.8 2.2 4.0 4.7 6.2 3.6 6.5 6.1 22.6 7.2 27.6 25.7 12.2 4.0 6.8 10.3 5.4 9.9 12.5 13.6 15.0 0.0 8.2 7.1 18.9 7.1 20.4 4.8 6.8 5.8 13.0 6.4 9.7 SEC13 "D3S1231E, npp-20, SEC13L1, SEC13R" ENSG00000157020 "SEC13 homolog, nuclear pore and COPII coat complex component" P55735 3 10293131-10321112 "Metabolic proteins, Predicted intracellular proteins, Transporters" "ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035292, HPA057943" Approved Supported Nucleoplasm,Vesicles NA NA 35000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 28: BEWO - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Vesicles" "HPA035292: AB_10959451, HPA057943: AB_2683560" "unprognostic (3.33e-3)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (4.95e-2)" "unprognostic (4.22e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (2.43e-1)" "unprognostic (2.67e-1)" "unprognostic (1.69e-1)" "unprognostic (4.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (4.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" 62.1 71.5 51.0 61.8 55.6 58.4 58.9 55.9 57.6 83.7 59.2 68.8 114.7 66.4 59.4 72.6 57.4 47.5 71.1 52.2 57.2 67.4 92.1 64.3 54.6 54.6 54.6 52.6 85.2 64.6 109.2 68.5 55.2 53.8 65.7 21.2 96.2 64.9 111.5 62.7 96.6 76.6 54.3 59.4 67.3 39.4 54.2 70.3 57.6 87.3 65.4 69.9 59.2 58.2 122.6 182.1 142.9 55.2 228.0 251.6 474.4 243.8 296.1 279.3 319.8 150.3 97.6 110.7 109.6 390.1 156.8 49.0 186.4 218.3 142.4 97.8 194.5 136.2 137.3 363.7 311.8 156.7 115.5 224.7 173.1 292.6 181.5 205.6 337.0 146.2 148.4 159.8 219.5 250.2 153.8 169.9 160.9 158.0 218.7 148.1 102.4 198.2 172.4 90.2 80.3 99.4 107.3 98.7 101.3 119.3 127.5 150.8 253.6 114.2 130.2 172.6 213.3 131.7 198.4 258.6 215.5 217.5 193.0 127.3 163.2 106.6 84.4 144.9 94.6 96.5 83.6 82.1 222.5 82.6 68.0 71.2 105.8 93.9 116.4 198.3 106.1 176.5 51.0 55.6 55.9 57.6 52.2 57.2 54.6 54.6 55.2 54.3 54.2 58.2 23.9 48.1 61.9 14.0 45.8 39.4 50.4 73.6 31.3 16.2 29.5 26.4 40.2 30.0 68.3 27.6 10.4 119.9 36.5 60.1 66.5 79.3 25.6 31.8 44.0 51.0 41.4 33.0 17.3 109.2 166.6 74.1 73.9 47.1 43.1 35.5 33.9 57.3 104.9 11.8 13.7 108.2 50.8 33.0 46.7 10.2 53.4 45.0 26.6 12.2 64.2 37.4 35.0 11.6 12.6 81.8 56.1 52.6 203.2 52.4 187.5 112.0 64.5 21.1 13.1 37.7 63.6 54.9 38.9 43.7 40.2 168.6 36.5 35.8 74.2 62.3 SEC23A ENSG00000100934 "Sec23 homolog A, COPII coat complex component" Q15436 14 39031919-39109646 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 347.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043806, HPA069974" Uncertain Approved Nucleoplasm,Vesicles NA NA 83000 "Cluster 46: Basophils - DNA binding" "Cluster 8: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Vesicles" "HPA043806: , HPA069974: AB_2686223" "unprognostic (2.40e-1)" "prognostic unfavorable (5.75e-4)" "prognostic favorable (3.56e-4)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (1.15e-2)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.69e-4)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.16e-1)" "unprognostic (2.73e-1)" "unprognostic (1.41e-3)" 45.9 32.0 11.4 31.8 14.2 13.1 20.9 18.3 16.8 36.2 31.4 40.0 57.7 42.7 19.9 34.1 21.5 32.1 46.9 13.3 18.9 23.1 80.8 20.2 21.0 13.8 14.0 33.9 12.0 8.1 10.5 27.1 15.3 34.0 34.2 38.5 10.5 52.6 54.2 12.8 52.6 90.5 7.6 20.5 16.8 23.5 12.7 18.9 17.9 58.5 22.0 40.7 17.9 15.4 52.1 90.8 76.9 74.7 161.3 173.0 25.9 195.1 176.4 135.2 166.8 93.2 44.2 12.6 46.9 279.6 54.9 41.2 99.6 86.3 208.6 39.6 36.9 21.8 67.7 347.3 122.4 35.9 31.3 134.0 48.8 91.6 73.7 114.6 130.8 26.9 15.6 30.1 125.8 47.5 32.9 16.9 18.4 81.7 91.3 44.0 111.8 19.1 84.7 75.6 8.5 20.5 132.8 43.0 51.8 68.6 51.5 12.4 138.4 75.0 57.8 110.8 52.0 27.0 36.6 56.0 50.3 31.4 70.2 70.5 34.3 38.6 26.6 29.3 38.4 23.6 33.1 34.9 31.1 21.1 34.9 28.0 29.5 42.1 27.3 26.7 38.1 31.4 11.4 14.2 18.3 16.8 13.3 18.9 13.8 14.0 15.3 7.6 12.7 15.4 35.4 16.0 26.9 34.9 30.5 25.9 33.5 15.5 15.4 39.7 11.8 10.3 54.6 15.7 18.8 31.3 68.8 16.0 36.0 87.0 7.9 9.8 13.4 11.3 42.8 41.1 24.5 6.1 48.3 5.6 43.7 55.0 26.5 18.8 27.9 56.9 118.9 133.6 25.6 30.3 51.1 31.6 12.2 36.4 32.3 18.6 74.9 24.3 24.9 48.7 25.6 19.4 32.0 34.2 44.3 17.8 34.1 71.5 38.5 37.5 88.6 32.8 10.1 58.7 39.5 27.6 51.4 18.0 15.5 15.7 24.0 24.8 32.3 31.0 30.2 56.5 SEC24A ENSG00000113615 "SEC24 homolog A, COPII coat complex component" O95486 5 134648785-134727909 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 89.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038901, HPA056825" Approved Approved "Nucleoli fibrillar center,Vesicles" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 44: Endometrium - Transcription" "Nucleoli fibrillar center, Vesicles" "HPA038901: AB_10674843, HPA056825: AB_2683249" "unprognostic (9.10e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (2.76e-2)" "unprognostic (4.98e-2)" "unprognostic (2.08e-1)" "unprognostic (4.53e-2)" "unprognostic (1.17e-1)" "unprognostic (6.66e-2)" "unprognostic (2.41e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-2)" "unprognostic (3.54e-1)" "unprognostic (1.18e-3)" "unprognostic (4.77e-2)" "unprognostic (3.00e-2)" "unprognostic (9.37e-3)" "unprognostic (8.97e-2)" 9.7 13.3 2.2 13.3 2.2 17.6 10.0 3.6 3.9 11.7 13.6 11.7 21.3 8.7 8.1 10.5 5.4 10.5 6.3 2.6 3.4 9.0 34.6 7.6 10.7 2.4 3.7 6.5 15.6 11.8 7.9 15.5 2.2 10.0 13.0 6.9 16.9 8.1 11.9 5.8 22.0 10.7 1.8 9.6 14.6 6.0 2.7 9.0 11.5 7.3 14.2 13.4 7.2 2.7 21.6 12.1 22.3 17.1 32.4 32.6 24.1 32.6 40.2 25.7 44.1 45.0 12.9 16.1 21.6 38.1 27.3 12.0 28.2 25.3 44.4 19.8 13.3 13.7 18.6 33.5 23.0 16.3 26.4 20.5 14.1 24.8 18.1 22.4 23.7 11.2 18.9 24.3 25.9 11.7 15.6 11.9 14.6 19.7 7.6 15.7 19.8 18.9 16.8 16.9 9.4 9.7 21.2 10.1 26.8 38.6 17.8 13.4 26.0 21.2 8.0 27.0 19.8 42.7 40.6 26.5 24.9 17.0 41.2 3.3 2.1 1.5 1.6 2.3 2.7 2.1 1.7 1.6 2.5 1.3 1.6 1.9 1.2 2.0 2.5 1.6 1.7 1.2 2.2 2.2 3.6 3.9 2.6 3.4 2.4 3.7 2.2 1.8 2.7 2.7 14.4 6.4 8.4 15.3 15.2 31.9 14.0 10.7 8.0 7.8 20.6 9.1 6.3 11.5 18.6 3.7 12.5 10.3 14.6 22.1 5.9 6.3 12.0 25.6 33.4 12.2 9.5 6.7 29.6 13.6 17.2 18.1 32.6 70.1 12.7 8.3 15.7 54.8 11.5 13.5 25.7 19.9 8.2 16.2 32.0 5.7 8.4 20.7 14.2 15.0 9.8 6.6 6.2 35.2 23.2 15.0 11.5 13.5 89.1 22.0 42.6 12.3 13.8 7.7 6.6 19.6 12.8 15.2 8.2 17.0 32.4 22.7 13.1 8.0 15.2 36.0 SEC24B ENSG00000138802 "SEC24 homolog B, COPII coat complex component" O95487 4 109433772-109540896 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 88.1;Oligodendrocytes: 91.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038181 Approved Approved Nucleoplasm,Vesicles NA NA 14000 "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA038181: AB_10672472" "unprognostic (1.19e-1)" "unprognostic (4.31e-3)" "unprognostic (8.58e-3)" "unprognostic (9.95e-2)" "unprognostic (1.22e-1)" "unprognostic (1.46e-1)" "unprognostic (6.67e-2)" "unprognostic (3.18e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (2.51e-3)" "unprognostic (7.47e-2)" "prognostic favorable (2.33e-6)" "unprognostic (2.67e-1)" "unprognostic (2.40e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" 19.3 13.7 7.2 13.2 7.5 28.0 17.4 14.7 9.9 16.3 15.0 15.7 14.1 16.9 12.9 17.2 15.0 13.8 15.6 6.8 7.6 16.7 46.2 14.8 13.9 7.5 6.9 21.4 18.6 21.9 11.2 20.6 7.8 15.6 16.1 32.6 14.3 16.1 28.1 19.8 12.7 17.9 7.3 14.7 13.3 11.3 7.4 27.2 18.5 22.9 16.7 17.5 16.0 9.6 21.1 18.9 29.3 22.1 34.9 34.7 16.8 27.0 32.8 22.5 19.8 17.4 23.8 19.4 13.8 41.1 19.3 17.4 33.2 26.9 33.0 24.0 16.6 20.3 16.6 19.2 23.4 27.0 22.9 34.4 33.7 25.8 30.8 31.8 33.7 19.7 31.5 17.3 33.6 17.1 39.2 12.5 11.2 26.1 15.0 25.1 25.9 11.3 27.1 25.8 20.6 16.5 20.8 43.8 16.0 30.0 12.9 10.3 31.3 26.2 17.6 23.1 19.5 16.6 22.3 18.1 23.3 10.7 21.5 6.1 9.5 11.5 8.6 10.4 9.5 10.3 9.5 9.0 11.8 8.9 10.8 9.3 9.2 11.5 10.5 4.6 9.1 9.0 7.2 7.5 14.7 9.9 6.8 7.6 7.5 6.9 7.8 7.3 7.4 9.6 25.1 25.6 15.4 63.0 23.0 35.4 20.1 11.8 28.5 27.0 12.9 10.8 30.5 14.3 17.4 5.5 6.2 13.3 13.2 22.7 5.9 10.4 4.4 18.7 14.6 22.5 15.6 11.6 71.1 13.1 9.2 16.4 19.9 21.9 11.4 15.9 16.8 29.9 12.3 16.8 84.1 15.6 4.1 17.6 16.8 7.9 20.5 18.7 17.8 88.1 14.5 20.3 13.4 76.9 91.6 12.6 18.7 21.8 21.3 22.5 16.5 9.6 19.6 22.0 13.1 16.3 16.8 14.7 13.6 22.2 36.7 16.1 17.0 9.9 14.4 30.3 SEC31A "ABP125, ABP130, KIAA0905, SEC31L1" ENSG00000138674 "SEC31 homolog A, COPII coat complex component" O94979 4 82818509-82901166 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005457 Approved Supported Vesicles,Cytosol NA NA 40000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cytosol" "HPA005457: AB_1079896" "unprognostic (3.50e-2)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (6.14e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "unprognostic (4.21e-3)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (5.53e-3)" "unprognostic (2.92e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.69e-4)" 98.7 103.3 52.2 78.4 54.3 119.4 111.4 62.4 70.1 145.5 94.9 107.1 124.2 119.7 162.1 92.6 90.9 122.1 110.7 54.0 61.4 133.6 174.8 96.2 88.2 58.4 58.7 152.8 192.6 116.4 108.4 143.2 58.7 113.4 127.2 87.9 134.0 111.3 96.8 107.8 111.0 131.5 50.9 76.5 110.1 77.8 54.4 93.8 168.0 85.6 102.1 113.1 94.1 63.9 146.2 65.2 183.6 130.4 318.9 394.5 133.3 264.8 295.4 146.0 179.2 113.2 182.3 188.3 113.7 532.2 84.6 68.1 183.3 176.2 200.4 193.4 72.7 115.3 110.5 302.1 316.4 124.4 140.7 380.5 217.7 223.5 254.3 251.2 240.5 83.8 178.4 181.1 264.2 128.6 164.9 99.6 126.1 154.0 58.3 121.2 100.1 140.3 237.2 83.0 118.6 131.2 105.7 180.7 174.9 184.8 142.1 137.8 248.2 190.7 98.9 169.0 168.8 135.1 62.4 256.7 190.6 147.8 224.2 84.3 66.9 51.2 65.1 74.0 80.5 60.0 57.6 64.3 73.3 50.0 56.9 54.6 19.2 89.9 83.1 61.1 52.7 71.8 52.2 54.3 62.4 70.1 54.0 61.4 58.4 58.7 58.7 50.9 54.4 63.9 62.6 105.8 85.3 50.9 58.1 60.5 60.5 64.1 56.9 52.3 54.5 43.7 85.5 51.5 109.8 47.8 54.2 57.3 61.0 62.8 27.4 65.8 30.6 90.1 164.6 65.0 38.3 41.2 61.0 71.2 85.3 125.2 100.9 119.7 75.2 241.0 65.0 94.0 45.9 42.1 60.0 99.4 50.8 51.2 55.3 19.3 139.1 63.8 51.6 67.5 60.4 36.5 38.1 74.9 72.6 67.5 46.3 126.0 152.2 76.3 121.0 65.9 100.5 66.9 52.6 86.5 98.9 30.3 34.6 62.2 74.2 81.5 55.4 78.9 54.9 101.1 SEMA3A "coll-1, Hsema-I, SEMA1, SEMAD, SemD" ENSG00000075213 "Semaphorin 3A" Q14563 7 83955777-84492724 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 22.6" "Cell type enhanced" "Detected in many" "Astrocytes: 58.4;Cone photoreceptor cells: 45.9;Excitatory neurons: 89.7;Rod photoreceptor cells: 66.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "non-classical monocyte: 1.5" "Lineage enriched" "Detected in single" 16 "monocytes: 1.5" "Cell line enhanced" "Detected in many" "AF22: 129.3;BJ: 102.9;fHDF/TERT166: 112.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029447, HPA052235" Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA 1600000 "Cluster 7: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA029447: AB_10602302, HPA052235: AB_2681770" "unprognostic (1.20e-1)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.51e-1)" "unprognostic (5.82e-2)" "unprognostic (1.37e-2)" "unprognostic (5.98e-3)" "unprognostic (2.92e-3)" "unprognostic (6.05e-3)" "unprognostic (1.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.44e-2)" "unprognostic (6.18e-12)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.61e-2)" "unprognostic (1.47e-4)" 6.8 0.2 3.8 3.8 5.8 0.1 1.5 0.6 3.0 4.4 0.0 9.8 1.4 1.0 2.2 5.8 1.6 5.6 2.5 2.0 0.7 0.4 0.4 2.3 3.3 3.8 0.2 0.4 0.4 0.5 2.1 10.4 4.6 2.9 5.7 22.6 0.4 0.4 0.1 1.1 2.4 4.7 0.6 3.8 2.0 1.2 0.3 0.5 1.7 0.5 1.6 5.4 0.6 4.4 11.8 32.8 129.3 0.1 3.8 3.1 8.4 102.9 60.0 8.5 5.3 11.4 30.7 0.0 4.8 112.0 1.1 57.0 0.3 24.6 11.8 0.0 4.2 0.0 6.0 0.0 3.3 2.6 0.0 3.9 0.0 18.1 4.4 26.2 32.1 0.1 0.1 0.2 3.4 0.6 0.0 0.0 48.6 0.5 11.6 2.3 55.3 3.4 18.5 0.8 9.8 5.2 0.8 0.2 1.1 20.7 0.6 1.1 18.3 11.2 11.6 32.6 15.1 7.6 5.5 0.0 11.5 4.5 22.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.8 5.8 0.6 3.0 2.0 0.7 3.8 0.2 4.6 0.6 0.3 4.4 1.0 3.2 1.7 58.4 0.0 0.9 0.0 15.4 0.0 15.1 0.2 0.3 6.0 0.0 22.4 0.0 45.9 0.4 0.3 0.1 0.0 0.1 0.2 2.0 0.7 7.3 0.0 0.0 89.7 2.0 0.2 9.3 0.0 9.0 1.3 3.5 1.8 0.1 1.0 3.3 10.0 0.0 2.0 0.3 2.7 0.2 2.5 0.5 1.8 7.5 0.0 19.6 0.0 9.5 5.8 5.5 0.0 0.0 0.0 0.3 0.0 0.0 15.6 66.3 0.0 1.5 2.1 1.7 1.9 0.4 1.3 0.3 1.1 18.6 0.0 0.2 SEMA3E "coll-5, KIAA0331, M-SemaK, SEMAH" ENSG00000170381 "Semaphorin 3E" O15041 7 83363238-83649139 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 176.3;Alveolar cells type 2: 110.2;Bipolar cells: 75.7;Excitatory neurons: 84.9;Oligodendrocyte precursor cells: 250.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.9;SK-BR-3: 19.9;U-2 OS: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029419, HPA063804" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA029419: AB_10602090, HPA063804: AB_2685127" "unprognostic (4.42e-2)" "unprognostic (1.48e-2)" "unprognostic (7.82e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (4.27e-2)" "unprognostic (9.36e-2)" "unprognostic (4.09e-2)" "unprognostic (3.25e-1)" "unprognostic (1.42e-1)" "unprognostic (9.09e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-6)" "unprognostic (1.32e-2)" "unprognostic (1.14e-1)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" 1.2 0.1 3.1 0.2 2.8 0.0 2.8 0.6 2.3 1.8 0.1 2.1 0.6 1.9 0.3 1.2 0.6 2.3 0.1 5.0 5.3 0.1 0.1 2.2 0.0 1.6 4.3 0.1 0.4 0.0 0.2 0.2 1.3 4.3 1.7 3.9 2.2 3.3 0.2 0.5 1.2 1.1 3.2 0.0 1.3 0.0 4.3 1.7 0.6 1.0 0.1 3.2 0.7 3.7 0.2 1.1 0.2 0.0 0.5 3.1 0.0 0.0 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.5 0.0 3.4 0.0 1.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 0.0 0.0 0.5 0.4 1.1 0.0 2.0 0.0 0.0 0.8 0.1 0.0 0.0 19.9 0.0 3.2 1.6 0.0 0.0 0.7 6.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.8 0.6 2.3 5.0 5.3 1.6 4.3 1.3 3.2 4.3 3.7 10.5 176.3 110.2 2.9 0.2 1.1 1.3 1.6 0.0 75.7 19.0 7.5 1.7 18.6 43.2 1.8 0.0 0.8 0.2 0.1 0.0 3.9 1.1 3.8 1.2 10.7 0.0 0.0 84.9 1.1 0.4 21.3 3.1 9.3 24.0 0.2 0.0 0.3 0.1 0.0 12.3 0.0 4.1 1.0 2.1 0.0 0.9 3.6 1.8 1.0 1.0 29.6 0.0 250.3 6.0 6.2 0.0 0.0 0.3 2.6 0.1 0.5 35.7 3.6 0.0 0.8 1.0 0.3 0.6 0.3 0.4 0.3 2.8 0.0 0.0 2.5 SEMA4G "FLJ20590, KIAA1619" ENSG00000095539 "Semaphorin 4G" Q9NTN9 10 100969518-100985871 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 84.6;liver: 102.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 66.4;Gastric mucus-secreting cells: 27.0;Hepatocytes: 60.5;Intestinal goblet cells: 34.6;Paneth cells: 38.5;Proximal enterocytes: 47.6;Undifferentiated cells: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 31.7;CACO-2: 30.5;Hep G2: 113.8;OE19: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038362, HPA077752" Uncertain Uncertain "Vesicles,Lipid droplets" "Intracellular and membrane" NA NA 1300000 "Cluster 37: B-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Vesicles, Lipid droplets" "HPA038362: AB_10669524, HPA077752: " "unprognostic (3.90e-3)" "unprognostic (9.43e-3)" "unprognostic (2.84e-1)" "unprognostic (1.13e-2)" "unprognostic (5.55e-2)" "unprognostic (8.11e-2)" "unprognostic (3.28e-1)" "unprognostic (3.71e-2)" "unprognostic (3.63e-1)" "unprognostic (1.41e-2)" "unprognostic (3.09e-2)" "unprognostic (3.14e-1)" "unprognostic (3.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.05e-2)" 2.4 12.7 13.1 5.9 10.9 0.4 3.6 18.9 12.3 6.9 12.8 53.6 53.4 3.5 32.1 3.6 5.9 9.0 3.0 10.0 11.6 19.1 102.4 5.8 2.5 11.2 14.4 18.9 31.3 7.3 9.9 3.9 11.5 20.2 84.6 7.3 8.5 3.0 2.6 18.3 41.2 4.6 9.6 3.1 20.9 3.7 17.0 0.8 15.3 0.8 0.9 4.0 5.0 9.9 0.2 31.7 8.0 3.4 5.0 1.6 6.8 1.2 3.4 1.7 1.7 30.5 5.2 0.5 4.2 1.5 0.6 2.1 8.0 1.4 1.4 0.7 4.9 1.7 3.0 113.8 12.5 1.2 1.0 8.3 1.8 1.6 0.9 22.2 4.4 3.5 3.3 0.4 2.5 2.0 0.5 1.2 1.3 69.1 1.8 3.1 0.7 1.5 7.4 1.0 2.5 12.5 1.1 2.1 3.2 8.7 8.7 1.5 3.0 1.0 3.7 0.8 0.3 1.1 0.6 0.5 0.9 1.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 10.9 18.9 12.3 10.0 11.6 11.2 14.4 11.5 9.6 17.0 9.9 0.3 3.2 1.1 3.9 1.2 0.0 0.6 0.7 0.6 3.5 2.5 2.0 1.2 20.0 0.2 0.0 0.0 8.8 0.0 66.4 0.0 2.7 0.2 1.6 0.7 0.6 8.5 0.8 3.0 2.6 1.9 2.0 27.0 0.3 0.0 3.4 2.2 60.5 0.9 11.8 14.1 34.6 2.0 3.3 0.0 0.2 2.1 0.2 1.8 0.0 0.0 0.9 0.0 3.5 5.5 2.4 38.5 1.2 0.2 3.0 47.6 6.4 2.4 1.6 0.0 0.1 0.4 1.1 1.9 0.5 0.1 2.9 0.2 12.7 45.9 0.9 SENP8 "DEN1, HsT17512, NEDP1, PRSC2" ENSG00000166192 "SUMO peptidase family member, NEDD8 specific" Q96LD8 15 72114258-72143692 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.6" "Group enriched" "Detected in many" 11 "Early spermatids: 86.5;Late spermatids: 222.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036273 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA036273: AB_10669985" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-4)" "unprognostic (5.43e-2)" "unprognostic (1.49e-1)" "unprognostic (6.09e-3)" "unprognostic (3.06e-2)" "unprognostic (4.35e-2)" "unprognostic (1.06e-1)" "unprognostic (2.04e-1)" "unprognostic (3.11e-2)" "unprognostic (1.19e-1)" "unprognostic (8.46e-12)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" "unprognostic (1.54e-2)" 1.1 1.7 2.7 1.1 2.4 2.8 2.0 1.1 3.1 1.7 0.0 1.9 1.8 1.7 3.3 2.3 2.5 1.9 4.0 2.2 2.1 4.4 2.5 1.5 1.5 1.4 1.7 2.4 1.5 2.4 2.1 1.7 1.9 2.1 1.9 4.6 1.6 1.7 6.3 1.6 1.5 1.6 0.4 1.5 2.0 15.6 1.7 1.5 5.0 5.7 1.2 1.7 1.0 2.6 1.5 2.7 4.7 3.8 5.6 6.9 2.7 4.1 2.5 2.2 2.0 2.1 3.4 1.5 5.7 2.4 4.0 3.4 7.4 5.9 3.3 1.6 4.0 2.5 3.7 1.9 3.9 2.8 1.3 3.3 5.8 1.4 6.2 2.9 2.1 4.4 3.7 2.7 5.4 3.8 2.9 3.7 4.0 3.4 2.5 1.9 4.2 3.3 6.0 2.6 5.8 2.0 4.4 3.3 4.2 5.6 5.1 2.1 2.2 4.5 1.7 7.8 2.0 2.2 2.9 1.8 2.1 4.0 3.3 1.1 0.9 0.7 0.8 2.2 1.1 1.9 1.3 1.2 2.9 0.6 1.5 1.8 0.3 3.5 3.2 0.8 1.1 1.0 2.7 2.4 1.1 3.1 2.2 2.1 1.4 1.7 1.9 0.4 1.7 2.6 1.2 6.4 5.3 3.9 0.4 0.3 1.4 2.5 1.2 4.5 2.4 2.4 5.4 1.5 4.5 1.8 4.2 6.7 0.3 1.5 13.7 3.3 86.5 2.5 2.7 1.8 1.2 3.2 4.6 1.7 3.4 2.6 4.1 2.6 0.0 3.4 1.8 1.5 2.1 1.7 6.1 1.5 2.0 2.6 0.6 222.9 1.8 1.7 0.0 2.8 3.8 10.6 0.0 6.0 4.0 1.4 3.2 1.2 0.2 1.7 2.3 8.1 6.0 4.0 0.0 2.3 1.3 10.7 12.6 1.4 0.4 7.8 1.0 3.0 2.2 1.0 SETDB1 "ESET, KG1T, KIAA0067, KMT1E, TDRD21" ENSG00000143379 "SET domain bifurcated histone lysine methyltransferase 1" Q15047 1 150926263-150964744 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 341.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018142, HPA058484" Uncertain Supported Nucleoplasm,Vesicles Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm Vesicles "HPA018142: AB_1856757, HPA058484: AB_2683731" "unprognostic (1.07e-1)" "unprognostic (4.08e-1)" "unprognostic (8.02e-2)" "unprognostic (2.24e-3)" "unprognostic (1.65e-2)" "unprognostic (9.57e-2)" "prognostic unfavorable (8.88e-4)" "unprognostic (6.03e-2)" "unprognostic (9.94e-3)" "unprognostic (7.13e-2)" "unprognostic (1.21e-1)" "unprognostic (6.65e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (1.59e-1)" "unprognostic (3.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" 13.5 11.3 7.1 15.2 8.2 18.1 16.7 12.8 8.9 14.4 8.7 13.4 12.5 18.1 13.1 11.8 15.3 11.5 8.2 6.7 7.9 11.7 11.5 13.4 19.6 8.2 7.6 19.4 13.3 15.7 8.6 17.7 7.6 11.4 15.5 14.2 12.3 12.2 16.4 14.4 13.7 16.5 6.0 19.9 13.4 25.1 8.4 21.6 15.5 11.7 20.3 13.1 12.7 10.3 22.9 26.3 37.1 24.6 17.5 23.2 61.7 18.6 21.2 26.2 22.2 17.9 31.1 44.9 24.9 20.7 10.4 28.1 35.0 20.0 20.7 21.8 43.3 25.5 27.3 20.8 24.7 45.3 23.2 30.5 22.0 21.8 34.8 26.6 31.2 28.3 43.4 35.6 18.9 44.1 31.6 26.4 51.1 32.1 20.6 36.3 24.3 33.4 20.1 25.9 27.1 49.1 28.4 32.9 22.5 44.5 35.7 60.4 21.2 15.3 15.7 17.0 26.3 36.6 42.3 341.6 15.7 15.7 15.1 6.9 8.3 5.7 5.8 11.6 6.1 6.1 5.3 6.6 9.7 8.3 5.7 5.9 4.8 6.3 8.5 6.5 3.5 4.3 7.1 8.2 12.8 8.9 6.7 7.9 8.2 7.6 7.6 6.0 8.4 10.3 8.5 6.4 14.0 15.3 15.3 5.5 9.3 6.6 10.2 11.0 9.8 10.7 5.5 10.0 7.8 7.3 18.8 13.9 8.8 6.6 3.9 7.6 26.1 10.8 13.3 8.3 3.6 9.2 19.6 5.7 8.5 9.1 10.2 10.7 7.6 17.9 11.4 8.1 9.9 6.7 19.4 9.7 12.2 17.2 5.1 31.0 10.2 13.9 1.8 23.4 14.4 6.2 14.4 15.6 23.5 8.1 9.5 9.8 8.9 8.2 7.6 6.4 11.0 10.4 6.6 10.2 10.3 24.4 15.9 10.9 5.1 10.0 10.2 14.6 10.7 7.8 SGK3 "SGK2, SGKL" ENSG00000104205 "Serum/glucocorticoid regulated kinase family member 3" Q96BR1 8 66712734-66862022 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.0" "Cell type enhanced" "Detected in many" "Breast glandular cells: 56.0;monocytes: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 28.4" "HPA006699, HPA027146" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" Vesicles Nucleoplasm "HPA006699: , HPA027146: AB_1856745" "prognostic favorable (5.52e-6)" "prognostic favorable (8.28e-4)" "unprognostic (8.52e-3)" "unprognostic (1.10e-2)" "unprognostic (3.75e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-1)" "unprognostic (1.69e-3)" "unprognostic (9.51e-2)" "unprognostic (8.86e-3)" "prognostic favorable (9.65e-4)" "unprognostic (1.94e-2)" "unprognostic (8.95e-2)" "unprognostic (4.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (5.29e-3)" 5.2 5.3 13.4 9.8 25.7 8.5 24.1 21.3 16.9 10.5 36.0 10.3 8.9 8.0 8.6 7.6 6.9 7.5 5.4 14.6 17.3 14.7 13.6 10.0 7.8 29.4 21.6 9.1 15.6 28.3 6.2 5.7 28.3 7.4 10.3 2.4 7.0 7.1 2.9 13.3 11.3 5.3 19.3 8.9 7.5 9.4 20.9 5.8 17.5 3.5 6.9 5.0 5.7 49.0 14.2 3.7 0.6 2.4 3.9 6.5 7.7 8.1 7.4 4.2 5.1 6.1 8.6 10.2 2.2 7.7 13.6 4.9 7.3 5.5 5.4 5.3 11.7 9.7 2.6 6.7 4.1 8.9 10.5 2.9 3.7 1.7 7.9 4.3 7.4 7.4 1.5 4.6 10.0 2.4 6.2 5.8 1.9 8.5 5.0 11.7 5.3 7.6 6.4 3.3 2.9 2.2 3.4 6.5 14.4 6.0 28.4 16.9 9.0 4.4 3.9 3.9 3.4 6.1 12.8 12.7 4.5 14.2 4.9 21.1 15.0 5.1 8.7 9.9 13.8 4.7 8.8 8.0 13.8 6.4 8.7 7.1 2.0 7.2 5.1 8.9 5.7 9.0 13.4 25.7 21.3 16.9 14.6 17.3 29.4 21.6 28.3 19.3 20.9 49.0 20.7 6.4 28.1 0.0 12.5 13.3 8.1 3.3 8.6 1.7 56.0 30.5 7.6 7.2 8.5 11.0 18.8 9.2 24.9 13.3 15.6 7.0 0.9 16.7 6.6 15.3 16.2 10.3 0.0 18.2 1.4 8.9 6.6 12.3 15.2 11.0 17.5 20.7 22.9 0.0 0.0 9.3 8.2 41.9 14.3 2.2 4.1 42.6 8.8 0.0 53.4 3.8 19.6 0.0 0.0 14.8 8.4 7.9 18.3 9.3 14.0 36.8 15.4 1.7 0.0 5.9 4.2 5.9 13.7 9.9 15.8 4.8 19.4 5.2 10.4 5.3 SH3RF1 "KIAA1494, POSH, RNF142, SH3MD2" ENSG00000154447 "SH3 domain containing ring finger 1" Q7Z6J0 4 169094259-169270956 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 146.3;Oligodendrocytes: 213.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 4.2;myeloid DC: 2.5;non-classical monocyte: 6.7" "Group enriched" "Detected in many" 15 "dendritic cells: 2.5;monocytes: 6.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074783 Approved Supported "Vesicles,Intermediate filaments" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" Vesicles "Intermediate filaments" "HPA074783: AB_2732268" "unprognostic (4.14e-1)" "unprognostic (4.67e-2)" "unprognostic (1.23e-1)" "unprognostic (7.83e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (1.29e-1)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (9.58e-2)" "unprognostic (4.77e-3)" "unprognostic (7.88e-2)" "prognostic favorable (5.51e-8)" "unprognostic (4.43e-2)" "unprognostic (1.63e-1)" "unprognostic (5.99e-2)" "unprognostic (1.77e-1)" 9.8 3.7 8.7 4.4 10.0 3.4 8.2 7.6 13.1 5.7 5.9 15.1 13.8 4.3 5.7 5.9 5.6 11.9 5.7 18.2 8.6 12.2 8.0 9.4 3.3 8.8 9.7 8.5 10.4 3.7 3.7 7.4 9.4 14.3 13.6 2.4 15.8 8.4 9.4 5.1 13.1 4.0 8.2 3.9 24.7 6.1 9.5 2.0 19.9 10.0 3.2 9.3 4.4 13.0 15.2 12.2 11.0 31.9 11.5 14.3 14.1 40.5 19.7 30.0 13.8 12.5 17.8 0.0 1.9 43.1 8.1 9.8 8.9 16.2 32.4 0.1 5.2 8.7 27.4 6.5 26.0 3.1 0.3 8.5 8.6 25.7 19.9 37.3 18.7 3.3 0.1 0.0 27.8 6.0 3.1 2.9 5.6 19.2 10.5 4.5 3.6 0.6 13.6 11.8 8.3 9.9 10.4 15.7 4.2 4.7 5.2 1.3 17.1 14.2 11.0 23.6 14.7 1.1 0.0 0.1 16.0 3.0 17.3 0.0 1.0 0.0 0.0 4.2 0.0 0.3 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.2 6.7 0.2 0.0 0.6 8.7 10.0 7.6 13.1 18.2 8.6 8.8 9.7 9.4 8.2 9.5 13.0 28.0 64.1 37.7 146.3 3.4 34.3 48.3 11.9 13.6 3.5 21.1 15.6 11.2 44.3 34.4 27.6 0.0 12.7 0.4 69.3 11.7 42.2 5.5 28.5 14.2 13.0 31.3 2.1 54.9 63.7 22.1 16.5 65.7 46.5 10.2 5.6 11.4 12.4 7.4 0.0 54.9 27.1 12.2 9.3 5.3 3.5 12.2 11.1 3.6 52.5 3.9 11.3 0.0 89.5 213.0 68.4 37.2 12.0 2.4 63.2 28.9 18.4 31.7 1.2 65.7 24.1 36.9 5.4 10.7 9.4 12.6 13.1 1.7 6.5 34.4 72.0 SHISA9 ENSG00000237515 "Shisa family member 9" B4DS77 16 12901598-13240416 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8" "Group enriched" "Detected in many" 17 "Excitatory neurons: 265.0;Inhibitory neurons: 427.9;Oligodendrocyte precursor cells: 636.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 48.5;LHCN-M2: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072399 Approved Vesicles,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Cytosol" "HPA072399: AB_2686517" "unprognostic (1.88e-2)" "unprognostic (3.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.69e-5)" "unprognostic (2.23e-2)" "unprognostic (2.03e-2)" "unprognostic (5.90e-5)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.53e-4)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" 0.5 2.8 12.5 0.8 12.7 1.3 0.6 0.0 14.8 0.3 0.0 3.2 0.8 0.4 1.1 0.5 0.2 0.4 0.6 10.9 6.3 1.9 0.6 0.2 0.4 6.9 5.9 0.4 0.6 0.1 0.9 0.4 6.2 4.2 0.9 3.7 0.9 0.7 1.5 0.9 0.9 0.6 1.7 0.4 0.5 0.7 11.0 0.1 2.1 0.0 0.3 0.2 0.2 4.2 0.8 0.4 0.6 0.5 0.2 0.2 0.5 0.4 0.0 0.0 0.0 0.3 0.5 0.5 48.5 0.1 0.7 0.6 0.1 0.2 0.1 0.6 0.2 0.6 0.9 0.3 0.1 0.6 0.6 1.5 0.1 0.1 3.3 0.4 0.1 0.6 0.4 1.0 40.5 5.5 0.4 0.7 10.2 0.7 0.5 0.6 0.4 0.3 10.9 1.5 10.1 0.5 0.4 1.4 0.4 4.4 0.9 0.4 0.4 0.6 5.8 0.6 0.4 0.9 1.0 0.5 0.4 0.3 1.0 0.8 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 12.5 12.7 0.0 14.8 10.9 6.3 6.9 5.9 6.2 1.7 11.0 4.2 0.0 25.6 20.1 5.2 0.1 0.1 0.5 0.2 0.0 0.8 1.7 0.8 1.3 1.5 7.0 1.8 0.0 0.1 0.0 0.3 1.9 1.4 4.8 0.1 0.5 1.1 0.0 0.0 265.0 0.0 0.0 2.0 0.0 0.3 11.4 0.0 0.0 0.0 0.0 0.0 427.9 0.3 0.0 0.0 0.4 3.4 0.3 1.0 0.0 5.6 0.0 0.5 0.0 636.3 4.9 0.1 2.3 0.0 0.0 1.8 0.0 1.3 11.8 0.3 0.0 6.6 0.2 0.5 2.0 0.0 0.1 0.1 1.3 0.0 0.8 0.6 SHISAL1 KIAA1644 ENSG00000138944 "Shisa like 1" Q3SXP7 22 44243665-44312951 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.2;endometrium 1: 33.6;smooth muscle: 29.3" "Cell type enriched" "Detected in single" 6 "Endometrial stromal cells: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SiHa: 36.2;U-2197: 80.8;U-87 MG: 46.3;WM-115: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051178 Uncertain Approved Vesicles,Cytosol No No "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "Vesicles, Cytosol" "HPA051178: AB_2681374" "unprognostic (4.07e-3)" "unprognostic (9.01e-2)" "unprognostic (1.83e-1)" "unprognostic (1.14e-1)" "unprognostic (6.54e-2)" "unprognostic (1.22e-1)" "unprognostic (7.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.10e-3)" "unprognostic (1.93e-3)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (1.51e-7)" "unprognostic (1.48e-2)" "unprognostic (2.41e-1)" "unprognostic (1.99e-4)" "unprognostic (1.10e-4)" 1.0 1.8 18.6 1.2 17.2 0.0 0.2 0.0 21.4 16.6 0.0 18.7 1.9 33.6 0.4 1.6 4.5 3.1 0.9 18.0 15.3 0.5 0.1 0.3 0.4 10.8 17.8 1.0 0.8 0.1 2.6 0.5 2.4 3.7 2.0 5.6 0.3 11.0 0.0 0.7 2.4 29.3 0.3 0.1 1.6 1.1 43.2 2.6 0.4 0.1 0.7 11.9 5.2 2.8 0.0 0.3 3.5 1.2 0.0 0.0 0.0 1.0 2.3 2.4 1.4 0.0 0.0 0.0 0.0 2.3 14.5 0.0 5.0 0.3 0.3 0.0 2.3 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.4 4.5 1.8 11.2 0.5 0.0 0.0 0.1 0.1 0.0 0.4 0.0 3.3 0.0 0.8 0.0 0.0 0.1 0.0 0.0 12.9 0.0 36.2 0.1 0.2 0.4 0.0 0.3 0.1 13.1 2.0 80.8 0.5 0.0 0.0 0.0 46.3 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 17.2 0.0 21.4 18.0 15.3 10.8 17.8 2.4 0.3 43.2 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 SHOC1 "C9orf84, FLJ32779, MZIP2, Zip2" ENSG00000165181 "Shortage in chiasmata 1" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 17.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.0;Endothelial cells: 1.0" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enriched" "Detected in some" 4 "U-2 OS: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA032108 Approved Vesicles,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 43: Testis - Unknown function" "Cluster 9: U-2 OS - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.0 2.4 0.4 0.0 0.4 0.1 0.0 1.8 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.7 2.2 0.0 0.1 0.0 0.9 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.1 1.1 17.1 1.0 0.0 0.0 0.0 0.3 0.1 0.2 1.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 5.0 1.1 0.4 0.0 0.0 0.3 0.1 0.0 21.7 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.8 0.7 0.7 0.7 0.9 0.5 1.1 0.4 1.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHOX "GCFX, PHOG, SHOXY, SS" ENSG00000185960 "Short stature homeobox" O15266 X 624344-659411 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 7.6" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "midbrain: 7.6;pons: 7.5" "Immune cell enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "BJ: 18.5;BJ hTERT+: 8.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "midbrain: 2.7;thalamus: 3.8" "HPA035141, HPA060931" Enhanced Nucleoplasm,Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Vesicles "HPA035141: AB_2674489, HPA060931: AB_2684388" "unprognostic (7.51e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-1)" "unprognostic (6.82e-2)" "unprognostic (2.45e-2)" "unprognostic (2.34e-1)" "unprognostic (9.24e-2)" "unprognostic (9.95e-2)" "unprognostic (5.67e-6)" "unprognostic (1.99e-1)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.38e-1)" 0.7 0.4 0.2 0.3 0.3 0.9 0.2 1.4 0.6 0.0 0.0 0.2 0.6 0.1 0.3 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.3 1.2 7.6 0.1 0.3 0.2 0.0 0.1 7.5 0.3 0.2 0.4 0.6 0.0 1.2 0.4 0.4 0.1 0.1 0.7 0.2 0.1 1.4 0.0 0.3 0.0 0.2 0.0 0.0 1.0 0.1 0.1 0.1 0.1 0.2 0.1 3.0 18.5 8.4 2.7 2.9 0.3 0.2 0.2 0.1 0.4 0.7 0.2 0.2 0.0 0.9 0.1 0.1 0.1 1.4 0.1 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.5 0.0 0.0 0.2 0.1 0.1 0.1 0.8 0.0 0.2 0.1 0.1 0.0 2.9 0.6 0.6 0.4 0.3 0.4 0.5 0.3 0.3 0.1 0.7 0.4 0.5 1.7 0.7 0.6 0.6 0.3 0.3 0.2 0.3 1.4 0.6 0.2 0.2 1.2 7.6 7.5 0.1 1.4 1.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 SIAH2 ENSG00000181788 "Siah E3 ubiquitin protein ligase 2" O43255 3 150741125-150763477 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061293, CAB069930" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 85: Liver - Metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Vesicles "CAB069930: AB_1217916, HPA061293: AB_2684470" "prognostic favorable (1.17e-4)" "unprognostic (1.04e-3)" "unprognostic (3.83e-2)" "unprognostic (9.15e-2)" "unprognostic (1.69e-1)" "unprognostic (6.91e-2)" "unprognostic (1.86e-2)" "unprognostic (5.68e-3)" "unprognostic (6.26e-2)" "unprognostic (1.95e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-2)" "unprognostic (5.56e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-2)" 15.8 78.6 16.4 20.8 19.0 44.7 17.1 17.4 24.9 48.0 17.3 17.7 13.5 33.4 18.6 46.1 27.2 14.3 16.2 16.9 16.7 12.1 61.2 13.2 35.8 15.8 15.5 24.4 20.9 15.9 11.0 43.1 17.9 19.4 15.4 7.8 16.4 34.7 12.3 30.4 12.9 29.4 15.5 24.4 17.9 8.0 16.5 25.1 8.0 12.8 45.3 23.5 39.6 26.0 54.0 13.4 10.5 20.1 35.4 26.4 41.7 22.9 26.5 27.3 32.4 28.4 24.7 31.3 31.0 24.1 22.8 31.4 28.6 20.7 25.6 24.4 19.5 61.5 16.0 94.7 50.4 34.3 16.0 24.1 47.0 16.3 36.9 21.7 21.5 60.2 15.5 110.8 17.4 66.4 58.7 17.4 33.1 52.3 26.0 44.0 22.7 110.4 17.4 17.9 38.4 19.1 17.4 15.4 39.8 23.8 99.5 50.0 15.0 17.7 15.8 40.1 31.0 130.6 55.9 42.0 17.6 48.6 9.2 8.9 2.2 8.6 1.6 1.2 2.5 2.2 2.8 2.5 2.0 2.2 1.4 1.4 4.7 1.4 1.3 2.6 1.6 0.9 16.4 19.0 17.4 24.9 16.9 16.7 15.8 15.5 17.9 15.5 16.5 26.0 15.9 6.4 4.8 6.8 99.0 146.7 82.3 11.8 153.1 47.0 32.3 22.2 17.8 25.8 11.7 22.0 37.5 192.0 62.6 30.2 13.7 8.5 3.4 56.0 29.2 22.5 38.3 226.7 14.1 6.6 23.4 28.8 44.4 96.5 10.2 18.7 20.7 54.4 32.6 35.3 11.0 39.9 14.2 115.5 102.7 2.1 44.1 70.4 44.4 14.0 22.7 32.7 32.0 5.0 11.5 10.5 17.9 30.9 128.7 56.7 20.7 17.9 16.5 2.8 13.1 11.8 29.9 0.7 10.8 154.1 142.4 389.4 86.1 28.6 34.5 81.8 SIGLEC14 ENSG00000254415 "Sialic acid binding Ig like lectin 14" Q08ET2 19 51642553-51646801 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 28.3;lymphoid tissue: 40.3" "Cell type enhanced" "Detected in some" "Hofbauer cells: 18.5;Kupffer cells: 41.5;Macrophages: 13.5;monocytes: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 109.1;intermediate monocyte: 125.1;myeloid DC: 65.4;neutrophil: 200.1;non-classical monocyte: 93.3" "Group enriched" "Detected in many" 7 "dendritic cells: 65.4;granulocytes: 200.1;monocytes: 125.1" "Group enriched" "Detected in some" 11 "HMC-1: 98.7;U-937: 24.7" "HPA014377, HPA014428" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA 24000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "Plasma membrane" "HPA014377: AB_2189277, HPA014428: " "unprognostic (3.05e-1)" "unprognostic (1.75e-1)" "unprognostic (6.47e-3)" "unprognostic (1.60e-1)" "unprognostic (3.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (9.77e-3)" "unprognostic (9.28e-2)" "unprognostic (6.73e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-3)" "unprognostic (8.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" 3.4 2.4 1.4 25.2 1.5 28.3 1.0 1.6 3.2 1.8 1.3 1.8 0.7 0.9 0.3 1.1 2.3 2.6 1.3 1.4 2.4 0.7 3.5 7.3 13.3 4.7 3.0 0.4 1.1 0.4 0.5 2.5 3.9 0.9 1.6 0.1 1.1 0.9 0.4 0.3 6.1 2.5 2.7 40.3 1.6 2.4 3.9 1.9 0.6 0.0 14.2 4.1 0.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 1.6 98.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 16.6 109.1 1.8 0.3 125.1 0.1 19.3 0.2 0.3 65.4 18.2 0.1 0.1 200.1 0.7 93.3 12.0 0.2 40.3 1.4 1.5 1.6 3.2 1.4 2.4 4.7 3.0 3.9 2.7 3.9 4.1 0.0 0.0 1.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 18.5 0.0 0.0 0.0 0.0 41.5 6.0 0.8 0.3 13.5 0.0 1.0 24.1 0.0 2.1 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 SIGLEC7 "CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2" ENSG00000168995 "Sialic acid binding Ig like lectin 7" Q9Y286 19 51142299-51153526 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 19.2" "Cell type enhanced" "Detected in some" "Hofbauer cells: 31.3;Kupffer cells: 57.4;Macrophages: 33.1;monocytes: 15.5;NK-cells: 69.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 242.1" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Karpas-707: 55.4;RPMI-8226: 33.7;U-937: 35.0" HPA075513 Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 2600000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" Vesicles "HPA075513: " "unprognostic (3.14e-1)" "unprognostic (5.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (4.95e-2)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.27e-2)" "unprognostic (6.61e-2)" "unprognostic (1.14e-3)" "unprognostic (2.58e-1)" "unprognostic (2.26e-2)" 3.7 2.9 0.9 10.6 1.0 4.6 1.0 1.0 1.9 0.6 1.2 1.9 1.6 0.5 0.4 0.4 1.2 2.6 1.3 0.8 1.3 1.6 7.4 5.0 7.7 2.1 1.5 0.4 0.5 0.7 0.6 6.2 1.9 0.7 2.4 0.2 0.7 0.4 0.2 0.2 2.2 3.8 1.4 19.2 0.9 0.9 2.2 1.5 0.5 0.3 2.4 3.1 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.4 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.0 1.2 1.1 0.0 0.2 35.0 0.0 3.2 140.2 242.1 10.6 105.8 18.9 3.8 0.2 4.8 65.5 0.2 0.3 4.4 116.7 96.8 44.0 2.9 0.0 80.9 0.9 1.0 1.0 1.9 0.8 1.3 2.1 1.5 1.9 1.4 2.2 2.4 0.4 0.0 2.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.8 0.0 0.2 8.3 0.1 0.0 0.0 0.4 0.0 0.2 0.6 0.0 8.8 0.0 0.0 0.2 0.3 0.0 0.0 1.3 0.0 6.1 0.8 31.3 0.0 0.0 0.0 0.0 57.4 3.5 0.0 1.5 33.1 0.0 0.0 15.5 0.0 69.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.5 0.4 0.0 0.0 SIK1 "msk, SNF1LK" ENSG00000142178 "Salt inducible kinase 1" P57059 21 43414483-43427131 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell cycle, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 88.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 302.0;Basal respiratory cells: 123.5;Langerhans cells: 141.9;Suprabasal keratinocytes: 422.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.3;HeLa: 63.1;hTCEpi: 45.4;LHCN-M2: 45.5;U-266/84: 37.7" "Low region specificity" "Detected in all" "CAB023801, HPA038211, HPA078064" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 61: Skin - Cornification" "Cluster 20: HeLa - Mitochondria" "Cluster 28: Keratinocytes - Keratinization" Nucleoplasm Vesicles "CAB023801: , HPA038211: AB_2675894, HPA078064: " "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (3.31e-3)" "unprognostic (3.00e-1)" "unprognostic (5.02e-2)" "unprognostic (7.97e-3)" "unprognostic (1.51e-1)" "unprognostic (7.30e-3)" "unprognostic (2.35e-3)" "unprognostic (4.97e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-1)" "unprognostic (3.89e-1)" "unprognostic (9.94e-3)" "unprognostic (3.88e-2)" "unprognostic (2.89e-1)" "unprognostic (1.82e-1)" 24.5 8.3 0.7 6.2 0.4 10.5 19.5 0.5 1.8 17.5 0.8 7.0 0.4 4.4 0.0 18.5 18.6 15.1 16.0 0.3 1.1 5.1 20.9 12.7 4.3 1.0 1.0 26.9 11.8 5.9 12.5 12.5 0.8 9.2 0.7 8.5 12.1 13.3 13.0 88.0 5.4 5.3 0.0 7.2 12.2 3.0 0.7 11.0 6.2 1.3 4.6 16.9 14.4 0.5 1.2 3.4 4.3 0.1 0.3 1.6 1.7 2.0 0.7 3.5 2.7 5.1 0.1 5.4 1.5 0.4 19.8 23.6 3.5 35.3 2.0 0.3 1.1 1.6 63.1 2.0 4.8 1.7 0.2 2.1 45.4 0.9 10.7 20.7 0.7 0.1 0.2 0.2 45.5 0.3 0.9 3.9 1.9 0.0 3.4 0.1 0.8 5.7 4.0 13.3 0.1 0.0 24.2 4.0 0.8 0.7 2.3 0.6 8.1 0.9 4.2 0.4 0.1 9.5 37.7 1.0 10.0 4.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.4 0.5 1.8 0.3 1.1 1.0 1.0 0.8 0.0 0.7 0.5 23.7 28.9 77.3 0.0 18.4 302.0 0.8 123.5 26.7 0.3 8.6 6.3 11.7 7.2 68.4 12.9 0.0 0.8 13.4 16.4 0.0 3.2 0.0 23.2 4.8 18.4 27.6 0.0 0.0 2.1 1.3 11.1 15.3 29.1 19.6 2.3 4.2 7.7 1.7 0.0 0.0 16.5 85.5 3.8 141.9 0.1 0.0 10.1 96.0 0.0 1.6 1.3 0.0 0.0 0.0 7.3 24.3 0.0 36.3 0.5 23.8 0.2 50.7 0.2 0.0 2.4 27.4 0.1 0.4 35.1 422.7 2.5 16.4 0.8 20.3 1.2 SIK1B ENSG00000275993 "Salt inducible kinase 1B (putative)" A0A0B4J2F2 21 6111131-6123778 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 243.9" "Cell type enhanced" "Detected in some" "Adipocytes: 11.9;Alveolar cells type 1: 25.6;Alveolar cells type 2: 27.2;Endometrial ciliated cells: 17.1;Glandular and luminal cells: 30.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 95.3;hTERT-RPE1: 117.7;Karpas-707: 120.6;LHCN-M2: 83.0;SiHa: 87.2" "HPA038211, HPA078064" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 31: Skin - Epidermis development" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" Nucleoplasm Vesicles "HPA038211: AB_2675894, HPA078064: " "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (3.32e-2)" "unprognostic (2.44e-1)" "unprognostic (6.58e-3)" "unprognostic (2.62e-2)" "unprognostic (6.56e-2)" "unprognostic (3.15e-2)" "unprognostic (5.52e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.41e-1)" "unprognostic (2.69e-3)" "unprognostic (7.41e-2)" 67.6 52.0 6.5 16.1 5.6 42.4 53.5 5.3 12.3 21.8 7.4 22.2 7.6 16.2 0.4 32.0 31.0 30.4 49.9 6.1 11.2 21.8 71.2 38.1 9.8 10.7 8.0 93.5 47.0 8.0 39.5 14.2 8.3 33.5 12.3 20.9 41.5 41.6 40.1 243.9 17.4 10.5 6.2 18.0 37.5 7.3 7.1 8.2 17.9 4.3 4.7 44.3 46.7 5.7 9.5 47.5 3.5 3.0 0.7 0.4 8.3 1.1 0.6 1.7 1.0 53.3 7.0 3.2 1.4 0.2 7.1 0.8 5.5 0.0 0.6 8.9 1.7 7.4 95.3 10.3 3.1 1.2 0.7 1.2 39.6 4.8 26.5 117.7 2.0 1.5 3.0 120.6 83.0 4.7 0.9 2.3 4.9 8.8 5.1 2.0 21.1 14.3 4.6 16.4 4.4 2.1 87.2 5.5 5.0 2.3 0.9 4.1 2.3 1.4 4.4 2.0 19.9 15.9 37.7 1.6 12.6 3.0 5.6 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.6 1.8 0.0 0.0 6.5 5.6 5.3 12.3 6.1 11.2 10.7 8.0 8.3 6.2 7.1 5.7 11.9 25.6 27.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 4.0 2.7 0.0 0.0 3.7 1.8 0.0 0.7 4.1 0.0 0.0 0.5 0.0 17.1 3.4 1.4 0.0 0.0 0.0 0.2 0.9 1.5 0.0 30.0 6.3 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.1 0.0 0.0 0.2 8.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.5 2.4 0.0 0.0 0.0 SIKE1 "FLJ21168, SIKE" ENSG00000052723 "Suppressor of IKBKE 1" Q9BRV8 1 114769479-114780685 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024177, HPA025726" Supported Approved "Vesicles,Focal adhesion sites" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "Focal adhesion sites" Vesicles "HPA024177: AB_1848798, HPA025726: AB_1848800" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (3.53e-2)" "unprognostic (4.52e-3)" "unprognostic (4.10e-1)" "unprognostic (6.04e-2)" "unprognostic (3.37e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-2)" "unprognostic (2.52e-2)" "unprognostic (1.94e-2)" "unprognostic (7.91e-2)" "unprognostic (2.38e-2)" "unprognostic (3.86e-2)" "unprognostic (9.06e-2)" "unprognostic (2.95e-3)" "unprognostic (1.05e-1)" 8.8 6.9 5.9 9.7 6.0 9.8 9.6 8.5 6.7 9.1 5.7 8.6 9.8 9.4 7.6 7.7 6.0 6.9 7.3 4.9 7.7 10.8 12.2 6.8 12.1 7.0 6.8 8.6 6.8 9.7 4.9 9.6 7.0 7.6 9.4 8.0 7.3 7.5 6.7 13.4 8.5 9.2 6.4 9.5 8.4 5.6 8.2 13.6 10.1 7.4 12.0 7.2 5.6 7.1 16.3 4.4 22.9 21.2 27.6 21.4 22.0 13.9 12.4 18.9 25.3 12.2 9.1 30.6 12.5 11.8 8.0 15.7 24.3 16.7 27.0 19.4 13.3 16.4 13.9 15.6 26.3 18.8 12.9 21.0 19.6 14.1 22.4 13.6 17.5 26.2 25.2 17.7 15.7 62.7 37.1 19.9 52.1 10.5 12.3 21.2 43.7 15.3 16.0 13.5 15.7 18.5 20.0 23.2 25.5 20.8 12.6 72.0 13.9 15.6 19.0 26.8 19.0 16.4 14.1 29.1 23.7 31.1 34.0 6.0 1.7 2.0 2.2 2.3 2.8 2.0 2.2 2.2 2.2 2.1 2.6 2.8 1.2 2.6 2.4 2.7 1.7 1.4 5.9 6.0 8.5 6.7 4.9 7.7 7.0 6.8 7.0 6.4 8.2 7.1 29.2 25.6 14.8 13.1 32.7 31.9 26.7 40.0 30.1 10.7 22.7 23.2 41.0 20.0 30.2 31.3 10.4 29.7 43.9 30.3 50.9 27.1 34.8 20.1 34.9 26.3 18.6 29.9 16.2 25.7 33.6 27.9 18.8 26.8 19.7 77.1 27.1 40.0 27.7 8.4 19.7 21.4 48.8 19.7 26.6 58.1 28.3 24.8 23.2 4.7 25.4 15.8 32.0 10.1 16.6 31.1 18.3 19.9 37.7 30.5 25.7 62.8 21.3 16.1 19.7 26.5 28.8 35.5 39.6 33.0 36.4 36.0 37.4 48.3 21.2 23.6 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1561385-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6" "Cell type enhanced" "Detected in some" "dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 1594.8" "Group enriched" "Detected in all" 6 "granulocytes: 1594.8;monocytes: 502.2" "Group enriched" "Detected in some" 4 "HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9" HPA047463 Uncertain Uncertain Vesicles,Centrosome NA NA 44000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles Centrosome "HPA047463: AB_2680057" "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 5.4 1.6 1.3 28.6 1.3 52.2 1.9 1.2 4.2 1.2 0.1 2.1 1.5 0.8 0.8 1.3 2.2 11.2 1.6 1.4 0.8 1.2 3.1 19.4 11.0 0.7 0.8 0.7 1.3 0.3 0.6 2.8 1.3 0.8 1.8 1.2 1.7 0.9 0.8 0.8 2.8 3.2 0.9 24.5 1.5 0.6 2.1 4.5 0.9 1.5 4.3 8.1 0.8 1.9 0.2 0.0 0.2 0.1 0.3 0.5 0.2 0.4 0.1 0.2 0.0 0.2 0.1 0.1 0.8 0.4 7.1 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.2 14.9 54.0 0.1 0.2 0.3 0.0 8.0 0.5 1.1 0.0 0.2 0.4 0.1 0.0 76.2 0.2 0.0 3.3 0.2 0.0 0.1 10.8 0.3 0.1 0.2 0.2 0.0 0.5 0.0 0.0 58.9 1.6 0.7 0.1 0.4 0.3 0.1 0.1 0.1 1.1 13.4 0.2 6.1 502.2 868.9 7.3 419.7 10.3 2.8 6.5 5.7 175.2 3.4 8.8 5.5 1594.8 8.2 357.6 165.7 11.8 287.0 1.3 1.3 1.2 4.2 1.4 0.8 0.7 0.8 1.3 0.9 2.1 1.9 0.6 3.2 5.2 0.3 1.2 0.0 0.1 0.2 0.6 0.2 0.1 0.0 0.5 0.0 1.6 0.0 0.0 0.2 10.9 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.1 0.7 0.0 0.2 7.0 0.0 1.8 0.2 14.7 0.0 0.1 0.0 0.0 29.4 0.0 0.0 0.0 30.9 0.0 0.0 26.7 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.8 0.0 0.0 0.0 SIRT6 ENSG00000077463 "Sirtuin 6" Q8N6T7 19 4174109-4182566 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Distal enterocytes: 199.2;Paneth cells: 129.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049729, HPA071776" Supported Supported Nucleoplasm,Vesicles No No "Cluster 52: Eosinophils - Transcription" "Cluster 45: Intestine - Brush border" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA049729: AB_2680865, HPA071776: AB_2686445" "unprognostic (4.58e-1)" "unprognostic (3.41e-3)" "unprognostic (1.36e-1)" "prognostic favorable (2.85e-4)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (2.93e-3)" "unprognostic (8.32e-2)" "unprognostic (1.86e-1)" "unprognostic (6.13e-2)" "unprognostic (7.27e-3)" "unprognostic (4.42e-2)" "unprognostic (5.84e-2)" "prognostic favorable (9.13e-4)" "unprognostic (5.17e-2)" "unprognostic (1.63e-1)" "prognostic favorable (2.58e-4)" 8.2 12.0 10.4 7.8 10.6 10.4 8.6 10.3 15.1 10.5 8.7 23.6 10.0 10.6 2.4 12.3 9.2 3.5 10.0 10.7 10.2 13.7 11.0 8.9 7.1 11.2 10.3 7.5 14.1 5.2 13.3 4.3 10.5 12.7 7.5 1.9 9.3 5.0 8.0 11.8 14.2 2.6 9.8 15.3 9.8 6.0 12.1 4.9 10.1 2.7 3.9 9.9 9.7 10.6 25.7 16.8 8.3 10.4 6.5 6.2 12.9 12.0 8.9 10.1 8.8 11.2 9.5 16.0 12.9 8.1 9.1 15.9 4.6 12.9 1.6 30.8 10.0 6.8 9.7 10.3 14.3 17.4 25.2 7.9 10.4 10.3 6.4 7.7 8.7 15.0 15.2 35.3 5.4 19.2 23.9 18.3 14.5 9.3 15.2 18.9 7.7 18.8 9.7 11.4 11.0 18.1 11.0 10.2 24.1 3.2 10.2 23.0 12.2 10.4 10.5 36.9 17.4 45.6 25.7 18.4 20.8 28.1 12.7 5.3 13.1 12.2 10.8 16.3 6.4 9.6 7.5 8.7 14.3 10.1 6.4 6.1 11.8 5.6 13.5 11.9 12.6 8.5 10.4 10.6 10.3 15.1 10.7 10.2 11.2 10.3 10.5 9.8 12.1 10.6 9.2 12.8 7.3 5.9 13.8 10.3 10.3 32.3 9.6 12.6 6.6 6.3 3.2 7.2 18.4 5.5 18.8 24.1 7.1 199.2 13.7 32.2 1.9 6.2 7.9 11.8 26.4 9.5 8.9 26.7 24.2 9.3 19.9 9.2 5.7 5.6 13.6 6.8 24.0 13.5 10.4 29.1 18.3 11.7 10.1 2.6 11.5 15.0 5.4 1.9 27.0 15.2 14.4 3.5 6.3 32.5 129.7 8.2 10.3 9.7 28.2 14.3 11.0 13.8 0.0 7.2 11.3 7.4 9.6 13.3 12.6 25.6 10.6 7.9 30.9 11.9 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 878 "kidney: 705.6" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 209.4" "Cancer enriched" "Detected in single" 4 "renal cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 25.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.1 0.0 0.3 0.1 0.2 0.2 0.1 0.5 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 705.6 0.4 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.4 0.2 0.6 0.5 0.6 0.4 0.2 0.3 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 38.6 0.0 0.0 0.0 0.0 209.4 0.0 13.5 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 13.2 0.3 0.1 0.0 1.0 0.0 0.0 0.0 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A2 "BSC, BSC2, NKCC1, PPP1R141" ENSG00000064651 "Solute carrier family 12 member 2" P55011 5 128083766-128189677 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 75.6" "Cell type enhanced" "Detected in all" "Intestinal goblet cells: 480.6;Oligodendrocytes: 566.6;Undifferentiated cells: 370.0" "Cancer enhanced" "Detected in all" "colorectal cancer: 54.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "OE19: 153.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020130, HPA063697" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "Plasma membrane" "HPA020130: AB_1854502, HPA063697: AB_2685094" "unprognostic (4.61e-2)" "unprognostic (2.63e-1)" "unprognostic (4.20e-3)" "prognostic favorable (8.60e-4)" "unprognostic (3.99e-1)" "unprognostic (5.65e-3)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (3.30e-1)" "unprognostic (2.95e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.79e-1)" "unprognostic (3.88e-3)" 8.4 17.5 15.0 10.8 48.4 4.4 43.9 46.3 23.2 7.2 40.4 48.5 41.7 8.4 2.4 4.6 6.0 39.4 6.1 13.5 31.1 6.6 4.2 10.3 5.6 40.8 43.1 5.4 6.1 14.7 5.5 4.9 38.6 23.5 58.9 16.8 75.6 2.6 15.4 28.4 49.1 10.2 27.1 4.5 61.8 8.0 32.4 4.1 8.6 8.3 6.0 7.3 3.5 64.8 13.5 65.3 65.8 25.6 16.1 10.4 13.6 12.2 9.1 8.6 8.9 26.4 20.9 19.9 16.1 10.6 7.8 39.5 12.7 14.0 13.2 20.0 15.8 5.7 11.4 3.8 4.9 7.3 9.5 11.1 5.0 19.1 11.2 6.4 14.2 8.5 9.4 13.2 13.4 14.2 13.0 6.1 7.7 153.6 21.1 7.1 18.5 8.2 10.0 45.0 11.5 7.3 24.6 10.6 9.9 7.0 5.9 3.7 24.1 21.2 14.2 16.3 15.7 11.0 10.7 21.6 11.2 4.2 17.6 0.3 0.4 0.2 1.1 0.7 1.9 1.7 1.0 1.4 0.6 2.1 1.1 1.6 0.2 2.4 0.5 6.4 1.1 0.3 15.0 48.4 46.3 23.2 13.5 31.1 40.8 43.1 38.6 27.1 32.4 64.8 38.3 16.0 46.2 23.8 20.5 22.9 20.1 44.9 10.8 76.6 186.9 86.7 18.0 137.2 52.1 33.1 127.2 1.4 34.4 48.2 1.9 68.6 55.8 33.1 43.1 44.2 74.4 2.5 160.6 48.2 2.7 21.3 199.3 38.4 18.4 28.8 12.8 8.8 4.2 80.8 73.2 480.6 57.0 8.6 12.0 95.3 85.4 11.4 204.5 105.9 2.5 22.6 11.3 55.3 566.6 50.1 60.6 29.0 20.2 131.6 38.8 10.6 19.6 86.4 72.3 33.9 64.3 29.1 27.1 14.9 30.0 1.4 21.1 14.1 370.0 21.5 SLC12A6 "ACCPN, KCC3" ENSG00000140199 "Solute carrier family 12 member 6" Q9UHW9 15 34229784-34338060 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" Neuropathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 15.2;neutrophil: 23.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 23.4" "Cell line enhanced" "Detected in many" "HaCaT: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034563 Uncertain Approved Vesicles,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 57: B-cells - Immune response" "Vesicles, Cytosol" "HPA034563: AB_10603887" "unprognostic (3.53e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (3.60e-1)" "unprognostic (3.55e-2)" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.58e-2)" "unprognostic (1.83e-1)" "prognostic favorable (3.33e-6)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (3.87e-2)" "unprognostic (1.41e-1)" 6.4 4.0 5.9 11.5 7.4 26.8 5.5 7.2 7.9 11.9 2.5 5.5 7.3 5.2 7.0 18.8 4.6 5.2 7.3 6.5 7.3 15.9 3.9 9.1 10.1 8.9 7.3 4.2 3.5 3.1 5.6 4.3 9.3 3.5 6.1 31.1 6.4 3.8 10.6 7.6 9.1 4.9 6.6 12.9 6.7 25.9 7.7 15.5 9.0 10.9 11.6 8.3 17.6 8.4 4.4 5.2 3.1 4.7 10.0 11.4 2.4 5.9 15.1 4.9 7.1 3.1 7.2 3.1 5.9 7.2 4.3 44.0 7.9 5.3 5.8 1.2 5.1 24.6 14.0 7.0 6.4 14.5 24.6 6.9 9.1 14.1 29.1 10.9 14.9 6.8 5.4 6.8 6.7 1.6 1.6 11.0 2.4 3.8 5.7 7.1 5.5 3.3 5.5 11.2 7.2 5.0 7.1 0.2 1.5 7.1 2.8 4.8 9.4 5.9 4.2 21.0 1.4 6.4 6.8 1.9 6.6 10.5 2.2 15.2 1.4 2.6 0.6 1.8 0.4 1.4 0.9 0.9 0.9 2.4 1.6 1.4 23.4 0.7 0.8 1.0 3.2 1.0 5.9 7.4 7.2 7.9 6.5 7.3 8.9 7.3 9.3 6.6 7.7 8.4 16.4 22.4 21.0 30.0 32.0 1.1 4.5 1.5 7.4 15.3 5.2 4.3 8.7 5.7 4.2 5.5 85.5 3.2 11.5 8.6 0.0 5.6 15.6 9.8 7.4 17.7 6.7 35.9 47.7 4.7 1.6 7.0 17.9 22.4 5.1 8.4 16.1 7.5 13.2 8.4 52.0 7.0 2.0 37.1 3.8 8.3 8.1 25.6 0.0 50.6 34.5 8.7 15.5 40.7 58.4 13.1 9.7 8.6 29.9 6.5 18.3 16.4 4.2 56.6 19.7 7.0 4.0 39.9 21.2 14.8 0.9 1.1 18.0 4.1 7.4 43.6 SLC16A10 "MCT10, TAT1" ENSG00000112394 "Solute carrier family 16 member 10" Q8TF71 6 111087503-111231194 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 53.7;skeletal muscle: 41.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 4.5" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.7;T-reg: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016860 Approved Supported "Vesicles,Cell Junctions" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 41: Macrophages - Immune response" "Vesicles, Cell Junctions" "HPA016860: AB_2189211" "unprognostic (2.03e-1)" "unprognostic (2.08e-1)" "unprognostic (6.11e-2)" "unprognostic (3.56e-4)" "unprognostic (2.24e-1)" "unprognostic (2.15e-1)" "unprognostic (1.64e-1)" "unprognostic (1.89e-1)" "unprognostic (1.86e-3)" "unprognostic (5.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-3)" "unprognostic (2.73e-1)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 2.9 5.5 1.4 3.0 8.6 0.8 0.8 4.2 3.4 0.6 53.7 1.2 8.5 0.5 1.4 0.8 0.8 1.5 2.3 2.0 1.2 10.0 13.5 4.6 0.9 1.1 5.0 0.9 29.7 7.9 1.0 23.7 2.8 1.3 1.8 0.7 3.1 0.2 41.2 15.3 5.0 0.3 0.2 1.8 5.3 4.2 9.6 10.9 2.7 6.0 1.3 1.9 1.2 1.1 0.9 1.0 0.4 2.2 0.1 0.1 3.1 0.0 0.2 0.8 1.2 9.0 0.4 5.2 1.4 0.3 2.5 0.1 49.4 0.1 1.0 0.1 20.2 8.2 0.7 7.4 0.1 7.6 7.4 0.0 0.0 0.1 0.0 0.2 0.0 10.9 1.4 0.2 0.1 3.6 9.8 0.8 14.6 0.2 3.2 5.4 6.8 37.2 0.0 0.5 10.7 3.3 0.2 0.7 1.8 3.6 1.8 0.9 0.1 0.1 1.8 0.5 2.5 2.6 0.1 1.5 0.3 5.8 0.8 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.2 1.7 1.5 0.3 0.1 0.0 0.1 1.6 0.1 1.4 8.6 4.2 3.4 2.0 1.2 1.1 5.0 2.8 0.2 9.6 1.1 0.4 9.6 32.8 2.0 1.5 9.7 10.7 0.0 4.6 6.9 2.0 1.3 9.1 0.0 3.1 5.5 2.1 1.9 0.7 2.1 1.9 0.2 9.0 0.4 0.8 1.4 6.6 1.7 33.9 12.5 1.8 8.9 3.6 1.3 1.3 2.5 4.2 25.4 21.4 1.7 47.8 4.8 0.0 12.4 12.4 8.2 0.0 33.8 44.4 0.0 0.7 1.6 0.0 16.6 0.3 2.0 0.9 0.0 4.8 3.9 10.9 17.7 0.7 0.7 0.0 18.5 1.0 11.6 11.2 1.2 14.8 1.2 5.8 9.2 8.5 1.2 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241093-117279430 "Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease variant, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.1;cervix: 30.0" "Cell type enriched" "Detected in many" 5 "granulocytes: 636.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 11 "hypothalamus: 20.8;midbrain: 81.1;pons: 70.5" "Immune cell enriched" "Detected in some" 15 "basophil: 59.5" "Lineage enriched" "Detected in many" 15 "granulocytes: 59.5" "Cell line enriched" "Detected in some" 19 "HMC-1: 351.0" "Region enhanced" "Detected in many" "midbrain: 62.7" "Region enriched" "Detected in all" 4 "midbrain: 111.6" HPA073224 Enhanced Approved Vesicles,Centrosome NA NA "Cluster 38: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Vesicles, Centrosome" "HPA073224: AB_2732222" "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.1 14.6 0.1 0.9 1.1 2.4 1.8 0.1 0.3 30.0 0.2 2.3 1.5 2.6 1.6 2.5 0.5 3.6 0.7 0.2 20.8 0.9 2.8 7.4 0.6 3.8 81.1 10.4 3.4 0.2 0.2 0.1 70.5 9.2 3.5 0.4 0.8 1.3 0.8 6.3 2.1 2.3 0.0 0.3 4.4 0.9 5.0 6.1 0.0 0.5 0.9 2.9 7.9 0.2 0.2 1.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.3 0.6 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.7 18.6 0.1 0.2 0.0 1.0 351.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 0.7 0.0 0.1 1.0 0.3 0.2 0.3 0.6 0.2 0.4 0.2 0.0 0.2 3.4 0.7 0.3 0.1 0.0 0.2 0.0 0.1 0.3 0.1 2.5 0.3 0.8 0.5 0.4 0.2 0.4 1.9 0.3 59.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 3.8 0.0 2.0 0.1 1.1 0.1 0.3 0.2 20.8 3.8 81.1 70.5 0.0 5.0 0.2 0.0 9.6 16.2 1.0 0.2 1.9 0.0 0.0 0.0 2.1 0.2 0.0 0.3 0.0 2.5 0.0 4.2 0.0 5.7 0.4 0.0 0.0 0.0 13.1 16.1 0.7 8.9 4.2 1.1 0.0 0.0 3.4 4.1 112.4 636.0 2.4 9.7 0.3 0.8 0.0 1.7 0.0 0.0 1.0 3.6 0.2 0.6 3.5 1.8 0.0 0.1 0.4 0.0 0.5 0.6 0.1 0.1 4.9 1.9 3.8 0.0 0.1 0.7 0.8 0.0 0.4 1.3 0.2 2.1 0.0 2.7 0.0 5.6 9.8 0.1 0.1 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36596588-36688334 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "brain: 776.8;choroid plexus: 400.6;retina: 221.1" "Cell type enhanced" "Detected in many" "Astrocytes: 1735.2;Microglial cells: 332.6;Muller glia cells: 472.6;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 249.0" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "classical monocyte: 1.5;intermediate monocyte: 1.2;myeloid DC: 1.6" "Group enriched" "Detected in many" 16 "dendritic cells: 1.6;monocytes: 1.5" "Cell line enhanced" "Detected in many" "AF22: 50.0;CACO-2: 112.6;HaCaT: 71.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Vesicles NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 39: CACO-2 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Vesicles" "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 30.7 16.4 500.4 7.4 544.2 3.3 17.7 549.4 776.8 8.7 400.6 3.0 0.5 1.6 1.1 10.5 6.0 8.0 45.4 514.6 502.5 2.2 3.8 10.2 17.4 477.6 510.1 12.6 5.0 2.2 18.1 20.3 502.4 3.2 1.1 221.1 4.7 4.7 14.1 6.0 3.2 4.1 495.4 9.3 2.2 1.2 532.8 3.6 3.4 9.2 5.4 7.0 5.3 494.9 1.3 0.2 50.0 5.3 5.9 14.3 37.7 0.3 0.0 2.4 4.9 112.6 5.6 0.0 27.8 2.3 1.0 71.4 16.9 9.1 2.2 1.8 33.0 0.0 0.5 0.0 2.5 1.3 0.6 26.9 34.5 14.4 5.3 1.8 0.0 1.1 0.0 0.2 8.7 0.2 0.1 0.1 6.0 0.1 5.9 0.0 0.5 0.0 0.1 3.1 4.7 0.0 5.1 14.6 2.1 24.4 0.2 3.1 0.0 6.2 10.3 0.1 20.7 0.0 0.0 0.3 21.7 37.7 12.6 0.0 1.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 500.4 544.2 549.4 776.8 514.6 502.5 477.6 510.1 502.4 495.4 532.8 494.9 1.1 3.2 0.5 1735.2 0.7 10.7 14.3 19.0 83.1 7.1 3.7 3.4 36.0 0.0 3.1 0.0 2.1 32.9 0.1 0.0 0.0 0.8 0.7 16.3 1.2 8.9 0.0 0.8 2.6 0.0 15.9 7.8 2.0 11.7 0.0 0.2 1.1 0.5 41.2 3.3 4.7 0.0 0.0 77.6 5.9 4.1 4.4 59.6 7.2 332.6 3.3 472.6 0.0 237.7 249.0 0.3 0.0 0.0 0.7 5.2 0.0 0.0 5.3 19.1 6.6 2.6 3.1 0.3 0.3 32.7 7.1 9.2 1.0 20.7 0.0 3.6 SLC22A3 "EMT, OCT3" ENSG00000146477 "Solute carrier family 22 member 3" O75751 6 160348378-160452577 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 67.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 78.9;Hepatocytes: 68.8;Leydig cells: 33.8;Pancreatic endocrine cells: 57.3;Skeletal myocytes: 29.8" "Cancer enhanced" "Detected in many" "prostate cancer: 19.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 27.6;HeLa: 38.1;Hep G2: 23.7;OE19: 12.0;RPTEC TERT1: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA029750 Approved Approved Vesicles,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 15: Hepatocytes - Hemostasis" Vesicles Cytosol "HPA029750: AB_10603888" "unprognostic (8.61e-2)" "prognostic unfavorable (7.19e-5)" "unprognostic (4.14e-1)" "unprognostic (1.49e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (3.36e-2)" "unprognostic (9.74e-2)" "unprognostic (9.36e-4)" "unprognostic (1.33e-2)" "unprognostic (2.58e-2)" "unprognostic (7.28e-2)" "unprognostic (7.96e-2)" "unprognostic (5.21e-2)" "unprognostic (8.13e-4)" "prognostic unfavorable (7.26e-4)" 11.7 15.2 2.1 3.8 2.7 0.0 6.6 3.3 2.1 15.9 1.8 8.8 1.7 18.4 27.6 7.7 18.7 11.0 1.5 2.0 3.5 6.3 34.9 16.4 16.2 6.2 3.8 21.1 0.7 0.2 1.3 44.3 4.5 43.4 2.4 0.2 51.8 52.6 67.4 10.7 5.7 26.3 3.3 0.6 6.0 2.6 4.2 0.5 2.0 8.5 4.9 6.2 15.7 3.2 0.0 27.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.5 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.4 0.0 0.0 0.0 38.1 23.7 1.2 0.0 0.0 0.8 6.9 3.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 12.0 7.7 0.0 0.0 0.0 13.8 0.0 0.0 0.0 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.7 3.3 2.1 2.0 3.5 6.2 3.8 4.5 3.3 4.2 3.2 0.6 16.0 78.9 6.2 0.1 4.7 0.3 2.1 2.8 0.2 0.2 0.3 2.9 5.7 6.4 0.0 0.0 0.3 0.1 0.2 5.9 8.2 0.6 0.2 10.2 1.0 0.0 0.0 0.5 3.0 0.3 10.0 12.8 0.3 2.5 0.8 0.0 68.8 0.7 0.0 25.1 1.6 2.0 1.0 2.4 1.6 33.8 0.3 3.6 7.5 0.0 0.0 0.0 19.6 0.2 57.3 0.1 24.5 0.1 6.1 2.1 2.9 0.8 0.1 0.0 29.8 12.3 0.3 0.2 3.7 6.7 0.4 1.2 0.0 2.8 0.8 SLC23A2 "KIAA0238, SLC23A1, SVCT2, YSPL2" ENSG00000089057 "Solute carrier family 23 member 2" Q9UGH3 20 4852356-5010293 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 99.3;choroid plexus: 88.4;retina: 107.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 236.8;Cone photoreceptor cells: 114.7;Excitatory neurons: 102.8;Inhibitory neurons: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052825, HPA059314" Approved Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 56: Bipolar cells - Visual perception" Vesicles "Golgi apparatus" "HPA052825: AB_2681965, HPA059314: AB_2683975" "unprognostic (3.83e-1)" "unprognostic (1.08e-2)" "unprognostic (1.95e-3)" "unprognostic (1.64e-3)" "unprognostic (8.05e-2)" "unprognostic (2.09e-1)" "prognostic favorable (3.35e-4)" "unprognostic (6.22e-3)" "unprognostic (2.08e-1)" "unprognostic (6.36e-3)" "prognostic favorable (7.14e-5)" "unprognostic (1.57e-1)" "unprognostic (1.60e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.08e-5)" 10.2 99.3 26.3 8.2 27.2 7.8 9.4 24.1 26.0 13.5 88.4 9.4 6.4 12.9 8.7 6.1 15.9 10.1 8.3 28.5 26.7 13.0 57.0 12.1 10.2 28.1 32.0 38.5 10.0 17.7 23.3 8.1 29.5 12.5 6.1 107.2 5.9 10.3 3.3 11.4 12.5 10.0 25.6 20.9 9.4 11.4 34.6 8.2 25.0 4.5 9.9 18.9 8.9 33.1 21.2 24.5 32.2 12.2 22.2 12.4 40.9 8.9 12.1 10.3 9.6 12.7 23.6 9.6 9.4 12.4 29.1 20.1 9.1 24.2 19.2 6.0 16.2 13.3 4.3 48.0 12.5 18.9 7.6 10.6 13.8 25.8 15.4 21.5 15.2 15.5 9.3 7.9 13.7 7.9 20.7 10.5 11.4 16.9 14.9 19.0 21.2 14.3 5.6 34.2 10.7 12.0 17.0 17.7 63.3 11.4 9.8 10.9 13.1 23.0 10.7 27.8 17.4 11.2 22.2 25.5 8.1 11.2 36.8 0.0 1.1 0.1 1.1 0.7 1.0 1.8 0.8 0.8 1.5 1.0 0.8 0.8 1.2 0.3 0.9 2.4 0.5 0.9 26.3 27.2 24.1 26.0 28.5 26.7 28.1 32.0 29.5 25.6 34.6 33.1 9.3 6.4 7.2 50.3 14.5 7.4 4.5 7.0 12.5 236.8 8.3 7.4 7.9 15.7 9.4 14.7 114.7 4.9 12.6 0.8 0.0 5.0 4.6 2.8 10.1 13.0 7.2 8.6 102.8 5.5 6.6 14.2 3.6 1.9 8.2 13.5 17.5 71.3 10.6 85.8 117.4 1.9 0.0 30.2 7.5 9.3 20.2 16.3 16.0 60.0 8.8 24.8 7.2 77.4 78.3 3.4 6.7 29.3 11.9 8.2 0.6 1.3 7.8 71.5 13.1 12.6 12.2 0.6 8.0 5.5 6.1 4.0 8.2 65.6 2.8 14.7 SLC25A25 "KIAA1896, MCSC, PCSCL" ENSG00000148339 "Solute carrier family 25 member 25" Q6KCM7 9 128068201-128109245 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 136.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020381 Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 16: U-266 - Nucleosome" "Cluster 44: Endometrium - Transcription" "Vesicles, Mitochondria" "HPA020381: AB_1857037" "unprognostic (4.62e-2)" "unprognostic (2.66e-2)" "unprognostic (2.56e-2)" "unprognostic (1.59e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.01e-4)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (4.96e-2)" "unprognostic (3.70e-2)" "prognostic favorable (4.65e-6)" "unprognostic (1.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.66e-3)" "unprognostic (1.42e-2)" 55.3 22.9 16.0 12.5 16.5 9.5 22.9 14.7 19.7 33.2 10.6 17.2 11.9 26.8 3.3 35.0 40.7 39.9 12.8 18.1 17.4 28.6 136.5 27.9 11.2 19.9 18.1 25.3 82.6 19.6 45.7 11.5 17.9 15.2 7.8 31.2 16.5 14.2 82.0 24.4 18.3 26.3 15.4 15.6 23.7 7.6 19.6 15.3 18.9 21.1 6.2 19.0 21.4 14.9 9.5 9.8 13.6 19.8 10.1 8.6 9.0 19.3 17.8 15.9 10.5 17.7 9.7 12.2 5.8 9.0 8.8 16.6 10.8 6.3 6.0 14.3 8.9 7.1 21.6 10.7 16.0 8.3 15.7 11.0 6.0 15.5 11.3 5.2 10.9 20.1 26.1 25.7 10.1 22.9 14.7 8.4 13.8 30.5 15.1 14.3 11.6 26.1 6.1 9.8 33.6 14.5 20.2 12.9 27.8 5.3 14.2 4.7 7.0 17.9 10.6 13.6 19.3 22.3 42.2 13.2 12.1 4.4 15.0 2.6 1.7 0.9 3.0 5.1 1.6 1.2 3.4 3.1 3.1 1.8 2.7 4.9 0.3 1.0 6.1 1.0 2.7 3.2 16.0 16.5 14.7 19.7 18.1 17.4 19.9 18.1 17.9 15.4 19.6 14.9 59.3 22.4 34.2 17.6 9.3 26.1 46.2 24.3 56.3 18.8 71.7 73.5 3.2 58.6 22.8 20.2 127.2 10.1 7.6 45.6 11.7 11.2 0.3 72.0 34.5 44.7 51.7 11.0 19.7 11.5 12.9 21.0 43.8 110.3 8.2 18.7 26.0 84.5 9.1 18.5 20.5 26.5 28.5 20.1 42.9 1.5 9.3 16.8 21.4 13.1 12.6 15.2 12.3 11.1 2.4 12.1 42.7 8.2 14.5 28.6 47.7 10.2 30.8 70.4 19.7 48.1 40.3 5.6 7.9 89.5 43.0 23.0 14.2 11.9 22.3 58.3 SLC25A35 FLJ40217 ENSG00000125434 "Solute carrier family 25 member 35" Q3KQZ1 17 8287763-8295400 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 20.9;Syncytiotrophoblasts: 17.4" "Cancer enhanced" "Detected in all" "endometrial cancer: 14.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051720 Uncertain Approved Vesicles,Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 71: Testis - DNA repair" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 66: Spermatocytes - Spermatogenesis" "Vesicles, Mitochondria" "HPA051720: AB_2681584" "unprognostic (4.73e-2)" "unprognostic (1.36e-3)" "unprognostic (1.21e-2)" "prognostic favorable (3.37e-7)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (5.27e-2)" "unprognostic (2.58e-1)" "unprognostic (8.30e-2)" "unprognostic (8.96e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.14e-6)" "unprognostic (5.31e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "prognostic favorable (1.91e-5)" 5.7 8.3 2.9 4.9 3.9 6.1 8.6 3.5 4.4 10.0 4.6 7.7 6.1 13.4 7.6 5.4 7.1 5.2 4.8 2.9 3.2 15.0 4.6 6.8 5.0 3.9 4.0 2.9 12.2 6.1 12.8 4.1 4.1 8.7 5.3 4.5 6.4 5.2 2.2 4.5 7.7 4.1 3.3 8.9 12.5 24.5 4.4 5.2 9.1 1.5 3.5 6.0 5.0 4.2 5.0 13.5 2.4 10.0 7.5 2.9 5.5 3.2 2.8 3.4 3.7 1.6 12.4 5.8 3.3 3.7 7.1 11.0 2.8 3.8 1.9 3.2 3.6 4.8 11.1 1.9 2.7 0.7 12.8 5.9 2.1 6.5 1.2 2.5 5.4 6.8 1.4 2.0 2.9 2.7 5.3 2.7 0.8 3.4 4.4 5.8 1.6 2.6 2.6 12.6 1.2 3.0 9.2 5.4 4.1 2.4 12.2 3.6 7.6 2.3 1.7 5.6 2.7 4.3 2.9 2.1 5.9 8.6 6.1 4.1 5.6 7.6 4.0 8.8 3.3 1.9 3.7 4.3 5.7 3.6 1.3 2.5 1.1 2.8 6.5 3.0 4.1 2.5 2.9 3.9 3.5 4.4 2.9 3.2 3.9 4.0 4.1 3.3 4.4 4.2 3.1 0.0 5.4 5.2 3.6 0.8 1.5 1.4 2.8 4.3 6.3 4.1 1.0 5.7 1.8 11.0 8.4 9.2 2.1 3.8 11.7 2.8 3.8 10.2 1.9 2.8 9.0 4.6 0.5 7.1 2.3 3.0 5.1 10.6 5.1 1.3 1.8 2.8 6.7 1.7 0.7 3.0 2.0 6.4 1.5 5.5 1.5 4.2 0.0 4.7 5.8 7.9 3.1 1.0 2.5 3.2 6.0 1.2 3.7 1.9 2.4 7.3 2.0 9.0 0.0 1.1 1.2 20.9 0.8 1.9 0.3 17.4 3.2 9.1 3.1 1.9 SLC29A3 "ENT3, FLJ11160" ENSG00000198246 "Solute carrier family 29 member 3" Q9BZD2 10 71319259-71381423 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 31.8;Hep G2: 35.9;RT4: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046085, HPA054976, HPA057905" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Vesicles" "HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550" "unprognostic (1.73e-1)" "unprognostic (2.38e-3)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (1.28e-1)" "unprognostic (4.71e-1)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (3.37e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.16e-4)" "unprognostic (3.43e-3)" 4.7 2.6 3.1 4.1 3.9 1.1 4.8 3.7 3.7 7.3 2.7 4.4 2.1 6.8 2.5 2.2 5.8 4.4 2.4 3.0 3.6 2.5 9.4 6.7 7.1 4.7 3.7 9.7 5.2 3.5 1.7 11.2 4.2 5.1 3.5 0.3 4.9 2.9 1.4 2.6 3.7 5.1 4.2 6.5 6.1 3.7 4.4 3.7 3.8 0.6 3.8 9.8 4.4 5.0 2.1 12.3 1.8 7.8 6.8 5.3 31.8 2.3 2.2 0.7 0.4 13.8 8.8 7.4 6.4 4.7 3.2 18.3 5.7 2.9 0.1 5.6 5.6 2.2 1.0 35.9 3.3 1.8 4.5 5.2 12.9 0.3 0.6 1.5 3.2 8.5 6.5 6.8 0.9 19.1 4.2 3.8 4.2 19.2 4.5 5.7 0.6 5.9 2.3 29.5 8.5 9.6 6.4 20.3 1.7 5.2 3.2 4.0 5.2 0.2 3.8 2.3 0.1 1.8 3.1 4.0 7.6 24.0 1.3 4.2 19.3 2.2 5.4 15.3 4.6 4.9 4.5 5.1 29.1 1.9 3.5 5.0 1.5 9.4 10.3 20.2 5.5 9.5 3.1 3.9 3.7 3.7 3.0 3.6 4.7 3.7 4.2 4.2 4.4 5.0 2.0 3.2 1.1 2.0 3.1 0.3 1.5 4.0 1.8 2.3 2.7 3.8 0.8 1.5 3.8 0.0 0.0 46.1 6.3 2.6 0.0 6.1 3.6 1.8 3.2 1.8 1.8 4.2 2.4 8.9 45.3 4.7 7.1 2.4 2.5 10.2 3.3 5.4 34.7 0.0 1.3 2.5 8.2 11.8 4.4 15.2 2.8 10.9 1.8 16.9 8.5 3.0 3.1 2.5 2.7 7.9 13.1 1.5 6.0 3.2 0.1 2.0 2.6 0.4 0.0 0.2 2.5 0.6 5.0 0.7 0.0 31.7 2.9 10.0 2.5 1.7 SLC30A1 "ZNT1, ZRC1" ENSG00000170385 "Solute carrier family 30 member 1" Q9Y6M5 1 211571568-211579161 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 86.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015275, HPA049000" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Plasma membrane" Vesicles "HPA015275: AB_1857083, HPA049000: AB_2680593" "unprognostic (1.13e-1)" "unprognostic (2.67e-3)" "unprognostic (6.94e-2)" "unprognostic (1.81e-3)" "unprognostic (3.47e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-2)" "unprognostic (1.82e-3)" "unprognostic (4.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.42e-3)" "unprognostic (4.78e-2)" "unprognostic (2.23e-2)" "unprognostic (3.03e-1)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (4.53e-2)" 14.8 18.0 15.7 10.9 17.0 29.8 8.5 15.2 19.3 18.6 27.8 15.4 28.2 10.8 9.9 8.0 12.5 12.4 10.0 16.9 15.4 20.5 86.1 7.2 6.1 17.9 17.3 7.8 11.3 10.3 4.6 10.1 16.8 7.8 13.6 6.1 9.3 7.9 1.8 16.0 19.9 11.6 16.7 15.4 9.5 13.4 18.9 4.5 16.9 4.8 7.1 12.2 7.5 13.2 10.3 15.0 7.7 9.9 32.4 14.9 70.5 27.3 19.3 13.8 13.6 6.4 46.6 5.8 24.1 24.4 19.3 17.2 11.5 15.4 16.4 15.0 9.3 4.7 28.8 14.7 18.1 15.8 10.0 22.5 37.5 17.7 28.4 20.5 8.6 3.4 18.7 25.5 17.2 9.1 3.2 9.9 24.2 10.6 12.0 10.0 3.7 20.4 42.5 26.4 7.8 13.7 26.7 13.6 62.7 14.2 7.0 20.2 14.6 10.4 24.8 35.4 22.1 11.9 19.0 4.5 9.8 15.7 9.3 1.4 1.3 0.5 0.4 1.5 0.5 0.2 0.3 0.2 0.9 0.1 0.3 0.4 0.1 0.4 1.2 0.5 0.3 0.4 15.7 17.0 15.2 19.3 16.9 15.4 17.9 17.3 16.8 16.7 18.9 13.2 29.7 9.6 9.8 3.9 8.8 28.6 8.2 3.0 16.5 11.0 24.9 14.7 21.0 18.6 4.2 36.8 6.2 11.6 19.9 54.5 1.9 6.9 44.0 37.0 19.1 27.3 9.5 26.1 0.6 12.5 32.7 15.9 8.6 66.4 5.1 7.5 17.9 94.9 32.0 6.7 0.6 22.8 2.0 27.2 14.5 6.8 9.9 25.5 21.4 3.7 18.8 29.0 1.0 1.0 0.1 9.5 41.7 7.5 8.6 13.9 49.2 29.8 6.4 9.4 6.6 15.9 11.7 37.9 17.4 24.2 46.2 24.5 14.2 14.8 23.3 13.7 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042430 Uncertain Approved Vesicles,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Vesicles, Cytosol" "HPA042430: AB_10806238" "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 8.8 11.0 3.9 4.9 4.8 2.9 8.4 4.6 4.7 12.3 9.2 7.2 6.9 8.8 12.9 8.0 9.5 7.8 7.6 4.6 5.3 10.4 17.2 8.4 5.0 4.4 4.2 8.0 30.9 11.6 5.9 6.6 4.6 8.3 6.4 6.8 11.2 11.0 4.7 6.4 7.7 7.1 5.2 5.8 8.8 5.4 5.2 7.1 18.8 4.8 6.2 6.8 7.9 7.3 18.9 17.7 7.3 8.3 24.4 23.5 12.9 13.1 21.2 19.8 18.7 8.5 22.0 9.9 24.1 13.1 19.8 17.1 14.3 15.2 20.8 16.5 13.3 11.3 6.5 15.8 41.5 13.3 8.9 18.4 26.7 9.7 49.5 20.5 19.8 12.4 8.6 27.8 14.3 14.3 5.0 3.7 6.8 17.7 14.9 5.6 8.1 29.1 9.7 11.8 7.9 5.9 11.1 24.5 21.4 11.3 8.1 11.2 21.4 10.1 4.9 17.9 13.1 33.2 14.4 12.3 14.6 8.8 14.0 12.7 8.4 6.2 8.9 6.3 9.6 5.4 6.0 6.8 10.4 3.5 5.4 5.5 1.7 6.6 6.5 16.1 5.7 5.9 3.9 4.8 4.6 4.7 4.6 5.3 4.4 4.2 4.6 5.2 5.2 7.3 9.0 22.4 25.0 16.0 14.8 8.9 11.7 20.8 18.2 17.5 16.0 9.0 23.8 18.6 21.5 11.0 27.1 18.2 21.1 14.2 5.9 15.3 13.7 11.2 20.3 13.7 12.5 8.4 17.9 15.4 28.3 19.7 20.9 16.6 12.0 12.8 16.4 64.3 19.5 18.5 17.4 18.1 12.2 14.7 15.8 13.2 18.6 15.2 12.4 10.3 19.0 15.4 12.3 11.1 20.8 14.4 5.3 21.4 33.3 19.5 18.9 17.1 23.4 23.0 13.1 16.0 16.0 19.5 9.2 12.2 9.5 37.6 15.3 10.2 13.9 10.9 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "intestine: 237.4;kidney: 110.0;liver: 171.1;pancreas: 306.8" "Cell type enriched" "Detected in some" 4 "Proximal enterocytes: 798.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 30.6;liver cancer: 36.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 53 "CACO-2: 39.9;Hep G2: 58.5" "Region enhanced" "Detected in single" "basal ganglia: 1.1" "Not detected" "Not detected" HPA018423 Approved Nucleoplasm,Vesicles NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favorable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.3 0.1 0.2 5.5 0.2 0.1 0.3 0.5 0.4 0.3 0.2 73.7 237.4 0.4 0.0 0.1 0.3 6.5 0.2 0.1 0.1 110.0 171.1 0.2 0.4 0.2 0.1 0.4 306.8 0.0 0.2 0.1 0.1 0.3 45.9 6.4 0.1 0.3 0.1 0.3 219.0 2.6 0.1 0.3 1.4 0.2 0.1 0.0 0.3 0.2 0.0 0.2 0.2 0.1 0.0 0.3 0.1 0.2 0.2 0.3 0.5 0.0 0.0 0.1 0.0 39.9 0.4 0.1 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.6 0.1 0.2 0.2 58.5 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.8 0.0 0.9 0.1 0.2 0.2 0.3 0.5 0.1 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.4 0.6 0.1 0.0 0.0 0.9 0.1 0.3 0.2 15.7 0.0 3.7 116.7 0.0 0.0 171.9 19.6 0.3 0.6 0.0 0.1 0.2 25.3 2.7 0.2 20.6 0.0 0.1 0.0 0.0 0.0 0.0 2.2 138.9 0.1 0.0 0.2 112.7 0.0 1.6 1.2 1.4 0.0 1.3 0.0 0.0 0.6 0.6 0.0 0.0 0.1 7.4 192.8 0.0 0.0 0.1 798.4 169.9 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.8 0.0 168.7 0.0 SLC44A2 CTL2 ENSG00000129353 "Solute carrier family 44 member 2" Q8IWA5 19 10602457-10644557 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 171.1;Extravillous trophoblasts: 257.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 333.2;SK-BR-3: 306.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003228, HPA070799" Approved Approved "Vesicles,Cell Junctions" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Vesicles, Cell Junctions" "HPA003228: AB_1080009, HPA070799: AB_2686314" "unprognostic (6.35e-3)" "unprognostic (5.75e-2)" "unprognostic (4.34e-1)" "unprognostic (3.06e-3)" "unprognostic (4.38e-2)" "unprognostic (8.41e-3)" "unprognostic (1.64e-1)" "unprognostic (2.52e-1)" "unprognostic (2.66e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (8.63e-2)" "prognostic favorable (1.71e-5)" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (8.21e-3)" "unprognostic (3.61e-2)" 74.7 33.2 69.6 43.9 85.0 65.0 72.7 78.4 67.4 64.6 33.4 58.3 26.7 43.0 36.2 81.6 59.0 55.8 71.4 62.7 69.7 68.7 17.8 98.5 75.3 99.6 76.5 32.3 41.2 48.7 20.5 157.5 87.0 43.8 49.5 29.1 55.5 65.8 141.2 78.3 50.8 43.6 84.3 115.5 112.9 82.5 79.1 48.8 64.9 92.4 77.7 56.3 69.2 97.6 333.2 8.3 70.0 42.1 103.9 63.5 201.1 69.6 169.5 112.3 131.6 75.6 154.9 65.6 91.1 193.9 13.6 254.1 10.7 53.2 71.6 1.7 9.3 42.0 39.3 3.1 115.0 0.6 33.9 69.2 69.8 42.3 37.2 91.0 86.8 30.2 20.2 10.8 172.6 243.6 35.1 32.1 24.9 96.9 29.3 74.1 102.7 2.9 37.1 171.8 6.9 42.0 56.7 306.1 7.7 73.8 123.0 3.2 79.8 50.1 18.4 60.5 18.0 4.0 7.9 64.8 12.5 29.1 57.3 146.3 39.4 227.9 114.1 113.0 90.4 92.1 78.5 87.4 20.7 94.8 83.3 87.1 482.8 79.2 278.3 100.4 95.7 147.4 69.6 85.0 78.4 67.4 62.7 69.7 99.6 76.5 87.0 84.3 79.1 97.6 84.0 54.5 29.1 32.3 53.4 9.7 17.3 17.2 13.1 12.3 45.8 29.1 38.6 28.6 47.7 92.0 14.6 137.8 51.9 49.9 1.9 44.1 171.1 15.8 31.4 52.7 9.6 45.0 14.3 44.3 257.0 22.6 84.6 38.6 20.3 7.1 75.7 1.9 37.0 3.3 15.5 17.7 14.2 38.7 3.9 35.1 38.8 22.8 5.4 15.9 10.2 36.4 88.6 18.6 18.4 41.1 31.9 56.4 18.9 9.8 20.1 3.7 19.0 3.0 59.2 26.3 29.4 3.2 2.9 33.5 8.5 93.4 41.2 6.8 23.4 20.6 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680509 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "prostate: 306.4" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 19.9;granulocytes: 119.2;Oligodendrocytes: 47.1;Prostatic glandular cells: 67.2" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 382 "basophil: 40.5" "Lineage enriched" "Detected in single" 382 "granulocytes: 40.5" "Cell line enriched" "Detected in many" 29 "HMC-1: 834.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 10: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 3: HMC-1 - Innate immune response" "Cluster 35: Glandular cells - Unknown function" Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.33e-5)" 1.4 3.6 6.7 3.2 19.5 0.8 1.6 17.6 13.4 3.7 1.9 4.8 4.6 1.7 0.5 1.6 2.1 3.8 1.5 8.0 10.3 2.1 11.2 3.4 2.7 25.1 17.3 2.7 0.8 0.3 4.7 0.5 21.8 306.4 3.2 0.1 2.8 0.6 5.6 1.5 4.8 1.0 12.6 12.4 16.8 1.4 16.6 0.5 1.0 2.3 0.8 2.8 1.1 44.7 9.7 3.0 2.8 2.7 0.0 0.1 2.2 1.3 0.3 3.3 2.7 7.1 18.0 2.7 4.6 0.3 3.0 3.5 1.6 3.3 0.5 3.9 2.9 29.0 0.6 2.0 1.9 5.0 834.2 0.3 1.1 2.3 0.0 2.2 9.4 4.5 4.9 1.7 1.4 2.3 0.8 8.5 12.2 16.7 10.7 1.0 4.1 1.5 3.7 13.7 1.2 2.9 1.5 20.6 3.9 2.3 4.7 1.4 9.6 1.4 9.5 3.5 7.1 0.4 0.6 0.4 1.8 1.5 7.1 40.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 19.5 17.6 13.4 8.0 10.3 25.1 17.3 21.8 12.6 16.6 44.7 0.2 0.0 3.2 1.0 4.0 0.0 1.0 0.6 0.0 0.4 1.5 1.8 2.0 2.8 1.0 1.8 0.0 0.5 0.1 5.7 0.0 1.7 0.2 1.9 0.2 1.7 0.0 3.4 0.2 0.5 0.1 0.7 19.9 0.2 119.2 0.2 0.7 6.6 1.9 0.0 0.3 6.9 2.0 1.0 0.3 0.4 1.8 2.0 0.0 0.0 0.6 0.1 0.0 2.0 47.1 3.9 8.0 1.5 0.3 67.2 0.9 1.8 3.2 0.1 6.6 0.1 0.8 0.0 2.6 0.4 0.1 0.0 0.9 0.2 6.7 0.9 SLC4A11 "BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1" ENSG00000088836 "Solute carrier family 4 member 11" Q8NBS3 20 3227417-3239559 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Symport, Transport" "Corneal dystrophy, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 51.3;salivary gland: 54.0;thyroid gland: 60.9" "Cell type enhanced" "Detected in many" "Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA018120, HPA058377" Uncertain Uncertain Nucleoplasm,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Vesicles "HPA018120: AB_1857186, HPA058377: " "unprognostic (2.33e-1)" "prognostic favorable (9.03e-4)" "unprognostic (1.18e-2)" "unprognostic (3.05e-2)" "unprognostic (1.00e-1)" "unprognostic (6.52e-2)" "unprognostic (9.66e-3)" "unprognostic (3.73e-2)" "unprognostic (3.10e-3)" "unprognostic (1.52e-3)" "unprognostic (2.94e-1)" "unprognostic (2.64e-1)" "prognostic favorable (6.21e-6)" "unprognostic (7.37e-2)" "unprognostic (4.30e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-3)" 2.4 6.9 4.5 0.7 3.5 0.4 3.4 2.3 3.1 10.9 5.6 0.4 0.1 0.5 2.6 16.5 1.7 1.1 0.8 2.9 1.4 51.3 0.2 2.0 1.4 2.0 2.3 0.2 0.5 0.6 4.3 0.2 2.6 5.4 0.3 0.4 54.0 7.0 5.2 12.8 0.6 0.3 0.8 0.7 2.5 5.9 4.3 1.0 60.9 0.1 1.8 3.4 5.8 1.9 11.0 15.5 1.8 7.9 5.1 1.3 21.1 5.4 3.4 2.8 1.6 1.1 14.1 0.0 6.1 1.9 6.6 70.6 8.3 16.8 0.5 0.1 3.2 0.7 7.5 43.0 3.2 4.0 13.6 0.7 6.8 3.4 3.2 2.3 7.0 9.8 1.6 9.7 2.9 7.2 0.5 0.4 12.1 13.6 20.7 2.6 10.3 3.5 16.9 30.7 0.9 4.9 2.7 17.5 0.3 5.4 6.7 7.0 12.1 2.1 7.0 0.5 2.7 0.4 0.6 0.1 0.1 2.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 4.5 3.5 2.3 3.1 2.9 1.4 2.0 2.3 2.6 0.8 4.3 1.9 0.8 0.0 0.0 1.6 0.0 0.8 2.2 16.3 8.0 0.2 4.9 4.4 1.1 0.0 25.5 112.2 0.0 0.1 0.6 0.8 0.0 0.7 5.8 2.3 0.6 0.7 0.0 0.0 0.3 0.5 0.1 0.3 5.1 4.2 0.0 0.2 1.1 0.0 0.4 0.0 0.1 0.2 79.3 0.3 0.0 2.2 0.0 0.5 0.0 0.0 0.6 0.1 0.0 0.0 0.3 3.0 1.3 0.4 0.0 3.7 0.0 0.5 48.1 0.2 26.3 0.6 5.8 3.0 4.7 3.3 0.4 0.0 0.2 0.1 0.2 5.7 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 subunit beta" Q86UW2 15 65045387-65053397 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 41.8;intestine: 107.1" "Cell type enhanced" "Detected in some" "Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria No NA "Cluster 9: Intestine - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favorable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.7 1.1 5.8 3.5 5.5 0.8 0.3 4.0 3.9 41.8 0.0 41.9 86.9 3.0 0.3 2.4 3.6 2.8 2.3 3.8 6.5 19.5 2.2 6.1 0.6 7.3 10.9 1.1 0.3 0.0 0.4 0.6 7.7 2.7 29.4 0.7 1.0 0.6 1.0 0.8 107.1 1.7 6.5 0.8 0.8 9.6 11.8 0.0 0.7 0.0 0.0 1.5 0.9 4.2 0.0 1.5 0.2 0.8 0.0 0.1 0.4 0.0 0.0 0.2 0.0 18.5 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 15.7 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.4 0.1 0.4 0.4 0.1 0.4 0.0 0.0 0.9 0.4 0.0 0.6 0.5 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 4.0 3.9 3.8 6.5 7.3 10.9 7.7 6.5 11.8 4.2 0.0 0.0 1.1 0.3 1.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.1 0.0 354.6 13.7 0.0 60.8 10.4 0.2 1.2 1.8 2.7 0.0 0.0 0.0 0.5 0.0 1.9 4.5 0.0 0.4 1.8 0.1 0.0 0.0 23.0 0.0 0.3 0.0 14.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 145.1 0.0 0.0 0.0 721.4 73.3 15.6 0.0 6.6 1.0 0.4 27.9 0.5 0.0 0.0 0.1 0.6 0.1 45.8 0.0 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816201-10940714 "Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 153.3" "Cell type enhanced" "Detected in some" "Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.0 0.0 50.5 0.0 78.7 0.0 1.1 57.3 32.6 0.7 9.6 0.0 0.0 0.5 0.1 8.2 0.5 0.0 0.0 22.6 96.6 0.0 0.1 0.0 0.0 60.0 128.4 0.0 0.1 0.5 0.3 0.4 61.9 0.7 0.0 11.0 1.0 0.0 0.2 5.7 0.0 0.1 41.8 0.4 0.0 1.4 153.3 0.0 0.0 0.0 0.1 0.4 1.8 21.1 5.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 13.5 0.0 2.2 0.0 0.0 0.2 0.3 0.0 16.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.9 4.5 3.9 0.1 0.0 0.1 5.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 78.7 57.3 32.6 22.6 96.6 60.0 128.4 61.9 41.8 153.3 21.1 0.0 0.0 0.0 85.2 0.0 1.3 0.7 0.3 4.0 8.4 0.9 0.9 1.4 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 13.7 0.0 7.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 25.8 0.0 0.0 0.0 0.8 0.9 3.4 0.2 0.0 6.5 0.0 26.4 0.0 23.1 0.8 0.2 0.0 6.8 0.0 0.5 0.0 0.0 0.0 1.5 0.0 0.6 0.1 0.6 1.8 10.6 3.7 1.0 0.1 0.0 0.0 1.7 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859491-84913629 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.9;retina: 15.7" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 42.1;Bipolar cells: 19.7;Excitatory neurons: 63.9;Inhibitory neurons: 57.4;Melanocytes: 32.0;Oligodendrocytes: 46.9" "Group enriched" "Detected in some" 4 "head and neck cancer: 2.2;melanoma: 7.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 93.5;ASC TERT1: 55.4;hTERT-HME1: 135.3;SCLC-21H: 91.7;SK-MEL-30: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 77: Retina - Visual perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 0.6 1.4 8.0 0.2 7.8 0.0 0.4 4.0 12.7 0.9 0.0 0.4 0.1 0.5 0.0 2.8 0.2 0.0 0.0 6.9 12.9 0.2 0.0 0.1 0.0 7.4 21.9 0.3 0.0 0.0 5.5 3.8 16.7 0.2 0.2 15.7 0.8 0.1 0.0 1.4 0.4 0.3 0.2 0.0 0.1 0.4 8.8 0.1 0.3 1.6 0.2 0.2 1.3 5.0 0.0 2.5 10.3 0.0 93.5 55.4 0.1 0.1 21.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 12.0 1.2 0.0 23.7 0.1 0.0 25.1 0.0 4.1 0.0 33.5 0.0 0.2 31.4 48.2 11.9 135.3 25.3 0.3 0.0 0.0 0.0 25.9 0.0 0.1 0.0 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 91.7 22.6 0.1 31.1 71.0 0.2 0.0 0.0 0.0 12.7 6.5 0.1 0.0 0.0 0.0 0.1 23.1 0.0 27.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 7.8 4.0 12.7 6.9 12.9 7.4 21.9 16.7 0.2 8.8 5.0 0.0 0.0 0.0 4.2 0.1 2.7 0.0 3.1 42.1 19.7 0.1 0.1 0.5 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 63.9 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.8 57.4 0.0 0.0 0.0 0.4 0.6 0.0 0.0 32.0 1.9 0.0 1.1 0.0 4.0 46.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 11.1 0.0 0.5 1.0 0.4 0.5 5.8 0.6 0.3 0.0 0.0 0.0 0.0 SLC6A4 "5-HTT, HTT, OCD1, SERT1" ENSG00000108576 "Solute carrier family 6 member 4" P31645 17 30194319-30236002 "FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 232.0" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Group enriched" "Detected in some" 11 "midbrain: 232.0;pons: 86.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4" "Region enriched" "Detected in some" 4 "midbrain: 58.4" "Group enriched" "Detected in some" 7 "midbrain: 38.9;pons: 29.1" "HPA054723, HPA071354, HPA074728" Supported Supported Supported "Golgi apparatus,Vesicles" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Vesicles" "HPA054723: , HPA071354: , HPA074728: AB_2686708" "unprognostic (7.45e-2)" "unprognostic (7.13e-2)" "unprognostic (2.26e-1)" "unprognostic (3.72e-4)" "unprognostic (2.07e-1)" "unprognostic (8.42e-3)" "unprognostic (2.73e-2)" "unprognostic (3.39e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-3)" "unprognostic (2.70e-3)" "unprognostic (1.16e-1)" "unprognostic (8.78e-2)" "unprognostic (4.98e-2)" "unprognostic (1.76e-1)" "unprognostic (4.05e-2)" "unprognostic (7.18e-2)" 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.5 10.3 0.0 0.0 2.8 1.7 0.0 0.9 0.1 0.2 0.2 0.0 28.8 0.1 14.8 232.0 0.1 1.4 0.2 0.0 18.4 86.1 0.1 0.1 0.1 0.7 0.2 0.1 0.5 40.3 0.0 0.0 0.1 0.9 0.3 0.2 0.0 0.5 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 10.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.1 0.2 14.8 232.0 86.1 0.0 0.2 0.2 1.1 16.0 5.0 0.3 0.0 0.1 0.4 0.1 17.1 1.2 0.1 0.0 1.0 0.0 1.9 1.8 0.0 125.4 1.5 0.2 0.0 0.0 2.8 0.2 0.6 3.2 0.0 0.0 0.9 0.0 8.6 1.3 0.0 0.5 2.5 0.2 2.2 0.3 9.5 0.0 0.6 2.3 0.0 1.0 1.2 2.2 0.3 5.9 0.0 0.0 0.1 0.5 2.1 0.5 0.5 0.4 0.0 0.4 0.1 0.3 100.9 0.4 0.7 0.8 0.0 1.3 0.5 0.5 0.9 4.8 0.3 106.4 0.5 0.2 4.1 0.3 SLC7A6 "KIAA0245, LAT-2, LAT3, y+LAT-2" ENSG00000103064 "Solute carrier family 7 member 6" Q92536 16 68264516-68301823 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.0" "Cell type enhanced" "Detected in many" "Microglial cells: 55.3;Syncytiotrophoblasts: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050713 Uncertain Uncertain "Vesicles,Plasma membrane" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Plasma membrane" "HPA050713: AB_2681218" "unprognostic (6.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-2)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (1.89e-3)" "unprognostic (7.82e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.84e-4)" 35.3 8.8 1.7 15.5 1.9 8.4 26.9 6.5 3.3 5.5 17.3 8.3 3.9 5.8 11.5 4.5 8.6 4.4 18.5 3.3 2.2 5.9 2.0 10.9 18.6 1.0 1.3 2.7 3.8 2.5 9.6 18.6 1.5 6.2 11.1 5.0 7.3 5.2 75.0 10.2 12.0 7.7 1.0 10.7 6.6 5.1 2.2 37.6 16.7 26.9 21.5 6.8 4.8 1.1 22.6 22.1 16.3 16.8 46.9 27.6 42.9 24.9 18.7 36.9 30.6 97.9 16.2 43.7 19.8 33.4 10.9 33.1 32.0 32.2 39.7 9.5 22.9 23.8 47.3 31.0 7.7 28.2 20.3 19.3 26.1 27.5 13.5 11.4 25.3 21.0 35.1 7.3 20.5 11.7 36.4 19.3 12.4 14.6 8.1 45.0 10.2 36.0 12.0 19.6 23.7 13.5 75.7 20.8 6.8 13.4 30.9 13.3 38.4 24.6 19.0 20.5 32.8 16.7 33.5 50.3 15.6 20.1 17.2 3.4 3.2 2.8 4.3 1.7 5.4 6.8 6.6 4.3 3.6 6.3 11.7 6.7 6.1 7.1 1.4 16.8 3.1 1.5 1.7 1.9 6.5 3.3 3.3 2.2 1.0 1.3 1.5 1.0 2.2 1.1 8.5 41.7 18.8 12.4 18.4 19.6 9.3 8.5 13.6 6.1 5.9 4.8 19.9 2.8 4.9 18.4 37.5 25.1 23.3 7.3 0.0 3.3 5.5 10.7 16.8 12.0 2.4 2.1 39.3 4.0 2.5 12.8 4.1 3.3 4.5 1.8 6.8 1.4 14.6 10.1 40.3 10.5 4.1 8.5 12.1 18.3 5.9 9.9 10.6 55.3 10.0 1.8 14.4 13.0 10.7 5.6 5.9 3.8 16.0 8.0 2.5 0.6 10.4 2.7 0.0 10.8 7.2 17.3 10.9 6.7 21.9 47.9 23.5 4.3 7.8 2.6 SLCO5A1 "OATP-J, OATP5A1, OATPRP4, SLC21A15" ENSG00000137571 "Solute carrier organic anion transporter family member 5A1" Q9H2Y9 8 69667046-69834978 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.5;skeletal muscle: 7.6;tongue: 11.1" "Group enriched" "Detected in many" 4 "Bipolar cells: 10.1;Cardiomyocytes: 14.4;Enteroendocrine cells: 15.6;Excitatory neurons: 8.6;Inhibitory neurons: 30.1;monocytes: 21.2;Oligodendrocyte precursor cells: 26.2;Plasma cells: 14.3;Prostatic glandular cells: 11.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.5;NTERA-2: 3.7;RPMI-8226: 3.6;SCLC-21H: 3.9;U-266/70: 2.1" "Group enriched" "Detected in some" 7 "basal ganglia: 2.3;olfactory bulb: 6.7" "Region enriched" "Detected in some" 7 "olfactory bulb: 12.8" HPA025062 Uncertain Supported "Vesicles,Plasma membrane" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" Vesicles "HPA025062: AB_1857220" "unprognostic (1.30e-3)" "unprognostic (7.35e-3)" "unprognostic (4.13e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (5.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.37e-4)" "unprognostic (1.75e-1)" "unprognostic (4.48e-4)" "unprognostic (1.74e-2)" "unprognostic (2.92e-6)" "unprognostic (2.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.13e-1)" "unprognostic (4.50e-2)" 0.1 0.0 0.3 0.9 0.4 0.9 0.1 0.0 0.4 0.2 0.0 0.2 0.2 0.2 0.0 0.5 0.3 0.2 3.7 0.2 0.6 0.0 0.0 0.1 1.0 0.2 0.0 0.0 0.4 0.0 1.5 0.0 0.2 2.3 0.4 0.7 0.3 0.0 7.6 0.1 0.3 0.1 0.0 0.5 0.2 0.3 0.1 6.5 0.0 11.1 0.9 0.6 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 1.5 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 3.7 0.0 0.6 0.6 0.6 3.6 0.0 0.0 3.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 2.1 0.3 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.6 0.2 0.0 0.2 0.0 0.1 0.1 0.1 3.2 0.0 3.6 3.6 0.3 1.8 0.0 0.6 10.1 0.2 0.3 14.4 0.0 0.6 0.0 2.1 0.0 0.0 0.6 0.0 1.8 0.6 0.4 1.7 2.0 15.6 0.0 8.6 1.3 0.0 4.0 0.0 1.7 0.0 0.0 0.0 0.2 0.1 1.7 30.1 2.0 0.0 0.0 3.6 0.6 0.0 0.7 0.0 3.7 21.2 0.5 0.0 26.2 2.2 2.1 0.1 0.0 14.3 11.8 0.0 0.1 0.0 0.3 0.0 3.4 2.0 1.1 2.6 0.4 0.4 0.0 0.1 0.4 1.5 1.5 SLF2 "C10orf6, FAM178A, FLJ10512, FLJ25012" ENSG00000119906 "SMC5-SMC6 complex localization factor 2" Q8IX21 10 100912963-100965134 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 108.1;Peritubular cells: 105.7;Theca cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 145.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038499, HPA057568" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA038499: AB_10672520, HPA057568: AB_2683471" "unprognostic (9.05e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-2)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.66e-2)" "unprognostic (1.54e-2)" "unprognostic (1.16e-3)" "unprognostic (2.85e-1)" "unprognostic (4.90e-2)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" 9.1 17.2 17.3 10.9 29.2 11.8 8.8 20.4 23.1 14.0 9.3 12.6 7.9 20.8 48.6 8.9 17.6 8.0 10.8 17.0 24.9 11.3 11.6 10.8 14.7 24.5 24.7 25.1 13.1 7.9 23.8 15.4 25.7 15.2 10.1 11.7 9.4 12.9 17.8 13.4 12.7 10.7 19.1 23.1 10.4 25.8 25.3 12.2 11.3 13.3 11.5 11.3 11.2 46.2 25.7 20.6 29.6 31.4 16.1 20.9 11.3 26.3 18.5 24.1 29.0 15.2 17.5 24.1 15.8 11.3 17.9 25.3 20.4 8.8 29.1 26.6 16.6 21.7 14.2 31.0 11.7 28.0 24.9 10.0 13.2 18.6 19.9 25.1 15.7 14.7 15.6 22.5 37.3 17.7 19.1 16.0 13.7 9.9 15.2 18.5 145.7 8.3 10.1 12.8 6.6 12.9 16.5 4.6 30.6 14.1 26.3 10.7 20.6 28.2 23.4 18.0 31.1 18.1 28.5 19.1 20.0 32.9 15.1 6.1 6.6 7.0 9.8 6.7 8.9 8.6 7.8 8.5 5.2 11.0 8.5 7.8 3.6 9.1 7.5 7.5 8.0 4.6 17.3 29.2 20.4 23.1 17.0 24.9 24.5 24.7 25.7 19.1 25.3 46.2 18.4 25.6 18.9 0.0 18.2 0.0 8.4 0.0 12.5 33.8 13.8 12.6 0.0 5.7 8.6 25.8 25.0 17.4 29.4 9.0 13.7 11.0 8.4 22.7 64.8 20.8 12.2 11.3 0.0 8.0 7.1 20.2 10.7 25.0 24.0 32.3 26.7 12.8 17.9 38.7 0.0 10.5 0.0 18.2 0.0 10.4 108.1 18.6 0.0 0.0 19.2 19.7 46.4 0.0 0.0 7.0 8.4 105.7 12.3 9.4 9.3 8.9 13.8 31.4 19.7 44.5 12.8 33.5 43.0 10.4 0.0 5.1 19.7 77.6 8.2 6.0 SLFN5 MGC19764 ENSG00000166750 "Schlafen family member 5" Q08AF3 17 35243071-35273655 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 261.6;Respiratory ciliated cells: 133.0;T-cells: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 24.7;MAIT T-cell: 30.6;memory CD4 T-cell: 30.7;memory CD8 T-cell: 28.9;naive CD4 T-cell: 37.5;naive CD8 T-cell: 31.2;NK-cell: 42.3;T-reg: 68.8" "Group enriched" "Detected in all" 7 "NK-cells: 42.3;T-cells: 68.8" "Cell line enhanced" "Detected in many" "HHSteC: 108.6;hTERT-HME1: 146.8" "Low region specificity" "Detected in all" HPA017760 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Vesicles "HPA017760: AB_2189993" "unprognostic (3.43e-1)" "unprognostic (3.26e-1)" "unprognostic (4.66e-2)" "unprognostic (1.60e-1)" "unprognostic (8.35e-2)" "unprognostic (1.15e-3)" "unprognostic (1.70e-2)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (7.01e-2)" "unprognostic (2.41e-3)" "unprognostic (2.39e-1)" "unprognostic (6.05e-3)" "unprognostic (3.27e-1)" "unprognostic (7.77e-2)" "unprognostic (3.92e-1)" "unprognostic (1.48e-1)" 17.8 8.7 2.7 23.9 2.5 5.4 11.6 2.1 2.5 20.0 3.8 6.4 7.0 14.1 3.4 8.9 14.0 12.1 8.6 2.6 3.5 5.0 5.8 21.1 32.4 6.1 2.2 5.6 3.7 6.7 1.5 14.1 4.9 10.3 7.8 2.3 18.0 15.7 20.7 5.0 8.0 11.5 4.9 25.8 9.9 2.0 3.5 40.9 11.5 10.1 28.2 19.9 5.2 5.7 21.3 10.7 1.7 1.8 30.2 52.2 4.2 54.3 85.4 44.5 49.2 0.2 13.5 2.7 34.1 54.0 11.8 87.1 1.0 24.5 30.9 0.7 1.9 0.4 11.6 1.3 108.6 1.6 0.6 59.9 60.5 34.0 146.8 26.8 20.6 22.0 0.2 31.1 31.4 1.7 26.9 1.3 1.7 4.7 8.0 0.0 17.9 0.2 11.6 51.8 3.6 0.0 6.0 5.6 93.7 6.0 35.9 0.8 81.2 17.6 6.8 12.9 12.5 6.0 0.6 0.4 51.9 0.3 26.0 6.3 4.3 2.9 24.7 6.4 30.6 0.9 30.7 28.9 3.6 1.6 37.5 31.2 1.8 42.3 7.8 1.2 68.8 18.2 2.7 2.5 2.1 2.5 2.6 3.5 6.1 2.2 4.9 4.9 3.5 5.7 126.9 60.9 71.7 1.6 8.4 4.6 27.1 97.8 8.0 1.6 16.5 15.9 10.1 28.6 92.3 18.4 0.0 0.3 75.6 1.8 1.9 71.7 1.9 95.0 23.2 90.4 1.2 3.6 4.1 38.8 5.3 30.3 18.8 56.0 61.3 1.4 79.2 4.7 13.2 6.7 3.6 4.6 46.8 26.5 14.4 0.4 7.5 22.6 12.4 12.2 49.1 6.7 261.6 3.0 10.1 70.0 3.8 1.5 17.6 122.5 1.7 1.9 133.0 4.2 13.1 34.9 29.8 0.5 1.9 10.2 4.0 0.3 128.6 5.4 1.0 74.2 SMARCA1 "hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI" ENSG00000102038 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1" P28370 X 129446501-129523500 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003335, HPA064712" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm Vesicles "HPA003335: AB_1080024, HPA064712: AB_2685332" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (6.21e-2)" "unprognostic (2.16e-2)" "unprognostic (5.44e-2)" "unprognostic (7.15e-2)" "unprognostic (3.41e-2)" "unprognostic (1.53e-1)" "prognostic favorable (3.03e-4)" "unprognostic (9.26e-2)" "prognostic favorable (5.09e-4)" "unprognostic (1.87e-3)" "unprognostic (1.28e-1)" "unprognostic (6.14e-2)" "unprognostic (2.33e-2)" 19.0 78.6 15.7 9.0 17.8 0.3 20.6 14.0 18.1 27.9 36.0 20.9 6.7 27.2 34.7 11.3 20.1 21.4 24.5 19.9 31.6 23.9 62.1 16.3 4.6 17.0 19.0 72.6 15.8 44.6 34.8 38.0 20.3 36.7 7.0 26.7 18.5 35.4 17.3 8.1 8.4 25.9 17.1 8.9 17.3 57.7 26.7 7.9 45.3 19.8 4.2 30.0 14.0 18.1 23.5 53.5 104.8 67.9 76.3 67.1 36.6 46.8 133.2 68.6 76.7 18.3 80.9 0.0 71.8 88.7 81.1 22.1 66.6 27.5 76.4 0.1 12.9 0.2 46.9 100.0 32.6 0.0 0.1 84.2 7.8 49.0 9.3 104.3 50.4 13.1 12.4 5.7 76.1 0.0 0.6 0.2 42.6 9.0 31.0 0.0 56.7 0.2 67.4 28.3 26.0 69.8 6.6 0.9 12.1 73.1 46.9 0.6 35.7 46.0 23.3 30.3 26.4 0.0 0.0 0.2 40.7 0.0 28.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.5 0.0 0.2 0.0 0.1 15.7 17.8 14.0 18.1 19.9 31.6 17.0 19.0 20.3 17.1 26.7 18.1 23.2 96.1 55.0 24.2 1.5 23.3 35.4 28.3 47.3 26.5 34.8 24.1 80.5 12.8 47.6 40.5 45.9 56.9 1.8 0.1 29.4 30.1 3.7 32.2 80.2 25.6 16.8 3.2 29.3 12.0 15.7 64.3 23.4 42.7 2.5 84.3 22.9 67.0 15.0 92.5 43.4 2.6 14.2 3.2 9.9 18.4 142.9 3.0 28.4 22.5 5.7 47.7 0.0 41.2 17.2 14.0 0.1 125.6 0.1 24.9 0.2 34.9 41.0 13.4 65.7 40.0 49.7 11.4 23.9 17.5 11.8 58.4 2.0 82.9 2.3 29.2 SMARCD1 "BAF60A, CRACD1, Rsc6p" ENSG00000066117 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1" Q96GM5 12 50085200-50100707 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Chromatin regulator" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004101 Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Vesicles "HPA004101: AB_1080026" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.02e-1)" "unprognostic (2.76e-1)" "prognostic unfavorable (2.53e-8)" "unprognostic (3.62e-2)" "unprognostic (1.44e-1)" "unprognostic (4.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" "unprognostic (2.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.38e-1)" "unprognostic (5.04e-2)" 25.8 28.1 25.2 23.2 27.6 44.0 24.9 24.4 27.0 23.5 20.8 22.0 23.2 27.9 27.1 27.5 23.8 17.9 18.3 26.3 23.8 25.3 19.0 23.9 35.0 25.7 25.7 26.4 22.5 47.3 19.7 28.9 25.3 23.2 27.2 25.1 24.3 21.8 16.9 24.3 27.8 28.8 24.8 31.3 20.5 23.8 25.8 57.2 26.8 16.1 47.6 23.5 21.7 27.6 28.4 47.6 134.8 75.8 41.1 38.9 68.1 35.1 62.0 100.3 58.2 130.0 42.1 109.4 51.0 67.2 44.4 35.4 112.9 91.5 87.3 84.4 87.0 107.2 49.4 75.8 49.3 95.0 41.1 40.2 60.2 59.8 107.4 66.1 119.5 114.0 93.1 64.8 50.6 67.7 137.6 54.0 166.0 43.2 76.6 165.5 34.9 96.0 57.3 66.1 71.4 121.3 73.1 35.2 139.3 100.4 79.4 78.7 70.4 50.1 56.0 31.7 69.9 91.6 88.2 95.4 40.6 37.7 56.9 3.4 1.2 2.2 2.9 1.2 2.9 3.6 1.6 2.0 1.8 2.7 1.0 3.3 0.5 1.7 1.9 3.5 2.7 1.2 25.2 27.6 24.4 27.0 26.3 23.8 25.7 25.7 25.3 24.8 25.8 27.6 29.7 0.0 9.6 11.1 42.9 16.6 22.3 17.7 42.7 33.7 33.2 30.2 6.5 15.7 20.5 27.6 20.9 21.1 39.6 21.6 52.8 32.8 4.3 20.0 36.9 30.1 31.1 25.7 9.3 29.0 19.4 17.8 14.8 30.5 16.5 40.0 17.5 15.1 17.3 26.9 10.5 18.2 10.2 14.4 13.1 9.1 16.4 16.8 17.8 7.5 27.1 26.5 29.9 11.1 17.1 36.8 14.8 16.1 28.9 28.8 19.5 47.9 9.4 28.8 32.9 31.6 28.2 28.4 36.5 31.3 19.6 11.1 30.0 26.8 19.1 15.9 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 125.0;Distal tubular cells: 92.0;Endometrial ciliated cells: 69.4;Erythroid cells: 142.5;Glandular and luminal cells: 67.6;Urothelial cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 56 "plasmacytoid DC: 207.6" "Lineage enriched" "Detected in many" 56 "dendritic cells: 207.6" "Cell line enhanced" "Detected in some" "HEL: 2.3;MCF7: 10.5;OE19: 2.8;SK-BR-3: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles "Golgi apparatus" "HPA065332: AB_2685471, HPA071268: AB_2686377" "unprognostic (6.97e-2)" "prognostic favorable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favorable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 1.3 0.6 4.5 1.9 8.5 11.4 1.5 8.5 6.4 8.4 10.7 10.5 9.6 1.2 0.8 27.4 7.4 4.4 12.2 5.0 5.6 28.4 1.4 3.1 1.1 11.2 8.8 2.7 2.5 3.4 2.4 1.9 9.6 4.2 2.6 0.7 7.8 1.9 0.5 14.3 15.2 0.5 7.2 4.8 10.1 2.2 7.8 0.6 15.9 0.3 3.6 6.1 14.6 16.4 1.8 1.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.4 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 10.5 0.1 0.0 0.0 2.8 0.1 0.3 0.3 0.0 0.0 2.0 0.8 0.0 0.0 4.5 0.0 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.5 0.5 1.1 0.3 0.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.1 0.0 207.6 0.0 13.7 4.5 8.5 8.5 6.4 5.0 5.6 11.2 8.8 9.6 7.2 7.8 16.4 0.7 9.6 7.0 0.7 1.6 1.1 7.3 4.8 0.6 1.5 1.2 0.9 25.1 10.0 13.9 125.0 2.1 3.1 51.9 48.4 92.0 2.9 0.1 69.4 10.1 1.8 14.4 142.5 0.0 0.5 5.8 2.3 26.0 67.6 0.0 0.3 1.8 0.2 0.7 0.0 0.0 16.1 44.7 0.6 0.9 0.3 0.6 17.0 7.2 0.0 1.2 3.3 1.0 0.0 17.9 10.7 54.2 1.5 0.9 7.4 15.5 0.9 48.0 2.1 0.0 1.4 3.1 0.4 0.5 10.0 8.4 32.8 0.8 0.3 2.3 90.6 SMURF1 KIAA1625 ENSG00000198742 "SMAD specific E3 ubiquitin protein ligase 1" Q9HCE7 7 99027440-99144108 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 100.2;Microglial cells: 89.9;Oligodendrocytes: 211.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 9.2;BJ: 15.2;EFO-21: 12.8;HDLM-2: 8.1;PC-3: 18.2;U-2 OS: 8.3;U-251 MG: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019671, HPA055245" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Nucleoplasm "HPA019671: , HPA055245: AB_2682757" "unprognostic (2.21e-1)" "unprognostic (6.15e-2)" "unprognostic (8.88e-2)" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (3.92e-3)" "unprognostic (2.58e-1)" "unprognostic (1.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.68e-1)" "unprognostic (3.81e-1)" "unprognostic (4.62e-2)" 17.7 13.9 0.7 0.3 0.8 1.1 14.3 0.5 0.9 13.4 1.1 12.7 0.0 12.3 0.0 22.0 12.2 0.0 9.0 0.8 0.3 11.6 11.7 18.5 0.0 1.1 0.7 20.6 15.5 0.0 11.2 0.0 1.0 13.3 0.0 0.7 15.0 0.0 12.7 20.2 11.7 0.0 0.1 10.0 16.1 20.9 0.8 0.0 8.5 0.0 0.0 12.4 15.5 1.8 9.2 0.0 0.1 0.2 0.0 0.0 1.3 15.2 0.1 0.4 0.0 0.0 0.4 1.6 12.8 0.0 0.3 4.5 0.0 0.1 0.0 8.1 2.3 0.0 0.7 0.7 0.1 0.1 3.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.9 0.1 0.8 0.1 1.3 1.9 2.8 0.0 18.2 2.5 1.2 0.0 0.0 0.4 0.3 1.5 0.7 0.5 0.9 0.3 0.3 0.0 1.4 0.0 8.3 1.3 9.4 2.0 4.9 1.3 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.5 0.9 0.8 0.3 1.1 0.7 1.0 0.1 0.8 1.8 9.7 19.2 27.5 59.4 8.9 25.9 25.5 10.0 25.0 28.2 10.3 7.2 4.4 20.0 18.5 12.9 8.4 7.7 4.6 17.1 1.9 14.7 6.2 13.3 8.8 12.8 11.4 0.4 100.2 16.0 10.3 10.8 46.9 23.3 2.5 6.8 9.7 9.3 6.6 26.9 77.0 11.0 4.1 4.1 10.9 8.5 6.2 8.8 8.8 89.9 5.5 3.3 5.2 70.4 211.9 34.8 14.9 13.9 5.4 37.9 7.1 5.5 22.1 7.6 6.6 10.4 15.1 32.8 2.4 19.3 22.0 21.1 8.8 6.5 8.1 77.5 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 20 "brain: 1658.7;retina: 492.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 559.2;Excitatory neurons: 1015.8;Inhibitory neurons: 552.8;Rod photoreceptor cells: 254.4" "Cancer enriched" "Detected in many" 4 "glioma: 28.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 23.8;SCLC-21H: 78.2;SH-SY5Y: 46.6;U-87 MG: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane" NA NA 9000 "Cluster 6: Brain - Smell perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 1.5 43.6 251.0 4.1 383.5 0.2 4.4 598.0 1658.7 0.8 0.0 5.7 3.7 7.9 12.9 0.5 7.7 2.3 3.2 420.4 142.2 1.4 1.0 1.8 0.4 427.4 24.7 6.9 6.3 1.2 54.3 0.6 386.6 3.2 2.3 492.0 0.5 19.6 0.8 0.7 3.9 8.1 38.1 0.2 6.3 3.6 147.6 0.5 0.7 0.1 0.4 1.1 1.6 726.9 0.0 4.7 3.9 0.0 0.4 0.1 0.0 2.0 0.0 4.8 1.4 0.0 0.0 0.0 4.3 0.0 3.4 0.8 0.6 0.0 9.6 0.5 0.3 0.0 6.8 0.7 3.5 0.0 0.5 4.4 0.0 3.9 0.0 10.7 0.0 2.8 0.0 23.8 1.6 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.0 0.1 0.9 0.0 78.2 46.6 0.7 0.1 0.0 2.4 0.0 6.5 0.0 5.0 6.8 0.0 2.3 0.1 12.9 0.1 56.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 251.0 383.5 598.0 1658.7 420.4 142.2 427.4 24.7 386.6 38.1 147.6 726.9 0.5 0.0 0.0 117.2 0.0 0.8 1.4 0.1 0.0 559.2 0.2 1.3 0.5 8.6 0.0 0.0 106.3 0.0 0.2 0.0 0.0 0.2 16.3 0.1 0.7 5.2 43.5 0.0 1015.8 0.0 0.1 3.9 0.0 0.2 0.0 0.6 0.0 0.2 0.1 65.6 552.8 3.4 0.0 0.0 0.4 83.3 17.1 0.1 1.8 120.9 0.0 71.9 0.0 179.4 113.3 1.0 2.6 68.8 0.0 0.6 0.1 3.0 0.0 254.4 0.0 0.0 1.3 1.1 0.4 0.0 0.9 0.0 0.0 2.6 0.1 0.1 SNX11 ENSG00000002919 "Sorting nexin 11" Q9Y5W9 17 48103357-48123601 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044787, HPA054660" Approved Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Endoplasmic reticulum" Vesicles "HPA044787: AB_10795988, HPA054660: AB_2682560" "unprognostic (1.75e-1)" "unprognostic (6.86e-3)" "unprognostic (4.34e-2)" "unprognostic (4.33e-3)" "unprognostic (2.45e-1)" "unprognostic (1.54e-1)" "unprognostic (2.68e-3)" "unprognostic (2.07e-1)" "unprognostic (9.27e-2)" "unprognostic (2.15e-1)" "unprognostic (5.42e-2)" "unprognostic (2.12e-1)" "unprognostic (5.22e-3)" "unprognostic (9.02e-3)" "unprognostic (2.70e-2)" "unprognostic (9.50e-2)" "unprognostic (3.89e-2)" 14.3 12.0 18.0 18.1 19.1 21.5 11.1 18.2 19.4 10.5 16.4 13.8 8.7 10.5 12.5 19.9 9.6 8.9 12.5 18.3 18.4 15.8 14.5 11.4 21.7 20.1 18.9 8.8 11.7 13.4 10.7 11.3 18.8 12.1 12.5 11.9 12.2 8.7 12.8 11.6 12.4 17.0 20.1 24.0 12.4 11.4 19.8 16.1 20.0 15.3 29.1 13.3 11.6 20.7 20.6 25.4 21.9 21.1 18.1 8.3 22.8 21.8 13.9 26.5 28.8 36.0 17.7 21.6 27.3 24.1 15.5 18.6 21.2 21.0 29.2 52.4 24.5 32.5 17.5 17.5 18.4 36.0 22.7 13.8 20.8 25.1 23.7 16.5 22.4 20.4 19.8 21.7 17.4 17.0 21.8 22.8 12.2 23.6 21.3 13.5 39.7 24.8 16.1 20.1 15.7 28.6 14.2 9.7 37.7 26.6 20.1 25.4 18.8 30.6 18.2 20.3 26.3 34.0 54.1 26.0 22.1 16.4 19.6 28.7 34.6 35.6 19.0 43.3 13.1 22.1 10.5 12.9 28.2 21.2 8.6 14.7 92.9 16.8 54.5 12.9 10.1 24.0 18.0 19.1 18.2 19.4 18.3 18.4 20.1 18.9 18.8 20.1 19.8 20.7 8.7 6.4 2.0 2.9 15.4 6.0 5.0 5.9 7.4 8.9 6.4 6.2 5.3 1.5 4.3 16.5 2.1 11.7 14.2 13.3 5.9 11.4 1.9 6.2 4.6 8.0 14.9 3.6 4.1 15.3 12.2 6.0 6.6 7.1 2.5 5.4 6.1 6.9 19.9 15.2 3.9 9.0 6.1 23.2 4.6 2.1 5.3 15.9 5.4 2.8 37.5 14.2 14.4 5.0 8.8 18.1 5.6 6.8 6.3 6.9 9.9 9.9 2.9 9.3 13.1 4.6 8.8 10.3 21.2 8.9 5.1 16.4 7.5 7.7 8.0 6.4 SNX14 RGS-PX2 ENSG00000135317 "Sorting nexin 14" Q9Y5W7 6 85505496-85594156 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017639 Approved Supported Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Vesicles, Cytosol" "HPA017639: AB_1857345" "unprognostic (1.16e-2)" "unprognostic (3.29e-2)" "unprognostic (2.19e-2)" "unprognostic (1.52e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (1.57e-2)" "unprognostic (3.14e-2)" "unprognostic (2.37e-2)" "unprognostic (1.10e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.87e-3)" "unprognostic (4.72e-3)" 27.3 39.9 39.0 23.0 40.5 31.4 41.7 44.4 61.0 30.8 49.7 39.7 29.8 23.5 57.3 24.3 28.2 28.3 24.8 40.7 47.0 54.4 69.6 39.6 32.6 40.1 40.7 26.8 43.6 47.1 36.3 36.2 43.1 33.2 35.1 47.2 27.8 30.8 16.4 28.6 31.7 22.4 40.9 37.4 45.3 87.0 42.5 18.9 40.5 12.9 28.8 35.1 24.7 44.2 46.1 27.3 44.5 64.9 98.3 71.6 46.0 58.0 78.5 44.2 67.5 49.0 75.4 60.3 69.8 74.4 85.9 60.7 30.5 58.8 69.4 53.3 18.0 66.1 36.4 75.1 80.9 62.4 65.0 63.0 43.7 52.0 51.6 81.1 79.4 23.2 67.7 50.4 96.9 52.1 4.4 117.0 18.3 72.1 31.1 26.2 90.6 29.1 107.1 82.7 19.8 44.5 35.0 76.6 56.3 57.9 47.9 108.9 71.6 35.4 21.8 44.1 60.3 50.4 87.0 22.8 71.3 72.2 71.8 36.7 21.5 33.0 19.9 33.6 14.7 13.3 13.4 18.1 26.2 14.7 12.0 15.0 9.9 22.9 40.9 7.9 16.7 15.7 39.0 40.5 44.4 61.0 40.7 47.0 40.1 40.7 43.1 40.9 42.5 44.2 28.5 93.0 47.2 76.4 25.3 14.7 18.7 32.8 15.9 36.4 23.3 15.1 16.9 15.7 39.1 22.0 56.3 50.4 32.6 30.7 5.9 31.7 87.1 37.3 22.2 26.9 31.8 13.2 115.2 41.6 31.9 23.1 37.8 32.5 31.6 36.0 26.0 28.7 35.4 15.2 124.4 26.1 65.1 37.7 22.3 21.6 19.6 33.4 28.4 63.7 43.1 26.1 41.2 85.5 91.0 34.4 22.0 29.3 23.8 15.7 31.9 25.1 58.9 40.7 19.7 26.2 33.0 173.0 14.9 15.9 14.8 56.5 26.4 26.5 28.6 17.7 SNX17 KIAA0064 ENSG00000115234 "Sorting nexin 17" Q15036 2 27370496-27377535 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043867 Supported Enhanced Vesicles,Cytosol No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles Cytosol "HPA043867: AB_10961129" "unprognostic (2.57e-1)" "unprognostic (7.14e-3)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.06e-3)" "unprognostic (1.86e-1)" "unprognostic (4.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.04e-2)" "unprognostic (9.25e-2)" "unprognostic (1.33e-1)" "unprognostic (6.20e-2)" "unprognostic (1.37e-1)" "unprognostic (2.39e-1)" "unprognostic (6.32e-3)" 62.5 74.6 32.2 23.1 32.6 19.8 57.0 35.3 31.8 59.7 32.1 58.5 17.3 62.8 16.6 62.2 57.7 22.1 60.3 30.3 32.7 54.6 62.9 53.8 32.3 33.5 33.1 62.4 53.9 42.5 61.1 28.1 37.1 54.2 23.3 12.8 50.3 31.6 49.2 57.0 53.3 33.4 36.3 80.8 54.1 34.1 35.0 43.9 54.3 33.9 33.8 59.8 50.9 37.0 40.1 70.0 45.3 56.4 85.9 71.5 29.0 47.3 85.2 71.8 52.2 43.5 37.8 39.5 55.4 113.9 61.9 23.7 42.4 63.8 57.9 40.7 72.5 44.8 20.3 55.4 80.9 47.6 41.6 66.9 56.7 49.6 59.5 54.1 78.3 32.7 35.5 32.8 87.2 47.7 50.2 31.3 29.2 62.5 67.1 22.7 74.0 64.9 53.5 34.1 46.3 55.1 38.6 39.0 18.1 31.9 30.5 29.6 50.6 57.4 31.6 33.8 45.5 56.8 47.5 49.4 50.0 49.8 60.9 87.5 138.7 88.9 65.6 135.2 66.9 72.7 61.2 67.6 135.6 73.2 57.5 60.6 30.8 72.2 146.9 73.8 78.5 231.9 32.2 32.6 35.3 31.8 30.3 32.7 33.5 33.1 37.1 36.3 35.0 37.0 60.8 16.0 39.1 6.5 68.3 32.5 48.2 78.3 32.5 30.9 47.1 61.3 31.5 35.8 43.3 29.5 14.6 173.5 69.3 56.9 82.2 84.0 8.9 34.4 39.9 52.7 55.1 49.2 6.8 63.9 132.7 60.3 35.2 25.6 43.1 64.5 47.5 64.9 134.9 45.4 7.7 48.3 79.3 118.1 42.7 9.7 58.4 83.4 69.4 2.8 141.9 80.1 76.2 11.1 11.2 64.8 54.1 85.0 60.3 41.4 75.4 95.3 38.6 23.2 32.9 41.4 68.4 58.0 53.2 55.0 34.4 99.6 63.2 102.1 60.0 34.9 SNX21 "C20orf161, dJ337O18.4, SNX-L" ENSG00000124104 "Sorting nexin family member 21" Q969T3 20 45833799-45843276 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Theca cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.8;classical monocyte: 1.6;eosinophil: 4.8;intermediate monocyte: 2.6;non-classical monocyte: 2.0" "Group enriched" "Detected in many" 8 "granulocytes: 4.8;monocytes: 2.6" "Cell line enhanced" "Detected in many" "EFO-21: 17.9;PC-3: 29.8;U-87 MG: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046359 Approved Approved "Vesicles,Centriolar satellite" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Centriolar satellite" "HPA046359: AB_10963216" "unprognostic (1.97e-1)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.24e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (4.96e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-2)" "unprognostic (2.18e-1)" 25.0 27.8 4.9 1.1 4.1 0.7 18.7 5.8 7.9 26.4 4.9 15.8 3.7 28.6 0.8 14.1 24.6 5.0 14.9 3.5 2.8 11.9 6.2 10.9 1.3 9.2 5.1 30.5 4.2 3.3 10.9 2.9 6.5 14.4 1.2 0.7 9.7 4.8 31.9 47.9 7.5 1.9 3.0 7.3 11.3 6.1 7.2 0.5 9.1 6.7 0.6 25.7 19.5 4.6 4.3 6.7 1.0 6.5 7.8 7.5 4.3 6.8 5.0 5.0 4.0 5.0 3.0 0.1 17.9 4.8 4.1 5.5 0.2 4.5 0.8 0.3 1.4 0.1 4.1 4.6 3.3 0.0 1.3 3.9 2.7 4.8 0.4 1.7 3.6 1.1 0.1 0.0 0.9 11.1 0.1 0.8 1.8 0.8 29.8 0.1 0.5 0.2 1.0 0.7 1.2 11.6 14.6 10.3 8.1 0.8 5.9 1.2 6.4 6.0 7.2 17.2 5.5 0.2 0.9 0.2 18.1 0.0 4.4 2.8 1.6 4.8 0.0 2.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.4 0.3 4.9 4.1 5.8 7.9 3.5 2.8 9.2 5.1 6.5 3.0 7.2 4.6 11.1 9.6 8.3 25.1 1.0 10.1 4.7 6.4 8.6 18.4 8.6 8.5 4.8 7.2 10.3 5.5 8.4 4.9 0.4 10.3 25.4 10.3 3.7 5.0 27.0 10.3 9.0 0.0 4.8 11.7 5.2 37.0 6.6 7.5 0.0 27.0 10.4 4.3 4.8 15.2 5.7 9.2 4.1 7.1 10.0 18.3 19.6 5.4 10.6 3.7 3.3 14.8 1.0 8.5 6.5 8.4 5.9 17.0 0.8 3.7 15.9 15.7 6.6 15.6 6.6 16.4 20.1 0.9 2.4 4.1 22.7 2.5 2.2 62.2 7.0 3.4 SNX22 FLJ13952 ENSG00000157734 "Sorting nexin 22" Q96L94 15 64151715-64157481 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8;thyroid gland: 38.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;B-cells: 33.4;Erythroid cells: 136.8;Oligodendrocyte precursor cells: 95.5" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 3.3;naive B-cell: 6.1" "Lineage enriched" "Detected in many" 6 "B-cells: 6.1" "Cell line enriched" "Detected in some" 5 "Daudi: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038470 Approved Nucleoplasm,Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles Nucleoplasm "HPA038470: AB_10673174" "prognostic favorable (2.89e-5)" "unprognostic (8.93e-3)" "unprognostic (2.89e-1)" "unprognostic (3.55e-2)" "unprognostic (3.24e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-2)" "unprognostic (1.94e-1)" "unprognostic (5.29e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-4)" "unprognostic (3.92e-1)" "unprognostic (2.52e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.74e-2)" 0.4 0.4 11.2 3.7 12.5 6.5 0.5 12.0 11.6 0.6 4.7 0.4 0.5 0.2 1.9 0.3 0.2 0.3 11.9 11.2 11.1 1.0 2.9 5.7 7.2 16.8 13.1 0.1 1.7 0.0 3.2 0.2 14.4 4.2 0.2 0.0 1.4 4.5 0.1 0.2 3.4 0.2 14.4 5.4 2.3 0.4 12.9 2.5 38.7 0.0 8.6 0.5 0.3 15.4 0.0 0.4 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.4 17.5 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.1 1.7 0.3 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.5 2.6 0.0 0.7 0.2 0.0 1.3 0.2 0.2 3.7 0.1 0.7 0.8 0.1 3.8 0.7 0.0 0.5 0.0 0.2 1.5 0.0 0.0 0.1 1.0 0.0 0.1 3.1 1.3 3.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.0 6.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.4 11.2 12.5 12.0 11.6 11.2 11.1 16.8 13.1 14.4 14.4 12.9 15.4 0.7 28.9 8.8 0.0 33.4 1.5 2.3 1.3 1.2 0.9 3.2 3.2 21.0 0.0 1.4 0.0 4.2 3.3 2.0 1.5 0.0 0.6 1.6 0.5 1.6 1.0 0.0 136.8 0.1 3.8 8.6 4.1 2.6 1.3 2.5 1.9 1.4 4.3 4.6 0.0 0.3 1.2 0.0 1.9 7.4 1.7 0.6 2.5 3.6 3.7 1.9 0.5 1.0 95.5 17.7 1.3 0.6 0.4 9.5 6.2 0.6 1.6 0.5 2.0 0.0 3.1 1.9 1.4 2.1 1.3 2.8 4.0 3.0 0.3 0.8 1.6 SNX5 ENSG00000089006 "Sorting nexin 5" Q9Y5X3 20 17941597-17968980 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 271.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 639.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020679, HPA051187, HPA076450" Approved Supported Vesicles,Cytosol NA NA 8200 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 18: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Cytosol" "CAB020679: , HPA051187: AB_2681379, HPA076450: " "unprognostic (6.00e-2)" "unprognostic (2.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.00e-2)" "unprognostic (4.47e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (2.30e-10)" "unprognostic (1.67e-1)" "unprognostic (6.19e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.77e-1)" "unprognostic (3.15e-2)" "unprognostic (6.50e-2)" "unprognostic (3.48e-2)" "unprognostic (2.99e-1)" 42.4 51.4 12.5 43.7 15.2 57.5 37.6 14.9 12.4 35.7 14.5 37.6 47.1 28.3 49.4 35.2 33.5 24.9 28.5 11.0 13.5 59.3 33.7 36.1 59.1 15.5 13.6 51.4 32.0 24.8 21.7 28.9 16.8 23.6 40.1 14.2 34.3 17.2 70.8 28.7 40.2 24.4 17.2 57.5 33.1 15.5 14.0 21.2 70.2 21.8 51.2 34.7 32.5 21.2 103.0 108.6 45.3 49.6 29.6 49.8 270.7 84.1 43.3 49.9 55.9 104.8 140.2 169.6 48.6 49.9 69.7 112.2 63.8 124.6 67.2 44.1 57.8 150.1 49.5 639.4 48.0 106.6 173.9 49.2 54.2 54.6 98.3 37.1 72.8 111.3 72.8 109.6 58.6 79.6 94.2 92.6 48.4 87.0 55.3 110.0 115.2 126.1 61.2 116.4 45.0 26.4 76.0 113.7 102.1 34.0 62.4 67.8 57.3 77.8 98.7 49.2 101.5 77.8 129.2 137.2 38.5 37.6 69.6 69.6 58.7 83.6 54.8 81.7 50.0 80.6 49.6 54.6 71.9 75.2 29.7 42.7 4.8 39.0 92.3 37.2 67.3 54.9 12.5 15.2 14.9 12.4 11.0 13.5 15.5 13.6 16.8 17.2 14.0 21.2 35.6 64.1 113.1 21.5 93.0 31.7 45.7 49.0 48.3 19.1 48.9 44.2 38.5 38.6 59.8 49.7 27.1 101.0 54.9 59.6 160.4 47.8 43.6 51.1 42.3 48.7 31.7 98.4 18.8 44.8 137.7 57.7 52.0 66.9 130.8 47.9 139.9 41.4 151.9 16.8 19.9 54.4 34.6 174.6 47.2 16.0 60.9 88.2 26.6 31.9 68.4 66.3 55.6 24.6 20.3 37.2 58.3 51.6 96.7 49.2 100.0 271.5 52.0 19.8 19.7 50.7 39.6 19.1 44.6 83.5 32.4 78.5 53.0 66.5 100.1 57.4 SNX7 ENSG00000162627 "Sorting nexin 7" Q9UNH6 1 98661701-98760500 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037419 Enhanced Approved "Vesicles,Cell Junctions" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "Cell Junctions" "HPA037419: AB_10671754" "unprognostic (3.19e-1)" "unprognostic (2.18e-1)" "prognostic favorable (5.10e-5)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (9.59e-7)" "unprognostic (1.53e-2)" "unprognostic (2.64e-1)" "unprognostic (1.41e-2)" "unprognostic (1.19e-3)" "unprognostic (1.88e-1)" "unprognostic (7.95e-3)" "unprognostic (1.68e-1)" "unprognostic (1.45e-1)" "unprognostic (8.65e-2)" "unprognostic (1.77e-1)" 19.5 13.8 10.2 7.5 9.5 0.1 17.1 8.6 9.9 20.6 7.5 30.1 23.5 19.4 12.6 16.6 15.6 16.2 22.1 10.1 13.6 24.9 12.8 11.3 3.4 11.6 12.7 11.3 13.7 15.1 8.4 16.8 10.7 14.3 29.9 3.2 14.1 16.4 5.4 11.0 22.9 25.8 9.8 5.4 16.9 15.7 16.4 3.6 12.2 10.9 4.7 20.3 14.3 10.8 50.4 26.7 15.8 21.6 54.9 86.3 8.9 31.3 56.6 45.9 59.2 15.6 18.4 0.0 39.7 77.1 37.7 14.2 16.8 44.4 45.5 0.2 32.3 0.0 41.2 27.1 32.4 0.0 0.0 43.5 46.8 37.8 16.5 51.7 64.9 0.7 0.0 0.1 73.3 10.3 0.4 0.0 15.2 20.0 38.0 0.0 35.4 0.1 45.3 39.8 7.8 93.5 41.6 39.0 23.7 26.2 0.0 1.8 44.9 44.7 24.8 35.0 64.2 0.0 0.1 0.1 63.3 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.2 9.5 8.6 9.9 10.1 13.6 11.6 12.7 10.7 9.8 16.4 10.8 14.1 19.2 6.7 23.2 0.5 14.7 44.7 60.0 9.6 0.7 16.3 23.0 49.1 27.1 22.0 23.9 0.0 34.1 0.1 37.4 37.2 47.0 19.3 29.4 33.0 17.8 21.0 0.0 18.3 80.7 33.8 37.9 20.9 19.6 1.3 22.4 17.9 12.0 12.9 3.3 25.7 26.6 48.8 2.1 13.7 23.9 34.2 5.0 35.6 12.2 37.2 12.8 0.0 58.8 8.2 56.8 25.7 52.6 0.1 28.5 34.1 69.0 27.2 0.8 32.9 23.1 36.2 15.5 10.5 27.1 16.3 14.1 1.6 30.2 49.1 57.3 SOBP FLJ10159 ENSG00000112320 "Sine oculis binding protein homolog" A7XYQ1 6 107490106-107661306 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 175.3;Excitatory neurons: 260.1;Granulosa cells: 149.3;Inhibitory neurons: 287.7;Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 278.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enhanced" "Detected in many" "AF22: 10.5;AN3-CA: 13.9;ASC diff: 12.9;HDLM-2: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029242 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 47: Non-specific - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Vesicles "HPA029242: AB_10603340" "unprognostic (7.11e-2)" "unprognostic (1.35e-3)" "unprognostic (9.01e-2)" "unprognostic (2.04e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "unprognostic (5.63e-2)" "unprognostic (9.84e-2)" "unprognostic (5.35e-3)" "prognostic favorable (1.55e-5)" "unprognostic (6.64e-2)" "unprognostic (2.00e-3)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-3)" 4.5 6.6 12.4 1.7 14.5 0.0 3.4 9.0 16.9 6.2 0.4 14.6 1.2 5.6 2.0 2.0 4.3 2.7 10.9 15.3 8.2 3.4 1.6 2.4 0.9 6.7 9.1 10.8 1.4 3.1 9.4 2.3 6.2 8.2 1.3 5.3 10.4 2.6 16.7 1.2 3.2 3.9 6.5 1.9 4.8 4.2 9.5 2.7 4.2 5.9 1.1 11.9 4.4 11.4 0.0 0.3 10.5 13.9 12.9 4.9 1.2 0.0 0.0 0.3 0.6 0.0 0.0 5.7 0.3 0.0 0.9 0.0 7.0 0.2 0.2 9.0 6.8 0.6 0.0 6.8 1.6 3.0 0.5 5.2 0.0 5.1 0.0 1.1 4.2 2.6 0.0 0.3 0.0 2.9 1.3 0.3 2.5 0.3 0.9 3.1 1.3 0.0 0.0 0.2 3.3 5.6 1.2 0.0 0.1 0.4 0.4 2.0 0.0 3.3 1.1 5.7 0.5 2.6 0.5 3.5 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 14.5 9.0 16.9 15.3 8.2 6.7 9.1 6.2 6.5 9.5 11.4 6.0 3.2 9.8 175.3 9.2 0.5 10.3 11.4 3.4 40.4 0.5 7.4 19.4 17.2 6.1 23.9 0.0 0.2 1.8 0.2 0.0 2.5 96.2 0.6 15.8 4.4 10.8 5.3 260.1 0.2 0.7 23.6 3.1 0.4 0.0 149.3 5.3 1.4 3.0 92.5 287.7 0.1 4.1 9.6 4.1 61.4 45.1 1.8 3.6 51.5 0.1 7.6 0.0 263.9 278.8 0.4 0.0 48.9 0.2 9.3 0.0 11.9 10.9 10.1 26.3 42.8 21.0 61.2 5.6 0.6 0.9 0.1 1.3 13.3 0.2 1.0 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.9" "Cell type enhanced" "Detected in many" "Astrocytes: 107.1;Bipolar cells: 70.3;Excitatory neurons: 41.4;Muller glia cells: 33.0;Oligodendrocytes: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 7.6;HaCaT: 19.6;HMC-1: 14.5;RPMI-8226: 9.1;SiHa: 14.1;THP-1: 8.4;U-937: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071818 Approved Vesicles,Cytosol NA NA "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Cytosol" "HPA071818: " "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 2.4 1.1 13.4 3.4 18.3 1.7 1.6 11.6 15.9 8.5 0.0 4.5 1.4 4.7 3.8 2.2 3.3 3.6 2.0 12.1 11.3 9.0 4.6 4.4 0.8 18.6 17.6 5.8 0.7 0.0 2.7 0.2 14.7 5.2 1.1 12.9 1.0 2.4 1.1 1.8 2.6 6.2 11.3 0.4 1.6 1.6 14.1 3.1 3.1 1.2 1.2 3.0 3.7 22.9 0.8 1.1 1.3 0.2 0.1 0.0 0.0 0.2 0.1 1.6 0.4 0.2 0.6 0.0 7.6 5.0 1.3 19.6 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.3 0.2 0.0 14.5 0.2 4.3 6.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.4 0.0 0.9 0.0 1.6 9.1 0.2 0.0 0.8 0.7 14.1 0.0 0.0 0.8 0.0 8.4 0.0 4.9 1.4 0.0 0.1 0.0 0.0 0.0 1.6 8.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 18.3 11.6 15.9 12.1 11.3 18.6 17.6 14.7 11.3 14.1 22.9 0.1 3.2 11.3 107.1 0.0 0.1 0.3 4.6 0.0 70.3 0.1 2.4 2.0 0.0 6.9 5.5 0.0 0.0 0.3 0.0 0.0 0.2 2.2 0.4 0.4 0.3 0.0 0.0 41.4 0.0 0.0 5.0 0.0 0.9 0.0 5.4 0.4 1.6 0.2 1.7 24.3 0.0 2.0 0.3 0.0 11.6 12.8 0.4 1.8 8.4 0.1 33.0 1.0 8.0 76.2 1.1 0.0 7.9 0.1 0.4 0.4 1.4 2.0 2.7 0.0 0.9 1.0 0.1 0.3 0.0 0.4 0.0 0.3 1.5 0.0 0.6 SOS2 ENSG00000100485 "SOS Ras/Rho guanine nucleotide exchange factor 2" Q07890 14 50117130-50231578 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004577, HPA047368, HPA052689" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 8: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Vesicles "CAB004577: AB_628270, HPA047368: AB_2680014, HPA052689: AB_2681917" "unprognostic (7.99e-2)" "unprognostic (6.17e-2)" "unprognostic (7.80e-2)" "unprognostic (4.93e-2)" "unprognostic (2.81e-2)" "unprognostic (7.64e-2)" "unprognostic (1.56e-1)" "unprognostic (3.08e-1)" "unprognostic (2.01e-1)" "unprognostic (3.88e-1)" "unprognostic (9.99e-2)" "unprognostic (8.21e-2)" "prognostic favorable (8.48e-8)" "unprognostic (2.47e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (6.57e-2)" 23.8 14.9 15.3 15.3 21.4 39.5 17.9 18.2 19.5 14.3 13.5 17.4 21.5 15.2 22.4 16.4 12.7 12.9 21.5 14.0 16.8 24.5 13.2 15.8 14.4 19.7 18.6 15.3 15.9 39.3 9.1 17.0 19.1 15.4 17.3 14.0 14.5 18.7 57.6 17.9 24.5 18.0 16.8 17.8 13.7 27.9 19.6 16.5 25.1 63.8 13.5 14.8 10.5 23.9 15.3 11.1 22.1 14.9 16.6 18.0 10.4 13.5 14.8 10.0 12.5 4.9 19.8 16.0 11.9 17.3 17.3 13.8 12.1 10.2 17.7 26.9 4.4 16.1 8.5 8.5 18.3 19.1 16.6 18.8 24.6 9.3 21.6 25.2 21.8 13.1 12.5 39.0 24.2 12.7 15.9 15.1 6.9 11.4 9.6 17.0 30.8 12.1 16.1 14.4 16.0 18.7 15.0 17.5 17.8 15.9 19.4 23.0 24.1 27.3 17.8 12.5 8.9 27.3 31.7 19.6 7.1 10.5 16.4 8.0 1.1 2.8 1.1 0.9 0.9 0.6 0.7 0.8 0.8 0.7 0.8 0.7 4.6 1.7 2.0 1.4 0.0 0.4 15.3 21.4 18.2 19.5 14.0 16.8 19.7 18.6 19.1 16.8 19.6 23.9 34.1 9.6 26.3 59.4 18.4 35.7 20.9 10.5 10.2 17.2 23.8 15.6 43.7 17.2 18.2 18.4 16.7 8.2 46.3 36.0 7.9 11.3 17.0 18.7 30.4 23.5 20.4 6.3 71.5 10.7 8.0 22.2 12.8 29.8 20.3 37.4 22.9 13.8 8.8 25.2 89.6 18.5 12.2 33.3 17.5 8.6 12.5 29.0 17.8 80.6 29.0 17.6 21.6 100.5 104.8 14.5 24.6 13.5 28.6 27.3 28.6 15.8 14.3 22.5 19.7 43.4 30.8 54.3 12.3 17.7 39.6 13.0 24.2 17.4 14.9 30.6 SP2 KIAA0048 ENSG00000167182 "Sp2 transcription factor" Q02086 17 47896150-47928957 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003357, CAB010245" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 8: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm Vesicles "CAB010245: AB_2121523, HPA003357: AB_1080070" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (6.30e-3)" "unprognostic (5.85e-2)" "unprognostic (1.18e-1)" "unprognostic (6.91e-2)" "unprognostic (5.66e-2)" "unprognostic (2.46e-1)" "unprognostic (6.46e-2)" "unprognostic (2.52e-1)" "unprognostic (1.44e-1)" "unprognostic (5.39e-2)" "prognostic favorable (1.82e-5)" "unprognostic (5.34e-3)" "unprognostic (4.28e-2)" "unprognostic (3.37e-2)" "unprognostic (8.66e-2)" 14.8 10.7 9.4 16.6 11.6 19.4 15.4 16.1 11.5 12.9 6.9 14.3 14.9 14.7 12.0 17.2 15.1 11.5 18.3 9.6 10.1 12.5 8.7 14.9 20.6 12.4 10.4 15.1 16.0 23.5 9.8 13.6 11.1 13.5 13.3 10.5 16.2 12.5 32.2 14.8 15.6 12.8 8.3 17.7 13.0 17.8 11.8 25.3 18.1 26.6 15.0 13.6 13.4 13.3 33.5 37.3 25.1 21.6 12.1 11.2 26.1 19.3 13.6 19.0 17.1 41.3 16.2 28.6 17.4 24.7 20.1 25.6 17.5 16.4 19.9 41.7 26.6 28.5 25.6 22.3 11.2 26.4 34.2 16.4 19.1 22.4 21.1 13.5 18.5 26.3 31.8 47.5 18.8 45.0 64.6 16.8 11.8 29.6 24.9 30.8 34.4 18.6 13.4 52.1 26.8 31.4 16.9 17.9 20.0 15.0 26.7 25.6 30.3 34.8 18.1 24.2 30.1 42.3 50.6 26.0 19.0 18.5 29.2 13.6 6.1 9.9 8.3 7.0 7.3 4.9 6.3 7.9 4.9 5.6 7.1 7.4 11.3 9.7 6.6 4.5 7.2 6.6 9.4 11.6 16.1 11.5 9.6 10.1 12.4 10.4 11.1 8.3 11.8 13.3 14.6 9.6 19.5 5.2 17.7 6.2 15.8 7.8 12.0 9.0 9.8 9.9 9.7 12.8 8.3 11.0 0.0 10.7 11.3 16.4 15.6 7.0 9.8 8.1 6.2 11.6 15.6 25.2 5.2 7.6 9.2 9.4 8.6 10.7 13.3 5.5 8.2 7.5 8.9 11.8 4.8 9.0 14.2 10.9 8.2 10.5 10.5 14.2 8.8 6.5 11.7 12.1 17.5 9.0 9.9 7.3 13.2 3.4 12.7 11.0 8.6 8.1 10.2 6.5 6.6 12.6 12.5 9.8 6.3 9.6 7.5 20.5 14.8 5.3 7.9 17.0 SPANXA1 "CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX" ENSG00000198021 "Sperm protein associated with the nucleus, X-linked, family member A1" Q9NS26 X 141583674-141585011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-2 OS: 3.2" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 9: U-2 OS - Unknown function" Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.2 0.2 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXA2 SPANX ENSG00000203926 "SPANX family member A2" Q9NS26 X 141589708-141590762 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 62 "testis: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;GAMG: 1.3;PC-3: 1.3;U-2197: 1.5" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXB1 "CT11.2, SPANXB2, SPANXF1, SPANXF2" ENSG00000227234 "SPANX family member B1" Q9NS25 X 141002594-141003706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "testis: 88.8" "Group enriched" "Detected in some" 160 "Early spermatids: 686.8;Late spermatids: 2015.4" "Group enriched" "Detected in some" 4 "breast cancer: 2.1;cervical cancer: 1.1;head and neck cancer: 2.1;lung cancer: 1.8;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 81.9;GAMG: 16.6;U-2 OS: 27.4" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" "unprognostic (8.55e-2)" 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.8 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.3 81.9 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 16.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 27.4 1.9 0.7 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 686.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2015.4 6.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.2 0.0 0.0 6.6 0.0 0.1 8.4 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXC "CT11.3, CTp11" ENSG00000198573 "SPANX family member C" Q9NY87 X 141241463-141242517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 31.0" "Group enriched" "Detected in some" 209 "Early spermatids: 468.6;Late spermatids: 1668.9" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 11.8;U-2 OS: 6.2" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" "unprognostic (3.56e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 6.2 0.0 0.3 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 1.0 0.2 0.1 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 468.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1668.9 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXD "CT11.4, SPANXE" ENSG00000196406 "SPANX family member D" Q9BXN6 X 141697411-141698739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 109 "testis: 23.2" "Group enriched" "Detected in some" 148 "Early spermatids: 491.4;Late spermatids: 1560.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 1.2;U-2 OS: 3.9" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 9: U-2 OS - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 491.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1560.9 5.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA21 "spergen-2, spergen2" ENSG00000187144 "Spermatogenesis associated 21" Q7Z572 1 16387117-16437424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 7.6" "Group enriched" "Detected in some" 8 "Early spermatids: 40.4;Late spermatids: 44.6" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.8" "Immune cell enhanced" "Detected in single" "basophil: 1.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.7" "Cell line enriched" "Detected in single" 7 "Hep G2: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA032080 Approved Vesicles,Cytosol No NA "Cluster 38: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Vesicles, Cytosol" "HPA032080: " "unprognostic (3.09e-1)" "unprognostic (8.26e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-1)" "unprognostic (2.37e-1)" "unprognostic (5.17e-3)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (3.14e-1)" "unprognostic (2.74e-10)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-1)" "unprognostic (9.71e-2)" 0.0 0.1 0.2 0.0 0.2 0.6 0.0 1.8 0.5 0.0 0.5 0.0 0.3 0.1 0.2 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.4 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.1 0.1 7.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 5.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.0 1.7 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.3 0.2 0.1 0.6 0.2 0.1 0.1 0.2 0.1 0.2 0.2 1.8 0.5 0.3 0.1 0.2 0.0 0.1 0.0 0.1 0.3 0.1 0.0 1.1 1.0 0.4 0.3 0.3 0.0 0.6 1.5 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.3 0.2 0.0 0.0 40.4 0.3 0.9 0.3 0.0 0.0 1.6 0.2 0.3 0.3 0.0 0.9 0.0 0.1 0.0 0.0 0.1 5.0 1.4 0.0 0.0 0.6 0.4 44.6 0.3 0.3 0.0 0.0 0.1 0.7 0.0 1.0 1.3 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.1 1.2 0.0 0.9 0.3 1.2 0.4 0.4 0.4 0.3 0.3 0.1 0.3 0.2 SPATA33 "C16orf55, FLJ31606" ENSG00000167523 "Spermatogenesis associated 33" Q96N06 16 89657740-89671272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "testis: 114.0" "Group enriched" "Detected in all" 8 "Early spermatids: 1778.0;Late spermatids: 4200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045648, HPA073096" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Vesicles "HPA045648: AB_2679405, HPA073096: AB_2686570" "unprognostic (1.05e-2)" "prognostic favorable (1.06e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.37e-1)" "unprognostic (3.97e-1)" "unprognostic (3.63e-2)" "unprognostic (2.03e-3)" "unprognostic (8.82e-2)" "unprognostic (4.02e-2)" "unprognostic (4.52e-2)" "unprognostic (3.26e-1)" "unprognostic (2.04e-1)" "unprognostic (1.60e-1)" 3.6 4.2 7.0 2.8 7.0 3.4 4.3 6.1 8.9 5.1 9.1 5.2 5.0 4.5 8.9 5.3 12.6 2.8 4.0 7.6 6.6 11.8 6.2 5.9 2.4 6.7 7.1 3.2 5.1 3.6 9.7 1.8 6.7 6.4 2.9 6.7 4.3 2.5 2.0 4.3 9.2 2.4 5.5 5.8 5.0 114.0 6.8 3.6 8.3 1.2 2.9 4.3 4.8 6.7 11.1 11.8 13.4 5.5 3.5 3.1 4.9 7.8 2.5 10.6 4.7 11.5 10.6 1.2 3.8 5.0 8.0 15.1 6.2 3.7 8.5 2.2 9.7 2.0 17.4 16.1 1.5 2.3 4.5 3.1 5.1 7.9 3.2 4.0 2.3 11.0 12.6 1.9 7.1 14.7 7.4 6.6 7.3 7.3 9.3 14.3 7.4 4.0 6.2 3.9 13.2 7.0 17.9 3.0 4.4 6.3 13.5 3.3 2.8 7.8 10.7 6.9 5.9 4.4 7.1 4.4 8.1 14.5 3.5 2.4 1.1 2.1 1.6 1.3 2.2 2.3 1.7 2.2 0.9 0.9 1.8 1.4 1.4 3.2 1.0 2.0 1.2 1.4 7.0 7.0 6.1 8.9 7.6 6.6 6.7 7.1 6.7 5.5 6.8 6.7 14.7 6.4 9.7 4.6 10.3 7.1 8.6 16.4 8.0 18.2 14.9 14.7 6.6 15.7 13.5 29.5 64.6 4.1 10.2 16.0 23.5 15.9 1778.0 94.9 13.3 13.3 17.5 22.7 7.0 17.7 5.6 13.0 32.1 11.9 1.3 11.4 8.9 14.6 9.0 23.5 4.4 9.9 12.2 2.9 8.0 4200.3 30.4 9.5 17.8 3.7 5.8 17.0 16.5 1.0 5.1 14.2 18.9 23.7 11.1 6.7 35.6 33.4 97.8 82.5 13.1 11.8 11.4 348.5 101.2 13.5 7.1 1.4 12.8 13.9 17.1 5.5 SPCS1 "HSPC033, SPC1, SPC12, YJR010C-A" ENSG00000114902 "Signal peptidase complex subunit 1" Q9Y6A9 3 52704955-52711148 "Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046091, HPA055273" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 16: U-266 - Nucleosome" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA046091: AB_10959614, HPA055273: AB_2682768" "unprognostic (5.47e-2)" "unprognostic (4.04e-1)" "prognostic favorable (9.28e-4)" "unprognostic (5.93e-2)" "unprognostic (6.88e-2)" "unprognostic (1.10e-2)" "unprognostic (3.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (5.56e-2)" "unprognostic (3.89e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.90e-4)" "unprognostic (5.96e-2)" "unprognostic (1.80e-1)" "unprognostic (3.58e-1)" "unprognostic (3.09e-2)" 95.3 154.7 75.1 64.1 76.6 61.3 100.5 80.7 101.1 97.4 88.7 110.1 94.8 101.0 110.8 117.0 92.1 48.4 119.7 75.4 83.9 137.3 172.8 87.8 71.2 82.3 80.5 91.1 231.2 89.5 141.1 59.4 82.1 96.3 84.7 124.6 145.2 79.1 142.2 109.0 103.9 53.0 81.7 105.6 151.1 153.2 81.4 66.6 113.2 49.7 87.1 103.0 94.7 84.9 114.6 102.2 113.4 139.3 164.9 134.4 157.2 157.6 144.5 139.4 128.4 108.1 171.0 114.6 65.7 145.4 142.5 110.2 109.9 142.5 149.1 154.3 115.8 138.6 169.2 164.6 175.1 213.3 229.1 104.7 190.5 148.5 174.4 130.5 117.4 147.5 118.8 418.0 151.8 105.5 168.8 207.2 195.8 317.2 203.9 67.9 95.7 608.6 232.7 148.3 73.6 157.4 148.7 178.1 224.2 102.4 188.1 248.1 106.2 127.3 119.1 226.3 192.1 406.2 654.1 169.8 196.5 209.4 169.8 292.7 129.9 258.2 131.1 137.0 155.1 202.0 158.5 144.2 143.9 149.3 146.8 152.1 100.1 119.6 152.5 620.5 177.1 253.8 75.1 76.6 80.7 101.1 75.4 83.9 82.3 80.5 82.1 81.7 81.4 84.9 172.5 64.1 104.2 23.8 282.3 156.5 227.9 470.7 136.1 465.4 289.0 351.0 148.7 221.6 283.6 310.8 118.9 373.5 488.1 195.2 361.9 353.8 597.8 286.4 180.8 157.6 167.7 143.9 27.1 339.4 399.8 181.9 119.8 181.5 211.6 138.7 131.4 301.8 311.0 102.6 34.4 291.3 325.5 202.9 189.9 1177.6 216.3 192.5 380.6 13.1 321.9 296.9 213.1 21.1 53.2 274.8 274.1 191.8 888.8 295.0 405.5 665.1 374.1 251.3 164.3 152.6 335.5 746.4 504.5 195.8 184.4 351.2 220.8 283.6 267.7 285.3 SPG21 "ABHD21, ACP33, BM-019, GL010, MAST" ENSG00000090487 "SPG21 abhydrolase domain containing, maspardin" Q9NZD8 15 64963022-64990310 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 181.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040407, HPA040436" Approved Supported Vesicles,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Vesicles, Cytosol" "HPA040407: AB_2676965, HPA040436: AB_10796454" "unprognostic (7.47e-2)" "unprognostic (2.94e-2)" "unprognostic (5.81e-2)" "unprognostic (2.98e-1)" "unprognostic (1.64e-1)" "unprognostic (5.40e-3)" "unprognostic (7.25e-2)" "unprognostic (1.43e-1)" "unprognostic (4.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.24e-3)" "unprognostic (1.15e-1)" "unprognostic (3.96e-1)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.57e-1)" "unprognostic (3.19e-1)" 56.6 61.7 48.4 50.8 54.1 69.4 68.8 51.5 52.9 60.4 66.0 61.6 52.1 60.2 150.1 46.1 73.4 54.7 54.4 47.8 50.3 85.3 113.1 61.9 56.9 52.1 50.2 55.3 54.7 72.1 47.1 66.3 52.7 49.8 59.3 38.6 45.7 59.0 74.3 58.5 46.6 64.5 51.1 52.6 60.1 35.0 52.6 57.7 83.1 42.4 58.8 61.2 47.8 59.4 87.0 127.0 62.8 119.5 158.7 155.7 78.0 52.8 179.7 103.2 119.8 57.4 131.1 99.1 80.6 124.8 153.1 113.3 182.1 124.5 97.8 41.0 58.5 85.7 81.7 104.0 200.7 82.2 72.7 107.0 139.3 82.1 154.2 100.7 125.6 112.2 72.7 78.3 127.8 124.1 75.8 71.5 69.6 193.9 66.3 78.2 67.3 174.6 107.1 103.6 76.7 68.6 62.7 131.4 124.9 123.3 89.9 140.9 61.5 87.1 90.6 125.4 80.6 55.6 101.8 58.2 112.8 215.1 75.1 9.9 138.2 15.5 14.1 84.2 13.1 39.0 13.8 14.7 76.9 37.6 19.9 10.9 181.4 15.7 69.8 25.1 17.5 52.3 48.4 54.1 51.5 52.9 47.8 50.3 52.1 50.2 52.7 51.1 52.6 59.4 29.4 9.6 56.3 11.1 67.7 74.9 81.8 70.6 66.6 16.2 62.7 39.4 32.1 61.5 51.5 71.7 37.5 202.9 33.6 42.7 137.0 97.1 6.0 32.9 36.9 56.9 64.8 54.3 13.1 74.1 92.2 67.5 46.9 34.3 28.5 37.5 38.2 121.6 153.9 20.2 13.7 58.2 61.1 158.7 145.4 13.2 86.6 128.5 80.0 16.9 123.2 24.8 64.9 5.5 19.6 62.3 93.5 89.9 66.2 145.2 121.1 202.3 57.9 18.9 39.5 93.4 39.5 35.4 51.3 75.4 82.8 186.5 46.5 35.5 69.5 123.5 SPINK9 ENSG00000204909 "Serine peptidase inhibitor Kazal type 9" Q5DT21 5 148321203-148339852 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 16.0;Alveolar cells type 2: 27.9;Club cells: 14.9;granulocytes: 10.1;Respiratory ciliated cells: 14.6" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 12.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 24.4;U-266/84: 26.9" "Low region specificity" "Detected in single" HPA038288 Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA 24000 "Cluster 42: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 16: U-266 - Nucleosome" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Vesicles" "HPA038288: AB_10795400" "unprognostic (1.84e-1)" "unprognostic (4.87e-3)" "unprognostic (2.88e-1)" "unprognostic (9.02e-2)" "unprognostic (5.49e-3)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "unprognostic (1.91e-2)" "unprognostic (3.93e-1)" "unprognostic (2.01e-1)" "unprognostic (3.99e-2)" "unprognostic (1.90e-1)" 1.5 3.2 17.1 3.0 13.7 6.5 0.5 19.2 26.6 0.6 5.0 2.0 2.2 2.6 1.9 2.2 1.0 1.4 2.0 14.6 10.6 1.8 1.6 1.1 2.6 10.0 6.1 1.8 1.1 0.5 0.1 3.2 10.8 2.5 1.7 10.3 1.5 0.5 3.8 3.4 2.4 0.5 2.6 1.9 2.4 4.2 11.5 3.2 1.5 0.1 1.6 0.9 0.0 28.0 15.4 2.6 2.9 3.4 0.7 1.2 2.8 3.5 0.2 0.3 0.5 5.3 10.8 3.4 24.4 0.1 2.0 3.5 0.9 0.7 1.0 6.1 1.4 7.7 8.3 2.7 0.3 2.9 2.6 0.2 0.7 0.5 0.1 2.0 0.0 2.5 4.9 18.3 0.4 9.6 2.5 4.7 13.7 5.5 5.0 3.9 3.4 4.0 1.0 10.0 6.3 7.9 3.0 8.6 2.8 8.6 14.0 3.0 5.9 4.4 14.1 3.9 4.5 11.1 26.9 4.0 2.6 2.1 6.2 12.4 1.8 1.0 1.1 1.0 1.4 0.8 1.3 1.4 0.4 1.9 1.8 1.8 6.6 3.9 2.2 1.9 0.9 0.1 17.1 13.7 19.2 26.6 14.6 10.6 10.0 6.1 10.8 2.6 11.5 28.0 0.1 16.0 27.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.0 14.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 1.9 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.1 10.1 0.1 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 2.2 0.4 0.0 0.1 0.0 0.3 14.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.7 0.0 0.0 0.2 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904358 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 192.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Plasma membrane" "HPA004194: AB_2667171, HPA059958: AB_2684179" "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavorable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 20.9 14.9 25.3 11.9 28.1 20.9 24.2 29.0 27.5 30.0 13.1 26.7 18.2 26.3 15.7 44.3 28.6 18.7 18.1 25.4 30.6 22.8 19.3 20.4 15.9 25.0 26.0 31.4 21.3 49.6 13.9 28.4 26.1 20.6 27.2 15.5 20.2 27.0 15.7 56.5 18.8 29.6 24.1 24.3 15.2 39.0 26.4 32.7 31.2 19.6 27.8 28.6 34.2 31.4 30.0 29.2 43.4 27.4 56.2 37.7 30.5 22.5 66.6 47.4 37.9 30.5 29.9 27.4 0.1 39.4 42.0 35.6 44.8 48.4 48.9 21.9 27.5 23.6 16.2 23.4 59.2 27.4 29.3 38.1 75.9 40.7 38.1 56.0 47.1 41.5 26.5 13.4 41.2 26.3 36.7 22.0 29.2 27.8 20.6 21.6 36.6 19.7 36.8 83.8 29.7 31.9 42.8 19.6 34.7 46.1 58.9 18.7 35.4 21.9 29.5 13.6 17.1 30.9 60.3 26.4 32.5 22.3 36.9 4.8 1.2 1.1 1.3 1.2 1.8 1.3 1.6 1.7 2.1 1.6 1.5 1.7 2.2 1.3 1.1 2.7 1.4 0.7 25.3 28.1 29.0 27.5 25.4 30.6 25.0 26.0 26.1 24.1 26.4 31.4 35.2 19.2 20.8 79.3 25.3 55.1 32.3 29.4 43.3 37.8 35.2 24.1 21.2 20.0 19.8 40.5 27.1 42.0 21.2 47.2 1.9 19.3 8.6 20.9 26.9 33.0 27.1 14.5 97.2 24.7 29.0 33.2 25.0 29.7 4.5 68.7 37.5 33.1 38.3 37.0 112.6 33.7 22.4 38.1 39.3 8.0 28.6 34.5 26.6 79.6 26.6 23.0 16.5 141.3 192.3 22.8 34.9 35.0 22.0 33.4 34.0 18.1 18.1 22.4 13.1 32.3 27.4 55.6 41.1 76.9 84.7 64.6 22.4 35.0 35.4 37.6 SPTAN1 ENSG00000197694 "Spectrin alpha, non-erythrocytic 1" Q13813 9 128552558-128633662 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding, Calmodulin-binding" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Bipolar cells: 296.6;Cone photoreceptor cells: 310.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004581, HPA007927" Enhanced Approved Vesicles,Microtubules NA NA 1600000 "Cluster 13: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "Vesicles, Microtubules" "CAB004581: AB_671135, HPA007927: AB_1857435" "unprognostic (1.46e-2)" "unprognostic (2.73e-2)" "unprognostic (1.56e-1)" "unprognostic (9.06e-2)" "unprognostic (3.24e-1)" "unprognostic (4.02e-2)" "unprognostic (2.56e-3)" "unprognostic (2.20e-1)" "unprognostic (1.81e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.84e-12)" "unprognostic (2.94e-2)" "unprognostic (1.60e-1)" "unprognostic (4.18e-3)" "unprognostic (2.19e-3)" 48.8 31.4 81.7 38.6 85.0 28.1 36.6 54.4 99.7 39.4 0.4 47.3 24.7 57.1 32.9 36.8 54.0 32.5 65.7 90.9 43.5 34.6 22.8 55.1 38.5 142.7 49.6 51.6 24.0 47.1 32.5 57.1 155.0 32.7 36.3 103.1 31.9 46.5 23.9 69.4 34.9 58.8 65.6 44.3 31.1 44.9 61.5 45.4 38.4 22.3 38.0 40.0 36.4 55.3 108.1 116.9 75.2 83.4 107.6 121.0 61.5 90.2 75.2 99.4 74.1 167.3 74.6 94.3 78.3 137.0 69.8 193.3 80.7 90.4 61.1 53.2 47.9 15.9 324.4 94.4 61.3 70.9 51.0 58.3 71.6 166.3 55.8 83.9 134.4 87.2 9.1 107.6 98.6 74.6 136.3 29.5 96.1 125.9 72.1 91.0 90.2 59.7 80.2 91.1 58.1 91.1 296.1 40.3 42.9 91.8 70.0 19.8 232.5 68.5 102.2 100.0 71.2 65.3 82.6 51.8 83.5 31.5 65.9 3.3 1.6 3.9 9.7 1.3 13.5 6.3 12.4 9.2 2.4 5.8 7.6 7.9 1.5 7.1 1.2 3.0 15.3 5.8 81.7 85.0 54.4 99.7 90.9 43.5 142.7 49.6 155.0 65.6 61.5 55.3 144.9 70.5 27.5 123.7 56.3 37.3 27.8 34.3 25.6 296.6 69.8 83.2 68.5 68.6 33.9 101.2 310.6 27.5 112.6 145.4 7.9 67.6 18.0 108.2 71.4 103.8 56.9 13.7 159.5 59.2 16.0 77.8 76.5 87.5 12.0 47.9 96.8 36.2 29.2 124.5 183.8 54.1 30.5 22.2 29.4 40.5 85.1 32.8 35.6 74.9 24.4 97.7 48.4 87.4 17.4 102.2 93.0 94.8 70.5 45.9 62.4 22.8 71.3 156.5 26.3 53.0 60.0 33.0 44.5 43.7 45.5 18.2 95.4 22.0 73.6 65.7 SQLE ENSG00000104549 "Squalene epoxidase" Q14534 8 124998497-125022283 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018038, HPA020762" Enhanced Uncertain Vesicles,Cytosol NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 37: Intestine - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Cytosol" "HPA018038: AB_2669753, HPA020762: AB_2670512" "unprognostic (1.37e-2)" "unprognostic (6.26e-3)" "unprognostic (5.12e-2)" "unprognostic (9.51e-3)" "unprognostic (4.63e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (4.76e-3)" "prognostic unfavorable (4.67e-4)" "unprognostic (3.45e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (9.71e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-3)" "unprognostic (7.74e-3)" 8.6 31.1 17.5 19.6 27.0 23.0 22.1 26.8 24.0 30.7 25.4 21.6 31.0 16.4 9.1 78.7 18.6 10.7 7.2 18.6 24.4 17.1 72.3 30.9 17.7 47.3 27.7 14.3 10.7 22.7 16.5 47.5 35.1 25.0 18.6 17.8 19.1 7.6 1.4 49.4 14.0 12.3 27.6 9.7 21.8 59.4 21.8 14.2 10.5 1.6 29.4 14.7 46.2 34.6 135.5 51.5 301.6 87.2 91.7 154.1 30.5 34.9 106.3 46.5 84.7 70.6 192.3 92.7 49.2 43.2 186.0 101.0 127.3 192.4 53.6 77.1 268.3 265.2 32.6 181.1 134.6 31.5 74.6 106.1 201.4 138.8 113.3 29.8 51.5 64.2 153.8 174.8 38.1 223.7 109.6 39.3 125.2 92.6 35.2 47.5 55.4 126.6 329.3 153.3 93.9 47.6 71.6 226.3 74.1 96.5 60.7 81.3 50.8 19.2 66.0 22.9 31.6 31.6 69.6 126.6 32.0 93.7 33.8 1.5 6.3 0.7 10.6 10.8 5.0 16.6 6.0 9.5 15.2 17.1 8.2 8.6 0.2 12.6 12.7 10.8 7.1 7.7 17.5 27.0 26.8 24.0 18.6 24.4 47.3 27.7 35.1 27.6 21.8 34.6 13.2 60.9 97.9 21.5 34.7 22.9 64.0 199.9 16.5 41.8 35.6 27.3 6.1 31.5 129.6 53.3 50.1 99.7 20.6 81.6 7.9 60.3 21.0 95.9 23.3 39.7 31.7 22.3 14.3 83.6 133.7 35.3 51.0 80.5 41.3 77.1 9.7 127.9 61.1 148.0 18.8 58.0 126.1 10.9 30.1 13.2 23.9 22.2 21.4 13.1 91.0 24.3 8.2 20.1 77.9 98.6 38.4 10.9 30.6 118.0 17.3 3.7 123.0 61.1 26.3 12.5 42.0 179.5 128.6 69.5 89.1 217.1 21.1 171.8 35.0 114.8 SQSTM1 "A170, OSIL, p60, p62, p62B, PDB3" ENSG00000161011 "Sequestosome 1" Q13501 5 179806398-179838078 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Autophagy, Differentiation, Immunity" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1183.4" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 2045.0;Urothelial cells: 2233.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 1923.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004587, HPA064165, HPA068843" Supported Enhanced Vesicles,Cytosol No No 81000 "Cluster 38: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 44: HDLM-2 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "Vesicles, Cytosol" "CAB004587: AB_628279, HPA064165: AB_2685203, HPA068843: AB_2732120" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (3.19e-1)" "unprognostic (9.45e-2)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.31e-5)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (5.65e-2)" "unprognostic (1.66e-1)" "unprognostic (1.70e-1)" "unprognostic (9.52e-2)" "unprognostic (3.21e-1)" "unprognostic (8.68e-3)" "unprognostic (4.41e-2)" "unprognostic (2.01e-1)" 335.0 472.6 171.4 86.0 208.8 135.8 269.5 199.6 207.2 242.8 218.9 262.0 112.1 278.8 91.7 192.3 207.5 188.2 310.1 163.8 200.6 221.5 392.0 263.4 81.4 203.9 183.3 235.6 231.3 121.4 181.5 118.7 190.5 206.2 82.3 46.4 289.7 174.2 1183.4 194.7 187.4 132.7 179.5 179.0 263.6 65.7 205.7 89.4 316.4 287.2 96.4 347.3 211.0 236.5 130.1 740.6 36.9 114.3 547.8 384.8 546.3 187.9 596.3 164.1 201.2 154.6 532.9 16.0 522.7 298.9 898.3 170.8 79.9 181.9 76.9 1923.9 97.6 58.5 303.9 223.4 1167.2 59.9 365.0 337.1 181.2 273.0 441.5 390.8 152.6 17.3 68.0 472.1 327.0 111.6 26.4 62.0 93.8 410.0 195.1 54.8 78.8 213.7 243.6 609.6 79.0 74.5 253.2 274.3 662.2 62.3 143.8 120.4 286.2 243.1 103.4 252.3 271.6 723.7 819.3 73.5 521.1 111.6 338.4 807.6 412.3 422.2 194.7 268.3 231.3 156.5 170.1 174.6 227.5 168.2 131.8 139.1 672.6 196.3 260.3 89.6 262.1 439.8 171.4 208.8 199.6 207.2 163.8 200.6 203.9 183.3 190.5 179.5 205.7 236.5 411.1 185.9 248.8 36.9 280.0 297.5 1289.0 320.4 799.6 81.7 280.7 253.0 38.5 314.5 247.8 121.4 54.2 266.8 276.4 572.9 234.8 906.0 34.2 408.7 255.4 415.8 340.4 89.0 35.2 686.7 133.2 516.0 1270.6 589.7 386.3 73.8 142.5 297.8 288.3 90.9 37.2 337.2 236.0 149.8 556.3 72.2 325.3 388.3 231.3 28.1 611.3 143.3 125.7 16.6 62.2 639.4 618.9 259.2 606.5 1281.6 311.3 327.1 190.1 73.5 164.3 356.4 316.1 45.5 48.0 595.4 259.1 2045.0 259.9 133.4 242.3 2233.9 SRRM5 ENSG00000226763 "Serine/arginine repetitive matrix 5" B3KS81 19 43596617-43614498 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 47.8" "Group enriched" "Detected in some" 43 "Early spermatids: 176.5;Late spermatids: 64.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA047399, HPA052924" Uncertain Approved Vesicles,Centrosome NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" Vesicles Centrosome "HPA047399: AB_10963088, HPA052924: " "unprognostic (3.95e-3)" "unprognostic (7.56e-3)" "unprognostic (6.72e-2)" "unprognostic (3.40e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "unprognostic (3.69e-2)" "unprognostic (2.16e-2)" "unprognostic (2.68e-5)" "unprognostic (2.44e-1)" "unprognostic (3.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.00e-3)" 0.5 0.9 1.0 0.5 1.2 0.4 0.5 2.3 1.3 0.8 0.6 0.8 0.3 0.5 0.3 1.0 0.7 0.4 0.9 0.9 1.0 1.4 1.1 0.6 1.0 1.1 0.9 0.9 1.2 0.2 1.6 0.2 1.1 1.9 0.1 1.9 0.9 0.1 0.5 0.8 0.7 0.1 0.6 0.9 0.7 47.8 1.0 0.1 1.1 0.0 0.0 0.6 0.9 1.2 1.3 1.1 0.4 0.8 0.4 0.3 0.3 0.3 0.1 0.1 0.1 0.7 0.5 0.4 0.7 0.1 0.3 0.8 0.4 0.1 0.2 0.5 0.5 0.4 1.1 0.6 0.1 0.3 0.6 0.3 0.4 0.0 0.1 0.4 0.1 0.6 0.3 1.1 0.0 1.1 0.5 0.5 0.1 0.9 0.3 0.8 0.3 0.3 0.3 1.7 0.8 0.3 0.1 0.4 0.4 0.5 0.9 0.2 0.6 1.1 0.7 0.4 0.6 1.3 0.9 0.5 0.6 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 2.3 1.3 0.9 1.0 1.1 0.9 1.1 0.6 1.0 1.2 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 2.8 0.3 0.3 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 176.5 0.3 0.4 0.1 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.4 0.0 0.7 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 64.9 1.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.9 0.0 0.8 0.1 0.7 0.6 0.8 0.3 0.1 0.2 0.3 0.1 0.1 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "ST14 transmembrane serine protease matriptase" Q9Y5Y6 11 130159782-130210362 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 144.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "thalamus: 10.0" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 25.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 25.0" "Cell line enhanced" "Detected in many" "CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA047014, HPA056258" Enhanced Approved Nucleoplasm,Vesicles NA NA 1100000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Vesicles" "HPA047014: AB_2679902, HPA056258: " "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favorable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 4.3 3.9 0.8 26.7 1.2 4.3 17.7 1.8 2.9 18.6 1.2 124.7 130.7 5.7 21.8 104.5 37.1 32.6 0.9 0.9 1.1 43.2 6.3 18.5 11.9 1.8 1.7 0.6 59.2 36.5 19.1 15.1 3.1 23.1 60.1 0.0 58.7 23.6 0.3 50.2 144.8 5.4 1.1 9.1 64.9 1.0 10.0 10.5 28.6 0.0 20.9 34.8 42.5 2.7 167.2 0.2 0.0 0.6 0.0 0.0 86.4 0.0 0.0 0.0 0.0 224.2 443.0 163.6 16.7 0.0 0.1 311.4 0.0 99.3 0.0 0.1 0.2 0.1 0.1 0.9 0.0 22.0 0.8 0.0 49.3 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 128.5 0.3 1.1 1.7 240.4 0.9 0.2 0.0 301.2 28.8 134.2 17.8 0.4 1.5 203.1 0.4 1.6 308.3 32.0 0.1 0.4 2.7 0.7 0.7 0.2 0.3 218.5 0.3 50.4 0.5 0.0 3.6 3.4 0.0 2.2 0.1 5.0 0.0 0.0 6.2 3.6 0.0 0.0 0.5 0.0 0.3 25.0 0.0 1.2 0.8 1.2 1.8 2.9 0.9 1.1 1.8 1.7 3.1 1.1 10.0 2.7 0.2 32.1 28.6 0.0 18.2 40.9 51.5 45.2 26.2 0.0 36.5 21.5 1.2 77.2 61.6 62.5 0.0 45.6 26.1 489.4 3.9 115.8 37.8 43.9 5.7 1.7 123.4 0.8 1.0 91.8 14.6 3.2 112.1 79.6 11.4 0.2 0.4 2.1 58.1 0.0 0.4 201.0 148.5 22.7 13.2 13.9 1.8 28.0 7.2 0.0 13.6 0.0 1.0 0.0 0.1 153.4 327.2 0.7 5.9 108.7 251.9 10.0 76.4 0.0 6.6 0.0 4.9 0.2 0.3 61.3 43.9 39.7 2.9 0.0 216.9 286.8 STAP1 "BRDG1, STAP-1" ENSG00000035720 "Signal transducing adaptor family member 1" Q9ULZ2 4 67558727-67607337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 51.0" "Group enriched" "Detected in some" 5 "B-cells: 60.8;granulocytes: 80.8;Ionocytes: 65.1;Plasma cells: 147.2" "Cancer enriched" "Detected in many" 7 "renal cancer: 13.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 88.1;naive B-cell: 107.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 185.4;U-698: 83.2" "Region enriched" "Detected in single" 5 "cerebellum: 2.3" "Low region specificity" "Detected in all" HPA038529 Enhanced Uncertain Nucleoplasm,Vesicles NA NA "Cluster 37: B-cells - Transcription" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Vesicles" "HPA038529: AB_10673011" "unprognostic (1.14e-4)" "unprognostic (1.49e-3)" "unprognostic (2.30e-2)" "unprognostic (2.17e-1)" "unprognostic (1.63e-3)" "unprognostic (6.30e-4)" "unprognostic (1.95e-3)" "unprognostic (6.95e-3)" "unprognostic (5.18e-2)" "unprognostic (6.38e-3)" "unprognostic (1.47e-1)" "unprognostic (8.43e-3)" "unprognostic (3.11e-2)" "unprognostic (1.49e-2)" "unprognostic (4.69e-2)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" 0.4 0.1 0.0 15.5 0.0 5.8 0.8 0.0 0.0 0.3 0.0 2.3 1.8 0.6 1.9 0.7 0.1 1.4 0.2 0.5 0.0 9.2 0.4 1.4 40.8 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.9 2.3 0.0 1.3 2.8 0.1 0.1 8.1 0.4 0.0 16.0 2.3 2.7 0.0 6.4 0.4 0.0 51.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 24.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 83.2 0.0 24.7 0.0 5.3 0.1 24.3 0.9 0.1 1.9 88.1 2.0 0.8 1.2 107.8 7.9 0.2 1.0 38.9 0.1 5.2 0.4 4.7 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.7 0.0 60.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 5.5 0.0 0.0 5.8 0.0 9.8 0.0 13.0 0.1 0.0 0.6 0.0 2.5 0.3 0.0 0.0 0.1 0.0 0.0 80.8 0.0 0.4 0.0 0.8 0.0 0.2 0.1 65.1 0.3 0.7 7.1 0.3 1.2 16.0 0.0 0.2 0.0 6.2 0.0 0.3 0.0 0.0 0.4 147.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.1 0.0 4.3 0.1 0.0 0.2 STARD5 MGC10327 ENSG00000172345 "StAR related lipid transfer domain containing 5" Q9NSY2 15 81309053-81324183 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 28.0;Plasma cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 5.8;RPMI-8226: 6.2;U-266/70: 7.1;U-937: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040662 Approved Approved Vesicles,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles Cytosol "HPA040662: AB_10959593" "unprognostic (5.35e-4)" "unprognostic (1.55e-1)" "unprognostic (2.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (2.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.08e-2)" "unprognostic (8.08e-2)" "unprognostic (6.81e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (4.84e-3)" "unprognostic (7.55e-3)" 1.0 0.6 0.6 6.0 0.8 4.3 0.7 3.4 1.3 7.2 1.9 2.8 2.2 4.6 5.0 3.4 1.8 1.3 0.8 0.6 0.7 0.7 5.1 1.1 7.7 0.9 1.0 1.2 0.6 0.6 0.4 1.6 1.2 3.6 3.7 0.4 1.6 2.1 0.6 7.9 4.2 1.8 0.9 6.2 2.1 0.7 0.7 0.5 0.8 0.3 1.5 2.5 5.5 1.4 0.3 0.0 0.0 0.9 2.3 2.3 0.1 0.3 0.3 0.8 1.2 0.1 0.1 4.8 0.0 1.5 0.2 4.0 1.1 1.0 0.6 0.1 0.4 1.8 0.3 0.4 0.5 2.8 5.8 2.0 2.0 0.3 0.6 1.5 0.1 1.9 0.6 1.3 0.5 0.1 0.5 4.0 0.3 0.2 0.0 0.1 0.7 6.2 0.3 1.4 0.3 0.1 0.1 0.5 0.6 0.3 0.6 0.6 0.2 1.3 0.6 1.3 0.1 7.1 1.5 1.8 0.9 6.8 0.4 5.0 1.8 2.3 3.0 2.4 2.5 1.0 2.7 3.2 2.6 0.7 3.9 3.9 1.3 2.6 2.3 1.4 3.6 3.7 0.6 0.8 3.4 1.3 0.6 0.7 0.9 1.0 1.2 0.9 0.7 1.4 3.8 0.0 1.1 0.0 11.4 13.3 12.0 28.0 10.8 1.8 2.7 4.2 0.3 0.0 4.9 0.0 6.2 2.5 4.2 22.1 3.9 1.3 15.2 2.5 14.4 2.5 11.4 2.5 2.2 1.4 4.0 8.5 15.8 2.3 10.2 1.0 3.6 25.4 5.2 1.7 2.0 24.3 2.0 7.9 10.9 1.5 5.0 8.0 1.8 1.9 0.7 1.2 2.1 0.0 0.4 1.8 14.4 9.8 31.5 3.3 23.9 0.7 4.0 0.9 0.0 3.8 2.8 0.9 0.7 19.6 16.3 4.9 4.2 6.3 19.9 9.6 STMN2 "SCG10, SCGN10" ENSG00000104435 "Stathmin 2" Q93045 8 79611117-79666158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 524.1" "Group enriched" "Detected in some" 4 "Excitatory neurons: 182.2;Horizontal cells: 148.0;Inhibitory neurons: 133.0;Rod photoreceptor cells: 53.4" "Group enriched" "Detected in many" 5 "glioma: 26.1;pancreatic cancer: 10.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 13 "dendritic cells: 2.2" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 663.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026922 Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "Endoplasmic reticulum" "HPA026922: AB_1857605" "unprognostic (4.41e-1)" "unprognostic (3.35e-2)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (8.20e-2)" "unprognostic (9.48e-2)" "unprognostic (1.82e-1)" "unprognostic (6.08e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-13)" "unprognostic (1.14e-1)" "unprognostic (3.86e-1)" "unprognostic (5.77e-3)" "unprognostic (9.59e-2)" 5.8 68.6 161.3 9.6 148.3 0.1 2.8 162.9 524.1 8.4 0.0 22.0 13.9 1.1 0.0 1.0 0.1 3.5 1.0 135.7 343.1 0.2 0.9 0.3 0.7 213.6 140.1 0.5 4.7 0.0 8.9 0.1 257.5 2.6 28.9 87.0 0.9 1.7 0.3 11.5 18.5 6.3 60.9 4.5 5.4 1.9 148.2 0.3 0.2 0.3 1.4 0.4 5.0 165.0 0.0 0.0 5.6 0.0 0.9 0.2 0.3 72.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 59.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 60.5 663.5 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 161.3 148.3 162.9 524.1 135.7 343.1 213.6 140.1 257.5 60.9 148.2 165.0 0.1 0.0 0.0 26.1 0.0 1.0 0.0 0.0 0.0 27.8 0.0 0.3 0.1 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 18.2 0.0 1.5 1.4 24.9 0.0 182.2 0.0 0.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 148.0 133.0 0.0 0.0 0.0 2.0 8.2 0.3 0.0 1.8 19.7 0.0 16.3 0.0 19.1 23.5 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 53.4 0.0 0.0 0.6 0.5 0.7 0.0 0.9 0.0 0.1 0.0 0.0 0.5 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 333.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 45.6;Horizontal cells: 92.5;Oligodendrocyte precursor cells: 27.6;Oligodendrocytes: 217.4" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 86.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 65: Brain - Ion transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 0.3 10.2 128.0 0.2 147.2 0.1 0.2 154.9 333.3 0.5 66.3 4.3 0.6 0.4 0.9 0.1 0.3 0.2 0.1 148.1 150.9 0.1 0.1 0.1 0.0 185.1 152.3 0.2 0.1 0.0 1.1 0.0 184.4 0.5 1.4 21.4 0.1 0.2 0.2 0.4 1.6 0.6 151.1 0.0 0.9 0.6 150.9 0.0 0.1 0.0 0.0 0.6 0.6 265.7 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 86.8 3.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.0 147.2 154.9 333.3 148.1 150.9 185.1 152.3 184.4 151.1 150.9 265.7 0.1 0.0 0.0 4.6 0.0 0.4 0.1 0.0 0.0 45.6 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 21.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 92.5 18.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.6 0.0 9.7 0.0 27.6 217.4 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 13.4 0.0 0.0 0.2 0.8 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 STX10 "hsyn10, SYN10" ENSG00000104915 "Syntaxin 10" O60499 19 13144058-13150383 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035303, HPA056439" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Vesicles" "HPA035303: AB_10671932, HPA056439: AB_2683135" "unprognostic (1.72e-2)" "unprognostic (2.26e-2)" "unprognostic (1.62e-2)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (1.21e-2)" "unprognostic (2.54e-3)" "prognostic favorable (8.26e-4)" "unprognostic (4.09e-1)" "unprognostic (3.66e-2)" "unprognostic (4.57e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.69e-7)" "unprognostic (2.39e-3)" "unprognostic (7.95e-2)" "unprognostic (2.23e-1)" "unprognostic (2.98e-2)" 45.3 58.7 42.1 35.6 44.3 72.3 47.1 45.3 52.3 65.5 47.0 57.2 47.7 48.7 17.1 80.7 49.6 29.5 56.1 42.2 41.7 60.9 78.8 66.9 42.5 44.6 43.3 50.7 48.3 27.9 49.1 17.0 43.1 49.9 19.8 11.6 52.0 20.4 35.8 68.2 60.7 20.9 40.7 87.0 60.3 17.7 43.6 35.3 56.6 16.6 28.2 51.4 55.4 48.5 99.9 68.8 51.8 138.1 51.5 52.8 17.2 55.4 49.4 46.1 48.4 31.8 88.3 66.5 80.5 66.8 33.7 76.3 44.9 67.0 26.6 113.4 86.0 60.8 154.4 66.5 38.2 71.4 63.2 54.3 55.3 57.4 37.2 62.8 58.1 85.9 32.9 34.6 31.8 87.2 105.6 125.2 55.2 51.3 112.5 117.3 54.1 96.6 44.4 47.2 60.0 121.3 57.9 66.2 127.6 14.9 45.1 67.9 58.4 75.3 38.7 145.9 77.5 78.1 75.2 57.0 98.0 172.8 59.8 41.5 162.3 120.4 48.1 128.4 40.7 39.9 41.4 48.7 119.1 40.3 36.3 37.3 267.6 32.1 151.5 31.2 51.4 80.7 42.1 44.3 45.3 52.3 42.2 41.7 44.6 43.3 43.1 40.7 43.6 48.5 31.6 16.0 21.6 13.1 29.9 35.4 34.5 52.0 31.3 21.3 43.0 37.5 12.6 30.0 53.6 20.2 6.2 17.7 32.2 54.3 27.4 42.5 1.0 23.9 28.3 31.3 16.3 33.2 16.6 56.1 26.2 27.6 40.8 24.7 53.8 33.7 31.1 18.8 82.4 13.5 11.8 48.0 46.8 86.7 45.8 3.0 25.1 62.0 48.0 7.5 86.1 21.4 48.4 11.1 14.0 57.0 53.8 31.2 25.3 19.9 77.9 28.3 38.2 17.1 26.3 21.2 31.0 9.0 16.2 38.6 43.2 19.4 39.1 23.6 55.5 38.4 STX1A "HPC-1, p35-1, STX1" ENSG00000106089 "Syntaxin 1A" Q16623 7 73699206-73719672 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Neurotransmitter transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 128.5;pituitary gland: 98.5" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 52.7;Excitatory neurons: 60.6;Pancreatic endocrine cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 139.9;U-87 MG: 92.2" "Group enriched" "Detected in all" 5 "amygdala: 246.2;basal ganglia: 93.9;cerebral cortex: 354.4;hippocampal formation: 229.1;white matter: 116.1" "Group enriched" "Detected in all" 8 "amygdala: 37.6;cerebral cortex: 103.4;hippocampal formation: 87.2" "CAB008372, HPA069176" Enhanced Approved "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 10: Brain - Neuronal signaling" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "Nuclear membrane" "CAB008372: AB_592786, HPA069176: AB_2686098" "unprognostic (5.12e-3)" "prognostic unfavorable (3.63e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.12e-3)" "unprognostic (1.88e-1)" "unprognostic (3.02e-8)" "unprognostic (1.11e-2)" "unprognostic (6.97e-2)" "unprognostic (3.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.70e-3)" "unprognostic (4.18e-6)" "unprognostic (2.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-3)" "unprognostic (6.20e-2)" 2.5 6.8 55.0 2.5 70.6 11.9 2.4 28.8 128.5 5.3 13.3 10.8 4.4 3.9 1.5 1.8 3.8 6.8 1.7 76.1 24.5 3.4 2.3 3.4 1.0 16.8 20.1 3.1 10.8 0.9 98.5 2.3 17.8 4.6 2.0 2.5 3.0 1.4 2.1 1.8 4.3 2.7 15.8 2.5 7.8 4.6 23.3 1.2 2.7 0.7 0.6 4.1 4.1 55.3 4.6 21.9 3.4 10.1 4.4 11.7 2.3 14.3 9.5 5.9 3.9 7.4 12.2 5.8 2.1 10.3 32.2 3.7 5.0 9.2 4.4 10.2 3.9 1.8 8.7 4.4 4.9 2.7 5.2 6.8 3.8 41.4 14.4 26.7 10.4 0.9 4.9 6.5 11.4 10.8 1.7 21.1 2.7 8.1 47.8 0.0 2.4 5.7 4.9 3.9 139.9 22.5 4.3 12.1 3.0 4.0 3.9 1.8 39.7 28.9 9.6 22.4 39.0 3.7 2.5 2.7 92.2 2.2 34.5 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.7 55.0 70.6 28.8 128.5 76.1 24.5 16.8 20.1 17.8 15.8 23.3 55.3 0.9 0.0 2.8 8.1 0.4 4.2 10.7 6.2 0.6 6.2 4.6 3.4 3.2 4.3 5.9 1.8 4.2 0.4 5.0 1.3 0.0 4.0 0.1 4.5 2.9 1.6 52.7 0.4 60.6 3.6 1.9 2.2 3.1 11.1 15.2 2.2 1.8 0.2 0.7 8.4 16.6 2.8 8.2 1.2 2.1 0.2 1.8 6.1 3.6 5.6 0.1 1.0 6.2 8.5 4.8 29.8 1.2 1.5 1.0 10.5 3.4 0.5 7.4 1.9 0.0 1.9 2.8 1.6 3.8 0.6 2.7 0.7 5.3 1.7 1.5 18.9 STX1B "STX1B1, STX1B2" ENSG00000099365 "Syntaxin 1B" P61266 16 30989256-31010638 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 137.2" "Cell type enhanced" "Detected in some" "Excitatory neurons: 36.8;Horizontal cells: 38.7;Inhibitory neurons: 31.1;Late spermatids: 13.8" "Cancer enriched" "Detected in some" 7 "glioma: 5.1" "Region enhanced" "Detected in many" "cerebral cortex: 137.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 11.1;hTERT-RPE1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079008" Supported Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 62: Horizontal cells - Visual perception" Vesicles "Nuclear membrane" "CAB079008: , HPA069176: AB_2686098" "unprognostic (1.43e-3)" "unprognostic (5.27e-2)" "unprognostic (2.40e-4)" "unprognostic (3.90e-3)" "unprognostic (3.98e-2)" "unprognostic (1.90e-2)" "unprognostic (2.21e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-1)" "unprognostic (3.72e-3)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (7.93e-2)" "unprognostic (1.57e-2)" 1.5 1.0 7.0 1.1 13.1 0.4 1.7 20.0 137.2 1.7 0.0 2.5 0.5 3.0 3.3 1.2 1.7 0.3 1.6 15.9 5.2 1.3 5.9 0.5 1.7 51.2 5.5 1.7 0.9 0.2 6.5 0.2 42.9 1.7 0.4 10.2 1.0 1.8 0.5 3.3 1.8 1.6 0.0 1.8 0.9 4.6 5.8 0.5 0.7 0.1 1.5 0.7 1.3 52.8 0.1 3.0 4.7 0.7 0.5 0.2 0.1 4.2 6.4 5.1 9.0 0.0 3.4 0.7 0.2 5.6 0.1 0.7 2.1 0.6 6.1 2.6 0.4 0.4 2.7 2.4 0.4 0.2 2.9 1.6 0.1 11.1 1.0 20.4 0.0 1.0 0.5 0.2 5.5 1.3 2.0 0.2 2.3 0.0 0.3 7.1 0.2 0.2 0.4 0.0 6.3 4.0 0.5 0.2 0.0 0.7 0.8 0.1 0.8 3.0 2.4 0.4 0.2 0.3 0.2 0.3 3.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.0 13.1 20.0 137.2 15.9 5.2 51.2 5.5 42.9 0.0 5.8 52.8 0.4 0.0 0.0 7.2 0.6 0.8 0.1 0.2 0.6 10.7 0.4 0.6 1.2 0.0 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.3 6.9 0.1 0.5 0.8 0.0 0.4 36.8 0.4 0.0 0.7 0.0 0.1 0.0 2.5 1.1 5.9 0.6 38.7 31.1 0.2 0.0 0.6 1.1 13.8 0.3 0.3 0.0 4.7 0.7 1.8 0.0 9.0 5.5 0.2 0.0 1.9 0.0 0.2 0.9 2.1 0.0 3.2 0.0 0.8 0.7 4.6 1.3 0.2 0.6 0.8 0.4 0.1 0.3 0.0 STX2 "EPIM, EPM, STX2A, STX2B, STX2C" ENSG00000111450 "Syntaxin 2" P32856 12 130789600-130839266 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 152.2;Endometrial ciliated cells: 86.4;Late spermatids: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079007" Uncertain Supported Approved "Nuclear membrane,Vesicles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 34: Spermatids - Unknown function" Vesicles "Nuclear membrane" "CAB079007: , HPA069176: AB_2686098" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (3.38e-2)" "unprognostic (9.85e-2)" "unprognostic (2.11e-2)" "unprognostic (4.16e-2)" "unprognostic (2.83e-1)" "unprognostic (7.62e-2)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.15e-5)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.63e-2)" "unprognostic (3.41e-3)" 17.7 11.0 11.2 9.1 11.7 6.4 12.0 12.3 13.4 15.1 24.7 21.2 4.2 14.3 9.8 6.0 16.3 9.9 17.0 12.2 12.1 14.4 13.3 17.8 8.6 15.5 12.3 15.3 10.9 5.9 14.6 13.2 14.5 8.4 6.8 16.7 5.0 10.6 6.7 5.1 11.4 17.2 13.0 12.4 11.4 17.0 11.8 6.9 12.4 7.9 6.2 14.5 10.7 16.3 9.6 18.3 26.8 22.4 27.8 63.2 2.8 44.2 35.8 50.8 35.7 5.5 6.6 11.7 6.6 50.5 16.4 2.8 24.4 6.6 54.9 18.7 9.2 6.4 15.9 15.7 30.6 9.2 15.5 23.4 8.3 24.9 20.1 48.2 27.6 12.7 25.7 11.2 46.2 5.6 13.3 10.6 17.9 2.9 28.2 13.7 18.9 7.0 28.7 2.1 24.3 25.4 20.4 1.8 18.1 23.4 6.1 6.4 36.5 30.1 20.3 33.1 19.6 8.1 6.7 7.9 35.0 10.8 24.4 1.0 0.4 0.6 0.5 0.5 0.5 0.5 0.6 0.5 0.3 0.3 0.6 0.6 0.4 0.2 0.2 0.3 0.4 0.2 11.2 11.7 12.3 13.4 12.2 12.1 15.5 12.3 14.5 13.0 11.8 16.3 35.3 22.4 14.8 20.5 6.2 3.4 1.2 2.1 3.4 5.6 2.1 3.0 17.2 11.5 6.9 29.5 0.0 1.8 12.3 0.4 9.8 19.1 152.2 86.4 40.0 22.4 6.7 32.4 33.6 7.4 7.1 26.5 2.6 7.6 1.3 10.9 17.9 19.0 11.5 0.0 17.6 0.7 2.0 11.5 12.3 114.4 28.0 15.1 14.2 23.4 10.3 12.3 6.2 15.1 24.3 14.5 0.1 24.5 10.2 2.0 0.1 17.6 33.9 31.4 13.1 26.1 29.6 42.0 34.2 1.7 1.4 0.8 14.2 11.7 0.6 0.5 STX3 STX3A ENSG00000166900 "Syntaxin 3" Q13277 11 59713456-59805882 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 313.2" "Cell type enhanced" "Detected in all" "Bipolar cells: 373.0;Cone photoreceptor cells: 394.0;Rod photoreceptor cells: 400.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 42.5;eosinophil: 74.1;neutrophil: 60.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 74.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 167.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002191, HPA069176" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 3: HMC-1 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles "Nuclear membrane" "HPA002191: AB_1080165, HPA069176: AB_2686098" "unprognostic (2.24e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.84e-2)" "unprognostic (2.36e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (1.64e-1)" "unprognostic (3.00e-1)" "unprognostic (7.71e-3)" "unprognostic (2.07e-2)" "unprognostic (5.55e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" "unprognostic (4.02e-2)" "unprognostic (1.17e-2)" 16.4 24.1 10.1 23.7 11.8 59.2 20.1 18.3 14.6 21.1 11.8 51.0 59.5 29.7 36.7 21.4 15.1 39.1 16.4 10.8 11.2 58.6 15.4 40.7 9.7 11.7 11.9 18.7 24.0 34.1 19.4 50.3 13.4 20.2 56.3 313.2 21.6 24.6 10.9 26.2 44.1 26.4 9.7 23.4 47.5 22.1 12.4 7.4 27.8 17.9 13.8 28.3 18.3 13.1 40.1 23.8 0.9 11.0 20.5 11.5 33.1 21.1 37.7 49.4 61.0 109.4 38.2 11.2 38.9 16.1 85.6 44.0 63.5 22.0 59.4 9.6 12.0 12.7 16.4 34.0 51.1 41.7 116.4 21.0 46.6 38.3 46.2 30.5 39.7 16.6 110.5 23.0 21.5 23.8 0.4 28.9 60.1 63.1 18.2 14.5 40.8 18.6 92.7 94.5 27.0 41.4 9.0 48.0 167.2 79.9 52.1 29.0 54.0 20.8 44.0 28.6 19.3 25.8 49.4 22.8 27.8 27.0 29.0 42.5 6.3 74.1 2.4 1.9 2.5 1.0 3.3 1.6 7.1 3.1 3.0 0.9 60.7 0.5 1.2 1.0 0.0 2.7 10.1 11.8 18.3 14.6 10.8 11.2 11.7 11.9 13.4 9.7 12.4 13.1 17.0 67.3 30.6 2.6 9.5 50.7 69.5 12.8 30.1 373.0 43.5 15.2 10.2 31.5 18.9 11.0 394.0 10.1 5.9 124.6 17.6 40.2 4.8 37.8 9.6 30.2 26.3 4.4 40.4 25.6 15.9 12.8 29.6 68.5 58.2 14.9 20.7 5.6 16.0 72.3 33.0 36.5 18.3 18.9 49.7 7.5 3.7 26.4 37.4 24.4 28.7 48.4 11.3 3.5 25.3 48.9 64.1 7.5 5.8 87.2 34.0 69.5 13.3 400.3 6.6 10.0 15.9 4.6 20.6 29.4 60.1 40.5 17.9 5.6 26.5 87.7 STX8 CARB ENSG00000170310 "Syntaxin 8" Q9UNK0 17 9250471-9576591 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 261.6;Late spermatids: 964.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001540 Approved Approved Vesicles,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" Vesicles Cytosol "HPA001540: AB_1080168" "unprognostic (8.68e-2)" "unprognostic (2.29e-2)" "unprognostic (2.53e-1)" "unprognostic (4.14e-3)" "unprognostic (3.36e-1)" "unprognostic (1.58e-2)" "unprognostic (6.91e-2)" "unprognostic (1.19e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (1.86e-3)" "unprognostic (2.54e-1)" "unprognostic (1.45e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-1)" "unprognostic (1.77e-2)" "unprognostic (1.51e-1)" 50.7 42.9 51.1 21.7 51.9 42.9 45.6 52.3 72.9 46.8 53.0 59.5 23.1 41.5 64.2 35.6 38.8 28.5 56.2 51.6 51.4 46.3 48.0 35.4 32.8 52.4 51.9 42.6 45.2 42.8 33.7 29.1 53.1 40.2 38.7 32.3 42.8 41.0 64.0 39.7 34.1 42.4 52.7 35.7 43.3 76.2 51.6 43.5 42.8 61.5 39.4 48.6 41.9 54.5 35.1 65.9 54.6 28.9 86.2 107.7 24.6 40.3 69.4 55.6 73.5 22.5 27.6 42.3 34.6 79.7 48.0 37.7 35.5 76.6 86.2 66.6 59.2 26.7 19.0 52.5 117.4 20.3 47.1 87.9 120.9 43.8 65.7 66.5 67.2 44.8 13.2 18.8 62.5 18.5 39.9 41.6 14.2 41.5 34.2 56.2 46.6 25.9 71.8 32.6 7.3 34.7 30.8 16.3 48.2 73.8 21.3 32.3 61.0 42.8 26.6 24.5 54.3 17.5 17.3 16.3 64.1 47.4 39.6 117.0 142.5 159.3 124.3 128.0 113.5 117.0 133.3 139.5 142.6 108.8 85.6 100.7 40.9 167.4 132.6 123.1 198.8 197.8 51.1 51.9 52.3 72.9 51.6 51.4 52.4 51.9 53.1 52.7 51.6 54.5 39.2 32.1 27.0 65.3 37.0 45.8 52.8 83.8 23.3 15.2 32.8 36.2 61.5 31.5 58.5 29.5 12.5 55.9 49.8 34.6 103.7 62.3 261.6 31.4 33.2 33.9 25.0 25.2 79.7 82.8 55.3 49.3 23.0 27.7 54.5 33.5 29.3 38.6 87.1 6.7 63.0 41.2 85.5 46.3 84.0 964.1 46.3 43.6 78.2 89.9 70.4 58.4 107.1 91.0 86.9 69.9 58.1 47.4 23.5 23.8 66.2 93.5 45.0 24.3 13.1 33.9 59.7 58.6 23.8 29.4 44.6 43.4 54.2 20.1 31.2 38.7 SULT2B1 HSST2 ENSG00000088002 "Sulfotransferase family 2B member 1" O00204 19 48552172-48599425 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 286.0;skin 1: 186.5;vagina: 145.9" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041724, HPA043539, HPA076510" Enhanced Enhanced Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" Vesicles Cytosol "HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: " "unprognostic (6.55e-2)" "unprognostic (1.47e-1)" "unprognostic (5.28e-3)" "unprognostic (8.74e-2)" "unprognostic (5.00e-2)" "unprognostic (5.97e-2)" "unprognostic (4.43e-2)" "unprognostic (3.29e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-2)" "unprognostic (4.42e-2)" "unprognostic (5.01e-6)" "unprognostic (7.96e-3)" "unprognostic (1.32e-1)" "unprognostic (8.04e-2)" "unprognostic (2.77e-2)" 0.3 0.2 0.5 0.4 0.4 0.1 11.5 0.6 0.8 74.4 0.4 0.8 9.3 0.5 6.8 286.0 1.2 2.7 0.2 0.5 0.5 13.0 0.3 9.4 0.0 0.5 0.7 0.1 0.7 7.9 0.4 1.5 0.5 22.6 0.2 0.0 53.6 3.7 0.4 186.5 18.2 0.1 0.4 0.1 3.5 0.5 0.9 0.4 1.9 0.0 28.3 0.7 145.9 0.5 12.6 15.8 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.9 74.2 0.1 0.1 0.0 0.7 3.9 0.1 0.3 0.0 0.5 0.4 0.0 0.5 0.5 0.0 0.0 7.2 0.2 2.1 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.0 46.8 0.0 0.5 0.0 122.9 0.0 0.1 0.0 0.1 0.0 3.5 0.2 0.1 0.0 6.2 0.3 0.0 36.7 0.1 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.3 0.5 0.1 0.0 0.3 0.2 0.6 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.5 0.4 0.6 0.8 0.5 0.5 0.5 0.7 0.5 0.4 0.9 0.5 0.4 19.2 0.5 1.0 0.0 24.1 30.5 11.6 0.0 0.0 16.8 12.4 0.6 5.7 40.2 9.2 0.0 3.2 0.0 4.4 0.0 12.2 0.0 15.7 1.4 0.9 4.8 0.0 1.0 1.2 3.1 1.2 2.6 17.5 0.0 0.1 0.0 0.3 0.7 0.0 0.9 12.6 24.4 0.0 4.8 0.9 0.3 0.4 12.4 1.0 0.0 1.6 0.0 0.5 0.8 18.5 7.9 0.0 0.0 62.3 75.9 1.3 6.7 0.6 0.0 0.1 2.2 0.2 11.1 56.0 137.4 1.9 0.6 2.0 9.2 114.6 SUMF2 DKFZp566I1024 ENSG00000129103 "Sulfatase modifying factor 2" Q8NBJ7 7 56064002-56080670 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024040, CAB025743, HPA074892" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" Yes No 750000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "CAB025743: , HPA024040: AB_1857651, HPA074892: " "unprognostic (2.93e-1)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.42e-2)" "prognostic favorable (3.96e-4)" "unprognostic (3.87e-2)" "unprognostic (9.11e-3)" "unprognostic (1.69e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.20e-2)" "unprognostic (1.92e-1)" "unprognostic (7.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.74e-2)" "unprognostic (2.64e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.71e-4)" 64.1 64.6 26.1 43.0 29.7 51.5 57.5 29.3 27.1 91.3 45.0 67.4 89.2 57.5 64.8 46.8 102.6 70.6 30.8 25.1 27.8 93.4 94.8 71.6 50.2 35.2 29.6 59.7 91.8 115.8 31.8 45.5 33.4 79.3 69.1 11.0 69.5 77.1 22.4 47.5 74.4 57.7 29.9 57.0 92.7 23.7 30.8 57.6 91.2 21.4 51.3 57.2 43.6 35.9 352.3 102.9 46.0 211.8 214.4 147.5 68.9 114.5 156.1 92.6 114.5 57.2 278.0 57.1 96.5 162.4 90.4 172.3 27.4 131.3 61.1 90.6 42.9 36.4 63.5 54.2 138.4 89.7 108.7 116.8 124.5 83.7 143.3 186.9 137.7 101.4 116.4 236.6 151.3 76.8 77.2 115.7 63.5 272.0 52.2 61.5 45.4 359.0 127.7 39.1 54.0 65.6 142.4 294.2 140.9 98.9 294.5 144.5 115.2 85.6 121.1 211.1 98.6 160.8 130.8 84.0 139.7 165.7 283.2 58.1 60.3 22.0 71.1 80.5 90.9 59.8 70.9 71.8 72.3 49.1 75.3 75.2 4.4 49.0 90.3 132.6 82.7 90.2 26.1 29.7 29.3 27.1 25.1 27.8 35.2 29.6 33.4 29.9 30.8 35.9 44.0 57.7 30.5 20.5 47.3 33.8 44.1 46.1 39.9 25.7 57.9 25.4 10.4 87.2 31.0 90.1 14.6 44.5 85.3 45.1 19.6 95.3 3.8 93.1 70.2 43.7 59.3 41.7 21.2 55.7 96.7 54.7 55.5 78.9 54.5 47.0 51.0 91.3 68.1 43.7 24.4 61.8 22.4 79.8 38.7 8.0 69.6 50.4 53.4 14.0 73.0 23.8 70.0 10.6 24.2 48.4 64.6 47.4 65.0 50.7 91.8 45.6 34.5 13.5 52.6 41.6 44.1 31.6 28.6 52.8 41.9 46.7 52.7 58.7 85.8 42.7 SUSD5 KIAA0527 ENSG00000173705 "Sushi domain containing 5" O60279 3 33150043-33218810 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Excitatory neurons: 15.4;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 61.3;Sertoli cells: 32.9;Smooth muscle cells: 29.0" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 31.1;HUVEC TERT2: 78.5;LHCN-M2: 30.4;TIME: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052788 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA 17000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus, Vesicles" "HPA052788: AB_2681948" "unprognostic (1.81e-1)" "unprognostic (1.52e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-3)" "unprognostic (1.39e-3)" "unprognostic (4.05e-2)" "unprognostic (3.72e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-3)" "unprognostic (6.45e-2)" "unprognostic (8.46e-2)" "unprognostic (1.89e-2)" 4.6 1.4 2.9 0.9 3.0 0.1 1.9 2.2 4.6 6.3 4.4 1.7 0.8 4.6 2.2 1.3 5.2 5.5 1.5 3.1 4.4 1.5 0.5 1.7 2.3 3.4 3.4 3.8 0.6 1.0 0.8 0.2 3.4 1.3 1.2 0.6 0.7 6.3 1.6 1.9 1.9 4.8 3.8 2.5 1.8 2.1 4.7 0.1 3.2 3.3 5.3 1.5 2.4 3.5 0.0 1.1 1.2 0.7 1.7 0.2 0.1 9.6 3.4 31.1 10.5 0.1 0.0 0.0 8.8 2.5 9.5 0.1 13.7 4.5 12.9 0.3 15.3 0.0 2.0 0.0 0.2 0.1 0.1 1.3 2.4 19.9 3.9 15.2 78.5 0.0 0.0 0.1 30.4 0.0 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.0 1.0 0.1 0.1 2.5 0.7 1.8 1.9 31.3 0.0 14.4 1.2 4.7 0.0 0.7 0.0 0.3 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.9 3.0 2.2 4.6 3.1 4.4 3.4 3.4 3.4 3.8 4.7 3.5 0.1 0.0 0.0 0.3 0.0 1.0 0.1 0.0 0.0 1.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 2.2 0.5 0.0 0.0 15.4 0.0 0.1 1.4 0.0 0.9 0.0 0.2 0.4 0.0 0.0 3.3 10.5 0.0 0.0 2.1 2.0 0.3 0.0 0.1 1.8 0.0 0.0 0.5 0.0 61.3 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 32.9 3.6 29.0 0.1 2.6 0.1 1.0 0.0 0.2 0.1 0.0 0.1 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083383-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 55.7" "Group enriched" "Detected in some" 4 "Excitatory neurons: 85.0;Inhibitory neurons: 82.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 15 "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Group enriched" "Detected in some" 5 "Karpas-707: 9.1;SCLC-21H: 3.7;SH-SY5Y: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.0 1.2 4.7 0.2 31.4 0.1 0.2 11.1 32.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.0 55.7 0.0 0.0 0.0 0.0 26.1 39.5 0.5 0.1 0.0 0.4 0.0 42.2 0.1 0.1 4.3 0.3 0.2 0.0 0.0 0.2 0.2 9.1 0.0 0.5 0.1 20.2 0.0 0.0 0.0 0.0 0.0 0.1 10.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 8.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 31.4 11.1 32.0 0.0 55.7 26.1 39.5 42.2 9.1 20.2 10.2 0.5 0.0 0.0 5.5 0.1 0.0 0.7 0.4 0.0 5.4 0.7 0.1 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 2.5 0.6 0.4 19.8 0.0 85.0 0.2 0.0 0.1 0.0 2.1 0.0 0.5 0.7 0.0 0.1 0.0 82.6 0.6 2.0 0.6 0.3 0.8 0.0 0.2 3.6 2.8 0.0 1.0 0.0 3.0 3.1 0.0 0.2 0.0 0.3 0.6 0.0 0.0 0.1 5.6 0.0 0.2 0.4 0.2 0.7 0.0 0.1 0.0 0.2 0.8 0.2 1.5 SYNPO2 MYOPODIN ENSG00000172403 "Synaptopodin 2" Q9UMS6 4 118850688-119061247 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 991.6;tongue: 493.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1" "Group enriched" "Detected in all" 5 "prostate cancer: 25.7;stomach cancer: 27.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2" "Region enriched" "Detected in all" 4 "thalamus: 27.1" "Low region specificity" "Detected in all" "HPA030665, CAB037231, HPA049707, HPA068563" Enhanced Enhanced "Vesicles,Actin filaments" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Vesicles, Actin filaments" "CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006" "unprognostic (1.50e-2)" "unprognostic (1.73e-2)" "unprognostic (5.32e-2)" "unprognostic (1.50e-2)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (5.71e-4)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (1.39e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (1.82e-2)" "unprognostic (1.35e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.91e-4)" 57.5 10.8 6.1 47.4 7.9 0.3 35.9 4.1 5.7 55.0 2.2 346.4 34.3 137.1 33.4 197.1 89.5 50.0 66.8 10.7 13.3 8.7 7.0 16.2 10.5 5.4 7.5 39.0 3.8 3.6 7.5 20.8 6.1 180.5 58.0 1.2 16.0 267.4 991.6 17.9 75.5 244.4 9.2 10.2 126.2 6.7 5.8 14.3 16.0 493.5 6.5 226.5 54.0 12.0 0.2 4.2 0.2 0.0 10.5 3.5 0.7 13.4 14.1 0.4 0.5 0.0 0.7 1.5 0.1 57.8 0.9 0.2 0.4 0.3 0.7 5.9 0.1 0.8 1.3 0.0 2.4 0.1 0.2 14.5 0.3 4.0 0.2 3.7 0.2 0.2 0.0 0.7 18.5 0.3 0.7 7.2 1.4 0.0 0.0 0.5 1.5 0.4 0.2 0.3 0.4 83.2 0.4 0.3 0.1 3.3 0.0 7.0 0.4 0.6 0.1 0.2 0.1 0.1 0.3 0.1 1.1 0.6 0.2 0.8 0.1 0.5 0.2 0.0 0.4 0.3 0.4 0.2 0.0 0.4 0.4 0.3 0.2 0.3 0.1 0.0 0.5 0.1 6.1 7.9 4.1 5.7 10.7 13.3 5.4 7.5 6.1 9.2 5.8 12.0 25.5 3.2 1.1 42.7 1.1 13.5 17.9 3.7 46.1 2.5 6.3 30.7 135.4 0.0 0.3 1.8 0.0 1.4 0.5 0.1 0.0 0.1 2.2 6.9 130.0 11.3 0.0 1.7 149.6 1.8 0.5 41.5 0.5 10.6 0.0 16.1 13.9 0.4 1.4 0.0 31.5 0.2 0.0 0.9 11.4 7.0 27.1 3.8 5.4 76.8 12.9 0.0 0.0 6.0 3.0 0.2 0.4 101.5 0.8 24.9 0.1 0.3 2.5 0.5 131.5 93.4 206.1 1.3 0.5 5.3 8.1 0.8 2.6 33.4 0.2 4.0 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.3;fallopian tube: 2.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.9;Distal tubular cells: 7.9;Excitatory neurons: 4.4;Inhibitory neurons: 15.4;Late spermatids: 16.2" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;K-562: 1.0;MCF7: 3.5;RT4: 1.3;SCLC-21H: 1.7" "Region enhanced" "Detected in all" "olfactory bulb: 49.5" "Low region specificity" "Detected in all" HPA055426 Approved Nucleoplasm,Vesicles NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA055426: AB_2682812" "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.0 0.3 0.9 0.1 1.9 0.0 0.0 0.0 0.9 0.5 0.4 0.8 0.2 0.0 0.1 0.0 2.2 0.0 0.0 0.6 5.1 0.8 0.3 0.0 0.0 4.1 1.7 0.0 0.0 0.0 0.5 0.0 4.3 0.4 0.4 0.1 0.0 0.7 0.0 0.0 0.3 0.1 2.4 0.0 0.4 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.9 0.6 5.1 4.1 1.7 4.3 2.4 6.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.5 0.0 2.5 0.0 0.0 0.1 0.0 0.0 7.9 0.0 1.5 1.8 0.3 0.1 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.0 0.0 0.8 1.4 0.0 0.0 0.0 15.4 0.2 0.0 0.0 0.0 16.2 0.3 0.0 0.0 1.0 0.0 0.6 0.0 0.5 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.7 0.2 0.0 0.0 0.3 0.2 3.7 0.0 0.0 0.1 0.0 3.2 0.1 0.1 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267892-43277535 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.7;pituitary gland: 30.7;retina: 25.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 66.8;Cone photoreceptor cells: 22.9;Enteroendocrine cells: 28.7;Excitatory neurons: 50.9;Fibroblasts: 23.0;Inhibitory neurons: 34.1" "Group enriched" "Detected in some" 5 "glioma: 2.0;pancreatic cancer: 4.1;prostate cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 245.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 3.7 15.9 21.5 1.4 18.6 0.1 0.0 74.7 42.6 0.0 0.0 1.2 0.8 0.0 0.0 0.1 0.0 0.0 1.3 18.6 50.4 0.1 0.0 0.9 0.0 10.5 15.3 0.5 3.7 0.0 30.7 0.1 39.3 0.6 0.8 25.2 0.1 8.3 0.0 0.0 0.7 0.6 13.5 0.0 3.2 1.6 18.3 0.4 0.3 0.0 0.0 0.0 0.5 10.9 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 245.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 18.6 74.7 42.6 18.6 50.4 10.5 15.3 39.3 13.5 18.3 10.9 0.0 0.0 1.1 8.8 0.0 0.1 0.0 0.0 0.0 66.8 0.0 0.0 3.6 0.0 2.5 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 28.7 0.0 50.9 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.4 0.0 2.5 0.0 7.5 7.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 10.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.1 SYTL3 "exophilin-6, SLP3" ENSG00000164674 "Synaptotagmin like 3" Q4VX76 6 158650014-158764876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 334.2;granulocytes: 135.4;NK-cells: 132.8;Plasma cells: 135.2;T-cells: 230.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 232.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 232.0" "Cell line enhanced" "Detected in many" "HMC-1: 23.9;U-138 MG: 18.9;U-2 OS: 19.1;U-266/70: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030584, HPA030585, HPA030586" Approved Approved "Nucleoli fibrillar center,Vesicles" NA Yes "Cluster 38: Basophils - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli fibrillar center, Vesicles" "HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226" "unprognostic (3.56e-3)" "prognostic favorable (8.84e-5)" "unprognostic (6.37e-2)" "unprognostic (1.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-2)" "unprognostic (5.45e-3)" "unprognostic (9.33e-3)" "unprognostic (1.75e-1)" "unprognostic (3.07e-1)" "unprognostic (5.63e-2)" "unprognostic (8.58e-3)" "unprognostic (1.55e-1)" "unprognostic (6.28e-2)" "unprognostic (2.80e-2)" "unprognostic (1.83e-1)" 5.5 1.8 1.5 7.5 1.7 13.9 4.3 2.2 1.6 6.0 23.9 4.2 3.8 3.5 6.4 4.0 14.4 4.8 7.1 2.3 2.7 5.3 2.5 16.8 8.4 3.8 2.9 2.8 1.5 1.8 2.1 1.6 3.4 5.4 2.4 0.4 15.3 5.8 14.9 3.3 9.9 2.8 2.9 19.8 7.1 3.8 2.9 17.4 25.2 8.2 6.0 5.0 3.6 4.6 7.1 1.0 0.1 0.5 0.9 0.9 0.4 3.1 2.0 0.8 2.1 0.6 5.8 0.1 0.5 5.3 2.6 0.8 0.1 0.9 2.9 15.1 0.4 5.8 0.2 0.0 1.7 1.7 23.9 3.1 2.1 6.1 1.0 2.6 1.4 1.1 0.3 5.6 6.8 0.3 0.1 2.0 0.1 1.3 1.0 0.0 5.6 0.7 2.8 0.4 15.6 1.2 1.0 9.7 0.8 0.3 2.0 0.3 8.8 18.9 19.1 0.5 0.6 28.5 7.1 0.6 12.0 8.3 0.6 232.0 16.0 0.8 37.3 3.3 22.0 1.0 14.7 25.3 4.6 0.3 15.7 19.3 35.5 43.1 1.4 1.3 16.4 18.9 1.5 1.7 2.2 1.6 2.3 2.7 3.8 2.9 3.4 2.9 2.9 4.6 2.8 16.0 13.1 2.3 23.5 4.6 2.9 4.4 1.8 0.2 4.4 3.7 4.1 1.5 15.9 14.7 2.1 1.3 334.2 1.0 5.9 0.8 10.8 51.0 3.0 4.2 0.0 4.4 3.4 0.6 0.5 4.8 17.3 37.4 135.4 0.4 3.9 1.9 4.2 0.0 4.8 1.8 4.1 11.5 20.3 18.1 0.0 26.6 10.6 28.1 17.6 0.1 132.8 2.0 2.5 0.6 0.1 0.7 135.2 1.8 2.0 1.9 51.5 0.5 0.0 2.3 2.4 2.1 8.4 2.6 4.4 1.9 230.2 0.9 1.3 3.1 TAMALIN GRASP ENSG00000161835 "Trafficking regulator and scaffold protein tamalin" Q7Z6J2 12 52006946-52015889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 243.8;B-cells: 60.6;dendritic cells: 114.1;Macrophages: 60.6;Plasma cells: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 37.4;TIME: 27.4;WM-115: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040664, HPA062028" Approved Approved "Nuclear bodies,Vesicles" No NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "Nuclear bodies" "HPA040664: AB_10794066, HPA062028: AB_2684664" "unprognostic (1.90e-1)" "unprognostic (1.29e-2)" "unprognostic (2.48e-2)" "unprognostic (2.39e-2)" "unprognostic (2.00e-2)" "unprognostic (2.38e-2)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (2.86e-1)" "unprognostic (8.71e-2)" "unprognostic (3.16e-3)" "unprognostic (7.20e-2)" "unprognostic (3.90e-3)" "unprognostic (1.99e-3)" "unprognostic (1.44e-1)" "unprognostic (3.53e-2)" "unprognostic (2.77e-2)" 31.9 6.3 9.8 4.1 14.9 23.8 26.9 3.2 21.5 17.6 0.4 9.4 2.2 22.0 1.6 7.1 22.2 9.6 24.2 10.5 3.7 12.2 4.2 46.8 3.8 5.0 4.9 14.9 5.7 2.8 6.2 8.9 4.8 13.0 1.9 0.1 6.5 3.1 10.6 10.7 9.8 6.0 4.1 18.2 8.6 2.6 7.6 3.7 16.3 8.4 2.3 12.5 17.1 7.1 0.0 0.0 4.4 0.2 1.9 3.6 1.0 0.2 1.1 0.0 1.1 0.0 0.0 0.0 10.0 0.0 0.4 0.1 1.3 0.0 0.4 0.2 1.3 0.3 0.0 6.2 7.4 0.3 3.3 7.2 0.0 0.3 0.0 0.0 37.4 1.0 1.6 0.0 0.9 0.2 3.1 10.5 4.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 1.1 1.6 0.0 0.2 7.5 2.7 0.0 0.3 27.4 0.0 2.5 0.2 0.0 0.2 0.0 0.1 0.6 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 9.8 14.9 3.2 21.5 10.5 3.7 5.0 4.9 4.8 4.1 7.6 7.1 243.8 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.2 114.1 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.0 0.0 TASL "CXorf21, FLJ11577" ENSG00000120280 "TLR adaptor interacting with endolysosomal SLC15A4" Q9HAI6 X 30558809-30577766 "Disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.5;lymphoid tissue: 10.9" "Cell type enriched" "Detected in some" 5 "Hofbauer cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 7 "THP-1: 166.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001185 Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 43: THP-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm Vesicles "HPA001185: AB_1078591" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (4.37e-2)" "unprognostic (2.27e-2)" "unprognostic (3.47e-2)" "unprognostic (5.25e-3)" "unprognostic (9.07e-3)" "unprognostic (5.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (3.60e-1)" "unprognostic (1.66e-3)" "unprognostic (8.99e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-2)" "unprognostic (3.23e-2)" 1.8 1.8 0.6 10.9 0.6 19.5 2.1 0.7 1.0 1.1 1.1 3.5 4.7 0.6 0.4 1.6 0.8 3.9 0.6 0.7 0.6 1.1 2.4 4.7 10.5 1.3 1.1 0.3 0.3 0.7 0.3 2.9 1.3 1.0 3.4 0.2 1.0 0.6 0.1 0.7 3.0 2.2 0.9 9.8 3.6 0.3 1.5 5.8 0.6 0.4 10.2 4.1 0.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.0 13.8 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 21.5 0.0 0.0 0.0 20.5 0.0 21.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.0 0.0 0.0 0.0 0.0 0.1 15.0 1.6 7.5 0.0 23.9 0.0 8.6 21.9 24.1 1.6 19.8 0.3 23.0 2.0 1.1 25.3 23.6 1.8 1.3 30.6 7.1 44.4 45.9 3.4 8.0 0.6 0.6 0.7 1.0 0.7 0.6 1.3 1.1 1.3 0.9 1.5 2.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 TBC1D5 KIAA0210 ENSG00000131374 "TBC1 domain family member 5" Q92609 3 17157162-18444817 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035125, HPA035126" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "Golgi apparatus" "HPA035125: AB_2674479, HPA035126: AB_10670696" "unprognostic (1.87e-1)" "unprognostic (3.57e-1)" "unprognostic (2.86e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (4.30e-3)" "unprognostic (3.07e-2)" "unprognostic (3.31e-1)" "unprognostic (3.56e-2)" "unprognostic (6.27e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "prognostic favorable (1.75e-7)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (5.72e-2)" "unprognostic (7.07e-2)" 17.9 17.4 13.7 17.0 21.1 25.2 18.6 18.2 15.5 20.1 6.0 13.5 10.8 17.6 12.1 16.8 22.5 19.2 15.8 13.8 16.1 19.9 14.7 18.0 23.1 21.9 17.7 28.1 18.3 25.7 8.5 17.5 22.8 14.0 13.9 10.9 14.1 16.4 9.3 14.0 13.8 18.3 18.3 24.0 13.8 18.9 16.0 20.3 30.0 11.3 23.2 14.8 10.1 29.9 26.3 28.8 23.2 22.0 45.0 65.5 25.4 27.6 39.7 17.7 15.3 14.0 23.2 48.5 29.1 56.3 27.1 8.0 20.6 33.6 36.6 43.0 7.9 46.6 11.1 16.5 28.8 45.7 39.0 42.6 39.3 38.5 23.2 39.8 40.9 28.3 29.6 43.6 43.5 17.6 22.5 10.5 19.1 16.8 30.0 48.9 29.6 34.7 26.3 20.0 8.8 41.0 52.5 12.2 18.6 21.7 34.6 37.6 44.7 48.7 21.6 25.6 30.4 25.2 36.6 46.7 37.5 42.3 46.5 11.7 8.1 11.9 5.8 6.5 7.5 10.3 4.4 4.2 9.2 11.3 3.2 3.8 10.4 4.3 6.3 5.8 5.2 4.8 13.7 21.1 18.2 15.5 13.8 16.1 21.9 17.7 22.8 18.3 16.0 29.9 40.4 16.0 35.0 226.6 56.0 18.4 20.0 15.8 42.7 20.3 23.0 19.9 18.6 25.8 27.8 14.7 10.4 17.1 28.9 9.2 5.9 17.7 64.1 19.6 28.9 30.7 13.1 31.3 333.2 9.9 16.7 32.5 20.4 28.2 18.9 31.5 34.6 19.9 21.4 35.3 350.5 13.4 10.2 35.6 22.9 40.2 30.7 34.9 14.2 324.2 23.2 26.6 32.0 341.8 565.6 12.3 9.1 30.5 20.7 9.8 13.7 15.9 16.3 22.3 6.6 34.0 20.4 20.7 25.5 28.4 17.0 8.2 30.0 35.5 14.5 17.6 TBK1 NAK ENSG00000183735 "TANK binding kinase 1" Q9UHD2 12 64452090-64502114 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045797, HPA060211" Uncertain Enhanced Nucleoplasm,Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Vesicles "HPA045797: AB_2679457, HPA060211: AB_2684222" "unprognostic (4.73e-2)" "unprognostic (8.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.90e-1)" "unprognostic (1.94e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.48e-4)" "unprognostic (1.69e-1)" "unprognostic (2.54e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (4.20e-6)" "unprognostic (4.35e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-2)" "unprognostic (9.56e-3)" 11.6 15.3 6.0 10.1 6.1 16.9 11.4 5.6 6.9 10.6 5.3 10.5 15.1 11.0 6.7 11.3 9.5 10.1 9.4 5.8 5.6 11.8 17.4 12.9 14.6 6.5 6.9 9.6 7.5 11.6 9.8 13.7 6.1 10.6 8.5 6.3 10.2 9.0 18.4 8.6 11.4 10.8 5.3 13.4 10.2 23.5 6.7 6.8 8.5 14.9 12.9 16.0 10.2 7.1 23.3 24.2 11.1 10.6 24.7 26.1 29.0 22.9 37.6 22.5 21.1 14.9 12.4 31.5 21.4 26.8 34.4 19.0 19.4 20.0 26.4 29.5 17.1 33.0 15.3 19.1 30.2 35.2 36.4 18.5 19.1 23.1 23.6 42.3 32.4 11.0 27.9 38.7 31.6 27.0 0.9 17.0 29.9 22.9 13.8 14.9 15.3 31.8 25.1 36.9 9.8 14.7 33.3 36.0 23.5 23.5 33.1 24.9 25.9 20.2 18.1 14.9 24.0 25.4 54.3 30.3 28.1 18.6 26.1 41.8 10.1 24.3 13.9 17.7 16.3 12.8 10.1 15.2 12.2 10.1 2.8 8.7 17.8 26.6 15.5 2.1 13.6 10.0 6.0 6.1 5.6 6.9 5.8 5.6 6.5 6.9 6.1 5.3 6.7 7.1 23.7 19.2 20.5 28.4 21.6 11.0 25.7 20.1 15.4 17.0 14.9 9.1 10.9 8.6 23.4 22.0 10.4 28.8 30.0 14.1 11.7 19.3 34.5 19.2 17.9 28.6 17.3 18.3 50.5 23.6 32.6 21.3 15.3 30.2 43.1 17.5 16.8 17.1 20.2 18.5 42.2 10.5 12.2 23.0 30.2 29.2 19.3 31.1 14.2 46.9 31.4 12.7 33.0 39.2 52.3 16.9 10.9 20.7 25.6 43.7 13.6 12.3 20.8 16.3 26.3 22.4 18.7 68.9 12.7 14.0 14.9 92.6 27.1 11.5 10.1 41.6 TCEA3 TFIIS.H ENSG00000204219 "Transcription elongation factor A3" O75764 1 23380909-23424748 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 513.3" "Cell type enhanced" "Detected in many" "Granulosa cells: 214.8;Hepatocytes: 205.9;Intestinal goblet cells: 376.2;Proximal tubular cells: 260.9;Undifferentiated cells: 223.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 8.4;naive CD4 T-cell: 13.6" "Lineage enriched" "Detected in many" 5 "T-cells: 13.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.3;Hep G2: 55.1;OE19: 28.7;SiHa: 18.2;T-47d: 28.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044960, HPA055811" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 32: T-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA044960: AB_10964053, HPA055811: AB_2682932" "unprognostic (1.58e-1)" "unprognostic (1.75e-3)" "unprognostic (9.18e-2)" "unprognostic (3.82e-2)" "unprognostic (2.77e-3)" "prognostic favorable (2.56e-4)" "unprognostic (2.86e-2)" "unprognostic (4.70e-3)" "unprognostic (7.37e-3)" "unprognostic (2.85e-1)" "unprognostic (2.22e-2)" "unprognostic (3.27e-1)" "unprognostic (2.23e-1)" "unprognostic (4.01e-1)" "unprognostic (5.20e-2)" "unprognostic (3.15e-1)" "unprognostic (5.58e-2)" 17.5 95.6 4.7 4.6 4.3 0.6 19.6 4.1 4.7 35.7 7.8 87.1 15.8 17.0 7.3 40.5 28.3 11.6 71.6 4.0 4.4 64.9 160.7 20.4 2.4 6.0 4.9 81.9 229.4 16.3 14.9 3.9 5.4 59.9 39.8 3.2 100.3 14.5 513.3 53.4 35.2 9.2 5.2 10.6 75.9 4.7 4.1 1.8 41.2 173.1 4.5 36.2 38.7 5.1 0.0 0.1 0.5 0.5 2.5 15.3 9.0 6.4 4.1 3.2 1.9 4.1 0.5 0.2 0.7 7.9 1.0 9.1 0.5 0.1 2.8 0.0 0.1 0.0 6.9 55.1 1.9 0.8 0.0 10.1 2.8 2.9 0.0 7.1 0.4 0.1 0.0 0.0 1.1 1.5 0.4 6.1 0.0 28.7 1.8 0.1 0.0 0.2 0.0 0.1 0.5 0.1 18.2 0.8 0.8 1.5 28.4 2.8 0.4 0.0 0.2 0.7 0.0 0.5 5.3 0.0 0.5 0.5 0.6 0.0 0.2 0.0 0.4 0.7 0.4 0.0 8.4 1.1 2.9 0.0 13.6 6.1 0.0 0.2 0.2 0.9 0.8 2.3 4.7 4.3 4.1 4.7 4.0 4.4 6.0 4.9 5.4 5.2 4.1 5.1 10.5 125.0 109.5 4.2 1.9 27.4 53.4 30.9 30.7 2.3 46.3 42.4 109.8 100.1 57.2 42.3 2.1 3.3 1.9 158.0 199.6 37.7 6.1 7.7 6.6 13.4 55.9 5.7 2.8 97.9 33.9 45.2 69.3 20.8 9.5 214.8 8.2 205.9 1.5 25.2 4.5 376.2 6.1 7.6 65.4 17.9 17.1 8.4 24.9 3.7 3.2 6.8 3.1 2.0 1.3 25.5 143.0 15.4 0.5 38.8 154.3 260.9 29.4 1.4 19.7 90.1 24.0 0.7 2.6 61.1 54.8 2.2 8.4 52.0 223.5 73.9 TCEANC2 "C1orf83, FLJ32112" ENSG00000116205 "Transcription elongation factor A N-terminal and central domain containing 2" Q96MN5 1 54053584-54112519 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 36.4;Spermatocytes: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046918 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 42: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Vesicles "HPA046918: AB_2679864" "unprognostic (2.80e-1)" "unprognostic (6.19e-2)" "unprognostic (6.56e-3)" "unprognostic (2.34e-1)" "unprognostic (5.12e-3)" "unprognostic (1.35e-3)" "unprognostic (1.73e-5)" "unprognostic (8.64e-2)" "unprognostic (7.93e-3)" "unprognostic (6.59e-2)" "unprognostic (3.55e-1)" "unprognostic (3.52e-2)" "unprognostic (9.63e-2)" "unprognostic (2.26e-3)" "unprognostic (8.57e-2)" "unprognostic (7.51e-3)" "unprognostic (2.08e-1)" 2.0 2.3 5.8 2.9 5.6 2.8 2.2 4.7 5.8 2.2 4.9 2.6 2.6 2.1 2.3 2.9 2.1 1.5 2.6 5.0 5.1 2.4 2.2 1.9 3.9 5.7 5.5 1.8 2.1 2.3 2.1 2.3 5.7 2.3 3.1 2.1 2.0 1.5 3.8 2.5 2.6 1.8 5.5 3.7 2.4 7.1 6.1 5.1 2.1 3.1 3.7 2.7 2.3 6.6 4.3 1.9 4.6 3.9 3.3 5.2 4.9 4.5 3.6 4.8 4.2 1.2 2.6 3.2 3.8 1.6 4.4 4.1 6.6 3.6 6.5 7.6 2.7 6.3 4.3 2.0 1.9 4.2 5.3 3.7 3.0 4.0 2.4 2.4 7.1 8.6 5.7 3.4 4.3 1.6 9.3 3.4 11.4 4.4 2.9 9.2 9.4 5.6 1.6 2.8 4.2 4.4 2.4 4.8 5.8 7.2 4.6 7.6 4.1 4.9 2.7 4.6 5.5 8.1 12.9 5.2 4.1 5.9 6.0 3.3 3.2 4.2 1.6 4.0 1.9 2.8 2.2 2.5 3.5 3.3 2.5 2.9 3.5 4.8 3.4 3.0 1.7 1.5 5.8 5.6 4.7 5.8 5.0 5.1 5.7 5.5 5.7 5.5 6.1 6.6 4.0 9.6 11.2 12.7 6.7 0.6 1.5 2.3 1.2 3.2 3.8 3.0 8.4 5.7 5.9 11.0 12.5 6.1 4.7 2.7 1.9 4.0 36.4 9.8 4.7 5.5 3.6 7.6 6.3 1.8 5.7 3.6 5.6 3.7 2.5 4.4 3.9 4.4 4.8 8.4 7.8 4.2 2.0 9.6 1.0 23.5 3.1 5.3 1.8 6.5 12.3 2.5 9.2 5.5 16.7 3.6 3.7 3.0 5.7 2.4 4.3 3.5 16.8 3.3 0.0 4.2 3.6 29.4 12.5 5.5 1.0 4.0 5.6 4.2 4.5 1.6 TCTN2 "C12orf38, FLJ12975, JBTS24, MKS8, TECT2" ENSG00000168778 "Tectonic family member 2" Q96GX1 12 123671110-123708399 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 27.6;Respiratory ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039900 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus, Vesicles" "HPA039900: AB_10673366" "unprognostic (3.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-2)" "unprognostic (1.63e-3)" "unprognostic (1.32e-1)" "unprognostic (3.09e-3)" "unprognostic (3.14e-2)" "unprognostic (7.05e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-3)" "unprognostic (2.23e-1)" "unprognostic (1.69e-1)" "unprognostic (2.79e-1)" "unprognostic (2.46e-1)" "unprognostic (7.86e-2)" "unprognostic (2.68e-1)" 5.3 4.4 5.5 2.6 6.4 1.9 7.2 5.8 5.3 10.0 30.4 5.7 2.1 11.0 11.0 3.4 28.5 6.4 4.8 4.9 9.5 10.0 1.4 8.3 3.3 8.4 11.5 14.7 6.9 14.1 16.3 4.6 6.5 9.6 4.0 17.6 9.1 8.6 1.7 8.3 3.8 6.0 7.1 4.1 5.4 11.1 8.7 2.5 12.4 2.1 3.0 5.2 6.7 4.1 14.9 15.1 10.7 15.6 15.0 16.5 13.1 5.4 10.9 11.5 8.7 7.9 14.5 0.5 9.2 8.9 10.0 19.6 6.2 4.9 11.2 2.5 7.6 1.2 10.6 7.2 5.0 3.7 4.8 8.0 8.8 16.3 4.8 34.9 15.7 5.1 7.1 0.3 7.1 7.9 4.5 7.4 6.8 5.9 9.1 4.0 10.8 1.5 13.7 11.1 6.5 8.3 18.2 6.0 8.4 11.0 25.5 5.6 9.8 16.0 8.2 14.7 7.1 4.3 8.9 1.4 20.9 0.4 9.7 1.7 0.2 1.2 1.9 0.6 2.7 1.9 2.2 2.0 0.4 2.1 2.4 2.4 0.3 0.8 0.5 2.5 1.4 0.2 5.5 6.4 5.8 5.3 4.9 9.5 8.4 11.5 6.5 7.1 8.7 4.1 2.7 3.2 5.3 6.5 1.8 4.1 2.3 2.6 1.2 4.4 4.8 2.3 3.8 5.7 3.9 7.3 12.5 2.8 2.1 1.2 0.0 2.9 6.1 27.6 5.0 1.7 1.2 2.5 10.4 2.1 3.0 4.6 2.6 4.3 3.8 5.0 2.9 0.4 1.3 0.0 14.4 1.8 2.0 0.3 1.2 2.8 2.5 1.0 5.4 2.8 1.4 4.6 1.0 2.5 1.3 2.0 0.8 4.9 1.1 1.4 0.2 1.9 32.1 14.5 0.0 6.0 2.7 11.5 10.9 0.6 2.3 1.1 2.4 2.3 3.0 1.0 TDGF1 "CR, CR-1, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582457 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.4;lymphoid tissue: 20.9" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 121.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 27.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 25.7;NTERA-2: 110.6;SuSa: 66.3" "Group enriched" "Detected in many" 5 "cerebellum: 11.2;pons and medulla: 8.7" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 39: Non-specific - Basic cellular processes" Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.4 3.4 2.4 0.5 1.9 0.3 0.3 2.1 4.8 0.7 1.4 2.6 0.7 1.0 2.0 0.1 0.1 0.6 0.6 1.8 1.7 23.4 1.3 0.4 0.4 2.1 1.8 7.7 0.4 0.1 0.1 0.2 2.2 0.4 4.6 0.4 1.0 0.3 1.5 0.3 0.5 1.2 1.7 20.9 2.7 0.5 3.1 15.1 0.8 1.5 0.1 0.2 0.1 1.9 0.1 0.2 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.0 1.8 0.0 0.2 0.0 0.0 25.7 0.2 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.2 110.6 4.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 66.3 0.1 0.1 1.8 0.2 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.7 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.9 0.3 0.1 0.1 0.0 0.0 2.4 1.9 2.1 4.8 1.8 1.7 2.1 1.8 2.2 1.7 3.1 1.9 0.9 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.5 0.0 0.0 0.0 0.9 121.3 0.2 5.0 0.3 0.1 8.2 2.4 0.0 0.0 0.0 0.0 0.3 8.2 0.2 0.0 14.3 0.4 1.4 0.1 0.0 0.0 5.5 0.0 0.0 0.0 1.0 0.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.3 0.6 0.0 0.2 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.1 17.7 6.1 0.0 TDRP "C8orf42, INM01, TDRP1, TDRP2" ENSG00000180190 "Testis development related protein" Q86YL5 8 489803-545781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 151.3;Early spermatids: 80.7;Syncytiotrophoblasts: 272.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 56.1;HBEC3-KT: 27.6;hTERT-RPE1: 23.7;SuSa: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008462 Approved Supported Vesicles,Cytosol NA NA 52000 "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Vesicles, Cytosol" "HPA008462: AB_1845777" "unprognostic (1.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (4.13e-2)" "unprognostic (1.08e-1)" "prognostic favorable (9.37e-4)" "unprognostic (1.74e-1)" "unprognostic (3.43e-2)" "unprognostic (5.46e-4)" "unprognostic (2.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.50e-1)" 8.7 10.4 12.4 2.2 13.6 0.2 8.7 12.8 14.4 13.3 23.0 6.8 2.1 10.0 9.8 3.9 18.5 10.7 4.6 12.5 14.7 26.9 15.9 9.8 4.4 14.2 13.5 19.5 8.9 16.1 16.7 36.4 13.2 14.7 2.6 16.9 6.5 8.6 1.7 3.3 4.9 5.1 12.4 4.0 6.1 14.0 15.5 4.8 24.6 2.6 5.1 9.9 7.7 10.8 9.9 9.8 16.7 0.0 0.0 0.0 56.1 5.6 3.5 5.3 4.6 0.0 0.0 0.0 2.3 1.8 5.3 2.1 0.0 27.6 6.6 0.0 0.7 0.1 0.0 14.8 6.4 0.0 4.1 6.4 21.4 0.0 10.0 23.7 0.8 0.1 1.2 0.0 5.7 0.0 0.1 0.1 20.0 0.0 2.1 0.0 0.0 0.0 17.0 14.5 5.0 8.1 0.0 17.2 4.5 27.4 5.7 0.0 0.3 0.3 1.7 0.0 0.5 0.0 0.0 0.0 1.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 13.6 12.8 14.4 12.5 14.7 14.2 13.5 13.2 12.4 15.5 10.8 20.4 22.4 15.4 41.8 1.0 23.5 28.6 7.3 39.3 17.8 15.8 10.8 4.4 12.8 10.5 18.4 2.1 151.3 0.4 0.5 43.0 10.2 80.7 19.5 10.7 21.2 7.8 0.0 33.3 4.8 61.2 12.2 0.5 7.3 0.0 9.7 7.9 21.0 12.7 10.1 39.9 1.6 16.2 1.9 5.8 16.1 7.2 7.4 8.8 53.4 0.2 9.2 0.0 16.6 4.5 2.9 1.0 6.4 2.5 34.3 0.0 20.7 28.4 12.4 19.7 9.0 10.5 21.5 11.0 7.1 7.0 272.1 0.9 1.7 0.7 14.7 TEP1 "p240, TLP1, TP1, TROVE1, VAULT2" ENSG00000129566 "Telomerase associated protein 1" Q99973 14 20365667-20413501 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 23.9;Gastric mucus-secreting cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029206 Supported Nucleoplasm,Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 21: OE19 - Mitochondria" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Vesicles "HPA029206: AB_10601271" "unprognostic (4.53e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "prognostic favorable (9.58e-4)" "unprognostic (2.27e-1)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-2)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.18e-1)" "unprognostic (6.18e-2)" "unprognostic (3.00e-1)" 9.4 7.8 3.4 12.1 4.1 5.1 8.7 3.2 4.0 7.8 6.0 17.4 28.0 6.9 7.3 6.8 7.2 10.7 6.8 3.3 4.3 6.5 6.5 11.0 15.0 6.0 5.3 6.2 6.2 13.7 5.7 6.6 5.1 7.9 17.9 5.0 8.3 6.3 10.3 7.9 15.5 9.7 3.8 14.8 9.6 2.3 5.8 10.2 8.1 5.1 15.1 7.5 7.8 5.2 9.2 4.2 4.1 4.5 26.1 9.9 7.3 6.8 6.0 4.0 5.1 8.7 10.2 8.1 4.2 17.0 7.3 9.3 3.5 13.6 6.8 7.8 3.5 9.5 9.4 5.7 7.5 8.0 16.1 14.1 11.8 6.5 5.2 17.1 15.2 6.7 3.1 5.8 14.0 5.4 4.7 5.8 1.8 28.4 3.6 12.2 10.2 2.8 13.2 13.8 1.2 1.9 5.4 12.8 4.2 11.8 6.5 4.9 20.1 15.5 10.6 4.9 1.9 12.9 6.9 5.1 3.7 6.9 5.5 3.6 2.3 0.0 1.0 2.8 1.0 1.7 0.5 1.0 0.8 2.4 0.5 0.6 4.5 0.5 2.9 5.4 0.6 0.3 3.4 4.1 3.2 4.0 3.3 4.3 6.0 5.3 5.1 3.8 5.8 5.2 3.7 9.6 14.1 13.1 8.4 2.8 4.8 3.1 2.8 0.3 3.2 2.8 3.2 8.6 5.6 1.8 2.1 2.0 14.3 23.9 1.9 4.8 0.2 2.9 4.2 5.8 4.2 2.1 1.9 5.1 2.5 3.4 25.5 4.2 10.8 2.6 8.2 4.9 6.4 0.0 2.1 12.8 0.0 10.4 4.6 1.3 5.0 10.2 5.4 16.9 12.9 2.6 7.2 4.5 3.9 6.0 12.8 3.8 8.4 5.1 21.8 3.8 12.2 2.6 0.0 5.1 6.1 0.0 0.6 2.4 1.4 1.9 5.0 2.2 8.3 4.9 TFG "FLJ36137, SPG57, TF6" ENSG00000114354 "Trafficking from ER to golgi regulator" Q92734 3 100709295-100748964 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019473, HPA052206" Approved Supported Vesicles,Cytosol No No 320000 "Cluster 38: Basophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" Vesicles Cytosol "HPA019473: AB_1857936, HPA052206: AB_2681760" "unprognostic (1.14e-1)" "unprognostic (3.58e-2)" "unprognostic (1.46e-1)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (4.14e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (3.31e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (4.58e-3)" "unprognostic (3.72e-2)" "unprognostic (2.82e-1)" "unprognostic (8.55e-2)" "unprognostic (3.33e-1)" "unprognostic (8.45e-2)" 62.2 73.0 40.7 37.2 40.4 37.4 52.4 43.5 46.4 53.9 46.7 63.8 89.8 52.0 78.5 85.7 51.2 56.4 82.6 41.3 45.4 71.9 113.9 55.6 29.4 44.2 43.2 48.2 66.7 89.0 64.1 79.2 44.4 47.9 69.6 40.9 60.6 61.3 75.5 58.9 76.6 66.5 43.2 42.6 54.4 47.7 42.3 40.6 64.1 58.2 54.9 61.6 57.3 44.4 203.8 107.5 126.7 79.0 160.1 176.4 163.9 141.1 190.4 182.5 213.0 136.0 96.1 24.7 103.3 180.4 141.3 143.1 143.4 161.5 216.2 123.8 87.4 99.7 69.3 130.0 183.3 70.2 51.8 149.3 216.6 108.4 190.8 165.1 165.5 44.5 73.1 63.5 191.9 143.9 63.3 56.7 122.5 193.8 169.3 55.5 77.8 89.0 226.5 125.9 96.4 93.1 95.0 118.2 175.8 103.4 141.7 103.1 113.1 103.0 130.8 48.4 104.4 56.2 65.8 92.1 171.2 79.7 130.7 84.3 43.6 42.8 30.8 45.2 37.4 37.4 31.6 34.5 43.1 35.9 29.4 29.7 26.1 43.1 44.8 29.3 41.0 37.0 40.7 40.4 43.5 46.4 41.3 45.4 44.2 43.2 44.4 43.2 42.3 44.4 67.9 60.9 36.9 46.4 43.3 136.6 105.9 183.6 69.4 46.8 58.0 50.2 83.5 48.6 93.1 36.8 25.0 211.6 43.1 111.8 137.0 190.3 101.5 70.8 70.4 70.2 52.6 27.1 54.8 107.7 201.5 97.8 47.4 79.0 76.8 62.9 53.9 68.4 86.2 57.2 59.2 128.5 122.1 27.3 84.9 45.5 70.8 43.6 64.0 38.4 98.5 88.0 28.8 49.3 55.0 130.5 91.0 74.1 75.8 133.5 202.5 106.4 63.9 60.3 39.5 81.3 87.2 79.2 51.5 68.0 118.9 284.4 43.2 90.0 97.2 123.0 TGM1 "ICR2, LI, LI1, TGASE, TGK" ENSG00000092295 "Transglutaminase 1" P22735 14 24249114-24264432 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 713.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Basal respiratory cells: 63.6;Club cells: 18.8;Distal tubular cells: 29.4;Squamous epithelial cells: 34.7" "Group enriched" "Detected in many" 4 "cervical cancer: 30.8;head and neck cancer: 78.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.5;HaCaT: 24.2;HeLa: 16.2;MCF7: 17.5;SK-BR-3: 21.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015159, HPA040171, HPA070372" Enhanced Approved "Vesicles,Plasma membrane" NA NA 530000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Plasma membrane" "CAB015159: AB_2202870, HPA040171: AB_2676869, HPA070372: " "unprognostic (2.95e-2)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (1.89e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.12e-2)" "unprognostic (2.39e-1)" "unprognostic (3.01e-2)" "unprognostic (6.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.94e-7)" "unprognostic (7.11e-2)" "unprognostic (7.38e-2)" "unprognostic (2.22e-3)" "unprognostic (1.86e-2)" 25.7 1.3 0.6 0.9 0.8 0.7 2.2 3.7 2.0 78.7 0.8 1.4 0.8 1.0 1.6 713.5 4.4 0.6 5.1 0.5 0.6 2.5 1.7 5.3 1.5 1.5 0.9 3.0 3.2 0.2 3.3 1.2 1.4 4.1 0.9 1.7 89.7 4.4 1.1 73.2 1.9 0.5 0.4 2.6 1.8 2.9 0.9 1.3 2.7 0.3 40.4 1.3 144.2 0.9 1.1 2.0 1.1 1.0 0.0 0.8 17.5 0.4 0.2 1.0 1.6 1.2 1.7 1.0 2.3 1.3 0.3 24.2 2.8 2.0 0.6 2.0 3.3 1.4 16.2 5.7 0.8 0.9 1.5 1.5 9.3 0.5 2.0 0.5 0.7 3.4 1.0 1.0 0.7 17.5 0.7 1.9 0.3 1.1 2.2 1.1 0.1 1.1 0.6 2.1 1.2 1.6 0.2 21.7 0.1 1.4 1.5 1.1 0.8 1.1 4.8 2.0 0.9 1.5 1.8 0.3 0.4 2.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 3.7 2.0 0.5 0.6 1.5 0.9 1.4 0.4 0.9 0.9 0.2 12.8 1.1 2.0 0.0 0.3 4.6 63.6 4.0 0.9 1.1 0.8 0.8 5.7 18.8 0.0 0.0 1.4 0.3 0.2 29.4 2.0 0.1 0.3 0.2 0.2 0.0 0.0 1.5 0.9 0.8 3.9 0.0 0.6 4.5 0.7 0.0 0.2 0.4 0.0 1.7 0.1 6.1 0.6 0.3 0.0 0.6 0.4 0.0 1.0 0.4 0.2 0.0 1.0 1.0 2.6 0.0 0.4 0.1 7.4 0.1 0.2 2.1 0.6 0.0 0.1 1.0 0.0 0.6 34.7 1.8 1.2 0.6 1.2 0.3 6.2 THOC3 "MGC5469, TEX1" ENSG00000051596 "THO complex 3" Q96J01 5 175917873-176034680 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 132.1;Early spermatids: 187.0;Squamous epithelial cells: 226.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042764, HPA044009, HPA045071" Approved Enhanced Nucleoplasm,Vesicles No No "Cluster 20: T-cells - T-cell receptor" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm Vesicles "HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461" "unprognostic (1.13e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-3)" "unprognostic (6.48e-3)" "unprognostic (8.60e-2)" "unprognostic (3.57e-2)" "unprognostic (3.06e-3)" "unprognostic (2.02e-2)" "unprognostic (3.41e-2)" "unprognostic (1.11e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-2)" "unprognostic (8.80e-3)" "unprognostic (3.20e-1)" "unprognostic (2.86e-1)" "unprognostic (3.16e-2)" "unprognostic (2.91e-1)" 12.0 14.5 22.0 11.4 15.9 35.1 21.4 23.0 40.6 23.1 19.1 27.0 12.5 13.4 63.2 82.9 15.1 8.0 9.3 40.2 14.9 16.3 22.2 11.9 29.1 15.5 13.3 18.8 15.3 10.0 15.9 17.4 15.9 14.6 21.1 12.1 22.5 14.9 12.6 26.5 16.2 12.2 13.2 17.7 17.5 51.3 15.4 39.2 20.5 17.6 45.5 17.4 33.5 15.9 82.1 44.7 47.0 102.7 44.1 39.3 168.0 48.4 44.6 104.5 120.4 63.5 65.2 105.6 68.3 27.9 112.6 69.2 71.6 206.0 109.7 73.5 103.3 57.3 46.2 70.7 14.6 94.6 49.2 33.3 85.9 90.0 45.2 23.3 58.3 98.0 88.1 46.5 66.9 98.7 64.0 57.9 40.1 82.3 160.3 110.7 59.3 110.4 75.2 60.7 89.5 51.4 100.0 48.5 52.5 67.4 55.3 86.1 45.1 35.9 40.8 55.6 88.2 23.2 44.1 64.4 26.7 90.1 28.5 16.5 26.9 15.1 39.3 33.5 48.4 49.6 81.7 48.9 43.1 70.6 99.7 62.4 3.9 42.3 31.5 39.8 133.6 59.1 22.0 15.9 23.0 40.6 40.2 14.9 15.5 13.3 15.9 13.2 15.4 15.9 14.9 12.8 8.6 2.0 35.8 44.5 34.1 64.5 132.1 12.3 17.7 18.0 4.0 10.0 24.4 25.8 10.4 40.8 25.1 8.1 41.1 25.1 187.0 50.2 18.4 16.1 16.8 63.9 5.2 19.2 84.3 15.2 26.5 44.9 12.0 18.8 13.9 20.3 24.6 6.7 3.7 16.3 26.4 13.2 14.9 122.0 14.6 14.3 8.8 1.9 15.4 8.9 27.8 4.5 2.0 21.9 11.6 19.2 55.9 18.4 10.4 46.8 15.8 12.0 19.7 10.6 22.8 107.9 48.3 226.5 40.9 20.0 33.3 25.0 27.7 31.1 TIAL1 TIAR ENSG00000151923 "TIA1 cytotoxic granule associated RNA binding protein like 1" Q01085 10 119571802-119597029 "Predicted intracellular proteins" Apoptosis RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060962 Approved Nucleoplasm,Vesicles NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 59: Non-specific - Translation" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Vesicles" "HPA060962: " "unprognostic (1.61e-2)" "unprognostic (9.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.76e-1)" "unprognostic (5.33e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (7.81e-6)" "unprognostic (5.54e-2)" "unprognostic (9.21e-2)" "unprognostic (3.89e-3)" "unprognostic (3.74e-1)" "unprognostic (1.32e-3)" "unprognostic (6.48e-3)" "unprognostic (6.35e-2)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (2.26e-2)" 32.2 29.7 14.3 26.8 18.3 49.0 31.3 27.5 20.2 32.2 16.7 33.2 23.9 43.6 37.4 46.1 29.8 28.7 31.5 13.0 15.7 29.9 34.1 30.6 40.1 15.8 15.3 35.3 36.3 28.2 28.3 32.5 16.9 27.1 27.8 29.6 34.9 18.6 58.1 35.3 35.8 25.6 14.7 35.1 35.0 32.6 15.4 25.0 32.0 21.7 27.6 29.3 34.2 24.5 50.0 26.8 68.9 83.5 35.8 53.9 34.0 46.1 46.1 31.7 36.5 22.1 51.1 48.2 29.4 31.6 24.9 53.8 42.3 25.0 42.9 63.5 34.1 30.4 47.1 36.6 29.2 57.5 52.3 41.1 30.3 30.5 76.1 137.9 41.6 32.9 23.2 47.7 33.3 15.2 62.2 60.5 37.9 29.5 24.3 43.9 52.2 35.2 43.3 26.7 19.3 32.8 39.2 35.0 40.4 35.1 30.9 29.5 38.9 34.9 25.2 35.6 47.2 35.5 62.3 48.4 31.7 57.9 27.1 2.5 2.5 2.4 3.8 2.3 4.2 3.2 4.3 3.7 2.5 2.8 4.5 4.8 2.5 4.5 3.0 4.1 4.6 1.9 14.3 18.3 27.5 20.2 13.0 15.7 15.8 15.3 16.9 14.7 15.4 24.5 64.6 44.8 60.1 24.5 72.7 63.6 75.8 54.0 66.6 55.7 52.7 53.1 37.9 42.9 54.7 23.9 31.3 66.0 87.3 54.6 46.9 54.4 13.7 45.2 69.1 58.5 52.7 90.7 37.7 54.7 108.3 57.8 48.9 53.3 35.4 73.7 57.1 49.6 58.4 45.4 50.6 46.5 30.5 57.0 46.4 8.2 61.2 61.3 37.4 38.4 79.7 49.3 61.8 54.8 91.9 70.0 43.4 45.1 73.7 99.1 49.5 48.0 40.7 48.9 52.6 53.9 63.6 62.9 49.1 72.6 64.2 77.4 80.6 53.6 53.8 94.2 TIMP3 SFD ENSG00000100234 "TIMP metallopeptidase inhibitor 3" P35625 22 32801705-32863041 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Sensory transduction, Vision" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1663.5;Fibroblasts: 967.5;Leydig cells: 1398.6;Peritubular cells: 1934.1;Sertoli cells: 2327.1;Smooth muscle cells: 1116.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 502.6;BJ: 1173.0;BJ hTERT+: 514.7;fHDF/TERT166: 1073.7;WM-115: 893.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068391 Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 700000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "Golgi apparatus" "HPA068391: " "unprognostic (4.98e-2)" "unprognostic (1.77e-3)" "unprognostic (1.60e-1)" "unprognostic (8.53e-4)" "unprognostic (1.67e-2)" "unprognostic (1.05e-2)" "unprognostic (7.01e-2)" "unprognostic (3.22e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (1.90e-5)" "unprognostic (3.92e-1)" "unprognostic (1.95e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.66e-3)" "unprognostic (1.44e-2)" "unprognostic (2.55e-3)" "unprognostic (3.11e-2)" 805.5 288.7 71.7 41.4 74.9 1.1 556.9 68.7 72.6 376.1 221.0 190.4 30.5 393.3 230.4 168.1 373.9 153.5 532.8 64.3 79.2 248.0 92.0 625.1 69.5 83.2 86.7 116.2 81.1 139.5 139.1 999.5 76.0 178.8 81.2 31.7 178.7 341.1 128.1 170.3 122.1 379.6 70.3 187.2 152.1 64.1 106.2 41.1 340.1 325.9 28.8 197.4 261.1 59.5 19.6 0.0 16.9 2.7 502.6 280.6 1.0 1173.0 514.7 94.1 110.8 20.5 0.3 0.1 28.1 1073.7 3.6 18.3 3.2 48.4 135.0 0.1 14.3 147.4 23.5 52.4 197.4 0.1 59.7 47.4 120.4 166.9 9.5 3.4 0.0 0.0 0.1 0.9 44.6 1.2 0.4 5.0 2.5 0.0 0.8 0.1 3.4 0.4 2.1 97.0 12.5 16.8 24.1 0.5 322.9 266.6 0.7 1.3 0.0 7.9 25.2 245.9 19.1 0.2 0.4 0.4 232.3 0.2 893.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 71.7 74.9 68.7 72.6 64.3 79.2 83.2 86.7 76.0 70.3 106.2 59.5 1663.5 365.4 35.9 101.9 5.3 77.4 766.2 49.5 10.2 4.0 31.2 177.2 279.9 14.3 22.2 51.5 4.2 492.2 4.6 0.3 3.9 2.5 14.9 27.9 747.6 677.3 1.8 35.3 26.1 0.7 433.7 967.5 21.4 23.9 89.2 11.4 743.9 102.0 109.2 3.3 15.7 0.0 24.4 39.3 95.0 57.7 1398.6 28.6 76.5 116.2 0.7 146.6 0.0 52.3 0.8 0.9 0.0 1934.1 9.5 159.5 0.0 15.5 8.5 5.5 2327.1 339.2 1116.6 6.2 7.0 14.3 56.4 809.0 21.5 4.8 0.7 163.4 TIPRL "dJ69E11.3, MGC3794, TIP41, TIPRL1" ENSG00000143155 "TOR signaling pathway regulator" O75663 1 168178962-168202109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027995, HPA054282" Approved Supported Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Vesicles, Cytosol" "HPA027995: AB_10602900, HPA054282: AB_2682435" "unprognostic (3.18e-2)" "unprognostic (1.05e-1)" "unprognostic (5.05e-2)" "unprognostic (3.17e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-3)" "prognostic unfavorable (1.60e-4)" "unprognostic (5.82e-2)" "unprognostic (3.32e-2)" "unprognostic (1.12e-2)" "unprognostic (4.30e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.45e-8)" "unprognostic (3.23e-1)" "unprognostic (1.57e-1)" "unprognostic (5.55e-2)" "unprognostic (8.61e-2)" 16.3 14.9 15.5 19.6 16.3 33.8 21.0 15.0 20.1 17.7 12.8 22.2 19.0 23.2 16.8 20.1 14.3 16.8 23.7 16.8 17.0 17.8 22.5 14.9 22.2 14.0 13.4 17.4 15.9 27.4 13.6 17.5 14.4 18.4 22.0 14.7 12.0 17.3 24.4 16.3 18.5 22.7 13.4 16.3 15.4 18.2 15.1 30.1 17.4 23.0 19.9 18.7 13.6 15.7 69.4 31.0 45.9 41.6 36.7 53.1 27.5 50.5 53.0 54.6 48.4 48.3 50.1 49.0 68.2 48.7 40.1 81.8 34.5 49.3 52.6 47.2 36.4 47.3 29.2 22.9 64.5 94.7 62.0 43.2 62.8 47.4 62.7 36.0 58.1 75.4 69.0 66.3 47.7 25.4 84.9 49.0 37.0 96.7 54.2 41.1 47.0 66.4 49.7 33.9 29.6 66.1 39.3 54.6 102.2 51.6 59.9 96.3 53.4 45.6 52.4 43.6 69.7 72.2 80.5 108.1 29.8 61.4 53.4 71.6 26.7 36.8 22.0 32.1 22.1 27.3 25.7 23.8 31.6 27.6 22.8 22.4 34.5 29.6 33.9 23.4 36.0 28.2 15.5 16.3 15.0 20.1 16.8 17.0 14.0 13.4 14.4 13.4 15.1 15.7 52.1 25.6 20.4 9.4 39.7 48.2 42.1 70.4 50.1 27.3 31.3 36.2 46.3 22.8 40.7 22.0 16.7 44.2 49.0 37.1 29.4 68.5 53.4 36.0 50.1 43.4 24.0 32.6 41.6 88.9 62.8 47.3 24.5 30.8 40.0 35.2 36.0 33.5 65.1 52.2 37.9 33.9 44.7 26.6 41.1 15.4 37.6 42.6 30.2 19.7 61.0 43.9 51.5 22.1 21.3 69.7 27.7 38.0 37.1 43.3 35.9 77.2 36.1 20.8 26.3 35.4 51.1 151.5 51.6 56.0 41.8 29.0 48.0 84.5 38.5 37.5 TLCD2 ENSG00000185561 "TLC domain containing 2" A6NGC4 17 1702816-1710377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 129.3;Distal enterocytes: 112.4;Proximal enterocytes: 68.9;Skeletal myocytes: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 3.4;neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.0;HaCaT: 8.4;SiHa: 11.2;T-47d: 9.4" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 14.2" HPA046063 Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles Nucleoli "HPA046063: AB_2679520" "unprognostic (1.78e-1)" "unprognostic (6.71e-2)" "unprognostic (2.56e-2)" "unprognostic (1.20e-1)" "unprognostic (8.64e-3)" "unprognostic (1.64e-1)" "unprognostic (3.32e-1)" "unprognostic (4.04e-2)" "unprognostic (7.94e-2)" "unprognostic (7.74e-2)" "unprognostic (2.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.36e-5)" "unprognostic (3.77e-2)" "unprognostic (2.82e-1)" "unprognostic (7.79e-2)" "unprognostic (4.44e-2)" 10.3 9.4 0.6 1.8 0.7 2.1 4.7 1.6 0.9 3.0 2.3 7.3 6.0 1.8 1.2 4.7 2.7 1.8 2.1 0.6 0.5 1.8 7.0 3.9 0.7 1.0 0.7 2.5 1.2 1.0 1.1 1.5 1.0 1.9 5.3 10.5 2.9 0.9 1.7 2.4 6.9 1.2 0.7 1.3 4.7 0.6 1.0 0.1 1.6 0.8 0.8 3.1 3.5 1.6 1.0 1.1 1.1 3.5 8.1 9.0 0.3 1.9 1.8 1.0 0.7 6.9 3.1 0.1 1.9 3.1 1.0 8.4 1.5 0.9 0.7 0.2 0.7 0.9 2.4 0.3 2.3 0.1 2.4 7.6 3.2 1.2 2.2 2.9 0.7 0.1 0.8 0.4 0.9 1.9 0.1 0.4 0.1 3.4 0.6 0.1 5.3 0.2 0.7 2.7 0.2 0.4 11.2 1.0 1.6 1.5 9.4 0.8 2.6 0.5 2.3 2.1 0.5 0.1 0.1 0.1 0.6 0.3 1.0 3.4 0.2 0.4 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.4 0.2 0.2 1.6 0.3 0.1 0.2 0.1 0.1 0.6 0.7 1.6 0.9 0.6 0.5 1.0 0.7 1.0 0.7 1.0 1.6 19.0 51.3 55.5 0.3 1.6 0.0 8.2 0.0 4.0 7.9 5.8 9.5 2.7 17.2 18.0 11.0 129.3 4.9 2.0 112.4 0.0 7.3 1.1 12.9 10.4 14.1 9.0 11.2 0.5 9.6 2.6 14.9 20.9 13.3 15.8 3.9 18.9 24.2 5.5 0.0 0.4 24.6 0.0 6.5 0.0 1.8 13.4 10.7 0.0 3.7 1.4 11.7 0.0 0.0 0.1 13.5 40.1 5.7 3.3 6.3 68.9 1.1 19.9 57.8 6.6 124.2 17.8 0.6 0.8 9.1 0.3 4.0 5.1 5.4 35.7 13.0 TLCD5 "MGC17839, TMEM136" ENSG00000181264 "TLC domain containing 5" Q6ZRR5 11 120325296-120333686 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 51.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 28.3;Cytotrophoblasts: 10.0;Extravillous trophoblasts: 4.2;Fibroblasts: 6.1;Syncytiotrophoblasts: 9.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074432 Approved Vesicles,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" Vesicles Cytosol "HPA074432: AB_2686689" "unprognostic (1.02e-1)" "unprognostic (6.56e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.65e-2)" "unprognostic (3.31e-2)" "unprognostic (6.81e-3)" "unprognostic (1.22e-1)" "unprognostic (1.39e-2)" "unprognostic (2.58e-1)" "unprognostic (2.86e-3)" "unprognostic (2.39e-1)" "unprognostic (2.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (7.28e-2)" 4.4 13.1 11.3 1.0 15.2 0.2 3.3 13.4 10.9 5.0 8.8 2.8 0.6 5.1 7.6 1.5 5.7 3.2 11.0 10.9 12.1 3.6 0.8 4.8 1.4 12.3 15.3 7.7 3.9 4.5 7.0 7.2 12.0 4.9 1.1 51.9 2.0 3.3 1.2 1.3 1.9 3.8 11.3 2.6 2.5 3.1 12.6 0.8 5.4 1.9 1.4 3.5 3.5 14.0 2.4 6.0 15.8 10.9 10.9 16.8 3.0 5.0 12.3 8.4 12.7 3.2 10.2 0.0 15.3 3.2 16.2 1.6 10.1 3.8 9.8 0.0 6.3 8.1 6.1 5.4 12.4 0.0 0.0 14.7 2.8 11.4 17.0 19.7 9.2 9.5 2.2 14.8 10.9 2.9 0.0 0.1 5.1 0.6 3.8 6.3 4.9 0.8 10.4 2.2 8.3 7.2 7.3 0.9 1.5 13.4 9.3 0.2 6.9 8.7 9.0 2.0 3.1 0.2 0.0 0.0 2.6 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.4 0.0 11.3 15.2 13.4 10.9 10.9 12.1 12.3 15.3 12.0 11.3 12.6 14.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 TM2D1 BBP ENSG00000162604 "TM2 domain containing 1" Q9BX74 1 61681046-61725423 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046058, HPA055621" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Vesicles "HPA046058: AB_2679519, HPA055621: AB_2682865" "unprognostic (1.80e-1)" "unprognostic (1.99e-3)" "unprognostic (1.68e-1)" "unprognostic (2.20e-2)" "unprognostic (5.79e-1)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (1.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.00e-1)" "unprognostic (2.28e-2)" "unprognostic (1.15e-2)" "unprognostic (4.60e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" 30.9 36.3 25.4 16.5 26.0 23.2 35.8 27.3 36.5 29.4 27.6 27.7 20.5 30.3 45.3 21.4 29.9 26.0 45.4 25.2 27.0 38.8 29.3 27.4 26.5 26.7 27.0 36.4 21.8 41.6 20.4 35.7 26.8 33.3 28.5 26.2 30.1 22.5 40.9 19.8 25.0 29.3 27.1 23.9 24.4 34.9 25.9 25.1 40.6 35.3 20.3 30.1 20.7 28.4 31.3 15.0 22.8 18.2 68.1 66.2 29.2 54.5 55.2 26.4 35.0 9.7 39.0 25.3 70.9 45.9 52.7 34.8 29.2 39.7 40.5 41.3 34.4 28.2 23.0 21.8 66.7 40.9 48.0 74.2 67.0 30.5 38.0 64.4 50.5 33.6 32.7 47.7 64.7 10.1 20.9 32.0 24.9 27.5 21.4 17.9 43.1 31.5 78.4 24.3 25.4 30.9 32.5 64.1 102.6 30.5 35.1 43.2 45.3 35.3 17.8 19.8 41.9 40.0 39.4 30.8 61.3 39.4 31.8 52.8 18.7 44.9 16.1 23.7 16.6 24.2 18.6 19.7 18.6 20.1 17.2 19.9 12.2 23.3 26.8 36.4 24.3 19.4 25.4 26.0 27.3 36.5 25.2 27.0 26.7 27.0 26.8 27.1 25.9 28.4 49.5 41.7 40.2 32.3 49.0 78.3 91.9 205.2 59.2 60.3 67.7 56.6 40.5 48.6 99.9 79.1 60.5 51.2 47.4 46.5 39.2 50.3 6.5 43.3 34.7 59.2 43.9 42.1 42.3 45.3 60.0 84.3 29.0 42.2 61.5 37.6 80.7 54.2 50.3 69.0 46.9 41.3 158.7 58.7 53.8 9.9 79.9 48.1 90.7 43.1 54.1 99.2 63.8 50.3 63.4 54.2 60.4 53.0 51.4 110.0 45.9 67.6 100.0 70.1 39.5 75.3 60.0 172.1 72.5 58.6 76.4 53.5 47.3 42.0 43.0 110.1 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.9" "Group enriched" "Detected in many" 4 "Adipocytes: 226.1;Endothelial cells: 188.9;Hepatic stellate cells: 151.0" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 94.8;EFO-21: 194.9;GAMG: 38.7;HUVEC TERT2: 65.9;NTERA-2: 47.2" "Low region specificity" "Detected in many" "HPA053639, HPA069378" Approved Supported Vesicles,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles Cytosol "HPA053639: , HPA069378: AB_2686133" "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favorable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 21.3 5.2 9.4 4.9 9.6 0.1 16.3 9.2 11.5 8.3 10.4 3.4 3.9 7.6 4.7 3.4 6.4 10.6 8.4 9.1 10.3 19.1 7.9 9.2 6.6 12.2 9.6 3.2 9.8 6.8 3.1 17.4 11.5 4.0 3.3 1.1 4.0 6.5 5.9 2.4 3.6 14.9 10.0 33.9 3.4 1.9 12.1 2.1 12.7 5.7 5.0 6.7 2.5 10.4 0.1 94.8 3.5 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.2 1.2 0.0 194.9 0.0 38.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.3 0.1 0.7 0.0 0.0 0.0 24.7 65.9 0.0 0.0 0.0 6.2 0.7 0.0 0.2 47.2 0.0 0.0 0.1 2.6 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.5 1.5 0.1 0.1 8.4 0.1 1.2 0.0 0.5 0.1 0.1 0.5 0.0 0.1 15.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 9.4 9.6 9.2 11.5 9.1 10.3 12.2 9.6 11.5 10.0 12.1 10.4 226.1 0.0 4.4 0.3 1.6 3.2 0.2 0.0 0.6 0.2 41.4 23.9 2.8 4.3 0.0 1.8 0.0 0.0 1.0 0.0 9.8 35.2 0.4 0.7 1.1 188.9 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.9 1.3 0.3 151.0 1.1 0.1 0.0 0.1 0.0 0.0 9.1 3.0 1.8 2.1 1.2 1.8 33.7 0.6 0.4 0.0 0.5 0.6 0.9 0.0 6.8 2.5 1.3 0.0 35.8 0.7 0.0 0.0 1.5 2.5 0.2 0.5 0.2 2.8 0.0 1.1 5.2 0.0 0.6 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 246.0" "Cell type enhanced" "Detected in all" "Granulosa cells: 482.7;Hepatocytes: 220.6;Muller glia cells: 204.7;Theca cells: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 38.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 69.2;RPTEC TERT1: 86.2;T-47d: 143.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: AB_2686551" "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favorable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 63.4 246.0 27.8 2.6 28.5 4.1 29.1 32.8 33.9 17.4 64.1 7.8 9.4 3.4 17.0 39.6 12.8 7.0 47.3 30.0 29.7 18.9 86.4 10.1 3.4 34.0 32.0 36.5 69.9 36.3 19.5 3.9 32.5 41.1 3.9 6.0 46.9 6.0 7.1 68.2 8.3 1.9 30.1 5.1 35.6 11.5 32.6 5.6 15.5 3.7 8.4 5.5 22.1 35.1 7.7 10.9 27.3 35.1 8.1 1.3 15.4 1.8 4.5 2.7 3.0 26.0 35.8 16.3 26.9 2.2 1.0 13.3 11.6 21.2 1.9 16.7 5.0 10.2 2.7 54.5 18.8 4.2 10.6 3.7 5.0 14.6 3.9 12.6 3.9 28.7 5.8 13.9 0.8 69.2 8.3 18.6 12.6 18.4 11.2 22.4 1.2 39.9 86.2 12.6 27.2 30.5 1.2 28.2 6.1 19.5 143.9 11.4 3.1 0.4 3.4 3.8 2.3 27.1 18.1 8.4 2.5 5.9 1.0 1.1 1.6 3.4 9.1 1.5 7.0 12.4 5.6 7.8 1.5 11.9 11.8 9.0 1.1 12.5 0.9 38.1 5.6 4.9 27.8 28.5 32.8 33.9 30.0 29.7 34.0 32.0 32.5 30.1 32.6 35.1 4.0 9.6 43.7 23.5 12.7 1.9 6.2 33.6 5.7 19.2 52.2 38.5 99.4 52.9 36.6 44.1 10.4 72.9 16.3 23.3 17.6 27.1 28.8 17.9 2.6 5.7 59.4 13.7 11.6 27.7 4.6 4.3 31.1 16.5 7.0 482.7 5.0 220.6 15.6 25.2 15.3 21.8 52.9 6.3 2.7 59.3 9.9 5.8 12.4 2.8 9.4 204.7 7.2 17.1 36.5 21.7 23.7 2.2 12.9 31.3 29.0 77.5 37.9 23.6 13.1 1.6 21.8 13.3 17.9 18.0 7.0 82.1 8.3 204.8 19.0 10.4 TM9SF3 SMBP ENSG00000077147 "Transmembrane 9 superfamily member 3" Q9HD45 10 96518110-96587452 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039609 Approved Approved "Golgi apparatus,Vesicles" NA NA 240000 "Cluster 46: Basophils - DNA binding" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "Golgi apparatus" "HPA039609: AB_10673535" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (1.43e-2)" "unprognostic (5.11e-2)" "unprognostic (4.95e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-2)" "unprognostic (3.09e-2)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (4.14e-3)" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (8.28e-3)" "unprognostic (6.18e-2)" 57.0 53.4 28.5 54.6 33.0 36.7 58.4 33.2 34.8 65.3 34.9 111.8 116.9 62.5 69.2 57.5 46.0 89.9 39.7 27.7 34.4 68.0 75.0 43.2 42.0 33.8 31.2 62.9 73.3 70.1 22.5 67.8 35.2 91.7 94.5 43.4 83.2 56.4 26.6 38.5 112.4 50.8 35.7 41.8 183.5 34.6 30.7 44.7 87.4 41.1 44.9 72.8 34.8 43.6 146.8 97.2 106.5 149.3 151.4 112.4 127.7 197.8 146.7 84.0 67.5 116.4 281.6 107.3 107.0 175.8 105.5 135.3 97.6 108.1 156.8 121.3 83.6 95.3 81.8 92.0 114.5 197.7 107.2 105.0 108.6 118.6 203.7 253.2 94.7 96.4 97.0 119.9 132.2 66.4 77.1 76.2 68.9 237.9 59.6 94.6 134.4 84.8 120.1 106.8 49.6 110.3 104.1 98.6 103.0 126.2 171.0 73.7 165.3 103.5 87.1 104.6 183.1 123.7 152.3 98.4 140.9 134.9 73.5 5.7 2.2 3.8 3.5 2.3 4.0 2.1 3.6 3.9 2.7 1.5 2.7 3.6 2.4 3.9 2.4 7.1 4.0 1.3 28.5 33.0 33.2 34.8 27.7 34.4 33.8 31.2 35.2 35.7 30.7 43.6 115.7 51.3 43.0 43.1 53.2 116.8 118.8 63.2 51.8 57.8 103.1 73.0 65.0 121.5 88.2 141.6 56.3 77.5 89.5 238.7 21.5 80.7 27.6 93.0 162.0 99.8 123.9 68.8 59.9 146.1 97.6 98.7 212.0 192.2 40.6 75.0 78.9 126.9 60.0 58.9 64.0 368.3 69.2 85.6 125.3 12.8 93.2 73.5 103.2 49.6 56.8 58.1 54.6 69.9 79.2 132.1 140.6 82.4 88.9 196.1 141.5 59.3 65.9 54.7 65.7 89.2 121.0 45.8 38.4 73.2 120.6 140.9 63.0 74.5 246.7 156.2 TMCC3 KIAA1145 ENSG00000057704 "Transmembrane and coiled-coil domain family 3" Q9ULS5 12 94567122-94650557 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.3" "Cell type enhanced" "Detected in many" "Adipocytes: 81.2;Distal enterocytes: 98.3;Microglial cells: 70.3;Oligodendrocytes: 119.8;Paneth cells: 70.1;Urothelial cells: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 46.9;neutrophil: 69.7" "Lineage enriched" "Detected in all" 9 "granulocytes: 69.7" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 31.3;Karpas-707: 41.9;U-266/84: 30.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014272 Approved Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 2: Karpas-707 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" Vesicles "HPA014272: AB_1858059" "unprognostic (1.03e-1)" "unprognostic (2.54e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (4.87e-4)" "unprognostic (1.30e-1)" "unprognostic (8.63e-2)" "unprognostic (5.87e-2)" "unprognostic (1.17e-2)" "unprognostic (9.12e-2)" "unprognostic (3.45e-3)" "unprognostic (1.24e-1)" "unprognostic (7.73e-2)" "unprognostic (1.80e-3)" "unprognostic (9.11e-2)" "unprognostic (2.32e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" 11.7 4.5 13.6 9.4 25.8 10.0 9.6 23.1 16.5 11.6 3.9 22.5 14.9 7.7 3.1 6.1 5.7 5.3 2.3 13.2 19.6 8.1 4.1 5.3 4.4 26.9 25.9 4.7 3.2 4.6 3.4 17.8 26.7 8.3 16.4 0.9 2.8 5.4 18.4 6.1 21.0 7.9 20.8 12.2 7.3 2.0 24.8 4.0 13.3 7.0 6.3 7.5 4.8 36.3 7.8 0.4 1.9 0.0 0.7 2.7 13.6 0.0 0.0 0.5 1.9 0.0 1.7 0.2 0.1 0.0 6.8 19.1 10.7 12.9 2.6 3.5 2.6 5.1 0.8 0.0 0.5 0.0 10.2 1.7 1.7 7.2 10.1 11.3 31.3 0.0 0.2 41.9 1.0 0.4 0.0 0.4 1.0 2.7 6.5 0.0 0.6 5.1 2.0 16.4 0.2 0.8 0.2 8.0 0.4 8.8 0.0 0.4 19.0 0.0 0.2 0.1 3.4 19.4 30.1 0.3 3.9 1.6 1.7 16.4 4.3 46.9 3.3 6.0 0.3 5.4 1.2 1.9 2.5 3.1 0.0 2.2 69.7 3.3 7.8 2.8 0.0 3.1 13.6 25.8 23.1 16.5 13.2 19.6 26.9 25.9 26.7 20.8 24.8 36.3 81.2 0.0 2.7 2.9 5.7 20.6 32.7 3.2 9.6 4.4 2.1 1.3 2.0 4.3 3.2 7.3 0.0 16.0 16.3 98.3 0.0 1.9 5.8 24.5 3.6 31.9 12.0 0.0 0.6 3.8 3.2 4.8 10.2 39.8 0.0 17.1 31.8 0.6 4.1 0.0 15.0 13.0 0.0 15.0 9.2 8.3 1.8 20.3 3.6 70.3 19.0 0.1 11.3 11.6 119.8 12.9 70.1 1.2 7.8 16.8 48.1 8.9 3.0 0.3 6.6 19.7 6.1 0.0 2.2 30.4 16.2 7.1 7.7 2.5 8.2 83.3 TMED8 FAM15B ENSG00000100580 "Transmembrane p24 trafficking protein family member 8" Q6PL24 14 77335029-77377094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 62.7;Cone photoreceptor cells: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001205 Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" Vesicles "HPA001205: AB_2204460" "unprognostic (1.07e-1)" "unprognostic (4.70e-2)" "unprognostic (4.85e-2)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.23e-3)" "unprognostic (1.12e-1)" "unprognostic (5.88e-2)" "unprognostic (2.77e-1)" 5.5 8.3 8.2 8.6 9.6 7.7 5.7 4.7 8.4 5.9 4.1 4.4 3.3 6.7 5.1 3.6 5.4 4.1 3.4 7.5 16.6 10.4 3.4 4.6 17.5 7.9 10.5 7.3 5.6 11.1 9.2 4.4 11.2 5.9 4.8 24.2 4.4 5.9 2.3 4.9 5.5 5.6 6.9 8.0 6.2 6.8 12.8 9.8 10.9 2.4 19.5 4.7 3.5 5.9 14.7 12.0 13.9 12.4 8.5 7.6 11.8 9.2 6.0 9.4 10.1 7.5 8.1 58.7 7.5 7.5 7.7 10.0 10.4 10.5 14.6 18.6 6.3 19.6 9.5 7.9 5.9 9.6 51.8 8.0 7.4 12.3 11.0 9.5 13.5 47.7 10.1 15.4 9.5 14.4 15.2 14.2 6.9 10.7 12.0 12.2 12.7 4.7 9.9 9.0 17.2 10.4 15.9 9.4 11.8 10.6 15.2 15.9 9.7 9.7 6.2 17.5 10.7 12.3 25.2 28.9 11.1 17.7 14.3 2.3 0.7 2.2 0.3 0.9 0.4 2.1 0.5 0.4 0.6 2.1 0.3 0.5 1.0 0.5 0.8 1.0 0.7 0.5 8.2 9.6 4.7 8.4 7.5 16.6 7.9 10.5 11.2 6.9 12.8 5.9 6.6 3.2 7.8 62.7 33.9 6.6 4.9 7.7 2.8 33.4 12.5 8.3 16.8 8.6 5.3 22.0 108.4 10.5 7.9 6.5 5.9 6.4 4.8 9.8 15.5 10.4 44.3 15.4 44.7 4.7 10.0 8.4 7.1 9.0 0.0 9.1 8.9 9.8 7.8 28.6 40.7 6.3 10.2 24.8 7.7 6.9 14.6 19.8 5.4 21.5 16.8 14.9 6.2 39.7 24.2 6.8 3.3 14.3 19.9 7.5 3.2 22.2 20.9 39.3 13.1 7.1 8.4 6.8 15.7 8.2 8.9 4.1 10.3 19.8 6.7 4.3 TMEM131 "CC28, KIAA0257, PRO1048, RW1, YR-23" ENSG00000075568 "Transmembrane protein 131" Q92545 2 97756333-97995948 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 129.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017678, HPA017682" Approved Uncertain "Vesicles,Intermediate filaments" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 44: Endometrium - Transcription" "Vesicles, Intermediate filaments" "HPA017678: AB_1858086, HPA017682: AB_1858087" "unprognostic (1.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (7.42e-2)" "unprognostic (8.58e-2)" "unprognostic (4.18e-2)" "unprognostic (7.59e-3)" "unprognostic (3.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (5.10e-3)" "unprognostic (5.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "unprognostic (1.77e-1)" 12.1 12.2 7.2 20.7 7.5 17.5 10.6 7.2 7.6 18.8 9.3 25.8 18.5 16.3 8.5 14.3 15.3 15.8 13.0 7.4 5.5 12.1 13.5 12.4 25.4 6.1 7.5 16.3 19.0 27.5 11.1 18.3 6.1 16.6 23.2 11.4 13.4 11.5 24.4 24.1 19.4 16.5 6.6 18.4 26.2 14.7 10.3 18.4 12.8 22.3 23.1 14.1 10.4 8.6 26.1 15.7 28.8 21.0 29.6 35.8 31.4 37.8 36.5 18.9 22.7 20.3 36.8 41.3 20.4 39.3 32.2 18.4 30.5 50.5 28.0 29.4 19.8 30.0 10.6 29.3 33.4 28.2 38.6 34.4 20.2 33.7 34.7 32.0 23.5 19.8 18.1 42.8 58.2 15.7 20.6 17.9 15.8 20.2 33.4 29.7 18.3 18.3 19.3 30.7 32.3 15.7 24.4 16.7 23.2 30.7 14.0 25.8 28.1 49.1 22.4 23.9 14.7 18.1 26.8 20.6 38.5 24.3 33.9 3.7 1.3 3.6 1.7 1.6 1.9 2.1 1.5 1.7 1.7 1.9 1.7 2.3 0.9 2.5 1.6 2.4 1.0 1.0 7.2 7.5 7.2 7.6 7.4 5.5 6.1 7.5 6.1 6.6 10.3 8.6 29.4 16.0 27.9 90.1 41.2 19.8 17.7 16.3 24.5 28.3 17.3 16.0 34.7 15.7 23.4 20.2 22.9 15.4 33.1 62.2 3.9 9.7 14.4 88.9 33.9 19.3 30.1 23.5 113.1 24.0 12.7 23.5 60.1 86.8 23.5 21.3 22.9 26.0 24.5 25.2 99.7 45.6 10.2 29.2 18.5 20.1 20.8 35.8 12.4 87.1 47.0 14.1 9.2 92.5 129.8 18.1 40.1 19.2 36.3 17.9 27.4 7.0 38.2 19.3 13.1 31.9 24.9 21.2 26.0 25.0 25.6 13.5 22.4 28.0 36.6 16.0 TMEM131L "DKFZp586H1322, KIAA0922" ENSG00000121210 "Transmembrane 131 like" A2VDJ0 4 153466346-153636711 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 49.4;lymphoid tissue: 48.3" "Cell type enhanced" "Detected in many" "Adipocytes: 13.6;Alveolar cells type 2: 9.6;B-cells: 9.9;dendritic cells: 13.2;Exocrine glandular cells: 9.3;monocytes: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 105.2;MOLT-4: 99.9;U-698: 122.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043472, HPA048443" Uncertain Approved "Nucleoli fibrillar center,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli fibrillar center" "HPA043472: AB_2678496, HPA048443: AB_2680395" "unprognostic (1.12e-1)" "prognostic favorable (6.69e-6)" "unprognostic (1.71e-1)" "unprognostic (3.75e-2)" "unprognostic (8.37e-2)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "unprognostic (3.30e-2)" "unprognostic (3.23e-2)" "unprognostic (4.11e-2)" "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (4.35e-3)" "unprognostic (2.92e-2)" "unprognostic (3.39e-2)" "unprognostic (3.94e-2)" "unprognostic (3.51e-2)" 9.8 1.7 1.6 20.9 4.0 49.4 7.2 1.0 2.7 5.6 1.0 6.4 2.3 6.3 9.4 6.7 5.0 4.9 8.7 1.5 1.6 3.5 20.7 6.6 47.8 1.9 1.4 4.6 31.2 1.1 3.9 3.9 1.9 5.9 4.6 0.4 8.1 4.8 24.5 6.9 10.9 6.9 1.0 24.6 6.1 4.4 2.0 48.3 4.1 6.2 45.4 6.1 6.0 2.8 5.8 3.7 15.7 16.5 9.1 7.9 0.3 8.3 4.0 5.6 7.1 25.8 3.7 105.2 2.0 11.1 6.2 5.7 12.1 14.3 8.5 9.7 8.7 20.6 7.0 6.7 5.9 22.9 1.2 7.3 8.7 7.4 6.9 6.3 14.4 19.1 19.7 0.4 5.7 10.7 99.9 16.6 14.0 0.2 5.4 34.3 15.2 6.8 3.8 2.4 11.7 9.1 6.5 14.2 8.6 8.0 5.5 16.6 11.6 7.5 13.2 9.1 6.9 11.2 12.1 122.4 2.2 13.5 6.2 11.8 19.4 21.1 12.3 36.8 16.7 28.2 15.5 11.7 20.9 27.3 25.8 17.5 21.0 24.3 31.6 2.1 20.9 17.6 1.6 4.0 1.0 2.7 1.5 1.6 1.9 1.4 1.9 1.0 2.0 2.8 13.6 6.4 9.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 5.5 4.3 0.0 0.0 1.8 0.0 0.0 0.5 13.2 0.0 1.9 2.0 0.0 1.3 8.2 3.2 0.0 0.0 0.0 9.3 0.2 3.7 0.0 1.1 5.1 5.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 16.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 4.8 0.0 0.0 1.5 5.8 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 7.2 5.1 0.0 0.0 TMEM164 "FLJ22679, RP13-360B22.2" ENSG00000157600 "Transmembrane protein 164" Q5U3C3 X 110002631-110182734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 84.5;Distal enterocytes: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 59.7" "Lineage enriched" "Detected in many" 18 "granulocytes: 59.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038784 Approved Approved "Vesicles,Cell Junctions" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 8: Non-specific - Mitochondria" "Cluster 3: HMC-1 - Innate immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Vesicles "Cell Junctions" "HPA038784: AB_10670790" "unprognostic (2.14e-3)" "unprognostic (3.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.65e-3)" "unprognostic (7.94e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (8.17e-6)" "unprognostic (9.85e-3)" "unprognostic (5.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "unprognostic (3.95e-1)" "unprognostic (7.66e-2)" "prognostic favorable (3.14e-4)" "unprognostic (1.76e-1)" "unprognostic (1.81e-2)" "unprognostic (4.19e-3)" 16.9 10.3 11.4 9.6 11.8 19.0 12.3 6.8 9.7 5.5 14.3 18.8 21.5 5.3 6.0 13.8 8.1 5.1 22.7 9.0 12.1 11.1 2.0 17.9 6.7 13.5 13.0 13.8 25.4 8.3 9.6 5.2 11.2 8.9 21.2 3.6 9.8 14.4 27.5 20.3 19.2 6.9 8.2 8.4 14.0 1.9 12.3 12.6 13.8 19.3 8.0 5.8 6.8 8.6 10.8 24.3 19.5 12.8 23.7 17.3 11.9 5.3 12.4 11.0 7.1 19.1 16.6 8.6 35.2 8.3 27.1 15.6 17.1 27.9 10.8 23.9 11.7 58.5 13.0 8.1 13.9 26.1 80.1 24.0 48.4 19.9 27.2 30.2 21.8 15.2 18.4 10.2 19.7 21.6 27.4 33.1 17.5 36.9 17.3 12.4 15.1 7.2 17.5 11.3 18.2 20.3 34.0 33.1 15.9 18.1 9.6 25.7 49.0 9.3 6.8 11.0 7.7 5.9 7.9 6.9 24.3 32.0 25.3 59.7 3.3 14.2 0.6 2.9 1.6 0.2 0.7 0.6 2.7 0.6 0.4 0.5 16.3 2.3 1.8 0.5 1.0 1.8 11.4 11.8 6.8 9.7 9.0 12.1 13.5 13.0 11.2 8.2 12.3 8.6 2.9 3.2 36.1 84.5 3.7 4.8 3.7 4.7 4.6 1.2 11.7 9.1 21.3 11.5 6.9 16.5 2.1 2.7 3.5 53.0 3.9 4.6 0.5 6.7 3.8 6.0 27.6 14.5 22.9 11.4 6.3 3.1 7.7 10.7 3.8 4.3 6.4 1.7 13.6 0.0 31.4 12.7 10.2 25.1 9.4 1.3 1.8 12.5 1.8 24.4 28.1 1.0 4.1 34.2 7.6 13.5 15.0 1.5 1.6 9.0 31.9 3.3 5.4 1.3 0.0 6.4 4.1 0.2 0.3 10.4 8.0 2.7 5.2 3.8 21.2 12.3 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 135.5" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 32.4;Excitatory neurons: 109.1;Inhibitory neurons: 109.2;Oligodendrocyte precursor cells: 33.7" "Group enriched" "Detected in many" 4 "endometrial cancer: 10.2;glioma: 13.2;prostate cancer: 19.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 138.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 45: Intestine - Brush border" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA052128: AB_2681738" "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 5.9 7.6 65.4 0.6 71.3 0.2 6.2 135.5 104.1 4.1 38.6 8.9 1.9 3.6 1.5 1.8 6.3 2.7 4.5 71.7 51.3 42.7 9.9 6.7 0.5 64.7 54.9 5.9 4.6 2.3 12.9 3.2 65.5 11.6 1.7 15.7 21.9 1.6 2.8 3.3 3.2 2.4 65.7 2.6 8.6 2.2 51.5 0.5 12.3 1.9 0.5 3.9 3.0 108.0 0.0 0.0 138.7 0.1 0.1 3.3 0.2 0.6 0.1 0.0 0.3 0.0 0.3 0.0 3.7 0.0 0.0 0.3 4.5 0.0 0.5 0.3 0.1 0.0 0.0 0.4 1.1 0.1 0.0 2.6 0.3 0.0 0.4 4.3 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.2 17.7 0.2 0.1 1.7 0.0 0.0 1.0 0.2 25.7 0.6 0.0 0.6 0.3 23.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.4 71.3 135.5 104.1 71.7 51.3 64.7 54.9 65.5 65.7 51.5 108.0 3.2 0.0 2.0 14.7 0.0 0.4 0.5 0.6 1.8 9.1 1.1 32.4 3.9 0.0 1.3 12.9 6.2 0.3 0.1 0.8 0.0 0.2 0.4 3.0 1.2 4.3 16.1 0.0 109.1 0.2 0.0 2.6 0.0 6.5 0.0 1.4 0.7 0.5 0.2 1.7 109.2 0.4 2.0 0.0 0.4 0.1 0.0 0.2 1.8 7.5 0.0 1.1 0.0 33.7 19.3 0.4 0.3 0.0 0.0 3.7 0.5 0.7 4.3 6.1 0.0 0.9 0.6 0.2 0.5 0.1 0.6 0.5 0.1 0.5 0.4 0.3 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074064-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.3;parathyroid gland: 11.9;tongue: 12.2" "Group enriched" "Detected in many" 5 "Astrocytes: 175.0;Excitatory neurons: 584.8;Inhibitory neurons: 566.2;Oligodendrocyte precursor cells: 306.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 6.0;HDLM-2: 5.7;NTERA-2: 5.1;RPTEC TERT1: 8.2;SCLC-21H: 6.4;WM-115: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048771 Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 39: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Nucleoli "HPA048771: AB_2680517" "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favorable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.3 1.4 3.7 0.6 5.4 0.0 0.5 0.2 7.4 0.3 0.0 0.8 0.0 0.8 0.4 0.7 0.3 0.3 11.3 7.0 5.0 1.3 0.0 0.3 1.4 1.5 5.9 0.1 0.9 11.9 4.2 0.0 5.6 2.3 0.3 5.5 1.2 0.5 4.6 0.2 0.4 1.0 0.6 0.7 0.3 0.5 5.2 1.4 8.5 12.2 3.1 0.5 0.2 1.9 0.0 0.1 0.0 0.0 0.5 0.2 1.5 0.1 2.3 0.7 0.8 0.0 0.0 1.9 2.0 0.1 0.5 0.0 6.0 0.0 1.9 5.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 5.1 0.0 0.0 0.4 0.9 2.6 8.2 2.4 6.4 3.9 0.1 0.2 0.9 1.2 0.8 0.0 0.0 0.1 0.9 2.7 0.0 0.0 0.0 0.0 0.4 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.4 0.2 7.4 7.0 5.0 1.5 5.9 5.6 0.6 5.2 1.9 1.3 0.0 0.0 175.0 0.0 0.5 0.7 0.9 0.6 25.5 1.4 0.5 48.7 0.0 1.3 1.8 2.1 0.0 0.0 0.0 1.9 0.1 1.3 0.2 0.1 1.2 0.0 0.0 584.8 0.4 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.1 30.3 566.2 0.0 2.0 0.0 0.0 1.6 0.0 0.1 1.8 24.4 0.0 4.2 0.0 306.1 81.3 0.8 0.0 0.7 0.0 2.2 0.0 3.4 0.2 1.8 0.0 3.9 0.8 1.4 0.7 2.9 0.1 0.3 0.3 0.2 0.1 2.0 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040189 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 24: Non-specific - Transcription regulation" Vesicles "Golgi apparatus" "HPA040189: AB_10793959" "unprognostic (1.93e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 14.6 12.4 16.6 12.2 17.0 9.1 18.7 9.7 17.5 27.3 8.3 22.7 24.6 15.2 9.0 13.1 12.7 16.5 10.3 17.6 17.5 7.9 14.9 13.3 9.4 13.3 15.1 10.3 34.3 13.4 11.8 15.0 14.1 20.0 24.8 10.5 52.3 20.9 10.2 16.1 28.5 17.4 12.9 14.3 35.7 21.3 22.3 6.3 21.3 8.7 8.2 20.6 13.4 14.9 22.1 12.6 17.5 27.0 45.1 41.1 33.4 49.1 28.6 25.1 28.4 21.5 26.5 9.3 24.7 41.0 53.5 32.0 26.1 32.4 39.6 13.7 18.7 17.3 18.9 45.6 36.8 21.9 15.8 34.3 31.2 27.9 37.6 37.6 40.7 13.1 33.4 11.3 41.4 13.3 9.7 27.1 13.6 43.8 15.9 9.3 20.1 10.6 23.9 17.1 51.3 35.3 36.0 33.3 24.2 23.9 12.7 30.4 39.1 25.7 17.4 43.1 43.0 6.6 4.9 10.0 31.0 26.8 25.1 5.7 1.1 3.0 2.2 1.1 1.7 0.4 1.2 1.8 0.8 0.4 1.1 1.5 0.7 2.0 1.9 1.0 1.3 0.8 16.6 17.0 9.7 17.5 17.6 17.5 13.3 15.1 14.1 12.9 22.3 14.9 26.7 12.8 33.1 19.9 9.4 20.4 15.6 20.5 17.6 15.6 30.0 18.8 14.2 27.1 23.1 16.5 18.8 8.8 46.0 47.2 3.9 23.3 4.2 16.8 27.7 27.5 44.3 21.5 61.1 32.7 12.5 16.6 49.5 40.5 11.4 36.8 21.0 22.5 10.2 20.2 66.3 35.9 18.3 15.3 16.4 6.7 13.1 14.7 14.2 28.1 13.3 6.0 51.5 43.2 61.7 35.3 25.7 17.7 26.6 37.5 39.4 4.6 25.8 14.6 6.6 12.7 17.8 13.1 22.7 23.6 21.0 5.2 27.0 24.2 30.5 37.1 TMEM182 FLJ30294 ENSG00000170417 "Transmembrane protein 182" Q6ZP80 2 102736905-103019900 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 24 "heart muscle: 97.6;skeletal muscle: 150.7;tongue: 127.7" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 150.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA045861 Approved Nucleoplasm,Vesicles NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Vesicles" "HPA045861: AB_2679475" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (5.10e-2)" "unprognostic (1.12e-4)" "unprognostic (5.35e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-2)" "unprognostic (1.10e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-1)" "unprognostic (4.19e-2)" "unprognostic (3.42e-2)" "unprognostic (9.88e-2)" "unprognostic (4.61e-2)" "unprognostic (1.10e-1)" "unprognostic (3.53e-1)" "unprognostic (2.36e-2)" 2.7 1.6 2.2 0.7 2.0 0.6 2.3 2.6 2.9 2.9 2.2 1.8 1.9 1.1 5.3 3.9 2.1 1.8 97.6 2.5 3.1 2.1 2.0 1.3 1.8 2.8 2.7 1.5 2.1 3.6 2.6 1.4 3.0 4.0 2.3 1.5 2.0 2.1 150.7 0.5 1.2 1.1 2.5 1.6 2.2 1.4 2.6 1.8 3.0 127.7 1.4 2.2 0.6 2.7 4.9 3.3 2.4 7.3 2.8 2.4 6.9 2.5 2.2 2.4 4.4 10.7 7.3 4.5 9.0 1.4 6.1 3.3 2.6 3.7 5.4 11.6 3.5 6.6 1.4 6.7 3.0 6.2 4.4 3.2 7.6 4.5 5.2 1.9 0.4 6.4 5.2 1.2 3.5 4.6 3.9 5.7 4.2 5.9 3.6 3.4 6.3 3.7 5.7 6.2 5.2 1.9 4.1 3.3 10.3 3.5 3.0 3.2 0.7 4.2 3.5 2.7 3.1 3.9 13.0 5.5 3.8 8.4 6.3 0.0 0.0 0.2 2.5 0.2 2.8 3.6 1.5 1.3 0.9 1.2 2.4 2.4 0.0 2.4 0.3 2.9 0.5 1.1 2.2 2.0 2.6 2.9 2.5 3.1 2.8 2.7 3.0 2.5 2.6 2.7 0.6 22.4 12.3 1.3 3.6 0.4 1.0 1.8 1.2 0.3 8.1 2.4 150.6 0.0 15.3 3.7 0.0 2.3 4.2 0.5 0.0 1.8 0.6 2.4 1.1 2.0 6.6 3.6 6.1 3.3 2.6 6.9 4.1 1.6 3.8 1.2 0.7 2.3 1.2 0.0 10.8 2.6 2.0 0.8 0.7 0.6 0.6 1.3 7.2 6.5 0.1 2.4 1.0 8.5 3.4 2.4 1.1 0.7 2.7 1.0 1.0 2.4 12.8 0.3 0.0 4.6 2.3 1.0 2.4 2.5 0.6 1.1 2.9 1.1 1.8 2.8 TMEM184C "FLJ10846, TMEM34" ENSG00000164168 "Transmembrane protein 184C" Q9NVA4 4 147617386-147672044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 131.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054013 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 16: U-266 - Nucleosome" "Cluster 29: Early spermatids - Spermatogenesis" Vesicles Nucleoplasm "HPA054013: AB_2682343" "unprognostic (5.45e-3)" "unprognostic (2.49e-2)" "unprognostic (3.93e-3)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (7.72e-3)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.37e-4)" "unprognostic (1.13e-1)" "prognostic favorable (2.31e-7)" "unprognostic (4.68e-2)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.31e-3)" 14.0 20.7 7.8 12.4 10.0 7.9 12.8 10.0 15.9 16.1 10.3 14.8 17.2 14.2 11.2 12.9 13.6 13.4 14.3 10.6 8.9 20.3 20.4 12.7 11.4 8.1 8.7 16.5 15.4 131.7 7.1 19.6 8.7 16.7 16.4 16.2 17.3 16.7 14.7 11.8 16.9 14.3 9.2 11.2 15.3 12.0 9.9 12.6 32.6 16.4 13.8 14.5 7.6 11.2 17.4 27.3 33.7 25.6 45.0 44.6 22.3 32.6 37.5 23.7 26.9 22.7 32.7 16.3 15.7 25.1 23.2 20.5 28.4 24.6 25.8 36.4 16.2 21.1 19.8 16.2 36.3 28.8 29.8 33.2 33.0 26.3 26.9 34.9 30.7 18.4 27.2 44.1 33.6 27.0 24.8 10.2 21.7 40.4 15.7 24.3 11.6 28.2 26.3 32.6 25.8 33.4 18.3 27.0 28.5 25.8 26.8 17.5 31.5 29.2 15.7 24.3 21.0 47.9 68.0 21.5 34.9 17.0 32.7 20.5 12.9 14.7 15.3 16.5 19.4 10.4 13.9 13.9 15.8 12.1 13.0 12.4 10.0 14.6 17.9 10.8 14.3 11.0 7.8 10.0 10.0 15.9 10.6 8.9 8.1 8.7 8.7 9.2 9.9 11.2 8.3 9.6 9.3 7.8 9.5 4.6 8.0 6.3 6.8 8.6 8.3 5.7 19.8 8.6 11.5 5.5 12.5 14.3 12.5 9.8 1.9 12.8 34.6 8.0 11.1 10.0 5.4 8.2 10.4 12.7 12.0 10.6 7.7 9.9 21.5 7.3 8.2 11.8 10.4 11.8 12.7 7.7 6.1 11.9 5.1 13.7 10.8 9.1 5.4 6.5 6.4 8.5 7.2 8.5 14.1 8.6 6.7 14.7 9.0 7.8 9.7 5.8 5.2 6.5 6.6 9.5 8.8 6.5 5.4 10.6 3.4 8.6 12.0 10.6 11.3 7.0 TMEM241 "C18orf45, FLJ44259, MGC11386" ENSG00000134490 "Transmembrane protein 241" Q24JQ0 18 23197144-23437961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 70.8;Oligodendrocyte precursor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "NK-cell: 6.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029489, HPA059922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" Vesicles "HPA029489: AB_2673067, HPA059922: AB_2684164" "unprognostic (1.44e-3)" "unprognostic (1.92e-1)" "unprognostic (7.80e-2)" "unprognostic (1.02e-2)" "unprognostic (1.37e-1)" "unprognostic (6.48e-2)" "unprognostic (1.15e-4)" "unprognostic (7.07e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.81e-3)" "unprognostic (9.53e-3)" "unprognostic (1.15e-1)" "unprognostic (1.42e-1)" "unprognostic (2.95e-1)" "unprognostic (4.93e-1)" "prognostic unfavorable (5.80e-4)" 2.1 0.6 0.7 1.8 0.9 1.1 2.3 0.0 1.7 1.8 0.7 1.7 1.5 2.0 1.6 1.7 1.7 1.6 1.5 1.5 0.2 1.1 1.7 1.4 1.4 0.1 0.1 1.6 1.3 2.4 1.1 2.3 0.0 0.9 2.2 0.3 1.2 0.9 1.0 0.8 1.1 2.9 0.0 1.5 1.4 0.6 0.2 1.0 2.2 0.9 1.5 1.6 1.0 1.1 3.2 4.5 1.2 4.1 5.5 5.3 3.5 1.6 1.9 1.9 3.8 1.3 7.6 13.1 3.4 2.7 6.6 6.0 2.9 7.8 5.3 1.4 1.5 2.4 4.5 3.7 3.3 2.7 2.1 5.3 6.5 6.3 6.6 4.1 6.6 6.3 5.5 4.1 5.3 4.6 2.6 0.5 1.8 10.6 2.9 1.9 5.8 11.2 2.6 1.9 4.6 4.3 7.1 3.2 4.2 4.3 4.0 0.8 3.0 10.3 2.4 3.6 3.9 8.4 8.1 5.3 5.1 8.4 7.2 1.2 0.5 0.0 0.9 2.2 1.3 1.3 0.2 0.9 2.0 2.2 0.8 1.2 0.0 6.0 0.8 0.7 1.2 1.1 0.7 0.9 0.0 1.7 1.5 0.2 0.1 0.1 0.0 0.0 0.2 1.1 3.7 0.0 6.9 4.9 3.5 2.8 3.3 3.9 4.0 1.0 16.1 7.9 1.4 1.5 5.2 3.7 4.2 8.3 4.7 1.8 0.0 2.3 0.0 2.4 4.6 2.5 1.2 3.8 70.8 2.2 8.7 3.9 7.1 3.2 2.5 4.2 3.3 3.8 3.1 10.1 16.0 4.0 6.1 0.6 2.9 0.3 1.8 2.4 1.8 11.2 1.4 1.0 5.2 21.6 9.9 3.0 3.1 1.2 5.7 4.6 2.0 3.3 8.3 1.3 0.0 4.2 3.0 1.4 5.5 6.2 4.4 4.7 2.1 4.2 2.3 2.9 TMEM25 FLJ14399 ENSG00000149582 "Transmembrane protein 25" Q86YD3 11 118531041-118547280 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA012163, HPA051562" Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 6900000 "Cluster 48: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus, Vesicles" "HPA012163: AB_1858112, HPA051562: AB_2681535" "unprognostic (1.53e-2)" "unprognostic (7.18e-2)" "unprognostic (2.43e-1)" "unprognostic (6.69e-2)" "unprognostic (3.61e-1)" "unprognostic (6.50e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (1.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.66e-2)" "unprognostic (8.19e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.15e-1)" "unprognostic (2.51e-1)" "unprognostic (1.26e-1)" "unprognostic (7.01e-2)" 6.9 25.3 35.0 3.8 36.0 2.2 14.6 33.9 44.3 14.9 32.2 16.0 46.0 15.3 25.7 11.1 13.7 8.9 8.9 37.5 36.7 18.6 23.1 9.9 4.8 32.1 30.3 23.4 17.6 23.3 29.5 6.0 32.0 15.7 3.7 22.3 21.0 18.3 18.5 8.7 35.2 10.8 31.5 5.3 13.3 6.5 35.1 5.1 15.9 9.9 5.3 14.4 11.6 35.1 3.4 0.7 5.8 9.5 6.0 0.9 5.6 5.2 9.9 4.9 9.8 27.1 18.8 0.3 20.1 5.3 10.9 14.8 0.0 18.3 4.4 11.9 11.1 0.5 5.4 6.0 16.0 0.3 0.5 7.3 10.9 5.3 0.9 35.9 7.2 13.7 2.6 11.7 4.9 4.1 6.0 0.5 4.9 0.1 12.8 8.1 4.2 12.3 25.3 0.3 17.0 11.5 5.1 33.7 0.1 8.7 43.8 0.6 2.5 2.1 10.6 0.4 1.6 11.7 8.3 3.1 0.4 0.2 0.2 0.7 0.2 0.2 5.1 0.2 7.1 4.0 7.3 2.9 0.5 2.6 10.0 5.4 0.4 7.4 0.2 3.4 6.0 3.5 35.0 36.0 33.9 44.3 37.5 36.7 32.1 30.3 32.0 31.5 35.1 35.1 5.1 6.4 3.9 11.1 6.2 5.7 10.7 14.7 13.1 27.7 27.7 30.6 6.1 14.3 9.3 16.5 29.2 37.1 4.8 0.9 11.7 16.6 2.8 4.1 5.0 6.4 11.4 5.2 20.1 6.4 16.9 8.7 2.6 5.5 8.9 18.0 3.6 9.6 2.9 11.8 22.0 7.8 10.2 0.0 1.9 5.5 23.3 1.1 7.2 2.8 3.4 28.8 5.2 8.5 6.5 5.0 5.5 23.3 5.5 5.5 149.1 25.6 7.4 41.1 0.0 12.1 7.5 3.9 5.2 4.0 3.7 16.3 4.7 15.3 15.0 5.7 TMEM267 "C5orf28, FLJ21657" ENSG00000151881 "Transmembrane protein 267" Q0VDI3 5 43444252-43483893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 38.2" "Cell type enhanced" "Detected in many" "Breast glandular cells: 20.2;Collecting duct cells: 16.5;Cytotrophoblasts: 26.3;Distal tubular cells: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059946, HPA072991" Approved Nucleoplasm,Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 1: Thyroid gland - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "HPA059946: AB_2684175, HPA072991: " "unprognostic (8.20e-2)" "unprognostic (2.02e-2)" "unprognostic (7.60e-2)" "unprognostic (8.11e-3)" "unprognostic (1.57e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.82e-2)" "unprognostic (4.77e-3)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-2)" "unprognostic (4.40e-3)" 7.6 7.0 5.7 8.8 5.4 4.9 15.1 5.5 6.2 10.9 7.1 8.4 7.6 8.4 11.9 8.1 8.6 7.7 6.0 5.3 6.5 9.8 7.2 7.6 10.4 5.7 6.6 7.7 7.6 10.7 5.7 6.7 6.5 9.0 9.9 8.1 8.6 9.9 6.2 10.4 6.5 9.6 6.2 8.6 9.9 7.3 5.7 9.2 38.2 3.7 9.6 8.6 6.7 6.4 20.0 18.0 9.5 21.2 17.2 34.8 10.8 28.0 17.3 14.9 10.8 7.9 41.7 21.9 37.7 28.9 15.8 16.3 9.2 12.6 21.3 26.7 14.8 12.9 37.2 8.8 32.0 26.5 17.9 28.9 35.3 22.3 31.7 15.0 16.7 26.3 17.1 39.9 32.8 17.1 14.5 15.3 4.4 20.4 17.4 9.9 23.5 27.3 18.7 20.1 13.2 9.3 56.1 31.5 27.9 8.7 46.0 18.4 21.9 24.0 19.4 14.9 14.1 17.0 26.5 21.6 18.1 37.3 21.6 16.6 11.1 4.4 15.1 13.5 22.3 14.5 20.2 15.9 12.7 13.4 20.3 16.6 1.9 18.9 16.0 9.8 17.5 14.3 5.7 5.4 5.5 6.2 5.3 6.5 5.7 6.6 6.5 6.2 5.7 6.4 9.7 6.4 3.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 20.2 13.2 0.0 0.0 1.8 16.5 0.0 26.3 6.3 0.0 27.4 13.8 0.0 8.4 9.1 2.6 0.0 0.0 0.0 13.6 10.2 4.5 0.0 9.2 2.5 6.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.9 0.0 0.0 13.7 6.6 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 10.5 3.7 6.6 0.0 0.0 TMEM39A "FLJ10902, SUSR2" ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119428949-119468830 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 12.4 10.5 2.2 14.4 4.3 12.9 10.2 4.1 3.5 19.5 10.9 9.0 10.0 13.2 10.9 9.0 11.7 12.6 11.1 2.2 3.1 6.4 13.0 12.4 10.0 4.0 3.4 13.1 28.4 12.8 15.4 18.1 4.3 9.1 9.3 5.0 13.3 14.3 7.2 8.8 8.0 9.7 3.1 9.2 9.8 7.8 4.7 12.1 16.6 11.9 13.6 14.4 10.5 6.2 28.3 15.1 24.1 17.4 56.1 54.2 24.1 26.4 54.3 37.2 50.0 26.1 21.2 12.0 27.4 28.7 37.9 28.7 29.3 12.1 38.0 12.6 11.2 15.5 13.5 25.4 37.9 27.1 23.4 29.7 20.5 25.9 61.5 37.5 23.6 18.5 16.1 35.5 19.6 14.1 13.7 7.0 20.5 29.8 31.5 16.5 11.3 25.7 9.2 10.7 10.7 15.8 26.6 15.2 33.4 17.3 14.8 23.8 18.5 20.2 17.2 13.8 17.3 39.5 12.5 28.5 27.6 18.2 26.8 12.7 10.9 7.3 11.7 5.8 11.9 7.7 7.1 9.6 12.3 9.0 5.6 6.1 3.8 11.9 4.6 17.3 8.9 9.4 2.2 4.3 4.1 3.5 2.2 3.1 4.0 3.4 4.3 3.1 4.7 6.2 8.5 9.6 15.8 9.8 14.3 22.8 16.0 21.8 8.6 4.7 14.6 10.8 10.8 7.2 16.2 7.3 6.2 26.5 24.7 7.4 5.9 11.6 22.8 8.2 26.3 10.8 10.8 9.0 12.4 14.2 57.6 28.9 13.3 17.9 1.3 13.5 7.9 12.0 13.3 1.7 14.0 18.3 6.1 15.0 54.9 6.8 17.1 17.8 10.6 12.2 31.0 3.9 9.2 25.1 21.8 10.2 6.6 13.2 57.8 20.6 8.0 3.0 14.9 6.4 6.6 15.9 25.2 26.1 18.5 9.6 21.7 59.8 17.4 9.4 11.1 20.4 TMEM45A "DERP7, FLJ10134" ENSG00000181458 "Transmembrane protein 45A" Q9NWC5 3 100492619-100577444 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skin 1: 475.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 425.3;Club cells: 841.5;Early spermatids: 207.3;Suprabasal keratinocytes: 254.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 406.9;ASC TERT1: 118.3;HSkMC: 125.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA062101 Uncertain Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 61: Skin - Cornification" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum" Vesicles "HPA062101: AB_2684682" "unprognostic (5.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.11e-1)" "unprognostic (1.43e-3)" "unprognostic (7.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (6.18e-11)" "unprognostic (1.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.02e-5)" "unprognostic (2.68e-2)" 19.4 18.1 1.4 11.7 3.3 2.0 42.8 1.7 2.5 38.4 2.3 10.3 3.6 18.3 3.2 16.5 20.9 18.9 21.9 1.5 1.8 3.7 99.0 13.1 2.6 1.9 1.9 11.9 23.3 2.7 22.9 40.9 1.8 9.1 6.6 1.7 26.9 6.3 3.2 475.1 6.4 25.4 1.7 5.0 7.0 13.3 1.9 1.6 9.1 2.5 50.7 19.5 79.5 2.1 28.6 2.0 2.7 9.6 406.9 118.3 0.3 66.9 62.0 9.4 84.8 2.5 0.6 0.0 32.6 44.1 24.6 31.9 2.4 13.0 23.4 7.2 8.4 23.9 9.3 8.0 25.7 0.4 1.5 125.4 7.4 17.1 25.4 39.0 3.5 0.0 0.6 3.2 22.6 0.3 0.1 0.7 3.2 0.0 16.8 0.0 23.3 0.4 0.6 1.0 2.9 19.4 16.4 8.5 7.3 18.2 0.8 13.6 9.3 62.9 44.3 0.5 15.2 53.8 32.9 0.1 49.7 1.9 42.6 0.0 0.9 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.6 1.4 3.3 1.7 2.5 1.5 1.8 1.9 1.9 1.8 1.7 1.9 2.1 1.6 60.9 61.4 0.7 3.0 94.6 5.4 425.3 9.6 3.2 19.1 8.9 2.5 1.5 841.5 0.0 0.0 2.6 0.4 0.2 0.0 7.5 207.3 3.0 79.1 8.9 1.2 1.3 0.8 14.9 46.3 56.3 2.0 2.0 65.0 10.7 15.0 137.1 5.8 8.4 2.4 2.0 63.1 6.5 25.4 25.4 16.1 6.6 23.2 13.1 1.1 3.5 0.0 16.1 11.8 6.5 2.6 27.8 26.8 3.1 0.3 0.2 121.0 0.9 6.6 22.8 56.6 1.5 3.3 5.4 254.9 7.5 6.4 26.7 0.1 4.4 TMEM63A KIAA0792 ENSG00000196187 "Transmembrane protein 63A" O94886 1 225845536-225882380 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 365.5;salivary gland: 121.1" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 112.2;SK-BR-3: 119.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066504, HPA066936, HPA068918" Enhanced "Vesicles,Centriolar satellite" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Centriolar satellite" "HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057" "unprognostic (5.31e-2)" "unprognostic (3.46e-2)" "unprognostic (2.14e-2)" "prognostic favorable (8.79e-4)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-2)" "unprognostic (2.57e-1)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.92e-2)" 24.5 17.9 58.1 27.0 167.3 42.7 29.1 132.2 120.4 35.9 24.6 33.8 26.3 25.7 22.7 15.2 28.2 27.3 20.9 71.6 94.9 33.3 40.2 31.2 35.6 199.1 127.1 28.4 56.7 17.8 11.8 24.2 191.7 57.6 37.0 3.6 121.1 37.3 16.5 21.5 34.5 18.1 95.7 31.6 47.7 5.3 135.3 27.8 19.0 13.7 27.0 26.4 23.2 365.5 27.6 8.3 7.0 20.2 54.1 18.7 47.7 20.6 22.2 22.5 22.6 29.7 20.0 7.7 37.1 25.2 13.3 41.4 7.5 12.5 10.3 25.8 13.4 33.4 21.0 18.0 12.6 12.5 84.1 19.5 7.8 13.5 8.1 31.1 14.8 17.0 28.2 6.3 18.0 17.4 11.2 12.7 37.8 87.5 13.2 11.1 21.3 112.2 34.1 71.8 0.6 3.7 15.2 119.3 14.5 16.0 27.7 11.9 17.8 12.9 8.9 12.1 18.9 2.5 10.4 2.0 11.9 7.0 24.3 6.3 3.9 3.6 10.3 3.1 11.4 5.8 13.1 9.8 2.9 5.5 11.4 6.9 5.5 10.2 5.3 11.5 19.8 6.9 58.1 167.3 132.2 120.4 71.6 94.9 199.1 127.1 191.7 95.7 135.3 365.5 11.0 6.4 9.2 45.7 23.3 3.3 24.9 5.7 2.2 0.8 30.0 16.8 6.5 34.3 14.0 20.2 2.1 38.7 37.0 34.7 1.9 36.3 9.1 43.1 10.6 8.6 19.2 6.3 1.0 25.5 6.6 8.9 48.9 49.8 17.2 44.8 10.8 22.2 16.7 0.0 1.7 35.0 24.4 11.7 5.3 13.5 18.3 14.2 3.6 26.2 10.4 12.9 40.2 5.5 323.2 18.4 29.0 13.2 9.1 41.6 13.0 14.8 23.1 1.8 26.3 8.8 10.8 0.6 5.3 4.2 4.1 22.4 23.3 7.2 57.6 35.1 TMEM87B FLJ14681 ENSG00000153214 "Transmembrane protein 87B" Q96K49 2 112055269-112119318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 89.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035183 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus, Vesicles" "HPA035183: AB_10600829" "unprognostic (3.19e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.28e-4)" "prognostic unfavorable (4.72e-4)" "unprognostic (4.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.07e-2)" "unprognostic (2.87e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.32e-1)" "unprognostic (5.35e-2)" "unprognostic (1.05e-1)" "unprognostic (3.25e-3)" 10.5 12.2 6.8 14.7 6.6 7.9 20.1 6.1 8.0 12.9 6.9 28.4 28.6 11.0 18.5 10.5 8.4 12.1 5.0 5.9 7.1 7.9 7.4 11.7 15.4 7.5 10.0 6.0 11.3 12.9 9.2 15.1 8.0 30.7 27.8 6.9 15.4 15.9 3.1 13.7 30.5 13.4 7.1 15.5 22.8 5.0 8.3 9.7 15.0 4.2 14.6 17.1 9.0 6.9 21.7 6.4 5.9 25.8 24.9 32.6 21.4 35.5 46.8 21.9 26.7 16.6 28.6 20.9 18.2 47.3 30.2 34.9 3.8 21.6 28.7 12.8 4.1 27.5 4.6 15.2 24.7 19.6 28.9 22.3 25.9 28.0 22.0 21.4 23.6 9.6 16.9 13.1 31.8 13.7 9.3 10.8 4.8 35.0 16.4 7.6 8.9 17.0 20.3 30.2 4.6 6.4 15.4 38.6 34.6 15.5 20.4 14.7 26.6 22.3 6.8 17.6 7.8 10.6 18.1 12.9 25.9 10.1 16.3 5.4 3.0 2.6 3.2 5.2 5.6 5.9 6.9 4.4 2.7 4.9 6.2 3.6 1.8 3.5 6.7 2.7 7.4 3.6 6.8 6.6 6.1 8.0 5.9 7.1 7.5 10.0 8.0 7.1 8.3 6.9 18.3 28.9 13.9 18.9 23.3 12.2 14.5 20.9 39.9 5.0 32.9 14.4 4.6 20.0 21.6 18.4 2.1 15.9 12.3 59.5 0.0 42.9 18.7 14.4 26.5 19.9 17.4 6.3 18.4 89.3 25.5 17.5 46.4 24.9 13.3 14.5 35.7 10.1 21.7 6.7 16.4 53.6 12.2 37.7 10.9 24.5 9.9 22.7 3.6 30.0 20.9 4.0 6.2 21.6 23.1 69.7 47.1 3.0 21.6 28.9 44.9 4.7 17.9 7.9 0.0 5.4 17.2 4.9 5.6 29.9 12.8 29.1 20.5 11.8 38.2 23.9 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 15 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038298 Uncertain Uncertain Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 0.7 6.2 14.2 0.5 14.1 0.0 0.4 14.0 18.0 0.7 10.5 1.0 0.4 0.5 0.7 1.5 0.6 0.2 0.7 14.1 19.3 2.3 0.8 1.0 0.8 19.6 15.7 1.5 0.2 0.1 9.9 0.4 19.2 0.5 0.3 0.7 0.5 1.0 3.6 0.7 0.5 0.4 16.0 0.7 0.3 1.5 18.7 0.5 0.9 1.2 0.8 0.6 0.9 14.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.0 2.7 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.5 10.7 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.7 0.1 1.2 0.0 0.3 0.1 0.1 0.3 2.3 0.3 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.4 0.4 14.2 14.1 14.0 18.0 14.1 19.3 19.6 15.7 19.2 16.0 18.7 14.9 1.9 0.0 0.0 0.3 0.0 0.8 0.2 0.5 0.0 3.8 0.2 0.6 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.9 0.4 0.5 0.2 0.0 0.7 0.0 0.0 1.7 0.4 0.1 0.4 0.0 0.1 0.0 0.1 0.4 0.1 0.6 0.0 0.8 0.0 0.0 0.0 0.4 1.5 0.6 0.3 0.0 1.9 0.1 1.4 0.0 0.0 0.3 1.2 0.0 0.4 0.0 0.3 0.0 0.0 0.6 0.5 0.0 1.1 1.0 2.6 3.2 0.0 0.9 0.1 0.2 0.1 0.0 0.2 TMUB2 MGC3123 ENSG00000168591 "Transmembrane and ubiquitin like domain containing 2" Q71RG4 17 44186970-44191929 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043137 Approved Approved Vesicles,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Vesicles, Cytosol" "HPA043137: AB_10794388" "unprognostic (4.57e-2)" "unprognostic (1.58e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-2)" "unprognostic (6.37e-2)" "unprognostic (1.85e-2)" "unprognostic (6.43e-3)" "unprognostic (1.07e-1)" "unprognostic (2.05e-1)" "unprognostic (3.35e-2)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "unprognostic (9.75e-3)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.78e-3)" 32.2 35.7 34.1 22.9 34.4 43.9 32.5 34.9 38.1 37.3 32.5 39.1 24.5 32.5 21.9 37.3 33.9 25.2 33.1 34.2 32.8 36.9 35.8 31.5 26.3 33.6 33.8 35.2 36.9 27.5 32.9 25.9 32.9 42.0 21.9 16.8 36.1 26.3 32.7 32.4 36.5 21.7 32.2 52.8 36.7 46.8 34.2 23.2 42.7 20.0 20.5 35.3 34.3 34.3 22.8 43.0 27.6 25.1 41.6 32.8 21.6 29.5 31.6 53.7 54.4 22.7 41.5 15.8 31.1 36.1 40.5 42.3 19.3 28.0 33.4 38.7 39.7 16.5 40.9 35.1 43.8 18.7 35.5 40.1 39.8 36.9 22.9 45.1 37.8 25.8 19.2 45.4 35.7 15.9 26.0 23.8 9.1 19.0 35.7 23.2 33.3 25.5 33.8 25.2 21.8 22.2 15.5 14.4 29.4 27.6 42.2 23.0 31.8 44.4 27.0 31.1 26.7 33.5 26.1 15.4 34.0 15.7 30.4 84.1 30.0 57.3 17.1 26.7 14.5 16.6 14.3 16.5 19.1 23.8 13.4 15.3 65.4 13.9 29.0 23.1 18.1 20.4 34.1 34.4 34.9 38.1 34.2 32.8 33.6 33.8 32.9 32.2 34.2 34.3 24.8 35.3 25.9 21.2 40.8 13.0 21.2 27.0 25.6 30.8 29.8 25.3 16.7 22.8 27.2 22.0 31.3 46.3 24.9 42.5 3.9 21.0 51.0 13.9 16.8 20.4 33.5 25.7 15.8 18.8 29.6 22.0 23.0 25.1 22.1 25.6 18.9 13.9 42.6 21.9 16.4 27.1 12.2 37.9 25.9 28.4 21.8 30.9 14.2 16.9 31.5 29.1 25.7 14.6 12.2 25.8 33.2 24.0 18.8 20.5 39.6 10.7 18.9 27.9 26.3 14.6 19.6 81.5 37.1 17.2 14.9 96.7 27.6 30.0 27.0 23.4 TNFSF4 "CD252, gp34, OX-40L, TXGP1" ENSG00000117586 "TNF superfamily member 4" P23510 1 173183731-173207331 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins" Cytokine "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 8.5;Granulosa cells: 37.0;Macrophages: 26.4;monocytes: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 42.0;HHSteC: 17.3;HUVEC TERT2: 81.2;LHCN-M2: 67.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059579 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Vesicles" "HPA059579: AB_2684071" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (4.58e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-3)" "unprognostic (2.13e-1)" "unprognostic (8.65e-2)" "unprognostic (5.17e-2)" "unprognostic (1.26e-2)" "unprognostic (1.18e-1)" "unprognostic (1.11e-7)" "unprognostic (3.73e-3)" "unprognostic (2.66e-1)" "unprognostic (9.49e-2)" "unprognostic (2.98e-2)" 1.2 2.0 1.1 2.3 1.2 0.6 0.6 1.8 1.5 1.0 0.1 1.0 0.3 0.8 0.5 0.6 0.9 1.1 1.0 1.1 0.9 0.8 0.9 1.2 2.2 1.2 1.2 1.1 1.1 0.5 1.5 0.5 1.2 1.4 1.2 1.4 0.4 0.6 0.2 0.3 0.8 0.8 0.8 1.7 0.7 4.0 1.1 3.7 0.4 0.2 1.9 1.5 0.8 1.2 0.1 0.0 0.4 1.2 2.7 14.1 0.2 4.1 0.9 0.2 0.3 0.2 0.1 0.2 0.7 42.0 0.2 0.1 0.1 0.1 0.3 0.7 0.1 0.1 0.4 1.6 17.3 0.3 0.2 6.2 0.3 2.1 0.3 1.3 81.2 1.5 0.1 0.5 67.5 0.0 0.7 0.4 0.3 0.1 0.6 2.0 0.1 0.6 0.6 0.1 0.1 0.6 0.3 0.2 0.9 1.3 0.0 0.7 0.6 0.1 0.1 0.4 0.2 0.9 1.4 0.3 0.2 7.7 4.4 0.0 0.1 0.1 0.5 0.0 0.3 0.5 0.2 0.4 0.3 0.5 0.4 0.4 0.7 1.7 0.0 1.2 0.4 2.8 1.1 1.2 1.8 1.5 1.1 0.9 1.2 1.2 1.2 0.8 1.1 1.2 0.2 0.0 0.5 8.5 0.8 0.8 0.3 0.4 0.6 0.4 0.2 0.0 1.5 1.5 0.1 1.8 0.0 0.2 2.2 0.9 0.0 0.1 5.8 0.2 0.4 1.0 0.0 0.8 3.6 0.0 0.2 3.7 0.0 0.1 0.0 37.0 0.0 1.2 0.5 0.0 5.2 0.0 0.0 0.6 2.3 2.2 0.3 26.4 1.8 0.0 8.2 1.3 2.1 2.5 4.0 0.3 0.1 1.9 0.4 0.4 0.0 0.2 0.8 0.5 0.0 0.6 3.7 0.3 0.2 0.0 0.6 0.0 2.4 0.7 0.1 0.1 TNK2 "ACK, ACK1, p21cdc42Hs" ENSG00000061938 "Tyrosine kinase non receptor 2" Q07912 3 195863364-195911945 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.9" "Cell type enhanced" "Detected in many" "Horizontal cells: 99.3;Oligodendrocyte precursor cells: 245.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041954, HPA069561" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Plasma membrane" Vesicles "HPA041954: AB_10794164, HPA069561: " "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-3)" "prognostic unfavorable (8.96e-4)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (8.89e-3)" "unprognostic (1.13e-1)" "unprognostic (8.92e-3)" "unprognostic (4.49e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (6.82e-2)" "unprognostic (9.76e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.00e-4)" 14.2 10.0 77.1 24.7 64.1 72.2 15.0 40.0 102.9 18.0 11.8 18.5 9.4 13.8 11.1 19.1 17.1 10.5 18.4 75.6 51.4 7.7 10.5 14.1 30.0 77.5 59.8 13.4 12.1 6.1 36.4 12.7 70.1 21.1 6.3 9.3 26.3 11.8 54.8 62.3 16.1 9.2 45.5 27.0 19.7 12.0 57.0 16.0 10.0 16.7 20.1 19.4 19.3 60.6 93.4 16.3 15.4 13.4 15.3 11.5 80.0 17.7 16.7 11.7 9.4 15.6 79.3 25.9 55.1 24.2 17.4 34.1 14.9 22.2 3.5 61.8 15.4 22.0 36.2 10.4 7.9 13.5 10.2 7.8 30.7 11.7 17.9 26.7 13.3 9.2 11.3 30.6 9.4 67.1 5.3 39.7 12.3 24.6 29.1 13.8 15.6 26.0 7.2 51.2 16.2 16.5 9.5 37.6 21.3 11.3 71.4 11.9 18.9 19.1 13.0 11.4 48.6 70.8 9.2 17.0 22.1 38.0 15.4 1.4 1.2 0.3 0.9 1.5 0.4 1.3 0.8 0.4 0.5 2.5 0.5 0.5 2.7 0.4 1.4 1.5 0.1 0.7 77.1 64.1 40.0 102.9 75.6 51.4 77.5 59.8 70.1 45.5 57.0 60.6 9.3 6.4 7.7 44.4 14.6 6.9 8.1 6.0 4.6 30.6 13.0 12.6 16.1 7.2 8.9 0.0 50.1 13.4 11.0 18.0 1.9 4.0 1.0 4.1 5.4 11.1 6.1 12.8 42.7 5.3 3.3 4.6 14.3 4.1 1.3 4.5 11.7 19.2 8.1 99.3 45.3 2.3 6.1 16.0 11.7 1.2 6.5 13.7 5.4 20.6 16.2 5.9 21.6 245.3 25.1 29.5 9.6 6.4 10.7 8.2 0.9 1.6 7.6 20.3 0.0 4.8 5.7 6.4 11.2 11.0 10.5 4.2 12.5 1.7 6.4 19.0 TNNC2 "CFAP85, FAP85" ENSG00000101470 "Troponin C2, fast skeletal type" P02585 20 45823214-45833745 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 109 "skeletal muscle: 30416.4;tongue: 8088.6" "Group enriched" "Detected in many" 4 "Proximal enterocytes: 338.7;Skeletal myocytes: 1165.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.2;head and neck cancer: 22.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Hep G2: 10.0;HSkMC: 14.8;SCLC-21H: 11.3" "Region enriched" "Detected in some" 5 "olfactory bulb: 6.1" "Low region specificity" "Detected in some" "HPA043174, HPA058481" Enhanced Approved Nucleoplasm,Vesicles No NA 560000 "Cluster 19: B-cells - Humoral immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm Vesicles "HPA043174: AB_10806380, HPA058481: AB_2683729" "unprognostic (1.13e-1)" "unprognostic (7.25e-2)" "unprognostic (3.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-5)" "unprognostic (1.80e-2)" "unprognostic (5.72e-3)" "unprognostic (3.12e-3)" "unprognostic (2.19e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (9.03e-3)" "unprognostic (7.15e-3)" "unprognostic (4.79e-1)" "unprognostic (5.23e-2)" "unprognostic (1.13e-1)" 6.6 5.5 4.8 0.4 5.7 1.1 8.3 5.2 6.9 2.2 4.4 5.3 2.5 4.2 1.0 128.5 3.0 2.2 4.0 4.8 4.5 1.7 2.5 3.2 0.5 4.4 4.5 6.5 2.2 1.2 3.1 0.2 4.5 44.3 2.2 1.3 176.3 1.3 30416.4 10.1 7.8 1.0 4.1 1.8 2.4 4.6 4.8 6.7 5.1 8088.6 0.7 2.5 3.0 5.5 0.1 0.0 0.2 0.4 1.6 1.0 1.7 0.1 0.4 0.0 0.1 0.2 1.1 0.4 1.1 1.0 0.4 0.4 0.0 0.4 0.0 0.0 0.3 0.0 1.0 10.0 0.4 0.3 0.2 14.8 0.2 0.1 0.7 0.3 0.0 1.2 0.1 0.5 0.2 1.2 0.7 0.1 0.0 0.4 0.6 0.3 0.6 0.2 0.4 0.1 11.3 0.5 1.6 0.1 0.4 0.5 1.3 0.4 0.5 0.2 0.3 0.9 0.2 1.5 0.4 0.2 1.4 0.1 0.2 0.0 0.6 1.3 0.1 1.1 0.6 5.3 1.3 0.2 0.3 4.6 0.0 0.3 2.0 0.3 0.8 0.8 3.9 8.7 4.8 5.7 5.2 6.9 4.8 4.5 4.4 4.5 4.5 4.1 4.8 5.5 0.9 3.2 0.6 0.3 3.1 0.8 0.5 2.0 0.0 4.2 3.1 1.7 0.5 2.8 3.6 3.7 0.0 2.4 0.5 171.7 3.9 1.5 6.9 37.1 1.0 3.8 22.9 0.0 1.9 5.1 0.4 7.2 0.5 2.3 0.0 13.9 0.0 1.1 0.3 0.0 0.7 108.2 14.2 0.3 1.1 47.0 1.2 22.4 0.0 0.0 2.1 1.4 1.0 0.0 0.6 3.3 92.9 3.0 0.5 0.7 338.7 1.0 4.3 2.4 0.0 1165.3 9.5 2.5 5.5 0.1 8.4 0.1 4.7 7.2 37.0 0.7 TNNI3 "CMD2A, CMH7, TNNC1" ENSG00000129991 "Troponin I3, cardiac type" P19429 19 55151767-55157773 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 622 "heart muscle: 10813.5" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 12618.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6" "Region enhanced" "Detected in many" "olfactory bulb: 10.9" "Low region specificity" "Detected in many" "CAB009349, HPA046428" Enhanced Approved Vesicles,Cytosol NA NA 2400000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 21: OE19 - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol Vesicles "CAB009349: AB_793465, HPA046428: AB_2679661" "unprognostic (2.12e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.37e-3)" "unprognostic (2.13e-1)" "unprognostic (9.62e-3)" "unprognostic (9.40e-2)" "unprognostic (3.34e-2)" "unprognostic (2.17e-3)" "unprognostic (4.02e-3)" "unprognostic (8.89e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (9.82e-2)" 1.1 3.0 0.3 0.0 0.5 0.0 17.3 0.2 0.4 0.7 0.7 0.7 0.0 0.3 0.1 0.8 6.2 0.9 10813.5 0.6 0.2 1.0 1.1 7.3 1.6 0.5 2.8 1.4 2.3 0.2 0.6 1.0 1.3 2.4 0.0 0.2 1.3 0.0 6.5 1.2 0.6 0.0 0.6 0.4 0.7 3.7 0.3 0.1 1.5 2.4 0.0 0.4 0.6 0.3 1.2 0.6 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 0.0 0.3 1.8 6.3 0.0 1.1 1.1 1.2 0.3 0.0 0.0 13.0 3.0 0.0 1.9 0.5 0.0 20.3 0.0 0.6 0.1 0.3 0.1 0.1 0.8 39.1 0.8 0.0 0.6 0.2 0.0 0.7 54.6 0.5 1.9 0.4 0.1 1.8 0.0 0.1 2.2 0.0 0.0 0.2 0.0 2.8 9.5 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.6 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.4 0.6 0.2 0.5 2.8 1.3 0.6 0.3 0.3 0.1 0.0 0.0 0.0 0.2 6.9 0.0 0.8 13.6 0.0 1.0 0.9 12618.4 8.6 1.8 5.5 0.0 1.4 0.1 0.4 0.0 0.7 56.2 3.5 0.1 131.3 1.8 0.0 0.0 0.2 0.5 202.7 0.0 1.3 0.0 996.2 0.0 0.0 2.2 1.7 0.2 0.4 2.0 0.3 0.7 222.9 0.3 4.6 1.8 1.9 0.0 4.2 0.0 0.0 0.1 1.0 0.0 1.9 0.0 0.0 0.0 0.1 11.2 0.5 0.0 0.4 123.6 6.4 16.1 0.7 2.8 2.5 0.6 1.2 1.0 0.1 TOB1 "APRO5, TOB, TROB, TROB1" ENSG00000141232 "Transducer of ERBB2, 1" P50616 17 50862223-50867978 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 253.3" "Low region specificity" "Detected in all" HPA047839 Approved Approved Nucleoplasm,Vesicles NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "HPA047839: AB_2680175" "unprognostic (3.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.45e-1)" "unprognostic (6.78e-3)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "unprognostic (3.50e-3)" "unprognostic (1.53e-1)" "unprognostic (3.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.04e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.92e-3)" "unprognostic (9.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-2)" "unprognostic (6.97e-2)" 42.6 210.2 32.6 22.3 34.9 70.2 65.3 31.6 40.8 55.3 59.3 47.4 56.1 23.9 26.5 77.7 54.6 47.6 44.7 29.8 39.4 67.9 168.6 36.8 18.9 37.3 48.2 63.4 207.9 81.4 50.1 13.8 38.6 72.3 57.5 101.8 99.8 92.2 178.6 133.5 48.1 29.4 31.8 17.8 87.5 26.0 33.4 17.7 95.4 109.9 21.0 81.9 70.9 40.2 44.1 88.7 28.1 11.5 51.4 25.4 22.0 31.9 79.2 20.5 25.0 36.0 54.6 40.0 60.6 43.9 20.7 61.0 19.5 54.1 21.1 20.4 29.3 4.8 100.7 60.5 72.0 21.5 18.9 54.5 65.5 23.9 120.0 27.3 9.9 12.2 17.0 33.7 43.4 119.0 16.1 19.4 10.2 109.4 33.9 14.0 35.6 47.6 80.9 89.4 16.6 40.4 55.1 158.9 19.9 42.5 253.3 27.1 13.2 23.3 16.7 26.7 15.8 51.9 57.7 18.5 19.2 10.2 9.1 417.7 53.5 285.6 245.8 107.3 269.9 40.7 222.7 192.5 119.1 31.9 192.1 233.6 130.7 28.8 152.5 38.5 206.0 169.0 32.6 34.9 31.6 40.8 29.8 39.4 37.3 48.2 38.6 31.8 33.4 40.2 101.6 115.4 118.3 71.8 53.1 283.2 232.9 119.8 284.0 125.3 180.6 179.6 115.5 210.1 81.8 68.0 56.3 20.8 124.8 183.3 103.7 42.6 97.9 143.7 51.7 40.7 203.4 18.1 11.5 54.1 2.0 83.5 123.3 176.2 63.9 19.7 33.2 205.6 35.4 18.5 14.1 223.2 48.8 27.6 249.2 40.4 26.4 89.9 71.2 5.6 29.1 118.3 20.6 16.6 34.1 41.8 186.7 59.8 41.3 187.2 126.2 60.4 87.8 62.7 164.3 137.3 123.8 36.9 12.1 153.8 230.7 10.9 154.7 77.4 167.6 287.2 TOR1A "DQ2, DYT1" ENSG00000136827 "Torsin family 1 member A" O14656 9 129812942-129824244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012473, HPA051195" Approved Supported "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA 20000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane, Vesicles" "CAB012473: AB_2240792, HPA051195: AB_2681382" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.95e-1)" "unprognostic (1.86e-3)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (2.10e-2)" "unprognostic (1.41e-1)" "unprognostic (4.10e-2)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (3.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.77e-1)" "unprognostic (1.99e-1)" 21.2 24.2 14.3 20.7 14.8 34.5 19.6 14.7 17.7 18.6 14.2 20.7 16.6 20.3 19.9 14.3 17.2 20.6 16.8 15.7 15.9 20.5 35.9 19.4 22.9 13.6 14.0 17.2 19.5 19.4 14.3 23.5 14.0 21.3 22.3 9.8 17.0 23.1 16.4 17.8 18.8 25.4 14.1 18.8 18.1 9.2 15.4 26.3 23.8 14.9 19.0 28.6 15.6 14.8 33.7 49.5 35.9 41.5 53.1 51.3 47.4 76.7 94.5 67.0 57.2 32.3 48.2 41.0 44.0 99.7 46.0 77.2 34.7 50.8 54.7 65.7 32.9 36.9 49.8 32.3 66.9 82.1 65.5 69.8 50.7 63.5 45.6 61.5 73.2 65.3 66.5 32.3 74.6 84.3 58.9 79.3 53.8 39.2 55.6 30.5 56.5 41.9 54.9 42.4 27.0 47.6 79.3 30.7 43.3 40.1 61.6 63.4 65.1 66.1 37.7 49.6 59.6 36.6 87.0 37.7 49.0 46.9 54.3 95.5 72.8 141.3 57.4 68.5 48.1 45.5 48.4 52.1 61.4 33.5 40.9 42.4 72.7 68.6 58.3 56.5 59.1 78.9 14.3 14.8 14.7 17.7 15.7 15.9 13.6 14.0 14.0 14.1 15.4 14.8 25.0 9.6 11.8 5.5 17.5 17.6 16.6 39.5 12.0 11.2 16.5 15.9 9.9 18.6 24.4 14.7 2.1 47.9 39.3 18.7 15.6 42.1 0.7 12.5 18.8 24.2 19.2 30.5 6.3 49.9 65.7 25.0 13.7 15.0 22.2 23.4 16.1 22.7 45.2 21.9 6.4 17.8 26.4 19.1 22.4 1.3 12.8 27.9 14.2 3.7 47.6 18.5 35.0 9.5 6.6 40.1 18.9 15.4 23.7 24.7 21.0 17.0 14.9 9.2 32.9 15.2 24.3 7.3 10.1 9.3 18.5 53.4 25.5 23.4 15.4 19.6 TPD52L2 "D54, hD54, TPD54" ENSG00000101150 "TPD52 like 2" O43399 20 63865228-63891545 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 187.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047489 Approved Approved Vesicles,Cytosol NA NA 1100000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" Vesicles Cytosol "HPA047489: AB_2680067" "unprognostic (1.17e-2)" "unprognostic (2.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (3.63e-3)" "unprognostic (9.95e-2)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (1.74e-8)" "unprognostic (2.79e-1)" "unprognostic (7.07e-2)" "unprognostic (3.33e-2)" "unprognostic (3.15e-3)" 85.1 84.6 75.8 52.8 76.8 98.9 68.9 76.0 88.1 74.1 74.0 79.7 38.3 72.6 31.4 109.6 68.0 42.6 85.7 76.8 81.6 66.2 51.4 60.8 43.2 80.8 77.4 60.7 45.5 38.3 58.9 65.9 79.5 66.3 35.2 24.6 50.3 60.9 70.2 70.8 52.6 72.1 78.0 71.4 54.5 40.2 83.5 35.7 49.8 53.4 41.7 83.6 71.5 81.4 175.2 87.9 54.5 66.9 122.4 193.8 80.4 196.7 173.0 343.1 145.0 326.9 194.9 70.0 211.3 200.0 204.2 168.4 111.5 269.0 198.7 39.5 46.4 66.9 112.6 199.6 129.9 85.0 66.3 140.3 296.6 138.5 221.3 121.6 160.1 74.0 140.4 101.0 137.0 96.3 83.5 109.4 78.7 172.6 308.1 114.0 59.5 113.3 135.8 76.0 82.3 92.2 230.9 177.5 165.3 80.3 120.6 171.5 170.1 273.4 79.1 160.9 145.4 63.2 108.6 85.0 256.8 79.0 86.6 66.9 73.0 47.1 29.4 55.1 36.8 33.5 32.3 34.2 47.6 31.4 32.4 29.8 137.3 47.5 48.1 24.0 38.8 74.6 75.8 76.8 76.0 88.1 76.8 81.6 80.8 77.4 79.5 78.0 83.5 81.4 37.5 16.0 23.4 36.2 26.6 44.1 28.3 58.8 33.0 18.9 28.0 31.1 45.4 20.0 31.3 22.0 6.2 77.2 28.6 27.8 39.2 50.5 7.8 21.7 38.4 36.7 18.6 26.9 19.6 32.1 104.0 37.7 23.9 31.9 38.7 25.8 28.9 14.5 187.3 8.4 21.7 27.2 20.3 47.4 33.0 12.1 42.0 52.3 28.4 7.5 50.6 32.5 27.8 13.6 32.3 74.8 25.1 65.1 29.4 51.7 37.5 36.6 26.5 19.7 46.0 18.9 65.6 13.9 25.6 37.2 42.3 108.8 25.0 42.3 27.9 44.4 TPI1 ENSG00000111669 "Triosephosphate isomerase 1" P60174 12 6867119-6870948 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Glycolysis" "Isomerase, Lyase" "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2470.8;tongue: 2005.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050924, HPA053568" Uncertain Approved Nucleoplasm,Vesicles NA NA 170000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Vesicles "HPA050924: AB_2681276, HPA053568: AB_2682193" "unprognostic (2.85e-1)" "unprognostic (5.58e-3)" "unprognostic (1.65e-1)" "unprognostic (1.62e-2)" "unprognostic (6.94e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (4.14e-3)" "unprognostic (7.49e-2)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (7.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" 340.4 588.6 446.2 269.7 480.2 334.8 274.5 476.5 541.9 314.1 446.9 425.6 421.0 240.5 220.2 764.4 248.2 216.8 819.8 481.0 462.0 609.0 536.1 308.6 253.9 459.2 460.4 269.9 238.1 496.4 236.8 287.2 467.2 272.1 435.3 625.0 377.6 273.3 2470.8 410.1 404.5 301.5 429.7 291.4 329.0 239.8 503.5 200.3 269.1 2005.8 410.4 363.8 440.6 454.4 1556.8 1350.5 706.1 1094.6 666.5 696.6 1236.3 1097.5 1184.9 1999.1 2407.5 1409.9 823.0 903.4 212.7 1069.7 1042.4 748.8 1671.0 1812.3 2189.4 1196.4 1265.1 1172.0 924.4 926.2 496.8 1351.5 924.0 764.0 739.7 1537.8 1305.0 2816.1 1233.3 451.0 615.0 336.5 1554.5 1130.0 709.6 1119.5 1741.0 1302.3 855.9 413.5 1156.1 930.7 1261.4 1061.1 497.2 830.0 953.3 977.8 542.7 1452.6 224.4 1003.2 778.2 1068.0 914.6 703.1 1631.7 653.4 285.7 1327.8 2153.1 821.2 784.9 1708.8 2304.1 2375.2 824.6 2402.3 845.7 863.3 820.0 808.0 2656.1 800.9 570.5 703.0 934.3 1387.7 2165.7 482.0 1106.3 4679.5 446.2 480.2 476.5 541.9 481.0 462.0 459.2 460.4 467.2 429.7 503.5 454.4 311.5 134.6 204.2 34.6 290.6 684.8 553.8 1756.4 414.9 284.6 294.3 303.3 552.5 391.7 673.0 389.9 110.5 1017.0 278.2 850.3 1508.5 1361.5 203.0 280.8 307.0 352.0 425.5 243.3 38.4 786.5 1824.0 386.5 408.3 343.9 362.8 364.8 276.6 547.3 937.3 297.8 33.7 567.2 1151.5 386.7 750.4 683.5 279.0 482.8 674.1 18.7 1129.8 739.6 312.0 17.1 26.7 1081.5 889.4 263.3 427.9 556.2 1595.9 1642.7 401.2 298.0 197.2 270.5 551.3 14.9 79.0 690.4 615.9 1530.4 352.9 869.2 827.0 652.5 TPRG1L "FAM79A, FLJ21811, RP11-46F15.3" ENSG00000158109 "Tumor protein p63 regulated 1 like" Q5T0D9 1 3625015-3630127 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063163, CAB079051" Supported Approved Vesicles,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 45: Intestine - Brush border" "Cluster 21: OE19 - Mitochondria" "Cluster 62: Horizontal cells - Visual perception" "Vesicles, Cytosol" "CAB079051: , HPA063163: AB_2684953" "unprognostic (1.92e-1)" "unprognostic (3.26e-3)" "unprognostic (4.46e-2)" "unprognostic (7.99e-2)" "unprognostic (4.50e-2)" "unprognostic (3.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (5.37e-2)" "unprognostic (1.50e-1)" "unprognostic (7.83e-3)" "prognostic favorable (1.76e-9)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" 45.7 37.3 80.3 21.4 84.6 35.4 36.5 58.7 92.7 39.5 56.9 49.4 50.1 36.5 40.7 56.8 48.1 37.7 52.5 87.7 81.1 65.6 85.5 34.4 27.4 80.3 74.7 49.0 38.1 38.4 47.0 24.0 83.9 33.3 46.4 49.8 39.9 47.0 67.6 54.7 54.4 35.7 62.9 30.2 40.5 18.7 80.3 25.0 43.5 70.0 38.5 41.7 39.8 76.9 31.3 22.0 13.3 23.9 98.1 67.8 12.2 45.4 62.4 41.3 27.2 41.5 27.9 11.5 39.6 62.5 22.2 48.1 16.1 42.0 34.7 36.7 25.7 16.0 24.4 48.4 59.4 23.6 18.3 51.3 60.7 34.2 34.7 50.2 59.0 19.7 11.6 39.8 58.3 14.3 17.1 24.2 17.9 71.5 50.9 14.2 19.8 27.8 42.5 32.3 37.1 36.6 24.3 49.8 50.6 30.2 31.2 20.3 67.7 34.5 10.2 79.3 13.1 35.9 49.8 13.0 20.4 51.2 4.6 20.7 3.6 5.6 5.9 2.9 7.6 4.9 6.7 6.0 3.2 6.2 6.2 7.2 18.9 3.2 3.1 8.9 4.1 3.8 80.3 84.6 58.7 92.7 87.7 81.1 80.3 74.7 83.9 62.9 80.3 76.9 21.1 16.0 17.8 9.4 9.3 12.0 10.1 9.2 6.8 50.4 15.6 16.9 39.7 12.8 8.8 11.0 8.4 10.6 23.0 69.8 11.7 18.0 3.0 30.1 13.3 16.8 19.2 11.0 12.8 35.4 12.3 20.3 11.7 19.5 8.2 8.2 28.2 61.4 15.7 126.2 10.1 29.2 20.3 18.6 9.7 4.1 18.6 12.8 7.2 2.8 14.0 71.3 20.6 4.5 6.6 33.8 27.4 21.4 9.7 10.8 62.3 37.6 22.9 38.0 6.6 16.3 19.9 7.0 12.8 21.0 18.9 9.2 12.9 21.8 28.4 9.4 TRAF3IP2 "ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522" ENSG00000056972 "TRAF3 interacting protein 2" O43734 6 111555381-111606906 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Inflammatory response, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 149.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA036352 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" Vesicles "HPA036352: AB_10672085" "unprognostic (1.94e-1)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-1)" "prognostic favorable (4.73e-5)" "unprognostic (2.81e-2)" "unprognostic (3.03e-2)" "unprognostic (1.01e-2)" "unprognostic (9.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.13e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (5.16e-5)" "unprognostic (1.11e-1)" "unprognostic (4.88e-1)" "unprognostic (2.34e-2)" "unprognostic (1.31e-1)" 19.7 16.3 24.8 19.5 24.8 32.4 19.9 24.3 29.4 24.9 23.7 34.0 28.6 36.2 47.2 26.5 34.7 14.2 8.3 24.4 26.0 9.3 8.6 17.5 16.3 27.2 28.2 13.9 21.6 13.6 9.3 14.2 25.6 19.2 26.4 5.9 25.3 30.8 11.4 35.0 25.1 22.1 21.7 6.8 35.5 3.0 28.7 21.0 14.8 14.8 22.5 26.5 18.1 22.9 32.2 11.0 6.8 15.7 35.9 39.0 15.6 39.8 62.2 9.9 14.1 8.7 14.1 6.2 13.2 33.5 35.5 58.2 8.0 86.2 18.4 43.2 11.6 12.7 10.6 11.9 13.9 6.9 22.6 47.1 57.5 29.9 110.1 24.9 20.0 15.2 13.6 1.9 13.2 22.0 51.2 19.4 9.0 30.6 8.8 53.3 12.4 2.7 29.5 52.4 27.3 6.9 12.1 71.8 47.8 12.7 31.6 18.0 9.2 19.2 7.6 149.7 35.5 0.8 12.4 16.8 45.8 10.8 50.1 25.8 2.5 5.3 3.8 0.8 12.7 6.4 7.6 5.6 2.6 8.6 7.6 7.4 3.5 5.7 0.3 0.8 17.9 3.1 24.8 24.8 24.3 29.4 24.4 26.0 27.2 28.2 25.6 21.7 28.7 22.9 24.7 3.2 13.8 26.1 10.8 30.1 61.5 46.3 11.4 7.5 8.3 8.6 4.9 7.2 21.6 3.7 12.5 19.3 3.8 30.0 5.9 35.4 0.1 20.9 14.5 18.3 13.2 5.2 5.9 31.9 28.8 14.4 18.3 32.7 20.2 7.7 3.9 5.5 6.0 6.7 10.8 16.9 16.2 1.3 10.7 0.5 7.2 5.8 12.4 7.5 6.2 14.2 8.2 19.6 6.6 20.2 26.3 7.5 4.5 42.9 18.5 5.9 18.3 5.5 0.0 14.7 10.5 0.8 2.1 16.2 24.6 20.9 7.9 4.6 21.9 45.0 TRAF7 "DKFZp586I021, MGC7807, RFWD1, RNF119" ENSG00000131653 "TNF receptor associated factor 7" Q6Q0C0 16 2155698-2178129 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041229 Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Vesicles "Plasma membrane" "HPA041229: AB_10794194" "unprognostic (1.94e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (2.77e-3)" "unprognostic (7.08e-2)" "unprognostic (3.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (9.23e-2)" "unprognostic (6.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.43e-1)" "unprognostic (8.48e-2)" 29.1 29.4 16.5 24.4 15.1 35.0 28.2 18.2 23.0 32.1 17.0 38.0 40.0 31.2 11.6 54.6 30.4 22.2 21.3 17.9 14.6 28.1 51.5 33.2 22.9 17.8 15.3 23.5 37.4 14.6 32.1 20.6 14.8 27.0 17.4 8.5 34.7 16.5 30.4 47.7 35.2 18.8 14.2 34.5 35.6 14.8 17.7 19.1 25.6 9.9 18.6 34.5 34.8 14.3 57.7 72.2 40.3 72.5 40.8 76.5 47.4 43.4 53.9 49.9 44.6 88.2 72.1 36.6 50.2 55.4 31.8 65.9 38.1 76.8 18.8 58.3 48.8 52.4 98.5 68.3 53.8 56.3 72.7 76.2 62.8 48.1 62.6 41.0 97.4 70.6 57.1 47.9 48.2 131.1 58.3 65.2 79.7 78.7 34.8 107.4 66.7 74.2 40.2 30.4 80.9 67.2 36.3 68.5 48.6 20.9 78.1 68.2 74.3 60.2 83.9 56.7 48.2 69.2 55.0 48.4 34.4 35.9 47.8 4.0 9.1 7.3 4.5 12.4 4.3 5.5 4.4 4.7 11.2 3.9 3.1 3.8 6.2 2.9 8.9 5.3 6.5 5.3 16.5 15.1 18.2 23.0 17.9 14.6 17.8 15.3 14.8 14.2 17.7 14.3 18.9 0.0 9.2 12.4 18.2 28.8 21.1 34.2 22.8 15.9 31.6 27.9 4.9 21.5 20.8 14.7 6.2 23.5 17.4 56.4 17.6 39.0 5.0 23.6 34.6 26.5 34.0 33.6 8.9 59.0 36.3 19.0 38.7 27.9 9.5 22.1 26.0 32.3 42.2 37.0 8.2 38.7 34.6 41.8 21.3 13.1 24.8 26.8 10.6 8.4 33.9 12.6 6.2 6.6 4.9 53.0 43.6 22.2 24.0 33.8 80.0 29.2 19.7 10.9 6.6 11.9 18.3 8.5 25.3 50.7 32.5 26.7 16.0 29.0 42.5 38.5 TRAPPC11 "C4orf41, FLJ12716, foigr, gry" ENSG00000168538 "Trafficking protein particle complex 11" Q7Z392 4 183659267-183713594 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038173 Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol Vesicles "HPA038173: " "unprognostic (2.24e-1)" "unprognostic (6.03e-2)" "unprognostic (9.92e-3)" "unprognostic (1.31e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.14e-2)" "unprognostic (6.24e-2)" "unprognostic (2.63e-1)" "unprognostic (6.50e-2)" "unprognostic (5.78e-2)" "unprognostic (2.17e-1)" "prognostic favorable (2.66e-5)" "unprognostic (6.59e-2)" "unprognostic (1.59e-1)" "unprognostic (2.25e-2)" "unprognostic (3.92e-2)" 12.1 15.9 4.3 13.4 5.5 11.4 15.5 8.3 6.4 12.4 15.4 13.2 11.0 14.1 11.8 13.8 12.4 11.0 12.4 5.5 4.8 14.8 16.9 13.6 14.9 3.4 4.1 20.8 14.2 19.1 6.8 13.8 3.7 14.1 15.0 13.8 14.8 12.1 15.1 12.1 11.7 15.7 4.4 14.2 13.5 16.0 4.9 17.8 14.8 18.7 17.6 13.6 8.0 6.0 15.1 14.4 23.2 23.1 28.5 31.3 17.6 21.6 21.7 17.8 16.2 9.0 19.1 20.7 6.0 21.8 13.9 10.8 21.2 20.5 20.4 23.1 9.3 26.0 12.0 12.8 26.2 28.3 24.8 24.2 21.5 17.8 20.6 23.2 26.5 23.9 21.1 41.8 22.5 10.8 34.1 13.8 8.7 10.2 10.7 23.4 13.8 15.8 22.8 15.3 15.6 20.7 21.1 21.6 21.4 20.5 16.6 31.0 26.7 10.1 11.9 9.7 12.4 21.8 12.7 12.4 20.6 18.7 18.0 3.8 12.9 8.2 5.7 14.9 7.6 4.7 6.2 6.1 12.8 3.4 5.7 5.9 3.7 10.0 25.6 3.3 5.4 7.6 4.3 5.5 8.3 6.4 5.5 4.8 3.4 4.1 3.7 4.4 4.9 6.0 9.5 3.2 14.5 33.0 12.3 4.5 3.1 7.4 9.1 11.0 5.7 6.2 14.8 8.6 9.1 7.3 8.4 7.9 10.0 9.8 3.9 7.4 57.7 8.2 13.3 9.1 13.1 12.0 47.5 9.3 8.4 12.0 12.2 8.0 7.6 18.7 9.3 8.5 11.6 8.4 47.4 7.2 0.0 16.0 6.8 7.3 13.4 16.1 3.6 30.0 19.5 6.4 11.3 37.2 35.2 9.0 7.1 11.3 10.6 5.5 11.7 4.6 12.9 13.6 0.0 9.9 8.6 7.7 14.9 10.4 6.1 7.0 9.4 12.4 7.9 5.9 TRAPPC2L HSPC176 ENSG00000167515 "Trafficking protein particle complex 2 like" Q9UL33 16 88856220-88862686 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 403.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041714 Approved Supported Vesicles,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Vesicles, Cytosol" "HPA041714: AB_10793930" "unprognostic (1.27e-2)" "unprognostic (2.32e-3)" "unprognostic (1.46e-1)" "prognostic favorable (3.75e-4)" "unprognostic (2.77e-1)" "unprognostic (2.69e-1)" "unprognostic (5.24e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-1)" "unprognostic (6.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.81e-1)" "unprognostic (1.02e-2)" "unprognostic (1.18e-1)" "unprognostic (1.00e-1)" "unprognostic (5.81e-2)" "unprognostic (1.94e-2)" 55.4 134.3 55.1 30.9 56.7 36.9 51.5 57.4 69.8 49.1 55.2 46.0 25.3 46.7 60.3 53.8 44.1 19.9 66.4 57.8 61.9 53.5 46.5 42.7 31.1 57.5 57.9 55.8 48.8 58.1 45.3 20.4 59.1 39.2 23.8 25.6 48.0 20.5 96.8 58.5 39.1 18.1 60.0 52.7 62.8 122.0 56.9 50.0 41.8 70.7 27.2 48.5 47.3 65.4 69.9 47.9 79.6 60.8 58.5 73.9 81.5 61.5 69.4 92.6 35.4 133.6 89.6 53.4 105.8 78.6 97.7 73.3 109.5 88.5 67.0 46.9 65.7 35.3 46.1 172.7 86.3 101.4 27.5 72.2 54.7 125.4 63.1 52.4 75.7 118.7 108.2 41.4 64.3 216.2 136.1 311.7 80.3 133.4 88.6 128.9 65.9 55.4 73.1 79.6 85.8 42.2 207.6 63.5 59.0 43.6 162.5 106.3 60.3 61.1 66.7 81.1 71.2 57.9 106.6 254.5 73.3 148.0 74.5 39.2 136.3 40.8 113.0 114.5 115.0 154.2 129.8 124.1 135.1 137.9 120.8 103.5 23.9 94.6 114.8 162.5 178.0 162.9 55.1 56.7 57.4 69.8 57.8 61.9 57.5 57.9 59.1 60.0 56.9 65.4 66.2 57.7 82.0 2.3 58.7 51.9 57.4 115.4 43.3 34.9 80.1 106.3 121.1 92.9 81.1 53.3 10.4 93.8 58.2 75.3 240.7 134.7 219.1 60.9 53.4 60.7 62.1 42.1 4.0 154.8 141.5 79.2 72.9 50.5 36.1 55.9 62.8 123.9 226.7 15.2 5.1 78.5 75.3 91.0 69.6 403.2 74.0 68.4 81.8 1.9 134.4 87.3 79.3 2.5 13.0 137.4 76.3 58.3 92.6 45.3 122.5 271.7 93.5 39.5 59.2 44.1 94.7 210.7 123.1 86.0 64.9 77.6 61.2 64.6 86.8 62.5 TRAPPC3L "bA259P20.2, BET3L, FLJ11180" ENSG00000173626 "Trafficking protein particle complex 3 like" Q5T215 6 116494989-116545684 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.1" "Cell type enhanced" "Detected in some" "Adipocytes: 1.6;Early spermatids: 1.8;Endothelial cells: 1.5;Hepatic stellate cells: 6.1;Kupffer cells: 4.2;Macrophages: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA060912 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 6: Brain - Smell perception" "Cluster 2: Karpas-707 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Vesicles" "HPA060912: " "unprognostic (1.34e-1)" "unprognostic (7.24e-2)" "unprognostic (1.93e-2)" "unprognostic (2.91e-1)" "unprognostic (5.25e-2)" "unprognostic (1.15e-2)" "unprognostic (8.98e-2)" "unprognostic (9.09e-4)" "unprognostic (8.41e-2)" "unprognostic (3.23e-2)" "unprognostic (1.96e-1)" "unprognostic (2.91e-3)" "unprognostic (2.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "unprognostic (8.11e-2)" "unprognostic (7.47e-3)" 0.7 0.7 1.6 0.8 1.7 3.7 1.0 8.1 5.0 0.4 0.3 0.7 1.0 1.2 1.8 0.7 0.5 1.1 0.9 2.3 0.0 0.7 1.4 1.2 1.7 0.6 0.1 1.0 0.7 3.0 0.0 3.9 1.6 0.7 0.5 4.2 1.2 0.7 1.2 2.3 1.0 0.4 0.1 4.7 1.1 1.5 0.7 0.5 1.8 0.2 0.6 0.5 0.0 3.9 0.8 0.4 1.0 1.5 0.3 1.0 1.1 0.5 0.5 0.4 0.5 0.5 0.7 1.3 0.6 0.2 0.8 1.0 0.3 0.6 0.5 0.6 0.6 1.4 1.9 0.6 0.5 0.9 0.6 0.4 0.3 0.2 0.3 1.5 0.8 1.0 0.8 6.6 0.3 1.5 0.9 1.0 0.9 0.3 0.6 0.8 0.7 2.2 0.7 1.3 1.0 0.7 0.8 0.4 0.5 1.2 0.7 0.8 1.0 1.2 0.9 1.2 0.6 1.2 0.8 0.8 0.8 0.9 0.7 0.6 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.3 0.1 2.8 1.6 1.7 8.1 5.0 2.3 0.0 0.6 0.1 1.6 0.1 0.7 3.9 1.6 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.5 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 6.1 0.1 1.1 0.0 0.1 0.0 0.0 4.2 0.0 0.4 0.3 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 TREH "MGC129621, TRE, TREA" ENSG00000118094 Trehalase O43280 11 118657316-118679690 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 66.3" "Group enriched" "Detected in some" 5 "Late spermatids: 315.7;Proximal enterocytes: 186.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039913, HPA042045" Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 12000000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 45: Enterocytes - Digestion" Cytosol Vesicles "HPA039913: AB_10674988, HPA042045: AB_2677817" "unprognostic (1.29e-1)" "unprognostic (1.58e-1)" "unprognostic (1.01e-2)" "unprognostic (5.22e-4)" "unprognostic (2.52e-1)" "unprognostic (9.83e-2)" "prognostic favorable (3.76e-4)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (2.42e-1)" "unprognostic (1.04e-1)" "unprognostic (1.63e-2)" "prognostic favorable (2.33e-6)" "unprognostic (2.09e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-1)" 0.7 0.2 1.6 0.3 3.7 0.0 0.4 0.6 3.8 0.3 0.0 1.6 60.0 0.4 0.6 1.6 0.3 2.6 1.0 1.1 2.7 13.4 6.1 0.2 0.1 2.1 2.0 0.2 1.8 0.0 0.3 0.1 1.9 0.5 1.3 0.0 0.2 0.0 0.0 0.1 66.3 0.1 0.6 0.1 1.7 1.8 2.5 0.0 0.4 0.0 0.0 0.4 0.3 6.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.7 0.6 3.8 1.1 2.7 2.1 2.0 1.9 0.6 2.5 6.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.3 0.3 1.5 0.0 1.8 0.0 0.1 0.0 2.3 7.9 0.2 45.6 0.8 1.6 0.1 3.0 0.0 0.1 2.5 0.0 0.3 4.6 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 7.0 0.0 0.0 0.4 315.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 5.3 0.9 6.3 1.9 0.1 0.3 186.3 32.8 0.0 0.0 0.0 0.3 0.2 1.7 0.8 2.1 0.0 0.0 0.1 0.0 3.7 0.0 TRIM33 "FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA" ENSG00000197323 "Tripartite motif containing 33" Q9UPN9 1 114392790-114511203 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 237.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 13.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 115.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004345 Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Vesicles Nucleoplasm "HPA004345: AB_1858287" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "prognostic favorable (6.20e-4)" "unprognostic (1.09e-2)" "unprognostic (8.42e-3)" "prognostic favorable (8.93e-4)" "unprognostic (1.34e-2)" "unprognostic (1.83e-1)" "unprognostic (6.75e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-2)" "unprognostic (4.84e-2)" "unprognostic (1.99e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" 9.3 8.1 10.1 10.7 11.3 25.4 13.5 18.3 16.9 12.5 8.2 9.5 8.8 15.2 29.8 11.7 9.1 10.9 8.9 11.5 9.9 13.5 12.2 10.9 13.3 8.0 9.1 14.4 12.2 15.3 7.3 16.0 8.2 12.6 10.1 18.8 10.7 11.0 8.8 14.8 8.9 11.8 8.1 12.7 11.2 25.3 9.5 17.8 14.2 10.7 12.8 11.5 9.8 11.3 30.9 16.3 30.1 22.6 12.5 13.1 51.0 15.4 16.3 20.9 22.1 18.5 12.8 32.8 15.5 18.1 13.6 17.4 27.6 18.0 28.6 24.9 16.4 31.6 21.7 21.6 13.8 40.3 25.3 12.5 12.9 24.9 25.2 16.0 17.8 27.3 40.1 22.5 20.2 115.4 40.9 17.0 40.7 11.7 16.3 34.8 45.9 10.8 14.9 47.7 20.8 21.9 29.2 34.7 27.4 19.3 15.8 21.7 20.1 14.5 23.4 33.8 21.7 15.7 15.6 33.4 20.4 23.0 42.0 13.2 1.2 6.1 2.5 1.5 2.2 3.0 2.6 2.7 1.5 1.4 2.0 3.1 3.6 4.1 2.4 3.0 1.6 0.8 10.1 11.3 18.3 16.9 11.5 9.9 8.0 9.1 8.2 8.1 9.5 11.3 31.0 19.2 33.3 70.5 35.4 52.8 28.9 28.6 25.6 75.6 35.9 23.9 29.2 30.0 32.3 55.2 98.0 64.9 53.9 33.3 1.9 21.0 237.3 50.4 37.5 33.2 52.1 37.9 120.7 23.6 34.0 28.7 30.1 90.0 37.4 55.6 40.7 44.3 29.6 26.9 108.5 30.4 30.5 50.3 47.9 97.9 49.0 37.2 19.6 79.6 42.9 31.5 54.6 116.6 101.8 31.4 34.9 36.9 31.6 47.3 26.6 17.3 31.4 58.3 32.9 38.3 32.5 60.0 31.9 31.2 55.4 87.7 42.8 48.1 31.2 55.3 TRIM44 "DIPB, MC7" ENSG00000166326 "Tripartite motif containing 44" Q96DX7 11 35662775-35818007 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049053, HPA057633" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles "Plasma membrane" "HPA049053: AB_2680613, HPA057633: AB_2683484" "unprognostic (2.73e-1)" "unprognostic (2.74e-1)" "unprognostic (1.37e-1)" "unprognostic (5.53e-2)" "unprognostic (3.91e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (9.06e-2)" "unprognostic (5.29e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (8.57e-2)" "unprognostic (1.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-1)" 12.6 10.7 16.9 12.3 16.4 6.0 11.1 18.5 21.9 10.9 8.3 13.5 10.6 10.9 10.2 9.1 11.1 11.6 11.6 16.6 17.0 18.0 14.4 11.9 12.8 16.0 16.7 10.3 15.5 11.1 7.9 13.3 16.1 10.4 11.1 27.0 9.4 11.4 11.5 8.3 12.0 12.2 17.8 14.1 11.3 6.7 17.3 12.1 14.9 9.8 13.2 11.1 8.6 19.0 20.1 16.9 26.4 12.3 19.6 29.6 0.1 18.5 21.9 22.7 20.6 19.7 13.3 26.7 17.1 24.3 25.7 15.4 9.1 21.1 25.4 17.6 17.4 28.7 23.0 11.4 26.0 22.7 23.7 22.4 23.2 13.3 36.0 25.1 24.3 9.2 45.4 9.3 24.1 12.1 24.1 11.1 14.9 4.2 14.5 16.6 68.4 14.5 21.0 26.9 18.1 15.5 27.7 19.6 21.0 14.3 29.5 19.0 27.4 28.9 23.8 16.6 21.2 15.7 15.0 0.1 23.9 23.7 22.2 0.2 0.9 0.3 0.9 1.2 0.8 1.1 0.9 0.9 0.8 1.5 1.1 1.2 0.0 1.2 1.5 1.8 0.3 0.5 16.9 16.4 18.5 21.9 16.6 17.0 16.0 16.7 16.1 17.8 17.3 19.0 67.5 60.9 72.6 78.4 68.5 26.8 57.9 19.8 74.0 221.5 45.3 38.2 58.9 55.8 45.6 25.8 204.3 55.4 72.1 70.3 33.2 62.8 18.8 78.0 74.0 62.4 51.4 39.3 151.7 71.1 25.9 49.4 74.9 54.4 58.9 107.1 49.2 53.3 42.7 84.1 134.5 57.6 16.2 65.7 37.8 13.4 36.1 70.3 19.6 84.3 76.9 72.2 72.1 121.7 171.0 53.3 50.4 37.2 59.6 90.3 50.9 75.6 48.4 173.4 98.6 71.9 52.1 88.2 81.5 46.1 26.7 52.1 47.0 58.5 54.5 59.9 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 112 "basophil: 11.2" "Lineage enriched" "Detected in single" 112 "granulocytes: 11.2" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 61.3" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM51GP ENSG00000220948 "Tripartite motif-containing 51G, pseudogene" 11 48975324-48983826 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.1" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 33: SK-MEL-30 - Melanocyte processes" Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM62 "DEAR1, FLJ10759" ENSG00000116525 "Tripartite motif containing 62" Q9BVG3 1 33145399-33182059 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.0" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "AF22: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050061 Approved "Vesicles,Focal adhesion sites" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 68: Oligodendrocytes - Mixed function" "Vesicles, Focal adhesion sites" "HPA050061: AB_2681001" "unprognostic (1.57e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (2.62e-2)" "unprognostic (1.14e-2)" "unprognostic (5.80e-2)" "unprognostic (5.10e-5)" "unprognostic (2.05e-2)" "unprognostic (1.14e-1)" "unprognostic (4.32e-2)" "unprognostic (3.55e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (2.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (2.05e-3)" 3.1 6.6 8.7 2.9 13.1 4.8 3.6 10.0 11.9 3.2 2.3 3.2 2.4 3.1 2.6 5.1 3.0 2.0 3.5 8.5 10.4 3.5 1.8 3.1 4.6 10.7 11.3 3.7 3.1 2.9 6.4 3.4 12.1 5.1 2.1 2.1 5.2 2.9 4.9 12.5 4.2 2.8 7.4 5.1 4.3 2.3 12.4 5.2 3.9 2.5 4.5 4.8 4.4 21.0 3.7 2.7 23.9 3.9 5.7 2.5 7.6 3.4 9.9 6.3 5.5 3.0 3.7 5.9 3.8 3.0 3.2 7.2 5.0 4.3 5.6 5.8 3.8 6.5 3.2 2.5 5.7 2.2 16.2 5.2 3.9 8.7 2.0 9.9 6.3 5.0 1.1 3.8 6.1 9.9 6.8 2.0 6.0 4.3 3.5 8.6 12.8 2.7 3.8 9.6 6.0 3.7 3.8 14.5 16.8 12.6 4.1 1.4 6.3 2.7 3.8 8.1 2.8 6.9 3.3 2.7 5.1 3.9 3.5 1.2 1.0 3.4 1.3 1.8 2.3 1.1 1.9 1.8 0.9 1.4 1.3 1.2 2.3 1.0 1.1 0.4 4.7 1.1 8.7 13.1 10.0 11.9 8.5 10.4 10.7 11.3 12.1 7.4 12.4 21.0 2.0 3.2 2.2 2.6 1.8 2.7 0.8 1.7 2.8 3.4 3.5 1.9 0.9 0.0 1.2 1.8 0.0 1.1 2.5 1.5 0.0 1.4 0.5 0.6 1.1 1.4 1.8 0.4 1.9 1.9 1.8 2.1 4.1 1.3 1.3 1.7 1.1 0.7 1.2 10.1 10.2 1.5 4.1 1.2 1.6 0.5 2.5 1.3 0.0 10.3 1.4 1.5 3.1 50.8 26.0 2.6 0.6 4.9 2.6 2.1 1.2 1.0 0.4 1.0 6.6 2.0 2.1 1.3 0.6 2.8 4.7 1.4 3.0 3.4 0.9 2.0 TRIM72 MG53 ENSG00000177238 "Tripartite motif containing 72" Q6ZMU5 16 31214091-31231537 "Predicted intracellular proteins, Transporters" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 151.8;tongue: 43.0" "Cell type enriched" "Detected in many" 5 "Skeletal myocytes: 45.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 0.9" "Region enriched" "Detected in many" 7 "cerebellum: 9.3" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 7.2;LHCN-M2: 12.6;RH-30: 29.7;U-266/70: 17.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054909 Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Vesicles Nucleoplasm "HPA054909: AB_2682639" "unprognostic (2.61e-1)" "unprognostic (3.21e-3)" "unprognostic (5.07e-2)" "unprognostic (9.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.13e-1)" "unprognostic (2.01e-3)" "unprognostic (2.80e-1)" "unprognostic (6.57e-2)" "unprognostic (4.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.49e-2)" "unprognostic (2.24e-10)" "unprognostic (7.70e-2)" "unprognostic (6.72e-2)" "unprognostic (4.15e-1)" "unprognostic (4.30e-4)" 0.2 0.2 0.9 0.2 0.8 0.8 0.2 9.3 1.0 0.1 0.5 0.2 0.2 0.2 0.3 1.0 0.1 0.2 0.8 0.7 0.4 0.1 0.1 0.2 0.3 1.0 0.5 0.2 0.3 0.1 0.0 0.2 1.3 1.9 0.1 0.8 2.5 0.1 151.8 0.5 0.2 0.1 0.1 0.3 0.3 0.3 0.5 0.1 0.2 43.0 0.2 0.1 0.0 1.2 0.1 0.1 0.2 0.4 0.2 0.1 0.3 0.3 0.1 0.0 0.0 0.2 0.4 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.3 0.1 0.2 0.7 0.2 0.2 7.2 0.3 1.2 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.8 12.6 0.1 0.1 0.5 0.2 0.2 0.2 0.3 29.7 4.1 0.0 0.2 2.6 0.2 0.1 0.3 0.1 0.3 0.2 2.6 0.1 0.2 0.2 0.2 0.1 17.9 1.7 0.2 0.2 0.4 0.2 1.9 0.3 0.5 0.3 0.3 0.3 0.4 0.3 0.2 0.3 0.6 0.4 0.3 1.5 0.6 0.4 0.6 0.2 0.1 0.9 0.8 9.3 1.0 0.7 0.4 1.0 0.5 1.3 0.1 0.5 1.2 4.7 3.2 3.8 0.0 0.8 0.1 3.1 0.0 0.0 1.0 3.1 8.0 3.0 0.0 2.5 0.0 2.1 0.3 2.4 0.0 0.0 0.0 0.3 1.5 4.7 1.5 0.0 0.0 0.2 0.0 0.3 2.5 0.0 4.0 1.3 0.8 0.4 0.0 0.2 0.0 0.1 0.2 0.0 1.2 0.3 0.0 0.0 3.1 0.0 0.0 0.6 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.1 0.1 0.0 0.9 0.0 45.6 2.2 0.1 0.2 0.8 0.3 0.1 2.2 1.2 0.9 1.5 TRIO ARHGEF23 ENSG00000038382 "Trio Rho guanine nucleotide exchange factor" O75962 5 14143342-14532128 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 205.7;Excitatory neurons: 400.9;Inhibitory neurons: 443.4;Microglial cells: 308.2;Oligodendrocyte precursor cells: 476.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 215.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008157, HPA064664" Supported Approved Vesicles,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Vesicles "HPA008157: AB_1858327, HPA064664: AB_2685315" "unprognostic (6.65e-2)" "unprognostic (4.21e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.39e-2)" "unprognostic (4.13e-1)" "unprognostic (2.18e-3)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (2.02e-1)" "unprognostic (1.82e-1)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.78e-2)" "unprognostic (1.96e-1)" "unprognostic (4.58e-3)" "unprognostic (2.23e-1)" 35.3 20.5 31.7 11.6 33.3 5.5 31.8 32.2 38.6 23.4 34.5 36.6 6.8 38.9 15.5 14.5 21.2 18.8 31.9 37.2 33.6 24.9 22.1 25.7 10.2 28.1 28.1 52.8 20.6 9.1 28.9 11.6 26.6 28.2 13.6 10.2 17.4 11.1 20.9 18.7 27.8 19.2 26.4 38.9 22.9 17.2 31.4 13.3 17.0 17.4 10.6 27.1 20.5 27.2 43.7 15.9 37.2 18.0 78.6 101.0 41.3 40.4 49.2 32.6 36.9 10.3 17.4 10.4 28.0 56.6 79.6 13.0 6.5 19.4 66.6 25.8 8.0 5.5 46.1 13.2 40.0 13.9 14.8 47.6 19.9 114.4 36.4 30.3 28.8 6.8 1.4 6.8 78.7 8.3 0.1 9.5 9.3 4.8 13.7 9.9 22.9 34.2 31.6 20.5 17.1 67.5 34.3 9.0 18.9 47.1 5.3 2.0 66.4 61.4 38.3 44.7 48.4 0.3 2.2 12.9 215.1 8.8 14.8 0.1 0.5 0.0 0.0 0.7 0.1 0.7 0.0 0.0 0.5 1.8 0.0 0.0 0.0 1.6 0.6 1.1 0.3 0.1 31.7 33.3 32.2 38.6 37.2 33.6 28.1 28.1 26.6 26.4 31.4 27.2 33.0 19.2 25.9 205.7 16.6 16.4 13.0 15.6 17.1 30.5 21.9 15.0 19.3 10.0 21.0 11.0 14.6 9.7 5.6 24.8 0.0 21.2 2.9 11.7 24.8 28.7 18.0 6.5 400.9 14.2 22.0 38.9 7.7 34.2 17.7 17.2 14.6 17.1 14.2 28.6 443.4 20.6 14.2 15.4 22.1 6.6 78.6 20.2 5.4 308.2 12.1 7.3 2.1 476.5 80.4 38.5 14.9 42.9 29.2 52.8 9.2 5.4 18.3 2.7 6.6 27.5 20.0 3.5 6.2 7.2 13.8 8.2 3.8 11.7 19.4 20.3 TRIP10 "CIP4, HSTP, STOT, STP" ENSG00000125733 "Thyroid hormone receptor interactor 10" Q15642 19 6737925-6751530 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 362.8" "Cell type enhanced" "Detected in many" "monocytes: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 26.4" "Lineage enriched" "Detected in many" 10 "dendritic cells: 26.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041934, HPA072625, HPA073886" Approved Supported Nucleoplasm,Vesicles NA NA 24000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 59: Non-specific - Translation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 3: Monocytes - Immune response regulation" Vesicles Nucleoplasm "HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244" "unprognostic (5.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.19e-2)" "unprognostic (6.57e-2)" "prognostic favorable (1.76e-4)" "unprognostic (6.73e-3)" "unprognostic (1.10e-3)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (7.87e-3)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.14e-2)" "unprognostic (1.42e-1)" "unprognostic (8.93e-2)" "unprognostic (8.83e-2)" 110.7 60.3 15.5 25.5 15.6 8.6 92.3 15.3 17.8 123.9 18.6 112.1 30.5 66.5 17.5 253.3 80.1 27.6 125.7 14.6 16.7 81.7 27.0 115.4 14.5 17.5 16.5 99.4 44.7 18.6 22.4 48.6 16.0 80.4 19.9 16.9 85.4 45.0 362.8 57.8 56.0 26.4 15.8 40.0 58.6 29.9 17.5 9.6 75.5 177.3 21.9 86.7 147.4 14.8 83.5 49.7 17.1 25.8 64.7 67.9 61.1 52.5 60.0 58.8 51.1 67.8 46.7 1.8 69.2 44.6 47.6 60.2 38.8 76.5 34.7 52.5 15.5 27.0 48.4 52.3 53.4 1.4 8.3 79.0 50.9 52.5 39.8 77.2 61.2 3.7 40.2 22.1 43.7 28.3 7.5 18.7 36.3 51.9 41.7 12.2 35.1 24.5 50.0 40.9 0.1 19.6 69.1 30.7 20.0 39.4 32.2 14.7 120.5 39.3 70.4 103.8 56.4 23.1 13.4 8.4 63.6 7.9 26.2 0.0 0.8 0.0 0.6 0.1 0.9 1.5 0.3 1.1 5.2 1.7 0.3 0.2 0.1 2.5 0.1 26.4 0.0 0.5 15.5 15.6 15.3 17.8 14.6 16.7 17.5 16.5 16.0 15.8 17.5 14.8 43.0 28.9 19.8 6.5 5.6 85.4 104.9 76.9 43.9 14.7 28.3 16.6 8.7 20.0 66.9 16.5 37.5 9.9 16.5 39.1 5.9 45.0 16.4 30.3 32.1 43.1 7.7 4.4 0.1 38.0 37.9 66.3 10.7 55.7 29.7 8.8 38.9 3.7 9.6 0.0 0.2 16.3 24.4 6.7 90.4 13.6 55.9 19.6 37.4 3.7 196.9 12.5 0.0 5.5 0.4 91.5 24.7 36.1 9.0 116.6 25.8 23.8 24.8 18.5 32.9 26.4 46.4 5.7 6.9 51.3 83.3 14.2 7.4 24.5 25.9 120.7 TSLP ENSG00000145777 "Thymic stromal lymphopoietin" Q969D9 5 111070062-111078026 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.5;urinary bladder: 12.0" "Group enriched" "Detected in many" 4 "Basal respiratory cells: 108.1;Basal squamous epithelial cells: 338.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.0;HHSteC: 17.1;hTCEpi: 10.3;hTEC/SVTERT24-B: 18.9;hTERT-HME1: 12.5;hTERT-RPE1: 38.6;U-87 MG: 14.1" "Not detected" "Not detected" HPA056350 Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 38400 "Cluster 85: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Vesicles" "HPA056350: " "unprognostic (6.47e-4)" "unprognostic (3.26e-1)" "unprognostic (6.57e-2)" "unprognostic (1.93e-1)" "unprognostic (5.03e-2)" "unprognostic (7.72e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-2)" "unprognostic (5.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-1)" "unprognostic (1.88e-1)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (2.76e-1)" "unprognostic (1.74e-3)" 1.6 0.7 0.3 1.3 0.3 0.0 1.5 0.3 0.5 1.4 0.2 1.1 0.7 0.8 0.3 3.8 0.6 8.8 4.3 0.3 0.3 1.2 11.5 1.9 0.4 0.4 0.3 0.3 0.3 0.4 0.4 0.1 0.4 6.2 0.9 0.0 1.2 4.0 1.4 0.8 1.0 0.6 0.3 0.4 1.2 4.8 1.1 0.2 2.7 1.4 0.5 12.0 1.9 0.4 0.0 0.0 0.0 1.8 2.3 15.0 0.0 0.0 2.3 0.4 2.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 1.5 0.5 0.8 0.0 2.4 2.8 0.1 0.0 17.1 0.5 0.0 0.3 10.3 18.9 12.5 38.6 0.0 6.6 0.3 0.0 3.2 0.0 2.5 0.0 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.9 0.0 0.0 4.1 0.0 0.0 14.1 0.3 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.3 0.4 0.3 0.4 0.3 1.1 0.4 6.2 0.0 3.1 0.3 0.1 55.8 26.6 108.1 338.6 0.0 6.5 8.0 7.4 0.0 35.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 38.5 0.1 0.9 10.5 0.0 0.0 0.0 0.0 0.1 10.0 0.0 0.1 0.0 0.9 7.9 9.4 0.2 0.0 0.0 0.0 24.4 1.2 5.0 26.3 0.6 0.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 24.7 0.2 1.6 3.5 0.0 0.0 6.9 3.8 0.4 0.9 38.0 25.1 0.0 0.8 1.9 0.1 3.1 TSPAN1 "NET-1, TSPAN-1" ENSG00000117472 "Tetraspanin 1" O60635 1 46175073-46185962 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 593.8;kidney: 244.3" "Cell type enhanced" "Detected in many" "Club cells: 723.5;Distal enterocytes: 1983.8;Late spermatids: 838.1;Paneth cells: 1127.7;Respiratory ciliated cells: 1817.6" "Cancer enhanced" "Detected in all" "prostate cancer: 455.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 57 "plasmacytoid DC: 5.6" "Lineage enriched" "Detected in single" 57 "dendritic cells: 5.6" "Cell line enhanced" "Detected in many" "A-431: 129.6;CAPAN-2: 216.7;HaCaT: 151.4;hTCEpi: 173.6;OE19: 257.9;RPTEC TERT1: 628.4;RT4: 308.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA011909 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Vesicles" "HPA011909: AB_2668565" "unprognostic (1.21e-1)" "unprognostic (3.11e-1)" "unprognostic (3.67e-2)" "unprognostic (4.12e-1)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.28e-6)" "unprognostic (5.90e-2)" "unprognostic (2.61e-1)" "unprognostic (4.90e-2)" "unprognostic (4.30e-2)" 1.9 4.3 0.5 53.2 0.7 0.0 6.2 1.7 1.1 78.2 1.4 523.3 25.4 17.7 34.7 5.5 122.4 28.9 0.9 0.5 0.5 244.3 3.9 32.1 0.4 1.2 0.6 0.4 3.1 72.0 17.3 1.1 1.1 194.7 593.8 0.0 101.0 65.9 0.8 2.5 96.7 20.8 1.0 0.7 213.1 27.3 0.6 1.9 121.9 0.1 4.9 104.9 9.9 1.8 129.6 2.0 0.0 0.0 0.2 0.0 1.8 0.1 2.7 0.1 0.0 0.0 216.7 0.0 40.2 0.3 0.2 151.4 0.0 111.2 0.1 0.0 0.0 0.0 1.1 7.6 0.0 0.0 0.2 0.0 173.6 0.7 60.9 3.6 0.3 1.3 0.0 0.0 1.6 4.9 0.0 0.5 0.1 257.9 8.1 0.1 0.1 1.6 628.4 308.2 1.9 0.0 0.3 13.0 0.5 0.5 9.0 0.1 1.4 0.0 0.7 0.4 0.7 1.5 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.5 0.7 1.7 1.1 0.5 0.5 1.2 0.6 1.1 1.0 0.6 1.8 2.5 25.6 29.5 0.3 7.4 1.0 194.4 499.9 4.0 0.0 14.5 11.0 0.7 11.5 723.5 579.4 0.0 0.3 0.2 1983.8 46.9 61.3 141.3 268.3 14.1 4.5 201.8 0.0 1.2 525.1 0.1 6.0 223.3 144.3 11.4 0.0 1.4 3.6 0.3 0.0 1.3 648.1 242.1 0.3 0.3 838.1 5.0 5.3 5.4 1.0 1.6 0.0 0.0 0.5 1.6 484.4 1127.7 1.9 0.7 211.7 505.4 477.8 1817.6 0.0 0.0 0.4 54.1 4.7 2.6 2.9 1.3 0.0 7.4 0.0 275.9 517.0 TSPAN12 "NET-2, TM4SF12" ENSG00000106025 "Tetraspanin 12" O95859 7 120787320-120858402 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Angiogenesis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 91.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 118.6;Collecting duct cells: 103.0;Distal tubular cells: 189.8;Glandular and luminal cells: 87.5;Proximal tubular cells: 111.1" "Cancer enhanced" "Detected in all" "renal cancer: 44.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 53.0;HUVEC TERT2: 58.3;RH-30: 52.2;RPTEC TERT1: 90.5;RT4: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051570, HPA058244" Uncertain Approved Vesicles,Microtubules NA NA "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Microtubules Vesicles "HPA051570: , HPA058244: AB_2683652" "unprognostic (2.40e-2)" "unprognostic (7.60e-2)" "unprognostic (3.66e-3)" "unprognostic (1.82e-2)" "unprognostic (3.97e-1)" "unprognostic (7.34e-3)" "unprognostic (1.60e-1)" "unprognostic (8.12e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (9.53e-2)" "unprognostic (7.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.18e-2)" "unprognostic (1.43e-1)" 11.9 65.9 4.1 5.3 4.4 0.4 8.7 5.2 5.2 21.4 2.8 24.0 39.4 10.5 14.9 5.0 10.9 20.4 47.7 3.3 4.7 91.6 35.8 45.8 4.5 8.0 6.2 1.7 17.4 10.7 7.5 20.3 5.2 6.8 20.4 1.8 46.8 22.4 3.3 1.6 42.0 11.9 4.6 28.2 22.1 3.9 8.1 2.7 23.4 5.5 4.3 17.5 4.0 3.6 0.0 1.4 15.1 0.2 3.1 1.0 14.7 0.3 0.6 1.2 5.0 2.5 4.0 0.0 10.4 0.4 1.8 0.2 7.7 1.6 1.9 0.0 53.0 2.8 14.5 2.2 8.1 0.1 2.5 0.3 0.0 0.4 0.3 2.1 58.3 0.0 0.7 1.8 6.8 2.0 0.2 0.4 24.5 11.1 9.4 0.1 52.2 2.0 90.5 65.4 12.5 7.4 0.7 1.3 0.0 20.0 8.0 1.9 2.5 12.3 3.8 0.1 6.5 15.8 0.0 0.2 1.7 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 4.4 5.2 5.2 3.3 4.7 8.0 6.2 5.2 4.6 8.1 3.6 40.0 118.6 45.0 18.6 1.7 2.5 20.3 1.8 14.8 0.0 19.4 3.8 62.5 64.3 19.9 103.0 0.0 40.5 0.0 18.0 189.8 6.8 0.6 63.4 9.0 38.0 9.6 2.7 1.8 7.2 53.5 10.0 14.8 87.5 2.5 1.8 18.2 32.9 4.1 0.0 2.9 16.9 6.1 0.8 3.6 1.5 4.1 1.5 5.4 3.7 0.0 0.5 0.0 10.1 0.4 4.7 30.5 0.7 2.2 9.1 68.3 111.1 5.7 0.1 0.0 11.6 16.6 0.6 8.9 13.8 2.0 24.2 1.9 9.6 35.5 28.3 TTC25 DKFZP434H0115 ENSG00000204815 "Tetratricopeptide repeat domain 25" Q96NG3 17 41930617-41966503 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 17.0;testis: 44.9" "Cell type enhanced" "Detected in many" "Early spermatids: 227.2;Endometrial ciliated cells: 65.3;Late spermatids: 43.5;Respiratory ciliated cells: 79.4;Spermatocytes: 98.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.0;U-87 MG: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023908 Enhanced Uncertain Vesicles,Centrosome NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Vesicles "HPA023908: AB_2241243" "unprognostic (3.08e-3)" "unprognostic (4.51e-2)" "unprognostic (6.96e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-1)" "unprognostic (4.57e-2)" "unprognostic (4.11e-2)" "unprognostic (1.41e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-4)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (2.10e-2)" "unprognostic (9.21e-3)" "unprognostic (3.76e-1)" "unprognostic (2.71e-1)" 0.6 0.6 1.8 0.0 1.8 2.7 0.8 1.6 1.8 2.6 6.8 1.1 0.1 1.5 1.3 0.1 17.0 0.5 0.7 1.8 2.4 2.0 0.4 2.8 0.1 3.1 3.3 1.3 0.7 1.9 5.6 0.3 2.4 0.9 0.1 1.7 0.3 0.4 0.5 0.4 0.3 0.5 2.2 0.2 0.5 44.9 2.6 0.3 2.0 0.2 0.0 0.8 0.5 1.7 0.1 1.2 1.4 1.4 0.3 0.3 0.2 0.0 0.6 0.2 0.3 0.2 1.0 0.1 0.5 0.2 0.4 0.3 0.2 0.1 0.3 0.2 0.3 0.3 0.3 0.0 0.4 0.0 0.7 0.2 0.2 0.6 0.0 0.8 0.0 0.7 0.1 0.8 0.2 0.8 0.8 0.1 0.4 0.0 0.1 0.0 0.1 1.0 1.3 0.1 3.0 2.0 0.1 0.4 1.1 0.4 0.5 0.3 0.0 0.1 0.6 0.5 0.3 1.0 0.9 0.1 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 1.8 1.6 1.8 1.8 2.4 3.1 3.3 2.4 2.2 2.6 1.7 0.4 3.2 4.8 2.9 0.0 0.0 0.5 0.0 0.0 2.7 0.5 1.1 1.6 1.5 14.9 3.7 8.4 0.5 0.0 0.3 1.9 2.3 227.2 65.3 2.6 0.9 0.0 18.7 5.2 0.8 0.7 3.0 0.5 3.1 3.8 0.6 0.7 0.2 0.4 3.3 4.6 0.2 0.0 0.0 0.0 43.5 3.4 0.4 0.0 1.0 0.2 2.8 0.0 1.0 0.7 0.4 0.1 1.9 0.0 0.2 0.0 3.4 79.4 5.2 13.1 4.1 0.6 98.4 3.5 0.0 0.0 0.1 0.2 1.5 0.2 0.3 TTI1 "KIAA0406, smg-10" ENSG00000101407 "TELO2 interacting protein 1" O43156 20 37983007-38033461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034230, HPA068338" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 39: CACO-2 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" Vesicles Nucleoplasm "CAB034230: AB_1564322, HPA068338: AB_2685975" "unprognostic (7.14e-3)" "unprognostic (3.15e-1)" "unprognostic (6.61e-2)" "prognostic unfavorable (3.30e-5)" "unprognostic (1.11e-1)" "unprognostic (5.37e-2)" "prognostic unfavorable (2.40e-7)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.49e-2)" "unprognostic (2.36e-1)" "unprognostic (9.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.80e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" 6.8 9.5 7.4 9.1 7.7 8.7 8.9 7.5 8.0 8.5 8.1 7.7 6.2 9.7 9.8 7.3 10.0 6.0 8.2 7.3 8.0 8.5 12.0 7.5 11.8 7.4 7.2 11.8 13.9 11.0 10.0 10.9 7.5 9.4 10.6 10.0 10.1 11.1 16.0 8.0 7.5 10.0 6.8 9.3 8.7 11.0 7.6 13.8 12.1 10.2 12.8 9.0 7.4 10.3 21.7 31.6 34.3 13.1 13.7 19.0 36.7 24.1 14.1 35.2 29.8 74.3 27.5 35.5 24.5 13.8 39.1 33.7 38.8 50.5 34.5 14.3 15.2 48.9 31.3 38.6 15.5 39.4 22.0 14.6 32.6 35.0 21.1 13.5 26.5 37.1 52.3 23.6 26.9 22.3 53.7 27.3 33.7 33.7 32.9 34.7 55.2 41.6 13.4 23.0 31.1 27.7 36.9 64.5 8.6 35.1 36.6 18.8 17.6 47.0 31.2 25.3 24.9 20.4 19.1 39.5 27.5 25.5 24.8 13.8 8.2 15.0 9.3 9.5 10.4 7.9 7.1 9.2 10.8 7.7 10.5 8.5 5.1 9.6 6.1 5.2 9.9 7.9 7.4 7.7 7.5 8.0 7.3 8.0 7.4 7.2 7.5 6.8 7.6 10.3 6.1 9.6 11.6 16.3 9.2 3.1 3.6 5.1 4.0 8.5 5.0 5.0 12.3 7.2 8.3 3.7 10.4 15.1 5.9 3.4 1.9 5.7 8.9 5.1 6.8 6.9 3.0 9.9 15.9 3.2 10.7 7.0 5.1 5.2 2.5 16.8 3.3 8.4 5.5 8.4 14.6 4.4 4.1 1.6 2.0 3.9 6.5 5.0 3.6 14.0 7.5 5.9 6.2 15.6 25.4 3.9 5.3 6.8 10.5 6.0 3.9 5.0 15.8 9.1 0.0 5.3 5.5 14.5 12.9 4.2 3.0 14.4 8.9 8.2 6.3 4.4 TTL MGC46235 ENSG00000114999 "Tubulin tyrosine ligase" Q8NG68 2 112482156-112541739 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066819 Approved Nucleoplasm,Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Nucleoplasm "HPA066819: AB_2685728" "unprognostic (1.05e-2)" "unprognostic (3.90e-3)" "unprognostic (2.25e-1)" "unprognostic (3.95e-3)" "unprognostic (9.75e-2)" "unprognostic (1.81e-2)" "prognostic unfavorable (5.65e-4)" "unprognostic (2.95e-1)" "unprognostic (3.65e-1)" "unprognostic (2.10e-1)" "unprognostic (5.48e-2)" "unprognostic (7.19e-2)" "unprognostic (6.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.45e-1)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" 1.0 0.8 2.3 0.9 3.0 1.8 0.6 1.6 3.0 0.6 0.1 0.8 0.6 1.0 0.8 1.1 0.5 1.1 1.6 2.4 1.7 0.8 0.6 1.3 1.0 1.5 1.9 0.6 0.8 0.8 0.3 1.2 1.6 0.6 0.8 1.4 0.4 0.7 3.7 1.4 0.6 1.3 0.8 0.9 0.6 0.6 2.7 1.0 0.9 3.8 0.8 1.0 0.4 3.5 2.9 2.2 2.7 6.2 3.2 4.6 1.1 4.9 4.0 5.1 4.4 2.7 1.0 2.7 2.7 4.2 3.3 2.0 4.8 2.5 6.2 1.9 2.7 2.3 3.1 3.4 1.4 3.2 1.1 2.1 1.7 7.5 4.0 2.3 4.4 1.8 3.8 2.1 4.1 1.5 2.8 1.8 2.4 0.8 4.4 3.0 3.1 1.5 1.6 2.2 5.8 4.0 3.8 1.2 6.7 1.8 1.3 1.8 4.4 6.0 4.4 4.8 3.7 1.1 2.5 2.2 6.7 2.4 2.6 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.0 2.3 3.0 1.6 3.0 2.4 1.7 1.5 1.9 1.6 0.8 2.7 3.5 14.0 12.8 6.4 19.2 7.0 20.3 4.9 8.3 4.6 15.6 6.4 6.0 39.1 2.8 6.7 12.9 12.5 3.2 10.6 8.0 0.0 7.2 12.2 8.3 28.3 18.5 11.3 16.2 34.1 9.6 2.4 12.6 2.6 10.8 0.0 11.7 15.7 10.4 11.4 8.4 24.0 5.8 16.2 24.2 19.2 5.1 3.1 17.0 7.2 20.6 17.2 9.8 8.2 24.6 72.8 9.4 5.2 5.7 9.1 6.6 2.4 6.0 4.2 20.2 6.6 15.4 12.2 4.5 5.0 6.5 18.0 1.2 7.6 7.7 6.1 4.1 TTLL6 FLJ35808 ENSG00000170703 "Tubulin tyrosine ligase like 6" Q8N841 17 48762235-48817214 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.9" "Group enriched" "Detected in some" 4 "Early spermatids: 49.7;Late spermatids: 176.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HDLM-2: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA052397 Enhanced Approved Vesicles,Microtubules NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" Microtubules Vesicles "HPA052397: AB_2681812" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-1)" "unprognostic (8.04e-2)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.21e-5)" "unprognostic (1.10e-2)" "unprognostic (6.01e-5)" "unprognostic (1.17e-1)" "unprognostic (3.28e-1)" "unprognostic (6.68e-2)" "unprognostic (2.09e-3)" 0.1 0.0 0.6 0.1 0.6 0.0 0.1 0.5 1.0 0.2 1.6 2.8 1.3 0.1 0.0 0.0 3.6 0.5 0.0 0.7 0.6 2.5 0.0 0.6 0.0 0.8 0.9 0.0 0.6 0.0 0.4 0.0 0.6 0.1 3.9 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.6 0.0 0.2 18.9 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.5 1.0 0.7 0.6 0.8 0.9 0.6 0.6 0.8 0.6 0.1 3.2 2.6 5.2 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.6 0.0 3.8 1.8 0.0 0.0 0.0 7.4 1.9 0.3 49.7 2.6 0.1 0.5 4.2 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.1 0.1 0.0 1.0 2.6 0.0 0.0 0.0 176.1 1.2 0.1 0.0 0.0 0.0 0.4 0.0 13.0 0.7 0.0 2.2 0.0 0.0 0.4 4.1 3.2 23.8 0.7 0.0 0.0 0.0 11.2 0.4 0.0 0.0 0.0 0.0 0.4 3.5 0.1 TUSC1 "CCDC89B, TSG-9" ENSG00000198680 "Tumor suppressor candidate 1" Q2TAM9 9 25676389-25678440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 164.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051426 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles Nucleoplasm "HPA051426: AB_2681481" "unprognostic (9.84e-2)" "unprognostic (3.56e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.78e-1)" "unprognostic (4.79e-3)" "unprognostic (1.72e-2)" "unprognostic (5.71e-2)" "unprognostic (1.85e-3)" "unprognostic (9.14e-3)" "unprognostic (1.03e-2)" "unprognostic (1.89e-3)" "unprognostic (2.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" 16.1 10.6 8.5 2.8 8.5 1.7 14.8 7.0 9.3 13.6 9.5 14.3 5.3 18.3 6.2 9.1 15.9 2.8 12.2 8.7 8.9 13.1 10.9 9.8 1.6 9.6 10.5 13.2 9.8 5.6 9.0 3.8 8.2 11.7 3.7 2.8 10.8 6.1 8.3 13.1 9.1 5.5 9.0 6.8 11.5 21.8 8.6 3.2 11.9 4.7 2.0 12.7 10.7 10.4 10.0 2.1 2.1 0.0 7.0 5.8 0.1 7.5 0.0 2.8 3.4 0.1 3.5 0.0 2.2 8.9 7.6 0.0 5.3 9.4 1.7 0.0 10.3 38.6 11.2 0.0 3.4 0.0 0.0 7.1 13.0 3.1 7.3 0.0 3.1 0.0 0.0 0.1 3.3 5.0 0.0 0.1 1.8 8.0 9.5 0.0 1.4 0.1 3.9 4.6 0.7 16.8 9.3 7.6 8.2 4.1 6.7 10.8 6.6 0.0 13.6 0.1 0.0 0.0 0.0 0.0 8.8 2.6 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 8.5 8.5 7.0 9.3 8.7 8.9 9.6 10.5 8.2 9.0 8.6 10.4 46.5 12.8 6.4 2.3 2.1 60.8 46.1 14.7 47.3 24.8 45.4 55.0 12.2 20.0 5.9 16.5 4.2 29.5 2.4 14.8 66.5 7.9 85.7 11.0 26.6 24.4 13.1 4.8 7.3 12.4 13.8 33.0 7.1 17.2 0.0 15.7 22.9 18.5 9.7 21.9 7.6 11.8 10.2 4.8 13.0 16.2 30.7 5.2 28.4 3.7 1.2 42.9 0.0 4.0 9.3 8.1 9.5 21.8 0.5 45.5 8.1 23.1 3.5 14.3 32.9 52.8 36.9 164.0 12.8 16.8 37.8 29.0 1.3 16.3 14.3 19.8 TUSC2 "C3orf11, FUS1, PAP, PDAP2" ENSG00000114383 "Tumor suppressor 2, mitochondrial calcium regulator" O75896 3 50320027-50328251 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 351.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030116 Approved Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 31: Spermatids - Spermatogenesis" Cytosol Vesicles "HPA030116: AB_10602253" "unprognostic (1.58e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-1)" "unprognostic (8.46e-2)" "unprognostic (2.73e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (2.53e-3)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.47e-2)" "unprognostic (1.99e-2)" "prognostic favorable (8.70e-7)" "unprognostic (9.22e-3)" "unprognostic (1.98e-1)" "unprognostic (3.15e-1)" "unprognostic (6.34e-3)" 17.7 25.4 53.4 14.9 54.1 12.4 17.0 51.0 56.2 16.3 43.9 25.2 12.8 17.7 28.2 18.9 20.6 11.5 35.4 54.8 55.5 29.2 25.9 18.4 17.1 54.6 56.2 15.8 27.4 34.8 21.5 17.3 55.6 22.1 16.6 36.0 18.4 17.8 50.9 13.8 20.3 13.7 50.5 23.7 26.9 22.6 56.1 20.4 23.1 36.4 20.5 20.5 14.2 50.8 24.7 20.2 27.5 30.1 29.8 15.4 30.1 19.3 26.5 36.3 30.7 35.6 22.0 41.8 21.0 18.3 37.4 15.5 33.9 25.7 31.7 24.8 31.2 20.6 18.6 38.7 26.1 36.7 34.8 16.8 40.7 36.5 18.1 25.5 38.0 32.8 25.4 19.6 21.1 18.8 38.7 46.5 37.6 30.4 28.9 13.3 13.4 34.4 36.9 26.4 14.7 30.3 14.4 25.4 29.9 27.2 24.2 44.3 30.3 10.8 26.6 24.8 40.2 47.6 79.7 29.4 24.2 24.1 17.4 16.7 21.2 34.6 24.0 19.6 24.3 23.0 20.8 25.2 14.2 24.6 23.5 25.2 30.2 22.4 18.1 26.3 25.2 32.3 53.4 54.1 51.0 56.2 54.8 55.5 54.6 56.2 55.6 50.5 56.1 50.8 39.8 12.8 17.0 3.9 41.7 57.5 36.8 60.7 37.0 55.5 61.0 44.2 39.6 55.8 37.9 57.0 22.9 62.9 54.4 46.5 115.4 73.9 123.1 55.6 15.8 39.2 50.4 40.4 12.9 74.1 55.5 24.9 25.0 28.4 29.9 16.4 40.4 72.7 76.6 74.0 11.4 46.1 73.2 46.1 51.1 351.8 27.1 37.7 55.2 5.6 57.6 69.0 59.8 4.0 7.8 74.0 61.0 24.8 45.8 67.8 72.0 178.6 71.5 45.5 13.1 18.0 38.5 54.1 49.2 47.4 91.2 69.6 38.7 28.9 46.1 63.7 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132679794 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 418.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017235, HPA076042" Supported Enhanced Vesicles,Cytosol NA NA 43000 "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" Cytosol Vesicles "HPA017235: AB_1858507, HPA076042: " "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 18.3 29.2 15.6 18.6 17.5 21.5 23.0 15.2 16.3 18.0 30.9 21.5 24.0 17.2 30.4 17.2 16.6 16.9 23.8 16.7 15.8 31.3 31.8 17.7 22.4 12.6 13.6 16.9 52.1 31.0 22.3 25.8 14.1 24.8 22.6 25.2 48.0 20.2 31.4 22.0 24.8 17.7 13.8 21.1 26.7 17.0 14.2 19.7 31.8 24.4 24.9 17.2 11.8 16.5 67.2 24.4 42.1 35.3 28.4 31.9 44.5 57.1 57.2 34.4 39.6 44.9 24.2 52.1 41.1 40.8 23.3 39.6 41.6 43.6 49.5 51.3 18.1 63.6 39.6 50.1 27.9 79.6 36.7 28.0 24.8 32.8 48.7 31.8 38.6 28.6 41.0 76.2 38.0 59.4 44.1 29.2 38.6 56.3 22.9 38.6 37.0 99.8 31.0 50.9 40.2 35.8 33.5 32.0 51.3 37.8 40.0 39.5 35.9 36.7 36.2 17.8 29.8 71.7 51.8 98.3 40.9 28.1 33.5 8.3 7.1 7.0 12.4 8.2 14.6 15.1 13.8 19.1 15.9 10.2 16.1 16.3 1.6 26.0 9.5 19.2 15.5 10.5 15.6 17.5 15.2 16.3 16.7 15.8 12.6 13.6 14.1 13.8 14.2 16.5 23.1 35.3 25.9 37.2 24.0 17.2 18.9 26.4 21.1 22.1 26.1 13.1 36.9 22.8 24.4 7.3 14.6 63.0 28.4 8.3 68.4 30.3 124.8 17.7 22.2 20.5 21.6 10.9 37.6 44.9 48.0 24.8 28.5 17.4 24.1 16.8 13.2 22.8 22.6 21.9 35.6 22.6 34.6 10.3 11.4 418.2 16.8 13.9 17.8 16.9 21.6 26.1 16.5 37.7 28.4 23.2 16.7 27.1 85.4 23.1 35.4 43.1 20.8 23.6 32.9 23.5 28.2 49.4 23.1 15.9 18.5 99.7 20.4 29.7 18.3 18.1 UGT1A6 "GNT1, HLUGP, UGT1F" ENSG00000167165 "UDP glucuronosyltransferase family 1 member A6" P19224 2 233691607-233773300 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 71.3;liver: 143.3;urinary bladder: 88.8" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 12.5;Early spermatids: 52.4;Gastric mucus-secreting cells: 14.3;Late spermatids: 23.3;Squamous epithelial cells: 17.3" "Group enriched" "Detected in many" 5 "liver cancer: 7.2;lung cancer: 3.1;renal cancer: 7.6;urothelial cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 1194.0" "Not detected" "Not detected" "CAB009819, HPA054065, HPA056023" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 34: Spermatids - Unknown function" Vesicles "Endoplasmic reticulum" "CAB009819: AB_2241481, HPA054065: AB_2682367, HPA056023: " "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (5.43e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.79e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-3)" "unprognostic (9.97e-2)" "unprognostic (2.16e-2)" "unprognostic (3.52e-1)" "unprognostic (7.50e-2)" "unprognostic (2.01e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 1.8 0.0 1.8 5.8 0.1 2.6 16.1 0.0 3.5 0.0 0.0 0.0 71.3 143.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 1.3 0.0 2.6 3.6 0.0 11.1 2.6 0.0 0.0 0.0 17.4 0.4 0.0 1.2 0.5 0.0 5.8 88.8 5.5 0.0 4.2 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 53.8 1.6 0.0 80.2 0.1 0.8 294.5 0.1 4.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.3 0.0 31.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.0 1194.0 0.0 0.1 0.2 0.1 3.2 149.0 0.0 0.0 7.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 1.2 12.5 0.0 0.0 0.0 0.3 0.0 2.9 1.8 0.0 0.0 0.0 0.4 0.0 0.0 52.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.5 0.0 0.0 0.4 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 23.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.5 1.8 0.1 0.0 0.0 0.0 0.0 1.2 0.2 17.3 1.1 0.0 0.0 0.0 0.1 3.0 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951006-36001028 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 51.1;liver: 58.0" "Cell type enhanced" "Detected in some" "Collecting duct cells: 49.7;Early spermatids: 125.9;Hepatocytes: 72.1;Late spermatids: 24.5;Proximal tubular cells: 87.0" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 42 "RH-30: 28.2" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol NA NA "Cluster 81: Kidney & Liver - Metabolism" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Cytosol" "HPA047697: AB_2680122, HPA056290: AB_2683088" "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 51.1 58.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.7 0.1 0.2 3.0 0.0 6.7 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.0 0.0 49.7 0.0 0.0 0.0 0.0 3.9 0.0 125.9 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 72.1 0.1 0.0 0.3 0.7 0.0 2.6 0.0 24.5 0.9 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.5 0.4 0.0 0.0 3.8 87.0 0.0 0.2 6.6 0.0 0.0 4.4 0.8 0.0 0.0 0.0 0.5 0.0 1.8 0.1 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942014-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 6.1" "Cell type enhanced" "Detected in many" "Adipocytes: 28.9;Basal respiratory cells: 17.9;dendritic cells: 12.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 12.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enriched" "Detected in single" 6 "T-cells: 2.7" "Cell line enhanced" "Detected in many" "SiHa: 66.7;U-2197: 47.4" "CAB018974, HPA066741" Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 27: Brain & Skin - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Plasma membrane" "CAB018974: , HPA066741: " "unprognostic (2.09e-5)" "prognostic unfavorable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 1.5 0.7 1.3 0.6 1.6 1.8 0.7 1.6 2.6 0.9 0.7 0.2 0.2 0.1 0.1 6.1 0.2 0.5 2.0 3.0 1.0 2.1 0.5 3.4 0.3 1.8 1.2 0.0 0.4 0.6 0.5 1.6 1.8 0.2 0.1 0.2 0.7 0.1 0.3 0.5 0.2 0.7 0.8 0.2 0.3 1.5 1.1 0.7 1.2 0.7 0.8 1.4 1.6 1.7 19.9 1.8 0.5 6.1 1.1 5.6 3.3 20.1 11.8 20.6 16.8 7.4 11.0 0.0 29.9 23.0 29.6 13.9 7.6 18.4 11.8 9.1 3.9 1.1 2.8 0.0 7.1 0.0 1.5 2.7 13.9 18.3 8.0 16.7 11.9 16.6 2.5 0.0 15.4 13.9 1.8 0.0 0.0 3.6 10.2 3.0 4.5 0.0 29.0 5.7 0.6 0.0 66.7 1.4 1.9 3.2 1.8 8.5 18.8 13.5 17.1 47.4 23.5 0.0 0.1 0.9 19.2 10.7 9.9 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.8 1.5 0.0 0.0 0.3 1.8 0.0 0.4 0.0 0.0 1.7 0.5 1.3 1.6 1.6 2.6 3.0 1.0 1.8 1.2 1.8 0.8 1.1 1.7 28.9 0.0 1.3 0.0 1.2 3.7 6.5 17.9 7.4 0.0 1.3 4.4 0.3 0.0 9.4 1.8 0.0 0.0 12.1 0.5 0.0 7.5 7.0 0.3 0.5 9.1 0.0 0.0 3.0 8.8 0.5 3.0 1.1 0.2 0.0 0.1 7.1 0.2 2.2 0.0 0.7 0.3 2.0 0.8 2.1 8.0 0.0 3.1 1.8 0.0 0.0 0.4 4.1 0.5 0.3 4.5 0.0 0.0 1.4 1.4 0.0 0.1 1.4 0.0 0.0 1.0 4.2 3.1 7.0 11.8 2.8 0.0 11.0 0.6 0.4 5.2 ULBP3 RAET1N ENSG00000131019 "UL16 binding protein 3" Q9BZM4 6 150061053-150069121 "Predicted intracellular proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 6.5;testis: 6.3" "Cell type enhanced" "Detected in single" "Gastric mucus-secreting cells: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA056541, HPA063007" Approved Uncertain "Vesicles,Centriolar satellite" "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" Vesicles "Centriolar satellite" "HPA056541: , HPA063007: AB_2684920" "unprognostic (4.87e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (2.99e-2)" "unprognostic (8.47e-2)" "unprognostic (1.96e-1)" "unprognostic (5.87e-2)" "unprognostic (8.71e-2)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (6.26e-2)" "unprognostic (3.43e-1)" "unprognostic (2.12e-1)" "unprognostic (5.45e-2)" "unprognostic (5.16e-2)" 1.3 1.2 1.6 0.7 1.8 0.7 1.0 1.6 2.4 0.5 0.4 0.8 1.1 1.0 0.9 1.5 2.0 1.3 0.7 1.7 1.4 1.7 1.0 1.5 0.5 0.9 0.9 0.8 0.7 0.9 0.1 0.9 0.9 0.7 0.8 0.8 0.4 0.5 6.5 1.1 0.5 0.5 0.2 0.6 1.9 6.3 1.3 0.5 4.9 0.4 0.9 1.0 0.5 1.9 6.2 2.0 6.5 7.3 1.6 11.9 2.3 6.1 2.6 7.2 8.0 11.0 5.1 0.2 11.8 9.9 10.9 8.3 17.7 20.5 7.7 3.7 7.8 0.6 2.9 0.5 2.5 0.1 1.1 10.2 3.5 15.0 8.1 6.9 9.7 0.2 0.5 0.8 6.3 7.0 0.3 0.5 3.1 2.6 14.8 6.2 5.9 0.3 17.5 12.4 1.2 0.5 12.2 8.2 3.0 3.4 2.5 1.7 5.6 1.2 9.8 20.5 13.3 0.3 0.2 4.1 9.6 3.7 5.1 0.8 0.2 0.2 2.2 0.2 2.9 0.8 1.5 2.4 0.2 0.5 0.8 1.2 1.0 0.6 0.2 0.3 2.3 0.4 1.6 1.8 1.6 2.4 1.7 1.4 0.9 0.9 0.9 0.2 1.3 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 UNC13D Munc13-4 ENSG00000092929 "Unc-13 homolog D" Q70J99 17 75827225-75844552 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Exocytosis "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 58.9;lymphoid tissue: 66.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 68.3;Hofbauer cells: 58.5;NK-cells: 61.8;Pancreatic endocrine cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 245.7;HeLa: 136.3;HMC-1: 245.9;SK-BR-3: 189.7" "Region enriched" "Detected in single" 6 "cerebellum: 5.0" "Low region specificity" "Detected in many" "HPA067117, HPA073525" Enhanced Supported Vesicles,Cytosol NA NA 1500000 "Cluster 38: Basophils - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol Vesicles "HPA067117: AB_2685784, HPA073525: AB_2686615" "unprognostic (6.79e-3)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.98e-2)" "unprognostic (1.42e-3)" "unprognostic (3.93e-1)" "unprognostic (1.37e-2)" "unprognostic (2.74e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.89e-1)" "prognostic unfavorable (5.28e-12)" "unprognostic (3.27e-2)" "unprognostic (5.58e-2)" "unprognostic (1.56e-1)" "unprognostic (8.59e-2)" 7.7 7.3 5.6 23.5 6.8 58.9 7.8 5.8 7.3 18.6 5.0 10.7 8.0 8.6 2.0 23.6 13.8 6.5 14.3 5.0 5.6 6.6 12.6 38.1 25.9 7.9 6.5 19.3 8.8 0.5 11.6 9.0 7.5 8.1 4.5 5.5 7.7 5.1 8.5 6.0 18.5 4.9 6.2 66.2 13.8 6.1 8.2 20.7 5.9 1.5 17.6 10.7 19.6 8.7 44.0 18.7 0.4 0.3 0.5 1.0 47.6 0.1 0.0 0.0 0.1 41.4 97.0 3.4 46.4 0.0 7.5 15.4 0.0 2.2 0.0 0.4 0.5 245.7 136.3 24.2 3.9 94.1 245.9 0.6 2.0 0.5 2.1 2.3 17.9 42.5 87.1 1.1 0.0 71.2 100.9 50.8 0.9 69.9 1.7 32.8 1.0 1.5 1.6 17.7 0.3 66.7 19.2 189.7 0.9 0.5 47.1 56.5 48.1 0.8 65.9 0.5 0.5 1.3 5.9 4.0 0.6 31.3 0.2 59.1 16.0 31.2 19.3 16.9 17.4 6.7 11.4 13.6 12.3 3.6 8.8 11.9 40.1 14.7 25.6 7.2 10.8 18.1 5.6 6.8 5.8 7.3 5.0 5.6 7.9 6.5 7.5 6.2 8.2 8.7 3.8 44.8 8.3 6.8 16.6 1.1 1.7 1.0 0.6 12.0 4.9 2.4 68.3 7.2 4.4 3.7 20.9 4.7 27.0 40.9 0.0 7.2 5.3 1.3 3.3 6.6 6.0 14.9 1.2 6.0 11.6 2.2 2.0 2.3 45.0 9.9 7.9 1.2 58.5 5.0 1.5 3.6 2.0 21.6 8.2 0.5 2.8 22.2 1.8 5.6 22.5 4.5 61.8 3.0 7.9 47.3 30.7 1.5 27.4 1.6 5.5 0.7 1.6 16.2 0.0 4.5 2.6 1.2 1.4 1.5 1.4 25.9 30.9 2.0 6.3 2.3 UNC80 "C2orf21, FLJ33496, KIAA1843, UNC-80" ENSG00000144406 "Unc-80 homolog, NALCN channel complex subunit" Q8N2C7 2 209771832-209999300 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.0;pituitary gland: 13.6;retina: 18.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5" "Cancer enhanced" "Detected in some" "glioma: 0.8;prostate cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042472, HPA050959" Enhanced Approved "Nuclear bodies,Vesicles" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear bodies" Vesicles "HPA042472: AB_10965318, HPA050959: " "unprognostic (7.91e-3)" "unprognostic (2.25e-4)" "unprognostic (1.44e-2)" "unprognostic (3.20e-4)" "unprognostic (1.92e-1)" "unprognostic (3.40e-2)" "unprognostic (3.31e-3)" "unprognostic (5.36e-2)" "unprognostic (5.16e-1)" "unprognostic (7.85e-2)" "unprognostic (5.24e-3)" "unprognostic (8.94e-2)" "unprognostic (1.50e-2)" "unprognostic (1.51e-2)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" "unprognostic (7.40e-3)" 0.0 3.9 6.4 0.0 9.9 0.0 0.0 15.6 21.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.4 1.1 0.0 6.9 4.9 0.1 0.0 0.1 0.0 6.7 1.5 0.5 1.0 0.2 13.6 0.0 5.8 0.9 0.1 18.9 0.1 0.2 0.0 0.1 0.1 0.2 1.1 0.2 0.4 3.5 2.6 0.1 0.3 0.0 0.0 0.2 0.0 5.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 9.9 15.6 21.0 6.9 4.9 6.7 1.5 5.8 1.1 2.6 5.0 0.2 0.0 1.1 49.0 0.0 0.8 0.3 1.9 0.0 117.7 0.2 0.1 2.1 0.0 0.7 0.0 66.7 0.0 0.0 0.0 0.0 0.0 31.9 1.1 1.7 0.5 0.0 0.0 432.0 0.0 0.0 1.1 0.0 0.1 1.3 0.6 0.0 0.0 0.1 52.2 354.7 0.0 0.0 0.0 0.0 10.5 0.9 0.3 0.0 10.3 0.0 26.6 0.0 290.5 12.8 0.1 0.0 1.9 0.0 1.2 0.0 0.2 0.8 75.6 0.0 0.2 0.1 7.5 3.8 0.0 0.1 0.0 0.0 15.1 0.0 0.3 UPRT "DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3" ENSG00000094841 "Uracil phosphoribosyltransferase homolog" Q96BW1 X 75156388-75304885 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000805 Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 3: T-cells - Adaptive immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "HPA000805: AB_1080482" "unprognostic (3.12e-3)" "unprognostic (5.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (1.18e-2)" "unprognostic (4.62e-2)" "unprognostic (1.04e-3)" "unprognostic (9.64e-2)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.14e-4)" "unprognostic (6.09e-2)" "unprognostic (2.54e-2)" "unprognostic (2.74e-1)" "unprognostic (4.53e-3)" 6.2 10.9 7.2 6.3 7.4 13.4 7.9 7.4 8.7 8.1 8.1 7.6 10.9 5.9 8.9 7.9 7.2 6.1 9.3 7.1 8.2 11.4 8.6 7.6 8.9 7.2 8.3 6.1 6.5 14.0 7.0 5.8 7.9 9.2 7.9 6.4 8.7 6.0 8.9 5.6 8.1 6.5 7.4 7.3 10.3 1.9 8.1 8.9 10.2 10.8 8.2 6.9 4.7 8.1 11.6 7.6 8.9 8.1 9.4 9.9 8.4 8.0 9.2 8.4 9.6 7.2 7.7 16.3 6.6 8.5 15.1 4.8 20.7 6.8 13.9 14.3 8.0 10.2 7.8 9.1 9.0 20.2 20.1 7.5 5.0 11.2 6.1 13.4 15.1 13.1 12.1 15.7 22.6 4.8 22.7 12.4 17.8 8.6 13.0 10.7 22.8 8.1 21.9 6.4 0.6 9.2 11.0 11.4 11.4 15.7 5.3 12.6 12.6 10.6 6.3 19.4 6.8 10.7 36.5 15.8 11.2 21.9 6.9 6.9 7.3 9.2 7.7 10.6 9.0 8.2 7.6 8.0 10.9 7.0 9.4 8.3 1.4 14.4 17.9 5.2 13.5 7.1 7.2 7.4 7.4 8.7 7.1 8.2 7.2 8.3 7.9 7.4 8.1 8.1 8.5 6.4 5.0 8.1 8.0 6.2 8.7 10.0 3.4 8.5 5.3 3.8 6.6 5.7 11.2 9.2 0.0 8.4 8.1 5.3 27.4 8.8 2.0 4.8 4.1 8.6 6.0 4.6 8.8 6.0 15.1 5.2 5.1 4.1 24.1 5.2 11.7 6.0 11.6 10.1 8.8 5.3 22.4 16.1 8.8 1.8 4.4 10.8 14.2 3.7 7.8 9.4 13.4 13.0 8.4 5.6 3.2 3.4 9.8 5.5 8.4 15.4 6.1 7.2 6.6 4.8 7.1 0.7 2.4 4.2 6.0 12.2 12.1 6.5 7.2 7.4 URM1 "C9orf74, MGC2668" ENSG00000167118 "Ubiquitin related modifier 1" Q9BTM9 9 128371361-128392016 "Predicted intracellular proteins" "tRNA processing, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053645, HPA065160" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 35: T-regs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Vesicles Nucleoplasm "HPA053645: AB_2682215, HPA065160: AB_2685423" "unprognostic (7.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (8.94e-3)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.04e-2)" "unprognostic (9.19e-2)" "unprognostic (5.61e-3)" "unprognostic (2.39e-2)" "unprognostic (2.36e-1)" "prognostic favorable (7.43e-6)" "unprognostic (1.77e-3)" "unprognostic (1.93e-1)" "unprognostic (2.47e-1)" "unprognostic (6.17e-2)" 20.1 23.8 35.5 16.3 40.3 26.2 20.0 37.7 37.8 21.2 28.1 22.0 20.2 21.2 15.1 22.0 18.8 11.2 31.1 33.8 35.9 26.8 24.6 17.6 21.7 40.3 41.2 19.5 30.0 18.9 17.9 14.7 38.0 22.7 16.5 12.4 17.2 14.1 25.2 20.9 20.8 16.8 35.7 28.0 23.2 12.5 38.6 23.6 19.3 25.5 20.7 21.9 18.7 42.4 17.9 36.6 34.5 21.6 31.2 29.9 29.9 17.8 27.8 40.1 27.4 28.5 32.7 41.6 14.2 37.8 26.0 63.8 40.3 38.7 20.7 27.7 27.5 37.2 53.4 32.9 28.7 40.8 30.9 40.5 33.3 31.4 28.2 30.6 49.0 44.7 43.9 26.2 29.5 39.9 54.7 54.9 39.5 71.5 41.0 44.5 41.8 48.6 33.5 16.3 27.6 37.6 31.5 51.3 41.4 18.5 50.7 32.2 32.1 31.6 30.0 30.3 30.0 25.2 54.2 39.8 31.4 33.6 38.7 6.1 14.1 10.0 14.5 18.3 12.2 11.7 12.7 13.6 16.8 12.3 12.4 13.5 3.5 12.2 17.6 12.2 15.7 12.6 35.5 40.3 37.7 37.8 33.8 35.9 40.3 41.2 38.0 35.7 38.6 42.4 49.9 16.0 24.5 13.7 36.8 22.7 32.9 60.0 16.5 19.2 37.1 32.9 22.4 25.8 26.1 27.6 14.6 84.1 37.1 57.3 70.5 69.2 2.5 21.5 31.6 47.4 22.2 53.0 12.6 112.2 85.1 32.1 35.7 19.8 37.4 34.6 38.9 23.1 81.6 10.1 13.3 53.3 28.5 42.6 27.7 4.2 31.1 31.6 53.4 4.7 70.5 32.2 59.8 15.1 38.7 89.5 49.3 31.2 29.4 38.4 90.4 51.4 17.4 14.4 19.7 26.3 32.6 24.1 27.1 29.4 23.9 71.7 37.4 48.1 66.7 31.7 USF2 "bHLHb12, FIP" ENSG00000105698 "Upstream transcription factor 2, c-fos interacting" Q15853 19 35268962-35279821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029764, HPA046567" Supported Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm Vesicles "HPA029764: AB_2673190, HPA046567: AB_2679702" "unprognostic (6.10e-3)" "unprognostic (2.27e-1)" "unprognostic (1.06e-2)" "unprognostic (5.03e-3)" "unprognostic (4.60e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "unprognostic (2.87e-1)" "unprognostic (2.10e-1)" "unprognostic (7.07e-2)" "prognostic favorable (5.12e-5)" "unprognostic (7.75e-2)" "unprognostic (8.12e-2)" "unprognostic (7.47e-2)" "unprognostic (5.75e-2)" "unprognostic (6.90e-2)" "prognostic favorable (3.28e-4)" 126.7 132.5 188.9 130.4 191.7 177.7 105.4 190.2 192.9 109.3 147.9 120.8 105.3 104.4 51.5 104.6 104.1 66.3 196.6 181.0 180.3 97.8 185.2 102.2 154.9 192.9 185.4 164.5 121.1 109.4 149.1 63.5 187.2 99.8 54.1 90.4 97.9 57.2 359.3 122.0 112.7 52.4 186.4 160.5 104.1 51.7 191.7 101.3 125.8 195.1 96.7 100.2 99.9 183.2 189.2 190.2 93.6 91.1 161.7 81.5 89.2 101.0 119.7 90.4 69.3 87.3 95.5 183.7 157.6 86.3 96.4 56.5 88.6 79.6 45.4 306.4 135.8 107.5 111.1 143.1 97.8 182.5 177.5 71.7 108.3 58.6 89.1 151.3 62.2 119.6 135.3 260.0 70.5 218.8 200.7 69.8 78.7 171.3 61.1 190.9 123.2 171.2 74.8 119.5 159.3 120.7 188.2 200.4 346.7 80.7 81.8 142.4 107.4 150.0 101.0 99.5 134.4 260.0 286.6 199.7 139.4 114.8 201.0 44.5 8.3 11.1 6.8 11.2 8.2 10.2 7.0 9.0 13.4 13.5 6.3 6.0 7.8 11.7 6.9 50.6 13.8 7.7 188.9 191.7 190.2 192.9 181.0 180.3 192.9 185.4 187.2 186.4 191.7 183.2 58.2 6.4 22.4 29.7 72.5 23.7 23.7 18.7 20.5 66.0 42.2 38.4 71.6 35.8 15.5 31.3 33.3 24.2 108.1 50.7 56.7 33.5 1.1 25.6 31.3 36.5 52.1 37.2 19.7 57.8 38.5 32.7 30.5 34.0 20.3 45.7 38.6 50.5 107.0 94.2 16.9 33.6 20.3 66.8 42.9 3.4 32.0 91.9 26.6 28.1 37.8 118.9 35.0 12.1 19.5 36.0 37.1 31.2 63.8 23.1 58.1 51.7 11.0 53.9 13.1 40.9 35.8 9.0 10.6 34.3 24.7 17.5 56.2 52.0 33.0 35.6 USP18 ENSG00000184979 "Ubiquitin specific peptidase 18" Q9UMW8 22 18150170-18177397 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 46.9;Extravillous trophoblasts: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 181.8;BJ hTERT+ SV40 Large T+ RasG12V: 196.2" HPA044768 Uncertain Supported Vesicles,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol Vesicles "HPA044768: AB_10963697" "unprognostic (2.06e-1)" "unprognostic (3.55e-2)" "unprognostic (1.57e-2)" "unprognostic (5.04e-3)" "unprognostic (1.40e-2)" "unprognostic (5.42e-2)" "unprognostic (3.29e-2)" "unprognostic (5.11e-3)" "unprognostic (1.81e-1)" "unprognostic (1.79e-3)" "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (4.29e-3)" "unprognostic (2.58e-1)" "unprognostic (2.77e-2)" "unprognostic (2.28e-2)" "unprognostic (8.38e-2)" 10.8 5.0 3.6 5.1 3.8 8.1 8.3 3.3 4.5 4.0 4.0 5.0 6.0 3.2 7.8 4.0 7.3 6.6 4.4 3.7 3.9 5.9 23.6 7.9 9.2 5.1 3.9 2.9 4.2 3.6 5.7 5.7 4.2 5.3 4.4 0.7 14.0 2.5 3.8 3.4 6.7 4.0 7.0 11.0 7.2 9.7 4.1 15.0 7.3 5.5 6.5 4.0 3.6 3.7 14.4 14.6 4.2 18.2 18.2 13.5 18.4 7.3 17.5 181.8 196.2 2.2 20.1 0.2 10.8 4.0 57.5 4.9 21.6 6.4 6.2 64.4 29.4 28.3 1.9 27.0 2.1 6.9 25.7 6.0 2.5 12.8 0.0 1.0 40.8 20.6 1.4 1.7 1.8 24.9 33.4 16.7 12.7 15.6 11.0 13.1 28.4 0.0 3.6 12.4 15.2 11.9 8.8 15.0 71.9 16.3 9.9 6.6 66.7 1.3 3.5 4.1 7.5 3.4 45.4 0.2 16.3 17.1 10.5 3.2 3.9 8.3 8.5 11.0 10.7 5.3 7.2 11.1 1.8 3.4 8.2 9.6 0.7 13.3 8.6 3.3 13.1 5.3 3.6 3.8 3.3 4.5 3.7 3.9 5.1 3.9 4.2 7.0 4.1 3.7 9.7 9.6 4.8 0.7 2.5 1.7 4.5 5.7 2.2 0.2 8.4 8.3 1.4 8.6 6.9 0.0 0.0 4.6 3.0 6.2 46.9 5.9 1.6 20.1 2.5 8.4 3.0 1.3 0.5 11.1 31.9 7.1 4.1 6.3 0.0 8.5 11.0 5.5 8.7 0.0 0.6 3.5 6.1 6.3 0.8 1.7 3.7 3.8 3.6 0.0 1.6 5.1 8.2 2.0 0.3 13.4 3.2 7.2 2.3 2.5 5.4 8.0 12.2 0.3 6.6 8.0 2.5 10.9 1.0 4.0 1.0 1.5 5.0 5.5 2.8 2.9 USP27X USP27 ENSG00000273820 "Ubiquitin specific peptidase 27 X-linked" A6NNY8 X 49879484-49882558 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.5;Bipolar cells: 15.8;Cytotrophoblasts: 44.5;Syncytiotrophoblasts: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SuSa: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077264 Approved Nucleoplasm,Vesicles NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 12: NES - Nervous system development" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles Nucleoplasm "HPA077264: AB_2686831" "unprognostic (4.12e-2)" "unprognostic (9.58e-3)" "unprognostic (2.29e-1)" "unprognostic (4.66e-2)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.14e-4)" "unprognostic (3.10e-3)" "unprognostic (3.91e-2)" "unprognostic (1.31e-2)" "prognostic favorable (9.31e-4)" "unprognostic (5.37e-2)" "unprognostic (7.45e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.58e-1)" 1.6 2.5 6.0 1.3 6.2 0.5 2.0 8.0 5.8 3.0 3.1 3.2 1.0 3.9 2.9 1.6 3.5 1.6 1.8 5.3 14.4 2.7 1.8 2.7 1.7 4.9 8.4 6.3 2.6 3.0 7.3 11.7 5.9 3.0 1.4 3.8 1.6 2.8 4.4 2.1 2.1 2.8 3.6 1.8 2.4 1.3 10.5 2.6 2.4 2.1 1.7 3.0 2.2 4.4 1.6 3.8 4.2 4.8 3.8 3.1 3.6 1.6 2.6 1.8 1.4 6.9 1.6 0.9 1.6 4.2 6.0 2.6 6.0 4.0 2.6 2.0 3.1 1.6 1.1 6.2 2.6 0.5 3.4 4.4 2.7 2.6 2.6 4.4 2.5 4.2 3.4 1.5 2.9 3.7 2.5 1.2 4.8 2.7 2.7 2.7 3.7 0.3 2.9 1.4 1.1 3.2 3.4 3.0 4.0 12.9 3.5 1.1 1.9 2.1 4.3 3.8 0.7 1.6 0.4 0.6 2.5 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 6.2 8.0 5.8 5.3 14.4 4.9 8.4 5.9 3.6 10.5 4.4 3.5 19.2 15.5 0.7 2.5 2.9 4.5 0.3 2.2 15.8 1.9 2.7 2.6 0.0 7.5 0.0 0.0 44.5 1.4 1.7 5.9 1.5 0.1 2.1 4.1 5.2 4.2 0.0 2.9 0.7 3.6 2.7 1.1 2.1 2.5 4.0 2.5 1.9 4.0 5.0 3.3 1.3 0.0 0.6 1.0 0.3 2.1 1.2 0.0 0.0 1.5 8.3 0.0 3.5 0.8 1.2 0.5 3.4 0.5 3.3 0.5 2.9 13.2 2.5 6.6 2.5 2.6 0.2 1.3 0.9 2.3 26.1 2.0 8.8 1.6 1.7 USP40 FLJ10785 ENSG00000085982 "Ubiquitin specific peptidase 40" Q9NVE5 2 233475520-233566782 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 79.3;Oligodendrocytes: 127.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005821 Uncertain Approved "Vesicles,Focal adhesion sites" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 64: Astrocytes - Nervous system maintenance" Vesicles "Focal adhesion sites" "HPA005821: AB_1080526" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" "unprognostic (3.70e-1)" "unprognostic (2.15e-1)" "unprognostic (5.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.45e-1)" "unprognostic (4.09e-2)" "unprognostic (1.90e-2)" "unprognostic (2.53e-2)" 11.8 12.0 10.4 7.5 17.0 3.4 13.9 12.8 11.4 10.0 16.5 9.4 10.5 10.6 24.0 10.4 11.5 11.6 8.2 10.2 12.0 14.2 13.2 12.5 7.2 19.4 14.2 15.9 14.0 16.8 8.5 12.4 19.0 13.5 9.5 14.2 12.9 10.4 9.6 19.7 10.1 8.5 12.3 9.9 13.1 14.7 16.2 10.1 16.4 7.6 7.8 9.6 7.5 25.4 17.3 19.9 17.6 12.0 25.2 23.0 15.7 16.4 12.4 14.7 16.0 14.3 20.2 0.4 4.7 26.4 38.6 30.3 13.3 29.7 20.6 0.0 9.0 13.3 17.4 24.3 22.3 5.8 8.9 22.2 21.1 22.2 30.9 26.2 17.3 8.1 22.0 3.2 21.4 14.0 6.2 8.5 7.9 17.8 16.0 0.0 36.3 8.1 17.9 27.6 9.6 10.3 13.5 13.5 16.9 12.9 15.4 12.9 17.3 20.9 13.1 8.9 20.6 6.0 4.9 0.8 27.1 10.2 18.6 0.0 1.0 0.0 0.5 1.1 0.2 0.4 0.5 0.4 1.5 0.7 0.7 0.7 0.1 0.5 0.9 1.9 0.8 0.5 10.4 17.0 12.8 11.4 10.2 12.0 19.4 14.2 19.0 12.3 16.2 25.4 11.8 32.1 35.5 79.3 7.9 7.4 9.1 13.6 15.4 18.1 17.0 14.7 10.7 10.0 19.9 16.5 25.0 21.2 6.7 9.9 7.9 9.4 8.4 19.8 18.3 11.1 15.0 5.7 25.9 12.6 10.6 11.9 21.4 21.3 9.5 23.4 12.8 25.4 8.2 23.5 38.2 10.9 4.1 11.6 3.6 10.7 6.8 9.1 3.6 40.3 5.9 11.9 4.1 48.2 127.7 10.5 12.6 8.2 10.9 12.9 13.9 14.6 21.0 19.4 13.1 17.5 10.6 30.2 20.9 17.2 10.5 15.7 5.5 21.1 12.1 10.0 USP47 ENSG00000170242 "Ubiquitin specific peptidase 47" Q96K76 11 11841423-11961887 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 315.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029286, HPA029289" Supported Approved "Vesicles,Intermediate filaments" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" Vesicles "HPA029286: AB_10599852, HPA029289: AB_10601675" "unprognostic (2.02e-1)" "unprognostic (2.72e-1)" "unprognostic (3.05e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (2.65e-2)" "unprognostic (2.27e-2)" "unprognostic (7.39e-2)" "unprognostic (1.54e-2)" "unprognostic (7.05e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-1)" "unprognostic (1.51e-1)" "unprognostic (9.96e-3)" "unprognostic (1.90e-1)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" 15.7 14.3 11.9 11.4 15.8 19.0 15.1 17.3 12.8 14.3 10.2 19.8 10.3 17.2 15.6 16.1 13.5 12.3 23.5 12.5 14.1 13.2 23.3 16.2 13.3 14.1 12.8 15.9 16.9 22.2 13.8 16.7 15.0 16.6 12.3 25.7 14.1 15.4 59.8 18.0 14.1 17.8 14.1 11.8 16.6 15.0 12.7 19.1 14.9 33.6 13.8 16.7 14.2 20.6 26.8 15.7 30.3 13.1 21.8 23.2 12.6 31.6 22.3 20.1 22.1 16.5 22.2 29.6 13.3 28.0 23.7 17.8 23.7 15.3 30.3 27.5 20.4 18.6 30.3 12.6 21.5 25.0 23.9 22.3 22.5 12.3 29.0 26.1 21.8 21.7 35.8 23.7 25.4 10.6 21.7 14.3 7.9 28.1 12.7 21.4 30.3 9.4 24.6 29.1 9.8 21.0 25.8 19.6 19.3 18.4 14.4 20.6 24.9 27.8 16.2 22.3 19.6 7.9 18.1 25.9 19.9 15.2 20.3 14.7 5.9 11.9 11.0 7.4 14.5 7.4 10.3 11.4 7.9 6.7 13.1 11.4 2.8 18.5 11.5 4.8 8.3 7.9 11.9 15.8 17.3 12.8 12.5 14.1 14.1 12.8 15.0 14.1 12.7 20.6 41.1 70.5 63.1 116.5 46.9 71.0 68.8 28.8 45.5 67.5 41.1 30.9 222.5 40.0 56.0 23.9 47.9 69.6 57.2 30.4 25.4 39.5 40.1 49.8 63.0 44.8 59.3 34.3 122.7 38.9 33.2 69.7 44.4 134.5 54.3 52.6 32.5 53.9 28.0 63.9 136.5 32.9 24.4 27.7 39.7 30.0 44.1 41.8 24.9 96.5 40.5 79.7 68.0 171.4 315.9 44.8 31.5 50.0 55.2 65.5 29.7 21.9 48.2 52.4 52.6 85.0 68.2 92.8 55.1 46.6 87.9 125.7 65.0 41.8 35.0 58.9 UTP3 "CRLZ1, DKFZp761F222, FLJ23256, SAS10" ENSG00000132467 "UTP3 small subunit processome component" Q9NQZ2 4 70688532-70690551 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035655, HPA041453" Approved Supported Nucleoli,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" Nucleoli Vesicles "HPA035655: AB_10601832, HPA041453: AB_2677488" "unprognostic (2.44e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-2)" "unprognostic (6.79e-3)" "unprognostic (2.13e-1)" "unprognostic (3.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (4.44e-3)" "prognostic favorable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (7.95e-2)" "unprognostic (2.24e-1)" "unprognostic (2.24e-2)" 22.4 22.7 8.9 25.5 9.5 19.1 18.7 9.4 11.3 14.0 10.0 16.9 16.3 16.1 15.0 20.6 16.3 14.6 17.0 9.9 9.8 21.0 27.1 18.6 33.0 9.1 9.3 15.7 14.9 16.3 9.4 16.3 9.1 15.1 16.4 12.0 15.9 13.7 15.9 18.8 21.5 20.2 8.7 34.5 17.8 11.4 9.6 32.1 16.0 13.1 31.5 22.1 12.3 10.0 33.7 32.3 42.4 35.4 58.9 44.3 36.3 68.4 43.9 38.4 37.0 42.4 43.7 147.4 42.1 58.9 43.8 27.7 62.7 93.7 55.4 45.9 35.9 56.1 43.0 45.9 63.9 85.9 47.9 60.4 55.2 47.0 46.0 42.3 52.2 42.3 65.3 48.2 62.8 69.7 79.9 47.8 29.6 68.9 46.7 33.8 58.3 60.5 69.7 53.7 35.5 48.4 29.1 65.4 44.5 46.1 36.1 34.2 58.5 38.8 65.9 37.3 44.3 69.6 55.4 104.8 47.3 41.4 34.8 8.4 10.7 5.6 6.4 12.6 6.8 7.0 5.3 7.4 13.4 6.1 7.7 6.7 0.8 6.8 11.3 13.5 7.3 5.5 8.9 9.5 9.4 11.3 9.9 9.8 9.1 9.3 9.1 8.7 9.6 10.0 19.2 57.7 54.2 4.9 23.7 22.9 44.3 42.2 24.5 19.4 12.3 14.4 20.6 14.3 50.5 12.9 6.2 26.7 30.0 11.8 19.6 29.3 1.1 22.8 29.3 26.7 15.0 16.8 6.2 29.8 14.6 23.6 21.9 25.1 29.2 16.7 16.8 25.1 21.9 16.8 5.9 14.7 30.5 37.8 24.2 2.2 17.4 24.2 12.4 5.6 27.9 26.8 30.9 2.5 8.9 22.6 9.5 25.2 18.5 23.0 15.9 27.9 45.7 22.3 13.1 30.8 48.8 11.5 9.5 23.0 25.6 21.6 24.6 22.2 15.6 29.9 VAC14 "ArPIKfyve, FLJ10305, TAX1BP2" ENSG00000103043 "VAC14 component of PIKFYVE complex" Q08AM6 16 70687439-70801160 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027766, HPA075382" Approved Supported Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" Vesicles Cytosol "HPA027766: AB_1848651, HPA075382: " "unprognostic (9.25e-2)" "prognostic favorable (8.33e-5)" "unprognostic (2.83e-2)" "unprognostic (1.51e-1)" "unprognostic (8.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.21e-2)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (1.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.26e-1)" "prognostic favorable (1.56e-6)" "unprognostic (1.61e-1)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (1.80e-1)" 17.3 25.0 20.6 14.5 19.3 11.3 17.1 19.5 24.7 16.2 18.0 16.7 12.1 16.9 8.6 19.0 15.1 10.2 20.3 20.8 20.5 26.3 27.1 16.9 24.7 21.5 20.0 14.3 23.7 17.5 16.6 10.9 21.4 17.5 8.3 6.8 17.4 10.7 24.3 23.0 17.9 11.5 19.2 22.5 20.7 16.2 21.6 15.5 21.4 12.0 13.9 18.1 14.9 21.6 25.9 25.3 21.0 23.6 29.9 20.3 32.0 18.5 29.0 34.6 15.5 31.6 41.0 33.3 23.3 22.5 39.9 32.3 27.8 30.1 16.3 10.0 28.2 16.9 18.6 39.5 76.8 29.1 33.7 36.0 30.9 50.7 45.1 20.7 33.0 29.2 30.1 14.6 30.1 37.3 27.1 48.5 36.9 20.4 22.7 32.3 14.9 48.6 16.7 17.4 24.9 26.7 60.9 18.5 43.0 15.2 27.4 27.0 26.7 45.7 25.9 29.2 20.4 20.4 27.5 62.9 76.1 25.1 21.3 0.8 2.7 4.4 1.5 3.6 1.4 2.5 2.2 3.1 5.6 3.9 2.0 1.8 1.0 2.4 3.6 3.1 1.3 1.1 20.6 19.3 19.5 24.7 20.8 20.5 21.5 20.0 21.4 19.2 21.6 21.6 5.1 3.2 4.2 15.0 10.1 4.2 7.8 7.0 9.6 8.4 8.4 7.4 12.6 12.8 8.0 3.7 2.1 16.7 4.0 11.5 5.9 19.2 20.4 14.2 5.4 8.2 9.1 5.7 11.7 22.5 29.2 5.9 11.7 6.7 5.7 11.6 16.4 15.9 42.9 10.1 13.8 10.0 14.2 18.3 13.5 74.4 6.2 15.6 10.6 10.3 19.2 6.8 8.2 8.5 16.3 20.8 10.8 3.4 15.8 8.9 13.7 15.0 14.6 7.7 6.6 5.9 7.9 4.8 13.5 10.3 9.1 19.6 6.5 8.7 12.6 7.1 VBP1 "PFD3, PFDN3" ENSG00000155959 "VHL binding protein 1" P61758 X 155197007-155239841 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006260, HPA023230" Approved Supported Vesicles,Cytosol NA NA 15000 "Cluster 49: Eosinophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Vesicles "CAB006260: AB_425740, HPA023230: AB_1858727" "unprognostic (1.55e-3)" "unprognostic (1.12e-3)" "unprognostic (3.35e-1)" "unprognostic (1.35e-2)" "unprognostic (3.78e-2)" "unprognostic (1.85e-3)" "unprognostic (5.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (9.80e-2)" "unprognostic (1.15e-1)" "unprognostic (5.76e-2)" "unprognostic (3.76e-2)" "unprognostic (4.54e-2)" "unprognostic (9.30e-2)" "unprognostic (3.80e-1)" 32.1 32.5 48.6 29.4 50.2 50.5 31.6 54.6 60.5 24.2 43.6 30.1 23.0 25.2 26.6 31.0 23.5 21.1 65.7 49.5 53.7 40.4 31.2 23.3 41.3 52.7 52.8 25.5 19.7 38.2 29.7 30.2 53.4 30.9 33.0 48.2 20.6 25.4 101.5 19.3 24.3 28.9 54.6 24.8 22.6 15.9 51.9 45.8 31.6 121.2 40.4 32.2 19.9 60.1 162.8 57.6 122.1 81.1 49.6 68.0 35.2 78.8 60.7 99.7 155.3 69.1 80.8 207.1 163.6 66.8 154.1 62.4 179.3 74.0 129.5 110.0 123.9 87.6 86.0 54.2 58.9 142.6 65.5 51.0 84.7 84.7 105.6 53.1 93.7 101.0 173.4 119.9 113.6 67.7 134.3 120.9 71.0 149.1 122.1 114.0 97.0 121.4 86.8 73.0 132.0 80.0 54.1 62.7 90.1 83.4 53.8 107.5 55.6 80.5 100.0 138.3 198.0 133.9 209.0 361.3 71.6 173.1 101.0 22.5 23.0 75.8 26.3 25.1 30.2 28.6 30.5 31.7 36.2 23.7 34.5 37.5 26.3 28.2 21.9 29.5 43.2 33.0 48.6 50.2 54.6 60.5 49.5 53.7 52.7 52.8 53.4 54.6 51.9 60.1 40.7 51.3 29.1 12.1 55.1 57.4 81.2 89.9 33.6 54.9 33.2 30.2 80.5 30.0 48.0 38.6 20.9 73.7 60.4 27.9 191.7 65.8 2.5 32.8 41.3 47.3 23.4 128.6 12.7 57.6 101.4 52.6 28.5 28.9 47.5 36.6 30.7 24.9 67.6 32.0 14.2 30.0 75.3 29.5 64.4 4.6 42.0 40.7 46.2 6.5 80.1 78.7 47.4 6.6 21.3 52.7 43.1 39.9 56.8 78.0 29.3 126.3 37.2 46.3 46.0 45.1 52.8 80.7 88.2 37.1 52.6 68.7 60.0 81.6 45.9 63.0 VGF "SCG7, SgVII" ENSG00000128564 "VGF nerve growth factor inducible" O15240 7 101162509-101165569 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 1407.4" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 128.3;Horizontal cells: 225.4" "Cancer enriched" "Detected in many" 6 "melanoma: 236.3" "Region enriched" "Detected in all" 6 "hypothalamus: 1407.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055177, HPA072505" Enhanced Enhanced "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1270000 3100000 "Cluster 73: Brain - Neuropeptide signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus, Vesicles" "HPA055177: AB_2682728, HPA072505: AB_2686528" "unprognostic (3.04e-2)" "unprognostic (3.45e-1)" "unprognostic (3.19e-3)" "prognostic unfavorable (4.25e-4)" "prognostic unfavorable (3.31e-4)" "unprognostic (1.51e-2)" "unprognostic (2.86e-2)" "unprognostic (1.66e-3)" "unprognostic (2.25e-2)" "unprognostic (8.77e-2)" "unprognostic (3.84e-3)" "unprognostic (3.70e-3)" "unprognostic (9.82e-3)" "unprognostic (3.79e-1)" "unprognostic (7.23e-2)" "unprognostic (4.36e-3)" "unprognostic (2.21e-1)" 2.1 3.1 23.7 0.8 24.8 0.1 0.1 5.5 174.6 0.0 0.0 0.5 0.1 0.7 0.0 0.0 0.0 0.0 0.1 22.7 1407.4 3.6 0.0 0.1 0.0 235.4 69.9 0.1 16.1 0.0 117.0 0.0 158.8 0.1 0.0 2.2 0.0 0.0 0.0 0.8 0.3 0.2 16.6 0.1 1.9 0.9 48.7 0.0 0.6 0.0 0.0 0.0 0.1 27.3 2.2 1.1 1.1 9.5 0.0 0.0 10.3 0.9 0.0 0.0 0.0 2.4 0.9 0.1 3.1 0.0 1.4 1.4 0.5 0.1 0.0 1.0 0.7 0.3 0.0 0.9 0.1 0.6 4.4 0.1 0.2 0.2 0.7 0.0 0.0 0.1 3.7 2.3 0.0 23.4 0.1 2.4 17.6 1.0 2.3 0.8 0.0 0.1 0.3 0.1 14.1 172.0 0.3 0.9 511.5 1.1 0.4 0.3 0.0 0.4 85.9 0.0 2.0 0.1 0.8 4.7 13.5 0.4 141.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 24.8 5.5 174.6 22.7 1407.4 235.4 69.9 158.8 16.6 48.7 27.3 1.7 0.0 0.0 3.6 0.9 1.5 1.0 0.0 1.2 22.0 0.9 0.6 2.9 0.0 0.0 0.0 0.0 1.5 1.0 1.3 29.4 0.3 0.1 0.4 0.4 0.9 128.3 0.0 22.7 0.0 8.4 0.3 3.1 0.5 0.0 1.4 0.0 0.0 0.6 225.4 37.7 4.5 0.0 0.0 0.4 0.6 0.6 0.7 0.0 11.2 0.0 2.1 0.0 4.0 4.8 5.9 2.8 0.0 0.9 4.3 2.7 1.2 0.0 5.0 0.0 0.1 0.8 0.2 4.3 0.6 2.3 1.4 0.5 5.4 2.3 0.6 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.5;Cone photoreceptor cells: 2.1;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 2.5;Rod photoreceptor cells: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.9;U-266/70: 2.5;U-266/84: 3.3" "Not detected" "Not detected" HPA062209 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 54: Non-specific - Microtubule organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.5 1.0 2.2 0.2 2.4 0.3 0.7 4.5 2.4 0.6 1.8 1.2 0.0 0.5 2.2 0.6 0.8 0.3 2.0 2.3 1.9 1.2 1.0 0.8 0.4 1.8 1.9 1.2 0.6 1.1 3.4 0.6 1.4 1.3 0.3 8.2 0.9 0.6 2.3 1.7 0.7 0.3 1.3 1.1 0.5 1.3 1.9 0.4 1.7 2.7 0.3 0.9 0.6 2.2 0.2 0.0 0.8 0.9 0.0 0.2 0.4 0.2 0.3 0.2 0.8 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.3 0.0 2.9 0.4 0.0 0.3 0.1 0.2 0.5 0.3 0.3 0.0 0.1 0.4 0.1 0.3 0.1 0.4 0.4 0.1 0.2 0.9 0.2 0.0 0.3 0.2 0.5 0.4 0.2 0.5 1.5 0.6 0.0 0.2 0.0 0.4 0.4 0.3 0.0 0.6 0.1 0.1 0.3 2.5 3.3 0.2 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.4 4.5 2.4 2.3 1.9 1.8 1.9 1.4 1.3 1.9 2.2 0.4 0.0 1.1 0.0 0.4 0.0 0.1 0.0 0.0 4.5 0.2 0.0 0.3 0.0 0.6 0.0 2.1 0.2 1.4 0.0 0.0 0.3 0.0 0.2 0.1 0.6 0.0 0.4 1.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.3 0.1 6.7 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 1.1 0.0 2.5 0.3 0.1 0.0 0.7 0.0 0.3 0.1 0.0 0.0 4.4 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.2 VPS29 "DC15, DC7, PEP11" ENSG00000111237 "VPS29 retromer complex component" Q9UBQ0 12 110491083-110502111 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039748 Uncertain Supported Vesicles,Cytosol NA NA 110000 "Cluster 51: Monocytes - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" "Vesicles, Cytosol" "HPA039748: AB_10674426" "unprognostic (9.46e-2)" "unprognostic (3.46e-3)" "unprognostic (2.16e-2)" "unprognostic (2.58e-1)" "unprognostic (3.08e-1)" "unprognostic (2.26e-2)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.52e-1)" "unprognostic (3.37e-2)" "prognostic favorable (7.70e-4)" "unprognostic (1.64e-1)" "unprognostic (2.10e-3)" "unprognostic (2.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.11e-1)" "unprognostic (5.57e-2)" "unprognostic (4.29e-3)" 61.1 62.7 45.6 57.0 47.0 96.2 59.2 46.2 61.8 50.3 47.0 76.4 64.1 52.9 89.5 71.1 50.3 51.1 73.8 48.7 48.3 79.2 77.6 54.9 69.7 47.2 46.3 47.1 56.6 54.8 53.7 47.3 47.4 62.7 79.0 99.6 58.5 71.3 127.3 46.8 65.7 67.1 48.0 76.5 62.8 32.6 46.1 63.2 54.1 100.8 72.0 65.1 50.6 51.1 103.5 98.6 91.9 65.6 100.4 98.7 72.6 94.9 98.1 93.9 84.2 100.0 87.0 94.0 97.1 94.3 87.7 95.5 123.1 88.0 97.0 112.2 98.9 115.4 122.6 83.0 87.4 139.5 97.1 66.0 73.3 79.3 87.4 114.1 166.0 116.6 112.1 85.5 170.0 51.9 110.3 196.4 52.6 90.9 124.8 72.2 93.5 131.8 157.0 149.7 98.1 51.8 107.9 94.0 122.8 78.5 128.6 106.0 94.0 80.6 53.4 112.9 113.0 58.0 87.5 112.1 93.9 130.8 87.8 246.2 262.7 259.4 139.1 356.8 155.3 195.9 175.5 164.9 318.3 158.7 159.8 156.8 178.7 202.9 405.4 214.0 224.8 385.1 45.6 47.0 46.2 61.8 48.7 48.3 47.2 46.3 47.4 48.0 46.1 51.1 138.8 76.9 96.2 21.2 93.7 143.5 172.6 395.9 70.6 39.0 93.4 109.2 282.4 90.1 209.7 101.2 27.1 192.8 116.5 156.3 289.5 231.0 56.8 94.7 79.8 125.0 83.2 147.5 30.2 179.8 187.6 120.2 60.1 104.1 153.9 78.1 94.9 158.7 409.9 42.1 26.7 149.8 248.2 158.0 296.1 82.6 92.2 178.7 177.9 30.9 295.2 107.9 101.0 22.6 30.4 217.9 182.2 105.7 94.8 157.4 142.2 404.7 131.1 111.8 157.8 81.9 212.1 256.4 148.4 108.3 173.0 178.8 111.2 105.8 164.5 187.7 VPS37C FLJ20847 ENSG00000167987 "VPS37C subunit of ESCRT-I" A5D8V6 11 61130257-61161615 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 1.4;eosinophil: 1.7;intermediate monocyte: 2.6;myeloid DC: 1.0;neutrophil: 3.8;non-classical monocyte: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.0;granulocytes: 3.8;monocytes: 2.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043348 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles Nucleoplasm "HPA043348: AB_10794658" "unprognostic (1.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-1)" "unprognostic (9.01e-2)" "prognostic unfavorable (5.85e-5)" "unprognostic (7.42e-2)" "unprognostic (1.14e-1)" "unprognostic (3.00e-1)" "unprognostic (3.41e-2)" "unprognostic (3.17e-2)" "prognostic favorable (2.37e-7)" "unprognostic (1.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.85e-1)" "unprognostic (7.05e-2)" 14.1 13.8 11.5 13.2 10.9 10.3 14.0 10.0 12.2 14.3 11.9 17.7 17.1 15.9 5.2 22.0 12.5 11.2 15.8 12.6 9.9 16.8 10.7 14.5 8.1 11.9 11.6 14.1 24.1 11.9 20.1 14.1 10.5 20.9 10.5 22.7 23.3 14.6 23.6 22.2 15.5 14.5 9.6 13.3 27.7 15.3 12.0 6.2 12.1 11.8 10.0 18.3 15.9 11.4 33.8 13.1 16.7 16.1 8.0 16.6 37.2 16.4 44.0 23.9 16.2 15.7 15.6 8.8 22.5 22.5 19.7 18.5 15.2 17.3 12.3 19.2 11.4 11.2 9.0 17.8 25.7 9.0 13.7 15.0 26.3 20.6 25.7 14.3 15.8 6.0 29.6 14.6 16.4 41.1 2.0 13.7 20.6 14.7 18.8 3.1 7.2 21.4 18.9 17.2 10.3 25.1 16.4 52.2 28.8 14.0 49.5 22.2 12.1 23.9 17.2 24.4 20.8 6.9 10.0 7.2 21.6 11.1 16.5 0.4 1.4 1.7 0.3 2.6 0.4 0.5 0.2 0.4 1.0 0.5 0.3 0.1 3.8 0.2 2.4 0.1 0.2 0.7 11.5 10.9 10.0 12.2 12.6 9.9 11.9 11.6 10.5 9.6 12.0 11.4 6.3 16.0 6.0 5.9 4.1 12.5 14.3 9.4 10.2 5.8 14.9 9.3 7.5 12.8 10.0 12.9 10.4 30.6 1.2 15.6 11.7 17.4 8.9 5.0 4.0 11.2 16.3 4.2 8.9 19.8 20.9 10.6 13.7 6.8 0.0 5.1 7.1 6.7 17.3 25.2 7.1 18.3 8.2 13.7 11.4 6.5 7.8 13.9 7.2 13.1 12.3 11.5 2.1 4.5 8.3 21.7 11.3 13.5 2.2 17.7 19.0 7.2 12.2 41.7 0.0 6.7 9.2 12.9 16.7 8.4 19.9 35.2 2.9 7.4 10.6 14.5 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" No No 32000 "Cluster 1: Neutrophils - Mixed function" "Cluster 37: Intestine - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489" "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 24.2 18.3 10.5 25.5 13.1 52.6 28.8 13.2 17.8 26.8 9.3 42.3 35.1 22.7 19.5 75.4 18.6 23.7 16.2 10.3 14.6 23.8 28.4 23.8 31.2 13.5 15.9 19.3 17.3 27.8 11.5 28.7 14.0 23.4 37.0 7.0 24.7 19.5 11.0 32.3 36.4 21.0 12.6 28.8 32.5 12.1 12.5 31.4 28.5 13.0 39.1 30.2 31.1 15.6 57.1 21.9 22.4 24.5 33.5 47.1 38.9 48.6 45.5 36.4 39.2 15.7 39.4 54.1 31.2 35.7 30.9 119.6 26.8 53.1 47.5 40.6 22.3 27.6 27.8 23.7 48.6 94.5 56.8 43.1 80.3 32.3 56.2 36.5 33.9 31.0 14.3 49.4 52.1 20.2 59.9 29.2 23.2 22.7 32.3 48.8 47.2 52.4 45.6 66.2 38.2 33.6 36.9 35.4 55.3 28.3 34.2 50.5 52.8 55.4 27.3 21.6 32.7 163.6 86.5 69.3 31.9 44.0 42.3 163.6 54.6 125.0 52.2 56.5 49.0 64.8 54.3 54.2 46.2 73.4 48.2 51.1 185.9 68.4 76.5 45.6 66.7 56.6 10.5 13.1 13.2 17.8 10.3 14.6 13.5 15.9 14.0 12.6 12.5 15.6 52.0 115.4 57.4 21.5 62.4 68.8 47.2 66.5 44.9 37.0 54.4 46.0 39.5 47.1 72.4 33.1 22.9 70.0 92.2 142.0 45.0 48.0 113.3 92.2 74.0 44.6 45.5 27.8 27.3 42.1 56.7 51.0 47.4 145.5 59.3 37.7 36.8 55.8 46.4 43.7 29.6 76.8 67.1 58.8 33.0 15.5 49.0 58.0 32.0 18.7 53.4 39.2 76.2 18.6 49.5 91.3 120.7 36.5 42.1 43.1 61.8 57.9 85.1 31.5 59.2 45.6 54.7 30.1 29.4 87.5 83.4 140.4 67.4 56.5 72.6 79.5 VRK3 ENSG00000105053 "VRK serine/threonine kinase 3" Q8IV63 19 49976468-50025946 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 135.6" "Group enriched" "Detected in all" 7 "Early spermatids: 557.6;Late spermatids: 1646.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056489 Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 21: OE19 - Mitochondria" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA056489: AB_2683150" "unprognostic (2.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-1)" "unprognostic (4.94e-3)" "unprognostic (1.23e-1)" "unprognostic (2.22e-3)" "unprognostic (9.78e-2)" "unprognostic (3.47e-1)" "unprognostic (8.79e-2)" "unprognostic (2.48e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-1)" "prognostic favorable (1.83e-4)" "unprognostic (9.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.66e-4)" 17.4 23.3 25.9 17.6 26.6 23.6 17.7 26.1 28.6 17.9 30.2 21.9 25.8 15.9 19.5 17.6 33.2 20.9 17.5 25.4 27.9 36.5 35.6 16.9 28.5 27.6 31.1 21.2 22.1 15.9 20.6 16.9 30.4 20.2 22.0 64.8 21.9 15.4 26.9 16.8 32.9 14.1 25.2 26.0 21.6 135.6 27.9 35.6 19.7 17.4 25.7 18.0 16.8 29.3 31.0 31.3 22.6 24.5 29.2 26.9 23.3 21.7 25.7 31.6 34.5 16.8 33.7 37.1 15.2 21.2 22.1 22.5 21.3 18.6 25.5 32.6 43.5 28.9 20.4 29.4 21.9 36.7 48.7 24.2 27.3 18.3 19.2 28.4 26.5 39.9 35.8 53.7 23.2 13.0 49.7 24.5 12.2 54.6 26.7 39.3 23.9 47.6 27.2 32.2 25.3 12.3 21.5 26.0 24.7 20.0 23.9 38.5 20.2 32.2 18.6 13.1 17.1 34.3 47.4 19.6 25.8 22.3 22.5 110.0 42.8 81.1 53.7 46.1 43.3 58.9 48.7 51.9 47.9 53.3 49.2 45.3 112.5 82.7 55.1 45.4 76.1 48.4 25.9 26.6 26.1 28.6 25.4 27.9 27.6 31.1 30.4 25.2 27.9 29.3 19.6 6.4 28.6 10.1 26.6 6.6 16.0 27.2 6.8 34.3 17.9 14.5 8.4 24.3 29.8 14.7 143.9 43.8 27.9 49.9 31.3 31.0 557.6 50.7 12.0 16.0 22.2 38.7 13.9 32.7 38.6 15.5 18.8 26.8 18.3 24.1 28.5 44.5 34.8 32.0 15.9 35.4 34.6 25.4 9.3 1646.8 22.1 22.9 14.2 6.5 40.6 33.2 41.2 10.1 15.3 34.2 67.9 25.9 18.6 20.6 87.5 91.4 71.8 116.0 13.1 12.0 15.2 142.8 52.6 10.5 10.9 57.3 28.0 24.9 36.0 30.1 VSIG1 "GPA34, MGC44287" ENSG00000101842 "V-set and immunoglobulin domain containing 1" Q86XK7 X 108044970-108079184 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "stomach 1: 193.6" "Cell type enriched" "Detected in some" 10 "Gastric mucus-secreting cells: 333.8" "Group enriched" "Detected in many" 17 "lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 12.0;T-reg: 12.9" "Lineage enriched" "Detected in many" 4 "T-cells: 12.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.5;HUVEC TERT2: 7.4;PC-3: 2.3;TIME: 1.7" "Not detected" "Not detected" "HPA001445, HPA036310, HPA036311" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 4: Stomach - Digestion" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Vesicles, Cytosol" "HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350" "unprognostic (4.33e-3)" "unprognostic (4.60e-2)" "unprognostic (3.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-1)" "unprognostic (4.80e-2)" "unprognostic (3.25e-2)" "unprognostic (9.79e-2)" "unprognostic (4.58e-1)" "unprognostic (2.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.25e-1)" "unprognostic (6.31e-7)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-3)" 0.0 0.1 0.1 1.3 0.3 0.5 0.1 0.2 0.3 0.0 0.2 0.2 1.2 0.1 0.3 0.2 0.0 8.4 0.0 0.2 0.2 0.1 0.1 1.0 1.9 0.1 0.1 0.0 0.2 0.0 2.6 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.5 0.0 0.0 0.8 193.6 47.7 0.1 0.8 0.1 0.0 1.6 8.9 0.1 0.1 0.1 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.6 0.0 1.1 0.0 7.4 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.2 0.6 2.3 0.2 0.0 0.0 0.3 0.6 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.7 0.1 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 1.0 0.0 3.8 2.8 8.1 3.6 0.0 1.3 12.0 5.8 0.3 0.1 0.1 0.1 12.9 2.6 0.1 0.3 0.2 0.3 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.2 25.6 11.0 1.0 2.4 0.6 0.9 0.7 0.0 0.9 0.2 0.1 0.5 1.5 0.7 0.0 0.0 0.0 0.1 0.4 0.0 2.9 6.1 1.1 0.1 1.0 0.0 0.0 4.1 4.6 0.0 0.6 333.8 0.2 2.5 0.0 0.0 0.0 0.1 0.0 1.4 0.3 0.0 0.0 0.4 10.8 0.6 0.7 0.0 0.0 0.3 0.1 1.0 0.0 0.1 32.9 0.0 0.0 1.0 0.6 0.0 0.0 0.9 0.8 0.0 1.1 0.2 1.0 0.6 0.0 0.0 0.1 4.5 0.2 0.1 3.8 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014236-49115522 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 88.5;Granulosa cells: 96.9;Late spermatids: 140.6;Sertoli cells: 59.2;Theca cells: 44.7" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 8.6;RH-30: 9.3;SH-SY5Y: 7.9;U-138 MG: 10.6;U-2197: 24.0;U-87 MG: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.25e-4)" 18.7 41.5 7.1 3.2 9.0 0.3 9.8 8.0 6.6 22.3 7.7 7.8 2.5 12.3 7.4 7.8 8.5 10.5 12.3 6.2 7.6 12.3 3.9 10.9 3.5 8.9 9.3 35.2 1.5 26.8 5.1 10.4 9.2 13.5 5.6 2.3 3.4 11.7 5.6 4.9 4.9 11.4 8.6 2.3 5.6 9.4 8.4 6.5 27.8 5.9 4.6 12.0 7.5 9.4 0.0 0.0 3.1 0.1 1.3 0.7 0.1 2.6 4.1 0.9 0.2 0.0 0.1 0.1 0.1 6.1 3.4 0.1 0.2 0.0 0.4 3.2 1.4 0.2 0.1 0.1 0.1 0.1 0.0 4.7 0.0 4.2 0.0 0.0 0.0 0.8 8.6 0.1 0.8 0.1 0.0 0.2 0.6 0.0 0.0 0.0 9.3 5.0 0.0 0.1 0.1 7.9 0.1 0.0 0.0 0.4 0.1 0.3 0.0 10.6 1.2 24.0 0.1 0.0 6.8 0.0 11.6 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.3 0.1 0.1 0.0 0.0 7.1 9.0 8.0 6.6 6.2 7.6 8.9 9.3 9.2 8.6 8.4 9.4 9.4 3.2 17.5 17.3 1.3 6.5 1.6 0.1 0.6 5.4 1.2 1.1 16.7 0.0 9.4 0.0 2.1 0.4 3.7 0.2 1.9 0.1 88.5 0.8 10.7 6.2 0.0 0.0 11.1 0.0 0.3 29.7 0.0 0.7 12.6 96.9 5.3 5.0 0.7 5.0 7.0 0.0 0.0 2.2 11.1 140.6 9.6 2.9 7.2 4.7 1.0 9.1 2.1 20.1 33.3 0.2 0.1 14.7 0.7 0.8 0.0 9.4 3.8 2.9 59.2 20.6 37.7 1.3 4.4 0.4 4.3 0.4 2.0 44.7 0.0 0.7 VTI1A "MVti1, Vti1-rp2" ENSG00000151532 "Vesicle transport through interaction with t-SNAREs 1A" Q96AJ9 10 112446998-112818744 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 135.2;Excitatory neurons: 244.7;Inhibitory neurons: 199.5;Late spermatids: 102.8;Microglial cells: 195.8;Oligodendrocyte precursor cells: 172.4;Oligodendrocytes: 218.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054108 Supported Supported "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Vesicles" "HPA054108: AB_2682382" "unprognostic (9.81e-2)" "unprognostic (6.42e-2)" "unprognostic (4.49e-2)" "unprognostic (1.50e-1)" "unprognostic (1.66e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.50e-5)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic favorable (7.27e-5)" "unprognostic (3.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-3)" "unprognostic (2.61e-1)" 6.6 4.7 3.7 7.0 3.7 13.8 4.7 2.3 4.7 3.5 1.1 6.4 7.2 3.8 4.9 7.3 3.2 4.6 5.8 4.8 2.6 6.8 4.7 5.1 7.7 2.8 3.7 3.1 3.9 7.5 2.6 4.0 3.5 4.7 7.5 4.2 5.2 4.8 7.4 5.9 7.2 5.7 1.8 5.6 5.5 4.5 4.3 8.6 6.3 6.1 9.4 5.2 4.4 4.6 13.5 11.2 10.1 14.1 15.5 13.4 6.1 14.1 17.4 11.0 12.2 12.7 13.6 14.0 5.3 16.0 9.3 15.6 8.8 11.2 14.9 18.0 8.1 11.9 8.1 13.3 11.0 16.8 16.8 10.4 13.9 12.6 25.9 12.4 11.9 14.1 11.3 16.9 14.8 9.5 13.3 12.8 4.4 10.5 6.5 13.9 14.6 6.2 11.5 11.9 4.6 9.0 10.0 8.6 9.5 8.4 7.8 9.3 17.0 8.7 7.4 10.8 15.8 7.4 11.0 15.9 14.2 15.3 8.6 9.2 7.0 9.6 5.4 9.3 5.1 5.5 4.5 4.4 5.2 4.6 4.3 4.4 11.4 5.7 8.7 4.9 7.2 4.6 3.7 3.7 2.3 4.7 4.8 2.6 2.8 3.7 3.5 1.8 4.3 4.6 13.5 12.8 10.3 135.2 33.1 11.2 14.5 8.8 13.6 16.5 7.8 4.6 14.0 7.2 11.6 5.5 43.8 7.6 31.5 17.0 7.9 15.4 42.9 11.4 15.5 13.6 18.5 18.1 244.7 25.0 12.3 12.9 21.9 17.0 19.6 10.2 8.9 8.1 18.8 21.9 199.5 10.7 14.2 17.0 27.0 102.8 6.8 20.9 12.4 195.8 19.0 6.0 25.7 172.4 218.6 29.7 12.2 5.7 23.9 12.6 17.2 9.4 11.7 20.7 0.0 13.5 14.1 11.1 9.2 17.0 16.3 14.4 25.4 9.7 12.1 19.7 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647085-67674820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206" "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favorable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 53.8 26.9 55.5 20.4 56.8 22.3 39.8 54.4 102.1 22.7 49.8 42.9 28.3 18.4 53.5 44.3 18.5 28.7 60.1 56.6 58.1 53.0 41.6 26.8 23.8 55.1 56.6 21.0 44.0 23.9 17.1 21.3 56.8 22.3 35.2 23.0 30.1 13.6 46.5 31.0 24.1 22.4 56.0 26.5 40.0 30.8 56.3 12.1 34.0 28.2 27.0 33.3 23.4 56.9 111.7 54.8 31.4 18.1 61.9 37.2 45.4 48.1 30.5 23.8 23.7 27.3 38.5 32.9 40.2 54.5 27.5 30.6 36.8 36.6 37.7 34.3 22.6 33.4 32.5 34.8 26.6 20.9 22.9 36.3 39.6 25.6 26.1 60.5 27.2 23.1 22.2 25.4 34.5 131.1 26.6 77.7 20.3 76.6 88.0 31.8 35.6 12.2 35.1 65.0 17.4 35.5 33.8 45.5 71.4 23.7 41.9 58.0 38.5 62.6 93.8 51.4 45.6 23.8 27.8 53.2 52.9 38.9 29.0 88.8 61.5 143.8 49.4 80.4 42.4 49.0 43.1 51.1 59.6 43.0 40.5 50.3 27.2 56.4 70.2 38.6 60.2 58.3 55.5 56.8 54.4 102.1 56.6 58.1 55.1 56.6 56.8 56.0 56.3 56.9 47.6 25.6 35.0 13.1 48.7 42.3 61.4 91.7 33.0 23.2 82.2 65.4 30.5 67.2 64.4 66.2 22.9 107.4 47.5 138.2 217.2 109.1 141.7 58.5 43.2 51.5 46.6 102.7 15.8 131.4 167.9 51.6 40.8 49.5 64.0 43.6 73.9 95.3 131.4 15.2 18.2 96.0 50.8 99.8 49.2 493.5 41.7 80.9 71.2 11.2 121.6 65.4 78.2 13.6 17.1 130.7 119.4 39.9 51.0 120.5 165.4 268.6 55.3 44.8 19.7 36.5 58.2 104.5 57.2 58.2 52.8 125.9 46.8 35.5 91.9 124.6 VTN VN ENSG00000109072 Vitronectin P04004 17 28367284-28373091 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "liver: 6039.5" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 5507.4" "Cancer enriched" "Detected in many" 85 "liver cancer: 2216.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "CACO-2: 1748.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016695, CAB016765, HPA060933, HPA068011" Supported Supported "Endoplasmic reticulum,Vesicles" "Secreted to blood" NA NA 606000000000 33000000000 "Cluster 62: Liver - Hemostasis" "Cluster 39: CACO-2 - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" "Endoplasmic reticulum, Vesicles" "CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: " "unprognostic (1.19e-1)" "unprognostic (2.12e-1)" "unprognostic (2.29e-2)" "unprognostic (6.13e-2)" "unprognostic (9.74e-2)" "unprognostic (8.42e-2)" "prognostic favorable (3.74e-4)" "unprognostic (6.20e-2)" "unprognostic (3.97e-1)" "unprognostic (8.95e-2)" "unprognostic (3.24e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (4.10e-11)" "unprognostic (8.82e-3)" "unprognostic (2.27e-1)" "unprognostic (4.86e-3)" "unprognostic (7.09e-2)" 6.2 98.9 2.4 2.5 2.7 0.3 0.9 5.4 3.7 1.0 0.4 0.9 4.6 1.4 0.9 0.5 2.2 61.2 53.1 2.5 2.8 3.6 6039.5 1.8 4.3 2.1 5.3 1.9 17.7 0.1 3.0 40.6 2.3 1.2 0.3 47.4 0.6 4.3 0.4 0.8 1.3 2.7 1.5 2.9 5.1 10.0 2.2 0.1 0.8 0.5 0.4 4.2 0.7 2.4 0.0 28.4 0.7 0.4 0.2 0.3 7.3 1.8 0.8 0.9 0.9 1748.9 0.1 1.2 0.2 0.2 0.2 0.7 0.0 0.0 0.1 0.2 0.2 1.2 1.1 86.7 2.5 6.1 0.5 0.4 0.0 0.6 0.0 3.9 0.1 0.0 1.6 0.3 0.2 0.7 0.2 0.0 0.8 0.4 0.1 0.4 3.5 0.1 0.3 0.0 1.0 1.4 115.6 8.0 0.2 4.3 0.3 0.0 1.0 0.4 0.3 0.1 0.2 1.0 0.5 1.4 0.5 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 2.4 2.7 5.4 3.7 2.5 2.8 2.1 5.3 2.3 1.5 2.2 2.4 0.1 0.0 1.1 2.0 21.5 0.0 0.0 0.0 0.0 13.0 0.1 0.1 18.1 1162.4 0.0 0.0 77.2 3.7 0.0 0.0 3.9 16.8 0.0 0.0 1.2 7.3 0.0 131.0 0.9 19.7 2.8 48.1 0.0 0.0 0.0 1.8 120.3 5507.4 4.7 38.7 1.0 0.1 0.0 160.3 0.3 0.2 0.0 0.3 0.0 0.0 20.1 6.9 0.0 1.0 0.5 23.5 1.2 1.5 0.0 0.0 0.1 9.5 0.0 38.3 0.0 0.4 1.5 4.2 0.6 0.0 0.0 9.6 9.0 0.7 0.0 0.0 VWA8 KIAA0564 ENSG00000102763 "Von Willebrand factor A domain containing 8" A3KMH1 13 41566835-41961120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 161.9;Excitatory neurons: 183.9;Inhibitory neurons: 252.6;Oligodendrocyte precursor cells: 151.3;Oligodendrocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039075, HPA045478" Uncertain Approved "Vesicles,Lipid droplets" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Lipid droplets" "HPA039075: AB_2676334, HPA045478: AB_2679341" "unprognostic (9.93e-2)" "unprognostic (4.12e-2)" "unprognostic (2.11e-1)" "unprognostic (2.57e-3)" "unprognostic (4.14e-2)" "unprognostic (1.50e-2)" "prognostic favorable (8.56e-4)" "unprognostic (1.03e-1)" "unprognostic (3.01e-2)" "unprognostic (3.31e-3)" "unprognostic (5.35e-2)" "unprognostic (2.44e-1)" "prognostic favorable (6.38e-14)" "unprognostic (1.84e-2)" "unprognostic (3.07e-2)" "unprognostic (2.12e-1)" "unprognostic (3.26e-1)" 8.0 7.8 5.1 3.7 6.8 5.7 8.7 9.5 5.6 9.2 14.3 6.8 7.1 7.2 5.5 5.7 6.4 5.3 13.7 2.9 5.0 17.6 21.6 4.9 4.5 5.5 6.4 6.3 7.3 14.6 3.8 5.0 6.2 6.1 7.5 15.1 7.7 5.8 29.3 4.1 5.4 6.0 4.0 3.7 6.6 4.1 7.9 7.7 7.1 35.1 4.4 6.2 3.8 5.1 5.2 7.6 7.6 10.5 7.0 10.2 7.1 8.2 12.0 7.3 5.8 10.0 8.2 13.8 5.4 7.2 5.9 18.3 7.1 20.0 9.1 15.6 12.3 13.1 7.0 12.7 7.5 17.3 1.7 12.0 12.2 7.0 16.7 9.9 7.4 10.8 12.7 9.6 6.5 7.0 9.8 8.9 11.4 13.6 7.0 0.1 4.8 14.5 19.7 18.8 4.7 10.0 10.2 15.9 11.4 8.3 6.6 13.2 6.6 5.5 5.8 7.1 7.8 9.7 9.9 21.4 6.1 8.2 7.3 0.6 0.4 0.0 1.1 0.4 1.6 0.7 0.6 1.0 0.9 1.0 0.8 1.2 0.2 1.6 0.6 0.5 0.4 0.8 5.1 6.8 9.5 5.6 2.9 5.0 5.5 6.4 6.2 4.0 7.9 5.1 7.5 16.0 2.6 161.9 9.2 4.0 16.5 8.2 9.6 10.7 13.1 5.7 45.5 11.5 10.4 5.5 35.5 7.6 7.3 7.5 1.9 3.7 35.4 10.1 7.6 5.3 3.0 12.0 183.9 1.6 2.1 6.2 15.8 14.4 0.0 5.8 2.2 16.5 3.9 3.3 252.6 7.8 4.1 3.8 4.0 14.2 5.9 11.5 5.4 69.3 4.1 4.9 4.1 151.3 146.1 4.0 9.3 5.3 18.2 16.0 9.4 8.2 6.7 42.6 0.0 7.6 8.9 5.5 4.8 12.5 2.8 2.9 10.4 8.5 9.4 11.9 WDFY1 "FENS-1, KIAA1435, WDF1, ZFYVE17" ENSG00000085449 "WD repeat and FYVE domain containing 1" Q8IWB7 2 223855716-223945357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050603, HPA079597" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Vesicles" "HPA050603: AB_2681188, HPA079597: " "unprognostic (2.49e-1)" "unprognostic (1.24e-1)" "unprognostic (2.94e-1)" "unprognostic (7.62e-2)" "unprognostic (8.24e-2)" "unprognostic (5.31e-2)" "unprognostic (2.63e-2)" "unprognostic (7.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.29e-2)" "unprognostic (1.23e-3)" "unprognostic (1.36e-1)" "unprognostic (3.81e-3)" "unprognostic (3.94e-1)" "unprognostic (2.98e-1)" "unprognostic (3.04e-1)" "unprognostic (7.55e-2)" 18.6 13.2 9.3 18.0 9.5 48.5 14.4 9.3 12.0 20.5 11.2 20.4 15.6 22.6 19.8 14.4 20.5 17.5 11.7 9.2 10.7 14.8 18.0 18.4 23.3 11.0 10.2 20.2 14.1 19.8 8.7 27.4 11.4 16.2 20.1 15.9 13.5 12.8 11.4 13.5 15.9 19.6 9.7 21.2 19.8 10.9 10.5 15.9 22.1 12.6 18.9 17.9 13.7 11.1 27.9 19.3 34.9 27.2 46.4 44.0 43.7 34.7 48.3 37.5 30.4 81.4 25.0 7.7 30.8 60.6 47.3 19.2 18.7 52.3 40.4 15.6 15.8 19.2 31.9 59.2 36.4 15.2 15.8 39.0 37.9 46.3 71.0 62.4 63.9 16.2 34.3 23.4 44.4 26.8 6.5 11.1 34.5 20.7 16.6 25.3 44.8 8.6 28.4 47.7 29.6 15.7 20.7 19.2 90.9 41.6 12.5 38.1 70.9 74.9 25.7 13.5 18.0 28.8 4.6 21.4 36.3 32.9 26.2 4.4 21.5 8.1 13.7 29.0 16.6 14.1 9.7 13.5 14.8 11.7 10.0 9.5 10.3 24.0 25.7 3.0 9.7 17.6 9.3 9.5 9.3 12.0 9.2 10.7 11.0 10.2 11.4 9.7 10.5 11.1 40.0 16.0 9.3 22.5 22.0 12.5 14.5 19.9 17.1 14.0 11.8 7.6 7.7 12.8 24.4 16.5 8.4 22.6 25.5 36.4 9.8 12.9 0.8 23.2 30.7 34.1 10.3 11.2 28.7 17.2 11.2 21.4 29.6 36.5 17.7 12.5 16.8 25.7 17.9 28.6 28.1 15.2 8.2 26.3 17.2 2.4 14.6 24.4 35.6 27.2 25.6 13.9 24.7 33.7 39.8 18.0 24.4 23.7 21.8 16.6 16.0 14.4 29.9 10.9 6.6 13.1 26.7 3.8 8.8 24.4 15.5 19.0 21.1 15.0 21.8 28.7 WDR24 "C16orf21, DKFZp434F054, JFP7" ENSG00000127580 "WD repeat domain 24" Q96S15 16 684622-690444 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039506 Approved Supported Vesicles,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Vesicles Cytosol "HPA039506: AB_10795148" "unprognostic (9.07e-2)" "unprognostic (2.67e-3)" "unprognostic (6.67e-2)" "unprognostic (1.48e-1)" "unprognostic (1.67e-1)" "unprognostic (8.15e-2)" "unprognostic (7.05e-2)" "unprognostic (4.35e-2)" "unprognostic (1.75e-1)" "unprognostic (5.09e-3)" "unprognostic (2.29e-3)" "unprognostic (2.05e-1)" "prognostic favorable (3.75e-6)" "unprognostic (5.38e-2)" "unprognostic (3.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" 6.1 9.1 3.9 4.0 3.6 3.9 6.2 5.0 6.9 7.5 4.1 7.1 4.8 7.9 1.0 7.1 7.5 2.8 7.9 3.8 3.0 7.5 11.2 6.0 4.8 4.2 4.0 9.2 7.2 5.8 9.4 3.2 3.5 8.5 1.1 1.8 6.9 3.0 11.7 8.5 7.1 2.0 3.2 9.2 7.8 14.2 3.9 4.3 8.7 4.1 2.4 7.5 6.6 3.7 6.1 14.0 6.2 8.6 5.9 4.2 10.9 7.5 6.7 9.2 8.0 15.3 8.8 9.4 12.8 3.4 2.3 9.4 6.1 7.4 2.0 15.9 19.0 6.4 19.8 5.8 9.4 7.9 9.6 7.4 4.9 6.6 5.5 4.8 5.0 9.0 12.7 10.3 3.4 22.2 14.0 5.8 9.7 3.1 10.6 20.4 5.1 17.6 3.0 4.2 15.1 6.9 8.5 14.3 8.7 2.8 13.2 7.8 7.3 6.6 6.8 7.4 7.3 21.9 21.5 15.3 4.3 7.8 9.4 4.3 5.1 2.8 6.6 3.0 5.4 4.3 4.2 4.9 5.1 3.7 4.9 4.8 1.2 3.0 7.8 4.1 6.1 5.0 3.9 3.6 5.0 6.9 3.8 3.0 4.2 4.0 3.5 3.2 3.9 3.7 2.9 6.4 6.2 2.3 4.2 1.1 2.6 4.7 4.0 5.1 5.2 4.4 5.0 1.5 5.0 7.3 2.1 7.4 2.9 6.0 7.9 4.9 17.1 12.2 2.9 3.1 10.1 5.2 2.0 5.6 4.4 3.1 6.6 2.9 4.5 6.9 2.5 9.6 5.1 21.9 2.0 7.3 4.1 6.3 1.6 48.0 5.6 3.9 0.0 1.9 4.4 7.3 1.0 2.0 2.4 4.5 2.1 3.0 6.8 3.8 8.0 6.4 19.4 2.6 19.7 2.6 4.2 18.8 8.7 2.1 1.6 7.4 3.4 7.6 5.5 2.0 WDR54 FLJ12953 ENSG00000005448 "WD repeat domain 54" Q9H977 2 74421678-74425755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 70.2" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 207.0;Late spermatids: 124.6;Respiratory ciliated cells: 395.9;Spermatocytes: 147.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043257, HPA053558" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Cytosol" "HPA043257: AB_10795981, HPA053558: AB_2682189" "unprognostic (1.12e-1)" "unprognostic (3.68e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (2.62e-1)" "unprognostic (3.06e-3)" "unprognostic (4.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (7.25e-3)" "unprognostic (3.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.85e-2)" 8.2 8.5 11.0 6.5 11.7 6.7 7.7 8.5 11.2 11.8 17.6 6.7 3.2 10.4 5.6 3.4 70.2 8.4 4.3 11.8 14.2 12.1 1.9 10.7 11.6 10.3 12.5 10.8 6.3 30.0 24.4 6.3 11.2 7.4 4.0 28.0 5.2 9.9 1.3 4.9 7.0 7.7 10.8 12.2 7.0 38.0 11.7 18.5 7.8 1.7 11.2 8.6 6.3 9.9 44.9 78.3 37.9 32.5 14.0 25.7 11.8 22.5 45.8 56.8 52.8 6.9 34.4 39.3 22.5 25.1 34.5 37.6 27.8 100.6 49.8 30.3 16.8 19.4 42.4 4.7 14.3 30.6 15.3 11.6 27.6 58.1 30.3 67.5 30.6 61.6 7.7 45.8 32.4 69.8 48.6 32.3 30.3 10.9 29.8 41.2 44.1 84.4 51.3 22.4 66.4 52.1 17.6 15.9 27.0 11.2 25.6 14.7 15.3 29.2 50.9 32.1 50.7 49.2 26.7 10.1 86.5 18.8 21.6 6.6 8.5 0.6 31.1 11.5 31.4 24.2 35.5 33.7 28.6 22.0 25.1 23.8 0.7 29.1 10.1 46.7 36.8 21.6 11.0 11.7 8.5 11.2 11.8 14.2 10.3 12.5 11.2 10.8 11.7 9.9 20.0 3.2 12.8 1.3 23.1 7.0 20.1 64.1 10.2 48.3 9.4 10.9 1.7 20.0 39.4 23.9 83.4 9.8 30.1 1.5 19.6 28.5 77.8 207.0 18.5 25.1 28.9 5.5 5.6 6.0 14.6 14.3 7.1 9.2 12.7 23.8 30.0 1.9 8.6 32.0 4.1 6.0 38.7 6.9 17.4 124.6 17.1 7.4 12.4 0.0 29.8 51.9 26.8 3.0 2.4 13.6 4.4 22.2 17.5 9.4 0.8 28.4 395.9 112.5 0.0 8.4 30.6 147.9 19.3 1.7 4.8 2.9 30.5 37.2 3.8 13.3 WDTC1 "ADP, DCAF9, KIAA1037" ENSG00000142784 "WD and tetratricopeptide repeats 1" Q8N5D0 1 27234632-27308636 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028177, HPA028180, HPA028182" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles "Golgi apparatus" "HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204" "unprognostic (3.18e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.69e-2)" "unprognostic (8.28e-2)" "unprognostic (3.31e-2)" "unprognostic (2.00e-3)" "unprognostic (1.25e-2)" "unprognostic (9.44e-2)" "unprognostic (2.44e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-3)" "unprognostic (1.73e-1)" "prognostic favorable (8.84e-8)" "unprognostic (1.28e-1)" "unprognostic (9.33e-2)" "unprognostic (3.01e-2)" "unprognostic (2.51e-2)" 16.5 24.4 25.4 10.5 22.3 14.7 17.5 20.2 25.4 18.9 12.7 24.7 12.9 19.7 7.0 18.0 19.9 10.5 35.9 21.8 20.0 19.9 18.7 16.9 14.4 25.3 21.0 19.0 22.1 47.7 16.9 10.6 24.4 19.3 9.5 33.5 20.1 15.1 63.0 24.8 18.0 12.0 19.4 17.7 23.2 37.6 23.5 19.8 18.4 54.4 12.7 19.8 18.5 21.1 19.8 8.6 13.5 1.3 18.9 15.8 5.6 12.0 20.1 12.7 15.5 2.9 19.3 17.0 14.0 24.0 9.3 10.1 13.0 18.4 11.0 23.2 22.0 17.7 8.9 7.9 17.0 9.0 22.4 15.1 29.6 15.8 14.4 22.9 17.4 5.4 18.2 17.2 13.6 11.1 14.6 21.6 6.3 13.0 18.1 7.3 10.1 18.7 15.2 4.2 19.7 16.9 15.7 6.6 14.4 10.1 9.8 15.5 15.2 10.3 6.2 14.5 5.9 24.7 14.2 8.1 20.8 17.3 12.5 0.1 0.2 2.7 1.4 0.3 0.5 0.6 0.3 0.6 0.7 0.4 0.2 0.6 2.1 0.4 0.2 0.5 0.4 0.5 25.4 22.3 20.2 25.4 21.8 20.0 25.3 21.0 24.4 19.4 23.5 21.1 10.8 9.6 10.7 19.6 13.8 12.9 10.3 8.4 16.5 31.4 18.5 14.5 15.6 14.3 7.6 31.3 54.2 14.2 14.3 17.3 9.8 15.1 29.8 15.3 8.2 10.1 16.7 32.8 22.4 14.1 4.8 10.6 16.3 13.2 1.3 15.4 18.5 16.6 13.0 21.9 21.2 16.9 6.1 21.0 11.3 66.2 17.1 15.8 10.6 19.7 18.9 15.8 28.8 16.6 22.2 16.0 10.1 16.6 12.3 17.2 26.6 19.1 18.4 70.0 6.6 17.1 10.3 30.9 6.6 13.0 17.3 16.4 13.3 14.1 15.0 16.8 WNT2B "WNT13, XWNT2" ENSG00000134245 "Wnt family member 2B" Q93097 1 112466541-112530165 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Leydig cells: 80.2;Peritubular cells: 197.5" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.4;HSkMC: 8.0;SuSa: 3.4;TIME: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047274, HPA066368" Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles Nucleoplasm "HPA047274: AB_2732539, HPA066368: AB_2685664" "unprognostic (2.08e-3)" "unprognostic (2.06e-3)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (9.42e-2)" "unprognostic (4.90e-3)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (5.94e-2)" "unprognostic (1.13e-1)" "unprognostic (5.65e-4)" "unprognostic (5.41e-2)" "unprognostic (7.64e-2)" "unprognostic (4.80e-2)" "unprognostic (2.49e-2)" 4.5 1.9 2.0 1.5 4.9 0.1 2.8 2.1 2.8 8.2 2.0 5.6 3.0 4.9 2.8 5.8 4.7 2.8 4.3 1.9 1.7 2.4 1.0 6.3 0.8 1.8 1.7 10.9 1.8 0.6 2.3 4.8 1.9 6.1 5.3 5.5 2.2 13.9 1.6 11.1 5.2 2.2 1.4 1.7 3.8 3.8 1.8 0.2 1.9 0.8 0.7 5.6 9.1 2.3 0.4 0.3 2.2 0.5 2.2 4.4 0.4 1.0 1.0 0.2 0.4 0.2 0.5 1.1 0.2 1.1 0.2 1.4 0.7 0.3 0.2 0.0 0.4 0.1 0.8 0.3 1.8 0.2 0.5 8.0 0.8 0.4 0.1 1.3 1.2 0.3 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.0 0.3 0.1 0.3 0.0 1.5 0.3 0.3 0.3 0.7 0.1 0.7 3.4 0.0 0.2 3.5 0.3 1.4 0.8 0.3 0.1 0.1 0.0 0.9 0.1 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.0 4.9 2.1 2.8 1.9 1.7 1.8 1.7 1.9 1.4 1.8 2.3 7.6 12.8 3.3 2.0 2.0 10.1 1.8 6.1 5.2 14.1 2.1 0.9 6.5 1.5 3.9 1.8 27.1 2.1 2.4 3.5 0.0 0.8 5.6 2.6 3.6 10.2 8.4 2.1 5.5 1.4 0.8 17.7 1.1 6.8 2.5 2.8 6.1 0.2 1.1 5.0 6.2 2.2 4.1 2.1 8.2 3.4 80.2 4.0 3.6 30.9 2.2 9.8 0.0 11.6 7.1 2.0 4.8 197.5 2.5 4.4 2.9 0.9 4.6 27.6 0.0 9.7 2.7 5.9 5.5 26.4 13.9 1.9 1.9 2.0 1.5 2.6 XAB2 "HCNP, HCRN, NTC90, SYF1" ENSG00000076924 "XPA binding protein 2" Q9HCS7 19 7619525-7629545 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 159.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048751 Supported Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Vesicles "HPA048751: AB_2680512" "unprognostic (1.13e-1)" "prognostic favorable (4.04e-4)" "unprognostic (1.99e-3)" "prognostic favorable (4.96e-4)" "unprognostic (1.35e-1)" "unprognostic (4.98e-3)" "unprognostic (4.95e-2)" "unprognostic (4.56e-3)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.69e-1)" "unprognostic (7.43e-3)" "unprognostic (3.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (1.80e-3)" 29.4 23.6 17.7 15.1 19.9 44.5 30.6 19.6 24.8 37.0 16.9 28.3 17.5 33.8 6.9 25.4 32.0 11.8 24.3 17.8 17.9 27.7 27.8 27.2 20.7 19.9 18.0 45.8 35.9 13.4 27.1 15.4 20.2 32.7 5.4 9.0 31.1 17.5 35.6 39.0 27.6 9.3 18.6 34.5 30.9 37.7 18.3 21.1 34.7 13.3 10.6 29.1 29.6 25.5 39.8 35.7 21.2 27.9 21.9 16.3 41.2 22.8 26.5 39.6 40.0 46.4 25.4 26.7 44.1 21.3 28.9 34.2 30.2 33.2 10.0 47.1 39.0 35.5 30.2 41.3 28.3 47.5 30.8 28.8 27.0 28.0 20.2 21.3 24.2 56.4 32.4 69.0 12.4 44.0 44.9 73.8 48.3 24.8 69.6 49.3 26.8 47.0 15.8 30.7 30.2 34.4 25.9 25.1 23.2 13.8 32.0 41.6 24.1 18.1 29.5 41.3 39.0 117.7 75.0 39.0 31.0 40.1 27.4 8.8 10.0 9.3 11.8 10.2 11.3 10.1 11.0 9.1 8.0 12.2 13.1 10.0 6.4 8.3 13.9 6.9 14.2 12.1 17.7 19.9 19.6 24.8 17.8 17.9 19.9 18.0 20.2 18.6 18.3 25.5 18.3 0.0 1.8 3.9 22.9 19.6 16.2 28.1 14.2 14.1 89.4 54.4 1.4 25.8 20.1 47.8 12.5 46.0 24.8 28.3 35.2 19.8 39.9 24.7 13.3 16.4 18.6 14.1 2.3 34.4 26.4 16.7 33.6 32.3 19.7 27.7 17.5 46.4 19.8 3.3 2.5 21.2 24.4 19.2 11.0 19.1 28.3 18.3 26.6 3.7 26.5 13.9 23.7 1.0 3.7 15.1 12.4 21.8 19.4 12.2 28.9 159.5 13.4 14.2 39.5 15.9 21.6 36.1 57.3 14.6 17.8 65.9 20.6 17.8 23.9 14.3 XAGE2 "CT12.2, GAGED3, XAGE-2, XAGE2B" ENSG00000155622 "X antigen family member 2" Q96GT9 X 52369021-52375680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 199.5" "Group enriched" "Detected in some" 13 "Cytotrophoblasts: 1027.3;Extravillous trophoblasts: 1890.1;Syncytiotrophoblasts: 1367.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 96.3;SK-BR-3: 22.7;SuSa: 27.9;T-47d: 20.1" "HPA052507, HPA060900" Supported Approved "Vesicles,Plasma membrane" NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Vesicles "Plasma membrane" "HPA052507: AB_2681855, HPA060900: AB_2684383" "unprognostic (1.21e-1)" "unprognostic (9.67e-2)" "unprognostic (1.49e-1)" "unprognostic (4.47e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 5.6 0.0 0.0 0.0 0.1 0.4 0.0 0.0 199.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 96.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 4.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 22.7 1.2 27.9 20.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.5 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1027.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 1890.1 6.7 0.0 0.0 0.0 0.0 0.0 0.0 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 1367.6 0.0 0.0 0.0 0.0 XAGE3 "CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3" ENSG00000171402 "X antigen family member 3" Q8WTP9 X 52862525-52868083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 121 "placenta: 382.1" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 2223.5;Extravillous trophoblasts: 1309.1;Syncytiotrophoblasts: 2678.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;U-266/70: 2.2;U-266/84: 2.1" "HPA052507, HPA060900" Supported Approved "Vesicles,Plasma membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 29: U-266 - Adaptive immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Plasma membrane" "HPA052507: AB_2681855, HPA060900: AB_2684383" "unprognostic (6.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.92e-1)" 3.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 382.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2223.5 0.0 0.1 0.0 0.2 0.3 0.1 0.0 4.5 0.0 0.0 0.0 0.4 1309.1 11.1 0.0 0.3 0.0 0.0 0.0 4.6 191.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 15.1 7.0 0.0 0.0 2678.1 0.0 0.0 0.1 0.0 XAGE5 "CT12.5, GAGED5, XAGE-5" ENSG00000171405 "X antigen family member 5" Q8WWM1 X 52812204-52818301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Cell type enhanced" "Detected in some" "Spermatocytes: 3.8;Spermatogonia: 9.0;Syncytiotrophoblasts: 1.9" "Cancer enriched" "Detected in single" 4 "liver cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "U-2 OS: 22.0" "HPA052507, HPA055941" Uncertain Approved Nucleoplasm,Vesicles No No "Cluster 78: Testis - Spermatogenesis" "Cluster 9: U-2 OS - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA052507: AB_2681855, HPA055941: AB_2682978" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 9.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 XRCC2 FANCU ENSG00000196584 "X-ray repair cross complementing 2" O43543 7 152644776-152676141 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 5.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 14.1;Extravillous trophoblasts: 21.2;Granulosa cells: 20.2;Spermatocytes: 31.3;Spermatogonia: 19.1;Syncytiotrophoblasts: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065153 Approved Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Vesicles" "HPA065153: AB_2685422" "unprognostic (9.31e-3)" "unprognostic (8.25e-2)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (9.10e-2)" "unprognostic (2.52e-2)" "unprognostic (3.36e-5)" "unprognostic (9.98e-3)" "unprognostic (5.82e-3)" "unprognostic (4.04e-3)" "unprognostic (1.06e-3)" "unprognostic (2.43e-2)" "unprognostic (1.55e-15)" "unprognostic (4.52e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-1)" "unprognostic (1.73e-2)" 0.2 0.2 0.9 2.3 0.6 5.3 1.5 1.6 2.8 0.3 0.0 1.1 1.7 1.1 0.9 1.0 0.5 0.4 1.0 0.6 1.9 0.4 0.4 0.5 2.9 0.6 0.6 1.0 0.0 0.6 0.0 2.1 1.4 0.7 1.7 1.9 0.2 0.4 0.1 1.9 1.5 0.5 1.1 1.0 1.0 3.0 1.0 3.6 0.6 0.0 2.5 0.5 0.1 1.9 16.5 10.4 18.3 15.8 1.1 1.8 15.0 11.8 3.9 8.2 10.3 14.7 12.8 24.8 9.5 3.5 13.7 13.7 12.8 7.1 19.3 8.9 17.3 16.8 15.5 10.0 0.3 27.3 9.3 0.9 1.1 15.6 3.6 2.0 3.8 15.5 34.2 22.8 8.3 12.6 32.4 21.2 21.6 10.8 12.9 22.8 19.3 15.3 3.1 10.3 16.7 18.1 11.7 7.6 5.0 11.3 5.4 8.3 4.2 17.2 6.9 13.3 23.0 8.8 14.5 19.0 11.0 20.9 20.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.6 1.6 2.8 0.6 1.9 0.6 0.6 1.4 1.1 1.0 1.9 0.2 0.0 1.1 1.6 1.9 1.3 1.0 1.0 0.0 4.9 0.8 0.4 2.9 0.0 1.4 1.8 0.0 11.2 0.4 0.9 0.0 1.1 11.7 0.9 1.9 1.1 0.0 14.1 2.3 0.2 21.2 2.5 3.1 1.4 0.0 20.2 1.1 0.2 2.4 0.0 2.0 1.7 2.0 0.6 0.8 4.9 0.9 0.8 0.0 0.0 0.6 1.1 3.1 4.5 2.0 0.5 0.1 1.2 6.1 0.6 0.3 0.3 0.1 2.3 0.0 1.9 1.8 31.3 19.1 2.7 1.4 12.6 2.2 1.2 2.3 1.0 YIF1A "54TM, FinGER7, YIF1, YIF1P" ENSG00000174851 "Yip1 interacting factor homolog A, membrane trafficking protein" O95070 11 66284580-66289145 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014840, HPA076194" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "HPA014840: AB_2217189, HPA076194: " "unprognostic (9.35e-2)" "unprognostic (7.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (4.38e-3)" "unprognostic (2.25e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (2.13e-1)" "unprognostic (6.39e-3)" "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.03e-1)" "unprognostic (2.64e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (8.70e-4)" 49.2 54.7 33.4 28.4 36.0 16.7 47.5 38.5 41.4 42.7 42.4 50.8 56.5 53.5 34.5 50.9 45.7 25.5 57.8 33.5 35.6 50.9 149.5 44.9 22.9 38.9 36.1 42.1 86.0 40.6 74.1 34.5 38.2 47.3 37.7 12.3 51.1 29.6 96.2 43.0 47.4 41.1 38.5 35.9 56.1 36.4 35.6 21.6 49.9 59.3 24.7 45.4 40.6 41.9 80.7 131.3 39.4 72.6 130.0 138.7 73.8 114.4 122.3 95.5 94.3 126.0 95.5 67.9 111.5 161.4 107.8 119.9 60.7 107.9 75.6 77.7 72.0 42.5 93.3 158.7 147.4 59.3 61.5 97.4 144.4 98.6 158.9 76.6 91.3 67.0 80.7 114.8 84.3 199.3 71.3 64.4 40.3 147.4 136.6 54.9 61.2 203.9 81.9 70.9 58.5 57.9 62.5 106.7 103.4 49.6 155.5 43.5 81.0 80.8 69.0 165.3 54.1 78.1 86.0 63.0 125.4 56.2 90.2 19.4 95.6 20.6 71.3 141.4 78.4 95.9 60.6 67.2 116.4 82.4 48.0 55.3 9.4 51.2 140.0 141.6 54.9 99.8 33.4 36.0 38.5 41.4 33.5 35.6 38.9 36.1 38.2 38.5 35.6 41.9 63.4 38.5 48.0 6.2 52.2 36.1 88.1 170.4 38.1 27.1 84.4 92.7 34.5 82.9 115.5 46.0 22.9 114.3 42.6 66.8 64.6 137.9 28.1 42.1 84.8 53.6 87.4 21.0 1.9 149.4 248.5 90.4 55.0 42.8 29.9 38.8 49.2 172.0 105.4 26.9 3.9 140.9 116.0 38.4 44.9 48.6 75.5 45.0 72.9 8.4 40.8 73.7 28.8 10.1 10.4 132.1 93.3 82.4 92.4 195.2 202.2 135.2 101.4 34.0 39.5 60.8 150.0 61.0 56.8 63.3 46.3 154.3 36.5 88.1 107.2 112.1 YIF1B FinGER8 ENSG00000167645 "Yip1 interacting factor homolog B, membrane trafficking protein" Q5BJH7 19 38303558-38317273 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039328, HPA055257, HPA062675" Approved Approved "Golgi apparatus,Vesicles" NA NA 37000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 10: Non-specific - Unknown function" Vesicles "Golgi apparatus" "HPA039328: AB_2676445, HPA055257: AB_2682762, HPA062675: AB_2684830" "unprognostic (2.51e-1)" "unprognostic (3.34e-1)" "unprognostic (1.38e-1)" "unprognostic (6.81e-2)" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.53e-5)" "unprognostic (1.37e-1)" "unprognostic (1.45e-2)" "unprognostic (5.53e-2)" "prognostic favorable (1.88e-4)" "unprognostic (4.57e-2)" "unprognostic (2.40e-2)" "unprognostic (3.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.64e-1)" "unprognostic (3.94e-3)" 30.1 30.7 29.3 33.0 32.4 69.1 26.7 37.0 38.3 33.5 29.0 26.6 20.4 24.1 10.9 33.2 25.6 16.5 40.6 30.2 32.6 27.2 58.3 35.7 32.1 36.3 30.9 26.7 27.1 16.9 29.1 23.5 38.6 23.7 16.1 13.6 30.2 12.5 35.0 26.0 24.0 18.1 33.4 47.7 22.0 23.1 34.0 20.9 19.8 26.7 20.9 26.8 25.6 38.5 43.7 108.9 48.3 57.5 68.4 63.5 37.8 103.2 79.0 75.7 110.7 53.5 32.6 75.7 44.4 121.1 81.5 27.4 85.9 54.6 28.7 81.1 43.3 117.0 48.2 56.5 94.8 82.4 132.9 52.3 47.9 78.0 33.8 76.1 71.3 99.4 152.9 205.3 68.5 46.0 87.6 98.9 37.0 74.9 33.7 89.0 58.6 117.9 48.9 40.6 34.8 58.1 34.5 76.7 55.4 37.2 29.9 163.2 68.8 74.6 73.2 108.4 83.9 76.4 122.1 51.8 96.1 150.5 54.6 81.9 155.7 179.0 60.8 119.4 54.4 49.3 57.3 54.8 300.3 42.7 46.7 47.5 42.8 44.0 70.8 127.0 59.0 120.2 29.3 32.4 37.0 38.3 30.2 32.6 36.3 30.9 38.6 33.4 34.0 38.5 27.4 0.0 5.5 5.5 22.8 17.7 19.4 25.8 18.2 12.2 22.6 18.7 4.7 18.6 14.2 22.0 12.5 44.7 17.0 16.0 0.0 39.4 6.3 17.5 18.2 23.9 14.4 33.2 7.3 27.7 52.9 23.8 16.3 18.6 22.9 43.4 37.1 30.5 94.4 11.8 7.4 24.7 32.6 42.3 37.4 8.5 9.0 53.3 35.6 3.7 34.4 20.8 16.5 4.0 12.7 15.5 13.5 9.1 69.4 14.8 8.1 16.1 20.7 15.5 6.6 11.1 40.3 20.6 31.9 30.7 20.0 27.6 18.8 26.2 25.9 19.5 ZBED6CL C7orf29 ENSG00000188707 "ZBED6 C-terminal like" Q96FA7 7 150322639-150332721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 72.3;parathyroid gland: 25.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 8.4;Exocrine glandular cells: 13.3;Pancreatic endocrine cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 85.2;K-562: 34.5" "Low region specificity" "Detected in all" "HPA019724, HPA055805" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 1: Pancreatic cells - Digestion" "Nuclear membrane" Vesicles "HPA019724: AB_1845756, HPA055805: AB_2682929" "prognostic favorable (9.48e-5)" "unprognostic (6.77e-2)" "unprognostic (2.06e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.35e-2)" "unprognostic (2.49e-3)" "unprognostic (2.78e-2)" "unprognostic (3.12e-2)" "unprognostic (3.44e-1)" "prognostic favorable (2.44e-5)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.86e-2)" "unprognostic (7.82e-2)" "unprognostic (8.52e-3)" "unprognostic (1.50e-3)" 1.3 72.3 1.0 5.2 0.8 3.8 2.1 0.6 0.8 3.0 3.1 4.0 3.3 4.3 1.2 3.0 4.1 1.6 1.2 1.1 1.1 5.3 12.1 3.1 6.9 1.1 1.0 6.0 7.2 25.6 5.4 0.8 0.8 3.5 3.1 1.7 2.7 2.1 0.5 3.6 5.0 1.8 0.6 4.9 4.2 1.1 1.2 5.6 4.0 0.2 6.7 2.7 2.1 0.6 8.1 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.3 0.9 10.9 8.4 4.8 4.0 0.1 0.0 3.5 0.0 0.0 0.7 85.2 5.4 6.3 13.3 17.6 2.1 0.0 8.4 1.4 3.9 0.0 0.0 0.3 0.4 16.2 34.5 11.8 0.0 3.3 14.5 2.8 5.3 3.4 0.0 0.0 0.5 10.2 3.2 16.4 15.1 8.4 14.9 3.2 0.5 2.4 1.0 3.6 0.2 0.0 0.0 0.0 0.1 10.0 3.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.2 0.8 0.5 0.6 0.9 0.2 0.8 0.8 0.8 0.8 0.7 0.0 0.2 0.6 0.7 1.0 0.8 0.6 0.8 1.1 1.1 1.1 1.0 0.8 0.6 1.2 0.6 0.0 0.0 1.5 0.0 0.6 0.3 0.5 1.0 0.0 1.0 1.2 0.9 0.9 2.8 1.6 1.8 8.4 1.5 2.2 2.2 5.9 2.8 0.0 3.1 0.4 0.9 4.8 0.8 0.0 13.3 0.8 0.6 1.5 3.3 1.3 1.3 0.4 3.7 0.6 0.0 0.0 2.4 4.1 1.2 0.0 0.4 2.8 0.7 0.0 0.0 3.4 1.2 3.1 0.0 0.0 13.4 1.2 1.2 0.2 0.4 1.3 0.9 0.6 0.6 0.0 0.9 0.2 0.4 0.9 0.9 0.1 1.9 1.4 1.1 2.3 0.4 ZC4H2 "HCA127, KIAA1166, MCS, MRXS4, WWS" ENSG00000126970 "Zinc finger C4H2-type containing" Q9NQZ6 X 64915802-65034713 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 37.4;Inhibitory neurons: 39.4;Oligodendrocyte precursor cells: 58.3;Oligodendrocytes: 59.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 37.3;REH: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049584 Approved Approved Vesicles,Microtubules NA NA "Cluster 30: Non-specific - Translation" "Cluster 57: Non-specific - Angiogenesis" "Cluster 5: NTERA-2 - Transcription" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Microtubules" "HPA049584: AB_2680825" "unprognostic (9.55e-3)" "unprognostic (1.03e-1)" "unprognostic (4.40e-1)" "unprognostic (1.56e-1)" "unprognostic (7.29e-3)" "unprognostic (9.71e-2)" "unprognostic (1.64e-3)" "unprognostic (9.72e-2)" "unprognostic (2.98e-1)" "unprognostic (3.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.44e-2)" "unprognostic (1.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.51e-5)" "unprognostic (5.34e-2)" 4.5 6.3 7.1 2.5 7.2 2.5 4.1 7.0 8.0 5.9 6.9 9.6 3.9 7.0 4.3 3.4 6.1 3.7 5.7 7.0 7.9 5.4 5.3 3.4 2.8 7.5 7.6 7.2 3.6 11.8 8.6 0.9 7.6 5.3 4.4 5.0 4.3 5.8 1.8 3.8 5.3 7.9 7.2 4.2 6.3 1.0 7.2 8.0 5.4 1.9 2.6 5.3 4.1 7.3 0.0 1.5 23.4 11.0 0.2 0.0 3.7 4.4 9.3 6.3 11.5 2.2 8.8 4.4 2.5 3.9 0.0 0.1 10.4 4.0 6.2 0.0 9.5 7.4 3.3 3.2 1.4 6.8 2.2 4.7 3.3 2.9 6.5 9.5 11.5 25.1 2.4 9.9 7.5 0.0 20.2 0.0 37.3 4.2 10.2 29.8 11.3 0.2 6.5 0.0 0.0 16.8 0.0 0.1 0.9 13.9 2.0 1.3 7.2 3.2 6.7 0.3 0.0 1.8 0.2 14.9 9.9 6.2 0.0 0.0 0.7 0.0 1.7 1.0 3.0 2.6 2.4 2.4 0.9 1.9 3.9 2.4 0.0 2.1 0.2 2.4 1.2 1.4 7.1 7.2 7.0 8.0 7.0 7.9 7.5 7.6 7.6 7.2 7.2 7.3 2.9 3.2 0.0 20.5 6.6 0.6 2.0 1.9 1.8 3.8 1.5 2.2 4.0 4.3 1.8 1.8 4.2 0.1 1.2 1.9 1.9 7.7 0.6 1.7 3.0 4.5 3.6 3.4 37.4 5.7 0.8 4.0 3.6 0.5 2.5 5.2 5.0 4.1 1.1 0.0 39.4 1.9 8.2 0.9 0.0 0.8 7.2 0.8 0.0 22.5 0.5 5.1 2.1 58.3 59.0 4.7 2.2 8.6 1.5 1.0 3.8 5.6 0.6 1.6 13.1 2.8 4.1 0.6 0.5 1.8 0.6 0.0 1.9 4.5 3.3 1.0 ZDHHC13 "FLJ10852, FLJ10941, HIP14L" ENSG00000177054 "Zinc finger DHHC-type palmitoyltransferase 13" Q8IUH4 11 19117099-19176422 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 120.5;Urothelial cells: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 136.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016759, HPA018791" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Vesicles "Golgi apparatus" "HPA016759: AB_1858993, HPA018791: AB_1858992" "unprognostic (1.43e-2)" "unprognostic (4.00e-3)" "unprognostic (1.08e-1)" "unprognostic (1.11e-3)" "unprognostic (2.95e-2)" "unprognostic (1.34e-2)" "unprognostic (1.55e-2)" "unprognostic (1.57e-1)" "unprognostic (3.57e-3)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (2.16e-1)" "unprognostic (6.95e-3)" "unprognostic (1.15e-1)" "unprognostic (7.93e-2)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" 4.8 5.7 5.2 7.8 5.2 9.7 8.9 6.6 7.1 9.3 6.6 16.9 11.2 6.7 5.1 37.2 12.9 8.7 9.1 5.4 5.7 9.2 2.2 6.1 9.6 5.5 5.0 5.3 11.2 14.9 11.7 6.2 5.8 8.2 18.2 16.1 10.2 5.4 1.6 18.8 11.3 6.1 5.3 5.7 18.5 14.4 5.0 11.7 8.7 2.9 22.4 22.4 15.4 5.2 41.6 19.3 18.0 15.5 6.3 7.2 17.3 19.4 17.8 21.3 24.4 11.7 9.7 21.1 13.1 16.3 47.9 61.3 26.0 12.8 23.3 26.4 22.6 11.1 12.6 9.7 14.6 15.2 18.5 8.3 14.7 9.0 12.5 19.9 136.8 28.9 10.7 10.3 22.1 13.5 19.6 12.2 15.1 38.7 17.6 21.3 25.0 5.0 21.9 27.0 31.3 23.0 23.2 28.0 10.7 17.3 13.2 17.6 39.6 18.9 13.2 29.2 15.8 8.7 28.5 19.2 22.6 15.5 33.6 11.6 4.7 32.7 8.5 7.9 7.8 8.7 6.6 9.6 5.9 5.5 6.2 8.3 6.0 6.3 6.4 5.6 9.4 4.6 5.2 5.2 6.6 7.1 5.4 5.7 5.5 5.0 5.8 5.3 5.0 5.2 8.1 9.6 10.7 28.7 9.6 24.2 22.3 27.2 14.2 12.0 7.5 4.8 34.1 12.8 41.3 16.5 10.4 8.7 10.6 20.1 5.9 25.1 120.5 21.5 6.6 11.3 15.6 11.6 27.2 19.2 18.8 9.2 24.5 30.8 12.0 16.2 12.8 0.9 6.1 16.8 34.9 24.7 36.7 6.8 8.3 46.6 7.8 6.2 3.6 9.4 20.8 52.8 18.6 19.6 20.9 20.4 16.4 2.2 10.4 47.4 15.5 3.5 57.0 8.8 0.0 5.4 7.4 58.1 31.7 21.3 36.2 6.3 11.4 7.7 21.4 103.0 ZDHHC17 "HIP14, HYPH, KIAA0946" ENSG00000186908 "Zinc finger DHHC-type palmitoyltransferase 17" Q8IUH5 12 76764103-76853696 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 102.2;Inhibitory neurons: 95.1;Oligodendrocytes: 115.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 17.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016807, HPA058674" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 12: NES - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus, Vesicles" "HPA016807: AB_1858999, HPA058674: AB_2732626" "unprognostic (1.06e-1)" "unprognostic (2.26e-2)" "unprognostic (2.63e-2)" "unprognostic (3.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-3)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.56e-3)" "unprognostic (5.42e-2)" "prognostic unfavorable (7.11e-5)" "unprognostic (1.77e-2)" "unprognostic (2.69e-1)" "unprognostic (2.98e-1)" "unprognostic (1.71e-2)" 15.6 14.1 18.6 12.1 20.4 23.7 16.1 23.1 25.9 15.8 11.8 13.7 7.5 21.7 12.3 8.0 12.8 10.5 12.5 19.8 18.9 11.0 9.8 10.6 14.8 18.2 18.6 20.1 10.2 12.7 11.0 16.4 18.9 14.1 10.1 31.0 8.1 12.8 11.8 10.2 10.3 14.6 19.2 14.4 8.5 12.8 19.4 14.9 11.8 14.2 11.4 11.7 11.7 27.8 8.2 9.5 30.1 15.4 17.6 18.5 14.6 16.2 13.4 10.5 9.2 7.8 5.8 11.2 9.5 15.9 10.5 7.5 12.1 10.1 16.2 9.5 12.6 16.4 13.1 12.0 11.9 16.5 13.9 17.6 10.3 10.0 14.7 35.2 12.2 15.2 18.0 5.2 13.8 7.6 12.0 21.9 22.1 3.6 11.3 16.1 10.7 12.3 12.0 12.3 11.7 20.1 17.8 6.4 10.7 25.7 14.4 16.3 16.9 14.3 11.0 8.8 9.3 8.1 8.5 11.9 5.4 7.6 15.0 6.2 2.3 5.7 3.6 2.4 2.9 2.5 2.9 2.6 2.8 3.9 3.0 2.5 5.9 2.0 2.5 17.1 1.3 1.5 18.6 20.4 23.1 25.9 19.8 18.9 18.2 18.6 18.9 19.2 19.4 27.8 33.4 32.1 18.3 75.7 20.1 7.1 10.4 9.8 12.5 54.6 9.9 10.7 21.3 12.8 15.5 12.9 39.6 20.3 74.1 5.0 0.0 8.0 11.3 11.8 23.8 24.8 19.2 12.0 102.2 4.7 10.2 21.2 7.1 10.1 41.2 20.7 20.3 10.6 8.8 28.6 95.1 7.5 8.2 12.3 19.4 13.7 20.2 14.9 5.4 54.4 14.9 26.1 18.6 88.4 115.8 6.8 4.5 21.1 13.5 10.2 8.4 5.5 18.0 38.1 0.0 32.3 22.0 17.7 22.6 9.5 5.5 5.6 18.1 19.6 6.2 5.5 ZDHHC20 "DHHC20, FLJ25952" ENSG00000180776 "Zinc finger DHHC-type palmitoyltransferase 20" Q5W0Z9 13 21372571-21459370 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.0" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 434.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014483, HPA014702" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Plasma membrane" "HPA014483: AB_1859000, HPA014702: AB_1859001" "unprognostic (1.31e-1)" "unprognostic (2.16e-3)" "unprognostic (7.31e-3)" "unprognostic (8.89e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.24e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.76e-2)" "unprognostic (7.65e-2)" "unprognostic (6.15e-2)" "unprognostic (1.13e-2)" 10.9 9.2 15.2 17.6 52.9 30.0 11.5 51.8 23.3 16.2 0.0 16.9 19.3 13.8 9.6 30.2 10.9 17.1 7.9 12.0 27.0 6.7 9.8 17.0 18.0 70.8 40.7 9.7 9.0 8.9 4.4 18.8 60.3 15.1 16.1 5.6 8.5 12.2 4.0 22.1 19.0 15.2 35.1 16.1 39.5 31.7 40.7 22.6 16.4 9.4 19.5 22.9 9.3 95.0 32.9 16.4 27.7 18.1 24.5 26.7 68.3 35.6 36.3 23.3 20.6 33.8 102.5 34.8 19.3 44.7 23.8 52.7 30.5 26.5 44.8 40.0 20.4 61.8 11.7 19.6 14.1 43.3 25.8 24.2 19.4 23.6 16.2 30.0 37.6 45.9 17.3 14.9 35.3 27.2 62.0 17.2 22.9 87.3 18.0 49.8 49.1 12.7 28.9 59.7 25.2 11.4 46.0 28.7 19.3 28.6 27.0 21.8 62.6 25.0 24.0 41.7 27.4 15.6 19.9 37.7 18.2 23.6 73.1 12.6 16.2 3.8 10.1 14.9 9.3 4.6 8.7 8.7 8.4 3.4 8.1 8.4 3.0 11.2 13.8 4.1 10.4 13.5 15.2 52.9 51.8 23.3 12.0 27.0 70.8 40.7 60.3 35.1 40.7 95.0 27.6 51.3 31.5 29.0 19.9 1.0 7.8 1.4 18.2 7.4 21.9 13.7 7.4 14.3 20.7 11.0 8.4 20.7 34.7 35.5 0.0 8.5 91.3 23.4 25.2 25.7 24.0 8.4 69.1 12.2 20.9 13.6 53.0 34.5 14.0 16.1 20.0 20.8 21.7 18.5 80.0 29.1 2.0 92.5 3.2 81.2 15.5 49.0 1.8 46.9 48.4 3.7 30.9 54.8 434.3 22.8 25.5 10.9 18.1 14.5 30.3 6.3 11.7 9.5 19.7 12.7 11.6 10.4 14.1 28.1 1.6 44.6 28.4 9.7 25.1 25.6 ZDHHC24 ENSG00000174165 "Zinc finger DHHC-type containing 24" Q6UX98 11 66520637-66546235 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016619 Approved Approved Vesicles,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" "Vesicles, Cytosol" "HPA016619: AB_2288672" "unprognostic (2.77e-1)" "unprognostic (2.51e-1)" "unprognostic (2.52e-1)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.28e-4)" "unprognostic (8.76e-2)" "unprognostic (7.74e-3)" "unprognostic (7.11e-2)" "unprognostic (6.20e-2)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (1.48e-1)" "unprognostic (8.10e-2)" "unprognostic (6.99e-3)" "unprognostic (3.10e-1)" "unprognostic (4.88e-1)" "unprognostic (1.35e-1)" 5.2 6.9 5.8 3.3 4.5 5.0 4.7 4.2 5.4 3.6 5.8 3.5 2.8 4.3 5.1 4.3 3.9 2.2 3.6 4.9 5.2 6.2 4.6 4.5 4.3 5.5 5.2 2.7 7.1 6.0 4.7 2.5 4.8 4.5 2.1 2.6 5.0 2.7 2.9 5.1 4.7 1.9 4.4 7.2 4.8 3.7 6.4 3.1 5.9 1.1 3.0 4.0 3.4 4.5 5.2 7.4 2.4 6.5 5.8 4.7 6.2 3.9 3.4 3.1 2.1 6.5 7.7 1.6 11.5 3.3 8.3 11.9 1.9 3.4 2.1 7.6 4.9 2.9 3.7 4.1 5.5 3.4 6.9 5.6 6.2 2.5 3.6 3.7 5.1 13.0 4.2 4.3 4.0 10.4 7.4 8.6 5.3 12.2 7.6 8.8 5.3 9.3 3.9 3.6 3.5 5.6 6.7 6.5 11.6 2.7 9.5 2.4 8.0 7.1 2.4 8.3 3.1 6.9 2.2 2.1 6.2 1.5 8.2 3.0 5.9 1.0 7.3 5.7 6.6 6.4 6.0 8.4 7.2 7.5 3.8 5.9 2.2 8.0 5.0 23.1 6.6 6.1 5.8 4.5 4.2 5.4 4.9 5.2 5.5 5.2 4.8 4.4 6.4 4.5 21.7 12.8 8.3 7.8 21.9 8.0 15.2 26.8 10.8 9.6 21.5 15.2 4.5 22.8 17.3 23.9 10.4 33.0 49.9 29.0 9.8 50.3 13.5 15.1 14.4 23.3 14.4 6.3 7.6 49.4 37.2 15.0 17.9 19.8 8.9 18.5 23.2 14.9 63.9 23.5 7.0 17.8 20.3 42.8 14.8 12.1 7.5 27.9 17.8 5.6 36.4 16.9 46.4 4.0 8.5 42.8 40.6 9.8 15.8 24.9 54.8 35.2 14.7 10.3 19.7 11.2 15.1 29.6 4.1 21.6 8.1 24.1 23.3 18.5 21.8 23.1 ZFAND3 "FLJ13222, TEX27" ENSG00000156639 "Zinc finger AN1-type containing 3" Q9H8U3 6 37819727-38154624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 821.8;Late spermatids: 3021.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016755 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA016755: AB_1859011" "unprognostic (3.32e-1)" "unprognostic (3.04e-2)" "unprognostic (1.36e-1)" "unprognostic (2.89e-2)" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (9.24e-2)" "unprognostic (1.37e-1)" "unprognostic (1.07e-1)" "unprognostic (1.36e-2)" "unprognostic (9.30e-2)" "unprognostic (1.48e-2)" "unprognostic (9.60e-3)" "unprognostic (1.01e-1)" "unprognostic (2.94e-1)" "unprognostic (7.41e-2)" "unprognostic (4.33e-1)" 44.2 42.3 36.6 31.7 38.0 42.6 36.4 36.8 36.4 42.6 33.2 50.3 39.3 41.2 35.3 37.4 33.4 36.3 51.1 37.0 41.4 47.7 53.3 37.8 28.1 46.2 40.8 32.3 39.0 56.6 33.8 48.8 41.5 35.3 32.1 39.4 32.8 46.1 137.8 33.8 39.5 46.9 39.2 31.6 42.0 113.0 38.2 39.7 52.0 67.3 29.3 49.3 31.2 42.9 59.1 33.8 116.8 82.8 72.4 75.9 42.5 88.6 115.6 87.3 92.8 68.4 33.4 24.6 71.8 106.8 96.2 39.5 48.3 73.4 122.3 102.2 30.6 75.6 17.3 65.3 171.0 29.5 59.4 96.1 93.7 91.7 157.0 101.6 76.8 56.9 37.3 48.1 68.4 50.6 50.2 27.0 33.4 84.5 38.4 52.4 48.4 29.6 79.5 94.0 74.2 63.2 54.6 43.6 151.5 98.1 70.2 61.5 81.5 87.2 66.2 47.5 58.8 47.3 47.7 74.2 32.4 47.1 91.9 0.5 1.7 6.1 1.5 1.7 1.1 1.3 1.1 1.2 0.9 1.9 0.9 1.5 6.0 1.6 1.3 2.9 1.5 0.9 36.6 38.0 36.8 36.4 37.0 41.4 46.2 40.8 41.5 39.2 38.2 42.9 25.4 22.4 11.5 241.0 27.0 27.3 30.9 20.0 52.9 25.8 19.8 19.4 23.0 25.8 11.6 47.8 22.9 35.0 23.2 55.2 74.3 27.3 821.8 25.4 26.6 28.1 16.2 22.5 332.7 29.3 33.1 27.2 31.6 33.2 5.1 33.9 27.5 48.8 33.8 30.3 262.9 30.5 6.1 43.7 44.3 3021.1 38.8 49.2 14.2 283.9 32.9 47.4 34.0 276.0 316.4 38.9 29.1 55.3 28.3 52.3 57.6 38.2 17.2 21.6 32.9 32.9 31.2 63.5 54.1 41.3 30.1 86.1 31.2 21.1 21.5 61.2 ZFP37 ZNF906 ENSG00000136866 "ZFP37 zinc finger protein" Q9Y6Q3 9 113038377-113056759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 15.5;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 2.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049112 Uncertain Approved Nucleoplasm,Vesicles Yes No "Cluster 4: T-regs - Cell cycle regulation" "Cluster 21: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Vesicles" "HPA049112: AB_2680637" "unprognostic (3.18e-1)" "unprognostic (9.57e-2)" "unprognostic (5.62e-2)" "unprognostic (3.54e-3)" "prognostic favorable (1.96e-4)" "unprognostic (7.84e-2)" "unprognostic (8.09e-2)" "unprognostic (2.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.53e-2)" "unprognostic (2.51e-2)" "unprognostic (1.38e-3)" "unprognostic (4.22e-2)" "unprognostic (9.46e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-1)" "unprognostic (2.07e-1)" 1.6 1.7 2.2 1.3 2.9 0.2 2.8 4.4 2.5 3.0 0.5 1.6 0.8 4.5 1.8 1.2 2.5 1.3 1.5 1.9 2.7 2.3 0.6 1.3 1.2 2.3 2.2 7.1 1.3 2.9 3.8 1.3 2.5 2.5 1.0 6.3 0.9 1.8 1.4 1.2 1.1 2.5 2.5 2.0 1.2 2.2 3.3 1.2 2.9 1.9 1.3 1.8 1.6 4.0 0.6 1.7 7.2 6.0 3.9 7.5 3.7 2.3 3.4 2.5 2.1 0.0 1.7 4.2 1.8 2.4 3.3 1.5 0.0 0.9 3.9 5.2 0.8 0.2 3.5 1.9 2.1 0.0 0.8 2.1 0.7 3.0 5.8 6.1 1.4 0.0 0.4 3.6 5.2 0.0 0.0 0.0 7.4 4.4 0.0 0.0 10.0 0.6 1.9 0.0 6.1 5.8 7.1 1.5 1.4 3.5 6.0 0.0 0.6 5.8 2.5 6.9 3.5 1.4 2.9 0.0 4.5 0.1 3.6 0.1 0.0 0.0 0.9 0.2 0.7 0.9 0.8 0.9 0.3 0.4 0.6 0.9 0.1 0.7 0.0 0.0 2.4 0.3 2.2 2.9 4.4 2.5 1.9 2.7 2.3 2.2 2.5 2.5 3.3 4.0 3.4 0.0 0.5 5.5 2.1 0.3 0.9 1.3 2.2 10.3 1.4 2.8 8.0 0.0 0.5 0.0 6.2 0.8 1.6 0.1 3.9 1.6 1.0 0.6 4.9 3.2 1.2 0.0 9.2 0.9 1.6 3.8 2.6 0.6 5.7 2.5 2.5 1.3 0.5 6.7 15.5 0.6 4.1 0.3 0.3 0.2 2.1 0.8 0.0 3.7 0.5 3.4 3.1 23.6 29.7 0.4 1.3 2.2 1.1 0.5 0.1 3.1 0.4 6.0 6.6 6.4 4.2 5.6 3.2 2.7 0.0 0.1 1.3 2.6 0.3 0.4 ZFYVE16 "KIAA0305, PPP1R69" ENSG00000039319 "Zinc finger FYVE-type containing 16" Q7Z3T8 5 80408013-80483379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 620.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 21.2;neutrophil: 21.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 80.7" "Low region specificity" "Detected in all" "HPA035935, HPA035936" Supported Enhanced Vesicles,Cytosol No No "Cluster 6: Non-specific - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" "Vesicles, Cytosol" "HPA035935: AB_10672076, HPA035936: AB_10669662" "unprognostic (1.11e-1)" "unprognostic (3.98e-2)" "unprognostic (1.78e-2)" "unprognostic (3.26e-1)" "unprognostic (7.19e-2)" "unprognostic (2.57e-2)" "unprognostic (7.25e-3)" "unprognostic (6.91e-2)" "unprognostic (4.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.15e-1)" "unprognostic (3.04e-1)" "unprognostic (4.64e-2)" "unprognostic (4.95e-2)" "unprognostic (6.91e-2)" "unprognostic (4.23e-2)" 8.4 8.7 5.1 8.1 12.0 5.2 8.7 5.7 6.4 15.1 4.3 6.4 5.1 12.7 2.5 7.2 7.2 11.2 14.0 4.1 8.2 9.5 10.3 9.1 5.6 7.0 8.5 12.3 6.4 9.0 3.9 13.0 7.6 8.5 6.3 8.6 5.0 6.6 6.1 4.3 6.8 9.9 6.5 9.0 6.6 9.3 8.3 5.0 9.5 8.4 4.5 9.5 4.7 15.5 11.9 13.4 23.4 21.9 14.0 14.3 15.5 17.6 15.2 15.4 20.7 9.9 16.5 7.9 12.5 14.6 16.4 11.9 17.2 14.4 16.9 5.1 10.9 8.6 16.3 11.3 11.6 2.6 6.3 15.4 7.5 12.9 12.4 12.4 18.0 7.3 8.5 12.0 16.8 14.9 5.7 2.5 5.3 6.1 6.5 11.7 48.3 8.4 12.9 22.1 8.8 19.5 25.3 11.6 80.7 14.1 20.2 7.7 16.0 9.2 10.3 14.3 14.6 3.6 7.6 7.8 12.1 8.0 21.0 21.2 4.5 2.5 1.8 2.8 1.0 3.6 0.9 1.6 1.8 3.2 0.7 0.9 21.3 3.0 5.4 3.0 1.0 0.4 5.1 12.0 5.7 6.4 4.1 8.2 7.0 8.5 7.6 6.5 8.3 15.5 49.3 25.6 22.2 127.0 25.8 18.2 14.0 16.4 15.4 94.9 23.4 18.2 52.3 14.3 33.8 31.3 114.7 22.1 28.9 20.3 9.8 16.2 7.4 47.6 85.6 33.1 21.6 7.8 87.7 12.3 11.8 33.7 23.9 37.5 10.1 59.7 35.7 16.8 26.5 80.8 114.0 11.3 2.0 59.8 71.5 7.0 37.9 71.4 19.6 64.6 34.7 26.3 17.5 182.0 620.2 16.4 20.2 44.4 19.0 16.5 16.3 13.6 49.9 75.3 32.9 58.6 43.3 49.0 22.0 15.6 25.4 37.4 17.5 44.7 12.9 20.1 ZFYVE9 "MADHIP, PPP1R173, SARA, SMADIP" ENSG00000157077 "Zinc finger FYVE-type containing 9" O95405 1 52142089-52348671 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 131.0;Inhibitory neurons: 162.6;Oligodendrocyte precursor cells: 80.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017702, HPA065852, HPA065862" Approved Enhanced Vesicles,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Cytosol" "CAB017702: AB_1128462, HPA065852: AB_2685568, HPA065862: AB_2685570" "unprognostic (5.05e-2)" "unprognostic (4.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-3)" "unprognostic (6.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (2.47e-2)" "unprognostic (5.36e-2)" "unprognostic (1.17e-3)" "unprognostic (2.14e-1)" "unprognostic (3.69e-1)" "unprognostic (1.99e-3)" "unprognostic (1.73e-2)" 9.3 8.2 13.7 3.3 14.5 1.1 11.2 20.5 16.6 12.4 31.1 8.3 5.7 12.0 7.3 9.1 10.0 6.9 7.2 15.5 13.2 12.9 9.2 9.8 2.2 13.0 13.2 16.3 15.0 25.7 8.9 6.3 14.2 11.1 8.2 13.7 9.2 11.1 25.7 10.7 5.5 11.2 10.9 3.6 7.4 13.8 13.5 5.3 16.9 20.2 3.4 8.9 8.6 13.5 17.9 8.3 11.7 15.1 27.5 25.0 19.2 14.2 18.8 16.5 18.8 9.6 1.4 0.0 8.7 20.0 22.7 6.5 20.8 22.5 25.1 0.1 14.6 5.1 9.3 11.4 18.0 4.5 2.9 16.7 24.9 14.2 31.9 20.1 24.0 11.8 8.0 3.2 22.2 3.9 6.5 3.3 15.4 4.7 14.8 5.7 20.1 1.7 9.4 38.5 9.9 10.2 15.9 13.4 18.4 23.2 6.2 5.9 22.3 16.6 6.7 12.8 8.6 4.5 2.9 2.2 11.8 5.4 6.8 1.3 0.0 0.1 0.2 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.3 0.2 0.2 0.1 0.0 0.1 0.0 0.1 13.7 14.5 20.5 16.6 15.5 13.2 13.0 13.2 14.2 10.9 13.5 13.5 11.5 9.6 5.9 61.7 0.7 5.1 10.0 4.0 10.8 19.9 6.6 5.7 13.6 7.2 9.4 1.8 4.2 5.5 1.1 8.8 7.9 6.4 12.6 6.3 19.1 9.3 17.5 0.0 131.0 7.4 5.3 11.0 23.4 7.9 1.3 16.0 5.0 8.5 0.5 23.5 162.6 8.1 2.0 0.6 1.3 17.3 15.2 0.5 7.2 45.9 0.2 10.0 1.0 80.9 37.5 4.1 7.9 16.6 3.5 7.8 8.2 10.2 2.5 14.3 13.1 20.9 8.3 45.5 46.8 11.7 7.4 2.9 3.8 15.0 6.3 6.4 ZG16B "HRPE773, JCLN2, PRO1567" ENSG00000162078 "Zymogen granule protein 16B" Q96DA0 16 2830169-2839585 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 717 "salivary gland: 63926.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 194.0;Basal respiratory cells: 181.6;Breast glandular cells: 154.9;Club cells: 343.9;Intestinal goblet cells: 232.2;Prostatic glandular cells: 398.1;Urothelial cells: 357.4" "Cancer enhanced" "Detected in many" "prostate cancer: 47.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.3;intermediate monocyte: 11.4;non-classical monocyte: 7.4" "Lineage enriched" "Detected in many" 7 "monocytes: 11.4" "Cell line enhanced" "Detected in some" "MCF7: 27.1;OE19: 57.5;SK-BR-3: 24.1;T-47d: 22.2" "Not detected" "Not detected" "HPA041125, HPA053549" Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 690000 "Cluster 7: Monocytes - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles Nucleoplasm "HPA041125: AB_10794264, HPA053549: AB_2682184" "unprognostic (5.29e-2)" "unprognostic (2.71e-1)" "unprognostic (4.37e-2)" "prognostic favorable (3.48e-6)" "unprognostic (1.39e-3)" "unprognostic (1.94e-2)" "unprognostic (2.34e-3)" "unprognostic (4.13e-2)" "unprognostic (1.01e-1)" "unprognostic (3.45e-3)" "unprognostic (1.37e-1)" "unprognostic (1.47e-2)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.17e-1)" "unprognostic (1.04e-1)" "unprognostic (8.33e-2)" 2.5 13.2 0.0 3.9 0.0 4.6 33.1 0.0 0.1 33.0 0.0 13.6 11.5 0.6 1.5 25.3 4.4 34.4 9.0 0.0 0.0 2.6 8.2 3.3 0.3 0.0 0.8 10.3 46.6 30.4 6.0 4.8 0.1 89.1 17.8 0.0 63926.2 7.1 6.1 47.7 9.6 0.4 0.0 4.2 33.2 4.4 0.0 0.2 2.9 0.1 5.9 11.2 16.3 0.0 0.0 1.1 0.0 0.0 0.3 1.9 0.2 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.3 0.0 0.2 2.1 0.0 4.4 0.0 0.0 0.0 9.0 2.8 2.4 1.6 0.0 0.0 0.1 0.2 0.0 1.2 0.1 0.0 0.0 0.2 3.6 0.2 27.1 0.0 0.4 0.1 57.5 5.0 0.0 0.0 8.6 0.2 6.3 0.0 0.0 0.1 24.1 0.0 0.1 22.2 0.0 3.1 0.1 0.5 1.9 0.1 0.0 0.5 0.3 0.3 6.5 0.3 1.7 6.3 0.0 0.0 11.4 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.4 1.2 7.4 0.0 0.5 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.5 9.1 194.0 181.6 0.0 0.0 154.9 82.5 0.0 70.1 343.9 1.8 0.0 0.1 2.0 107.1 0.0 5.9 7.7 3.5 1.6 2.8 58.2 0.4 0.0 28.1 3.2 1.8 21.9 13.0 5.7 1.7 0.7 0.1 14.6 0.0 0.0 232.2 140.4 4.6 0.5 5.7 0.0 4.4 83.6 0.0 5.6 0.0 0.0 0.0 0.0 46.4 65.3 0.0 0.0 398.1 12.5 0.0 74.7 0.0 0.0 0.0 19.2 1.4 0.6 9.5 24.0 0.3 2.5 21.3 76.7 357.4 ZGLP1 "GATAD3, GLP-1, GLP1" ENSG00000220201 "Zinc finger GATA like protein 1" P0C6A0 19 10304803-10309880 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 9.5;Hofbauer cells: 12.7;Kupffer cells: 20.0;Macrophages: 12.6;Spermatogonia: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 32.8;U-937: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA049855 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Vesicles" "HPA049855: AB_2680916" "unprognostic (1.73e-2)" "unprognostic (3.43e-3)" "unprognostic (1.42e-3)" "unprognostic (1.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-4)" "unprognostic (1.18e-1)" "unprognostic (1.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-4)" "unprognostic (2.82e-2)" "unprognostic (6.57e-7)" "unprognostic (6.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.57e-1)" "unprognostic (2.57e-4)" 1.9 1.5 5.0 1.0 5.2 0.5 2.3 4.6 10.7 4.0 4.3 2.4 1.0 2.5 0.4 1.9 3.3 0.8 1.7 5.3 4.4 7.8 6.4 2.2 1.7 4.2 4.0 5.2 3.3 0.5 8.3 0.9 4.0 6.8 0.2 0.5 2.5 1.0 1.2 2.1 2.6 0.2 3.7 5.0 1.9 5.0 4.4 0.4 9.2 0.4 0.7 2.6 2.7 4.8 0.5 1.2 1.7 0.6 1.1 0.5 4.3 0.9 0.3 0.8 1.8 1.2 0.4 1.9 0.9 0.3 0.8 1.8 1.2 0.4 0.3 1.6 5.5 1.8 2.0 0.7 0.7 0.0 0.5 0.9 2.5 0.8 0.5 0.7 0.2 1.4 1.8 1.3 1.1 2.0 0.2 32.8 2.7 0.4 2.0 1.8 0.8 0.8 0.7 0.8 1.4 1.6 0.4 0.3 1.6 0.4 2.5 0.6 0.6 2.5 2.9 2.4 0.3 6.2 7.9 0.9 0.4 8.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 5.2 4.6 10.7 5.3 4.4 4.2 4.0 4.0 3.7 4.4 4.8 1.1 0.0 1.8 4.6 0.5 0.9 0.6 1.2 0.0 1.6 2.0 2.4 0.8 0.0 1.2 1.8 0.0 0.5 0.8 0.9 0.0 0.6 0.8 0.9 1.3 1.1 0.0 0.4 9.5 0.0 0.4 0.6 0.0 0.9 0.0 2.7 0.7 1.2 12.7 6.7 6.9 0.7 0.0 20.0 7.9 1.3 0.9 12.6 3.6 2.8 7.8 1.7 0.0 1.5 1.6 0.3 1.5 0.7 0.1 0.9 0.4 0.4 1.5 1.5 0.0 0.5 0.8 2.2 16.3 0.3 0.9 0.1 0.6 0.8 1.6 0.0 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.1;choroid plexus: 8.1" "Group enriched" "Detected in some" 7 "Astrocytes: 20.5;Microglial cells: 15.0;Spermatocytes: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 22.0;HEK 293: 12.7;NTERA-2: 15.1;SCLC-21H: 85.5" "Group enriched" "Detected in all" 5 "basal ganglia: 18.9;cerebellum: 18.4;thalamus: 5.3" "Region enriched" "Detected in all" 7 "cerebellum: 39.7" HPA074045 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.0 0.0 2.8 0.0 3.5 0.0 0.0 17.1 11.2 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.1 0.0 0.0 0.0 0.0 2.8 2.1 0.0 0.0 0.0 0.2 0.0 3.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 2.2 22.0 1.8 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.0 2.1 0.0 3.1 0.0 1.1 0.0 4.5 0.0 0.0 4.0 12.7 0.0 2.1 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.9 3.3 0.0 0.0 1.7 0.0 1.7 15.1 0.0 0.3 1.9 0.8 0.0 0.0 0.0 85.5 0.0 2.4 2.0 0.0 1.6 0.0 2.8 0.0 1.2 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.5 17.1 11.2 3.9 2.1 2.8 2.1 3.0 1.8 3.1 2.6 0.1 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.0 0.0 1.9 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZMYND19 MIZIP ENSG00000165724 "Zinc finger MYND-type containing 19" Q96E35 9 137582081-137590512 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "retina: 287.8" "Group enriched" "Detected in many" 14 "Cone photoreceptor cells: 244.0;Rod photoreceptor cells: 680.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020642, HPA050761" Supported Approved "Golgi apparatus,Vesicles" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "HPA020642: AB_1859078, HPA050761: AB_2681228" "unprognostic (2.30e-2)" "unprognostic (9.62e-3)" "unprognostic (3.45e-2)" "unprognostic (7.99e-2)" "unprognostic (2.66e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.18e-1)" "unprognostic (2.48e-1)" "unprognostic (1.35e-1)" "unprognostic (9.33e-2)" "unprognostic (1.99e-2)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (4.30e-2)" "unprognostic (1.62e-1)" "unprognostic (1.72e-1)" 11.9 16.5 19.6 9.4 19.9 9.1 11.9 18.8 23.9 14.2 18.6 12.4 8.8 11.2 5.0 26.5 11.4 7.2 14.1 20.0 19.5 12.9 21.1 12.0 11.9 18.7 19.2 12.9 16.1 8.0 16.9 8.5 19.7 16.5 5.7 287.8 15.9 7.1 14.2 27.7 12.4 6.8 18.9 15.1 22.2 49.5 19.4 9.5 10.8 8.8 9.4 13.3 16.6 19.8 28.9 44.7 41.8 45.5 22.1 21.3 42.1 38.8 25.8 41.7 31.8 53.1 28.7 51.7 43.6 25.8 40.2 71.7 51.3 38.9 13.2 33.8 49.7 26.9 86.1 41.8 34.4 58.4 33.9 16.8 58.7 38.0 37.1 18.4 22.3 40.5 66.3 22.2 25.6 97.2 68.4 88.7 60.7 86.4 61.9 73.8 36.8 79.6 25.7 24.2 60.1 39.4 37.4 79.4 35.4 18.5 53.7 89.9 21.3 51.1 38.9 76.8 63.8 21.4 54.9 56.8 31.6 44.8 35.9 0.0 0.3 0.3 0.5 1.6 1.2 0.8 0.3 0.2 0.3 0.3 0.5 0.4 0.0 0.1 0.2 0.9 1.0 0.1 19.6 19.9 18.8 23.9 20.0 19.5 18.7 19.2 19.7 18.9 19.4 19.8 6.1 9.6 7.2 3.6 4.0 17.5 5.6 3.2 5.2 23.6 14.9 19.2 6.2 2.8 2.4 1.8 244.0 5.2 6.8 5.3 0.0 3.2 4.5 6.5 12.8 5.6 2.4 6.9 4.1 3.6 6.8 6.3 10.7 8.1 1.3 10.6 3.9 7.6 4.4 11.8 4.0 8.8 6.1 3.2 5.7 4.4 2.8 3.6 5.4 1.9 2.2 31.6 5.2 2.0 2.1 4.2 4.6 3.0 10.9 10.2 1.9 3.1 1.3 680.0 0.0 6.9 6.7 27.8 28.7 4.5 22.9 4.5 4.6 8.5 7.8 7.1 ZNF132 pHZ-12 ENSG00000131849 "Zinc finger protein 132" P52740 19 58432814-58440153 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.0;Cone photoreceptor cells: 4.2;Early spermatids: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA008726 Uncertain Approved "Vesicles,Intermediate filaments" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Vesicles "Intermediate filaments" "HPA008726: AB_1080664" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (6.79e-3)" "unprognostic (3.06e-2)" "unprognostic (8.16e-2)" "unprognostic (4.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.32e-3)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.92e-4)" "unprognostic (4.51e-1)" "prognostic favorable (7.26e-13)" "unprognostic (2.70e-1)" "unprognostic (7.65e-2)" "unprognostic (6.09e-2)" "unprognostic (3.72e-1)" 1.4 2.3 1.8 1.3 1.9 0.3 2.6 4.7 2.7 2.7 4.6 1.7 1.2 1.8 3.5 1.6 3.8 1.3 3.0 1.8 1.9 3.0 0.8 1.8 1.8 1.5 2.3 3.7 1.6 8.9 3.4 1.8 1.6 2.9 1.1 5.0 3.0 3.1 1.9 2.3 1.1 2.1 1.4 2.3 1.5 3.1 1.7 1.6 5.4 1.7 2.2 1.9 1.5 2.7 1.2 1.3 3.4 1.2 3.9 3.3 0.1 2.6 3.2 2.1 2.0 0.1 1.0 3.3 0.2 3.2 2.1 1.3 0.0 3.9 1.5 0.5 5.9 0.6 1.1 0.7 3.4 1.3 2.1 3.5 1.3 3.6 2.3 2.5 2.0 0.5 0.4 0.3 4.1 0.5 0.7 0.1 3.5 0.4 1.2 0.4 0.7 0.9 1.3 1.4 3.0 3.1 1.0 0.9 1.1 3.6 0.2 3.2 2.4 2.1 0.2 0.5 0.5 4.1 0.8 0.0 1.0 0.1 1.4 0.0 0.8 0.8 0.9 1.0 2.2 1.1 1.1 0.5 1.2 1.4 1.7 1.4 0.0 1.2 1.2 1.0 1.1 0.8 1.8 1.9 4.7 2.7 1.8 1.9 1.5 2.3 1.6 1.4 1.7 2.7 0.4 0.0 0.5 1.6 0.6 0.0 0.6 0.5 0.0 1.2 0.4 0.4 4.0 1.5 0.2 0.0 4.2 0.5 0.2 0.1 0.0 0.6 3.7 1.2 1.0 0.8 0.0 1.7 2.0 0.4 0.2 0.7 2.0 0.4 1.3 1.6 0.4 0.9 0.5 3.3 2.3 0.8 0.0 0.3 0.0 0.7 0.6 0.7 0.0 0.0 0.2 1.4 0.0 1.0 2.5 0.1 0.0 0.7 0.5 0.9 0.3 1.5 0.7 1.7 0.0 0.7 0.8 2.5 0.8 0.8 0.3 0.4 0.5 0.8 0.2 0.3 ZNF133 "pHZ-13, pHZ-66, ZNF150" ENSG00000125846 "Zinc finger protein 133" P52736 20 18288283-18316996 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 37.1;Inhibitory neurons: 42.0;Oligodendrocyte precursor cells: 32.6;Oligodendrocytes: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001493 Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Vesicles" "HPA001493: AB_1080666" "unprognostic (9.09e-3)" "unprognostic (3.24e-1)" "unprognostic (8.27e-3)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" "unprognostic (1.54e-2)" "prognostic unfavorable (4.46e-6)" "unprognostic (6.01e-3)" "unprognostic (8.60e-2)" "unprognostic (4.17e-1)" "unprognostic (1.04e-3)" "unprognostic (7.36e-2)" "prognostic unfavorable (2.20e-5)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (1.52e-1)" 12.3 13.1 16.8 4.6 17.1 4.3 14.5 19.0 19.0 17.1 20.5 15.7 5.2 13.3 16.5 14.8 14.1 7.7 11.1 16.9 17.7 18.1 13.0 10.9 5.7 16.1 16.4 17.6 16.0 11.4 21.2 8.7 16.7 18.7 6.8 10.5 12.9 8.8 14.0 16.7 10.3 10.5 15.5 15.5 12.9 10.2 16.9 7.1 17.4 9.8 5.9 14.1 15.1 17.8 10.0 10.8 8.3 12.0 19.9 13.7 17.6 9.2 13.5 11.5 16.6 8.7 11.5 2.6 5.4 10.9 13.2 21.4 8.1 24.1 10.8 2.9 5.6 6.8 9.9 19.4 14.9 5.8 1.0 13.4 16.3 9.6 28.0 15.6 11.2 11.0 8.1 2.8 10.0 10.0 7.2 9.5 6.9 11.9 10.6 6.2 11.4 6.4 11.3 6.8 11.7 11.9 7.1 18.9 13.3 11.5 7.4 15.7 8.0 12.1 5.8 8.6 9.2 9.1 9.8 0.9 3.7 3.9 7.0 1.5 3.1 2.4 5.9 2.2 3.9 3.2 5.0 4.0 3.9 3.4 3.8 4.6 1.0 8.7 3.5 2.1 4.0 2.7 16.8 17.1 19.0 19.0 16.9 17.7 16.1 16.4 16.7 15.5 16.9 17.8 3.7 6.4 9.2 18.6 2.5 2.2 2.7 7.3 3.4 7.5 4.6 7.4 7.9 5.7 5.7 1.8 4.2 5.0 0.8 2.2 3.9 4.5 14.7 5.1 7.7 4.7 1.2 3.2 37.1 2.3 3.2 5.3 5.1 4.5 7.0 7.1 5.3 4.2 4.7 3.3 42.0 4.6 2.0 3.8 0.9 25.0 7.8 2.2 0.0 21.5 1.4 3.1 4.1 32.6 31.8 3.7 1.5 4.5 2.3 3.3 2.5 3.4 5.0 5.0 0.0 4.4 3.6 6.1 2.6 3.0 3.1 2.3 1.9 3.7 3.3 3.0 ZNF215 "ZKSCAN11, ZSCAN43" ENSG00000149054 "Zinc finger protein 215" Q9UL58 11 6926404-7001004 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 13.7;Inhibitory neurons: 8.5;Plasma cells: 27.5;Spermatogonia: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-698: 19.8" "Low region specificity" "Detected in many" "HPA047243, HPA051010" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Vesicles" "HPA047243: , HPA051010: AB_2681308" "unprognostic (2.18e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-2)" "unprognostic (1.08e-1)" "unprognostic (8.18e-2)" "unprognostic (4.76e-2)" "unprognostic (1.01e-4)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (1.05e-1)" "unprognostic (3.44e-1)" "unprognostic (1.45e-2)" "unprognostic (9.01e-3)" "unprognostic (4.29e-3)" "unprognostic (7.89e-2)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" 0.4 0.4 0.4 1.3 0.4 0.7 1.3 0.2 0.5 0.8 0.1 2.0 2.2 0.7 0.6 0.9 0.4 0.5 0.4 0.4 0.5 1.0 0.3 0.5 3.4 0.5 0.4 0.8 2.2 0.0 0.2 0.2 0.4 0.8 2.6 0.4 1.4 0.4 0.2 0.5 1.9 0.5 0.2 1.6 0.8 1.5 0.6 1.2 0.8 0.1 4.2 1.1 0.7 0.3 2.9 1.1 1.8 0.2 1.2 1.7 6.4 7.0 5.7 3.6 6.5 0.2 0.0 10.1 2.1 3.2 4.3 3.1 4.8 6.4 6.3 0.0 7.5 0.0 0.3 0.0 1.2 6.5 0.0 3.2 3.1 0.1 7.0 1.4 5.3 0.1 11.5 3.1 1.3 0.0 0.1 0.0 8.9 0.0 1.6 0.0 0.0 1.3 0.1 5.3 0.0 0.2 0.0 2.4 0.0 4.4 0.1 2.4 2.8 2.0 5.8 2.4 0.0 0.3 0.1 19.8 4.8 0.0 1.9 1.5 0.4 0.1 0.1 0.2 0.0 0.6 0.1 0.3 0.4 0.5 0.3 0.1 0.6 0.2 0.1 0.7 0.2 0.3 0.4 0.4 0.2 0.5 0.4 0.5 0.5 0.4 0.4 0.2 0.6 0.3 0.2 0.0 0.0 0.3 2.5 0.4 1.7 1.0 1.8 0.6 0.7 0.3 0.2 0.0 0.9 7.3 6.2 0.4 0.1 0.9 1.9 0.1 0.3 0.8 1.8 0.6 1.2 2.5 13.7 1.8 2.6 1.1 0.0 0.9 1.3 0.6 0.0 0.9 0.4 3.3 8.5 3.5 0.0 0.3 0.0 0.3 0.0 0.8 1.8 3.7 0.0 0.1 0.0 1.5 0.4 0.3 0.8 0.0 27.5 0.6 2.0 1.1 0.4 0.0 0.0 0.2 0.7 5.6 9.1 2.3 0.3 0.0 0.8 2.2 2.2 0.8 ZNF229 ENSG00000278318 "Zinc finger protein 229" Q9UJW7 19 44417519-44448578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.9" HPA001494 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Vesicles "Plasma membrane" "HPA001494: AB_1080692" "unprognostic (2.59e-1)" "unprognostic (7.41e-4)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (3.90e-1)" "unprognostic (2.17e-1)" "unprognostic (3.34e-2)" "unprognostic (7.18e-3)" "unprognostic (1.17e-2)" "unprognostic (4.66e-2)" "unprognostic (4.18e-2)" "unprognostic (5.04e-3)" "prognostic favorable (8.43e-5)" "unprognostic (3.66e-3)" "unprognostic (2.01e-2)" "unprognostic (2.18e-1)" "unprognostic (4.34e-1)" 0.5 1.7 1.3 0.1 1.4 0.1 1.0 1.3 1.6 1.0 1.7 0.9 0.7 1.1 1.1 0.7 1.9 0.5 1.4 1.4 1.4 0.8 0.7 0.6 0.3 1.3 1.3 2.3 0.8 2.7 1.3 1.1 1.3 1.2 0.1 4.5 0.7 0.8 0.8 0.3 0.4 0.8 1.2 0.6 0.6 0.7 1.5 1.1 2.0 1.2 0.3 0.8 0.5 1.6 0.0 3.7 2.7 0.0 2.9 2.4 0.0 4.4 1.4 2.1 2.8 0.0 0.6 0.0 1.7 2.5 3.4 1.3 0.0 2.8 1.4 0.0 1.4 0.4 1.2 0.3 5.0 0.0 0.0 3.4 0.0 1.7 6.9 2.9 2.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 3.4 0.0 1.0 0.0 0.0 1.3 2.1 5.5 0.7 1.0 1.9 0.3 0.0 2.0 0.0 0.0 1.9 1.3 0.1 0.5 0.1 3.1 2.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.3 0.1 0.0 1.5 0.0 0.0 0.0 0.1 1.3 1.4 1.3 1.6 1.4 1.4 1.3 1.3 1.3 1.2 1.5 1.6 1.4 0.0 0.0 5.9 0.4 0.1 0.7 2.0 1.8 5.8 2.1 2.2 3.7 0.0 1.3 0.0 4.2 0.9 0.0 0.2 3.9 1.7 0.7 1.6 1.7 1.3 0.0 2.1 3.1 1.2 0.6 1.0 2.6 1.0 0.0 3.4 1.4 0.2 0.7 1.7 4.5 0.3 0.0 0.6 0.0 0.5 0.9 0.3 0.0 1.0 0.1 4.7 0.0 7.5 2.2 2.0 0.3 1.9 0.0 1.6 0.3 1.6 4.5 6.9 0.0 1.0 1.5 1.8 2.4 1.4 0.0 0.8 0.2 3.4 0.5 0.9 ZNF302 "ZNF135L, ZNF140L, ZNF327" ENSG00000089335 "Zinc finger protein 302" Q9NR11 19 34677639-34686397 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 203.2;choroid plexus: 142.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059503 Approved "Vesicles,Cytokinetic bridge" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Vesicles, Cytokinetic bridge" "HPA059503: AB_2684043" "unprognostic (3.52e-1)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (2.25e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-3)" "unprognostic (1.82e-2)" "unprognostic (4.63e-2)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.41e-4)" "unprognostic (2.34e-1)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "prognostic favorable (9.85e-5)" 13.7 18.1 139.4 10.2 142.4 4.6 24.0 142.8 203.2 17.5 142.3 20.0 12.4 19.5 21.6 9.1 18.5 11.1 25.4 139.0 140.3 19.8 19.0 14.6 17.8 140.2 141.5 28.0 24.4 21.5 16.7 11.9 141.4 18.0 15.4 45.2 13.5 18.8 37.2 12.8 15.7 14.8 140.7 19.4 14.9 15.5 140.7 17.2 19.1 30.4 16.7 18.0 12.1 147.3 10.5 16.0 33.3 13.2 30.8 23.6 11.6 17.8 21.8 16.0 17.3 11.9 9.5 16.3 21.7 13.5 12.0 8.5 16.3 10.4 17.1 1.3 13.6 31.2 18.0 0.3 16.5 0.3 2.4 22.3 15.0 9.9 1.8 20.0 13.8 11.4 0.3 0.9 25.2 5.5 16.9 16.7 15.1 18.9 10.6 12.5 27.0 9.1 16.9 14.0 14.8 24.1 16.2 6.0 21.9 17.7 12.7 24.8 13.6 7.4 17.6 6.8 8.9 18.6 35.1 5.1 6.8 2.4 33.9 28.1 10.1 17.2 14.9 10.0 20.7 23.3 17.0 14.0 8.8 25.0 28.0 22.3 7.5 19.4 13.4 20.3 14.9 9.1 139.4 142.4 142.8 203.2 139.0 140.3 140.2 141.5 141.4 140.7 140.7 147.3 32.2 28.9 27.6 41.8 33.2 26.8 34.0 16.0 19.9 56.5 24.4 30.9 58.9 25.8 22.1 22.0 52.1 16.8 26.6 10.4 45.0 17.5 31.3 12.7 29.7 34.3 19.9 20.8 41.5 11.4 6.8 41.0 21.4 11.8 29.1 63.0 28.5 11.8 10.1 48.8 42.4 13.4 14.2 14.5 44.9 6.3 59.4 15.7 24.9 29.0 17.8 73.5 42.2 54.8 76.1 10.0 16.4 51.1 14.8 40.1 20.6 14.3 25.6 88.8 52.6 73.5 40.5 67.0 40.2 15.7 21.5 5.5 29.3 44.8 11.6 30.8 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" Q70YC5 10 62374192-62480288 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;esophagus: 10.2" "Group enriched" "Detected in some" 6 "Excitatory neurons: 112.7;Oligodendrocyte precursor cells: 113.6;Oligodendrocytes: 195.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 22.7;hippocampal formation: 8.3;thalamus: 8.0;white matter: 16.6" "Group enriched" "Detected in many" 9 "gdT-cell: 2.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.7;naive CD8 T-cell: 2.7;NK-cell: 6.4;T-reg: 5.9" "Group enriched" "Detected in many" 62 "NK-cells: 6.4;T-cells: 5.9" "Cell line enhanced" "Detected in many" "HaCaT: 22.3;PC-3: 13.9;U-251 MG: 18.6;U-87 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052446 Supported Approved Vesicles,Centrosome NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Centrosome" "HPA052446: AB_2681836" "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.1 1.3 1.0 0.1 2.8 0.0 0.3 1.5 22.7 0.9 0.0 0.0 0.1 0.1 0.2 10.2 0.1 0.3 1.0 8.3 0.0 0.1 0.0 0.7 0.0 0.0 3.2 0.0 0.4 5.6 1.6 0.1 0.0 1.8 0.1 5.1 1.1 2.0 0.0 0.8 0.1 0.1 0.0 0.3 0.0 0.5 8.0 0.5 0.6 0.1 1.4 0.8 1.1 16.6 6.3 0.6 0.1 0.0 0.1 0.0 0.0 5.5 5.8 2.6 2.1 0.0 1.0 0.0 0.2 3.1 8.4 22.3 0.0 0.4 3.5 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.9 6.6 0.9 0.0 0.0 0.0 5.5 2.1 0.7 0.0 0.9 0.0 13.9 0.0 0.2 0.0 0.3 2.8 0.1 1.2 1.1 0.2 0.6 0.0 0.0 0.0 0.0 1.1 6.1 0.0 18.6 0.0 0.0 0.0 12.9 0.0 1.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.1 2.7 0.0 0.0 0.4 2.7 0.0 6.4 0.0 0.0 5.9 0.8 1.0 2.8 1.5 22.7 8.3 0.0 0.0 3.2 0.0 0.0 8.0 16.6 0.0 0.0 0.0 15.3 0.2 0.5 3.7 0.6 0.0 13.5 0.3 0.3 2.6 1.5 0.1 3.7 2.1 0.0 2.8 0.0 0.0 0.2 0.5 0.3 0.2 0.2 0.0 0.0 112.7 0.0 0.0 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.1 18.5 23.4 0.0 0.0 0.3 1.1 0.3 0.0 0.4 0.0 6.5 0.0 2.7 0.0 113.6 195.5 0.9 0.0 0.0 1.9 1.2 0.0 0.7 0.1 5.3 0.0 0.8 0.8 0.1 0.7 0.0 0.4 0.0 3.9 0.2 0.0 6.0 ZNF442 FLJ14356 ENSG00000198342 "Zinc finger protein 442" Q9H7R0 19 12345944-12365905 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell type enhanced" "Detected in many" "Adipocytes: 7.7;Granulosa cells: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 5.5" "HPA045738, HPA053407" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane" Vesicles "HPA045738: AB_10968057, HPA053407: AB_2682138" "unprognostic (2.61e-2)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (7.36e-2)" "unprognostic (1.28e-1)" "unprognostic (5.53e-2)" "unprognostic (6.64e-2)" "unprognostic (2.07e-2)" "unprognostic (3.17e-3)" "unprognostic (1.35e-1)" "unprognostic (7.52e-3)" "unprognostic (1.78e-1)" "unprognostic (1.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.99e-2)" 1.6 1.0 2.5 1.0 4.3 0.5 1.7 3.4 2.3 1.8 5.7 1.1 0.6 1.9 1.1 0.9 2.1 0.6 1.2 2.0 4.5 2.1 2.0 1.2 1.3 10.0 6.0 4.9 1.7 1.3 0.9 1.0 7.7 1.7 1.3 1.2 0.9 2.1 0.8 1.3 0.8 1.6 3.9 1.7 0.9 1.3 6.1 1.2 2.0 1.5 1.0 1.8 1.5 5.3 0.2 0.0 1.7 2.2 1.0 0.5 0.1 2.3 0.6 2.0 1.6 1.6 0.5 2.0 0.7 1.2 0.8 0.4 1.4 1.1 1.9 0.0 0.2 0.1 3.2 1.5 0.8 0.0 1.9 0.9 1.2 0.8 0.3 0.1 0.2 1.4 2.9 0.2 1.8 1.5 2.4 0.3 1.4 0.3 1.0 0.1 2.5 0.1 0.8 1.3 0.1 0.4 0.0 0.0 0.0 1.9 2.2 1.5 0.0 2.6 1.3 3.3 1.4 2.0 5.5 0.0 0.1 0.0 1.0 0.5 0.3 2.2 0.8 0.5 0.5 2.5 0.5 0.5 0.5 0.4 1.3 0.8 0.6 0.4 0.4 0.5 0.0 0.3 2.5 4.3 3.4 2.3 2.0 4.5 10.0 6.0 7.7 3.9 6.1 5.3 7.7 0.0 2.6 1.0 2.4 0.4 1.1 2.2 1.8 1.6 1.9 1.9 2.8 1.5 0.6 1.8 6.2 0.4 1.6 0.7 1.9 0.9 1.0 0.9 1.6 3.2 1.2 0.4 0.9 0.9 0.4 2.5 0.0 1.2 2.5 7.0 3.6 1.6 1.5 0.0 1.5 0.7 2.0 2.4 0.6 0.5 0.6 1.5 3.6 1.9 1.6 2.2 3.1 0.5 1.3 0.2 0.1 0.4 2.7 0.8 0.3 3.7 1.8 1.7 0.0 4.8 3.9 2.4 2.5 1.2 0.6 0.4 1.3 0.6 0.5 0.6 ZNF550 MGC41917 ENSG00000251369 "Zinc finger protein 550" Q7Z398 19 57535257-57559863 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003251 Uncertain Approved Vesicles,Microtubules NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles Microtubules "HPA003251: AB_1080736" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-2)" "unprognostic (1.43e-1)" "unprognostic (2.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.61e-2)" "unprognostic (2.66e-3)" "unprognostic (3.46e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.33e-2)" "unprognostic (1.59e-1)" "unprognostic (2.69e-2)" "unprognostic (6.68e-3)" "unprognostic (1.52e-1)" 2.8 3.7 1.8 5.1 2.0 5.2 6.0 5.8 2.7 5.5 3.2 2.8 2.2 4.6 3.9 3.1 4.6 3.1 5.6 1.7 2.9 2.9 3.0 3.4 6.7 1.5 1.8 9.1 2.4 7.8 2.5 6.5 2.3 6.0 2.9 7.3 4.2 4.4 2.2 4.0 3.6 3.3 1.1 7.7 3.5 2.8 1.7 7.4 4.8 3.3 5.4 3.6 1.3 2.9 4.3 3.0 8.4 8.0 2.8 6.9 0.0 5.7 4.8 5.0 2.1 3.7 3.9 1.2 3.9 4.2 4.0 3.6 4.4 5.0 6.3 0.1 23.2 11.5 10.9 4.9 4.1 10.1 4.3 5.8 3.0 3.9 11.2 6.9 4.2 10.6 1.8 0.1 5.4 1.0 15.5 4.4 9.2 1.3 5.8 12.3 8.7 12.1 2.7 7.6 7.8 11.0 7.2 4.8 3.5 5.9 5.5 6.6 4.8 6.9 4.2 2.6 5.6 24.0 24.0 10.0 2.8 5.8 6.1 0.4 1.4 2.0 3.6 1.9 4.5 1.8 4.5 2.5 2.0 2.6 5.8 3.4 0.4 5.2 0.6 0.7 4.5 2.3 1.8 2.0 5.8 2.7 1.7 2.9 1.5 1.8 2.3 1.1 1.7 2.9 4.5 0.0 1.1 4.2 8.9 5.1 3.9 2.6 5.7 4.5 4.7 3.6 7.2 2.8 3.4 0.0 6.2 4.2 4.9 0.5 1.9 2.8 1.0 3.4 4.7 5.8 3.6 5.0 4.8 1.2 4.4 3.9 0.5 2.9 5.1 8.3 5.0 3.2 2.3 11.8 5.3 2.8 4.1 1.9 2.2 0.6 4.7 1.4 3.6 2.8 2.5 3.0 12.3 4.0 3.7 2.2 0.8 0.7 3.4 6.7 1.2 0.9 6.5 5.1 0.0 3.3 4.4 3.2 5.0 4.4 6.8 5.2 6.2 4.4 2.7 4.3 ZNF574 FLJ22059 ENSG00000105732 "Zinc finger protein 574" Q6ZN55 19 42068477-42081552 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 40.9;Spermatocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023196, HPA057274" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm Vesicles "HPA023196: AB_2671105, HPA057274: AB_2683392" "unprognostic (3.90e-1)" "unprognostic (3.68e-2)" "unprognostic (3.39e-2)" "unprognostic (7.84e-2)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (9.49e-2)" "unprognostic (2.84e-2)" "unprognostic (5.24e-2)" "unprognostic (1.55e-3)" "unprognostic (6.36e-3)" "unprognostic (2.11e-1)" "unprognostic (2.10e-2)" "unprognostic (6.48e-2)" "unprognostic (3.51e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" 8.1 5.4 6.8 4.6 6.1 11.1 7.9 9.5 7.7 8.4 4.3 9.5 6.7 10.3 2.7 9.6 8.8 5.1 6.8 6.2 6.2 5.5 5.4 5.6 6.5 6.9 5.8 9.6 7.9 6.1 6.5 5.0 5.8 7.5 2.8 4.1 8.1 6.7 9.3 12.8 7.5 3.7 5.6 8.4 7.2 27.1 6.3 6.3 6.0 6.4 4.2 8.2 7.5 6.3 15.0 41.1 9.0 11.4 8.1 8.0 9.7 11.0 9.6 14.2 13.6 16.2 10.1 21.4 9.7 9.1 7.5 8.9 10.4 14.1 5.6 11.4 17.6 20.5 10.1 14.0 8.6 12.6 13.5 9.5 13.9 13.2 11.1 8.7 7.9 11.8 17.1 13.3 10.1 31.2 15.2 10.9 16.1 13.5 16.2 20.7 8.6 9.3 7.4 19.7 14.9 12.8 11.3 24.0 7.3 6.2 11.0 20.5 9.5 19.2 14.9 5.8 16.4 14.3 9.3 15.7 10.6 11.9 11.0 12.3 10.5 16.7 16.2 7.8 17.6 17.3 12.1 17.8 12.5 12.8 12.6 11.9 13.3 10.9 11.2 11.1 10.3 12.9 6.8 6.1 9.5 7.7 6.2 6.2 6.9 5.8 5.8 5.6 6.3 6.3 6.0 0.0 3.3 1.3 11.3 29.3 15.1 6.1 40.9 7.5 11.0 7.6 4.3 4.3 6.0 1.8 2.1 7.9 6.3 5.8 1.9 6.9 25.3 6.1 5.7 7.6 3.5 8.6 1.4 5.1 6.7 6.6 7.7 5.7 12.7 5.4 6.8 3.1 5.1 3.3 1.7 7.6 6.1 2.5 11.0 15.7 5.6 3.0 8.8 1.0 7.5 3.9 4.1 1.5 0.9 4.3 8.5 8.6 8.1 10.6 6.4 4.3 5.2 9.8 6.6 8.8 8.0 35.5 20.5 22.1 22.7 4.8 10.6 3.8 7.9 9.6 ZNF586 FLJ20070 ENSG00000083828 "Zinc finger protein 586" Q9NXT0 19 57769655-57819939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 18.9" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA030306, HPA060782" Approved Approved "Nucleoli fibrillar center,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 57: B-cells - Immune response" "Nucleoli fibrillar center" Vesicles "HPA030306: AB_2673423, HPA060782: AB_2684362" "prognostic favorable (9.83e-5)" "unprognostic (1.60e-2)" "unprognostic (2.93e-1)" "unprognostic (1.72e-3)" "unprognostic (2.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.10e-2)" "unprognostic (1.02e-3)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (1.88e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (6.01e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "prognostic favorable (5.36e-4)" 5.2 4.3 3.6 6.3 4.0 25.4 6.9 18.9 4.1 6.1 5.9 5.6 5.9 5.9 5.0 6.6 5.9 4.9 6.0 3.6 4.6 5.3 4.8 5.8 11.8 2.4 2.2 9.0 6.5 4.2 4.8 6.9 2.0 8.4 5.9 9.3 8.9 4.1 9.7 8.3 6.5 5.8 0.3 10.4 7.2 5.0 3.0 13.4 6.2 7.2 9.8 6.5 7.2 4.3 7.2 6.0 8.6 9.6 4.1 3.7 14.4 5.0 5.3 7.0 3.8 2.8 7.2 16.1 0.4 4.6 6.6 4.7 1.6 7.2 13.1 2.4 30.9 12.2 15.1 1.6 7.5 12.0 10.4 6.4 7.5 5.2 7.6 7.9 8.5 15.6 8.0 0.7 8.3 1.7 12.3 8.2 12.8 4.8 17.3 11.9 3.2 20.2 8.3 17.8 11.9 5.9 2.3 7.4 5.8 7.4 7.1 7.6 4.6 9.2 5.1 0.3 8.8 15.4 23.0 17.1 5.0 1.3 6.6 8.0 9.6 31.5 8.4 8.0 8.2 7.0 10.8 8.9 8.9 9.7 13.3 12.2 29.5 10.1 5.4 6.6 15.1 7.3 3.6 4.0 18.9 4.1 3.6 4.6 2.4 2.2 2.0 0.3 3.0 4.3 3.9 0.0 1.5 3.6 13.6 12.1 7.9 6.6 9.6 3.6 4.9 4.2 4.8 0.0 3.3 3.7 0.0 7.1 8.5 2.1 9.8 3.4 0.9 4.3 2.8 4.5 3.0 4.4 4.0 2.0 6.9 3.4 2.6 5.7 3.8 8.6 5.0 3.5 5.5 6.7 4.7 4.0 8.2 8.2 6.8 1.1 0.9 5.6 3.6 1.9 7.1 3.1 6.2 3.0 3.4 2.1 1.7 2.6 9.2 3.6 4.4 5.9 2.2 5.2 6.6 2.6 3.8 10.4 8.7 7.0 11.4 10.0 9.2 4.5 4.0 8.5 ZNF605 ENSG00000196458 "Zinc finger protein 605" Q86T29 12 132918306-132956306 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061970, HPA062655" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA061970: AB_2684649, HPA062655: AB_2684820" "unprognostic (2.38e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-2)" "unprognostic (6.38e-2)" "unprognostic (3.83e-2)" "unprognostic (1.16e-6)" "unprognostic (3.62e-1)" "unprognostic (1.15e-1)" "unprognostic (4.03e-1)" "unprognostic (2.13e-2)" "unprognostic (1.10e-2)" "unprognostic (2.89e-1)" "unprognostic (6.58e-2)" "unprognostic (1.10e-1)" "unprognostic (7.53e-2)" "unprognostic (9.06e-3)" 2.9 4.1 5.7 2.5 5.7 1.4 5.2 7.3 6.8 4.6 6.6 5.1 2.8 4.3 5.4 3.5 4.6 2.7 4.4 5.6 4.7 4.7 4.3 2.9 3.2 5.4 5.0 5.4 3.9 6.2 6.7 3.3 5.5 5.2 2.8 8.4 4.5 3.8 4.2 5.0 4.2 3.2 4.3 3.9 4.0 2.1 5.4 4.0 6.9 5.2 2.9 4.4 4.2 6.4 4.8 3.8 9.7 9.2 5.2 10.7 7.2 6.5 3.7 2.9 2.1 0.6 0.6 2.0 3.4 5.6 3.6 2.6 4.2 1.6 3.6 1.6 7.2 9.2 3.4 3.0 3.9 3.9 9.7 6.8 7.0 2.0 4.4 9.0 2.2 4.7 1.4 0.1 7.4 1.3 5.1 5.4 7.5 1.3 5.2 4.7 6.3 1.4 5.0 8.1 6.2 7.1 2.9 1.7 4.5 5.7 10.6 11.1 4.4 3.6 5.8 5.4 2.6 0.0 0.0 1.6 0.1 3.2 2.2 0.4 0.2 0.2 0.2 0.1 0.1 0.5 0.2 0.3 0.1 0.3 0.5 0.3 0.3 0.3 0.1 0.2 0.0 0.1 5.7 5.7 7.3 6.8 5.6 4.7 5.4 5.0 5.5 4.3 5.4 6.4 8.4 19.2 33.5 21.9 9.3 3.4 8.1 3.3 18.8 33.6 10.5 11.2 22.5 15.7 25.1 9.2 29.2 7.5 5.0 7.3 9.8 7.2 2.2 8.1 15.0 12.7 6.1 7.6 24.9 3.3 3.6 12.6 15.3 7.1 10.1 20.2 13.6 4.9 3.9 40.4 25.2 10.1 6.1 7.3 2.7 2.5 15.8 6.1 0.0 11.2 8.9 16.4 13.4 28.1 15.8 7.5 4.5 13.5 5.8 9.5 5.8 5.2 13.7 35.2 13.1 16.2 11.5 6.8 7.9 9.4 4.5 5.6 10.8 23.0 7.1 6.2 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 19.4" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "prostate cancer: 10.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favorable (1.92e-6)" 3.2 3.2 3.4 2.6 3.8 1.4 7.0 4.6 4.2 3.1 3.2 5.2 2.2 3.5 3.8 3.4 3.2 2.8 3.5 3.5 5.1 4.9 2.9 3.8 4.2 4.0 4.2 3.8 2.5 6.0 3.2 6.6 3.9 19.4 5.0 7.2 2.9 4.0 2.7 3.6 2.9 4.1 3.5 4.3 2.8 2.8 4.0 5.6 4.3 3.5 4.2 3.6 2.8 4.2 2.9 3.8 6.2 6.3 5.5 5.7 1.5 5.0 7.8 6.4 8.1 1.3 3.5 2.7 2.6 6.1 5.8 3.2 6.3 6.1 6.9 0.1 8.2 5.4 2.8 3.7 5.5 0.3 7.2 4.6 7.1 6.2 5.0 7.7 7.1 6.2 2.5 0.0 6.6 0.5 8.9 4.1 4.5 1.3 5.9 4.7 7.0 2.8 6.5 9.9 4.2 4.0 8.0 5.8 4.6 9.8 6.3 6.4 4.6 2.7 5.3 2.2 5.3 5.5 0.0 4.9 0.1 0.0 8.5 5.7 5.2 10.5 7.1 5.3 6.5 6.0 7.4 8.3 7.0 9.0 7.6 9.9 5.4 7.7 9.4 3.5 7.7 5.4 3.4 3.8 4.6 4.2 3.5 5.1 4.0 4.2 3.9 3.5 4.0 4.2 2.0 3.2 2.6 2.0 0.9 0.5 0.6 0.8 0.6 2.4 1.6 1.0 4.6 1.5 2.7 3.7 0.0 6.1 1.5 1.9 3.9 2.5 2.3 1.2 1.2 3.0 1.2 0.0 2.4 2.2 1.7 1.2 1.5 1.6 1.3 4.9 3.3 1.5 3.2 0.0 2.0 3.7 6.1 1.6 1.5 1.2 1.2 1.2 0.0 4.7 3.0 2.3 3.1 4.5 4.6 1.8 2.1 1.5 0.5 1.6 1.0 1.4 0.5 4.0 0.0 1.6 1.5 1.9 2.1 1.5 0.6 7.1 1.4 2.3 2.1 0.7 ZNF638 "MGC26130, NP220, ZFML, Zfp638" ENSG00000075292 "Zinc finger protein 638" Q14966 2 71276561-71435069 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 342.3;Oligodendrocytes: 619.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036784, HPA057395" Supported Enhanced Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA036784: AB_10672478, HPA057395: AB_2683426" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (7.57e-2)" "unprognostic (1.26e-3)" "unprognostic (2.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-2)" "unprognostic (5.68e-3)" "unprognostic (2.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (2.66e-3)" "unprognostic (3.28e-1)" "unprognostic (7.68e-2)" "unprognostic (1.93e-2)" "prognostic favorable (8.73e-5)" 21.1 22.1 35.7 21.6 48.9 28.2 24.6 77.6 52.3 23.0 37.7 22.0 15.6 29.2 18.4 19.8 22.1 19.1 41.0 35.7 41.3 24.2 30.9 21.2 25.0 41.9 36.8 37.3 21.9 27.9 24.9 23.2 41.9 22.2 19.5 48.6 21.0 19.5 51.5 16.8 19.0 22.9 34.8 23.1 21.8 29.7 38.9 30.9 29.8 33.7 22.6 21.3 17.1 82.5 36.2 51.0 77.0 36.1 44.4 48.3 59.2 40.4 46.6 33.6 30.0 49.2 34.6 59.2 36.6 37.1 52.3 29.9 72.1 41.4 48.7 60.5 40.1 77.8 54.8 45.4 38.3 72.0 50.6 30.8 39.5 36.1 66.7 47.8 52.5 39.2 79.4 33.8 49.6 36.1 50.9 52.9 66.7 54.1 32.4 43.0 116.5 41.7 36.0 54.3 59.0 38.7 49.8 34.7 52.8 76.3 32.3 43.7 54.3 41.4 60.0 31.1 41.2 27.6 45.7 57.4 34.8 46.3 45.8 64.1 17.0 33.5 18.1 16.3 17.2 25.4 17.1 17.2 14.0 26.0 22.5 16.7 29.1 21.5 24.1 17.7 16.0 10.8 35.7 48.9 77.6 52.3 35.7 41.3 41.9 36.8 41.9 34.8 38.9 82.5 63.1 67.3 112.4 227.9 63.9 31.7 56.8 40.8 46.1 111.5 36.8 35.4 107.0 27.1 59.0 40.5 123.0 42.5 46.7 39.2 19.6 43.0 15.7 54.2 63.7 65.9 38.4 57.2 286.9 40.9 29.0 83.5 50.0 59.2 79.1 112.8 38.6 48.6 32.5 67.3 268.4 34.2 32.6 41.9 33.3 15.8 75.2 49.6 23.2 225.8 71.6 56.4 56.7 342.3 619.5 39.6 35.7 63.9 50.5 60.0 38.1 21.6 74.7 104.0 32.9 98.3 73.1 110.1 78.3 37.4 30.3 50.2 56.1 74.0 36.8 58.9 ZNF768 FLJ23436 ENSG00000169957 "Zinc finger protein 768" Q9H5H4 16 30524004-30526821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024630, HPA066512" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA024630: AB_1859446, HPA066512: AB_2685683" "unprognostic (2.33e-1)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" "unprognostic (1.73e-1)" "unprognostic (7.94e-3)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "unprognostic (2.74e-1)" "prognostic favorable (9.30e-6)" "unprognostic (4.49e-2)" "unprognostic (1.94e-1)" "unprognostic (3.13e-1)" "prognostic favorable (6.46e-4)" 22.3 23.2 31.4 9.9 32.9 13.3 22.6 30.6 35.0 28.7 28.3 42.6 29.8 30.8 9.9 22.8 27.5 10.1 49.3 27.8 27.7 34.8 38.5 19.0 7.3 32.3 31.9 28.9 25.7 30.2 27.2 11.3 30.3 30.3 17.0 13.7 25.6 21.1 93.8 28.2 31.1 13.4 28.5 22.1 30.9 39.3 33.0 6.0 23.7 53.1 7.4 34.9 23.0 29.9 27.1 33.3 37.0 36.1 17.6 20.3 29.1 20.2 22.5 32.7 28.4 21.3 36.8 17.1 30.1 14.2 26.3 35.4 24.8 24.1 19.4 38.5 52.6 40.0 24.0 30.0 44.1 26.8 121.3 17.9 52.5 25.1 32.4 30.2 21.9 6.7 47.4 28.0 17.1 74.9 10.0 64.7 34.8 22.0 27.1 50.7 24.7 42.5 23.9 14.0 43.6 48.4 11.5 59.9 77.3 15.9 59.3 66.5 14.9 34.2 25.9 19.4 22.8 41.3 32.4 21.1 28.5 41.4 35.2 0.0 0.4 1.0 0.0 0.6 0.1 1.1 0.1 0.0 0.6 0.4 0.1 0.0 0.5 0.6 0.1 0.5 0.0 0.2 31.4 32.9 30.6 35.0 27.8 27.7 32.3 31.9 30.3 28.5 33.0 29.9 9.7 9.6 1.9 8.8 4.1 5.5 6.7 9.5 6.8 13.3 15.4 12.6 7.6 14.3 5.5 16.5 2.1 7.2 2.0 50.4 11.7 12.2 18.4 10.9 9.9 9.2 18.0 3.8 2.6 16.2 8.0 6.5 10.7 13.3 3.8 15.5 14.6 17.9 12.7 21.9 3.4 29.1 8.2 8.1 7.7 7.4 10.8 6.1 5.4 4.7 6.8 16.5 0.0 4.0 4.5 11.6 38.2 13.2 2.2 7.9 38.9 17.0 7.4 12.7 6.6 11.8 10.5 15.2 5.1 10.0 5.7 3.6 2.1 14.1 31.3 5.3 ZNF891 ENSG00000214029 "Zinc finger protein 891" A8MT65 12 133104779-133130274 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 31.4;Early spermatids: 70.4;Horizontal cells: 40.4;Rod photoreceptor cells: 32.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040301 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA040301: AB_10795380" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" "unprognostic (3.29e-1)" "unprognostic (3.72e-1)" "unprognostic (7.51e-3)" "unprognostic (5.98e-3)" "unprognostic (1.94e-2)" "unprognostic (7.90e-2)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.60e-2)" "unprognostic (6.09e-2)" "unprognostic (5.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (2.07e-3)" "unprognostic (6.68e-2)" 0.9 1.7 1.4 1.0 1.6 1.3 2.0 3.8 1.7 1.3 1.1 0.9 0.8 2.1 1.4 1.2 1.3 0.9 0.8 1.6 1.1 1.2 0.8 0.9 1.3 1.4 1.3 2.3 0.9 1.3 1.4 1.0 1.2 1.1 1.1 4.7 1.1 1.1 1.0 1.7 0.9 1.5 1.0 1.2 1.0 4.2 1.4 1.3 1.8 1.4 1.3 0.8 0.9 2.8 1.1 1.4 4.1 0.1 1.4 1.9 3.5 0.8 1.2 2.2 1.7 0.9 0.6 0.1 1.1 1.2 2.6 1.6 3.0 1.8 1.6 0.0 2.3 3.7 3.7 1.2 1.4 2.3 1.9 1.4 0.9 2.0 2.0 2.0 1.4 3.0 2.4 0.3 2.2 0.8 3.4 2.6 3.5 2.2 2.0 3.4 3.8 2.4 1.0 2.2 3.5 1.5 3.0 0.6 1.0 3.0 2.9 1.3 0.8 2.0 2.4 1.5 1.5 0.2 0.1 3.4 0.5 0.9 1.5 0.5 0.3 0.6 0.9 0.3 0.7 1.1 0.7 0.9 0.3 1.3 1.3 1.3 0.4 1.0 0.3 0.6 0.9 0.4 1.4 1.6 3.8 1.7 1.6 1.1 1.4 1.3 1.2 1.0 1.4 2.8 6.4 3.2 5.3 2.0 14.3 1.8 5.9 2.3 2.8 31.4 3.2 3.9 5.7 5.7 6.7 11.0 29.2 3.4 5.2 1.1 0.0 3.9 70.4 6.6 11.9 5.9 6.7 4.0 2.8 1.9 2.3 6.2 3.6 5.6 1.3 16.7 6.8 2.0 2.0 40.4 3.4 2.4 0.0 2.8 0.8 10.0 5.3 4.3 1.8 1.9 2.7 10.6 10.3 3.5 3.6 1.8 2.1 6.0 2.7 3.7 2.4 2.2 9.5 32.4 19.7 11.2 8.4 14.2 14.1 3.0 1.7 2.3 6.5 8.9 3.2 2.4 ZNHIT6 "BCD1, C1orf181, FLJ20729, NY-BR-75" ENSG00000117174 "Zinc finger HIT-type containing 6" Q9NWK9 1 85649417-85708433 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018132 Uncertain Approved "Nuclear speckles,Vesicles" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles, Vesicles" "HPA018132: AB_1848789" "unprognostic (1.37e-1)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.27e-3)" "unprognostic (1.61e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.08e-6)" "unprognostic (1.11e-1)" "unprognostic (3.89e-2)" "unprognostic (8.48e-2)" "unprognostic (9.91e-3)" "unprognostic (2.92e-2)" "unprognostic (1.27e-3)" "unprognostic (5.91e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (7.37e-2)" 10.3 6.6 7.2 5.2 8.2 5.2 10.1 6.8 7.7 14.6 5.3 9.7 2.9 11.0 4.4 11.8 9.6 3.6 7.7 6.8 7.9 9.0 6.7 6.9 6.4 7.7 7.4 10.4 7.2 4.2 7.5 4.7 7.6 8.9 4.2 3.3 9.5 4.4 7.8 11.1 7.9 5.5 8.1 8.1 6.9 6.1 7.6 5.5 8.5 3.9 6.0 11.6 11.3 9.1 13.5 9.1 8.9 8.1 19.2 17.4 11.3 17.0 16.3 11.5 11.0 9.2 6.8 10.4 19.7 10.4 24.7 11.2 15.9 10.9 18.6 14.3 13.7 21.6 10.3 10.7 16.2 35.4 8.3 17.2 10.0 15.3 13.4 11.4 13.7 16.4 20.2 13.3 17.6 5.1 20.9 9.2 13.5 11.0 16.5 16.6 19.7 12.0 18.7 25.2 8.6 5.6 13.3 20.3 19.3 9.3 9.0 8.9 15.6 14.8 10.0 12.5 24.7 8.5 9.3 28.2 3.4 22.0 13.1 0.6 0.7 0.1 1.8 0.7 2.0 1.9 1.6 2.0 1.2 2.4 2.0 2.0 0.1 1.8 0.7 2.1 1.8 0.8 7.2 8.2 6.8 7.7 6.8 7.9 7.7 7.4 7.6 8.1 7.6 9.1 22.0 16.0 22.5 22.5 20.3 16.2 14.4 12.5 13.1 31.8 10.6 9.9 17.6 11.5 38.0 31.3 33.3 9.0 21.0 25.6 3.9 11.9 4.2 15.5 47.4 20.9 9.5 8.4 40.4 8.8 13.7 22.2 6.1 16.1 27.8 22.4 14.3 10.6 7.5 15.2 30.0 20.9 16.2 13.5 7.4 3.8 13.4 9.1 7.2 22.5 11.0 17.6 27.8 34.2 45.3 12.2 11.6 12.8 11.1 11.1 15.5 6.3 18.0 38.8 19.7 22.4 20.7 35.8 21.6 14.0 16.3 2.7 20.1 25.8 20.5 10.8